Citrus Sinensis ID: 047196
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 827 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.899 | 0.736 | 0.338 | 1e-114 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.917 | 0.736 | 0.332 | 1e-108 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.938 | 0.757 | 0.322 | 6e-98 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.873 | 0.736 | 0.338 | 1e-95 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.874 | 0.577 | 0.314 | 3e-93 | |
| C0LGW6 | 966 | LRR receptor-like serine/ | no | no | 0.898 | 0.769 | 0.306 | 2e-89 | |
| Q42371 | 976 | LRR receptor-like serine/ | no | no | 0.896 | 0.759 | 0.314 | 4e-89 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.868 | 0.574 | 0.318 | 1e-87 | |
| Q6XAT2 | 967 | LRR receptor-like serine/ | no | no | 0.921 | 0.788 | 0.309 | 2e-84 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.950 | 0.699 | 0.282 | 4e-84 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 412 bits (1058), Expect = e-114, Method: Compositional matrix adjust.
Identities = 302/893 (33%), Positives = 437/893 (48%), Gaps = 149/893 (16%)
Query: 55 TDQQALLALKAHISYDPTNLLAQNSTSNTSVCNWIGITCNVNSHRVTALNISSLNLQGTI 114
TD+QALL K+ +S D +L+ + S +CNW G+TC + RVT L + L L G I
Sbjct: 24 TDRQALLQFKSQVSEDKRVVLSSWNHS-FPLCNWKGVTCGRKNKRVTHLELGRLQLGGVI 82
Query: 115 PPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLD 174
P +GNLS L +L+L N G IP + + +L++LD N L G + +N S +L+
Sbjct: 83 SPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRLLN 142
Query: 175 IRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGA 234
+RLDS++L G +P L L LNL + G
Sbjct: 143 LRLDSNRLGG-------------------------SVPSELGSLTNLVQLNLYGNNMRGK 177
Query: 235 IPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVK 294
+P + NLT+L +++L +N L GEIP ++ L + +L L NN GV P A++N+S++K
Sbjct: 178 LPTSLGNLTLLEQLALSHNNLEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLK 237
Query: 295 KIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSG 354
+ + N G + + LPN+ N+G N F+G+IP+ ++N S L L M N+ +G
Sbjct: 238 LLGIGYNHFSGRLRPDLGILLPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTG 297
Query: 355 IIP--------------------------------------NTIGLTGNPLDGVLPTSIG 376
IP T+G+ N L G LP SI
Sbjct: 298 SIPTFGNVPNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIA 357
Query: 377 NLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLP 436
NLS L + + I GSIP I NL NL L L+ N L+G +P + G+L L+ L L
Sbjct: 358 NLSAKLVTLDLGGTLISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLF 417
Query: 437 FNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTF 496
N+L+G IP + ++ L TL L+ N F G +P+ LGN + L +G N+L +P
Sbjct: 418 SNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEI 477
Query: 497 WNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIG----------- 545
++ +L D+S NSL G L DIG L+ + ++L N SG +P T+G
Sbjct: 478 MKIQQLLRLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLE 537
Query: 546 ---------DLKDL---QNISLACNGLEGLIPE---SFGYLTELNLSFNKLEGEIPRGGP 590
DLK L + + L+ N L G IPE SF L LNLSFN LEG++P G
Sbjct: 538 GNLFYGDIPDLKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGI 597
Query: 591 FANFTAKSFMGNEKLC-GLPNLQFPKC--------KRRTRRKSKKKM-----LLLVIVLP 636
F N T S +GN LC G+ Q C K+ + R K + + L+++L
Sbjct: 598 FENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLF 657
Query: 637 LSTALIIAVPLALKYKSIRGGKSKTL----RRFSYQDLFRATEKFSKENLIGVGSFGSVY 692
+++ +I + K K TL + SY DL AT FS N++G GSFG+VY
Sbjct: 658 MASVTLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVY 717
Query: 693 KG-RLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKA---- 747
K L + VA+KV + A+KSF AECE +K+IRHRN VK +++CS+ DF+
Sbjct: 718 KALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFR 777
Query: 748 --------------------LDCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIH 787
++ +H + +L + ++LNI IDVAS L+YLH P+ H
Sbjct: 778 ALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAH 837
Query: 788 CDLKPKNVF----------DFGIGRLLT--GDRSMIQTETLV----TIGYMAP 824
CDLKP NV DFG+ RLL + S + TIGY AP
Sbjct: 838 CDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAP 890
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 394 bits (1013), Expect = e-108, Method: Compositional matrix adjust.
Identities = 304/914 (33%), Positives = 430/914 (47%), Gaps = 155/914 (16%)
Query: 39 LLLYLVVAVAAASNITTDQQALLALKAHISYDPTNLLAQNSTSNTSVCNWIGITCNVNSH 98
LLL + + A + TD QALL K+ +S + + + ++ CNWIG+TC
Sbjct: 14 LLLQVCIFAQARFSNETDMQALLEFKSQVSENNKREVLASWNHSSPFCNWIGVTCGRRRE 73
Query: 99 RVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQL 158
RV +LN+ L G I P +GNLS L LNL+ N IP + + +L++L+ S N L
Sbjct: 74 RVISLNLGGFKLTGVISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLL 133
Query: 159 SGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKC 218
G + S N S + + L S+ L HG +P L
Sbjct: 134 EGRIPSSLSNCSRLSTVDLSSNHLG------------------------HG-VPSELGSL 168
Query: 219 KRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNN 278
+L +L+L L+G P + NLT L+K+ N++RGEIP E+ L + + N+
Sbjct: 169 SKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMRGEIPDEVARLTQMVFFQIALNS 228
Query: 279 LVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITN 338
G P A++N+S+++ + L DNS G+ LPN+ RL LG N+F+G IP + N
Sbjct: 229 FSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTLAN 288
Query: 339 ASKLVYLDMGTNSFSGIIPNTIG------------------------------------- 361
S L D+ +N SG IP + G
Sbjct: 289 ISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLEY 348
Query: 362 --LTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGS 419
+ N L G LP SI NLS +L ++++ I G+IP I NL +L L LE N L+G
Sbjct: 349 LDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGE 408
Query: 420 IPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLR 479
+PV+FG+L LQ + L N ++G IP ++ RL L L N F G IP LG L
Sbjct: 409 LPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLL 468
Query: 480 SPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGD 539
+ +NRL +P + + + DLS+N L G ++G L +++G+ S N SG
Sbjct: 469 DLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGK 528
Query: 540 IPSTIGD-----------------------LKDLQNISLACNGLEGLIPE---SFGYLTE 573
+P IG L L+N+ + N L G IP S L
Sbjct: 529 MPQAIGGCLSMEFLFMQGNSFDGAIPDISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRN 588
Query: 574 LNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLC-GLPNLQFPKC-----KRRTRRKSKKK 627
LNLS NK EG +P G F N TA S GN +C G+ +Q C R+ + S +K
Sbjct: 589 LNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRK 648
Query: 628 MLLLVIVLPLSTALIIAVPLALKYKSIRGGK----------SKTLRRF----SYQDLFRA 673
++ I + +++ L+I + +L + R K S TL F SY++L A
Sbjct: 649 KVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSA 708
Query: 674 TEKFSKENLIGVGSFGSVYKGRLHDGIE---VAIKVFHQNCAMALKSFEAECEVMKNIRH 730
T +FS NLIG G+FG+V+KG L G E VA+KV + A KSF AECE K IRH
Sbjct: 709 TSRFSSTNLIGSGNFGNVFKGLL--GPENKLVAVKVLNLLKHGATKSFMAECETFKGIRH 766
Query: 731 RNHVKRISSCSN-----EDFKA-------------------LDCLHSTNCSLNIFDKLNI 766
RN VK I+ CS+ DF+A L+ ++ + SL +KLNI
Sbjct: 767 RNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNI 826
Query: 767 MIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG-DRSMIQTE- 814
IDVASALEYLH PV HCD+KP N+ DFG+ +LL DR +
Sbjct: 827 AIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQF 886
Query: 815 ----TLVTIGYMAP 824
TIGY AP
Sbjct: 887 SSAGVRGTIGYAAP 900
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 359 bits (921), Expect = 6e-98, Method: Compositional matrix adjust.
Identities = 300/931 (32%), Positives = 433/931 (46%), Gaps = 155/931 (16%)
Query: 19 ITKLITTSNLLSFHVPLTHCLLLYLVVAVAAASNITTDQQALLALKAHISYDPTNLLAQN 78
+ +LI S LL V L H +V A TD+QALL K+ +S + + ++ +
Sbjct: 7 VMRLILVSALL-VSVSLEHS---DMVCAQTIRLTEETDKQALLEFKSQVS-ETSRVVLGS 61
Query: 79 STSNTSVCNWIGITCNVNSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDI 138
+ +C+W G+ C + RVT +++ L L G + P +GNLS L +LNL+ N G I
Sbjct: 62 WNDSLPLCSWTGVKCGLKHRRVTGVDLGGLKLTGVVSPFVGNLSFLRSLNLADNFFHGAI 121
Query: 139 PPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLK 198
P + + +L++L+ S N L G G +PV + N
Sbjct: 122 PSEVGNLFRLQYLNMS-NNLFG-----------------------GVIPVVLSNCSSLST 157
Query: 199 VLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGE 258
+ + ++ G +PL +L LL+LG L+G P + NLT L+ + N++ GE
Sbjct: 158 LDLSSNHLEQG-VPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEGE 216
Query: 259 IPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNV 318
IP +I L + + N GV P I+N+S++ + + NS G+ LPN+
Sbjct: 217 IPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPNL 276
Query: 319 ERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIG----------------- 361
+ L +G+N F+GTIP ++N S L LD+ +N +G IP + G
Sbjct: 277 QILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGN 336
Query: 362 -----------LTG-----------NPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQL 399
LT N L G LP I NLS L + + I GSIP
Sbjct: 337 YSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPHG 396
Query: 400 ISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGL 459
I NL +L LDL N LTG +P + G L +L+ + L N L+G IP L +++ L L L
Sbjct: 397 IGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYL 456
Query: 460 AGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLD 519
N F GSIPS LG+ + L +LG+N+L +P L ++ ++S N L GPL D
Sbjct: 457 LNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQD 516
Query: 520 IGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFGY--LTELNLS 577
IG L+ ++ +++S N SG IP T+ + L+ + L N G IP+ G L L+LS
Sbjct: 517 IGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRGLTGLRFLDLS 576
Query: 578 FNKLEGEIPR------------------------GGPFANFTAKSFMGNEKLC-GLPNLQ 612
N L G IP G F N +A S GN LC G+P+LQ
Sbjct: 577 KNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQ 636
Query: 613 FPKCKRR-TRRKSKKKMLLLVIV-------LPLSTALIIAVPLALKYKSIRGGKSKTLRR 664
C RR S + ++ + V L L ++ L+ KS+R ++ R
Sbjct: 637 LQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRS 696
Query: 665 F----------SYQDLFRATEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAM 713
F SY +L++ T FS NLIG G+FG+V+KG L VAIKV +
Sbjct: 697 FSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRG 756
Query: 714 ALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALD----------------CLHSTNC- 756
A KSF AECE + IRHRN VK ++ CS+ DF+ D LH
Sbjct: 757 AAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIE 816
Query: 757 -------SLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFG 799
+L +F +LNI IDVASAL YLH P+ HCD+KP N+ DFG
Sbjct: 817 ETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFG 876
Query: 800 IGRLLTG-DRSMIQTE-----TLVTIGYMAP 824
+ +LL DR + TIGY AP
Sbjct: 877 LAQLLLKFDRDTFHIQFSSAGVRGTIGYAAP 907
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 351 bits (901), Expect = 1e-95, Method: Compositional matrix adjust.
Identities = 274/810 (33%), Positives = 412/810 (50%), Gaps = 88/810 (10%)
Query: 85 VCNWIGITCNVNSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFT 144
VCNW G+ CN S +V L+IS +L G I P + NL+ LT L+LS N G IPP I +
Sbjct: 53 VCNWSGVKCNKESTQVIELDISGRDLGGEISPSIANLTGLTVLDLSRNFFVGKIPPEIGS 112
Query: 145 MHK-LKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNI-CN-YLHYLKVLF 201
+H+ LK L S+N L G++ L+ ++ + L S++L+G +PV + CN L+ +
Sbjct: 113 LHETLKQLSLSENLLHGNIPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYID 172
Query: 202 LAKNMFHGQIPLALS-KCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIP 260
L+ N G+IPL K L+ L L KL+G +P +SN T L+ + L +N L GE+P
Sbjct: 173 LSNNSLTGEIPLNYHCHLKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESNMLSGELP 232
Query: 261 HE-IGYLPNLENLVLGFNNLVG------VVP--AAIFNMSTVKKIYLLDNSLLGSFSLGI 311
+ I +P L+ L L +N+ V + P A++ N S ++++ L NSL G + +
Sbjct: 233 SQVISKMPQLQFLYLSYNHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGGEITSSV 292
Query: 312 DLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVL 371
N+ +++L NR G+IP I+N L L++ +N SG IP
Sbjct: 293 RHLSVNLVQIHLDQNRIHGSIPPEISNLLNLTLLNLSSNLLSGPIPR------------- 339
Query: 372 PTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQ 431
+ LS LE +Y+SN ++ G IP + ++ L LLD+ N L+GSIP +FG L +L+
Sbjct: 340 --ELCKLS-KLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLR 396
Query: 432 GLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIP-SCLGNLTSLR-SPDLGSNRLT 489
L L N L+G++P L L L L+ N +G+IP + NL +L+ +L SN L+
Sbjct: 397 RLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLS 456
Query: 490 SVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKD 549
+P + +L DLSSN L G + +G+ + +NLSRN FS +PS++G L
Sbjct: 457 GPIPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPY 516
Query: 550 LQNISLACNGLEGLIPESF---GYLTELNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLC 606
L+ + ++ N L G IP SF L LN SFN L G + G F+ T +SF+G+ LC
Sbjct: 517 LKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLC 576
Query: 607 G-LPNLQFPKCKRRTRRKSKKKM---------LLLVIVLPL------STALIIAVPLALK 650
G + +Q CK++ + S +L V PL L + ++
Sbjct: 577 GSIKGMQ--ACKKKHKYPSVLLPVLLSLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVE 634
Query: 651 YKSIRGGKSKTLRRFSYQDLFRATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQN 710
+ + R SYQ L AT F+ +LIG G FG VYKG L + +VA+KV
Sbjct: 635 DEEKQNQNDPKYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPK 694
Query: 711 CAMALK-SFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHSTNCS------------ 757
A+ SF+ EC+++K RHRN ++ I++CS F AL N S
Sbjct: 695 TALEFSGSFKRECQILKRTRHRNLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSS 754
Query: 758 --LNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLT 805
L++ +NI DVA + YLH V+HCDLKP N+ DFGI RL+
Sbjct: 755 KNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQ 814
Query: 806 GDRSMIQTETLV-----------TIGYMAP 824
G + T+ V ++GY+AP
Sbjct: 815 GVEETVSTDDSVSFGSTDGLLCGSVGYIAP 844
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 343 bits (880), Expect = 3e-93, Method: Compositional matrix adjust.
Identities = 251/799 (31%), Positives = 412/799 (51%), Gaps = 76/799 (9%)
Query: 96 NSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSD 155
N+ + L +S L G IP ++ N SL L+LS+N L+G IP S+F + +L L ++
Sbjct: 335 NNTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNN 394
Query: 156 NQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLAL 215
N L G+LSS NL+++ + L + L G++P I +L L++++L +N F G++P+ +
Sbjct: 395 NSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEI-GFLGKLEIMYLYENRFSGEMPVEI 453
Query: 216 SKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLG 275
C RLQ ++ +LSG IP I L L ++ LR N+L G IP +G + + L
Sbjct: 454 GNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLA 513
Query: 276 FNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSF 335
N L G +P++ ++ ++ + +NSL G+ + ++L N+ R+N N+F+G+I
Sbjct: 514 DNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSL-INLKNLTRINFSSNKFNGSISPL 572
Query: 336 ITNASKLVYLDMGTNSFSGIIPNTIG---------LTGNPLDGVLPTSIGNLSMSLENIY 386
++S L + D+ N F G IP +G L N G +P + G +S L +
Sbjct: 573 CGSSSYLSF-DVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKIS-ELSLLD 630
Query: 387 ISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPD 446
IS ++ G IP + L +DL N L+G IP G+L L L L NK GS+P
Sbjct: 631 ISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPT 690
Query: 447 QLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFD 506
++ L + TL L GN +GSIP +GNL +L + +L N+L+ LPST L +
Sbjct: 691 EIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELR 750
Query: 507 LSSNSLDGPLSLDIGNLR-VVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIP 565
LS N+L G + ++IG L+ + ++LS NNF+G IPSTI L L+++ L+ N L G +P
Sbjct: 751 LSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVP 810
Query: 566 ESFGYLTE---LNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPNLQFPKCKRRTRR 622
G + LNLS+N LEG++ + F+ + A +F+GN LCG P + + +R
Sbjct: 811 GQIGDMKSLGYLNLSYNNLEGKLKK--QFSRWQADAFVGNAGLCGSPLSHCNRAGSKNQR 868
Query: 623 KSKKKMLLLVIVLPLSTA---LIIAVPLALK-----YKSIRGGKSKTL------------ 662
K ++++ + A +++ + L K +K +RGG S
Sbjct: 869 SLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFS 928
Query: 663 -----RRFSYQDLFRATEKFSKENLIGVGSFGSVYKGRLHDGIEVAI-KVFHQNCAMALK 716
+ D+ AT ++E +IG G G VYK L +G +A+ K+ ++ M+ K
Sbjct: 929 NGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNK 988
Query: 717 SFEAECEVMKNIRHRNHVKRISSCSNE---------DFKA----LDCLHSTNCS-----L 758
SF E + + IRHR+ VK + CS++ ++ A D LH+ + L
Sbjct: 989 SFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVL 1048
Query: 759 NIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808
+L I + +A +EYLH+ P++H D+K NV DFG+ ++LTG+
Sbjct: 1049 GWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNY 1108
Query: 809 SM-IQTETLV--TIGYMAP 824
++ T+ + GY+AP
Sbjct: 1109 DTNTESNTMFAGSYGYIAP 1127
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGW6|ERL1_ARATH LRR receptor-like serine/threonine-protein kinase ERL1 OS=Arabidopsis thaliana GN=ERL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 331 bits (848), Expect = 2e-89, Method: Compositional matrix adjust.
Identities = 262/856 (30%), Positives = 399/856 (46%), Gaps = 113/856 (13%)
Query: 35 LTHCLLLYLVVAVAAASNITTDQQALLALKAHISYDPTNLLAQNSTSNTSVCNWIGITCN 94
L+ ++ ++V VA+A N + +AL+A+K S LL + N+ +C+W G+ C+
Sbjct: 10 LSLAMVGFMVFGVASAMN--NEGKALMAIKGSFSNLVNMLLDWDDVHNSDLCSWRGVFCD 67
Query: 95 VNSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFS 154
S+ V +LN+SSLNL G I P +G+L +L +++L NKL+G IP I L +LD S
Sbjct: 68 NVSYSVVSLNLSSLNLGGEISPAIGDLRNLQSIDLQGNKLAGQIPDEIGNCASLVYLDLS 127
Query: 155 DNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLA 214
+N L G + L + + L +++L+G +P + + LK L LA N G+I
Sbjct: 128 ENLLYGDIPFSISKLKQLETLNLKNNQLTGPVPATLTQ-IPNLKRLDLAGNHLTGEISRL 186
Query: 215 LSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVL 274
L + LQ L L L+G + ++ LT L +R N L G IP IG + + L +
Sbjct: 187 LYWNEVLQYLGLRGNMLTGTLSSDMCQLTGLWYFDVRGNNLTGTIPESIGNCTSFQILDI 246
Query: 275 GFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPS 334
+N + G +P +N+ ++ V L+L NR +G IP
Sbjct: 247 SYNQITGEIP---YNIGFLQ-----------------------VATLSLQGNRLTGRIPE 280
Query: 335 FITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGG 394
I L LD+ N G IP P+ +GNLS + +Y+ + G
Sbjct: 281 VIGLMQALAVLDLSDNELVGPIP--------PI-------LGNLSFT-GKLYLHGNMLTG 324
Query: 395 SIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARL 454
IP + N+S L L L NKL G+IP G+L++L L L N+L G IP + A L
Sbjct: 325 PIPSELGNMSRLSYLQLNDNKLVGTIPPELGKLEQLFELNLANNRLVGPIPSNISSCAAL 384
Query: 455 NTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDG 514
N + GN SGSIP NL SL +L SN +P ++ ++ DLS N+ G
Sbjct: 385 NQFNVHGNLLSGSIPLAFRNLGSLTYLNLSSNNFKGKIPVELGHIINLDKLDLSGNNFSG 444
Query: 515 PLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFGY---- 570
+ L +G+L ++ +NLSRN+ SG +P+ G+L+ +Q I ++ N L G+IP G
Sbjct: 445 SIPLTLGDLEHLLILNLSRNHLSGQLPAEFGNLRSIQMIDVSFNLLSGVIPTELGQLQNL 504
Query: 571 -----------------------LTELNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCG 607
L LN+SFN L G +P F+ F SF+GN LCG
Sbjct: 505 NSLILNNNKLHGKIPDQLTNCFTLVNLNVSFNNLSGIVPPMKNFSRFAPASFVGNPYLCG 564
Query: 608 LPNLQFPKCKRRTRRKSKKKMLLLVIVLPLSTAL---IIAVPLALKYKSIRGGKSKTLRR 664
N C + + + L+ IVL + T L +AV +++ K I G SK
Sbjct: 565 --NWVGSICGPLPKSRVFSRGALICIVLGVITLLCMIFLAVYKSMQQKKILQGSSKQAEG 622
Query: 665 F-------------SYQDLFRATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNC 711
++ D+ R TE +++ +IG G+ +VYK L +AIK +
Sbjct: 623 LTKLVILHMDMAIHTFDDIMRVTENLNEKFIIGYGASSTVYKCALKSSRPIAIKRLYNQY 682
Query: 712 AMALKSFEAECEVMKNIRHRN----HVKRISSCSN-------EDFKALDCLHST--NCSL 758
L+ FE E E + +IRHRN H +S N E+ D LH + L
Sbjct: 683 PHNLREFETELETIGSIRHRNIVSLHGYALSPTGNLLFYDYMENGSLWDLLHGSLKKVKL 742
Query: 759 NIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808
+ +L I + A L YLH + +IH D+K N+ DFGI + + +
Sbjct: 743 DWETRLKIAVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDENFEAHLSDFGIAKSIPASK 802
Query: 809 SMIQTETLVTIGYMAP 824
+ T L TIGY+ P
Sbjct: 803 THASTYVLGTIGYIDP 818
|
Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ER and ERL2. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q42371|ERECT_ARATH LRR receptor-like serine/threonine-protein kinase ERECTA OS=Arabidopsis thaliana GN=ERECTA PE=1 SV=1 | Back alignment and function description |
|---|
Score = 330 bits (845), Expect = 4e-89, Method: Compositional matrix adjust.
Identities = 269/856 (31%), Positives = 406/856 (47%), Gaps = 115/856 (13%)
Query: 39 LLLYLVVAVAAASNITTDQQA-LLALKAHISYDPTNLLAQNSTSNTS-VCNWIGITCNVN 96
+LL + ++ + +T+++ A LL +K D N+L +TS +S C W G++C
Sbjct: 8 VLLGFLFCLSLVATVTSEEGATLLEIKKSFK-DVNNVLYDWTTSPSSDYCVWRGVSCENV 66
Query: 97 SHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDN 156
+ V ALN+S LNL G I P +G+L SL +++L N+LSG IP I L+ LD S N
Sbjct: 67 TFNVVALNLSDLNLDGEISPAIGDLKSLLSIDLRGNRLSGQIPDEIGDCSSLQNLDLSFN 126
Query: 157 QLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALS 216
+LSG + L + + L +++L G +P + + + LK+L LA+N G+IP +
Sbjct: 127 ELSGDIPFSISKLKQLEQLILKNNQLIGPIPSTL-SQIPNLKILDLAQNKLSGEIPRLIY 185
Query: 217 KCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGF 276
+ LQ L L L G I ++ LT L +RNN L G IP IG + L L +
Sbjct: 186 WNEVLQYLGLRGNNLVGNISPDLCQLTGLWYFDVRNNSLTGSIPETIGNCTAFQVLDLSY 245
Query: 277 NNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFI 336
N L G +P D+ V L+L N+ SG IPS I
Sbjct: 246 NQLTGEIP--------------------------FDIGFLQVATLSLQGNQLSGKIPSVI 279
Query: 337 TNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSI 396
L LD+ N SG IP P+ +GNL+ + E +Y+ + + GSI
Sbjct: 280 GLMQALAVLDLSGNLLSGSIP--------PI-------LGNLTFT-EKLYLHSNKLTGSI 323
Query: 397 PQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNT 456
P + N+S L L+L N LTG IP G+L L L + N L G IPD L LN+
Sbjct: 324 PPELGNMSKLHYLELNDNHLTGHIPPELGKLTDLFDLNVANNDLEGPIPDHLSSCTNLNS 383
Query: 457 LGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPL 516
L + GNKFSG+IP L S+ +L SN + +P + ++ DLS+N ++G +
Sbjct: 384 LNVHGNKFSGTIPRAFQKLESMTYLNLSSNNIKGPIPVELSRIGNLDTLDLSNNKINGII 443
Query: 517 SLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFGY------ 570
+G+L ++ +NLSRN+ +G +P G+L+ + I L+ N + G IPE
Sbjct: 444 PSSLGDLEHLLKMNLSRNHITGVVPGDFGNLRSIMEIDLSNNDISGPIPEELNQLQNIIL 503
Query: 571 --------------------LTELNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPN 610
LT LN+S N L G+IP+ F+ F+ SF+GN LCG
Sbjct: 504 LRLENNNLTGNVGSLANCLSLTVLNVSHNNLVGDIPKNNNFSRFSPDSFIGNPGLCG-SW 562
Query: 611 LQFP-KCKRRTRRKSKKKMLLLVIVLPLSTALIIAVPLALKYKS----IRGGKSKTLRRF 665
L P RRT R S + +L I + L++ + A + + + G K +
Sbjct: 563 LNSPCHDSRRTVRVSISRAAILGIAIGGLVILLMVLIAACRPHNPPPFLDGSLDKPVTYS 622
Query: 666 S--------------YQDLFRATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNC 711
+ Y+D+ R TE S++ +IG G+ +VYK L + VAIK + +
Sbjct: 623 TPKLVILHMNMALHVYEDIMRMTENLSEKYIIGHGASSTVYKCVLKNCKPVAIKRLYSHN 682
Query: 712 AMALKSFEAECEVMKNIRHRNHVK-RISSCSN----------EDFKALDCLH--STNCSL 758
++K FE E E++ +I+HRN V + S S+ E+ D LH + +L
Sbjct: 683 PQSMKQFETELEMLSSIKHRNLVSLQAYSLSHLGSLLFYDYLENGSLWDLLHGPTKKKTL 742
Query: 759 NIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808
+ +L I A L YLH S +IH D+K N+ DFGI + L +
Sbjct: 743 DWDTRLKIAYGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDLEARLTDFGIAKSLCVSK 802
Query: 809 SMIQTETLVTIGYMAP 824
S T + TIGY+ P
Sbjct: 803 SHTSTYVMGTIGYIDP 818
|
Receptor kinase that, together with ERL1 and ERL2, regulates aerial architecture, including inflorescence (e.g. shoot apical meristem-originating organ shape, elongation of the internode and pedicels, and adaxial-abaxial polarity), and stomatal patterning (e.g. density and clustering), probably by tuning cell division and expansion. Modulates plant transpiration efficiency by controlling stomatal density, leaf photosynthetic capacity, epidermal cell expansion, mesophyll cell proliferation and cell-cell contact. Probable major trait regulating canalization (maintenance of phenotype despite varying environment) in many aspect of the plant physiology (e.g. plant morphology, light-dependent leaves number, branch number, flowering time, phytate and mineral concentrations) by transducing microenvironmental variation into phenotypic differentiation (ecological amplifier). May maintain development integrity in heat stress conditions. Regulates cell wall composition and structure. Confers resistance to the pathogenic bacteria Ralstonia solanacearum and to the necrotrophic fungi Plectosphaerella cucumerina and Pythium irregulare, and required for callose deposition upon infection. Resistance to P.cucumerina seems cell wall-mediated. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 325 bits (832), Expect = 1e-87, Method: Compositional matrix adjust.
Identities = 258/810 (31%), Positives = 401/810 (49%), Gaps = 92/810 (11%)
Query: 96 NSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSD 155
N+ + L +S L G IP +L SL L+LS+N L+G IP ++F + +L L +
Sbjct: 334 NNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHN 393
Query: 156 NQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLAL 215
N L G+LS NL+++ + L + L G+LP I + L L+VLFL +N F G+IP +
Sbjct: 394 NTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEI-SALRKLEVLFLYENRFSGEIPQEI 452
Query: 216 SKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLG 275
C L+++++ G IP I L L + LR N+L G +P +G L L L
Sbjct: 453 GNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLNILDLA 512
Query: 276 FNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSF 335
N L G +P++ + ++++ L +NSL G+ + +SL N+ R+NL NR +GTI
Sbjct: 513 DNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSL-ISLRNLTRINLSHNRLNGTIHPL 571
Query: 336 ITNASKLVYLDMGTNSFSGIIPNTIG---------LTGNPLDGVLPTSIGNLSMSLENIY 386
++S L + D+ N F IP +G L N L G +P ++G + L +
Sbjct: 572 CGSSSYLSF-DVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIR-ELSLLD 629
Query: 387 ISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPD 446
+S+ + G+IP + L +DL N L+G IP G+L +L L L N+ S+P
Sbjct: 630 MSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPT 689
Query: 447 QLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFD 506
+L + +L L L GN +GSIP +GNL +L +L N+ + LP L +
Sbjct: 690 ELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELR 749
Query: 507 LSSNSLDGPLSLDIGNLR-VVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIP 565
LS NSL G + ++IG L+ + ++LS NNF+GDIPSTIG L L+ + L+ N L G +P
Sbjct: 750 LSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVP 809
Query: 566 ESFGYLTE---LNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPNLQFPKCKR-RTR 621
S G + LN+SFN L G++ + F+ + A SF+GN LCG P +C R R+
Sbjct: 810 GSVGDMKSLGYLNVSFNNLGGKLKK--QFSRWPADSFLGNTGLCGSP---LSRCNRVRSN 864
Query: 622 RKSKKKMLLLVIVLPLSTAL------IIAVPLALKYKS---------------------- 653
K + V+++ +AL I+ + L K +
Sbjct: 865 NKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQA 924
Query: 654 -----IRGGKSKTLRRFSYQDLFRATEKFSKENLIGVGSFGSVYKGRLHDGIEVAI-KVF 707
R G SK+ R ++D+ AT S+E +IG G G VYK L +G VA+ K+
Sbjct: 925 THKPLFRNGASKSDIR--WEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKIL 982
Query: 708 HQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSN-------------EDFKALDCLHST 754
++ M+ KSF E + + IRHR+ VK + CS+ ++ D LH
Sbjct: 983 WKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHED 1042
Query: 755 NCSLN----IFD---KLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------D 797
L + D +L I + +A +EYLH P++H D+K NV D
Sbjct: 1043 KPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGD 1102
Query: 798 FGIGRLLTGD---RSMIQTETLVTIGYMAP 824
FG+ ++LT + + T + GY+AP
Sbjct: 1103 FGLAKVLTENCDTNTDSNTWFACSYGYIAP 1132
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6XAT2|ERL2_ARATH LRR receptor-like serine/threonine-protein kinase ERL2 OS=Arabidopsis thaliana GN=ERL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 314 bits (805), Expect = 2e-84, Method: Compositional matrix adjust.
Identities = 260/840 (30%), Positives = 389/840 (46%), Gaps = 78/840 (9%)
Query: 35 LTHCLLLYLVVAVAAASNITTDQQALLALKAHISYDPTNLLAQNSTSNTSVCNWIGITCN 94
L CL + + + + + S + + +AL+A+KA S LL + N C+W G+ C+
Sbjct: 10 LFFCLGMVVFMLLGSVSPMNNEGKALMAIKASFSNVANMLLDWDDVHNHDFCSWRGVFCD 69
Query: 95 VNSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFS 154
S V +LN+S+LNL G I LG+L +L +++L NKL G IP I L ++DFS
Sbjct: 70 NVSLNVVSLNLSNLNLGGEISSALGDLMNLQSIDLQGNKLGGQIPDEIGNCVSLAYVDFS 129
Query: 155 DNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLA 214
N L G + L + + L +++L+G +P + + LK L LA+N G+IP
Sbjct: 130 TNLLFGDIPFSISKLKQLEFLNLKNNQLTGPIPATLTQ-IPNLKTLDLARNQLTGEIPRL 188
Query: 215 LSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVL 274
L + LQ L L L+G + ++ LT L +R N L G IP IG + E L +
Sbjct: 189 LYWNEVLQYLGLRGNMLTGTLSPDMCQLTGLWYFDVRGNNLTGTIPESIGNCTSFEILDV 248
Query: 275 GFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPS 334
+N + GV+P I V + L N L G I L + + L+L N +G IP
Sbjct: 249 SYNQITGVIPYNI-GFLQVATLSLQGNKLTGRIPEVIGL-MQALAVLDLSDNELTGPIPP 306
Query: 335 FITNASKLVYLDMGTNSFSGIIPNTIG---------LTGNPLDGVLPTSIGNLSMSLENI 385
+ N S L + N +G IP +G L N L G +P +G L E +
Sbjct: 307 ILGNLSFTGKLYLHGNKLTGQIPPELGNMSRLSYLQLNDNELVGKIPPELGKLEQLFE-L 365
Query: 386 YISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIP 445
++N N+ G IP IS+ + L ++ GN L+G++P+ F L L L L N G IP
Sbjct: 366 NLANNNLVGLIPSNISSCAALNQFNVHGNFLSGAVPLEFRNLGSLTYLNLSSNSFKGKIP 425
Query: 446 DQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFF 505
+L H+ L+TL L+GN FSGSIP LG+L L +L N L LP+ F NL+ I
Sbjct: 426 AELGHIINLDTLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLNGTLPAEFGNLRSIQII 485
Query: 506 DLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIP 565
D+S N L G + ++G L+ + + L+ N G IP + + L N
Sbjct: 486 DVSFNFLAGVIPTELGQLQNINSLILNNNKIHGKIPDQLTNCFSLAN------------- 532
Query: 566 ESFGYLTELNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCG-----LPNLQFPKCKRRT 620
LN+SFN L G IP F F+ SF GN LCG + PK + T
Sbjct: 533 --------LNISFNNLSGIIPPMKNFTRFSPASFFGNPFLCGNWVGSICGPSLPKSQVFT 584
Query: 621 RRKSKKKMLLLVIVLPLSTALIIAVPLALKYKSIRGGKSKT-------------LRRFSY 667
R + +++ + L + IAV + + K + G SK + ++
Sbjct: 585 RVAV---ICMVLGFITLICMIFIAVYKSKQQKPVLKGSSKQPEGSTKLVILHMDMAIHTF 641
Query: 668 QDLFRATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKN 727
D+ R TE ++ +IG G+ +VYK +AIK + + FE E E + +
Sbjct: 642 DDIMRVTENLDEKYIIGYGASSTVYKCTSKTSRPIAIKRIYNQYPSNFREFETELETIGS 701
Query: 728 IRHRN----HVKRISSCSN-------EDFKALDCLH--STNCSLNIFDKLNIMIDVASAL 774
IRHRN H +S N E+ D LH L+ +L I + A L
Sbjct: 702 IRHRNIVSLHGYALSPFGNLLFYDYMENGSLWDLLHGPGKKVKLDWETRLKIAVGAAQGL 761
Query: 775 EYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
YLH + +IH D+K N+ DFGI + + ++ T L TIGY+ P
Sbjct: 762 AYLHHDCTPRIIHRDIKSSNILLDGNFEARLSDFGIAKSIPATKTYASTYVLGTIGYIDP 821
|
Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ERL1 and ER. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 313 bits (802), Expect = 4e-84, Method: Compositional matrix adjust.
Identities = 277/979 (28%), Positives = 421/979 (43%), Gaps = 193/979 (19%)
Query: 39 LLLYLVVAVAAASNITTDQQALLALKAHISYDPTNLLAQNSTSNTSVCNWIGITCNVNSH 98
+L L + V + ++ +D Q LL LK D N L + + + CNWIG+ C+
Sbjct: 19 VLFLLTLLVWTSESLNSDGQFLLELKNRGFQDSLNRLHNWNGIDETPCNWIGVNCSSQGS 78
Query: 99 R-------VTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFL 151
VT+L++SS+NL G + P +G L +L LNL++N L+GDIP I KL+ +
Sbjct: 79 SSSSNSLVVTSLDLSSMNLSGIVSPSIGGLVNLVYLNLAYNALTGDIPREIGNCSKLEVM 138
Query: 152 DFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNY------------------ 193
++NQ GS+ LS + + ++KLSG LP I +
Sbjct: 139 FLNNNQFGGSIPVEINKLSQLRSFNICNNKLSGPLPEEIGDLYNLEELVAYTNNLTGPLP 198
Query: 194 -----LHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKI 248
L+ L +N F G IP + KC L+LL L +SG +PKEI L L+++
Sbjct: 199 RSLGNLNKLTTFRAGQNDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQEV 258
Query: 249 SLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFS 308
L NK G IP +IG L +LE L L N+LVG +P+ I NM ++KK+YL N L G+
Sbjct: 259 ILWQNKFSGFIPKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIP 318
Query: 309 ---------LGIDLS--------------------------------------LPNVERL 321
+ ID S L N+ +L
Sbjct: 319 KELGKLSKVMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKL 378
Query: 322 NLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGL---------TGNPLDGVLP 372
+L +N +G IP N + + L + NS SG+IP +GL + N L G +P
Sbjct: 379 DLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGKIP 438
Query: 373 TSI-----------------GNLS------MSLENIYISNCNIGGSIPQLISNLSNLLLL 409
I GN+ SL + + + G P + L NL +
Sbjct: 439 PFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAI 498
Query: 410 DLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIP 469
+L+ N+ +G +P G QKLQ L+L N+ + ++P+++ L+ L T ++ N +G IP
Sbjct: 499 ELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIP 558
Query: 470 SCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNL------ 523
S + N L+ DL N LP +L + LS N G + IGNL
Sbjct: 559 SEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTEL 618
Query: 524 -------------------RVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLI 564
+ I +NLS N+FSG+IP IG+L L +SL N L G I
Sbjct: 619 QMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEI 678
Query: 565 PESFGYLTEL---NLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCG------------LP 609
P +F L+ L N S+N L G++P F N T SF+GN+ LCG P
Sbjct: 679 PTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGHLRSCDPSHSSWP 738
Query: 610 NLQFPKC--KRRTRRKSKKK-------MLLLVIVLPLSTALIIAVPLALKYKSIRGGKSK 660
++ K RR R +LL+ IV+ + + K +S
Sbjct: 739 HISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYVHDKEPFFQESD 798
Query: 661 TL----RRFSYQDLFRATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFH-------Q 709
RF+ +D+ AT+ F ++G G+ G+VYK + G +A+K
Sbjct: 799 IYFVPKERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNN 858
Query: 710 NCAMALKSFEAECEVMKNIRHRNHVKRISSCSNED-------FKAL------DCLHSTNC 756
N SF AE + IRHRN V+ S C ++ ++ + + LH
Sbjct: 859 NSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGGKS 918
Query: 757 -SLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLT 805
S++ + I + A L YLH +IH D+K N+ DFG+ +++
Sbjct: 919 HSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVID 978
Query: 806 GDRSMIQTETLVTIGYMAP 824
S + + GY+AP
Sbjct: 979 MPLSKSVSAVAGSYGYIAP 997
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 827 | ||||||
| 359483198 | 1087 | PREDICTED: probable LRR receptor-like se | 0.943 | 0.717 | 0.437 | 0.0 | |
| 224139658 | 1019 | predicted protein [Populus trichocarpa] | 0.902 | 0.732 | 0.417 | 1e-176 | |
| 255572272 | 1089 | serine-threonine protein kinase, plant-t | 0.944 | 0.717 | 0.407 | 1e-175 | |
| 255578886 | 1043 | serine-threonine protein kinase, plant-t | 0.948 | 0.751 | 0.432 | 1e-174 | |
| 359485453 | 1202 | PREDICTED: probable LRR receptor-like se | 0.871 | 0.599 | 0.440 | 1e-167 | |
| 449465016 | 1092 | PREDICTED: probable LRR receptor-like se | 0.943 | 0.714 | 0.385 | 1e-166 | |
| 224116832 | 1061 | predicted protein [Populus trichocarpa] | 0.877 | 0.684 | 0.429 | 1e-166 | |
| 298204751 | 1979 | unnamed protein product [Vitis vinifera] | 0.897 | 0.374 | 0.426 | 1e-165 | |
| 147853795 | 1420 | hypothetical protein VITISV_005816 [Viti | 0.877 | 0.511 | 0.424 | 1e-165 | |
| 147776333 | 1205 | hypothetical protein VITISV_000078 [Viti | 0.862 | 0.591 | 0.435 | 1e-163 |
| >gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 640 bits (1652), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 417/954 (43%), Positives = 529/954 (55%), Gaps = 174/954 (18%)
Query: 45 VAVAAASNITTDQQALLALKAHISYDPTNLLAQNSTSNTSVCNWIGITCNVNSHRVTALN 104
VA + + TDQ +LLALKAHI+ DP ++LA N ++ TS C WIG++CN RV AL+
Sbjct: 21 ACVAMSLSNFTDQSSLLALKAHITLDPHHVLAGNWSTKTSFCEWIGVSCNAQQQRVIALD 80
Query: 105 ISSLNLQGTIPPQLGNLS------------------------SLTTLNLSHNKLSGDIPP 140
+S+L L+GTIPP LGNLS SL ++NL +N LSG IPP
Sbjct: 81 LSNLGLRGTIPPDLGNLSFLVSLDLSSNNFHGPVPVEVGQLTSLLSMNLQYNLLSGQIPP 140
Query: 141 SIFTMHKL------------------------------------------------KFLD 152
S +++L K LD
Sbjct: 141 SFGNLNRLQSLFLGNNSFTGTIPPSIGNMSMLETLGLGGNHLQGNIPEEIGKLSTMKILD 200
Query: 153 FSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNY-LHYLKVLFLAKNMFHGQI 211
NQL G++ S FN+SS+ +I L + LSG+LP ++CN+ L L+ + L+ N F G I
Sbjct: 201 IQSNQLVGAIPSAIFNISSLQEIALTYNSLSGDLPSSMCNHELSALRGIRLSANRFTGPI 260
Query: 212 PLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLEN 271
P LSKC LQ L L F K +G IP+ I +LT L +SL N L GE+P EIG L L
Sbjct: 261 PSNLSKCGELQTLYLSFNKFTGGIPRSIDSLTKLTMLSLAANSLSGEVPCEIGSLCTLNV 320
Query: 272 LVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGT 331
L + N+L G +P IFN+S++ L N+L G+ LPN+E L L +N SG
Sbjct: 321 LNIEDNSLTGHIPFQIFNISSMVSGSLTRNNLSGNLPPNFGSYLPNLENLILEINWLSGI 380
Query: 332 IPSFITNASKLVYLDMGTNSFSGIIPNTIG------------------------------ 361
IPS I NASKL LD G N +G IP+ +G
Sbjct: 381 IPSSIGNASKLRSLDFGYNMLTGSIPHALGSLRFLERLNLGVNNLKGESYIQELSFLTSL 440
Query: 362 ----------LTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDL 411
L+ NPL G+LP SIGNLS SL+ + C + G+IP I NLSNL LL L
Sbjct: 441 TNCKRLRILYLSFNPLIGILPISIGNLSTSLQRFEANTCKLKGNIPTEIGNLSNLYLLSL 500
Query: 412 EGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSC 471
N LTG+IP + G+LQKLQGLYLP NKL GSIP+ +C L L L L N+ SGSIP+C
Sbjct: 501 NNNDLTGTIPPSIGQLQKLQGLYLPSNKLQGSIPNDICQLRNLGELFLTNNQLSGSIPAC 560
Query: 472 LGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINL 531
LG LT LR LGSN+L S +PST W+L IL D+SSN L G L D+GNL+V++ I+L
Sbjct: 561 LGELTFLRHLYLGSNKLNSTIPSTLWSLIHILSLDMSSNFLVGYLPSDMGNLKVLVKIDL 620
Query: 532 SRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFG---------------------- 569
SRN SG+IPS IG L+DL ++SLA N EG I SF
Sbjct: 621 SRNQLSGEIPSNIGGLQDLTSLSLAHNRFEGPILHSFSNLKSLEFMDLSDNALFGEIPKS 680
Query: 570 -----YLTELNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPNLQFPKCKRRTRRKS 624
YL L++SFN L GEIP GPFANF+A+SFM N+ LCG P L+ P C+ TR +
Sbjct: 681 LEGLVYLKYLDVSFNGLYGEIPPEGPFANFSAESFMMNKALCGSPRLKLPPCRTGTRWST 740
Query: 625 KKKMLLLVIVLP--LST----ALIIAVPLALKYKSIRGGKSKTL-----RRFSYQDLFRA 673
LLL +LP LST ALI K ++ +S++L RR SYQ++F+A
Sbjct: 741 TISWLLLKYILPAILSTLLFLALIFVWTRCRKRNAVLPTQSESLLTATWRRISYQEIFQA 800
Query: 674 TEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNH 733
T FS NL+G GS GSVY+G L DG AIKVF+ A KSF+AECEVM +IRHRN
Sbjct: 801 TNGFSAGNLLGRGSLGSVYRGTLSDGKNAAIKVFNLQEEAAFKSFDAECEVMHHIRHRNL 860
Query: 734 VKRISSCSNE--DFKAL-----------DCLHSTNCSLNIFDKLNIMIDVASALEYLHFS 780
+K +SSCSN DFKAL L+S N L+I +LNIMIDVA A+EYLH
Sbjct: 861 IKIVSSCSNSYIDFKALVLEYVPNGSLERWLYSHNYCLDILQRLNIMIDVALAMEYLHHG 920
Query: 781 HSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
STPV+HCDLKP N+ DFGI +LL + S+ +T+TL TIGYMAP
Sbjct: 921 CSTPVVHCDLKPSNILLDEDFGGHVGDFGIAKLLREEESIRETQTLATIGYMAP 974
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 627 bits (1616), Expect = e-176, Method: Compositional matrix adjust.
Identities = 373/894 (41%), Positives = 491/894 (54%), Gaps = 148/894 (16%)
Query: 55 TDQQALLALKAHISYDPTNLLAQNSTSNTSVCNWIGITCNVNSHRVTALNISSLNLQGTI 114
TDQ ALLA K HI++DP N+L + +S TS CNW+G++C++ RVTAL++SS+ L GTI
Sbjct: 30 TDQSALLAFKDHITFDPQNMLTHSWSSKTSFCNWMGVSCSLRRQRVTALDLSSMGLLGTI 89
Query: 115 PPQLGNLSSLTTLNLSHNKLSGD-------------------------IPPSIFTMHKLK 149
PPQLGNLS L L L +N GD +P S +H+L+
Sbjct: 90 PPQLGNLSFLQYLILYNNSFHGDLPSEIGNLRRLQVMDIGSNKLSLVIVPESFGNLHRLE 149
Query: 150 FLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHG 209
L F N L+G++ S FN+SS+ + L + L G LP N+C++L L++L L+ N G
Sbjct: 150 ELRFDGNNLTGTIPSTIFNISSLKVLDLMFNGLFGSLPKNMCDHLPRLEMLLLSSNQLSG 209
Query: 210 QIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNL 269
QIP L KC+ LQLL L + +G IP+E+ G+LP L
Sbjct: 210 QIPSDLFKCRELQLLWLPYNNFTGVIPEEL------------------------GFLPML 245
Query: 270 ENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFS 329
E L LG N L G +P +IFNM++++ + + N+L GS + LPN+E L L LN +
Sbjct: 246 EVLNLGVNMLSGDLPRSIFNMTSLRTMQICCNNLSGSIPQENSIDLPNLEELQLNLNGIT 305
Query: 330 GTIPSFITNASKLVYLDMGTNSFSGIIPNTIG---------------------------- 361
G++P F+ N S+L LD+ N +G + G
Sbjct: 306 GSMPRFLGNMSRLEILDLSYNKMTGNVLQEFGNLRALQVLSLQSNSFTNHPSSQTLNFIT 365
Query: 362 ------------LTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLL 409
+ NPLDG+LP S+GNLS L Y+ + G+IP I NLSNL++L
Sbjct: 366 SLTNSRQLKELHIGDNPLDGMLPNSVGNLSSFLTKFYVYASKLKGNIPGEIGNLSNLIVL 425
Query: 410 DLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIP 469
LE N L G IP T G L+K+Q LYL N L GSIP +C RL + L N SG IP
Sbjct: 426 SLEENSLMGPIPTTVGGLRKIQVLYLHKNNLNGSIPSDICLARRLVDITLNNNVLSGEIP 485
Query: 470 SCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGI 529
SC+GNLTSLR+ L N L+S +P W+LKD+L +L SN L G L +G + IGI
Sbjct: 486 SCIGNLTSLRNLYLHFNILSSTIPMALWSLKDLLILNLHSNFLYGSLPSQVGEMEAAIGI 545
Query: 530 NLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFG-------------------- 569
LS N SG+IPSTIG L++L SL+ N +G IPE+FG
Sbjct: 546 RLSSNQLSGNIPSTIGSLQNLIRFSLSKNSFQGSIPEAFGGLVSLELLDLSQNNLSGEIP 605
Query: 570 -------YLTELNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPNLQFPKCKRRTRR 622
YL ++SFN L+GEIPRGGPFANFTA+SF+ N+ LCG LQ P C +R+
Sbjct: 606 KSLEALRYLEFFSVSFNGLQGEIPRGGPFANFTARSFIMNKGLCGPSRLQVPPCSIESRK 665
Query: 623 KSKKKMLLLVIVLPLSTALIIAVPLALKYKSIRGGKSK-----------TLRRFSYQDLF 671
SK K LL LP ++++ V R K RR SY +L
Sbjct: 666 DSKTKSRLLRFSLPTVASILLVVAFIFLVMGCRRRYRKDPIPEALPVTAIQRRISYLELL 725
Query: 672 RATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHR 731
AT +F + NL+G+GSFGSVY+GRL DG+ VA+K+F+ A +SF+ ECE+M+NIRHR
Sbjct: 726 HATNEFHESNLLGIGSFGSVYQGRLRDGLNVAVKIFNLQLQRAFRSFDTECEIMRNIRHR 785
Query: 732 NHVKRISSCSNEDFKAL-----------DCLHSTNCSLNIFDKLNIMIDVASALEYLHFS 780
N VK I SCSN DFKAL L+S N L+I ++NIMIDVASALEYLH
Sbjct: 786 NLVKIICSCSNLDFKALVLEYMPKGSLEKWLYSHNYCLDIIQRVNIMIDVASALEYLHHG 845
Query: 781 HSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
+ +PV+HCDLKP NV DFGI +LL + S QT TL TIGYMAP
Sbjct: 846 YPSPVVHCDLKPSNVLLDEDMVAHVCDFGIAKLLGENESFAQTRTLATIGYMAP 899
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 621 bits (1602), Expect = e-175, Method: Compositional matrix adjust.
Identities = 390/956 (40%), Positives = 523/956 (54%), Gaps = 175/956 (18%)
Query: 42 YLVVAVAAASNITTDQQALLALKAHISYDPTNLLAQNSTSNTSVCNWIGITCNVNSHRVT 101
+L ++A + TD ALL LK H ++DP +++N +S TS C+W G+TC+ +RV
Sbjct: 17 WLQFSLAIPKSNLTDLSALLVLKEHSNFDP--FMSKNWSSATSFCHWYGVTCSERHNRVV 74
Query: 102 ALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGS 161
AL +S++ ++G +PP +GNLS L +++S+N SG +P + +H+LKF++FS+N G
Sbjct: 75 ALTLSNMGIKGIVPPHIGNLSFLVHIDMSNNSYSGHLPNELGNLHRLKFMNFSNNSFVGE 134
Query: 162 L-----------------SSVTFNLSSVLDIR----------------LDS--------- 179
+ +S+T SS+ +I LD+
Sbjct: 135 IPSSLAMLPKLQHLLLANNSLTAGRSSIFNITTLNTLDLNDNLLGGNILDNIGGNLSNLQ 194
Query: 180 ------DKLSGELPVNI------------------------CNYLHYLKVLFLAKNMFHG 209
++LSG P I CN L++L LA N +G
Sbjct: 195 VLNMGLNQLSGSFPPKILDLPSLKFIYLQVNNLSGNLKEILCNQNSKLQLLNLAGNQLYG 254
Query: 210 QIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNL 269
QIP L KCK L+ L L K +G+IP+ I NLT L+ +SL N L G IP EIG L NL
Sbjct: 255 QIPSDLYKCKELRSLALHANKFTGSIPRTIGNLTKLKWLSLGRNNLTGRIPLEIGNLQNL 314
Query: 270 ENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFS 329
+ + L FNNL G +P A+FN+ST+K I + N+LLG+ + L LPN+ L LG+N+ S
Sbjct: 315 QIVHLSFNNLNGSIPHALFNISTMKWIAMTSNNLLGNLPTSLGLHLPNLIWLYLGINKLS 374
Query: 330 GTIPSFITNASKLVYLDMGTNSFSGIIPNTIG---------------------------- 361
G IPS+I+NASKL L++ +NSF+G IP+++G
Sbjct: 375 GPIPSYISNASKLTILELPSNSFTGFIPDSLGDLRNLQTLKLGANLLSSKKTSQELTIFS 434
Query: 362 ------------LTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLL 409
L+ NPLDG LP S+GNLS SLE+ S+ I GS+ + I NLS+L L
Sbjct: 435 SLKNCQNLKYLWLSYNPLDGYLPHSVGNLSNSLESFLASDGLIKGSVHESIGNLSSLTRL 494
Query: 410 DLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIP 469
+L N LTG IP T G L+ LQGLYL N L GSIP +LC L L L L GNK SGSIP
Sbjct: 495 NLGNNDLTGRIPTTIGTLKHLQGLYLHGNDLDGSIPSELCDLRTLYNLELTGNKLSGSIP 554
Query: 470 SCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGI 529
+C NLTSLR+ L SNR S + ST W LKDIL +L+SN L G L +I NLR V I
Sbjct: 555 TCFSNLTSLRNLFLASNRFVSTISSTLWTLKDILQVNLASNYLTGSLPSEIENLRAVYMI 614
Query: 530 NLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFG-------------------- 569
N+S+N SG+IP +IG L+DL + L+ N L+G IP+S G
Sbjct: 615 NISKNQLSGEIPISIGGLQDLAQLYLSGNKLQGPIPQSVGDIKSLEFLDLSSNNLSGMIP 674
Query: 570 -------YLTELNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPNLQFPKCK----R 618
YL N+SFN L+GEIP GG F+NF+A+SF+GNE LCG LQ CK R
Sbjct: 675 KSLDNLLYLKYFNVSFNYLQGEIPEGGSFSNFSAQSFIGNEALCGSARLQVSPCKDDNSR 734
Query: 619 RTRRKSKKKMLLLVIVLPLSTALIIAVPLALKYKSIRGGKSK---------TLRRFSYQD 669
T K +L V+ + ++A + LK R K T+RR SY +
Sbjct: 735 ATETPGSKIVLRYVLPAIVFAVFVLAFVIMLKRYCERKAKFSIEDDFLALTTIRRISYHE 794
Query: 670 LFRATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIR 729
L AT F + N +G+GSFGSVYKG L DG +A KVF+ A KSF+ ECEV++N+R
Sbjct: 795 LQLATNGFQESNFLGMGSFGSVYKGTLSDGTVIAAKVFNLQLERAFKSFDTECEVLRNLR 854
Query: 730 HRNHVKRISSCSNEDFKAL-----------DCLHSTNCSLNIFDKLNIMIDVASALEYLH 778
HRN VK I+SCS +FKAL L+S + LN +LNIM+DVAS LEYLH
Sbjct: 855 HRNLVKIITSCSGPNFKALVLEFMPNWSLEKWLYSDDYFLNNLQRLNIMLDVASVLEYLH 914
Query: 779 FSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
++ P+ HCD+KP NV DFGI +LL + S++QT TL TIGYMAP
Sbjct: 915 HGYTIPMAHCDIKPSNVLLNEDMVAFLADFGISKLLGEEGSVMQTMTLATIGYMAP 970
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255578886|ref|XP_002530297.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223530195|gb|EEF32104.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 617 bits (1591), Expect = e-174, Method: Compositional matrix adjust.
Identities = 395/914 (43%), Positives = 515/914 (56%), Gaps = 130/914 (14%)
Query: 39 LLLYLVVAVA-AASNITTDQQALLALKAHISYDPTNLLAQNSTSNTSVCNWIGITCNVNS 97
LL V++A +NI +DQ ALLALK I DP NLLA N + TSVC W+G+TC
Sbjct: 16 LLYSFFVSIADGVTNIASDQDALLALKVRIIRDPNNLLAANWSITTSVCTWVGVTCGARH 75
Query: 98 HRVTALNISSLNLQGTIPPQLGNLSSLT------------------------TLNLSHNK 133
RVTAL++S + L GTIPP LGNLS L +S N
Sbjct: 76 GRVTALDLSDMGLTGTIPPHLGNLSFLAFISFYNNRFHGSLPDELSKLRRIKAFGMSTNY 135
Query: 134 LSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFN--LSSVLDIRLDSDKLSGELPVNIC 191
SG+IP I + +L+ L S N+ +G L ++ N +SS+ + ++ L+G LP NI
Sbjct: 136 FSGEIPSWIGSFTQLQRLSLSSNKFTGLLPAILANNTISSLWLLDFGTNNLTGRLPPNIF 195
Query: 192 NYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLR 251
+L L+ L+L N+F+G IP L C++L+LL L F G+I K+I NLT+L+++ L
Sbjct: 196 THLANLRALYLNSNLFNGPIPSTLMACQQLKLLALSFNHFEGSIHKDIGNLTMLQELYLG 255
Query: 252 NNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGI 311
N G IP EIG L +LE ++L N L G+VP+ I+N S + I L N L G L
Sbjct: 256 GNNFSGTIPDEIGDLAHLEEIILNVNGLSGLVPSGIYNASKMTAIGLALNQLSGY--LPS 313
Query: 312 DLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIG---------- 361
+LPN+E + N F+G IP + NASKL +D+G NSF G IP+ +G
Sbjct: 314 SSNLPNLEFFIIEDNNFTGPIPVSLFNASKLGNIDLGWNSFYGPIPDELGNLKSLEVFSF 373
Query: 362 ------------------------------LTGNPLDGVLPTSIGNLSMSLENIYISNCN 391
L+ NPL+G LP S+GNLS SLE + I +C
Sbjct: 374 WVNHLTVKSSSSGLSLFSSLTKCKHLRRFDLSNNPLNGNLPISVGNLSSSLEVVEIFDCG 433
Query: 392 IGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHL 451
I G+IP+ I NLS+L LDL N L G+IP T +L KLQ L L +N+L GS P +LC L
Sbjct: 434 ITGTIPKEIGNLSSLSWLDLGANDLRGTIPTTIRKLGKLQELKLHYNRLEGSFPYELCDL 493
Query: 452 ARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNS 511
L L L N SG IPSCLGN+ SLR+ +G N+ +S +PST W L DIL +LSSNS
Sbjct: 494 QSLAYLYLEVNALSGQIPSCLGNVNSLRTLSMGMNKFSSTIPSTLWRLADILELNLSSNS 553
Query: 512 LDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFG-- 569
L G L++DIGNL+ V I+LS N SG IPS+IG LK L N+SLA N LEG IP+ FG
Sbjct: 554 LSGSLAVDIGNLKAVTLIDLSGNQLSGHIPSSIGGLKTLLNLSLAVNRLEGSIPQLFGDA 613
Query: 570 -------------------------YLTELNLSFNKLEGEIPRGGPFANFTAKSFMGNEK 604
YLT N+SFN+L+GEIP G F N +AKSFMGN+
Sbjct: 614 ISLQLLDLSNNNLSGEIPKSLEELRYLTYFNVSFNELQGEIPNGRAFINLSAKSFMGNKG 673
Query: 605 LCGLPNLQFPKCKRRTRRKSKKKMLLLVIVLPLSTALIIAVPLALKYKSIRGGKS----- 659
LCG LQ C+ T + SK L + ++T L I A+ IR K
Sbjct: 674 LCGAAKLQVQPCETSTHQGSKAASKLALRYGLMATGLTILAVAAVAIIFIRSRKRNMRIT 733
Query: 660 ------KTLRRFSYQDLFRATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAM 713
TL+R SY++L +AT+KF++ NL+G GSFGSVYKG DG VA+KVF+
Sbjct: 734 EGLLPLATLKRISYRELEQATDKFNEMNLLGRGSFGSVYKGTFSDGSSVAVKVFNLQVEG 793
Query: 714 ALKSFEAECEVMKNIRHRNHVKRISSCS--NEDFKAL-------DCLHSTNCS----LNI 760
A KSF+ ECEV++ IRHRN VK I+SCS N DFKAL L CS L +
Sbjct: 794 AFKSFDVECEVLRMIRHRNLVKIITSCSDINIDFKALVLEFMPNYSLEKWLCSPKHFLEL 853
Query: 761 FDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810
++LNIM+DVASA+EYLH ++ P++HCDLKP N+ DFGI +LL + S
Sbjct: 854 LERLNIMLDVASAVEYLHHGYAMPIVHCDLKPSNILLDENMVAHVTDFGIAKLLGDEHSF 913
Query: 811 IQTETLVTIGYMAP 824
IQT TL T+GYMAP
Sbjct: 914 IQTITLATVGYMAP 927
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485453|ref|XP_003633276.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 594 bits (1532), Expect = e-167, Method: Compositional matrix adjust.
Identities = 362/821 (44%), Positives = 480/821 (58%), Gaps = 100/821 (12%)
Query: 103 LNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSL 162
L++S G IP +G+LS+L TL L N+L+G IP I + L L+ + + LSG +
Sbjct: 267 LDLSINQFTGFIPQAIGSLSNLETLYLGFNQLAGGIPGEIGNLSNLNLLNSASSGLSGPI 326
Query: 163 SSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQ 222
+ FN+SS+ +I ++ LSG LP++IC +L L+ L L+ N GQ+P LS C L
Sbjct: 327 PAEIFNISSLQEIGFANNSLSGSLPMDICKHLPNLQWLLLSLNQLSGQLPTTLSLCGELL 386
Query: 223 LLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGV 282
L L + +G+IP+EI NL+ L +I R + G IP E+G L NL+ L L NNL G+
Sbjct: 387 TLTLAYNNFTGSIPREIGNLSKLEQIYFRRSSFTGNIPKELGNLVNLQFLSLNVNNLTGI 446
Query: 283 VPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKL 342
VP AIFN+S ++ + L N L GS I LPN+E+L +G N FSG IP I+N S L
Sbjct: 447 VPEAIFNISKLQVLSLAGNHLSGSLPSSIGSWLPNLEQLLIGGNEFSGIIPMSISNMSNL 506
Query: 343 VYLDMGTNSFSGIIPNTIG----------------------------------------L 362
+ LD+ N F G +P +G +
Sbjct: 507 ISLDISDNFFIGNVPKDLGNLRQLQLLGLSHNQLTNEHSASELAFLTSLTNCIFLRTLSI 566
Query: 363 TGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPV 422
+ NPL G++P S+GNLS+SLE IY S+C + G+IP ISNL+NL+ L L+ N LTG IP
Sbjct: 567 SDNPLKGMIPNSLGNLSISLEIIYASDCQLRGTIPTGISNLTNLIGLRLDDNDLTGLIPT 626
Query: 423 TFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPD 482
FGRLQKLQ L + N++ GSIP LCHL L L L+ NK SG+IPSC GNLT LR+
Sbjct: 627 PFGRLQKLQMLSISQNRIHGSIPSGLCHLTNLAFLDLSSNKLSGTIPSCSGNLTGLRNVY 686
Query: 483 LGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPS 542
L SN L S +PS+ NL+ +L +LSSN L+ L L +GN++ ++ ++LS+N FSG+IPS
Sbjct: 687 LHSNGLASEIPSSLCNLRGLLVLNLSSNFLNSQLPLQVGNMKSLVALDLSKNQFSGNIPS 746
Query: 543 TI------------------------GDLKDLQNISLACNGLEGLIP---ESFGYLTELN 575
TI GDL L+++ L+ N L G IP E YL LN
Sbjct: 747 TISLLQNLLQLYLSHNKLQGHIPPNFGDLVSLESLDLSGNNLSGTIPKSLEHLKYLEYLN 806
Query: 576 LSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPNLQFPKCKRRTRRKSKKKMLLLVIVL 635
+SFNKL+GEIP GGPFANFTA+SF+ N LCG P Q C++ +R+ +K +L ++ L
Sbjct: 807 VSFNKLQGEIPNGGPFANFTAESFISNLALCGAPRFQVMACEKDSRKNTKSLLLKCIVPL 866
Query: 636 PLSTALIIAVPLALKYKSIRGGKSKT-----------LRRFSYQDLFRATEKFSKENLIG 684
+S + II V L +++K R KS+T R +Q+L AT F ++NLIG
Sbjct: 867 SVSLSTIILVVLFVQWKR-RQTKSETPIQVDLSLPRMHRMIPHQELLYATNYFGEDNLIG 925
Query: 685 VGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNED 744
GS G VYKG L DG+ VA+KVF+ A KSFE ECEVM+NIRHRN K ISSCSN D
Sbjct: 926 KGSLGMVYKGVLSDGLIVAVKVFNLELQGAFKSFEVECEVMRNIRHRNLAKIISSCSNLD 985
Query: 745 FKAL-----------DCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPK 793
FKAL L+S N L+ +L IMIDVAS LEYLH +S PV+HCDLKP
Sbjct: 986 FKALVLEYMPNGSLEKWLYSHNYYLDFVQRLKIMIDVASGLEYLHHYYSNPVVHCDLKPS 1045
Query: 794 NVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
NV DFGI +LL G M +T+TL T+GYMAP
Sbjct: 1046 NVLLDDDMVAHISDFGIAKLLMGSEFMKRTKTLGTVGYMAP 1086
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449465016|ref|XP_004150225.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 593 bits (1529), Expect = e-166, Method: Compositional matrix adjust.
Identities = 377/977 (38%), Positives = 527/977 (53%), Gaps = 197/977 (20%)
Query: 47 VAAASNITTDQQALLALKAHISYDPTNLLAQNSTSNTSVCNWIGITCNVNSHRVTALNIS 106
+A A NITTDQ ALLAL+AHI+ DP + N ++ TSVCNW+GI C V RVT+LN S
Sbjct: 1 MAFAQNITTDQAALLALRAHITSDPFGITTNNWSATTSVCNWVGIICGVKHKRVTSLNFS 60
Query: 107 SLNLQGTIPPQLGNLSSLT------------------------TLNLSHNKLSGDIPPSI 142
+ L GT PP++G LS LT ++L +N SG+IP I
Sbjct: 61 FMGLTGTFPPEVGTLSFLTYVTIKNNSFHDPLPIELTNLPRLKMMSLGNNNFSGEIPTWI 120
Query: 143 FTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNY--------- 193
+ +++ L NQ SG + + FNL+S++ + L ++LSG +P I N
Sbjct: 121 GRLPRMEELYLYGNQFSGLIPTSLFNLTSLIMLNLQENQLSGSIPREIGNLTLLQDLYLN 180
Query: 194 -------------LHYLKVLFLAKNMFHGQIPL--------------------------- 213
L L+ L + N+F G IPL
Sbjct: 181 SNQLTEIPTEIGTLQSLRTLDIEFNLFSGPIPLFIFNLSSLVILGLSGNNFIGGLPDDIC 240
Query: 214 ----------------------ALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLR 251
L KC+ L+ + L + + +G+IP+ + NLT +++I L
Sbjct: 241 EDLPSLGGLYLSYNQLSGQLPSTLWKCENLEDVALAYNQFTGSIPRNVGNLTRVKQIFLG 300
Query: 252 NNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGI 311
N L GEIP+E+GYL NLE L + N G +P IFN+S + I L+ N L G+ +
Sbjct: 301 VNYLSGEIPYELGYLQNLEYLAMQENFFNGTIPPTIFNLSKLNTIALVKNQLSGTLPADL 360
Query: 312 DLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIG---------- 361
+ LPN+ +L LG N +GTIP ITN+S L D+G NSFSG+IPN G
Sbjct: 361 GVGLPNLVQLMLGRNELTGTIPESITNSSMLTLFDVGDNSFSGLIPNVFGRFENLRWINL 420
Query: 362 ------------------------------LTGNPLDGVLPTSIGNLSMSLENIYISNCN 391
L+ NPL+ LP+S N S S + + + N
Sbjct: 421 ELNNFTTESPPSERGIFSFLTNLTSLVRLELSHNPLNIFLPSSFVNFSSSFQYLSMVNTG 480
Query: 392 IGGSIPQLISN-LSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCH 450
I G IP+ I N L +L++L ++ N++TG+IP + G+L++LQGL+L N L G+IP ++C
Sbjct: 481 IKGMIPKDIGNFLRSLIVLVMDDNQITGTIPTSIGKLKQLQGLHLSNNSLEGNIPAEICQ 540
Query: 451 LARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSN 510
L L+ L LA NK SG+IP C NL++LR+ LGSN L S +PS+ W+L IL +LSSN
Sbjct: 541 LENLDELYLANNKLSGAIPECFDNLSALRTLSLGSNNLNSTMPSSLWSLSYILHLNLSSN 600
Query: 511 SLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFG- 569
SL G L ++IGNL VV+ I++S+N SG+IPS+IG L +L N+SL N LEG IP+SFG
Sbjct: 601 SLRGSLPVEIGNLEVVLDIDVSKNQLSGEIPSSIGGLINLVNLSLLHNELEGSIPDSFGN 660
Query: 570 --------------------------YLTELNLSFNKLEGEIPRGGPFANFTAKSFMGNE 603
+L + N+SFN+LEGEIP GGPF+NF+A+SF+ N
Sbjct: 661 LVNLEILDLSSNNLTGVIPRSLEKLSHLEQFNVSFNQLEGEIPNGGPFSNFSAQSFISNI 720
Query: 604 KLCGLPN-LQFPKCKRRTRRKSKKKMLLLVIVLPLSTALIIAVPLALKYKSIRGGKSKTL 662
LC + Q C +T + S +K LV +LP ++++ L L + + R K + +
Sbjct: 721 GLCSASSRFQVAPCTTKTSQGSGRKTNKLVYILPSILLAMLSLILLLLFMTYRHRKKEQV 780
Query: 663 ------------RRFSYQDLFRATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQN 710
RR +YQ+L +AT+ FS+ NLIG GSFGSVYK L DG A+K+F
Sbjct: 781 REDTPLPYQPAWRRTTYQELSQATDGFSESNLIGRGSFGSVYKATLSDGTIAAVKIFDLL 840
Query: 711 CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL-----------DCLHSTNCSLN 759
A KSFE ECE++ NIRHRN VK I+SCS+ DFKAL L++ +C LN
Sbjct: 841 TQDANKSFELECEILCNIRHRNLVKIITSCSSVDFKALILEYMPNGNLDMWLYNHDCGLN 900
Query: 760 IFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809
+ ++L+I+IDVA AL+YLH + P++HCDLKP N+ DFGI +LL G S
Sbjct: 901 MLERLDIVIDVALALDYLHNGYGKPIVHCDLKPNNILLDGDMVAHLTDFGISKLLGGGDS 960
Query: 810 MIQTETLVTIGYMAPGL 826
+ QT TL T+GYMAP L
Sbjct: 961 ITQTITLATVGYMAPEL 977
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 591 bits (1524), Expect = e-166, Method: Compositional matrix adjust.
Identities = 368/857 (42%), Positives = 480/857 (56%), Gaps = 131/857 (15%)
Query: 96 NSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSD 155
N + LN+ ++G I ++ NLS+L L+L HN SG I P +F M L+ ++
Sbjct: 86 NVTALETLNLEGNFIEGNISEEIRNLSNLKILDLGHNHFSGVISPILFNMPSLRLINLRA 145
Query: 156 NQLSGSLSSVTF--NLSSVLDI-------------------------RLDSDKLSGELPV 188
N LSG L V N+ S L++ L+S++ +G +P
Sbjct: 146 NSLSGILQVVMIMSNIPSTLEVLNLGYNQLHGRIPSNLHKCTELRVLDLESNRFTGSIPK 205
Query: 189 NICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKI 248
IC L LK L+L KN GQIP +++ L+ L L L+G IP+EI N T L +I
Sbjct: 206 EICT-LTKLKELYLGKNNLTGQIPGEIARLVSLEKLGLEVNGLNGNIPREIGNCTYLMEI 264
Query: 249 SLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFS 308
+ NN L G IP+E+G L L+ L LGFNN+ G +P+ FN S ++++ + N L G
Sbjct: 265 HVENNNLTGVIPNEMGNLHTLQELDLGFNNITGSIPSTFFNFSILRRVNMAYNYLSGHLP 324
Query: 309 LGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIG------- 361
L LPN+E L L N SG IP I NASKL+ LD+ NSFSG IP+ +G
Sbjct: 325 SNTGLGLPNLEELYLEKNELSGPIPDSIGNASKLIVLDLSYNSFSGRIPDLLGNLRNLQK 384
Query: 362 ---------------------------------LTGNPLDGVLPTSIGNLSMSLENIYIS 388
GNPL G LP SIGNLS SLE +Y
Sbjct: 385 LNLAENILTSKSLRSELSFLSSLSNCRSLAYLRFNGNPLRGRLPVSIGNLSASLEELYAF 444
Query: 389 NCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQL 448
+C I G+IP+ I NLSNL+ L L+ N+LTG+IP GRL+ LQ L NKL G IP+++
Sbjct: 445 DCRIIGNIPRGIGNLSNLIGLILQQNELTGAIPSEIGRLKHLQDFSLASNKLQGHIPNEI 504
Query: 449 CHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLS 508
CHL RL+ L L N FSGS+P+CL N+TSLR LGSNR TS+ P+TFW+LKD+L +LS
Sbjct: 505 CHLERLSYLYLLENGFSGSLPACLSNITSLRELYLGSNRFTSI-PTTFWSLKDLLQINLS 563
Query: 509 SNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESF 568
NSL G L L+IGNL+VV I+ S N SGDIP++I DL++L + SL+ N ++G IP SF
Sbjct: 564 FNSLTGTLPLEIGNLKVVTVIDFSSNQLSGDIPTSIADLQNLAHFSLSDNRMQGPIPSSF 623
Query: 569 G---------------------------YLTELNLSFNKLEGEIPRGGPFANFTAKSFMG 601
G +L N+SFN+L+GEI GGPFANF+ +SFM
Sbjct: 624 GDLVSLEFLDLSRNSLSGAIPKSLEKLVHLKTFNVSFNRLQGEILDGGPFANFSFRSFMD 683
Query: 602 NEKLCGLPNLQFPKCKR-RTRRKSKKKMLLLVIVLPLSTALIIAVPLALKYKSIRGGKSK 660
NE LCG +Q P CK T R+SK+ ++ + + A II V LAL R +
Sbjct: 684 NEALCGPIRMQVPPCKSISTHRQSKRPREFVIRYIVPAIAFIILV-LALAVIIFRRSHKR 742
Query: 661 ------------TLRRFSYQDLFRATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFH 708
T R+ SY +L+RATE F++ NL+G GS GSVYKG L DG+ +A+KVFH
Sbjct: 743 KLSTQEDPLPPATWRKISYHELYRATEGFNETNLLGTGSCGSVYKGTLSDGLCIAVKVFH 802
Query: 709 QNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL-----------DCLHSTNCS 757
L F++ECEV++ +RHRN VK ISSC N DFKAL L+S N
Sbjct: 803 LQLEGELMRFDSECEVLRMLRHRNLVKIISSCCNLDFKALILEFIPHGSLEKWLYSHNYY 862
Query: 758 LNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGD 807
L+I +LNIMIDVASALEYLH + PV+HCDLKP NV DFGI RLL
Sbjct: 863 LDILQRLNIMIDVASALEYLHHGCTRPVVHCDLKPSNVLINEDMVAHVSDFGISRLLGEG 922
Query: 808 RSMIQTETLVTIGYMAP 824
++ QT TL TIGYMAP
Sbjct: 923 DAVTQTLTLATIGYMAP 939
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|298204751|emb|CBI25249.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 589 bits (1519), Expect = e-165, Method: Compositional matrix adjust.
Identities = 393/921 (42%), Positives = 506/921 (54%), Gaps = 179/921 (19%)
Query: 45 VAVAAASNITTDQQALLALKAHISYDPTNLLAQNSTSNTSVCNWIGITCNVNSHRVTALN 104
VA + + TDQ +LLALKAHI+ DP ++LA N ++ TS C WIG++CN RV AL+
Sbjct: 496 ACVAMSLSNFTDQSSLLALKAHITLDPHHVLAGNWSTKTSFCEWIGVSCNAQQQRVIALD 555
Query: 105 ISSLNLQGTIPPQLGNLSSLTTLNLS------------------------HNKLSGDIPP 140
+S+L L+GTIPP LGNLS L +L+LS +N +G IPP
Sbjct: 556 LSNLGLRGTIPPDLGNLSFLVSLDLSSNNFHGPIPPSFGNLNRLQSLFLGNNSFTGTIPP 615
Query: 141 SIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVL 200
SI M L+ LD NQL G++ S FN+SS+ +I L + LSG +P I ++L L+ L
Sbjct: 616 SIGNMSMLETLDIQSNQLVGAIPSAIFNISSLQEIALTYNSLSGTIPEEI-SFLPSLEYL 674
Query: 201 FLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEI--------------------- 239
+L N F IP A+ K L+ ++LG SG++P +I
Sbjct: 675 YLRSNSFTSPIPSAIFKISTLKAIDLGKNGFSGSMPLDIMCAHRPSLQLIGLDSNRFTGT 734
Query: 240 -----SNLTILRKISLRNNKLR-GEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTV 293
N T LR++ L +N L GE+P EIG L L L + N+L G +P IFN+S++
Sbjct: 735 IHGGIGNCTSLRELYLSSNDLTAGEVPCEIGSLCTLNVLNIEDNSLTGHIPFQIFNISSM 794
Query: 294 KKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFS 353
L N+L G+ LPN+E L L +N SG IPS I NASKL LD G N +
Sbjct: 795 VSGSLTRNNLSGNLPPNFGSYLPNLENLILEINWLSGIIPSSIGNASKLRSLDFGYNMLT 854
Query: 354 GIIPNTIG----------------------------------------LTGNPLDGVLPT 373
G IP+ +G L+ NPL G+LP
Sbjct: 855 GSIPHALGSLRFLERLNLGVNNLKGESYIQELSFLTSLTNCKRLRILYLSFNPLIGILPI 914
Query: 374 SIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGL 433
SIGNLS SL+ + C + G+IP I NLSNL LL L N LTG+IP + G+LQKLQGL
Sbjct: 915 SIGNLSTSLQRFEANTCKLKGNIPTEIGNLSNLYLLSLNNNDLTGTIPPSIGQLQKLQGL 974
Query: 434 YLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLP 493
YLP NKL GSIP+ +C L L L L N+ SGSIP+CLG LT LR LGSN+L S +P
Sbjct: 975 YLPSNKLQGSIPNDICQLRNLGELFLTNNQLSGSIPACLGELTFLRHLYLGSNKLNSTIP 1034
Query: 494 STFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNI 553
ST W+L IL D+SSN L G L D+GNL+V++ I+LSRN SG+IPS IG L+DL ++
Sbjct: 1035 STLWSLIHILSLDMSSNFLVGYLPSDMGNLKVLVKIDLSRNQLSGEIPSNIGGLQDLTSL 1094
Query: 554 SLACNGLEGLIPESFG---------------------------YLTELNLSFNKLEGEIP 586
SLA N EG I SF YL L++SFN L GEIP
Sbjct: 1095 SLAHNRFEGPILHSFSNLKSLEFMDLSDNALFGEIPKSLEGLVYLKYLDVSFNGLYGEIP 1154
Query: 587 RGGPFANFTAKSFMGNEKLCGLPNLQFPKCKRRTRRKSKKKMLLLVIVLPLSTALIIAVP 646
GPFANF+A+SFM N+ LC R+++ VLP + ++
Sbjct: 1155 PEGPFANFSAESFMMNKALC--------------RKRNA--------VLPTQSESLL--- 1189
Query: 647 LALKYKSIRGGKSKTLRRFSYQDLFRATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKV 706
+ T RR SYQ++F+AT FS NL+G GS GSVY+G L DG AIKV
Sbjct: 1190 ------------TATWRRISYQEIFQATNGFSAGNLLGRGSLGSVYRGTLSDGKNAAIKV 1237
Query: 707 FHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNE--DFKAL-----------DCLHS 753
F+ A KSF+AECEVM +IRHRN +K +SSCSN DFKAL L+S
Sbjct: 1238 FNLQEEAAFKSFDAECEVMHHIRHRNLIKIVSSCSNSYIDFKALVLEYVPNGSLERWLYS 1297
Query: 754 TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRL 803
N L+I +LNIMIDVA A+EYLH STPV+HCDLKP N+ DFGI +L
Sbjct: 1298 HNYCLDILQRLNIMIDVALAMEYLHHGCSTPVVHCDLKPSNILLDEDFGGHVGDFGIAKL 1357
Query: 804 LTGDRSMIQTETLVTIGYMAP 824
L + S+ +T+TL TIGYMAP
Sbjct: 1358 LREEESIRETQTLATIGYMAP 1378
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147853795|emb|CAN81714.1| hypothetical protein VITISV_005816 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 588 bits (1517), Expect = e-165, Method: Compositional matrix adjust.
Identities = 351/826 (42%), Positives = 470/826 (56%), Gaps = 100/826 (12%)
Query: 98 HRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQ 157
++ L++S G IP +G+LS+L + L++N L+G IP I + L L
Sbjct: 263 RQLRGLSLSLNQFTGGIPQAIGSLSNLEEVYLAYNNLAGGIPREIGNLSNLNSLQLGSCG 322
Query: 158 LSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSK 217
+SG + FN+SS+ I L + L G LP++IC +LH L+ L+L+ N GQ+P LS
Sbjct: 323 ISGPIPPEIFNISSLQMIDLTDNSLHGSLPMDICKHLHNLQGLYLSFNQLSGQLPTTLSL 382
Query: 218 CKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFN 277
C +L L+L + +G IP NLT+L+ + L N ++G IP+E+G L NL+NL L N
Sbjct: 383 CGQLLSLSLWGNRFTGNIPPSFGNLTVLQDLELXENNIQGNIPNELGNLINLQNLKLSVN 442
Query: 278 NLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFIT 337
NL G++P AIFN+S ++ + L N GS I LP++E L +G N FSG IP I+
Sbjct: 443 NLTGIIPEAIFNISKLQTLXLAQNHFSGSLPSSIGTQLPDLEGLAIGXNEFSGIIPMSIS 502
Query: 338 NASKLVYLDMGTNSFSGIIPNTIG------------------------------------ 361
N S+L LD+ N F+G +P +G
Sbjct: 503 NMSELTVLDIWANFFTGDVPKDLGNLRRLEFLNLGFNQLTDEHSTSEVGFLTSLTNCKFL 562
Query: 362 ----LTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLT 417
+ NPL G+LP S+GNLS+SLE+ S C G+IP I NL NL+ L L N LT
Sbjct: 563 RRLWIEDNPLKGILPNSLGNLSISLESFDASACQFKGTIPTGIGNLINLIDLRLNDNDLT 622
Query: 418 GSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTS 477
G IP++FG LQKLQ + N++ GSIP LCHL L L L+ NK SG+IP C GNLT+
Sbjct: 623 GLIPISFGHLQKLQWFAISGNRIHGSIPSVLCHLRNLGYLDLSSNKLSGTIPGCFGNLTA 682
Query: 478 LRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFS 537
LR+ L SN L S +PS+ W L+D+L +LSSN L+ L L++GN++ ++ ++LS+N FS
Sbjct: 683 LRNISLHSNGLASEIPSSLWTLRDLLVLNLSSNFLNCQLPLEVGNMKSLLVLDLSKNQFS 742
Query: 538 GDIPSTI------------------------GDLKDLQNISLACNGLEGLIP---ESFGY 570
G+IPSTI G L L+ + L+ N G IP E+ Y
Sbjct: 743 GNIPSTISLLQNLLQLYLSHNKLQGHMPPNFGALVSLEYLDLSGNNFSGTIPTSLEALKY 802
Query: 571 LTELNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPNLQFPKCKRRTRRKSKKKMLL 630
L LN+SFNKL+GEIP GPFANFTA+SF+ N LCG P Q C++ RR +K +L
Sbjct: 803 LKYLNVSFNKLQGEIPNRGPFANFTAESFISNLALCGAPRFQVMACEKDARRNTKSLLLK 862
Query: 631 LVIVLPLSTALIIAVPLALKYKSIRGGKSKT-----------LRRFSYQDLFRATEKFSK 679
++ L +S + +I V L +K R +S++ R S+Q+L AT F +
Sbjct: 863 CIVPLSVSLSTMILVVLFTLWKR-RQTESESPVQVDLLLPRMHRLISHQELLYATSYFGE 921
Query: 680 ENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISS 739
ENLIG GS G VYKG L DG+ VA+KVF+ A KSFE ECEVM+NIRHRN K ISS
Sbjct: 922 ENLIGKGSLGMVYKGVLSDGLIVAVKVFNLELHGAFKSFEVECEVMRNIRHRNLAKIISS 981
Query: 740 CSNEDFKAL-----------DCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHC 788
CSN DFKAL L+S N L+ +L IMIDVAS LEYLH +S PV+HC
Sbjct: 982 CSNLDFKALVLEYMPNESLEKWLYSHNYCLDFIQRLKIMIDVASGLEYLHHDYSNPVVHC 1041
Query: 789 DLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
DLKP NV DFGI +LL G M +T+TL TIGYMAP
Sbjct: 1042 DLKPSNVLLDDDMVAHISDFGIAKLLMGSEFMKRTKTLGTIGYMAP 1087
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147776333|emb|CAN72034.1| hypothetical protein VITISV_000078 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 581 bits (1497), Expect = e-163, Method: Compositional matrix adjust.
Identities = 354/812 (43%), Positives = 462/812 (56%), Gaps = 99/812 (12%)
Query: 112 GTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSS 171
G IP +G+L +L L L+ NKL+G IP I + L L N +SG + + FN+SS
Sbjct: 282 GGIPQAIGSLCNLEELYLAFNKLTGGIPREIGNLSNLNILQLGSNGISGPIPAEIFNISS 341
Query: 172 VLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKL 231
+ I ++ LSG LP+ IC +L L+ L+LA+N GQ+P LS C L L+L F K
Sbjct: 342 LQVIDFTNNSLSGSLPMGICKHLPNLQGLYLAQNHLSGQLPTTLSLCGELLFLSLSFNKF 401
Query: 232 SGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMS 291
G+IP+EI NL+ L I LR+N L G IP G L L+ L LG N L G VP AIFN+S
Sbjct: 402 RGSIPREIGNLSKLEHIDLRSNSLVGSIPTSFGNLKALKFLNLGINFLTGTVPEAIFNIS 461
Query: 292 TVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNS 351
++ + L+ N L GS I LP++E L +G N FSGTIP I+N SKL L + NS
Sbjct: 462 ELQNLALVQNHLSGSLPSSIGTWLPDLEGLYIGANEFSGTIPMSISNMSKLTVLSLSDNS 521
Query: 352 FSGIIPNTI-----------------------------GLTG-----------NPLDGVL 371
F+G +P + LT NPL G L
Sbjct: 522 FTGNVPKDLCNLTKLKFLNLAHNQLTDEHLASGVGFLTSLTNCKFLRYLWIGYNPLKGTL 581
Query: 372 PTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQ 431
P S+GNL ++LE+ C G+IP I NL+NL+ LDL N LTGSIP T GRLQKLQ
Sbjct: 582 PNSLGNLPIALESFTAYACQFRGTIPTGIGNLTNLIWLDLGANDLTGSIPTTLGRLQKLQ 641
Query: 432 GLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSV 491
L++ N++ GSIP+ LCHL L LGL+ NK SGS PSC G+L +LR L SN L
Sbjct: 642 RLHIAGNRIRGSIPNDLCHLKNLGYLGLSSNKLSGSTPSCFGDLLALRELFLDSNALAFN 701
Query: 492 LPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQ 551
+P++ W+L+D+L +LSSN L G L ++GN++ + ++LS+N SG IPS +G L+ L
Sbjct: 702 IPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGYIPSRMGKLQYLI 761
Query: 552 NISLACNGLEGLIPESFG---------------------------YLTELNLSFNKLEGE 584
+SL+ N L+G I FG YL LN+SFNKL+GE
Sbjct: 762 TLSLSQNRLQGPIXVEFGDLVSLESLDLSHNNLSGTIPKSLEALIYLKYLNVSFNKLQGE 821
Query: 585 IPRGGPFANFTAKSFMGNEKLCGLPNLQFPKCKR--RTRRKSKKKMLLLVIVLPLSTALI 642
IP GGPF FTA+SFM NE LCG P+ Q C + RT+ K +L I+LP+ + +
Sbjct: 822 IPNGGPFVKFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFILKYILLPVGSTVT 881
Query: 643 IAVPLALKYKS---------IRGGKSKTLRRFSYQDLFRATEKFSKENLIGVGSFGSVYK 693
+ V + L + I T + S+Q L AT F ++NLIG GS G VYK
Sbjct: 882 LVVFIVLWIRRRDNMEIPTPIDSWLLGTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYK 941
Query: 694 GRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL----- 748
G L +G+ VAIKVF+ AL+SF++ECEVM+ IRHRN V+ I+ CSN DFKAL
Sbjct: 942 GVLSNGLNVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRIITCCSNLDFKALVLEYM 1001
Query: 749 ------DCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------ 796
L+S N L++ +LNIMIDVASALEYLH S+ V+HCDLKP NV
Sbjct: 1002 PNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCDLKPSNVLLDDDMV 1061
Query: 797 ----DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
DFGI +LLT SM QT+TL TIGYMAP
Sbjct: 1062 AHVADFGIAKLLTETESMQQTKTLGTIGYMAP 1093
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 827 | ||||||
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.652 | 0.534 | 0.297 | 3.8e-89 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.766 | 0.618 | 0.316 | 8.1e-87 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.642 | 0.515 | 0.281 | 1.2e-84 | |
| TAIR|locus:2047525 | 980 | AT2G24130 [Arabidopsis thalian | 0.841 | 0.710 | 0.301 | 1.7e-84 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.675 | 0.446 | 0.305 | 6.8e-83 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.640 | 0.424 | 0.313 | 6.2e-81 | |
| TAIR|locus:2182855 | 967 | ERL2 "ERECTA-like 2" [Arabidop | 0.880 | 0.752 | 0.285 | 3e-74 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.834 | 0.588 | 0.273 | 1.1e-72 | |
| UNIPROTKB|O24435 | 813 | O24435 "Receptor kinase-like p | 0.754 | 0.767 | 0.310 | 3.2e-72 | |
| TAIR|locus:2122239 | 1136 | AT4G36180 [Arabidopsis thalian | 0.651 | 0.474 | 0.314 | 1.6e-71 |
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 602 (217.0 bits), Expect = 3.8e-89, Sum P(3) = 3.8e-89
Identities = 168/564 (29%), Positives = 270/564 (47%)
Query: 55 TDQQALLALKAHISYDPTNLLAQNSTSNTSVCNWIGITCNVNSHRVTALNISSLNLQGTI 114
TD+QALL K+ +S D +L+ + S +CNW G+TC + RVT L + L L G I
Sbjct: 24 TDRQALLQFKSQVSEDKRVVLSSWNHS-FPLCNWKGVTCGRKNKRVTHLELGRLQLGGVI 82
Query: 115 PPQXXXXXXXXXXXXXXXXXXGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLD 174
P G IP + + +L++LD N L G + +N S +L+
Sbjct: 83 SPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRLLN 142
Query: 175 IRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGA 234
+RLDS++L G +P + + + +++ NM G++P +L L+ L L L G
Sbjct: 143 LRLDSNRLGGSVPSELGSLTNLVQLNLYGNNM-RGKLPTSLGNLTLLEQLALSHNNLEGE 201
Query: 235 IPKEISNLTILRKISLRNNKLRGEIPHEIGYLPXXXXXXXXXXXXXXXX-PAAIFNMSTV 293
IP +++ LT + + L N G P + L P + +
Sbjct: 202 IPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNL 261
Query: 294 KKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSF--ITNASKLVYL---DMG 348
+ N GS + ++ +ERL + N +G+IP+F + N KL++L +G
Sbjct: 262 LSFNMGGNYFTGSIPTTLS-NISTLERLGMNENNLTGSIPTFGNVPNL-KLLFLHTNSLG 319
Query: 349 TNS-----FSGIIPN-----TIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQ 398
++S F + N T+G+ N L G LP SI NLS L + + I GSIP
Sbjct: 320 SDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPY 379
Query: 399 XXXXXXXXXXXXXEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLG 458
+ N L+G +P + G+L L+ L L N+L+G IP + ++ L TL
Sbjct: 380 DIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLD 439
Query: 459 LAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSL 518
L+ N F G +P+ LGN + L +G N+L +P ++ +L D+S NSL G L
Sbjct: 440 LSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQ 499
Query: 519 DIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFGYL--TELNL 576
DIG L+ + ++L N SG +P T+G+ ++++ L N G IP+ G + E++L
Sbjct: 500 DIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKGLVGVKEVDL 559
Query: 577 SFNKLEGEIPRGGPFANFTAKSFM 600
S N L G IP FA+F+ ++
Sbjct: 560 SNNDLSGSIPEY--FASFSKLEYL 581
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 746 (267.7 bits), Expect = 8.1e-87, Sum P(2) = 8.1e-87
Identities = 213/673 (31%), Positives = 322/673 (47%)
Query: 99 RVTALNISSLNLQGTIPPQXXXXXXXXXXXXXXXXXXGDIPPSI-FTMHKLKFLDFSDNQ 157
R+ L +S ++QG+IP G IP I ++ L L N
Sbjct: 128 RLQLLELSDNSIQGSIPAAIGACTKLTSLDLSHNQLRGMIPREIGASLKHLSNLYLYKNG 187
Query: 158 LSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSK 217
LSG + S NL+S+ + L ++LSG +P ++ L L + L +N G IP ++
Sbjct: 188 LSGEIPSALGNLTSLQEFDLSFNRLSGAIPSSL-GQLSSLLTMNLGQNNLSGMIPNSIWN 246
Query: 218 CKRLQLLNLGFKKLSGAIPKE-ISNLTILRKISLRNNKLRGEIPHEIGYLPXXXXXXXXX 276
L+ ++ KL G IP L +L I + N+ G+IP +
Sbjct: 247 LSSLRAFSVRENKLGGMIPTNAFKTLHLLEVIDMGTNRFHGKIPASVANASHLTVIQIYG 306
Query: 277 XXXXXXXPAAIFNMSTVKKIYLLDN--SLLGSFSLGIDLSLPN---VERLNLGLNRFSGT 331
+ + + ++YL N G L N ++ LNLG N G
Sbjct: 307 NLFSGIITSGFGRLRNLTELYLWRNLFQTREQDDWGFISDLTNCSKLQTLNLGENNLGGV 366
Query: 332 IPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCN 391
+P+ +N S + SF + L N + G +P IGNL + L+++Y+ N N
Sbjct: 367 LPNSFSNLSTSL-------SF-------LALELNKITGSIPKDIGNL-IGLQHLYLCNNN 411
Query: 392 IGGSIPQXXXXXXXXXXXXXEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHL 451
GS+P N L+GSIP+ G L +L L L NK +G IP L +L
Sbjct: 412 FRGSLPSSLGRLKNLGILLAYENNLSGSIPLAIGNLTELNILLLGTNKFSGWIPYTLSNL 471
Query: 452 ARLNTLGLAGNKFSGSIPSCLGNLTSLRSP-DLGSNRLTSVLPSTFWNLKDILFFDLSSN 510
L +LGL+ N SG IPS L N+ +L ++ N L +P +LK+++ F SN
Sbjct: 472 TNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVSKNNLEGSIPQEIGHLKNLVEFHAESN 531
Query: 511 SLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFGY 570
L G + +G+ +++ + L N SG IPS +G LK L+ + L+ N L G IP S
Sbjct: 532 RLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSALGQLKGLETLDLSSNNLSGQIPTSLAD 591
Query: 571 LT---ELNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCG-LPNLQFPXXXXXXXXXXXX 626
+T LNLSFN GE+P G FA + S GN KLCG +P+L P
Sbjct: 592 ITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQGNAKLCGGIPDLHLPRCCPLLENRKHF 651
Query: 627 XMLLLVIVLPLSTALIIAVPLALKY--KSIRGGKSKTLRR----FSYQDLFRATEKFSKE 680
+L + + L + A++ ++ L + + ++ +G S+T + SY L +AT+ F+
Sbjct: 652 PVLPISVSLAAALAILSSLYLLITWHKRTKKGAPSRTSMKGHPLVSYSQLVKATDGFAPT 711
Query: 681 NLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSC 740
NL+G GSFGSVYKG+L+ VA+KV ALKSF AECE ++N+RHRN VK ++ C
Sbjct: 712 NLLGSGSFGSVYKGKLNIQDHVAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTIC 771
Query: 741 SN-----EDFKAL 748
S+ DFKA+
Sbjct: 772 SSIDNRGNDFKAI 784
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 581 (209.6 bits), Expect = 1.2e-84, Sum P(3) = 1.2e-84
Identities = 155/551 (28%), Positives = 248/551 (45%)
Query: 55 TDQQALLALKAHISYDPTNLLAQNSTSNTSVCNWIGITCNVNSHRVTALNISSLNLQGTI 114
TD QALL K+ +S + + + ++ CNWIG+TC RV +LN+ L G I
Sbjct: 30 TDMQALLEFKSQVSENNKREVLASWNHSSPFCNWIGVTCGRRRERVISLNLGGFKLTGVI 89
Query: 115 PPQXXXXXXXXXXXXXXXXXXGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLD 174
P IP + + +L++L+ S N L G + S N S +
Sbjct: 90 SPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNCSRLST 149
Query: 175 IRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGA 234
+ L S+ L +P + + L L +L L+KN G P +L LQ L+ + ++ G
Sbjct: 150 VDLSSNHLGHGVPSELGS-LSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMRGE 208
Query: 235 IPKEISNLTILRKISLRNNKLRGEIPHEIGYLPXXXXXXXXXXXXXXXXPAAI-FNMSTV 293
IP E++ LT + + N G P + + A + + +
Sbjct: 209 IPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLPNL 268
Query: 294 KKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYL-----DMG 348
+++ L N G+ + ++ ++ER ++ N SG+IP L +L +G
Sbjct: 269 RRLLLGTNQFTGAIPKTL-ANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLG 327
Query: 349 TNSFSGI-----IPNTIGL----TG-NPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQ 398
NS SG+ + N L G N L G LP SI NLS +L ++++ I G+IP
Sbjct: 328 NNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPH 387
Query: 399 XXXXXXXXXXXXXEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLG 458
E N L+G +PV+FG+L LQ + L N ++G IP ++ RL L
Sbjct: 388 DIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLH 447
Query: 459 LAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSL 518
L N F G IP LG L + +NRL +P + + + DLS+N L G
Sbjct: 448 LNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPE 507
Query: 519 DIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFGYLTELNLSF 578
++G L +++G+ S N SG +P IG ++ + + N +G IP+ ++ N+ F
Sbjct: 508 EVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPDISRLVSLKNVDF 567
Query: 579 --NKLEGEIPR 587
N L G IPR
Sbjct: 568 SNNNLSGRIPR 578
|
|
| TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 741 (265.9 bits), Expect = 1.7e-84, Sum P(2) = 1.7e-84
Identities = 234/775 (30%), Positives = 355/775 (45%)
Query: 76 AQNSTSNTSVCNWIGITCNVNSHRVTALNISSLNLQGTIPPQXXXXXXXXXXXXXXXXXX 135
+ +S+ VCNW G+ CN S +V L+IS +L G I P
Sbjct: 44 SSSSSMLVDVCNWSGVKCNKESTQVIELDISGRDLGGEISPSIANLTGLTVLDLSRNFFV 103
Query: 136 GDIPPSIFTMHK-LKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNI-CN- 192
G IPP I ++H+ LK L S+N L G++ L+ ++ + L S++L+G +PV + CN
Sbjct: 104 GKIPPEIGSLHETLKQLSLSENLLHGNIPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNG 163
Query: 193 YLHYLKVLFLAKNMFHGQIPLALSKC--KRLQLLNLGFKKLSGAIPKEISNLTILRKISL 250
L+ + L+ N G+IPL C K L+ L L KL+G +P +SN T L+ + L
Sbjct: 164 SSSSLQYIDLSNNSLTGEIPLNYH-CHLKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDL 222
Query: 251 RNNKLRGEIPHEI-------GYLPXXXXXXXXXXXXXXXXP--AAIFNMSTVKKIYLLDN 301
+N L GE+P ++ +L P A++ N S ++++ L N
Sbjct: 223 ESNMLSGELPSQVISKMPQLQFLYLSYNHFVSHNNNTNLEPFFASLANSSDLQELELAGN 282
Query: 302 SLLGSFSLGI-DLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNT- 359
SL G + + LS+ N+ +++L NR G+IP I+N L L++ +N SG IP
Sbjct: 283 SLGGEITSSVRHLSV-NLVQIHLDQNRIHGSIPPEISNLLNLTLLNLSSNLLSGPIPREL 341
Query: 360 --------IGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQXXXXXXXXXXXXX 411
+ L+ N L G +P +G++ L + +S N+ GSIP
Sbjct: 342 CKLSKLERVYLSNNHLTGEIPMELGDIPR-LGLLDVSRNNLSGSIPDSFGNLSQLRRLLL 400
Query: 412 EGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIP-DQLCHLARLNT-LGLAGNKFSGSIP 469
GN L+G++P + G+ L+ L L N L G+IP + + +L L L L+ N SG IP
Sbjct: 401 YGNHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIP 460
Query: 470 SCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGI 529
L + + S DL SN L+ +P + + +LS N L +G L + +
Sbjct: 461 LELSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKEL 520
Query: 530 NLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFGYLTELNLSFNKLEGEIPRGG 589
++S N +G IP + Q S L LN SFN L G + G
Sbjct: 521 DVSFNRLTGAIPPSF------QQSST---------------LKHLNFSFNLLSGNVSDKG 559
Query: 590 PFANFTAKSFMGNEKLCG-LPNLQ-------FPXXXXXXXXXXXXXMLLLVIVLPLSTAL 641
F+ T +SF+G+ LCG + +Q +P +L V PL
Sbjct: 560 SFSKLTIESFLGDSLLCGSIKGMQACKKKHKYPSVLLPVLLSLIATPVLCVFGYPLVQRS 619
Query: 642 IIAVPLALKYKSIRGGKSKTLR------RFSYQDLFRATEKFSKENLIGVGSFGSVYKGR 695
L + K + K + R SYQ L AT F+ +LIG G FG VYKG
Sbjct: 620 RFGKNLTVYAKEEVEDEEKQNQNDPKYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGV 679
Query: 696 LHDGIEVAIKVFHQNCAMALK-SFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHST 754
L + +VA+KV A+ SF+ EC+++K RHRN ++ I++CS F AL
Sbjct: 680 LRNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRIITTCSKPGFNALVLPLMP 739
Query: 755 NCSL--------------NIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNV 795
N SL ++ +NI DVA + YLH V+HCDLKP N+
Sbjct: 740 NGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNI 794
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 660 (237.4 bits), Expect = 6.8e-83, Sum P(3) = 6.8e-83
Identities = 180/589 (30%), Positives = 291/589 (49%)
Query: 93 CNVNSHRVTALNISSLNLQGTIPPQXXXXXXXXXXXXXXXXXXGDIPPSIFTMHKLKFLD 152
C+ N+ + L +S L G IP + G IP S+F + +L L
Sbjct: 333 CS-NNTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLY 391
Query: 153 FSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIP 212
++N L G+LSS NL+++ + L + L G++P I +L L++++L +N F G++P
Sbjct: 392 LNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEI-GFLGKLEIMYLYENRFSGEMP 450
Query: 213 LALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPXXXXX 272
+ + C RLQ ++ +LSG IP I L L ++ LR N+L G IP +G
Sbjct: 451 VEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVI 510
Query: 273 XXXXXXXXXXXPAAIFNMSTVKKIYLL-DNSLLGSFSLGIDLSLPNVERLNLGLNRFSGT 331
P++ F T +++++ +NSL G+ + ++L N+ R+N N+F+G+
Sbjct: 511 DLADNQLSGSIPSS-FGFLTALELFMIYNNSLQGNLPDSL-INLKNLTRINFSSNKFNGS 568
Query: 332 IPSFITNASKLVYLDMGTNSFSGIIPNTIG---------LTGNPLDGVLPTSIGNLSMSL 382
I ++S L + D+ N F G IP +G L N G +P + G +S L
Sbjct: 569 ISPLCGSSSYLSF-DVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKIS-EL 626
Query: 383 ENIYISNCNIGGSIPQXXXXXXXXXXXXXEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAG 442
+ IS ++ G IP N L+G IP G+L L L L NK G
Sbjct: 627 SLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVG 686
Query: 443 SIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDI 502
S+P ++ L + TL L GN +GSIP +GNL +L + +L N+L+ LPST L +
Sbjct: 687 SLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKL 746
Query: 503 LFFDLSSNSLDGPLSLDIGNLR-VVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLE 561
LS N+L G + ++IG L+ + ++LS NNF+G IPSTI L L+++ L+ N L
Sbjct: 747 FELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLV 806
Query: 562 GLIPESFGYLTEL---NLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPNLQFPXXXX 618
G +P G + L NLS+N LEG++ + F+ + A +F+GN LCG P
Sbjct: 807 GEVPGQIGDMKSLGYLNLSYNNLEGKLKK--QFSRWQADAFVGNAGLCGSPLSHCNRAGS 864
Query: 619 XXXXXXXXXMLLLVIVLPLSTAL---IIAVPLALK-----YKSIRGGKS 659
++++ + A+ ++ + L K +K +RGG S
Sbjct: 865 KNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNS 913
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 643 (231.4 bits), Expect = 6.2e-81, Sum P(3) = 6.2e-81
Identities = 172/549 (31%), Positives = 263/549 (47%)
Query: 53 ITTDQQALLALKAHISYDPT--NLLAQNSTSNTSVCNWIGITC-NVNSHRVTALNISSLN 109
I D Q LL +K + +P + L Q ++ N + C+W G+TC N RV ALN++ L
Sbjct: 23 INNDLQTLLEVKKSLVTNPQEDDPLRQWNSDNINYCSWTGVTCDNTGLFRVIALNLTGLG 82
Query: 110 LQGTIPPQXXXXXXXXXXXXXXXXXXGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNL 169
L G+I P G IP ++ + L+ L NQL+G + S +L
Sbjct: 83 LTGSISPWFGRFDNLIHLDLSSNNLVGPIPTALSNLTSLESLFLFSNQLTGEIPSQLGSL 142
Query: 170 SSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFK 229
++ +R+ ++L G++P + N ++ L++L LA G IP L + R+Q L L
Sbjct: 143 VNIRSLRIGDNELVGDIPETLGNLVN-LQMLALASCRLTGPIPSQLGRLVRVQSLILQDN 201
Query: 230 KLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPXXXXXXXXXXXXXXXXPAAIFN 289
L G IP E+ N + L + N L G IP E+G L P+ +
Sbjct: 202 YLEGPIPAELGNCSDLTVFTAAENMLNGTIPAELGRLENLEILNLANNSLTGEIPSQLGE 261
Query: 290 MSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGT 349
MS ++ + L+ N L G + L N++ L+L N +G IP N S+L+ L +
Sbjct: 262 MSQLQYLSLMANQLQGLIPKSL-ADLGNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLAN 320
Query: 350 NSFSGIIP------NT----IGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQX 399
N SG +P NT + L+G L G +P + SL+ + +SN ++ GSIP+
Sbjct: 321 NHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQ-SLKQLDLSNNSLAGSIPEA 379
Query: 400 XXXXXXXXXXXXEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGL 459
N L G++ + L LQ L L N L G +P ++ L +L L L
Sbjct: 380 LFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFL 439
Query: 460 AGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLD 519
N+FSG IP +GN TSL+ D+ N +P + LK++ L N L G L
Sbjct: 440 YENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLPAS 499
Query: 520 IGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESF---GYLTELNL 576
+GN + ++L+ N SG IPS+ G LK L+ + L N L+G +P+S LT +NL
Sbjct: 500 LGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINL 559
Query: 577 SFNKLEGEI 585
S N+L G I
Sbjct: 560 SHNRLNGTI 568
|
|
| TAIR|locus:2182855 ERL2 "ERECTA-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 677 (243.4 bits), Expect = 3.0e-74, Sum P(2) = 3.0e-74
Identities = 221/774 (28%), Positives = 329/774 (42%)
Query: 51 SNITTDQQALLALKAHISYDPTNLLAQNSTSNTSVCNWIGITCNVNSHRVTALNISSLNL 110
S + + +AL+A+KA S LL + N C+W G+ C+ S V +LN+S+LNL
Sbjct: 26 SPMNNEGKALMAIKASFSNVANMLLDWDDVHNHDFCSWRGVFCDNVSLNVVSLNLSNLNL 85
Query: 111 QGTIPPQXXXXXXXXXXXXXXXXXXGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLS 170
G I G IP I L ++DFS N L G + L
Sbjct: 86 GGEISSALGDLMNLQSIDLQGNKLGGQIPDEIGNCVSLAYVDFSTNLLFGDIPFSISKLK 145
Query: 171 SVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKK 230
+ + L +++L+G +P + + LK L LA+N G+IP L + LQ L L
Sbjct: 146 QLEFLNLKNNQLTGPIPATLTQ-IPNLKTLDLARNQLTGEIPRLLYWNEVLQYLGLRGNM 204
Query: 231 LSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPXXXXXXXXXXXXXXXXPAAIFNM 290
L+G + ++ LT L +R N L G IP IG P I
Sbjct: 205 LTGTLSPDMCQLTGLWYFDVRGNNLTGTIPESIGNCTSFEILDVSYNQITGVIPYNI-GF 263
Query: 291 STVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTN 350
V + L N L G I L + + L+L N +G IP + N S L + N
Sbjct: 264 LQVATLSLQGNKLTGRIPEVIGL-MQALAVLDLSDNELTGPIPPILGNLSFTGKLYLHGN 322
Query: 351 SFSGIIPNTIG---------LTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQXXX 401
+G IP +G L N L G +P +G L E + ++N N+ G IP
Sbjct: 323 KLTGQIPPELGNMSRLSYLQLNDNELVGKIPPELGKLEQLFE-LNLANNNLVGLIPSNIS 381
Query: 402 XXXXXXXXXXEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAG 461
GN L+G++P+ F L L L L N G IP +L H+ L+TL L+G
Sbjct: 382 SCAALNQFNVHGNFLSGAVPLEFRNLGSLTYLNLSSNSFKGKIPAELGHIINLDTLDLSG 441
Query: 462 NKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIG 521
N FSGSIP LG+L L +L N L LP+ F NL+ I D+S N L G + ++G
Sbjct: 442 NNFSGSIPLTLGDLEHLLILNLSRNHLNGTLPAEFGNLRSIQIIDVSFNFLAGVIPTELG 501
Query: 522 NLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFGYLTELNLSFNKL 581
L+ + + L+ N G IP + + L N++++ N L G+IP + SF
Sbjct: 502 QLQNINSLILNNNKIHGKIPDQLTNCFSLANLNISFNNLSGIIPPMKNFTRFSPASFF-- 559
Query: 582 EGEIPRGGPFANFTAKSFMGNEKLCG--LPNLQFPXXXXXXXXXXXXXMLLLVIVLPLST 639
G PF +++G+ +CG LP Q L+ +I + +
Sbjct: 560 ------GNPFL---CGNWVGS--ICGPSLPKSQVFTRVAVICMVLGFITLICMIFIAVYK 608
Query: 640 ALIIAVPLALKYKSIRGGKSKTLRRF-----SYQDLFRATEKFSKENLIGVGSFGSVYKG 694
+ L K G + ++ D+ R TE ++ +IG G+ +VYK
Sbjct: 609 SKQQKPVLKGSSKQPEGSTKLVILHMDMAIHTFDDIMRVTENLDEKYIIGYGASSTVYKC 668
Query: 695 RLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRN----HVKRISSCSN-------E 743
+AIK + + FE E E + +IRHRN H +S N E
Sbjct: 669 TSKTSRPIAIKRIYNQYPSNFREFETELETIGSIRHRNIVSLHGYALSPFGNLLFYDYME 728
Query: 744 DFKALDCLHSTN--CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNV 795
+ D LH L+ +L I + A L YLH + +IH D+K N+
Sbjct: 729 NGSLWDLLHGPGKKVKLDWETRLKIAVGAAQGLAYLHHDCTPRIIHRDIKSSNI 782
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 642 (231.1 bits), Expect = 1.1e-72, Sum P(2) = 1.1e-72
Identities = 199/728 (27%), Positives = 325/728 (44%)
Query: 96 NSHRVTALNISSLNLQGTIPPQXXXXXXXXXXXXXXXXXXGDIPPSIFTMHKLKFLDFSD 155
N ++ AL I L +IP G I I + L+ L
Sbjct: 286 NLVQLQALRIYKNKLTSSIPSSLFRLTQLTHLGLSENHLVGPISEEIGFLESLEVLTLHS 345
Query: 156 NQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLAL 215
N +G NL ++ + + + +SGELP ++ L L+ L N+ G IP ++
Sbjct: 346 NNFTGEFPQSITNLRNLTVLTVGFNNISGELPADL-GLLTNLRNLSAHDNLLTGPIPSSI 404
Query: 216 SKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPXXXXXXXX 275
S C L+LL+L +++G IP+ + L IS+ N GEIP +I
Sbjct: 405 SNCTGLKLLDLSHNQMTGEIPRGFGRMN-LTFISIGRNHFTGEIPDDIFNCSNLETLSVA 463
Query: 276 XXXXXXXXPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSF 335
I + ++ + + NSL G I +L ++ L L N F+G IP
Sbjct: 464 DNNLTGTLKPLIGKLQKLRILQVSYNSLTGPIPREIG-NLKDLNILYLHSNGFTGRIPRE 522
Query: 336 ITNASKLVYLDMGTNSFSGIIP---------NTIGLTGNPLDGVLPTSIGNLSMSLENIY 386
++N + L L M +N G IP + + L+ N G +P L SL +
Sbjct: 523 MSNLTLLQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLE-SLTYLS 581
Query: 387 ISNCNIGGSIPQXXXXXXXXXXXXXEGNKLTGSIP-VTFGRLQKLQGLYLPF--NKLAGS 443
+ GSIP N LTG+IP L+ +Q LYL F N L G+
Sbjct: 582 LQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGELLASLKNMQ-LYLNFSNNLLTGT 640
Query: 444 IPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPS-TFWNLKDI 502
IP +L L + + L+ N FSGSIP L ++ + D N L+ +P F + I
Sbjct: 641 IPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMI 700
Query: 503 LFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEG 562
+ +LS NS G + GN+ ++ ++LS NN +G+IP ++ +L L+++ LA N L+G
Sbjct: 701 ISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKG 760
Query: 563 LIPESFGYLTELNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPNLQFPXXXXXXXX 622
+PES G +N S L G G + K +K
Sbjct: 761 HVPES-GVFKNINAS--DLMGNTDLCG--SKKPLKPCTIKQKSSHFSKRTRVILIILGSA 815
Query: 623 XXXXXMLLLVIVLPLSTALIIAVPLALKYKSIRGGKSKTLRRFSYQDLFRATEKFSKENL 682
+LLLV++L + + + + L+RF ++L +AT+ F+ N+
Sbjct: 816 AALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANI 875
Query: 683 IGVGSFGSVYKGRLHDGIEVAIKVFH--QNCAMALKSFEAECEVMKNIRHRNHVKRIS-S 739
IG S +VYKG+L DG +A+KV + + A + K F E + + ++HRN VK + +
Sbjct: 876 IGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFA 935
Query: 740 CSNEDFKAL-----------DCLHSTNCSL-NIFDKLNIMIDVASALEYLHFSHSTPVIH 787
+ KAL D +H + + ++ +K+++ + +AS ++YLH + P++H
Sbjct: 936 WESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGFPIVH 995
Query: 788 CDLKPKNV 795
CDLKP N+
Sbjct: 996 CDLKPANI 1003
|
|
| UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 730 (262.0 bits), Expect = 3.2e-72, P = 3.2e-72
Identities = 205/660 (31%), Positives = 312/660 (47%)
Query: 73 NLLAQNSTSNTSVCNWIGITCNV-NSHRVTALNISSLNLQGTIPPQXXXXXXXXXXXXXX 131
+L + N++ + C W+G+ C + HRV L + S NL G I P
Sbjct: 52 SLASWNTSGHGQHCTWVGVVCGRRHPHRVVKLRLRSSNLAGIISPSLGNLSFLRTLQLSD 111
Query: 132 XXXXGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNIC 191
G IP + + +L+ L + N LSG + + NL+S+ + L ++ LSG +P ++
Sbjct: 112 NHLSGKIPQELSRLSRLQQLVLNFNSLSGEIPAALGNLTSLSVLELTNNTLSGAIPSSL- 170
Query: 192 NYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLR 251
L L L LA+N G IP + + +RL L+L F LSGAIP I N++ L +
Sbjct: 171 GKLTGLTDLALAENTLSGSIPSSFGQLRRLSFLSLAFNNLSGAIPDPIWNISSLTIFEVI 230
Query: 252 NNKLRGEIP-HEIGYLPXXXXXXXXXXXXXXXXPAAIFNMSTVKKIYLLDNSLLGSFSLG 310
+NKL G +P + LP PA+I N S + + NS G
Sbjct: 231 SNKLSGTLPTNAFSNLPSLQEVYMYYNQFHGRIPASIGNASNISIFTIGLNSFSGVVPPE 290
Query: 311 IDLSLPNVERLNLG--LNRFSGT----IPSFITNASKLVYLDMGTNSFSGIIPNTIG--- 361
I + N++RL L L+ T + +TN S L +++G F G++P+++
Sbjct: 291 IG-RMRNLQRLELPETLSEAEETNDWKFMTALTNCSNLQEVELGGCKFGGVLPDSVSNLS 349
Query: 362 -------LTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQXXXXXXXXXXXXXEGN 414
+ N + G LP IGNL ++L+ + ++N ++ GS+P + N
Sbjct: 350 SSLVSLSIRDNKISGSLPRDIGNL-VNLQYLSLANNSLTGSLPSSFSKLKNLRRLTVDNN 408
Query: 415 KLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGN 474
KL GS+P+T G L +L + + FN G+IP L +L +L + L N F G IP + +
Sbjct: 409 KLIGSLPLTIGNLTQLTNMEVQFNAFGGTIPSTLGNLTKLFQINLGHNNFIGQIPIEIFS 468
Query: 475 LTSLRSP-DLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSR 533
+ +L D+ N L +P LK+I+ F SN L G IG +++ + L
Sbjct: 469 IPALSEILDVSHNNLEGSIPKEIGKLKNIVEFHADSNKLSGENPSTIGECQLLQHLFLQN 528
Query: 534 NNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFG---YLTELNLSFNKLEGEIPRGGP 590
N +G IP + LK L + L+ N L G IP S G L LNLSFN GE+P G
Sbjct: 529 NFLNGSIPIALTQLKGLDTLDLSGNNLSGQIPMSLGDMPLLHSLNLSFNSFHGEVPTNGV 588
Query: 591 FANFTAKSFMGNEKLCG-LPNLQFPXXXXXXXXXXXXXMLLLVIVLPL-STALIIAVPLA 648
FAN + GN +CG +P L P +LLLV+V+ L ST + ++
Sbjct: 589 FANASEIYIQGNAHICGGIPELHLPTCSLKSRKKKKHQILLLVVVICLVSTLAVFSLLYM 648
Query: 649 L------KYKSIRGGKSKTLR-RFSYQDLFRATEKFSKENLIGVGSFGSVYKGRL--HDG 699
L + K + S +Y+ L +AT+ FS +L+G GSFGSVYKG DG
Sbjct: 649 LLTCHKRRKKEVPATTSMQGHPMITYKQLVKATDGFSSSHLLGSGSFGSVYKGEFDSQDG 708
|
|
| TAIR|locus:2122239 AT4G36180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 642 (231.1 bits), Expect = 1.6e-71, Sum P(2) = 1.6e-71
Identities = 178/566 (31%), Positives = 265/566 (46%)
Query: 59 ALLALKAHISYDPTNLLAQNSTSNTSV-CNWIGITCNVNSHRVTALNISSLNLQGTIPPQ 117
AL A K ++ +DP L S + C+W G+ C +HRVT + + L L G I +
Sbjct: 31 ALTAFKLNL-HDPLGALTSWDPSTPAAPCDWRGVGCT--NHRVTEIRLPRLQLSGRISDR 87
Query: 118 XXXXXXXXXXXXXXXXXXGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRL 177
G IP S+ +L + N LSG L NL+S+ +
Sbjct: 88 ISGLRMLRKLSLRSNSFNGTIPTSLAYCTRLLSVFLQYNSLSGKLPPAMRNLTSLEVFNV 147
Query: 178 DSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPK 237
++LSGE+PV + + L +L + + N F GQIP L+ +LQLLNL + +L+G IP
Sbjct: 148 AGNRLSGEIPVGLPSSLQFLDI---SSNTFSGQIPSGLANLTQLQLLNLSYNQLTGEIPA 204
Query: 238 EISNLTILRKISLRNNKLRGEIPHEIGYLPXXXXXXXXXXXXXXXXPAAIFNMSTVKKIY 297
+ NL L+ + L N L+G +P I PAA + ++ +
Sbjct: 205 SLGNLQSLQYLWLDFNLLQGTLPSAISNCSSLVHLSASENEIGGVIPAAYGALPKLEVLS 264
Query: 298 LLDNSLLGS--FSLGIDLSLPNVERLNLGLNRFSGTI-PSFITNA-SKLVYLDMGTNSFS 353
L +N+ G+ FSL + SL V+ LG N FS + P N + L LD+ N S
Sbjct: 265 LSNNNFSGTVPFSLFCNTSLTIVQ---LGFNAFSDIVRPETTANCRTGLQVLDLQENRIS 321
Query: 354 GIIP----NTIGL-----TGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQXXXXXX 404
G P N + L +GN G +P IGNL LE + ++N ++ G IP
Sbjct: 322 GRFPLWLTNILSLKNLDVSGNLFSGEIPPDIGNLKR-LEELKLANNSLTGEIPVEIKQCG 380
Query: 405 XXXXXXXEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKF 464
EGN L G IP G ++ L+ L L N +G +P + +L +L L L N
Sbjct: 381 SLDVLDFEGNSLKGQIPEFLGYMKALKVLSLGRNSFSGYVPSSMVNLQQLERLNLGENNL 440
Query: 465 SGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLR 524
+GS P L LTSL DL NR + +P + NL ++ F +LS N G + +GNL
Sbjct: 441 NGSFPVELMALTSLSELDLSGNRFSGAVPVSISNLSNLSFLNLSGNGFSGEIPASVGNLF 500
Query: 525 VVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFGYLTEL---NLSFNKL 581
+ ++LS+ N SG++P + L ++Q I+L N G++PE F L L NLS N
Sbjct: 501 KLTALDLSKQNMSGEVPVELSGLPNVQVIALQGNNFSGVVPEGFSSLVSLRYVNLSSNSF 560
Query: 582 EGEIPRGGPFANFTAKSFMGNEKLCG 607
GEIP+ F + + + G
Sbjct: 561 SGEIPQTFGFLRLLVSLSLSDNHISG 586
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| fgenesh4_pg.C_LG_XVI000210 | hypothetical protein (1019 aa) | ||||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 827 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-81 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-56 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-46 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-41 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-24 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-23 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-21 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-20 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-20 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-19 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-18 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-18 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-15 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-13 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-12 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-12 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-12 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-12 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-11 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-10 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-10 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-09 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-09 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-09 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-09 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-09 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-09 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-09 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-09 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-09 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-08 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-08 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-08 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-08 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-08 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 8e-08 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-07 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-07 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-07 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-07 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-07 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-07 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-07 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-07 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-07 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-07 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-06 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-06 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-06 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-06 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-06 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-06 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-06 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-06 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-06 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-06 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-06 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-06 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-06 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-05 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-05 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-05 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-05 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-05 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-05 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-05 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-05 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-05 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-05 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-05 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-05 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-05 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-05 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-05 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 9e-05 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-05 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-04 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-04 | |
| pfam03109 | 117 | pfam03109, ABC1, ABC1 family | 2e-04 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-04 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-04 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-04 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-04 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-04 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-04 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-04 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-04 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-04 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-04 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-04 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 8e-04 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-04 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-04 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 0.001 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 0.001 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 0.001 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 0.001 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 0.001 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 0.001 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 0.001 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 0.002 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 0.002 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 0.002 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 0.002 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 0.002 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.002 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 0.002 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 0.002 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 0.003 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.003 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 0.003 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 0.003 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 0.003 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 0.003 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 0.003 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 0.003 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 0.003 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 0.004 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 280 bits (718), Expect = 4e-81
Identities = 192/559 (34%), Positives = 288/559 (51%), Gaps = 60/559 (10%)
Query: 35 LTHCLLLYLVVAVAAASNITTDQQALLALKAHISYDPTNLLAQNSTSNTSVCNWIGITCN 94
+ L+L ++ A + + LL+ K+ I+ DP L+ ++S VC W GITCN
Sbjct: 13 IFMLFFLFLNFSMLHAEEL----ELLLSFKSSIN-DPLKYLSNWNSSAD-VCLWQGITCN 66
Query: 95 VNSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTM-HKLKFLDF 153
NS RV ++++S N+ G I + L + T+NLS+N+LSG IP IFT L++L+
Sbjct: 67 -NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNL 125
Query: 154 SDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPL 213
S+N +GS+ G +P L+ L L+ NM G+IP
Sbjct: 126 SNNNFTGSIP-------------------RGSIPN--------LETLDLSNNMLSGEIPN 158
Query: 214 ALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLV 273
+ L++L+LG L G IP ++NLT L ++L +N+L G+IP E+G + +L+ +
Sbjct: 159 DIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIY 218
Query: 274 LGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSF--SLGIDLSLPNVERLNLGLNRFSGT 331
LG+NNL G +P I ++++ + L+ N+L G SLG +L N++ L L N+ SG
Sbjct: 219 LGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLG---NLKNLQYLFLYQNKLSGP 275
Query: 332 IPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCN 391
IP I + KL+ LD+ NS SG IP + N LE +++ + N
Sbjct: 276 IPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQN----------------LEILHLFSNN 319
Query: 392 IGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHL 451
G IP +++L L +L L NK +G IP G+ L L L N L G IP+ LC
Sbjct: 320 FTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSS 379
Query: 452 ARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNS 511
L L L N G IP LG SLR L N + LPS F L + F D+S+N+
Sbjct: 380 GNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNN 439
Query: 512 LDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFGYL 571
L G ++ ++ + ++L+RN F G +P + G K L+N+ L+ N G +P G L
Sbjct: 440 LQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSL 498
Query: 572 TE---LNLSFNKLEGEIPR 587
+E L LS NKL GEIP
Sbjct: 499 SELMQLKLSENKLSGEIPD 517
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 209 bits (533), Expect = 2e-56
Identities = 138/390 (35%), Positives = 203/390 (52%), Gaps = 25/390 (6%)
Query: 109 NLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFN 168
NL G IP ++G L+SL L+L +N L+G IP S+ + L++L N+LSG + F+
Sbjct: 223 NLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFS 282
Query: 169 LSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGF 228
L ++ + L + LSGE+P + L L++L L N F G+IP+AL+ RLQ+L L
Sbjct: 283 LQKLISLDLSDNSLSGEIPELVIQ-LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWS 341
Query: 229 KKLSGAIPKEI---SNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPA 285
K SG IPK + +NLT+L L N L GEIP + NL L+L N+L G +P
Sbjct: 342 NKFSGEIPKNLGKHNNLTVL---DLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPK 398
Query: 286 AIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYL 345
++ +++++ L DNS G LP V L++ N G I S + L L
Sbjct: 399 SLGACRSLRRVRLQDNSFSGELPSEF-TKLPLVYFLDISNNNLQGRINSRKWDMPSLQML 457
Query: 346 DMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSN 405
+ N F G +P++ G S LEN+ +S G++P+ + +LS
Sbjct: 458 SLARNKFFGGLPDSFG-----------------SKRLENLDLSRNQFSGAVPRKLGSLSE 500
Query: 406 LLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFS 465
L+ L L NKL+G IP +KL L L N+L+G IP + L+ L L+ N+ S
Sbjct: 501 LMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLS 560
Query: 466 GSIPSCLGNLTSLRSPDLGSNRLTSVLPST 495
G IP LGN+ SL ++ N L LPST
Sbjct: 561 GEIPKNLGNVESLVQVNISHNHLHGSLPST 590
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 3e-46
Identities = 126/362 (34%), Positives = 184/362 (50%), Gaps = 17/362 (4%)
Query: 240 SNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMS-TVKKIYL 298
+N + + I L + G+I I LP ++ + L N L G +P IF S +++ + L
Sbjct: 66 NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNL 125
Query: 299 LDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPN 358
+N+ GS G S+PN+E L+L N SG IP+ I + S L LD+G N G IPN
Sbjct: 126 SNNNFTGSIPRG---SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN 182
Query: 359 TIG---------LTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLL 409
++ L N L G +P +G + SL+ IY+ N+ G IP I L++L L
Sbjct: 183 SLTNLTSLEFLTLASNQLVGQIPRELGQMK-SLKWIYLGYNNLSGEIPYEIGGLTSLNHL 241
Query: 410 DLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIP 469
DL N LTG IP + G L+ LQ L+L NKL+G IP + L +L +L L+ N SG IP
Sbjct: 242 DLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP 301
Query: 470 SCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGI 529
+ L +L L SN T +P +L + L SN G + ++G + +
Sbjct: 302 ELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVL 361
Query: 530 NLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFG---YLTELNLSFNKLEGEIP 586
+LS NN +G+IP + +L + L N LEG IP+S G L + L N GE+P
Sbjct: 362 DLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELP 421
Query: 587 RG 588
Sbjct: 422 SE 423
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 163 bits (413), Expect = 3e-41
Identities = 116/312 (37%), Positives = 161/312 (51%), Gaps = 24/312 (7%)
Query: 289 NMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFI-TNASKLVYLDM 347
N S V I L ++ G S I LP ++ +NL N+ SG IP I T +S L YL++
Sbjct: 67 NSSRVVSIDLSGKNISGKISSAI-FRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNL 125
Query: 348 GTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLL 407
N+F+G IP G +P +LE + +SN + G IP I + S+L
Sbjct: 126 SNNNFTGSIPR----------GSIP--------NLETLDLSNNMLSGEIPNDIGSFSSLK 167
Query: 408 LLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGS 467
+LDL GN L G IP + L L+ L L N+L G IP +L + L + L N SG
Sbjct: 168 VLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGE 227
Query: 468 IPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVI 527
IP +G LTSL DL N LT +PS+ NLK++ + L N L GP+ I +L+ +I
Sbjct: 228 IPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLI 287
Query: 528 GINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPE---SFGYLTELNLSFNKLEGE 584
++LS N+ SG+IP + L++L+ + L N G IP S L L L NK GE
Sbjct: 288 SLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGE 347
Query: 585 IPRG-GPFANFT 595
IP+ G N T
Sbjct: 348 IPKNLGKHNNLT 359
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-24
Identities = 69/211 (32%), Positives = 109/211 (51%), Gaps = 2/211 (0%)
Query: 96 NSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSD 155
+S + L + S +L+G IP LG SL + L N SG++P + + FLD S+
Sbjct: 378 SSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISN 437
Query: 156 NQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLAL 215
N L G ++S +++ S+ + L +K G LP + + L+ L L++N F G +P L
Sbjct: 438 NNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS--KRLENLDLSRNQFSGAVPRKL 495
Query: 216 SKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLG 275
L L L KLSG IP E+S+ L + L +N+L G+IP +P L L L
Sbjct: 496 GSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLS 555
Query: 276 FNNLVGVVPAAIFNMSTVKKIYLLDNSLLGS 306
N L G +P + N+ ++ ++ + N L GS
Sbjct: 556 QNQLSGEIPKNLGNVESLVQVNISHNHLHGS 586
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 2e-23
Identities = 54/166 (32%), Positives = 82/166 (49%), Gaps = 28/166 (16%)
Query: 683 IGVGSFGSVYKGRLH-DGIEVAIKVFH-QNCAMALKSFEAECEVMKNIRHRNHVKRISSC 740
+G G FG+VY R G +VAIK+ ++ + L+ E E++K + H N VK
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 741 SNEDFKAL-----------DCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCD 789
+E+ L D L L+ + L I++ + LEYLH S +IH D
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRD 117
Query: 790 LKPKNVF-----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
LKP+N+ DFG+ +LLT D+S+++T + T YMAP
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT-IVGTPAYMAP 162
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 5e-21
Identities = 50/171 (29%), Positives = 72/171 (42%), Gaps = 29/171 (16%)
Query: 677 FSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFH-QNCAMALKSFEAECEVMKNIRHRNHV 734
+ +G GSFG VY R G VAIKV + + E +++K ++H N V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 735 KRISSCSNEDFKAL-----------DCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHST 783
+ +ED L D L L+ + + + SALEYLH S
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLH-SKG- 117
Query: 784 PVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
++H DLKP+N+ DFG+ R L + T + T YMAP
Sbjct: 118 -IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL--TTFVGTPEYMAP 165
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 1e-20
Identities = 47/176 (26%), Positives = 74/176 (42%), Gaps = 34/176 (19%)
Query: 678 SKENLIGVGSFGSVYKGRL-----HDGIEVAIKVFHQNCAM-ALKSFEAECEVMKNIRHR 731
+ +G G+FG VYKG+L +EVA+K ++ + ++ F E +M+ + H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 732 NHVKRISSCSNE-------------DFKALDCLHSTNCSLNIFDKLNIMIDVASALEYLH 778
N VK + C+ E D L L++ D L+ + +A +EYL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLL--SYLRKNRPKLSLSDLLSFALQIARGMEYL- 118
Query: 779 FSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
S IH DL +N DFG+ R L D + + I +MAP
Sbjct: 119 --ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAP 172
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 6e-20
Identities = 46/166 (27%), Positives = 73/166 (43%), Gaps = 29/166 (17%)
Query: 683 IGVGSFGSVYKGRLH-DGIEVAIKVF---HQNCAMALKSFEAECEVMKNIRHRNHVKRIS 738
+G GSFG+VYK + G VA+K+ + ++ E +++ + H N V+ I
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKK-DQTARREIRILRRLSHPNIVRLID 65
Query: 739 SCSNEDFKA----------LDCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHC 788
+ ++D L S L+ + I + + LEYLH S+ +IH
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLH-SNG--IIHR 122
Query: 789 DLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
DLKP+N+ DFG+ + L S + T T YMAP
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAP 167
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 6e-19
Identities = 45/175 (25%), Positives = 77/175 (44%), Gaps = 29/175 (16%)
Query: 676 KFSKENLIGVGSFGSVYKGRLHD-GIEVAIKV--FHQNCAMALKSFEAECEVMKNIRHRN 732
++++ L+G GSFGSVY D G +A+K + L++ E E ++ +++H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 733 HVKRISSCSNEDFKALDCL--HSTNCSL----NIFDKLNI------MIDVASALEYLHFS 780
V+ S +E+ L+ + + SL F KL + L YLH S
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH-S 119
Query: 781 HSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-TIGYMAP 824
+ ++H D+K N+ DFG + L + T ++ T +MAP
Sbjct: 120 NG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 4e-18
Identities = 45/177 (25%), Positives = 73/177 (41%), Gaps = 33/177 (18%)
Query: 676 KFSKENLIGVGSFGSVYKGRLHD-----GIEVAIKVFHQNCA-MALKSFEAECEVMKNIR 729
+ K+ +G G+FG VYKG L +VA+K + + + F E +MK +
Sbjct: 2 ELGKK--LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLS 59
Query: 730 HRNHVKRISSCSNED-------FKA----LDCLHSTNCSLNIFDKLNIMIDVASALEYLH 778
H N V+ + C+ + + LD L L + D L + + +A +EYL
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYL- 118
Query: 779 FSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTE-TLVTIGYMAP 824
S +H DL +N DFG+ R + D + + I +MAP
Sbjct: 119 --ESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAP 173
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 5e-18
Identities = 46/175 (26%), Positives = 73/175 (41%), Gaps = 31/175 (17%)
Query: 678 SKENLIGVGSFGSVYKGRL-----HDGIEVAIKVFHQNCAM-ALKSFEAECEVMKNIRHR 731
+ +G G+FG VYKG L +EVA+K ++ + ++ F E +M+ + H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 732 NHVKRISSCSNED-------FKALDCLHS-----TNCSLNIFDKLNIMIDVASALEYLHF 779
N VK + C+ E+ + L L++ D L+ + +A +EYL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL-- 119
Query: 780 SHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
S IH DL +N DFG+ R L D + I +MAP
Sbjct: 120 -ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAP 173
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (185), Expect = 7e-15
Identities = 47/192 (24%), Positives = 74/192 (38%), Gaps = 63/192 (32%)
Query: 676 KFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEA---ECEVMKNIRHR 731
K+ IG GSFG VY R DG +K + M+ K E E +++K + H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN-MSEKEREDALNEVKILKKLNHP 59
Query: 732 NHVKRISSCSNEDFKALDCLHSTNCSLNI----------FDK----------------LN 765
N +K E F+ L I K L+
Sbjct: 60 NIIKYY-----ESFE-------EKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILD 107
Query: 766 IMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTET 815
+ + AL+YLH ++H D+KP+N+F DFGI ++L+ + +T
Sbjct: 108 WFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT-- 162
Query: 816 LVTIG---YMAP 824
+G Y++P
Sbjct: 163 --VVGTPYYLSP 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 1e-14
Identities = 49/180 (27%), Positives = 73/180 (40%), Gaps = 40/180 (22%)
Query: 681 NLIGVGSFGSVYKGRLHDG----IEVAIKVFHQNCAM--ALKSFEAECEVMKNIRHRNHV 734
+G G+FG VYKG+L EVA+K A K F E VMK + H N V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLK-EDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 735 KRISSCSNED----------FKALD-------CLHSTNC--SLNIFDKLNIMIDVASALE 775
+ + C+ E+ L + + +L++ D L+ I +A +E
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 776 YLHFSHSTPVIHCDLKPKNVF----------DFGIGRLL-TGDRSMIQTETLVTIGYMAP 824
YL S +H DL +N DFG+ R + D +T + I +MAP
Sbjct: 120 YL---ASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-13
Identities = 44/116 (37%), Positives = 67/116 (57%), Gaps = 1/116 (0%)
Query: 97 SHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDN 156
S R+ L++S G +P +LG+LS L L LS NKLSG+IP + + KL LD S N
Sbjct: 474 SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHN 533
Query: 157 QLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIP 212
QLSG + + + + + L ++LSGE+P N+ N ++V ++ N HG +P
Sbjct: 534 QLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQV-NISHNHLHGSLP 588
|
Length = 968 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 4e-13
Identities = 50/169 (29%), Positives = 77/169 (45%), Gaps = 29/169 (17%)
Query: 680 ENLIGVGSFGSVYKG--RLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRI 737
++ +G G +G VY+G + + VA+K ++ M ++ F E VMK I+H N V+ +
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLT-VAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLL 68
Query: 738 SSCSNE-------DFKA----LDCLHSTN-CSLNIFDKLNIMIDVASALEYLHFSHSTPV 785
C+ E +F LD L N +N L + ++SA+EYL +
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---F 125
Query: 786 IHCDLKPKN----------VFDFGIGRLLTGDRSMIQTETLVTIGYMAP 824
IH DL +N V DFG+ RL+TGD I + AP
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 174
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-12
Identities = 35/87 (40%), Positives = 49/87 (56%)
Query: 387 ISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPD 446
+ N + G IP IS L +L ++L GN + G+IP + G + L+ L L +N GSIP+
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484
Query: 447 QLCHLARLNTLGLAGNKFSGSIPSCLG 473
L L L L L GN SG +P+ LG
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 51/173 (29%), Positives = 69/173 (39%), Gaps = 31/173 (17%)
Query: 676 KFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHV 734
F IG G FG VYK R G EVAIKV + E +++K +H N V
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 735 KRISSCSNEDF-----------KALDCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHST 783
K S +D D L STN +L + ++ LEYLH +
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG-- 118
Query: 784 PVIHCDLKPKNVF----------DFGI-GRLLTGDRSMIQTETLV-TIGYMAP 824
+IH D+K N+ DFG+ +L T+V T +MAP
Sbjct: 119 -IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT----KARNTMVGTPYWMAP 166
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 54/170 (31%), Positives = 76/170 (44%), Gaps = 23/170 (13%)
Query: 676 KFSKENLIGVGSFGSVYKG-RLHDGIEVAIK--VFHQNCAMALKSFEAECEVMKNIRHRN 732
+ +LIG G+FG VYKG L G VAIK + ALKS E +++KN++H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 733 HVKRISSCSNEDFKALDCLHSTNCSL-NI---FDKLN---IMIDVASALEYLHFSHSTPV 785
VK I S D + ++ N SL I F + + V L+ L + H V
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGV 120
Query: 786 IHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-TIGYMAP 824
IH D+K N+ DFG+ L ++V T +MAP
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--DDASVVGTPYWMAP 168
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 69.0 bits (167), Expect = 3e-12
Identities = 47/182 (25%), Positives = 75/182 (41%), Gaps = 38/182 (20%)
Query: 676 KFSKENLIGVGSFGSVYKGRLHDGIEVAIKVF---HQNCAMALKSFEAECEVMKNIRHRN 732
+ +G GSFG VY R D VA+KV ++ + ++ F E +++ ++ H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 733 HVKRISS--------------CSNEDFKALDCLHSTNCSLNIFDKLNIMIDVASALEYLH 778
++ ++ + L L+ + L I+ + SALEYLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 779 FSHSTPVIHCDLKPKNVF-----------DFGIGRLLTGDRSMIQTETL-----VTIGYM 822
S +IH D+KP+N+ DFG+ +LL S L T GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 823 AP 824
AP
Sbjct: 176 AP 177
|
Length = 384 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 7e-12
Identities = 35/86 (40%), Positives = 48/86 (55%)
Query: 409 LDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSI 468
L L+ L G IP +L+ LQ + L N + G+IP L + L L L+ N F+GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 469 PSCLGNLTSLRSPDLGSNRLTSVLPS 494
P LG LTSLR +L N L+ +P+
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPA 508
|
Length = 623 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 40/158 (25%), Positives = 70/158 (44%), Gaps = 25/158 (15%)
Query: 672 RATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHR 731
R E+F+ E +G G FG V++G + + VAIK+ + + + F+ E + +K +RH+
Sbjct: 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHK 62
Query: 732 NHVKRISSCS--------NEDFKALDCLHSTNC----SLNIFDKLNIMIDVASALEYLHF 779
+ + + CS E + L L + +++ VA + YL
Sbjct: 63 HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 780 SHSTPVIHCDLKPKNVF----------DFGIGRLLTGD 807
+S IH DL +N+ DFG+ RL+ D
Sbjct: 123 QNS---IHRDLAARNILVGEDLVCKVADFGLARLIKED 157
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-11
Identities = 34/104 (32%), Positives = 57/104 (54%), Gaps = 4/104 (3%)
Query: 88 WIGITCNVNSHR----VTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIF 143
W G C +S + + L + + L+G IP + L L ++NLS N + G+IPPS+
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG 463
Query: 144 TMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELP 187
++ L+ LD S N +GS+ L+S+ + L+ + LSG +P
Sbjct: 464 SITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 46/184 (25%), Positives = 68/184 (36%), Gaps = 45/184 (24%)
Query: 683 IGVGSFGSVYKGRLHDGIE------VAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVK 735
+G G+FG V+ G + VA+K + A K FE E E++ N +H N VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 736 RISSCSNE------------------------DFKALDCLHSTNCSLNIFDKLNIMIDVA 771
C+ D L S L + L I + +A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 772 SALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGR-LLTGDRSMIQTETLVTIG 820
S + YL H +H DL +N DFG+ R + T D + T++ I
Sbjct: 133 SGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 821 YMAP 824
+M P
Sbjct: 190 WMPP 193
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-11
Identities = 30/91 (32%), Positives = 51/91 (56%), Gaps = 1/91 (1%)
Query: 177 LDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIP 236
LD+ L G +P +I + L +L+ + L+ N G IP +L L++L+L + +G+IP
Sbjct: 425 LDNQGLRGFIPNDI-SKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP 483
Query: 237 KEISNLTILRKISLRNNKLRGEIPHEIGYLP 267
+ + LT LR ++L N L G +P +G
Sbjct: 484 ESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 7e-11
Identities = 24/67 (35%), Positives = 44/67 (65%)
Query: 98 HRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQ 157
+ ++N+S +++G IPP LG+++SL L+LS+N +G IP S+ + L+ L+ + N
Sbjct: 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNS 501
Query: 158 LSGSLSS 164
LSG + +
Sbjct: 502 LSGRVPA 508
|
Length = 623 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 42/164 (25%), Positives = 70/164 (42%), Gaps = 26/164 (15%)
Query: 683 IGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSN 742
+G G FG V++G ++ VA+K M K F AE ++MK +RH ++ + C+
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPG-TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 743 ED-----------FKALDCLH-STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDL 790
E+ L+ L +L + +++ VAS + YL + IH DL
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDL 129
Query: 791 KPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
+NV DFG+ R++ D + I + AP
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAP 173
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-10
Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 5/106 (4%)
Query: 360 IGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGS 419
+GL L G +P I L L++I +S +I G+IP + ++++L +LDL N GS
Sbjct: 423 LGLDNQGLRGFIPNDISKLR-HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 420 IPVTFGRLQKLQGLYLPFNKLAGSIP----DQLCHLARLNTLGLAG 461
IP + G+L L+ L L N L+G +P +L H A N AG
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAG 527
|
Length = 623 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 43/164 (26%), Positives = 71/164 (43%), Gaps = 26/164 (15%)
Query: 683 IGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSN 742
+G G FG V+ G + +VA+K M+ ++F E ++MK +RH V+ + CS
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 743 ED-------FKA----LDCLHS-TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDL 790
E+ + + LD L S L + +++ +A + YL S IH DL
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL---ESRNYIHRDL 129
Query: 791 KPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
+N+ DFG+ RL+ D + I + AP
Sbjct: 130 AARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAP 173
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 6e-10
Identities = 30/82 (36%), Positives = 49/82 (59%)
Query: 224 LNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVV 283
L L + L G IP +IS L L+ I+L N +RG IP +G + +LE L L +N+ G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 284 PAAIFNMSTVKKIYLLDNSLLG 305
P ++ +++++ + L NSL G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSG 504
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 7e-10
Identities = 37/131 (28%), Positives = 63/131 (48%), Gaps = 19/131 (14%)
Query: 482 DLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIP 541
L + L +P+ L+ + +LS NS+ G + +G++ + ++LS N+F+G IP
Sbjct: 424 GLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP 483
Query: 542 STIGDLKDLQNISLACNGLEGLIPESFGYLTELNLSFNKLEGEIPRGGPFANFTAKSFMG 601
++G L L+ ++L N L G +P + G G + F NFT
Sbjct: 484 ESLGQLTSLRILNLNGNSLSGRVPAALG-------------GRLLHRASF-NFT-----D 524
Query: 602 NEKLCGLPNLQ 612
N LCG+P L+
Sbjct: 525 NAGLCGIPGLR 535
|
Length = 623 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 7e-10
Identities = 47/181 (25%), Positives = 74/181 (40%), Gaps = 42/181 (23%)
Query: 683 IGVGSFGSVYK-GRLHDGIEVAIKVFH------QNCAMALKSFEAECEVMKNIRHRNHVK 735
IG GSFG+V K R DG + K + + +E +++ ++H N V+
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV----SEVNILRELKHPNIVR 63
Query: 736 ---RISSCSNED-FKALDCLHSTNCSLNI------FDKL------NIMIDVASALEYLHF 779
RI SN+ + ++ + + I + I+ + AL H
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 780 -SHSTP-VIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-TIGYMAPGL 826
S V+H DLKP N+F DFG+ ++L D S +T V T YM+P
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF--AKTYVGTPYYMSPEQ 181
Query: 827 L 827
L
Sbjct: 182 L 182
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 44/157 (28%), Positives = 59/157 (37%), Gaps = 27/157 (17%)
Query: 683 IGVGSFGSVYKG--RLHDG--IEVAIKVFHQNCAMALKS-FEAECEVMKNIRHRNHVKRI 737
+G G+FGSV KG + G +EVA+K Q A K F E VM + H V+ I
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 738 SSCSNEDF------KALDCLHS---TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHC 788
C E L L + + D + VA + YL H +H
Sbjct: 63 GVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH---FVHR 119
Query: 789 DLKPKNVF----------DFGIGRLLTGDRSMIQTET 815
DL +NV DFG+ R L + T
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (144), Expect = 2e-09
Identities = 48/177 (27%), Positives = 74/177 (41%), Gaps = 33/177 (18%)
Query: 677 FSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAEC--EV--MKNIRHR 731
+ K +G G++G VYK R G VA+K + + + E+ +K ++H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHP 58
Query: 732 NHVKRISSCSNED-----FKALDC-----LHSTNCSLNIFDKLNIMIDVASALEYLHFSH 781
N VK + E F+ D L L+ +IM + L Y H SH
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH-SH 117
Query: 782 STPVIHCDLKPKNVF----------DFGIGRLLT-GDRSMIQTETLVTIGYMAPGLL 827
++H DLKP+N+ DFG+ R R+ T +VT+ Y AP +L
Sbjct: 118 R--ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY--THEVVTLWYRAPEIL 170
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 2e-09
Identities = 50/176 (28%), Positives = 73/176 (41%), Gaps = 33/176 (18%)
Query: 674 TEKFSKENLIGVGSFGSVYKG-RLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRN 732
E + IG G+ G VYK G EVAIK + E +MK+ +H N
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPN 76
Query: 733 HVKRISS--CSNEDFKALD-----CLHSTNCSLNIFDKLN------IMIDVASALEYLHF 779
V S +E + ++ L T+ F ++N + +V LEYL
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSL--TDIITQNFVRMNEPQIAYVCREVLQGLEYL-- 132
Query: 780 SHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-TIGYMAP 824
HS VIH D+K N+ DFG LT ++S + ++V T +MAP
Sbjct: 133 -HSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAP 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-09
Identities = 31/79 (39%), Positives = 43/79 (54%)
Query: 209 GQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPN 268
G IP +SK + LQ +NL + G IP + ++T L + L N G IP +G L +
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 269 LENLVLGFNNLVGVVPAAI 287
L L L N+L G VPAA+
Sbjct: 492 LRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 3e-09
Identities = 50/173 (28%), Positives = 68/173 (39%), Gaps = 30/173 (17%)
Query: 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNH 733
E F +G GS+GSVYK G VAIKV L+ E ++K
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE--EDLQEIIKEISILKQCDSPYI 60
Query: 734 VKRISS-CSNEDF----------KALDCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHS 782
VK S N D D + TN +L + I+ LEYLH +
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK- 119
Query: 783 TPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-TIGYMAP 824
IH D+K N+ DFG+ LT +M + T++ T +MAP
Sbjct: 120 --KIHRDIKAGNILLNEEGQAKLADFGVSGQLTD--TMAKRNTVIGTPFWMAP 168
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 3e-09
Identities = 46/179 (25%), Positives = 75/179 (41%), Gaps = 37/179 (20%)
Query: 681 NLIGVGSFGSVYKGR-LHDGIEVAIKVFH-QNCAMAL-KSFEAECEVMKNIRHRNH---V 734
IG G++G+VYK R L+ G VA+K + S E ++K + H V
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 735 KRISSCSNED----------FKALDCLHST---NCSLNIFDK---LNIMIDVASALEYLH 778
+ + C F+ +D +T C ++M + +++LH
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH 124
Query: 779 FSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827
SH ++H DLKP+N+ DFG+ R+ M T +VT+ Y AP +L
Sbjct: 125 -SHR--IVHRDLKPQNILVTSDGQVKIADFGLARIY--SFEMALTSVVVTLWYRAPEVL 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 56/182 (30%), Positives = 82/182 (45%), Gaps = 39/182 (21%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHD-GIEVAIKVFHQN------CAMALKSFEAECEVMKN 727
EK+ K + IG GS+G V+K R + G VAIK F ++ +AL+ E ++K
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR----EIRMLKQ 56
Query: 728 IRHRNHVKRISSCSNEDFKALDCLH-----STNCSLNIFDK-------LNIMIDVASALE 775
++H N V I E F+ LH + LN +K I + L+
Sbjct: 57 LKHPNLVNLI-----EVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQ 111
Query: 776 YLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAPG 825
++F H IH D+KP+N+ DFG R+LTG T+ + T Y AP
Sbjct: 112 AVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY-TDYVATRWYRAPE 170
Query: 826 LL 827
LL
Sbjct: 171 LL 172
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 45/149 (30%), Positives = 59/149 (39%), Gaps = 37/149 (24%)
Query: 682 LIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMAL-----KSFEAECEVMKNIRHRNHVKR 736
IG G+FG VYKG L EVA+K C L + F E E++K H N VK
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVK----TCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL 57
Query: 737 ISSCSNE-------------DFKALDCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHST 783
I C + L L L + L + +D A+ +EYL S
Sbjct: 58 IGVCVQKQPIYIVMELVPGGSL--LTFLRKKKNRLTVKKLLQMSLDAAAGMEYL---ESK 112
Query: 784 PVIHCDLKPKN----------VFDFGIGR 802
IH DL +N + DFG+ R
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 51/193 (26%), Positives = 82/193 (42%), Gaps = 49/193 (25%)
Query: 676 KFSKENLIGVGSFGSVYKGRL------HDGIEVAIKVFHQNCAMALKS-FEAECEVMKNI 728
+F +E +G G+FG VYKG L VAIK +N ++ F E E+M ++
Sbjct: 8 RFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL 65
Query: 729 RHRNHVKRISSCSNE--------------------------DFKALDCLHSTNCSLNIFD 762
+H N V + C+ E D A + SL+ D
Sbjct: 66 QHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125
Query: 763 KLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLL-TGDRSMI 811
L+I I +A+ +EYL H +H DL +N DFG+ R + + D +
Sbjct: 126 FLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRV 182
Query: 812 QTETLVTIGYMAP 824
Q+++L+ + +M P
Sbjct: 183 QSKSLLPVRWMPP 195
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 38/143 (26%), Positives = 59/143 (41%), Gaps = 27/143 (18%)
Query: 682 LIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCS 741
IG G FG V G + G +VA+K + A ++F AE VM +RH N V+ +
Sbjct: 13 TIGKGEFGDVMLG-DYRGQKVAVKCLKDDSTAA-QAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 742 NED-------FKA----LDCLHSTNCSLNIFDKLNIM-IDVASALEYLHFSHSTPVIHCD 789
+ + A +D L S ++ + +DV +EYL +H D
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL---EEKNFVHRD 127
Query: 790 LKPKNVF----------DFGIGR 802
L +NV DFG+ +
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 6e-09
Identities = 48/172 (27%), Positives = 69/172 (40%), Gaps = 33/172 (19%)
Query: 681 NLIGVGSFGSVYKG-RLHDGIEVAIKV--FHQNCAMALKSFEAECEVMKNIRHRNHVK-- 735
N IG G+FG VY L G +A+K N +K E +V++ ++H N VK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 736 -----RISSCSNEDFKALDCLHSTNCSL----NIFDKLNIMIDVASALEYLHFSHSTPVI 786
R ++ C T L I D+ I + LE L + HS ++
Sbjct: 66 GVEVHREKVYIFMEY----CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIV 121
Query: 787 HCDLKPKNVF----------DFG----IGRLLTGDRSMIQTETLVTIGYMAP 824
H D+KP N+F DFG + T +Q+ T YMAP
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS-LAGTPAYMAP 172
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 48/158 (30%), Positives = 68/158 (43%), Gaps = 39/158 (24%)
Query: 677 FSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKR 736
F KE +G G FG V+ G+ I+VAIK+ + AM+ F E +VM + H N V+
Sbjct: 8 FLKE--LGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQL 64
Query: 737 ISSCSNE-------DFKALDCLHSTNCSLN-------IFDK---LNIMIDVASALEYLHF 779
C+ + ++ A CL LN L++ DV A+EYL
Sbjct: 65 YGVCTKQRPIFIVTEYMANGCL------LNYLRERKGKLGTEWLLDMCSDVCEAMEYL-- 116
Query: 780 SHSTPVIHCDLKPKN----------VFDFGIGRLLTGD 807
S IH DL +N V DFG+ R + D
Sbjct: 117 -ESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 38/170 (22%), Positives = 67/170 (39%), Gaps = 32/170 (18%)
Query: 682 LIGVGSFGSVYKGRLHD----GIEVAIKVFHQNCAMALKS-FEAECEVMKNIRHRNHVKR 736
IG G FG VY+G I VA+K + +++ F E +M+ H + VK
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 737 ISSCSNE------------DFKALDCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHSTP 784
I + + ++ ++ + L + + ++AL YL S
Sbjct: 73 IGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQL--STALAYL---ESKR 127
Query: 785 VIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
+H D+ +NV DFG+ R L + ++ + I +MAP
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAP 177
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 2e-08
Identities = 42/177 (23%), Positives = 70/177 (39%), Gaps = 30/177 (16%)
Query: 677 FSKENLIGVGSFGSVYKGR-LHDGIEVAIK---VFHQNCAMALKSFEAECEVMKNIRHRN 732
+ K IG G++G VYK R G VA+K + ++ + + E ++++ +RH N
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR-EIKLLQKLRHPN 59
Query: 733 HVKRI----SSCSNEDFKALDC--------LHSTNCSLNIFDKLNIMIDVASALEYLHFS 780
V+ S + + L S M + L+YLH +
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN 119
Query: 781 HSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827
++H D+K N+ DFG+ R T S T ++T+ Y P LL
Sbjct: 120 G---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELL 173
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 47/171 (27%), Positives = 72/171 (42%), Gaps = 34/171 (19%)
Query: 683 IGVGSFGSVYKGR-LHDG----IEVAIKVFHQNCA-MALKSFEAECEVMKNIRHRNHVKR 736
+G G+FG+VYKG + +G I VAIKV + + A K E VM ++ H + V+
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 737 ISSCSNE------DFKALDCL------HSTNCSLNIFDKLNIMIDVASALEYLHFSHSTP 784
+ C + L CL H N + LN + +A + YL
Sbjct: 75 LGICLSSQVQLITQLMPLGCLLDYVRNHKDN--IGSQYLLNWCVQIAKGMSYLEEKR--- 129
Query: 785 VIHCDLKPKNVF----------DFGIGRLL-TGDRSMIQTETLVTIGYMAP 824
++H DL +NV DFG+ +LL ++ V I +MA
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMAL 180
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 4e-08
Identities = 47/178 (26%), Positives = 78/178 (43%), Gaps = 30/178 (16%)
Query: 676 KFSKENLIGVGSFGSVYKGR-LHDGIEVAIK---VFHQNCAMALKSFEA--ECEVMKNIR 729
++ K +G G++ VYK R G VAIK + + A +F A E ++++ ++
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 730 HRNHVKRISSCSNEDFKAL--DCLHS--------TNCSLNIFDKLNIMIDVASALEYLHF 779
H N + + ++ L + + + + L D + M+ LEYLH
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH- 119
Query: 780 SHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827
S+ ++H DLKP N+ DFG+ R G + T +VT Y AP LL
Sbjct: 120 SNW--ILHRDLKPNNLLIASDGVLKLADFGLAR-SFGSPNRKMTHQVVTRWYRAPELL 174
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 41/163 (25%), Positives = 66/163 (40%), Gaps = 36/163 (22%)
Query: 676 KFSKENLIGVGSFGSVYKGRLHD------GIEVAIKVFHQNCAMALKS-FEAECEVMKNI 728
KF K+ +G G FG V R +D G +VA+K + + +S FE E E+++ +
Sbjct: 7 KFIKQ--LGEGHFGKVELCR-YDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL 63
Query: 729 RHRNHVKRISSCSNEDFKAL-------------DCLHSTNCSLNIFDKLNIMIDVASALE 775
H N VK C ++L D L +N+ L + ++
Sbjct: 64 DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMD 123
Query: 776 YLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808
YL IH DL +N+ DFG+ ++L D+
Sbjct: 124 YLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 6e-08
Identities = 43/145 (29%), Positives = 60/145 (41%), Gaps = 29/145 (20%)
Query: 682 LIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALK-SFEAECEVMKNIRHRNHVKRISSC 740
L+G G+FG V+KG L D VA+K ++ LK F +E ++K H N VK I C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 741 SNE-------------DFKALDCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIH 787
+ DF L L L + +D A+ + YL S IH
Sbjct: 62 TQRQPIYIVMELVPGGDF--LSFLRKKKDELKTKQLVKFALDAAAGMAYL---ESKNCIH 116
Query: 788 CDLKPKN----------VFDFGIGR 802
DL +N + DFG+ R
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 8e-08
Identities = 15/40 (37%), Positives = 27/40 (67%)
Query: 55 TDQQALLALKAHISYDPTNLLAQNSTSNTSVCNWIGITCN 94
D+ ALLA K+ ++ DP+ L+ + S++ C+W G+TC+
Sbjct: 3 DDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 45/170 (26%), Positives = 70/170 (41%), Gaps = 27/170 (15%)
Query: 676 KFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVK 735
+E IG G FG V+ G + +VAIK + AM+ + F E +VM + H V+
Sbjct: 7 TLVQE--IGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQ 63
Query: 736 RISSCSNE-------DFKALDC----LHSTNCSLNIFDKLNIMIDVASALEYLHFSHSTP 784
C+ +F C L + + L + +DV + YL S+
Sbjct: 64 LYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYL---ESSN 120
Query: 785 VIHCDLKPKN----------VFDFGIGRLLTGDRSMIQTETLVTIGYMAP 824
VIH DL +N V DFG+ R + D+ T T + + +P
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSP 170
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 51/176 (28%), Positives = 75/176 (42%), Gaps = 27/176 (15%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHD-GIEVAIKVF--HQNCAMALKSFEAECEVMKNIRHR 731
EK+ L+G GS+G V K + + G VAIK F ++ M K E ++K +RH
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 732 NHVKRISSCSNE----------DFKALDCLHSTNCSLNIFDKLNIMIDVASALEYLHFSH 781
N V I + D LD L L+ + + +E+ H SH
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH-SH 119
Query: 782 STPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827
+ +IH D+KP+N+ DFG R L + T+ + T Y AP LL
Sbjct: 120 N--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VYTDYVATRWYRAPELL 172
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 42/145 (28%), Positives = 64/145 (44%), Gaps = 30/145 (20%)
Query: 683 IGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKS-FEAECEVMKNIRHRNHVKRISSC 740
IG G+FG V+ GRL D VA+K + LK+ F E ++K H N V+ I C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 741 SNE-------------DFKALDCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIH 787
+ + DF L L + L + + + ++ + A+ +EYL H IH
Sbjct: 63 TQKQPIYIVMELVQGGDF--LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIH 117
Query: 788 CDLKPKN----------VFDFGIGR 802
DL +N + DFG+ R
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 54/180 (30%), Positives = 80/180 (44%), Gaps = 34/180 (18%)
Query: 674 TEKFSKENLIGVGSFGSVYKGR-LHDGIEVA---IKVFHQNCAMALKSFEAECEVMKNIR 729
F E IG G F VYK L DG VA +++F A A + E +++K +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 730 HRNHVKRISSC--SNEDFKALDCLHSTNCSLNI--FDKLNIMID----------VASALE 775
H N +K ++S +NE L+ + + S I F K +I + SALE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 776 YLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-TIGYMAP 824
++ HS ++H D+KP NVF D G+GR + +LV T YM+P
Sbjct: 121 HM---HSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSP 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 30/89 (33%), Positives = 53/89 (59%), Gaps = 5/89 (5%)
Query: 248 ISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSF 307
+ L N LRG IP++I L +L+++ L N++ G +P ++ ++++++ + L NS GS
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 308 --SLGIDLSLPNVERLNLGLNRFSGTIPS 334
SLG L ++ LNL N SG +P+
Sbjct: 483 PESLG---QLTSLRILNLNGNSLSGRVPA 508
|
Length = 623 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 48/181 (26%), Positives = 77/181 (42%), Gaps = 31/181 (17%)
Query: 670 LFRATEKFSKENLIGVGSFGSVYKGR-LHDG----IEVAIKVFHQNCA-MALKSFEAECE 723
+ + TE F K ++G G+FG+VYKG + +G I VAIK + + A K E
Sbjct: 3 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61
Query: 724 VMKNIRHRNHVKRISSCSNEDFKALDCLHSTNCSLNIFDK----------LNIMIDVASA 773
VM ++ + + + + C + + L C L+ + LN + +A
Sbjct: 62 VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 121
Query: 774 LEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTE-TLVTIGYM 822
+ YL ++H DL +NV DFG+ +LL D E V I +M
Sbjct: 122 MNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 823 A 823
A
Sbjct: 179 A 179
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 26/69 (37%), Positives = 33/69 (47%), Gaps = 15/69 (21%)
Query: 766 IMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTET 815
+ ++ ALEYLH S +IH D+KP N+ DF I +T D T T
Sbjct: 105 WICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT--TST 159
Query: 816 LVTIGYMAP 824
T GYMAP
Sbjct: 160 SGTPGYMAP 168
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 43/165 (26%), Positives = 69/165 (41%), Gaps = 23/165 (13%)
Query: 682 LIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSC 740
++G G++G VY R L + +AIK + + ++ E + ++HRN V+ + S
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 741 SNEDFKALDCLHSTNCSLN---------IFDKLNIMIDVASA-LEYLHFSHSTPVIHCDL 790
S F + SL+ + D +I LE L + H ++H D+
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDI 134
Query: 791 KPKNVF-----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
K NV DFG + L G +T T T+ YMAP
Sbjct: 135 KGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT-GTLQYMAP 178
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 52/168 (30%), Positives = 74/168 (44%), Gaps = 33/168 (19%)
Query: 683 IGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSN 742
IG G FG V G + G +VA+K +N A A ++F AE VM +RH N V+ +
Sbjct: 14 IGKGEFGDVMLGD-YRGNKVAVKCI-KNDATA-QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 743 E--------DFKA----LDCLHSTNCSLNIFDKL-NIMIDVASALEYLHFSHSTPVIHCD 789
E ++ A +D L S S+ D L +DV A+EYL + +H D
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EANNFVHRD 127
Query: 790 LKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827
L +NV DFG LT + S Q + + + AP L
Sbjct: 128 LAARNVLVSEDNVAKVSDFG----LTKEASSTQDTGKLPVKWTAPEAL 171
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 49/185 (26%), Positives = 71/185 (38%), Gaps = 44/185 (23%)
Query: 681 NLIGVGSFGSVYKGRLHD-------GIEVAIKVFHQNCAMALKS-FEAECEVMKNIRHRN 732
N +G G+FG VY+G D I VA+K + K F E +M N H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 733 HVKRISSCSNEDFKAL--------DCLHSTNCS---------LNIFDKLNIMIDVASALE 775
VK + C + + + D L + L + + L+I +DVA
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 776 YLHFSHSTPVIHCDLKPKNVF---------------DFGIGR-LLTGDRSMIQTETLVTI 819
YL H IH DL +N DFG+ R + D + E L+ +
Sbjct: 121 YLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 820 GYMAP 824
+MAP
Sbjct: 178 RWMAP 182
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 4e-07
Identities = 38/176 (21%), Positives = 63/176 (35%), Gaps = 42/176 (23%)
Query: 683 IGVGSFGSVYKGR-LHDGIEVAIKVFH--------QNCAMALKSFEAECEVMKNIRHRNH 733
IG G+ G V+K + G VA+K N A+ E + ++ +H
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR------EIKALQACQHPYV 61
Query: 734 VKRI------SSCS------NEDFKALDCLHSTNCSLNIFDKLNIMIDVASALEYLHFSH 781
VK + S D + M+ L+ + + H
Sbjct: 62 VKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRML-----LKGVAYMH 116
Query: 782 STPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827
+ ++H DLKP N+ DFG+ RL + + + + + T Y AP LL
Sbjct: 117 ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL 172
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 5e-07
Identities = 44/173 (25%), Positives = 73/173 (42%), Gaps = 20/173 (11%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHD-GIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHR 731
K+ ++G G++G V K R G VAIK F ++ K+ E +V++ +RH
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 732 NHVKRISSCSNED-----FKALDC--LHSTNCSLNIFDKLNIMIDVASALEYLHFSHSTP 784
N V + + F+ ++ L S + + L+ + + HS
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN 120
Query: 785 VIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827
+IH D+KP+N+ DFG R L + T+ + T Y AP LL
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELL 173
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 8e-07
Identities = 31/88 (35%), Positives = 47/88 (53%), Gaps = 11/88 (12%)
Query: 299 LDNSLLGSFSLGIDLS-LPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIP 357
LDN L F + D+S L +++ +NL N G IP + + + L LD+ NSF+G IP
Sbjct: 425 LDNQGLRGF-IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP 483
Query: 358 NTIG---------LTGNPLDGVLPTSIG 376
++G L GN L G +P ++G
Sbjct: 484 ESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 8e-07
Identities = 46/173 (26%), Positives = 70/173 (40%), Gaps = 28/173 (16%)
Query: 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNH 733
E + IG G++G VYK R + G VAIKV + + E ++K RH N
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 734 VKRISSCSNED--FKAL---------DCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHS 782
V S D + + D T L+ +L I L+ L + H
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLS---ELQIAYVCRETLKGLAYLHE 119
Query: 783 TPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-TIGYMAP 824
T IH D+K N+ DFG+ LT ++ + ++ + T +MAP
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLT--ATIAKRKSFIGTPYWMAP 170
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 82/285 (28%), Positives = 121/285 (42%), Gaps = 39/285 (13%)
Query: 213 LALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENL 272
L L+ L L N + I SNL L L +NK+ +P + LPNL+NL
Sbjct: 113 LELTNLTSLDLDNNNITDIPPLIGLLKSNLKEL---DLSDNKIE-SLPSPLRNLPNLKNL 168
Query: 273 VLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTI 332
L FN+L +P + N+S + + L + + I+L L +E L+L N +
Sbjct: 169 DLSFNDLS-DLPKLLSNLSNLNNLD-LSGNKISDLPPEIEL-LSALEELDLSNNSII-EL 224
Query: 333 PSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNI 392
S ++N L L++ N LP SIGNLS +LE + +SN I
Sbjct: 225 LSSLSNLKNLSGLELSNNKLED----------------LPESIGNLS-NLETLDLSNNQI 267
Query: 393 GGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLC-HL 451
S + +L+NL LDL GN L+ ++P L L L +L ++ L
Sbjct: 268 --SSISSLGSLTNLRELDLSGNSLSNALP--------LIALLLLLLELLLNLLLTLKALE 317
Query: 452 ARLNTLGLAGNKFS---GSIPSCLGNLTSLRSPDLGSNRLTSVLP 493
+LN++ L N S S P L L SL + N L
Sbjct: 318 LKLNSILLNNNILSNGETSSPEALSILESLNNLWTLDNALDESNL 362
|
Length = 394 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 49/195 (25%), Positives = 81/195 (41%), Gaps = 53/195 (27%)
Query: 676 KFSKENLIGVGSFGSVYKGRLH-DGIE----VAIKVFHQ-NCAMALKSFEAECEVMKNIR 729
+F +E +G +FG +YKG L+ G++ VAIK N F+ E +M +
Sbjct: 8 RFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELH 65
Query: 730 HRNHVKRISSCSNE-------DFKALDCLH--------------------STNCSLNIFD 762
H N V + + E ++ LH + SL+ D
Sbjct: 66 HPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGD 125
Query: 763 KLNIMIDVASALEYL--HFSHSTPVIHCDLKPKNVF----------DFGIGR-LLTGDRS 809
L+I I +A+ +EYL HF +H DL +N+ D G+ R + + D
Sbjct: 126 FLHIAIQIAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYY 180
Query: 810 MIQTETLVTIGYMAP 824
+Q ++L+ I +M P
Sbjct: 181 RVQPKSLLPIRWMPP 195
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 1e-06
Identities = 53/182 (29%), Positives = 77/182 (42%), Gaps = 44/182 (24%)
Query: 681 NLIGVGSFGSVYKGR-LHDGIEVAIK----VFH--QNCAMALKSFEAECEVMKNIRHRN- 732
IG G++G V G +VAIK VF + L+ E ++++++RH N
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHLRHENI 61
Query: 733 -HVKRIS-SCSNEDFKAL---------DCLHS---TNCSLNIFDKLN-IMIDVASALEYL 777
+ I S EDF + D LH + L D + + + L+YL
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELMETD-LHKVIKSPQPLTD-DHIQYFLYQILRGLKYL 119
Query: 778 HFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ--TETLVTIGYMAPG 825
H ++ VIH DLKP N+ DFG+ R + D TE +VT Y AP
Sbjct: 120 HSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPE 176
Query: 826 LL 827
LL
Sbjct: 177 LL 178
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 46/169 (27%), Positives = 72/169 (42%), Gaps = 29/169 (17%)
Query: 683 IGVGSFGSVYKGR-LHDGIEVAIK---VFHQN---CAMALKSFEAECEVMKNIRHRNHVK 735
IG G++G VYK R G VAIK + ++ AL+ E +++K + H N +K
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR----EIKLLKELNHPNIIK 62
Query: 736 RISSCSNEDFKAL--DCLHSTNCSL-----NIFDKLNIMIDVASALEYLHFSHSTPVIHC 788
+ ++ L + + + L + I + L+ L F HS ++H
Sbjct: 63 LLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHR 122
Query: 789 DLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827
DLKP+N+ DFG+ R T +VT Y AP LL
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFGSPVRPY-THYVVTRWYRAPELL 170
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 49/196 (25%), Positives = 74/196 (37%), Gaps = 53/196 (27%)
Query: 676 KFSKENLIGVGSFGSVYKGRL---HDGIEVAIKVFHQ-NCAMALKSFEAECEVM--KNIR 729
K+ E IG G++G VYK + DG E AIK F S A E+ + ++
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 730 HRNHVKRISSCSNEDFKAL---------DCL-----HSTNCSLNIFDKL--NIMIDVASA 773
H N V + K++ D H ++I + +++ + +
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 774 LEYLHFSHSTPVIHCDLKPKNVF--------------DFGIGR--------LLTGDRSMI 811
+ YLH + V+H DLKP N+ D G+ R L D
Sbjct: 121 VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP--- 174
Query: 812 QTETLVTIGYMAPGLL 827
+VTI Y AP LL
Sbjct: 175 ---VVVTIWYRAPELL 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 40/152 (26%), Positives = 60/152 (39%), Gaps = 27/152 (17%)
Query: 677 FSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKR 736
F KE +G G FG V G+ +VAIK+ + +M+ F E +VM + H V+
Sbjct: 8 FLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQL 64
Query: 737 ISSCSNE-------DFKALDC----LHSTNCSLNIFDKLNIMIDVASALEYLHFSHSTPV 785
C+ + ++ + C L L + DV + YL S
Sbjct: 65 YGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYL---ESKQF 121
Query: 786 IHCDLKPKN----------VFDFGIGRLLTGD 807
IH DL +N V DFG+ R + D
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 43/171 (25%), Positives = 74/171 (43%), Gaps = 21/171 (12%)
Query: 672 RATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHR 731
R T K K+ +G G FG V+ G + +VAIK Q +M+ ++F AE +MK ++H
Sbjct: 5 RETLKLVKK--LGAGQFGEVWMGYYNGHTKVAIKSLKQG-SMSPEAFLAEANLMKQLQHP 61
Query: 732 NHVKRISSCSNEDFKALDCLHSTNCSLNIFD-------KLNIMIDVASAL-EYLHFSHST 783
V+ + + E + ++ +N +ID+A+ + E + F
Sbjct: 62 RLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK 121
Query: 784 PVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
IH DL+ N+ DFG+ RL+ + + I + AP
Sbjct: 122 NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 172
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 52/191 (27%), Positives = 77/191 (40%), Gaps = 57/191 (29%)
Query: 676 KFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEA--------ECEVMK 726
++K IG G++G VYKGR G VA+K + L+S E E ++K
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMK------KIRLESEEEGVPSTAIREISLLK 54
Query: 727 NIRHRNHVKRISSCSNEDFKALDCLHSTNCSLNIFDKLNI-------------MIDVASA 773
++H N V D L + IF+ L++ +D
Sbjct: 55 ELQHPNIVC-----------LQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELV 103
Query: 774 LEYLH-------FSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETL 816
YL+ F HS V+H DLKP+N+ DFG+ R G + T +
Sbjct: 104 KSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEV 162
Query: 817 VTIGYMAPGLL 827
VT+ Y AP +L
Sbjct: 163 VTLWYRAPEVL 173
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 47/190 (24%), Positives = 77/190 (40%), Gaps = 45/190 (23%)
Query: 676 KFSKENLIGVGSFGSVYKGR-LHDGIEVAIK-VFHQNCA-----MALKSFEAECEVMKNI 728
K+ K IG G+FG V+K R VA+K V +N AL+ E ++++ +
Sbjct: 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR----EIKILQLL 68
Query: 729 RHRNHVKRISSCSNE---------------DFKALDC---LHSTNCSLNIFDKLNIMIDV 770
+H N V I C + +F D L + N + + +M +
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKML 128
Query: 771 ASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGR---LLTGDRSMIQTETLV 817
+ L Y+H + ++H D+K N+ DFG+ R L + T +V
Sbjct: 129 LNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV 185
Query: 818 TIGYMAPGLL 827
T+ Y P LL
Sbjct: 186 TLWYRPPELL 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 47/196 (23%), Positives = 73/196 (37%), Gaps = 65/196 (33%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECE----------- 723
+++ K IG G++G VYK R N +ALK E E
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDR----------VTNETIALKKIRLEQEDEGVPSTAIRE 51
Query: 724 --VMKNIRHRNHVKRISSCSNEDFKALDCLHSTNCSLNIFDKLNI--------------- 766
++K ++H N V + D +HS +F+ L++
Sbjct: 52 ISLLKEMQHGNIV-----------RLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKN 100
Query: 767 --MIDVA--SALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRLLTGDRSMI 811
+I L + + HS V+H DLKP+N+ DFG+ R G
Sbjct: 101 PRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRT 159
Query: 812 QTETLVTIGYMAPGLL 827
T +VT+ Y AP +L
Sbjct: 160 FTHEVVTLWYRAPEIL 175
|
Length = 294 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 52/186 (27%), Positives = 80/186 (43%), Gaps = 39/186 (20%)
Query: 672 RATEKFSKENLIGVGSFGSVYKGRLHDGIE-VAIKVFHQNC---AMALKSFEAECEVMKN 727
R+ +F K N IG G++G VY+ R E VA+K + + + S E ++ N
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLN 62
Query: 728 IRHRNHV--------KRISS-------CSNEDFKALDCLHSTNCSLNIFDKLNIMIDVAS 772
+RH N V K + S C +D +L L + + +M+ +
Sbjct: 63 LRHPNIVELKEVVVGKHLDSIFLVMEYC-EQDLASL--LDNMPTPFSESQVKCLMLQLLR 119
Query: 773 ALEYLHFSHSTPVIHCDLKPKN----------VFDFGIGRLL-TGDRSMIQTETLVTIGY 821
L+YLH + +IH DLK N + DFG+ R + M T +VT+ Y
Sbjct: 120 GLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM--TPKVVTLWY 174
Query: 822 MAPGLL 827
AP LL
Sbjct: 175 RAPELL 180
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 5e-06
Identities = 45/158 (28%), Positives = 68/158 (43%), Gaps = 42/158 (26%)
Query: 676 KFSKENLIGVGSFGSVYKGRLHDGIE-VAIK-VFHQNCAMALKSFEA-ECEVMKNIRHRN 732
K+ K IG G++G+V+K + + E VA+K V + + S E ++K ++H+N
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 733 HVKRISSCSNEDFKALDCLHSTN--------CSLNI---FDKLNIMIDVASA-------L 774
V+ D LHS C ++ FD N ID L
Sbjct: 61 IVRLY-----------DVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLL 109
Query: 775 EYLHFSHSTPVIHCDLKPKNVF----------DFGIGR 802
+ L F HS V+H DLKP+N+ DFG+ R
Sbjct: 110 KGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 6e-06
Identities = 40/167 (23%), Positives = 62/167 (37%), Gaps = 34/167 (20%)
Query: 677 FSKENLIGVGSFGSVYKGRL-HDGIEVAIKVF---HQNCAMALKSFEAECEVM-KNIRHR 731
F +IG GSF +V + E AIK+ +K + E EV+ + H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 732 NHVKRISS-------------CSNEDFKALDCLHSTNCSLNIFDKLNIMIDVASALEYLH 778
+K + N + L + SL+ ++ ALEYLH
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGEL--LQYIR-KYGSLDEKCTRFYAAEILLALEYLH 119
Query: 779 FSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTET 815
S +IH DLKP+N+ DFG ++L + S +
Sbjct: 120 ---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKG 163
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 7e-06
Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 37/177 (20%)
Query: 683 IGVGSFGSVYKGR-LHDGIEVAIK-VFHQNCAMALK-SFEAECEVMKNIRHRNH---VKR 736
IGVG++G+VYK R H G VA+K V Q L S E ++K + +H V+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 737 ISSC----SNEDFKALDCLHSTNCSLNIF-DKL-----------NIMIDVASALEYLHFS 780
+ C ++ + K + L + DK+ ++M L++L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFL--- 124
Query: 781 HSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827
H+ ++H DLKP+N+ DFG+ R+ + M T +VT+ Y AP +L
Sbjct: 125 HANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC--QMALTPVVVTLWYRAPEVL 179
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 7e-06
Identities = 52/177 (29%), Positives = 77/177 (43%), Gaps = 34/177 (19%)
Query: 677 FSKENLIGVGSFGSVYKGRLH-DGIEVAIK---VFHQNCAMALKSFEAECEVMKNIRHRN 732
F E IG G F VY+ D VA+K +F A A + E +++K + H N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 733 HVKRISS--CSNEDFKALDCLHSTNCSLNI--FDKLNIMI----------DVASALEYLH 778
+K + S NE L+ + + S I F K +I + SA+E++H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 779 FSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-TIGYMAP 824
S V+H D+KP NVF D G+GR + + +LV T YM+P
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSP 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 8e-06
Identities = 68/245 (27%), Positives = 104/245 (42%), Gaps = 47/245 (19%)
Query: 608 LPNLQFPKCKRRTRRKSKKKMLLLVIVLPLSTA-LIIAVPLALKYKSIRGGKSKTLRRFS 666
LP+ K R RR+ + LPL +AVPL L S S + +
Sbjct: 12 LPSTARHTTKSRPRRRPD-------LTLPLPQRDPSLAVPLPLPPPS--SSSSSSSSSSA 62
Query: 667 YQDLFRATEKFS---KENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALK-SFEAE 721
A + S + N IG G+ G+VYK G A+KV + N ++ E
Sbjct: 63 SGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICRE 122
Query: 722 CEVMKNIRHRNHVKRISSCSN--EDFKALDCL--HSTNCSL---NIFDKLNIMIDVA--- 771
E+++++ H N VK C + + + L SL +I D+ + DVA
Sbjct: 123 IEILRDVNHPNVVK----CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQ-FLADVARQI 177
Query: 772 -SALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-TI 819
S + YLH H ++H D+KP N+ DFG+ R+L ++M + V TI
Sbjct: 178 LSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILA--QTMDPCNSSVGTI 232
Query: 820 GYMAP 824
YM+P
Sbjct: 233 AYMSP 237
|
Length = 353 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 55/177 (31%), Positives = 79/177 (44%), Gaps = 34/177 (19%)
Query: 677 FSKENLIGVGSFGSVYKGR-LHDGIEVAIK---VFHQNCAMALKSFEAECEVMKNIRHRN 732
F E IG G F VY+ L DG+ VA+K +F A A E +++K + H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 733 HVKRISSC--SNEDFKALDCLHSTNCSLNI--FDKLNIMI----------DVASALEYLH 778
+K +S NE L+ + + S I F K +I + SALE++H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 779 FSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-TIGYMAP 824
S V+H D+KP NVF D G+GR + + +LV T YM+P
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSP 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 46/164 (28%), Positives = 75/164 (45%), Gaps = 30/164 (18%)
Query: 670 LFRATEKFSKENLIGVGSFGSVYKG-RLHDG----IEVAIKVFHQNCA-MALKSFEAECE 723
+ + TE + ++G G+FG+VYKG + +G I VAIK+ ++ A F E
Sbjct: 3 ILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL 61
Query: 724 VMKNIRHRNHVKRISSCSNEDFKALDCLHSTNCSL--------NIFDK--LNIMIDVASA 773
+M ++ H + V+ + C + + + L C L NI + LN + +A
Sbjct: 62 IMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKG 121
Query: 774 LEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGD 807
+ YL ++H DL +NV DFG+ RLL GD
Sbjct: 122 MMYL---EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 40/168 (23%), Positives = 68/168 (40%), Gaps = 19/168 (11%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHV 734
E E +G G FG V+ G + VAIK M+ ++F E +VMK +RH V
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLV 64
Query: 735 KRISSCSNEDFKALDCLHSTNCSLNIFD-------KLNIMIDVASALEY-LHFSHSTPVI 786
+ + S E + S L+ +L ++D+A+ + + + +
Sbjct: 65 QLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 124
Query: 787 HCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
H DL+ N+ DFG+ RL+ + + I + AP
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 172
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 1e-05
Identities = 51/191 (26%), Positives = 65/191 (34%), Gaps = 65/191 (34%)
Query: 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNH 733
E F+ IG GSFG VYK VAIKV + L+ E E E +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKV------IDLEEAEDEIEDI-------- 46
Query: 734 VKRISSCSNEDFKALDCLHST--------NCSLNI----------FDKLN---------- 765
+ I S + T L I D L
Sbjct: 47 QQEIQFLSQ-----CRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIA 101
Query: 766 -IMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTE 814
I+ +V LEYL H IH D+K N+ DFG+ LT +M +
Sbjct: 102 FILREVLLGLEYL---HEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLT--STMSKRN 156
Query: 815 TLV-TIGYMAP 824
T V T +MAP
Sbjct: 157 TFVGTPFWMAP 167
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 42/180 (23%), Positives = 67/180 (37%), Gaps = 41/180 (22%)
Query: 683 IGVGSFGSVYKGRLHD------GIEVAIKVFHQNCAMALK-SFEAECEVMKNIRHRNHVK 735
+G GSFG VY+G VAIK ++N +M + F E VMK + V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 736 RISSCSNE-------DFKALDCLHS----------TNCSLNIF---DKLNIMIDVASALE 775
+ S + A L S N L + + ++A +
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 776 YLHFSHSTPVIHCDLKPKN----------VFDFGIGRLL-TGDRSMIQTETLVTIGYMAP 824
YL + +H DL +N + DFG+ R + D + L+ + +MAP
Sbjct: 134 YL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 40/164 (24%), Positives = 71/164 (43%), Gaps = 26/164 (15%)
Query: 683 IGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSN 742
+G G FG V+ G ++ +VA+K M++++F E +MK ++H V+ + +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 743 E-------DFKA----LDCLHSTNCSLNIFDKLNIMIDVASAL-EYLHFSHSTPVIHCDL 790
E ++ A LD L S + KL ID ++ + E + + IH DL
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKL---IDFSAQIAEGMAYIERKNYIHRDL 129
Query: 791 KPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
+ NV DFG+ R++ + + I + AP
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 173
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 52/183 (28%), Positives = 73/183 (39%), Gaps = 44/183 (24%)
Query: 677 FSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEA--ECEVMKNIRHRNH 733
F K IG G++G VYK R G VA+K + A E ++K + H N
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 734 VKRISSCSNEDFKALDCLHSTNCSLNIFDKLN----IMIDVASALE--------YLH--- 778
VK LD +H+ N +F+ L+ +D + YL
Sbjct: 62 VK-----------LLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLL 110
Query: 779 ----FSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
F HS V+H DLKP+N+ DFG+ R G T +VT+ Y AP
Sbjct: 111 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAP 169
Query: 825 GLL 827
+L
Sbjct: 170 EIL 172
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 39/168 (23%), Positives = 67/168 (39%), Gaps = 19/168 (11%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHV 734
E + +G G FG V+ G + +VAIK M ++F E ++MK +RH V
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLV 64
Query: 735 KRISSCSNEDFKALDCLHSTNCSLNIFD-------KLNIMIDVASAL-EYLHFSHSTPVI 786
+ S E + L+ KL ++D+A+ + + + + I
Sbjct: 65 PLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYI 124
Query: 787 HCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
H DL+ N+ DFG+ RL+ + + I + AP
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAP 172
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 32/108 (29%), Positives = 54/108 (50%), Gaps = 16/108 (14%)
Query: 318 VERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGN 377
++ L L G IP+ I+ L +++ NS G I P S+G+
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNI---------------PPSLGS 464
Query: 378 LSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFG 425
++ SLE + +S + GSIP+ + L++L +L+L GN L+G +P G
Sbjct: 465 IT-SLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 2e-05
Identities = 43/170 (25%), Positives = 67/170 (39%), Gaps = 37/170 (21%)
Query: 683 IGVGSFGSVYKGRLH--DGIEVAIKVFHQNCAMAL-KSFEAECEVMKNIRHRNHVKRISS 739
+G GS G VYK R H G A+K H + K E + +++ VK
Sbjct: 9 LGQGSSGVVYKVR-HKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK---- 63
Query: 740 CSNEDFK------ALDC-----LHSTNCSLNIFDKLNIM---IDVASALEYLHFSHSTPV 785
C +K L+ L + + + + L+YLH +
Sbjct: 64 CYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--I 121
Query: 786 IHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-TIGYMAP 824
IH D+KP N+ DFGI ++L + ++ Q T V T+ YM+P
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYMSP 169
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 51/181 (28%), Positives = 76/181 (41%), Gaps = 31/181 (17%)
Query: 670 LFRATEKFSKENLIGVGSFGSVYKG-RLHDG----IEVAIKVFHQNCA-MALKSFEAECE 723
+ + TE K ++G G+FG+VYKG + DG I VAIKV +N + A K E
Sbjct: 3 ILKETE-LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAY 61
Query: 724 VMKNIRHRNHVKRISSCSNEDFKALDCLHSTNCSLNIF----------DKLNIMIDVASA 773
VM + + + C + + L C L+ D LN + +A
Sbjct: 62 VMAGVGSPYVCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKG 121
Query: 774 LEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTE-TLVTIGYM 822
+ YL ++H DL +NV DFG+ RLL D + + V I +M
Sbjct: 122 MSYL---EEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWM 178
Query: 823 A 823
A
Sbjct: 179 A 179
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 4e-05
Identities = 42/159 (26%), Positives = 61/159 (38%), Gaps = 36/159 (22%)
Query: 699 GIEVAIKVF---HQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF---------- 745
G EVAIK+ F E + + H N V + S
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 746 -KALDCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKN---------- 794
+ L + + + +L + +M+ V AL +H+ ++H DLKP+N
Sbjct: 63 GRTLREVLAADGALPAGETGRLMLQVLDALAC---AHNQGIVHRDLKPQNIMVSQTGVRP 119
Query: 795 ---VFDFGIGRLLTG----DRSMI--QTETLVTIGYMAP 824
V DFGIG LL G D + + TE L T Y AP
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAP 158
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 44/153 (28%), Positives = 66/153 (43%), Gaps = 27/153 (17%)
Query: 677 FSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKR 736
F KE +G G FG V+ G+ I+VAIK ++ AM+ + F E +VM + H V+
Sbjct: 8 FMKE--LGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQL 64
Query: 737 ISSCSNE-------DFKALDC-LHSTNCSLNIFDK---LNIMIDVASALEYLHFSHSTPV 785
C+ + +F C L+ K L++ DV +EYL +
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---F 121
Query: 786 IHCDLKPKN----------VFDFGIGRLLTGDR 808
IH DL +N V DFG+ R + D
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 42/166 (25%), Positives = 73/166 (43%), Gaps = 31/166 (18%)
Query: 683 IGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSC-S 741
IG G FG+V +G + G +VA+K C + ++F E VM + H+N V+ +
Sbjct: 14 IGEGEFGAVLQGE-YTGQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 742 NEDFKALDCLHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLK 791
N + ++ + N +++ L +DVA +EYL S ++H DL
Sbjct: 71 NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYL---ESKKLVHRDLA 127
Query: 792 PKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827
+N+ DFG+ R+ SM + + + + AP L
Sbjct: 128 ARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVKWTAPEAL 169
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 6e-05
Identities = 42/168 (25%), Positives = 62/168 (36%), Gaps = 34/168 (20%)
Query: 683 IGVGSFGSVYKGRLH--DGIEVAIKVFHQNCAMAL-KSFEAECEVMKNIRHRNHVKRISS 739
+G G+ G V K H G +A+K A+ K E +++ V +
Sbjct: 9 LGAGNSGVVSKVL-HRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 740 CSNEDFKALDCLHSTNC-SLNIFDKL-----------NIMIDVASALEYLHFSHSTPVIH 787
N ++ C+ + SL+ K I + V L YLH H +IH
Sbjct: 68 FYNNGDISI-CMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIH 124
Query: 788 CDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-TIGYMAP 824
D+KP N+ DFG+ L + T V T YMAP
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK----TFVGTSSYMAP 168
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 7e-05
Identities = 43/174 (24%), Positives = 67/174 (38%), Gaps = 46/174 (26%)
Query: 683 IGVGSFGSVYKGRLHD-GIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCS 741
+G G+FG VYK + + G+ A K+ L+ F E +++ +H N V +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 742 NE----------DFKALDCLHSTNCSLNIFDKLN----------IMIDVASALEYLHFSH 781
E D ALD +I +L + + AL +LH
Sbjct: 73 YENKLWILIEFCDGGALD---------SIMLELERGLTEPQIRYVCRQMLEALNFLH--- 120
Query: 782 STPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGY-MAP 824
S VIH DLK N+ DFG+ ++ + +T + Y MAP
Sbjct: 121 SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNK--STLQKRDTFIGTPYWMAP 172
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 8e-05
Identities = 48/170 (28%), Positives = 67/170 (39%), Gaps = 31/170 (18%)
Query: 683 IGVGSFGSVYKGR-LHDGIEVAIKVFH-QNCAMALKSFEAECEVMKNIRHRNHVKRISSC 740
IGVG+ VY L + +VAIK + C ++ E + M H N VK +S
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 741 SNED--------FKALDCLH--STNCSLNIFDKLNI---MIDVASALEYLHFSHSTPVIH 787
D L ++ D+ I + +V LEYLH S IH
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIH 125
Query: 788 CDLKPKNVF----------DFGIGRLL--TGDRSMIQTETLV-TIGYMAP 824
D+K N+ DFG+ L GDR+ +T V T +MAP
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-05
Identities = 40/170 (23%), Positives = 68/170 (40%), Gaps = 19/170 (11%)
Query: 673 ATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRN 732
E +G G FG V+ G + +VA+K M+ +SF E ++MK +RH
Sbjct: 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPG-TMSPESFLEEAQIMKKLRHDK 62
Query: 733 HVKRISSCSNEDFKALDCLHSTNCSLNIFD-------KLNIMIDVASALEY-LHFSHSTP 784
V+ + S E + S L+ KL ++D+A+ + + +
Sbjct: 63 LVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN 122
Query: 785 VIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
IH DL+ N+ DFG+ RL+ + + I + AP
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAP 172
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 9e-05
Identities = 47/185 (25%), Positives = 74/185 (40%), Gaps = 30/185 (16%)
Query: 671 FRATEKFSKENLIGVGSFGSVYKG-RLHDGIEVAIKVFHQNCAM---ALKSFEAECEVMK 726
F ++ IG G++G V G +VAIK + A ++ E ++++
Sbjct: 1 FDVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILR 59
Query: 727 NIRHRNHV--KRISSCSNEDFK----ALDCLHSTNCSLNIFDKLNIMIDVASALEY---- 776
+ +H N + + I DFK +D L ++ I + + Y
Sbjct: 60 HFKHDNIIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYFLYQLLR 118
Query: 777 -LHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG---DRSMIQTETLVTIGYM 822
L + HS VIH DLKP N+ DFG+ R L+ + TE + T Y
Sbjct: 119 GLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYR 178
Query: 823 APGLL 827
AP LL
Sbjct: 179 APELL 183
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (107), Expect = 9e-05
Identities = 45/159 (28%), Positives = 64/159 (40%), Gaps = 57/159 (35%)
Query: 683 IGVGSFGSVYKGRLHDGIE-VAIKVFHQNCAMALKSFEAEC----EVMKNIR----HRNH 733
+G G+FGSVY R + E VAIK + S+E EC EV K++R H N
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKK----KFYSWE-ECMNLREV-KSLRKLNEHPNI 60
Query: 734 VKRISSCSNEDFKALDCLHST--NCSLNIFD-------KL-------NIMIDVASALEYL 777
VK E F+ D L+ N++ K +I+ + L ++
Sbjct: 61 VKLK-----EVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 778 H----FSHSTPVIHCDLKPKNVF----------DFGIGR 802
H F H DLKP+N+ DFG+ R
Sbjct: 116 HKHGFF-------HRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 9e-05
Identities = 46/188 (24%), Positives = 79/188 (42%), Gaps = 34/188 (18%)
Query: 672 RATEKFSKENLIGVGSFGSVYKGRLHD-GIEVAIK---VFHQNCAMALKSFEAECEVMKN 727
R +KF IG G++G VYK R D G VA+K + ++ + + E ++++
Sbjct: 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQ 62
Query: 728 IRHRNHVKRISSCSNEDFKALDCLHSTNCSLNIFDKLNI---------MID-----VAS- 772
+ HRN V + + ALD +F+ ++ ++ + S
Sbjct: 63 LNHRNIV-NLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF 121
Query: 773 ---ALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTI 819
LE L++ H +H D+K N+ DFG+ RL + S T ++T+
Sbjct: 122 MKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITL 181
Query: 820 GYMAPGLL 827
Y P LL
Sbjct: 182 WYRPPELL 189
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 71/221 (32%), Positives = 104/221 (47%), Gaps = 12/221 (5%)
Query: 395 SIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLA-R 453
+ + NL L LDL N+L +I L L L L N + IP + L
Sbjct: 84 DGSENLLNLLPLPSLDLNLNRLRSNISELL-ELTNLTSLDLDNNNIT-DIPPLIGLLKSN 141
Query: 454 LNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLD 513
L L L+ NK S+PS L NL +L++ DL N L+ LP NL ++ DLS N +
Sbjct: 142 LKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKI- 198
Query: 514 GPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFGY--- 570
L +I L + ++LS N+ ++ S++ +LK+L + L+ N LE +PES G
Sbjct: 199 SDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSN 256
Query: 571 LTELNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPNL 611
L L+LS N++ I G N GN LP +
Sbjct: 257 LETLDLSNNQIS-SISSLGSLTNLRELDLSGNSLSNALPLI 296
|
Length = 394 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 1e-04
Identities = 21/60 (35%), Positives = 29/60 (48%)
Query: 381 SLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKL 440
+L+++ +SN + L NL +LDL GN LT P F L L+ L L N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 45/169 (26%), Positives = 69/169 (40%), Gaps = 28/169 (16%)
Query: 683 IGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEA-ECEVMKNIRHRNHVKRISSC 740
+G G++ +VYKGR G VA+K H + S E +MK ++H N V+
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 741 SNE------------DFKALDCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHC 788
E D K H +L+ + + L+ + F H V+H
Sbjct: 68 HTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQL---LKGIAFCHENRVLHR 124
Query: 789 DLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827
DLKP+N+ DFG+ R + E +VT+ Y AP +L
Sbjct: 125 DLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNE-VVTLWYRAPDVL 172
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 51/192 (26%), Positives = 73/192 (38%), Gaps = 62/192 (32%)
Query: 677 FSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECE-----------V 724
+ K IG G++G VYK R G VA+K E E E +
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIR---------LETEDEGVPSTAIREISL 51
Query: 725 MKNIRHRNHVKRISSCSNEDFKALDCLHSTNCSLNIFDKLN------------IMIDVAS 772
+K + H N V+ LD +HS N +F+ L+ +D
Sbjct: 52 LKELNHPNIVR-----------LLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPL 100
Query: 773 ALEYLH-------FSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTET 815
YL+ + HS V+H DLKP+N+ DFG+ R G T
Sbjct: 101 IKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHE 159
Query: 816 LVTIGYMAPGLL 827
+VT+ Y AP +L
Sbjct: 160 VVTLWYRAPEIL 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|111949 pfam03109, ABC1, ABC1 family | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 2e-04
Identities = 13/34 (38%), Positives = 18/34 (52%), Gaps = 1/34 (2%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFH 708
+F +E I S V++ L DG EVA+KV
Sbjct: 12 AEFDEEP-IAAASIAQVHRAVLKDGEEVAVKVQR 44
|
This family includes ABC1 from yeast and AarF from E. coli. These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex and E. coli AarF is required for ubiquinone production. It has been suggested that members of the ABC1 family are novel chaperonins. These proteins are unrelated to the ABC transporter proteins. Length = 117 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 42/176 (23%), Positives = 78/176 (44%), Gaps = 28/176 (15%)
Query: 677 FSKENLIGVGSFGSVYKGRLHDGIEVAIK--VFHQNCAMA----LKSFEAECEVMKNIRH 730
++K ++G G++G+VY G + G +A+K + +A + + E +++K+++H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 731 RNHVKRISSCSNED----FKALDCLHSTNCSLNIFDKLNIMI---DVASALEYLHFSHST 783
N V+ + +C +++ F S + LN F L + L+ + + H+
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN 121
Query: 784 PVIHCDLKPKNVF----------DFGIGRLL-----TGDRSMIQTETLVTIGYMAP 824
V+H D+K NV DFG R L G S + T +MAP
Sbjct: 122 CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 50/189 (26%), Positives = 80/189 (42%), Gaps = 34/189 (17%)
Query: 665 FSYQDLFRAT----EKFSKENLIGVGSFGSVYKGRLHD-GIEVAIKVFH---QNCAMALK 716
F Q+L + +++ + +G G++G V G +VAIK Q+ A +
Sbjct: 1 FYRQELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKR 60
Query: 717 SFEAECEVMKNIRHRNHVKRIS----SCSNEDFKALDCL-HSTNCSLNIFDKLNIMID-- 769
++ E ++K++ H N + + + S EDF+ + + H LN K + D
Sbjct: 61 TYR-ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDH 119
Query: 770 ----VASALEYLHFSHSTPVIHCDLKPKNV----------FDFGIGRLLTGDRSMIQTET 815
V L L + HS +IH DLKP N+ DFG+ R D M T
Sbjct: 120 IQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT--DDEM--TGY 175
Query: 816 LVTIGYMAP 824
+ T Y AP
Sbjct: 176 VATRWYRAP 184
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 3e-04
Identities = 45/168 (26%), Positives = 66/168 (39%), Gaps = 32/168 (19%)
Query: 683 IGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFE---AECEVMKNIRHRNHVKRIS 738
+G GSFG V R G A+KV + + K E E ++ I H VK
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 739 SCSNED--FKALDC-----LHSTNCSLNIFD----KLNIMIDVASALEYLHFSHSTPVIH 787
+ E+ + L+ L S F + ++ ALEYLH S +I+
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVLALEYLH-SLG--IIY 116
Query: 788 CDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-TIGYMAP 824
DLKP+N+ DFG+ + +T T T Y+AP
Sbjct: 117 RDLKPENILLDADGHIKLTDFGLAK--ELSSEGSRTNTFCGTPEYLAP 162
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 4e-04
Identities = 20/60 (33%), Positives = 29/60 (48%)
Query: 453 RLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSL 512
L +L L+ N+ + L +L+ DL N LTS+ P F L + DLS N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 38/171 (22%), Positives = 59/171 (34%), Gaps = 31/171 (18%)
Query: 682 LIGVGSFGSVYKGRLH----DGIEVAIKVFH-QNCAMALKSFEAECEVMKNIRHRNHVKR 736
+G GSFG V +G I VA+K + + F E +M ++ H N ++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 737 ISSCSNEDFKA----------LDCLH-STNCSLNIFDKLNIMIDVASALEYLHFSHSTPV 785
LD L I + + +A+ + YL
Sbjct: 62 YGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---F 118
Query: 786 IHCDLKPKNVF----------DFGIGR-LLTGDRSMIQTETL-VTIGYMAP 824
IH DL +N+ DFG+ R L + + E L V + AP
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAP 169
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 50/179 (27%), Positives = 81/179 (45%), Gaps = 40/179 (22%)
Query: 683 IGVGSFGSVYKGR-LHDGIE-VAIK---VFHQNCAMALKSFEAECEVMKNIR---HRNHV 734
IG G++G V+K R L +G VA+K V M L + E V++++ H N V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNVV 67
Query: 735 KRISSCS----NEDFKALDCLHSTNCSLNIF-DKL-----------NIMIDVASALEYLH 778
+ C+ + + K + L + DK+ ++M + L++LH
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 779 FSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827
SH V+H DLKP+N+ DFG+ R+ + M T +VT+ Y AP +L
Sbjct: 128 -SHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVVVTLWYRAPEVL 181
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 43/185 (23%), Positives = 72/185 (38%), Gaps = 46/185 (24%)
Query: 683 IGVGSFGSVYKGRLH------DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKR 736
+G G+FG V+ + D + VA+K A K F+ E E++ N++H + VK
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 737 ISSCSNED-----FKAL--------------DCL-------HSTNCSLNIFDKLNIMIDV 770
C + D F+ + D + L + L+I +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 771 ASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGR-LLTGDRSMIQTETLVTI 819
AS + YL H +H DL +N DFG+ R + + D + T++ I
Sbjct: 133 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 820 GYMAP 824
+M P
Sbjct: 190 RWMPP 194
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 47/190 (24%), Positives = 74/190 (38%), Gaps = 61/190 (32%)
Query: 676 KFSKENLIGVGSFGSVYKG-RLHDGIEVAIKVF-----HQNCAMALKSFEAECEVMKNIR 729
++ K L+G GSFGSVY+G L DG A+K Q A+K E E ++ ++
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 730 HRNHVKRISSCSNEDFKALDCLHSTNCSLNIFDKL-------NIMIDVAS---------- 772
H N V+ + + ED +L IF +L ++ S
Sbjct: 61 HPNIVQYLGTEREED------------NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYT 108
Query: 773 -----ALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLT---GDRSMIQTE 814
LEYLH + +H D+K N+ DFG+ + + +S +
Sbjct: 109 RQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSP 165
Query: 815 TLVTIGYMAP 824
+MAP
Sbjct: 166 Y-----WMAP 170
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 51/205 (24%), Positives = 73/205 (35%), Gaps = 51/205 (24%)
Query: 671 FRATEKFS-KENLIGVGSFGSVYKGR-LHDGIEVAIK------------VFHQNCAMALK 716
F +E++ K +G G++G V K G VAIK Q M
Sbjct: 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGI 63
Query: 717 SFEA--ECEVMKNIRHRNHVKRISSCSNEDFKAL--DCLHS-------TNCSLNIFDKLN 765
F E ++M I+H N + + DF L D + S L
Sbjct: 64 HFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKC 123
Query: 766 IMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGR------------- 802
I++ + + L LH + +H DL P N+F DFG+ R
Sbjct: 124 ILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 803 LLTGDRSMIQTETLVTIGYMAPGLL 827
T R T +VT+ Y AP LL
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELL 205
|
Length = 335 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 5e-04
Identities = 47/188 (25%), Positives = 79/188 (42%), Gaps = 33/188 (17%)
Query: 665 FSYQDLFRAT----EKFSKENLIGVGSFGSVYKG-RLHDGIEVAIKVFH---QNCAMALK 716
F +++ + E+++ +G G++GSV G +VAIK Q+ A +
Sbjct: 1 FYREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKR 60
Query: 717 SFEAECEVMKNIRHRN-------HVKRISSCSNEDFKALDCLHSTNCSLNIFDKLN---I 766
++ E ++K+++H N +S +DF + T+ + L+ +
Sbjct: 61 AYR-ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKV 119
Query: 767 MIDVASALEYLHFSHSTPVIHCDLKPKN----------VFDFGIGRLLTGDRSMIQTETL 816
V L L + HS +IH DLKP N + DFG+ R D M T +
Sbjct: 120 QYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR--HADAEM--TGYV 175
Query: 817 VTIGYMAP 824
VT Y AP
Sbjct: 176 VTRWYRAP 183
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (101), Expect = 5e-04
Identities = 48/177 (27%), Positives = 69/177 (38%), Gaps = 53/177 (29%)
Query: 683 IGVGSFGSVYKGRLHDGIEV-AIKVFHQNCAMALKSFE---AECEVMKNIRHRNHVKRIS 738
+G GSFG V R + A+K+ + + LK E E ++++IRH V
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 739 SCSNEDFKALDCLHSTNCSL--------NIFDKLNIM----IDVA--------SALEYLH 778
S F+ +N L +F L VA ALEYLH
Sbjct: 69 S-----FQ-----DDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH 118
Query: 779 FSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-TIGYMAP 824
S +++ DLKP+N+ DFG + + G T TL T Y+AP
Sbjct: 119 ---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAP 167
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 5e-04
Identities = 26/67 (38%), Positives = 33/67 (49%), Gaps = 13/67 (19%)
Query: 774 LEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRLLTGDRSM--IQTETLVTIG 820
L L + HS V+H DLKP NVF DFG+ R++ S +E LVT
Sbjct: 124 LRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183
Query: 821 YMAPGLL 827
Y +P LL
Sbjct: 184 YRSPRLL 190
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 42/186 (22%), Positives = 70/186 (37%), Gaps = 61/186 (32%)
Query: 682 LIGVGSFGSVYKGRLHD---GIEVAIKVFH-----QNCAMALKSFEAECEVMKNIRHRNH 733
L+G G+FG VY +D G E+A+K + + E E +++KN++H
Sbjct: 9 LLGQGAFGRVY--LCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH-ER 65
Query: 734 VKRISSCSNED------------------FKALDCLHSTNCSLNIFDKLNIMIDVASALE 775
+ + C +D KA L + + K I LE
Sbjct: 66 IVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGAL-----TETVTRKYTRQI-----LE 115
Query: 776 YLHFSHSTPVIHCDLKPKNVF----------DFGIGRLL-------TGDRSMIQTETLVT 818
+ + HS ++H D+K N+ DFG + L TG +S+ T
Sbjct: 116 GVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPY--- 172
Query: 819 IGYMAP 824
+M+P
Sbjct: 173 --WMSP 176
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 6e-04
Identities = 23/59 (38%), Positives = 37/59 (62%), Gaps = 3/59 (5%)
Query: 100 VTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSI--FTMHKLKFLDFSDN 156
+ L++S + G+IP LG L+SL LNL+ N LSG +P ++ +H+ F +F+DN
Sbjct: 468 LEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASF-NFTDN 525
|
Length = 623 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 7e-04
Identities = 42/163 (25%), Positives = 66/163 (40%), Gaps = 43/163 (26%)
Query: 680 ENLIGVGSFGSVYKGRL-HDG---IEVAIKVF------HQNCAMALKSFEAECEVMKNIR 729
E +IG G FG V +GRL G I VAIK Q + F +E +M
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR-----RDFLSEASIMGQFD 63
Query: 730 HRN--HVKRISSCSNEDFKALDCLHSTNCSLNIFDKLN-----------IMIDVASALEY 776
H N H++ + + S + + N +L+ F + N ++ +A+ ++Y
Sbjct: 64 HPNIIHLEGVVTKSRPVMIITEFME--NGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 121
Query: 777 LHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809
L +H DL +N+ DFG+ R L D S
Sbjct: 122 L---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 8e-04
Identities = 17/60 (28%), Positives = 28/60 (46%)
Query: 99 RVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQL 158
+ +L++S+ L L +L L+LS N L+ P + + L+ LD S N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 49/171 (28%), Positives = 70/171 (40%), Gaps = 30/171 (17%)
Query: 683 IGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMAL--KSFEAECEVMKNIRHRNHVKRISS 739
+G GS+G V R DG + IK + A K+ E E +++ ++H N V S
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 740 CSNED---------FKALDCLHSTNCS----LNIFDKLNIMIDVASALEYLHFSHSTPVI 786
ED + D H L + + +A AL+YLH H ++
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---IL 124
Query: 787 HCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827
H DLK +NVF D GI R+L M T + T YM+P L
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-LIGTPYYMSPELF 174
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 50/182 (27%), Positives = 83/182 (45%), Gaps = 32/182 (17%)
Query: 671 FRATEKFSKENLIGVGSFGSVYKGR--LHDGIEVA---IKVFHQNCA--MALKSFEAECE 723
F E + K + +G G++ +V+KGR L + + VA I++ H+ A A++ E
Sbjct: 1 FGKLETYVKLDKLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIR----EVS 55
Query: 724 VMKNIRHRNHVK-----RISSCSNEDFKALDC---LHSTNCSLNIFDKLNIMIDVASALE 775
++KN++H N V C F+ LD + NC N+ N+ I + L
Sbjct: 56 LLKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCG-NLMSMHNVKIFMFQLLR 114
Query: 776 YLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAPG 825
L + H ++H DLKP+N+ DFG+ R + E +VT+ Y P
Sbjct: 115 GLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNE-VVTLWYRPPD 173
Query: 826 LL 827
+L
Sbjct: 174 VL 175
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 0.001
Identities = 40/180 (22%), Positives = 63/180 (35%), Gaps = 48/180 (26%)
Query: 683 IGVGSFGSVY---KGRLHDGIEVAIKVFHQNCA-----MALKSFEAECEVMKNIRHRNHV 734
I G++G V+ K D AIKV A + E +++ + V
Sbjct: 1 ISKGAYGRVFLAKKKSTGD--IYAIKVI--KKADMIRKNQVDQVLTERDILSQAQSPYVV 56
Query: 735 KRISS-------------CSNEDFKALDCLHSTNCSLNIFDKLNIMIDVASALEYLHFSH 781
K S D +L L + D+ I +A + L + H
Sbjct: 57 KLYYSFQGKKNLYLVMEYLPGGDLASL--LENVGS----LDEDVARIYIAEIVLALEYLH 110
Query: 782 STPVIHCDLKPKNVF----------DFG------IGRLLTGDRSMIQTETLV-TIGYMAP 824
S +IH DLKP N+ DFG + R + + + + +V T Y+AP
Sbjct: 111 SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 52/186 (27%), Positives = 87/186 (46%), Gaps = 40/186 (21%)
Query: 671 FRATEKFSKENLIGVGSFGSVYKGR--LHDGIEVA---IKVFHQNCA--MALKSFEAECE 723
F E + K + +G G++ +VYKGR L D + VA I++ H+ A A++ E
Sbjct: 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIR----EVS 56
Query: 724 VMKNIRHRNHVKRISSCSNED-----FKALDC---LHSTNCSLNIFDKLNIMIDVASALE 775
++K+++H N V E F+ LD + +C N + N+ + + L
Sbjct: 57 LLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCG-NSINMHNVKLFLFQLLR 115
Query: 776 YLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTET----LVTIGY 821
L++ H V+H DLKP+N+ DFG+ R + I T+T +VT+ Y
Sbjct: 116 GLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS-----IPTKTYSNEVVTLWY 170
Query: 822 MAPGLL 827
P +L
Sbjct: 171 RPPDIL 176
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 49/196 (25%), Positives = 78/196 (39%), Gaps = 49/196 (25%)
Query: 673 ATEKFSKENLIGVGSFGSVYKGRL------HDGIEVAIKVFHQNCAMALK-SFEAECEVM 725
+T +F +E +G FG VYKG L VAIK L+ F+ E +
Sbjct: 5 STVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMR 62
Query: 726 KNIRHRNHVKRI-------------SSCSNED---FKALDCLHS----------TNCSLN 759
++H N V + S CS+ D F + HS +L
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 760 IFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGR-LLTGDR 808
D ++I+ +A+ +E+L H V+H DL +NV D G+ R + D
Sbjct: 123 PADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY 179
Query: 809 SMIQTETLVTIGYMAP 824
+ +L+ I +M+P
Sbjct: 180 YKLMGNSLLPIRWMSP 195
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 28/72 (38%), Positives = 34/72 (47%), Gaps = 20/72 (27%)
Query: 766 IMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTET 815
I + + ALEYLH S VIH D+KP NV DFGI L S+ +T
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD--SVAKT-- 161
Query: 816 LVTIG---YMAP 824
+ G YMAP
Sbjct: 162 -IDAGCKPYMAP 172
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 49/184 (26%), Positives = 75/184 (40%), Gaps = 31/184 (16%)
Query: 666 SYQDLF--RATEK-FSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFE-- 719
+LF EK F+ IG GSFG+VY R + VAIK + + + ++
Sbjct: 3 EIAELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI 62
Query: 720 -AECEVMKNIRHRNHVKRISSCSNEDFKAL----DCLHSTNCSLNIFDK----LNIMIDV 770
E ++ +RH N ++ C + A CL S + L + K + I
Sbjct: 63 IKEVRFLQQLRHPNTIE-YKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAIC 121
Query: 771 ASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIG 820
AL+ L + HS IH D+K N+ DFG L++ S + T
Sbjct: 122 HGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPY----- 176
Query: 821 YMAP 824
+MAP
Sbjct: 177 WMAP 180
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 43/182 (23%), Positives = 70/182 (38%), Gaps = 43/182 (23%)
Query: 683 IGVGSFGSVYKGRLH------DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKR 736
+G G+FG V+ + D I VA+K A K F E E++ N++H + VK
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 737 ISSCSNEDFKALDCLHSTNCSLNIFDK-----------------------LNIMIDVASA 773
C D + + + LN F + L+I +A+
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 774 LEYLHFSHSTPVIHCDLKPKNVF----------DFGIGR-LLTGDRSMIQTETLVTIGYM 822
+ YL H +H DL +N DFG+ R + + D + T++ I +M
Sbjct: 133 MVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 823 AP 824
P
Sbjct: 190 PP 191
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 43/169 (25%), Positives = 68/169 (40%), Gaps = 53/169 (31%)
Query: 676 KFSKENLIGVGSFGSVYKGRLH--DGIEVAIK------VFHQNC---AMALKSFEAECEV 724
K+ K LIG GSFGSVY G ++ G +A+K V + L + E +
Sbjct: 1 KWIKGALIGSGSFGSVYLG-MNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIAL 59
Query: 725 MKNIRHRNHVKRISSCSNEDFKALDCLHSTNCSLNIF------DKLNIMIDVASALEY-- 776
+K ++H N V+ + S + D LNIF + +++ A E
Sbjct: 60 LKELQHENIVQYLGSSLDADH------------LNIFLEYVPGGSVAALLNNYGAFEETL 107
Query: 777 -----------LHFSHSTPVIHCDLKPKNVF----------DFGIGRLL 804
L++ H+ +IH D+K N+ DFGI + L
Sbjct: 108 VRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKL 156
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 47/171 (27%), Positives = 73/171 (42%), Gaps = 26/171 (15%)
Query: 675 EKFSKENLIGVGSFGSVYKG-RLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNH 733
+K+++ IG G+ G+VY + G EVAIK + + E VM+ +H N
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNI 78
Query: 734 VKRISS--CSNEDFKALDCLHS-------TNCSLNIFDKLNIMIDVASALEYLHFSHSTP 784
V + S +E + ++ L T + D+ I L+ L F HS
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM---DEGQIAAVCRECLQALEFLHSNQ 135
Query: 785 VIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGY-MAP 824
VIH D+K N+ DFG +T ++S + T+V Y MAP
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAP 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.002
Identities = 41/187 (21%), Positives = 71/187 (37%), Gaps = 46/187 (24%)
Query: 683 IGVGSFGSVYKGR-LHDGIEVAIK---VFHQNCAMALKSFEAECEVMKNIRHRNHVKRIS 738
+G G+FG VYK R + G VA+K + ++ + + E +++K ++H N V I
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLKHPNVVPLID 74
Query: 739 ---SCSNEDFKALDC---------------LHSTNCSLNIFDKLNIMIDVASALEYLHFS 780
++ + L + + L M+ + + YLH +
Sbjct: 75 MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN 134
Query: 781 HSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ----------TETLVTIG 820
H ++H D+K N+ DFG+ R G + T +VT
Sbjct: 135 H---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRW 191
Query: 821 YMAPGLL 827
Y P LL
Sbjct: 192 YRPPELL 198
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 43/180 (23%), Positives = 72/180 (40%), Gaps = 44/180 (24%)
Query: 677 FSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRH---R 731
+ + LIG G++G+VY+G+ + G VA+K+ + + + + E ++ +R
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 732 NHVKRISS-------------CSNEDFKAL---DCLHSTNCSLNIFDKLNIMIDVASALE 775
N K S + L + S+ I+ +V AL+
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-------IIREVLVALK 115
Query: 776 YLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGY-MAP 824
Y+H VIH D+K N+ DFG+ LL + S + T V Y MAP
Sbjct: 116 YIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS--KRSTFVGTPYWMAP 170
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 44/175 (25%), Positives = 79/175 (45%), Gaps = 27/175 (15%)
Query: 676 KFSKENLIGVGSFGSVYK-GRLHDGIEVAIKVF--HQNCAMALKSFEAECEVMKNIRHRN 732
K+ K ++G G+FG V+ R D V IK Q + + EC+V+K + H N
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 733 HVKRISSCSNEDFKALDCLHSTNCSLN--IFDKLNIMIDVASALEY-------LHFSHST 783
++ + + + ++ +L I + N ++D + L + LH H+
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 784 PVIHCDLKPKNVF-----------DFGIGRLLTGDRSMIQTETLV-TIGYMAPGL 826
++H DLK +N+ DFGI ++L+ S + T+V T Y++P L
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISPEL 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.002
Identities = 25/70 (35%), Positives = 33/70 (47%), Gaps = 16/70 (22%)
Query: 766 IMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGI-GRLLTGDRSMIQTE 814
+ + + AL YL H VIH D+KP N+ DFGI GRL+ S +T
Sbjct: 119 MTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVD---SKAKTR 173
Query: 815 TLVTIGYMAP 824
+ YMAP
Sbjct: 174 SAGCAAYMAP 183
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 48/180 (26%), Positives = 79/180 (43%), Gaps = 34/180 (18%)
Query: 675 EKFSKENLIGVGSFGSV---YKGRLHDGIEVAIKVFH---QNCAMALKSFEAECEVMKNI 728
E++ +G G++GSV Y RL +VA+K Q+ A +++ E ++K++
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQ--KVAVKKLSRPFQSLIHARRTYR-ELRLLKHM 71
Query: 729 RHRNHVKRIS----SCSNEDFKALDCLHS-TNCSLNIFDKLNIMID------VASALEYL 777
+H N + + + S E+F + + + LN K + D + L L
Sbjct: 72 KHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGL 131
Query: 778 HFSHSTPVIHCDLKPKNV----------FDFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827
+ HS +IH DLKP NV DFG+ R D M T + T Y AP ++
Sbjct: 132 KYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEM--TGYVATRWYRAPEIM 187
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 48/187 (25%), Positives = 73/187 (39%), Gaps = 60/187 (32%)
Query: 683 IGVGSFG---SVYKGRLHDGIEVAIK----VFHQNCAMALKSFEAECEVMKNIRHRNHVK 735
IG G+FG SV R DG VA+K VF ++ K E +++ +H N +
Sbjct: 8 IGYGAFGVVWSVTDPR--DGKRVALKKMPNVFQN--LVSCKRVFRELKMLCFFKHDNVLS 63
Query: 736 RISSCSNEDFKALDCLHSTNCSL--NIF--------DKLNIMI---------------DV 770
ALD L + I+ D I++ +
Sbjct: 64 -----------ALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQI 112
Query: 771 ASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIG 820
L+YLH + ++H D+KP N+ DFG+ R+ D S T+ +VT
Sbjct: 113 LRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY 169
Query: 821 YMAPGLL 827
Y AP +L
Sbjct: 170 YRAPEIL 176
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 22/70 (31%), Positives = 36/70 (51%), Gaps = 14/70 (20%)
Query: 767 MIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETL 816
+ + SA+ Y+H ++H D+K N+F DFGI ++L + SM +T +
Sbjct: 107 LFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VV 162
Query: 817 VTIGYMAPGL 826
T YM+P L
Sbjct: 163 GTPYYMSPEL 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 43/169 (25%), Positives = 67/169 (39%), Gaps = 44/169 (26%)
Query: 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEV--AIKVFHQNCAMA-LKSFEAECEVMKNI-R 729
E E++IG G+FG V + + DG+++ AIK+ + + + F E EV+ +
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 730 HRNHVKRISSCSNEDF-----------KALDCL---------------HSTNCSLNIFDK 763
H N + + +C N + LD L H T +L
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 764 LNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGR 802
L DVA+ ++YL IH DL +NV DFG+ R
Sbjct: 122 LQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.003
Identities = 49/228 (21%), Positives = 79/228 (34%), Gaps = 47/228 (20%)
Query: 316 PNVERLNLGLN------RFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDG 369
P+++ L L LN R ++ +T L LD+ N+ DG
Sbjct: 51 PSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGP-------------DG 97
Query: 370 VLPTSIGNLSMSLENIYISNCNIGGSIPQLI-----SNLSNLLLLDLEGNKLTG----SI 420
S SL+ + ++N +G +L+ L L L N+L G ++
Sbjct: 98 CGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEAL 157
Query: 421 PVTFGRLQKLQGLYLPFNKLAGSIPDQLC----HLARLNTLGLAGNKF----SGSIPSCL 472
+ L+ L L N + + L L L L N + ++ L
Sbjct: 158 AKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETL 217
Query: 473 GNLTSLRSPDLGSNRLTSV--------LPSTFWNLKDILFFDLSSNSL 512
+L SL +LG N LT L S +L + LS N +
Sbjct: 218 ASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTL---SLSCNDI 262
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 35/137 (25%), Positives = 55/137 (40%), Gaps = 19/137 (13%)
Query: 683 IGVGSFGSVYKGRLHD-GIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCS 741
+G G+FG VYK + + G A KV L+ + E E++ H VK + +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 742 NE-------DFKALDCLHSTNCSLNI-FDKLNIMIDVASALEYLHFSHSTPVIHCDLKPK 793
+ +F + + L+ + I + LE L + HS +IH DLK
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAG 139
Query: 794 NVF----------DFGI 800
NV DFG+
Sbjct: 140 NVLLTLDGDIKLADFGV 156
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 45/183 (24%), Positives = 69/183 (37%), Gaps = 47/183 (25%)
Query: 682 LIGVGSFGSVYKGRLHDGIE--VAIK-VFHQNCAMAL------KSFE---AECEVMK-NI 728
+G G+FG VYK R + + +A+K + N A KS +E ++K +
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 729 RHRNHVKR----------------ISSCS-NEDFKALDCLHSTNCSLNIFDKLNIMIDVA 771
RH N V+ I E F +L I+ NI + +
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIW---NIFVQMV 123
Query: 772 SALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGY 821
AL YLH ++H DL P N+ DFG+ + + + T + TI Y
Sbjct: 124 LALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL--TSVVGTILY 179
Query: 822 MAP 824
P
Sbjct: 180 SCP 182
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 41/159 (25%), Positives = 64/159 (40%), Gaps = 41/159 (25%)
Query: 682 LIGVGSFGSVYKGRLH--DG--IEVAIKVFH-QNCAMA-LKSFEAECEVMKNIRHRNHVK 735
++G G FGSV +G+L DG ++VA+K + ++ F +E MK+ H N +K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 736 RISSC-SNEDFKALDC------------LHSTNCSLNIFDK---------LNIMIDVASA 773
I C + + LHS + L M+D+A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 774 LEYLHFSHSTPVIHCDLKPKN----------VFDFGIGR 802
+EYL + IH DL +N V DFG+ +
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.003
Identities = 46/189 (24%), Positives = 78/189 (41%), Gaps = 45/189 (23%)
Query: 672 RATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEA---------- 720
R+ +++ K N I G++G VY+ R G VA+K LK +
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALK--------KLKMEKEKEGFPITSLR 53
Query: 721 ECEVMKNIRHRN--HVKRISSCSNED--FKALDCL-HSTNCSLNIFDKL-------NIMI 768
E ++ ++H N VK + SN D + ++ + H + + +M+
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLML 113
Query: 769 DVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVT 818
+ S + +LH ++H DLK N+ DFG+ R G T+ +VT
Sbjct: 114 QLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQLVVT 169
Query: 819 IGYMAPGLL 827
+ Y AP LL
Sbjct: 170 LWYRAPELL 178
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 40/184 (21%), Positives = 71/184 (38%), Gaps = 45/184 (24%)
Query: 683 IGVGSFGSVYKGRLH------DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKR 736
+G G+FG V+ H D + VA+K + A + F+ E E++ ++H++ V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 737 ISSCSNEDFKALDCLHSTNCSLNIFDK-------------------------LNIMIDVA 771
C+ + + + LN F + L I +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 772 SALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGR-LLTGDRSMIQTETLVTIG 820
S + YL H +H DL +N DFG+ R + + D + T++ I
Sbjct: 133 SGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 821 YMAP 824
+M P
Sbjct: 190 WMPP 193
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 48/182 (26%), Positives = 82/182 (45%), Gaps = 32/182 (17%)
Query: 671 FRATEKFSKENLIGVGSFGSVYKGR--LHDGIEV--AIKVFHQNCA--MALKSFEAECEV 724
F E + K +G G++ +V+KGR L + + I++ H+ A A++ E +
Sbjct: 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR----EVSL 57
Query: 725 MKNIRHRNHVKRISSCSNED------FKALDC---LHSTNCSLNIFDKLNIMIDVASALE 775
+K+++H N V + + D F+ LD + +C NI N+ I + L
Sbjct: 58 LKDLKHANIVT-LHDIVHTDKSLTLVFEYLDKDLKQYMDDCG-NIMSMHNVKIFLYQILR 115
Query: 776 YLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAPG 825
L + H V+H DLKP+N+ DFG+ R + E +VT+ Y P
Sbjct: 116 GLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNE-VVTLWYRPPD 174
Query: 826 LL 827
+L
Sbjct: 175 VL 176
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 49/177 (27%), Positives = 74/177 (41%), Gaps = 46/177 (25%)
Query: 683 IGVGSFGSVYKG--RLHDGIEVAIKVFHQNCAMALKSFEA--ECEVMKNIRHRN------ 732
+G GS+ +VYKG R+ +G VA+KV + F A E ++K ++H N
Sbjct: 13 LGEGSYATVYKGISRI-NGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLHD 70
Query: 733 --HVKRISSCSNEDFKALDC----------LHSTNCSLNIFDKLNIMIDVASALEYLHFS 780
H K + E + D LH N L +F L L Y+H
Sbjct: 71 IIHTKETLTFVFE-YMHTDLAQYMIQHPGGLHPYNVRLFMFQLLR-------GLAYIHGQ 122
Query: 781 HSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827
H ++H DLKP+N+ DFG+ R + +E +VT+ Y P +L
Sbjct: 123 H---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSE-VVTLWYRPPDVL 175
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.004
Identities = 26/76 (34%), Positives = 37/76 (48%), Gaps = 17/76 (22%)
Query: 766 IMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLT----GDRSMI 811
IM + AL+Y+H S VIH DLKP N+ DFG+ R L+ + +
Sbjct: 112 IMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV 168
Query: 812 QTETLVTIGYMAPGLL 827
T+ + T Y AP +L
Sbjct: 169 LTDYVATRWYRAPEIL 184
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 45/174 (25%), Positives = 73/174 (41%), Gaps = 27/174 (15%)
Query: 672 RATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHR 731
R + K K+ +G G FG V+ + +VA+K +M++++F AE VMK ++H
Sbjct: 5 RESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHD 61
Query: 732 NHVKRISSCSNEDF----------KALDCLHSTNCSLNIFDKLNIMIDVASAL-EYLHFS 780
VK + + E LD L S S KL ID ++ + E + F
Sbjct: 62 KLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL---IDFSAQIAEGMAFI 118
Query: 781 HSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
IH DL+ N+ DFG+ R++ + + I + AP
Sbjct: 119 EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 172
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 827 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.97 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.97 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 99.93 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.91 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.91 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.91 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.91 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.91 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.9 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.9 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.89 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.89 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.88 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.88 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.87 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.87 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.86 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.86 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.86 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.86 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.85 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.85 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.84 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.84 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.84 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.84 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.84 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.83 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.83 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.83 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.83 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.82 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.82 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.81 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.81 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.81 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.81 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.81 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.81 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.8 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.8 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.79 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.79 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.79 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.79 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.79 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.79 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.79 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.78 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.78 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.78 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.78 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.78 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.78 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.78 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.78 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.78 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.78 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.78 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.77 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.77 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.77 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.77 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.77 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.77 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.77 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.77 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.77 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.77 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.77 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.77 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.77 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.77 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.77 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.77 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.77 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.77 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.76 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.76 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.76 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.76 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.76 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.76 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.76 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.76 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.76 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.76 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.76 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.76 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.76 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.76 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.75 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.75 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.75 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.75 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.75 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.75 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.75 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.75 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.75 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.75 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.75 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.75 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.74 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.74 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.74 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.74 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.74 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.74 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.74 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.74 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.74 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.74 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.73 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.73 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.73 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.73 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.73 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.73 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.73 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.73 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.73 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.73 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.73 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.73 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.73 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.73 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.73 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.73 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.73 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.73 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.73 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.73 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.73 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.73 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.72 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.72 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.72 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.72 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.72 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.72 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.72 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.72 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.72 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.72 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.72 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.72 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.72 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.72 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.72 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.72 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.72 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.72 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.72 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.72 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.71 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.71 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.71 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.71 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.71 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.71 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.71 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.71 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.71 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.71 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.71 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.71 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.71 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.71 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.71 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.71 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.7 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.7 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.7 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.7 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.7 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.7 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.7 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.7 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.7 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.7 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.7 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.7 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.7 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.7 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.7 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.7 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.7 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.7 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.7 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.7 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.7 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.7 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.69 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.69 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.69 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.69 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.69 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.69 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.69 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.69 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.69 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.69 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.69 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.69 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.69 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.69 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.68 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.68 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.68 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.68 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.68 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.68 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.68 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.68 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.68 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.68 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.68 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.68 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.68 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.68 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.68 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.68 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.68 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.68 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.68 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.68 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.68 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.68 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.68 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.68 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.68 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.68 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.68 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.67 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.67 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.67 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.67 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.67 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.67 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.67 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.67 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.67 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.67 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.67 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.67 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.67 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.67 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.67 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.67 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.67 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.67 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.67 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.67 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.67 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.67 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.67 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.67 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.67 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.66 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.66 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.66 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.66 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.66 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.66 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.66 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.66 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.66 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.66 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.66 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.66 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.66 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.66 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.66 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.66 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.66 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.66 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.66 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.66 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.66 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.66 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.66 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.66 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.65 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.65 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.65 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.65 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.65 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.65 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.65 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.65 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.65 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.65 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.65 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.65 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.65 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.65 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.65 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.65 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.65 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.65 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.65 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.65 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.65 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.65 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.65 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.65 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.65 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.65 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.64 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.64 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.64 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.64 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.64 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.64 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.64 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.64 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.64 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.64 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.64 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.64 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.63 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.63 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.63 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.63 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.63 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.63 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.63 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.63 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.63 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.63 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.63 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.63 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.63 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.63 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.63 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.63 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.62 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.62 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.62 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.62 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.62 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.62 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.62 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.61 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.61 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.61 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.61 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.61 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.61 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.61 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.61 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.61 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.61 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.61 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.61 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.61 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.61 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.61 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.61 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.61 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.6 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.6 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.6 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.6 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.6 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.6 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.59 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.59 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.59 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.59 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.59 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.59 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.59 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.58 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.58 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.58 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.58 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.58 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.58 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.57 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.57 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.57 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.56 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.56 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.56 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.56 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.55 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.55 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.55 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.55 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.54 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.53 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.53 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.52 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.52 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.52 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.52 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.51 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.5 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.49 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.47 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.47 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.46 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.43 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.41 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.4 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.37 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.37 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.35 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.35 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.35 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.34 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.34 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.34 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.33 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.32 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.25 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.24 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.24 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.23 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.2 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.2 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.19 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.17 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.16 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.16 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.15 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.14 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.14 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.13 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.11 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.08 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.04 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 98.92 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.9 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.87 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.85 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.84 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.82 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.8 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.79 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.76 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 98.75 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.75 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 98.73 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.69 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.69 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.67 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.66 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.63 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.58 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.56 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 98.55 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.55 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 98.47 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 98.47 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.44 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.36 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 98.28 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 98.28 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.23 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 98.22 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.22 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.21 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.09 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 98.07 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.06 | |
| KOG2120 | 419 | consensus SCF ubiquitin ligase, Skp2 component [Po | 97.93 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 97.9 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 97.89 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.86 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 97.85 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 97.82 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 97.78 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 97.74 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.7 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 97.63 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 97.61 | |
| KOG3665 | 699 | consensus ZYG-1-like serine/threonine protein kina | 97.58 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 97.58 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 97.58 | |
| KOG2120 | 419 | consensus SCF ubiquitin ligase, Skp2 component [Po | 97.57 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 97.52 | |
| PRK15386 | 426 | type III secretion protein GogB; Provisional | 97.46 | |
| PRK15386 | 426 | type III secretion protein GogB; Provisional | 97.4 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 97.1 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 97.1 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-96 Score=915.58 Aligned_cols=750 Identities=31% Similarity=0.517 Sum_probs=545.8
Q ss_pred CHHHHHHHHHHHhhcCCCCCCcCCCCCCCCCCCCcccceecCCCCCcEEEEEcCCCCCccccCccccCCCCCCEEECCCC
Q 047196 53 ITTDQQALLALKAHISYDPTNLLAQNSTSNTSVCNWIGITCNVNSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHN 132 (827)
Q Consensus 53 ~~~~~~aLl~~k~~~~~~~~~~l~~w~~~~~~~C~W~gv~C~~~~~~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N 132 (827)
.+.|++||++||+++ .+|.+.+.+|. .+.|||.|.||+|+. .++|+.|||++++++|.++++|..+++|++|+|++|
T Consensus 27 ~~~~~~~l~~~~~~~-~~~~~~~~~w~-~~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n 103 (968)
T PLN00113 27 HAEELELLLSFKSSI-NDPLKYLSNWN-SSADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNN 103 (968)
T ss_pred CHHHHHHHHHHHHhC-CCCcccCCCCC-CCCCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCC
Confidence 568999999999998 57877788997 667999999999985 469999999999999999999999999999999999
Q ss_pred CCCccCChhhh-hccccceEEecCCCCCCccccccCCCCCCcEEEcCCCCCCCCcchhHhhccccccEEEeecccccccC
Q 047196 133 KLSGDIPPSIF-TMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQI 211 (827)
Q Consensus 133 ~l~g~~p~~~~-~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~ 211 (827)
+++|.+|..+. .+++|++|||++|+++|.+|. ..+++|++|+|++|.+++.+|..+..+ ++|++|+|++|.+.+.+
T Consensus 104 ~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l-~~L~~L~L~~n~l~~~~ 180 (968)
T PLN00113 104 QLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSF-SSLKVLDLGGNVLVGKI 180 (968)
T ss_pred ccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcC-CCCCEEECccCcccccC
Confidence 99999998876 889999999999988877664 346677777777777776667666553 36777777777776666
Q ss_pred CccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEeecccCcccCchhhhcCC
Q 047196 212 PLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMS 291 (827)
Q Consensus 212 p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 291 (827)
|..++++++|++|++++|.+++.+|..++++++|++|+|++|++++.+|..++.+++|++|+|++|++++.+|..+.+++
T Consensus 181 p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~ 260 (968)
T PLN00113 181 PNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLK 260 (968)
T ss_pred ChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCC
Confidence 76667777777777777766666666666666666666666666666666666666666666666666666666666666
Q ss_pred CccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceeecCCC---------ccC
Q 047196 292 TVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNT---------IGL 362 (827)
Q Consensus 292 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~---------~~l 362 (827)
+|+.|++++|.+.+.+|..+. .+++|+.|++++|++.+.+|..+.++++|+.|++++|.+++.+|.. +.+
T Consensus 261 ~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L 339 (968)
T PLN00113 261 NLQYLFLYQNKLSGPIPPSIF-SLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQL 339 (968)
T ss_pred CCCEEECcCCeeeccCchhHh-hccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEEC
Confidence 666666666666666655544 5556666666666666555555555555555555555555544432 123
Q ss_pred CCCCCcc------------------------cCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCccccc
Q 047196 363 TGNPLDG------------------------VLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTG 418 (827)
Q Consensus 363 ~~n~l~g------------------------~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g 418 (827)
++|.+.+ .+|..+.... +++.|++++|++.+.+|..+..+++|+.|++++|++++
T Consensus 340 ~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~-~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~ 418 (968)
T PLN00113 340 WSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSG-NLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSG 418 (968)
T ss_pred cCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcC-CCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeee
Confidence 4444444 4444444433 45555555555555556666666666667777777766
Q ss_pred cccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCccccCCCcccccCCccccc
Q 047196 419 SIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWN 498 (827)
Q Consensus 419 ~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 498 (827)
.+|..|..+++|+.|++++|.+++.+|..+..+++|+.|++++|++.+.+|..+. .++|+.||+++|++++.+|..+.+
T Consensus 419 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~-~~~L~~L~ls~n~l~~~~~~~~~~ 497 (968)
T PLN00113 419 ELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG-SKRLENLDLSRNQFSGAVPRKLGS 497 (968)
T ss_pred ECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccc-cccceEEECcCCccCCccChhhhh
Confidence 6666677777777777777777777776666777777777777777777776553 477888899999999999999999
Q ss_pred cccccccCCCCCCCCCCCcccccccccCceEEcccceeeecccccccCCCCCCEEECCCCcceeecCCCCc---CCceEe
Q 047196 499 LKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFG---YLTELN 575 (827)
Q Consensus 499 l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~---~L~~L~ 575 (827)
+++|+.|+|++|+++|.+|..++.+++|+.|++++|+++|.+|..++++++|+.|||++|+++|.+|..+. .|+.||
T Consensus 498 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ 577 (968)
T PLN00113 498 LSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVN 577 (968)
T ss_pred hhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEe
Confidence 99999999999999999999999999999999999999999999999999999999999999999998765 689999
Q ss_pred CcCCcCeecCCCCCCCCCCcccccccCccccCCC-CCCCcccccccccccccceeeeehhhHHHHHHHHH--HHHhhhhh
Q 047196 576 LSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLP-NLQFPKCKRRTRRKSKKKMLLLVIVLPLSTALIIA--VPLALKYK 652 (827)
Q Consensus 576 ls~N~l~g~ip~~~~~~~~~~~~~~~n~~lc~~p-~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 652 (827)
+++|+++|.+|..++|.++.+.++.||+.+||.+ ....++|..... .+.++ ++++++++++++++ +.++++++
T Consensus 578 ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~---~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 653 (968)
T PLN00113 578 ISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK---TPSWW-FYITCTLGAFLVLALVAFGFVFIR 653 (968)
T ss_pred ccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccc---cceee-eehhHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999843 334567753211 11122 22222222221111 11222222
Q ss_pred cccCC--C-----Cccc----------cccchhHHHHHhhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHH
Q 047196 653 SIRGG--K-----SKTL----------RRFSYQDLFRATEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMA 714 (827)
Q Consensus 653 ~~~~~--~-----~~~~----------~~~~~~~~~~~~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~ 714 (827)
+++.. + ...+ +.++++ ...+.|...++||+|+||.||+|+. .+|+.||||++.....
T Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-- 728 (968)
T PLN00113 654 GRNNLELKRVENEDGTWELQFFDSKVSKSITIN---DILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-- 728 (968)
T ss_pred hhhcccccccccccccccccccccccchhhhHH---HHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--
Confidence 22110 0 0001 112222 2335677889999999999999986 5789999999864322
Q ss_pred HHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeeccCCC-------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 047196 715 LKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHSTNC-------SLNIFDKLNIMIDVASALEYLHFSHSTPVIH 787 (827)
Q Consensus 715 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~~~-------~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiH 787 (827)
...+|++++++++|||||+++|+|.+++..++.+.+...+ .++|.++.+|+.++|+|++|||+.++++|+|
T Consensus 729 --~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH 806 (968)
T PLN00113 729 --IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVV 806 (968)
T ss_pred --ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeec
Confidence 1245789999999999999999998877655544443322 3688899999999999999999888999999
Q ss_pred ccCCCccee---------eecccccccCCCccccccceecccccccccC
Q 047196 788 CDLKPKNVF---------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 788 rDlK~~NIl---------DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
||+||+||+ +||.++... ......||++|||||++
T Consensus 807 ~dlkp~Nil~~~~~~~~~~~~~~~~~~-----~~~~~~~t~~y~aPE~~ 850 (968)
T PLN00113 807 GNLSPEKIIIDGKDEPHLRLSLPGLLC-----TDTKCFISSAYVAPETR 850 (968)
T ss_pred CCCCHHhEEECCCCceEEEeccccccc-----cCCCccccccccCcccc
Confidence 999999998 223322211 11223578999999974
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-58 Score=573.76 Aligned_cols=484 Identities=34% Similarity=0.556 Sum_probs=421.2
Q ss_pred CCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccC-CCCCCcEEEcCCCCCCCCcchhHhhccccccEE
Q 047196 122 SSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTF-NLSSVLDIRLDSDKLSGELPVNICNYLHYLKVL 200 (827)
Q Consensus 122 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~-~l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~~L 200 (827)
.+++.|||++|+++|.+|..|..+++|++|||++|+++|.+|..+. .+++|++|+|++|+++|.+|.. .+++|++|
T Consensus 69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~---~l~~L~~L 145 (968)
T PLN00113 69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRG---SIPNLETL 145 (968)
T ss_pred CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCcc---ccCCCCEE
Confidence 4789999999999999999999999999999999999999998766 9999999999999999999863 35699999
Q ss_pred EeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEeecccCc
Q 047196 201 FLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLV 280 (827)
Q Consensus 201 ~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 280 (827)
+|++|.+++.+|..++++++|++|++++|.+++.+|..++++++|++|+|++|++++.+|..++.+++|++|+|++|+++
T Consensus 146 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~ 225 (968)
T PLN00113 146 DLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLS 225 (968)
T ss_pred ECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceeecCCC-
Q 047196 281 GVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNT- 359 (827)
Q Consensus 281 ~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~- 359 (827)
+.+|..+.++++|+.|++++|.+.+.+|..+. .+++|+.|++++|++++.+|..+.++++|+.|++++|.+.+.+|..
T Consensus 226 ~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~ 304 (968)
T PLN00113 226 GEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLG-NLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELV 304 (968)
T ss_pred CcCChhHhcCCCCCEEECcCceeccccChhHh-CCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhH
Confidence 99999999999999999999999999998876 8999999999999999999999999999999999999999988854
Q ss_pred --------ccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCc
Q 047196 360 --------IGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQ 431 (827)
Q Consensus 360 --------~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~ 431 (827)
+.+++|.+.+.+|..+..++ +|+.|++++|++++.+|..+..+++|+.|++++|++++.+|..+..+++|+
T Consensus 305 ~~l~~L~~L~l~~n~~~~~~~~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~ 383 (968)
T PLN00113 305 IQLQNLEILHLFSNNFTGKIPVALTSLP-RLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLF 383 (968)
T ss_pred cCCCCCcEEECCCCccCCcCChhHhcCC-CCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCC
Confidence 34788999999999988887 899999999999999999999999999999999998888887777777777
Q ss_pred EEECCCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCccccCCCcccccCCccccc-------------
Q 047196 432 GLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWN------------- 498 (827)
Q Consensus 432 ~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------------- 498 (827)
.|++++|++.+.+|..+..+++|+.|++++|++++.+|..+..++.|+.||+++|.+++.+|..+..
T Consensus 384 ~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~ 463 (968)
T PLN00113 384 KLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNK 463 (968)
T ss_pred EEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCce
Confidence 7777777777767766666666666666666666666666666666666666666655555543333
Q ss_pred ----------cccccccCCCCCCCCCCCcccccccccCceEEcccceeeecccccccCCCCCCEEECCCCcceeecCCCC
Q 047196 499 ----------LKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESF 568 (827)
Q Consensus 499 ----------l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~ 568 (827)
.++|+.||+++|++++.+|..+.+++.|+.|++++|+++|.+|..++++++|+.|+|++|+++|.+|..+
T Consensus 464 ~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 543 (968)
T PLN00113 464 FFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASF 543 (968)
T ss_pred eeeecCcccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhH
Confidence 3556777778888888888888899999999999999999999999999999999999999999999876
Q ss_pred c---CCceEeCcCCcCeecCCCC-CCCCCCcccccccCccccCCCC
Q 047196 569 G---YLTELNLSFNKLEGEIPRG-GPFANFTAKSFMGNEKLCGLPN 610 (827)
Q Consensus 569 ~---~L~~L~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~lc~~p~ 610 (827)
+ +|+.||+++|+++|.+|.. ..+..+....+.+|+..+.+|.
T Consensus 544 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~ 589 (968)
T PLN00113 544 SEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPS 589 (968)
T ss_pred hCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCC
Confidence 4 7899999999999999975 3455566677788876665553
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=329.98 Aligned_cols=367 Identities=23% Similarity=0.268 Sum_probs=288.9
Q ss_pred CCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcCCCCCCCCcchhHhhccccccEEEe
Q 047196 123 SLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFL 202 (827)
Q Consensus 123 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~~L~L 202 (827)
.-+.||+|+|.++.+.+..|.++++|+.+++..|.++ .+|......++++.|+|.+|.++ ++..+-...++.|+.|||
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~-sv~se~L~~l~alrslDL 156 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLIS-SVTSEELSALPALRSLDL 156 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccc-cccHHHHHhHhhhhhhhh
Confidence 3467999999999888999999999999999999997 56776667777999999999988 455554455668999999
Q ss_pred ecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEeecccCccc
Q 047196 203 AKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGV 282 (827)
Q Consensus 203 s~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 282 (827)
|.|.++...-..|..-.++++|+|++|.|+..--..|.++.+|..|.|+.|+++...+..|.+|++|+.|+|..|+|.-.
T Consensus 157 SrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~iriv 236 (873)
T KOG4194|consen 157 SRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIV 236 (873)
T ss_pred hhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeee
Confidence 99999876666788888999999999999987788899999999999999999977777888899999999999998765
Q ss_pred CchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceeecCCCccC
Q 047196 283 VPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGL 362 (827)
Q Consensus 283 ~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l 362 (827)
--..|.++.+|+.|.+..|.+.. +..+.+..+.++++|+|+.|+++..-..++.++++|+.|++|+|.+..+-++
T Consensus 237 e~ltFqgL~Sl~nlklqrN~I~k-L~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d---- 311 (873)
T KOG4194|consen 237 EGLTFQGLPSLQNLKLQRNDISK-LDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHID---- 311 (873)
T ss_pred hhhhhcCchhhhhhhhhhcCccc-ccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecc----
Confidence 55667788888888888887753 4445555778888888888888877777888888888888888887654433
Q ss_pred CCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCC
Q 047196 363 TGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAG 442 (827)
Q Consensus 363 ~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g 442 (827)
.|.-. ..|++|+|++|+++...+..|..+..|+.|.|++|+++..-...|..+++|+.|||++|.+++
T Consensus 312 -----------~Wsft-qkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~ 379 (873)
T KOG4194|consen 312 -----------SWSFT-QKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSW 379 (873)
T ss_pred -----------hhhhc-ccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEE
Confidence 22222 268888888888887777778888888888888888876666677778888888888888876
Q ss_pred CCCc---cccccccccEEecCCCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCC
Q 047196 443 SIPD---QLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSS 509 (827)
Q Consensus 443 ~~p~---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~ 509 (827)
.|-+ .|.+++.|+.|++.+|++....-..|.++..|++|||.+|.|..+-|.+|..+ .|+.|-+..
T Consensus 380 ~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nS 448 (873)
T KOG4194|consen 380 CIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNS 448 (873)
T ss_pred EEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcc
Confidence 6644 36667778888888888875444567777888888888888877777777776 666665543
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=337.79 Aligned_cols=442 Identities=27% Similarity=0.417 Sum_probs=264.1
Q ss_pred EEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcCC
Q 047196 100 VTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDS 179 (827)
Q Consensus 100 v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~ 179 (827)
++.|+++.|++. .+|++++.+..+..|+.|+|+++ .+|++++++.+|+.||.++|.+. .+|+.++.+..+..++..+
T Consensus 70 l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~ 146 (565)
T KOG0472|consen 70 LTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATN 146 (565)
T ss_pred eeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccc
Confidence 444555555554 34555555555555555555554 55555555555555555555554 3444555555555566556
Q ss_pred CCCCCCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccc
Q 047196 180 DKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEI 259 (827)
Q Consensus 180 n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 259 (827)
|+++ ++|.+++.+. +|..|++.+|++....|..+. +++|++||...|-++ .+|..++.|.+|.-|+|+.|++. .+
T Consensus 147 N~i~-slp~~~~~~~-~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~l 221 (565)
T KOG0472|consen 147 NQIS-SLPEDMVNLS-KLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FL 221 (565)
T ss_pred cccc-cCchHHHHHH-HHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cC
Confidence 6555 4555555544 556666666666543333333 666666666666554 55666666666666666666665 45
Q ss_pred cccccCcCCCcEEEeecccCcccCchhhh-cCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccC
Q 047196 260 PHEIGYLPNLENLVLGFNNLVGVVPAAIF-NMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITN 338 (827)
Q Consensus 260 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 338 (827)
| +|..+..|++|+++.|++. .+|+... ++.++..||+.+|++. ++|.++. .+.+|++||+++|.+++ .|..+++
T Consensus 222 P-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~c-lLrsL~rLDlSNN~is~-Lp~sLgn 296 (565)
T KOG0472|consen 222 P-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEIC-LLRSLERLDLSNNDISS-LPYSLGN 296 (565)
T ss_pred C-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHH-HhhhhhhhcccCCcccc-CCccccc
Confidence 5 6666666666666666665 3444433 6666777777776664 4555554 56667777777777764 4556666
Q ss_pred CCCCcEEEcCCCcceeecCCCc------------------cCCCC----CCcccCCCchh---cccccccEEEccCCcCc
Q 047196 339 ASKLVYLDMGTNSFSGIIPNTI------------------GLTGN----PLDGVLPTSIG---NLSMSLENIYISNCNIG 393 (827)
Q Consensus 339 l~~L~~L~Ls~N~l~g~~p~~~------------------~l~~n----~l~g~~p~~~~---~~~~~L~~L~Ls~N~l~ 393 (827)
+ .|+.|.+-+|.+..+-.+.+ +++.- --.+..|.+.+ ....+.+.|+++.-+++
T Consensus 297 l-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt 375 (565)
T KOG0472|consen 297 L-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT 375 (565)
T ss_pred c-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccc
Confidence 6 66667666666532111000 01100 00011111110 01124667777777776
Q ss_pred cccCccccCCC---CCceEeccCccccccccccccCCCCCcE-EECCCCCCCCCCCccccccccccEEecCCCcccccCC
Q 047196 394 GSIPQLISNLS---NLLLLDLEGNKLTGSIPVTFGRLQKLQG-LYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIP 469 (827)
Q Consensus 394 g~~p~~~~~l~---~L~~L~Ls~N~l~g~~p~~~~~l~~L~~-L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p 469 (827)
.+|+....-. -.+..+++.|++. .+|..+..+..++. +.+++|.+ +.+|..++.+++|..|+|++|.+. .+|
T Consensus 376 -~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~i-sfv~~~l~~l~kLt~L~L~NN~Ln-~LP 451 (565)
T KOG0472|consen 376 -LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKI-SFVPLELSQLQKLTFLDLSNNLLN-DLP 451 (565)
T ss_pred -cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCcc-ccchHHHHhhhcceeeecccchhh-hcc
Confidence 3444332222 2667777777776 46665555555443 34444444 467777777777777777777776 677
Q ss_pred ccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccceeeecccccccCCCC
Q 047196 470 SCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKD 549 (827)
Q Consensus 470 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~ 549 (827)
..++.+..|+.||+|.|+|. .+|..+..+..++.+-.++|++....|..+.++..|..|||.+|.+. .||+.+++|++
T Consensus 452 ~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~Lgnmtn 529 (565)
T KOG0472|consen 452 EEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTN 529 (565)
T ss_pred hhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccc
Confidence 77777777777777777776 36777777777777777777776655555777777777777777777 67777777777
Q ss_pred CCEEECCCCcce
Q 047196 550 LQNISLACNGLE 561 (827)
Q Consensus 550 L~~L~Ls~N~l~ 561 (827)
|++|++++|.|.
T Consensus 530 L~hLeL~gNpfr 541 (565)
T KOG0472|consen 530 LRHLELDGNPFR 541 (565)
T ss_pred eeEEEecCCccC
Confidence 777777777776
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=339.01 Aligned_cols=465 Identities=27% Similarity=0.345 Sum_probs=372.8
Q ss_pred cEEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcC
Q 047196 99 RVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLD 178 (827)
Q Consensus 99 ~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~ 178 (827)
.++.+++++|.+. .+.+.+.+|..|.+|++++|++. ..|++++.+..++.|+.|+|+++ .+|.++..+.+++.++.+
T Consensus 46 ~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s 122 (565)
T KOG0472|consen 46 DLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCS 122 (565)
T ss_pred chhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcc
Confidence 4677899999987 45567899999999999999998 89999999999999999999997 688999999999999999
Q ss_pred CCCCCCCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEccccccccc
Q 047196 179 SDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGE 258 (827)
Q Consensus 179 ~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 258 (827)
+|.+. ++|++++.++ .|+.|+..+|+++ ..|+.+.++.+|..+++.+|++....|..+. |+.|++||...|-+. .
T Consensus 123 ~n~~~-el~~~i~~~~-~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-t 197 (565)
T KOG0472|consen 123 SNELK-ELPDSIGRLL-DLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-T 197 (565)
T ss_pred cccee-ecCchHHHHh-hhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-c
Confidence 99998 7999999987 8999999999997 6788999999999999999999976666665 999999999999886 8
Q ss_pred ccccccCcCCCcEEEeecccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccC
Q 047196 259 IPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITN 338 (827)
Q Consensus 259 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 338 (827)
+|+.++.+.+|+.|+|..|.+.. +| .|..++.|.++++..|++. .+|.+....++++..|||..|++. ..|+.+.-
T Consensus 198 lP~~lg~l~~L~~LyL~~Nki~~-lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~cl 273 (565)
T KOG0472|consen 198 LPPELGGLESLELLYLRRNKIRF-LP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICL 273 (565)
T ss_pred CChhhcchhhhHHHHhhhccccc-CC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHH
Confidence 99999999999999999999974 55 7999999999999988874 678888888999999999999998 68999999
Q ss_pred CCCCcEEEcCCCcceeecCCC-------ccCCCCCCcccCCCchhcccc--cccEEE-------ccCCc---C-ccccC-
Q 047196 339 ASKLVYLDMGTNSFSGIIPNT-------IGLTGNPLDGVLPTSIGNLSM--SLENIY-------ISNCN---I-GGSIP- 397 (827)
Q Consensus 339 l~~L~~L~Ls~N~l~g~~p~~-------~~l~~n~l~g~~p~~~~~~~~--~L~~L~-------Ls~N~---l-~g~~p- 397 (827)
+.+|++||+|+|.+++..+.. +.+.||++...- ..+-+... -|++|. ++.-. - .+..|
T Consensus 274 LrsL~rLDlSNN~is~Lp~sLgnlhL~~L~leGNPlrTiR-r~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~ 352 (565)
T KOG0472|consen 274 LRSLERLDLSNNDISSLPYSLGNLHLKFLALEGNPLRTIR-REIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPS 352 (565)
T ss_pred hhhhhhhcccCCccccCCcccccceeeehhhcCCchHHHH-HHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCC
Confidence 999999999999998755431 224455543110 00000000 011110 00000 0 00111
Q ss_pred ---ccccCCCCCceEeccCccccccccccccCCC---CCcEEECCCCCCCCCCCccccccccccE-EecCCCcccccCCc
Q 047196 398 ---QLISNLSNLLLLDLEGNKLTGSIPVTFGRLQ---KLQGLYLPFNKLAGSIPDQLCHLARLNT-LGLAGNKFSGSIPS 470 (827)
Q Consensus 398 ---~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~---~L~~L~Ls~N~l~g~~p~~~~~l~~L~~-L~Ls~N~l~~~~p~ 470 (827)
.....+.+.+.|+++.-+++ .+|+....-. -....+++.|++. ++|..+..++.+.+ +.+++|.+ +-+|.
T Consensus 353 ~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~i-sfv~~ 429 (565)
T KOG0472|consen 353 ESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKI-SFVPL 429 (565)
T ss_pred Ccccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCcc-ccchH
Confidence 12234567888999999988 4555433322 3778999999998 78988888877765 44555555 57888
Q ss_pred cccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccceeeecccccccCCCCC
Q 047196 471 CLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDL 550 (827)
Q Consensus 471 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L 550 (827)
.+..+++|..|+|++|.+.. +|..++.+..|+.||+|.|+|. .+|..+..+..++.+-.++|++...-|+.+.+|.+|
T Consensus 430 ~l~~l~kLt~L~L~NN~Ln~-LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL 507 (565)
T KOG0472|consen 430 ELSQLQKLTFLDLSNNLLND-LPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNL 507 (565)
T ss_pred HHHhhhcceeeecccchhhh-cchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhc
Confidence 99999999999999998874 7889999999999999999886 578888888888888888899986666669999999
Q ss_pred CEEECCCCcceeecCCCC---cCCceEeCcCCcCe
Q 047196 551 QNISLACNGLEGLIPESF---GYLTELNLSFNKLE 582 (827)
Q Consensus 551 ~~L~Ls~N~l~g~ip~~~---~~L~~L~ls~N~l~ 582 (827)
..|||.+|.+... |..+ .+|++|++++|.|.
T Consensus 508 ~tLDL~nNdlq~I-Pp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 508 TTLDLQNNDLQQI-PPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred ceeccCCCchhhC-ChhhccccceeEEEecCCccC
Confidence 9999999999754 5444 47889999999987
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=327.25 Aligned_cols=357 Identities=23% Similarity=0.259 Sum_probs=304.7
Q ss_pred cccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEee
Q 047196 196 YLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLG 275 (827)
Q Consensus 196 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 275 (827)
.-++||+++|.++..-+..|.++++|+.+++..|.++ .+|...+...+|+.|+|.+|.|+..-.+++..++.|+.||||
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS 157 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS 157 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence 4567888888888877888888999999999999887 677766666679999999999887777888889999999999
Q ss_pred cccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceee
Q 047196 276 FNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGI 355 (827)
Q Consensus 276 ~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 355 (827)
.|.|+.+--.+|..-.++++|++++|.++. +..+-+..+.+|..|.|+.|+++...+..|.++++|+.|+|..|.+.-.
T Consensus 158 rN~is~i~~~sfp~~~ni~~L~La~N~It~-l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~iriv 236 (873)
T KOG4194|consen 158 RNLISEIPKPSFPAKVNIKKLNLASNRITT-LETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIV 236 (873)
T ss_pred hchhhcccCCCCCCCCCceEEeeccccccc-cccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeee
Confidence 999887766777777889999999998864 3333344788899999999999988788888899999999999987521
Q ss_pred cCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEEC
Q 047196 356 IPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYL 435 (827)
Q Consensus 356 ~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 435 (827)
- ++ .+..+. +|+.|.|..|+++..-...|..+.++++|+|+.|+++..-..++-++++|+.|+|
T Consensus 237 e----~l-----------tFqgL~-Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~l 300 (873)
T KOG4194|consen 237 E----GL-----------TFQGLP-SLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDL 300 (873)
T ss_pred h----hh-----------hhcCch-hhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhcc
Confidence 0 01 223333 7999999999999888889999999999999999999888888899999999999
Q ss_pred CCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCC
Q 047196 436 PFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGP 515 (827)
Q Consensus 436 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~ 515 (827)
|+|.+...-++.+...+.|++|+|++|+++..-+..|..+..|+.|.|++|.+...-...|..+++|+.|||++|.+++.
T Consensus 301 S~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~ 380 (873)
T KOG4194|consen 301 SYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWC 380 (873)
T ss_pred chhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEE
Confidence 99999988899999999999999999999988888899999999999999999988888999999999999999999887
Q ss_pred Cc---ccccccccCceEEcccceeeecccccccCCCCCCEEECCCCcceeecCCCCcC
Q 047196 516 LS---LDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFGY 570 (827)
Q Consensus 516 ~p---~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~ 570 (827)
|. ..|.+|+.|+.|+|.+|+|....-..|..+.+|+.|||.+|-+...-|.+|..
T Consensus 381 IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~ 438 (873)
T KOG4194|consen 381 IEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEP 438 (873)
T ss_pred EecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeeccccccc
Confidence 64 35677999999999999999766678999999999999999999999988874
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=331.42 Aligned_cols=438 Identities=27% Similarity=0.361 Sum_probs=344.5
Q ss_pred cEEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcC
Q 047196 99 RVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLD 178 (827)
Q Consensus 99 ~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~ 178 (827)
+++.||+++|.+. ..|..+..+.+|+.|+++.|.+. ..|.+..++.+|++|+|.+|.+. ..|..+..+.+|++|+++
T Consensus 46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS 122 (1081)
T KOG0618|consen 46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLS 122 (1081)
T ss_pred eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccc
Confidence 4889999998875 67888999999999999999998 77899999999999999999887 678899999999999999
Q ss_pred CCCCCCCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEccccccccc
Q 047196 179 SDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGE 258 (827)
Q Consensus 179 ~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 258 (827)
+|.|. .+|.-+..+. .++.++.++|.-... ++... .+.+++..|.+.+.++..+..++. .|||++|++.
T Consensus 123 ~N~f~-~~Pl~i~~lt-~~~~~~~s~N~~~~~----lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-- 191 (1081)
T KOG0618|consen 123 FNHFG-PIPLVIEVLT-AEEELAASNNEKIQR----LGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-- 191 (1081)
T ss_pred hhccC-CCchhHHhhh-HHHHHhhhcchhhhh----hcccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh--
Confidence 99997 6887776654 788888888832222 22222 888999999999999988888877 7999999986
Q ss_pred ccccccCcCCCcEEEeecccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccC
Q 047196 259 IPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITN 338 (827)
Q Consensus 259 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 338 (827)
-..+..+.+|+.|....|+++... -...+++.|+.++|.+....+.. .-.+|+++++++|++++ +|+|++.
T Consensus 192 -~~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~~~p---~p~nl~~~dis~n~l~~-lp~wi~~ 262 (1081)
T KOG0618|consen 192 -VLDLSNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTTLDVHP---VPLNLQYLDISHNNLSN-LPEWIGA 262 (1081)
T ss_pred -hhhhhhccchhhhhhhhcccceEE----ecCcchheeeeccCcceeecccc---ccccceeeecchhhhhc-chHHHHh
Confidence 245677889999999999886432 23468899999999987433322 23579999999999995 5699999
Q ss_pred CCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCccccc
Q 047196 339 ASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTG 418 (827)
Q Consensus 339 l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g 418 (827)
+.+|+.++..+|+++ .+|..+.... +|+.|.+.+|.+. -+|.....+++|++|||..|+|..
T Consensus 263 ~~nle~l~~n~N~l~----------------~lp~ri~~~~-~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~ 324 (1081)
T KOG0618|consen 263 CANLEALNANHNRLV----------------ALPLRISRIT-SLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPS 324 (1081)
T ss_pred cccceEecccchhHH----------------hhHHHHhhhh-hHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccc
Confidence 999999999999985 3444454444 7888888888887 567777788889999999888875
Q ss_pred cccccccCCCC-CcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCccccCCCcccccCCcccc
Q 047196 419 SIPVTFGRLQK-LQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFW 497 (827)
Q Consensus 419 ~~p~~~~~l~~-L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 497 (827)
.++..+.-+.. |..|+.+.|++....--.=..++.|+.|.+.+|+++...-+.+.+.+.|+.|+|++|++.......+.
T Consensus 325 lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~ 404 (1081)
T KOG0618|consen 325 LPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLR 404 (1081)
T ss_pred cchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHh
Confidence 54444444443 77777777877633222223467788888888888877777788888888888888888766556677
Q ss_pred ccccccccCCCCCCCCCCCcccccccccCceEEcccceeeecccccccCCCCCCEEECCCCccee-ecCCCC--cCCceE
Q 047196 498 NLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEG-LIPESF--GYLTEL 574 (827)
Q Consensus 498 ~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g-~ip~~~--~~L~~L 574 (827)
++..|+.|+||+|+++ .+|..+.++..|+.|..-+|++. ..| ++..++.|+.+|+|+|+|+. .+|... .+|++|
T Consensus 405 kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyL 481 (1081)
T KOG0618|consen 405 KLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYL 481 (1081)
T ss_pred chHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCccccee
Confidence 8888888888888887 47788888888888888888887 566 78888888888888888864 445444 378888
Q ss_pred eCcCCc
Q 047196 575 NLSFNK 580 (827)
Q Consensus 575 ~ls~N~ 580 (827)
|+|+|.
T Consensus 482 dlSGN~ 487 (1081)
T KOG0618|consen 482 DLSGNT 487 (1081)
T ss_pred eccCCc
Confidence 888885
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=314.50 Aligned_cols=365 Identities=24% Similarity=0.385 Sum_probs=311.5
Q ss_pred CcEEEEEcCCCCCc-cccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEE
Q 047196 98 HRVTALNISSLNLQ-GTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIR 176 (827)
Q Consensus 98 ~~v~~L~L~~~~l~-g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ 176 (827)
.-|+..|+++|.++ +.+|.+...++.++.|.|...++. .+|++++.+.+|++|.+++|++. .+-..+..|+.|+.++
T Consensus 7 pFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~ 84 (1255)
T KOG0444|consen 7 PFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVI 84 (1255)
T ss_pred ceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHh
Confidence 46899999999999 578999999999999999999987 89999999999999999999987 3445677888999999
Q ss_pred cCCCCCC-CCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccc
Q 047196 177 LDSDKLS-GELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKL 255 (827)
Q Consensus 177 L~~n~l~-g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l 255 (827)
+..|++. .-||.+++.+- .|++||||+|++. ..|..+..-+++-+|+||+|+|..+.-.-|.+++.|-+||||+|++
T Consensus 85 ~R~N~LKnsGiP~diF~l~-dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrL 162 (1255)
T KOG0444|consen 85 VRDNNLKNSGIPTDIFRLK-DLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRL 162 (1255)
T ss_pred hhccccccCCCCchhcccc-cceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchh
Confidence 9999884 35999999855 8999999999997 7899999999999999999999854444577999999999999999
Q ss_pred cccccccccCcCCCcEEEeecccCcccCchhhhcCCCccEEEecCCccc-cccChhhhcCCCCccEEeCcCCccccccCc
Q 047196 256 RGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLL-GSFSLGIDLSLPNVERLNLGLNRFSGTIPS 334 (827)
Q Consensus 256 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 334 (827)
. .+|+.+..|.+|++|+|++|.+.-.--..+..|++|++|.+++.+-+ ..+|..+. .+.+|..+|++.|.+. .+|+
T Consensus 163 e-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld-~l~NL~dvDlS~N~Lp-~vPe 239 (1255)
T KOG0444|consen 163 E-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLD-DLHNLRDVDLSENNLP-IVPE 239 (1255)
T ss_pred h-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchh-hhhhhhhccccccCCC-cchH
Confidence 8 78899999999999999999875433334456778888888876554 56777776 7889999999999997 6899
Q ss_pred cccCCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCc
Q 047196 335 FITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGN 414 (827)
Q Consensus 335 ~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 414 (827)
.+-++.+|+.|+||+|+++.. ....+.+. +|+.|++|.|+++ .+|+.++.++.|+.|.+.+|
T Consensus 240 cly~l~~LrrLNLS~N~iteL----------------~~~~~~W~-~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~N 301 (1255)
T KOG0444|consen 240 CLYKLRNLRRLNLSGNKITEL----------------NMTEGEWE-NLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNN 301 (1255)
T ss_pred HHhhhhhhheeccCcCceeee----------------eccHHHHh-hhhhhccccchhc-cchHHHhhhHHHHHHHhccC
Confidence 999999999999999998742 12233333 7899999999998 78999999999999999999
Q ss_pred cccc-cccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCccccCCCccc
Q 047196 415 KLTG-SIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLT 489 (827)
Q Consensus 415 ~l~g-~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 489 (827)
+++- -+|..++++.+|+++..++|++. .+|+.++.+..|+.|.|+.|++- .+|..+.-++.|+.||+..|.=-
T Consensus 302 kL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnL 375 (1255)
T KOG0444|consen 302 KLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNL 375 (1255)
T ss_pred cccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCc
Confidence 8752 37888999999999999999887 78999999999999999999987 78988888999999999888644
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-33 Score=300.62 Aligned_cols=367 Identities=26% Similarity=0.384 Sum_probs=269.2
Q ss_pred CCCCCCEEECCCCCCCc-cCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcCCCCCCCCcchhHhhcccccc
Q 047196 120 NLSSLTTLNLSHNKLSG-DIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLK 198 (827)
Q Consensus 120 ~L~~L~~L~Ls~N~l~g-~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~ 198 (827)
-|+..+-.|+|+|.|+| ..|.....|++++.|.|...++. .+|.++..+- +|+
T Consensus 5 VLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-------------------------~vPeEL~~lq-kLE 58 (1255)
T KOG0444|consen 5 VLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-------------------------QVPEELSRLQ-KLE 58 (1255)
T ss_pred ccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-------------------------hChHHHHHHh-hhh
Confidence 35566778889999884 68888888888888888887776 5777777644 788
Q ss_pred EEEeecccccccCCccCCCCCCCcEEEccCCCCc-ccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEeecc
Q 047196 199 VLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLS-GAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFN 277 (827)
Q Consensus 199 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 277 (827)
+|.+++|++. .+-..++.++.|+.+.+..|++. .-+|..+..|..|+.||||+|++. +.|..+.+-+++-+|+||+|
T Consensus 59 HLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N 136 (1255)
T KOG0444|consen 59 HLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYN 136 (1255)
T ss_pred hhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccC
Confidence 8888888876 45567778888888888888874 346777888888888888888887 78888888888888888888
Q ss_pred cCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceeecC
Q 047196 278 NLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIP 357 (827)
Q Consensus 278 ~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p 357 (827)
+|..+.-.-+-+++.|-.|++++|.+. .+|..+. .+.+|+.|+|++|.+.----..+..+++|+.|.+++.+=+
T Consensus 137 ~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~R-RL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRT---- 210 (1255)
T KOG0444|consen 137 NIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIR-RLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRT---- 210 (1255)
T ss_pred ccccCCchHHHhhHhHhhhccccchhh-hcCHHHH-HHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccch----
Confidence 887544445567777777777777764 4555554 5667777777777654322233445666667776665432
Q ss_pred CCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCC
Q 047196 358 NTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPF 437 (827)
Q Consensus 358 ~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 437 (827)
...+|+++..+. +|..+|+|.|++. .+|..+-++.+|+.|+||+|+|+. +....+...+|+.|+||.
T Consensus 211 ----------l~N~Ptsld~l~-NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~ite-L~~~~~~W~~lEtLNlSr 277 (1255)
T KOG0444|consen 211 ----------LDNIPTSLDDLH-NLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITE-LNMTEGEWENLETLNLSR 277 (1255)
T ss_pred ----------hhcCCCchhhhh-hhhhccccccCCC-cchHHHhhhhhhheeccCcCceee-eeccHHHHhhhhhhcccc
Confidence 124666776666 7788888888886 677777788888888888888773 444555667778888888
Q ss_pred CCCCCCCCccccccccccEEecCCCcccc-cCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCC
Q 047196 438 NKLAGSIPDQLCHLARLNTLGLAGNKFSG-SIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPL 516 (827)
Q Consensus 438 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~ 516 (827)
|+++ .+|+.++.++.|+.|.+.+|+++- -||+.++.+.+|+++..++|.+. ..|..+..|..|+.|.|+.|.+- .+
T Consensus 278 NQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TL 354 (1255)
T KOG0444|consen 278 NQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TL 354 (1255)
T ss_pred chhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-ec
Confidence 8887 678888888888888888887762 36777787888888777777775 56777777777777777777775 46
Q ss_pred cccccccccCceEEccccee
Q 047196 517 SLDIGNLRVVIGINLSRNNF 536 (827)
Q Consensus 517 p~~~~~l~~L~~L~Ls~N~l 536 (827)
|..+.-++.|..||+..|.=
T Consensus 355 PeaIHlL~~l~vLDlreNpn 374 (1255)
T KOG0444|consen 355 PEAIHLLPDLKVLDLRENPN 374 (1255)
T ss_pred hhhhhhcCCcceeeccCCcC
Confidence 77777777777777777753
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-34 Score=316.17 Aligned_cols=461 Identities=28% Similarity=0.379 Sum_probs=334.5
Q ss_pred EEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcCC
Q 047196 100 VTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDS 179 (827)
Q Consensus 100 v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~ 179 (827)
++.|+++.|-+-...-+...+--.|+.||||+|.+. ..|..+..+..|+.|+++.|.+. ..|....++++|+++.|..
T Consensus 23 ~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~ 100 (1081)
T KOG0618|consen 23 LQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKN 100 (1081)
T ss_pred HHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheecc
Confidence 666777776554322223333334788888888776 77777888888888888888776 4456777777777777777
Q ss_pred CCCCCCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccc
Q 047196 180 DKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEI 259 (827)
Q Consensus 180 n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 259 (827)
|.+. .+|.++.. +.+|++|+++.|+|. .+|..+..++.+..+..++|.... .++.+. .+.++|..|.+.+.+
T Consensus 101 n~l~-~lP~~~~~-lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~----~lg~~~-ik~~~l~~n~l~~~~ 172 (1081)
T KOG0618|consen 101 NRLQ-SLPASISE-LKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQ----RLGQTS-IKKLDLRLNVLGGSF 172 (1081)
T ss_pred chhh-cCchhHHh-hhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhh----hhcccc-chhhhhhhhhcccch
Confidence 7776 57776655 337777777777774 677777777777777777772221 122222 677777777777777
Q ss_pred cccccCcCCCcEEEeecccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCC
Q 047196 260 PHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNA 339 (827)
Q Consensus 260 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 339 (827)
+.++..++. .|||.+|.+. -..+.++.+|+.+....|.+..- ....++++.|+.+.|.++...+.. --
T Consensus 173 ~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l-----~~~g~~l~~L~a~~n~l~~~~~~p--~p 240 (1081)
T KOG0618|consen 173 LIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSEL-----EISGPSLTALYADHNPLTTLDVHP--VP 240 (1081)
T ss_pred hcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceE-----EecCcchheeeeccCcceeecccc--cc
Confidence 777777766 6888888776 23456677777777777766421 224567778888888776333222 23
Q ss_pred CCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCcccccc
Q 047196 340 SKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGS 419 (827)
Q Consensus 340 ~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ 419 (827)
.+|+++|++.|++++ +|++++.+. +|+.++..+|+++ .+|..+...++|+.|+..+|.++ -
T Consensus 241 ~nl~~~dis~n~l~~----------------lp~wi~~~~-nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-y 301 (1081)
T KOG0618|consen 241 LNLQYLDISHNNLSN----------------LPEWIGACA-NLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-Y 301 (1081)
T ss_pred ccceeeecchhhhhc----------------chHHHHhcc-cceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-h
Confidence 567788888887763 566777776 8888888888885 67788888888888888888887 5
Q ss_pred ccccccCCCCCcEEECCCCCCCCCCCccc-cccc-cccEEecCCCcccccCCc-cccCCCCCCccccCCCcccccCCccc
Q 047196 420 IPVTFGRLQKLQGLYLPFNKLAGSIPDQL-CHLA-RLNTLGLAGNKFSGSIPS-CLGNLTSLRSPDLGSNRLTSVLPSTF 496 (827)
Q Consensus 420 ~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~-~~l~-~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~ 496 (827)
+|+....++.|+.|+|..|+|. ..|+.+ .-.. +|+.|+.+.|++. ..|. .=..++.|+.|++.+|.++...-+.+
T Consensus 302 ip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~-~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l 379 (1081)
T KOG0618|consen 302 IPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLS-TLPSYEENNHAALQELYLANNHLTDSCFPVL 379 (1081)
T ss_pred CCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhcccc-ccccccchhhHHHHHHHHhcCcccccchhhh
Confidence 6677777888888888888887 445433 3232 3677778888876 3342 12245678999999999988776678
Q ss_pred cccccccccCCCCCCCCCCCcccccccccCceEEcccceeeecccccccCCCCCCEEECCCCcceeecCC--CCcCCceE
Q 047196 497 WNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPE--SFGYLTEL 574 (827)
Q Consensus 497 ~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~--~~~~L~~L 574 (827)
-+.++|+.|+|++|++.......+.++..|+.|+||+|.++ .+|.++.++..|+.|....|++... |+ .+.+|+.+
T Consensus 380 ~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~f-Pe~~~l~qL~~l 457 (1081)
T KOG0618|consen 380 VNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSF-PELAQLPQLKVL 457 (1081)
T ss_pred ccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeec-hhhhhcCcceEE
Confidence 88999999999999998666677889999999999999999 7899999999999999999999754 43 23589999
Q ss_pred eCcCCcCee-cCCCCCCCCCCcccccccCccc
Q 047196 575 NLSFNKLEG-EIPRGGPFANFTAKSFMGNEKL 605 (827)
Q Consensus 575 ~ls~N~l~g-~ip~~~~~~~~~~~~~~~n~~l 605 (827)
|+|.|+|+- .+|..-+..++....+.||..+
T Consensus 458 DlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 458 DLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred ecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence 999999974 3454434467777888999853
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=286.17 Aligned_cols=165 Identities=39% Similarity=0.629 Sum_probs=140.5
Q ss_pred cccccchhHHHHHhhcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeee
Q 047196 661 TLRRFSYQDLFRATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSC 740 (827)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~ 740 (827)
..+.|++.++..||++|+..++||+|+||.||+|.+++|+.||||++.....+..++|.+|++++++++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999999999999988765432145699999999999999999999999
Q ss_pred ecCCc-eeeeeeccC-----------CC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------e
Q 047196 741 SNEDF-KALDCLHST-----------NC-SLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------D 797 (827)
Q Consensus 741 ~~~~~-~~l~~l~~~-----------~~-~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------D 797 (827)
.+.+. ..+.+.+.. .. .++|.+|++||.++|+||+|||+.+.++||||||||+||| |
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 98874 666544432 23 6799999999999999999999999999999999999999 9
Q ss_pred ecccccccC-CCccccccc-eecccccccccC
Q 047196 798 FGIGRLLTG-DRSMIQTET-LVTIGYMAPGLL 827 (827)
Q Consensus 798 FGla~~~~~-~~~~~~~~~-~gt~~Y~APE~l 827 (827)
||+|+.... .... ... .||.||+||||+
T Consensus 221 FGLa~~~~~~~~~~--~~~~~gt~gY~~PEy~ 250 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSV--STTVMGTFGYLAPEYA 250 (361)
T ss_pred ccCcccCCccccce--eeecCCCCccCChhhh
Confidence 999977654 2221 112 699999999984
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-26 Score=236.05 Aligned_cols=149 Identities=32% Similarity=0.498 Sum_probs=122.4
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
..+|...+.||+|+||+||+|+.+ ++.+||||.+... .++..+....|+.+|+.++|||||++++++..+++.++..
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 457888888999999999999864 6899999999765 4556677899999999999999999999999998776644
Q ss_pred eccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------------eecccccc
Q 047196 751 LHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------------DFGIGRLL 804 (827)
Q Consensus 751 l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------------DFGla~~~ 804 (827)
.+-.. +.+........+.|+|.|+++| |+++||||||||.||| |||+||.+
T Consensus 89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L---~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFL---HENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 44332 2455566677999999999999 5778999999999998 99999988
Q ss_pred cCCCccccccceecccccccccC
Q 047196 805 TGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 805 ~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
..... . .+.+|++.||||||+
T Consensus 166 ~~~~~-a-~tlcGSplYMAPEV~ 186 (429)
T KOG0595|consen 166 QPGSM-A-ETLCGSPLYMAPEVI 186 (429)
T ss_pred CchhH-H-HHhhCCccccCHHHH
Confidence 74432 2 335699999999984
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-24 Score=266.78 Aligned_cols=324 Identities=21% Similarity=0.298 Sum_probs=173.6
Q ss_pred CcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEccccccccccccccc
Q 047196 185 ELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIG 264 (827)
Q Consensus 185 ~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 264 (827)
.+|..+.....+|+.|++.+|.+. .+|..| ...+|+.|++.+|++. .+|..+..+++|+.|+|++++..+.+| .++
T Consensus 579 ~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls 654 (1153)
T PLN03210 579 HLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLS 654 (1153)
T ss_pred ecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccc
Confidence 345555544556777777776664 456555 4567777777777765 456666777777777777765445565 366
Q ss_pred CcCCCcEEEeecccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCcE
Q 047196 265 YLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVY 344 (827)
Q Consensus 265 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 344 (827)
.+++|++|+|++|.....+|..+.++++|+.|++++|...+.+|..+ .+++|+.|++++|...+.+|.. ..+|+.
T Consensus 655 ~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i--~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~ 729 (1153)
T PLN03210 655 MATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI--NLKSLYRLNLSGCSRLKSFPDI---STNISW 729 (1153)
T ss_pred cCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC--CCCCCCEEeCCCCCCccccccc---cCCcCe
Confidence 67777777777776666677777777777777777666555555543 4566666666666544444432 234555
Q ss_pred EEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCccccccccccc
Q 047196 345 LDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTF 424 (827)
Q Consensus 345 L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~ 424 (827)
|++++|.+.. +|. .+ .+. +|++|++.++.... ++ +.+....|..+
T Consensus 730 L~L~~n~i~~-lP~---------------~~-~l~-~L~~L~l~~~~~~~-l~----------------~~~~~l~~~~~ 774 (1153)
T PLN03210 730 LDLDETAIEE-FPS---------------NL-RLE-NLDELILCEMKSEK-LW----------------ERVQPLTPLMT 774 (1153)
T ss_pred eecCCCcccc-ccc---------------cc-ccc-ccccccccccchhh-cc----------------ccccccchhhh
Confidence 5555555431 121 11 111 34444444322110 00 00111111112
Q ss_pred cCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCccccCCCcccccCCccccccccccc
Q 047196 425 GRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILF 504 (827)
Q Consensus 425 ~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 504 (827)
...++|+.|+|++|...+.+|.+++++++|+.|++++|...+.+|..+ ++++|+.|++++|.....+|.. ..+|+.
T Consensus 775 ~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~ 850 (1153)
T PLN03210 775 MLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISD 850 (1153)
T ss_pred hccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCE
Confidence 223445555555555444555555555555555555544333444443 4555555555554443333332 234555
Q ss_pred cCCCCCCCCCCCcccccccccCceEEccc-ceeeecccccccCCCCCCEEECCCC
Q 047196 505 FDLSSNSLDGPLSLDIGNLRVVIGINLSR-NNFSGDIPSTIGDLKDLQNISLACN 558 (827)
Q Consensus 505 LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~-N~l~g~ip~~~~~l~~L~~L~Ls~N 558 (827)
|+|++|.++ .+|.++..+++|+.|++++ |++. .+|..+..++.|+.|+++++
T Consensus 851 L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 851 LNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred eECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCC
Confidence 555555554 3455555566666666655 3333 35555556666666666655
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-23 Score=262.96 Aligned_cols=364 Identities=20% Similarity=0.249 Sum_probs=248.7
Q ss_pred CcEEEEEcCCCCCcc--ccCccccCCCCCCEEECCCCC------CCccCChhhhhcc-ccceEEecCCCCCCccccccCC
Q 047196 98 HRVTALNISSLNLQG--TIPPQLGNLSSLTTLNLSHNK------LSGDIPPSIFTMH-KLKFLDFSDNQLSGSLSSVTFN 168 (827)
Q Consensus 98 ~~v~~L~L~~~~l~g--~~~~~l~~L~~L~~L~Ls~N~------l~g~~p~~~~~l~-~L~~LdLs~N~l~g~~p~~~~~ 168 (827)
.+|..+.+.-..+.. .-+.+|.++++|+.|.+.++. +...+|..|..++ +|+.|++.+|.+.
T Consensus 532 ~~v~~i~l~~~~~~~~~i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~--------- 602 (1153)
T PLN03210 532 KKVLGITLDIDEIDELHIHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR--------- 602 (1153)
T ss_pred ceeeEEEeccCccceeeecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC---------
Confidence 456655554333321 123456777777777775543 2334566565543 4666666666554
Q ss_pred CCCCcEEEcCCCCCCCCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEE
Q 047196 169 LSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKI 248 (827)
Q Consensus 169 l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 248 (827)
.+|..+. ..+|+.|+|.+|.+. .+|..+..+++|+.|+|+++...+.+|. ++.+++|+.|
T Consensus 603 ----------------~lP~~f~--~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L 662 (1153)
T PLN03210 603 ----------------CMPSNFR--PENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETL 662 (1153)
T ss_pred ----------------CCCCcCC--ccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEE
Confidence 3444431 246777777777765 4566677788888888887665556664 7778888888
Q ss_pred EcccccccccccccccCcCCCcEEEeecccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCcc
Q 047196 249 SLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRF 328 (827)
Q Consensus 249 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l 328 (827)
+|++|.....+|..++++++|+.|++++|.....+|..+ ++++|+.|++++|...+.+|. ..++|+.|++++|.+
T Consensus 663 ~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~----~~~nL~~L~L~~n~i 737 (1153)
T PLN03210 663 KLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPD----ISTNISWLDLDETAI 737 (1153)
T ss_pred EecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCcccccc----ccCCcCeeecCCCcc
Confidence 888877666788888888888888888876656677655 678888888888877666663 346788999999988
Q ss_pred ccccCccccCCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCce
Q 047196 329 SGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLL 408 (827)
Q Consensus 329 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 408 (827)
. .+|..+ .+++|+.|++.++..... ... +. .++........+|+.|++++|...+.+|..++++++|+.
T Consensus 738 ~-~lP~~~-~l~~L~~L~l~~~~~~~l-~~~-------~~-~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~ 806 (1153)
T PLN03210 738 E-EFPSNL-RLENLDELILCEMKSEKL-WER-------VQ-PLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEH 806 (1153)
T ss_pred c-cccccc-cccccccccccccchhhc-ccc-------cc-ccchhhhhccccchheeCCCCCCccccChhhhCCCCCCE
Confidence 6 466654 577888888876442211 000 00 011111122337889999998888888988999999999
Q ss_pred EeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCccccCCCcc
Q 047196 409 LDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRL 488 (827)
Q Consensus 409 L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 488 (827)
|++++|...+.+|..+ ++++|+.|++++|.....+|.. ..+|+.|+|++|.++ .+|.++..+++|+.|++++|+-
T Consensus 807 L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~ 881 (1153)
T PLN03210 807 LEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNN 881 (1153)
T ss_pred EECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCC
Confidence 9998876555677665 6888999999887665566653 357888888888887 6788888888888888887443
Q ss_pred cccCCccccccccccccCCCCCC
Q 047196 489 TSVLPSTFWNLKDILFFDLSSNS 511 (827)
Q Consensus 489 ~~~~p~~~~~l~~L~~LdLs~N~ 511 (827)
-..+|..+..+++|+.+++++|.
T Consensus 882 L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 882 LQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred cCccCcccccccCCCeeecCCCc
Confidence 33466677778888888887764
|
syringae 6; Provisional |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-25 Score=220.16 Aligned_cols=149 Identities=30% Similarity=0.377 Sum_probs=117.4
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l 751 (827)
+.|+...++|+|+||+||||+.+ +|+.||||++... .+...+-..|||++|++++|+|+|.+++.|.......+.+.
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 45778889999999999999965 5999999999643 34445667899999999999999999988876654444333
Q ss_pred ccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 752 HSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 752 ~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
+.+. ..........+..|+++|+.|+ |++++|||||||+||| |||+||.+...+. .
T Consensus 82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~c---Hk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd-~ 157 (396)
T KOG0593|consen 82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFC---HKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD-N 157 (396)
T ss_pred ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhh---hhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc-h
Confidence 3222 2234444567889999999888 6788999999999999 9999999875433 3
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
.|..+.|.+|+|||.+
T Consensus 158 YTDYVATRWYRaPELL 173 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELL 173 (396)
T ss_pred hhhhhhhhhccChhhh
Confidence 4667899999999974
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=222.59 Aligned_cols=148 Identities=25% Similarity=0.354 Sum_probs=116.8
Q ss_pred hcccccceEecCCceEEEEEE-ecCCcEEEEEEEcccchH-------HHHHHHHHHHHHHhcCCCCceEEEeeeecCCce
Q 047196 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAM-------ALKSFEAECEVMKNIRHRNHVKRISSCSNEDFK 746 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~~-------~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~ 746 (827)
+.|-..+.+|+|+||.|-+|. .++|+.||||++.+.... ......+|+++|+++.|||||++.+++..++..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 346667899999999999996 568999999999753211 122357999999999999999999999998877
Q ss_pred eeeeeccCCCC----------CCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------eeccccc
Q 047196 747 ALDCLHSTNCS----------LNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------DFGIGRL 803 (827)
Q Consensus 747 ~l~~l~~~~~~----------l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------------DFGla~~ 803 (827)
+|...+.+++. +....-..++.|+..|+.|| |+++|+||||||+||| |||+||.
T Consensus 252 YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYL---H~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYL---HSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred EEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHH---HHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 66555544332 33334456899999999999 5889999999999998 9999998
Q ss_pred ccCCCccccccceecccccccccC
Q 047196 804 LTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 804 ~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
.....- ..+.||||.|+||||+
T Consensus 329 ~g~~sf--m~TlCGTpsYvAPEVl 350 (475)
T KOG0615|consen 329 SGEGSF--MKTLCGTPSYVAPEVL 350 (475)
T ss_pred ccccee--hhhhcCCccccChhhe
Confidence 763322 2346799999999986
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=233.62 Aligned_cols=149 Identities=26% Similarity=0.387 Sum_probs=125.9
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEccc---chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeee-
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQN---CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALD- 749 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~- 749 (827)
..|...++||+|+|+.||+++. .+|+.||+|++++. ...+.+...+||++.+.++|||||++++++.+.+..++.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5699999999999999999996 78999999999763 244567889999999999999999999999998876653
Q ss_pred -eecc--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 750 -CLHS--------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 750 -~l~~--------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
..+. ....++..+...+..||+.|+.|| |+.+|||||||.+|++ |||+|..+..+...
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYL---H~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYL---HSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHH---HhcCceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 2222 235677888889999999999999 5778999999999998 99999998766554
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
. .+.||||-|+||||+
T Consensus 175 k-~TlCGTPNYIAPEVl 190 (592)
T KOG0575|consen 175 K-KTLCGTPNYIAPEVL 190 (592)
T ss_pred c-ceecCCCcccChhHh
Confidence 3 346799999999985
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=227.01 Aligned_cols=150 Identities=29% Similarity=0.379 Sum_probs=123.8
Q ss_pred hcccccceEecCCceEEEEEE-ecCCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecC--Cceeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNE--DFKALD 749 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~--~~~~l~ 749 (827)
+.|+..++||+|.||.||||+ ..+|+.||+|+++.+. ........|||.||++++|||||++.+...+. ...+|.
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 457778899999999999998 4689999999997654 33455678999999999999999999998776 344444
Q ss_pred eeccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 750 CLHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 750 ~l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
+.|+. ...++..+...++.|++.||+|+ |.++|+|||||.+||| |||+|+++.....
T Consensus 197 FeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~c---H~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 197 FEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYC---HSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred EecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHH---hhcCeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 43332 23566778888999999999998 6789999999999998 9999999987776
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
...|..+.|.+|.|||.+
T Consensus 274 ~~~T~rVvTLWYRpPELL 291 (560)
T KOG0600|consen 274 APYTSRVVTLWYRPPELL 291 (560)
T ss_pred cccccceEEeeccChHHh
Confidence 656778899999999975
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-24 Score=225.81 Aligned_cols=150 Identities=30% Similarity=0.437 Sum_probs=115.7
Q ss_pred hhcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHH--hcCCCCceEEEeeeecCCce----e
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMK--NIRHRNHVKRISSCSNEDFK----A 747 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~--~l~H~niv~~~~~~~~~~~~----~ 747 (827)
.......++||+|+||.||||.+.+ +.||||+++.. ..+.|..|-+|.+ .++|+||++++++-...+.. .
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhccC-ceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 3455666889999999999999875 89999999643 3456777766665 56899999999987665422 2
Q ss_pred ee-eeccC--------CCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCeEEccCCCccee----------eecccc
Q 047196 748 LD-CLHST--------NCSLNIFDKLNIMIDVASALEYLHFS------HSTPVIHCDLKPKNVF----------DFGIGR 802 (827)
Q Consensus 748 l~-~l~~~--------~~~l~~~~~~~i~~~ia~~L~~Lh~~------h~~~iiHrDlK~~NIl----------DFGla~ 802 (827)
+. -.|.. .-..+|.+..+|+..+|+||+|||++ |+|+|+|||||+.||| |||+|.
T Consensus 285 LVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred EEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 21 12211 23468999999999999999999975 7789999999999999 999999
Q ss_pred cccCCCcccc-ccceecccccccccC
Q 047196 803 LLTGDRSMIQ-TETLVTIGYMAPGLL 827 (827)
Q Consensus 803 ~~~~~~~~~~-~~~~gt~~Y~APE~l 827 (827)
.+..+..... ...+||.+|||||++
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvL 390 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVL 390 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHH
Confidence 8875544322 236799999999985
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5e-24 Score=229.37 Aligned_cols=146 Identities=32% Similarity=0.512 Sum_probs=115.9
Q ss_pred cccceEecCCceEEEEEEecCCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC-c--eeeeeec
Q 047196 678 SKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNED-F--KALDCLH 752 (827)
Q Consensus 678 ~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~-~--~~l~~l~ 752 (827)
...+.+|+|+||+||+|.+++...||||++.... ....++|.+|+.+|++++|||||+++|+|.++. . .+++++.
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 3345599999999999999865559999997543 222568999999999999999999999999886 2 2333332
Q ss_pred ---------c-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEEccCCCccee-----------eecccccccCCCcc
Q 047196 753 ---------S-TNCSLNIFDKLNIMIDVASALEYLHFSHSTP-VIHCDLKPKNVF-----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 753 ---------~-~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~-iiHrDlK~~NIl-----------DFGla~~~~~~~~~ 810 (827)
. ....+++..++.+|.+||+|+.|||. .+ ||||||||+||| |||+++...... .
T Consensus 124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~ 199 (362)
T KOG0192|consen 124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-T 199 (362)
T ss_pred CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-c
Confidence 2 24578899999999999999999964 44 999999999998 999998775432 1
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
..+...||+.|||||++
T Consensus 200 ~~~~~~GT~~wMAPEv~ 216 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVL 216 (362)
T ss_pred cccCCCCCccccChhhh
Confidence 22335699999999986
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-24 Score=232.85 Aligned_cols=157 Identities=31% Similarity=0.554 Sum_probs=124.5
Q ss_pred chhHHHHHhhcccccceEecCCceEEEEEEecCCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecC
Q 047196 666 SYQDLFRATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNE 743 (827)
Q Consensus 666 ~~~~~~~~~~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~ 743 (827)
+..++....+.+...+.||+|+||+||||++.+ .||||++... ...+.+.|+.||..+++-||.||+-++|||..+
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 345555556667778899999999999999975 7999999754 345678999999999999999999999999998
Q ss_pred Cceee----------eeeccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eeccccc
Q 047196 744 DFKAL----------DCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRL 803 (827)
Q Consensus 744 ~~~~l----------~~l~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~ 803 (827)
....+ .++|.....++..+.++||.|||+|+.|| |.++|||||||+.||+ |||+|..
T Consensus 461 ~~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YL---HAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 461 PLAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYL---HAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred ceeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhh---hhhhhhhhhccccceEEccCCcEEEecccceee
Confidence 87544 34555566777888899999999999999 6899999999999998 9999865
Q ss_pred ccCCCcccccc-ceecccccccccC
Q 047196 804 LTGDRSMIQTE-TLVTIGYMAPGLL 827 (827)
Q Consensus 804 ~~~~~~~~~~~-~~gt~~Y~APE~l 827 (827)
.........-. .-|..-|||||+|
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvI 562 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVI 562 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHH
Confidence 43221111111 1278889999986
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-24 Score=221.88 Aligned_cols=289 Identities=19% Similarity=0.154 Sum_probs=171.0
Q ss_pred cEEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecC-CCCCCccccccCCCCCCcEEEc
Q 047196 99 RVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSD-NQLSGSLSSVTFNLSSVLDIRL 177 (827)
Q Consensus 99 ~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~-N~l~g~~p~~~~~l~~L~~L~L 177 (827)
..+.|+|..|+|+.+.+.+|+.+++||+||||+|+|+.+-|++|..+.+|..|-+-+ |+|+......|.+|.+++.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 567788888888877777888888888888888888888888888888776664444 7887665566777777777777
Q ss_pred CCCCCCCCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccc
Q 047196 178 DSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRG 257 (827)
Q Consensus 178 ~~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 257 (827)
.-|++. .++.+.+.-+++|..|.+.+|.+...--..|..+..++.+.+.-|.+-. ..+++.+.. +..
T Consensus 148 Nan~i~-Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~ic-----dCnL~wla~-------~~a 214 (498)
T KOG4237|consen 148 NANHIN-CIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFIC-----DCNLPWLAD-------DLA 214 (498)
T ss_pred Chhhhc-chhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccc-----ccccchhhh-------HHh
Confidence 777766 5666666556666666666666654333356666666666666665320 111111111 111
Q ss_pred cccccccCcCCCcEEEeecccCcccCchhhhcC-CCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccc
Q 047196 258 EIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNM-STVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFI 336 (827)
Q Consensus 258 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~ 336 (827)
..|.++++.....-..+.++++..+-+..|... ..+..-..+.....+..|..-+..+++|+.|+|++|++++.-+.+|
T Consensus 215 ~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aF 294 (498)
T KOG4237|consen 215 MNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAF 294 (498)
T ss_pred hchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhh
Confidence 223333444433333444444433222222211 1111111223334445555555577777777777777777777777
Q ss_pred cCCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCccc
Q 047196 337 TNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKL 416 (827)
Q Consensus 337 ~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l 416 (827)
..+..++.|.|..|++. ..-...|.+++.|+.|+|.+|+|
T Consensus 295 e~~a~l~eL~L~~N~l~----------------------------------------~v~~~~f~~ls~L~tL~L~~N~i 334 (498)
T KOG4237|consen 295 EGAAELQELYLTRNKLE----------------------------------------FVSSGMFQGLSGLKTLSLYDNQI 334 (498)
T ss_pred cchhhhhhhhcCcchHH----------------------------------------HHHHHhhhccccceeeeecCCee
Confidence 66666666666555543 23334455566666666666666
Q ss_pred cccccccccCCCCCcEEECCCCCC
Q 047196 417 TGSIPVTFGRLQKLQGLYLPFNKL 440 (827)
Q Consensus 417 ~g~~p~~~~~l~~L~~L~Ls~N~l 440 (827)
+..-|..|..+..|..|+|-.|.+
T Consensus 335 t~~~~~aF~~~~~l~~l~l~~Np~ 358 (498)
T KOG4237|consen 335 TTVAPGAFQTLFSLSTLNLLSNPF 358 (498)
T ss_pred EEEecccccccceeeeeehccCcc
Confidence 666666666666666666655554
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-23 Score=201.74 Aligned_cols=149 Identities=31% Similarity=0.457 Sum_probs=117.2
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchH--HHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAM--ALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l 751 (827)
.+|...+++|+|.||.||+|+. .+|+.||||++...... -.....|||+.|+.++|+|||.+++.+...+...+...
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3577889999999999999985 57999999999765322 12457899999999999999999999877654433222
Q ss_pred cc----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 752 HS----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 752 ~~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
+. ....+...+...++.++.+|++|+ |.+.|+|||+||.|+| |||+|+.+......
T Consensus 82 fm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~---H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~- 157 (318)
T KOG0659|consen 82 FMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYC---HSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI- 157 (318)
T ss_pred eccccHHHHhcccccccCHHHHHHHHHHHHHHHHHH---HhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc-
Confidence 22 233466667778889999999999 5778999999999998 99999998654432
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
.+..+.|.+|+|||.+
T Consensus 158 ~~~~V~TRWYRAPELL 173 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELL 173 (318)
T ss_pred cccceeeeeccChHHh
Confidence 3445789999999964
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.5e-23 Score=209.87 Aligned_cols=146 Identities=26% Similarity=0.323 Sum_probs=116.0
Q ss_pred ccccceEecCCceEEEEEEec-CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc-eeeeeecc
Q 047196 677 FSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF-KALDCLHS 753 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~-~~l~~l~~ 753 (827)
++..+.||+|..|+|||++++ +++.+|+|++.... ....++..+|++++++.+||+||+++|++..... ..+-..++
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 345678999999999999865 78999999996543 4456789999999999999999999999988763 44433344
Q ss_pred CCCCC----------CHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccc
Q 047196 754 TNCSL----------NIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQT 813 (827)
Q Consensus 754 ~~~~l----------~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~ 813 (827)
+.+++ .....-.|+.+|.+||.|||+ ++.||||||||+||| |||.++.+... . ..
T Consensus 161 DgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--~-a~ 235 (364)
T KOG0581|consen 161 DGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--I-AN 235 (364)
T ss_pred CCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--h-cc
Confidence 44443 334445799999999999984 467999999999999 99999988655 2 23
Q ss_pred cceecccccccccC
Q 047196 814 ETLVTIGYMAPGLL 827 (827)
Q Consensus 814 ~~~gt~~Y~APE~l 827 (827)
+.+||..|||||-+
T Consensus 236 tfvGT~~YMsPERi 249 (364)
T KOG0581|consen 236 TFVGTSAYMSPERI 249 (364)
T ss_pred cccccccccChhhh
Confidence 46799999999954
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=233.98 Aligned_cols=263 Identities=24% Similarity=0.349 Sum_probs=125.0
Q ss_pred ccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEeec
Q 047196 197 LKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGF 276 (827)
Q Consensus 197 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 276 (827)
-..|+++.|.++ .+|..+. ++|+.|++++|+++. +|.. +++|++|+|++|+|+ .+|.. .++|+.|+|++
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~ 271 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIFS 271 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCCC---CCCCcEEEecCCccC-cccCc---ccccceeeccC
Confidence 445666666655 3454443 245555555555553 3321 344555555555554 23321 23444555555
Q ss_pred ccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceeec
Q 047196 277 NNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGII 356 (827)
Q Consensus 277 N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~ 356 (827)
|.++. +|. ...+|+.|++++|+++. +|.. .++|+.|++++|++++.
T Consensus 272 N~L~~-Lp~----------------------------lp~~L~~L~Ls~N~Lt~-LP~~---p~~L~~LdLS~N~L~~L- 317 (788)
T PRK15387 272 NPLTH-LPA----------------------------LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLASL- 317 (788)
T ss_pred Cchhh-hhh----------------------------chhhcCEEECcCCcccc-cccc---ccccceeECCCCccccC-
Confidence 54442 121 11345555555555553 3321 24556666666655531
Q ss_pred CCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECC
Q 047196 357 PNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLP 436 (827)
Q Consensus 357 p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 436 (827)
|. + +.+|+.|++++|++++ +|.. ..+|+.|+|++|+|++ +|.. ..+|+.|+++
T Consensus 318 p~------------l-------p~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls 370 (788)
T PRK15387 318 PA------------L-------PSELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAY 370 (788)
T ss_pred CC------------C-------cccccccccccCcccc-cccc---ccccceEecCCCccCC-CCCC---Ccccceehhh
Confidence 11 0 1145556666666653 3331 1356666666666663 3322 2345555666
Q ss_pred CCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCC
Q 047196 437 FNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPL 516 (827)
Q Consensus 437 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~ 516 (827)
+|++++ +|.. ..+|+.|++++|++++ +|... ++|+.|++++|++++ +|..+ .+|+.|++++|+++ .+
T Consensus 371 ~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l~---s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~L 437 (788)
T PRK15387 371 NNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVLP---SELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RL 437 (788)
T ss_pred cccccc-Cccc---ccccceEEecCCcccC-CCCcc---cCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-cc
Confidence 666653 4432 2345566666666552 44322 345555555555553 33321 23444555555554 34
Q ss_pred cccccccccCceEEcccceeeecccccc
Q 047196 517 SLDIGNLRVVIGINLSRNNFSGDIPSTI 544 (827)
Q Consensus 517 p~~~~~l~~L~~L~Ls~N~l~g~ip~~~ 544 (827)
|..++.++.|..|+|++|+|+|.+|..+
T Consensus 438 P~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 438 PESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred ChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 4444444444444444444444444443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.1e-23 Score=210.62 Aligned_cols=150 Identities=31% Similarity=0.403 Sum_probs=118.6
Q ss_pred hhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALD 749 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~ 749 (827)
.++|+..++||+|+||+||.++. ++++.+|+|++++.. ....+...+|..+|.+++||.||++...+.+++..++.
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 46799999999999999999985 468999999997653 22456788999999999999999999999887765553
Q ss_pred --eeccC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 750 --CLHST--------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 750 --~l~~~--------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
++..+ .+.+......-++..|+.||.|| |+.+|||||+||+||| |||++|....+..
T Consensus 104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~L---H~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYL---HSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHH---HhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence 33321 23344444556778889999999 5788999999999999 9999997655443
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
.. .+.+||+.|||||++
T Consensus 181 ~t-~tfcGT~eYmAPEil 197 (357)
T KOG0598|consen 181 AT-RTFCGTPEYMAPEIL 197 (357)
T ss_pred cc-ccccCCccccChHHH
Confidence 32 336799999999985
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-23 Score=206.05 Aligned_cols=151 Identities=29% Similarity=0.408 Sum_probs=115.3
Q ss_pred hcccccceEecCCceEEEEEE-ecCCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCce----e
Q 047196 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFK----A 747 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~-~~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~----~ 747 (827)
.+|...++||+|+||.|||+. ..+|..||.|.+.-. ..+..+.+..||.+|++++|||||++++.-..++.. +
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 467788999999999999997 678999999998643 244567889999999999999999988743333322 2
Q ss_pred eeeecc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEccCCCccee----------eeccccc
Q 047196 748 LDCLHS------------TNCSLNIFDKLNIMIDVASALEYLHFSHSTP--VIHCDLKPKNVF----------DFGIGRL 803 (827)
Q Consensus 748 l~~l~~------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~--iiHrDlK~~NIl----------DFGla~~ 803 (827)
|++... ...........++..|++.||..+|+.. ++ |+||||||.||+ |||++|.
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 222211 1223445556789999999999997633 44 999999999998 9999999
Q ss_pred ccCCCccccccceecccccccccC
Q 047196 804 LTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 804 ~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
+..+...+ .+.+|||.||+||.+
T Consensus 178 l~s~~tfA-~S~VGTPyYMSPE~i 200 (375)
T KOG0591|consen 178 LSSKTTFA-HSLVGTPYYMSPERI 200 (375)
T ss_pred hcchhHHH-HhhcCCCcccCHHHH
Confidence 97665543 456799999999975
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.1e-22 Score=228.64 Aligned_cols=267 Identities=23% Similarity=0.327 Sum_probs=177.9
Q ss_pred CCcEEEcCCCCCCCCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEc
Q 047196 171 SVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISL 250 (827)
Q Consensus 171 ~L~~L~L~~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 250 (827)
.-..|+++.+.++ .+|..+.. +|+.|++++|+++. +|. .+++|++|++++|+|+. +|.. .++|+.|++
T Consensus 202 ~~~~LdLs~~~Lt-sLP~~l~~---~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~L 269 (788)
T PRK15387 202 GNAVLNVGESGLT-TLPDCLPA---HITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTS-LPVL---PPGLLELSI 269 (788)
T ss_pred CCcEEEcCCCCCC-cCCcchhc---CCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCc-ccCc---ccccceeec
Confidence 4568999999998 79987753 89999999999985 564 35899999999999995 5643 468999999
Q ss_pred ccccccccccccccCcCCCcEEEeecccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCcccc
Q 047196 251 RNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSG 330 (827)
Q Consensus 251 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~ 330 (827)
++|.++ .+|.. .++|+.|++++|+++. +|.. +++|+.|++++|. +++
T Consensus 270 s~N~L~-~Lp~l---p~~L~~L~Ls~N~Lt~-LP~~---p~~L~~LdLS~N~-------------------------L~~ 316 (788)
T PRK15387 270 FSNPLT-HLPAL---PSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQ-------------------------LAS 316 (788)
T ss_pred cCCchh-hhhhc---hhhcCEEECcCCcccc-cccc---ccccceeECCCCc-------------------------ccc
Confidence 999998 55653 3678899999999875 3431 2345555555554 443
Q ss_pred ccCccccCCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEe
Q 047196 331 TIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLD 410 (827)
Q Consensus 331 ~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 410 (827)
+|... .+|..|++++|++++ +|. ++.+|+.|+|++|+|++ +|.. .++|+.|+
T Consensus 317 -Lp~lp---~~L~~L~Ls~N~L~~-LP~-------------------lp~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~ 368 (788)
T PRK15387 317 -LPALP---SELCKLWAYNNQLTS-LPT-------------------LPSGLQELSVSDNQLAS-LPTL---PSELYKLW 368 (788)
T ss_pred -CCCCc---ccccccccccCcccc-ccc-------------------cccccceEecCCCccCC-CCCC---Ccccceeh
Confidence 22211 234445555555442 111 11246666666666663 3432 24566667
Q ss_pred ccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCccccCCCcccc
Q 047196 411 LEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTS 490 (827)
Q Consensus 411 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 490 (827)
+++|++++ +|.. ..+|+.|++++|+|++ +|.. .++|+.|++++|++++ +|... .+|+.|++++|+++
T Consensus 369 Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt- 435 (788)
T PRK15387 369 AYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT- 435 (788)
T ss_pred hhcccccc-Cccc---ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-
Confidence 77777664 4432 2457777777777763 5543 2467777888888773 66532 45677888888887
Q ss_pred cCCccccccccccccCCCCCCCCCCCccccccc
Q 047196 491 VLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNL 523 (827)
Q Consensus 491 ~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l 523 (827)
.+|..+.++++|+.|+|++|.|+|.++..+..+
T Consensus 436 ~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l 468 (788)
T PRK15387 436 RLPESLIHLSSETTVNLEGNPLSERTLQALREI 468 (788)
T ss_pred ccChHHhhccCCCeEECCCCCCCchHHHHHHHH
Confidence 467778888888888888888888777665443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.1e-23 Score=214.29 Aligned_cols=147 Identities=28% Similarity=0.425 Sum_probs=117.6
Q ss_pred hcccccceEecCCceEEEEEE-ecCCcEEEEEEEcccchHHHHH--HHHHHHHHHhcC-CCCceEEEeeeecCC-ceee-
Q 047196 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKS--FEAECEVMKNIR-HRNHVKRISSCSNED-FKAL- 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~--~~~Ei~~l~~l~-H~niv~~~~~~~~~~-~~~l- 748 (827)
++|...+.+|.|.||.||+|+ ..+|+.||||+++..-.. +++ =.|||..|+++. |||||++.+.+.+.+ ..++
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 567778899999999999998 457899999999654322 333 268999999999 999999999988776 2222
Q ss_pred -eee--------ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 749 -DCL--------HSTNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 749 -~~l--------~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
+++ ......+...+...|+.||.+||+|+ |++|+.|||+||+||| |||+||-+.....
T Consensus 89 fE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hi---Hk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP 165 (538)
T KOG0661|consen 89 FEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHI---HKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP 165 (538)
T ss_pred HHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHH---HhcCcccccCChhheEecccceeEecccccccccccCCC
Confidence 222 12344567778889999999999999 5789999999999998 9999998764433
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
.|..+.|.+|+|||++
T Consensus 166 --YTeYVSTRWYRAPEvL 181 (538)
T KOG0661|consen 166 --YTEYVSTRWYRAPEVL 181 (538)
T ss_pred --cchhhhcccccchHHh
Confidence 4667889999999985
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-22 Score=213.24 Aligned_cols=149 Identities=34% Similarity=0.495 Sum_probs=120.5
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l 751 (827)
++|...+.||+|+||+||||+.+ +++.||+|.+.+.. .+..+...+|++|+++++|||||.+++++......++...
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46777789999999999999876 57889999997643 4456789999999999999999999999887665544222
Q ss_pred c---------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 752 H---------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 752 ~---------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
+ ..++.+.......|+.++..||.|| |+.+|+|||+||.||| |||+||....... ..
T Consensus 82 ~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yL---hs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~-vl 157 (808)
T KOG0597|consen 82 YAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYL---HSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS-VL 157 (808)
T ss_pred hhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHH---HhcCcccccCCcceeeecCCCceeechhhhhhhcccCce-ee
Confidence 2 2345677777888999999999999 5788999999999999 9999998765433 34
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
+...|||.|||||++
T Consensus 158 tsikGtPlYmAPElv 172 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELV 172 (808)
T ss_pred eeccCcccccCHHHH
Confidence 445599999999974
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.1e-22 Score=198.48 Aligned_cols=151 Identities=25% Similarity=0.332 Sum_probs=115.5
Q ss_pred HhhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchH--HHHHHHHHHHHHHhcCCCCceEEEeeeecC----Cc
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAM--ALKSFEAECEVMKNIRHRNHVKRISSCSNE----DF 745 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~----~~ 745 (827)
..++|+..+.|++|+||.||+|+.+ +++.||.|+++..... ..-.-.|||.+|.+++|||||.+-...... -|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 3457888899999999999999864 6899999998754321 123457999999999999999977665443 24
Q ss_pred eeeeeecc--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCC
Q 047196 746 KALDCLHS--------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGD 807 (827)
Q Consensus 746 ~~l~~l~~--------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~ 807 (827)
.+|+++.. ....+...+...+..|+.+|++||| ..-|+|||||++|+| |||+||.+...
T Consensus 154 ~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 154 IVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 44444332 1234555667779999999999995 677999999999988 99999998654
Q ss_pred CccccccceecccccccccC
Q 047196 808 RSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 808 ~~~~~~~~~gt~~Y~APE~l 827 (827)
.. ..|..+.|.+|+|||.+
T Consensus 231 ~k-~~T~lVVTLWYRaPELL 249 (419)
T KOG0663|consen 231 LK-PYTPLVVTLWYRAPELL 249 (419)
T ss_pred cc-cCcceEEEeeecCHHHh
Confidence 33 24556789999999974
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.8e-21 Score=223.86 Aligned_cols=274 Identities=16% Similarity=0.274 Sum_probs=130.3
Q ss_pred hccCCCHHHHHHHHHHHhhcCCCCC--CcCCCCCCCCCCCCcccc----------------eecCCCCCcEEEEEcCCCC
Q 047196 48 AAASNITTDQQALLALKAHISYDPT--NLLAQNSTSNTSVCNWIG----------------ITCNVNSHRVTALNISSLN 109 (827)
Q Consensus 48 ~~~~~~~~~~~aLl~~k~~~~~~~~--~~l~~w~~~~~~~C~W~g----------------v~C~~~~~~v~~L~L~~~~ 109 (827)
+.+.....|.+.+++..+.+.+.+. +.-..|. .++|+|.-.. |.|.. +.||.+...+..
T Consensus 56 ~~~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~-~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~~--~~vt~l~~~g~~ 132 (754)
T PRK15370 56 PPETASPEEIKSKFECLRMLAFPAYADNIQYSRG-GADQYCILSENSQEILSIVFNTEGYTVEGGG--KSVTYTRVTESE 132 (754)
T ss_pred CCCCCCHHHHHHHHHHHHHhcCCchhhccccccC-CCCcccccCCcchhhheeeecCCceEEecCC--Cccccccccccc
Confidence 4455667888999999998844332 1122376 5678886544 56753 467777665422
Q ss_pred CccccCccccCCCCCCEEE----CCCCCCCccC---Chhhhh-----ccccceEEecCCCCCCccccccCCCCCCcEEEc
Q 047196 110 LQGTIPPQLGNLSSLTTLN----LSHNKLSGDI---PPSIFT-----MHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRL 177 (827)
Q Consensus 110 l~g~~~~~l~~L~~L~~L~----Ls~N~l~g~~---p~~~~~-----l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L 177 (827)
.......+- +.-.+.. -..+.-.+.- -.++.. ..+...|+++++.++. +|..+. .+++.|+|
T Consensus 133 ~~~~~~~~~---~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~L 206 (754)
T PRK15370 133 QASSASGSK---DAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLTT-IPACIP--EQITTLIL 206 (754)
T ss_pred ccccCCCCC---ChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcCc-CCcccc--cCCcEEEe
Confidence 211110000 0000000 0000000000 001111 1234455555555542 232221 24555555
Q ss_pred CCCCCCCCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccc
Q 047196 178 DSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRG 257 (827)
Q Consensus 178 ~~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 257 (827)
+.|+++ .+|..++ .+|++|++++|+++ .+|..+. .+|+.|+|++|.++ .+|..+. ++|+.|++++|+++
T Consensus 207 s~N~Lt-sLP~~l~---~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~- 275 (754)
T PRK15370 207 DNNELK-SLPENLQ---GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS- 275 (754)
T ss_pred cCCCCC-cCChhhc---cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-
Confidence 555555 3555443 25666666666665 3444332 35666666666665 4555443 35677777777766
Q ss_pred cccccccCcCCCcEEEeecccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCcccc
Q 047196 258 EIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFIT 337 (827)
Q Consensus 258 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 337 (827)
.+|..+. ++|+.|+|++|++++ +|..+. ++|+.|++++|.+.. +|..+ .++|+.|++++|.+++ +|..+.
T Consensus 276 ~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l---~~sL~~L~Ls~N~Lt~-LP~~l~ 345 (754)
T PRK15370 276 CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-LPETL---PPGLKTLEAGENALTS-LPASLP 345 (754)
T ss_pred ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-CCccc---cccceeccccCCcccc-CChhhc
Confidence 4555443 467777777776664 333221 234444455444432 22211 1345555555555543 333332
Q ss_pred CCCCCcEEEcCCCcce
Q 047196 338 NASKLVYLDMGTNSFS 353 (827)
Q Consensus 338 ~l~~L~~L~Ls~N~l~ 353 (827)
++|+.|++++|+++
T Consensus 346 --~sL~~L~Ls~N~L~ 359 (754)
T PRK15370 346 --PELQVLDVSKNQIT 359 (754)
T ss_pred --CcccEEECCCCCCC
Confidence 34555555555443
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2e-23 Score=213.19 Aligned_cols=374 Identities=22% Similarity=0.232 Sum_probs=177.3
Q ss_pred cccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEccc-ccccccccccccCcCCCcEEEe
Q 047196 196 YLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRN-NKLRGEIPHEIGYLPNLENLVL 274 (827)
Q Consensus 196 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L 274 (827)
.-..++|..|+|+...|.+|+.+++|+.|||+.|+|+.+-|+.|.++.+|..|-+.+ |+|+......|++|..|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 344555555555555555555555555555555555555555555555554443333 5555333344555555555555
Q ss_pred ecccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccc------------cccCccccCCCCC
Q 047196 275 GFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFS------------GTIPSFITNASKL 342 (827)
Q Consensus 275 s~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~------------~~~p~~~~~l~~L 342 (827)
.-|++..+..+.|..++++..|.+.+|.+. .++...+..+..++.+.+..|.+- ...|..++...-.
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~ 226 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCV 226 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceec
Confidence 555555555555555555555555555442 222222224444455544444421 0111111111111
Q ss_pred cEEEcCCCcceeecCCCcc----------CCCCCCcccCCCc-hhcccccccEEEccCCcCccccCccccCCCCCceEec
Q 047196 343 VYLDMGTNSFSGIIPNTIG----------LTGNPLDGVLPTS-IGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDL 411 (827)
Q Consensus 343 ~~L~Ls~N~l~g~~p~~~~----------l~~n~l~g~~p~~-~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 411 (827)
.-..+.++++...-+..+. .+.....+..|.. |..++ +|+.|+|++|++++.-+.+|.....++.|.|
T Consensus 227 ~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~-~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L 305 (498)
T KOG4237|consen 227 SPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLP-NLRKLNLSNNKITRIEDGAFEGAAELQELYL 305 (498)
T ss_pred chHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcc-cceEeccCCCccchhhhhhhcchhhhhhhhc
Confidence 1111222222111111000 0111122222222 22333 5666666666666666666666666666666
Q ss_pred cCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccc-----------------cCCccccC
Q 047196 412 EGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSG-----------------SIPSCLGN 474 (827)
Q Consensus 412 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~-----------------~~p~~~~~ 474 (827)
..|++...-...|.++..|+.|+|.+|+|+..-|..|..+.+|.+|+|-.|.+.- -.|.+ +.
T Consensus 306 ~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~C-q~ 384 (498)
T KOG4237|consen 306 TRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPRC-QS 384 (498)
T ss_pred CcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCCCC-CC
Confidence 6666665555556666666666666666666666666666666666666655520 00100 11
Q ss_pred CCCCCccccCCCcccc---cCCccc---------ccccccc-ccCCCCCCCCCCCcccccccccCceEEcccceeeeccc
Q 047196 475 LTSLRSPDLGSNRLTS---VLPSTF---------WNLKDIL-FFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIP 541 (827)
Q Consensus 475 l~~L~~L~Ls~N~l~~---~~p~~~---------~~l~~L~-~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip 541 (827)
-..++.++++.+.+.. ..|++. ..++-+. +..-|++.+. .+|..+. ....++++.+|+++ .+|
T Consensus 385 p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~-~vp 460 (498)
T KOG4237|consen 385 PGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT-SVP 460 (498)
T ss_pred CchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC--chhHHHhcccchhc-ccC
Confidence 1123334444333321 011111 1111121 1222222222 2222211 12346788888887 677
Q ss_pred ccccCCCCCCEEECCCCcceeecCCCCc---CCceEeCcCC
Q 047196 542 STIGDLKDLQNISLACNGLEGLIPESFG---YLTELNLSFN 579 (827)
Q Consensus 542 ~~~~~l~~L~~L~Ls~N~l~g~ip~~~~---~L~~L~ls~N 579 (827)
.+ .+.+| .+|+|+|+++..--..|+ +|.+|-+|||
T Consensus 461 ~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 461 DE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred HH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 76 56677 888888888765554444 5667777776
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.8e-21 Score=199.44 Aligned_cols=150 Identities=27% Similarity=0.348 Sum_probs=115.0
Q ss_pred hhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccch--HHHHHHHHHHHHHHhcCCCC-ceEEEeeeecCC-----
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCA--MALKSFEAECEVMKNIRHRN-HVKRISSCSNED----- 744 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~H~n-iv~~~~~~~~~~----- 744 (827)
...|+..++||+|+||+||+|+. .+|+.||+|+++.... .......+|+.++++++|+| ||++.+++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34566778899999999999985 5789999999975433 23345689999999999999 999999998766
Q ss_pred -ceeeeeeccC----------C---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecc
Q 047196 745 -FKALDCLHST----------N---CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGI 800 (827)
Q Consensus 745 -~~~l~~l~~~----------~---~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGl 800 (827)
..++.+.+.. . ..++......++.|+.+|++|| |+++|+||||||.||| |||+
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~---H~~~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFL---HSHGILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHH---HhCCeecccCCcceEEECCCCcEeeeccch
Confidence 3323222211 1 1234445678999999999999 5788999999999998 9999
Q ss_pred cccccCCCccccccceecccccccccC
Q 047196 801 GRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 801 a~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
|+........ .+..++|.+|.|||++
T Consensus 167 Ara~~ip~~~-yt~evvTlWYRaPEvL 192 (323)
T KOG0594|consen 167 ARAFSIPMRT-YTPEVVTLWYRAPEVL 192 (323)
T ss_pred HHHhcCCccc-ccccEEEeeccCHHHh
Confidence 9977533332 3556799999999984
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.6e-21 Score=197.69 Aligned_cols=144 Identities=29% Similarity=0.449 Sum_probs=107.3
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCce---e---
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFK---A--- 747 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~---~--- 747 (827)
-.|...+++|.|+||.||+|... +++.||||+..++... --+|.++|++++|||||++.-++...... +
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 35777899999999999999864 5789999998655331 24799999999999999999887653222 1
Q ss_pred -eeeecc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------eecccccc
Q 047196 748 -LDCLHS-----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRLL 804 (827)
Q Consensus 748 -l~~l~~-----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGla~~~ 804 (827)
++++-. .+......+..-+..|+.+|++||| +.+|+||||||.|+| |||.||.+
T Consensus 100 VleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 100 VLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 122111 1122333334458889999999996 578999999999998 99999998
Q ss_pred cCCCccccccceecccccccccC
Q 047196 805 TGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 805 ~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
...... .+..-|..|+|||.+
T Consensus 177 ~~~epn--iSYicSRyYRaPELi 197 (364)
T KOG0658|consen 177 VKGEPN--ISYICSRYYRAPELI 197 (364)
T ss_pred ccCCCc--eeEEEeccccCHHHH
Confidence 655432 335579999999974
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.2e-21 Score=187.71 Aligned_cols=147 Identities=27% Similarity=0.344 Sum_probs=120.3
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALD 749 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~ 749 (827)
.++|+..+.+|.|+||+|...+.+ +|..+|+|++.+.. .++.++...|..+|+.+.||.+|++.+.+.+....+|.
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 357888899999999999999865 68899999997654 23456788999999999999999999999998877764
Q ss_pred eeccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 750 CLHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 750 ~l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
..+..+ +.++.....-+|.+|+.|++||| +..|++||+||+||| |||+||.+.+..
T Consensus 123 meyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT- 198 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRT- 198 (355)
T ss_pred EeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCcE-
Confidence 444333 23455556679999999999995 667999999999998 999999886542
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
.+-||||.|+|||++
T Consensus 199 ---~TlCGTPeYLAPEii 213 (355)
T KOG0616|consen 199 ---WTLCGTPEYLAPEII 213 (355)
T ss_pred ---EEecCCccccChHHh
Confidence 235699999999985
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.1e-21 Score=199.03 Aligned_cols=152 Identities=28% Similarity=0.401 Sum_probs=114.8
Q ss_pred HhhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccch--------------HHHHHHHHHHHHHHhcCCCCceEEE
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCA--------------MALKSFEAECEVMKNIRHRNHVKRI 737 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~--------------~~~~~~~~Ei~~l~~l~H~niv~~~ 737 (827)
....|+....||+|.||+|-+|+. .+++.||||++.+... ...+...+||.+|++++|+|||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 446788889999999999999985 4789999999964221 0135789999999999999999999
Q ss_pred eeeecCC--ceee--eeeccC-------CCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------
Q 047196 738 SSCSNED--FKAL--DCLHST-------NCS-LNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF--------- 796 (827)
Q Consensus 738 ~~~~~~~--~~~l--~~l~~~-------~~~-l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl--------- 796 (827)
.+..+.. ..+| +++..+ .+. ++..+..++.+++..||+||| .++||||||||+|+|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~VKI 251 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGTVKI 251 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCcEEe
Confidence 9987653 2333 333321 122 666778899999999999995 578999999999998
Q ss_pred -eecccccccCCC---c-cccccceecccccccccC
Q 047196 797 -DFGIGRLLTGDR---S-MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 -DFGla~~~~~~~---~-~~~~~~~gt~~Y~APE~l 827 (827)
|||.+-...... . ......+|||+|||||.+
T Consensus 252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c 287 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELC 287 (576)
T ss_pred eccceeeecccCCccccHHHHhhcCCCccccchHhh
Confidence 999886552111 0 111235799999999963
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.2e-21 Score=201.10 Aligned_cols=143 Identities=29% Similarity=0.515 Sum_probs=113.6
Q ss_pred cceEecCCceEEEEEE-ecCCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc--eeeeeecc-
Q 047196 680 ENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF--KALDCLHS- 753 (827)
Q Consensus 680 ~~~iG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~--~~l~~l~~- 753 (827)
++++|.|.||+||-|. .++|+.||||++.+-. .++....+.|++||++++||.||.+.-.|...+. .+|+.++.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 4799999999999997 4689999999997642 3345678999999999999999998888776653 34444443
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------eecccccccCCCcccc
Q 047196 754 --------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 754 --------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------------DFGla~~~~~~~~~~~ 812 (827)
+.+.+....-.-.+.||..||.||| .++|+|.||||+||| |||+||++....- .
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF--R 723 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF--R 723 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhhh--h
Confidence 2345555555567889999999995 578999999999998 9999999875433 2
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
.+.+||++|.||||+
T Consensus 724 rsVVGTPAYLaPEVL 738 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVL 738 (888)
T ss_pred hhhcCCccccCHHHH
Confidence 456799999999985
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-20 Score=197.50 Aligned_cols=149 Identities=30% Similarity=0.446 Sum_probs=115.2
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc----eeeee
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF----KALDC 750 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~----~~l~~ 750 (827)
++...+.||+|+||.||++... +|+..|||.+........+.+++|+++|++++|||||+++|.....+. .+|++
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 4667789999999999999865 499999999876533336678999999999999999999997433331 22344
Q ss_pred eccC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------eecccccccC--CC
Q 047196 751 LHST---------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRLLTG--DR 808 (827)
Q Consensus 751 l~~~---------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGla~~~~~--~~ 808 (827)
...+ .+.+.......+.++|.+||+|| |+++||||||||+||| |||.|+.... ..
T Consensus 98 ~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~yl---Hs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 98 APGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYL---HSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 3321 12567777888999999999999 4889999999999998 9999987764 21
Q ss_pred ccccccceecccccccccC
Q 047196 809 SMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~~~~~~gt~~Y~APE~l 827 (827)
........||+.|||||++
T Consensus 175 ~~~~~~~~Gtp~~maPEvi 193 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVI 193 (313)
T ss_pred ccccccccCCccccCchhh
Confidence 1122345699999999985
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.1e-21 Score=205.91 Aligned_cols=148 Identities=28% Similarity=0.508 Sum_probs=117.6
Q ss_pred cccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee--eeec-
Q 047196 676 KFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL--DCLH- 752 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l--~~l~- 752 (827)
.+...+.||+|.||.||.|.+.....||||.+... ....+.|.+|+++|++++|++||+++|.|..++..++ +++.
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 34456789999999999999988789999998765 3455789999999999999999999999998773333 3332
Q ss_pred --------c-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccc
Q 047196 753 --------S-TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQT 813 (827)
Q Consensus 753 --------~-~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~ 813 (827)
. ....+...+.+.++.|||+|++|| .++++|||||.+.||| |||+||...++......
T Consensus 286 GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YL---es~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~ 362 (468)
T KOG0197|consen 286 GSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYL---ESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE 362 (468)
T ss_pred CcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHH---HhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence 2 234566778889999999999999 4778999999999999 99999965555443333
Q ss_pred cceecccccccccC
Q 047196 814 ETLVTIGYMAPGLL 827 (827)
Q Consensus 814 ~~~gt~~Y~APE~l 827 (827)
..--...|.|||.+
T Consensus 363 ~~kfPIkWtAPEa~ 376 (468)
T KOG0197|consen 363 GGKFPIKWTAPEAL 376 (468)
T ss_pred CCCCCceecCHHHH
Confidence 33347789999964
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.4e-21 Score=206.33 Aligned_cols=144 Identities=27% Similarity=0.377 Sum_probs=113.1
Q ss_pred cccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCce--eee
Q 047196 676 KFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFK--ALD 749 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~--~l~ 749 (827)
.|.+.+.||.|+||.||-|+. ++.+.||||++.-.. ...++.+..||..|++++|||.|.+-|+|..+.-. +|+
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 467778899999999999985 467899999997543 34567889999999999999999999998776533 333
Q ss_pred eeccC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 750 CLHST--------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 750 ~l~~~--------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
|..+. ...+...+...|..|+.+||+||| +.+.||||||+.||| |||.|.+..+..
T Consensus 107 YClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn--- 180 (948)
T KOG0577|consen 107 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN--- 180 (948)
T ss_pred HHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCchh---
Confidence 33221 233445555668889999999995 667899999999999 999888765443
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
+.+|||+|||||||
T Consensus 181 --sFvGTPywMAPEVI 194 (948)
T KOG0577|consen 181 --SFVGTPYWMAPEVI 194 (948)
T ss_pred --cccCCccccchhHh
Confidence 36799999999986
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.8e-20 Score=202.43 Aligned_cols=151 Identities=24% Similarity=0.384 Sum_probs=118.8
Q ss_pred HhhcccccceEecCCceEEEEEEe-cCCcEEEEEEEccc----ch-HHHHHHHHHHHHHHhcC-CCCceEEEeeeecCCc
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQN----CA-MALKSFEAECEVMKNIR-HRNHVKRISSCSNEDF 745 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~----~~-~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~ 745 (827)
..+.|...+.||+|+||+||.|+. .+|+.||||.+... .. ...+...+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 346788899999999999999975 56899999977543 11 23456778999999999 9999999999988776
Q ss_pred eeeeeeccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------eecccccc
Q 047196 746 KALDCLHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRLL 804 (827)
Q Consensus 746 ~~l~~l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGla~~~ 804 (827)
.++...+..+ +.+...+...+..|++.|++|+ |+++|+||||||+||| |||+++..
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~---H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYC---HSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHH---HhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 5543333222 4556667778999999999999 5789999999999998 99999987
Q ss_pred cCCCccccccceecccccccccC
Q 047196 805 TGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 805 ~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
..... .....+||+.|+|||++
T Consensus 172 ~~~~~-~l~t~cGsp~Y~aPEvl 193 (370)
T KOG0583|consen 172 PGEDG-LLKTFCGSPAYAAPEVL 193 (370)
T ss_pred CCCCC-cccCCCCCcccCCHHHh
Confidence 42212 23446799999999985
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.1e-21 Score=203.93 Aligned_cols=149 Identities=26% Similarity=0.394 Sum_probs=120.0
Q ss_pred hcccccceEecCCceEEEEEE-ecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC--ceeeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNED--FKALDCL 751 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~--~~~l~~l 751 (827)
..|....+||+|+.|.||.|+ ..++..||||++........+-...|+.+|+..+|+|||.++..+...+ +.+|+++
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 346667889999999999997 4678999999998766555566889999999999999999999887665 4445555
Q ss_pred ccCC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccccc
Q 047196 752 HSTN-------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTE 814 (827)
Q Consensus 752 ~~~~-------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~ 814 (827)
..+. ..++..+...|++++.+||+|| |.++|+|||||++||| |||+++.+...... ..+
T Consensus 353 ~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fL---H~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K-R~T 428 (550)
T KOG0578|consen 353 EGGSLTDVVTKTRMTEGQIAAICREILQGLKFL---HARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK-RST 428 (550)
T ss_pred CCCchhhhhhcccccHHHHHHHHHHHHHHHHHH---HhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCc-ccc
Confidence 4432 2345566778999999999999 5788999999999999 99999888665542 345
Q ss_pred ceecccccccccC
Q 047196 815 TLVTIGYMAPGLL 827 (827)
Q Consensus 815 ~~gt~~Y~APE~l 827 (827)
.+||++|||||++
T Consensus 429 mVGTPYWMAPEVv 441 (550)
T KOG0578|consen 429 MVGTPYWMAPEVV 441 (550)
T ss_pred ccCCCCccchhhh
Confidence 6799999999985
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.6e-20 Score=193.57 Aligned_cols=149 Identities=28% Similarity=0.441 Sum_probs=111.0
Q ss_pred hcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHH--hcCCCCceEEEeeeecCCc----eee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMK--NIRHRNHVKRISSCSNEDF----KAL 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~--~l~H~niv~~~~~~~~~~~----~~l 748 (827)
+.....+.||+|.||.||+|+++ |+.||||++....+ +.+.+|.+|.+ .+||+||..++++-..+.. .++
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred heeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 34566789999999999999997 68999999965543 34666777666 5699999999987544321 122
Q ss_pred eeeccCC---------CCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeEEccCCCccee----------eecccccc
Q 047196 749 DCLHSTN---------CSLNIFDKLNIMIDVASALEYLHF-----SHSTPVIHCDLKPKNVF----------DFGIGRLL 804 (827)
Q Consensus 749 ~~l~~~~---------~~l~~~~~~~i~~~ia~~L~~Lh~-----~h~~~iiHrDlK~~NIl----------DFGla~~~ 804 (827)
...+.+. ..++....++++..+|.||++||. .-+|.|.|||||+.||| |+|+|-..
T Consensus 287 vTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h 366 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 366 (513)
T ss_pred eeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEe
Confidence 2222222 234556678999999999999994 35789999999999999 99999766
Q ss_pred cCCCcc---ccccceecccccccccC
Q 047196 805 TGDRSM---IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 805 ~~~~~~---~~~~~~gt~~Y~APE~l 827 (827)
..+... .....+||.+|||||++
T Consensus 367 ~~~t~~idi~~N~rVGTKRYMAPEvL 392 (513)
T KOG2052|consen 367 DSDTDTIDIPPNPRVGTKRYMAPEVL 392 (513)
T ss_pred cccCCcccCCCCCccceeeccChHHh
Confidence 544322 23456799999999986
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.1e-20 Score=218.48 Aligned_cols=16 Identities=6% Similarity=-0.095 Sum_probs=9.4
Q ss_pred CCHHHHHHHHHHHhhc
Q 047196 52 NITTDQQALLALKAHI 67 (827)
Q Consensus 52 ~~~~~~~aLl~~k~~~ 67 (827)
|.+.+.+|+--+..-.
T Consensus 39 ~~~~~~~~~~~~~~~~ 54 (754)
T PRK15370 39 SSEHQVEAQNCIAYLC 54 (754)
T ss_pred ccchHHHHHHHHHHHh
Confidence 4455666766666544
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8e-21 Score=182.54 Aligned_cols=149 Identities=24% Similarity=0.365 Sum_probs=116.8
Q ss_pred HhhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL 748 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l 748 (827)
+.++|+.++.+|+|.||.||.|+. +++..||+|++.+.. .+..+++.+||+|-+.++||||.++++++.++...++
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 346789999999999999999985 468899999986532 2234679999999999999999999999998876666
Q ss_pred eeeccCCC------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccC
Q 047196 749 DCLHSTNC------------SLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806 (827)
Q Consensus 749 ~~l~~~~~------------~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~ 806 (827)
...+...+ .++......+..|+|.|+.|+ |.++||||||||+|+| |||.+-.-..
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~---h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYC---HLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHh---ccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 44443222 234444567889999999998 6889999999999998 9998754432
Q ss_pred CCccccccceecccccccccC
Q 047196 807 DRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 807 ~~~~~~~~~~gt~~Y~APE~l 827 (827)
.. ....+||.-|.|||+.
T Consensus 177 ~k---R~tlcgt~dyl~pEmv 194 (281)
T KOG0580|consen 177 NK---RKTLCGTLDYLPPEMV 194 (281)
T ss_pred CC---ceeeecccccCCHhhc
Confidence 21 2345799999999974
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.3e-22 Score=189.11 Aligned_cols=149 Identities=28% Similarity=0.441 Sum_probs=116.7
Q ss_pred hhcccccceEecCCceEEEEEE-ecCCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~-~~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
++.|+..++||+|.|+.||++. .++|+.+|+|++... .....++.++|++|-+.++|||||++...+.++.+.++.+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 3556777889999999999996 467999999987543 2335678899999999999999999999999988888766
Q ss_pred eccCCCCC----------CHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------eecccccccCC
Q 047196 751 LHSTNCSL----------NIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------DFGIGRLLTGD 807 (827)
Q Consensus 751 l~~~~~~l----------~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------------DFGla~~~~~~ 807 (827)
....+..+ +....-...+||.+++.|+ |.++|||||+||+|++ |||+|..+. +
T Consensus 90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yC---H~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~ 165 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYC---HSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-D 165 (355)
T ss_pred ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH---HhcCceeccCChhheeeeeccCCCceeecccceEEEeC-C
Confidence 55443321 2223335677888888888 6889999999999988 999999887 3
Q ss_pred CccccccceecccccccccC
Q 047196 808 RSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 808 ~~~~~~~~~gt~~Y~APE~l 827 (827)
+.. -...+|||+|||||++
T Consensus 166 g~~-~~G~~GtP~fmaPEvv 184 (355)
T KOG0033|consen 166 GEA-WHGFAGTPGYLSPEVL 184 (355)
T ss_pred ccc-cccccCCCcccCHHHh
Confidence 332 2345699999999984
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.5e-20 Score=197.21 Aligned_cols=152 Identities=28% Similarity=0.395 Sum_probs=118.2
Q ss_pred HhhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc---hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCcee
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC---AMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFKA 747 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~ 747 (827)
...+|..++.||+|+|++||+|+. +++++||||++.+.. ....+-..+|-++|.++ .||.||+++--+.++...+
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 446788899999999999999985 568999999997542 22234567888999999 8999999998888776544
Q ss_pred eeeeccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCC
Q 047196 748 LDCLHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGD 807 (827)
Q Consensus 748 l~~l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~ 807 (827)
+...+.. .+.++......+|.+|..|++|| |+.+||||||||+||| |||.|+.+.+.
T Consensus 151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleyl---H~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYL---HSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHH---HhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 4333322 24566666677999999999999 6889999999999999 99999998542
Q ss_pred Ccc----------cc--ccceecccccccccC
Q 047196 808 RSM----------IQ--TETLVTIGYMAPGLL 827 (827)
Q Consensus 808 ~~~----------~~--~~~~gt~~Y~APE~l 827 (827)
... .. .+.+||..|++||++
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL 259 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELL 259 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHh
Confidence 211 11 346799999999985
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.5e-20 Score=185.36 Aligned_cols=155 Identities=25% Similarity=0.408 Sum_probs=122.8
Q ss_pred cchhHHHHHhhcccccceEecCCceEEEEEE-ecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcC-CCCceEEEeeeec
Q 047196 665 FSYQDLFRATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIR-HRNHVKRISSCSN 742 (827)
Q Consensus 665 ~~~~~~~~~~~~~~~~~~iG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~ 742 (827)
-+|+|+.+-|+ +.+|+|+|+.|..+. +.+|.++|||++.+...+...+..+|++++...+ |+||+++++++.+
T Consensus 73 g~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 73 GKFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred chHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 35788887775 579999999999996 6789999999998887778889999999999996 9999999999998
Q ss_pred CCceeeeeeccCCCC----------CCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------eec
Q 047196 743 EDFKALDCLHSTNCS----------LNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------DFG 799 (827)
Q Consensus 743 ~~~~~l~~l~~~~~~----------l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------------DFG 799 (827)
++..++.+....++. ++..+.-+|..+||.||.|| |.++|.|||+||+||| ||-
T Consensus 148 d~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFl---H~kgIAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 148 DTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFL---HTKGIAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred cceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHH---hhcCcccccCCccceeecCCCCcCceeeeccc
Confidence 887777665544332 34455668999999999999 6899999999999999 666
Q ss_pred ccccc--cCCCcccc----ccceecccccccccC
Q 047196 800 IGRLL--TGDRSMIQ----TETLVTIGYMAPGLL 827 (827)
Q Consensus 800 la~~~--~~~~~~~~----~~~~gt~~Y~APE~l 827 (827)
++... ..+-+.+. .+.+|+..||||||.
T Consensus 225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVV 258 (463)
T KOG0607|consen 225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVV 258 (463)
T ss_pred cccccccCCCCCCCCCccccCcccchhhcchhHH
Confidence 55433 33322222 234588899999974
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.3e-20 Score=201.89 Aligned_cols=143 Identities=27% Similarity=0.441 Sum_probs=116.3
Q ss_pred ceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeeccCCCCCC
Q 047196 681 NLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHSTNCSLN 759 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~~~~l~ 759 (827)
-++|+|.||+||-|+.. +...+|||.++....+..+....||.+.++++|+|||+++|+|.+..+..+...+..+++++
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 47999999999999965 56779999998877777788899999999999999999999999888766555555555443
Q ss_pred H-------------HHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------eecccccccCCCccccccc
Q 047196 760 I-------------FDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRLLTGDRSMIQTET 815 (827)
Q Consensus 760 ~-------------~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGla~~~~~~~~~~~~~~ 815 (827)
- ...--+.+||.+||.||| +..|||||||-.||| |||.+|.+.+-..+..+ .
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET-F 736 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET-F 736 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCCccccc-c
Confidence 2 222347789999999995 566999999999998 99999988776655332 3
Q ss_pred eecccccccccC
Q 047196 816 LVTIGYMAPGLL 827 (827)
Q Consensus 816 ~gt~~Y~APE~l 827 (827)
.||..|||||+|
T Consensus 737 TGTLQYMAPEvI 748 (1226)
T KOG4279|consen 737 TGTLQYMAPEVI 748 (1226)
T ss_pred ccchhhhChHhh
Confidence 499999999986
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-19 Score=197.02 Aligned_cols=148 Identities=29% Similarity=0.435 Sum_probs=118.3
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccch---HHHHHHHHHHHHHHhcC-CCCceEEEeeeecCCceee-
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA---MALKSFEAECEVMKNIR-HRNHVKRISSCSNEDFKAL- 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~l- 748 (827)
+.|+..+.||+|.||.||+++.+ +|+.+|+|++.+... .....+.+|+++|+++. |||+|.+.+.+...+..++
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 45777789999999999999865 599999999976543 23467899999999999 9999999999988874443
Q ss_pred -eeeccCC------C-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee--------------eecccccccC
Q 047196 749 -DCLHSTN------C-SLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF--------------DFGIGRLLTG 806 (827)
Q Consensus 749 -~~l~~~~------~-~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl--------------DFGla~~~~~ 806 (827)
+....+. . .++..+...++.+++.++.|+| +.+|+|||+||+|+| |||+|+....
T Consensus 115 mEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred EEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 3332211 1 1566777889999999999995 589999999999998 9999998876
Q ss_pred CCccccccceecccccccccC
Q 047196 807 DRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 807 ~~~~~~~~~~gt~~Y~APE~l 827 (827)
. . .....+||++|+|||++
T Consensus 192 ~-~-~~~~~~Gtp~y~APEvl 210 (382)
T KOG0032|consen 192 G-E-RLHTIVGTPEYVAPEVL 210 (382)
T ss_pred C-c-eEeeecCCccccCchhh
Confidence 2 2 22446799999999985
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.8e-20 Score=201.73 Aligned_cols=161 Identities=28% Similarity=0.450 Sum_probs=128.5
Q ss_pred ccchhHHHHHhhccc---------ccceEecCCceEEEEEEec----CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcC
Q 047196 664 RFSYQDLFRATEKFS---------KENLIGVGSFGSVYKGRLH----DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIR 729 (827)
Q Consensus 664 ~~~~~~~~~~~~~~~---------~~~~iG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~ 729 (827)
.++|+|.-+|...|. .+++||.|.||.||+|+++ ....||||.++... +++..+|..|+.||++.+
T Consensus 609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd 688 (996)
T KOG0196|consen 609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD 688 (996)
T ss_pred CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence 467888777776664 3589999999999999875 24679999998764 456778999999999999
Q ss_pred CCCceEEEeeeecCCceeeeeeccCCCCC-----------CHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee--
Q 047196 730 HRNHVKRISSCSNEDFKALDCLHSTNCSL-----------NIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-- 796 (827)
Q Consensus 730 H~niv~~~~~~~~~~~~~l~~l~~~~~~l-----------~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-- 796 (827)
||||+++.|........++...+++++.| .+.+...+.++||.|+.|| .+.+.|||||.+.|||
T Consensus 689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYL---sdm~YVHRDLAARNILVN 765 (996)
T KOG0196|consen 689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYL---SDMNYVHRDLAARNILVN 765 (996)
T ss_pred CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHH---hhcCchhhhhhhhheeec
Confidence 99999999999888776665555555444 4445667899999999999 5788999999999999
Q ss_pred --------eecccccccCCCcccccccee--cccccccccC
Q 047196 797 --------DFGIGRLLTGDRSMIQTETLV--TIGYMAPGLL 827 (827)
Q Consensus 797 --------DFGla~~~~~~~~~~~~~~~g--t~~Y~APE~l 827 (827)
|||++|.+.++.....+..-| ..+|.|||.|
T Consensus 766 snLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAI 806 (996)
T KOG0196|consen 766 SNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAI 806 (996)
T ss_pred cceEEEeccccceeecccCCCccccccCCccceeecChhHh
Confidence 999999887665443332223 6789999975
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.8e-20 Score=187.04 Aligned_cols=153 Identities=28% Similarity=0.406 Sum_probs=114.9
Q ss_pred HHhhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcc--cchHHHHHHHHHHHHHHhcCCCCceEEEeeeecC---Cc
Q 047196 672 RATEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQ--NCAMALKSFEAECEVMKNIRHRNHVKRISSCSNE---DF 745 (827)
Q Consensus 672 ~~~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~--~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~---~~ 745 (827)
...+.|...+.||+|+||.|+.|.. .+|+.||||++.. ......++-.||+++|+.++|+|||.+.+....+ .+
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 3445566678899999999999986 4789999999863 3344567789999999999999999998887552 21
Q ss_pred e--ee--eeec-------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccc
Q 047196 746 K--AL--DCLH-------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLL 804 (827)
Q Consensus 746 ~--~l--~~l~-------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~ 804 (827)
. ++ +.+. ..+..+......-+..|+.+||.|+ |+.+|+|||+||+|++ |||+||..
T Consensus 99 ~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyi---HSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 99 NDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYI---HSANVIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred ceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchh---hcccccccccchhheeeccCCCEEeccccceeec
Confidence 1 11 1111 1122366666667889999999999 6788999999999998 99999988
Q ss_pred cCCC-ccccccceecccccccccC
Q 047196 805 TGDR-SMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 805 ~~~~-~~~~~~~~gt~~Y~APE~l 827 (827)
.... ....|..+.|.+|.|||++
T Consensus 176 ~~~~~~~~mTeYVaTRWYRAPEll 199 (359)
T KOG0660|consen 176 DKFFEDGFMTEYVATRWYRAPELL 199 (359)
T ss_pred cccCcccchhcceeeeeecCHHHH
Confidence 5431 1123567789999999974
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.4e-19 Score=197.00 Aligned_cols=152 Identities=21% Similarity=0.238 Sum_probs=117.2
Q ss_pred HhhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL 748 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l 748 (827)
..++|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+++++.++|||||++++++..+...++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3467888999999999999999865 58899999986422 2234568899999999999999999999988776555
Q ss_pred eeeccCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 749 DCLHSTN---------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 749 ~~l~~~~---------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
...+... ..+.......++.+++.||+||| +++|+||||||+||| |||+|+.......
T Consensus 121 v~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 121 VMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 197 (370)
T ss_pred EEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence 4333322 23455566778999999999995 678999999999998 9999987643322
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
......+||++|||||++
T Consensus 198 ~~~~~~~gt~~Y~aPE~~ 215 (370)
T cd05621 198 VRCDTAVGTPDYISPEVL 215 (370)
T ss_pred eecccCCCCcccCCHHHH
Confidence 222334599999999964
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.9e-20 Score=201.61 Aligned_cols=146 Identities=29% Similarity=0.463 Sum_probs=114.4
Q ss_pred ccccceEecCCceEEEEEE-ecCCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC--------ce
Q 047196 677 FSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNED--------FK 746 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~--------~~ 746 (827)
+...+.+|+|+||.||+|+ ..+|+.||||.++... ....++.-+|+++|++++|+|||++++.-.... ..
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 4456789999999999999 4579999999987532 334566789999999999999999988754432 12
Q ss_pred eeeeeccC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee--------------eeccc
Q 047196 747 ALDCLHST-----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF--------------DFGIG 801 (827)
Q Consensus 747 ~l~~l~~~-----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl--------------DFGla 801 (827)
+|++...+ ...+...+.+.+..+++.|+.||| +.+|+||||||.||+ |||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 23333221 135777788899999999999995 778999999999998 99999
Q ss_pred ccccCCCccccccceecccccccccC
Q 047196 802 RLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 802 ~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
|-+.++.. .++.+||..|.|||++
T Consensus 172 rel~d~s~--~~S~vGT~~YLhPel~ 195 (732)
T KOG4250|consen 172 RELDDNSL--FTSLVGTEEYLHPELY 195 (732)
T ss_pred ccCCCCCe--eeeecCchhhcChHHH
Confidence 99876553 2456699999999974
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.2e-20 Score=167.32 Aligned_cols=148 Identities=28% Similarity=0.381 Sum_probs=113.6
Q ss_pred cccccceEecCCceEEEEEEe-cCCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 676 KFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
+|+..++||+|.||+||||+. .+++.||.|+++.+ .........+||.+++.++|+|||++++....+....+.+.+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 466678899999999999984 56899999998653 233345678999999999999999999887766654443222
Q ss_pred ----------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 753 ----------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 753 ----------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
..++.++.......+.|+.+|+.++ |++.+.|||+||.|+| |||+|+.+...-...
T Consensus 83 cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fc---hshnvlhrdlkpqnllin~ngelkladfglarafgipvrcy- 158 (292)
T KOG0662|consen 83 CDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFC---HSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY- 158 (292)
T ss_pred hhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhh---hhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEee-
Confidence 1234556666667888999999998 5667999999999988 999999876543332
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
...+.|.+|.+|.++
T Consensus 159 saevvtlwyrppdvl 173 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVL 173 (292)
T ss_pred eceeeeeeccCccee
Confidence 234579999999874
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.4e-19 Score=197.29 Aligned_cols=144 Identities=25% Similarity=0.285 Sum_probs=111.5
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
.+|+..+.||+|+||.||+|.. .+++.||+|+.. .+.+.+|++++++++|||||++++++.......+...+.
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 4688899999999999999986 468999999743 235688999999999999999999887665444322111
Q ss_pred ---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccccc
Q 047196 754 ---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTE 814 (827)
Q Consensus 754 ---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~ 814 (827)
....+.+.+...++.++++||+||| +.+|+||||||+||+ |||+|+............
T Consensus 166 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~ 242 (391)
T PHA03212 166 KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG 242 (391)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccccccc
Confidence 1234667778899999999999995 568999999999998 999997643322211223
Q ss_pred ceecccccccccC
Q 047196 815 TLVTIGYMAPGLL 827 (827)
Q Consensus 815 ~~gt~~Y~APE~l 827 (827)
.+||++|+|||++
T Consensus 243 ~~gt~~y~aPE~~ 255 (391)
T PHA03212 243 WAGTIATNAPELL 255 (391)
T ss_pred ccCccCCCChhhh
Confidence 4599999999974
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.4e-19 Score=186.73 Aligned_cols=146 Identities=21% Similarity=0.312 Sum_probs=112.9
Q ss_pred ccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 677 FSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
|+..+.||+|+||.||+|.. .+|+.||||++.... ......+.+|++++++++|++++++.+++...+...+...+
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 66778999999999999985 578999999986432 22334678999999999999999999998776654442222
Q ss_pred cC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 753 ST------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 753 ~~------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
.. ...+.+.....++.+++.|++||| +++|+||||||+||+ |||+++.......
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET- 157 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe-
Confidence 11 123566777889999999999995 678999999999997 9999987543222
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
.....||.+|||||++
T Consensus 158 -~~~~~g~~~y~aPE~~ 173 (285)
T cd05631 158 -VRGRVGTVGYMAPEVI 173 (285)
T ss_pred -ecCCCCCCCccCHhhh
Confidence 1234589999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.9e-20 Score=204.76 Aligned_cols=148 Identities=27% Similarity=0.449 Sum_probs=116.0
Q ss_pred ccccceEecCCceEEEEEEec------CCcEEEEEEEcccchH-HHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeee
Q 047196 677 FSKENLIGVGSFGSVYKGRLH------DGIEVAIKVFHQNCAM-ALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALD 749 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~ 749 (827)
....+.||+|+||+||+|+.. +...||||.++..... ..++|+||++++++++|||||+++|.|.+++...|.
T Consensus 488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~Mv 567 (774)
T KOG1026|consen 488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMV 567 (774)
T ss_pred eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEE
Confidence 344567999999999999753 2467999999876544 678999999999999999999999999998876664
Q ss_pred eeccC--------------------C----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------
Q 047196 750 CLHST--------------------N----CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF--------- 796 (827)
Q Consensus 750 ~l~~~--------------------~----~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl--------- 796 (827)
+.|.. . ..++..+.+.||.|||.|++||. ++.+|||||...|.|
T Consensus 568 FEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~VKI 644 (774)
T KOG1026|consen 568 FEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVVKI 644 (774)
T ss_pred EEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEEEe
Confidence 33321 1 12677888999999999999995 455999999999988
Q ss_pred -eecccccc-cCCCccccccceecccccccccC
Q 047196 797 -DFGIGRLL-TGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 -DFGla~~~-~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
|||++|.+ ..|.........-.++|||||-|
T Consensus 645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsI 677 (774)
T KOG1026|consen 645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESI 677 (774)
T ss_pred cccccchhhhhhhhhcccCCceeeeecCCHHHh
Confidence 99999865 33333333234457899999954
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.8e-19 Score=193.90 Aligned_cols=151 Identities=24% Similarity=0.435 Sum_probs=111.5
Q ss_pred hhcccccceEecCCceEEEEEEe------cCCcEEEEEEEcccc-hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCc
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRL------HDGIEVAIKVFHQNC-AMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDF 745 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~ 745 (827)
.++|+..++||+|+||.||+|+. .+++.||||++.... ....+.+.+|+++++++ +|||||+++++|...+.
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46788889999999999999974 235789999986543 33456789999999999 89999999998876442
Q ss_pred -e--eeeeeccC--------------------------------------------------------------------
Q 047196 746 -K--ALDCLHST-------------------------------------------------------------------- 754 (827)
Q Consensus 746 -~--~l~~l~~~-------------------------------------------------------------------- 754 (827)
. .++++...
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 1 22222110
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc-cccceecccc
Q 047196 755 --NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI-QTETLVTIGY 821 (827)
Q Consensus 755 --~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~-~~~~~gt~~Y 821 (827)
...+++.+...++.|+++||+||| +++|+||||||+||+ |||+|+....+.... .....+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 012455667789999999999996 678999999999998 999998764332221 1222367899
Q ss_pred cccccC
Q 047196 822 MAPGLL 827 (827)
Q Consensus 822 ~APE~l 827 (827)
||||++
T Consensus 243 ~aPE~~ 248 (338)
T cd05102 243 MAPESI 248 (338)
T ss_pred cCcHHh
Confidence 999974
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.2e-19 Score=189.04 Aligned_cols=150 Identities=24% Similarity=0.398 Sum_probs=111.8
Q ss_pred hcccccceEecCCceEEEEEEecC-----------------CcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEE
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHD-----------------GIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKR 736 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~-----------------g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~ 736 (827)
++|...++||+|+||.||+|++++ +..||||++.... ....++|.+|++++++++|||||++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467788899999999999997532 3479999987543 3345679999999999999999999
Q ss_pred EeeeecCCceeeeeeccCC-----------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 047196 737 ISSCSNEDFKALDCLHSTN-----------------------------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIH 787 (827)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~~-----------------------------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiH 787 (827)
++++.+.+...+...+... ..+.+.....++.+++.|++||| +.+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence 9999876654432222111 12455667889999999999996 567999
Q ss_pred ccCCCccee----------eecccccccCCCcc-ccccceecccccccccC
Q 047196 788 CDLKPKNVF----------DFGIGRLLTGDRSM-IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 788 rDlK~~NIl----------DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l 827 (827)
|||||+||+ |||+++.+...... ......++..|||||++
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 212 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECI 212 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHH
Confidence 999999998 99999865432221 11122357899999973
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-19 Score=176.34 Aligned_cols=151 Identities=23% Similarity=0.358 Sum_probs=119.1
Q ss_pred HHhhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc--------hHHHHHHHHHHHHHHhc-CCCCceEEEeeee
Q 047196 672 RATEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC--------AMALKSFEAECEVMKNI-RHRNHVKRISSCS 741 (827)
Q Consensus 672 ~~~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--------~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~ 741 (827)
...+.|...+++|+|..++|.++.. ++|.++|+|++.... ....++-.+|+.||+++ .||+|+++.+.|.
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 3446788889999999999999865 578999999986422 12234567899999998 5999999999998
Q ss_pred cCCceeeeeeccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eeccc
Q 047196 742 NEDFKALDCLHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIG 801 (827)
Q Consensus 742 ~~~~~~l~~l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla 801 (827)
...+.++.+.-... ..++..+..+|++++.+|++|| |.+.|||||+||+||| |||+|
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeyl---Ha~~IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYL---HARNIVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHH---HHhhhhhcccChhheeeccccceEEecccee
Confidence 88876654332221 2356666778999999999999 5788999999999999 99999
Q ss_pred ccccCCCccccccceecccccccccC
Q 047196 802 RLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 802 ~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
..+...... ...||||||.|||.+
T Consensus 171 ~~l~~GekL--relCGTPgYLAPEti 194 (411)
T KOG0599|consen 171 CQLEPGEKL--RELCGTPGYLAPETI 194 (411)
T ss_pred eccCCchhH--HHhcCCCcccChhhe
Confidence 988655432 456799999999975
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.8e-19 Score=188.10 Aligned_cols=149 Identities=26% Similarity=0.385 Sum_probs=113.9
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
++|...+.||+|+||.||+|+.. +++.||+|+++... ......+.+|++++++++|||++++++++..++..++...+
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888899999999999999864 68999999986432 22345678999999999999999999998776654432222
Q ss_pred cC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 753 ST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 753 ~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
.. ...+.+.....++.++++||+||| +++|+||||||+||+ |||+++........ .
T Consensus 85 ~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~-~ 160 (288)
T cd07871 85 LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT-Y 160 (288)
T ss_pred CCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc-c
Confidence 11 123456677789999999999995 678999999999998 99998765432221 1
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
....||+.|+|||++
T Consensus 161 ~~~~~~~~y~aPE~~ 175 (288)
T cd07871 161 SNEVVTLWYRPPDVL 175 (288)
T ss_pred cCceecccccChHHh
Confidence 234589999999963
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=189.66 Aligned_cols=143 Identities=27% Similarity=0.289 Sum_probs=110.1
Q ss_pred ceEecCCceEEEEEEe-cCCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeeccCC-
Q 047196 681 NLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHSTN- 755 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~~- 755 (827)
++||+|+||.||+|+. .+|+.||||++.... .....++.+|++++++++||||+++.+++...+..++...+...
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999986 468999999987532 23345688999999999999999999998887755543333222
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccccce
Q 047196 756 ---------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETL 816 (827)
Q Consensus 756 ---------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~~~ 816 (827)
..+.+.....++.|++.||+||| +.+|+||||||+||+ |||+++........ ....+
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~ 156 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFC 156 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCc-cccee
Confidence 23566677789999999999995 678999999999998 99998754322221 12345
Q ss_pred ecccccccccC
Q 047196 817 VTIGYMAPGLL 827 (827)
Q Consensus 817 gt~~Y~APE~l 827 (827)
||+.|||||++
T Consensus 157 gt~~y~aPE~~ 167 (323)
T cd05571 157 GTPEYLAPEVL 167 (323)
T ss_pred cCccccChhhh
Confidence 99999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.8e-19 Score=193.54 Aligned_cols=152 Identities=22% Similarity=0.243 Sum_probs=116.7
Q ss_pred HhhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL 748 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l 748 (827)
..++|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++++.++|||++++++++..+...++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3467888999999999999999864 68999999986432 2233557899999999999999999999888776555
Q ss_pred eeeccCCC---------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 749 DCLHSTNC---------SLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 749 ~~l~~~~~---------~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
...+...+ .+.......++.++++||+||| +++|+||||||+||| |||+++.......
T Consensus 121 v~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 121 VMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM 197 (370)
T ss_pred EEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 43333222 2444556678899999999995 678999999999998 9999987644332
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
......+||+.|||||++
T Consensus 198 ~~~~~~~gt~~y~aPE~~ 215 (370)
T cd05596 198 VRCDTAVGTPDYISPEVL 215 (370)
T ss_pred ccCCCCCCCcCeECHHHh
Confidence 222335699999999964
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=193.02 Aligned_cols=128 Identities=23% Similarity=0.278 Sum_probs=102.6
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
++|+..+.||+|+||+||+|+.. +++.||||++.... ......+.+|++++++++|++||++++.+.+....++..
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 36888899999999999999864 68999999996532 223457889999999999999999999998776554433
Q ss_pred eccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eeccccccc
Q 047196 751 LHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLT 805 (827)
Q Consensus 751 l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~ 805 (827)
.+.. ...+.+.....++.+++.||+||| +.+|+||||||+||| |||+++.+.
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 2221 234566777889999999999995 678999999999998 999987653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-19 Score=196.22 Aligned_cols=144 Identities=29% Similarity=0.487 Sum_probs=111.0
Q ss_pred cceEecCCceEEEEEEec-CCcEEEEEEEcc----cchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc-
Q 047196 680 ENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQ----NCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS- 753 (827)
Q Consensus 680 ~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~----~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~- 753 (827)
..+||+|+|-+||||.+. +|.+||--.++. ..+...++|..|+++|+.++|+|||+++.++.+.....+.....
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 467999999999999864 588888544432 23455689999999999999999999999998765433322111
Q ss_pred -CCC----------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------eecccccccCCCccc
Q 047196 754 -TNC----------SLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 754 -~~~----------~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGla~~~~~~~~~~ 811 (827)
..+ ..+.......++||.+||.|||. |.|||||||||..||+ |.|+|++......
T Consensus 125 ~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a-- 201 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA-- 201 (632)
T ss_pred ccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHHhhcccc--
Confidence 122 23344456799999999999997 7899999999999999 9999998765433
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
...+|||.|||||++
T Consensus 202 -ksvIGTPEFMAPEmY 216 (632)
T KOG0584|consen 202 -KSVIGTPEFMAPEMY 216 (632)
T ss_pred -ceeccCccccChHHH
Confidence 235699999999974
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.9e-20 Score=190.22 Aligned_cols=149 Identities=28% Similarity=0.359 Sum_probs=116.0
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCcee--eee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKA--LDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~--l~~ 750 (827)
..|...+.||+|+||.||||.. ..++.||+|++.... +...+..++|+.++..++++||.+++|.+..+.... |++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 3577778999999999999985 568999999997653 345678899999999999999999999987765433 333
Q ss_pred eccCC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 751 LHSTN--------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 751 l~~~~--------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
+..+. ..++.....-|.+++..|+.|+| .++.+|||||+.||+ |||+|..+..+....
T Consensus 93 ~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr- 168 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR- 168 (467)
T ss_pred hcCcchhhhhccCCCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhhcc-
Confidence 33321 11233444457789999999994 678999999999998 999998887655443
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
...+||+.||||||+
T Consensus 169 ~tfvGTPfwMAPEVI 183 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVI 183 (467)
T ss_pred ccccccccccchhhh
Confidence 446799999999986
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.8e-19 Score=193.92 Aligned_cols=126 Identities=23% Similarity=0.293 Sum_probs=102.4
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeee
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l 751 (827)
+|+..+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+++++.++|+|||++++++...+..++...
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 6788899999999999999864 68999999996532 2334568899999999999999999999988776555333
Q ss_pred ccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccc
Q 047196 752 HST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLL 804 (827)
Q Consensus 752 ~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~ 804 (827)
+.. ...+.......++.|++.||+||| +.+|+||||||+||| |||+++.+
T Consensus 82 ~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 151 (364)
T cd05599 82 YLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151 (364)
T ss_pred CCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceec
Confidence 221 234566777889999999999995 678999999999998 99998765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=192.98 Aligned_cols=156 Identities=22% Similarity=0.231 Sum_probs=119.0
Q ss_pred HHHHHhhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC
Q 047196 669 DLFRATEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNED 744 (827)
Q Consensus 669 ~~~~~~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~ 744 (827)
+.....++|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+++++.++|||||++++.+..+.
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34445578999999999999999999865 68899999986422 223456889999999999999999999988777
Q ss_pred ceeeeeeccCCC---------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eeccccccc
Q 047196 745 FKALDCLHSTNC---------SLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLT 805 (827)
Q Consensus 745 ~~~l~~l~~~~~---------~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~ 805 (827)
..++...+...+ .+.......++.+++.||+||| +++|+||||||+||+ |||+|+...
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 655433332222 2344556678899999999995 678999999999998 999998765
Q ss_pred CCCccccccceecccccccccC
Q 047196 806 GDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 806 ~~~~~~~~~~~gt~~Y~APE~l 827 (827)
..........+||+.|||||++
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~l 215 (371)
T cd05622 194 KEGMVRCDTAVGTPDYISPEVL 215 (371)
T ss_pred cCCcccccCcccCccccCHHHH
Confidence 4332222335699999999974
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.5e-19 Score=194.31 Aligned_cols=151 Identities=31% Similarity=0.465 Sum_probs=114.3
Q ss_pred HhhcccccceEecCCceEEEEEEecC--C--cE-EEEEEEcc---cchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLHD--G--IE-VAIKVFHQ---NCAMALKSFEAECEVMKNIRHRNHVKRISSCSNED 744 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~~--g--~~-vAvK~l~~---~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~ 744 (827)
..++....++||+|+||.||+|+++. + .. ||||.... ....+.++|.+|+++|++++|||||+++|++....
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 34445556899999999999998643 3 23 89999875 23566789999999999999999999999998766
Q ss_pred ceee--eeecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eeccccc
Q 047196 745 FKAL--DCLHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRL 803 (827)
Q Consensus 745 ~~~l--~~l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~ 803 (827)
..++ +.... ....++..+++.++.++|+||+|| |++++|||||-+.|+| |||+++.
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YL---h~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYL---HSKNCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHH---HHCCCcchhHhHHHheecCCCeEEeCccccccC
Confidence 5443 33322 223578899999999999999999 5788999999999998 9999876
Q ss_pred ccCCCccccccceecccccccccC
Q 047196 804 LTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 804 ~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
-... ........-...|+|||.+
T Consensus 312 ~~~~-~~~~~~~klPirWLAPEtl 334 (474)
T KOG0194|consen 312 GSQY-VMKKFLKKLPIRWLAPETL 334 (474)
T ss_pred Ccce-eeccccccCcceecChhhh
Confidence 4311 1111111246789999974
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.5e-20 Score=183.53 Aligned_cols=147 Identities=27% Similarity=0.315 Sum_probs=114.4
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
+-|+..+++|+|+||.||||.. ..|..||||++.... ..++...||.+|++.+.+.+|+++|.|......++...+.
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 3477778999999999999975 469999999987643 4678899999999999999999999997765444433332
Q ss_pred C-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 754 T-----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 754 ~-----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
+ ...+...+.-.|.+...+||+|||... -||||||+.||| |||.|..+.+... ..
T Consensus 111 GAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-KR 186 (502)
T KOG0574|consen 111 GAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-KR 186 (502)
T ss_pred CCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHH-hh
Confidence 2 234555555668889999999998654 689999999999 9999988764322 12
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
.+..||+.|||||||
T Consensus 187 NTVIGTPFWMAPEVI 201 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVI 201 (502)
T ss_pred CccccCcccccHHHH
Confidence 334599999999985
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.4e-18 Score=180.90 Aligned_cols=150 Identities=28% Similarity=0.389 Sum_probs=115.6
Q ss_pred hcccccceEecCCceEEEEEE-ecCCcEEEEEEEccc-chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee--ee
Q 047196 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQN-CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL--DC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~-~~~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l--~~ 750 (827)
+.|+..++||.|.-++||+|+ .+.++.||||++... +....+...+|++.|+-++|||||+++..+..+...++ .+
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 568888999999999999997 567899999999753 33446889999999999999999999988877664443 22
Q ss_pred eccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 751 LHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 751 l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
+..+ ...++......|.+++.+||.|| |.+|-||||+|+.||| |||....+...+..
T Consensus 106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YL---H~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R 182 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYL---HQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR 182 (516)
T ss_pred hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHH---HhcCceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence 2211 12245555667889999999999 5788999999999999 99977665443322
Q ss_pred --cc-ccceecccccccccC
Q 047196 811 --IQ-TETLVTIGYMAPGLL 827 (827)
Q Consensus 811 --~~-~~~~gt~~Y~APE~l 827 (827)
.. ...+||+.|||||++
T Consensus 183 ~~~rf~tfvgtp~wmAPEvl 202 (516)
T KOG0582|consen 183 QVTRFNTFVGTPCWMAPEVL 202 (516)
T ss_pred eeEeeccccCcccccChHHh
Confidence 12 334699999999983
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.4e-18 Score=191.46 Aligned_cols=149 Identities=26% Similarity=0.364 Sum_probs=114.3
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
++|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|+|||++++++...+..++...+
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 34566688999999999999864 68999999986543 33456789999999999999999999998776655443333
Q ss_pred cCCC------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccccce
Q 047196 753 STNC------SLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETL 816 (827)
Q Consensus 753 ~~~~------~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~~~ 816 (827)
...+ .........++.++++||+||| +.+|+||||||+||| |||+++.+...... ....+
T Consensus 154 ~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~-~~~~~ 229 (353)
T PLN00034 154 MDGGSLEGTHIADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP-CNSSV 229 (353)
T ss_pred CCCCcccccccCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc-ccccc
Confidence 2222 2344556789999999999996 678999999999998 99999876433221 12346
Q ss_pred ecccccccccC
Q 047196 817 VTIGYMAPGLL 827 (827)
Q Consensus 817 gt~~Y~APE~l 827 (827)
||..|+|||++
T Consensus 230 gt~~y~aPE~~ 240 (353)
T PLN00034 230 GTIAYMSPERI 240 (353)
T ss_pred cCccccCcccc
Confidence 89999999974
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.1e-18 Score=190.46 Aligned_cols=150 Identities=23% Similarity=0.278 Sum_probs=115.2
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
++|+..+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.+++.++|+||+++.+++.+++..++..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36788899999999999999864 68999999986421 223456889999999999999999999988777655433
Q ss_pred eccCC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 751 LHSTN-----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 751 l~~~~-----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
.+... ..+.......++.|++.|++||| +++|+||||||+||+ |||+++.+.....
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 32221 23455566778999999999995 678999999999998 9999876644333
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
......+||++|||||++
T Consensus 158 ~~~~~~~gt~~y~aPE~~ 175 (331)
T cd05597 158 VQSNVAVGTPDYISPEIL 175 (331)
T ss_pred ccccceeccccccCHHHH
Confidence 222234589999999974
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-18 Score=193.12 Aligned_cols=126 Identities=21% Similarity=0.254 Sum_probs=100.6
Q ss_pred cccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeee
Q 047196 676 KFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l 751 (827)
.|...+.||+|+||+||+|+. .+++.||||++.... ....+.+.+|++++++++|+|||++++++.+.+..++...
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 477788999999999999986 468999999996532 2345678999999999999999999999988776555433
Q ss_pred ccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccc
Q 047196 752 HSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLL 804 (827)
Q Consensus 752 ~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~ 804 (827)
+... ..+.+.....++.+++.||+||| +.+|+||||||+||| |||+++.+
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 3222 23455556678889999999995 678999999999998 99997643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-18 Score=192.85 Aligned_cols=126 Identities=25% Similarity=0.278 Sum_probs=100.8
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
++|...+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+..++..
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3677889999999999999986 468999999986432 234567889999999999999999999998877665544
Q ss_pred eccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eeccccc
Q 047196 751 LHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRL 803 (827)
Q Consensus 751 l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~ 803 (827)
.+... ..+.......++.+++.||+||| +.+|+||||||+||+ |||+|+.
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~ 150 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTG 150 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccc
Confidence 33322 23445556678899999999995 678999999999998 9999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-18 Score=187.78 Aligned_cols=150 Identities=25% Similarity=0.384 Sum_probs=114.8
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA-MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l 751 (827)
.++|+..+.||+|+||.||+|+.. +|+.||||++..... .....+.+|++++++++|||+|++.+++...+..++...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367888999999999999999865 689999999865432 223457889999999999999999999887765544322
Q ss_pred cc----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 752 HS----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 752 ~~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
+. ....+.......++.+++.||+||| +++|+||||||+||+ |||+++....... .
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 159 (303)
T cd07869 84 YVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH-T 159 (303)
T ss_pred CCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc-c
Confidence 21 1233556667789999999999995 678999999999998 9999875432221 1
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
.....||+.|+|||++
T Consensus 160 ~~~~~~~~~y~aPE~~ 175 (303)
T cd07869 160 YSNEVVTLWYRPPDVL 175 (303)
T ss_pred CCCCcccCCCCChHHH
Confidence 2234589999999963
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.3e-18 Score=188.71 Aligned_cols=150 Identities=27% Similarity=0.456 Sum_probs=112.6
Q ss_pred hcccccceEecCCceEEEEEEec-CCc----EEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGI----EVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~----~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l 748 (827)
.+|+..+.||+|+||.||+|++. +|+ .||||++.... ....++|.+|+.+++.++|+|+++++|+|......++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v 86 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 86 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceee
Confidence 45888899999999999999853 343 48999986542 3455789999999999999999999999977653332
Q ss_pred -eeec---------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 749 -DCLH---------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 749 -~~l~---------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
++.. .....+.+...+.++.++++||+||| +++|+||||||+||+ |||+++......
T Consensus 87 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 163 (316)
T cd05108 87 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163 (316)
T ss_pred eecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCCC
Confidence 1111 11224566777889999999999995 678999999999998 999998775433
Q ss_pred cccc-ccceecccccccccC
Q 047196 809 SMIQ-TETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~~-~~~~gt~~Y~APE~l 827 (827)
.... ....++..|||||++
T Consensus 164 ~~~~~~~~~~~~~y~apE~~ 183 (316)
T cd05108 164 KEYHAEGGKVPIKWMALESI 183 (316)
T ss_pred cceeccCCccceeecChHHh
Confidence 3211 112246789999964
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.4e-18 Score=189.30 Aligned_cols=146 Identities=24% Similarity=0.316 Sum_probs=114.6
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
.+|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++..++..++..
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888899999999999999875 68999999986532 233467899999999999999999999998877655433
Q ss_pred eccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 751 LHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 751 l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
.+... ..+.......++.+++.||+||| +.+|+||||||+||+ |||+++......
T Consensus 98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-- 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-- 172 (329)
T ss_pred cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--
Confidence 32221 23455556678899999999995 678999999999998 999998764322
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
....||+.|+|||++
T Consensus 173 --~~~~gt~~y~aPE~~ 187 (329)
T PTZ00263 173 --FTLCGTPEYLAPEVI 187 (329)
T ss_pred --ceecCChhhcCHHHH
Confidence 123589999999974
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.3e-19 Score=182.34 Aligned_cols=148 Identities=24% Similarity=0.367 Sum_probs=121.1
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
.+|+..+.+|+|.||+|-+|.. ..|+.||||.++++. .+..-+.++||+||+.+.||||+..+..+.+.+-.++..
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4577778899999999999974 679999999997653 445567899999999999999999999998887665544
Q ss_pred eccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 751 LHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 751 l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
.+.. .+.+...+...+.+||..|+.|+ |+.+|+|||||.+||| |||++-.+..+.-
T Consensus 133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYC---HknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf- 208 (668)
T KOG0611|consen 133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYC---HKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF- 208 (668)
T ss_pred EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHH---hhccceecccchhheeecCCCCeeeeccchhhhhccccH-
Confidence 4432 24566777788999999999887 6889999999999999 9999988765543
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
.++.||++-|.+||++
T Consensus 209 -LqTFCGSPLYASPEIv 224 (668)
T KOG0611|consen 209 -LQTFCGSPLYASPEIV 224 (668)
T ss_pred -HHHhcCCcccCCcccc
Confidence 2457799999999974
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-18 Score=185.81 Aligned_cols=128 Identities=24% Similarity=0.351 Sum_probs=98.7
Q ss_pred HhhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL 748 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l 748 (827)
..++|+...+||+|+||.||.|+- .+|..+|+|++++.. ..+.+..+.|-.+|...+++.+|+++..+.+.++.++
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 446799999999999999999985 569999999997654 3346778899999999999999999999998887665
Q ss_pred --eeeccCC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eeccccc
Q 047196 749 --DCLHSTN--------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRL 803 (827)
Q Consensus 749 --~~l~~~~--------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~ 803 (827)
+++.+++ +.+.......++.++.-|++-+ |+.++|||||||+|+| |||+++.
T Consensus 219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~i---H~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESI---HQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHH---HHcCcccccCChhheeecCCCCEeeccccccch
Confidence 4444332 2233333334444444555555 7899999999999998 9999754
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.1e-19 Score=193.11 Aligned_cols=140 Identities=25% Similarity=0.441 Sum_probs=107.4
Q ss_pred hcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee--eeec
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL--DCLH 752 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l--~~l~ 752 (827)
+.+.+.+-+|.|+.|.||+|+++ ++.||||++++.. +.+|+-|++++|+||+.+.|+|.......+ ++..
T Consensus 124 e~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 124 EEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred HHhhhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence 33456688999999999999997 4799999875432 457899999999999999999988764433 3322
Q ss_pred cC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccccc
Q 047196 753 ST--------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTE 814 (827)
Q Consensus 753 ~~--------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~ 814 (827)
.+ .....-....+...+||.|+.||| .+.|||||||+-||| |||.++-+.+.. ...+
T Consensus 196 ~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S--TkMS 270 (904)
T KOG4721|consen 196 QGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS--TKMS 270 (904)
T ss_pred cccHHHHHhccCccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhhh--hhhh
Confidence 11 112223334578899999999995 556999999999999 999999876542 2355
Q ss_pred ceecccccccccC
Q 047196 815 TLVTIGYMAPGLL 827 (827)
Q Consensus 815 ~~gt~~Y~APE~l 827 (827)
.+||..|||||||
T Consensus 271 FaGTVaWMAPEvI 283 (904)
T KOG4721|consen 271 FAGTVAWMAPEVI 283 (904)
T ss_pred hhhhHhhhCHHHh
Confidence 6799999999986
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.5e-18 Score=187.15 Aligned_cols=143 Identities=27% Similarity=0.300 Sum_probs=110.4
Q ss_pred ceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeeccCC-
Q 047196 681 NLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHSTN- 755 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~~- 755 (827)
++||+|+||.||+++.. +|+.||||++.... ......+.+|++++++++|||++++.+++...+..++...+...
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 68999999986532 23456788999999999999999999998877755543333221
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccccce
Q 047196 756 ---------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETL 816 (827)
Q Consensus 756 ---------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~~~ 816 (827)
..+.+.+...++.+++.||+||| +.+|+||||||+||+ |||+++........ ....+
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~-~~~~~ 156 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT-MKTFC 156 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccc-ccccc
Confidence 24566777889999999999995 678999999999998 99998764322221 12245
Q ss_pred ecccccccccC
Q 047196 817 VTIGYMAPGLL 827 (827)
Q Consensus 817 gt~~Y~APE~l 827 (827)
||+.|||||++
T Consensus 157 gt~~y~aPE~~ 167 (328)
T cd05593 157 GTPEYLAPEVL 167 (328)
T ss_pred CCcCccChhhh
Confidence 89999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.6e-18 Score=189.53 Aligned_cols=146 Identities=25% Similarity=0.316 Sum_probs=114.2
Q ss_pred hcccccceEecCCceEEEEEEecC--CcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHD--GIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALD 749 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~--g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~ 749 (827)
++|...+.||+|+||.||+|+.+. +..||||++.... ....+.+.+|+++++.++|||||++++++.+++..++.
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 568888999999999999998543 3689999986432 23346788999999999999999999999887765553
Q ss_pred eeccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 750 CLHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 750 ~l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
..+... ..+.+.....++.+++.||+||| +.+|+||||||+||| |||+++......
T Consensus 110 ~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~- 185 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT- 185 (340)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc-
Confidence 333221 23556667789999999999995 678999999999998 999998654221
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
....||+.|||||++
T Consensus 186 ---~~~~gt~~y~aPE~~ 200 (340)
T PTZ00426 186 ---YTLCGTPEYIAPEIL 200 (340)
T ss_pred ---ceecCChhhcCHHHH
Confidence 224589999999974
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.1e-18 Score=186.89 Aligned_cols=145 Identities=24% Similarity=0.313 Sum_probs=113.9
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeee
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l 751 (827)
+|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+....++...
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 5778899999999999999865 68999999986432 2345678899999999999999999988877765544333
Q ss_pred ccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 752 HSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 752 ~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
+... ..+.+.....++.++++||+||| +++|+||||||+||+ |||+++......
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~--- 155 (291)
T cd05612 82 YVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT--- 155 (291)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc---
Confidence 2221 23556667789999999999995 678999999999998 999998764321
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
...+||+.|+|||++
T Consensus 156 -~~~~gt~~y~aPE~~ 170 (291)
T cd05612 156 -WTLCGTPEYLAPEVI 170 (291)
T ss_pred -ccccCChhhcCHHHH
Confidence 123589999999963
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.9e-18 Score=186.38 Aligned_cols=143 Identities=26% Similarity=0.296 Sum_probs=110.1
Q ss_pred ceEecCCceEEEEEEe-cCCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeeccCC-
Q 047196 681 NLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHSTN- 755 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~~- 755 (827)
++||+|+||.||+++. .+|..||+|++.... ......+.+|++++++++|||++++.+++...+..++...+...
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999986 468999999986532 23445678899999999999999999998877655543333221
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccccce
Q 047196 756 ---------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETL 816 (827)
Q Consensus 756 ---------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~~~ 816 (827)
..+.+.....++.++++||+||| +.+|+||||||+||+ |||+++........ .....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~ 156 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFC 156 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc-ccccc
Confidence 23566777889999999999995 678999999999998 99998754322221 12245
Q ss_pred ecccccccccC
Q 047196 817 VTIGYMAPGLL 827 (827)
Q Consensus 817 gt~~Y~APE~l 827 (827)
||+.|||||++
T Consensus 157 gt~~y~aPE~~ 167 (323)
T cd05595 157 GTPEYLAPEVL 167 (323)
T ss_pred CCcCcCCcccc
Confidence 89999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.9e-18 Score=188.46 Aligned_cols=150 Identities=21% Similarity=0.260 Sum_probs=115.3
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
++|...+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.+++.++|++|+++.+++.+++..++..
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36788899999999999999865 68899999986432 223456888999999999999999999998877655533
Q ss_pred eccC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 751 LHST-----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 751 l~~~-----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
.+.. ...+.+.....++.+++.||+|+| +++|+||||||+||+ |||+++.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 3322 223455666778899999999995 678999999999998 9999987654433
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
.......||++|||||++
T Consensus 158 ~~~~~~~gt~~y~aPE~~ 175 (331)
T cd05624 158 VQSSVAVGTPDYISPEIL 175 (331)
T ss_pred eeeccccCCcccCCHHHH
Confidence 222234589999999963
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.7e-18 Score=184.91 Aligned_cols=149 Identities=24% Similarity=0.324 Sum_probs=115.6
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
+|+..+.||+|+||.||+|+.+ +++.||||++.... ....+.+.+|++++++++|+|||++.+++...+..++...+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 5778899999999999999875 58899999986532 23346788999999999999999999998777655543332
Q ss_pred cC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 753 ST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 753 ~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
.. ...+.+.....++.+++.||+||| +++|+||||||+||+ |||+++..........
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 82 VEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence 22 123566677889999999999995 678999999999998 9999987643322222
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
....||++|+|||++
T Consensus 159 ~~~~~~~~y~aPE~~ 173 (287)
T cd07848 159 TEYVATRWYRSPELL 173 (287)
T ss_pred cccccccccCCcHHH
Confidence 234589999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.4e-18 Score=187.94 Aligned_cols=145 Identities=23% Similarity=0.351 Sum_probs=115.0
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeee
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l 751 (827)
+|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++++.++|||||++++++...+..++...
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 5788899999999999999875 58999999996542 2234578899999999999999999999988776655433
Q ss_pred ccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 752 HSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 752 ~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
+... ..+.+.....++.+++.|++||| +.+|+||||||+||+ |||+++.....
T Consensus 82 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~---- 154 (333)
T cd05600 82 YVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY---- 154 (333)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCcccccc----
Confidence 3222 23556667789999999999995 678999999999998 99998765431
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
....+||+.|+|||++
T Consensus 155 ~~~~~gt~~y~aPE~~ 170 (333)
T cd05600 155 ANSVVGSPDYMAPEVL 170 (333)
T ss_pred cCCcccCccccChhHh
Confidence 1234589999999974
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.4e-18 Score=186.05 Aligned_cols=141 Identities=28% Similarity=0.287 Sum_probs=108.9
Q ss_pred EecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeeccC----
Q 047196 683 IGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHST---- 754 (827)
Q Consensus 683 iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~---- 754 (827)
||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++|||||++.+++..++..++...+..
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999865 58899999986432 2344678899999999999999999999887765554332221
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccccceec
Q 047196 755 ------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVT 818 (827)
Q Consensus 755 ------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~~~gt 818 (827)
...+++.....++.++++||+||| +++|+||||||+||+ |||+++........ ....+||
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt 156 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK-TNTFCGT 156 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCc-cccccCC
Confidence 234567777889999999999995 678999999999998 99999864332221 2234589
Q ss_pred ccccccccC
Q 047196 819 IGYMAPGLL 827 (827)
Q Consensus 819 ~~Y~APE~l 827 (827)
++|||||++
T Consensus 157 ~~y~aPE~~ 165 (312)
T cd05585 157 PEYLAPELL 165 (312)
T ss_pred cccCCHHHH
Confidence 999999974
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.7e-18 Score=187.31 Aligned_cols=149 Identities=23% Similarity=0.295 Sum_probs=115.8
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeee
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l 751 (827)
+|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++++.++|+|++++.+++.+.+..++...
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 5788899999999999999864 68999999997542 2245678899999999999999999998887765554333
Q ss_pred ccCC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 752 HSTN-----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 752 ~~~~-----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
+... ..+.+.....++.++++||.||| +.+|+||||||+||+ |||+++.+......
T Consensus 82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 3221 34556666778899999999995 678999999999998 99999876544332
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
......||+.|+|||++
T Consensus 159 ~~~~~~gt~~y~aPE~~ 175 (330)
T cd05601 159 NSKLPVGTPDYIAPEVL 175 (330)
T ss_pred eeecccCCccccCHHHh
Confidence 22234589999999974
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.3e-18 Score=195.97 Aligned_cols=145 Identities=21% Similarity=0.274 Sum_probs=112.8
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
...|...+.||+|+||.||+|+.. +++.||||... ...+.+|++++++++|+|||++++++......++...+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 346888899999999999999865 58899999642 22457899999999999999999998776654442211
Q ss_pred ----------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc-c
Q 047196 753 ----------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM-I 811 (827)
Q Consensus 753 ----------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~-~ 811 (827)
.....+++.+...|+.|+++||+||| +.+|+||||||+||| |||+++........ .
T Consensus 242 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 242 YRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence 11234778888999999999999995 678999999999998 99999876443221 1
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
.....||+.|||||++
T Consensus 319 ~~~~~GT~~Y~APE~~ 334 (461)
T PHA03211 319 HYGIAGTVDTNAPEVL 334 (461)
T ss_pred ccccCCCcCCcCHHHH
Confidence 1223589999999974
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.2e-18 Score=191.19 Aligned_cols=149 Identities=27% Similarity=0.380 Sum_probs=114.4
Q ss_pred cccccceEecCCceEEEEEEe-cCCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC-----cee
Q 047196 676 KFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNED-----FKA 747 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~-----~~~ 747 (827)
+|+..+.||+|+||.||+|+. .+|+.||||++... .....+++.+|+++++.++|+||+++++++..++ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 467789999999999999986 47899999998643 2334567889999999999999999999887654 222
Q ss_pred --eeeecc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 748 --LDCLHS-------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 748 --l~~l~~-------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
++++.. ....+.+.....++.++++||+||| +.+|+||||||+||+ |||+|+......
T Consensus 81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE 157 (372)
T ss_pred EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence 222221 1234677778889999999999995 678999999999998 999998764333
Q ss_pred ccccccceecccccccccC
Q 047196 809 SMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~~~~~~gt~~Y~APE~l 827 (827)
....+..++|+.|+|||++
T Consensus 158 ~~~~~~~~~~~~y~aPE~~ 176 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEIL 176 (372)
T ss_pred cccCCCCCcCCCcCCHHHH
Confidence 2222334579999999963
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.5e-18 Score=187.65 Aligned_cols=150 Identities=23% Similarity=0.266 Sum_probs=114.7
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
++|+..++||+|+||.||+++.+ +++.||+|++.+.. ....+.|.+|+.++..++|++++++.+++.+++..++..
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36788899999999999999875 57889999986432 223345889999999999999999999988776555433
Q ss_pred eccC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 751 LHST-----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 751 l~~~-----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
.+.. ...+.+.....++.+++.|++||| +++|+||||||+||+ |||+++.+.....
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 3221 123455566778999999999995 578999999999998 9999976644333
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
......+||++|||||++
T Consensus 158 ~~~~~~~gt~~y~aPE~~ 175 (332)
T cd05623 158 VQSSVAVGTPDYISPEIL 175 (332)
T ss_pred ceecccccCccccCHHHH
Confidence 222234599999999974
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.4e-18 Score=190.44 Aligned_cols=125 Identities=22% Similarity=0.260 Sum_probs=99.2
Q ss_pred cccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeee
Q 047196 676 KFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l 751 (827)
.|+..++||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++|+|||++++++.+.+..++...
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 477889999999999999986 468899999986532 2345678999999999999999999999988776554333
Q ss_pred ccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eeccccc
Q 047196 752 HSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRL 803 (827)
Q Consensus 752 ~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~ 803 (827)
+... ..+.......++.+++.|++||| +.+|+||||||+||| |||+|+.
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~ 150 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence 3222 22344455678889999999995 678999999999998 9999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.6e-18 Score=194.21 Aligned_cols=145 Identities=30% Similarity=0.420 Sum_probs=109.3
Q ss_pred hhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC--------
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNED-------- 744 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~-------- 744 (827)
.++|...++||+|+||.||+|+. .+++.||||++.... ....+|+.++++++|+|+|++.+++....
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 35788899999999999999986 468999999885432 23457999999999999999988764321
Q ss_pred ce--eeeeecc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------eecc
Q 047196 745 FK--ALDCLHS-----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGI 800 (827)
Q Consensus 745 ~~--~l~~l~~-----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGl 800 (827)
+. +++++.. ....+.+.....++.|+++||+||| +.+|+||||||+||| |||+
T Consensus 141 ~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 141 FLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred EEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeecccc
Confidence 11 2232221 1234566677789999999999995 678999999999998 9999
Q ss_pred cccccCCCccccccceecccccccccC
Q 047196 801 GRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 801 a~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
|+.+...... ...+||+.|||||++
T Consensus 218 a~~~~~~~~~--~~~~~t~~y~aPE~~ 242 (440)
T PTZ00036 218 AKNLLAGQRS--VSYICSRFYRAPELM 242 (440)
T ss_pred chhccCCCCc--ccCCCCcCccCHHHh
Confidence 9876543221 234589999999963
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.4e-18 Score=194.54 Aligned_cols=149 Identities=21% Similarity=0.263 Sum_probs=115.6
Q ss_pred cccccceEecCCceEEEEEEec-C-CcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-D-GIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~-g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
.|...+.||+|+||.||+|... + ++.||+|.+..........+.+|++++++++|||||++++++..++..++...+.
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3788899999999999999753 4 6789999876555555567889999999999999999999998877665544333
Q ss_pred CCC--------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 754 TNC--------------SLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 754 ~~~--------------~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
..+ .+.+.....++.+++.||.|+| +++|+||||||+||| |||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 222 2455566778899999999995 678999999999998 9999987654322
Q ss_pred c-ccccceecccccccccC
Q 047196 810 M-IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~-~~~~~~gt~~Y~APE~l 827 (827)
. .....+||++|||||++
T Consensus 225 ~~~~~~~~gt~~y~aPE~~ 243 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELW 243 (478)
T ss_pred cccccccCCCccccCHhHh
Confidence 1 12234589999999974
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.7e-18 Score=185.55 Aligned_cols=149 Identities=23% Similarity=0.288 Sum_probs=112.2
Q ss_pred cccccceEecCCceEEEEEEe----cCCcEEEEEEEcccc----hHHHHHHHHHHHHHHhcC-CCCceEEEeeeecCCce
Q 047196 676 KFSKENLIGVGSFGSVYKGRL----HDGIEVAIKVFHQNC----AMALKSFEAECEVMKNIR-HRNHVKRISSCSNEDFK 746 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~----~~g~~vAvK~l~~~~----~~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~ 746 (827)
+|+..+.||+|+||.||+++. .+|+.||+|++.... ....+.+.+|++++++++ |++++++.+++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 367788999999999999975 257899999986432 223456889999999995 89999999888776654
Q ss_pred eeeeeccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccC
Q 047196 747 ALDCLHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806 (827)
Q Consensus 747 ~l~~l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~ 806 (827)
++...+.. ...+.+.....++.++++||+||| +.+|+||||||+||| |||+++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 44322221 123566667789999999999995 678999999999998 9999986543
Q ss_pred CCccccccceecccccccccC
Q 047196 807 DRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 807 ~~~~~~~~~~gt~~Y~APE~l 827 (827)
.........+||+.|||||++
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~ 178 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEII 178 (332)
T ss_pred cCCCccccccCCccccCHHHh
Confidence 322222234589999999974
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.9e-18 Score=190.09 Aligned_cols=150 Identities=23% Similarity=0.422 Sum_probs=111.5
Q ss_pred hcccccceEecCCceEEEEEEe------cCCcEEEEEEEcccc-hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCce
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL------HDGIEVAIKVFHQNC-AMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFK 746 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~ 746 (827)
++|+..+.||+|+||.||+|+. .++..||||+++... ....+.+.+|+++++.+ +|||||+++++|...+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4688889999999999999963 235689999986432 33456789999999999 899999999999776544
Q ss_pred eeeeecc-------------------------------------------------------------------------
Q 047196 747 ALDCLHS------------------------------------------------------------------------- 753 (827)
Q Consensus 747 ~l~~l~~------------------------------------------------------------------------- 753 (827)
++...+.
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 3321110
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 754 ------------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 754 ------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
....+++.....++.++++|++||| +++|+||||||+||+ |||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 0113566777889999999999996 578999999999998 999998764432211
Q ss_pred -cccceecccccccccC
Q 047196 812 -QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 -~~~~~gt~~Y~APE~l 827 (827)
.....++..|||||++
T Consensus 272 ~~~~~~~~~~y~aPE~~ 288 (375)
T cd05104 272 VKGNARLPVKWMAPESI 288 (375)
T ss_pred ccCCCCCCcceeChhHh
Confidence 1112256789999974
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.76 E-value=3e-18 Score=187.55 Aligned_cols=149 Identities=28% Similarity=0.416 Sum_probs=111.6
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC-------c
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNED-------F 745 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~-------~ 745 (827)
+|+..++||+|+||.||+|+.. +|+.||||++... ......++.+|++++++++|||||++.+++.... +
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 3677889999999999999864 6899999998642 2223457889999999999999999998875432 1
Q ss_pred eeeeeecc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 746 KALDCLHS-------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 746 ~~l~~l~~-------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
..++++.. ....+.+.....++.|+++||+||| +.+|+||||||+||+ |||+++....+.
T Consensus 81 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 81 VVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 157 (338)
T ss_pred EEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence 22232211 1224667777889999999999995 678999999999998 999998654322
Q ss_pred cc--ccccceecccccccccC
Q 047196 809 SM--IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~--~~~~~~gt~~Y~APE~l 827 (827)
.. .....+||+.|+|||++
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~ 178 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELC 178 (338)
T ss_pred CccccccCCCCCCCcCCHHHH
Confidence 21 11234589999999963
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.9e-18 Score=189.54 Aligned_cols=125 Identities=23% Similarity=0.248 Sum_probs=98.9
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeee
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l 751 (827)
+|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++|+|||++++.+.+++..++...
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 5778899999999999999864 68999999986432 1234568899999999999999999999987776555333
Q ss_pred ccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eeccccc
Q 047196 752 HSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRL 803 (827)
Q Consensus 752 ~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~ 803 (827)
+... ..+.......++.+++.||+||| +.+|+||||||+||+ |||+|+.
T Consensus 82 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~ 150 (376)
T cd05598 82 YIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (376)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence 3222 22344555668899999999995 678999999999998 9999853
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.1e-19 Score=194.58 Aligned_cols=147 Identities=27% Similarity=0.345 Sum_probs=112.9
Q ss_pred ccccceEecCCceEEEEEEecC-CcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee--eeecc
Q 047196 677 FSKENLIGVGSFGSVYKGRLHD-GIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL--DCLHS 753 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l--~~l~~ 753 (827)
|.....+|.|+||+||||..++ +...|.|++........+.|.-||+||+.++||+||++++.|+-++..++ ++.-+
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 3444668999999999998654 56678898877777778899999999999999999999988766554333 33322
Q ss_pred C---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccccc
Q 047196 754 T---------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTE 814 (827)
Q Consensus 754 ~---------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~ 814 (827)
+ +..+...+..-|+.+++.||.|| |+..|||||||+.||| |||++........ ...+
T Consensus 114 GAVDaimlEL~r~LtE~QIqvvc~q~ldALn~L---Hs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q-kRDs 189 (1187)
T KOG0579|consen 114 GAVDAIMLELGRVLTEDQIQVVCYQVLDALNWL---HSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ-KRDS 189 (1187)
T ss_pred chHhHHHHHhccccchHHHHHHHHHHHHHHHHH---hhcchhhhhccccceEEEecCcEeeecccccccchhHHh-hhcc
Confidence 1 22355666777999999999999 5788999999999998 9998765432221 1234
Q ss_pred ceecccccccccC
Q 047196 815 TLVTIGYMAPGLL 827 (827)
Q Consensus 815 ~~gt~~Y~APE~l 827 (827)
.+|||+||||||.
T Consensus 190 FIGTPYWMAPEVv 202 (1187)
T KOG0579|consen 190 FIGTPYWMAPEVV 202 (1187)
T ss_pred ccCCcccccchhe
Confidence 6799999999984
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.9e-18 Score=188.90 Aligned_cols=150 Identities=22% Similarity=0.438 Sum_probs=110.8
Q ss_pred hcccccceEecCCceEEEEEEec------CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCce
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH------DGIEVAIKVFHQNC-AMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFK 746 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~ 746 (827)
++|+..+.||+|+||.||+|+.. ++..||||++.... ....+.+.+|+++++++ +|+|||+++++|......
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 46888899999999999999742 24579999996542 33456788999999999 899999999998776544
Q ss_pred eeeeeccC------------------------------------------------------------------------
Q 047196 747 ALDCLHST------------------------------------------------------------------------ 754 (827)
Q Consensus 747 ~l~~l~~~------------------------------------------------------------------------ 754 (827)
++...+..
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 33111100
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc-cccc
Q 047196 755 --------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI-QTET 815 (827)
Q Consensus 755 --------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~-~~~~ 815 (827)
...+++.+...++.++++||+||| +++|+||||||+||+ |||+++......... ....
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 012456667889999999999995 678999999999998 999998664332211 1112
Q ss_pred eecccccccccC
Q 047196 816 LVTIGYMAPGLL 827 (827)
Q Consensus 816 ~gt~~Y~APE~l 827 (827)
.++..|||||++
T Consensus 275 ~~~~~y~aPE~~ 286 (374)
T cd05106 275 RLPVKWMAPESI 286 (374)
T ss_pred CCccceeCHHHh
Confidence 256789999964
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.6e-18 Score=187.24 Aligned_cols=150 Identities=23% Similarity=0.306 Sum_probs=116.6
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCce--
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFK-- 746 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~-- 746 (827)
.++|....++|+|+||+|+.++.+ +++.+|||+++++. ....+....|.+|+.-. +||.++.++.++...+..
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 367888999999999999999975 57899999998754 23345667787777766 599999999888766533
Q ss_pred eeeeeccC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 747 ALDCLHST-------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 747 ~l~~l~~~-------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
+|++...+ ...++..+..-+|..|+-||+|| |+++||+||||.+||| |||++|-....+.
T Consensus 447 vmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fL---H~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~ 523 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFL---HENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD 523 (694)
T ss_pred EEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHH---HhcCceeeecchhheEEcccCcEEecccccccccCCCCC
Confidence 34433222 24567777778999999999999 5889999999999998 9999997653333
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
.+ .+.+|||.|||||++
T Consensus 524 ~T-sTfCGTpey~aPEil 540 (694)
T KOG0694|consen 524 RT-STFCGTPEFLAPEVL 540 (694)
T ss_pred cc-ccccCChhhcChhhh
Confidence 22 346799999999985
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.2e-18 Score=188.36 Aligned_cols=149 Identities=25% Similarity=0.334 Sum_probs=116.1
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeee
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l 751 (827)
+|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++++.++|+|++++++++.+.+..++...
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 5788899999999999999865 68999999986532 1345678999999999999999999999887775554332
Q ss_pred ccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC---
Q 047196 752 HST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR--- 808 (827)
Q Consensus 752 ~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~--- 808 (827)
+.. ...+.......++.++++||+||| +++|+||||||+||+ |||+++......
T Consensus 82 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 82 YMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 221 134566677789999999999996 588999999999998 999998764432
Q ss_pred -------------------------ccccccceecccccccccC
Q 047196 809 -------------------------SMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 -------------------------~~~~~~~~gt~~Y~APE~l 827 (827)
........||+.|+|||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 202 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVL 202 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHH
Confidence 0111234589999999974
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.8e-18 Score=182.82 Aligned_cols=144 Identities=25% Similarity=0.270 Sum_probs=109.8
Q ss_pred ceEecCCceEEEEEEe-cCCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeeccC--
Q 047196 681 NLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHST-- 754 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~-- 754 (827)
+.||+|+||.||+++. .+|+.||||++.... .....++.+|+++++.++||||+++.+++...+..++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 468999999986532 2334567889999999999999999998877765544333222
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccccce
Q 047196 755 --------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETL 816 (827)
Q Consensus 755 --------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~~~ 816 (827)
...+.+.....++.+++.||+|||. ..+|+||||||+||+ |||+++........ .....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~ 157 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-MKTFC 157 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc-ccccc
Confidence 2245677778899999999999962 368999999999998 99998754322221 12245
Q ss_pred ecccccccccC
Q 047196 817 VTIGYMAPGLL 827 (827)
Q Consensus 817 gt~~Y~APE~l 827 (827)
||+.|||||++
T Consensus 158 gt~~y~aPE~~ 168 (325)
T cd05594 158 GTPEYLAPEVL 168 (325)
T ss_pred CCcccCCHHHH
Confidence 89999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.2e-17 Score=182.25 Aligned_cols=148 Identities=22% Similarity=0.283 Sum_probs=115.7
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
++|+..+.||+|+||.||+++.. +|..||+|.+.... ....+++.+|++++++++|||+|++++++...+..++...+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 57888899999999999999865 68899999987542 33456799999999999999999999998877655543333
Q ss_pred cCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 753 STN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 753 ~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
... ..+.+.....++.+++.|+.|||. ..+|+||||||+||+ |||+++.......
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 159 (331)
T cd06649 85 MDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--- 159 (331)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccccccc---
Confidence 222 234555667899999999999974 346999999999998 9999876543221
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
....||+.|+|||++
T Consensus 160 ~~~~g~~~y~aPE~~ 174 (331)
T cd06649 160 NSFVGTRSYMSPERL 174 (331)
T ss_pred ccCCCCcCcCCHhHh
Confidence 224589999999974
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.3e-18 Score=186.67 Aligned_cols=126 Identities=23% Similarity=0.276 Sum_probs=101.1
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeee
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l 751 (827)
+|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++.+++|++++++++++...+..++...
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 5778899999999999999865 68999999986432 2234678899999999999999999999887775544332
Q ss_pred ccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccc
Q 047196 752 HST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLL 804 (827)
Q Consensus 752 ~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~ 804 (827)
+.. ...+.......++.+++.||+||| +++|+||||||+||+ |||+++.+
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~ 151 (360)
T cd05627 82 FLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL 151 (360)
T ss_pred CCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence 222 223556667789999999999995 678999999999998 99998755
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.4e-18 Score=198.71 Aligned_cols=150 Identities=27% Similarity=0.392 Sum_probs=113.4
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
++|+..++||+|+||.||+|+.. +|+.||||++.... ....++|.+|++++++++|||+|++++++.+.+..++..
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46888899999999999999864 58999999986532 234567999999999999999999999998776554432
Q ss_pred eccCCC---------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eec
Q 047196 751 LHSTNC---------------------SLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFG 799 (827)
Q Consensus 751 l~~~~~---------------------~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFG 799 (827)
.+..++ ..++...+.++.++++||+||| +.+|+||||||+||+ |||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence 222111 2234456789999999999996 578999999999998 999
Q ss_pred ccccccCCCc-----------------cccccceecccccccccC
Q 047196 800 IGRLLTGDRS-----------------MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 800 la~~~~~~~~-----------------~~~~~~~gt~~Y~APE~l 827 (827)
+|+....... ......+||++|||||++
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l 203 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERL 203 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHh
Confidence 9987621110 001123589999999963
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.5e-18 Score=193.33 Aligned_cols=151 Identities=28% Similarity=0.431 Sum_probs=114.5
Q ss_pred cccccceEecCCceEEEEEEecCC-cEEEEEEEcccchHHHHHHHHHHHHHHhcC-CCCceEEEee-eecC---C--cee
Q 047196 676 KFSKENLIGVGSFGSVYKGRLHDG-IEVAIKVFHQNCAMALKSFEAECEVMKNIR-HRNHVKRISS-CSNE---D--FKA 747 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~~g-~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~~~~~-~~~~---~--~~~ 747 (827)
+.+.+++|.+|||+.||.|+...+ ..||+|++-...++..+.+.+||++|++++ |+|||.+++. .... . +.+
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 456678999999999999997654 999999987777888899999999999998 9999999994 2221 1 222
Q ss_pred ---eeeecc----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccc
Q 047196 748 ---LDCLHS----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLL 804 (827)
Q Consensus 748 ---l~~l~~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~ 804 (827)
|++... ....++..+.++|+.++++|+++||+ .+++|||||||.+||| |||-|.-.
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~ 196 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSATTK 196 (738)
T ss_pred EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence 233321 12346778889999999999999997 6899999999999999 99987543
Q ss_pred cCCC-ccc-----cc--cceecccccccccC
Q 047196 805 TGDR-SMI-----QT--ETLVTIGYMAPGLL 827 (827)
Q Consensus 805 ~~~~-~~~-----~~--~~~gt~~Y~APE~l 827 (827)
.... ... .. ...-|+-|+|||+|
T Consensus 197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMI 227 (738)
T KOG1989|consen 197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMI 227 (738)
T ss_pred cCCCccHHHHHHHHHHHHhhCCccccChHHH
Confidence 2211 110 00 11248999999986
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.6e-18 Score=183.18 Aligned_cols=143 Identities=25% Similarity=0.354 Sum_probs=105.1
Q ss_pred cceEecCCceEEEEEEec---CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc--ee--eeeec
Q 047196 680 ENLIGVGSFGSVYKGRLH---DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF--KA--LDCLH 752 (827)
Q Consensus 680 ~~~iG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~--~~--l~~l~ 752 (827)
..+||+|+||.||+|+.. +++.||||++.... ....+.+|++++++++|||||++++.+..... .+ +++..
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999864 46789999986532 23456789999999999999999998754321 11 12211
Q ss_pred c----------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee--------------eecccc
Q 047196 753 S----------------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF--------------DFGIGR 802 (827)
Q Consensus 753 ~----------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl--------------DFGla~ 802 (827)
. ....+.......++.|++.||+||| +.+|+||||||+||| |||+|+
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 0 0113556667789999999999995 678999999999987 999998
Q ss_pred cccCCCcc--ccccceecccccccccC
Q 047196 803 LLTGDRSM--IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 803 ~~~~~~~~--~~~~~~gt~~Y~APE~l 827 (827)
........ ......||++|||||++
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~ 187 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELL 187 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHH
Confidence 76433221 11234589999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.1e-18 Score=183.34 Aligned_cols=143 Identities=25% Similarity=0.331 Sum_probs=107.5
Q ss_pred ceEecCCceEEEEEEe----cCCcEEEEEEEcccc----hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 681 NLIGVGSFGSVYKGRL----HDGIEVAIKVFHQNC----AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~----~~g~~vAvK~l~~~~----~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
+.||+|+||.||+++. .+++.||||++.... ......+.+|++++++++||||+++++++..++..++...+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 257899999986432 12345678999999999999999999998877655443333
Q ss_pred cCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 753 STN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 753 ~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
... ..+.......++.++++||+||| +.+|+||||||+||+ |||+++........ .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~ 157 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV-T 157 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCc-c
Confidence 222 23445556678899999999995 678999999999998 99998754332221 1
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
....||++|+|||++
T Consensus 158 ~~~~gt~~y~aPE~~ 172 (323)
T cd05584 158 HTFCGTIEYMAPEIL 172 (323)
T ss_pred cccCCCccccChhhc
Confidence 224589999999974
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.6e-18 Score=186.01 Aligned_cols=150 Identities=24% Similarity=0.365 Sum_probs=113.6
Q ss_pred HhhcccccceEecCCceEEEEEEec-CCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC-----
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNED----- 744 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~----- 744 (827)
..++|...+.||+|+||.||+|+.. +|+.||||++... ......++.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999864 6899999998643 2234567889999999999999999999875432
Q ss_pred ---ceeeeeeccC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccC
Q 047196 745 ---FKALDCLHST-----NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806 (827)
Q Consensus 745 ---~~~l~~l~~~-----~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~ 806 (827)
+..++++... ...++......++.|+++||+||| +.+|+||||||+||+ |||+++....
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 99 QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred ceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 1222333211 123455666779999999999995 678999999999998 9999976533
Q ss_pred CCccccccceecccccccccC
Q 047196 807 DRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 807 ~~~~~~~~~~gt~~Y~APE~l 827 (827)
... .....||+.|+|||++
T Consensus 176 ~~~--~~~~~~t~~y~aPE~~ 194 (359)
T cd07876 176 NFM--MTPYVVTRYYRAPEVI 194 (359)
T ss_pred Ccc--CCCCcccCCCCCchhc
Confidence 221 2234589999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.5e-18 Score=179.78 Aligned_cols=147 Identities=29% Similarity=0.451 Sum_probs=107.8
Q ss_pred cccccceEecCCceEEEEEEe-c-CCcEEEEEEEcccc--hHHHHHHHHHHHHHHhc---CCCCceEEEeeeecC-----
Q 047196 676 KFSKENLIGVGSFGSVYKGRL-H-DGIEVAIKVFHQNC--AMALKSFEAECEVMKNI---RHRNHVKRISSCSNE----- 743 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~-~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l---~H~niv~~~~~~~~~----- 743 (827)
+|+..+.||+|+||.||+|+. . +|+.||||++.... ......+.+|+++++++ +||||++++++|...
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 577889999999999999986 3 46889999986432 22234567788877766 699999999988531
Q ss_pred Cceee--eeecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccc
Q 047196 744 DFKAL--DCLHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGR 802 (827)
Q Consensus 744 ~~~~l--~~l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~ 802 (827)
...++ ++... ....+.+.....++.+++.||+||| +.+|+||||||+||+ |||+++
T Consensus 82 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 82 TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 11222 22211 1123667788899999999999995 678999999999998 999998
Q ss_pred cccCCCccccccceecccccccccC
Q 047196 803 LLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 803 ~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
...... ......||+.|+|||++
T Consensus 159 ~~~~~~--~~~~~~~~~~y~aPE~~ 181 (290)
T cd07862 159 IYSFQM--ALTSVVVTLWYRAPEVL 181 (290)
T ss_pred eccCCc--ccccccccccccChHHH
Confidence 764332 12234589999999963
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.1e-18 Score=178.51 Aligned_cols=150 Identities=19% Similarity=0.278 Sum_probs=112.3
Q ss_pred hcccccceEecCCceEEEEEEec----CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH----DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALD 749 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~ 749 (827)
.+|+..+.||+|+||.||+|.++ .+..||+|+++... ....+.|.+|++++++++|||+|++.+++...+..++.
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46778899999999999999753 35789999987643 33456799999999999999999999998876655443
Q ss_pred eeccC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 750 CLHST-----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 750 ~l~~~-----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
..+.. ...+.+.+...++.+++.|++||| +++|+||||||+||+ |||.+.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 32221 235678888999999999999995 678999999999998 888765432221
Q ss_pred ccccccceecccccccccC
Q 047196 809 SMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~~~~~~gt~~Y~APE~l 827 (827)
........++..|+|||++
T Consensus 162 ~~~~~~~~~~~~y~aPE~~ 180 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAI 180 (266)
T ss_pred hhcccCCCCceeecCHHHH
Confidence 1111112256789999963
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.8e-18 Score=182.87 Aligned_cols=149 Identities=25% Similarity=0.371 Sum_probs=114.0
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
++|...+.||+|+||.||+|+.+ +++.||||+++... ......+.+|++++++++|+|++++++++..++..++...+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888899999999999999865 67899999986432 22334678899999999999999999999877655443322
Q ss_pred cC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 753 ST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 753 ~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
.. ...+.+.....++.++++||+||| +++|+||||||+||+ |||+++........ .
T Consensus 86 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~ 161 (309)
T cd07872 86 LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT-Y 161 (309)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCccc-c
Confidence 21 223566677789999999999995 678999999999998 99998765332221 1
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
....+|+.|+|||++
T Consensus 162 ~~~~~~~~y~aPE~~ 176 (309)
T cd07872 162 SNEVVTLWYRPPDVL 176 (309)
T ss_pred ccccccccccCCHHH
Confidence 224579999999963
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.9e-18 Score=176.95 Aligned_cols=149 Identities=25% Similarity=0.400 Sum_probs=113.9
Q ss_pred hcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc-
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS- 753 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~- 753 (827)
.+|+..+.||+|+||.||+|+++++..||+|.+.... ...+.|.+|++++++++|||++++++++...+..++...+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4577788999999999999998888899999876432 23457899999999999999999999987766544422221
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccc
Q 047196 754 ----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQT 813 (827)
Q Consensus 754 ----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~ 813 (827)
....+++.....++.+++.|++||| +++|+||||||+||+ |||+++...........
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence 1234677788899999999999995 678999999999998 89988765433222112
Q ss_pred cceecccccccccC
Q 047196 814 ETLVTIGYMAPGLL 827 (827)
Q Consensus 814 ~~~gt~~Y~APE~l 827 (827)
...++..|+|||++
T Consensus 160 ~~~~~~~y~aPE~~ 173 (256)
T cd05114 160 GAKFPVKWSPPEVF 173 (256)
T ss_pred CCCCchhhCChhhc
Confidence 22356789999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.2e-17 Score=180.01 Aligned_cols=149 Identities=19% Similarity=0.262 Sum_probs=107.5
Q ss_pred HhhcccccceEecCCceEEEEEEec--CCcEEEEEEEccc-----chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLH--DGIEVAIKVFHQN-----CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF 745 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~--~g~~vAvK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~ 745 (827)
..++|...+.||+|+||+||+|+.+ +++.||||++... .....+.|.+|++++++++|+|+|+.+..+ ...+
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-~~~~ 94 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-GKDG 94 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-CCcE
Confidence 3467999999999999999999864 5778899987532 122356799999999999999999644332 3344
Q ss_pred eeeeeeccCCCCCCHH---HHHHHHHHHHHHHHHHHhcCCCCeEEccC-CCccee----------eecccccccCCCccc
Q 047196 746 KALDCLHSTNCSLNIF---DKLNIMIDVASALEYLHFSHSTPVIHCDL-KPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 746 ~~l~~l~~~~~~l~~~---~~~~i~~~ia~~L~~Lh~~h~~~iiHrDl-K~~NIl----------DFGla~~~~~~~~~~ 811 (827)
.+++++.. ..+... ....++.+++++|+|+| +++|+|||| ||+||| |||+|+.+.......
T Consensus 95 LVmE~~~G--~~L~~~~~~~~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~ 169 (365)
T PRK09188 95 LVRGWTEG--VPLHLARPHGDPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALY 169 (365)
T ss_pred EEEEccCC--CCHHHhCccchHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchh
Confidence 44555432 222111 12467889999999995 679999999 999998 999999775433211
Q ss_pred c-------ccceecccccccccC
Q 047196 812 Q-------TETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~-------~~~~gt~~Y~APE~l 827 (827)
. +...+++.|+|||++
T Consensus 170 ~~~~~~d~~~~~~~~~~~~pe~~ 192 (365)
T PRK09188 170 RIAAYEDLRHLLKHKRTYAPDAL 192 (365)
T ss_pred hhhhhhhhhhhhccCccCCcccC
Confidence 1 334588999999975
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.74 E-value=8e-18 Score=185.55 Aligned_cols=151 Identities=24% Similarity=0.333 Sum_probs=113.9
Q ss_pred HHhhcccccceEecCCceEEEEEEec-CCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC----
Q 047196 672 RATEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNED---- 744 (827)
Q Consensus 672 ~~~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~---- 744 (827)
...++|...+.||+|+||.||+|... .++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34578999999999999999999864 5889999998643 2334567889999999999999999999875432
Q ss_pred ----ceeeeeeccC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eeccccccc
Q 047196 745 ----FKALDCLHST-----NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLT 805 (827)
Q Consensus 745 ----~~~l~~l~~~-----~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~ 805 (827)
+..++++... ...+++.....++.++++||+||| +++|+||||||+||+ |||+++...
T Consensus 94 ~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 94 FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred cceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 1122222211 123556667789999999999995 678999999999998 999998654
Q ss_pred CCCccccccceecccccccccC
Q 047196 806 GDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 806 ~~~~~~~~~~~gt~~Y~APE~l 827 (827)
.... .....||+.|+|||++
T Consensus 171 ~~~~--~~~~~~t~~y~aPE~~ 190 (355)
T cd07874 171 TSFM--MTPYVVTRYYRAPEVI 190 (355)
T ss_pred Cccc--cCCccccCCccCHHHH
Confidence 3221 2334589999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2e-18 Score=199.18 Aligned_cols=70 Identities=30% Similarity=0.393 Sum_probs=59.0
Q ss_pred HhhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeec
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSN 742 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~ 742 (827)
...+|++.+++|+|+||.|||++-+ ||+.||||++.... .+......+|+.+++++.|||+|+++.++.+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVE 548 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVE 548 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhc
Confidence 4467888899999999999999965 89999999997653 3345678899999999999999998876544
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-17 Score=181.84 Aligned_cols=147 Identities=23% Similarity=0.279 Sum_probs=110.2
Q ss_pred ccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHH---HhcCCCCceEEEeeeecCCceeee
Q 047196 677 FSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVM---KNIRHRNHVKRISSCSNEDFKALD 749 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l---~~l~H~niv~~~~~~~~~~~~~l~ 749 (827)
|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++ ++++|||++++++++...+..++.
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 455688999999999999864 68999999996532 22345566776655 567899999999998877655553
Q ss_pred eeccC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 750 CLHST---------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 750 ~l~~~---------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
..+.. ...+++.....++.+++.|++||| +.+|+||||||+||+ |||+++........
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR 157 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCc
Confidence 33322 234677788899999999999995 678999999999998 99998754322221
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
....+||+.|||||++
T Consensus 158 -~~~~~g~~~y~aPE~~ 173 (324)
T cd05589 158 -TSTFCGTPEFLAPEVL 173 (324)
T ss_pred -ccccccCccccCHhHh
Confidence 1234589999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.5e-17 Score=185.09 Aligned_cols=151 Identities=25% Similarity=0.463 Sum_probs=112.2
Q ss_pred hhcccccceEecCCceEEEEEEec------CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcC-CCCceEEEeeeecCCc
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH------DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIR-HRNHVKRISSCSNEDF 745 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~ 745 (827)
.++|...++||+|+||.||+|+.. .+..||||++.... ....+.|.+|++++++++ |||||+++++|.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 356778899999999999999752 13579999996543 334567999999999996 9999999999987665
Q ss_pred eee--eeeccC---------------------------------------------------------------------
Q 047196 746 KAL--DCLHST--------------------------------------------------------------------- 754 (827)
Q Consensus 746 ~~l--~~l~~~--------------------------------------------------------------------- 754 (827)
.++ +++...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 443 222100
Q ss_pred -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---
Q 047196 755 -----------------------------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF--- 796 (827)
Q Consensus 755 -----------------------------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl--- 796 (827)
...+.+.+...++.++++|++||| +.+|+||||||+||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeC
Confidence 012455666789999999999995 578999999999998
Q ss_pred -------eecccccccCCCccc-cccceecccccccccC
Q 047196 797 -------DFGIGRLLTGDRSMI-QTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 -------DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l 827 (827)
|||+++......... .....+++.|||||++
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~ 311 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESI 311 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhh
Confidence 999998764432221 1223467889999964
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-17 Score=180.96 Aligned_cols=143 Identities=24% Similarity=0.234 Sum_probs=109.0
Q ss_pred ceEecCCceEEEEEEec-CCcEEEEEEEccc---chHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCceeeeeeccCC
Q 047196 681 NLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN---CAMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFKALDCLHSTN 755 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~l~~l~~~~ 755 (827)
+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++.++ +|||||++++++...+..++...+...
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999864 6889999998753 223445678899988877 799999999998877765554333222
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccccc
Q 047196 756 ----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTET 815 (827)
Q Consensus 756 ----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~~ 815 (827)
..+.+.....++.++++|++||| +++|+||||||+||+ |||+++........ ....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~-~~~~ 156 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TSTF 156 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCc-cccc
Confidence 24566677889999999999995 678999999999998 99998754322211 1234
Q ss_pred eecccccccccC
Q 047196 816 LVTIGYMAPGLL 827 (827)
Q Consensus 816 ~gt~~Y~APE~l 827 (827)
.||+.|+|||++
T Consensus 157 ~gt~~y~aPE~~ 168 (329)
T cd05618 157 CGTPNYIAPEIL 168 (329)
T ss_pred cCCccccCHHHH
Confidence 589999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.1e-18 Score=179.97 Aligned_cols=148 Identities=27% Similarity=0.353 Sum_probs=113.5
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCA--MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l 751 (827)
+-|+.++.||+|.|++|-.|+. -+|+.||||++.+... ....++.+|++.|+-++|||||+++.........++...
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 3477778899999999999974 4799999999976532 234578889999999999999999988765544333221
Q ss_pred c-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------eecccccccCCCc
Q 047196 752 H-----------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRLLTGDRS 809 (827)
Q Consensus 752 ~-----------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGla~~~~~~~~ 809 (827)
- .....+...-..++..||..|+.|+|..| ||||||||+||. |||++-.+.....
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence 1 11233444456678999999999998766 999999999986 9999876654443
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
.+..+|+.+|-|||++
T Consensus 175 --L~TsCGSLAYSAPEIL 190 (864)
T KOG4717|consen 175 --LTTSCGSLAYSAPEIL 190 (864)
T ss_pred --hhcccchhhccCchhh
Confidence 2456899999999985
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.2e-18 Score=186.37 Aligned_cols=143 Identities=21% Similarity=0.283 Sum_probs=111.1
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
..+|...+.||+|+||.||+|+.. +++.||+|+.... ....|+.++++++|+|||++++++......++...+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 356899999999999999999865 5788999975332 235699999999999999999998877655442221
Q ss_pred ----------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 753 ----------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 753 ----------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
.....+.+.....|+.+++.||+||| +++|+||||||+||+ |||+++....... .
T Consensus 139 ~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~--~ 213 (357)
T PHA03209 139 YSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA--F 213 (357)
T ss_pred cCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccCcc--c
Confidence 12235678888999999999999995 568999999999998 9999875432211 1
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
....||+.|+|||++
T Consensus 214 ~~~~gt~~y~aPE~~ 228 (357)
T PHA03209 214 LGLAGTVETNAPEVL 228 (357)
T ss_pred ccccccccccCCeec
Confidence 224589999999974
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.6e-17 Score=180.93 Aligned_cols=143 Identities=23% Similarity=0.232 Sum_probs=109.7
Q ss_pred ceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCceeeeeeccC-
Q 047196 681 NLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFKALDCLHST- 754 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~l~~l~~~- 754 (827)
++||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.+++++ +|||||++++++......++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999864 68999999997532 23345688999999998 69999999999887765554333222
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccccc
Q 047196 755 ---------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTET 815 (827)
Q Consensus 755 ---------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~~ 815 (827)
...+.+.....++.+++.|++||| +++|+||||||+||+ |||+++........ ....
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~-~~~~ 156 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT-TSTF 156 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCc-cccc
Confidence 234667778889999999999995 678999999999998 99998753222211 1234
Q ss_pred eecccccccccC
Q 047196 816 LVTIGYMAPGLL 827 (827)
Q Consensus 816 ~gt~~Y~APE~l 827 (827)
+||+.|+|||++
T Consensus 157 ~gt~~y~aPE~~ 168 (329)
T cd05588 157 CGTPNYIAPEIL 168 (329)
T ss_pred cCCccccCHHHH
Confidence 589999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.3e-17 Score=180.10 Aligned_cols=148 Identities=23% Similarity=0.298 Sum_probs=115.3
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEccc-chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN-CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
++|+..+.||+|+||.||+|+.. +|..||+|++... .....+.+.+|++++++++|+|||++++++...+..++...+
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 57888899999999999999865 6889999988654 233456799999999999999999999999887765554333
Q ss_pred cCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 753 STN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 753 ~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
... ..+.+.....++.+++.|+.|||. ..+|+||||||+||+ |||+++.......
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--- 159 (333)
T cd06650 85 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--- 159 (333)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhcc---
Confidence 322 224455567899999999999973 346999999999998 9999876533211
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
....||..|+|||++
T Consensus 160 ~~~~~~~~y~aPE~~ 174 (333)
T cd06650 160 NSFVGTRSYMSPERL 174 (333)
T ss_pred ccCCCCccccCHHHh
Confidence 223589999999974
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.6e-17 Score=180.70 Aligned_cols=148 Identities=22% Similarity=0.192 Sum_probs=109.5
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCC-ceEEEeeeecCCceeeee
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRN-HVKRISSCSNEDFKALDC 750 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~n-iv~~~~~~~~~~~~~l~~ 750 (827)
+|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+..|+++++.++|++ ++++.+++...+..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4677889999999999999865 57899999986532 233467889999999998765 667777776665444432
Q ss_pred eccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 751 LHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 751 l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
.+.. ...+.+.....++.+++.||+||| +++|+||||||+||| |||+++........
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence 2221 123566777889999999999995 578999999999998 99998753222111
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
....+||+.|+|||++
T Consensus 158 -~~~~~gt~~y~aPE~~ 173 (324)
T cd05587 158 -TRTFCGTPDYIAPEII 173 (324)
T ss_pred -eeeecCCccccChhhh
Confidence 1234589999999974
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.5e-18 Score=184.28 Aligned_cols=148 Identities=23% Similarity=0.313 Sum_probs=120.8
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
+.|+.++.+|.|+-|.|..|+. .+|+.+|||++.+.. .......++||-+|+-+.|||++++++.+.+....++..
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4577788999999999999985 579999999997652 223457899999999999999999999998887777655
Q ss_pred eccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 751 LHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 751 l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
+|..+ +.+...+..++..||..|+.|+|. .+|+|||+||+|+| |||+|.+-..+.-
T Consensus 92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl- 167 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL- 167 (786)
T ss_pred EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCCcc-
Confidence 55443 445666778899999999999964 45999999999988 9999987655432
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
. .+.||++.|.|||++
T Consensus 168 L-eTSCGSPHYA~PEIV 183 (786)
T KOG0588|consen 168 L-ETSCGSPHYAAPEIV 183 (786)
T ss_pred c-cccCCCcccCCchhh
Confidence 2 346799999999985
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.73 E-value=2e-17 Score=179.32 Aligned_cols=143 Identities=26% Similarity=0.362 Sum_probs=105.4
Q ss_pred cceEecCCceEEEEEEec---CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC--cee--eeeec
Q 047196 680 ENLIGVGSFGSVYKGRLH---DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNED--FKA--LDCLH 752 (827)
Q Consensus 680 ~~~iG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~--~~~--l~~l~ 752 (827)
..+||+|+||.||+|+.. ++..||+|++.... ....+.+|++++++++|||+|++.+++.... ..+ +++..
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999864 35789999986532 2345788999999999999999999885432 222 22221
Q ss_pred c----------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee--------------eecccc
Q 047196 753 S----------------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF--------------DFGIGR 802 (827)
Q Consensus 753 ~----------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl--------------DFGla~ 802 (827)
. ....+.+.....++.|+++||+||| +.+|+||||||+||+ |||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 1 0113556667789999999999995 678999999999987 999998
Q ss_pred cccCCCcc--ccccceecccccccccC
Q 047196 803 LLTGDRSM--IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 803 ~~~~~~~~--~~~~~~gt~~Y~APE~l 827 (827)
........ ......||++|+|||++
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~ 187 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELL 187 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHh
Confidence 76433221 11234589999999974
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.4e-17 Score=184.26 Aligned_cols=150 Identities=24% Similarity=0.331 Sum_probs=113.5
Q ss_pred HhhcccccceEecCCceEEEEEEec-CCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC-----
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNED----- 744 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~----- 744 (827)
..++|...+.||+|+||.||+|... .++.||||++... .....+.+.+|+.+++.++|||++++++.+...+
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4567899999999999999999864 5889999998653 2334567889999999999999999998875432
Q ss_pred ---ceeeeeeccC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccC
Q 047196 745 ---FKALDCLHST-----NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806 (827)
Q Consensus 745 ---~~~l~~l~~~-----~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~ 806 (827)
+..++++... ...+++.....++.|+++||+||| +++|+||||||+||+ |||+|+....
T Consensus 102 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 102 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred CeEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 1222332211 123456667789999999999995 678999999999998 9999986543
Q ss_pred CCccccccceecccccccccC
Q 047196 807 DRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 807 ~~~~~~~~~~gt~~Y~APE~l 827 (827)
... .....||++|+|||++
T Consensus 179 ~~~--~~~~~~t~~y~aPE~~ 197 (364)
T cd07875 179 SFM--MTPYVVTRYYRAPEVI 197 (364)
T ss_pred CCc--ccCCcccCCcCCHHHH
Confidence 221 2334589999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.8e-18 Score=197.01 Aligned_cols=149 Identities=29% Similarity=0.509 Sum_probs=112.6
Q ss_pred cccccceEecCCceEEEEEEecC--Cc----EEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCcee-
Q 047196 676 KFSKENLIGVGSFGSVYKGRLHD--GI----EVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKA- 747 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~~--g~----~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~- 747 (827)
..+..+.||+|.||.||+|...+ |. .||||.+.... .+...+|.+|..+|++++|||||+++|.|.+....+
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 34456789999999999998643 43 49999997653 556778999999999999999999999998865443
Q ss_pred -eeeeccC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eeccc
Q 047196 748 -LDCLHST---------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIG 801 (827)
Q Consensus 748 -l~~l~~~---------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla 801 (827)
+++++.+ ...+...+.+.++.+||+|+.||+ ++++|||||.+.|+| |||+|
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccchh
Confidence 3444332 224667788999999999999996 555999999999988 99999
Q ss_pred ccc-cCCCccccccceecccccccccC
Q 047196 802 RLL-TGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 802 ~~~-~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
|.+ ..+.........-...|||||.+
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl 876 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESL 876 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHH
Confidence 944 33322211111235689999974
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.3e-17 Score=173.55 Aligned_cols=150 Identities=22% Similarity=0.414 Sum_probs=115.4
Q ss_pred hhcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
.++|+..++||+|+||.||+|...++..||+|.+.... ...+.+.+|++++++++|+|++++++++...+..++...+.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 35688889999999999999998888899999976432 23567899999999999999999999887766544432221
Q ss_pred C------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 754 T------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 754 ~------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
. .....+.++..++.++++|++||| +.+++||||||+||+ |||+++.........
T Consensus 84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 1 234566777889999999999996 567999999999988 999998764332222
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
.....++..|+|||++
T Consensus 161 ~~~~~~~~~y~aPE~~ 176 (261)
T cd05072 161 REGAKFPIKWTAPEAI 176 (261)
T ss_pred cCCCccceecCCHHHh
Confidence 2222357789999963
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.73 E-value=2e-17 Score=180.02 Aligned_cols=143 Identities=29% Similarity=0.351 Sum_probs=106.2
Q ss_pred ceEecCCceEEEEEEe-cCCcEEEEEEEcccc---hHHHHHHHHHHH-HHHhcCCCCceEEEeeeecCCceeeeeeccC-
Q 047196 681 NLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC---AMALKSFEAECE-VMKNIRHRNHVKRISSCSNEDFKALDCLHST- 754 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~-~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~- 754 (827)
++||+|+||.||+|+. .+|+.||||++.... ....+++.+|.. +++.++|||||++++++...+..++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999986 468999999986532 223345566665 5778999999999999887765554333222
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccccc
Q 047196 755 ---------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTET 815 (827)
Q Consensus 755 ---------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~~ 815 (827)
...+.+.....++.++++||+||| +.+|+||||||+||+ |||+++....... .....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~~ 156 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TTTTF 156 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-Ccccc
Confidence 234566677789999999999995 678999999999998 9999875432211 12234
Q ss_pred eecccccccccC
Q 047196 816 LVTIGYMAPGLL 827 (827)
Q Consensus 816 ~gt~~Y~APE~l 827 (827)
+||+.|||||++
T Consensus 157 ~gt~~y~aPE~~ 168 (325)
T cd05604 157 CGTPEYLAPEVI 168 (325)
T ss_pred cCChhhCCHHHH
Confidence 589999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=2e-17 Score=179.45 Aligned_cols=143 Identities=27% Similarity=0.318 Sum_probs=109.8
Q ss_pred ceEecCCceEEEEEEe----cCCcEEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeeccC
Q 047196 681 NLIGVGSFGSVYKGRL----HDGIEVAIKVFHQNCA--MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHST 754 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~----~~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~ 754 (827)
+.||+|+||.||+++. .+|+.||||++..... .....+.+|++++++++|||||++++++..++..++...+..
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 3578999999975322 234567889999999999999999999887765554333222
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccccc
Q 047196 755 ----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTE 814 (827)
Q Consensus 755 ----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~ 814 (827)
...+++.....++.++++||+||| +.+|+||||||+||+ |||+++........ ...
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~-~~~ 157 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-AYS 157 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc-eec
Confidence 224567777889999999999995 678999999999998 99998865433221 123
Q ss_pred ceecccccccccC
Q 047196 815 TLVTIGYMAPGLL 827 (827)
Q Consensus 815 ~~gt~~Y~APE~l 827 (827)
..||+.|||||++
T Consensus 158 ~~g~~~y~aPE~~ 170 (318)
T cd05582 158 FCGTVEYMAPEVV 170 (318)
T ss_pred ccCChhhcCHHHH
Confidence 4589999999963
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.4e-17 Score=182.05 Aligned_cols=151 Identities=24% Similarity=0.435 Sum_probs=111.6
Q ss_pred hhcccccceEecCCceEEEEEEec------CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCc
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH------DGIEVAIKVFHQNC-AMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDF 745 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~ 745 (827)
.++|+..++||+|+||.||+|+.. +++.||+|+++... ....+.+.+|+++++++ +|+||++++++|...+.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 357888899999999999999632 35789999986532 33446788999999999 89999999998865442
Q ss_pred ee---eeeeccC--------------------------------------------------------------------
Q 047196 746 KA---LDCLHST-------------------------------------------------------------------- 754 (827)
Q Consensus 746 ~~---l~~l~~~-------------------------------------------------------------------- 754 (827)
.. +++....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 21 1111100
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc-ccceeccccc
Q 047196 755 -NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ-TETLVTIGYM 822 (827)
Q Consensus 755 -~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~-~~~~gt~~Y~ 822 (827)
...+++.....++.+++.|++||| +.+|+||||||+||+ |||+++.+........ ....++..||
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 014567778899999999999996 678999999999997 9999987644332221 2223678899
Q ss_pred ccccC
Q 047196 823 APGLL 827 (827)
Q Consensus 823 APE~l 827 (827)
|||++
T Consensus 243 aPE~~ 247 (337)
T cd05054 243 APESI 247 (337)
T ss_pred CcHHh
Confidence 99963
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.2e-17 Score=178.91 Aligned_cols=143 Identities=21% Similarity=0.262 Sum_probs=105.6
Q ss_pred ceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCceeeeeeccCC
Q 047196 681 NLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFKALDCLHSTN 755 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~l~~l~~~~ 755 (827)
++||+|+||.||+|+.. +++.||||++.... ....+.+..|.+++... +||||+++++++...+..++...+...
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 58899999986532 22334566677777654 899999999998777655443332221
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccccc
Q 047196 756 ----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTET 815 (827)
Q Consensus 756 ----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~~ 815 (827)
..+.......++.|++.||+||| +++|+||||||+||+ |||+++....... .....
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~-~~~~~ 156 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG-KASTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC-ccccc
Confidence 23555666779999999999996 578999999999998 9999976533222 12234
Q ss_pred eecccccccccC
Q 047196 816 LVTIGYMAPGLL 827 (827)
Q Consensus 816 ~gt~~Y~APE~l 827 (827)
+||+.|||||++
T Consensus 157 ~gt~~y~aPE~~ 168 (316)
T cd05592 157 CGTPDYIAPEIL 168 (316)
T ss_pred cCCccccCHHHH
Confidence 589999999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.9e-17 Score=179.79 Aligned_cols=143 Identities=24% Similarity=0.243 Sum_probs=108.4
Q ss_pred ceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCceeeeeeccC-
Q 047196 681 NLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFKALDCLHST- 754 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~l~~l~~~- 754 (827)
++||+|+||.||+|+.. +|+.||||++.... ....+.+..|+++++.+ +||||+++++++...+..++...+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999865 58899999986532 22345678899999876 79999999999887765544333322
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccccc
Q 047196 755 ---------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTET 815 (827)
Q Consensus 755 ---------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~~ 815 (827)
...+.+.....++.++++||+||| +.+|+||||||+||+ |||+++........ ....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~-~~~~ 156 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT-TTTF 156 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcc-cccc
Confidence 224566677889999999999995 678999999999998 99998764322221 2234
Q ss_pred eecccccccccC
Q 047196 816 LVTIGYMAPGLL 827 (827)
Q Consensus 816 ~gt~~Y~APE~l 827 (827)
.||+.|+|||++
T Consensus 157 ~gt~~y~aPE~~ 168 (321)
T cd05591 157 CGTPDYIAPEIL 168 (321)
T ss_pred ccCccccCHHHH
Confidence 589999999963
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.9e-17 Score=174.34 Aligned_cols=139 Identities=23% Similarity=0.326 Sum_probs=103.9
Q ss_pred ceEecCCceEEEEEEecC-------------CcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCcee
Q 047196 681 NLIGVGSFGSVYKGRLHD-------------GIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKA 747 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~~-------------g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~ 747 (827)
+.||+|+||.||+|++.+ ...||+|++........+.|.+|+.++++++|||+|++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 358999999999997532 2358999886554445567899999999999999999999998765544
Q ss_pred eeeecc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------------eec
Q 047196 748 LDCLHS-----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------------DFG 799 (827)
Q Consensus 748 l~~l~~-----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------------DFG 799 (827)
+...+. ....+++.....++.|+++|++|| |+++|+||||||+||+ |||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYL---EDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHh---hhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 422221 123467777889999999999999 4788999999999988 455
Q ss_pred ccccccCCCccccccceecccccccccC
Q 047196 800 IGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 800 la~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
++..... .....++..|||||++
T Consensus 158 ~~~~~~~-----~~~~~~~~~y~aPE~~ 180 (262)
T cd05077 158 IPITVLS-----RQECVERIPWIAPECV 180 (262)
T ss_pred CCccccC-----cccccccccccChhhh
Confidence 5443221 1223478899999964
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.5e-17 Score=175.71 Aligned_cols=146 Identities=22% Similarity=0.318 Sum_probs=112.2
Q ss_pred ccccceEecCCceEEEEEEe-cCCcEEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 677 FSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCA---MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
|+..++||+|+||.||++.. .+++.||||++..... .....+.+|++++++++|+|+|++.+.+...+..++...+
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 66778999999999999986 4689999999865321 2234578899999999999999999998776655443222
Q ss_pred cC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 753 ST------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 753 ~~------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
.. ...+.+.....++.+++.|++||| +.+|+||||||+||+ |||+++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET- 157 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc-
Confidence 11 123567777889999999999996 568999999999988 9999876543222
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
....+|++.|||||++
T Consensus 158 -~~~~~~~~~y~aPE~~ 173 (285)
T cd05605 158 -IRGRVGTVGYMAPEVV 173 (285)
T ss_pred -cccccCCCCccCcHHh
Confidence 1234589999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.7e-17 Score=175.72 Aligned_cols=150 Identities=27% Similarity=0.423 Sum_probs=114.9
Q ss_pred hcccccceEecCCceEEEEEEe------cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL------HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~------~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l 748 (827)
.+|...+.||+|+||+||++.. .++..||||.+........+.+.+|++++++++|+|++++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 4677889999999999999974 2346799999876655556789999999999999999999999987665544
Q ss_pred eeeccC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------
Q 047196 749 DCLHST-----------------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF--------- 796 (827)
Q Consensus 749 ~~l~~~-----------------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl--------- 796 (827)
...+.. ...+.+.....++.+++.|++||| +++|+||||||+||+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence 332211 013677788899999999999995 678999999999998
Q ss_pred -eecccccccCCCcc-ccccceecccccccccC
Q 047196 797 -DFGIGRLLTGDRSM-IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 -DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l 827 (827)
|||+++........ ......++..|+|||++
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 194 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI 194 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHh
Confidence 99998765432211 11223357889999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.4e-19 Score=191.27 Aligned_cols=202 Identities=23% Similarity=0.234 Sum_probs=110.9
Q ss_pred EEcCCCCCc-cccCccccCCCCCCEEECCCCCCCcc----CChhhhhccccceEEecCCCCCC------ccccccCCCCC
Q 047196 103 LNISSLNLQ-GTIPPQLGNLSSLTTLNLSHNKLSGD----IPPSIFTMHKLKFLDFSDNQLSG------SLSSVTFNLSS 171 (827)
Q Consensus 103 L~L~~~~l~-g~~~~~l~~L~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~LdLs~N~l~g------~~p~~~~~l~~ 171 (827)
|+|..+.++ +.....+..++.|+.|+++++.++.. ++..+...+.|++|+++++.+.+ .++..+..+++
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~ 82 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG 82 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence 556666665 23334455666677777777776432 44455556667777777776652 22334555666
Q ss_pred CcEEEcCCCCCCCCcchhHhhcc--ccccEEEeecccccc----cCCccCCCC-CCCcEEEccCCCCccc----CCCcCc
Q 047196 172 VLDIRLDSDKLSGELPVNICNYL--HYLKVLFLAKNMFHG----QIPLALSKC-KRLQLLNLGFKKLSGA----IPKEIS 240 (827)
Q Consensus 172 L~~L~L~~n~l~g~ip~~~~~~~--~~L~~L~Ls~N~l~~----~~p~~l~~l-~~L~~L~L~~n~l~~~----~p~~~~ 240 (827)
|+.|++++|.+.+..+..+.... ++|++|++++|.+++ .+...+..+ ++|+.|++++|.+++. ++..+.
T Consensus 83 L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~ 162 (319)
T cd00116 83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALR 162 (319)
T ss_pred eeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHH
Confidence 66666666666654444443332 237777777776652 222334445 6667777777766632 233444
Q ss_pred CCccccEEEccccccccc----ccccccCcCCCcEEEeecccCcccCc----hhhhcCCCccEEEecCCccc
Q 047196 241 NLTILRKISLRNNKLRGE----IPHEIGYLPNLENLVLGFNNLVGVVP----AAIFNMSTVKKIYLLDNSLL 304 (827)
Q Consensus 241 ~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~l~~n~l~ 304 (827)
.+++|++|++++|.+++. ++..+..+++|++|+|++|.+++... ..+..+++|++|++++|.+.
T Consensus 163 ~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~ 234 (319)
T cd00116 163 ANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLT 234 (319)
T ss_pred hCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCc
Confidence 555666677766666532 23334444566666666666653322 22333444555555554443
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.2e-17 Score=186.32 Aligned_cols=145 Identities=24% Similarity=0.308 Sum_probs=111.8
Q ss_pred hcccccceEecCCceEEEEEEec---CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH---DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l 751 (827)
.+|...+.||+|+||.||+|... .++.||||.+... +.+.+|++++++++|||||++++++......++...
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 46888899999999999999753 3578999987543 235689999999999999999998876654443221
Q ss_pred c---------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc-
Q 047196 752 H---------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI- 811 (827)
Q Consensus 752 ~---------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~- 811 (827)
+ .....+.+.+...++.+++.||+||| +++|+||||||+||+ |||+|+.+.......
T Consensus 167 ~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~ 243 (392)
T PHA03207 167 KYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ 243 (392)
T ss_pred hcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCccccccc
Confidence 1 12345678888999999999999996 578999999999998 999997664432221
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
.....||+.|+|||++
T Consensus 244 ~~~~~gt~~y~aPE~~ 259 (392)
T PHA03207 244 CYGWSGTLETNSPELL 259 (392)
T ss_pred ccccccccCccCHhHh
Confidence 1223589999999974
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.1e-18 Score=181.32 Aligned_cols=148 Identities=26% Similarity=0.456 Sum_probs=114.9
Q ss_pred ccccceEecCCceEEEEEEecCCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee--eeecc
Q 047196 677 FSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL--DCLHS 753 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l--~~l~~ 753 (827)
....++||+|.||.|..++...+..||||.++... .....+|.+||++|.+++|||||+++|.|..++...+ ++++.
T Consensus 540 L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEn 619 (807)
T KOG1094|consen 540 LRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMEN 619 (807)
T ss_pred eehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhc
Confidence 34457899999999999998888999999998654 4456899999999999999999999999988765544 33322
Q ss_pred CC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccc-cCCCcccc
Q 047196 754 TN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLL-TGDRSMIQ 812 (827)
Q Consensus 754 ~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~-~~~~~~~~ 812 (827)
+. ...+-..-..|+.|||.|++||. +-++||||+.+.|+| |||++|-+ ..+...++
T Consensus 620 GDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vq 696 (807)
T KOG1094|consen 620 GDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQ 696 (807)
T ss_pred CcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCceeee
Confidence 11 11233345679999999999995 567999999999998 99999954 44444444
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
...+-.+.|||||-|
T Consensus 697 gr~vlpiRwmawEsi 711 (807)
T KOG1094|consen 697 GRAVLPIRWMAWESI 711 (807)
T ss_pred cceeeeeeehhHHHH
Confidence 444568899999953
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.7e-17 Score=175.21 Aligned_cols=141 Identities=21% Similarity=0.255 Sum_probs=108.2
Q ss_pred cceEecCCceEEEEEEecCCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeec--CC--cee--eee
Q 047196 680 ENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSN--ED--FKA--LDC 750 (827)
Q Consensus 680 ~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~--~~--~~~--l~~ 750 (827)
...||+|++|.||+|.+ +|+.||||++.... ....+.|.+|++++++++|||||+++|++.+ +. ... +++
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36899999999999998 58899999986532 2235678999999999999999999999876 22 222 233
Q ss_pred ecc--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 751 LHS--------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 751 l~~--------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
... ....+++.....++.+++.|+.|+|.. .+++||||||+||+ |||+++......
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---- 177 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---- 177 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc----
Confidence 222 123467788899999999999999742 35779999999998 999988664321
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
....||..|+|||++
T Consensus 178 ~~~~~~~~y~aPE~~ 192 (283)
T PHA02988 178 FKNVNFMVYFSYKML 192 (283)
T ss_pred ccccCcccccCHHHh
Confidence 224588999999974
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.7e-17 Score=178.77 Aligned_cols=148 Identities=22% Similarity=0.195 Sum_probs=110.0
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcC-CCCceEEEeeeecCCceeeee
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIR-HRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~l~~ 750 (827)
+|...+.||+|+||.||+|+.. +++.||||++.... ....+.+..|.+++..+. |++++++.+++...+..++..
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4677889999999999999865 57899999987542 223345677888888875 777888888887766554433
Q ss_pred eccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 751 LHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 751 l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
.+.. ...+.+.+...++.++++||+||| +.+|+||||||+||| |||+++........
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence 3222 134566777889999999999996 578999999999998 99998754322221
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
.....||+.|||||++
T Consensus 158 -~~~~~gt~~y~aPE~~ 173 (323)
T cd05616 158 -TKTFCGTPDYIAPEII 173 (323)
T ss_pred -cccCCCChhhcCHHHh
Confidence 1234589999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.6e-17 Score=182.31 Aligned_cols=150 Identities=24% Similarity=0.370 Sum_probs=113.5
Q ss_pred HHHhhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc--
Q 047196 671 FRATEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF-- 745 (827)
Q Consensus 671 ~~~~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~-- 745 (827)
....++|...+.||+|+||.||+|.. .+++.||||++.... ....+++.+|++++++++|+|||++++++.....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 44567899999999999999999985 468899999986532 2234567899999999999999999887653211
Q ss_pred ----eee--eeecc------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eeccccc
Q 047196 746 ----KAL--DCLHS------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRL 803 (827)
Q Consensus 746 ----~~l--~~l~~------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~ 803 (827)
.++ ++... ....+++.....++.|+++||+||| +++|+||||||+||+ |||+++.
T Consensus 91 ~~~~~~~~~~~~~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 91 NFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred ccCcEEEEeecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCcccee
Confidence 111 11100 1234667777889999999999995 678999999999998 9999986
Q ss_pred ccCCCccccccceecccccccccC
Q 047196 804 LTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 804 ~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
..... ...+||+.|+|||++
T Consensus 168 ~~~~~----~~~~~t~~y~aPE~~ 187 (343)
T cd07878 168 ADDEM----TGYVATRWYRAPEIM 187 (343)
T ss_pred cCCCc----CCccccccccCchHh
Confidence 54321 234589999999974
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.8e-17 Score=173.71 Aligned_cols=146 Identities=23% Similarity=0.281 Sum_probs=114.8
Q ss_pred cccccceEecCCceEEEEEEe-cCCcEEEEEEEccc-chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 676 KFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQN-CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
+|+..++||+|+||.||+|+. .+++.||||++... .....++|.+|++++++++|||++++++++...+...+...+.
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 567778999999999999985 46889999998654 2334567999999999999999999999998876655543333
Q ss_pred CCC------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccccccee
Q 047196 754 TNC------SLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV 817 (827)
Q Consensus 754 ~~~------~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~~~g 817 (827)
..+ .+.+.....++.+++.|++||| +.+|+|+||||+||+ |||++....... ....+|
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---~~~~~~ 155 (279)
T cd06619 82 DGGSLDVYRKIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---AKTYVG 155 (279)
T ss_pred CCCChHHhhcCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---ccCCCC
Confidence 322 2455666789999999999995 678999999999998 999987654321 123458
Q ss_pred cccccccccC
Q 047196 818 TIGYMAPGLL 827 (827)
Q Consensus 818 t~~Y~APE~l 827 (827)
|..|+|||++
T Consensus 156 ~~~y~aPE~~ 165 (279)
T cd06619 156 TNAYMAPERI 165 (279)
T ss_pred ChhhcCceee
Confidence 9999999974
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.1e-17 Score=174.55 Aligned_cols=153 Identities=25% Similarity=0.379 Sum_probs=116.9
Q ss_pred HHHhhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeee
Q 047196 671 FRATEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALD 749 (827)
Q Consensus 671 ~~~~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~ 749 (827)
+.+++++.....||+|+||.||+|+.. +++.||+|.+........+.+.+|++++++++|+|++++++++..++..++.
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 345667777789999999999999854 6788999998766655667899999999999999999999999887655543
Q ss_pred eeccCC-----------CCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------eeccccccc
Q 047196 750 CLHSTN-----------CSL--NIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRLLT 805 (827)
Q Consensus 750 ~l~~~~-----------~~l--~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGla~~~~ 805 (827)
..+... ..+ .+.....++.++++|++||| +.+|+||||||+||+ |||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 332221 122 45556678899999999995 678999999999988 888876554
Q ss_pred CCCccccccceecccccccccC
Q 047196 806 GDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 806 ~~~~~~~~~~~gt~~Y~APE~l 827 (827)
..... .....|++.|+|||++
T Consensus 161 ~~~~~-~~~~~~~~~~~aPE~~ 181 (268)
T cd06624 161 GINPC-TETFTGTLQYMAPEVI 181 (268)
T ss_pred cCCCc-cccCCCCccccChhhh
Confidence 32221 1123478999999963
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.1e-17 Score=178.22 Aligned_cols=143 Identities=29% Similarity=0.329 Sum_probs=105.0
Q ss_pred ceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHH-HHHhcCCCCceEEEeeeecCCceeeeeeccCC
Q 047196 681 NLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECE-VMKNIRHRNHVKRISSCSNEDFKALDCLHSTN 755 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~-~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~~ 755 (827)
++||+|+||.||+|+.. +|+.||||++.... .....++.+|+. +++.++|||||++++++...+..++...+...
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 68999999986532 122345556654 68899999999999988777655543333222
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccccc
Q 047196 756 ----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTET 815 (827)
Q Consensus 756 ----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~~ 815 (827)
..+.......++.++++||+||| +.+|+||||||+||+ |||+++....... .....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 156 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-TTSTF 156 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-ccccc
Confidence 23455566678999999999995 678999999999998 9999875422221 12234
Q ss_pred eecccccccccC
Q 047196 816 LVTIGYMAPGLL 827 (827)
Q Consensus 816 ~gt~~Y~APE~l 827 (827)
+||+.|+|||++
T Consensus 157 ~gt~~y~aPE~~ 168 (321)
T cd05603 157 CGTPEYLAPEVL 168 (321)
T ss_pred cCCcccCCHHHh
Confidence 589999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.9e-19 Score=192.93 Aligned_cols=104 Identities=19% Similarity=0.162 Sum_probs=52.0
Q ss_pred EEeeccccc-ccCCccCCCCCCCcEEEccCCCCccc----CCCcCcCCccccEEEcccccccc------cccccccCcCC
Q 047196 200 LFLAKNMFH-GQIPLALSKCKRLQLLNLGFKKLSGA----IPKEISNLTILRKISLRNNKLRG------EIPHEIGYLPN 268 (827)
Q Consensus 200 L~Ls~N~l~-~~~p~~l~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~------~~p~~~~~l~~ 268 (827)
|+|..+.++ ...+..+..+.+|+.|+++++.++.. ++..+...+.|++|+++++.+.+ .++..+..+++
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~ 82 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG 82 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence 555666655 23334444555566666666666422 33444455556666666665541 22334444555
Q ss_pred CcEEEeecccCcccCchhhhcCCC---ccEEEecCCcc
Q 047196 269 LENLVLGFNNLVGVVPAAIFNMST---VKKIYLLDNSL 303 (827)
Q Consensus 269 L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~l~~n~l 303 (827)
|++|++++|.+.+..+..+..+.. |+.|++++|.+
T Consensus 83 L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~ 120 (319)
T cd00116 83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGL 120 (319)
T ss_pred eeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCcc
Confidence 555555555555444444333333 44444444443
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.1e-18 Score=176.63 Aligned_cols=148 Identities=22% Similarity=0.329 Sum_probs=114.2
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCcee--e
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCA---MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKA--L 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~--l 748 (827)
..|..-++||+|+||.||-++. .+|+.+|.|++.+... +...-...|-++|.++..+.||.+..++...+..- +
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 4578889999999999999975 5799999999865432 22334678999999999999999887776665332 2
Q ss_pred eeec----------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 749 DCLH----------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 749 ~~l~----------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
..+. .....++..+..-+|.+|+.||++| |..+||.||+||+||| |.|+|--+....
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehl---H~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHL---HRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHH---HhcceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 2221 1234567777788999999999999 5788999999999999 888887776554
Q ss_pred ccccccceecccccccccC
Q 047196 809 SMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~~~~~~gt~~Y~APE~l 827 (827)
.. +..+||.|||||||+
T Consensus 342 ~~--~~rvGT~GYMAPEvl 358 (591)
T KOG0986|consen 342 PI--RGRVGTVGYMAPEVL 358 (591)
T ss_pred cc--ccccCcccccCHHHH
Confidence 43 345799999999985
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.1e-17 Score=177.66 Aligned_cols=143 Identities=20% Similarity=0.270 Sum_probs=107.3
Q ss_pred ceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCceeeeeeccCC
Q 047196 681 NLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFKALDCLHSTN 755 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~l~~l~~~~ 755 (827)
+.||+|+||+||+|+.. +++.||||+++... ....+.+..|.++++.. +||||+++++++...+..++...+...
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 57899999987542 12345567788888764 899999999998877665443333221
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccccc
Q 047196 756 ----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTET 815 (827)
Q Consensus 756 ----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~~ 815 (827)
..+++.+...++.++++|++||| +++|+||||||+||+ |||+++........ ....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~ 156 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc-eeee
Confidence 24566777889999999999995 678999999999998 99998754222111 1234
Q ss_pred eecccccccccC
Q 047196 816 LVTIGYMAPGLL 827 (827)
Q Consensus 816 ~gt~~Y~APE~l 827 (827)
.||+.|||||++
T Consensus 157 ~gt~~y~aPE~~ 168 (316)
T cd05619 157 CGTPDYIAPEIL 168 (316)
T ss_pred cCCccccCHHHH
Confidence 589999999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.4e-18 Score=170.92 Aligned_cols=152 Identities=29% Similarity=0.353 Sum_probs=108.8
Q ss_pred HhhcccccceEecCCceEEEEEEec---C--CcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLH---D--GIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF 745 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~---~--g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~ 745 (827)
....|+....||+|.||.||||..+ + .+.+|+|+++... .......-||+.+++.++|+|+|.+...+...+.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 3456888899999999999999643 2 2379999996542 1223456789999999999999998877655332
Q ss_pred -eeeeeecc------------C--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee--------------
Q 047196 746 -KALDCLHS------------T--NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------- 796 (827)
Q Consensus 746 -~~l~~l~~------------~--~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------------- 796 (827)
..+.+.+. . ...+.-.....|..|+..|+.||| +.=|+||||||+||+
T Consensus 102 ~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 102 KVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred eEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEee
Confidence 22211111 1 122333445678899999999995 667999999999998
Q ss_pred eecccccccCCCcc--ccccceecccccccccC
Q 047196 797 DFGIGRLLTGDRSM--IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~l 827 (827)
|+|+||++...-.. .....+.|++|.|||.+
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELL 211 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELL 211 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHh
Confidence 99999998643221 12335589999999974
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.2e-17 Score=175.70 Aligned_cols=141 Identities=26% Similarity=0.288 Sum_probs=107.7
Q ss_pred EecCCceEEEEEEec-CCcEEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeeccC----
Q 047196 683 IGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA---MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHST---- 754 (827)
Q Consensus 683 iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~---- 754 (827)
||+|+||+||+++.. +|+.||||++..... ...+.+..|++++++++|+|++++.+++......++...+..
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999864 689999999865322 233567889999999999999999988877665444222211
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccccc
Q 047196 755 ----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTE 814 (827)
Q Consensus 755 ----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~ 814 (827)
...+++.....++.|++.|++||| +.+|+||||||+||+ |||+++.+...... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence 124567777889999999999995 678999999999997 99999766433221 122
Q ss_pred ceecccccccccC
Q 047196 815 TLVTIGYMAPGLL 827 (827)
Q Consensus 815 ~~gt~~Y~APE~l 827 (827)
..||+.|+|||++
T Consensus 157 ~~g~~~y~aPE~~ 169 (280)
T cd05608 157 YAGTPGFMAPELL 169 (280)
T ss_pred cCCCcCccCHHHh
Confidence 3589999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.3e-17 Score=188.77 Aligned_cols=153 Identities=24% Similarity=0.316 Sum_probs=112.8
Q ss_pred HHhhcccccceEecCCceEEEEEEe-cCCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc---
Q 047196 672 RATEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF--- 745 (827)
Q Consensus 672 ~~~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~--- 745 (827)
...++|...+.||+|+||.||+|+. .+|+.||||++... .......+.+|+.++..++|+|+|+....+...+.
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3456899999999999999999985 57899999998653 23445678899999999999999998776543221
Q ss_pred -----e--eeeeeccC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------
Q 047196 746 -----K--ALDCLHST------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---------- 796 (827)
Q Consensus 746 -----~--~l~~l~~~------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---------- 796 (827)
. .+++.... ...+.......++.+++.||.|+| +++|+||||||+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEE
Confidence 1 12222111 123455566778899999999995 678999999999998
Q ss_pred eecccccccCCCcc-ccccceecccccccccC
Q 047196 797 DFGIGRLLTGDRSM-IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l 827 (827)
|||+++.+...... .....+||++|||||++
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~ 217 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIW 217 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHh
Confidence 99999876433221 12234589999999974
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.3e-17 Score=178.08 Aligned_cols=143 Identities=31% Similarity=0.355 Sum_probs=105.0
Q ss_pred ceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHH-HHHhcCCCCceEEEeeeecCCceeeeeeccC-
Q 047196 681 NLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECE-VMKNIRHRNHVKRISSCSNEDFKALDCLHST- 754 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~-~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~- 754 (827)
++||+|+||+||+|+.. +|+.||||++.... ....+++.+|.. +++.++|||||++++++...+..++...+..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999864 68999999986432 122344555554 5688999999999998877765544332222
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccccc
Q 047196 755 ---------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTET 815 (827)
Q Consensus 755 ---------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~~ 815 (827)
...+.+.....++.++++||+||| +.+|+||||||+||| |||+++....... .....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 156 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-TTSTF 156 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-ccccc
Confidence 123556667789999999999995 678999999999998 9999875432222 12234
Q ss_pred eecccccccccC
Q 047196 816 LVTIGYMAPGLL 827 (827)
Q Consensus 816 ~gt~~Y~APE~l 827 (827)
+||+.|||||++
T Consensus 157 ~gt~~y~aPE~~ 168 (323)
T cd05575 157 CGTPEYLAPEVL 168 (323)
T ss_pred cCChhhcChhhh
Confidence 589999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.6e-17 Score=174.30 Aligned_cols=150 Identities=27% Similarity=0.410 Sum_probs=111.8
Q ss_pred hcccccceEecCCceEEEEEEe-----cCCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-----HDGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-----~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l 748 (827)
.+|+..+.||+|+||.||+|+. .++..||+|.+.... ....++|.+|++++++++|+|+|++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3567778999999999999974 246789999986432 3345679999999999999999999999877665443
Q ss_pred eeeccCC---------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----
Q 047196 749 DCLHSTN---------------------------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----- 796 (827)
Q Consensus 749 ~~l~~~~---------------------------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----- 796 (827)
...+... ..+++.+...++.+++.|++||| +++|+||||||+||+
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence 2222111 12456667889999999999996 568999999999998
Q ss_pred -----eecccccccCCCc-cccccceecccccccccC
Q 047196 797 -----DFGIGRLLTGDRS-MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 -----DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l 827 (827)
|||+++....... .......++..|+|||++
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 198 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAI 198 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHh
Confidence 9999986543322 112223367789999973
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.8e-17 Score=178.37 Aligned_cols=143 Identities=24% Similarity=0.283 Sum_probs=107.9
Q ss_pred ceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCceeeeeeccC-
Q 047196 681 NLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFKALDCLHST- 754 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~l~~l~~~- 754 (827)
++||+|+||.||+|+.+ +++.||||++.... ....+.+.+|++++..+ +|||++++++++...+..++...+..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 68999999986532 22345678899998877 69999999999877765544332221
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccccc
Q 047196 755 ---------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTET 815 (827)
Q Consensus 755 ---------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~~ 815 (827)
...++......++.+++.||+||| +++|+||||||+||+ |||+++........ ....
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~-~~~~ 156 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT-TSTF 156 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc-cccc
Confidence 234566677789999999999995 678999999999998 99998754322211 2234
Q ss_pred eecccccccccC
Q 047196 816 LVTIGYMAPGLL 827 (827)
Q Consensus 816 ~gt~~Y~APE~l 827 (827)
.||+.|||||++
T Consensus 157 ~gt~~y~aPE~~ 168 (320)
T cd05590 157 CGTPDYIAPEIL 168 (320)
T ss_pred ccCccccCHHHH
Confidence 589999999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.72 E-value=5e-17 Score=173.38 Aligned_cols=146 Identities=23% Similarity=0.314 Sum_probs=111.8
Q ss_pred ccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 677 FSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
|+..+.||+|+||+||+|+. .+++.||||++.... ....+.+.+|++++++++|++++++.+++..++...+...+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 55678899999999999986 468999999986532 12234578899999999999999999888777655442222
Q ss_pred cC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 753 ST------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 753 ~~------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
.. ...+.+.....++.|++.|+.||| +++|+||||||+||+ |||+++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES- 157 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence 11 124667778899999999999995 678999999999988 9998876532221
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
.....|+..|+|||++
T Consensus 158 -~~~~~g~~~~~aPE~~ 173 (285)
T cd05632 158 -IRGRVGTVGYMAPEVL 173 (285)
T ss_pred -ccCCCCCcCccChHHh
Confidence 1234589999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.9e-17 Score=176.40 Aligned_cols=149 Identities=26% Similarity=0.384 Sum_probs=110.2
Q ss_pred cccccceEecCCceEEEEEEec------CCcEEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH------DGIEVAIKVFHQNCA-MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL 748 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l 748 (827)
+|...+.||+|+||.||+|+.. ++..||||++..... ...+.|.+|++++++++|||||++++++.......+
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4566788999999999999753 257899999875432 334678999999999999999999999876654433
Q ss_pred eeeccC--------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee------
Q 047196 749 DCLHST--------------------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------ 796 (827)
Q Consensus 749 ~~l~~~--------------------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------ 796 (827)
...+.. ...+.+.....++.++++|++|+| +++|+||||||+||+
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCc
Confidence 211110 123566677889999999999995 678999999999998
Q ss_pred ----eecccccccCCCccc-cccceecccccccccC
Q 047196 797 ----DFGIGRLLTGDRSMI-QTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 ----DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l 827 (827)
|||+++......... .....+++.|+|||++
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 198 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAI 198 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHH
Confidence 999988664332211 1222357899999963
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.72 E-value=5e-17 Score=170.98 Aligned_cols=150 Identities=27% Similarity=0.439 Sum_probs=114.6
Q ss_pred hhcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
.++|+..+.||+|+||.||+|...+++.||||.++... ...++|.+|++++++++|+|++++++++...+..++...+.
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 35688889999999999999998777889999986543 23467899999999999999999999987766544422221
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 754 ------------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 754 ------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
....+++.....++.+++.|+.||| +++|+||||||+||+ |||+++.........
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 1124678888999999999999995 568999999999988 999998765332211
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
.....++..|+|||++
T Consensus 161 ~~~~~~~~~y~aPE~~ 176 (261)
T cd05068 161 REGAKFPIKWTAPEAA 176 (261)
T ss_pred cCCCcCceeccCcccc
Confidence 1111234689999973
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.4e-17 Score=177.39 Aligned_cols=143 Identities=21% Similarity=0.294 Sum_probs=106.9
Q ss_pred ceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCceeeeeeccC-
Q 047196 681 NLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFKALDCLHST- 754 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~l~~l~~~- 754 (827)
++||+|+||.||+|+.+ +|+.||||+++... ....+.+..|++++... +|++++++++++...+..++...+..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999875 68999999986532 12345567788888765 89999999999887775554332222
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccccc
Q 047196 755 ---------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTET 815 (827)
Q Consensus 755 ---------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~~ 815 (827)
...+++.....++.++++|++||| +.+|+||||||+||+ |||+++....... .....
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 156 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-RASTF 156 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-ceecc
Confidence 124566677789999999999995 678999999999998 9999875322221 12234
Q ss_pred eecccccccccC
Q 047196 816 LVTIGYMAPGLL 827 (827)
Q Consensus 816 ~gt~~Y~APE~l 827 (827)
+||++|+|||++
T Consensus 157 ~gt~~y~aPE~~ 168 (316)
T cd05620 157 CGTPDYIAPEIL 168 (316)
T ss_pred CCCcCccCHHHH
Confidence 589999999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.3e-17 Score=173.97 Aligned_cols=152 Identities=25% Similarity=0.368 Sum_probs=113.1
Q ss_pred HhhcccccceEecCCceEEEEEEec------CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLH------DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF 745 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~ 745 (827)
..++|+..+.||+|+||.||+|... .++.||||++.... .....+|.+|+.++++++|+|+|++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567899999999999999999753 25679999986432 3345678999999999999999999999877665
Q ss_pred eeeeeeccCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------
Q 047196 746 KALDCLHSTN--------------------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF--------- 796 (827)
Q Consensus 746 ~~l~~l~~~~--------------------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl--------- 796 (827)
.++...+... ...++.....++.++++|++||| +++++||||||+||+
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence 4442222111 12356667889999999999996 578999999999998
Q ss_pred -eecccccccCCCccc-cccceecccccccccC
Q 047196 797 -DFGIGRLLTGDRSMI-QTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 -DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l 827 (827)
|||+++......... .....+++.|||||++
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 193 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL 193 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHh
Confidence 999987654322211 1122357889999974
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.9e-17 Score=172.32 Aligned_cols=150 Identities=24% Similarity=0.401 Sum_probs=114.4
Q ss_pred hcccccceEecCCceEEEEEEec----CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH----DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALD 749 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~ 749 (827)
++|+..+.||+|+||+||+|+++ +...||||+++... ....++|.+|+.++++++|+|++++++++...+..++.
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 56888899999999999999864 24579999986543 33456799999999999999999999998776655443
Q ss_pred eeccC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 750 CLHST-----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 750 ~l~~~-----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
..+.. ...+.+.....++.+++.|++||| +++|+||||||+||+ |||+++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 22221 234677888899999999999995 678999999999998 999998775222
Q ss_pred cccc-ccceecccccccccC
Q 047196 809 SMIQ-TETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~~-~~~~gt~~Y~APE~l 827 (827)
.... ....++..|+|||++
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~ 180 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAI 180 (266)
T ss_pred cceeccCCCCCccccChhhh
Confidence 2111 112246789999963
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.72 E-value=4e-17 Score=175.07 Aligned_cols=150 Identities=24% Similarity=0.345 Sum_probs=113.3
Q ss_pred hcccccceEecCCceEEEEEEecC-----------------CcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEE
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHD-----------------GIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKR 736 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~-----------------g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~ 736 (827)
++|+..+.||+|+||.||+|+..+ +..||+|++.... ....++|.+|++++++++|+|++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 568888999999999999987532 2468999987543 3456789999999999999999999
Q ss_pred EeeeecCCceeeeeeccCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCcce
Q 047196 737 ISSCSNEDFKALDCLHSTN---------------------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNV 795 (827)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~~---------------------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NI 795 (827)
++++..++..++...+... ..+.+.....++.+++.|++||| +.+|+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhce
Confidence 9999876654443222111 14567778899999999999996 56899999999998
Q ss_pred e----------eecccccccCCCcc-ccccceecccccccccC
Q 047196 796 F----------DFGIGRLLTGDRSM-IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 796 l----------DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l 827 (827)
+ |||+++........ ......+++.|||||++
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 204 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESV 204 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHh
Confidence 8 99998765433221 11223367899999963
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.5e-18 Score=180.46 Aligned_cols=149 Identities=24% Similarity=0.375 Sum_probs=114.5
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc-eee--
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF-KAL-- 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~-~~l-- 748 (827)
++|...+++|+|+||.++..+.+ ++..|++|++.... ....+...+|+.++++++|||||.+.+.+.+.+. ..+
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56788899999999999998754 57899999986543 3334567899999999999999999999887765 333
Q ss_pred eeeccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 749 DCLHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 749 ~~l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
++..++. ..+...+......|+..|+.||| +..|+|||||+.||+ |||+||.+..+.
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 3333221 11223344567788888888885 677999999999998 999999998776
Q ss_pred ccccccceecccccccccC
Q 047196 809 SMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~~~~~~gt~~Y~APE~l 827 (827)
..+ .+.+||+.||.||++
T Consensus 161 ~~a-~tvvGTp~YmcPEil 178 (426)
T KOG0589|consen 161 SLA-STVVGTPYYMCPEIL 178 (426)
T ss_pred hhh-heecCCCcccCHHHh
Confidence 443 336699999999974
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.3e-17 Score=177.39 Aligned_cols=143 Identities=28% Similarity=0.314 Sum_probs=103.8
Q ss_pred ceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHH-HHHHhcCCCCceEEEeeeecCCceeeeeeccCC
Q 047196 681 NLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAEC-EVMKNIRHRNHVKRISSCSNEDFKALDCLHSTN 755 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei-~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~~ 755 (827)
+.||+|+||.||+|+.. +++.||+|++.... .....++.+|. .+++.++|+|||++++++...+..++...+...
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999865 57889999986532 12223444454 457889999999999998877755543333222
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccccc
Q 047196 756 ----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTET 815 (827)
Q Consensus 756 ----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~~ 815 (827)
..+.......++.++++||+||| +.+|+||||||+||+ |||+++....... .....
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~~~~ 156 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTSTF 156 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Ccccc
Confidence 22444555678999999999995 678999999999998 9999976432222 12234
Q ss_pred eecccccccccC
Q 047196 816 LVTIGYMAPGLL 827 (827)
Q Consensus 816 ~gt~~Y~APE~l 827 (827)
+||+.|||||++
T Consensus 157 ~gt~~y~aPE~~ 168 (325)
T cd05602 157 CGTPEYLAPEVL 168 (325)
T ss_pred cCCccccCHHHH
Confidence 589999999963
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.7e-17 Score=177.18 Aligned_cols=143 Identities=24% Similarity=0.243 Sum_probs=108.9
Q ss_pred ceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCceeeeeeccC-
Q 047196 681 NLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFKALDCLHST- 754 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~l~~l~~~- 754 (827)
++||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.++.++ +|++++++++++...+..++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999864 57899999997542 23345688999999988 59999999998877665444332221
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccccc
Q 047196 755 ---------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTET 815 (827)
Q Consensus 755 ---------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~~ 815 (827)
...+.+.....++.++++|++||| +++|+||||||+||+ |||+++........ ....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-~~~~ 156 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT-TSTF 156 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCc-eecc
Confidence 234667778889999999999995 678999999999998 99998753222211 1234
Q ss_pred eecccccccccC
Q 047196 816 LVTIGYMAPGLL 827 (827)
Q Consensus 816 ~gt~~Y~APE~l 827 (827)
+||+.|+|||++
T Consensus 157 ~gt~~y~aPE~~ 168 (327)
T cd05617 157 CGTPNYIAPEIL 168 (327)
T ss_pred cCCcccCCHHHH
Confidence 589999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.5e-17 Score=174.50 Aligned_cols=150 Identities=29% Similarity=0.426 Sum_probs=113.0
Q ss_pred hcccccceEecCCceEEEEEEec-----CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC--ce-
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-----DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNED--FK- 746 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-----~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~--~~- 746 (827)
.+|+..+.||+|+||.||+|+.+ +++.||||++........+.|.+|++++++++|||+|++.+++...+ ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 35777889999999999999742 57899999987666666778999999999999999999999875432 22
Q ss_pred -eeeeecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccC
Q 047196 747 -ALDCLHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806 (827)
Q Consensus 747 -~l~~l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~ 806 (827)
.+++... ....+.+.....++.+++.||+||| +++|+||||||+||+ |||+++....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 2222211 1234677888899999999999995 678999999999998 9999987654
Q ss_pred CCcccc--ccceecccccccccC
Q 047196 807 DRSMIQ--TETLVTIGYMAPGLL 827 (827)
Q Consensus 807 ~~~~~~--~~~~gt~~Y~APE~l 827 (827)
...... ....++..|+|||++
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~ 183 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESL 183 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHh
Confidence 332111 111235569999963
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.1e-17 Score=174.48 Aligned_cols=150 Identities=25% Similarity=0.407 Sum_probs=110.6
Q ss_pred hcccccceEecCCceEEEEEEec-CCc----EEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGI----EVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~----~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l 748 (827)
++|+..+.||+|+||.||+|++. +|+ .||+|.+.... .....++..|+..+++++|||||++++++......++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i 86 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLV 86 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEE
Confidence 46777889999999999999863 444 47888875432 2344678889999999999999999999865543222
Q ss_pred -eeec---------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 749 -DCLH---------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 749 -~~l~---------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
++.. .....+++.....++.|++.|++||| +++++||||||+||+ |||+++......
T Consensus 87 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 87 TQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred EEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence 2211 11234677788899999999999995 678999999999998 999998764332
Q ss_pred ccc-cccceecccccccccC
Q 047196 809 SMI-QTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~-~~~~~gt~~Y~APE~l 827 (827)
... .....++.+|+|||++
T Consensus 164 ~~~~~~~~~~~~~y~~pE~~ 183 (279)
T cd05111 164 KKYFYSEHKTPIKWMALESI 183 (279)
T ss_pred cccccCCCCCcccccCHHHh
Confidence 211 1223367899999963
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.8e-17 Score=177.59 Aligned_cols=148 Identities=21% Similarity=0.199 Sum_probs=109.5
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCC-CCceEEEeeeecCCceeeee
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRH-RNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H-~niv~~~~~~~~~~~~~l~~ 750 (827)
+|+..++||+|+||.||+|+.. +|+.||||++.... ....+.+..|+++++.+.| ++++++.+++...+..++..
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3667789999999999999864 68999999987532 2234567889999998876 55667777776665544432
Q ss_pred eccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 751 LHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 751 l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
.+.. ...+.+.+...++.+++.|++||| +++|+||||||+||+ |||+++........
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence 2221 134677788899999999999996 678999999999997 99998764332221
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
.....||+.|||||++
T Consensus 158 -~~~~~gt~~y~aPE~~ 173 (323)
T cd05615 158 -TRTFCGTPDYIAPEII 173 (323)
T ss_pred -ccCccCCccccCHHHH
Confidence 1224589999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.8e-17 Score=172.35 Aligned_cols=149 Identities=24% Similarity=0.431 Sum_probs=113.6
Q ss_pred hcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee--eeec
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL--DCLH 752 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l--~~l~ 752 (827)
++|...+.||+|+||.||+|+..++..||||.+.... ...++|.+|++++++++|||+++++++|...+..++ ++..
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4577788999999999999998777789999986543 234678999999999999999999999877664443 3221
Q ss_pred c---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccc
Q 047196 753 S---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQT 813 (827)
Q Consensus 753 ~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~ 813 (827)
. ....+.+.....++.+++.|++||| +++|+||||||+||+ |||.++...........
T Consensus 83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05113 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV 159 (256)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence 1 1224677888999999999999995 678999999999998 89988765433221111
Q ss_pred cceecccccccccC
Q 047196 814 ETLVTIGYMAPGLL 827 (827)
Q Consensus 814 ~~~gt~~Y~APE~l 827 (827)
...++..|+|||++
T Consensus 160 ~~~~~~~y~~pe~~ 173 (256)
T cd05113 160 GSKFPVRWSPPEVL 173 (256)
T ss_pred CCccChhhCCHHHH
Confidence 22356789999963
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.7e-17 Score=190.39 Aligned_cols=152 Identities=21% Similarity=0.265 Sum_probs=107.3
Q ss_pred HhhcccccceEecCCceEEEEEEecC--CcEEEEEEEc-----------------ccchHHHHHHHHHHHHHHhcCCCCc
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLHD--GIEVAIKVFH-----------------QNCAMALKSFEAECEVMKNIRHRNH 733 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~~--g~~vAvK~l~-----------------~~~~~~~~~~~~Ei~~l~~l~H~ni 733 (827)
..++|+..+.||+|+||+||+|..+. ++.+++|.+. .........+.+|++++++++|+||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 34679999999999999999987542 3333333110 0111234568899999999999999
Q ss_pred eEEEeeeecCCceeeeeeccC--------C------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---
Q 047196 734 VKRISSCSNEDFKALDCLHST--------N------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF--- 796 (827)
Q Consensus 734 v~~~~~~~~~~~~~l~~l~~~--------~------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl--- 796 (827)
|++++++...+..++...... . ......+...|+.|++.||+||| +++|+||||||+|||
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNC 302 (501)
T ss_pred CcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECC
Confidence 999999987765544221110 0 11123345679999999999996 678999999999998
Q ss_pred -------eecccccccCCCccccccceecccccccccC
Q 047196 797 -------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 -------DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
|||+++.+...........+||+.|+|||++
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~ 340 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEIL 340 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhh
Confidence 9999987754333222234589999999974
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.3e-17 Score=173.33 Aligned_cols=150 Identities=30% Similarity=0.474 Sum_probs=112.2
Q ss_pred hcccccceEecCCceEEEEEEe-cCCc----EEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGI----EVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~----~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l 748 (827)
.+|+..++||+|+||.||+|++ .+|+ .||||++.... ....+++.+|+.+++.++|+|+++++++|.......+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l~ 86 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLV 86 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEEE
Confidence 5678889999999999999985 3454 48999986543 3445678999999999999999999999876543222
Q ss_pred -eeec---------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 749 -DCLH---------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 749 -~~l~---------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
++.. .....+.+...+.++.++++|++||| +++|+||||||+||+ |||+++......
T Consensus 87 ~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~ 163 (279)
T cd05109 87 TQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE 163 (279)
T ss_pred EEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeeccccc
Confidence 2221 11234677788899999999999995 678999999999998 999998765332
Q ss_pred cccc-ccceecccccccccC
Q 047196 809 SMIQ-TETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~~-~~~~gt~~Y~APE~l 827 (827)
.... ....+++.|+|||++
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~ 183 (279)
T cd05109 164 TEYHADGGKVPIKWMALESI 183 (279)
T ss_pred ceeecCCCccchhhCCHHHh
Confidence 2111 112246789999963
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.8e-17 Score=174.31 Aligned_cols=138 Identities=21% Similarity=0.319 Sum_probs=102.5
Q ss_pred eEecCCceEEEEEEecC-------------------------CcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEE
Q 047196 682 LIGVGSFGSVYKGRLHD-------------------------GIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKR 736 (827)
Q Consensus 682 ~iG~G~fg~Vy~~~~~~-------------------------g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~ 736 (827)
.||+|+||.||+|.+.. ...||||++........++|.+|++++++++|||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997421 14589999865544445678999999999999999999
Q ss_pred EeeeecCCceeeeeeccC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------
Q 047196 737 ISSCSNEDFKALDCLHST-----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF--------- 796 (827)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~-----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl--------- 796 (827)
+++|.+....++...+.. ...+.+..++.++.|+++|++||| +++|+||||||+||+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence 999988776554332221 234567778899999999999995 678999999999998
Q ss_pred --------eecccccccCCCccccccceecccccccccC
Q 047196 797 --------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 --------DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
|||+++.... .....++..|+|||++
T Consensus 159 ~~~~~kl~d~g~~~~~~~-----~~~~~~~~~~~aPe~~ 192 (274)
T cd05076 159 TSPFIKLSDPGVSFTALS-----REERVERIPWIAPECV 192 (274)
T ss_pred ccceeeecCCcccccccc-----ccccccCCcccCchhh
Confidence 3444322211 1123468889999964
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.8e-17 Score=170.50 Aligned_cols=149 Identities=23% Similarity=0.329 Sum_probs=115.9
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
.+|+..+.||+|+||.||+|+. .+|+.||+|++..........+.+|+.++++++|+|++++++++..++..++...+.
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4688889999999999999986 568899999987554444567889999999999999999999988776555433322
Q ss_pred C----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccc
Q 047196 754 T----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQT 813 (827)
Q Consensus 754 ~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~ 813 (827)
. ...+++.+...++.++++|++||| +.+|+|||+||+||+ |||+++........ ..
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~-~~ 164 (267)
T cd06646 89 GGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK-RK 164 (267)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecccccc-cC
Confidence 2 224566677889999999999995 578999999999987 99998766432211 12
Q ss_pred cceecccccccccC
Q 047196 814 ETLVTIGYMAPGLL 827 (827)
Q Consensus 814 ~~~gt~~Y~APE~l 827 (827)
...|++.|+|||++
T Consensus 165 ~~~~~~~y~~PE~~ 178 (267)
T cd06646 165 SFIGTPYWMAPEVA 178 (267)
T ss_pred ccccCccccCHhHc
Confidence 23588999999963
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.1e-17 Score=179.72 Aligned_cols=150 Identities=31% Similarity=0.548 Sum_probs=115.7
Q ss_pred hcccccceEecCCceEEEEEEec---CC--cEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC-cee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH---DG--IEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNED-FKA 747 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~---~g--~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~-~~~ 747 (827)
+.....++||+|.||.||+|.+. .| ..||||.-+.++ ....+.|.+|.-+|++++|||||+++|.|.+.. +..
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~Wiv 468 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIV 468 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEE
Confidence 34455678999999999999863 23 348899887644 445678999999999999999999999998765 333
Q ss_pred ee---------eeccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 748 LD---------CLHSTNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 748 l~---------~l~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
|+ ++......++......++.|++.+|+|| ++.+.|||||...||| |||++|-+.++.
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYL---eSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYL---ESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHH---HhhchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 42 3333445677777788999999999999 5788999999999999 999999887654
Q ss_pred ccccccceecccccccccC
Q 047196 809 SMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~~~~~~gt~~Y~APE~l 827 (827)
....+...-.+.|||||-+
T Consensus 546 yYkaS~~kLPIKWmaPESI 564 (974)
T KOG4257|consen 546 YYKASRGKLPIKWMAPESI 564 (974)
T ss_pred hhhccccccceeecCcccc
Confidence 4322211236789999964
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.8e-17 Score=170.69 Aligned_cols=149 Identities=31% Similarity=0.507 Sum_probs=113.8
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
.+|...+.||+|+||.||+|... .++.||+|++.... ...+++.+|++++++++|+|++++++++..++..++...+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 35777889999999999999864 58899999986543 34567899999999999999999999987766544322221
Q ss_pred C------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 754 T------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 754 ~------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
. ...+.+..+..++.++++|++||| +.+|+||||||+||+ |||+++.........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 1 124677788899999999999995 678999999999988 999988765432221
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
.....++.+|+|||++
T Consensus 162 ~~~~~~~~~y~aPE~~ 177 (263)
T cd05052 162 HAGAKFPIKWTAPESL 177 (263)
T ss_pred cCCCCCccccCCHHHh
Confidence 1112246789999963
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.1e-17 Score=172.36 Aligned_cols=150 Identities=27% Similarity=0.430 Sum_probs=115.2
Q ss_pred hcccccceEecCCceEEEEEEec------CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH------DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l 748 (827)
++|...+.||+|+||.||+|+.. ++..||+|.+........+.+.+|++++++++|+|++++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45777889999999999999742 356799999876655566789999999999999999999999987765544
Q ss_pred eeeccC--------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee------
Q 047196 749 DCLHST--------------------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------ 796 (827)
Q Consensus 749 ~~l~~~--------------------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------ 796 (827)
...+.. ...+++..+..++.+++.|++||| +++|+||||||+||+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence 322221 123677788999999999999995 678999999999997
Q ss_pred ----eecccccccCCCcc-ccccceecccccccccC
Q 047196 797 ----DFGIGRLLTGDRSM-IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 ----DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l 827 (827)
|||+++........ ......++..|+|||++
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 197 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI 197 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHh
Confidence 99998765432211 11223468899999963
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.9e-17 Score=171.45 Aligned_cols=146 Identities=21% Similarity=0.333 Sum_probs=111.7
Q ss_pred ccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 677 FSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
|+..++||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++++++|++++++.+.+...+..++...+
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667788999999999999864 68999999986432 22234678899999999999999999998877655443322
Q ss_pred cCC------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 753 STN------------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 753 ~~~------------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
... ..+.......++.+++.|+.||| +++|+||||||+||+ |||++.........
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 158 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc
Confidence 211 23556677889999999999995 678999999999987 99998765432221
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
....||..|||||++
T Consensus 159 --~~~~g~~~y~aPE~~ 173 (285)
T cd05630 159 --KGRVGTVGYMAPEVV 173 (285)
T ss_pred --cCCCCCccccChHHH
Confidence 223589999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.5e-17 Score=175.39 Aligned_cols=143 Identities=22% Similarity=0.246 Sum_probs=108.8
Q ss_pred ceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCceeeeeeccC-
Q 047196 681 NLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFKALDCLHST- 754 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~l~~l~~~- 754 (827)
++||+|+||+||+|+.+ +++.||||++.... ......+.+|+++++.+ +|||++++++++...+..++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 57899999997542 22345678899999888 69999999999877765544333221
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccccc
Q 047196 755 ---------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTET 815 (827)
Q Consensus 755 ---------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~~ 815 (827)
...+.+.....++.+++.||+||| +.+|+||||||+||+ |||+++........ ....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~ 156 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT-TSTF 156 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc-ccce
Confidence 224677778889999999999995 678999999999998 99998753222211 1224
Q ss_pred eecccccccccC
Q 047196 816 LVTIGYMAPGLL 827 (827)
Q Consensus 816 ~gt~~Y~APE~l 827 (827)
+||+.|||||++
T Consensus 157 ~g~~~y~aPE~~ 168 (318)
T cd05570 157 CGTPDYIAPEIL 168 (318)
T ss_pred ecCccccCHHHh
Confidence 589999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.3e-17 Score=171.81 Aligned_cols=147 Identities=26% Similarity=0.350 Sum_probs=115.3
Q ss_pred ccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeeccC-
Q 047196 677 FSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHST- 754 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~- 754 (827)
|+..+.||+|+||.||+|+.. ++..+|+|.+........+.+.+|++++++++|+|++++++++......++...+..
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 456678999999999999865 578899999876655666789999999999999999999999887765544332221
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccccc
Q 047196 755 ----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTE 814 (827)
Q Consensus 755 ----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~ 814 (827)
...+.+.....++.++++||+||| +.+|+||||||+||+ |||+++....... ....
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~ 162 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRDS 162 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccccc-cccc
Confidence 234677788899999999999996 578999999999997 9999876533221 1122
Q ss_pred ceecccccccccC
Q 047196 815 TLVTIGYMAPGLL 827 (827)
Q Consensus 815 ~~gt~~Y~APE~l 827 (827)
..+++.|+|||++
T Consensus 163 ~~~~~~y~aPE~~ 175 (282)
T cd06643 163 FIGTPYWMAPEVV 175 (282)
T ss_pred ccccccccCHhhc
Confidence 4589999999974
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.7e-17 Score=171.43 Aligned_cols=148 Identities=27% Similarity=0.412 Sum_probs=111.9
Q ss_pred cccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeeccC-
Q 047196 676 KFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHST- 754 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~- 754 (827)
+|+..+.||+|+||.||+|+.+++..+|||++..... ....|.+|++++++++|+|++++++++...+..++...+..
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 4677889999999999999987778899999864322 33568899999999999999999999877665544322211
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccccc
Q 047196 755 ----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTE 814 (827)
Q Consensus 755 ----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~ 814 (827)
...+.+.....++.++++|++||| +.+|+||||||+||+ |||+++............
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (256)
T cd05059 84 GCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG 160 (256)
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccccccCC
Confidence 224567778899999999999995 678999999999987 999987654322111111
Q ss_pred ceecccccccccC
Q 047196 815 TLVTIGYMAPGLL 827 (827)
Q Consensus 815 ~~gt~~Y~APE~l 827 (827)
..++..|+|||++
T Consensus 161 ~~~~~~y~~Pe~~ 173 (256)
T cd05059 161 TKFPVKWAPPEVF 173 (256)
T ss_pred CCCCccccCHHHh
Confidence 1245689999963
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.7e-17 Score=185.32 Aligned_cols=151 Identities=22% Similarity=0.286 Sum_probs=106.9
Q ss_pred HHHHhhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCC------ceEEEeeeec
Q 047196 670 LFRATEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRN------HVKRISSCSN 742 (827)
Q Consensus 670 ~~~~~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~n------iv~~~~~~~~ 742 (827)
+...+++|+..++||+|+||+||+|... +++.||||+++... ...+.+..|++++++++|.+ ++++.+++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3345678999999999999999999864 57899999986432 23445677888888887654 7788887765
Q ss_pred CCc-eeeeeecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------------
Q 047196 743 EDF-KALDCLHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---------------- 796 (827)
Q Consensus 743 ~~~-~~l~~l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---------------- 796 (827)
+.. .++..... ....+.+.....|+.|+++||+|||. +.+||||||||+|||
T Consensus 203 ~~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 203 ETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred CCceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCccccccccccc
Confidence 432 22211111 12346677778899999999999973 358999999999987
Q ss_pred ----------eecccccccCCCccccccceecccccccccC
Q 047196 797 ----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 ----------DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
|||.+.... ...+..+||++|||||++
T Consensus 281 ~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~ 317 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVV 317 (467)
T ss_pred CCCCceEEECCCCccccCc----cccccccCCccccCcHHh
Confidence 455443211 112334689999999974
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.5e-17 Score=171.26 Aligned_cols=140 Identities=24% Similarity=0.315 Sum_probs=106.5
Q ss_pred EecCCceEEEEEEec-CCcEEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeeccCC---
Q 047196 683 IGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA---MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHSTN--- 755 (827)
Q Consensus 683 iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~~--- 755 (827)
||+|+||.||+++.+ +|+.||+|++..... ...+.+..|++++++++|||++++.+++......++...+...
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999864 689999999864321 1234566799999999999999999988777655443333221
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccccce
Q 047196 756 ---------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETL 816 (827)
Q Consensus 756 ---------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~~~ 816 (827)
..+++.....++.+++.|++||| +++|+||||||+||+ |||++........ .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eeccC
Confidence 23566677789999999999995 678999999999998 9999876643321 12235
Q ss_pred ecccccccccC
Q 047196 817 VTIGYMAPGLL 827 (827)
Q Consensus 817 gt~~Y~APE~l 827 (827)
||..|+|||++
T Consensus 156 ~~~~y~aPE~~ 166 (277)
T cd05607 156 GTNGYMAPEIL 166 (277)
T ss_pred CCCCccCHHHH
Confidence 89999999973
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.7e-17 Score=168.28 Aligned_cols=144 Identities=28% Similarity=0.425 Sum_probs=109.3
Q ss_pred ceEecCCceEEEEEEecCCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeeccC-----
Q 047196 681 NLIGVGSFGSVYKGRLHDGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHST----- 754 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~----- 754 (827)
++||+|+||.||+|...++..||+|++.... ......|.+|++++++++|+|++++++.|...+..++...+..
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999999998888999999986543 3334578999999999999999999999987765444332221
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccccceec
Q 047196 755 ------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVT 818 (827)
Q Consensus 755 ------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~~~gt 818 (827)
...+++.....++.++++++.|+| +++++||||||+||+ |||+++..............++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 224567788899999999999995 678999999999988 9998875432221111112246
Q ss_pred ccccccccC
Q 047196 819 IGYMAPGLL 827 (827)
Q Consensus 819 ~~Y~APE~l 827 (827)
+.|+|||++
T Consensus 158 ~~y~aPE~~ 166 (250)
T cd05085 158 IKWTAPEAL 166 (250)
T ss_pred ccccCHHHh
Confidence 789999973
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.70 E-value=9e-17 Score=171.17 Aligned_cols=150 Identities=31% Similarity=0.519 Sum_probs=112.0
Q ss_pred hcccccceEecCCceEEEEEEecC------CcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCcee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHD------GIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKA 747 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~------g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~ 747 (827)
++|+..+.||+|+||.||+|.... ...||+|.+.... ....++|.+|++++++++|||++++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467778899999999999998542 2579999986543 334567999999999999999999999987765443
Q ss_pred eeeeccCC--------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----
Q 047196 748 LDCLHSTN--------------------------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----- 796 (827)
Q Consensus 748 l~~l~~~~--------------------------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----- 796 (827)
+...+... ..+++.....++.++++|++||| +.+|+||||||+||+
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence 32221111 23556667889999999999995 568999999999997
Q ss_pred -----eecccccccCCCc-cccccceecccccccccC
Q 047196 797 -----DFGIGRLLTGDRS-MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 -----DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l 827 (827)
|||+++....... .......+++.|||||++
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 198 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAI 198 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHh
Confidence 9999876533221 112223468899999963
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.1e-17 Score=190.73 Aligned_cols=154 Identities=23% Similarity=0.332 Sum_probs=115.0
Q ss_pred HHhhcccccceEecCCceEEEEEEec-CCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC--c-
Q 047196 672 RATEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNED--F- 745 (827)
Q Consensus 672 ~~~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~--~- 745 (827)
....+|...+.||+|+||.||+|+.. ++..||+|++... .......|.+|+.++++++|||||++++++.... .
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34567999999999999999999864 5788999998643 2334567899999999999999999999875432 2
Q ss_pred -eeeeeeccC------------CCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCeEEccCCCccee------------
Q 047196 746 -KALDCLHST------------NCSLNIFDKLNIMIDVASALEYLHFSH----STPVIHCDLKPKNVF------------ 796 (827)
Q Consensus 746 -~~l~~l~~~------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h----~~~iiHrDlK~~NIl------------ 796 (827)
.+++++... ...+.+.....|+.||+.||+|||... .++||||||||+|||
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 223333211 134667778899999999999998643 257999999999986
Q ss_pred ---------------eecccccccCCCccccccceecccccccccC
Q 047196 797 ---------------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 ---------------DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
|||+++.+..... ....+||+.|+|||++
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL 213 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELL 213 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHH
Confidence 6777765532211 1234589999999974
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.5e-17 Score=170.53 Aligned_cols=148 Identities=25% Similarity=0.459 Sum_probs=112.1
Q ss_pred hcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCce-eeeeecc
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFK-ALDCLHS 753 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~-~l~~l~~ 753 (827)
++|+..+.||+|+||.||+|...++..||+|.+..... ..+.|.+|++++++++|++++++++++.+.... .+++...
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~ 84 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMSK 84 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecCC
Confidence 46777889999999999999988888899999865432 345789999999999999999999987554322 2222211
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccc
Q 047196 754 ----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQT 813 (827)
Q Consensus 754 ----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~ 813 (827)
....+++.++..++.+++.|++||| +++|+||||||+||+ |||+++.+.........
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05070 85 GSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQ 161 (260)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccccccc
Confidence 1224677888999999999999996 567999999999987 99998776433222112
Q ss_pred cceeccccccccc
Q 047196 814 ETLVTIGYMAPGL 826 (827)
Q Consensus 814 ~~~gt~~Y~APE~ 826 (827)
...++..|+|||+
T Consensus 162 ~~~~~~~y~aPE~ 174 (260)
T cd05070 162 GAKFPIKWTAPEA 174 (260)
T ss_pred CCCCCccccChHH
Confidence 2235678999996
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.8e-17 Score=171.77 Aligned_cols=150 Identities=29% Similarity=0.452 Sum_probs=113.8
Q ss_pred hcccccceEecCCceEEEEEEec------CCcEEEEEEEcccchH-HHHHHHHHHHHHHhcCCCCceEEEeeeecCCcee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH------DGIEVAIKVFHQNCAM-ALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKA 747 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~ 747 (827)
++|...+.||+|+||.||+|+.. +++.||||++...... ..+.|.+|++++++++|+|++++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 45777889999999999999763 2478999998754333 4578999999999999999999999998776554
Q ss_pred eeeeccC------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------
Q 047196 748 LDCLHST------------------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------- 796 (827)
Q Consensus 748 l~~l~~~------------------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------- 796 (827)
+...+.. ...+.+.+...++.+++.|++||| +.+|+||||||+||+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence 4332211 123566677889999999999995 678999999999997
Q ss_pred ---eecccccccCCCcc-ccccceecccccccccC
Q 047196 797 ---DFGIGRLLTGDRSM-IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 ---DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l 827 (827)
|||+++........ ......+++.|+|||++
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 196 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESI 196 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhh
Confidence 99998765332211 11223367889999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.9e-17 Score=179.26 Aligned_cols=150 Identities=24% Similarity=0.459 Sum_probs=111.0
Q ss_pred hcccccceEecCCceEEEEEEec------CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcC-CCCceEEEeeeecCCce
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH------DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIR-HRNHVKRISSCSNEDFK 746 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~ 746 (827)
++|...+.||+|+||.||+|+++ .++.||||++.... ....+.+.+|++++.++. |||||+++++|......
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 45777889999999999999853 24689999997543 233457899999999997 99999999999776543
Q ss_pred ee--eeeccC----------------------------------------------------------------------
Q 047196 747 AL--DCLHST---------------------------------------------------------------------- 754 (827)
Q Consensus 747 ~l--~~l~~~---------------------------------------------------------------------- 754 (827)
++ ++....
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 32 221100
Q ss_pred ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee--
Q 047196 755 ------------------------------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-- 796 (827)
Q Consensus 755 ------------------------------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-- 796 (827)
...+++.+...++.+++.|++||| +++|+||||||+||+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEEe
Confidence 012455667789999999999995 678999999999998
Q ss_pred --------eecccccccCCCcc-ccccceecccccccccC
Q 047196 797 --------DFGIGRLLTGDRSM-IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 --------DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l 827 (827)
|||+++........ ......++..|||||++
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~ 313 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESI 313 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHh
Confidence 99999865433221 11223468899999964
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.4e-17 Score=169.71 Aligned_cols=144 Identities=21% Similarity=0.321 Sum_probs=105.4
Q ss_pred ceEecCCceEEEEEEecC---CcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeeccCCC
Q 047196 681 NLIGVGSFGSVYKGRLHD---GIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHSTNC 756 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~~---g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~~~ 756 (827)
+.||+|+||.||+|+..+ +..+|+|+++... ......|.+|++++++++|||++++++++.+....++...+...+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998643 4679999986543 233457899999999999999999999987766544433222211
Q ss_pred ---------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc-
Q 047196 757 ---------------SLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM- 810 (827)
Q Consensus 757 ---------------~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~- 810 (827)
..++.....++.+++.|++||| +.+|+||||||+||+ |||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 2234455678899999999995 678999999999998 99998764332211
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
......++..|+|||++
T Consensus 158 ~~~~~~~~~~y~aPE~~ 174 (269)
T cd05087 158 TPDQLWVPLRWIAPELV 174 (269)
T ss_pred cCCCcCCcccccCHhHh
Confidence 11223468899999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.5e-17 Score=177.90 Aligned_cols=150 Identities=23% Similarity=0.421 Sum_probs=109.6
Q ss_pred hcccccceEecCCceEEEEEEe------cCCcEEEEEEEcccc-hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCce
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL------HDGIEVAIKVFHQNC-AMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFK 746 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~ 746 (827)
++|+..+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|++++.++ +|+|+|+++++|...+..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5688899999999999999973 347889999997543 33456788999999999 689999999988654321
Q ss_pred ---eeeeeccC---------------------------------------------------------------------
Q 047196 747 ---ALDCLHST--------------------------------------------------------------------- 754 (827)
Q Consensus 747 ---~l~~l~~~--------------------------------------------------------------------- 754 (827)
++++....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 22221100
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccc-ccee
Q 047196 755 ------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQT-ETLV 817 (827)
Q Consensus 755 ------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~-~~~g 817 (827)
...+++.+...++.++++|++||| +++|+||||||+||+ |||+++....+...... ...+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 012456667789999999999995 679999999999998 99998875433221111 1225
Q ss_pred cccccccccC
Q 047196 818 TIGYMAPGLL 827 (827)
Q Consensus 818 t~~Y~APE~l 827 (827)
+..|+|||++
T Consensus 244 ~~~y~aPE~~ 253 (343)
T cd05103 244 PLKWMAPETI 253 (343)
T ss_pred CcceECcHHh
Confidence 6789999963
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.8e-17 Score=171.81 Aligned_cols=151 Identities=25% Similarity=0.479 Sum_probs=119.4
Q ss_pred HhhcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
+..+|+..+.||+|+||.||+|...+++.||+|++..........+.+|++++++++|+|++++++++...+..++...+
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 44678888999999999999999888999999999776555567799999999999999999999998877655443322
Q ss_pred cC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 753 ST------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 753 ~~------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
.. ...+++.+...++.+++.|++||| +++|+||||||+||+ |||+++........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 21 234677788899999999999995 678999999999998 99998776433221
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
.....++..|+|||++
T Consensus 161 -~~~~~~~~~~~~PE~~ 176 (261)
T cd05148 161 -SSDKKIPYKWTAPEAA 176 (261)
T ss_pred -ccCCCCceEecCHHHH
Confidence 1222357789999963
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.2e-17 Score=174.17 Aligned_cols=148 Identities=27% Similarity=0.391 Sum_probs=113.5
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
++|...+.||+|+||.||+|+.+ +++.||+|.+.... ......+.+|++++++++|+||+++++++..++..++...+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888899999999999999865 68899999986432 22334678899999999999999999999877655443222
Q ss_pred c----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 753 S----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 753 ~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
. ....+.+.....++.++++|++||| +.+|+||||||+||+ |||+++........ .
T Consensus 86 ~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~ 161 (301)
T cd07873 86 LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT-Y 161 (301)
T ss_pred cccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc-c
Confidence 1 1233566677789999999999995 678999999999998 99998765332221 1
Q ss_pred ccceeccccccccc
Q 047196 813 TETLVTIGYMAPGL 826 (827)
Q Consensus 813 ~~~~gt~~Y~APE~ 826 (827)
....+++.|+|||+
T Consensus 162 ~~~~~~~~y~~PE~ 175 (301)
T cd07873 162 SNEVVTLWYRPPDI 175 (301)
T ss_pred cccceeecccCcHH
Confidence 22347899999996
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.3e-17 Score=169.61 Aligned_cols=149 Identities=24% Similarity=0.456 Sum_probs=112.7
Q ss_pred hcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCce-eeeeecc
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFK-ALDCLHS 753 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~-~l~~l~~ 753 (827)
++|+..++||+|+||.||+|..++++.||||++..... ..+.|.+|++++++++|+|++++.+++...... .+++...
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYMEN 84 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcCCC
Confidence 56778899999999999999988889999999875432 346789999999999999999999887543322 1222211
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccc
Q 047196 754 ----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQT 813 (827)
Q Consensus 754 ----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~ 813 (827)
....+.+.+...++.+++.|++||| +.+++||||||+||+ |||+++...........
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05067 85 GSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTARE 161 (260)
T ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccccc
Confidence 1234567778889999999999995 678999999999988 99998776532222222
Q ss_pred cceecccccccccC
Q 047196 814 ETLVTIGYMAPGLL 827 (827)
Q Consensus 814 ~~~gt~~Y~APE~l 827 (827)
...++..|+|||++
T Consensus 162 ~~~~~~~y~~pe~~ 175 (260)
T cd05067 162 GAKFPIKWTAPEAI 175 (260)
T ss_pred CCcccccccCHHHh
Confidence 23357789999963
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.4e-17 Score=173.03 Aligned_cols=150 Identities=25% Similarity=0.396 Sum_probs=111.5
Q ss_pred hcccccceEecCCceEEEEEEecC---------------CcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEe
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHD---------------GIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRIS 738 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~---------------g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~ 738 (827)
++|+..+.||+|+||.||+|+..+ ...||||+++... ......|.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 467888999999999999987532 2358999986542 334567999999999999999999999
Q ss_pred eeecCCceeeeeeccCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee
Q 047196 739 SCSNEDFKALDCLHSTN----------------------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF 796 (827)
Q Consensus 739 ~~~~~~~~~l~~l~~~~----------------------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl 796 (827)
++......++...+... ..+.+...+.++.++++|++||| +.+++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence 99776655443322211 12466777889999999999995 678999999999998
Q ss_pred ----------eecccccccCCCccc-cccceecccccccccC
Q 047196 797 ----------DFGIGRLLTGDRSMI-QTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 ----------DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l 827 (827)
|||+++......... .....++..|+|||++
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 203 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESI 203 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhh
Confidence 999987654322211 1122357789999963
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-16 Score=172.60 Aligned_cols=151 Identities=26% Similarity=0.444 Sum_probs=112.5
Q ss_pred hhcccccceEecCCceEEEEEEec--------CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecC
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH--------DGIEVAIKVFHQNC-AMALKSFEAECEVMKNI-RHRNHVKRISSCSNE 743 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~ 743 (827)
.++|...+.||+|+||.||+|+.. ++..||+|.+.... ....+++.+|+++++.+ +|+|++++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 456788899999999999999741 24579999986532 34457799999999999 899999999998876
Q ss_pred CceeeeeeccCC--------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-
Q 047196 744 DFKALDCLHSTN--------------------------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF- 796 (827)
Q Consensus 744 ~~~~l~~l~~~~--------------------------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl- 796 (827)
...++...+... ..+.+.+...++.++++|++||| +.+|+||||||+||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEE
Confidence 654442222111 13456677889999999999995 668999999999988
Q ss_pred ---------eecccccccCCCcccc-ccceecccccccccC
Q 047196 797 ---------DFGIGRLLTGDRSMIQ-TETLVTIGYMAPGLL 827 (827)
Q Consensus 797 ---------DFGla~~~~~~~~~~~-~~~~gt~~Y~APE~l 827 (827)
|||+++.......... ....+++.|+|||++
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 211 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEAL 211 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhh
Confidence 9999987643322211 112357789999963
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.6e-17 Score=175.87 Aligned_cols=141 Identities=24% Similarity=0.264 Sum_probs=104.3
Q ss_pred EecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhc---CCCCceEEEeeeecCCceeeeeeccC-
Q 047196 683 IGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNI---RHRNHVKRISSCSNEDFKALDCLHST- 754 (827)
Q Consensus 683 iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l---~H~niv~~~~~~~~~~~~~l~~l~~~- 754 (827)
||+|+||+||+|+.. +|+.||||++.... ......+..|..++.+. +||+++++.+++...+..++...+..
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999864 68999999986432 12234456677777766 69999999998877765544332221
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccccc
Q 047196 755 ---------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTET 815 (827)
Q Consensus 755 ---------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~~ 815 (827)
...+.......++.|+++|++||| +++|+||||||+||+ |||+++........ ....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-~~~~ 156 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT-TNTF 156 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC-ccCc
Confidence 234566677789999999999995 678999999999998 99998764322221 2234
Q ss_pred eecccccccccC
Q 047196 816 LVTIGYMAPGLL 827 (827)
Q Consensus 816 ~gt~~Y~APE~l 827 (827)
+||+.|||||++
T Consensus 157 ~gt~~y~aPE~~ 168 (330)
T cd05586 157 CGTTEYLAPEVL 168 (330)
T ss_pred cCCccccCHHHH
Confidence 589999999964
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.9e-17 Score=169.96 Aligned_cols=150 Identities=27% Similarity=0.430 Sum_probs=112.0
Q ss_pred hcccccceEecCCceEEEEEEecC----CcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCcee-e
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHD----GIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKA-L 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~-l 748 (827)
.+|...+.||+|+||.||+|...+ ...||||...... ....+.+.+|++++++++|+|++++++++......+ +
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~ 85 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVM 85 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEE
Confidence 346777899999999999998643 2469999886554 445678999999999999999999999887654322 2
Q ss_pred eeecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 749 DCLHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 749 ~~l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
++... ....+++..+..++.++++|++||| +.+++||||||+||+ |||+++.......
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 86 ELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY 162 (270)
T ss_pred EcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeecccccc
Confidence 22211 1224677888899999999999995 678999999999998 9999887654422
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
...+...++..|+|||++
T Consensus 163 ~~~~~~~~~~~y~aPE~~ 180 (270)
T cd05056 163 YKASKGKLPIKWMAPESI 180 (270)
T ss_pred eecCCCCccccccChhhh
Confidence 212222245789999963
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.70 E-value=8e-17 Score=170.24 Aligned_cols=142 Identities=23% Similarity=0.280 Sum_probs=103.3
Q ss_pred eEecCCceEEEEEEecC---CcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeeccCCC-
Q 047196 682 LIGVGSFGSVYKGRLHD---GIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHSTNC- 756 (827)
Q Consensus 682 ~iG~G~fg~Vy~~~~~~---g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~~~- 756 (827)
.||+|+||.||+|+..+ ...||+|.+.... ......|.+|+++++.++|+||+++++++......++...+...+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 3568899875433 334567899999999999999999999998776554433222211
Q ss_pred --------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc-c
Q 047196 757 --------------SLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM-I 811 (827)
Q Consensus 757 --------------~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~-~ 811 (827)
...+.....++.|++.|++||| +.+|+||||||+||+ |||+++........ .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 1234456789999999999995 678999999999987 99998754332211 1
Q ss_pred cccceeccccccccc
Q 047196 812 QTETLVTIGYMAPGL 826 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~ 826 (827)
.....+++.|+|||+
T Consensus 159 ~~~~~~~~~y~aPE~ 173 (269)
T cd05042 159 KDCHAVPLRWLAPEL 173 (269)
T ss_pred cCCCCCcccccCHHH
Confidence 122235778999996
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.3e-17 Score=175.89 Aligned_cols=149 Identities=19% Similarity=0.288 Sum_probs=119.6
Q ss_pred hcccccceEecCCceEEEEEEecCCcEEEEEEEcc--cchHHHHHHHHHHHHHHhcC-CCCceEEEeeeecCCceeeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQ--NCAMALKSFEAECEVMKNIR-HRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~--~~~~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~l~~l 751 (827)
..|+..+.||+||.++||++...+.+.||+|++.. .+.+....|..|++.|.+++ |.+||++++|-..+.+.+|...
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 35777899999999999999988888899988643 34556788999999999996 8999999999988887776544
Q ss_pred ccC----------CCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------eecccccccCCCcc-
Q 047196 752 HST----------NCS-LNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---------DFGIGRLLTGDRSM- 810 (827)
Q Consensus 752 ~~~----------~~~-l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---------DFGla~~~~~~~~~- 810 (827)
.+. ... .+| .+..+..++.+++.++ |+.+|||.||||.|.| |||+|+.+..+...
T Consensus 441 ~Gd~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~I---H~~gIVHSDLKPANFLlVkG~LKLIDFGIA~aI~~DTTsI 516 (677)
T KOG0596|consen 441 CGDIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTI---HQHGIVHSDLKPANFLLVKGRLKLIDFGIANAIQPDTTSI 516 (677)
T ss_pred cccccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHH---HHhceeecCCCcccEEEEeeeEEeeeechhcccCccccce
Confidence 332 122 234 5567888998898888 5789999999999976 99999998776654
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
...+.+||+.||+||.+
T Consensus 517 ~kdsQvGT~NYMsPEAl 533 (677)
T KOG0596|consen 517 VKDSQVGTVNYMSPEAL 533 (677)
T ss_pred eeccccCcccccCHHHH
Confidence 34567899999999964
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.3e-17 Score=187.54 Aligned_cols=154 Identities=26% Similarity=0.440 Sum_probs=129.0
Q ss_pred ccCCCHHHHHHHHHHHhhcCCCCCCcCCCCCCCCCCCC----cccceecCCC--C--CcEEEEEcCCCCCccccCccccC
Q 047196 49 AASNITTDQQALLALKAHISYDPTNLLAQNSTSNTSVC----NWIGITCNVN--S--HRVTALNISSLNLQGTIPPQLGN 120 (827)
Q Consensus 49 ~~~~~~~~~~aLl~~k~~~~~~~~~~l~~w~~~~~~~C----~W~gv~C~~~--~--~~v~~L~L~~~~l~g~~~~~l~~ 120 (827)
.+.+.+.|.+||+++|+++. ++.. .+|. +..|| .|.||.|+.. . .+|+.|+|+++++.|.+|+.++.
T Consensus 366 ~~~t~~~~~~aL~~~k~~~~-~~~~--~~W~--g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~ 440 (623)
T PLN03150 366 ESKTLLEEVSALQTLKSSLG-LPLR--FGWN--GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISK 440 (623)
T ss_pred ccccCchHHHHHHHHHHhcC-Cccc--CCCC--CCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhC
Confidence 34567789999999999983 4432 3675 33342 7999999532 2 25999999999999999999999
Q ss_pred CCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcCCCCCCCCcchhHhhccccccEE
Q 047196 121 LSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVL 200 (827)
Q Consensus 121 L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~~L 200 (827)
+++|+.|+|++|.++|.+|+.++.+++|++|||++|+++|.+|..+.++++|++|+|++|+++|.+|..+.....++..+
T Consensus 441 L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l 520 (623)
T PLN03150 441 LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASF 520 (623)
T ss_pred CCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceE
Confidence 99999999999999999999999999999999999999999999999999999999999999999998877654456667
Q ss_pred Eeecccc
Q 047196 201 FLAKNMF 207 (827)
Q Consensus 201 ~Ls~N~l 207 (827)
++.+|..
T Consensus 521 ~~~~N~~ 527 (623)
T PLN03150 521 NFTDNAG 527 (623)
T ss_pred EecCCcc
Confidence 7776653
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.69 E-value=7.7e-17 Score=169.69 Aligned_cols=149 Identities=26% Similarity=0.441 Sum_probs=111.5
Q ss_pred hcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc-eeeeeecc
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF-KALDCLHS 753 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~-~~l~~l~~ 753 (827)
++|...++||+|+||.||+|+..++..||+|++..... ..++|.+|++++++++|+|++++++.+.+... ..++++..
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~ 84 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSK 84 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCCC
Confidence 56888899999999999999887767899999875322 34578999999999999999999988754332 22222221
Q ss_pred C----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccc
Q 047196 754 T----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQT 813 (827)
Q Consensus 754 ~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~ 813 (827)
. ...+++.....++.++++||+|+| +.+|+||||||+||+ |||.++...........
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~ 161 (262)
T cd05071 85 GSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 161 (262)
T ss_pred CcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccccccc
Confidence 1 123567778889999999999995 678999999999987 99998766433222212
Q ss_pred cceecccccccccC
Q 047196 814 ETLVTIGYMAPGLL 827 (827)
Q Consensus 814 ~~~gt~~Y~APE~l 827 (827)
...++..|+|||+.
T Consensus 162 ~~~~~~~y~~PE~~ 175 (262)
T cd05071 162 GAKFPIKWTAPEAA 175 (262)
T ss_pred CCcccceecCHhHh
Confidence 23367789999963
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.69 E-value=9.1e-17 Score=169.56 Aligned_cols=149 Identities=28% Similarity=0.341 Sum_probs=116.0
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
++|...+.||+|+||.||+|+. .+++.||+|+++.........+.+|+.+++.++|||++++++++...+..++...+.
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4677788899999999999986 468999999987654445567889999999999999999999988776555433222
Q ss_pred C----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccc
Q 047196 754 T----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQT 813 (827)
Q Consensus 754 ~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~ 813 (827)
. ...++..+...++.+++.|+.||| +.+|+||||||+||+ |||+++....... ...
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~-~~~ 164 (267)
T cd06645 89 GGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA-KRK 164 (267)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc-ccc
Confidence 1 234566777889999999999996 568999999999997 9999876543221 112
Q ss_pred cceecccccccccC
Q 047196 814 ETLVTIGYMAPGLL 827 (827)
Q Consensus 814 ~~~gt~~Y~APE~l 827 (827)
...|+..|+|||++
T Consensus 165 ~~~~~~~y~aPE~~ 178 (267)
T cd06645 165 SFIGTPYWMAPEVA 178 (267)
T ss_pred cccCcccccChhhh
Confidence 34589999999973
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.69 E-value=9.9e-17 Score=168.33 Aligned_cols=141 Identities=26% Similarity=0.480 Sum_probs=104.8
Q ss_pred EecCCceEEEEEEec---CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCce-eeeeecc----
Q 047196 683 IGVGSFGSVYKGRLH---DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFK-ALDCLHS---- 753 (827)
Q Consensus 683 iG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~-~l~~l~~---- 753 (827)
||+|+||.||+|.+. ++..||||++.... ....++|.+|++++++++|+|+++++++|...... .+++...
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L~ 82 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPLN 82 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCHH
Confidence 899999999999753 35679999986543 33456799999999999999999999988654322 2222211
Q ss_pred -----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc--ccce
Q 047196 754 -----TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ--TETL 816 (827)
Q Consensus 754 -----~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~--~~~~ 816 (827)
....+++.+...++.++++|++||| +.+|+||||||+||+ |||+++....+..... +...
T Consensus 83 ~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05115 83 KFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK 159 (257)
T ss_pred HHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCC
Confidence 1234677788899999999999995 568999999999997 9999886644332211 1112
Q ss_pred eccccccccc
Q 047196 817 VTIGYMAPGL 826 (827)
Q Consensus 817 gt~~Y~APE~ 826 (827)
++..|+|||+
T Consensus 160 ~~~~y~aPE~ 169 (257)
T cd05115 160 WPLKWYAPEC 169 (257)
T ss_pred CCcccCCHHH
Confidence 3678999996
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=5.5e-18 Score=196.44 Aligned_cols=152 Identities=24% Similarity=0.374 Sum_probs=111.9
Q ss_pred HhhcccccceEecCCceEEEEEE-ecCCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCce--e
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFK--A 747 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~--~ 747 (827)
.+-++....+||.|.||.||-|. ..+|+..|||.+.... ....+...+|+.++..++|||+|+++|.-...+.. +
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 34467778899999999999997 5679999999875432 33446678999999999999999999987665433 3
Q ss_pred eeeeccCC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 748 LDCLHSTN--------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 748 l~~l~~~~--------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
|+++..+. ...+..--..+..|++.|++||| +.+||||||||+||+ |||.|..+.....
T Consensus 1313 MEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 34433221 11122222346678999999995 678999999999998 9999988765432
Q ss_pred cc---cccceecccccccccC
Q 047196 810 MI---QTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~---~~~~~gt~~Y~APE~l 827 (827)
.. ....+||+.|||||+|
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvi 1410 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVI 1410 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhh
Confidence 21 2235699999999986
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-16 Score=168.75 Aligned_cols=147 Identities=27% Similarity=0.405 Sum_probs=106.8
Q ss_pred cccceEecCCceEEEEEEecC-Cc--EEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC--------
Q 047196 678 SKENLIGVGSFGSVYKGRLHD-GI--EVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNED-------- 744 (827)
Q Consensus 678 ~~~~~iG~G~fg~Vy~~~~~~-g~--~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~-------- 744 (827)
...++||+|+||.||+|++.+ +. .||||.++.. .....+.|.+|++++++++|+|+++++++|....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 346789999999999998754 33 5999988643 2344678999999999999999999999875421
Q ss_pred ceeeeeeccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecc
Q 047196 745 FKALDCLHST--------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGI 800 (827)
Q Consensus 745 ~~~l~~l~~~--------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGl 800 (827)
...+++.... ...+++.....++.++++|++||| +++|+||||||+||+ |||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCc
Confidence 1222322211 123567777889999999999996 578999999999998 9999
Q ss_pred cccccCCCccc-cccceecccccccccC
Q 047196 801 GRLLTGDRSMI-QTETLVTIGYMAPGLL 827 (827)
Q Consensus 801 a~~~~~~~~~~-~~~~~gt~~Y~APE~l 827 (827)
++......... .....+++.|+|||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~ 186 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESL 186 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHc
Confidence 98764332211 1112256789999973
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-16 Score=167.09 Aligned_cols=144 Identities=27% Similarity=0.457 Sum_probs=107.3
Q ss_pred ceEecCCceEEEEEEec-CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee--eeecc---
Q 047196 681 NLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL--DCLHS--- 753 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l--~~l~~--- 753 (827)
+.||+|+||.||+|+.. +++.||+|...... ......|.+|++++++++|+|+++++++|......++ ++...
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36899999999999864 68999999876432 3445679999999999999999999999977665444 22211
Q ss_pred ------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccc-cce
Q 047196 754 ------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQT-ETL 816 (827)
Q Consensus 754 ------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~-~~~ 816 (827)
....+.+.+...++.++++||+||| +.+|+||||||+||+ |||+++........... ...
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 1224677778889999999999995 678999999999998 89998764322111100 011
Q ss_pred ecccccccccC
Q 047196 817 VTIGYMAPGLL 827 (827)
Q Consensus 817 gt~~Y~APE~l 827 (827)
++..|+|||++
T Consensus 158 ~~~~y~aPE~~ 168 (252)
T cd05084 158 IPVKWTAPEAL 168 (252)
T ss_pred CceeecCchhh
Confidence 34579999964
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-16 Score=168.25 Aligned_cols=149 Identities=28% Similarity=0.395 Sum_probs=113.5
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEccc---chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN---CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
++|+..+.||+|+||.||+|+.. +++.||||++... .....+.+.+|++++++++|||++++++++...+...+..
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888899999999999999864 6899999987532 2344567899999999999999999999987766544432
Q ss_pred eccCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccC
Q 047196 751 LHSTN--------------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806 (827)
Q Consensus 751 l~~~~--------------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~ 806 (827)
.+... ..+.......++.++++|++||| +.+|+||||||+||+ |||+++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 22211 22455566789999999999995 678999999999998 9998876643
Q ss_pred CCccccccceecccccccccC
Q 047196 807 DRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 807 ~~~~~~~~~~gt~~Y~APE~l 827 (827)
.... .....|++.|+|||++
T Consensus 159 ~~~~-~~~~~~~~~~~aPE~~ 178 (267)
T cd08228 159 KTTA-AHSLVGTPYYMSPERI 178 (267)
T ss_pred hhHH-HhcCCCCccccChhhh
Confidence 3221 1123478899999963
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=1e-16 Score=171.53 Aligned_cols=151 Identities=26% Similarity=0.427 Sum_probs=113.8
Q ss_pred HhhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee--
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCA-MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL-- 748 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l-- 748 (827)
++++|...+.||+|+||.||+|.. .+|+.||||++..... .....+.+|++++++++|+|++++.+++..++..++
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 457888999999999999999986 4688999999865432 223467889999999999999999999887665443
Q ss_pred eeecc--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 749 DCLHS--------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 749 ~~l~~--------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
++... ....+.+.....++.+++.||+||| +.+|+||||||+||+ |||+++........
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 159 (291)
T cd07870 83 EYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT 159 (291)
T ss_pred ecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence 22211 1123456667789999999999995 568999999999998 99998764332211
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
.....+++.|+|||++
T Consensus 160 -~~~~~~~~~y~aPE~~ 175 (291)
T cd07870 160 -YSSEVVTLWYRPPDVL 175 (291)
T ss_pred -CCCccccccccCCcee
Confidence 1223478999999973
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.4e-16 Score=169.38 Aligned_cols=151 Identities=21% Similarity=0.308 Sum_probs=113.3
Q ss_pred hhcccccceEecCCceEEEEEEecC-----CcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC-ce
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLHD-----GIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNED-FK 746 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~~-----g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~-~~ 746 (827)
.++|...++||+|+||.||+|...+ +..||+|++.... ....+.+.+|++++++++|+|++++++++.... ..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678888999999999999998754 6889999986542 344577899999999999999999999987632 22
Q ss_pred eeeeecc-----------C--C-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------ee
Q 047196 747 ALDCLHS-----------T--N-----CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DF 798 (827)
Q Consensus 747 ~l~~l~~-----------~--~-----~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DF 798 (827)
++...+. . . ..+.+.+...++.+++.|++||| +.+|+||||||+||+ ||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCC
Confidence 2211111 0 0 34667788899999999999996 678999999999998 99
Q ss_pred cccccccCCCccc-cccceecccccccccC
Q 047196 799 GIGRLLTGDRSMI-QTETLVTIGYMAPGLL 827 (827)
Q Consensus 799 Gla~~~~~~~~~~-~~~~~gt~~Y~APE~l 827 (827)
|+++.+....... .....++..|+|||++
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~ 191 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESL 191 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHH
Confidence 9998664332211 1122357789999963
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.69 E-value=1e-16 Score=171.29 Aligned_cols=152 Identities=24% Similarity=0.368 Sum_probs=111.9
Q ss_pred HhhcccccceEecCCceEEEEEEec------CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLH------DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF 745 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~ 745 (827)
..++|+..+.||+|+||.||+|..+ .+..||||.+.... .....++.+|+.++++++|+|++++++++...+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4577888999999999999999643 24589999886443 2334568899999999999999999999877665
Q ss_pred eeeeeeccCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------
Q 047196 746 KALDCLHSTN--------------------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF--------- 796 (827)
Q Consensus 746 ~~l~~l~~~~--------------------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl--------- 796 (827)
.++...+... ....+.....++.+++.|++||| +++|+||||||+||+
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence 5543332211 11234456779999999999995 678999999999998
Q ss_pred -eecccccccCCCccc-cccceecccccccccC
Q 047196 797 -DFGIGRLLTGDRSMI-QTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 -DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l 827 (827)
|||+++......... .....++..|+|||++
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~ 193 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL 193 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHh
Confidence 999988654322211 1112357789999963
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-16 Score=170.35 Aligned_cols=147 Identities=29% Similarity=0.467 Sum_probs=106.7
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccch--HHHHHHHHHHHHHHhc---CCCCceEEEeeeecCC-----
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA--MALKSFEAECEVMKNI---RHRNHVKRISSCSNED----- 744 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l---~H~niv~~~~~~~~~~----- 744 (827)
+|+..+.||+|+||.||+|+.. +|+.||+|++..... .....+.+|+++++++ +||||+++++++....
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 3677889999999999999865 689999999864321 1223456787777765 6999999999875421
Q ss_pred cee--eeeecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eeccccc
Q 047196 745 FKA--LDCLHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRL 803 (827)
Q Consensus 745 ~~~--l~~l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~ 803 (827)
... +++... ....+.+.....++.+++.|++|+| +.+|+||||||+||+ |||+++.
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCcccc
Confidence 112 222211 1123567777889999999999995 678999999999998 9999987
Q ss_pred ccCCCccccccceecccccccccC
Q 047196 804 LTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 804 ~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
...... .....||..|+|||++
T Consensus 158 ~~~~~~--~~~~~~~~~y~aPE~~ 179 (288)
T cd07863 158 YSCQMA--LTPVVVTLWYRAPEVL 179 (288)
T ss_pred ccCccc--CCCccccccccCchHh
Confidence 643221 2234589999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.69 E-value=8.4e-17 Score=173.29 Aligned_cols=150 Identities=27% Similarity=0.488 Sum_probs=110.4
Q ss_pred hcccccceEecCCceEEEEEEec-CCc----EEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGI----EVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~----~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l 748 (827)
++|+..+.||+|+||.||+|+.. +|+ .||+|.+.... .....++.+|+.++++++|+|+++++++|......++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v 86 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLV 86 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCceee
Confidence 45777889999999999999853 444 57899886543 3334578999999999999999999999876543222
Q ss_pred -eeec---------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 749 -DCLH---------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 749 -~~l~---------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
++.. .....+.+.....++.++++|++||| +++|+||||||+||+ |||+++......
T Consensus 87 ~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~ 163 (303)
T cd05110 87 TQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163 (303)
T ss_pred ehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccCcc
Confidence 1111 11224566777899999999999995 678999999999998 999998765333
Q ss_pred cccc-ccceecccccccccC
Q 047196 809 SMIQ-TETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~~-~~~~gt~~Y~APE~l 827 (827)
.... ....++..|+|||++
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~ 183 (303)
T cd05110 164 KEYNADGGKMPIKWMALECI 183 (303)
T ss_pred cccccCCCccccccCCHHHh
Confidence 2211 122357789999964
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.4e-16 Score=165.89 Aligned_cols=150 Identities=23% Similarity=0.341 Sum_probs=113.9
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc-----hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC-----AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l 748 (827)
++|...+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++|||++++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688889999999999999986 468999999986432 1234578999999999999999999999988775554
Q ss_pred eeeccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 749 DCLHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 749 ~~l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
...+... ..+.......++.++++|++||| +.+|+||||||+||+ |||+++......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 3333222 23445566789999999999995 678999999999988 999987654322
Q ss_pred cccc--ccceecccccccccC
Q 047196 809 SMIQ--TETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~~--~~~~gt~~Y~APE~l 827 (827)
.... ....|+..|+|||++
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~ 179 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVI 179 (263)
T ss_pred cccccccCCCcCccccCccee
Confidence 2111 223478899999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-16 Score=168.37 Aligned_cols=150 Identities=25% Similarity=0.430 Sum_probs=112.7
Q ss_pred hcccccceEecCCceEEEEEEec-C---CcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-D---GIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALD 749 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~---g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~ 749 (827)
++|+..+.||+|+||.||+|+.. + +..||+|.+.... ....+.|.+|++++++++|||++++.+++...+..++.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46778899999999999999853 2 3479999986543 33456899999999999999999999998776655442
Q ss_pred eeccC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 750 CLHST-----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 750 ~l~~~-----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
..+.. ...+.+.+...++.+++.|++||| +.+|+||||||+||+ |||+++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 22221 234577778899999999999995 678999999999997 999998765433
Q ss_pred cccccc--ceecccccccccC
Q 047196 809 SMIQTE--TLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~~~~--~~gt~~Y~APE~l 827 (827)
....+. ..++..|+|||++
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~ 181 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAI 181 (267)
T ss_pred ceeeecCCCccceeecCHhHh
Confidence 221111 1135689999974
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.1e-16 Score=169.24 Aligned_cols=149 Identities=27% Similarity=0.333 Sum_probs=116.8
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
+.|+..+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++|+|++++.+.+..+...++...+.
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 45777889999999999999865 58999999997766666778999999999999999999999987766544433222
Q ss_pred C-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 754 T-----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 754 ~-----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
. ...+++.....++.+++++++||| +.+|+||||||+||+ |||++......... .
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~-~ 167 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR-R 167 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccccccc-c
Confidence 1 234567778889999999999995 678999999999988 99988754322211 1
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
....+++.|+|||++
T Consensus 168 ~~~~~~~~y~aPE~~ 182 (292)
T cd06644 168 DSFIGTPYWMAPEVV 182 (292)
T ss_pred ceecCCccccCceee
Confidence 223478999999974
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.4e-16 Score=169.88 Aligned_cols=149 Identities=24% Similarity=0.322 Sum_probs=115.8
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
+|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|+|++++++++......++...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 3667788999999999999864 68999999987543 23356789999999999999999999998876655443322
Q ss_pred c----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 753 S----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 753 ~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
. ....+++.+...++.++++|++||| +.+|+|+||||+||+ |||+++..........
T Consensus 81 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 81 MPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 2 1233567778899999999999996 568999999999987 9999887654332222
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
....|+.+|+|||++
T Consensus 158 ~~~~~~~~y~aPE~~ 172 (286)
T cd07832 158 SHQVATRWYRAPELL 172 (286)
T ss_pred ccccCcccccCceee
Confidence 334589999999974
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.1e-16 Score=166.07 Aligned_cols=149 Identities=23% Similarity=0.446 Sum_probs=112.3
Q ss_pred hcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCcee-eeeecc
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKA-LDCLHS 753 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~-l~~l~~ 753 (827)
++|...+.||+|+||.||+|...++..||+|.+... ....+.|.+|++++++++|+|++++.+.+....... +++...
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAK 84 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeCCC
Confidence 568888999999999999999877788999988654 334567899999999999999999999887633221 222211
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccc
Q 047196 754 ----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQT 813 (827)
Q Consensus 754 ----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~ 813 (827)
.....++..+..++.+++.|++||| +.+++||||||+||+ |||.++...........
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 161 (260)
T cd05073 85 GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 161 (260)
T ss_pred CcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCccccc
Confidence 1123566777889999999999996 568999999999988 99988766433222222
Q ss_pred cceecccccccccC
Q 047196 814 ETLVTIGYMAPGLL 827 (827)
Q Consensus 814 ~~~gt~~Y~APE~l 827 (827)
...++..|+|||++
T Consensus 162 ~~~~~~~y~~PE~~ 175 (260)
T cd05073 162 GAKFPIKWTAPEAI 175 (260)
T ss_pred CCcccccccCHhHh
Confidence 22356789999974
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.9e-16 Score=169.93 Aligned_cols=149 Identities=27% Similarity=0.327 Sum_probs=116.6
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
.+|+..+.||+|+||.||+|.. .+++.||+|.+........+.+.+|++++++++|+|++++++.+......++...+.
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4677788999999999999985 468999999987655455677899999999999999999999988766555433332
Q ss_pred CC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccccc
Q 047196 754 TN---------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTE 814 (827)
Q Consensus 754 ~~---------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~ 814 (827)
.. ..+.+.+...++.+++.|++||| +.+|+||||||+||+ |||+++........ ...
T Consensus 100 ~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~ 175 (296)
T cd06654 100 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RST 175 (296)
T ss_pred CCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccccccc-cCc
Confidence 22 23566778889999999999995 678999999999988 99988765433221 122
Q ss_pred ceecccccccccC
Q 047196 815 TLVTIGYMAPGLL 827 (827)
Q Consensus 815 ~~gt~~Y~APE~l 827 (827)
..|++.|+|||++
T Consensus 176 ~~~~~~y~aPE~~ 188 (296)
T cd06654 176 MVGTPYWMAPEVV 188 (296)
T ss_pred ccCCccccCHHHH
Confidence 3588999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.1e-16 Score=170.13 Aligned_cols=150 Identities=24% Similarity=0.420 Sum_probs=113.8
Q ss_pred hcccccceEecCCceEEEEEEe------cCCcEEEEEEEcccc-hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCce
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL------HDGIEVAIKVFHQNC-AMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFK 746 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~ 746 (827)
++|...+.||+|+||.||+|.. .++..||||++.... ....+.+.+|+++++++ +|+|++++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 5688889999999999999974 135679999986543 33456799999999999 799999999999877655
Q ss_pred eeeeeccC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccc
Q 047196 747 ALDCLHST------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLL 804 (827)
Q Consensus 747 ~l~~l~~~------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~ 804 (827)
++...+.. ...+.+.+...++.+++.|++||| +++|+||||||+||+ |||+++.+
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence 44332221 122677888899999999999995 678999999999988 99998866
Q ss_pred cCCCccc-cccceecccccccccC
Q 047196 805 TGDRSMI-QTETLVTIGYMAPGLL 827 (827)
Q Consensus 805 ~~~~~~~-~~~~~gt~~Y~APE~l 827 (827)
....... .....++..|+|||++
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~ 215 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESI 215 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhh
Confidence 4332211 1112357889999963
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.7e-16 Score=166.76 Aligned_cols=148 Identities=25% Similarity=0.447 Sum_probs=110.7
Q ss_pred hcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc-eeeeeecc
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF-KALDCLHS 753 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~-~~l~~l~~ 753 (827)
++|...+.||+|+||.||+|...++..||+|++.... ...+.|.+|++++++++|+|++++++++..... ..+++...
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCC
Confidence 4577888999999999999998777789999876433 234578899999999999999999988754332 22222221
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccc
Q 047196 754 ----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQT 813 (827)
Q Consensus 754 ----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~ 813 (827)
....+.+.....++.+++.|++||| +.+|+||||||+||+ |||+++...........
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05069 85 GSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQ 161 (260)
T ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccC
Confidence 1123567778899999999999995 678999999999988 99998766433221112
Q ss_pred cceeccccccccc
Q 047196 814 ETLVTIGYMAPGL 826 (827)
Q Consensus 814 ~~~gt~~Y~APE~ 826 (827)
...++..|+|||+
T Consensus 162 ~~~~~~~y~~Pe~ 174 (260)
T cd05069 162 GAKFPIKWTAPEA 174 (260)
T ss_pred CCccchhhCCHHH
Confidence 2236778999996
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.2e-16 Score=167.33 Aligned_cols=150 Identities=16% Similarity=0.343 Sum_probs=112.7
Q ss_pred hcccccceEecCCceEEEEEEec------CCcEEEEEEEcccchH-HHHHHHHHHHHHHhcCCCCceEEEeeeecCCcee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH------DGIEVAIKVFHQNCAM-ALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKA 747 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~ 747 (827)
++|+....||+|+||.||+|+.+ +...||+|.+...... ..++|.+|++++++++|+|++++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56788899999999999999853 2467999988654333 4578999999999999999999999987755444
Q ss_pred e--eeecc--------CCC---------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------ee
Q 047196 748 L--DCLHS--------TNC---------SLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DF 798 (827)
Q Consensus 748 l--~~l~~--------~~~---------~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DF 798 (827)
+ ++... ... .+.+..+..++.++++|++||| +.+|+||||||+||+ ||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence 3 22211 011 4678888999999999999995 678999999999998 78
Q ss_pred cccccccCCCccccccceecccccccccC
Q 047196 799 GIGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 799 Gla~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
|+++..............++..|+|||++
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~ 190 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAV 190 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhh
Confidence 87765432222112233468889999963
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.68 E-value=2e-16 Score=168.68 Aligned_cols=148 Identities=28% Similarity=0.369 Sum_probs=112.9
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
+|+..+.||+|+||.||+|+.. +|..||||++.... ....+.+.+|++++++++|||++++++++..++..++...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 3667789999999999999864 68999999986432 22345688999999999999999999999876655443222
Q ss_pred cC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 753 ST------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 753 ~~------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
.. ...+++.....++.++++||+||| +++|+||||||+||+ |||+++.......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (285)
T cd07861 81 LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR- 156 (285)
T ss_pred CCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc-
Confidence 11 134667777889999999999995 678999999999998 9998876533221
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
......+++.|+|||++
T Consensus 157 ~~~~~~~~~~y~aPE~~ 173 (285)
T cd07861 157 VYTHEVVTLWYRAPEVL 173 (285)
T ss_pred cccCCcccccccChHHh
Confidence 12233578999999963
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.1e-16 Score=169.36 Aligned_cols=151 Identities=27% Similarity=0.354 Sum_probs=113.9
Q ss_pred HHhhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCC-----
Q 047196 672 RATEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNI-RHRNHVKRISSCSNED----- 744 (827)
Q Consensus 672 ~~~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~----- 744 (827)
.+++.|+..+.||+|+||.||+|+.. +++.||||++.... ....++.+|+++++++ +|+|++++.+++...+
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45677888899999999999999864 58899999986543 2345788999999999 6999999999986532
Q ss_pred -ceee--eeecc----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eeccc
Q 047196 745 -FKAL--DCLHS----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIG 801 (827)
Q Consensus 745 -~~~l--~~l~~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla 801 (827)
..++ ++... ....+.+.....++.|++.|++||| +++|+|||+||+||+ |||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 2222 22211 1124567777889999999999996 568999999999987 99998
Q ss_pred ccccCCCccccccceecccccccccC
Q 047196 802 RLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 802 ~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
+....... ......|+..|+|||++
T Consensus 159 ~~~~~~~~-~~~~~~g~~~y~aPE~~ 183 (272)
T cd06637 159 AQLDRTVG-RRNTFIGTPYWMAPEVI 183 (272)
T ss_pred eecccccc-cCCcccccccccCHhHh
Confidence 86543222 12234589999999974
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.7e-16 Score=170.04 Aligned_cols=152 Identities=27% Similarity=0.423 Sum_probs=113.5
Q ss_pred HhhcccccceEecCCceEEEEEEec------CCcEEEEEEEccc-chHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCC
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLH------DGIEVAIKVFHQN-CAMALKSFEAECEVMKNI-RHRNHVKRISSCSNED 744 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~------~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~ 744 (827)
..++|+..+.||+|+||.||+|... ....||+|++... ......++.+|+++++++ +|+|++++++++....
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 3456888899999999999999753 2367999998753 233456789999999999 8999999999987766
Q ss_pred ceeeeeecc--------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee--
Q 047196 745 FKALDCLHS--------------------------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-- 796 (827)
Q Consensus 745 ~~~l~~l~~--------------------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-- 796 (827)
..++...+. ....+++...+.++.+++.|++||| +++|+||||||+||+
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEc
Confidence 544322111 1234667778899999999999995 678999999999998
Q ss_pred --------eecccccccCCCccc-cccceecccccccccC
Q 047196 797 --------DFGIGRLLTGDRSMI-QTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 --------DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l 827 (827)
|||+++.+....... .....++..|+|||++
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 206 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEAL 206 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHh
Confidence 999998765432211 1112256789999963
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.7e-17 Score=177.77 Aligned_cols=155 Identities=28% Similarity=0.467 Sum_probs=119.4
Q ss_pred HHHHHhhcccccceEecCCceEEEEEEecC-CcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCcee
Q 047196 669 DLFRATEKFSKENLIGVGSFGSVYKGRLHD-GIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKA 747 (827)
Q Consensus 669 ~~~~~~~~~~~~~~iG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~ 747 (827)
+++....++...+++|-|.||.||.|.|+. ...||||.++.+ .+..++|..|+.+|+.++|||+|+++|.|..+...+
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 343344456677899999999999999864 678999999765 456789999999999999999999999998876555
Q ss_pred eeeeccCCC------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eeccccccc
Q 047196 748 LDCLHSTNC------------SLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLT 805 (827)
Q Consensus 748 l~~l~~~~~------------~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~ 805 (827)
+...++..+ .+...-.+.+|.||+.|++||. .+.+|||||.+.|.| |||++|+..
T Consensus 340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 433322221 1223334678999999999995 567999999999987 999999998
Q ss_pred CCCccccccceecccccccccC
Q 047196 806 GDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 806 ~~~~~~~~~~~gt~~Y~APE~l 827 (827)
+|...+-...-..+.|.|||-+
T Consensus 417 gDTYTAHAGAKFPIKWTAPEsL 438 (1157)
T KOG4278|consen 417 GDTYTAHAGAKFPIKWTAPESL 438 (1157)
T ss_pred CCceecccCccCcccccCcccc
Confidence 8766433323347789999953
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.9e-16 Score=169.49 Aligned_cols=147 Identities=24% Similarity=0.274 Sum_probs=114.1
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
+|+..+.||+|+||.||+++.. +|..||+|.+.... .....++.+|++++++++||||+++++++..++..++...+.
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~ 81 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM 81 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence 5788899999999999999864 68889999986542 334467889999999999999999999998877665544333
Q ss_pred CC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccc
Q 047196 754 TN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQT 813 (827)
Q Consensus 754 ~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~ 813 (827)
.. ..+.+.....++.++++|+.|||. ..+|+||||||+||+ |||+++....... .
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~---~ 156 (308)
T cd06615 82 DGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---N 156 (308)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccccccc---c
Confidence 22 234555667899999999999974 357999999999998 8998876532211 2
Q ss_pred cceecccccccccC
Q 047196 814 ETLVTIGYMAPGLL 827 (827)
Q Consensus 814 ~~~gt~~Y~APE~l 827 (827)
...|+..|+|||++
T Consensus 157 ~~~~~~~~~aPE~~ 170 (308)
T cd06615 157 SFVGTRSYMSPERL 170 (308)
T ss_pred cCCCCcCccChhHh
Confidence 24588999999963
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.6e-16 Score=168.98 Aligned_cols=150 Identities=25% Similarity=0.335 Sum_probs=117.9
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
.++|+..+.||+|+||.||+|+.. ++..||+|+.........+.|.+|++++++++|+|++++++.+......++...+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356888889999999999999864 6899999998766666667899999999999999999999998877655443322
Q ss_pred cC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 753 ST-----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 753 ~~-----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
.. ...+++.....++.+++.|+.||| +.+|+||||||+||+ |||++.........
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~- 159 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK- 159 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcccccc-
Confidence 21 234667778889999999999995 678999999999988 89987765432221
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
.....+++.|+|||++
T Consensus 160 ~~~~~~~~~y~~PE~~ 175 (280)
T cd06611 160 RDTFIGTPYWMAPEVV 175 (280)
T ss_pred cceeecchhhcCHHHH
Confidence 1223589999999963
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.3e-16 Score=169.31 Aligned_cols=149 Identities=27% Similarity=0.324 Sum_probs=117.2
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
.+|...+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.++++++|+|++++++++...+..++...+.
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5688889999999999999985 578999999997654445567899999999999999999999998776555433332
Q ss_pred CC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccccc
Q 047196 754 TN---------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTE 814 (827)
Q Consensus 754 ~~---------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~ 814 (827)
.. ..+.+.+...++.++++|+.||| +.+|+||||||+||+ |||+++........ ...
T Consensus 99 ~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-~~~ 174 (297)
T cd06656 99 AGGSLTDVVTETCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RST 174 (297)
T ss_pred CCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC-cCc
Confidence 22 23566678889999999999995 678999999999998 99998765433221 122
Q ss_pred ceecccccccccC
Q 047196 815 TLVTIGYMAPGLL 827 (827)
Q Consensus 815 ~~gt~~Y~APE~l 827 (827)
..+++.|+|||++
T Consensus 175 ~~~~~~y~aPE~~ 187 (297)
T cd06656 175 MVGTPYWMAPEVV 187 (297)
T ss_pred ccCCccccCHHHH
Confidence 3478999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.68 E-value=2e-16 Score=169.02 Aligned_cols=148 Identities=24% Similarity=0.278 Sum_probs=112.5
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcC-CCCceEEEeeeecCCceee--ee
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIR-HRNHVKRISSCSNEDFKAL--DC 750 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~l--~~ 750 (827)
+|...+.||+|+||.||+++.. +|+.||||++.... ......+.+|+.++.++. |+|+|++++++..+...++ ++
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556678999999999999864 68999999986532 334567899999999996 9999999998877654433 22
Q ss_pred ecc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 751 LHS------------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 751 l~~------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
... ....+.+.....++.++++|++||| ++.+|+||||||+||+ |||+++.+....
T Consensus 85 ~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh--~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 85 MDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK--EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred ccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh--hcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 211 1234566777889999999999997 3458999999999997 999987664332
Q ss_pred ccccccceecccccccccC
Q 047196 809 SMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~~~~~~gt~~Y~APE~l 827 (827)
.. ....|++.|+|||++
T Consensus 163 ~~--~~~~~~~~y~aPE~~ 179 (288)
T cd06616 163 AK--TRDAGCRPYMAPERI 179 (288)
T ss_pred cc--ccccCccCccCHHHh
Confidence 21 223478999999974
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.7e-16 Score=166.35 Aligned_cols=148 Identities=27% Similarity=0.456 Sum_probs=108.3
Q ss_pred ccccceEecCCceEEEEEEec-C---CcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc-----
Q 047196 677 FSKENLIGVGSFGSVYKGRLH-D---GIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF----- 745 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~~-~---g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~----- 745 (827)
|...+.||+|+||.||+|... + +..||||++.... .....++.+|++.+++++|+|++++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 455688999999999999864 2 3779999986432 3345689999999999999999999998865432
Q ss_pred -eee--eeecc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------ee
Q 047196 746 -KAL--DCLHS--------------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DF 798 (827)
Q Consensus 746 -~~l--~~l~~--------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DF 798 (827)
.++ ++... ....+.+.....++.+++.||+||| +.+|+||||||+||+ ||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence 122 22111 1124567777889999999999996 578999999999998 99
Q ss_pred cccccccCCCcccc-ccceecccccccccC
Q 047196 799 GIGRLLTGDRSMIQ-TETLVTIGYMAPGLL 827 (827)
Q Consensus 799 Gla~~~~~~~~~~~-~~~~gt~~Y~APE~l 827 (827)
|+++.......... ....++..|+|||++
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~ 187 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESL 187 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhc
Confidence 99987643322111 112246789999964
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.2e-16 Score=167.97 Aligned_cols=146 Identities=31% Similarity=0.540 Sum_probs=108.3
Q ss_pred ccceEecCCceEEEEEEec-----CCcEEEEEEEccc-chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee--ee
Q 047196 679 KENLIGVGSFGSVYKGRLH-----DGIEVAIKVFHQN-CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL--DC 750 (827)
Q Consensus 679 ~~~~iG~G~fg~Vy~~~~~-----~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l--~~ 750 (827)
..+.||.|+||.||+|++. .+..||||.+... .....+.|.+|++.+++++||||++++|+|...+...+ ++
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3468999999999999876 2578999999653 33457889999999999999999999999996553333 22
Q ss_pred e---------ccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 751 L---------HST-NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 751 l---------~~~-~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
. ... ...+++..+..|+.++|+||+||| +.+|+|+||+++||+ |||+++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence 2 112 346788999999999999999997 457999999999998 89988776322221
Q ss_pred -ccccceecccccccccC
Q 047196 811 -IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 -~~~~~~gt~~Y~APE~l 827 (827)
..........|+|||++
T Consensus 160 ~~~~~~~~~~~~~aPE~~ 177 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVL 177 (259)
T ss_dssp EESTTSESGGGGS-HHHH
T ss_pred cccccccccccccccccc
Confidence 12223467899999963
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=6.1e-17 Score=173.10 Aligned_cols=147 Identities=22% Similarity=0.367 Sum_probs=113.2
Q ss_pred hcccccceEecCCceEEEEEEecC-CcEEEEEEEcccchH---H-----HHHHHHHHHHHHhcC---CCCceEEEeeeec
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHD-GIEVAIKVFHQNCAM---A-----LKSFEAECEVMKNIR---HRNHVKRISSCSN 742 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~---~-----~~~~~~Ei~~l~~l~---H~niv~~~~~~~~ 742 (827)
.+|...+.+|+|+||.|+.|.++. ..+|.||.+.+...- . .-..-.||+||..++ |+||++++.++.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 357778899999999999998764 567999987553211 0 113457999999998 9999999999999
Q ss_pred CCceeeeeeccCC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eeccc
Q 047196 743 EDFKALDCLHSTN-----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIG 801 (827)
Q Consensus 743 ~~~~~l~~l~~~~-----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla 801 (827)
.++.+++....+. ..++..+..-|.+||+.|+++| |+.+|||||||-+||+ |||.|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hl---h~~~ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHL---HDQGIVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccc---cccCceecccccccEEEecCCeEEEeeccch
Confidence 8887775443322 2344556667999999999998 7899999999999987 99988
Q ss_pred ccccCCCccccccceecccccccccC
Q 047196 802 RLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 802 ~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
.......- ...+||.+|.|||++
T Consensus 718 a~~ksgpf---d~f~gtv~~aapevl 740 (772)
T KOG1152|consen 718 AYTKSGPF---DVFVGTVDYAAPEVL 740 (772)
T ss_pred hhhcCCCc---ceeeeeccccchhhh
Confidence 76543221 235699999999985
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.7e-16 Score=169.39 Aligned_cols=158 Identities=24% Similarity=0.336 Sum_probs=116.9
Q ss_pred cchhHHHHHhhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhc-CCCCceEEEeeeec
Q 047196 665 FSYQDLFRATEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNI-RHRNHVKRISSCSN 742 (827)
Q Consensus 665 ~~~~~~~~~~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~ 742 (827)
+.++++..+.++|+..+.||+|+||.||+|+.. +++.||+|++.... ....++.+|+.+++++ +|+|++++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 445566677889999999999999999999864 58899999875432 2335688999999999 69999999998743
Q ss_pred C-----Cceee--eeecc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------
Q 047196 743 E-----DFKAL--DCLHS------------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------- 796 (827)
Q Consensus 743 ~-----~~~~l--~~l~~------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------- 796 (827)
. +..++ ++... ....+.+.....++.++++|+.||| +.+|+||||||+||+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCE
Confidence 2 22222 32211 1123455566779999999999995 678999999999997
Q ss_pred ---eecccccccCCCccccccceecccccccccC
Q 047196 797 ---DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 ---DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
|||+++........ .....|++.|+|||++
T Consensus 164 kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~ 196 (286)
T cd06638 164 KLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVI 196 (286)
T ss_pred EEccCCceeecccCCCc-cccccCCCcccChhhh
Confidence 99998766432221 2234589999999964
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.3e-16 Score=167.57 Aligned_cols=152 Identities=25% Similarity=0.419 Sum_probs=112.2
Q ss_pred HhhcccccceEecCCceEEEEEEec------CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLH------DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF 745 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~ 745 (827)
.+++|...+.||+|+||.||+|... .+..||+|...... ......|.+|+.++++++|+|++++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3467888899999999999999864 35779999886443 3344679999999999999999999998876654
Q ss_pred eee--eeeccC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee------------
Q 047196 746 KAL--DCLHST---------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------------ 796 (827)
Q Consensus 746 ~~l--~~l~~~---------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------------ 796 (827)
.++ ++.... ...+.+.+...++.++++|++||| +++++||||||+||+
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEe
Confidence 443 222110 113677788899999999999995 567999999999988
Q ss_pred -eecccccccCCCcccc-ccceecccccccccC
Q 047196 797 -DFGIGRLLTGDRSMIQ-TETLVTIGYMAPGLL 827 (827)
Q Consensus 797 -DFGla~~~~~~~~~~~-~~~~gt~~Y~APE~l 827 (827)
|||+++.......... .....+..|||||++
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 193 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAF 193 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHH
Confidence 8888876532221111 111235689999973
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.1e-16 Score=168.05 Aligned_cols=150 Identities=25% Similarity=0.408 Sum_probs=113.2
Q ss_pred hcccccceEecCCceEEEEEEec------CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH------DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l 748 (827)
.+|...++||+|+||.||+++.. ++..||+|++........+.|.+|++++++++|+|++++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 35666789999999999999632 356899999876655566789999999999999999999999887665444
Q ss_pred eeeccCC-------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------
Q 047196 749 DCLHSTN-------------------------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------- 796 (827)
Q Consensus 749 ~~l~~~~-------------------------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------- 796 (827)
...+... ..+.+.....++.+++.|++||| +++|+||||||+||+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence 2221111 23567788899999999999995 678999999999998
Q ss_pred ---eecccccccCCCcc-ccccceecccccccccC
Q 047196 797 ---DFGIGRLLTGDRSM-IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 ---DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l 827 (827)
|||+++........ ......+++.|+|||++
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 196 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI 196 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHh
Confidence 99998765432211 11122357889999963
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.8e-16 Score=167.02 Aligned_cols=150 Identities=29% Similarity=0.476 Sum_probs=111.3
Q ss_pred hcccccceEecCCceEEEEEEec-CCc----EEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGI----EVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~----~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l 748 (827)
.+|+..+.||+|+||.||+|... +|+ .||+|.+.... .....++.+|++++++++|+|+++++++|......++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v 86 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLI 86 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEE
Confidence 46777899999999999999864 333 68999886553 3345689999999999999999999999877332221
Q ss_pred -eeec---------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 749 -DCLH---------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 749 -~~l~---------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
++.. .....+++.....++.++++|++||| +++|+||||||+||+ |||+++......
T Consensus 87 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 87 TQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred EecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 2111 11234677888999999999999996 578999999999998 999998765332
Q ss_pred cccc-ccceecccccccccC
Q 047196 809 SMIQ-TETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~~-~~~~gt~~Y~APE~l 827 (827)
.... ....++..|+|||++
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~ 183 (279)
T cd05057 164 KEYHAEGGKVPIKWMALESI 183 (279)
T ss_pred cceecCCCcccccccCHHHh
Confidence 2111 111246789999963
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.68 E-value=3e-16 Score=166.57 Aligned_cols=150 Identities=25% Similarity=0.367 Sum_probs=113.2
Q ss_pred hcccccceEecCCceEEEEEEecC------CcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCcee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHD------GIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKA 747 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~------g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~ 747 (827)
++|...+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+++++.++|+|++++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 567788999999999999998642 3689999986543 334567899999999999999999999987766544
Q ss_pred eeeeccCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------e
Q 047196 748 LDCLHSTN--------------------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------D 797 (827)
Q Consensus 748 l~~l~~~~--------------------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------D 797 (827)
+...+... ..+.+.....++.+++.|+.||| +.+|+||||||+||+ |
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEECC
Confidence 43222111 12456677889999999999995 678999999999988 9
Q ss_pred ecccccccCCCcc-ccccceecccccccccC
Q 047196 798 FGIGRLLTGDRSM-IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 798 FGla~~~~~~~~~-~~~~~~gt~~Y~APE~l 827 (827)
||+++.+...... ......++..|+|||++
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 193 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESL 193 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHH
Confidence 9998866433221 11223468899999963
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.2e-18 Score=157.11 Aligned_cols=159 Identities=30% Similarity=0.519 Sum_probs=135.5
Q ss_pred CCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCcc
Q 047196 402 NLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSP 481 (827)
Q Consensus 402 ~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 481 (827)
++++.+.|-||+|+++ .+|+.+..+.+|+.|++++|++. .+|.+++.++.|+.|+++-|++. ..|..|+.++.|++|
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 4677778888888887 56667788888888888888887 67888888888888888888887 788889999999999
Q ss_pred ccCCCccc-ccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccceeeecccccccCCCCCCEEECCCCcc
Q 047196 482 DLGSNRLT-SVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGL 560 (827)
Q Consensus 482 ~Ls~N~l~-~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l 560 (827)
||++|++. ..+|..|..+..|+.|.|+.|.++ .+|.+++++++|+.|.+..|.+- ..|.+++.++.|+.|.+.+|++
T Consensus 108 dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl 185 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRL 185 (264)
T ss_pred hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccccee
Confidence 99998885 467888999999999999999997 67889999999999999999987 7899999999999999999999
Q ss_pred eeecC
Q 047196 561 EGLIP 565 (827)
Q Consensus 561 ~g~ip 565 (827)
+-..|
T Consensus 186 ~vlpp 190 (264)
T KOG0617|consen 186 TVLPP 190 (264)
T ss_pred eecCh
Confidence 86555
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.2e-16 Score=173.39 Aligned_cols=144 Identities=26% Similarity=0.393 Sum_probs=111.2
Q ss_pred cccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcC-CC-----CceEEEeeeecCCceee
Q 047196 676 KFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIR-HR-----NHVKRISSCSNEDFKAL 748 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-H~-----niv~~~~~~~~~~~~~l 748 (827)
+|+..++||+|+||.|.||.. ++++.||||+++.. +....+-..|+.+|..++ |. |+|++++++...+...+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 788899999999999999975 56999999999654 334456678999999998 43 69999999877665544
Q ss_pred ee--ec--------c-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee------------eeccccccc
Q 047196 749 DC--LH--------S-TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------------DFGIGRLLT 805 (827)
Q Consensus 749 ~~--l~--------~-~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------------DFGla~~~~ 805 (827)
.+ +. . ....++......|+.||+.||.+|| +.+|||+||||+||| |||.|....
T Consensus 266 VfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 266 VFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred eehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEecccccccC
Confidence 22 11 1 1234566667789999999999995 778999999999998 999987653
Q ss_pred CCCccccccceecccccccccC
Q 047196 806 GDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 806 ~~~~~~~~~~~gt~~Y~APE~l 827 (827)
..-. ..+-+..|+|||||
T Consensus 343 q~vy----tYiQSRfYRAPEVI 360 (586)
T KOG0667|consen 343 QRVY----TYIQSRFYRAPEVI 360 (586)
T ss_pred Ccce----eeeeccccccchhh
Confidence 2211 23458899999986
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.5e-16 Score=169.94 Aligned_cols=150 Identities=27% Similarity=0.417 Sum_probs=111.4
Q ss_pred hcccccceEecCCceEEEEEEec--------CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCC
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH--------DGIEVAIKVFHQNC-AMALKSFEAECEVMKNI-RHRNHVKRISSCSNED 744 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~ 744 (827)
++|...+.||+|+||.||+|+.. ++..||+|.+.... ....+++.+|+++++++ +|+|+++++++|...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 56888899999999999999742 23579999987542 33456788999999999 7999999999998776
Q ss_pred ceeeeeeccC--------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee--
Q 047196 745 FKALDCLHST--------------------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-- 796 (827)
Q Consensus 745 ~~~l~~l~~~--------------------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-- 796 (827)
..++...+.. ...+.+.+.+.++.+++.|++||| +.+|+||||||+||+
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEc
Confidence 5544222211 123667788899999999999996 678999999999988
Q ss_pred --------eecccccccCCCcccc-ccceecccccccccC
Q 047196 797 --------DFGIGRLLTGDRSMIQ-TETLVTIGYMAPGLL 827 (827)
Q Consensus 797 --------DFGla~~~~~~~~~~~-~~~~gt~~Y~APE~l 827 (827)
|||.++.......... ....+++.|||||++
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 214 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 214 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHh
Confidence 8998876543211111 111245789999963
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.3e-16 Score=168.37 Aligned_cols=147 Identities=22% Similarity=0.271 Sum_probs=114.1
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEccc-chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN-CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
+|+..+.||+|+||.||+|+.. +|+.||+|.+... .......+.+|++++++++|+|++++++++...+..++...+.
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5677889999999999999875 6899999988653 2334567899999999999999999999887766554422221
Q ss_pred C-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 754 T-------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 754 ~-------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
. ...+++.....++.++++|+.|||. +.+|+||||||+||+ |||+++.+.....
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 158 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA- 158 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc-
Confidence 1 1256777888999999999999973 458999999999988 9999876532221
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
....++++|+|||++
T Consensus 159 --~~~~~~~~y~aPE~~ 173 (286)
T cd06622 159 --KTNIGCQSYMAPERI 173 (286)
T ss_pred --ccCCCccCccCcchh
Confidence 223478899999963
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.9e-16 Score=168.47 Aligned_cols=149 Identities=28% Similarity=0.339 Sum_probs=117.5
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
.+|+..+.||+|+||.||+|.. .+|+.||||++........+.+.+|++++++++|+|++++++++..++..++...+.
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 3588889999999999999985 568999999987654445567899999999999999999999998776555433322
Q ss_pred C---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccccc
Q 047196 754 T---------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTE 814 (827)
Q Consensus 754 ~---------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~ 814 (827)
. ...+++.++..++.+++.|++||| +.+|+||||||+||+ |||+++........ ...
T Consensus 99 ~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~ 174 (296)
T cd06655 99 AGGSLTDVVTETCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-RST 174 (296)
T ss_pred CCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc-CCC
Confidence 2 224677888899999999999995 678999999999998 99988765443221 122
Q ss_pred ceecccccccccC
Q 047196 815 TLVTIGYMAPGLL 827 (827)
Q Consensus 815 ~~gt~~Y~APE~l 827 (827)
..++..|+|||++
T Consensus 175 ~~~~~~y~aPE~~ 187 (296)
T cd06655 175 MVGTPYWMAPEVV 187 (296)
T ss_pred cCCCccccCcchh
Confidence 3588999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.7e-16 Score=164.97 Aligned_cols=146 Identities=27% Similarity=0.477 Sum_probs=111.5
Q ss_pred ccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHH--HHHHHHHHHHHHhcCCCCceEEEeeeecCCceee--eee
Q 047196 677 FSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMA--LKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL--DCL 751 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~--~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l--~~l 751 (827)
|+..+.||+|+||+||+++.. +++.||+|++....... .....+|+.++++++|+||+++.+++......++ ++.
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999875 56789999997654332 2344669999999999999999999987665443 222
Q ss_pred cc--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccc
Q 047196 752 HS--------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQT 813 (827)
Q Consensus 752 ~~--------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~ 813 (827)
.. ....+++.....++.++++||+||| +.+|+||||||+||+ |||.+........ ...
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~-~~~ 156 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE-NFN 156 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS-EBS
T ss_pred ccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc-ccc
Confidence 22 1345677788999999999999996 468999999999998 9999876422222 122
Q ss_pred cceeccccccccc
Q 047196 814 ETLVTIGYMAPGL 826 (827)
Q Consensus 814 ~~~gt~~Y~APE~ 826 (827)
...+|..|+|||+
T Consensus 157 ~~~~~~~y~aPE~ 169 (260)
T PF00069_consen 157 PFVGTPEYMAPEV 169 (260)
T ss_dssp SSSSSGGGSCHHH
T ss_pred ccccccccccccc
Confidence 3458999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.9e-16 Score=163.79 Aligned_cols=150 Identities=22% Similarity=0.320 Sum_probs=110.7
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEccc-----chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC--ce
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN-----CAMALKSFEAECEVMKNIRHRNHVKRISSCSNED--FK 746 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~--~~ 746 (827)
.+|+..+.||+|+||.||+|... +|+.||||++... .....+.+.+|++++++++|+|+++.++++.+.. ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46788899999999999999864 5899999988532 1234567899999999999999999999876542 22
Q ss_pred ee--eeeccC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccC
Q 047196 747 AL--DCLHST--------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806 (827)
Q Consensus 747 ~l--~~l~~~--------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~ 806 (827)
.+ ++.... ...+++.....++.+++.||+||| +.+|+||||||+||+ |||+++....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 22 222111 123456667889999999999995 667999999999998 9999876532
Q ss_pred CCcc--ccccceecccccccccC
Q 047196 807 DRSM--IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 807 ~~~~--~~~~~~gt~~Y~APE~l 827 (827)
.... ......|+..|+|||++
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~ 181 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVI 181 (265)
T ss_pred ccccccccccCCCCccccChhhh
Confidence 2111 11223488999999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.2e-17 Score=182.66 Aligned_cols=147 Identities=30% Similarity=0.487 Sum_probs=114.0
Q ss_pred ccccceEecCCceEEEEEEe-cCC----cEEEEEEEccc-chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee--
Q 047196 677 FSKENLIGVGSFGSVYKGRL-HDG----IEVAIKVFHQN-CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL-- 748 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~-~~g----~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l-- 748 (827)
..+.++||+|+||+||||.+ +.| .+||||++... ..+..+++.+|+-+|++++|||++|++|.|.....+..
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq 777 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQ 777 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHH
Confidence 44568999999999999975 443 57999998654 45567889999999999999999999999987663322
Q ss_pred --------eeeccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 749 --------DCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 749 --------~~l~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
++.+.....+...+.+.+..|||+|+.||| .++++||||.+.||| |||+|+++..+...
T Consensus 778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 333334455666677889999999999995 788999999999999 99999999776654
Q ss_pred ccccce-eccccccccc
Q 047196 811 IQTETL-VTIGYMAPGL 826 (827)
Q Consensus 811 ~~~~~~-gt~~Y~APE~ 826 (827)
...... ..+.|||=|.
T Consensus 855 y~~~~gK~pikwmale~ 871 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALES 871 (1177)
T ss_pred ccccccccCcHHHHHHH
Confidence 322211 3567887664
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.6e-16 Score=163.09 Aligned_cols=145 Identities=26% Similarity=0.460 Sum_probs=113.4
Q ss_pred hhcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
.++|+..+.||+|+||.||+|... |+.||||++..... ..+++.+|+.++++++|+|++++++++...+...+...+.
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 356788899999999999999875 78999999976543 5678999999999999999999999988655444422221
Q ss_pred CC------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 754 TN------------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 754 ~~------------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
.. ..+.+.....++.+++.|+.||| +.+|+||||||+||+ |||.++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 11 14677888899999999999995 678999999999998 8998876632211
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
...++.+|+|||++
T Consensus 158 --~~~~~~~~~ape~~ 171 (256)
T cd05039 158 --SGKLPVKWTAPEAL 171 (256)
T ss_pred --cCCCcccccCchhh
Confidence 12356789999963
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.1e-16 Score=168.97 Aligned_cols=147 Identities=23% Similarity=0.409 Sum_probs=109.2
Q ss_pred ccccceEecCCceEEEEEEec------CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeee
Q 047196 677 FSKENLIGVGSFGSVYKGRLH------DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALD 749 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~ 749 (827)
|...+.||+|+||.||+|+.. ....||+|.+.... ....+++.+|++++++++|||||++++.|...+..++.
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence 566788999999999999752 23579999886543 33456799999999999999999999998776654442
Q ss_pred eeccCC----------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCcce
Q 047196 750 CLHSTN----------------------------------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNV 795 (827)
Q Consensus 750 ~l~~~~----------------------------------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NI 795 (827)
..+... ..+.+.....++.+++.|++||| +.+|+||||||+||
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~ni 158 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNV 158 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhheE
Confidence 222110 12456677899999999999996 67899999999999
Q ss_pred e----------eecccccccCCCcccc-ccceeccccccccc
Q 047196 796 F----------DFGIGRLLTGDRSMIQ-TETLVTIGYMAPGL 826 (827)
Q Consensus 796 l----------DFGla~~~~~~~~~~~-~~~~gt~~Y~APE~ 826 (827)
+ |||+++.......... ....++..|+|||+
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~ 200 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIES 200 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHH
Confidence 8 9999886543322111 11235778999996
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1e-17 Score=163.25 Aligned_cols=149 Identities=26% Similarity=0.390 Sum_probs=110.8
Q ss_pred cccccceEecCCceEEEEEEe-cCCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee----
Q 047196 676 KFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL---- 748 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l---- 748 (827)
+.+..+-||-|+||+||..++ ++|+.||.|++..- .-...+++.+|++++.-.+|.|+...++........+.
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 456678899999999999986 47999999998642 22345788999999999999999987766543321111
Q ss_pred ---eee----c---cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 749 ---DCL----H---STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 749 ---~~l----~---~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
+.+ | .....++-....-...||.+||.|| |+.+|+||||||.|+| |||+||....+.
T Consensus 134 V~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYL---HsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 134 VLTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYL---HTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHH---hhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 111 1 1122344334445678999999999 5788999999999987 999999887666
Q ss_pred ccccccceecccccccccC
Q 047196 809 SMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~~~~~~gt~~Y~APE~l 827 (827)
....+..+.|-+|.|||++
T Consensus 211 ~~hMTqEVVTQYYRAPEiL 229 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELL 229 (449)
T ss_pred hhhhHHHHHHHHhccHHHh
Confidence 5555556689999999975
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.4e-16 Score=166.37 Aligned_cols=151 Identities=24% Similarity=0.453 Sum_probs=113.5
Q ss_pred hhcccccceEecCCceEEEEEEec-CC---cEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DG---IEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL 748 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g---~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l 748 (827)
..+|+..+.||+|+||.||+|+.. ++ ..||||++.... ....+++.+|++++++++|+|++++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 356888899999999999999864 33 379999986542 3445679999999999999999999999987765544
Q ss_pred eeeccC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCC
Q 047196 749 DCLHST-----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGD 807 (827)
Q Consensus 749 ~~l~~~-----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~ 807 (827)
...+.. ...+++.+...++.+++.|++||| +.+|+||||||+||+ |||+++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 332221 234677788899999999999995 668999999999987 99998766433
Q ss_pred Ccccccc--ceecccccccccC
Q 047196 808 RSMIQTE--TLVTIGYMAPGLL 827 (827)
Q Consensus 808 ~~~~~~~--~~gt~~Y~APE~l 827 (827)
....... ...+..|+|||++
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~ 182 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAI 182 (268)
T ss_pred cccceeccCCCcCceecCHHHh
Confidence 2211111 1135679999963
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=2e-16 Score=168.99 Aligned_cols=150 Identities=25% Similarity=0.381 Sum_probs=112.6
Q ss_pred hhcccccceEecCCceEEEEEEec------CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCce
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH------DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFK 746 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~ 746 (827)
..+|+..+.||+|+||.||+|+.. ++..||+|++.... ....++|.+|++++++++|||++++++++..++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457888899999999999999853 46789999987543 33456799999999999999999999998876644
Q ss_pred eeeeeccCC--------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCcc
Q 047196 747 ALDCLHSTN--------------------------------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKN 794 (827)
Q Consensus 747 ~l~~l~~~~--------------------------------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~N 794 (827)
++...+... ..+.+...+.++.+++.||+||| +++++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence 432222111 12456667889999999999996 6789999999999
Q ss_pred ee----------eecccccccCCCcc-ccccceeccccccccc
Q 047196 795 VF----------DFGIGRLLTGDRSM-IQTETLVTIGYMAPGL 826 (827)
Q Consensus 795 Il----------DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~ 826 (827)
|+ |||+++........ .......+..|+|||+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 203 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPES 203 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHH
Confidence 88 99998765432211 1112235678999996
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.4e-16 Score=168.42 Aligned_cols=153 Identities=27% Similarity=0.400 Sum_probs=115.6
Q ss_pred HHhhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC----
Q 047196 672 RATEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNED---- 744 (827)
Q Consensus 672 ~~~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~---- 744 (827)
...++|+..+.||+|+||.||+|..+ +|+.||||+++... ......+.+|++++++++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35578889999999999999999875 58999999986432 223356788999999999999999999886644
Q ss_pred ------ceee--eeecc--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------ee
Q 047196 745 ------FKAL--DCLHS--------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DF 798 (827)
Q Consensus 745 ------~~~l--~~l~~--------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DF 798 (827)
..++ ++... ....+++.....++.+++.||+||| +.+|+||||||+||+ ||
T Consensus 84 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 84 FKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred ccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCcc
Confidence 2222 22211 1234678888999999999999995 668999999999987 99
Q ss_pred cccccccCCCccccccceecccccccccC
Q 047196 799 GIGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 799 Gla~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
|+++..............++..|+|||++
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~ 189 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELL 189 (302)
T ss_pred cccccccCCcccccccceeccCccChHHh
Confidence 99887654332211223468899999963
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.1e-17 Score=157.84 Aligned_cols=152 Identities=23% Similarity=0.294 Sum_probs=114.1
Q ss_pred hcccccceEecCCceEEEEEE-ecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc-----eee
Q 047196 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF-----KAL 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~-----~~l 748 (827)
++|...+.+|+|+|+.||.++ ..+++.+|+|++.-...+..+...+|++..++++|||++++++++..+.. .++
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl 100 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL 100 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence 568888999999999999998 67889999999976666677889999999999999999999888744321 222
Q ss_pred --eee------------ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccc
Q 047196 749 --DCL------------HSTNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLL 804 (827)
Q Consensus 749 --~~l------------~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~ 804 (827)
.+. ...+...+..+.+.|..++++||++||. -.++.+||||||+||| |||.+...
T Consensus 101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a 179 (302)
T KOG2345|consen 101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-KEPPYAHRDIKPANILLSDSGLPVLMDLGSATQA 179 (302)
T ss_pred EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-cCCcccccCCCcceeEecCCCceEEEeccCcccc
Confidence 111 1122356777888999999999999985 4567999999999998 99987654
Q ss_pred cCC---Cccc---c--ccceecccccccccC
Q 047196 805 TGD---RSMI---Q--TETLVTIGYMAPGLL 827 (827)
Q Consensus 805 ~~~---~~~~---~--~~~~gt~~Y~APE~l 827 (827)
... ...+ + .+..-|..|+|||.+
T Consensus 180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf 210 (302)
T KOG2345|consen 180 PIQIEGSRQALRLQEWAEERCTIPYRAPELF 210 (302)
T ss_pred ceEeechHHHHHHHHHHHHhCCCcccCchhe
Confidence 211 1100 0 112248899999964
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.2e-16 Score=172.01 Aligned_cols=156 Identities=24% Similarity=0.369 Sum_probs=118.1
Q ss_pred ccchhHHHHHhhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeee
Q 047196 664 RFSYQDLFRATEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSC 740 (827)
Q Consensus 664 ~~~~~~~~~~~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~ 740 (827)
.....++...+++|...+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++++++|+||+++.+++
T Consensus 6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~ 85 (345)
T cd07877 6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF 85 (345)
T ss_pred hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence 344566777889999999999999999999985 578999999986532 23346788999999999999999999887
Q ss_pred ecCC------ceee-eeecc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------
Q 047196 741 SNED------FKAL-DCLHS-------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---------- 796 (827)
Q Consensus 741 ~~~~------~~~l-~~l~~-------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---------- 796 (827)
.... ..++ ..... ....+.+.....++.++++|++||| +.+|+||||||+||+
T Consensus 86 ~~~~~~~~~~~~~lv~~~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~ 162 (345)
T cd07877 86 TPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 162 (345)
T ss_pred eecccccccccEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEEe
Confidence 5432 1111 11111 1124677788889999999999996 578999999999998
Q ss_pred eecccccccCCCccccccceeccccccccc
Q 047196 797 DFGIGRLLTGDRSMIQTETLVTIGYMAPGL 826 (827)
Q Consensus 797 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~ 826 (827)
|||+++...... ....++..|+|||+
T Consensus 163 dfg~~~~~~~~~----~~~~~~~~y~aPE~ 188 (345)
T cd07877 163 DFGLARHTDDEM----TGYVATRWYRAPEI 188 (345)
T ss_pred cccccccccccc----cccccCCCccCHHH
Confidence 999887643221 22347899999996
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.1e-16 Score=163.64 Aligned_cols=143 Identities=24% Similarity=0.429 Sum_probs=106.2
Q ss_pred eEecCCceEEEEEEec---CCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCcee-eeeeccC-
Q 047196 682 LIGVGSFGSVYKGRLH---DGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKA-LDCLHST- 754 (827)
Q Consensus 682 ~iG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~-l~~l~~~- 754 (827)
.||+|+||.||+|.++ ++..||||++.... ....+++.+|+.++++++|+|++++++++..+.... +++....
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~ 81 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP 81 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence 5899999999999653 57889999986432 344578999999999999999999999986554322 2222111
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc--cccc
Q 047196 755 -------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI--QTET 815 (827)
Q Consensus 755 -------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~--~~~~ 815 (827)
...+++.....++.+++.|++|+| +++|+||||||.||+ |||+++......... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 82 LNKFLQKNKHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence 123566778899999999999995 678999999999987 999998765433221 1112
Q ss_pred eecccccccccC
Q 047196 816 LVTIGYMAPGLL 827 (827)
Q Consensus 816 ~gt~~Y~APE~l 827 (827)
.++..|+|||++
T Consensus 159 ~~~~~y~aPE~~ 170 (257)
T cd05116 159 KWPVKWYAPECM 170 (257)
T ss_pred CCCccccCHhHh
Confidence 246789999963
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.5e-16 Score=167.86 Aligned_cols=149 Identities=25% Similarity=0.463 Sum_probs=111.5
Q ss_pred cccccceEecCCceEEEEEEe-----cCCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecC--Cce-
Q 047196 676 KFSKENLIGVGSFGSVYKGRL-----HDGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNE--DFK- 746 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~-----~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~--~~~- 746 (827)
-|...+.||+|+||.||+|++ .++..||+|.+.... ....+.+.+|++++++++|+|++++.+++... ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 356778899999999999974 247889999986442 34456799999999999999999999988764 222
Q ss_pred -eeeeecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccC
Q 047196 747 -ALDCLHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806 (827)
Q Consensus 747 -~l~~l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~ 806 (827)
.+++... ....+++.++..++.+++.|++|+| +++|+||||||+||+ |||+++.+..
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 2232211 1124677888899999999999995 678999999999998 9999887643
Q ss_pred CCcc--ccccceecccccccccC
Q 047196 807 DRSM--IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 807 ~~~~--~~~~~~gt~~Y~APE~l 827 (827)
.... ......++..|+|||++
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~ 184 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECL 184 (284)
T ss_pred CccceeecCCCCCCccccCHHHh
Confidence 3221 11122367789999963
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=4e-16 Score=166.89 Aligned_cols=145 Identities=27% Similarity=0.336 Sum_probs=114.3
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeee
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l 751 (827)
+|...+.||+|+||.||++... +++.||||++.... ....+.+.+|++++++++|||++++++++.++...++...
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 5777899999999999999864 68999999986432 2345678999999999999999999999887765544332
Q ss_pred ccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 752 HST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 752 ~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
+.. ...+.......++.++++|+.||| +.+|+||||||+||+ |||+++......
T Consensus 82 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~--- 155 (290)
T cd05580 82 YVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT--- 155 (290)
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCC---
Confidence 221 234566777889999999999996 578999999999998 999987764431
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
....|+++|+|||++
T Consensus 156 -~~~~~~~~y~aPE~~ 170 (290)
T cd05580 156 -YTLCGTPEYLAPEII 170 (290)
T ss_pred -CCCCCCccccChhhh
Confidence 223489999999963
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.8e-16 Score=166.37 Aligned_cols=147 Identities=26% Similarity=0.410 Sum_probs=109.2
Q ss_pred cccceEecCCceEEEEEEe-----cCCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC--ceee-
Q 047196 678 SKENLIGVGSFGSVYKGRL-----HDGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNED--FKAL- 748 (827)
Q Consensus 678 ~~~~~iG~G~fg~Vy~~~~-----~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~--~~~l- 748 (827)
...+.||+|+||+||+++. .+++.||+|.+.... ....+.|.+|++++++++|||++++.+++.... ..++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 6778999999999988653 357899999987543 234567899999999999999999999886543 2222
Q ss_pred -eeecc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 749 -DCLHS-------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 749 -~~l~~-------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
++... ....+++.+...++.++++|++||| +.+|+||||||+||+ |||+++........
T Consensus 87 ~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 163 (283)
T cd05080 87 MEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 163 (283)
T ss_pred ecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCcchh
Confidence 22211 1234678888999999999999996 668999999999998 99999876533221
Q ss_pred c--cccceecccccccccC
Q 047196 811 I--QTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~--~~~~~gt~~Y~APE~l 827 (827)
. .....++..|+|||++
T Consensus 164 ~~~~~~~~~~~~~~~PE~~ 182 (283)
T cd05080 164 YRVREDGDSPVFWYAVECL 182 (283)
T ss_pred hccCCCCCCCceeeCHhHh
Confidence 1 1112256779999963
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.67 E-value=6.1e-16 Score=163.23 Aligned_cols=149 Identities=22% Similarity=0.302 Sum_probs=110.6
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccc-----hHHHHHHHHHHHHHHhcCCCCceEEEeeeecC--Ccee
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC-----AMALKSFEAECEVMKNIRHRNHVKRISSCSNE--DFKA 747 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~--~~~~ 747 (827)
+|...+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++|+|++++.+++... ...+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 6788899999999999999864 68999999885321 23346789999999999999999999987653 2222
Q ss_pred eeeeccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCC
Q 047196 748 LDCLHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGD 807 (827)
Q Consensus 748 l~~l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~ 807 (827)
+...+.. ...+++.....++.++++|++||| +.+|+||||||+||+ |||+++.+...
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 2221111 124567777889999999999995 678999999999988 99998765332
Q ss_pred Ccc--ccccceecccccccccC
Q 047196 808 RSM--IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 808 ~~~--~~~~~~gt~~Y~APE~l 827 (827)
... ......++.+|+|||++
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~ 181 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVI 181 (266)
T ss_pred cccCCccccCCccccccCHHHh
Confidence 111 11123478999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.6e-16 Score=162.90 Aligned_cols=148 Identities=24% Similarity=0.305 Sum_probs=114.7
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
+|+..+.||+|+||.||+|+.. +|+.||+|++... .....+++.+|++++++++|||++++++++...+..++...+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 3667789999999999999864 6899999998643 234567899999999999999999999998877655443322
Q ss_pred cC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 753 ST------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 753 ~~------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
.. ...+.+.....++.+++.|+.||| +.+|+||||||+||+ |||+++.+......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 21 234566677889999999999995 678999999999997 99998876543221
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
.....|++.|+|||++
T Consensus 158 -~~~~~~~~~y~aPE~~ 173 (256)
T cd08529 158 -ANTIVGTPYYLSPELC 173 (256)
T ss_pred -hhccccCccccCHHHh
Confidence 1223488999999973
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.2e-16 Score=168.22 Aligned_cols=145 Identities=28% Similarity=0.342 Sum_probs=114.1
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEccc---chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN---CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
+.|...+.||+|+||.||+|+.. +|+.||+|++... .....+++.+|++++++++|||++++.++|...+..++..
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45788899999999999999864 6899999998643 2334467899999999999999999999998776555432
Q ss_pred ecc----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 751 LHS----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 751 l~~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
.+. ....+.+.....++.|++.|+.||| +.+|+||||||+||+ |||+++.....
T Consensus 95 e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--- 168 (307)
T cd06607 95 EYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--- 168 (307)
T ss_pred HhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence 221 1234677788889999999999995 678999999999998 89988755322
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
....+++.|+|||++
T Consensus 169 --~~~~~~~~y~aPE~~ 183 (307)
T cd06607 169 --NSFVGTPYWMAPEVI 183 (307)
T ss_pred --CCccCCccccCceee
Confidence 123478899999963
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.67 E-value=8e-17 Score=169.12 Aligned_cols=139 Identities=24% Similarity=0.367 Sum_probs=103.2
Q ss_pred ceEecCCceEEEEEEecC--------CcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee--ee
Q 047196 681 NLIGVGSFGSVYKGRLHD--------GIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL--DC 750 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~~--------g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l--~~ 750 (827)
+.||+|+||.||+|..+. ...||+|.+........+++..|+.+++.++|||+|++++++..++..++ ++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 368999999999997532 23488898865555556788999999999999999999999987654444 22
Q ss_pred ecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee------------------eeccccc
Q 047196 751 LHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------------------DFGIGRL 803 (827)
Q Consensus 751 l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------------------DFGla~~ 803 (827)
... ....+++.....++.|++.|++||| +++|+||||||+||+ |||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 221 1224677788889999999999995 678999999999988 4444432
Q ss_pred ccCCCccccccceecccccccccC
Q 047196 804 LTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 804 ~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
... .....+++.|+|||++
T Consensus 158 ~~~-----~~~~~~~~~y~aPE~~ 176 (258)
T cd05078 158 VLP-----KEILLERIPWVPPECI 176 (258)
T ss_pred cCC-----chhccccCCccCchhc
Confidence 211 1123478899999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.6e-16 Score=164.92 Aligned_cols=149 Identities=26% Similarity=0.420 Sum_probs=112.4
Q ss_pred hcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeeccC
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHST 754 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~ 754 (827)
.+|+..+.||+|+||.||+|.+.+++.+|||++..... ....|.+|++++++++||+++++++++......++...+..
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 35777889999999999999887788999999865432 24578999999999999999999999877665544322221
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccc
Q 047196 755 -----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQT 813 (827)
Q Consensus 755 -----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~ 813 (827)
...+.+.....++.+++.|++||| +.+++||||||+||+ |||+++...........
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence 233567777889999999999995 567999999999988 89988765432211111
Q ss_pred cceecccccccccC
Q 047196 814 ETLVTIGYMAPGLL 827 (827)
Q Consensus 814 ~~~gt~~Y~APE~l 827 (827)
...++.+|+|||++
T Consensus 160 ~~~~~~~~~aPe~~ 173 (256)
T cd05112 160 GTKFPVKWSSPEVF 173 (256)
T ss_pred CCccchhhcCHhHh
Confidence 22356789999963
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.7e-16 Score=164.89 Aligned_cols=149 Identities=24% Similarity=0.381 Sum_probs=113.6
Q ss_pred cccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc------hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee
Q 047196 676 KFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC------AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL 748 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~------~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l 748 (827)
+|+..+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|++++++++|+|+|++++++.+.+...+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 367788999999999999985 578999999986432 1235679999999999999999999999987765444
Q ss_pred eeeccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------eecccccccCC
Q 047196 749 DCLHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRLLTGD 807 (827)
Q Consensus 749 ~~l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGla~~~~~~ 807 (827)
...+... ..+++.....++.++++|++||| +.+|+||||||+||+ |||.++.....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 3333221 24566677889999999999995 678999999999988 88888766432
Q ss_pred Ccc---ccccceecccccccccC
Q 047196 808 RSM---IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 808 ~~~---~~~~~~gt~~Y~APE~l 827 (827)
... ......||..|+|||++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~ 180 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVL 180 (268)
T ss_pred cccCCccccccccccceeCHhHh
Confidence 111 11223478999999963
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.4e-16 Score=172.43 Aligned_cols=150 Identities=24% Similarity=0.405 Sum_probs=112.7
Q ss_pred hhcccccceEecCCceEEEEEEe-cCCcEEEEEEEccc-chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc-----e
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQN-CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF-----K 746 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~-----~ 746 (827)
+++|...+.||+|+||.||+|+. .+|+.||||++... ......++.+|++++++++|+|++++++++....+ .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46788899999999999999985 46899999998642 23345678899999999999999999988765432 1
Q ss_pred ee--eeecc------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 747 AL--DCLHS------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 747 ~l--~~l~~------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
++ +++.. ....+.+.....++.++++||+||| +.+|+||||||+||+ |||+++......
T Consensus 84 ~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 84 YIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred EEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 21 22211 1234667777889999999999995 678999999999997 999987654322
Q ss_pred ccc--cccceeccccccccc
Q 047196 809 SMI--QTETLVTIGYMAPGL 826 (827)
Q Consensus 809 ~~~--~~~~~gt~~Y~APE~ 826 (827)
... .....||..|||||+
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~ 180 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEI 180 (336)
T ss_pred cccCCcCCcCcCCCccChHH
Confidence 211 122358999999996
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.5e-16 Score=164.40 Aligned_cols=150 Identities=27% Similarity=0.474 Sum_probs=113.9
Q ss_pred hhcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
.++|...+.||+|+||.||+|...+++.||||.+.... ...+++.+|++++++++|+|++++++++......++...+.
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 35788889999999999999998778889999987543 23467899999999999999999999987655444322221
Q ss_pred C------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 754 T------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 754 ~------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
. ...+.+.+...++.+++.|++||| +.+|+||||||+||+ |||+++....+....
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence 1 124677788899999999999995 667999999999988 999887664322111
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
.....++..|+|||++
T Consensus 161 ~~~~~~~~~y~~PE~~ 176 (261)
T cd05034 161 REGAKFPIKWTAPEAA 176 (261)
T ss_pred hhccCCCccccCHHHh
Confidence 1112246789999963
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.7e-16 Score=165.89 Aligned_cols=149 Identities=29% Similarity=0.417 Sum_probs=114.2
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEccc---chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQN---CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
++|+..+.||+|+||.||+|+. .+|+.||||.+... .....+++.+|+++++.++|+|++++++++..++..++..
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4577788999999999999985 57899999988642 2234567899999999999999999999987766544322
Q ss_pred eccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccC
Q 047196 751 LHST--------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806 (827)
Q Consensus 751 l~~~--------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~ 806 (827)
.+.. ...+.+.....++.++++|++||| +.+|+|+||||+||+ |||+++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 2111 223567777889999999999995 678999999999997 9998876643
Q ss_pred CCccccccceecccccccccC
Q 047196 807 DRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 807 ~~~~~~~~~~gt~~Y~APE~l 827 (827)
.... .....|+.+|+|||++
T Consensus 159 ~~~~-~~~~~~~~~~~ape~~ 178 (267)
T cd08229 159 KTTA-AHSLVGTPYYMSPERI 178 (267)
T ss_pred CCcc-cccccCCcCccCHHHh
Confidence 3221 1223588999999963
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.4e-16 Score=177.37 Aligned_cols=152 Identities=18% Similarity=0.261 Sum_probs=102.5
Q ss_pred HhhcccccceEecCCceEEEEEEe-----------------cCCcEEEEEEEcccchHHHH--------------HHHHH
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRL-----------------HDGIEVAIKVFHQNCAMALK--------------SFEAE 721 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~-----------------~~g~~vAvK~l~~~~~~~~~--------------~~~~E 721 (827)
..++|+..++||+|+||.||+|.+ .+++.||||++........+ .+..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 356899999999999999999964 23568999998643322222 34457
Q ss_pred HHHHHhcCCCCc-----eEEEeeeecC--------CceeeeeeccCC---------------------------------
Q 047196 722 CEVMKNIRHRNH-----VKRISSCSNE--------DFKALDCLHSTN--------------------------------- 755 (827)
Q Consensus 722 i~~l~~l~H~ni-----v~~~~~~~~~--------~~~~l~~l~~~~--------------------------------- 755 (827)
+.++.+++|.++ ++++++|... ...++.+.+..+
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 788888887765 5667776431 122232222111
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccccceeccccccc
Q 047196 756 -CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824 (827)
Q Consensus 756 -~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~~~gt~~Y~AP 824 (827)
..+++.....++.++++++.|+| +.+|+||||||+||+ |||+++..............+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12245556778999999999996 567999999999998 9999976543222111122358899999
Q ss_pred ccC
Q 047196 825 GLL 827 (827)
Q Consensus 825 E~l 827 (827)
|++
T Consensus 380 E~l 382 (507)
T PLN03224 380 EEL 382 (507)
T ss_pred hhh
Confidence 974
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.4e-16 Score=165.39 Aligned_cols=137 Identities=26% Similarity=0.444 Sum_probs=101.7
Q ss_pred ceEecCCceEEEEEEecC-C----------cEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee-
Q 047196 681 NLIGVGSFGSVYKGRLHD-G----------IEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL- 748 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~~-g----------~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l- 748 (827)
+.||+|+||.||+|+.++ + ..||+|++...... .+.|.+|++++++++|+|++++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 468999999999998754 3 25788877544332 6789999999999999999999999876 33333
Q ss_pred -eeecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------------eeccc
Q 047196 749 -DCLHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------------DFGIG 801 (827)
Q Consensus 749 -~~l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------------DFGla 801 (827)
++... ....+.+..+..++.+++.||+||| +++|+||||||+||+ |||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 22211 1124667778899999999999995 678999999999987 56666
Q ss_pred ccccCCCccccccceecccccccccC
Q 047196 802 RLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 802 ~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
+.... .....++..|+|||++
T Consensus 156 ~~~~~-----~~~~~~~~~y~aPE~~ 176 (259)
T cd05037 156 ITVLS-----REERVERIPWIAPECI 176 (259)
T ss_pred ccccc-----ccccccCCCccChhhh
Confidence 54332 1123467889999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.6e-16 Score=169.98 Aligned_cols=150 Identities=27% Similarity=0.426 Sum_probs=110.5
Q ss_pred hcccccceEecCCceEEEEEEec--------CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCC
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH--------DGIEVAIKVFHQNC-AMALKSFEAECEVMKNI-RHRNHVKRISSCSNED 744 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~ 744 (827)
.+|...+.||+|+||.||+|+.. .+..||+|.+.... ....+++.+|+++++++ +|+||++++++|...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 45778899999999999999742 12469999886532 33457899999999999 7999999999998766
Q ss_pred ceeeeeeccC--------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee--
Q 047196 745 FKALDCLHST--------------------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-- 796 (827)
Q Consensus 745 ~~~l~~l~~~--------------------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-- 796 (827)
..++...+.. ...+.+.+...++.++++|++||| +++|+||||||+||+
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEc
Confidence 4443222111 123567778889999999999995 678999999999998
Q ss_pred --------eecccccccCCCccc-cccceecccccccccC
Q 047196 797 --------DFGIGRLLTGDRSMI-QTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 --------DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l 827 (827)
|||+++......... .....++..|||||++
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 208 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEAL 208 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHh
Confidence 999987654322111 1112246789999974
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.4e-16 Score=163.48 Aligned_cols=149 Identities=29% Similarity=0.401 Sum_probs=115.1
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEccc---chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN---CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
++|+..+.||+|+||.||+|... +|+.||+|.++.. .....+++.+|++++++++|+++++.++++...+...+..
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 56888899999999999999875 7899999988532 2334568999999999999999999999988766554422
Q ss_pred eccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccC
Q 047196 751 LHST--------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806 (827)
Q Consensus 751 l~~~--------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~ 806 (827)
.+.. ...+.+.+...++.++++|++||| +.+|+||||||+||+ |||+++.+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 2211 123566777889999999999995 678999999999988 9998876543
Q ss_pred CCccccccceecccccccccC
Q 047196 807 DRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 807 ~~~~~~~~~~gt~~Y~APE~l 827 (827)
.... .....+++.|+|||++
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~ 178 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERI 178 (267)
T ss_pred CCcc-cceecCCccccCHHHh
Confidence 3221 1223488999999963
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.1e-16 Score=170.49 Aligned_cols=148 Identities=26% Similarity=0.364 Sum_probs=112.5
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
+|+..+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|++++++++|+|++++++++.+....++...+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 3667788999999999999864 68999999986432 12235678899999999999999999988776654442222
Q ss_pred c----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 753 S----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 753 ~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
. ....+++.....++.++++|+.||| +++|+||||||+||+ |||+++........ .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~ 156 (284)
T cd07839 81 CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC-Y 156 (284)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC-c
Confidence 1 1234677778899999999999996 568999999999998 99998865432221 1
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
....+++.|+|||++
T Consensus 157 ~~~~~~~~y~aPE~~ 171 (284)
T cd07839 157 SAEVVTLWYRPPDVL 171 (284)
T ss_pred CCCccccCCcChHHH
Confidence 223478999999963
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.1e-16 Score=168.10 Aligned_cols=151 Identities=27% Similarity=0.429 Sum_probs=111.2
Q ss_pred hhcccccceEecCCceEEEEEEec--------CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecC
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH--------DGIEVAIKVFHQNC-AMALKSFEAECEVMKNI-RHRNHVKRISSCSNE 743 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~ 743 (827)
.++|...+.||+|+||.||+|+.. .+..||+|++.... .....++.+|+++++++ +|||||+++++|...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 357888899999999999999741 24579999986532 34456789999999999 699999999998776
Q ss_pred CceeeeeeccC--------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-
Q 047196 744 DFKALDCLHST--------------------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF- 796 (827)
Q Consensus 744 ~~~~l~~l~~~--------------------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl- 796 (827)
...++...+.. ...+.+.+...++.+++.|++||| +++|+||||||+||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEE
Confidence 64433222111 123667778889999999999995 678999999999998
Q ss_pred ---------eecccccccCCCccc-cccceecccccccccC
Q 047196 797 ---------DFGIGRLLTGDRSMI-QTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 ---------DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l 827 (827)
|||+++......... .....++..|||||++
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 208 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEAL 208 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHH
Confidence 999998664322111 1111245689999963
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.3e-16 Score=168.03 Aligned_cols=149 Identities=22% Similarity=0.365 Sum_probs=110.3
Q ss_pred hcccccceEecCCceEEEEEEec-----------------CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEE
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-----------------DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKR 736 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-----------------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~ 736 (827)
++|+..+.||+|+||.||+++.. ++..||||++.... ....++|.+|++++++++|+|++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888899999999999998532 24569999987543 3345689999999999999999999
Q ss_pred EeeeecCCceeeeeeccCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCcce
Q 047196 737 ISSCSNEDFKALDCLHSTN---------------------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNV 795 (827)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~~---------------------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NI 795 (827)
++++...+..++...+... ..+++.....++.+++.|++||| +.+|+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence 9998776654442222111 12445677889999999999996 66899999999998
Q ss_pred e----------eecccccccCCCccc-cccceeccccccccc
Q 047196 796 F----------DFGIGRLLTGDRSMI-QTETLVTIGYMAPGL 826 (827)
Q Consensus 796 l----------DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~ 826 (827)
+ |||+++.+....... .....+++.|+|||+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~ 203 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWES 203 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHH
Confidence 8 999988654332211 111224678999995
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.3e-16 Score=162.59 Aligned_cols=147 Identities=27% Similarity=0.342 Sum_probs=113.6
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccc-----hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeee
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC-----AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALD 749 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~ 749 (827)
+|+..+.||+|+||+||+|... +++.||+|++.... ....+.+.+|++++++++|+|++++.+++......++.
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999875 78999999986432 23456799999999999999999999998876654443
Q ss_pred eeccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 750 CLHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 750 ~l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
..+.. ...+++.....++.++++|++||| +.+|+|+||||+||+ |||+++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 32221 123567777889999999999996 568999999999997 899887654332
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
......|+..|+|||++
T Consensus 157 -~~~~~~~~~~y~~pe~~ 173 (258)
T cd06632 157 -FAKSFKGSPYWMAPEVI 173 (258)
T ss_pred -cccccCCCcceeCHHHh
Confidence 11223478999999963
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.5e-18 Score=156.65 Aligned_cols=161 Identities=26% Similarity=0.478 Sum_probs=144.7
Q ss_pred cccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecC
Q 047196 381 SLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLA 460 (827)
Q Consensus 381 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 460 (827)
.++.|.||+|+++ .+|..+..+.+|+.|++++|+++ .+|.+++.+++|+.|+++-|++. ..|..|+.++.|++|||.
T Consensus 34 ~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldlt 110 (264)
T KOG0617|consen 34 NITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLT 110 (264)
T ss_pred hhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhcc
Confidence 6788899999998 67778899999999999999998 67889999999999999999998 789999999999999999
Q ss_pred CCcccc-cCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccceeeec
Q 047196 461 GNKFSG-SIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGD 539 (827)
Q Consensus 461 ~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ 539 (827)
+|++.. .+|..|..++.|+.|+|+.|.+. .+|..++++++|+.|.+..|.+- .+|.+++.+..|++|.+.+|.++ .
T Consensus 111 ynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~-v 187 (264)
T KOG0617|consen 111 YNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT-V 187 (264)
T ss_pred ccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee-e
Confidence 999975 46888888999999999999997 57888999999999999999986 58999999999999999999999 6
Q ss_pred ccccccCC
Q 047196 540 IPSTIGDL 547 (827)
Q Consensus 540 ip~~~~~l 547 (827)
+|++++++
T Consensus 188 lppel~~l 195 (264)
T KOG0617|consen 188 LPPELANL 195 (264)
T ss_pred cChhhhhh
Confidence 78777765
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.5e-16 Score=167.60 Aligned_cols=148 Identities=28% Similarity=0.470 Sum_probs=109.2
Q ss_pred hcccccceEecCCceEEEEEEec-CCc--EEEEEEEccc-chHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCceeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGI--EVAIKVFHQN-CAMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFKALD 749 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~--~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~l~ 749 (827)
.+|+..+.||+|+||.||+|+.+ +|. .+|+|++... .....+++.+|++++.++ +|+|++++++++..++..++.
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 56788899999999999999864 454 4688877643 234456889999999999 899999999998776655443
Q ss_pred eeccCC--------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------
Q 047196 750 CLHSTN--------------------------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------- 796 (827)
Q Consensus 750 ~l~~~~--------------------------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------- 796 (827)
..+... ..+.+.+...++.++++|++||| +++|+||||||+||+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcE
Confidence 222111 13567778899999999999995 678999999999998
Q ss_pred ---eecccccccCCCccccccceecccccccccC
Q 047196 797 ---DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 ---DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
|||+++....... .....++..|+|||++
T Consensus 164 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~ 195 (303)
T cd05088 164 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESL 195 (303)
T ss_pred EeCccccCcccchhhh--cccCCCcccccCHHHH
Confidence 9998864321111 1112246789999963
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.2e-16 Score=166.99 Aligned_cols=148 Identities=30% Similarity=0.432 Sum_probs=113.4
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeee--e
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALD--C 750 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~--~ 750 (827)
+|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||++++++++.+.+..++. +
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 3777889999999999999864 68999999986432 22335788999999999999999999998776655443 2
Q ss_pred ecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 751 LHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 751 l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
+.. ....+.+.....++.++++|++||| +++++||||||+||+ |||+++........
T Consensus 81 ~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~- 156 (284)
T cd07860 81 LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT- 156 (284)
T ss_pred cccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc-
Confidence 211 1234677788899999999999996 568999999999988 89988765432221
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
.....++++|+|||++
T Consensus 157 ~~~~~~~~~y~aPE~~ 172 (284)
T cd07860 157 YTHEVVTLWYRAPEIL 172 (284)
T ss_pred cccccccccccCCeEE
Confidence 1223478899999963
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.1e-16 Score=164.80 Aligned_cols=149 Identities=27% Similarity=0.463 Sum_probs=111.3
Q ss_pred cccccceEecCCceEEEEEEec-CC---cEEEEEEEccc-chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DG---IEVAIKVFHQN-CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g---~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
+|+..+.||+|+||.||+|+.. +| ..||||++... .....++|..|++++++++|||++++.+++..+...++..
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4677889999999999999864 33 36999998654 3445678999999999999999999999987766544422
Q ss_pred eccC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 751 LHST-----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 751 l~~~-----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
.+.. ...+++.+...++.++++|++||| +.+++||||||+||+ |||+++.......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 2211 234567778899999999999996 578999999999987 9999876643322
Q ss_pred cc-cccce---ecccccccccC
Q 047196 810 MI-QTETL---VTIGYMAPGLL 827 (827)
Q Consensus 810 ~~-~~~~~---gt~~Y~APE~l 827 (827)
.. ..... .+..|+|||++
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~ 183 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAI 183 (269)
T ss_pred ccccccccCCCcceeecCHhHh
Confidence 11 11111 24579999974
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.3e-16 Score=167.73 Aligned_cols=149 Identities=26% Similarity=0.341 Sum_probs=113.3
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceEEEeeeecC--Cceee-
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA--MALKSFEAECEVMKNIRHRNHVKRISSCSNE--DFKAL- 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~--~~~~l- 748 (827)
++|+..+.||+|+||.||+|+.+ +++.||||++..... .....+.+|++++++++|||++++.+++... ...++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999875 588999999864332 2234577899999999999999999988765 33333
Q ss_pred -eeecc--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 749 -DCLHS--------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 749 -~~l~~--------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
+++.. ....+++.....++.++++||+||| +.+|+||||||+||+ |||+++.......
T Consensus 85 ~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 85 MEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred ehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 22211 1224677888899999999999996 568999999999998 9999887654322
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
. .....+++.|+|||++
T Consensus 162 ~-~~~~~~~~~~~aPE~~ 178 (293)
T cd07843 162 P-YTQLVVTLWYRAPELL 178 (293)
T ss_pred c-cccccccccccCchhh
Confidence 1 1223478899999963
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.9e-16 Score=168.91 Aligned_cols=148 Identities=31% Similarity=0.431 Sum_probs=115.3
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
+|+..+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|++++++++|+|++++++++..+...++...+
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 5777899999999999999875 58999999875432 22345788999999999999999999998776655543322
Q ss_pred cC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 753 ST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 753 ~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
.. ...+++.....++.++++|++||| +.+|+|||+||+||+ |||+++.+...... .
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~-~ 157 (286)
T cd07846 82 VDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV-Y 157 (286)
T ss_pred CCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc-c
Confidence 21 224678888999999999999996 568999999999988 99998876443321 2
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
....++.+|+|||++
T Consensus 158 ~~~~~~~~y~aPE~~ 172 (286)
T cd07846 158 TDYVATRWYRAPELL 172 (286)
T ss_pred CcccceeeccCcHHh
Confidence 234578999999963
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.9e-16 Score=166.41 Aligned_cols=148 Identities=25% Similarity=0.289 Sum_probs=114.9
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
++|+..+.||+|+||+||+|+.. +|+.||+|++.... ....+.+.+|+++++.++|+|++++++++...+..++...+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45777789999999999999864 68899999876542 33456899999999999999999999999887766554433
Q ss_pred cCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 753 STN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 753 ~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
... ..+.+.....++.+++.|+.|||. .++|+||||||+||+ |||+++.......
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~--- 159 (284)
T cd06620 85 MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA--- 159 (284)
T ss_pred CCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhcc---
Confidence 322 234566677899999999999984 347999999999988 9998865432211
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
...+|+..|+|||++
T Consensus 160 ~~~~~~~~~~aPE~~ 174 (284)
T cd06620 160 DTFVGTSTYMSPERI 174 (284)
T ss_pred CccccCcccCCHHHH
Confidence 123589999999973
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.9e-16 Score=169.65 Aligned_cols=150 Identities=27% Similarity=0.354 Sum_probs=116.5
Q ss_pred HhhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeee
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALD 749 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~ 749 (827)
....|.....||+|.|++|..|+. .+|..||||.+++.. ....+.+.+|+++|+.+.|||||+++.+...+...++.
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 345688889999999999999985 468999999997643 33456689999999999999999999998876655543
Q ss_pred eeccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 750 CLHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 750 ~l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
..+... +.........+..|+..+++|+ |++.|||||||++||+ |||++..+....
T Consensus 134 ~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYc---H~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~- 209 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYC---HSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL- 209 (596)
T ss_pred EEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHH---hhcceeccccchhhcccccccceeeeccccceeecccc-
Confidence 333221 2222344556788999999999 5788999999999998 999998876332
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
...+.+|++.|.|||+.
T Consensus 210 -~lqt~cgsppyAaPEl~ 226 (596)
T KOG0586|consen 210 -MLQTFCGSPPYAAPELF 226 (596)
T ss_pred -cccccCCCCCccChHhh
Confidence 22346799999999974
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.1e-16 Score=166.85 Aligned_cols=149 Identities=28% Similarity=0.407 Sum_probs=112.2
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA-MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
++|+..+.||+|+||.||+|+.+ +++.||||.+..... .....+.+|++++++++|+|++++.+++...+..++...+
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56888899999999999999865 689999999865322 1234567899999999999999999998877655543322
Q ss_pred cC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 753 ST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 753 ~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
.. ...+.+.....++.++++||.||| +.+|+||||||+||+ |||+++....... ..
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~ 160 (291)
T cd07844 85 LDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-TY 160 (291)
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-cc
Confidence 21 123456667788999999999995 678999999999998 9998865432211 11
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
....++..|+|||++
T Consensus 161 ~~~~~~~~~~aPE~~ 175 (291)
T cd07844 161 SNEVVTLWYRPPDVL 175 (291)
T ss_pred cccccccccCCcHHh
Confidence 223468899999963
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.66 E-value=9.3e-16 Score=161.65 Aligned_cols=148 Identities=24% Similarity=0.387 Sum_probs=112.4
Q ss_pred ccccceEecCCceEEEEEEecCCcEEEEEEEcccc------hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 677 FSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNC------AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~------~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
|...+.||+|+||.||+|...+|+.||||.+.... ....+.+.+|++++++++|+|++++.+++.+.+..++..
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 56778999999999999988889999999886431 223456899999999999999999999998876555533
Q ss_pred eccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc-
Q 047196 751 LHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS- 809 (827)
Q Consensus 751 l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~- 809 (827)
.+... ..+.+.....++.+++.|++||| +.+|+|+||||+||+ |||+++.......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 82 EFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 33221 23456666788999999999996 567999999999988 9998876532111
Q ss_pred ----cccccceecccccccccC
Q 047196 810 ----MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ----~~~~~~~gt~~Y~APE~l 827 (827)
.......|+..|+|||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~ 180 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVI 180 (265)
T ss_pred ccccccccccCCCccccChhhh
Confidence 011123478999999974
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.1e-16 Score=164.44 Aligned_cols=143 Identities=25% Similarity=0.411 Sum_probs=108.2
Q ss_pred ceEecCCceEEEEEEecC--C--cEEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee--eeecc
Q 047196 681 NLIGVGSFGSVYKGRLHD--G--IEVAIKVFHQNCA-MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL--DCLHS 753 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~~--g--~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l--~~l~~ 753 (827)
++||+|+||.||+|.+.+ + ..||||.+..... ...++|.+|++++++++|+|+|++++.+.. ...++ ++...
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 3699999976654 566789999999999999999999998876 33322 22111
Q ss_pred ---------CC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc--
Q 047196 754 ---------TN-CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI-- 811 (827)
Q Consensus 754 ---------~~-~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~-- 811 (827)
.. ..+.+.....++.++++||+||| +++++||||||+||+ |||+++.+.......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 11 24677888889999999999995 678999999999988 999998775432221
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
.....++.+|+|||++
T Consensus 157 ~~~~~~~~~y~~pE~~ 172 (257)
T cd05040 157 EEHLKVPFAWCAPESL 172 (257)
T ss_pred ccCCCCCceecCHHHh
Confidence 1122367899999963
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.2e-16 Score=166.65 Aligned_cols=148 Identities=29% Similarity=0.391 Sum_probs=113.4
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccchH-----HHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeee
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAM-----ALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALD 749 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~-----~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~ 749 (827)
+|+..+.||+|+||.||+|... +|+.||||++...... ....+..|++++++++|+|++++++++.+.+..++.
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3667788999999999999864 6899999998754322 335677899999999999999999999876654442
Q ss_pred eecc---------CC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 750 CLHS---------TN-CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 750 ~l~~---------~~-~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
..+. .. ..+++.....++.++++||+||| +.+|+||||||+||+ |||+++.......
T Consensus 81 ~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred EcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 2221 11 24678888899999999999995 678999999999988 9999877654322
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
. .....+++.|+|||++
T Consensus 158 ~-~~~~~~~~~y~aPE~~ 174 (298)
T cd07841 158 K-MTHQVVTRWYRAPELL 174 (298)
T ss_pred c-ccccccceeeeCHHHH
Confidence 1 1223468899999963
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.2e-16 Score=164.86 Aligned_cols=149 Identities=32% Similarity=0.411 Sum_probs=115.0
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l 751 (827)
++|+..+.||+|+||.||+|+.+ +|+.||+|++.... ....+.+.+|++++++++|+|++++++++......++...
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 35777889999999999999875 58999999986432 2234568899999999999999999999887665444222
Q ss_pred cc----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 752 HS----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 752 ~~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
+. ....+++.....++.++++|++||| +++|+||||||+||+ |||+++........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~- 156 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD- 156 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCccc-
Confidence 21 1234678888999999999999995 578999999999998 99998876543221
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
.....++..|+|||++
T Consensus 157 ~~~~~~~~~~~aPE~~ 172 (286)
T cd07847 157 YTDYVATRWYRAPELL 172 (286)
T ss_pred ccCcccccccCCHHHH
Confidence 1223478899999963
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.66 E-value=1e-15 Score=160.38 Aligned_cols=148 Identities=22% Similarity=0.297 Sum_probs=113.9
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEccc-chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN-CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
+|+..+.||+|+||.||+++.. ++..||+|.++.. .....+.+.+|++++++++|+|++++.+++...+..++...+.
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 3667789999999999999864 6889999998643 2344567889999999999999999999988777655533322
Q ss_pred CC------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 754 TN------------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 754 ~~------------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
.. ..+.......++.+++.|+.||| +.+|+|+||||+||+ |||.++........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~- 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY- 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecccccc-
Confidence 11 23455666788999999999995 678999999999998 99998766433221
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
.....|++.|+|||++
T Consensus 157 ~~~~~~~~~~~aPE~~ 172 (255)
T cd08219 157 ACTYVGTPYYVPPEIW 172 (255)
T ss_pred cccccCCccccCHHHH
Confidence 1224588999999963
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.7e-16 Score=170.47 Aligned_cols=147 Identities=26% Similarity=0.404 Sum_probs=111.2
Q ss_pred hhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc-----
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF----- 745 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~----- 745 (827)
..+|...+.||+|+||.||+|+. .+|+.||||++.... ......+.+|++++++++|+|++++++++.....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 36888889999999999999986 468999999986432 2234568899999999999999999998764321
Q ss_pred ---eeeeeecc-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCC
Q 047196 746 ---KALDCLHS-----TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGD 807 (827)
Q Consensus 746 ---~~l~~l~~-----~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~ 807 (827)
..++++.. ....+.+.....++.++++|++||| +.+|+||||||+||+ |||+++.....
T Consensus 94 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~ 170 (342)
T cd07879 94 DFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE 170 (342)
T ss_pred eEEEEecccccCHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC
Confidence 11222211 1124667777889999999999995 678999999999998 99998764322
Q ss_pred CccccccceecccccccccC
Q 047196 808 RSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 808 ~~~~~~~~~gt~~Y~APE~l 827 (827)
. ....++..|+|||++
T Consensus 171 ~----~~~~~~~~y~aPE~~ 186 (342)
T cd07879 171 M----TGYVVTRWYRAPEVI 186 (342)
T ss_pred C----CCceeeecccChhhh
Confidence 1 224578999999963
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.4e-16 Score=168.69 Aligned_cols=147 Identities=24% Similarity=0.278 Sum_probs=113.8
Q ss_pred ccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeeccC-
Q 047196 677 FSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHST- 754 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~- 754 (827)
|.....||+|+||.||++... ++..||||++........+.+.+|+.++++++|+|++++++.+...+..++...+..
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 333467999999999999864 688999999876555556778999999999999999999999887766555333322
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccccce
Q 047196 755 --------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETL 816 (827)
Q Consensus 755 --------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~~~ 816 (827)
...+++.+...++.++++|++||| +++|+||||||+||+ |||++......... .....
T Consensus 104 ~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~~~ 179 (292)
T cd06658 104 GALTDIVTHTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKSLV 179 (292)
T ss_pred CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-Cceee
Confidence 134567778899999999999996 568999999999997 99988765433221 12245
Q ss_pred ecccccccccC
Q 047196 817 VTIGYMAPGLL 827 (827)
Q Consensus 817 gt~~Y~APE~l 827 (827)
|+..|+|||++
T Consensus 180 ~~~~y~aPE~~ 190 (292)
T cd06658 180 GTPYWMAPEVI 190 (292)
T ss_pred cCccccCHHHH
Confidence 89999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.65 E-value=7.9e-16 Score=162.88 Aligned_cols=149 Identities=26% Similarity=0.335 Sum_probs=111.6
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccch----------HHHHHHHHHHHHHHhcCCCCceEEEeeeecCC
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA----------MALKSFEAECEVMKNIRHRNHVKRISSCSNED 744 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~----------~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~ 744 (827)
+|...+.||+|+||.||+|... +|+.||||+++.... ...+.+.+|++++++++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 3566789999999999999754 689999998753211 12356889999999999999999999988776
Q ss_pred ceeeeeeccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccc
Q 047196 745 FKALDCLHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLL 804 (827)
Q Consensus 745 ~~~l~~l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~ 804 (827)
..++...+.. ...+++.....++.+++.|+.||| +++++||||||+||+ |||+++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 5554332221 134566677789999999999995 678999999999988 99998765
Q ss_pred cCCCccc-cccceecccccccccC
Q 047196 805 TGDRSMI-QTETLVTIGYMAPGLL 827 (827)
Q Consensus 805 ~~~~~~~-~~~~~gt~~Y~APE~l 827 (827)
....... .....|+..|+|||++
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~ 182 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVI 182 (272)
T ss_pred cccccccccccccCCccccCHHHh
Confidence 3322111 1223478999999963
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.1e-16 Score=164.02 Aligned_cols=144 Identities=26% Similarity=0.432 Sum_probs=103.7
Q ss_pred ceEecCCceEEEEEEec----CCcEEEEEEEccc-chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC-ceee--eeec
Q 047196 681 NLIGVGSFGSVYKGRLH----DGIEVAIKVFHQN-CAMALKSFEAECEVMKNIRHRNHVKRISSCSNED-FKAL--DCLH 752 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~----~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~-~~~l--~~l~ 752 (827)
+.||+|+||.||+|... ++..||||++... .....+.+.+|+.++++++|||+++++++|...+ ..++ ++..
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2457999998543 3345678899999999999999999999876433 2222 2221
Q ss_pred c---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc--
Q 047196 753 S---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI-- 811 (827)
Q Consensus 753 ~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~-- 811 (827)
. ......+.....++.++++|++||| +.+|+||||||+||+ |||+++.........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 1 1223456667889999999999995 678999999999998 999987654322110
Q ss_pred -cccceecccccccccC
Q 047196 812 -QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 -~~~~~gt~~Y~APE~l 827 (827)
.....++..|+|||++
T Consensus 158 ~~~~~~~~~~y~aPE~~ 174 (262)
T cd05058 158 NHTGAKLPVKWMALESL 174 (262)
T ss_pred ccccCcCCccccChhHh
Confidence 1122357789999963
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.6e-16 Score=165.82 Aligned_cols=158 Identities=27% Similarity=0.381 Sum_probs=119.0
Q ss_pred cchhHHHHHhhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhc-CCCCceEEEeeeec
Q 047196 665 FSYQDLFRATEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNI-RHRNHVKRISSCSN 742 (827)
Q Consensus 665 ~~~~~~~~~~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~ 742 (827)
++.+++..++++|+..+.||+|+||.||+|.. .+++.||+|++.... .....+.+|+.+++++ +|+|++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 34456666788999999999999999999986 468999999986432 2345678899999999 89999999999865
Q ss_pred CC-------ceeeeeecc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------
Q 047196 743 ED-------FKALDCLHS------------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------- 796 (827)
Q Consensus 743 ~~-------~~~l~~l~~------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------- 796 (827)
.+ +..+++... ....+.+.....++.+++.|++||| +.+|+||||||+||+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCE
Confidence 43 122233221 1234667778889999999999995 678999999999997
Q ss_pred ---eecccccccCCCccccccceecccccccccC
Q 047196 797 ---DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 ---DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
|||+++........ .....|+..|+|||++
T Consensus 168 kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~ 200 (291)
T cd06639 168 KLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVI 200 (291)
T ss_pred EEeecccchhccccccc-ccCccCCccccChhhh
Confidence 99998765432221 1223578999999963
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.65 E-value=7.4e-16 Score=182.56 Aligned_cols=148 Identities=26% Similarity=0.306 Sum_probs=115.8
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++++.++|+|||++++++...+..++..
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 56888899999999999999875 68999999986432 233467899999999999999999999888776655544
Q ss_pred eccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 751 LHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 751 l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
.+... ..+.+.....|+.+++.||+||| ..+|+||||||+||| |||+++........
T Consensus 84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~~~~ 160 (669)
T cd05610 84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELN 160 (669)
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCccccCCccc
Confidence 33222 23455667889999999999996 568999999999998 99999876543322
Q ss_pred ccccceeccccccccc
Q 047196 811 IQTETLVTIGYMAPGL 826 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~ 826 (827)
....++|+.|+|||.
T Consensus 161 -~~~~~~t~~~~~pe~ 175 (669)
T cd05610 161 -MMDILTTPSMAKPKN 175 (669)
T ss_pred -ccccccCccccCccc
Confidence 223458999999984
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=9.3e-17 Score=179.15 Aligned_cols=144 Identities=30% Similarity=0.511 Sum_probs=106.5
Q ss_pred ccccceEecCCce-EEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcC-CCCceEEEeeeecCCceeee-----
Q 047196 677 FSKENLIGVGSFG-SVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIR-HRNHVKRISSCSNEDFKALD----- 749 (827)
Q Consensus 677 ~~~~~~iG~G~fg-~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~l~----- 749 (827)
|...+++|.|+-| .||+|.+. |++||||++-... ..-..+||..|+.-+ |||||++++.-.+..|.++.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 5566789999987 59999985 6899999984432 234578999999884 99999998887777776652
Q ss_pred -----eeccC--C-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------------eecccccccC
Q 047196 750 -----CLHST--N-CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---------------DFGIGRLLTG 806 (827)
Q Consensus 750 -----~l~~~--~-~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---------------DFGla~~~~~ 806 (827)
++... . ..........+..|++.|+++|| +-+||||||||.||| |||++|.+..
T Consensus 587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 11111 0 01111334678889999999996 467999999999998 9999999877
Q ss_pred CCccccc--cceecccccccccC
Q 047196 807 DRSMIQT--ETLVTIGYMAPGLL 827 (827)
Q Consensus 807 ~~~~~~~--~~~gt~~Y~APE~l 827 (827)
+...... ...||-||+|||++
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L 686 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQL 686 (903)
T ss_pred CcchhhcccCCCCcccccCHHHH
Confidence 6654322 23389999999974
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.65 E-value=7.3e-16 Score=163.34 Aligned_cols=148 Identities=28% Similarity=0.303 Sum_probs=116.0
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
+|+..+.||.|+||.||+|+.. +++.||+|++.... ......+.+|++++++++|+|++++.+++.++...++...+.
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5777788999999999999865 68999999986543 334567899999999999999999999988776555433222
Q ss_pred C---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccccc
Q 047196 754 T---------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTE 814 (827)
Q Consensus 754 ~---------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~ 814 (827)
. ...+.+.....++.+++.|+.||| +++|+||||||+||+ |||+++........ ...
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~~~ 157 (274)
T cd06609 82 GGGSCLDLLKPGKLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK-RNT 157 (274)
T ss_pred CCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccccc-ccc
Confidence 1 125677788899999999999995 678999999999988 99998876543221 122
Q ss_pred ceecccccccccC
Q 047196 815 TLVTIGYMAPGLL 827 (827)
Q Consensus 815 ~~gt~~Y~APE~l 827 (827)
..+++.|+|||++
T Consensus 158 ~~~~~~y~~PE~~ 170 (274)
T cd06609 158 FVGTPFWMAPEVI 170 (274)
T ss_pred ccCCccccChhhh
Confidence 3578899999974
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.4e-16 Score=164.53 Aligned_cols=143 Identities=20% Similarity=0.326 Sum_probs=102.6
Q ss_pred eEecCCceEEEEEEecCC---cEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeeccCCC-
Q 047196 682 LIGVGSFGSVYKGRLHDG---IEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHSTNC- 756 (827)
Q Consensus 682 ~iG~G~fg~Vy~~~~~~g---~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~~~- 756 (827)
.||+|+||.||+|+..++ ..+++|.+.... ....+.|.+|+.+++.++|||+|++++.|......++...+...+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999975433 356677765443 334568999999999999999999999998766554433322211
Q ss_pred -------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc-ccc
Q 047196 757 -------------SLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS-MIQ 812 (827)
Q Consensus 757 -------------~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~-~~~ 812 (827)
...+.....++.++++||+||| +.+|+||||||+||+ |||+++....... ...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 1223344678899999999996 567999999999997 9998864322111 111
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
....++..|+|||++
T Consensus 159 ~~~~~~~~y~aPE~~ 173 (268)
T cd05086 159 DDKCVPLRWLAPELV 173 (268)
T ss_pred cCCcCcccccCchhc
Confidence 223478899999973
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.65 E-value=6e-16 Score=163.82 Aligned_cols=147 Identities=27% Similarity=0.430 Sum_probs=106.5
Q ss_pred ccccceEecCCceEEEEEEec----CCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc-----
Q 047196 677 FSKENLIGVGSFGSVYKGRLH----DGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF----- 745 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~~----~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~----- 745 (827)
|...++||+|+||.||+|.+. +++.||||++... .....+++.+|++++++++|||++++++++...+.
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 455678999999999999753 3688999998653 23345678999999999999999999998754321
Q ss_pred ---eeeeeecc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------ee
Q 047196 746 ---KALDCLHS--------------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DF 798 (827)
Q Consensus 746 ---~~l~~l~~--------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DF 798 (827)
.++++... ....+.+.....++.+++.|++||| +.+|+||||||+||+ ||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence 11111110 0113566677889999999999995 568999999999998 99
Q ss_pred cccccccCCCccc-cccceeccccccccc
Q 047196 799 GIGRLLTGDRSMI-QTETLVTIGYMAPGL 826 (827)
Q Consensus 799 Gla~~~~~~~~~~-~~~~~gt~~Y~APE~ 826 (827)
|+++......... .....+++.|++||+
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~ 186 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALES 186 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhH
Confidence 9988664322111 111235678999996
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.5e-16 Score=165.86 Aligned_cols=148 Identities=28% Similarity=0.459 Sum_probs=107.4
Q ss_pred hcccccceEecCCceEEEEEEec-CC--cEEEEEEEccc-chHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCceeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DG--IEVAIKVFHQN-CAMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFKALD 749 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g--~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~l~ 749 (827)
++|+..++||+|+||.||+|... ++ ..+|+|.+... .....+.|.+|+++++++ +|||++++++++......++.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 46778889999999999999865 34 34789888642 233456799999999999 799999999998776543332
Q ss_pred eeccCC--------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------
Q 047196 750 CLHSTN--------------------------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------- 796 (827)
Q Consensus 750 ~l~~~~--------------------------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------- 796 (827)
..+... ..+.+.....++.+++.|++||| +++|+||||||+||+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence 221111 13556677889999999999996 578999999999998
Q ss_pred ---eecccccccCCCccccccceecccccccccC
Q 047196 797 ---DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 ---DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
|||+++....... ......+..|+|||++
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~ 190 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESL 190 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhh
Confidence 9998864321111 1111235679999973
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.1e-15 Score=160.21 Aligned_cols=148 Identities=22% Similarity=0.330 Sum_probs=115.4
Q ss_pred cccccceEecCCceEEEEEEe-cCCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 676 KFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
+|+..++||+|+||.||.++. .+++.||+|++... .....+++.+|++++++++|+|++++++++.+.+..++...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 477789999999999999985 46889999998643 234556789999999999999999999999887765543222
Q ss_pred cC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 753 ST------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 753 ~~------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
.. ...+++.+...++.++++|++||| +.+++||||||+||+ |||+++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~ 157 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM 157 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEccccccc
Confidence 21 123567777889999999999995 568999999999988 99998876443321
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
.....|++.|+|||++
T Consensus 158 -~~~~~~~~~y~ape~~ 173 (256)
T cd08221 158 -AETVVGTPYYMSPELC 173 (256)
T ss_pred -ccccCCCccccCHhhc
Confidence 1234589999999963
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.4e-16 Score=167.41 Aligned_cols=148 Identities=30% Similarity=0.420 Sum_probs=110.2
Q ss_pred cccccceEecCCceEEEEEEec---CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecC--Ccee
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH---DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNE--DFKA 747 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~--~~~~ 747 (827)
+|+..+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++|||++++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3667788999999999999864 47899999987632 23345678899999999999999999999876 4333
Q ss_pred eeeeccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee--------------eec
Q 047196 748 LDCLHST--------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF--------------DFG 799 (827)
Q Consensus 748 l~~l~~~--------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl--------------DFG 799 (827)
+...+.. ...+.......++.|++.|++||| +.+|+||||||+||+ |||
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 3222211 113455566789999999999995 678999999999987 888
Q ss_pred ccccccCCCcc--ccccceeccccccccc
Q 047196 800 IGRLLTGDRSM--IQTETLVTIGYMAPGL 826 (827)
Q Consensus 800 la~~~~~~~~~--~~~~~~gt~~Y~APE~ 826 (827)
+++........ ......+|+.|+|||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 186 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPEL 186 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHH
Confidence 88765432221 1122347899999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.6e-16 Score=169.93 Aligned_cols=150 Identities=23% Similarity=0.382 Sum_probs=113.3
Q ss_pred HHHhhcccccceEecCCceEEEEEEe-cCCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc--
Q 047196 671 FRATEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF-- 745 (827)
Q Consensus 671 ~~~~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~-- 745 (827)
+...++|+..+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++|+||+++++++.....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 34567899999999999999999985 47899999998543 22334568899999999999999999998765321
Q ss_pred ------eeeeeec------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eeccccc
Q 047196 746 ------KALDCLH------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRL 803 (827)
Q Consensus 746 ------~~l~~l~------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~ 803 (827)
..+++.. .....+.+.....++.++++|++||| +.+|+||||||+||+ |||+++.
T Consensus 91 ~~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 91 RFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred ccceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 1112211 01235677778889999999999995 678999999999998 9999876
Q ss_pred ccCCCccccccceecccccccccC
Q 047196 804 LTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 804 ~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
..... ....+++.|+|||++
T Consensus 168 ~~~~~----~~~~~~~~y~aPE~~ 187 (343)
T cd07880 168 TDSEM----TGYVVTRWYRAPEVI 187 (343)
T ss_pred cccCc----cccccCCcccCHHHH
Confidence 53221 223478999999963
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.6e-16 Score=170.13 Aligned_cols=151 Identities=25% Similarity=0.351 Sum_probs=113.4
Q ss_pred HHhhcccccceEecCCceEEEEEEe-cCCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC----
Q 047196 672 RATEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNED---- 744 (827)
Q Consensus 672 ~~~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~---- 744 (827)
...++|+..+.||+|+||.||+|+. .+|+.||||++... ......++.+|++++++++|+|++++++++....
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 3457799999999999999999986 47899999998642 2334456788999999999999999999875432
Q ss_pred ----ceeeeeeccC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eeccccccc
Q 047196 745 ----FKALDCLHST-----NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLT 805 (827)
Q Consensus 745 ----~~~l~~l~~~-----~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~ 805 (827)
+..++++... ...++..+...++.++++||+||| +.+|+||||||+||+ |||+++...
T Consensus 93 ~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 93 FQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred cCcEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 2222332211 112566667789999999999996 568999999999998 999998754
Q ss_pred CCCccccccceecccccccccC
Q 047196 806 GDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 806 ~~~~~~~~~~~gt~~Y~APE~l 827 (827)
.... .....++..|+|||++
T Consensus 170 ~~~~--~~~~~~~~~y~aPE~~ 189 (353)
T cd07850 170 TSFM--MTPYVVTRYYRAPEVI 189 (353)
T ss_pred CCCC--CCCCcccccccCHHHH
Confidence 3322 1223578999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.8e-16 Score=170.11 Aligned_cols=152 Identities=29% Similarity=0.386 Sum_probs=114.3
Q ss_pred HhhcccccceEecCCceEEEEEEec-CCcEEEEEEEccc--chHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCC--ce
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN--CAMALKSFEAECEVMKNI-RHRNHVKRISSCSNED--FK 746 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~--~~ 746 (827)
..++|+..+.||+|+||.||+|... +|+.||||++... .......+.+|+++++++ +|+||+++++++...+ ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467888899999999999999865 6889999998542 223345678899999999 9999999999886543 12
Q ss_pred e--eeeecc------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 747 A--LDCLHS------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 747 ~--l~~l~~------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
+ +++... ....+.+..+..++.+++.||+||| +.+|+||||||+||+ |||+++......
T Consensus 85 ~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 85 YLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred EEEecccccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 2 233221 1125677788889999999999996 578999999999988 999988764432
Q ss_pred cc----ccccceecccccccccC
Q 047196 809 SM----IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~----~~~~~~gt~~Y~APE~l 827 (827)
.. ......||.+|+|||++
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~ 184 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEIL 184 (337)
T ss_pred ccccCcchhcccccccccCceee
Confidence 21 11223489999999963
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.65 E-value=7.1e-16 Score=167.18 Aligned_cols=143 Identities=27% Similarity=0.347 Sum_probs=112.1
Q ss_pred ccccceEecCCceEEEEEEec-CCcEEEEEEEccc---chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 677 FSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN---CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
|+..+.||+|+||.||+|+.. +|..||+|++... .....+.+.+|++++++++|+|+|++++++.+++..++...+
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 667788999999999999864 6899999998643 223446788999999999999999999999877655443222
Q ss_pred c----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 753 S----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 753 ~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
. ....+++.+...++.+++.|+.||| +.+|+||||||+||+ |||+++.....
T Consensus 107 ~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~----- 178 (317)
T cd06635 107 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----- 178 (317)
T ss_pred CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc-----
Confidence 1 1234677888889999999999995 678999999999998 88887654321
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
....|++.|+|||++
T Consensus 179 ~~~~~~~~y~aPE~~ 193 (317)
T cd06635 179 NSFVGTPYWMAPEVI 193 (317)
T ss_pred ccccCCccccChhhh
Confidence 223488999999973
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.65 E-value=9.4e-16 Score=163.28 Aligned_cols=148 Identities=26% Similarity=0.299 Sum_probs=109.5
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccc-hHHHHHHHHHHHH-HHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC-AMALKSFEAECEV-MKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~-l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
+|+..+.||+|+||.||+|+.. +|+.||||++.... .....++..|+.+ ++..+|+|+|++++++......++...+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 81 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV 81 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence 5778889999999999999865 69999999986542 2233455566664 6777899999999999876654442221
Q ss_pred c-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 753 S-------------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 753 ~-------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
. ....+++.....++.|++.|++|||. ..+++||||||+||+ |||+++.......
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (283)
T cd06617 82 MDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA 159 (283)
T ss_pred hcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 1 12345677778999999999999963 238999999999987 9999886543221
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
.+...|+..|+|||++
T Consensus 160 --~~~~~~~~~y~aPE~~ 175 (283)
T cd06617 160 --KTIDAGCKPYMAPERI 175 (283)
T ss_pred --cccccCCccccChhhc
Confidence 1223478999999963
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.6e-16 Score=166.89 Aligned_cols=149 Identities=30% Similarity=0.376 Sum_probs=116.0
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
+|+..+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++|+|++++++++...+..++...+
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5778899999999999999865 58899999986432 23346789999999999999999999999876654443222
Q ss_pred cC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 753 ST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 753 ~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
.. ...+++.+...++.++++|++||| +.+|+|||+||+||+ |||+++..........
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 82 VERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence 21 123567777889999999999996 568999999999988 9999887655433222
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
....++.+|+|||++
T Consensus 159 ~~~~~~~~~~~PE~~ 173 (288)
T cd07833 159 TDYVATRWYRAPELL 173 (288)
T ss_pred cCcccccCCcCCchh
Confidence 334578999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.5e-16 Score=167.39 Aligned_cols=145 Identities=16% Similarity=0.212 Sum_probs=105.0
Q ss_pred cceEecC--CceEEEEEEe-cCCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeeccC
Q 047196 680 ENLIGVG--SFGSVYKGRL-HDGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHST 754 (827)
Q Consensus 680 ~~~iG~G--~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~ 754 (827)
.++||+| +||+||+++. .+|+.||||++.... ....+.+.+|+++++.++|||||++++++..++..++...+..
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4679999 7889999986 578999999986532 2334567889999999999999999999988775554332221
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc--
Q 047196 755 ------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM-- 810 (827)
Q Consensus 755 ------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~-- 810 (827)
...+++.....++.|+++||+||| +.+|+||||||+||+ |||.+.........
T Consensus 83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 123667778889999999999995 678999999999998 55543322111110
Q ss_pred ----ccccceecccccccccC
Q 047196 811 ----IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ----~~~~~~gt~~Y~APE~l 827 (827)
......++..|+|||++
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~ 180 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVL 180 (327)
T ss_pred ccccccccccceecccChHHh
Confidence 01112467889999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.4e-16 Score=163.74 Aligned_cols=148 Identities=27% Similarity=0.404 Sum_probs=113.7
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA-MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
+|+..+.||+|++|.||+|+.. +|+.||||++..... ...+.+.+|++++++++|+|++++++++...+..++...+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4777899999999999999975 689999999875432 23456788999999999999999999998776554433221
Q ss_pred C------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 754 T------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 754 ~------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
. ...+.+.....++.+++.|++||| +.+|+||||||+||+ |||+++....... .
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 156 (284)
T cd07836 81 DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-T 156 (284)
T ss_pred CccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-c
Confidence 1 124677788899999999999995 678999999999998 8888875533221 1
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
.....++..|+|||++
T Consensus 157 ~~~~~~~~~y~~PE~~ 172 (284)
T cd07836 157 FSNEVVTLWYRAPDVL 172 (284)
T ss_pred cccccccccccChHHh
Confidence 1234578999999963
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.1e-15 Score=161.10 Aligned_cols=150 Identities=22% Similarity=0.327 Sum_probs=111.7
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEccc-----chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc--e
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN-----CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF--K 746 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~--~ 746 (827)
.+|+..+.||+|+||.||+|+.. +|+.||+|++... .....+.+.+|++++++++|+|++++++++...+. .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888899999999999999864 6899999987532 12345678999999999999999999998865431 2
Q ss_pred --eeeeecc--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccC
Q 047196 747 --ALDCLHS--------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806 (827)
Q Consensus 747 --~l~~l~~--------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~ 806 (827)
++++... ....+.+.....++.+++.|+.||| +.+|+||||||+||+ |||+++....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 2222211 1123566677889999999999995 678999999999998 9999876532
Q ss_pred CCc--cccccceecccccccccC
Q 047196 807 DRS--MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 807 ~~~--~~~~~~~gt~~Y~APE~l 827 (827)
... .......|+..|+|||++
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~ 181 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVI 181 (264)
T ss_pred ccccCccccccCCcccccCHhhh
Confidence 111 111223488999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=9.6e-16 Score=164.28 Aligned_cols=149 Identities=27% Similarity=0.348 Sum_probs=111.9
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l 751 (827)
++|+..+.||+|++|.||+|+.. +|+.||||++.... ....+.+.+|++++++++|+|++++++++......++...
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999865 68999999986432 2234568899999999999999999999987765554332
Q ss_pred ccCC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------eecccccccCCCc
Q 047196 752 HSTN-----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRLLTGDRS 809 (827)
Q Consensus 752 ~~~~-----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGla~~~~~~~~ 809 (827)
+... ...++.....++.+++.||+||| +++|+||||||+||+ |||+++.......
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 82 YLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred cccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 2211 11344555678899999999995 678999999999988 8888875533221
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
. .....+++.|+|||++
T Consensus 159 ~-~~~~~~~~~y~~PE~~ 175 (294)
T PLN00009 159 T-FTHEVVTLWYRAPEIL 175 (294)
T ss_pred c-cccCceeecccCHHHH
Confidence 1 1223578999999963
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.1e-16 Score=166.69 Aligned_cols=126 Identities=28% Similarity=0.348 Sum_probs=101.5
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeee
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA---MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l 751 (827)
+|+..+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|++++++++|+|++++++.+......++...
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 5788899999999999999865 589999999865432 245678999999999999999999999887765544332
Q ss_pred ccC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccc
Q 047196 752 HST------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLL 804 (827)
Q Consensus 752 ~~~------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~ 804 (827)
+.. ...+.+.....++.++++|++||| +.+|+||||||+||+ |||++...
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 153 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQS 153 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence 211 134566777789999999999995 678999999999998 89987654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.65 E-value=7.5e-16 Score=160.92 Aligned_cols=144 Identities=32% Similarity=0.471 Sum_probs=108.5
Q ss_pred ceEecCCceEEEEEEecCCcEEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc------
Q 047196 681 NLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCA-MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS------ 753 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~------ 753 (827)
++||+|+||.||+|...+++.||+|++..... ...++|.+|++++++++|+|++++++++......++...+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46899999999999976699999999875433 35568999999999999999999999988776554433222
Q ss_pred -----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc-cccee
Q 047196 754 -----TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ-TETLV 817 (827)
Q Consensus 754 -----~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~-~~~~g 817 (827)
....+.+.....++.+++++++||| +.+|+||||||+||+ |||+++.......... ....+
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 1223566677889999999999995 678999999999998 8999876542221111 11124
Q ss_pred cccccccccC
Q 047196 818 TIGYMAPGLL 827 (827)
Q Consensus 818 t~~Y~APE~l 827 (827)
+..|+|||++
T Consensus 158 ~~~y~~PE~~ 167 (251)
T cd05041 158 PIKWTAPEAL 167 (251)
T ss_pred eeccCChHhh
Confidence 6679999963
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.65 E-value=1e-15 Score=161.40 Aligned_cols=148 Identities=28% Similarity=0.407 Sum_probs=111.1
Q ss_pred ccccceEecCCceEEEEEEec-CCcEEEEEEEcccch---------HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCce
Q 047196 677 FSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA---------MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFK 746 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---------~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~ 746 (827)
|.....||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++|||++++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 556788999999999999864 688999998854321 1235788999999999999999999998877655
Q ss_pred eeeeeccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccC
Q 047196 747 ALDCLHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806 (827)
Q Consensus 747 ~l~~l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~ 806 (827)
.+...+... ..+++.....++.+++.|++||| +.+++||||||+||+ |||+++....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred EEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 443333221 23556667789999999999996 568999999999998 9999887653
Q ss_pred CCcc-----ccccceecccccccccC
Q 047196 807 DRSM-----IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 807 ~~~~-----~~~~~~gt~~Y~APE~l 827 (827)
.... ......|+..|+|||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~ 184 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVV 184 (267)
T ss_pred ccccCCccccccccCCCcCccChhHh
Confidence 2111 01122478899999963
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.65 E-value=7e-16 Score=161.86 Aligned_cols=144 Identities=34% Similarity=0.544 Sum_probs=111.0
Q ss_pred ceEecCCceEEEEEEecC----CcEEEEEEEcccchH-HHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc--
Q 047196 681 NLIGVGSFGSVYKGRLHD----GIEVAIKVFHQNCAM-ALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS-- 753 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~-- 753 (827)
+.||+|+||.||+|+... +..||||++...... ..+.+.+|++++++++|+|++++++++......++...+.
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998653 788999998765332 3678999999999999999999999988755444322211
Q ss_pred ---------C--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccC
Q 047196 754 ---------T--------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806 (827)
Q Consensus 754 ---------~--------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~ 806 (827)
. ...+++.+...++.++++|++||| +.+|+||||||+||+ |||.++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 1 245678888999999999999995 688999999999998 8999887654
Q ss_pred CCcc-ccccceecccccccccC
Q 047196 807 DRSM-IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 807 ~~~~-~~~~~~gt~~Y~APE~l 827 (827)
.... ......++..|+|||++
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~ 179 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESL 179 (262)
T ss_pred ccccccccCCCcCccccCHHHh
Confidence 3211 11223478899999963
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.8e-16 Score=167.63 Aligned_cols=147 Identities=27% Similarity=0.291 Sum_probs=112.9
Q ss_pred ccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeeccC-
Q 047196 677 FSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHST- 754 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~- 754 (827)
|+....||+|+||.||+|+.. +++.||||++........+.+.+|+.+++.++|||++++++++..++..++...+..
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 333457999999999999864 689999999865444445678899999999999999999999877665554333222
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccccce
Q 047196 755 --------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETL 816 (827)
Q Consensus 755 --------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~~~ 816 (827)
...+++.....++.+++.|++||| +.+|+||||||+||+ |||+++........ .....
T Consensus 103 ~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~~~ 178 (297)
T cd06659 103 GALTDIVSQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKSLV 178 (297)
T ss_pred CCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc-cccee
Confidence 124567778889999999999995 678999999999997 99998765433221 12345
Q ss_pred ecccccccccC
Q 047196 817 VTIGYMAPGLL 827 (827)
Q Consensus 817 gt~~Y~APE~l 827 (827)
|+.+|+|||++
T Consensus 179 ~~~~y~aPE~~ 189 (297)
T cd06659 179 GTPYWMAPEVI 189 (297)
T ss_pred cCccccCHHHH
Confidence 89999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.4e-15 Score=159.76 Aligned_cols=149 Identities=29% Similarity=0.361 Sum_probs=116.1
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
++|+..+.+|+|+||.||+|... +++.+|+|++........+.+.+|++++++++|||++++++++......++...+.
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 56888899999999999999864 57899999987655555678999999999999999999999887766544432221
Q ss_pred C-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 754 T-----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 754 ~-----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
. ...++..+...++.+++.|++||| +.+|+||||||+||+ |||++......... .
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~ 158 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK-R 158 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhhhc-c
Confidence 1 134666677789999999999995 578999999999988 99988765432211 1
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
....++..|+|||++
T Consensus 159 ~~~~~~~~y~~Pe~~ 173 (262)
T cd06613 159 KSFIGTPYWMAPEVA 173 (262)
T ss_pred ccccCCccccCchhh
Confidence 223478899999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.3e-15 Score=160.38 Aligned_cols=149 Identities=26% Similarity=0.379 Sum_probs=114.9
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA--MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
+|...+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++|+|++++++.+...+..++...+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 3667789999999999999864 689999999875433 3567899999999999999999999998776655443332
Q ss_pred cC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 753 ST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 753 ~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
.. ...+.+.....++.++++|++||| +.+|+||||||+||+ |||++...........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 21 123566777889999999999995 677999999999997 9999877654332211
Q ss_pred c---cceecccccccccC
Q 047196 813 T---ETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~---~~~gt~~Y~APE~l 827 (827)
. ...++..|+|||++
T Consensus 158 ~~~~~~~~~~~~~~PE~~ 175 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVI 175 (264)
T ss_pred ccccCCcCCcCccChhhc
Confidence 1 13478899999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.64 E-value=5.1e-16 Score=164.86 Aligned_cols=148 Identities=28% Similarity=0.321 Sum_probs=114.1
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++|+|++++++++...+..++...+.
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3566678999999999999864 58899999986443 334567999999999999999999999988776555433332
Q ss_pred C---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccccc
Q 047196 754 T---------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTE 814 (827)
Q Consensus 754 ~---------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~ 814 (827)
. ...+.+.....++.++++|+.||| +++|+|+||||+||+ |||+++.+...... ...
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-~~~ 160 (277)
T cd06642 85 GGGSALDLLKPGPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK-RNT 160 (277)
T ss_pred CCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcchh-hhc
Confidence 2 134567777889999999999995 678999999999987 99998766433211 122
Q ss_pred ceecccccccccC
Q 047196 815 TLVTIGYMAPGLL 827 (827)
Q Consensus 815 ~~gt~~Y~APE~l 827 (827)
..|+..|+|||++
T Consensus 161 ~~~~~~y~aPE~~ 173 (277)
T cd06642 161 FVGTPFWMAPEVI 173 (277)
T ss_pred ccCcccccCHHHh
Confidence 3478999999964
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.64 E-value=9.7e-16 Score=160.44 Aligned_cols=147 Identities=31% Similarity=0.364 Sum_probs=115.9
Q ss_pred hcccccceEecCCceEEEEEEecC-CcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHD-GIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
++|+..+.||+|+||.||+|+..+ +..||+|.+..... .+++.+|++++++++|+|++++++++......++...+.
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 568888999999999999998764 78999999865432 678999999999999999999999988776554433222
Q ss_pred C-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 754 T-----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 754 ~-----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
. ...+++.....++.++++|+.||| +.+|+||||+|+||+ |||++......... .
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~-~ 156 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK-R 156 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCccc-c
Confidence 1 234677788899999999999996 567999999999997 99998876543211 1
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
....++..|+|||++
T Consensus 157 ~~~~~~~~y~~PE~~ 171 (256)
T cd06612 157 NTVIGTPFWMAPEVI 171 (256)
T ss_pred ccccCCccccCHHHH
Confidence 223478999999963
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=9.1e-16 Score=160.72 Aligned_cols=146 Identities=31% Similarity=0.556 Sum_probs=110.5
Q ss_pred cccceEecCCceEEEEEEecC-----CcEEEEEEEcccchH-HHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee--e
Q 047196 678 SKENLIGVGSFGSVYKGRLHD-----GIEVAIKVFHQNCAM-ALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL--D 749 (827)
Q Consensus 678 ~~~~~iG~G~fg~Vy~~~~~~-----g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l--~ 749 (827)
...+.||+|+||.||+|+..+ +..||+|++...... ..+.+.+|++++++++|+|++++++++...+..++ +
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 446789999999999998653 388999998655432 56789999999999999999999999887654433 2
Q ss_pred eecc---------CCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 750 CLHS---------TNCS-LNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 750 ~l~~---------~~~~-l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
+... .... +.+.+...++.+++.|++|| |+.+|+||||||+||+ |||+++.......
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~l---h~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL---ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHH---hcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 2211 1111 67778889999999999999 4678999999999998 8999877654322
Q ss_pred cccccceeccccccccc
Q 047196 810 MIQTETLVTIGYMAPGL 826 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~ 826 (827)
.......+++.|+|||+
T Consensus 159 ~~~~~~~~~~~y~~Pe~ 175 (258)
T smart00219 159 YKKKGGKLPIRWMAPES 175 (258)
T ss_pred cccccCCCcccccChHH
Confidence 21111226789999996
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.1e-15 Score=163.84 Aligned_cols=149 Identities=28% Similarity=0.337 Sum_probs=115.8
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
.+|...+.||+|+||.||+|.. .++..||+|++........+.+.+|+.++++++|||++++.+++...+..++...+.
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5688889999999999999975 468899999986544445577899999999999999999999987776555533322
Q ss_pred CC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccccc
Q 047196 754 TN---------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTE 814 (827)
Q Consensus 754 ~~---------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~ 814 (827)
.. ..+.+.+...++.++++|+.||| +.+++||||||+||+ |||++......... ...
T Consensus 99 ~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~-~~~ 174 (293)
T cd06647 99 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RST 174 (293)
T ss_pred CCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc-ccc
Confidence 21 23566777889999999999995 678999999999987 89988765433221 122
Q ss_pred ceecccccccccC
Q 047196 815 TLVTIGYMAPGLL 827 (827)
Q Consensus 815 ~~gt~~Y~APE~l 827 (827)
..|++.|+|||++
T Consensus 175 ~~~~~~y~~PE~~ 187 (293)
T cd06647 175 MVGTPYWMAPEVV 187 (293)
T ss_pred ccCChhhcCchhh
Confidence 3488999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.3e-15 Score=162.87 Aligned_cols=149 Identities=23% Similarity=0.272 Sum_probs=110.5
Q ss_pred cccccceEecCCceEEEEEEe----cCCcEEEEEEEcccch----HHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCce
Q 047196 676 KFSKENLIGVGSFGSVYKGRL----HDGIEVAIKVFHQNCA----MALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFK 746 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~----~~g~~vAvK~l~~~~~----~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~ 746 (827)
+|+..+.||+|+||.||+|+. .+|+.||+|++..... ...+++.+|+++++++ +|+||+++.+++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 366778999999999999975 3689999999865321 2346788999999999 589999998887766554
Q ss_pred eeeeeccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccC
Q 047196 747 ALDCLHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806 (827)
Q Consensus 747 ~l~~l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~ 806 (827)
++...+... ..+.+.....++.++++|++||| +.+++||||||+||+ |||+++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 443322221 23455566678889999999995 678999999999998 9999887644
Q ss_pred CCccccccceecccccccccC
Q 047196 807 DRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 807 ~~~~~~~~~~gt~~Y~APE~l 827 (827)
..........|+..|+|||++
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~ 178 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIV 178 (290)
T ss_pred ccccccccccCCcccCChhhc
Confidence 322222234489999999974
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.64 E-value=8.7e-16 Score=163.73 Aligned_cols=147 Identities=27% Similarity=0.359 Sum_probs=112.8
Q ss_pred ccccceEecCCceEEEEEEec-CCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecC--Cceeeeee
Q 047196 677 FSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNE--DFKALDCL 751 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~--~~~~l~~l 751 (827)
|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|+|++++++++... ...++...
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 456678999999999999865 58899999997652 33346788999999999999999999999876 44433222
Q ss_pred cc----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 752 HS----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 752 ~~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
+. ....+.+.....++.++++|++||| +.+++|+||||+||+ |||++..........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 11 1135677788899999999999996 568999999999998 999988765433211
Q ss_pred cccceeccccccccc
Q 047196 812 QTETLVTIGYMAPGL 826 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~ 826 (827)
.+...++..|+|||+
T Consensus 158 ~~~~~~~~~y~~PE~ 172 (287)
T cd07840 158 YTNRVITLWYRPPEL 172 (287)
T ss_pred ccccccccccCCcee
Confidence 223346889999995
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.8e-15 Score=159.08 Aligned_cols=151 Identities=26% Similarity=0.357 Sum_probs=114.2
Q ss_pred cccccceEecCCceEEEEEEe-cCCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC--cee--e
Q 047196 676 KFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNED--FKA--L 748 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~--~~~--l 748 (827)
+|+..+.+|.|+||.||++.. .+|+.||+|++... .....+++.+|++++++++|+|++++++++.... ..+ +
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 366778999999999999985 46889999998643 2344567899999999999999999998875432 122 2
Q ss_pred eeecc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEEccCCCccee----------eecccccc
Q 047196 749 DCLHS------------TNCSLNIFDKLNIMIDVASALEYLHFSH--STPVIHCDLKPKNVF----------DFGIGRLL 804 (827)
Q Consensus 749 ~~l~~------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h--~~~iiHrDlK~~NIl----------DFGla~~~ 804 (827)
++... ....+++.....++.++++|++|||..+ +.+|+||||||+||+ |||+++..
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 22211 1235667778889999999999997554 899999999999998 89988876
Q ss_pred cCCCccccccceecccccccccC
Q 047196 805 TGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 805 ~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
...... .....+++.|+|||++
T Consensus 161 ~~~~~~-~~~~~~~~~~~~pE~~ 182 (265)
T cd08217 161 GHDSSF-AKTYVGTPYYMSPEQL 182 (265)
T ss_pred cCCccc-ccccccCCCccChhhh
Confidence 543321 1223589999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.64 E-value=9.7e-16 Score=165.52 Aligned_cols=150 Identities=29% Similarity=0.379 Sum_probs=112.5
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceEEEeeeecCC--cee-
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA--MALKSFEAECEVMKNIRHRNHVKRISSCSNED--FKA- 747 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~--~~~- 747 (827)
.++|+..+.||+|+||.||+|... +|+.||+|++..... .....+.+|++++++++|+|++++.+++.+.. ..+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467888999999999999999864 689999999864321 12235678999999999999999999886543 122
Q ss_pred -eeeecc--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 748 -LDCLHS--------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 748 -l~~l~~--------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
+++... ....+.+.+...++.++++|++||| +.+|+||||||+||+ |||+++......
T Consensus 86 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 86 VMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 222211 1234677788889999999999995 567999999999998 999988765332
Q ss_pred ccccccceecccccccccC
Q 047196 809 SMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~~~~~~gt~~Y~APE~l 827 (827)
.. .+...+++.|+|||++
T Consensus 163 ~~-~~~~~~~~~y~aPE~~ 180 (309)
T cd07845 163 KP-MTPKVVTLWYRAPELL 180 (309)
T ss_pred CC-CCcccccccccChhhh
Confidence 21 1223468899999963
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.6e-15 Score=160.48 Aligned_cols=142 Identities=29% Similarity=0.479 Sum_probs=103.8
Q ss_pred ceEecCCceEEEEEEec-CCc--EEEEEEEccc-chHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCceeeeeeccC-
Q 047196 681 NLIGVGSFGSVYKGRLH-DGI--EVAIKVFHQN-CAMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFKALDCLHST- 754 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~-~g~--~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~l~~l~~~- 754 (827)
++||+|+||.||+|+.. +|. .+|+|.+... .....+.+.+|+++++++ +|||++++++++......++...+..
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 46899999999999875 343 4788888643 234456789999999999 79999999999987665444222211
Q ss_pred -------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eec
Q 047196 755 -------------------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFG 799 (827)
Q Consensus 755 -------------------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFG 799 (827)
...+.+.+...++.+++.|++||| +++|+||||||+||+ |||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence 113567778899999999999996 678999999999998 999
Q ss_pred ccccccCCCccccccceecccccccccC
Q 047196 800 IGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 800 la~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
+++...... .......+..|+|||++
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~ 183 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESL 183 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHH
Confidence 876322111 11111246789999963
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.6e-15 Score=159.45 Aligned_cols=148 Identities=28% Similarity=0.335 Sum_probs=114.5
Q ss_pred cccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 676 KFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
-|+..+.||+|+||.||+|.. .+++.||||+..... ....+.+.+|++++++++|+|++++++++..++..++...+.
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 366778899999999999986 468899999986432 334567899999999999999999999998877555433222
Q ss_pred C---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccccc
Q 047196 754 T---------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTE 814 (827)
Q Consensus 754 ~---------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~ 814 (827)
. ...+++.....++.+++.++.|| |+.+|+|+||||+||+ |||+++.+..... ....
T Consensus 85 ~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~ 160 (277)
T cd06641 85 GGGSALDLLEPGPLDETQIATILREILKGLDYL---HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRNT 160 (277)
T ss_pred CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHH---ccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh-hhcc
Confidence 1 23456777788999999999999 5689999999999988 9999876543221 1122
Q ss_pred ceecccccccccC
Q 047196 815 TLVTIGYMAPGLL 827 (827)
Q Consensus 815 ~~gt~~Y~APE~l 827 (827)
..++.+|+|||++
T Consensus 161 ~~~~~~y~~PE~~ 173 (277)
T cd06641 161 FVGTPFWMAPEVI 173 (277)
T ss_pred ccCCccccChhhh
Confidence 3478899999963
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.2e-15 Score=159.96 Aligned_cols=143 Identities=28% Similarity=0.450 Sum_probs=108.0
Q ss_pred hcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC-ceee--eee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNED-FKAL--DCL 751 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~-~~~l--~~l 751 (827)
.+|...+.||+|+||.||+|..+ |..||+|.+.... ..+.|.+|+.++++++|+|++++++++...+ ..++ ++.
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46777899999999999999765 7789999986543 2457899999999999999999999865433 2222 222
Q ss_pred cc----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 752 HS----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 752 ~~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
.. ....+.+.....++.+++.|++||| +.+|+||||||+||+ |||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 21 1113567778899999999999995 678999999999998 999887543322
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
....++..|+|||++
T Consensus 157 -~~~~~~~~y~aPE~~ 171 (256)
T cd05082 157 -DTGKLPVKWTAPEAL 171 (256)
T ss_pred -CCCccceeecCHHHH
Confidence 122356789999963
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.2e-15 Score=162.43 Aligned_cols=149 Identities=22% Similarity=0.323 Sum_probs=111.6
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeee
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l 751 (827)
+|+..+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|+++++.++|+|++++++.+..++..++...
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 5777899999999999999865 57899999986543 2234578899999999999999999999887775544333
Q ss_pred ccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC---
Q 047196 752 HSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR--- 808 (827)
Q Consensus 752 ~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~--- 808 (827)
+... ..+.+.....++.++++|++|+| +.+|+||||||+||+ |||+++......
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 82 YVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 3221 33566667788999999999996 578999999999997 999887421100
Q ss_pred -----------ccccccceecccccccccC
Q 047196 809 -----------SMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 -----------~~~~~~~~gt~~Y~APE~l 827 (827)
........++.+|+|||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 188 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVI 188 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhc
Confidence 0001112478899999963
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.4e-15 Score=159.43 Aligned_cols=144 Identities=28% Similarity=0.445 Sum_probs=106.0
Q ss_pred ceEecCCceEEEEEEec--C--CcEEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee-eeecc-
Q 047196 681 NLIGVGSFGSVYKGRLH--D--GIEVAIKVFHQNCA-MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL-DCLHS- 753 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~--~--g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l-~~l~~- 753 (827)
++||+|+||.||+|++. + +..||+|.+..... ...+++.+|++++++++|+|+|++++++......++ ++...
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG 80 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence 46999999999999753 2 36899999875543 345679999999999999999999998865443222 22211
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccc--c
Q 047196 754 -------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQT--E 814 (827)
Q Consensus 754 -------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~--~ 814 (827)
....+.+..+..++.++++|++||| ..+|+||||||+||+ |||+++........... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 81 PLLKYLKKRREIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 1124677788999999999999995 567999999999988 99998876443322111 1
Q ss_pred ceecccccccccC
Q 047196 815 TLVTIGYMAPGLL 827 (827)
Q Consensus 815 ~~gt~~Y~APE~l 827 (827)
..++..|+|||++
T Consensus 158 ~~~~~~y~aPE~~ 170 (257)
T cd05060 158 GRWPLKWYAPECI 170 (257)
T ss_pred ccccccccCHHHh
Confidence 1235689999963
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.63 E-value=1e-15 Score=165.26 Aligned_cols=150 Identities=25% Similarity=0.411 Sum_probs=111.4
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc-----
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF----- 745 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~----- 745 (827)
.++|+..+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++|||+++.+++|.....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 356888999999999999999864 68999999986432 2223456789999999999999999998865432
Q ss_pred -----eeeeeec--------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccc
Q 047196 746 -----KALDCLH--------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGR 802 (827)
Q Consensus 746 -----~~l~~l~--------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~ 802 (827)
..+++.. .....+.+.+...++.+++.|++||| +.+|+||||||+||+ |||++.
T Consensus 91 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 91 KGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 1222221 11224677778899999999999996 568999999999997 999987
Q ss_pred cccCCCcc---ccccceeccccccccc
Q 047196 803 LLTGDRSM---IQTETLVTIGYMAPGL 826 (827)
Q Consensus 803 ~~~~~~~~---~~~~~~gt~~Y~APE~ 826 (827)
........ ......++..|+|||+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~ 194 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPEL 194 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHH
Confidence 66432211 1122347889999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.2e-15 Score=157.75 Aligned_cols=147 Identities=26% Similarity=0.377 Sum_probs=112.7
Q ss_pred cccccceEecCCceEEEEEEe-cCCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 676 KFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
+|+..+.||+|+||.||+|.. .+++.||||++... .....+.+.+|++++++++|+|+++.++.+..++..++...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 467788999999999999986 46889999998643 233456899999999999999999999988766655443322
Q ss_pred cC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------eecccccccCCCc
Q 047196 753 ST------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRLLTGDRS 809 (827)
Q Consensus 753 ~~------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGla~~~~~~~~ 809 (827)
.. ...+.+.....++.+++++++||| +.+|+||||||+||+ |||+++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 21 123567777889999999999995 678999999999988 8888876543321
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
.....|+..|+|||++
T Consensus 158 --~~~~~~~~~y~aPE~~ 173 (256)
T cd08220 158 --AYTVVGTPCYISPELC 173 (256)
T ss_pred --ccccccCCcccCchhc
Confidence 1223478999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.1e-15 Score=160.12 Aligned_cols=149 Identities=28% Similarity=0.351 Sum_probs=115.8
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
+.|+..+.||+|+||.||+|... ++..||||++.... ....+.+.+|++++++++|+|++++++++.++...++...+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 34667788999999999999865 58899999987543 34567899999999999999999999999887766554433
Q ss_pred cCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccc
Q 047196 753 STN---------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQT 813 (827)
Q Consensus 753 ~~~---------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~ 813 (827)
... ..+.+.+...++.++++|++|+| +.+++|+||+|+||+ |||+++....... ...
T Consensus 84 ~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~ 159 (277)
T cd06640 84 LGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRN 159 (277)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-ccc
Confidence 322 23566667789999999999995 678999999999988 9999877643322 122
Q ss_pred cceecccccccccC
Q 047196 814 ETLVTIGYMAPGLL 827 (827)
Q Consensus 814 ~~~gt~~Y~APE~l 827 (827)
...++..|+|||++
T Consensus 160 ~~~~~~~y~apE~~ 173 (277)
T cd06640 160 TFVGTPFWMAPEVI 173 (277)
T ss_pred cccCcccccCHhHh
Confidence 23478899999973
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.2e-16 Score=171.95 Aligned_cols=148 Identities=26% Similarity=0.438 Sum_probs=112.0
Q ss_pred ccccceEecCCceEEEEEEec--CC--cEEEEEEEcccchH-HHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee---
Q 047196 677 FSKENLIGVGSFGSVYKGRLH--DG--IEVAIKVFHQNCAM-ALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL--- 748 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~~--~g--~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l--- 748 (827)
....++||+|+||+|++|.|. .| ..||||.++.+... ....|.+|+.+|-+++|+|+|+++|...+....+.
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~EL 191 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFEL 191 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhh
Confidence 344578999999999999875 34 45999999766433 57899999999999999999999999876433221
Q ss_pred -------eeecc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 749 -------DCLHS-TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 749 -------~~l~~-~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
+.++. ....+-......++.|||.|+.||. .++.||||+...|+| |||+.|.+......
T Consensus 192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 22332 1223444556789999999999994 677999999999998 99999998765554
Q ss_pred cc-ccce-ecccccccccC
Q 047196 811 IQ-TETL-VTIGYMAPGLL 827 (827)
Q Consensus 811 ~~-~~~~-gt~~Y~APE~l 827 (827)
+. .... ..+.|.|||-+
T Consensus 269 Yvm~p~rkvPfAWCaPEsL 287 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESL 287 (1039)
T ss_pred eEecCCCcCcccccCHhHh
Confidence 31 1111 46789999954
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.5e-15 Score=157.52 Aligned_cols=148 Identities=30% Similarity=0.444 Sum_probs=111.4
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC-ceee--e
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNED-FKAL--D 749 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~-~~~l--~ 749 (827)
+|+..+.||+|+||.||+++.. +++.||||++.... ....+.+.+|++++++++|+|++++.+.+...+ ..++ +
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 3677889999999999999864 57899999986432 334567899999999999999999998875443 2222 2
Q ss_pred eecc----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 750 CLHS----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 750 ~l~~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
+... ....+.+.+...++.+++.|++|+| +.+|+||||||+||+ |||+++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 2211 1123667778899999999999995 678999999999987 9999887643322
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
. .....+++.|+|||++
T Consensus 158 ~-~~~~~~~~~y~aPE~~ 174 (257)
T cd08223 158 M-ASTLIGTPYYMSPELF 174 (257)
T ss_pred c-cccccCCcCccChhHh
Confidence 1 1223478999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.6e-15 Score=160.20 Aligned_cols=148 Identities=24% Similarity=0.263 Sum_probs=114.0
Q ss_pred cccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeeccC
Q 047196 676 KFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHST 754 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~ 754 (827)
.|...+.||+|++|.||+|.. .+++.||+|++........+.+.+|+.++++++|+|++++++++...+..++...+..
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 355567999999999999985 4688999999875554455678999999999999999999999877665554333322
Q ss_pred C---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccccc
Q 047196 755 N---------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTET 815 (827)
Q Consensus 755 ~---------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~~ 815 (827)
. ..+++.....++.+++.|++||| +.+|+||||||+||+ |||+++........ ....
T Consensus 100 ~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~ 175 (285)
T cd06648 100 GGALTDIVTHTRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-RKSL 175 (285)
T ss_pred CCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-cccc
Confidence 1 24566677889999999999995 678999999999997 88887765433221 1223
Q ss_pred eecccccccccC
Q 047196 816 LVTIGYMAPGLL 827 (827)
Q Consensus 816 ~gt~~Y~APE~l 827 (827)
.|++.|+|||++
T Consensus 176 ~~~~~y~aPE~~ 187 (285)
T cd06648 176 VGTPYWMAPEVI 187 (285)
T ss_pred cCCccccCHHHh
Confidence 489999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.5e-15 Score=161.72 Aligned_cols=158 Identities=26% Similarity=0.343 Sum_probs=117.1
Q ss_pred cchhHHHHHhhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhc-CCCCceEEEeeeec
Q 047196 665 FSYQDLFRATEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNI-RHRNHVKRISSCSN 742 (827)
Q Consensus 665 ~~~~~~~~~~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~ 742 (827)
.+..++..+.+.|+..+.+|+|+||.||+|+. .+++.||+|++.... ....++..|+.+++++ +|+|++++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 35566666778899999999999999999986 468899999986543 2345688999999999 69999999999853
Q ss_pred C------Ccee--eeeecc----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee--------
Q 047196 743 E------DFKA--LDCLHS----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------- 796 (827)
Q Consensus 743 ~------~~~~--l~~l~~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------- 796 (827)
. +..+ +++... ....+.+.....++.+++.|++||| +.+|+|||+||+||+
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEE
Confidence 2 2222 233221 1123455566788999999999995 578999999999988
Q ss_pred --eecccccccCCCccccccceecccccccccC
Q 047196 797 --DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 --DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
|||+++........ .....|++.|+|||++
T Consensus 162 l~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~l 193 (282)
T cd06636 162 LVDFGVSAQLDRTVGR-RNTFIGTPYWMAPEVI 193 (282)
T ss_pred EeeCcchhhhhccccC-CCcccccccccCHhhc
Confidence 99998765322211 1224589999999964
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.7e-15 Score=162.38 Aligned_cols=149 Identities=26% Similarity=0.352 Sum_probs=110.5
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccch--HHHHHHHHHHHHHHhcC-CCCceEEEeeeecCCc-----
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA--MALKSFEAECEVMKNIR-HRNHVKRISSCSNEDF----- 745 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~----- 745 (827)
++|+..+.||+|+||.||+|+.. +|+.||||++..... .....+.+|++++++++ |+|++++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 35788899999999999999864 689999999764321 22356888999999996 5999999998865443
Q ss_pred --eeeeeeccC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------eecc
Q 047196 746 --KALDCLHST------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGI 800 (827)
Q Consensus 746 --~~l~~l~~~------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGl 800 (827)
..++++... ...+.+.....++.++++||+||| +++|+||||||+||+ |||+
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeeccc
Confidence 223332210 123567788889999999999995 678999999999998 8888
Q ss_pred cccccCCCccccccceecccccccccC
Q 047196 801 GRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 801 a~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
++.+...... .....+++.|+|||++
T Consensus 158 ~~~~~~~~~~-~~~~~~~~~~~aPE~~ 183 (295)
T cd07837 158 GRAFSIPVKS-YTHEIVTLWYRAPEVL 183 (295)
T ss_pred ceecCCCccc-cCCcccccCCCChHHh
Confidence 8765332211 1223478899999963
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.9e-15 Score=160.44 Aligned_cols=148 Identities=26% Similarity=0.395 Sum_probs=114.5
Q ss_pred cccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcC---CCCceEEEeeeecCCceeeee
Q 047196 676 KFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC-AMALKSFEAECEVMKNIR---HRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~---H~niv~~~~~~~~~~~~~l~~ 750 (827)
.|+..+.||+|+||.||+|.. .+++.||||++.... ....+++.+|++++++++ |+|++++++++......++..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 366678899999999999986 568999999986542 334567889999999997 999999999988766544433
Q ss_pred eccC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 751 LHST---------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 751 l~~~---------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
.+.. ...+.+.....++.++++|+.||| +.+|+||||||+||+ |||++.........
T Consensus 82 e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~- 157 (277)
T cd06917 82 EYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK- 157 (277)
T ss_pred ecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc-
Confidence 2221 234667778889999999999995 678999999999998 99998876543321
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
.....|+..|+|||++
T Consensus 158 ~~~~~~~~~y~aPE~~ 173 (277)
T cd06917 158 RSTFVGTPYWMAPEVI 173 (277)
T ss_pred cccccCCcceeCHHHh
Confidence 2223589999999963
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.5e-15 Score=161.75 Aligned_cols=149 Identities=27% Similarity=0.421 Sum_probs=110.8
Q ss_pred hcccccceEecCCceEEEEEEec-----CCcEEEEEEEcccchH-HHHHHHHHHHHHHhcCCCCceEEEeeeec--CCce
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-----DGIEVAIKVFHQNCAM-ALKSFEAECEVMKNIRHRNHVKRISSCSN--EDFK 746 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-----~g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~~~~~~~~--~~~~ 746 (827)
+.|...+.||+|+||.||+|++. +++.||||++...... ..+.|.+|++++++++|+|++++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 34666788999999999999853 3688999998755432 46789999999999999999999998876 2222
Q ss_pred ee--eeecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eeccccccc
Q 047196 747 AL--DCLHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLT 805 (827)
Q Consensus 747 ~l--~~l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~ 805 (827)
.+ ++... ....+++.....++.++++||+||| +.+|+||||||+||+ |||++....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 22 32221 1123677788899999999999996 578999999999998 999988765
Q ss_pred CCCccc--cccceeccccccccc
Q 047196 806 GDRSMI--QTETLVTIGYMAPGL 826 (827)
Q Consensus 806 ~~~~~~--~~~~~gt~~Y~APE~ 826 (827)
...... .....++..|+|||+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~ 183 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPEC 183 (284)
T ss_pred cCCcceeccCCCCCcccccCcHH
Confidence 332211 111224667999996
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.8e-15 Score=157.95 Aligned_cols=149 Identities=27% Similarity=0.337 Sum_probs=115.4
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
+|+..+.||.|+||.||+|... ++..||+|++.... ....+.+.+|+++++.++|+|+++.++.+...+..++...+.
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 81 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL 81 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence 5788899999999999999854 68899999986532 335678999999999999999999999887776554433222
Q ss_pred CC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 754 TN-------------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 754 ~~-------------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
.. ..+++.....++.+++.|++||| +.+|+||||||+||+ |||++..+......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 82 SGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred CCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 11 23566677789999999999995 678999999999998 99988776543322
Q ss_pred ---ccccceecccccccccC
Q 047196 811 ---IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ---~~~~~~gt~~Y~APE~l 827 (827)
......|+..|+|||++
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~ 178 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVM 178 (267)
T ss_pred cccccccccCChhhcChHHH
Confidence 11223489999999973
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.1e-15 Score=161.84 Aligned_cols=149 Identities=24% Similarity=0.293 Sum_probs=112.9
Q ss_pred hcccccceEecCCceEEEEEEecC-CcEEEEEEEcccc-hHHHHHHHHHHHHHHhcC-CCCceEEEeeeecCCceeeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHD-GIEVAIKVFHQNC-AMALKSFEAECEVMKNIR-HRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~l~~l 751 (827)
++|+..+.||+|+||.||+|...+ |+.||||++.... .....++.+|++++.+.. |+|+++++++|......++...
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 567788999999999999999764 8999999986532 234456777888777775 9999999999987765544222
Q ss_pred ccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 752 HST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 752 ~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
+.. ...+++..+..++.++++|++|||. .++|+||||||+||+ |||+++.+......
T Consensus 95 ~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~- 171 (296)
T cd06618 95 LMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK- 171 (296)
T ss_pred ccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc-
Confidence 221 2346777788999999999999973 358999999999988 99998766433221
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
....++..|+|||++
T Consensus 172 -~~~~~~~~y~aPE~~ 186 (296)
T cd06618 172 -TRSAGCAAYMAPERI 186 (296)
T ss_pred -cCCCCCccccCHhhc
Confidence 223478899999974
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.3e-15 Score=163.21 Aligned_cols=149 Identities=24% Similarity=0.263 Sum_probs=99.3
Q ss_pred hcccccceEecCCceEEEEEEecC----CcEEEEEEEcccchHH-----------HHHHHHHHHHHHhcCCCCceEEEee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHD----GIEVAIKVFHQNCAMA-----------LKSFEAECEVMKNIRHRNHVKRISS 739 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~~~-----------~~~~~~Ei~~l~~l~H~niv~~~~~ 739 (827)
.+|...++||+|+||.||+|+..+ +..+|+|+........ ......+...+..++|+++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 468888999999999999998653 4566777543221110 0112334455667789999999987
Q ss_pred eecCCc------eeeeeeccC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------
Q 047196 740 CSNEDF------KALDCLHST-------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---------- 796 (827)
Q Consensus 740 ~~~~~~------~~l~~l~~~-------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---------- 796 (827)
+..... ..++.+... .....+.....|+.++++|++||| +++|+||||||+|||
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~~l~ 168 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYII 168 (294)
T ss_pred eeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcEEEE
Confidence 655431 111211110 112345556789999999999995 678999999999998
Q ss_pred eecccccccCCCcc------ccccceeccccccccc
Q 047196 797 DFGIGRLLTGDRSM------IQTETLVTIGYMAPGL 826 (827)
Q Consensus 797 DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~ 826 (827)
|||+|+.+...... ......||+.|+|||+
T Consensus 169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~ 204 (294)
T PHA02882 169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDA 204 (294)
T ss_pred EcCCceeeccCCcccccccccccccCCCccccCHHH
Confidence 99999876432211 1112348999999996
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.5e-16 Score=157.57 Aligned_cols=145 Identities=26% Similarity=0.370 Sum_probs=107.1
Q ss_pred Hhhccccc-ceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCC---c-
Q 047196 673 ATEKFSKE-NLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNI-RHRNHVKRISSCSNED---F- 745 (827)
Q Consensus 673 ~~~~~~~~-~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~---~- 745 (827)
.|++|... ++||-|--|+|..+.. .+|+.+|.|++... +..++|+++.-+. .|||||..++.|.+.- .
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 34555443 6899999999999975 47899999998543 3457888876665 5999999999886521 1
Q ss_pred --eeeeeecc----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------eecc
Q 047196 746 --KALDCLHS----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------DFGI 800 (827)
Q Consensus 746 --~~l~~l~~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------------DFGl 800 (827)
.+|+++.. +...++..+.-+|+.+|+.|+.|| |+.+|.||||||+|+| |||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~l---H~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYL---HSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHH---HhcchhhccCChhheeeecCCCCcceEeccccc
Confidence 12333332 123456667788999999999999 5778999999999998 9999
Q ss_pred cccccCCCccccccceecccccccccC
Q 047196 801 GRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 801 a~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
||.-..... ..+.+-|++|+|||++
T Consensus 211 AK~t~~~~~--L~TPc~TPyYvaPevl 235 (400)
T KOG0604|consen 211 AKETQEPGD--LMTPCFTPYYVAPEVL 235 (400)
T ss_pred ccccCCCcc--ccCCcccccccCHHHh
Confidence 987543222 2334579999999985
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.9e-15 Score=161.11 Aligned_cols=143 Identities=25% Similarity=0.316 Sum_probs=111.3
Q ss_pred ccccceEecCCceEEEEEEec-CCcEEEEEEEccc---chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 677 FSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN---CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
|...+.||+|+||+||+|+.. +|+.||+|++... .....+.+.+|++++++++|+|++++.+++.+.+..++...+
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999864 6889999998643 233446788999999999999999999999887655543322
Q ss_pred c----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 753 S----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 753 ~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
. ....+.+.+...++.+++.+++||| +.+|+||||||+||+ |||++......
T Consensus 103 ~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~----- 174 (313)
T cd06633 103 CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA----- 174 (313)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCCC-----
Confidence 1 1234677788889999999999996 567999999999998 88887543211
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
....|+..|+|||++
T Consensus 175 ~~~~~~~~y~aPE~~ 189 (313)
T cd06633 175 NSFVGTPYWMAPEVI 189 (313)
T ss_pred CCccccccccChhhc
Confidence 223588999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.3e-16 Score=163.26 Aligned_cols=153 Identities=27% Similarity=0.396 Sum_probs=113.4
Q ss_pred hhcccccceEecCCceEEEEEE-ecCCcEEEEEEEccc--ch-----HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc
Q 047196 674 TEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQN--CA-----MALKSFEAECEVMKNIRHRNHVKRISSCSNEDF 745 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~-~~~g~~vAvK~l~~~--~~-----~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~ 745 (827)
.++|-..+++|+|+|+.||||. +...+.||||+-..+ .. ...+...+|.+|.+.++||.||++++++.-+..
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 3567777899999999999997 455788999985322 11 124567789999999999999999999865443
Q ss_pred e---eeeeeccC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------eeccc
Q 047196 746 K---ALDCLHST--------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------DFGIG 801 (827)
Q Consensus 746 ~---~l~~l~~~--------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------------DFGla 801 (827)
. ++++...- ....+..+...|+.+|..||.||.+ -++||||-||||.||| |||++
T Consensus 542 sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 2 23333221 1223445567899999999999975 5799999999999998 99999
Q ss_pred ccccCCCcc-----cccc-ceecccccccccC
Q 047196 802 RLLTGDRSM-----IQTE-TLVTIGYMAPGLL 827 (827)
Q Consensus 802 ~~~~~~~~~-----~~~~-~~gt~~Y~APE~l 827 (827)
|+..++... ..++ ..||.+|.+||.+
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcF 652 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECF 652 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCccee
Confidence 998654332 1222 3489999999963
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.9e-15 Score=160.91 Aligned_cols=147 Identities=29% Similarity=0.394 Sum_probs=112.8
Q ss_pred ccccceEecCCceEEEEEEec-CCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 677 FSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
|+..+.||+|++|.||+|... +|..||||++.... ....+.+.+|++++++++|+|++++++++.+++..++...+.
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 456688999999999999864 79999999986442 223356889999999999999999999998776555433221
Q ss_pred C---------C--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 754 T---------N--CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 754 ~---------~--~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
. . ..+++.....++.++++||+||| +++++||||+|+||+ |||+++........ .
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~ 156 (283)
T cd07835 81 DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-Y 156 (283)
T ss_pred CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-c
Confidence 1 1 24678888999999999999996 568999999999988 99998765322211 1
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
....++..|+|||++
T Consensus 157 ~~~~~~~~~~aPE~~ 171 (283)
T cd07835 157 THEVVTLWYRAPEIL 171 (283)
T ss_pred CccccccCCCCCcee
Confidence 223468899999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.3e-15 Score=155.20 Aligned_cols=147 Identities=33% Similarity=0.386 Sum_probs=114.9
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA--MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
+|+..+.||+|++|.||+|+.. +++.||||.+..... ...+.+.+|++++++++|+|++++++++......++...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 3667789999999999999865 688999999875533 4567899999999999999999999998776654443222
Q ss_pred cC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 753 ST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 753 ~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
.. ...+++.....++.+++.|+.||| +.+|+||||||+||+ |||+++........ .
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~ 156 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-D 156 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-c
Confidence 21 135677788899999999999995 678999999999988 89988876543321 1
Q ss_pred ccceeccccccccc
Q 047196 813 TETLVTIGYMAPGL 826 (827)
Q Consensus 813 ~~~~gt~~Y~APE~ 826 (827)
....++..|+|||+
T Consensus 157 ~~~~~~~~y~~pe~ 170 (254)
T cd06627 157 ASVVGTPYWMAPEV 170 (254)
T ss_pred cccccchhhcCHhh
Confidence 22347899999996
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.7e-15 Score=155.97 Aligned_cols=148 Identities=25% Similarity=0.330 Sum_probs=117.0
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA-MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
+|+..+.||+|++|.||+|+.. +++.||||++..... ...+.+.+|++.+++++|+|++++++++......++...+.
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 5777899999999999999875 589999999876543 45678999999999999999999999988776555433322
Q ss_pred C----------CCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 754 T----------NCSLNIFDKLNIMIDVASALEYLHFSHS-TPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 754 ~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~-~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
. ...++......++.++++|++|+| + .+++||||||+||+ |||.++.........
T Consensus 82 ~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~- 157 (264)
T cd06623 82 DGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC- 157 (264)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc-
Confidence 2 134566777899999999999994 6 88999999999998 899888765433221
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
....++..|+|||++
T Consensus 158 ~~~~~~~~y~~pE~~ 172 (264)
T cd06623 158 NTFVGTVTYMSPERI 172 (264)
T ss_pred cceeecccccCHhhh
Confidence 123478999999963
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.2e-15 Score=156.64 Aligned_cols=148 Identities=25% Similarity=0.367 Sum_probs=114.1
Q ss_pred cccccceEecCCceEEEEEEe-cCCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 676 KFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
+|+..+.||+|+||.||+++. .+|+.||+|++... .....+++.+|++++++++|+|++++.+++.+.+..++...+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 467789999999999999985 46899999998643 233456789999999999999999999998777665543332
Q ss_pred cC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 753 ST------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 753 ~~------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
.. ...+.+.+...++.+++.|++||| +.+++|+||+|+||+ |||++.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 21 123466677889999999999995 578999999999998 99998766433221
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
.....|++.|+|||++
T Consensus 158 -~~~~~~~~~~~~pe~~ 173 (256)
T cd08218 158 -ARTCIGTPYYLSPEIC 173 (256)
T ss_pred -hhhccCCccccCHHHh
Confidence 1223478999999973
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.6e-15 Score=157.79 Aligned_cols=150 Identities=25% Similarity=0.359 Sum_probs=114.5
Q ss_pred HhhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCc-----
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDF----- 745 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~----- 745 (827)
++++|+..+.||+|+||.||+|+.. +++.||+|++..... ..+++.+|+++++++ +|+|++++++++.....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 5678999999999999999999875 578999999875433 346789999999999 69999999999865442
Q ss_pred -e--eeeeeccC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecc
Q 047196 746 -K--ALDCLHST------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGI 800 (827)
Q Consensus 746 -~--~l~~l~~~------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGl 800 (827)
. ++++.... ...+++.....++.++++|++|| |+.+|+||||+|+||+ |||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~l---H~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYL---HENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH---hcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 2 22322211 23456667778999999999999 4778999999999998 8998
Q ss_pred cccccCCCccccccceecccccccccC
Q 047196 801 GRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 801 a~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
+........ ......|+..|+|||++
T Consensus 160 ~~~~~~~~~-~~~~~~~~~~y~aPE~~ 185 (275)
T cd06608 160 SAQLDSTLG-RRNTFIGTPYWMAPEVI 185 (275)
T ss_pred ceecccchh-hhcCccccccccCHhHh
Confidence 876533222 12234589999999963
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.61 E-value=8.4e-16 Score=166.01 Aligned_cols=150 Identities=26% Similarity=0.377 Sum_probs=111.7
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCce----
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA--MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFK---- 746 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~---- 746 (827)
.++|+..+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++|+|++++++.+......
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468899999999999999999864 689999999864322 1234578899999999999999998876543211
Q ss_pred ----ee--eeec--------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccc
Q 047196 747 ----AL--DCLH--------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGR 802 (827)
Q Consensus 747 ----~l--~~l~--------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~ 802 (827)
++ ++.. .....+++.....++.++++||+||| +.+|+||||||+||+ |||+++
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 22 2111 11235677888899999999999995 678999999999997 999987
Q ss_pred cccCCCcc----------ccccceeccccccccc
Q 047196 803 LLTGDRSM----------IQTETLVTIGYMAPGL 826 (827)
Q Consensus 803 ~~~~~~~~----------~~~~~~gt~~Y~APE~ 826 (827)
........ ..+...+++.|+|||+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 197 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPEL 197 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHH
Confidence 65432211 0122347889999996
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=6e-17 Score=157.89 Aligned_cols=146 Identities=26% Similarity=0.290 Sum_probs=102.7
Q ss_pred cccceEecCCceEEEEEEe-cCCcEEEEEEEcccc-hHHHHHHHHHHHHHHh-cCCCCceEEEeeeecCCceee--eeec
Q 047196 678 SKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC-AMALKSFEAECEVMKN-IRHRNHVKRISSCSNEDFKAL--DCLH 752 (827)
Q Consensus 678 ~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~-l~H~niv~~~~~~~~~~~~~l--~~l~ 752 (827)
+....||.|+||+|+|-.. +.|+..|||+++... ....+++..|.++..+ =+-||||+++|.+..+...++ +.+.
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd 146 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD 146 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence 3446799999999999975 479999999997643 4567789999875544 468999999999987764443 2111
Q ss_pred cC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 753 ST------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 753 ~~------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
.. ...+...-.-.|..-+..||.||...+ .|||||+||+||| |||+...+.+. .
T Consensus 147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S--i 222 (361)
T KOG1006|consen 147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS--I 222 (361)
T ss_pred hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH--H
Confidence 00 011111111234555678999998654 4999999999999 99998766433 2
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
+.+.-+|-..|||||-|
T Consensus 223 AkT~daGCrpYmAPERi 239 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERI 239 (361)
T ss_pred HhhhccCCccccChhcc
Confidence 33445588899999964
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.4e-15 Score=166.10 Aligned_cols=151 Identities=28% Similarity=0.409 Sum_probs=113.2
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC------
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNED------ 744 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~------ 744 (827)
.++|+..+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++|+|++++.+++....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367888899999999999999864 68999999986532 233567788999999999999999888764322
Q ss_pred ceeeeeecc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCC
Q 047196 745 FKALDCLHS-------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGD 807 (827)
Q Consensus 745 ~~~l~~l~~-------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~ 807 (827)
+..+++... ....+++.....++.++++||+||| +++|+||||||+||+ |||+++.....
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 84 YVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 122222211 1234677788899999999999996 568999999999998 99998766432
Q ss_pred Ccc---ccccceecccccccccC
Q 047196 808 RSM---IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 808 ~~~---~~~~~~gt~~Y~APE~l 827 (827)
... .....+|+..|+|||++
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~ 183 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELL 183 (334)
T ss_pred CcCCCcccccccccccccChHHh
Confidence 221 11223588999999963
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.7e-15 Score=156.89 Aligned_cols=119 Identities=24% Similarity=0.319 Sum_probs=93.6
Q ss_pred hcccccceEecCCceEEEEEEecC-CcEEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHD-GIEVAIKVFHQNCA---MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
+.|+..+.+|+|.-|+||.+++++ +..+|+|++.+... ....+.+.|-+||+.++||.+..++..+..+.+..+..
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 456777889999999999999864 68899999976542 23456788999999999999999999998888766543
Q ss_pred eccCCC------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee
Q 047196 751 LHSTNC------------SLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF 796 (827)
Q Consensus 751 l~~~~~------------~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl 796 (827)
.+-.++ .+......-+|..|.-||+|| |..|||.|||||+|||
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYL---HmlGivYRDLKPENIL 211 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYL---HMLGIVYRDLKPENIL 211 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHH---HhhceeeccCCcceeE
Confidence 332222 234444556778888899999 5789999999999998
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.61 E-value=6.7e-15 Score=153.30 Aligned_cols=147 Identities=31% Similarity=0.440 Sum_probs=115.9
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeeccC
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHST 754 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~ 754 (827)
+|+..+.||+|++|.||++... +++.||+|++........+.+.+|++++++++|++++++++.+......++...+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3667789999999999999875 688999999976654456789999999999999999999999877655444322221
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccc
Q 047196 755 -----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQT 813 (827)
Q Consensus 755 -----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~ 813 (827)
...+.+.+...++.++++|++||| ..+++||||||+||+ |||.+........ ..
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~ 155 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RN 155 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--cc
Confidence 135677788889999999999995 578999999999987 8998876654321 12
Q ss_pred cceecccccccccC
Q 047196 814 ETLVTIGYMAPGLL 827 (827)
Q Consensus 814 ~~~gt~~Y~APE~l 827 (827)
...++..|+|||++
T Consensus 156 ~~~~~~~~~~PE~~ 169 (253)
T cd05122 156 TMVGTPYWMAPEVI 169 (253)
T ss_pred ceecCCcccCHHHH
Confidence 23478999999963
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.61 E-value=2e-15 Score=158.20 Aligned_cols=147 Identities=22% Similarity=0.351 Sum_probs=112.8
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
+|+..+.||+|+||.||+|... +|..||+|.+.... ....+.+.+|++++++++|+|++++++.+......++...+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4677889999999999999865 58899999986532 23345788999999999999999999998777655443322
Q ss_pred cC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------eecccccccCCCc
Q 047196 753 ST------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRLLTGDRS 809 (827)
Q Consensus 753 ~~------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGla~~~~~~~~ 809 (827)
.. ...+++.....++.++++|++||| +.+|+|+||||+||+ |||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 21 123577788899999999999996 567999999999988 7888776543322
Q ss_pred cccccceeccccccccc
Q 047196 810 MIQTETLVTIGYMAPGL 826 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~ 826 (827)
. .....|++.|+|||+
T Consensus 158 ~-~~~~~~~~~~~ape~ 173 (257)
T cd08225 158 L-AYTCVGTPYYLSPEI 173 (257)
T ss_pred c-ccccCCCccccCHHH
Confidence 1 122348899999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.5e-15 Score=166.10 Aligned_cols=149 Identities=26% Similarity=0.390 Sum_probs=112.1
Q ss_pred hhcccccceEecCCceEEEEEEe-cCCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC------
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNED------ 744 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~------ 744 (827)
.++|...+.||+|+||.||+|+. .+|+.||||++... ......++.+|++++++++|+|++++.+++....
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 35688889999999999999985 46899999998643 2233456788999999999999999998775432
Q ss_pred -ceeeeeecc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccC
Q 047196 745 -FKALDCLHS-------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806 (827)
Q Consensus 745 -~~~l~~l~~-------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~ 806 (827)
+.++++... ....+.......++.++++|+.||| +++|+||||||+||+ |||+++....
T Consensus 84 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 84 VYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 122222211 1234667778889999999999995 668999999999997 9999987643
Q ss_pred CCccccccceeccccccccc
Q 047196 807 DRSMIQTETLVTIGYMAPGL 826 (827)
Q Consensus 807 ~~~~~~~~~~gt~~Y~APE~ 826 (827)
... ......++..|+|||+
T Consensus 161 ~~~-~~~~~~~~~~y~aPE~ 179 (337)
T cd07858 161 KGD-FMTEYVVTRWYRAPEL 179 (337)
T ss_pred Ccc-cccccccccCccChHH
Confidence 321 1123357889999996
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.6e-15 Score=157.20 Aligned_cols=143 Identities=27% Similarity=0.517 Sum_probs=108.0
Q ss_pred hcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCcee-eeeecc
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKA-LDCLHS 753 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~-l~~l~~ 753 (827)
++|...+.||+|+||.||+|.. .++.||+|+..... ..+.+.+|+.++++++|+|++++.+++......+ +++...
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~ 82 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSK 82 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCC
Confidence 4578889999999999999975 57789999986543 3457899999999999999999999986654322 222211
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccc
Q 047196 754 ----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQT 813 (827)
Q Consensus 754 ----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~ 813 (827)
....+.+.....++.++++|++||| +.+++||||||+||+ |||+++...... .
T Consensus 83 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----~ 155 (254)
T cd05083 83 GNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----D 155 (254)
T ss_pred CCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccC----C
Confidence 1123567777889999999999995 678999999999998 999887543211 1
Q ss_pred cceecccccccccC
Q 047196 814 ETLVTIGYMAPGLL 827 (827)
Q Consensus 814 ~~~gt~~Y~APE~l 827 (827)
....+..|+|||++
T Consensus 156 ~~~~~~~y~~pe~~ 169 (254)
T cd05083 156 NSKLPVKWTAPEAL 169 (254)
T ss_pred CCCCCceecCHHHh
Confidence 12246789999964
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.6e-15 Score=160.69 Aligned_cols=144 Identities=25% Similarity=0.261 Sum_probs=111.9
Q ss_pred cceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeeccCC---
Q 047196 680 ENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHSTN--- 755 (827)
Q Consensus 680 ~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~~--- 755 (827)
..+||+|+||.||+|.. .+|+.||||++..........+.+|+.++++++|+|+++.++++...+..++...+...
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 35799999999999986 46899999998665555566799999999999999999999998877665553333221
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccccceecc
Q 047196 756 ------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTI 819 (827)
Q Consensus 756 ------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~~~gt~ 819 (827)
..+.+.....++.+++.|++||| +.+|+||||||+||+ |||++......... .....|++
T Consensus 105 ~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~ 180 (292)
T cd06657 105 TDIVTHTRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKSLVGTP 180 (292)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccccc-ccccccCc
Confidence 24566777889999999999996 568999999999988 99988765432211 12234889
Q ss_pred cccccccC
Q 047196 820 GYMAPGLL 827 (827)
Q Consensus 820 ~Y~APE~l 827 (827)
+|+|||++
T Consensus 181 ~y~~pE~~ 188 (292)
T cd06657 181 YWMAPELI 188 (292)
T ss_pred cccCHHHh
Confidence 99999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.5e-15 Score=162.48 Aligned_cols=152 Identities=26% Similarity=0.364 Sum_probs=112.9
Q ss_pred HHHHHhhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC-
Q 047196 669 DLFRATEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNED- 744 (827)
Q Consensus 669 ~~~~~~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~- 744 (827)
++...+++|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||+|++.+++....
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 44556788999999999999999999854 78999999885422 223467889999999999999999999886532
Q ss_pred ceeeeeeccC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccC
Q 047196 745 FKALDCLHST--------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806 (827)
Q Consensus 745 ~~~l~~l~~~--------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~ 806 (827)
..++...+.. ...+.......++.++++|++||| +.+|+||||||+||+ |||.++....
T Consensus 84 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 84 DIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred cEEEEeehhccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 2222221111 123445556678999999999995 678999999999997 8998875432
Q ss_pred CCccccccceecccccccccC
Q 047196 807 DRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 807 ~~~~~~~~~~gt~~Y~APE~l 827 (827)
. .....++..|+|||++
T Consensus 161 ~----~~~~~~~~~y~aPE~~ 177 (328)
T cd07856 161 Q----MTGYVSTRYYRAPEIM 177 (328)
T ss_pred C----cCCCcccccccCceee
Confidence 1 1223478899999963
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.61 E-value=2e-15 Score=159.47 Aligned_cols=144 Identities=32% Similarity=0.488 Sum_probs=105.1
Q ss_pred ceEecCCceEEEEEEecC-------CcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 681 NLIGVGSFGSVYKGRLHD-------GIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~~-------g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
+.||+|+||.||+|+..+ ++.||||.+.... .....+|.+|++++++++||||++++++|...+..++...+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998642 2579999886543 23456789999999999999999999998776654432222
Q ss_pred cC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------------eecc
Q 047196 753 ST-----------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---------------DFGI 800 (827)
Q Consensus 753 ~~-----------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---------------DFGl 800 (827)
.. ...+.+.+.+.++.++++|++||| +.+++||||||+||+ |||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 11 123566778889999999999996 677999999999987 7787
Q ss_pred cccccCCCccc-cccceecccccccccC
Q 047196 801 GRLLTGDRSMI-QTETLVTIGYMAPGLL 827 (827)
Q Consensus 801 a~~~~~~~~~~-~~~~~gt~~Y~APE~l 827 (827)
++......... .....++..|+|||++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 185 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESL 185 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHH
Confidence 76553222111 1112357889999963
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.5e-15 Score=159.27 Aligned_cols=147 Identities=29% Similarity=0.359 Sum_probs=113.8
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeee
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l 751 (827)
+|+..+.||.|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++|||++++++.+.+++..++...
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 3677889999999999999875 58999999986532 2345789999999999999999999988877665544332
Q ss_pred ccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 752 HST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 752 ~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
+.. ...+.......++.++++|+.||| +.+|+|+||||+||+ |||.+........
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-- 155 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL-- 155 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc--
Confidence 221 135667777889999999999996 568999999999998 8998876543321
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
.....|+..|+|||++
T Consensus 156 ~~~~~~~~~y~~PE~~ 171 (258)
T cd05578 156 TTSTSGTPGYMAPEVL 171 (258)
T ss_pred ccccCCChhhcCHHHH
Confidence 1223478899999963
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.61 E-value=2e-15 Score=158.93 Aligned_cols=146 Identities=23% Similarity=0.256 Sum_probs=113.0
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
+|+..+.||+|+||.||+|..+ +++.||+|++.... ....+++.+|++++++++|+|++++++.+......++...+.
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 4667788999999999999875 68999999987543 344567899999999999999999999987776555433222
Q ss_pred C-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEEccCCCccee----------eecccccccCCCccc
Q 047196 754 T-----------NCSLNIFDKLNIMIDVASALEYLHFSHS-TPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 754 ~-----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~-~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
. ...+.......++.++++|++|+| + .+++||||||+||+ |||.++........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 157 (265)
T cd06605 82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK- 157 (265)
T ss_pred CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-
Confidence 2 134455666789999999999995 5 78999999999998 89988765432211
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
...++..|+|||++
T Consensus 158 --~~~~~~~y~~PE~~ 171 (265)
T cd06605 158 --TFVGTSSYMAPERI 171 (265)
T ss_pred --cccCChhccCHHHH
Confidence 14478899999963
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.3e-15 Score=163.10 Aligned_cols=148 Identities=25% Similarity=0.341 Sum_probs=108.2
Q ss_pred cccccceEecCCceEEEEEEec-C--CcEEEEEEEccc--chHHHHHHHHHHHHHHhcC-CCCceEEEeeeecC----Cc
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-D--GIEVAIKVFHQN--CAMALKSFEAECEVMKNIR-HRNHVKRISSCSNE----DF 745 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~--g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~----~~ 745 (827)
+|+..+.||+|+||.||+++.. + +..||||++... .....+.+.+|++++++++ |+|+|++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 3667788999999999999864 4 788999998643 2223467889999999995 99999999875432 11
Q ss_pred eee--eeecc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccC
Q 047196 746 KAL--DCLHS-------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806 (827)
Q Consensus 746 ~~l--~~l~~-------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~ 806 (827)
.++ ++... ....+++.....++.|++.||+||| +.+|+||||||+||+ |||+++.+..
T Consensus 81 ~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 81 LYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred EEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 111 21111 1234677788889999999999995 678999999999997 9999986543
Q ss_pred CCcc---ccccceeccccccccc
Q 047196 807 DRSM---IQTETLVTIGYMAPGL 826 (827)
Q Consensus 807 ~~~~---~~~~~~gt~~Y~APE~ 826 (827)
.... ......||..|+|||+
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~ 180 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEI 180 (332)
T ss_pred ccccccccccCcccCccccCcHH
Confidence 2211 1122358999999996
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.9e-15 Score=165.63 Aligned_cols=149 Identities=28% Similarity=0.392 Sum_probs=111.6
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC---------
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNED--------- 744 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~--------- 744 (827)
.+|...+.||+|+||.||+|+. .+|+.||+|++........+.+.+|++++++++|+|++++++++....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 5788889999999999999986 468999999987655555677899999999999999999887654432
Q ss_pred -------ceeeeeecc------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------eecc
Q 047196 745 -------FKALDCLHS------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGI 800 (827)
Q Consensus 745 -------~~~l~~l~~------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGl 800 (827)
+..+++... ....+.+.....++.|+++|+.||| +.+|+||||||+||+ |||+
T Consensus 85 ~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~dfg~ 161 (342)
T cd07854 85 LTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGL 161 (342)
T ss_pred ccccceEEEEeecccccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEECCccc
Confidence 112222211 1124566777889999999999996 568999999999987 8998
Q ss_pred cccccCCCcc--ccccceeccccccccc
Q 047196 801 GRLLTGDRSM--IQTETLVTIGYMAPGL 826 (827)
Q Consensus 801 a~~~~~~~~~--~~~~~~gt~~Y~APE~ 826 (827)
++.+...... ......++..|+|||+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 189 (342)
T cd07854 162 ARIVDPHYSHKGYLSEGLVTKWYRSPRL 189 (342)
T ss_pred ceecCCccccccccccccccccccCHHH
Confidence 8765322111 1122347889999996
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.8e-15 Score=155.96 Aligned_cols=148 Identities=25% Similarity=0.395 Sum_probs=111.2
Q ss_pred cccccceEecCCceEEEEEEecC--CcEEEEEEEccc----------chHHHHHHHHHHHHHHh-cCCCCceEEEeeeec
Q 047196 676 KFSKENLIGVGSFGSVYKGRLHD--GIEVAIKVFHQN----------CAMALKSFEAECEVMKN-IRHRNHVKRISSCSN 742 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~~--g~~vAvK~l~~~----------~~~~~~~~~~Ei~~l~~-l~H~niv~~~~~~~~ 742 (827)
+|+..+.||+|+||.||+|+... ++.||||++... ......++.+|++++.+ ++|+|++++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36677889999999999998754 688999987532 12234567889998875 799999999999987
Q ss_pred CCceeeeeeccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------ee
Q 047196 743 EDFKALDCLHST--------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DF 798 (827)
Q Consensus 743 ~~~~~l~~l~~~--------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DF 798 (827)
.+..++...+.. ...+.+.....++.+++.|+.||| ...+|+||||||+||+ ||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc--cCCceeecCCCHHHEEECCCCcEEEecc
Confidence 766554333221 123556677889999999999996 2468999999999998 99
Q ss_pred cccccccCCCccccccceecccccccccC
Q 047196 799 GIGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 799 Gla~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
|.++...... ......|+..|+|||++
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~ 185 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIV 185 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhh
Confidence 9988754332 12234589999999963
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.8e-15 Score=161.81 Aligned_cols=143 Identities=27% Similarity=0.346 Sum_probs=111.3
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEccc---chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeee
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN---CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l 751 (827)
.|+..+.||+|+||.||+|+.. ++..||||.+... .....+++.+|++++++++|+|++++.+++......++...
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 4666788999999999999864 6889999998632 23345678899999999999999999999887766554332
Q ss_pred cc----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 752 HS----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 752 ~~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
+. ....+++.+...++.+++.|+.||| +.+|+||||||+||+ |||++......
T Consensus 96 ~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---- 168 (308)
T cd06634 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (308)
T ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc----
Confidence 21 1223566777889999999999996 568999999999998 88888765322
Q ss_pred cccceeccccccccc
Q 047196 812 QTETLVTIGYMAPGL 826 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~ 826 (827)
....+++.|+|||+
T Consensus 169 -~~~~~~~~y~aPE~ 182 (308)
T cd06634 169 -NXFVGTPYWMAPEV 182 (308)
T ss_pred -ccccCCccccCHHH
Confidence 22347899999996
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.4e-17 Score=160.87 Aligned_cols=150 Identities=29% Similarity=0.486 Sum_probs=108.8
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcc-c-chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc------
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQ-N-CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF------ 745 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~-~-~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~------ 745 (827)
..|+...+||+|.||.||+|+.+ +|+.||+|++-. + .........+|+.+|..++|+|++.+++.|....-
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34667789999999999999864 578899987532 1 11223456789999999999999999988854210
Q ss_pred --eeee---eec-------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eeccccc
Q 047196 746 --KALD---CLH-------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRL 803 (827)
Q Consensus 746 --~~l~---~l~-------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~ 803 (827)
.++. +.| .....++..+..+++.++..||.|+| ...|+|||+|++|+| |||+||.
T Consensus 97 ~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 97 ATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 1111 111 12234556667788999999999994 677999999999998 9999987
Q ss_pred ccCCCcc---ccccceecccccccccC
Q 047196 804 LTGDRSM---IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 804 ~~~~~~~---~~~~~~gt~~Y~APE~l 827 (827)
+...... ..+..+.|.+|.+||.+
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEll 200 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELL 200 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHh
Confidence 7543221 23556789999999964
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=4e-15 Score=162.71 Aligned_cols=149 Identities=28% Similarity=0.338 Sum_probs=109.4
Q ss_pred ccc-ccceEecCCceEEEEEEec-CCcEEEEEEEcccchHH--------------HHHHHHHHHHHHhcCCCCceEEEee
Q 047196 676 KFS-KENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMA--------------LKSFEAECEVMKNIRHRNHVKRISS 739 (827)
Q Consensus 676 ~~~-~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~--------------~~~~~~Ei~~l~~l~H~niv~~~~~ 739 (827)
+|. ..+.||+|+||.||+|+.. +++.||||++....... ...+.+|++++++++|+|+++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 444 3467999999999999864 68999999985432111 1247789999999999999999999
Q ss_pred eecCCceeeeeeccC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecc
Q 047196 740 CSNEDFKALDCLHST---------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGI 800 (827)
Q Consensus 740 ~~~~~~~~l~~l~~~---------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGl 800 (827)
+..+++.++...+.. ...+.......++.++++|++||| +.+|+||||||+||+ |||+
T Consensus 89 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 89 YVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred EecCCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECCccc
Confidence 887776554332221 123566677889999999999995 678999999999998 9998
Q ss_pred cccccCCC-------------ccccccceecccccccccC
Q 047196 801 GRLLTGDR-------------SMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 801 a~~~~~~~-------------~~~~~~~~gt~~Y~APE~l 827 (827)
++....+. ........++++|+|||++
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 205 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELL 205 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhc
Confidence 87654111 0011223468899999974
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.60 E-value=6.1e-15 Score=157.38 Aligned_cols=150 Identities=31% Similarity=0.353 Sum_probs=117.0
Q ss_pred HhhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeee
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l 751 (827)
.++.|+..+.+|+|+||.||+|..+ ++..||+|++..... ..+.+.+|++++++++|+|++++++++......++...
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4456777889999999999999876 688999999976544 45678999999999999999999999887766555333
Q ss_pred ccC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 752 HST-----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 752 ~~~-----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
+.. ...+++..+..++.++++|++||| +.+|+|+|+||+||+ |||++.........
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 172 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK 172 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh
Confidence 222 115777888899999999999995 689999999999997 88887655432211
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
.....++.+|+|||++
T Consensus 173 -~~~~~~~~~y~~PE~~ 188 (286)
T cd06614 173 -RNSVVGTPYWMAPEVI 188 (286)
T ss_pred -hccccCCcccCCHhHh
Confidence 1223478899999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.4e-15 Score=162.88 Aligned_cols=149 Identities=29% Similarity=0.411 Sum_probs=113.6
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC-----cee
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNED-----FKA 747 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~-----~~~ 747 (827)
+|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++++.++|+|++++.+++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4677789999999999999865 58999999987543 334567999999999999999999999887654 222
Q ss_pred e--eeecc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 748 L--DCLHS-------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 748 l--~~l~~-------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
+ ++... ....+++.....++.++++|++||| +.+|+||||||+||+ |||+++......
T Consensus 81 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 81 IVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157 (330)
T ss_pred EEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence 2 22211 1225677778889999999999995 678999999999998 999988765432
Q ss_pred c--cccccceecccccccccC
Q 047196 809 S--MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~--~~~~~~~gt~~Y~APE~l 827 (827)
. .......++..|+|||++
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~ 178 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELL 178 (330)
T ss_pred cccccccccccccCcCCceee
Confidence 1 112234578999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.4e-15 Score=166.73 Aligned_cols=155 Identities=26% Similarity=0.377 Sum_probs=115.5
Q ss_pred hHHHHHhhcccccceEecCCceEEEEEE-ecCCcEEEEEEEcccchHHHHHHHHHHHHHHhc-CCCCceEEEeeeecC--
Q 047196 668 QDLFRATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNI-RHRNHVKRISSCSNE-- 743 (827)
Q Consensus 668 ~~~~~~~~~~~~~~~iG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~-- 743 (827)
+.+...++.|+..++||.|.+|.||+++ .++|+.+|||++..... ..++.+.|.++++.. .|||++.++|++...
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 3344456678889999999999999998 56789999999865432 335678889999888 499999999998653
Q ss_pred ---Cce--eeeeeccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------ee
Q 047196 744 ---DFK--ALDCLHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DF 798 (827)
Q Consensus 744 ---~~~--~l~~l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DF 798 (827)
+.. +|++.-.+ ...+.|.....|.+.+..|+.+| |...++|||+|-.||| ||
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HL---H~nkviHRDikG~NiLLT~e~~VKLvDF 167 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHL---HNNKVIHRDIKGQNVLLTENAEVKLVDF 167 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHH---hhcceeeecccCceEEEeccCcEEEeee
Confidence 333 33333221 12345555667888888899888 4666999999999998 99
Q ss_pred cccccccCCCccccccceecccccccccC
Q 047196 799 GIGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 799 Gla~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
|+++.+...... ..+.+|||.||||||+
T Consensus 168 GvSaQldsT~gr-RnT~iGtP~WMAPEVi 195 (953)
T KOG0587|consen 168 GVSAQLDSTVGR-RNTFIGTPYWMAPEVI 195 (953)
T ss_pred eeeeeeeccccc-ccCcCCCcccccceee
Confidence 999887644332 2345699999999986
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.9e-15 Score=158.33 Aligned_cols=145 Identities=24% Similarity=0.306 Sum_probs=108.0
Q ss_pred ccccceEecCCceEEEEEEec-CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcC-CCCceEEEeeeecC--Cceeeeee
Q 047196 677 FSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIR-HRNHVKRISSCSNE--DFKALDCL 751 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~--~~~~l~~l 751 (827)
|+..+.||+|+||.||+|+.. +++.||||++.... ........+|+++++++. |+|++++++++.+. +..++...
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 445678999999999999864 68999999986532 112234457999999986 99999999998876 44333222
Q ss_pred cc----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------eecccccccCCCcccc
Q 047196 752 HS----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 752 ~~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---------DFGla~~~~~~~~~~~ 812 (827)
+. ....+.+.+...++.++++||+||| +.+|+||||||+||+ |||+++........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~~~~kl~dfg~~~~~~~~~~~-- 155 (282)
T cd07831 81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKDDILKLADFGSCRGIYSKPPY-- 155 (282)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcCCCeEEEecccccccccCCCc--
Confidence 11 1234678888999999999999996 568999999999988 88888766433221
Q ss_pred ccceeccccccccc
Q 047196 813 TETLVTIGYMAPGL 826 (827)
Q Consensus 813 ~~~~gt~~Y~APE~ 826 (827)
....++..|+|||+
T Consensus 156 ~~~~~~~~y~aPE~ 169 (282)
T cd07831 156 TEYISTRWYRAPEC 169 (282)
T ss_pred CCCCCCcccCChhH
Confidence 22347899999995
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.59 E-value=7.1e-15 Score=156.95 Aligned_cols=146 Identities=28% Similarity=0.324 Sum_probs=110.0
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC--ceee--e
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNED--FKAL--D 749 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~--~~~l--~ 749 (827)
+|+..+.||.|++|.||+|... +++.||+|.+.... .....++.+|++++++++|+||+++++++.... ..++ +
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 5778899999999999999874 58899999987543 234567899999999999999999999886543 2222 2
Q ss_pred eecc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCC
Q 047196 750 CLHS------------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGD 807 (827)
Q Consensus 750 ~l~~------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~ 807 (827)
+... ....+.......++.++++|++||| +.+++||||+|+||+ |||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 2211 1122455566789999999999995 678999999999988 99998755322
Q ss_pred CccccccceecccccccccC
Q 047196 808 RSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 808 ~~~~~~~~~gt~~Y~APE~l 827 (827)
.. ....++..|+|||++
T Consensus 159 ~~---~~~~~~~~y~~pE~~ 175 (287)
T cd06621 159 LA---GTFTGTSFYMAPERI 175 (287)
T ss_pred cc---ccccCCccccCHHHh
Confidence 21 122368899999963
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.6e-16 Score=182.13 Aligned_cols=155 Identities=24% Similarity=0.225 Sum_probs=117.4
Q ss_pred HHHHhhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc
Q 047196 670 LFRATEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA---MALKSFEAECEVMKNIRHRNHVKRISSCSNEDF 745 (827)
Q Consensus 670 ~~~~~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~ 745 (827)
+....++|+..++||+|+||.|...+.+ +++.||+|++.+... .....|..|-.+|.....+-||.+..++.++.+
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence 3344578999999999999999999875 588999999976432 234568889999999888889999988888887
Q ss_pred eeeeeeccCCCC----------CCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eeccccccc
Q 047196 746 KALDCLHSTNCS----------LNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLT 805 (827)
Q Consensus 746 ~~l~~l~~~~~~----------l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~ 805 (827)
.++...+..++. +...... ..+|+.+..|+..|+.|.|||||||.||| |||.+-.+.
T Consensus 150 LYlVMdY~pGGDlltLlSk~~~~pE~~Ar---FY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFDRLPEDWAR---FYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred eEEEEecccCchHHHHHhhcCCChHHHHH---HHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 666444433321 1111111 34555566666668899999999999999 999888777
Q ss_pred CCCccccccceecccccccccC
Q 047196 806 GDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 806 ~~~~~~~~~~~gt~~Y~APE~l 827 (827)
.++......++|||-|++||++
T Consensus 227 ~dG~V~s~~aVGTPDYISPEvL 248 (1317)
T KOG0612|consen 227 ADGTVRSSVAVGTPDYISPEVL 248 (1317)
T ss_pred CCCcEEeccccCCCCccCHHHH
Confidence 7777666677899999999985
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.59 E-value=6.5e-15 Score=156.55 Aligned_cols=140 Identities=23% Similarity=0.250 Sum_probs=100.4
Q ss_pred eEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHH---HhcCCCCceEEEeeeecCCceeeeeeccC
Q 047196 682 LIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVM---KNIRHRNHVKRISSCSNEDFKALDCLHST 754 (827)
Q Consensus 682 ~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l---~~l~H~niv~~~~~~~~~~~~~l~~l~~~ 754 (827)
+||+|+||.||+++.. +|+.||||.+.... ....+.+.+|..++ ...+|++++++.+++..++..++...+..
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999864 68999999986432 11223344554433 34479999999988877665444322221
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccccc
Q 047196 755 ----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTE 814 (827)
Q Consensus 755 ----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~ 814 (827)
...+.+.....++.|++.|++||| +.+|+||||||+||+ |||+++....... ..
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~ 154 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HA 154 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc---cC
Confidence 234667778889999999999996 567999999999998 9999875533221 22
Q ss_pred ceecccccccccC
Q 047196 815 TLVTIGYMAPGLL 827 (827)
Q Consensus 815 ~~gt~~Y~APE~l 827 (827)
..||+.|+|||++
T Consensus 155 ~~~~~~y~aPE~~ 167 (279)
T cd05633 155 SVGTHGYMAPEVL 167 (279)
T ss_pred cCCCcCccCHHHh
Confidence 3589999999963
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.59 E-value=4e-15 Score=156.46 Aligned_cols=141 Identities=27% Similarity=0.336 Sum_probs=107.9
Q ss_pred EecCCceEEEEEEec-CCcEEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeeccC----
Q 047196 683 IGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA---MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHST---- 754 (827)
Q Consensus 683 iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~---- 754 (827)
||+|+||.||+++.. +|+.||+|++..... ...+.+.+|++++++++|+|++++++.+..+...++...+..
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 589999999999976 489999999865432 345678999999999999999999988877665544332221
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc-------c
Q 047196 755 ------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM-------I 811 (827)
Q Consensus 755 ------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~-------~ 811 (827)
...+++..+..++.++++||+||| +.+|+||||+|+||+ |||++......... .
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 124577778899999999999996 678999999999998 89988765433110 1
Q ss_pred cccceeccccccccc
Q 047196 812 QTETLVTIGYMAPGL 826 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~ 826 (827)
.....++..|+|||+
T Consensus 158 ~~~~~~~~~~~~Pe~ 172 (265)
T cd05579 158 DKRIVGTPDYIAPEV 172 (265)
T ss_pred ccCcccCccccCHHH
Confidence 122347889999996
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=4e-15 Score=171.89 Aligned_cols=147 Identities=25% Similarity=0.278 Sum_probs=86.6
Q ss_pred HhhcccccceEecCCceEEEEEEec-C----CcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEee------ee
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLH-D----GIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISS------CS 741 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~----g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~------~~ 741 (827)
..++|...+.||+|+||.||+|++. + +..||||++....... .+..| .+....+.+++.+... +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e--~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE--IWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH--HHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4578999999999999999999864 4 7899999975432211 11111 0111111111111000 01
Q ss_pred cCCceeeeeeccCCCC------------------------------CCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCC
Q 047196 742 NEDFKALDCLHSTNCS------------------------------LNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLK 791 (827)
Q Consensus 742 ~~~~~~l~~l~~~~~~------------------------------l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK 791 (827)
.+...++.+.+..... ........++.|+++||+||| +++|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence 1111111111111000 001123468889999999995 6789999999
Q ss_pred Cccee-----------eecccccccCCCccccccceeccccccccc
Q 047196 792 PKNVF-----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGL 826 (827)
Q Consensus 792 ~~NIl-----------DFGla~~~~~~~~~~~~~~~gt~~Y~APE~ 826 (827)
|+||| |||+|+.+...........++|++|||||.
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~ 328 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQ 328 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHH
Confidence 99998 999998764433222334568999999994
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.59 E-value=5.4e-15 Score=157.93 Aligned_cols=148 Identities=22% Similarity=0.288 Sum_probs=110.4
Q ss_pred ccccceEecCCceEEEEEEe----cCCcEEEEEEEcccc----hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCcee
Q 047196 677 FSKENLIGVGSFGSVYKGRL----HDGIEVAIKVFHQNC----AMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFKA 747 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~----~~g~~vAvK~l~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~ 747 (827)
|+..+.||+|+||.||+++. .+++.||||++.... ....+.+.+|+++++++ +|+|++++.+.+......+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 56678899999999999974 257889999986432 22345788999999999 5999999988876665544
Q ss_pred eeeeccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCC
Q 047196 748 LDCLHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGD 807 (827)
Q Consensus 748 l~~l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~ 807 (827)
+...+.. ...+.+.....++.+++++++||| +.+++||||||.||+ |||+++.....
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 4332222 123556667788999999999996 578999999999987 99998876443
Q ss_pred CccccccceecccccccccC
Q 047196 808 RSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 808 ~~~~~~~~~gt~~Y~APE~l 827 (827)
.........|+..|+|||++
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~ 178 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVI 178 (288)
T ss_pred cccccccccCCccccCHHHh
Confidence 32222223478999999963
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.3e-14 Score=151.91 Aligned_cols=147 Identities=28% Similarity=0.431 Sum_probs=114.4
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
+|+..+.||+|+||.||++... ++..||+|++.... ....+++.+|++++++++|+|+++..+.+...+..++...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 3667789999999999999865 68899999987543 24566789999999999999999999988776554442222
Q ss_pred cC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 753 ST--------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 753 ~~--------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
.. ...+++.....++.++++|++||| +.+++|+||||+||+ |||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 11 244667788899999999999996 568999999999998 899887765443
Q ss_pred ccccccceeccccccccc
Q 047196 809 SMIQTETLVTIGYMAPGL 826 (827)
Q Consensus 809 ~~~~~~~~gt~~Y~APE~ 826 (827)
.. .....|++.|+|||+
T Consensus 158 ~~-~~~~~~~~~y~~pe~ 174 (258)
T cd08215 158 DL-AKTVVGTPYYLSPEL 174 (258)
T ss_pred ce-ecceeeeecccChhH
Confidence 21 122458899999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.2e-14 Score=153.02 Aligned_cols=140 Identities=24% Similarity=0.334 Sum_probs=108.0
Q ss_pred EecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeeccC----
Q 047196 683 IGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHST---- 754 (827)
Q Consensus 683 iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~---- 754 (827)
||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++|+|++++++.+.++...++...+..
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999875 58999999986532 2345679999999999999999999999877765544333222
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccccceec
Q 047196 755 ------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVT 818 (827)
Q Consensus 755 ------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~~~gt 818 (827)
...+.......++.++++|++|+| +++++|+||||+||+ |||+++....... .....++
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~--~~~~~~~ 155 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--TWTFCGT 155 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc--cccccCC
Confidence 123556677789999999999995 688999999999997 9999887654321 1223478
Q ss_pred ccccccccC
Q 047196 819 IGYMAPGLL 827 (827)
Q Consensus 819 ~~Y~APE~l 827 (827)
..|+|||++
T Consensus 156 ~~~~~PE~~ 164 (262)
T cd05572 156 PEYVAPEII 164 (262)
T ss_pred cCccChhHh
Confidence 999999963
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=5.5e-15 Score=144.79 Aligned_cols=146 Identities=23% Similarity=0.321 Sum_probs=105.1
Q ss_pred cccceEecCCceEEEEEEec-CCcEEEEEEEccc-chHHHHHHHHHHHHHHhcC-CCCceEEEeeeecCCce--eeeeec
Q 047196 678 SKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN-CAMALKSFEAECEVMKNIR-HRNHVKRISSCSNEDFK--ALDCLH 752 (827)
Q Consensus 678 ~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~--~l~~l~ 752 (827)
+....+|.|+.|.|++++.+ +|..+|||.+... .+...++..+.+.++.+-. -|.||+.+||+...... .|+.+.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 34466999999999999864 6899999999754 4556678888888777664 79999999998654322 122211
Q ss_pred c--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccccc
Q 047196 753 S--------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTE 814 (827)
Q Consensus 753 ~--------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~ 814 (827)
. ........-.-++...+..||.||.+-| +|+|||+||+||| |||++..+.+.... +.
T Consensus 175 ~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh--tr 250 (391)
T KOG0983|consen 175 TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH--TR 250 (391)
T ss_pred HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc--cc
Confidence 1 1122222222356777889999998654 6999999999999 99999877654433 33
Q ss_pred ceecccccccccC
Q 047196 815 TLVTIGYMAPGLL 827 (827)
Q Consensus 815 ~~gt~~Y~APE~l 827 (827)
..|-+.|||||-+
T Consensus 251 sAGC~~YMaPERi 263 (391)
T KOG0983|consen 251 SAGCAAYMAPERI 263 (391)
T ss_pred ccCCccccCcccc
Confidence 4588999999964
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.7e-14 Score=150.89 Aligned_cols=149 Identities=26% Similarity=0.325 Sum_probs=115.4
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecC--Cceeeee
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNE--DFKALDC 750 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~--~~~~l~~ 750 (827)
+|...+.||+|++|.||+|... +++.|++|++.... ....+.+.+|++++++++|+|++++++.+... ...++..
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3667789999999999999875 68999999986543 24567899999999999999999999998876 4444322
Q ss_pred eccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 751 LHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 751 l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
.+.. ...+++.++..++.++++|++||| +.+++|+|++|+||+ |||.+.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 2221 125677888899999999999996 578999999999998 89888776544321
Q ss_pred -ccccceecccccccccC
Q 047196 811 -IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 -~~~~~~gt~~Y~APE~l 827 (827)
......++..|+|||++
T Consensus 158 ~~~~~~~~~~~y~~pE~~ 175 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVI 175 (260)
T ss_pred ccccCCCCCccccCHhhh
Confidence 01223478899999963
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=4.4e-15 Score=147.22 Aligned_cols=123 Identities=16% Similarity=0.193 Sum_probs=89.2
Q ss_pred cceEecCCceEEEEEEecCCcEEEEEEEcccchH--H-------HH-----------------HHHHHHHHHHhcCCCCc
Q 047196 680 ENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAM--A-------LK-----------------SFEAECEVMKNIRHRNH 733 (827)
Q Consensus 680 ~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~--~-------~~-----------------~~~~Ei~~l~~l~H~ni 733 (827)
...||+|+||.||+|..++|+.||||+++..... . .. ...+|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999999888999999998643210 0 11 22459999999988776
Q ss_pred eEEEeeeecCCceeeeeeccC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------
Q 047196 734 VKRISSCSNEDFKALDCLHST--------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF--------- 796 (827)
Q Consensus 734 v~~~~~~~~~~~~~l~~l~~~--------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl--------- 796 (827)
.....+.....+..|+++... ...++..+...++.++++++.|+| |+.+|+||||||+||+
T Consensus 82 ~~p~~~~~~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~--H~~giiHrDlkP~NIli~~~~v~Li 159 (190)
T cd05147 82 PCPEPILLKSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILY--QDCRLVHADLSEYNLLYHDGKLYII 159 (190)
T ss_pred CCCcEEEecCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHH--HhCCcccCCCCHHHEEEECCcEEEE
Confidence 433333233345555555431 234556667889999999999997 4668999999999998
Q ss_pred eecccccc
Q 047196 797 DFGIGRLL 804 (827)
Q Consensus 797 DFGla~~~ 804 (827)
|||+|...
T Consensus 160 DFG~a~~~ 167 (190)
T cd05147 160 DVSQSVEH 167 (190)
T ss_pred EccccccC
Confidence 99998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.58 E-value=1e-14 Score=154.87 Aligned_cols=140 Identities=24% Similarity=0.308 Sum_probs=106.2
Q ss_pred EecCCceEEEEEEe-cCCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeeccC----
Q 047196 683 IGVGSFGSVYKGRL-HDGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHST---- 754 (827)
Q Consensus 683 iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~---- 754 (827)
||+|+||+||+|.. .+|+.||+|++.... ....+.+.+|++++++++|||++++.+++...+..++...+..
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999975 468999999986532 1234467889999999999999999998877665444322211
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccccce
Q 047196 755 --------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETL 816 (827)
Q Consensus 755 --------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~~~ 816 (827)
...+.+.+...++.++++|+.||| +.+|+||||||+||+ |||.++....... .....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--ccccc
Confidence 124667778889999999999995 678999999999998 9998876543221 12234
Q ss_pred ecccccccccC
Q 047196 817 VTIGYMAPGLL 827 (827)
Q Consensus 817 gt~~Y~APE~l 827 (827)
++..|+|||++
T Consensus 156 ~~~~y~~PE~~ 166 (277)
T cd05577 156 GTPGYMAPEVL 166 (277)
T ss_pred CCCCcCCHHHh
Confidence 78899999973
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.4e-16 Score=166.00 Aligned_cols=148 Identities=22% Similarity=0.327 Sum_probs=113.6
Q ss_pred hcccccceEecCCceEEEEEEecCCc-EEEEEEEccc---chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHDGI-EVAIKVFHQN---CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~g~-~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
.+++....+|-|+||.|-..+.+... .+|+|.+++. ...+.++...|-++|...+.|.||+++.-+.+..+.+|..
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34555567999999999998876533 4888888653 2445677889999999999999999998888877665521
Q ss_pred ec----------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 751 LH----------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 751 l~----------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
.. ...+.++.....-++..+.+|++|| |+++||.|||||+|.+ |||+||.+......
T Consensus 500 EaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYL---H~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT 576 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYL---HRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT 576 (732)
T ss_pred HhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHH---HhcCceeccCChhheeeccCCceEEeehhhHHHhccCCce
Confidence 11 1233455555566888899999999 5788999999999987 99999998655442
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
.+.+|||.|+|||++
T Consensus 577 --wTFcGTpEYVAPEII 591 (732)
T KOG0614|consen 577 --WTFCGTPEYVAPEII 591 (732)
T ss_pred --eeecCCcccccchhh
Confidence 457799999999986
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.4e-14 Score=154.00 Aligned_cols=140 Identities=23% Similarity=0.257 Sum_probs=101.6
Q ss_pred eEecCCceEEEEEEe-cCCcEEEEEEEcccch---HHHHHHHHHH---HHHHhcCCCCceEEEeeeecCCceeeeeeccC
Q 047196 682 LIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCA---MALKSFEAEC---EVMKNIRHRNHVKRISSCSNEDFKALDCLHST 754 (827)
Q Consensus 682 ~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~---~~~~~~~~Ei---~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~ 754 (827)
+||+|+||.||+|+. .+|+.||+|++..... .....+..|. +.++...|++++++.+++..++..++...+..
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999986 4689999999865321 1122334443 34555679999999988877665544332221
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccccc
Q 047196 755 ----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTE 814 (827)
Q Consensus 755 ----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~ 814 (827)
...+.+..+..++.++++|++||| +++|+||||||+||+ |||+++....... ..
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~---~~ 154 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HA 154 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC---cC
Confidence 234677888899999999999996 578999999999987 9999875533221 22
Q ss_pred ceecccccccccC
Q 047196 815 TLVTIGYMAPGLL 827 (827)
Q Consensus 815 ~~gt~~Y~APE~l 827 (827)
..|+..|+|||++
T Consensus 155 ~~~~~~y~aPE~~ 167 (278)
T cd05606 155 SVGTHGYMAPEVL 167 (278)
T ss_pred cCCCcCCcCcHHh
Confidence 3589999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.7e-14 Score=153.73 Aligned_cols=146 Identities=29% Similarity=0.461 Sum_probs=108.5
Q ss_pred ccccceEecCCceEEEEEEec-CCcEEEEEEEcccc--hHHHHHHHHHHHHHHhc---CCCCceEEEeeeecCCc-----
Q 047196 677 FSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC--AMALKSFEAECEVMKNI---RHRNHVKRISSCSNEDF----- 745 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l---~H~niv~~~~~~~~~~~----- 745 (827)
|+..+.||+|+||.||+|+.+ +++.||||++.... ......+.+|+++++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 456788999999999999976 48999999986432 12234567788877766 59999999999876553
Q ss_pred eee--eeecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccc
Q 047196 746 KAL--DCLHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLL 804 (827)
Q Consensus 746 ~~l--~~l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~ 804 (827)
.++ ++... ....+.+.....++.++++||+||| +.+|+|+|+||+||+ |||+++..
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCcceec
Confidence 222 22111 1124678888999999999999996 567999999999997 99988776
Q ss_pred cCCCccccccceecccccccccC
Q 047196 805 TGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 805 ~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
...... ....++..|+|||++
T Consensus 158 ~~~~~~--~~~~~~~~~~~PE~~ 178 (287)
T cd07838 158 SFEMAL--TSVVVTLWYRAPEVL 178 (287)
T ss_pred cCCccc--ccccccccccChHHh
Confidence 433221 223478899999963
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.56 E-value=7.5e-15 Score=156.21 Aligned_cols=147 Identities=29% Similarity=0.359 Sum_probs=112.6
Q ss_pred ccccceEecCCceEEEEEEec-CCcEEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 677 FSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA--MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
|+..+.||+|++|.||+|... +|+.||+|++..... .....+.+|++++++++|+++++.++++..++..++...+.
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 445678999999999999864 689999999865432 24567889999999999999999999887766444322221
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccc
Q 047196 754 ----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQT 813 (827)
Q Consensus 754 ----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~ 813 (827)
....+++.....++.++++|+.||| +.+|+|+||||+||+ |||.+........ ...
T Consensus 81 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-~~~ 156 (283)
T cd05118 81 DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-PYT 156 (283)
T ss_pred CCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-ccc
Confidence 1235677788899999999999996 578999999999998 8998877654431 112
Q ss_pred cceecccccccccC
Q 047196 814 ETLVTIGYMAPGLL 827 (827)
Q Consensus 814 ~~~gt~~Y~APE~l 827 (827)
...++..|+|||++
T Consensus 157 ~~~~~~~~~~PE~~ 170 (283)
T cd05118 157 HYVVTRWYRAPELL 170 (283)
T ss_pred CccCcccccCcHHH
Confidence 23478899999963
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.6e-16 Score=170.07 Aligned_cols=149 Identities=25% Similarity=0.383 Sum_probs=114.8
Q ss_pred hhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc--eeeee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF--KALDC 750 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~--~~l~~ 750 (827)
.++|+....+|.|.||.||||+. ..++..|||+++.......+-..+|+-+++..+|+|||.++|.|...+. ..|++
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 35688889999999999999986 4689999999987655566677889999999999999999998866543 33443
Q ss_pred eccC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 751 LHST--------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 751 l~~~--------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
.-.+ -+.+...+.-.+++...+|++|| |+.+-+|||||-.||+ |||.+..+...-. ..
T Consensus 94 cgggslQdiy~~TgplselqiayvcRetl~gl~yl---hs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~-Kr 169 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYL---HSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA-KR 169 (829)
T ss_pred cCCCcccceeeecccchhHHHHHHHhhhhccchhh---hcCCcccccccccceeecccCceeecccCchhhhhhhhh-hh
Confidence 3221 23455556666778888899998 5778899999999999 9998876643211 12
Q ss_pred ccceeccccccccc
Q 047196 813 TETLVTIGYMAPGL 826 (827)
Q Consensus 813 ~~~~gt~~Y~APE~ 826 (827)
.+..||++||||||
T Consensus 170 ksfiGtpywmapEv 183 (829)
T KOG0576|consen 170 KSFIGTPYWMAPEV 183 (829)
T ss_pred hcccCCccccchhH
Confidence 34569999999997
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.9e-14 Score=156.85 Aligned_cols=113 Identities=21% Similarity=0.270 Sum_probs=87.9
Q ss_pred ceEecC--CceEEEEEEe-cCCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeeccC-
Q 047196 681 NLIGVG--SFGSVYKGRL-HDGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHST- 754 (827)
Q Consensus 681 ~~iG~G--~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~- 754 (827)
..||+| +||+||+|+. .+|+.||||++.... ....+.+.+|+.+++.++|||||++++++..++..++...+..
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 9999999986 478999999986432 3345778999999999999999999999987765544222211
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee
Q 047196 755 -----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF 796 (827)
Q Consensus 755 -----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl 796 (827)
...+.+.....++.++++||+||| +.+|+||||||+||+
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nil 133 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHIL 133 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEE
Confidence 123455666789999999999995 678999999999998
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.1e-14 Score=154.68 Aligned_cols=148 Identities=29% Similarity=0.380 Sum_probs=113.3
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcC-CCCceEEEeeeecCCceeeee
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIR-HRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~l~~ 750 (827)
+|...+.||+|+||.||+|+.. +|..||+|++.... ....+.+.+|++++++++ |+|++++++.+...+..++..
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 5777889999999999999865 68999999986532 233467889999999999 999999998887665544432
Q ss_pred eccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc-
Q 047196 751 LHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS- 809 (827)
Q Consensus 751 l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~- 809 (827)
.+.. ...+.+.....++.+++.|++||| +.+++|+||||+||+ |||++........
T Consensus 82 e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 82 EYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 2221 235678888999999999999996 568999999999998 9999876643321
Q ss_pred ------------------cccccceeccccccccc
Q 047196 810 ------------------MIQTETLVTIGYMAPGL 826 (827)
Q Consensus 810 ------------------~~~~~~~gt~~Y~APE~ 826 (827)
.......++..|+|||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~ 193 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPEL 193 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHH
Confidence 11112347889999996
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.2e-14 Score=151.99 Aligned_cols=145 Identities=23% Similarity=0.332 Sum_probs=112.1
Q ss_pred cccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 676 KFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
+|+..+.||+|+||.||+++. .+++.+|+|++.... .....++.+|++++++++|+|++++.+++......++...+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 367778999999999999975 468899999986432 33456788999999999999999999888776554443322
Q ss_pred cCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 753 STN--------------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 753 ~~~--------------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
... ..+++.....++.++++|++||| +.+++||||||+||+ |||+++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 211 23566667789999999999995 778999999999987 999988775442
Q ss_pred ccccccceeccccccccc
Q 047196 809 SMIQTETLVTIGYMAPGL 826 (827)
Q Consensus 809 ~~~~~~~~gt~~Y~APE~ 826 (827)
. ....+++.|+|||+
T Consensus 158 ~---~~~~~~~~~~~Pe~ 172 (256)
T cd08530 158 A---KTQIGTPHYMAPEV 172 (256)
T ss_pred c---ccccCCccccCHHH
Confidence 1 22347899999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.5e-15 Score=142.47 Aligned_cols=147 Identities=22% Similarity=0.428 Sum_probs=111.4
Q ss_pred HhhcccccceEecCCceEEEEEE-ecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcC-CCCceEEEeeeecCCcee--e
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIR-HRNHVKRISSCSNEDFKA--L 748 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~--l 748 (827)
..++|+..+++|+|.|+.||.|. ..+.+.++||+++. ...+...+|+.+|..++ |||||++++...++.... +
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 44678888999999999999997 56678899999853 34567889999999998 999999999887765332 2
Q ss_pred eeeccCC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------eecccccccCCCcc
Q 047196 749 DCLHSTN-------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 749 ~~l~~~~-------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGla~~~~~~~~~ 810 (827)
.+.+..+ ..+...+......++..||.|+ |+.||+|||+||.|++ |.|+|..+......
T Consensus 113 iFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyC---HS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY 189 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYC---HSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 189 (338)
T ss_pred HhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHH---HhcCcccccCCcceeeechhhceeeeeecchHhhcCCCcee
Confidence 2222111 2344555566777888888887 6899999999999987 99999988655442
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
...+.+..|-.||.+
T Consensus 190 --nVRVASRyfKGPELL 204 (338)
T KOG0668|consen 190 --NVRVASRYFKGPELL 204 (338)
T ss_pred --eeeeehhhcCCchhe
Confidence 234578888999964
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.5e-14 Score=154.02 Aligned_cols=146 Identities=26% Similarity=0.319 Sum_probs=110.1
Q ss_pred ccccceEecCCceEEEEEEec-CCcEEEEEEEcccch-HHHHHHHHHHHHHHhcC-CCCceEEEeeeecCCceeeeeecc
Q 047196 677 FSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA-MALKSFEAECEVMKNIR-HRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
|...+.||+|+||.||+|+.. +++.||||++..... .......+|++.+++++ |+|++++++++...+..++...+.
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 456688999999999999975 578999999865322 22234567999999999 999999999887765544322211
Q ss_pred C-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 754 T-----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 754 ~-----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
. ...+.+.....++.+++.++.||| +.+|+|+||||+||+ |||+++....... .
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 155 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--Y 155 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--c
Confidence 1 124677888899999999999996 568999999999998 9998876543222 1
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
....++..|+|||++
T Consensus 156 ~~~~~~~~~~aPE~~ 170 (283)
T cd07830 156 TDYVSTRWYRAPEIL 170 (283)
T ss_pred CCCCCcccccCceee
Confidence 224578999999963
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.2e-14 Score=154.64 Aligned_cols=147 Identities=30% Similarity=0.391 Sum_probs=111.9
Q ss_pred ccccceEecCCceEEEEEEec-CCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 677 FSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++|+|++++.+++.+.+..++...+.
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 445678999999999999865 58999999987542 233467889999999999999999999987765544433221
Q ss_pred C----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccc
Q 047196 754 T----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQT 813 (827)
Q Consensus 754 ~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~ 813 (827)
. ...+++..+..++.++++|++||| +.+|+||||||+||+ |||.++........ ..
T Consensus 81 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~~ 156 (282)
T cd07829 81 DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-YT 156 (282)
T ss_pred CcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc-cC
Confidence 1 135677788899999999999996 568999999999998 89988766433221 12
Q ss_pred cceecccccccccC
Q 047196 814 ETLVTIGYMAPGLL 827 (827)
Q Consensus 814 ~~~gt~~Y~APE~l 827 (827)
...++..|+|||++
T Consensus 157 ~~~~~~~~~aPE~~ 170 (282)
T cd07829 157 HEVVTLWYRAPEIL 170 (282)
T ss_pred ccccCcCcCChHHh
Confidence 23467889999963
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.54 E-value=9.5e-15 Score=160.22 Aligned_cols=147 Identities=25% Similarity=0.356 Sum_probs=111.1
Q ss_pred HhhcccccceEecCCceEEEEEEec-CCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc----
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF---- 745 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~---- 745 (827)
..++|+..+.||+|+||.||+|+.. ++..||||++... .....+.+.+|+.++++++|+|++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4567888999999999999999875 5889999998643 22334567889999999999999998876654332
Q ss_pred --eeeeeecc--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eeccccccc
Q 047196 746 --KALDCLHS--------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLT 805 (827)
Q Consensus 746 --~~l~~l~~--------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~ 805 (827)
.++...+. ....+++.+...++.++++|++||| +.+|+||||||+||+ |||++....
T Consensus 93 ~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 93 QDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred ccEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 22211111 1234677788889999999999995 578999999999987 899987654
Q ss_pred CCCccccccceeccccccccc
Q 047196 806 GDRSMIQTETLVTIGYMAPGL 826 (827)
Q Consensus 806 ~~~~~~~~~~~gt~~Y~APE~ 826 (827)
.. .....++..|+|||+
T Consensus 170 ~~----~~~~~~~~~y~aPE~ 186 (343)
T cd07851 170 DE----MTGYVATRWYRAPEI 186 (343)
T ss_pred cc----ccCCcccccccCHHH
Confidence 32 122357889999996
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.53 E-value=8.5e-15 Score=137.96 Aligned_cols=146 Identities=25% Similarity=0.311 Sum_probs=103.7
Q ss_pred cccceEecCCceEEEEEEe-cCCcEEEEEEEcccc-hHHHHHHHHHHHHHHh-cCCCCceEEEeeeecCCceee--eeec
Q 047196 678 SKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC-AMALKSFEAECEVMKN-IRHRNHVKRISSCSNEDFKAL--DCLH 752 (827)
Q Consensus 678 ~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~-l~H~niv~~~~~~~~~~~~~l--~~l~ 752 (827)
.....||+|+||.|-+-++ .+|...|||+++..- .+..++..+|+.+..+ ..-|.+|.++|.+.++....+ +.+.
T Consensus 49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~ 128 (282)
T KOG0984|consen 49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD 128 (282)
T ss_pred hhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh
Confidence 3446699999999999885 479999999987542 3445677888876544 468999999998876553322 1111
Q ss_pred -----------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 753 -----------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 753 -----------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
..+.....+-.=+||..|.+||.|||. +-.|||||+||+||| |||++..+.+.- +
T Consensus 129 tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi--A 204 (282)
T KOG0984|consen 129 TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI--A 204 (282)
T ss_pred hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhh--H
Confidence 011222333344799999999999984 567999999999999 999987765432 2
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
.+...|-..|||||.+
T Consensus 205 kt~daGCkpYmaPEri 220 (282)
T KOG0984|consen 205 KTMDAGCKPYMAPERI 220 (282)
T ss_pred HHHhcCCCccCChhhc
Confidence 2323477789999964
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.9e-14 Score=154.40 Aligned_cols=141 Identities=17% Similarity=0.196 Sum_probs=99.9
Q ss_pred EecCCceEEEEEEecCCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeeccC------
Q 047196 683 IGVGSFGSVYKGRLHDGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHST------ 754 (827)
Q Consensus 683 iG~G~fg~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~------ 754 (827)
+|.|+++.||+++. +|+.||||++... .....+.+.+|++++++++|+|++++++++...+..++.+.+..
T Consensus 10 ~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 88 (314)
T cd08216 10 FEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED 88 (314)
T ss_pred hcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHH
Confidence 44445555555444 6899999998654 34456789999999999999999999998877665554332221
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc------cc
Q 047196 755 ------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM------IQ 812 (827)
Q Consensus 755 ------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~------~~ 812 (827)
...+.......++.++++||+||| +.+|+||||||+||+ |||.+......... ..
T Consensus 89 ~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~ 165 (314)
T cd08216 89 LLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP 165 (314)
T ss_pred HHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccc
Confidence 123455666789999999999996 567999999999998 78877654322110 11
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
....++..|+|||++
T Consensus 166 ~~~~~~~~y~aPE~~ 180 (314)
T cd08216 166 KSSVKNLPWLSPEVL 180 (314)
T ss_pred ccccccccccCHHHh
Confidence 123367899999973
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=7.5e-15 Score=146.84 Aligned_cols=150 Identities=25% Similarity=0.293 Sum_probs=106.1
Q ss_pred hhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCce--e
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFK--A 747 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~--~ 747 (827)
.++|+..+++|+|.||+|..++- .+|+.+|+|++++.. ......-..|-++|+..+||.+..+-..+...+.. +
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 35788889999999999999985 479999999997642 23345567799999999999887654443333221 2
Q ss_pred eeeeccC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 748 LDCLHST--------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 748 l~~l~~~--------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
|++...+ ....+.....-+...|..||.||| +++||.||+|.+|++ |||+.|---..+.
T Consensus 247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~ 323 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD 323 (516)
T ss_pred EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcccccc
Confidence 2222111 112333333446678888999995 689999999999987 9999986433333
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
. ....+|||.|.||||+
T Consensus 324 t-~kTFCGTPEYLAPEVl 340 (516)
T KOG0690|consen 324 T-TKTFCGTPEYLAPEVL 340 (516)
T ss_pred e-eccccCChhhcCchhh
Confidence 2 2346799999999986
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.52 E-value=7.6e-14 Score=146.60 Aligned_cols=139 Identities=27% Similarity=0.323 Sum_probs=102.1
Q ss_pred ceEecCCceEEEEEEec-CCcEEEEEEEcccch---HHHHHHHHHHHH-HHhcCCCCceEEEeeeecCCceeeeeeccCC
Q 047196 681 NLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA---MALKSFEAECEV-MKNIRHRNHVKRISSCSNEDFKALDCLHSTN 755 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~-l~~l~H~niv~~~~~~~~~~~~~l~~l~~~~ 755 (827)
+.||+|+||.||+|+.. +|+.||||+++.... .....+..|..+ ....+|+|++++++++...+..++...+...
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999864 689999999865321 122344555554 4455899999999999877655553333221
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccccc
Q 047196 756 ----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTET 815 (827)
Q Consensus 756 ----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~~ 815 (827)
..+.......++.++++||.||| +.+|+||||||+||+ |||+++..... ...
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-----~~~ 153 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-----KKF 153 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceecccc-----ccC
Confidence 34566677889999999999995 578999999999997 89988754321 123
Q ss_pred eecccccccccC
Q 047196 816 LVTIGYMAPGLL 827 (827)
Q Consensus 816 ~gt~~Y~APE~l 827 (827)
.|+..|+|||++
T Consensus 154 ~~~~~y~~pe~~ 165 (260)
T cd05611 154 VGTPDYLAPETI 165 (260)
T ss_pred CCCcCccChhhh
Confidence 478899999963
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.52 E-value=1e-13 Score=146.30 Aligned_cols=147 Identities=20% Similarity=0.199 Sum_probs=103.9
Q ss_pred hHHHHHhhcccccceE--ecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhc-CCCCceEEEeeeecC
Q 047196 668 QDLFRATEKFSKENLI--GVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNI-RHRNHVKRISSCSNE 743 (827)
Q Consensus 668 ~~~~~~~~~~~~~~~i--G~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~ 743 (827)
.+.....++|+..+.+ |+|+||.||+++. .+++.+|+|........ . .|+.....+ +|+|++++++++...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~--~e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN---A--IEPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc---h--hhHHHHHHhhcCCCEEEEEEEEecC
Confidence 3444445566666665 9999999999986 46889999998543211 1 122222222 699999999999877
Q ss_pred CceeeeeeccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------eecccc
Q 047196 744 DFKALDCLHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGR 802 (827)
Q Consensus 744 ~~~~l~~l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGla~ 802 (827)
+..++...+.. ...+.+.+...++.|+++|++||| +.+|+||||||+||+ |||+++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 65544332221 235678888899999999999995 677999999999988 788776
Q ss_pred cccCCCccccccceecccccccccC
Q 047196 803 LLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 803 ~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
..... ....|+..|+|||++
T Consensus 159 ~~~~~-----~~~~~~~~y~aPE~~ 178 (267)
T PHA03390 159 IIGTP-----SCYDGTLDYFSPEKI 178 (267)
T ss_pred ecCCC-----ccCCCCCcccChhhh
Confidence 54322 123478999999974
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.52 E-value=2e-14 Score=150.93 Aligned_cols=147 Identities=27% Similarity=0.369 Sum_probs=107.3
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEccc-----chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeee
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN-----CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALD 749 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~ 749 (827)
+|...+.||+|+||.||+++.. .+..+++|.++.. ......++.+|++++++++|||++++++++.+.+...+.
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 3667789999999999999864 3455666665421 122334677899999999999999999888766544433
Q ss_pred eeccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------eecccccccC
Q 047196 750 CLHST--------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---------DFGIGRLLTG 806 (827)
Q Consensus 750 ~l~~~--------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---------DFGla~~~~~ 806 (827)
..+.. ...+++.....++.++++|+.||| +.+++|+|+||+||+ |||+++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKNNLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeecCCEeecccCceeecCC
Confidence 22211 234667778889999999999995 678999999999987 8998877643
Q ss_pred CCccccccceeccccccccc
Q 047196 807 DRSMIQTETLVTIGYMAPGL 826 (827)
Q Consensus 807 ~~~~~~~~~~gt~~Y~APE~ 826 (827)
.... .....|++.|+|||+
T Consensus 158 ~~~~-~~~~~~~~~~~~pe~ 176 (260)
T cd08222 158 SCDL-ATTFTGTPYYMSPEA 176 (260)
T ss_pred Cccc-ccCCCCCcCccCHHH
Confidence 3221 122347889999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.2e-13 Score=137.44 Aligned_cols=125 Identities=18% Similarity=0.230 Sum_probs=92.6
Q ss_pred cceEecCCceEEEEEEecCCcEEEEEEEcccchH--------------------------HHHHHHHHHHHHHhcCCCCc
Q 047196 680 ENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAM--------------------------ALKSFEAECEVMKNIRHRNH 733 (827)
Q Consensus 680 ~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~--------------------------~~~~~~~Ei~~l~~l~H~ni 733 (827)
...||+|+||.||+|+..+|+.||||+++..... ....+.+|.+.+.+++|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3679999999999999778999999998753210 01234689999999999987
Q ss_pred eEEEeeeecCCceeeeeeccC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------
Q 047196 734 VKRISSCSNEDFKALDCLHST--------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF--------- 796 (827)
Q Consensus 734 v~~~~~~~~~~~~~l~~l~~~--------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl--------- 796 (827)
.....+...+.+..++++... ...++..+...++.+++.++.++|+ ..+|+||||||+||+
T Consensus 82 ~~p~~~~~~~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~~~~~~li 159 (190)
T cd05145 82 PVPEPILLKKNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYHDGKPYII 159 (190)
T ss_pred CCceEEEecCCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEECCCEEEE
Confidence 544444334455556665432 1224445677899999999999973 368999999999988
Q ss_pred eecccccccC
Q 047196 797 DFGIGRLLTG 806 (827)
Q Consensus 797 DFGla~~~~~ 806 (827)
|||+|+....
T Consensus 160 DFG~a~~~~~ 169 (190)
T cd05145 160 DVSQAVELDH 169 (190)
T ss_pred EcccceecCC
Confidence 9999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.50 E-value=6.7e-14 Score=145.93 Aligned_cols=140 Identities=29% Similarity=0.345 Sum_probs=107.7
Q ss_pred EecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeeccC----
Q 047196 683 IGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHST---- 754 (827)
Q Consensus 683 iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~---- 754 (827)
||+|+||.||++... +++.||+|++.... ....+.+..|++++++++|+|++++++.+..+...++...+..
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999865 58999999986543 2245678999999999999999999988877665444222221
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccccceec
Q 047196 755 ------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVT 818 (827)
Q Consensus 755 ------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~~~gt 818 (827)
...+++.....++.++++|+.|+| +.+++|+||||+||+ |||++......... .....++
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~ 156 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR-TNTFCGT 156 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCc-ccCCcCC
Confidence 224677788889999999999996 578999999999998 89988766443211 1223478
Q ss_pred cccccccc
Q 047196 819 IGYMAPGL 826 (827)
Q Consensus 819 ~~Y~APE~ 826 (827)
.+|+|||+
T Consensus 157 ~~~~~Pe~ 164 (250)
T cd05123 157 PEYLAPEV 164 (250)
T ss_pred ccccChHH
Confidence 89999996
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.49 E-value=3e-14 Score=148.47 Aligned_cols=125 Identities=27% Similarity=0.345 Sum_probs=97.0
Q ss_pred HhhcccccceEecCCceEEEEEEec----CCcEEEEEEEcccchHHHHHHHHHHHHHHhcC-CCCceEEEeeeecCCcee
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLH----DGIEVAIKVFHQNCAMALKSFEAECEVMKNIR-HRNHVKRISSCSNEDFKA 747 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~ 747 (827)
....|...++||+|.|++||+|.+. ..+.||+|.+.... ...+...|+++|..+. +.|++++.++....+...
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 3456788899999999999999742 46789999985432 2356889999999996 788999988887777655
Q ss_pred eeeeccCC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------eecccc
Q 047196 748 LDCLHSTN-------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGR 802 (827)
Q Consensus 748 l~~l~~~~-------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGla~ 802 (827)
...-|.+. ..++..+...+...+.+||+++ |..+|||||+||+|+| |||+|.
T Consensus 112 ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~---h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHL---HKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred EEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhh---hccCccccCCCccccccccccCCceEEechhHH
Confidence 43333222 2355566667788888899988 6899999999999988 999986
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.47 E-value=4.9e-14 Score=164.78 Aligned_cols=114 Identities=38% Similarity=0.648 Sum_probs=62.9
Q ss_pred ccccCCCCCCCCCCCcccccccccCceEEcccceeeecccccccCCCCCCEEECCCCcceeecCCCCc---CCceEeCcC
Q 047196 502 ILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFG---YLTELNLSF 578 (827)
Q Consensus 502 L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~---~L~~L~ls~ 578 (827)
++.|+|++|.++|.+|.+++.++.|+.|+|++|+|+|.+|..++.+++|+.|||++|+++|.+|+.++ +|+.|||++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 34455555555555555555555555555555555555555555555555555555555555554332 445555555
Q ss_pred CcCeecCCCC--CCCCCCcccccccCccccCCCCCCCcccc
Q 047196 579 NKLEGEIPRG--GPFANFTAKSFMGNEKLCGLPNLQFPKCK 617 (827)
Q Consensus 579 N~l~g~ip~~--~~~~~~~~~~~~~n~~lc~~p~~~~~~c~ 617 (827)
|+++|.+|.. ..+.......+.+|+.+|+.|.. +.|.
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l--~~C~ 538 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGL--RACG 538 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCccccCCCCC--CCCc
Confidence 5555555542 11122334567889999997643 5675
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.47 E-value=4.5e-13 Score=136.96 Aligned_cols=147 Identities=29% Similarity=0.428 Sum_probs=112.9
Q ss_pred ccccceEecCCceEEEEEEecC-CcEEEEEEEcccchH-HHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeeccC
Q 047196 677 FSKENLIGVGSFGSVYKGRLHD-GIEVAIKVFHQNCAM-ALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHST 754 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~ 754 (827)
|+..+.||+|++|.||+|...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++...+..++...+..
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4456789999999999998764 889999999765444 56789999999999999999999999877655444222211
Q ss_pred C----------CC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccc
Q 047196 755 N----------CS-LNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQT 813 (827)
Q Consensus 755 ~----------~~-l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~ 813 (827)
. .. +++.....++.++++++.|+| +.+++|+|++|.||+ |||.+............
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 1 12 667777889999999999996 558999999999988 99988876544311112
Q ss_pred cceeccccccccc
Q 047196 814 ETLVTIGYMAPGL 826 (827)
Q Consensus 814 ~~~gt~~Y~APE~ 826 (827)
...++..|++||+
T Consensus 158 ~~~~~~~~~~pe~ 170 (225)
T smart00221 158 TVKGTPFYLAPEV 170 (225)
T ss_pred ceeccCCcCCHhH
Confidence 2347889999996
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.3e-13 Score=161.01 Aligned_cols=148 Identities=28% Similarity=0.435 Sum_probs=109.4
Q ss_pred ccccceEecCCceEEEEEEec----C----CcEEEEEEEcccc-hHHHHHHHHHHHHHHhcC-CCCceEEEeeeecCCce
Q 047196 677 FSKENLIGVGSFGSVYKGRLH----D----GIEVAIKVFHQNC-AMALKSFEAECEVMKNIR-HRNHVKRISSCSNEDFK 746 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~~----~----g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~ 746 (827)
....+.+|+|.||.|++|... . ...||||.++... ..+.+.+..|+++|+.+. |+|+|.++|+|......
T Consensus 298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~ 377 (609)
T KOG0200|consen 298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPL 377 (609)
T ss_pred ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCce
Confidence 344458999999999999743 1 3569999987543 345678999999999995 99999999999885443
Q ss_pred eeeeecc-----------CC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----
Q 047196 747 ALDCLHS-----------TN---------------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---- 796 (827)
Q Consensus 747 ~l~~l~~-----------~~---------------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---- 796 (827)
++...+. .. ..+...+.+.++.|||.|++|| .+.++||||+-+.|||
T Consensus 378 ~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L---~~~~~vHRDLAaRNVLi~~~ 454 (609)
T KOG0200|consen 378 YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYL---ASVPCVHRDLAARNVLITKN 454 (609)
T ss_pred EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHH---hhCCccchhhhhhhEEecCC
Confidence 3311111 11 1377788899999999999999 5677999999999999
Q ss_pred ------eecccccccCCCcccccccee--cccccccccC
Q 047196 797 ------DFGIGRLLTGDRSMIQTETLV--TIGYMAPGLL 827 (827)
Q Consensus 797 ------DFGla~~~~~~~~~~~~~~~g--t~~Y~APE~l 827 (827)
|||+||....+.........| ...|||||-+
T Consensus 455 ~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl 493 (609)
T KOG0200|consen 455 KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESL 493 (609)
T ss_pred CEEEEccccceeccCCCCceEecCCCCccceeecCHHHh
Confidence 999999765443322111222 4469999953
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.4e-13 Score=148.76 Aligned_cols=124 Identities=24% Similarity=0.330 Sum_probs=92.3
Q ss_pred ccccceEecCCceEEEEEE-ecCCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCcee--eee
Q 047196 677 FSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKA--LDC 750 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~--l~~ 750 (827)
|-..+.||-|+||+|..++ .++...+|+|.+++.+ ..+....+.|-.||+..+.+-+|+++..+.+.+..+ |++
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 6666789999999999997 4556779999997654 234567889999999999999999999988877544 455
Q ss_pred eccCCC--------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eeccccc
Q 047196 751 LHSTNC--------SLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRL 803 (827)
Q Consensus 751 l~~~~~--------~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~ 803 (827)
+-.++. .+...-..-++..++.|+++. |..++|||||||.||| |||+..-
T Consensus 711 IPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesV---HkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTG 778 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESV---HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG 778 (1034)
T ss_pred cCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHH---HhccceecccCccceEEccCCceeeeecccccc
Confidence 443321 111111223455677788888 6889999999999999 9998643
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.41 E-value=8.9e-13 Score=136.49 Aligned_cols=130 Identities=18% Similarity=0.101 Sum_probs=95.9
Q ss_pred CCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeeccCC---------
Q 047196 686 GSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHSTN--------- 755 (827)
Q Consensus 686 G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~~--------- 755 (827)
|.||.||+++. .+|+.||+|++.... .+.+|...+....|||++++++++.+.+..++...+...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999986 468999999986542 234566666667899999999998776655543332221
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccccceeccccccc
Q 047196 756 -CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824 (827)
Q Consensus 756 -~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~~~gt~~Y~AP 824 (827)
..+.+.....++.++++|++|+| +++|+||||||+||+ |||.++...... ....++..|+||
T Consensus 79 ~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~aP 151 (237)
T cd05576 79 FLNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYCAP 151 (237)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccccCC
Confidence 23566777889999999999995 678999999999998 888775543221 122357789999
Q ss_pred ccC
Q 047196 825 GLL 827 (827)
Q Consensus 825 E~l 827 (827)
|++
T Consensus 152 E~~ 154 (237)
T cd05576 152 EVG 154 (237)
T ss_pred ccc
Confidence 963
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=7.2e-14 Score=143.89 Aligned_cols=149 Identities=23% Similarity=0.264 Sum_probs=101.3
Q ss_pred hcccccceEecCCceEEEEEEecC-CcEEEEEEEcccchH---HHHHHHHHHHHHHhcC-CCCceEEEeeeecCC--cee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHD-GIEVAIKVFHQNCAM---ALKSFEAECEVMKNIR-HRNHVKRISSCSNED--FKA 747 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~---~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~--~~~ 747 (827)
.+|....+||+|+||+|..|+.++ .+.+|||+++++..- ..+--..|-++|+--. -|.+|++..++...+ +.+
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 368888999999999999998764 677999999764311 1122234555655443 455666555544433 333
Q ss_pred eeeeccCC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 748 LDCLHSTN--------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 748 l~~l~~~~--------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
|++...++ +........-+|..||-||-+| |+++||.||||..||+ |||+.+--..++.
T Consensus 429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFL---h~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~ 505 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFL---HSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGV 505 (683)
T ss_pred EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhh---hcCCeeeeeccccceEeccCCceEeeecccccccccCCc
Confidence 44433221 2333444567888999999999 6899999999999998 9999986433333
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
.. .+.+|||-|||||++
T Consensus 506 TT-kTFCGTPdYiAPEIi 522 (683)
T KOG0696|consen 506 TT-KTFCGTPDYIAPEII 522 (683)
T ss_pred ce-eeecCCCcccccceE
Confidence 22 336799999999985
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=6.3e-13 Score=133.48 Aligned_cols=150 Identities=23% Similarity=0.265 Sum_probs=105.4
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEccc---chHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCcee-
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN---CAMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFKA- 747 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~- 747 (827)
..+|+..++||+|+|++|..++++ +.+.+|+|++++. ..+.....+.|-.+..+. .||.+|-+..++..+...+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 467888999999999999999865 5788999998642 223344556666666655 5899998887766554332
Q ss_pred -eeeeccC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 748 -LDCLHST--------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 748 -l~~l~~~--------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
+++...+ ...+......-+...|.-||.|| |+++||.||+|..||| |+|+.|--..++
T Consensus 329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~fl---h~rgiiyrdlkldnvlldaeghikltdygmcke~l~~g 405 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFL---HERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG 405 (593)
T ss_pred EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHH---hhcCeeeeeccccceEEccCCceeecccchhhcCCCCC
Confidence 2332221 12333333444666777788777 6899999999999998 999988654443
Q ss_pred ccccccceecccccccccC
Q 047196 809 SMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~~~~~~gt~~Y~APE~l 827 (827)
... .+.+|||.|+|||++
T Consensus 406 d~t-stfcgtpnyiapeil 423 (593)
T KOG0695|consen 406 DTT-STFCGTPNYIAPEIL 423 (593)
T ss_pred ccc-ccccCCCcccchhhh
Confidence 332 346799999999975
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=4.2e-13 Score=134.94 Aligned_cols=147 Identities=26% Similarity=0.353 Sum_probs=105.9
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc------
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF------ 745 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~------ 745 (827)
.+|.....+|.|.- .|.-|... .+++||+|++...- ....++..+|..++..+.|+|+|+++.++.-...
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 35666677888877 56666432 57899999985431 2345677899999999999999999988754321
Q ss_pred --eeeeeeccC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 746 --KALDCLHST-----NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 746 --~~l~~l~~~-----~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
..++++... ...++......|..|+..|+.|| |+.+|+||||||+||+ |||+|+.-..+
T Consensus 96 ~y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~l---hs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~- 171 (369)
T KOG0665|consen 96 VYLVMELMDANLCQVILMELDHETISYILYQMLCGIKHL---HSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD- 171 (369)
T ss_pred HHHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHH---HhcceeecccCcccceecchhheeeccchhhcccCcc-
Confidence 112222211 12344455567889999999999 5789999999999987 99999875444
Q ss_pred ccccccceecccccccccC
Q 047196 809 SMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~~~~~~gt~~Y~APE~l 827 (827)
...+..++|..|.|||++
T Consensus 172 -~~mtpyVvtRyyrapevi 189 (369)
T KOG0665|consen 172 -FMMTPYVVTRYYRAPEVI 189 (369)
T ss_pred -cccCchhheeeccCchhe
Confidence 234567789999999985
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.3e-12 Score=126.21 Aligned_cols=145 Identities=26% Similarity=0.406 Sum_probs=100.5
Q ss_pred hhcccccceEecCCceEEEEEE-ecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeee-ecCCcee--ee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSC-SNEDFKA--LD 749 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~-~~~~~~~--l~ 749 (827)
..+|...++||.|+||.+|.|. ..+|+.||||+-..... ..+...|..+.+.++|..-++.+.++ .+.++.+ |+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 3578889999999999999997 67899999998654432 23567789999999887666554444 3344433 33
Q ss_pred eecc--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------eecccccccCCC
Q 047196 750 CLHS--------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------DFGIGRLLTGDR 808 (827)
Q Consensus 750 ~l~~--------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------------DFGla~~~~~~~ 808 (827)
.+-. .....+..+.+-.|-|+..-++|+| .+++|||||||+|.| |||+||.+.+..
T Consensus 92 LLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~ 168 (341)
T KOG1163|consen 92 LLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR 168 (341)
T ss_pred ccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence 3321 1123344455667888888889985 567999999999977 999999876543
Q ss_pred cc------ccccceecccccc
Q 047196 809 SM------IQTETLVTIGYMA 823 (827)
Q Consensus 809 ~~------~~~~~~gt~~Y~A 823 (827)
+. ....-.||..|.+
T Consensus 169 t~~HIpyre~r~ltGTaRYAS 189 (341)
T KOG1163|consen 169 TRQHIPYREDRNLTGTARYAS 189 (341)
T ss_pred ccccCccccCCccceeeeehh
Confidence 22 1122337877754
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.7e-12 Score=132.62 Aligned_cols=135 Identities=35% Similarity=0.426 Sum_probs=103.7
Q ss_pred CceEEEEEEec-CCcEEEEEEEcccchHH-HHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeeccCC---------
Q 047196 687 SFGSVYKGRLH-DGIEVAIKVFHQNCAMA-LKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHSTN--------- 755 (827)
Q Consensus 687 ~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~-~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~~--------- 755 (827)
+||.||+|+.. +|+.||+|++....... .+.+.+|++.+++++|+|++++++++.......+.......
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999876 48999999987654333 67899999999999999999999998776544442222111
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccccceeccccccc
Q 047196 756 -CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824 (827)
Q Consensus 756 -~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~~~gt~~Y~AP 824 (827)
..+++.....++.++++++.||| +.+|+|+||+|.||+ |||.+........ .....++..|+||
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~p 155 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGL--LTTFVGTPEYMAP 155 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeeccccc--cccccCCcCCCCH
Confidence 12566777889999999999996 568999999999988 8988877654321 1224478899999
Q ss_pred cc
Q 047196 825 GL 826 (827)
Q Consensus 825 E~ 826 (827)
|+
T Consensus 156 E~ 157 (244)
T smart00220 156 EV 157 (244)
T ss_pred HH
Confidence 96
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.8e-12 Score=133.51 Aligned_cols=146 Identities=23% Similarity=0.343 Sum_probs=102.3
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCC--CC----ceEEEeeeecCCce
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRH--RN----HVKRISSCSNEDFK 746 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H--~n----iv~~~~~~~~~~~~ 746 (827)
+.+|.....+|+|.||+|.++-.+ .+..||||+++.- ....+...-|+++++++.+ |+ .|++.+++.-....
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 577888899999999999999753 5789999998543 3344566789999999943 22 44454443322222
Q ss_pred --eee--------eecc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------------
Q 047196 747 --ALD--------CLHS-TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------------------- 796 (827)
Q Consensus 747 --~l~--------~l~~-~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------------------- 796 (827)
+.+ ++.. ............++.|++++++|| |+..++|-||||+|||
T Consensus 167 CivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fL---h~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~ 243 (415)
T KOG0671|consen 167 CIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFL---HDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFI 243 (415)
T ss_pred EEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHH---HhcceeecCCChheEEEeccceEEEeccCCcccee
Confidence 111 1111 112344556678999999999999 5778999999999998
Q ss_pred -----------eecccccccCCCccccccceecccccccccC
Q 047196 797 -----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 -----------DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
|||-|..-.... ...+.|..|.|||||
T Consensus 244 r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEVi 281 (415)
T KOG0671|consen 244 RPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVI 281 (415)
T ss_pred ccCCCcceEEEecCCcceeccCc----ceeeeccccCCchhe
Confidence 888886543332 234579999999986
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.34 E-value=9.8e-12 Score=125.08 Aligned_cols=140 Identities=36% Similarity=0.577 Sum_probs=104.2
Q ss_pred EecCCceEEEEEEecC-CcEEEEEEEcccchH-HHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeeccC------
Q 047196 683 IGVGSFGSVYKGRLHD-GIEVAIKVFHQNCAM-ALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHST------ 754 (827)
Q Consensus 683 iG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~------ 754 (827)
||+|++|.||+++..+ |+.++||++...... ..+.+.+|++.+++++|+++++.++++......++...+..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998754 899999998765432 35679999999999999999999999887554433222211
Q ss_pred ---C--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------eecccccccCCCccccccceec
Q 047196 755 ---N--CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRLLTGDRSMIQTETLVT 818 (827)
Q Consensus 755 ---~--~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGla~~~~~~~~~~~~~~~gt 818 (827)
. ..+++..+..++.+++++++|+| +.+++|+||+|.||+ |||.+........ ......+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 1 24667778889999999999995 558999999999998 5666654432211 01123367
Q ss_pred cccccccc
Q 047196 819 IGYMAPGL 826 (827)
Q Consensus 819 ~~Y~APE~ 826 (827)
..|++||+
T Consensus 157 ~~~~~pe~ 164 (215)
T cd00180 157 PAYMAPEV 164 (215)
T ss_pred CCccChhH
Confidence 88999996
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=9.1e-13 Score=144.49 Aligned_cols=143 Identities=26% Similarity=0.334 Sum_probs=104.4
Q ss_pred hhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCceee--e
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFKAL--D 749 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~l--~ 749 (827)
++.|.....+|.|+|+.|-++.. .++...|||++.+... .-.+|+.++... +|+|+|++.+.|.+....++ +
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 45666777799999999999975 4688899999876522 234677666655 69999999999988765544 3
Q ss_pred eeccCC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------eecccccccCCCccc
Q 047196 750 CLHSTN-------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 750 ~l~~~~-------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGla~~~~~~~~~~ 811 (827)
.+.... ......++..|+.+++.++.||| .++|||||+||+||| |||.++....+
T Consensus 397 ~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---- 469 (612)
T ss_pred hccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh----
Confidence 322211 01111344569999999999995 578999999999998 99999887654
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
....+-|..|.|||++
T Consensus 470 ~~tp~~t~~y~APEvl 485 (612)
T KOG0603|consen 470 CDTPALTLQYVAPEVL 485 (612)
T ss_pred hcccchhhcccChhhh
Confidence 1223468899999984
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.34 E-value=8.4e-12 Score=124.93 Aligned_cols=115 Identities=17% Similarity=0.289 Sum_probs=76.9
Q ss_pred ccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhc-----CCCCceEEEeeeecCCc--eeee
Q 047196 677 FSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNI-----RHRNHVKRISSCSNEDF--KALD 749 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-----~H~niv~~~~~~~~~~~--~~l~ 749 (827)
....+.||+|+||.||. .-.++.. +||++........+.+.+|+.+++.+ +||||++++|++..... ...+
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 45568899999999996 2234444 79988654444556799999999999 57999999999877531 1111
Q ss_pred eecc--C--CCCCCHH-------HHHHHHHHHHHHH-HHHHhcCCCCeEEccCCCccee
Q 047196 750 CLHS--T--NCSLNIF-------DKLNIMIDVASAL-EYLHFSHSTPVIHCDLKPKNVF 796 (827)
Q Consensus 750 ~l~~--~--~~~l~~~-------~~~~i~~~ia~~L-~~Lh~~h~~~iiHrDlK~~NIl 796 (827)
.+.. + .+.+... ....++.++..++ +||| +.+|+||||||+||+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~~~~e~~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NIL 137 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQCRYEEDVAQLRQLLKKLKRYLL---DNRIVTMELKPQNIL 137 (210)
T ss_pred EEecCCCCcchhHHHHHHcccccHhHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEE
Confidence 1111 1 1122110 1123455666565 7884 678999999999998
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1e-13 Score=148.79 Aligned_cols=193 Identities=25% Similarity=0.417 Sum_probs=165.7
Q ss_pred EEcCCCCCccccCc-cccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcCCCC
Q 047196 103 LNISSLNLQGTIPP-QLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDK 181 (827)
Q Consensus 103 L~L~~~~l~g~~~~-~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~ 181 (827)
|.|++..+....-. +=-.|+.-...||+.|++. ++|.++..+..|+.|.|.+|.+. .+|..+.++..|.+|+|+.|.
T Consensus 55 l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~Nq 132 (722)
T KOG0532|consen 55 LLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQ 132 (722)
T ss_pred cccccchhhcCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccch
Confidence 44555555432111 1245677778999999998 89999999999999999999986 678889999999999999999
Q ss_pred CCCCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccc
Q 047196 182 LSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPH 261 (827)
Q Consensus 182 l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 261 (827)
++ .+|..++.+. |++|-+++|+++ .+|..++.+..|..||.+.|.+. .+|..++++.+|+.|.++.|++. .+|+
T Consensus 133 lS-~lp~~lC~lp--Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~ 206 (722)
T KOG0532|consen 133 LS-HLPDGLCDLP--LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPE 206 (722)
T ss_pred hh-cCChhhhcCc--ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCH
Confidence 98 7999999865 999999999997 78999999999999999999997 67888999999999999999998 7888
Q ss_pred cccCcCCCcEEEeecccCcccCchhhhcCCCccEEEecCCcccc
Q 047196 262 EIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLG 305 (827)
Q Consensus 262 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~ 305 (827)
++..|+ |..||+|.|+++ .+|..|.+|+.|++|.|.+|.+..
T Consensus 207 El~~Lp-Li~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqS 248 (722)
T KOG0532|consen 207 ELCSLP-LIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQS 248 (722)
T ss_pred HHhCCc-eeeeecccCcee-ecchhhhhhhhheeeeeccCCCCC
Confidence 888665 899999999998 589999999999999999998863
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.32 E-value=7e-14 Score=150.05 Aligned_cols=171 Identities=29% Similarity=0.422 Sum_probs=133.4
Q ss_pred cEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCC
Q 047196 383 ENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGN 462 (827)
Q Consensus 383 ~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 462 (827)
...|++.|++. ++|..++.+-.|+.+.|..|.+. .+|..+.++..|.+|||+.|+++ .+|..++.++ |+.|-+++|
T Consensus 78 ~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNN 153 (722)
T KOG0532|consen 78 VFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNN 153 (722)
T ss_pred hhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecC
Confidence 45677777776 67777777777888888888877 67777888888888888888887 6777777776 788888888
Q ss_pred cccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccceeeecccc
Q 047196 463 KFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPS 542 (827)
Q Consensus 463 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~ 542 (827)
+++ .+|..++.+..|..||.+.|++.. +|..++++.+|+.|++..|++.. +|.++..|+ |..||+|+|+++ .||-
T Consensus 154 kl~-~lp~~ig~~~tl~~ld~s~nei~s-lpsql~~l~slr~l~vrRn~l~~-lp~El~~Lp-Li~lDfScNkis-~iPv 228 (722)
T KOG0532|consen 154 KLT-SLPEEIGLLPTLAHLDVSKNEIQS-LPSQLGYLTSLRDLNVRRNHLED-LPEELCSLP-LIRLDFSCNKIS-YLPV 228 (722)
T ss_pred ccc-cCCcccccchhHHHhhhhhhhhhh-chHHhhhHHHHHHHHHhhhhhhh-CCHHHhCCc-eeeeecccCcee-ecch
Confidence 886 678888877888888888888874 56677888888888888888874 556666444 677888888888 6888
Q ss_pred cccCCCCCCEEECCCCccee
Q 047196 543 TIGDLKDLQNISLACNGLEG 562 (827)
Q Consensus 543 ~~~~l~~L~~L~Ls~N~l~g 562 (827)
.|.+|+.|++|-|.+|.|..
T Consensus 229 ~fr~m~~Lq~l~LenNPLqS 248 (722)
T KOG0532|consen 229 DFRKMRHLQVLQLENNPLQS 248 (722)
T ss_pred hhhhhhhheeeeeccCCCCC
Confidence 88888888888888888864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.4e-11 Score=133.58 Aligned_cols=147 Identities=29% Similarity=0.362 Sum_probs=103.5
Q ss_pred cccccceEecCCceEEEEEEecC--CcEEEEEEEcccchHHHHHHHHHHHHHHhcCC----CCceEEEeee-ecCCceee
Q 047196 676 KFSKENLIGVGSFGSVYKGRLHD--GIEVAIKVFHQNCAMALKSFEAECEVMKNIRH----RNHVKRISSC-SNEDFKAL 748 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~~--g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H----~niv~~~~~~-~~~~~~~l 748 (827)
+|...+.||+|+||.||.+.... ...+|+|............+..|+.++..+.+ +++.++++.. ..+.+.++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 78889999999999999998654 35788888755432222267889999998873 4566677666 35544443
Q ss_pred e--eec---------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------------eecccc
Q 047196 749 D--CLH---------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---------------DFGIGR 802 (827)
Q Consensus 749 ~--~l~---------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---------------DFGla~ 802 (827)
. .+- .....++..+...|+.|+..+|+++ |+.+++||||||+|+. |||+|+
T Consensus 99 VM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~l---H~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 99 VMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDL---HSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHH---HhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 2 111 1124567778889999999999999 5789999999999965 999999
Q ss_pred --cccCCCc----cc---cccceecccccccc
Q 047196 803 --LLTGDRS----MI---QTETLVTIGYMAPG 825 (827)
Q Consensus 803 --~~~~~~~----~~---~~~~~gt~~Y~APE 825 (827)
.+..+.. .. .....||..|++++
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~ 207 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASIN 207 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHH
Confidence 4322221 11 12234899998875
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.24 E-value=4.1e-11 Score=123.04 Aligned_cols=126 Identities=16% Similarity=0.178 Sum_probs=87.0
Q ss_pred cccccceEecCCceEEEEEE--ecCCcEEEEEEEcccch----------------------H--HHHHHHHHHHHHHhcC
Q 047196 676 KFSKENLIGVGSFGSVYKGR--LHDGIEVAIKVFHQNCA----------------------M--ALKSFEAECEVMKNIR 729 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~--~~~g~~vAvK~l~~~~~----------------------~--~~~~~~~Ei~~l~~l~ 729 (827)
.|...+.||+|+||.||+|. ..+|+.||||+++.... . ....+.+|+++++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 36667889999999999998 46899999999864311 0 1134678999999998
Q ss_pred CCC--ceEEEeeeecCCceeeeeeccCC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEEccCCCccee--
Q 047196 730 HRN--HVKRISSCSNEDFKALDCLHSTN--------CSLNIFDKLNIMIDVASALEYLHFSHSTP-VIHCDLKPKNVF-- 796 (827)
Q Consensus 730 H~n--iv~~~~~~~~~~~~~l~~l~~~~--------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~-iiHrDlK~~NIl-- 796 (827)
+.. +.+.+++ ...+.+++++.... ......+...++.++++++.++| ..+ |+|||+||+||+
T Consensus 109 ~~~i~~p~~~~~--~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 109 EAGVPVPKPIAW--RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNILVH 183 (237)
T ss_pred hcCCCCCeeeEe--cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhEEEE
Confidence 643 2333332 23344444443311 12233345678999999999995 667 999999999987
Q ss_pred -------eecccccccC
Q 047196 797 -------DFGIGRLLTG 806 (827)
Q Consensus 797 -------DFGla~~~~~ 806 (827)
|||.|+....
T Consensus 184 ~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 184 DGKVVIIDVSQSVELDH 200 (237)
T ss_pred CCCEEEEEChhhhccCC
Confidence 8998876543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.8e-11 Score=123.60 Aligned_cols=144 Identities=22% Similarity=0.345 Sum_probs=97.8
Q ss_pred hcccccceEecCCceEEEEEE-ecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeee---ecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSC---SNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~---~~~~~~~l~~ 750 (827)
-.|...++||+|+||+.+.|+ +-++++||||.-+... ...++..|.+..+.+.+.--|+-+-|+ ...+..+++.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 368889999999999999997 5678999999754332 123466777777777654444433333 2223333333
Q ss_pred ecc--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------------eecccccccCC
Q 047196 751 LHS--------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---------------DFGIGRLLTGD 807 (827)
Q Consensus 751 l~~--------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---------------DFGla~~~~~~ 807 (827)
+-. .+..++..+...||.|+..-++|+| ++..|.|||||+|.| |||+||.+.+.
T Consensus 106 LGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 106 LGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred hCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 221 2234555666789999999999995 566999999999976 99999998654
Q ss_pred Cccc------cccceecccccc
Q 047196 808 RSMI------QTETLVTIGYMA 823 (827)
Q Consensus 808 ~~~~------~~~~~gt~~Y~A 823 (827)
.... ..+--||..||+
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMS 204 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMS 204 (449)
T ss_pred cccccCccccccccccceeeeE
Confidence 3321 111238999996
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.23 E-value=3.2e-11 Score=139.75 Aligned_cols=128 Identities=19% Similarity=0.241 Sum_probs=91.3
Q ss_pred hhcccccceEecCCceEEEEEEecCCcEEEEEE-Eccc-c------hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKV-FHQN-C------AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF 745 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~-l~~~-~------~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~ 745 (827)
...|...+.||+|+||.||+|++.+.. +++|+ .... . ....+++.+|++++++++|++++....++..+..
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 344566789999999999999876543 34443 2211 1 1123578999999999999999887777666444
Q ss_pred eeeeeeccCCCCCCH--HHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------eeccccccc
Q 047196 746 KALDCLHSTNCSLNI--FDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---------DFGIGRLLT 805 (827)
Q Consensus 746 ~~l~~l~~~~~~l~~--~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---------DFGla~~~~ 805 (827)
.++...+.....+.. .....++.++++++.|+| +.+|+|||+||+||+ |||+++...
T Consensus 411 ~~lv~E~~~g~~L~~~l~~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl~~~~~~liDFGla~~~~ 478 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLEGNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIVRDDRLYLIDFGLGKYSD 478 (535)
T ss_pred CEEEEEecCCCcHHHHHHHHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEEECCcEEEEeCcccccCC
Confidence 444333333333332 235678999999999995 678999999999998 999998753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.20 E-value=7.9e-11 Score=118.21 Aligned_cols=126 Identities=20% Similarity=0.205 Sum_probs=86.9
Q ss_pred cccccceEecCCceEEEEEEecCCcEEEEEEEcccch----------------------HHHHHHHHHHHHHHhcCCCC-
Q 047196 676 KFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCA----------------------MALKSFEAECEVMKNIRHRN- 732 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~----------------------~~~~~~~~Ei~~l~~l~H~n- 732 (827)
-|...+.||+|+||.||+|..++|+.||||+++.... .....+.+|+.++.++.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 3666789999999999999988899999998754320 01123678999999998874
Q ss_pred -ceEEEeeeecCCceeeeeeccCC-CCCCH-HHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eec
Q 047196 733 -HVKRISSCSNEDFKALDCLHSTN-CSLNI-FDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFG 799 (827)
Q Consensus 733 -iv~~~~~~~~~~~~~l~~l~~~~-~~l~~-~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFG 799 (827)
+.+.++. ......++++.... ..... .....++.++++++.++| +.+|+||||||+||+ |||
T Consensus 96 ~v~~~~~~--~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~~~~~~~liDfg 170 (198)
T cd05144 96 PVPKPIDW--NRHAVVMEYIDGVELYRVRVLEDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVDDDEKIYIIDWP 170 (198)
T ss_pred CCCceeec--CCceEEEEEeCCcchhhccccccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEcCCCcEEEEECC
Confidence 4444432 22333444443321 01111 234568889999999986 578999999999998 999
Q ss_pred ccccccC
Q 047196 800 IGRLLTG 806 (827)
Q Consensus 800 la~~~~~ 806 (827)
++.....
T Consensus 171 ~~~~~~~ 177 (198)
T cd05144 171 QMVSTDH 177 (198)
T ss_pred ccccCCC
Confidence 9865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.8e-11 Score=136.88 Aligned_cols=179 Identities=38% Similarity=0.576 Sum_probs=122.2
Q ss_pred cccEEEccCCcCccccCccccCCC-CCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEec
Q 047196 381 SLENIYISNCNIGGSIPQLISNLS-NLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGL 459 (827)
Q Consensus 381 ~L~~L~Ls~N~l~g~~p~~~~~l~-~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 459 (827)
.++.|++.+|+++ .+|.....+. +|+.|++++|++. .+|..++.++.|+.|++++|+++ .+|...+..+.|+.|++
T Consensus 117 ~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~l 193 (394)
T COG4886 117 NLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDL 193 (394)
T ss_pred ceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheec
Confidence 4667777777776 4555556563 7788888888777 45556677778888888888877 55555556777788888
Q ss_pred CCCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccceeeec
Q 047196 460 AGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGD 539 (827)
Q Consensus 460 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ 539 (827)
++|+++ .+|.....+..|+.+++++|.+. ..+..+.+++++..+.+++|++... +..++.+..++.|++++|+++ .
T Consensus 194 s~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~-~~~~~~l~~l~~L~~s~n~i~-~ 269 (394)
T COG4886 194 SGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDL-PESIGNLSNLETLDLSNNQIS-S 269 (394)
T ss_pred cCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeeec-cchhccccccceecccccccc-c
Confidence 888877 56665555566777788877533 2455566777777777777777542 555666777777777777777 3
Q ss_pred ccccccCCCCCCEEECCCCcceeecCCC
Q 047196 540 IPSTIGDLKDLQNISLACNGLEGLIPES 567 (827)
Q Consensus 540 ip~~~~~l~~L~~L~Ls~N~l~g~ip~~ 567 (827)
++. ++.+.+++.|+++.|.++..+|..
T Consensus 270 i~~-~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 270 ISS-LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred ccc-ccccCccCEEeccCccccccchhh
Confidence 333 677777777777777776665543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.19 E-value=7.7e-11 Score=118.40 Aligned_cols=117 Identities=19% Similarity=0.324 Sum_probs=82.4
Q ss_pred eEecCCceEEEEEEecCCcEEEEEEEcccc--------hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC--ceeeeee
Q 047196 682 LIGVGSFGSVYKGRLHDGIEVAIKVFHQNC--------AMALKSFEAECEVMKNIRHRNHVKRISSCSNED--FKALDCL 751 (827)
Q Consensus 682 ~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~--------~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~--~~~l~~l 751 (827)
.||+|+||.||+|.+ +|..|+||+..... ....+++.+|++++++++|+++.....++...+ ...++++
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 56889999864321 112356889999999999887554444443333 3344444
Q ss_pred ccCCCCCCHHHHH---HHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------eecccccc
Q 047196 752 HSTNCSLNIFDKL---NIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---------DFGIGRLL 804 (827)
Q Consensus 752 ~~~~~~l~~~~~~---~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---------DFGla~~~ 804 (827)
. +..+...... .++.++++++.++ |+.+++|||+||.||+ |||+++..
T Consensus 80 ~--g~~l~~~~~~~~~~~~~~i~~~l~~l---H~~gi~H~Dl~~~Nil~~~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 E--GKPLKDVIEEGNDELLREIGRLVGKL---HKAGIVHGDLTTSNIIVRDDKLYLIDFGLGKYS 139 (199)
T ss_pred C--CccHHHHHhhcHHHHHHHHHHHHHHH---HHCCeecCCCCcceEEEECCcEEEEECCCCcCC
Confidence 3 2222211111 7899999999999 4789999999999987 99988764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.8e-11 Score=127.64 Aligned_cols=147 Identities=27% Similarity=0.409 Sum_probs=101.2
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCC------CceEEEeeeecCCce
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHR------NHVKRISSCSNEDFK 746 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~------niv~~~~~~~~~~~~ 746 (827)
..+|......|+|-|+.|.+|... .|..||||++..+..+ .+.=.+|+++|+++... +.++++-.+......
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL 509 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL 509 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence 356878888999999999999864 5889999999876443 34456788888887521 233333322222222
Q ss_pred eee--eec----------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------eeccccc
Q 047196 747 ALD--CLH----------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRL 803 (827)
Q Consensus 747 ~l~--~l~----------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGla~~ 803 (827)
.|. .++ ..+..+.......++.|+.-||..| -.-+|+|.||||.||| |||-|..
T Consensus 510 ClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklL---K~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~ 586 (752)
T KOG0670|consen 510 CLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLL---KKCGVLHADIKPDNILVNESKNILKLCDFGSASF 586 (752)
T ss_pred EEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHH---HhcCeeecccCccceEeccCcceeeeccCccccc
Confidence 121 111 1233455556667888998899988 4668999999999998 9999977
Q ss_pred ccCCCccccccceecccccccccC
Q 047196 804 LTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 804 ~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
..... .+..+.+..|.|||+|
T Consensus 587 ~~ene---itPYLVSRFYRaPEIi 607 (752)
T KOG0670|consen 587 ASENE---ITPYLVSRFYRAPEII 607 (752)
T ss_pred ccccc---ccHHHHHHhccCccee
Confidence 65433 2445678899999986
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.16 E-value=1e-10 Score=118.65 Aligned_cols=118 Identities=21% Similarity=0.326 Sum_probs=85.1
Q ss_pred ceEecCCceEEEEEEecCCcEEEEEEEcccc---h-----HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc--eeeee
Q 047196 681 NLIGVGSFGSVYKGRLHDGIEVAIKVFHQNC---A-----MALKSFEAECEVMKNIRHRNHVKRISSCSNEDF--KALDC 750 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~---~-----~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~--~~l~~ 750 (827)
+.||+|++|.||+|+. .|..|+||+..... . ....++.+|++++..++|+++.....++...+. ..+++
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 56789999864321 1 123468899999999999988766666544333 33344
Q ss_pred eccCCCCCCH------HHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------eecccccc
Q 047196 751 LHSTNCSLNI------FDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---------DFGIGRLL 804 (827)
Q Consensus 751 l~~~~~~l~~------~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---------DFGla~~~ 804 (827)
+.. ..+.. ..+..++.++++++.++| +.+++|||++|+||+ |||.++..
T Consensus 81 ~~G--~~L~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEG--EPLKDLINSNGMEELELSREIGRLVGKLH---SAGIIHGDLTTSNMILSGGKIYLIDFGLAEFS 144 (211)
T ss_pred eCC--cCHHHHHHhccHHHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEECCCEEEEECCcccCC
Confidence 332 22111 145688999999999995 678999999999987 99988753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.4e-10 Score=110.54 Aligned_cols=121 Identities=18% Similarity=0.208 Sum_probs=92.0
Q ss_pred cceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCC--CceEEEeeeecCCcee--eeeeccCC
Q 047196 680 ENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHR--NHVKRISSCSNEDFKA--LDCLHSTN 755 (827)
Q Consensus 680 ~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~--niv~~~~~~~~~~~~~--l~~l~~~~ 755 (827)
.+.+|+|.++.||+++..+ ..++||....... ...+.+|+++++.++|. .+.+++++....+..+ ++++....
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 4679999999999999755 7899999865433 45789999999999874 7888877766543333 34433221
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eeccccc
Q 047196 756 -CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRL 803 (827)
Q Consensus 756 -~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~ 803 (827)
..++......++.+++++++++|..+.++++|+|+||+||+ |||.++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 12245667788999999999999877789999999999988 8887764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.1e-10 Score=117.13 Aligned_cols=126 Identities=15% Similarity=0.109 Sum_probs=89.2
Q ss_pred hhcccccceEecCCceEEEEEEecCCcEEEEEEEcccch---HHHHH------HHHHHHHHHhcCCCCceEEEeeeecCC
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCA---MALKS------FEAECEVMKNIRHRNHVKRISSCSNED 744 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~---~~~~~------~~~Ei~~l~~l~H~niv~~~~~~~~~~ 744 (827)
..+|...+++|.|+||.||.... ++..+|||++..... ...+. |++|++.+.+++|+++.....+.....
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 46788999999999999999765 567899999964322 22222 689999999999999999887754332
Q ss_pred ----------ceeeeeeccCCCCCCHHH--HHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------eeccccc
Q 047196 745 ----------FKALDCLHSTNCSLNIFD--KLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---------DFGIGRL 803 (827)
Q Consensus 745 ----------~~~l~~l~~~~~~l~~~~--~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---------DFGla~~ 803 (827)
...|+++... .+.... ......++++++..+ |..+|+|||+||+|++ |||..+.
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~--tL~~~~~~~~~~~~~i~~~l~~l---H~~gi~H~Dikp~Nili~~~gi~liDfg~~~~ 183 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGV--ELNDMPEISEDVKAKIKASIESL---HQHGMVSGDPHKGNFIVSKNGLRIIDLSGKRC 183 (232)
T ss_pred cccccccCCeEEEEEEECCc--cHHHhhhccHHHHHHHHHHHHHH---HHcCCccCCCChHHEEEeCCCEEEEECCCccc
Confidence 2234444432 221110 123456788888888 5789999999999987 8887765
Q ss_pred cc
Q 047196 804 LT 805 (827)
Q Consensus 804 ~~ 805 (827)
..
T Consensus 184 ~~ 185 (232)
T PRK10359 184 TA 185 (232)
T ss_pred cc
Confidence 53
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.5e-11 Score=133.75 Aligned_cols=198 Identities=34% Similarity=0.518 Sum_probs=162.7
Q ss_pred EEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCC-CCcEEECCCCCCCCCCCccccccccccEEecCCC
Q 047196 384 NIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQ-KLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGN 462 (827)
Q Consensus 384 ~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~-~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 462 (827)
.++++.|.+...+ ..+..++.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~~~-~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRSNI-SELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccccCc-hhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 5777777775333 33445588999999999999 5666777774 9999999999998 67778899999999999999
Q ss_pred cccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccceeeecccc
Q 047196 463 KFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPS 542 (827)
Q Consensus 463 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~ 542 (827)
+++ .+|...+.++.|+.|++++|+++. +|........|+++++++|.+. .++..+.++..+..+.+++|++. .+|.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~~-l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~ 249 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKISD-LPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPE 249 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCcccc-CchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccc
Confidence 998 677777788999999999999986 5555556677999999999633 35667888999999999999998 4478
Q ss_pred cccCCCCCCEEECCCCcceeecC-CCCcCCceEeCcCCcCeecCCCC
Q 047196 543 TIGDLKDLQNISLACNGLEGLIP-ESFGYLTELNLSFNKLEGEIPRG 588 (827)
Q Consensus 543 ~~~~l~~L~~L~Ls~N~l~g~ip-~~~~~L~~L~ls~N~l~g~ip~~ 588 (827)
.++.+++++.|++++|+++...+ ..+..++.|++++|.++...|..
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~i~~~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISSISSLGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred hhccccccceeccccccccccccccccCccCEEeccCccccccchhh
Confidence 89999999999999999987654 23458999999999999877764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=3.5e-11 Score=118.30 Aligned_cols=143 Identities=20% Similarity=0.348 Sum_probs=97.7
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhc-CCCCceEEEeee-ecCCceeeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNI-RHRNHVKRISSC-SNEDFKALDCL 751 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~-~~~~~~~l~~l 751 (827)
+.|...+.+|+|.||++-.++.+ +.+.+++|-++... ...++|.+|..---.+ .|.|||.-++.. ...++.+....
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 45777789999999999999865 56789999886542 3457899988643344 378888654432 23343333333
Q ss_pred ccCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee------------eecccccccCCCcc
Q 047196 752 HSTN---------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------------DFGIGRLLTGDRSM 810 (827)
Q Consensus 752 ~~~~---------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------------DFGla~~~~~~~~~ 810 (827)
+.+. ..+....-..|+.|++.|+.|+ |++.+||||||.+||| |||..+.....
T Consensus 103 ~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fM---HsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t--- 176 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFM---HSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT--- 176 (378)
T ss_pred cCccchhhhhcCcccccHHHHHHHHHHHHHHHHHh---hccchhhcccccceEEEecCCccEEEeeecccccccCce---
Confidence 3221 2344455668999999999999 6899999999999999 88876543211
Q ss_pred ccccce-eccccccccc
Q 047196 811 IQTETL-VTIGYMAPGL 826 (827)
Q Consensus 811 ~~~~~~-gt~~Y~APE~ 826 (827)
...+ .+..|-|||+
T Consensus 177 --V~~~~~~~~y~~pe~ 191 (378)
T KOG1345|consen 177 --VKYLEYVNNYHAPEL 191 (378)
T ss_pred --ehhhhhhcccCCcHH
Confidence 1111 3567888885
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.6e-10 Score=112.03 Aligned_cols=120 Identities=15% Similarity=0.116 Sum_probs=83.8
Q ss_pred cccceEecCCceEEEEEEecCCcEEEEEEEcccch----HHHHHHHHHHHHHHhcCC-CCceEEEeeeecCCceeeeeec
Q 047196 678 SKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCA----MALKSFEAECEVMKNIRH-RNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 678 ~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~----~~~~~~~~Ei~~l~~l~H-~niv~~~~~~~~~~~~~l~~l~ 752 (827)
.....+++|+||+||.+.. .++.++.+.+..... .....|.+|+++|+++.| +++.+++++ ...+..++++.
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~--~~~~lvmeyI~ 81 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW--DGRHLDRSYLA 81 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE--cCEEEEEeeec
Confidence 4567899999999997765 577888887754422 112358899999999965 668887775 22333444443
Q ss_pred cCCCCCCH---HHHHHHHHHHHHHHHHHHhcCCCCeEEccC-CCccee----------eeccccccc
Q 047196 753 STNCSLNI---FDKLNIMIDVASALEYLHFSHSTPVIHCDL-KPKNVF----------DFGIGRLLT 805 (827)
Q Consensus 753 ~~~~~l~~---~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDl-K~~NIl----------DFGla~~~~ 805 (827)
.. .+.. .....+..+++++++++ |+.+|+|||| ||+||+ |||+|+...
T Consensus 82 G~--~L~~~~~~~~~~~~~qi~~~L~~l---H~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 82 GA--AMYQRPPRGDLAYFRAARRLLQQL---HRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred Cc--cHHhhhhhhhHHHHHHHHHHHHHH---HHCcCccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence 22 1110 12245677888899888 5778999999 799988 999998544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.11 E-value=3.5e-10 Score=122.30 Aligned_cols=146 Identities=34% Similarity=0.531 Sum_probs=108.4
Q ss_pred ccccceEecCCceEEEEEEecCCcEEEEEEEcccchH---HHHHHHHHHHHHHhcCCC-CceEEEeeeecCCc--eeeee
Q 047196 677 FSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAM---ALKSFEAECEVMKNIRHR-NHVKRISSCSNEDF--KALDC 750 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~---~~~~~~~Ei~~l~~l~H~-niv~~~~~~~~~~~--~~l~~ 750 (827)
|...+.+|.|+||.||++... ..+|+|.+...... ....|.+|+.+++.+.|+ +++++......... ..+++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 455678999999999999876 78999998654322 467899999999999998 69999988855543 22222
Q ss_pred eccC--------C---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------eecccccccCCC
Q 047196 751 LHST--------N---CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRLLTGDR 808 (827)
Q Consensus 751 l~~~--------~---~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGla~~~~~~~ 808 (827)
.... . ..........+..+++.++.|+| +.+++|||+||+||+ |||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 2211 1 14555667789999999999885 667999999999998 999998665433
Q ss_pred cc-----ccccceecccccccccC
Q 047196 809 SM-----IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~-----~~~~~~gt~~Y~APE~l 827 (827)
.. ......||..|+|||.+
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~ 180 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVL 180 (384)
T ss_pred ccccccccccccccccccCCHHHh
Confidence 21 12345699999999963
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.7e-10 Score=120.79 Aligned_cols=119 Identities=22% Similarity=0.293 Sum_probs=90.0
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcC-----CC---CceEEEeeeecCC-
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIR-----HR---NHVKRISSCSNED- 744 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-----H~---niv~~~~~~~~~~- 744 (827)
++|...+++|-|.|++||.|-. .+.+.||+|+.+. ..+..+....||++|++++ |+ .||++++.+....
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 5788889999999999999975 4568899999754 3445567789999999996 22 4999998875532
Q ss_pred ---ceeeeeeccC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee
Q 047196 745 ---FKALDCLHST-----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF 796 (827)
Q Consensus 745 ---~~~l~~l~~~-----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl 796 (827)
...|.+..-+ ...+......+|+.||..||.|||..| +|||-||||+|||
T Consensus 157 NG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvL 220 (590)
T KOG1290|consen 157 NGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVL 220 (590)
T ss_pred CCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceee
Confidence 2222222111 223455667789999999999999655 7999999999999
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.04 E-value=6.5e-10 Score=110.44 Aligned_cols=123 Identities=20% Similarity=0.223 Sum_probs=78.8
Q ss_pred cceEecCCceEEEEEEecCCcEEEEEEEcccchH--HHH----------------------HHHHHHHHHHhcCCCC--c
Q 047196 680 ENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAM--ALK----------------------SFEAECEVMKNIRHRN--H 733 (827)
Q Consensus 680 ~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~--~~~----------------------~~~~Ei~~l~~l~H~n--i 733 (827)
.+.||+|+||.||+|...+|+.||||++...... ... ....|.+.+.++++.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 3579999999999999878999999998643211 111 1145666777765543 2
Q ss_pred eEEEeeeecCCceeeeeeccCC---CCCC---H-HHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------e
Q 047196 734 VKRISSCSNEDFKALDCLHSTN---CSLN---I-FDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---------D 797 (827)
Q Consensus 734 v~~~~~~~~~~~~~l~~l~~~~---~~l~---~-~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---------D 797 (827)
.+.++. ......++++.... ..+. . .+...++.+++.++.++|. +++|+|||+||+||+ |
T Consensus 82 ~~~~~~--~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~~~~~~liD 157 (187)
T cd05119 82 PKPIDL--NRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVDDGKVYIID 157 (187)
T ss_pred CceEec--CCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEECCcEEEEE
Confidence 233322 22333444444311 1111 1 3456788889999999862 278999999999987 8
Q ss_pred ecccccccC
Q 047196 798 FGIGRLLTG 806 (827)
Q Consensus 798 FGla~~~~~ 806 (827)
||.|.....
T Consensus 158 fg~a~~~~~ 166 (187)
T cd05119 158 VPQAVEIDH 166 (187)
T ss_pred CcccccccC
Confidence 988865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=5.9e-10 Score=115.00 Aligned_cols=157 Identities=20% Similarity=0.259 Sum_probs=107.6
Q ss_pred hHHHHHhhcccccceEecCCceEEEEEEec------CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeee
Q 047196 668 QDLFRATEKFSKENLIGVGSFGSVYKGRLH------DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSC 740 (827)
Q Consensus 668 ~~~~~~~~~~~~~~~iG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~ 740 (827)
+++....++++...++-+|.||.||+|.+. +.+.|-||.+++.. +.+...+..|.-.+..+.|||+.+..+.+
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 344445566777788999999999999654 34557778776543 44567899999999999999999999998
Q ss_pred ecCCceeeeee-cc----------------C--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----
Q 047196 741 SNEDFKALDCL-HS----------------T--NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----- 796 (827)
Q Consensus 741 ~~~~~~~l~~l-~~----------------~--~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----- 796 (827)
.++...-+..+ +. . ...+...+...+|.|+|.|++|| |+++|||.||.+.|.+
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hl---h~~~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHL---HNHGVIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHH---HhcCcccchhhhhcceehhhe
Confidence 76432211111 10 1 11234455677899999999999 5788999999999966
Q ss_pred -----eecccccccCCCccccc-cceecccccccccC
Q 047196 797 -----DFGIGRLLTGDRSMIQT-ETLVTIGYMAPGLL 827 (827)
Q Consensus 797 -----DFGla~~~~~~~~~~~~-~~~gt~~Y~APE~l 827 (827)
|=.++|-+...+..... ..--...||+||-+
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal 470 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEAL 470 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHH
Confidence 66666655443332111 11125689999953
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.90 E-value=2.5e-10 Score=119.67 Aligned_cols=86 Identities=24% Similarity=0.299 Sum_probs=42.9
Q ss_pred cccccEEEeeccccccc-CCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEccccccccccc--ccccCcCCCc
Q 047196 194 LHYLKVLFLAKNMFHGQ-IPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIP--HEIGYLPNLE 270 (827)
Q Consensus 194 ~~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~ 270 (827)
++.|+.|.|+.|.++-. +-.....+++|+.|+|..|..-+........+..|+.|||++|++- ..+ ...+.++.|+
T Consensus 196 l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~ 274 (505)
T KOG3207|consen 196 LSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLN 274 (505)
T ss_pred hhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchh
Confidence 33555555555555421 1112234556666666666422222233344555666666666654 222 2345566666
Q ss_pred EEEeecccCc
Q 047196 271 NLVLGFNNLV 280 (827)
Q Consensus 271 ~L~Ls~N~l~ 280 (827)
.|+++.+.+.
T Consensus 275 ~Lnls~tgi~ 284 (505)
T KOG3207|consen 275 QLNLSSTGIA 284 (505)
T ss_pred hhhccccCcc
Confidence 6666666554
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.1e-09 Score=77.95 Aligned_cols=41 Identities=39% Similarity=0.827 Sum_probs=30.7
Q ss_pred HHHHHHHHHHHhhcCCCCCCcCCCCCCCC-CCCCcccceecC
Q 047196 54 TTDQQALLALKAHISYDPTNLLAQNSTSN-TSVCNWIGITCN 94 (827)
Q Consensus 54 ~~~~~aLl~~k~~~~~~~~~~l~~w~~~~-~~~C~W~gv~C~ 94 (827)
++|++||++||+++..+|.+.+.+|.... .+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 67999999999999667778899998543 799999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.85 E-value=9.4e-10 Score=109.70 Aligned_cols=130 Identities=28% Similarity=0.413 Sum_probs=61.7
Q ss_pred CCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCcccc
Q 047196 404 SNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDL 483 (827)
Q Consensus 404 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 483 (827)
..|+.+|||+|.|+ .+..+..-+++++.|++|+|.+.. + ..+..+++|+.||||+|.++ .+-.|-..+.+.+.|.|
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-V-QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEeccccceee-e-hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence 34444444444444 233334444444555555554431 1 12444455555555555554 23333333444455555
Q ss_pred CCCcccccCCccccccccccccCCCCCCCCCC-CcccccccccCceEEcccceeeec
Q 047196 484 GSNRLTSVLPSTFWNLKDILFFDLSSNSLDGP-LSLDIGNLRVVIGINLSRNNFSGD 539 (827)
Q Consensus 484 s~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~-~p~~~~~l~~L~~L~Ls~N~l~g~ 539 (827)
+.|.+... ..+..+-+|..||+++|++... --..+|+++.|+.+.|.+|.+.+.
T Consensus 360 a~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 360 AQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred hhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 55544321 1233444555555555555421 123456666777777777777643
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=3.4e-10 Score=115.75 Aligned_cols=235 Identities=21% Similarity=0.283 Sum_probs=124.6
Q ss_pred CcEEEEEcCCCCCccc----cCccccCCCCCCEEECCCC---CCCccCChhh-------hhccccceEEecCCCCCCccc
Q 047196 98 HRVTALNISSLNLQGT----IPPQLGNLSSLTTLNLSHN---KLSGDIPPSI-------FTMHKLKFLDFSDNQLSGSLS 163 (827)
Q Consensus 98 ~~v~~L~L~~~~l~g~----~~~~l~~L~~L~~L~Ls~N---~l~g~~p~~~-------~~l~~L~~LdLs~N~l~g~~p 163 (827)
..++.|+|++|.+.-. +.+.+.+.++|+.-++|+- ++...+|+.+ ...++|++||||+|.|.-.-+
T Consensus 30 ~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~ 109 (382)
T KOG1909|consen 30 DSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGI 109 (382)
T ss_pred CceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccch
Confidence 4688999999887532 4456777888888888863 2233456544 345689999999998864333
Q ss_pred c----ccCCCCCCcEEEcCCCCCCCCcchhHhh------------ccccccEEEeeccccccc----CCccCCCCCCCcE
Q 047196 164 S----VTFNLSSVLDIRLDSDKLSGELPVNICN------------YLHYLKVLFLAKNMFHGQ----IPLALSKCKRLQL 223 (827)
Q Consensus 164 ~----~~~~l~~L~~L~L~~n~l~g~ip~~~~~------------~~~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~ 223 (827)
. .+....+|++|.|.+|.+.-.--..+.. ..+.|+++..++|++... +...|...+.|+.
T Consensus 110 ~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~lee 189 (382)
T KOG1909|consen 110 RGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEE 189 (382)
T ss_pred HHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccccce
Confidence 2 2445677777777777664110011111 123555555555555321 1122344455555
Q ss_pred EEccCCCCcc----cCCCcCcCCccccEEEccccccccc----ccccccCcCCCcEEEeecccCcccCchhhhcCCCccE
Q 047196 224 LNLGFKKLSG----AIPKEISNLTILRKISLRNNKLRGE----IPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKK 295 (827)
Q Consensus 224 L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 295 (827)
+.+..|.+.. .+...+..+++|++|||++|.|+.. +...+..+++|++|++++|.+...-..++.
T Consensus 190 vr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~------- 262 (382)
T KOG1909|consen 190 VRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFV------- 262 (382)
T ss_pred EEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHH-------
Confidence 5555555421 0112234455555555555555422 222333444555555555544322221111
Q ss_pred EEecCCccccccChhhhcCCCCccEEeCcCCccccc----cCccccCCCCCcEEEcCCCcc
Q 047196 296 IYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGT----IPSFITNASKLVYLDMGTNSF 352 (827)
Q Consensus 296 L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l 352 (827)
..+....|+|++|.+.+|.++.. +-..+...+.|..|+|++|.+
T Consensus 263 -------------~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 263 -------------DALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred -------------HHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 11122356777777777776532 222344566677777777766
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.1e-09 Score=109.14 Aligned_cols=90 Identities=33% Similarity=0.316 Sum_probs=46.0
Q ss_pred ccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCccccCCCcccccCC-ccccccccc
Q 047196 424 FGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLP-STFWNLKDI 502 (827)
Q Consensus 424 ~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L 502 (827)
+..+++|+.||||+|.++ .+-.+-..+-+.+.|.|+.|.+. --+.++.+.+|..||+++|+|..... ..+++++.|
T Consensus 325 La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE--~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCL 401 (490)
T KOG1259|consen 325 LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIE--TLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCL 401 (490)
T ss_pred hhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHh--hhhhhHhhhhheeccccccchhhHHHhcccccccHH
Confidence 333444444444444443 22333334445555555555543 11234455566666666666643221 345666777
Q ss_pred cccCCCCCCCCCCC
Q 047196 503 LFFDLSSNSLDGPL 516 (827)
Q Consensus 503 ~~LdLs~N~l~g~~ 516 (827)
+.+.|.+|.+.+..
T Consensus 402 E~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 402 ETLRLTGNPLAGSV 415 (490)
T ss_pred HHHhhcCCCccccc
Confidence 77777777776543
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.5e-09 Score=113.91 Aligned_cols=182 Identities=23% Similarity=0.207 Sum_probs=126.0
Q ss_pred cEEEEEcCCCCCccccC-ccccCCCCCCEEECCCCCCCccCC--hhhhhccccceEEecCCCCCCccccc-cCCCCCCcE
Q 047196 99 RVTALNISSLNLQGTIP-PQLGNLSSLTTLNLSHNKLSGDIP--PSIFTMHKLKFLDFSDNQLSGSLSSV-TFNLSSVLD 174 (827)
Q Consensus 99 ~v~~L~L~~~~l~g~~~-~~l~~L~~L~~L~Ls~N~l~g~~p--~~~~~l~~L~~LdLs~N~l~g~~p~~-~~~l~~L~~ 174 (827)
.++.+.|.+....-.-. .....+++++.||||+|-|....| .-...|++|+.|+||.|.+.-...+. -..+++|+.
T Consensus 122 kL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~ 201 (505)
T KOG3207|consen 122 KLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQ 201 (505)
T ss_pred hhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhhe
Confidence 34444555444331111 356788999999999998875433 33457999999999999987544433 336788999
Q ss_pred EEcCCCCCCCCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccC-CCcCcCCccccEEEcccc
Q 047196 175 IRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAI-PKEISNLTILRKISLRNN 253 (827)
Q Consensus 175 L~L~~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~Ls~N 253 (827)
|.|+++.++-.--..+....++|+.|+|..|..-+........+..|+.|||++|++-... -...+.++.|+.|+++.+
T Consensus 202 L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~t 281 (505)
T KOG3207|consen 202 LVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSST 281 (505)
T ss_pred EEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhcccc
Confidence 9999998873222233344569999999999644444445567789999999999885321 134678899999999999
Q ss_pred ccccc-cccc-----ccCcCCCcEEEeecccCc
Q 047196 254 KLRGE-IPHE-----IGYLPNLENLVLGFNNLV 280 (827)
Q Consensus 254 ~l~~~-~p~~-----~~~l~~L~~L~Ls~N~l~ 280 (827)
.+... +|+. ...+++|++|+++.|++.
T Consensus 282 gi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 282 GIASIAEPDVESLDKTHTFPKLEYLNISENNIR 314 (505)
T ss_pred CcchhcCCCccchhhhcccccceeeecccCccc
Confidence 88643 2332 245788899999888875
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.79 E-value=3.4e-09 Score=102.07 Aligned_cols=128 Identities=27% Similarity=0.305 Sum_probs=33.7
Q ss_pred ccCCCCCCEEECCCCCCCccCChhhh-hccccceEEecCCCCCCccccccCCCCCCcEEEcCCCCCCCCcchhHhhcccc
Q 047196 118 LGNLSSLTTLNLSHNKLSGDIPPSIF-TMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHY 196 (827)
Q Consensus 118 l~~L~~L~~L~Ls~N~l~g~~p~~~~-~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~~ 196 (827)
+.+...++.|+|.+|.|+.+ +.++ .+.+|+.||||+|.++... .+..+..|++|+++.|+++ .++..+...+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l~--~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKLE--GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S--T--T----TT--EEE--SS----S-CHHHHHH-TT
T ss_pred cccccccccccccccccccc--cchhhhhcCCCEEECCCCCCcccc--CccChhhhhhcccCCCCCC-ccccchHHhCCc
Confidence 34444566666666666532 2344 4566666677766665321 1223333333333333333 233222222334
Q ss_pred ccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccC-CCcCcCCccccEEEcccccccccc---cccccCcCCCcEE
Q 047196 197 LKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAI-PKEISNLTILRKISLRNNKLRGEI---PHEIGYLPNLENL 272 (827)
Q Consensus 197 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~---p~~~~~l~~L~~L 272 (827)
|++|+|++|++. ..- -..++.+++|++|+|.+|.++..- ...+..+|+|+.|
T Consensus 90 L~~L~L~~N~I~------------------------~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~L 145 (175)
T PF14580_consen 90 LQELYLSNNKIS------------------------DLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVL 145 (175)
T ss_dssp --EEE-TTS---------------------------SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEE
T ss_pred CCEEECcCCcCC------------------------ChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhhee
Confidence 444444444443 211 123455666777777777665321 1235567778777
Q ss_pred Ee
Q 047196 273 VL 274 (827)
Q Consensus 273 ~L 274 (827)
|-
T Consensus 146 D~ 147 (175)
T PF14580_consen 146 DG 147 (175)
T ss_dssp TT
T ss_pred CC
Confidence 64
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.76 E-value=8.4e-09 Score=123.52 Aligned_cols=92 Identities=25% Similarity=0.276 Sum_probs=58.9
Q ss_pred CcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEccccccccccccccc
Q 047196 185 ELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIG 264 (827)
Q Consensus 185 ~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 264 (827)
.++..++..++.|++|||++|.=-+.+|..+++|-+|++|+++...++ .+|..++++..|.+|++..+.-...+|....
T Consensus 561 ~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~ 639 (889)
T KOG4658|consen 561 EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILL 639 (889)
T ss_pred hcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhh
Confidence 355555555666666666666555566666666777777777766666 5666677777777777766655444555556
Q ss_pred CcCCCcEEEeecc
Q 047196 265 YLPNLENLVLGFN 277 (827)
Q Consensus 265 ~l~~L~~L~Ls~N 277 (827)
.+++|++|.+...
T Consensus 640 ~L~~Lr~L~l~~s 652 (889)
T KOG4658|consen 640 ELQSLRVLRLPRS 652 (889)
T ss_pred hcccccEEEeecc
Confidence 6677777766544
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=98.75 E-value=3e-09 Score=129.63 Aligned_cols=39 Identities=13% Similarity=0.368 Sum_probs=34.8
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee
Q 047196 755 NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF 796 (827)
Q Consensus 755 ~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl 796 (827)
...+++.+...++.||++||+||| +++|+||||||+|||
T Consensus 74 ~~~~~~~~~~~i~~qi~~al~~lH---~~gIvHrDlKP~NiL 112 (793)
T PLN00181 74 DRSVDAFECFHVFRQIVEIVNAAH---SQGIVVHNVRPSCFV 112 (793)
T ss_pred cccccHHHHHHHHHHHHHHHHHHH---hCCeeeccCCchhEE
Confidence 345788889999999999999995 678999999999998
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.75 E-value=7.2e-09 Score=99.84 Aligned_cols=103 Identities=22% Similarity=0.368 Sum_probs=28.5
Q ss_pred cccEEEeecccccccCCccCC-CCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccc-cCcCCCcEEE
Q 047196 196 YLKVLFLAKNMFHGQIPLALS-KCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEI-GYLPNLENLV 273 (827)
Q Consensus 196 ~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~ 273 (827)
+++.|+|++|.++.. +.++ .+.+|+.|+|++|.++.. +.+..++.|++|++++|+|+. +++.+ ..+++|++|+
T Consensus 20 ~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELY 94 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--EEE
T ss_pred ccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEE
Confidence 567777777777632 2444 466777777777777643 245667777777777777763 33333 3467777777
Q ss_pred eecccCcccCc-hhhhcCCCccEEEecCCcc
Q 047196 274 LGFNNLVGVVP-AAIFNMSTVKKIYLLDNSL 303 (827)
Q Consensus 274 Ls~N~l~~~~p-~~~~~l~~L~~L~l~~n~l 303 (827)
|++|+|...-- ..+..+++|+.|++.+|.+
T Consensus 95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv 125 (175)
T PF14580_consen 95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPV 125 (175)
T ss_dssp -TTS---SCCCCGGGGG-TT--EEE-TT-GG
T ss_pred CcCCcCCChHHhHHHHcCCCcceeeccCCcc
Confidence 77777654211 2233344444444444443
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.73 E-value=6.6e-08 Score=99.58 Aligned_cols=121 Identities=15% Similarity=0.258 Sum_probs=80.3
Q ss_pred cceEe-cCCceEEEEEEecCCcEEEEEEEcccc-------------hHHHHHHHHHHHHHHhcCCCCc--eEEEeeeecC
Q 047196 680 ENLIG-VGSFGSVYKGRLHDGIEVAIKVFHQNC-------------AMALKSFEAECEVMKNIRHRNH--VKRISSCSNE 743 (827)
Q Consensus 680 ~~~iG-~G~fg~Vy~~~~~~g~~vAvK~l~~~~-------------~~~~~~~~~Ei~~l~~l~H~ni--v~~~~~~~~~ 743 (827)
..++| .|+.|+||+.+.. +..++||.+.... .....++.+|++++.+++|+++ ++.++++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 46788 8999999999875 6789999874321 1123568899999999999885 5666654332
Q ss_pred C-c-----eeeeeeccCCCCCCHH-----HHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccc
Q 047196 744 D-F-----KALDCLHSTNCSLNIF-----DKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGR 802 (827)
Q Consensus 744 ~-~-----~~l~~l~~~~~~l~~~-----~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~ 802 (827)
. . .+++++... ..+... .......++++++.++ |+.+|+||||||.||| |||.++
T Consensus 115 ~~~~~~~~lV~e~l~G~-~~L~~~l~~~~l~~~~~~~i~~~l~~l---H~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~ 190 (239)
T PRK01723 115 HGLFYRADILIERIEGA-RDLVALLQEAPLSEEQWQAIGQLIARF---HDAGVYHADLNAHNILLDPDGKFWLIDFDRGE 190 (239)
T ss_pred cCcceeeeEEEEecCCC-CCHHHHHhcCCCCHHHHHHHHHHHHHH---HHCCCCCCCCCchhEEEcCCCCEEEEECCCcc
Confidence 1 1 222322211 111100 0123467888999998 5789999999999998 888877
Q ss_pred ccc
Q 047196 803 LLT 805 (827)
Q Consensus 803 ~~~ 805 (827)
...
T Consensus 191 ~~~ 193 (239)
T PRK01723 191 LRT 193 (239)
T ss_pred cCC
Confidence 643
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.69 E-value=2.4e-09 Score=120.17 Aligned_cols=127 Identities=28% Similarity=0.351 Sum_probs=59.2
Q ss_pred CCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEeecccCcccCchhhhcCCCccEEE
Q 047196 218 CKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIY 297 (827)
Q Consensus 218 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 297 (827)
+..++.+++..|.+.. +-..+..+++|..|++.+|+|.+ +...+..+++|++|+|++|.|+...+ +..++.|+.|+
T Consensus 71 l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~ 146 (414)
T KOG0531|consen 71 LTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELN 146 (414)
T ss_pred hHhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheeccccccccccc--hhhccchhhhe
Confidence 3444444455554442 22234555556666666666652 22224556666666666666654432 22333344444
Q ss_pred ecCCccccccChhhhcCCCCccEEeCcCCccccccC-ccccCCCCCcEEEcCCCcc
Q 047196 298 LLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIP-SFITNASKLVYLDMGTNSF 352 (827)
Q Consensus 298 l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l 352 (827)
+++|.+...-.. ..++.|+.+++++|++...-+ . ...+.+++.+++..|.+
T Consensus 147 l~~N~i~~~~~~---~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i 198 (414)
T KOG0531|consen 147 LSGNLISDISGL---ESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSI 198 (414)
T ss_pred eccCcchhccCC---ccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCch
Confidence 444444321110 124555555555555553322 1 23444555555555544
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.69 E-value=2.9e-09 Score=119.42 Aligned_cols=173 Identities=28% Similarity=0.338 Sum_probs=81.9
Q ss_pred CCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCc
Q 047196 314 SLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIG 393 (827)
Q Consensus 314 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~ 393 (827)
.+.+|+.|++..|++... ...+..+.+|++|++++|.++...+ +..+. .|+.|++++|.++
T Consensus 93 ~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~~-----------------l~~l~-~L~~L~l~~N~i~ 153 (414)
T KOG0531|consen 93 KLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLEG-----------------LSTLT-LLKELNLSGNLIS 153 (414)
T ss_pred cccceeeeeccccchhhc-ccchhhhhcchheeccccccccccc-----------------hhhcc-chhhheeccCcch
Confidence 345566666666666532 2224556666666666666653321 11222 3555666666665
Q ss_pred cccCccccCCCCCceEeccCcccccccc-ccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCccc
Q 047196 394 GSIPQLISNLSNLLLLDLEGNKLTGSIP-VTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCL 472 (827)
Q Consensus 394 g~~p~~~~~l~~L~~L~Ls~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 472 (827)
.. ..+..+.+|+.+++++|+++..-+ . ...+.+++.+++..|.+.. ...+..+..+..+++.+|.++..-+ +
T Consensus 154 ~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i~~~~~--l 226 (414)
T KOG0531|consen 154 DI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNKISKLEG--L 226 (414)
T ss_pred hc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhcccccceeccC--c
Confidence 22 223335666666666666654333 1 3455555666666665541 2223333444444555555542221 1
Q ss_pred cCCCC--CCccccCCCcccccCCccccccccccccCCCCCCCC
Q 047196 473 GNLTS--LRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLD 513 (827)
Q Consensus 473 ~~l~~--L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~ 513 (827)
..+.. |+.+++++|.+... +..+..+..+..+|+++|+++
T Consensus 227 ~~~~~~~L~~l~l~~n~i~~~-~~~~~~~~~l~~l~~~~n~~~ 268 (414)
T KOG0531|consen 227 NELVMLHLRELYLSGNRISRS-PEGLENLKNLPVLDLSSNRIS 268 (414)
T ss_pred ccchhHHHHHHhcccCccccc-cccccccccccccchhhcccc
Confidence 11111 45555555555432 122333344444444444443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.67 E-value=8.2e-08 Score=107.66 Aligned_cols=122 Identities=25% Similarity=0.367 Sum_probs=77.0
Q ss_pred cceEecCCceEEEEEEecCCcEEEEEEEcccchHHH----------------------------------------HHHH
Q 047196 680 ENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMAL----------------------------------------KSFE 719 (827)
Q Consensus 680 ~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~----------------------------------------~~~~ 719 (827)
.+.||.|++|.||+|++++|+.||||+.+....... -.|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999999999999999854321100 0255
Q ss_pred HHHHHHHhcC----CCCceEEEeeee---cCCceeeeeeccCCCCCCHH--------HHHHHHHHHHHHHHHHHhcCCCC
Q 047196 720 AECEVMKNIR----HRNHVKRISSCS---NEDFKALDCLHSTNCSLNIF--------DKLNIMIDVASALEYLHFSHSTP 784 (827)
Q Consensus 720 ~Ei~~l~~l~----H~niv~~~~~~~---~~~~~~l~~l~~~~~~l~~~--------~~~~i~~~ia~~L~~Lh~~h~~~ 784 (827)
+|++.+.+++ |.+-|.....+. ......++++... .+... ++..++..+++. |++..|..+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~--~L~~~~~~~~~~~~~~~ia~~~~~~--~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGI--PLSDIAALDEAGLDRKALAENLARS--FLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCc--ccccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhCC
Confidence 5666665553 444444433332 2333444555432 22111 234566655553 334446789
Q ss_pred eEEccCCCccee----------eeccccccc
Q 047196 785 VIHCDLKPKNVF----------DFGIGRLLT 805 (827)
Q Consensus 785 iiHrDlK~~NIl----------DFGla~~~~ 805 (827)
++|+|+||+||+ |||+++.+.
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 999999999987 999987764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.66 E-value=2.1e-08 Score=79.28 Aligned_cols=58 Identities=40% Similarity=0.508 Sum_probs=27.6
Q ss_pred CcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEeeccc
Q 047196 221 LQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNN 278 (827)
Q Consensus 221 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 278 (827)
|++|++++|+++...+..|.++++|++|++++|+++...|..|..+++|++|++++|+
T Consensus 3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 4444444444443333444445555555555555544444444555555555555444
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.63 E-value=3.1e-08 Score=78.32 Aligned_cols=61 Identities=33% Similarity=0.396 Sum_probs=55.2
Q ss_pred ccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccc
Q 047196 195 HYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKL 255 (827)
Q Consensus 195 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l 255 (827)
++|++|++++|+++...+..|.++++|++|++++|.++...|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3789999999999987778899999999999999999988888999999999999999975
|
... |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.9e-07 Score=91.04 Aligned_cols=121 Identities=16% Similarity=0.131 Sum_probs=80.5
Q ss_pred ceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEE-EeeeecCCceeeeeeccCCCCCC
Q 047196 681 NLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKR-ISSCSNEDFKALDCLHSTNCSLN 759 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~-~~~~~~~~~~~l~~l~~~~~~l~ 759 (827)
+.++.|.++.||+++.. |..|++|+...... ....+.+|+++++.+.+.++++. +..........++++......-.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~~ 81 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLTE 81 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCccccc
Confidence 46789999999999865 67899998754321 12346789999999877666643 33333334455555544321100
Q ss_pred HHHHHHHHHHHHHHHHHHHhcC--CCCeEEccCCCccee---------eeccccc
Q 047196 760 IFDKLNIMIDVASALEYLHFSH--STPVIHCDLKPKNVF---------DFGIGRL 803 (827)
Q Consensus 760 ~~~~~~i~~~ia~~L~~Lh~~h--~~~iiHrDlK~~NIl---------DFGla~~ 803 (827)
......++.+++++++.||... ...++|+|+||.||+ |||.|..
T Consensus 82 ~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~~~~~~liDf~~a~~ 136 (170)
T cd05151 82 DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLDDGRLWLIDWEYAGM 136 (170)
T ss_pred cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEECCeEEEEecccccC
Confidence 1112346678999999997543 334799999999987 8887764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=5.2e-08 Score=116.88 Aligned_cols=106 Identities=20% Similarity=0.330 Sum_probs=88.2
Q ss_pred cccEEEeeccc--ccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEE
Q 047196 196 YLKVLFLAKNM--FHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLV 273 (827)
Q Consensus 196 ~L~~L~Ls~N~--l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 273 (827)
.|++|-+..|. +.-..+..|..++.|++|||++|.=-+.+|+.++++-+||+|+|++..++ .+|..+++|+.|.+|+
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln 624 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN 624 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence 68888888886 43333444778999999999998777789999999999999999999998 8999999999999999
Q ss_pred eecccCcccCchhhhcCCCccEEEecCCc
Q 047196 274 LGFNNLVGVVPAAIFNMSTVKKIYLLDNS 302 (827)
Q Consensus 274 Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~ 302 (827)
+..+.....+|.....+.+|++|.+....
T Consensus 625 l~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 625 LEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred cccccccccccchhhhcccccEEEeeccc
Confidence 99887766667777778888888887654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.55 E-value=6.4e-08 Score=114.44 Aligned_cols=119 Identities=28% Similarity=0.368 Sum_probs=74.8
Q ss_pred HHHHhhcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCce----EEEeeeecCCc
Q 047196 670 LFRATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHV----KRISSCSNEDF 745 (827)
Q Consensus 670 ~~~~~~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv----~~~~~~~~~~~ 745 (827)
.....+.|...+.||+|+||+||+|...+|+.||+|+-+.... + +|.-=-+++.+++ +-+. .+..++.-.+.
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~--W-EfYI~~q~~~RLk-~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP--W-EFYICLQVMERLK-PQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc--e-eeeehHHHHHhhc-hhhhcchHHHHHHHccCCc
Confidence 3445567888899999999999999987799999998643321 1 1222334445554 2211 11111111111
Q ss_pred eee-----------eeeccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee
Q 047196 746 KAL-----------DCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF 796 (827)
Q Consensus 746 ~~l-----------~~l~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl 796 (827)
.++ +.+. .....+|.-.+.++.++++.++.|| ..+|||+||||.|.+
T Consensus 769 S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfl 826 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFL 826 (974)
T ss_pred ceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeE
Confidence 111 1111 2234566667788899999999995 567999999999965
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.55 E-value=4e-08 Score=113.77 Aligned_cols=146 Identities=21% Similarity=0.313 Sum_probs=96.9
Q ss_pred ccceEecCCceEEEEEEe-cCCcEEEEEEEc-----ccchH-HHHHHHHHHHHHHhcCCCCceEEEeeeecCC--ceeee
Q 047196 679 KENLIGVGSFGSVYKGRL-HDGIEVAIKVFH-----QNCAM-ALKSFEAECEVMKNIRHRNHVKRISSCSNED--FKALD 749 (827)
Q Consensus 679 ~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~-----~~~~~-~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~--~~~l~ 749 (827)
..+++|.|++|.|+.... ......+.|... ..... ....+..|..+-..++|+|++..+..+.+.. ...|+
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 457899999998887754 334445555432 11111 1223667888889999999876554433321 11122
Q ss_pred eecc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc---
Q 047196 750 CLHS-------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS--- 809 (827)
Q Consensus 750 ~l~~-------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~--- 809 (827)
+... ....+...+...+..|+..|+.|+ |+.+|.|||+|++|++ |||.+.....+.+
T Consensus 402 ~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~---h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~ 478 (601)
T KOG0590|consen 402 YCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYL---HSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNI 478 (601)
T ss_pred cccHHHHHHHhcccccchhhhhHHHHHHHHHHHHH---HhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhh
Confidence 2111 122455667778999999999999 5788999999999987 9999887654433
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
......+|+-.|+|||++
T Consensus 479 ~~~~g~~gS~pY~apE~~ 496 (601)
T KOG0590|consen 479 HESSGIVGSDPYLAPEVL 496 (601)
T ss_pred hhhcCcccCCcCcCcccc
Confidence 233445689999999985
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.3e-08 Score=110.35 Aligned_cols=141 Identities=23% Similarity=0.308 Sum_probs=94.5
Q ss_pred eEecCCceEEEEEEe----cCCcEEEEEEEcccchH--HHHHHHHHHHHHHhcC-CCCceEEEeeeecCCce--eeeeec
Q 047196 682 LIGVGSFGSVYKGRL----HDGIEVAIKVFHQNCAM--ALKSFEAECEVMKNIR-HRNHVKRISSCSNEDFK--ALDCLH 752 (827)
Q Consensus 682 ~iG~G~fg~Vy~~~~----~~g~~vAvK~l~~~~~~--~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~--~l~~l~ 752 (827)
++|+|+||+|+..+- +.|..+|.|++.+.... .......|..++...+ ||.+|++......+... .+++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 368999999998642 24778999988654321 1125567888999998 99999977665444322 223332
Q ss_pred cCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccccccee
Q 047196 753 STN-----CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV 817 (827)
Q Consensus 753 ~~~-----~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~~~g 817 (827)
... ..-..++....+..+|+.+-.+.+.|+-+|+|||+|++||+ |||+.|....... .+|
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-----~cg 155 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-----ACG 155 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh-----ccc
Confidence 211 11223344455556666555555568999999999999998 9999987654332 279
Q ss_pred cccccccccC
Q 047196 818 TIGYMAPGLL 827 (827)
Q Consensus 818 t~~Y~APE~l 827 (827)
|.-|||||++
T Consensus 156 t~eymApEI~ 165 (612)
T KOG0603|consen 156 TYEYRAPEII 165 (612)
T ss_pred chhhhhhHhh
Confidence 9999999984
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.47 E-value=6.8e-08 Score=112.18 Aligned_cols=146 Identities=23% Similarity=0.255 Sum_probs=94.3
Q ss_pred cccccceEecCCceEEEEEEecCCcEEEEEEEcccc-hHHHHHHHH---HHHHHHhcCCCCceEEEeeeecCCceeee--
Q 047196 676 KFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNC-AMALKSFEA---ECEVMKNIRHRNHVKRISSCSNEDFKALD-- 749 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~-~~~~~~~~~---Ei~~l~~l~H~niv~~~~~~~~~~~~~l~-- 749 (827)
++.-.+.+|.+.|=+|.||+.+.|. |+||++-+.. .-..+.|.+ |++ ..-++|||.+++...-......++.
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 4566678999999999999988886 8999986543 223334443 444 5667899999877664443333331
Q ss_pred ----eeccCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eeccccc--ccCCCcc
Q 047196 750 ----CLHSTN---CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRL--LTGDRSM 810 (827)
Q Consensus 750 ----~l~~~~---~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~--~~~~~~~ 810 (827)
-+|..- .-+...++.=|+.|+..|+.-+ |..+|+|+|||.+||| ||.-=|. +..|...
T Consensus 102 yvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qc---H~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 102 YVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQC---HKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred HHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHH---HHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 122211 1233445666999999999888 6789999999999999 8864442 1223222
Q ss_pred cccccee----ccccccccc
Q 047196 811 IQTETLV----TIGYMAPGL 826 (827)
Q Consensus 811 ~~~~~~g----t~~Y~APE~ 826 (827)
.-+.... -..|+|||-
T Consensus 179 df~fFFDTSrRRtCYiAPER 198 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPER 198 (1431)
T ss_pred cceEEEecCCceeeecChHh
Confidence 1111111 236999994
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.8e-08 Score=101.04 Aligned_cols=165 Identities=20% Similarity=0.198 Sum_probs=120.7
Q ss_pred ccccCCCCCCEEECCCCCCCccCChhh----hhccccceEEecCCCCCC----c---------cccccCCCCCCcEEEcC
Q 047196 116 PQLGNLSSLTTLNLSHNKLSGDIPPSI----FTMHKLKFLDFSDNQLSG----S---------LSSVTFNLSSVLDIRLD 178 (827)
Q Consensus 116 ~~l~~L~~L~~L~Ls~N~l~g~~p~~~----~~l~~L~~LdLs~N~l~g----~---------~p~~~~~l~~L~~L~L~ 178 (827)
+++...+.|++||||.|-|.-.-+..| .++..|++|.|.+|.+.- . .......-..|+++...
T Consensus 86 ~aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~ 165 (382)
T KOG1909|consen 86 KALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICG 165 (382)
T ss_pred HHHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEee
Confidence 356677799999999999875555444 467889999999998751 1 11224455678999999
Q ss_pred CCCCCCCcch----hHhhccccccEEEeecccccc----cCCccCCCCCCCcEEEccCCCCcc----cCCCcCcCCcccc
Q 047196 179 SDKLSGELPV----NICNYLHYLKVLFLAKNMFHG----QIPLALSKCKRLQLLNLGFKKLSG----AIPKEISNLTILR 246 (827)
Q Consensus 179 ~n~l~g~ip~----~~~~~~~~L~~L~Ls~N~l~~----~~p~~l~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~ 246 (827)
.|++.. -+. ..+...+.|+.+.++.|.+.- .+-..+..+++|+.|||.+|.|+. .+...+..+++|+
T Consensus 166 rNrlen-~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~ 244 (382)
T KOG1909|consen 166 RNRLEN-GGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLR 244 (382)
T ss_pred cccccc-ccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchhe
Confidence 998863 232 334555789999999997752 123457899999999999999973 2445667788999
Q ss_pred EEEcccccccccccccc-----cCcCCCcEEEeecccCcc
Q 047196 247 KISLRNNKLRGEIPHEI-----GYLPNLENLVLGFNNLVG 281 (827)
Q Consensus 247 ~L~Ls~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~ 281 (827)
.|++++|.+...-...| ...++|++|.+.+|.++.
T Consensus 245 El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~ 284 (382)
T KOG1909|consen 245 ELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITR 284 (382)
T ss_pred eecccccccccccHHHHHHHHhccCCCCceeccCcchhHH
Confidence 99999999975433332 246889999999998864
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.36 E-value=2e-06 Score=97.76 Aligned_cols=126 Identities=21% Similarity=0.280 Sum_probs=75.8
Q ss_pred hcccccceEecCCceEEEEEEecC-CcEEEEEEEcccchH------------------------------H----HH---
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHD-GIEVAIKVFHQNCAM------------------------------A----LK--- 716 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~------------------------------~----~~--- 716 (827)
..|+. +.+|+|++|.||+|++++ |+.||||+.+.+... . .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34665 789999999999999987 999999999643210 0 01
Q ss_pred ---HHHHHHHHHHhcC----CCCceEEEeeee---cCCceeeeeeccCCCCCCHH--------HHHHHHHHHHHHHHHHH
Q 047196 717 ---SFEAECEVMKNIR----HRNHVKRISSCS---NEDFKALDCLHSTNCSLNIF--------DKLNIMIDVASALEYLH 778 (827)
Q Consensus 717 ---~~~~Ei~~l~~l~----H~niv~~~~~~~---~~~~~~l~~l~~~~~~l~~~--------~~~~i~~~ia~~L~~Lh 778 (827)
.|.+|+.-+.+++ +.+.|.....+. ......|+++... .++.. ++..++...++ .|+.
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~--~l~d~~~l~~~g~d~~~la~~~v~--~~~~ 274 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGI--PVSDVAALRAAGTDMKLLAERGVE--VFFT 274 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCc--cHHhHHHHHhcCCCHHHHHHHHHH--HHHH
Confidence 2455665555553 444444333332 2334445555432 22211 11233333322 2344
Q ss_pred hcCCCCeEEccCCCccee--------------eeccccccc
Q 047196 779 FSHSTPVIHCDLKPKNVF--------------DFGIGRLLT 805 (827)
Q Consensus 779 ~~h~~~iiHrDlK~~NIl--------------DFGla~~~~ 805 (827)
..+..+++|+|+||+||+ |||+...+.
T Consensus 275 Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 275 QVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 445689999999999987 999877654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.1e-06 Score=91.38 Aligned_cols=144 Identities=20% Similarity=0.284 Sum_probs=81.3
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEccc---chHHHHHHHHHHHHHHhcCC----------CCceEEEeeee
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN---CAMALKSFEAECEVMKNIRH----------RNHVKRISSCS 741 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H----------~niv~~~~~~~ 741 (827)
.+...+.||.|+++.||.++.. +|+++|||++... .....+++++|.-....+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4556788999999999999975 5899999997532 23346777777755555433 11221111111
Q ss_pred cC-------------Cce------eee-----------eeccCCC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEc
Q 047196 742 NE-------------DFK------ALD-----------CLHSTNC---SLNIFDKLNIMIDVASALEYLHFSHSTPVIHC 788 (827)
Q Consensus 742 ~~-------------~~~------~l~-----------~l~~~~~---~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHr 788 (827)
-. .+. .+. .+..... .+....|+.+..|+.+.+++|| ..+|+|+
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHg 169 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHG 169 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEES
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEec
Confidence 00 010 000 0000001 1122345667788899999995 5789999
Q ss_pred cCCCccee----------eecccccccCCCccccccceeccccccccc
Q 047196 789 DLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGL 826 (827)
Q Consensus 789 DlK~~NIl----------DFGla~~~~~~~~~~~~~~~gt~~Y~APE~ 826 (827)
||||+|++ ||+-........ .. ...+.+|.+||+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~~-~~~~~~~~PPe~ 213 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRY---RC-SEFPVAFTPPEL 213 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEE---EG-GGS-TTTS-HHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCcee---ec-cCCCcccCChhh
Confidence 99999998 666544332111 11 224678999985
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.5e-07 Score=92.87 Aligned_cols=145 Identities=17% Similarity=0.326 Sum_probs=97.0
Q ss_pred ceEecCCceEEEEEEecCCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee--------
Q 047196 681 NLIGVGSFGSVYKGRLHDGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC-------- 750 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~-------- 750 (827)
.++.+...|..|+|++.. ..+++|++... ...-.+.|..|.-.++-..||||.+.+|.|..+....+..
T Consensus 196 tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 457888899999999974 45556666432 3334567999999999999999999999998875433311
Q ss_pred ---eccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-eec-ccccccCCCcc--ccccceeccccc
Q 047196 751 ---LHST-NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-DFG-IGRLLTGDRSM--IQTETLVTIGYM 822 (827)
Q Consensus 751 ---l~~~-~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-DFG-la~~~~~~~~~--~~~~~~gt~~Y~ 822 (827)
+|.. +...+..+..++|.++|+|++|||.. ++-|..--+.+..|+ |-. .||+-..+... ......-.|.||
T Consensus 275 ynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfqe~gr~y~pawm 353 (448)
T KOG0195|consen 275 YNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEVGRAYSPAWM 353 (448)
T ss_pred HHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeeeccccccCcccC
Confidence 2221 12345667889999999999999964 455555567777777 333 33333222221 111122478999
Q ss_pred ccccC
Q 047196 823 APGLL 827 (827)
Q Consensus 823 APE~l 827 (827)
+||.+
T Consensus 354 speal 358 (448)
T KOG0195|consen 354 SPEAL 358 (448)
T ss_pred CHHHH
Confidence 99964
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.23 E-value=3.1e-07 Score=106.78 Aligned_cols=123 Identities=27% Similarity=0.431 Sum_probs=76.2
Q ss_pred hcccccceEecCCceEEEEEEecC-CcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHD-GIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
.+|+..+.|..|+||.||..+.+. .+.+|+| +.++.- +.|- ++.....|.+| |.|.... ..
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-----ilRn--ilt~a~npfvv---gDc~tll-------k~ 144 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----ILRN--ILTFAGNPFVV---GDCATLL-------KN 144 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccch-----hhhc--cccccCCccee---chhhhhc-------cc
Confidence 468888999999999999998764 5668884 333221 1111 44444455554 3332110 00
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc--------------
Q 047196 754 TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS-------------- 809 (827)
Q Consensus 754 ~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~-------------- 809 (827)
.+.+ | .+.+.+++|+ |+.+|+|||+||.|++ |||+.+.......
T Consensus 145 -~g~l-P-------vdmvla~Eyl---h~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~E 212 (1205)
T KOG0606|consen 145 -IGPL-P-------VDMVLAVEYL---HSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHE 212 (1205)
T ss_pred -CCCC-c-------chhhHHhHhh---ccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHH
Confidence 0111 1 1226689999 6789999999999988 9999876321100
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
......+||+.|+||||+
T Consensus 213 f~dKqvcgTPeyiaPeVi 230 (1205)
T KOG0606|consen 213 FQDKQVCGTPEYIAPEVI 230 (1205)
T ss_pred hhhccccCCccccChhhh
Confidence 011224699999999986
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.2e-06 Score=91.33 Aligned_cols=65 Identities=25% Similarity=0.248 Sum_probs=43.1
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee--------------eecccccccCCC--ccc---cccceeccc
Q 047196 760 IFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF--------------DFGIGRLLTGDR--SMI---QTETLVTIG 820 (827)
Q Consensus 760 ~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl--------------DFGla~~~~~~~--~~~---~~~~~gt~~ 820 (827)
...+.-|..|+.+|+.|| |+++|.|||+|+.||| |||++-.-...+ -.. ....-|--.
T Consensus 340 ~r~~~~~laQlLEav~hL---~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~ 416 (598)
T KOG4158|consen 340 YRTGRVILAQLLEAVTHL---HKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAK 416 (598)
T ss_pred hHHHHHHHHHHHHHHHHH---HHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcce
Confidence 334556778888888888 5789999999999998 999763221100 001 111125667
Q ss_pred ccccccC
Q 047196 821 YMAPGLL 827 (827)
Q Consensus 821 Y~APE~l 827 (827)
-||||+.
T Consensus 417 lmAPEi~ 423 (598)
T KOG4158|consen 417 LMAPEIA 423 (598)
T ss_pred ecchhhh
Confidence 8999973
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.22 E-value=4.9e-08 Score=108.34 Aligned_cols=177 Identities=27% Similarity=0.282 Sum_probs=102.9
Q ss_pred CccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCC----------CCCCccccccccccEEecCCCcccc
Q 047196 397 PQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLA----------GSIPDQLCHLARLNTLGLAGNKFSG 466 (827)
Q Consensus 397 p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~----------g~~p~~~~~l~~L~~L~Ls~N~l~~ 466 (827)
|-.+..+.+|++|.|.++.+... -.-..--..|+.|. -+|.+. |.+-..+ ....|...+.++|++.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~~-~GL~~lr~qLe~LI-C~~Sl~Al~~v~ascggd~~ns~-~Wn~L~~a~fsyN~L~- 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLSTA-KGLQELRHQLEKLI-CHNSLDALRHVFASCGGDISNSP-VWNKLATASFSYNRLV- 177 (1096)
T ss_pred CceeccccceeeEEecCcchhhh-hhhHHHHHhhhhhh-hhccHHHHHHHHHHhccccccch-hhhhHhhhhcchhhHH-
Confidence 45567778899999988877531 00000001222222 122221 1111110 1224666677777776
Q ss_pred cCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccceeeecccccccC
Q 047196 467 SIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGD 546 (827)
Q Consensus 467 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~ 546 (827)
.+..++.-++.|+.|||++|+++... .+..++.|+.|||++|.+.-..-.....+. |+.|++++|.++.. ..+.+
T Consensus 178 ~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie~ 252 (1096)
T KOG1859|consen 178 LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTL--RGIEN 252 (1096)
T ss_pred hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhh--hhHHh
Confidence 45556666677777777777776643 566777777777777777654433444444 77777777777632 34567
Q ss_pred CCCCCEEECCCCcceeec---C-CCCcCCceEeCcCCcCe
Q 047196 547 LKDLQNISLACNGLEGLI---P-ESFGYLTELNLSFNKLE 582 (827)
Q Consensus 547 l~~L~~L~Ls~N~l~g~i---p-~~~~~L~~L~ls~N~l~ 582 (827)
+++|+.||+++|-|++.- | ..+..|..|+|.+|.+.
T Consensus 253 LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 253 LKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred hhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 777777777777776532 1 22346677777777664
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.21 E-value=8.6e-08 Score=85.35 Aligned_cols=135 Identities=18% Similarity=0.232 Sum_probs=88.2
Q ss_pred cccEEEccCCcCccccCc---cccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEE
Q 047196 381 SLENIYISNCNIGGSIPQ---LISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTL 457 (827)
Q Consensus 381 ~L~~L~Ls~N~l~g~~p~---~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 457 (827)
.+..++|++|.+- .+++ .+.....|+..+|++|.+....+..-...+.++.|+|++|.++ .+|.++..++.|+.|
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 3556777777764 2333 3344456677788888887544333345567788888888887 677778888888888
Q ss_pred ecCCCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCccc
Q 047196 458 GLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLD 519 (827)
Q Consensus 458 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~ 519 (827)
+++.|.+. ..|..+..+.++-+||..+|.+.. +|.....-+..-..++.++.+.+.-+..
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~e-id~dl~~s~~~al~~lgnepl~~~~~~k 165 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARAE-IDVDLFYSSLPALIKLGNEPLGDETKKK 165 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCcccc-CcHHHhccccHHHHHhcCCcccccCccc
Confidence 88888887 456666667778888888777763 3433333333344556666666655543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.09 E-value=2.3e-05 Score=77.20 Aligned_cols=119 Identities=19% Similarity=0.175 Sum_probs=78.2
Q ss_pred ceEecCCceEEEEEEecC-------CcEEEEEEEcccc-------------h---------HHH----HHHHHHHHHHHh
Q 047196 681 NLIGVGSFGSVYKGRLHD-------GIEVAIKVFHQNC-------------A---------MAL----KSFEAECEVMKN 727 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~~-------g~~vAvK~l~~~~-------------~---------~~~----~~~~~Ei~~l~~ 727 (827)
..||.|.-+.||.|.-.+ +..+|||+.+... . ... ...++|.+.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997543 4799999874211 0 001 123489999999
Q ss_pred cCCC--CceEEEeeeecCCceeeeeeccCC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-
Q 047196 728 IRHR--NHVKRISSCSNEDFKALDCLHSTN--------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF- 796 (827)
Q Consensus 728 l~H~--niv~~~~~~~~~~~~~l~~l~~~~--------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl- 796 (827)
+... ++-+.+++ .....+|+++.... ..++..+...+..++.+++.+++ |..+|||+|+++.||+
T Consensus 83 l~~~Gv~vP~pi~~--~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~--H~~glVHGDLs~~NIL~ 158 (197)
T cd05146 83 MQKAGIPCPEVVVL--KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLY--KECNLVHADLSEYNMLW 158 (197)
T ss_pred HHHcCCCCCeEEEe--cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHH--HhCCeecCCCCHHHEEE
Confidence 8643 33334432 55566666654321 11222234566778888888885 5678999999999998
Q ss_pred --------eeccccc
Q 047196 797 --------DFGIGRL 803 (827)
Q Consensus 797 --------DFGla~~ 803 (827)
|||.|-.
T Consensus 159 ~~~~v~iIDF~qav~ 173 (197)
T cd05146 159 HDGKVWFIDVSQSVE 173 (197)
T ss_pred ECCcEEEEECCCcee
Confidence 8887643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.07 E-value=7.9e-07 Score=96.63 Aligned_cols=68 Identities=16% Similarity=0.260 Sum_probs=53.8
Q ss_pred HhhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeee
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSC 740 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~ 740 (827)
...+|+....+|+|+||+|+.+... ++..+|||++.... .....+..+|+.-++++.|++++++...+
T Consensus 47 ~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~s~~rvl~~~~s~a~feh~g~~~~~ha~ 116 (516)
T KOG1033|consen 47 EANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREESRSRVLREVSSLAEFEHPGIKRYFHAW 116 (516)
T ss_pred hhccccccccccccCccccCCccccccchhhHHHHhcccchhhhhhhhhccccchhhhcccchhhheece
Confidence 3457888999999999999999865 45689999987543 34456778899999999999999866543
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.06 E-value=1.6e-07 Score=104.38 Aligned_cols=175 Identities=23% Similarity=0.276 Sum_probs=83.2
Q ss_pred CCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCC---ccc--cccC--------------------C------
Q 047196 120 NLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSG---SLS--SVTF--------------------N------ 168 (827)
Q Consensus 120 ~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g---~~p--~~~~--------------------~------ 168 (827)
+++.|+.+..-.-.-++ |-.+..+.+||+|.|.++.++. ..+ ..+. .
T Consensus 85 kt~~lkl~~~pa~~pt~--pi~ifpF~sLr~LElrg~~L~~~~GL~~lr~qLe~LIC~~Sl~Al~~v~ascggd~~ns~~ 162 (1096)
T KOG1859|consen 85 KTKVLKLLPSPARDPTE--PISIFPFRSLRVLELRGCDLSTAKGLQELRHQLEKLICHNSLDALRHVFASCGGDISNSPV 162 (1096)
T ss_pred hheeeeecccCCCCCCC--CceeccccceeeEEecCcchhhhhhhHHHHHhhhhhhhhccHHHHHHHHHHhccccccchh
Confidence 33334444333333333 6678899999999999998862 111 0000 0
Q ss_pred CCCCcEEEcCCCCCCCCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEE
Q 047196 169 LSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKI 248 (827)
Q Consensus 169 l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 248 (827)
...|...+.+.|.+. .-.+...+++.|+.|||++|+++.. ..+..|+.|++|||++|.+.-..--...++. |+.|
T Consensus 163 Wn~L~~a~fsyN~L~--~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L 237 (1096)
T KOG1859|consen 163 WNKLATASFSYNRLV--LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLL 237 (1096)
T ss_pred hhhHhhhhcchhhHH--hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heee
Confidence 001222333333332 1111223344556666666665532 1455556666666666665522111222222 5566
Q ss_pred EcccccccccccccccCcCCCcEEEeecccCcccCc-hhhhcCCCccEEEecCCcc
Q 047196 249 SLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVP-AAIFNMSTVKKIYLLDNSL 303 (827)
Q Consensus 249 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~n~l 303 (827)
.+++|.++.. ..+.+|++|+.|||++|-+.+.-. ..+..+..|+.|+|.+|.+
T Consensus 238 ~lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl 291 (1096)
T KOG1859|consen 238 NLRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPL 291 (1096)
T ss_pred eecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcc
Confidence 6666655421 234555666666666665544321 1123344455555555544
|
|
| >KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=97.93 E-value=2.4e-07 Score=92.97 Aligned_cols=183 Identities=23% Similarity=0.344 Sum_probs=89.7
Q ss_pred cccceecCCCCCcEEEEEcCCCCCccccCccccCCCC--CCEEECCCCCCCccCC---hhhhh-ccccceEEecCCCCCC
Q 047196 87 NWIGITCNVNSHRVTALNISSLNLQGTIPPQLGNLSS--LTTLNLSHNKLSGDIP---PSIFT-MHKLKFLDFSDNQLSG 160 (827)
Q Consensus 87 ~W~gv~C~~~~~~v~~L~L~~~~l~g~~~~~l~~L~~--L~~L~Ls~N~l~g~~p---~~~~~-l~~L~~LdLs~N~l~g 160 (827)
+|.|..-+. .--+.+|+.+..|. |..++.+.. ...+.+..--+ ..| +.+.- =++|++||||+-.++.
T Consensus 127 Rfyr~~~de--~lW~~lDl~~r~i~---p~~l~~l~~rgV~v~Rlar~~~--~~prlae~~~~frsRlq~lDLS~s~it~ 199 (419)
T KOG2120|consen 127 RFYRLASDE--SLWQTLDLTGRNIH---PDVLGRLLSRGVIVFRLARSFM--DQPRLAEHFSPFRSRLQHLDLSNSVITV 199 (419)
T ss_pred HHhhccccc--cceeeeccCCCccC---hhHHHHHHhCCeEEEEcchhhh--cCchhhhhhhhhhhhhHHhhcchhheeH
Confidence 566655443 35778888877665 333333322 22233332111 112 11111 1347777777766653
Q ss_pred c-cccccCCCCCCcEEEcCCCCCCCCcchhHhhccccccEEEeeccc-cccc-CCccCCCCCCCcEEEccCCCCcccCCC
Q 047196 161 S-LSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNM-FHGQ-IPLALSKCKRLQLLNLGFKKLSGAIPK 237 (827)
Q Consensus 161 ~-~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~~L~Ls~N~-l~~~-~p~~l~~l~~L~~L~L~~n~l~~~~p~ 237 (827)
. +-..+...+.|+.|.|.++.+...|-..+.... +|+.|+|+.+. |+.. ..--+.+|+.|+.|+|+.+.++...-.
T Consensus 200 stl~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~-~L~~lnlsm~sG~t~n~~~ll~~scs~L~~LNlsWc~l~~~~Vt 278 (419)
T KOG2120|consen 200 STLHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNS-NLVRLNLSMCSGFTENALQLLLSSCSRLDELNLSWCFLFTEKVT 278 (419)
T ss_pred HHHHHHHHHHHhhhhccccccccCcHHHHHHhccc-cceeeccccccccchhHHHHHHHhhhhHhhcCchHhhccchhhh
Confidence 2 222234455566666666666655555555433 67777777553 2211 112245677777777777766533211
Q ss_pred -cCcCC-ccccEEEccccc--c-cccccccccCcCCCcEEEeecc
Q 047196 238 -EISNL-TILRKISLRNNK--L-RGEIPHEIGYLPNLENLVLGFN 277 (827)
Q Consensus 238 -~~~~l-~~L~~L~Ls~N~--l-~~~~p~~~~~l~~L~~L~Ls~N 277 (827)
.+.+. .+|+.|+|++.. + ...+..-...+++|.+||||.|
T Consensus 279 v~V~hise~l~~LNlsG~rrnl~~sh~~tL~~rcp~l~~LDLSD~ 323 (419)
T KOG2120|consen 279 VAVAHISETLTQLNLSGYRRNLQKSHLSTLVRRCPNLVHLDLSDS 323 (419)
T ss_pred HHHhhhchhhhhhhhhhhHhhhhhhHHHHHHHhCCceeeeccccc
Confidence 11111 345666666542 1 1122222345566666666654
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=97.90 E-value=3.3e-06 Score=84.89 Aligned_cols=85 Identities=24% Similarity=0.280 Sum_probs=47.4
Q ss_pred CccccEEEcccccccc--cccccccCcCCCcEEEeecccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCcc
Q 047196 242 LTILRKISLRNNKLRG--EIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVE 319 (827)
Q Consensus 242 l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~ 319 (827)
.+.++.|||.+|.|+. ++-.-+.++|.|++|+|+.|++...|...-..+.+|+.|-+.+..+.-.........+|.++
T Consensus 70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vt 149 (418)
T KOG2982|consen 70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVT 149 (418)
T ss_pred hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhh
Confidence 4667778888887762 33334567788888888888776554322234455666655554443222222222444455
Q ss_pred EEeCcCC
Q 047196 320 RLNLGLN 326 (827)
Q Consensus 320 ~L~L~~N 326 (827)
.|.++.|
T Consensus 150 elHmS~N 156 (418)
T KOG2982|consen 150 ELHMSDN 156 (418)
T ss_pred hhhhccc
Confidence 5555544
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=97.89 E-value=4.1e-06 Score=84.29 Aligned_cols=85 Identities=22% Similarity=0.290 Sum_probs=44.2
Q ss_pred CCCCCEEECCCCCCCc--cCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcCCCCCCCCcchhHhhcccccc
Q 047196 121 LSSLTTLNLSHNKLSG--DIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLK 198 (827)
Q Consensus 121 L~~L~~L~Ls~N~l~g--~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~ 198 (827)
.+.++.|||.+|.|+. .+-.-+.+|+.|++|+||.|.++..|-..-..+.+|++|-|.+..++=.--.++..-++.++
T Consensus 70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vt 149 (418)
T KOG2982|consen 70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVT 149 (418)
T ss_pred hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhh
Confidence 4566666777776653 23333456677777777777776554433344445555555554443222222223334555
Q ss_pred EEEeecc
Q 047196 199 VLFLAKN 205 (827)
Q Consensus 199 ~L~Ls~N 205 (827)
.|++|.|
T Consensus 150 elHmS~N 156 (418)
T KOG2982|consen 150 ELHMSDN 156 (418)
T ss_pred hhhhccc
Confidence 5555555
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.86 E-value=1.4e-05 Score=57.98 Aligned_cols=37 Identities=35% Similarity=0.704 Sum_probs=30.3
Q ss_pred CCCCEEECCCCCCCccCChhhhhccccceEEecCCCCC
Q 047196 122 SSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLS 159 (827)
Q Consensus 122 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~ 159 (827)
++|++|+|++|+|+ .+|+.+++|++|++||+++|+|+
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 47889999999998 67778899999999999999887
|
... |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=97.85 E-value=1.3e-05 Score=78.51 Aligned_cols=58 Identities=24% Similarity=0.246 Sum_probs=44.8
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee--------eecccccccCCCccccccceeccccccccc
Q 047196 755 NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF--------DFGIGRLLTGDRSMIQTETLVTIGYMAPGL 826 (827)
Q Consensus 755 ~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl--------DFGla~~~~~~~~~~~~~~~gt~~Y~APE~ 826 (827)
...+++.+...|+.|+++||+|||..+ ||+||+ .||+++..... ...||+.|||||+
T Consensus 11 ~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~fG~~~~~~~~------~~~g~~~y~aPE~ 75 (176)
T smart00750 11 GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKLDGSVAFKTPE------QSRVDPYFMAPEV 75 (176)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceeeccceEeeccc------cCCCcccccChHH
Confidence 345789999999999999999997543 999998 37776654322 1258999999997
Q ss_pred C
Q 047196 827 L 827 (827)
Q Consensus 827 l 827 (827)
+
T Consensus 76 ~ 76 (176)
T smart00750 76 I 76 (176)
T ss_pred h
Confidence 4
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00012 Score=74.55 Aligned_cols=99 Identities=13% Similarity=0.167 Sum_probs=68.0
Q ss_pred ceEecCCceEEEEEEecCCcEEEEEEEcccch-HHHHHHHHHHHHHHhcCCCC--ceEEEeeeecCC-----ceeeeeec
Q 047196 681 NLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCA-MALKSFEAECEVMKNIRHRN--HVKRISSCSNED-----FKALDCLH 752 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H~n--iv~~~~~~~~~~-----~~~l~~l~ 752 (827)
+.++.|.++.||+++..+|+.+++|....... .....+.+|+++++.+++.. +.+++.++.... +.+++++.
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999887778999998754322 13456889999999998644 455666665422 34444443
Q ss_pred cCC-------CCCCHHHHHHHHHHHHHHHHHHHh
Q 047196 753 STN-------CSLNIFDKLNIMIDVASALEYLHF 779 (827)
Q Consensus 753 ~~~-------~~l~~~~~~~i~~~ia~~L~~Lh~ 779 (827)
... ..++..++..++.++++++.++|.
T Consensus 84 G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~ 117 (223)
T cd05154 84 GRVLRDRLLRPELSPEERRALARALADTLAALHS 117 (223)
T ss_pred CEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhC
Confidence 321 123445667788888888888883
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.78 E-value=3.2e-06 Score=75.54 Aligned_cols=112 Identities=21% Similarity=0.252 Sum_probs=71.4
Q ss_pred cccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecC
Q 047196 381 SLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLA 460 (827)
Q Consensus 381 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 460 (827)
.|+..+|++|.+....+..-...+.++.|+|++|+++ .+|..+..++.|+.|+++.|.+. ..|.-+..+.++-.|+..
T Consensus 54 el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~ 131 (177)
T KOG4579|consen 54 ELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSP 131 (177)
T ss_pred eEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCC
Confidence 4555677777776444444444557777777777777 46666777777777777777776 456666667777777777
Q ss_pred CCcccccCCccccCCCCCCccccCCCcccccCCcc
Q 047196 461 GNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPST 495 (827)
Q Consensus 461 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 495 (827)
+|... .+|..+---+..-..++.++.+.+.-|..
T Consensus 132 ~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~k 165 (177)
T KOG4579|consen 132 ENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKK 165 (177)
T ss_pred CCccc-cCcHHHhccccHHHHHhcCCcccccCccc
Confidence 77775 45544322233334456677776655543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.74 E-value=7e-06 Score=95.30 Aligned_cols=150 Identities=23% Similarity=0.271 Sum_probs=103.1
Q ss_pred cccccceEecCCceEEEEEEec--CCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcC-CCCceEEEeeeecCCceeeee
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH--DGIEVAIKVFHQNC--AMALKSFEAECEVMKNIR-HRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~--~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~l~~ 750 (827)
.|...+.||+|+|+.|-..... ....+|+|.+.... .....+...|..+-+.+. |+|++..++...+.++.++..
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 4566677999999999888653 34567777765432 223344555777777777 999999999887766555422
Q ss_pred eccC-----------CC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------eecccccccC-
Q 047196 751 LHST-----------NC-SLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRLLTG- 806 (827)
Q Consensus 751 l~~~-----------~~-~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGla~~~~~- 806 (827)
-+.. .. .........+..++..++.|+|- ..++.|||+||+|.+ |||+|..+..
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 1111 11 22334455677888899999942 778999999999976 9999988765
Q ss_pred CCc-ccccccee-cccccccccC
Q 047196 807 DRS-MIQTETLV-TIGYMAPGLL 827 (827)
Q Consensus 807 ~~~-~~~~~~~g-t~~Y~APE~l 827 (827)
++. ......+| ++.|+|||+.
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~ 201 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHL 201 (601)
T ss_pred CCcceeeecccCCCCCCCCcccc
Confidence 322 22233458 9999999973
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.70 E-value=3.8e-05 Score=55.71 Aligned_cols=37 Identities=38% Similarity=0.635 Sum_probs=23.9
Q ss_pred cccEEEcccccccccccccccCcCCCcEEEeecccCcc
Q 047196 244 ILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVG 281 (827)
Q Consensus 244 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 281 (827)
+|++|++++|+|+ .+|+.+++|++|++|++++|+++.
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~~ 38 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPISD 38 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCSB
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCCC
Confidence 5667777777776 456667777777777777777663
|
... |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00022 Score=68.06 Aligned_cols=119 Identities=18% Similarity=0.304 Sum_probs=74.2
Q ss_pred ceEecCCceEEEEEEecCCcEEEEEEE-cccc--h-----HHHHHHHHHHHHHHhcCCCCceEEEeeeecCC--ceeeee
Q 047196 681 NLIGVGSFGSVYKGRLHDGIEVAIKVF-HQNC--A-----MALKSFEAECEVMKNIRHRNHVKRISSCSNED--FKALDC 750 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~~g~~vAvK~l-~~~~--~-----~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~--~~~l~~ 750 (827)
..+++|+-+.+|.+.+. |..+.+|.- ++.- + -...+-.+|++++++++---+-...-+..+++ ...|++
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999775 345666643 2211 1 12356788999999987543333222333333 355565
Q ss_pred eccCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------eeccccc
Q 047196 751 LHSTNCS-LNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---------DFGIGRL 803 (827)
Q Consensus 751 l~~~~~~-l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---------DFGla~~ 803 (827)
+...... .-+..+..++..|-..+.-| |..+|+|+|+.++||+ |||++..
T Consensus 81 I~G~~lkd~l~~~~~~~~r~vG~~vg~l---H~~givHGDLTtsNiIl~~~~i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEARPDLLREVGRLVGKL---HKAGIVHGDLTTSNIILSGGRIYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhcchHHHHHHHHHHHHH---HhcCeecCCCccceEEEeCCcEEEEECCcccc
Confidence 5443211 01111345666676677777 6789999999999987 9999975
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.0003 Score=69.09 Aligned_cols=112 Identities=19% Similarity=0.269 Sum_probs=68.9
Q ss_pred EEEEEEecCCcEEEEEEEcccc--------------h------------HHHHHHHHHHHHHHhcCCCCc-eEEEeeeec
Q 047196 690 SVYKGRLHDGIEVAIKVFHQNC--------------A------------MALKSFEAECEVMKNIRHRNH-VKRISSCSN 742 (827)
Q Consensus 690 ~Vy~~~~~~g~~vAvK~l~~~~--------------~------------~~~~~~~~Ei~~l~~l~H~ni-v~~~~~~~~ 742 (827)
-||.|...+|..||||..+... . ......++|.+.|.++....+ |+-. +...
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p-~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKP-YDYN 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--E-EEEE
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcE-EEEe
Confidence 3899998889999999975311 0 012357789999999987754 3332 2334
Q ss_pred CCceeeeeeccCCCCCC--------HHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------eecccccc
Q 047196 743 EDFKALDCLHSTNCSLN--------IFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---------DFGIGRLL 804 (827)
Q Consensus 743 ~~~~~l~~l~~~~~~l~--------~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---------DFGla~~~ 804 (827)
....+|+++...+..+. ..+...+..++.+.+..++ |..+|+|+|+.+.||+ |||.|...
T Consensus 80 ~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~--~~~givHGDLs~~NIlv~~~~~~iIDf~qav~~ 156 (188)
T PF01163_consen 80 RNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKML--HKAGIVHGDLSEYNILVDDGKVYIIDFGQAVDS 156 (188)
T ss_dssp TTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHH--HCTTEEESS-STTSEEEETTCEEE--GTTEEET
T ss_pred CCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHH--HhcCceecCCChhhEEeecceEEEEecCcceec
Confidence 66667777762221111 1224456667777566654 5779999999999998 88877544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.58 E-value=2.2e-05 Score=92.13 Aligned_cols=94 Identities=20% Similarity=0.232 Sum_probs=67.4
Q ss_pred CcchhHhhccccccEEEeecccccc-cCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccc-ccccc
Q 047196 185 ELPVNICNYLHYLKVLFLAKNMFHG-QIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRG-EIPHE 262 (827)
Q Consensus 185 ~ip~~~~~~~~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~ 262 (827)
..|..++..+|+|+.|.+++=.+.. .+-....++++|..||+|+.+++.. ..++++++|+.|.+.+=.+.. ..-..
T Consensus 138 ~W~~kig~~LPsL~sL~i~~~~~~~~dF~~lc~sFpNL~sLDIS~TnI~nl--~GIS~LknLq~L~mrnLe~e~~~~l~~ 215 (699)
T KOG3665|consen 138 GWPKKIGTMLPSLRSLVISGRQFDNDDFSQLCASFPNLRSLDISGTNISNL--SGISRLKNLQVLSMRNLEFESYQDLID 215 (699)
T ss_pred cHHHHHhhhCcccceEEecCceecchhHHHHhhccCccceeecCCCCccCc--HHHhccccHHHHhccCCCCCchhhHHH
Confidence 5777888888899999998866643 2223345788888999998888744 567888888888888766642 22235
Q ss_pred ccCcCCCcEEEeecccCc
Q 047196 263 IGYLPNLENLVLGFNNLV 280 (827)
Q Consensus 263 ~~~l~~L~~L~Ls~N~l~ 280 (827)
+.+|++|++||+|.....
T Consensus 216 LF~L~~L~vLDIS~~~~~ 233 (699)
T KOG3665|consen 216 LFNLKKLRVLDISRDKNN 233 (699)
T ss_pred HhcccCCCeeeccccccc
Confidence 667888888888876543
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.58 E-value=1.6e-05 Score=79.01 Aligned_cols=136 Identities=20% Similarity=0.144 Sum_probs=65.6
Q ss_pred CCCCcEEEccCCCCcccCC----CcCcCCccccEEEccccccccc-----ccccccCcCCCcEEEeecccCcccC----c
Q 047196 218 CKRLQLLNLGFKKLSGAIP----KEISNLTILRKISLRNNKLRGE-----IPHEIGYLPNLENLVLGFNNLVGVV----P 284 (827)
Q Consensus 218 l~~L~~L~L~~n~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~~----p 284 (827)
-+.|+....+.|++..-.- ..+..-..|+.+.+..|.|.-. +--.+..+.+|+.|||..|-++-.- .
T Consensus 156 kp~Le~vicgrNRlengs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La 235 (388)
T COG5238 156 KPKLEVVICGRNRLENGSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLA 235 (388)
T ss_pred CCCceEEEeccchhccCcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHH
Confidence 3456666666665531100 0011113456666666655411 0112334566666666666654321 1
Q ss_pred hhhhcCCCccEEEecCCccccccChhhh-----cCCCCccEEeCcCCccccccCcc------c-cCCCCCcEEEcCCCcc
Q 047196 285 AAIFNMSTVKKIYLLDNSLLGSFSLGID-----LSLPNVERLNLGLNRFSGTIPSF------I-TNASKLVYLDMGTNSF 352 (827)
Q Consensus 285 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~p~~------~-~~l~~L~~L~Ls~N~l 352 (827)
..+...+.|+.|.+.+|-++..-...+. ...|+|..|-..+|...+.+-.. . .+++-|..|.+.+|.+
T Consensus 236 ~al~~W~~lrEL~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~~i~~~~l~~~e~~~~p~L~~le~ngNr~ 315 (388)
T COG5238 236 DALCEWNLLRELRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGGIILDISLNEFEQDAVPLLVDLERNGNRI 315 (388)
T ss_pred HHhcccchhhhccccchhhccccHHHHHHHhhhhcCCCccccccchhhhcCceeeeechhhhhhcccHHHHHHHHccCcc
Confidence 2233344466666666655432111111 23567777777777665432111 1 2456666777777776
Q ss_pred e
Q 047196 353 S 353 (827)
Q Consensus 353 ~ 353 (827)
.
T Consensus 316 ~ 316 (388)
T COG5238 316 K 316 (388)
T ss_pred h
Confidence 5
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00059 Score=64.88 Aligned_cols=121 Identities=18% Similarity=0.252 Sum_probs=79.7
Q ss_pred ccceEecCCceEEEEEEecCCcEEEEEE-Ecccc-------hHHHHHHHHHHHHHHhcCCCCceEEEee-e-ecCCceee
Q 047196 679 KENLIGVGSFGSVYKGRLHDGIEVAIKV-FHQNC-------AMALKSFEAECEVMKNIRHRNHVKRISS-C-SNEDFKAL 748 (827)
Q Consensus 679 ~~~~iG~G~fg~Vy~~~~~~g~~vAvK~-l~~~~-------~~~~~~~~~Ei~~l~~l~H~niv~~~~~-~-~~~~~~~l 748 (827)
...++-+|+-+.|+++.+. |+...||. +.+.. +-..++..+|++++.+++--.|....-+ + ...+..+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4578999999999999886 56666664 33221 1134678899999999874433322222 2 33556677
Q ss_pred eeeccCCC-----------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------eeccccc
Q 047196 749 DCLHSTNC-----------SLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------DFGIGRL 803 (827)
Q Consensus 749 ~~l~~~~~-----------~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------------DFGla~~ 803 (827)
++++.... ..........+..+-+.+.-| |...|||+||-.+||+ |||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igkl---H~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKL---HDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHh---hhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 77654211 111111246777777788888 5778999999999987 9998754
|
|
| >KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=97.57 E-value=3.1e-06 Score=85.13 Aligned_cols=57 Identities=19% Similarity=0.159 Sum_probs=28.3
Q ss_pred ccEEEcccccccc-cccccccCcCCCcEEEeecccCcccCchhhhcCCCccEEEecCC
Q 047196 245 LRKISLRNNKLRG-EIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDN 301 (827)
Q Consensus 245 L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n 301 (827)
|++|||++..|+. .+...+..+.+|+.|.|.++++...+-..+..-.+|+.++++.+
T Consensus 187 lq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~ 244 (419)
T KOG2120|consen 187 LQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMC 244 (419)
T ss_pred hHHhhcchhheeHHHHHHHHHHHHhhhhccccccccCcHHHHHHhccccceeeccccc
Confidence 5555555554431 12223344555555555555555555555555555555555443
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.52 E-value=5.3e-05 Score=75.52 Aligned_cols=114 Identities=16% Similarity=0.049 Sum_probs=64.4
Q ss_pred CCccccEEEcccccccccccc-----cccCcCCCcEEEeecccCccc-----CchhhhcCCCccEEEecCCccccccChh
Q 047196 241 NLTILRKISLRNNKLRGEIPH-----EIGYLPNLENLVLGFNNLVGV-----VPAAIFNMSTVKKIYLLDNSLLGSFSLG 310 (827)
Q Consensus 241 ~l~~L~~L~Ls~N~l~~~~p~-----~~~~l~~L~~L~Ls~N~l~~~-----~p~~~~~l~~L~~L~l~~n~l~~~~~~~ 310 (827)
+-+.|+......|++.. .|. .+..-.+|+++.+..|.|.-. +-..++.+.+|+.|++.+|.++-.-...
T Consensus 155 ~kp~Le~vicgrNRlen-gs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~ 233 (388)
T COG5238 155 DKPKLEVVICGRNRLEN-GSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRY 233 (388)
T ss_pred cCCCceEEEeccchhcc-CcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHH
Confidence 44668888888887742 121 122235778888888866421 1112345678888888888776332221
Q ss_pred hh---cCCCCccEEeCcCCccccccCcc----c--cCCCCCcEEEcCCCcceee
Q 047196 311 ID---LSLPNVERLNLGLNRFSGTIPSF----I--TNASKLVYLDMGTNSFSGI 355 (827)
Q Consensus 311 ~~---~~l~~L~~L~L~~N~l~~~~p~~----~--~~l~~L~~L~Ls~N~l~g~ 355 (827)
+. ...+.|+.|.+..|-++..-... | ...++|..|-..+|...+.
T Consensus 234 La~al~~W~~lrEL~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~ 287 (388)
T COG5238 234 LADALCEWNLLRELRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGG 287 (388)
T ss_pred HHHHhcccchhhhccccchhhccccHHHHHHHhhhhcCCCccccccchhhhcCc
Confidence 11 23455788887777665322211 1 1235667777777766543
|
|
| >PRK15386 type III secretion protein GogB; Provisional | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00025 Score=76.93 Aligned_cols=32 Identities=19% Similarity=0.184 Sum_probs=16.8
Q ss_pred CCCCccccCCCcccccCCccccccccccccCCCCC
Q 047196 476 TSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSN 510 (827)
Q Consensus 476 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N 510 (827)
++|++|++++|.... .|..+. .+|+.|+++.|
T Consensus 156 sSLk~L~Is~c~~i~-LP~~LP--~SLk~L~ls~n 187 (426)
T PRK15386 156 PSLKTLSLTGCSNII-LPEKLP--ESLQSITLHIE 187 (426)
T ss_pred CcccEEEecCCCccc-Cccccc--ccCcEEEeccc
Confidence 456666666665442 232222 35666666655
|
|
| >PRK15386 type III secretion protein GogB; Provisional | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0003 Score=76.30 Aligned_cols=32 Identities=19% Similarity=0.335 Sum_probs=18.6
Q ss_pred ccccEEEcccccccccccccccCcCCCcEEEeecc
Q 047196 243 TILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFN 277 (827)
Q Consensus 243 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 277 (827)
++|++|++++|... .+|+.+- .+|+.|+++.|
T Consensus 156 sSLk~L~Is~c~~i-~LP~~LP--~SLk~L~ls~n 187 (426)
T PRK15386 156 PSLKTLSLTGCSNI-ILPEKLP--ESLQSITLHIE 187 (426)
T ss_pred CcccEEEecCCCcc-cCccccc--ccCcEEEeccc
Confidence 45777777766644 3343332 46777777665
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.00022 Score=79.48 Aligned_cols=148 Identities=27% Similarity=0.262 Sum_probs=90.1
Q ss_pred ccccceEec--CCceEEEEEEe---cCCcEEEEEEEcc--cchHHHHHHHHHHHHHHhcC-CCCceEEEeeeecCCceee
Q 047196 677 FSKENLIGV--GSFGSVYKGRL---HDGIEVAIKVFHQ--NCAMALKSFEAECEVMKNIR-HRNHVKRISSCSNEDFKAL 748 (827)
Q Consensus 677 ~~~~~~iG~--G~fg~Vy~~~~---~~g~~vAvK~l~~--~~~~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~l 748 (827)
|....-+|. |.+|.||.++. .++..+|+|+=+. ........=.+|+.-..+++ |+|.|+......+.+..++
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfi 195 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFI 195 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCccee
Confidence 445567899 99999999975 4688899998322 11222223356676666665 8999996666555554444
Q ss_pred eeeccC----------CCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEEccCCCccee-----------eeccccc
Q 047196 749 DCLHST----------NCSLNIFDKLNIMIDVAS----ALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRL 803 (827)
Q Consensus 749 ~~l~~~----------~~~l~~~~~~~i~~~ia~----~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGla~~ 803 (827)
+..... ...+.......+..+..+ |+.++ |...|+|-|+||.||+ |||+...
T Consensus 196 qtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~---hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~ 272 (524)
T KOG0601|consen 196 QTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHL---HSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSK 272 (524)
T ss_pred eeccccchhHHhhhcccccCCchhhhhHHhhhhhccccccccc---CCCcccccccchhheecccccceeecCCcceeEE
Confidence 222111 111122223344444444 55555 7889999999999998 8888776
Q ss_pred ccCCCccc--c-ccc-eecccccccccC
Q 047196 804 LTGDRSMI--Q-TET-LVTIGYMAPGLL 827 (827)
Q Consensus 804 ~~~~~~~~--~-~~~-~gt~~Y~APE~l 827 (827)
+....-.. . ... .|-.-|+|||.+
T Consensus 273 i~~~~~~~~~~~~~r~~~~~~Y~~ke~~ 300 (524)
T KOG0601|consen 273 ISDGNFSSVFKVSKRPEGDCIYAAKELL 300 (524)
T ss_pred ccCCccccceeeeecCCCCceEeChhhh
Confidence 65432110 0 011 356679999963
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.00035 Score=77.78 Aligned_cols=101 Identities=26% Similarity=0.349 Sum_probs=70.6
Q ss_pred HHhcCCCCceEEEeeeecCCceeeeeec-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCc
Q 047196 725 MKNIRHRNHVKRISSCSNEDFKALDCLH-----------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPK 793 (827)
Q Consensus 725 l~~l~H~niv~~~~~~~~~~~~~l~~l~-----------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~ 793 (827)
|+.++|.|+.+++|.|.++......+-+ .....++|.-...+.++++.|++|+| +++--.|+.+++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh--~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH--NSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh--cCcceeeeeeccc
Confidence 3568899999999999887544432222 22345788888899999999999997 4554599999999
Q ss_pred cee----------eecccccccCCCc-cccccceecccccccccC
Q 047196 794 NVF----------DFGIGRLLTGDRS-MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 794 NIl----------DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~l 827 (827)
|.+ |||+..+...... .......-..-|.|||++
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPell 123 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELL 123 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHh
Confidence 976 9999887643111 011111124568999974
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 827 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 9e-37 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-36 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-21 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-14 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-08 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-08 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-08 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-08 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-08 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-08 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-07 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-07 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-07 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-07 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-07 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-07 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-07 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-07 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-07 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-07 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-07 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-07 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-07 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-07 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-07 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-07 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-07 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-07 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-07 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-07 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-07 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-06 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-06 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-06 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-06 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-06 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-06 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-06 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-06 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-06 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-06 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-06 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-06 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-06 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-06 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-06 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-05 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-05 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-05 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-05 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-05 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-05 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-05 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-05 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-05 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-05 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-05 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-05 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-05 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-05 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-05 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-05 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-05 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-05 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-05 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-05 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-05 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-05 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-05 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-05 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-05 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-05 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-05 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-05 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-05 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-05 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-05 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-05 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-05 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-05 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-05 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-05 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-05 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-05 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-05 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-05 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-05 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-05 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-05 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-05 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-05 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-05 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-05 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-05 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-05 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-05 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-05 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-05 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-05 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-05 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-05 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-05 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-05 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-05 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-05 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-05 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 9e-05 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-04 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-04 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-04 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-04 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-04 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-04 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-04 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-04 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-04 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-04 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-04 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-04 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-04 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-04 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-04 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-04 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-04 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-04 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-04 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-04 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-04 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-04 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 3e-04 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-04 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-04 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-04 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-04 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-04 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-04 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-04 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-04 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-04 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-04 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-04 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-04 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-04 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-04 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-04 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-04 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-04 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-04 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-04 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 4e-04 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-04 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-04 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 4e-04 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-04 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-04 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-04 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-04 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-04 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-04 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-04 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-04 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-04 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-04 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-04 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-04 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-04 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-04 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-04 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-04 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-04 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-04 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-04 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-04 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-04 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-04 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-04 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-04 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 8e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-04 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-04 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-04 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 827 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-136 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-135 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-116 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-86 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-70 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 8e-60 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 2e-80 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 3e-58 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-75 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-69 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-68 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-56 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-12 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 5e-08 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 7e-73 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-71 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-64 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-56 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-61 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-59 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-56 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 4e-53 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-44 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 5e-04 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 5e-56 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-48 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 9e-48 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-39 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 6e-23 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-46 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-44 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-37 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-23 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 8e-45 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-42 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 5e-43 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 5e-38 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 3e-17 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-42 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 3e-41 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 5e-28 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-40 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 5e-39 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 7e-34 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 6e-31 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 3e-37 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 9e-32 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 8e-24 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 9e-24 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 1e-20 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 6e-36 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 2e-34 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-33 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-33 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-32 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-32 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 3e-06 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 4e-33 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 8e-32 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 6e-28 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-11 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 7e-09 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-32 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-30 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 4e-32 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 1e-31 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 2e-24 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 6e-24 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 5e-19 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 3e-13 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-30 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 3e-30 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 4e-15 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 2e-30 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 4e-30 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 7e-30 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 5e-28 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 8e-16 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 8e-12 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 6e-29 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-25 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 6e-25 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-24 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-24 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-22 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 9e-29 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 1e-28 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 2e-28 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 2e-27 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 8e-25 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 6e-13 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 3e-04 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 2e-28 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 6e-28 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 6e-28 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-27 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-26 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 6e-25 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 5e-23 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 3e-22 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-18 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-14 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 7e-28 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-27 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 2e-27 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 8e-27 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 1e-26 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 3e-26 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 5e-21 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-17 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-04 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 3e-25 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-19 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-18 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-16 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 3e-14 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 8e-25 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 2e-24 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 2e-24 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 1e-23 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 1e-23 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-22 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-22 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-20 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-13 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 4e-11 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 2e-22 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 7e-21 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 5e-19 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 2e-18 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 1e-17 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-13 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 5e-22 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-20 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 3e-20 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 2e-18 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 2e-17 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 5e-22 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 2e-20 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 2e-20 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 2e-17 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 7e-10 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-21 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 5e-21 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-18 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 4e-16 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-12 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 6e-21 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 4e-19 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 1e-18 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 7e-18 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 3e-12 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 2e-09 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 2e-06 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 9e-21 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 6e-18 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 3e-16 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-19 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 2e-19 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 3e-19 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 3e-19 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 4e-19 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 3e-16 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-11 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 5e-04 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 3e-19 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 5e-19 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 1e-18 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 7e-16 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 7e-16 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 3e-19 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 6e-19 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 8e-19 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-18 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-18 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 2e-18 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 2e-18 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 2e-18 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 3e-18 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 4e-18 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 8e-18 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 9e-18 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 1e-17 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 1e-17 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 1e-17 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 1e-17 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 2e-17 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-17 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 3e-17 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 3e-17 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 4e-17 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 5e-16 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 4e-15 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 8e-15 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-14 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-12 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 2e-16 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 3e-16 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 3e-16 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 4e-16 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 7e-16 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 8e-16 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 9e-16 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 1e-15 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 1e-15 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 1e-15 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 1e-15 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-15 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-15 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 2e-15 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-15 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-15 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-14 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-09 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 2e-15 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-15 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 2e-15 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 3e-15 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 3e-15 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 1e-14 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-14 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-12 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 3e-12 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-11 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 1e-08 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 3e-15 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 4e-15 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 5e-15 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 7e-15 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 7e-15 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 8e-15 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 7e-13 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 7e-13 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 2e-10 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 4e-10 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 9e-15 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 6e-14 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 1e-13 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 4e-13 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 5e-09 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 9e-15 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 1e-14 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-14 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 1e-14 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 1e-14 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 2e-14 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 2e-14 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 2e-14 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 3e-14 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 1e-13 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 3e-13 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 1e-12 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 3e-14 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 1e-10 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-07 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 3e-07 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 1e-05 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 4e-14 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 5e-14 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 8e-14 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 4e-13 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 9e-13 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 8e-12 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 3e-07 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 3e-04 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 6e-14 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 7e-14 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 8e-14 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 1e-13 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 1e-13 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-13 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 7e-13 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-11 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 6e-08 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 2e-13 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 2e-13 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 3e-13 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 4e-13 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 5e-13 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 7e-13 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 8e-13 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 1e-12 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 2e-12 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-12 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-12 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 5e-11 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 6e-09 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-12 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 3e-12 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 4e-09 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 7e-07 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-04 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 5e-04 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 4e-12 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 1e-11 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-08 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 3e-08 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 8e-08 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-05 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 6e-05 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-04 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 4e-12 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 4e-12 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 6e-12 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-11 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 1e-10 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-10 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 7e-10 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 6e-12 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 6e-12 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 6e-09 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 3e-07 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 3e-05 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 7e-12 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 9e-12 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-11 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 1e-11 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 1e-11 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 1e-11 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 1e-11 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 2e-11 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 2e-11 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 2e-11 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 2e-11 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 2e-11 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 2e-11 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 2e-11 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 3e-11 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 3e-11 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 3e-11 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 4e-11 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 5e-11 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 5e-11 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 7e-11 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 8e-11 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-09 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 2e-07 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 3e-07 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 2e-05 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 9e-11 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 1e-10 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 1e-10 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 1e-10 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-10 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 2e-10 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 2e-10 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 2e-10 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-10 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 3e-10 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 3e-10 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 4e-10 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 4e-10 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 4e-10 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 4e-10 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 5e-10 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 1e-08 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 5e-06 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 6e-10 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 7e-10 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 7e-08 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 5e-04 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 7e-10 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 8e-10 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 9e-10 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 9e-10 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 9e-10 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-09 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 1e-09 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 1e-09 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 2e-08 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 8e-08 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 6e-04 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 9e-04 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 1e-09 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 2e-09 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-09 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 3e-09 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 4e-09 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 4e-09 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 5e-09 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 5e-09 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 5e-09 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 5e-09 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 6e-09 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 6e-09 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 3e-06 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 5e-04 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 6e-09 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 7e-09 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 8e-09 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 9e-09 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 9e-09 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 1e-08 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 1e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-05 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 1e-08 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 1e-08 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 5e-05 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-08 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 2e-08 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 2e-04 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 2e-08 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 2e-08 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-08 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 1e-07 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 8e-07 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 6e-06 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 3e-08 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 3e-08 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 2e-07 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 2e-06 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 2e-05 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 4e-08 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-06 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-05 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 4e-08 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 5e-08 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 5e-08 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 5e-08 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 5e-08 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 6e-08 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 7e-08 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 7e-08 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-07 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 1e-07 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 1e-07 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 7e-07 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 2e-04 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 1e-07 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 1e-07 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 2e-07 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 2e-07 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-07 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 2e-07 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 3e-07 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 3e-07 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 4e-07 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 4e-07 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 4e-07 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 5e-07 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 5e-07 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 6e-07 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 6e-07 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 6e-07 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 7e-07 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 7e-07 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 8e-07 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 9e-07 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 1e-06 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 1e-06 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-06 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-06 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 2e-06 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 2e-06 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 2e-06 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 3e-06 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 3e-06 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-06 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-04 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 4e-06 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-06 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 8e-05 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 6e-06 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 4e-04 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 7e-06 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 1e-05 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 1e-05 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 1e-05 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 2e-05 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 2e-05 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 2e-05 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 2e-05 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 2e-05 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 3e-05 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 3e-05 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 3e-05 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 4e-05 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 5e-05 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 5e-05 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 9e-05 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 9e-05 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 8e-04 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-04 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 2e-04 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 2e-04 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 2e-04 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 3e-04 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 4e-04 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 7e-04 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 422 bits (1086), Expect = e-136
Identities = 158/574 (27%), Positives = 242/574 (42%), Gaps = 87/574 (15%)
Query: 96 NSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSD 155
+ L++SS N IP LG+ S+L L++S NKLSGD +I T +LK L+ S
Sbjct: 198 RCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISS 256
Query: 156 NQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLAL 215
NQ G + L S+ + L +K +GE+P + L L L+ N F+G +P
Sbjct: 257 NQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFF 314
Query: 216 SKCKRLQLLNLGFKKLSGAIPKE-ISNLTILRKISLRNNKLRGEIPHEIGYL-PNLENLV 273
C L+ L L SG +P + + + L+ + L N+ GE+P + L +L L
Sbjct: 315 GSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLD 374
Query: 274 LGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIP 333
L NN G + + ++ L L N F+G IP
Sbjct: 375 LSSNNFSGPILPNLCQ-----------------------NPKNTLQELYLQNNGFTGKIP 411
Query: 334 SFITNASKLVYLDMGTNSFSGIIPNTIG---------LTGNPLDGVLPTSIGNLSMSLEN 384
++N S+LV L + N SG IP+++G L N L+G +P + + +LE
Sbjct: 412 PTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVK-TLET 470
Query: 385 IYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSI 444
+ + ++ G IP +SN +NL + L N+LTG IP GRL+ L L L N +G+I
Sbjct: 471 LILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNI 530
Query: 445 PDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGS------------------- 485
P +L L L L N F+G+IP+ + + + + +
Sbjct: 531 PAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGA 590
Query: 486 ---NRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPS 542
+ L +++S G S N ++ +++S N SG IP
Sbjct: 591 GNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPK 650
Query: 543 TIGDLKDLQNISLACNGLEGLIPESFGYLTE---LNLSFNKL------------------ 581
IG + L ++L N + G IP+ G L L+LS NKL
Sbjct: 651 EIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEID 710
Query: 582 ------EGEIPRGGPFANFTAKSFMGNEKLCGLP 609
G IP G F F F+ N LCG P
Sbjct: 711 LSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP 744
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 419 bits (1079), Expect = e-135
Identities = 160/566 (28%), Positives = 264/566 (46%), Gaps = 38/566 (6%)
Query: 48 AAASNITTDQQALLALKAHISYDPTNLLAQNSTSNTSVCNWIGITCNVNSHRVTALNISS 107
+ + ++ + L++ K + D L + +SN + C + G+TC +VT++++SS
Sbjct: 5 SPSQSLYREIHQLISFKDVLP-DKNLL--PDWSSNKNPCTFDGVTCR--DDKVTSIDLSS 59
Query: 108 LNLQ---GTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSS 164
L + L +L+ L +L LS++ ++G + L LD S N LSG +++
Sbjct: 60 KPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSV-SGFKCSASLTSLDLSRNSLSGPVTT 118
Query: 165 VT--FNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLAL---SKCK 219
+T + S + + + S+ L V+ L+ L+VL L+ N G + C
Sbjct: 119 LTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCG 178
Query: 220 RLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNL 279
L+ L + K+SG + +S L + + +N IP +G L++L + N L
Sbjct: 179 ELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKL 235
Query: 280 VGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFIT-N 338
G AI + +K + + N +G L +++ L+L N+F+G IP F++
Sbjct: 236 SGDFSRAISTCTELKLLNISSNQFVGPIPPLP---LKSLQYLSLAENKFTGEIPDFLSGA 292
Query: 339 ASKLVYLDMGTNSFSGIIPNTIG---------LTGNPLDGVLPT-SIGNLSMSLENIYIS 388
L LD+ N F G +P G L+ N G LP ++ + L+ + +S
Sbjct: 293 CDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMR-GLKVLDLS 351
Query: 389 NCNIGGSIPQLISNLS-NLLLLDLEGNKLTGSIPVTFGRLQK--LQGLYLPFNKLAGSIP 445
G +P+ ++NLS +LL LDL N +G I + K LQ LYL N G IP
Sbjct: 352 FNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIP 411
Query: 446 DQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFF 505
L + + L +L L+ N SG+IPS LG+L+ LR L N L +P +K +
Sbjct: 412 PTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETL 471
Query: 506 DLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIP 565
L N L G + + N + I+LS N +G+IP IG L++L + L+ N G IP
Sbjct: 472 ILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIP 531
Query: 566 ESFG---YLTELNLSFNKLEGEIPRG 588
G L L+L+ N G IP
Sbjct: 532 AELGDCRSLIWLDLNTNLFNGTIPAA 557
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 370 bits (952), Expect = e-116
Identities = 138/507 (27%), Positives = 225/507 (44%), Gaps = 33/507 (6%)
Query: 103 LNISSLNLQGTIP-PQLGNLSSLTTLNLSHNKLSGDIPPSIFT---MHKLKFLDFSDNQL 158
LN+SS L L+SL L+LS N +SG +LK L S N++
Sbjct: 131 LNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKI 190
Query: 159 SGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKC 218
SG + ++ + + S+ S +P + + L+ L ++ N G A+S C
Sbjct: 191 SGDVDV--SRCVNLEFLDVSSNNFSTGIP-FLGD-CSALQHLDISGNKLSGDFSRAISTC 246
Query: 219 KRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEI-GYLPNLENLVLGFN 277
L+LLN+ + G IP L L+ +SL NK GEIP + G L L L N
Sbjct: 247 TELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGN 304
Query: 278 NLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFIT 337
+ G VP + S ++ + L N+ G + L + ++ L+L N FSG +P +T
Sbjct: 305 HFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLT 364
Query: 338 NAS-KLVYLDMGTNSFSGIIPNTIG-----------LTGNPLDGVLPTSIGNLSMSLENI 385
N S L+ LD+ +N+FSG I + L N G +P ++ N S L ++
Sbjct: 365 NLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCS-ELVSL 423
Query: 386 YISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIP 445
++S + G+IP + +LS L L L N L G IP ++ L+ L L FN L G IP
Sbjct: 424 HLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIP 483
Query: 446 DQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFF 505
L + LN + L+ N+ +G IP +G L +L L +N + +P+ + + +++
Sbjct: 484 SGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWL 543
Query: 506 DLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLE--GL 563
DL++N +G + + ++ N +G I + + A N LE G+
Sbjct: 544 DLNTNLFNGTIPAAMFKQSG----KIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGI 599
Query: 564 IPESFG---YLTELNLSFNKLEGEIPR 587
E N++ G
Sbjct: 600 RSEQLNRLSTRNPCNITSRVYGGHTSP 626
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 287 bits (736), Expect = 1e-86
Identities = 84/596 (14%), Positives = 189/596 (31%), Gaps = 65/596 (10%)
Query: 45 VAVAAASNITTDQQALLALKAHIS------YDPTNLLAQNSTSNTSVCNW---IGITCNV 95
+ ++ + D AL + ++ N N + W G++ N
Sbjct: 20 IKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLN- 78
Query: 96 NSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGD----IPPSIFTMHKLKFL 151
++ RVT L++ G +P +G L+ L L L + + P I +
Sbjct: 79 SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQK 138
Query: 152 DFSDNQLSGSLSSVTF--NLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHG 209
+ + S ++ ++SD + + L + N
Sbjct: 139 QKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITL-KDTQIGQLSNNITF 197
Query: 210 QIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNL 269
+ A+ + +L+ +G E + + + L +L
Sbjct: 198 -VSKAVMRLTKLRQFYMGNSPFVAENICEAWENE-----NSEYAQQYKTEDLKWDNLKDL 251
Query: 270 ENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLS-------LPNVERLN 322
++ + + +P + + ++ I + N + L D ++ +
Sbjct: 252 TDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIY 311
Query: 323 LGLNRF-SGTIPSFITNASKLVYLDMGTNSFSGIIPN--------TIGLTGNPLDGVLPT 373
+G N + + + + KL L+ N G +P ++ L N + +
Sbjct: 312 IGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPAN 371
Query: 374 SIGNLSMSLENIYISNCNIGGSIPQL--ISNLSNLLLLDLEGNKLTG-------SIPVTF 424
G +EN+ ++ + IP + ++S + +D N++ + T
Sbjct: 372 FCGFTE-QVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTP 429
Query: 425 GRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSG-------SIPSCLGNLTS 477
+ + + L N+++ + + L+++ L GN + N
Sbjct: 430 FKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYL 489
Query: 478 LRSPDLGSNRLTSVLPS-TFWNLKDILFFDLSSNSLDGPLSLDIGNLR------VVIGIN 530
L S DL N+LT + L ++ DLS NS N + +
Sbjct: 490 LTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRD 548
Query: 531 LSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFGYLTELNLSFNKLEGEIP 586
N + P I L + + N + + + ++ L++ N
Sbjct: 549 AQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPNISVLDIKDNPNISIDL 604
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 243 bits (621), Expect = 2e-70
Identities = 86/557 (15%), Positives = 166/557 (29%), Gaps = 66/557 (11%)
Query: 56 DQQALLALKAHISYDPTNLLAQNSTSNTSVCNWIGITCNVNSHRVTALNISSLNLQGTIP 115
L+ A D L N + G L++ G P
Sbjct: 17 IVPIKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQ---PGANWNFNKELDMWGAQP 73
Query: 116 P-QLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLD 174
L + +T L+L SG +P +I + +L+ L + +
Sbjct: 74 GVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERL---------- 123
Query: 175 IRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFK--KLS 232
P I + + + + L+
Sbjct: 124 ----------FGPKGISA-NMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQ 172
Query: 233 GAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMST 292
+I K +I +N + + + L L +G + V +
Sbjct: 173 KSIKKSSRITLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENEN 231
Query: 293 VKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSF 352
+ L D +L ++ + + +P+F+ ++ +++ N
Sbjct: 232 -----SEYAQQYKTEDLKWD-NLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRG 285
Query: 353 SGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNI-GGSIPQLISNLSNLLLLDL 411
D ++ IYI N+ + + + L +L+
Sbjct: 286 ISGEQ-------LKDDWQALADAPVGE-KIQIIYIGYNNLKTFPVETSLQKMKKLGMLEC 337
Query: 412 EGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPS- 470
N+L G +P FG KL L L +N++ + ++ L A NK IP+
Sbjct: 338 LYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNI 395
Query: 471 -CLGNLTSLRSPDLGSNRLTSV-------LPSTFWNLKDILFFDLSSNSLDGPLSLDIGN 522
+++ + + D N + SV L T + ++ +LS+N +
Sbjct: 396 FDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFST 455
Query: 523 LRVVIGINLSRNNFSG-------DIPSTIGDLKDLQNISLACNGLEGLIPE----SFGYL 571
+ INL N + D + L +I L N L L + + YL
Sbjct: 456 GSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYL 515
Query: 572 TELNLSFNKLEGEIPRG 588
++LS+N P
Sbjct: 516 VGIDLSYNSFSK-FPTQ 531
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 8e-60
Identities = 65/425 (15%), Positives = 138/425 (32%), Gaps = 46/425 (10%)
Query: 103 LNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSL 162
N T + NL LT + + + +P + + +++ ++ + N+
Sbjct: 230 ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS-- 287
Query: 163 SSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMF-HGQIPLALSKCKRL 221
+ K + + ++++++ N + +L K K+L
Sbjct: 288 --------------GEQLKDDWQALADAPV-GEKIQIIYIGYNNLKTFPVETSLQKMKKL 332
Query: 222 QLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVG 281
+L + +L G +P + L ++L N++ + G+ +ENL N L
Sbjct: 333 GMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY 391
Query: 282 VVPAA-IFNMSTVKKIYLLDNSLLGSFSLGID------LSLPNVERLNLGLNRFSGTIPS 334
+ ++S + I N + D NV +NL N+ S
Sbjct: 392 IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKE 451
Query: 335 FITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGG 394
+ S L +++ N + I N++ + N L +I + +
Sbjct: 452 LFSTGSPLSSINLMGNMLTEIPKNSLKD--------ENENFKNTY-LLTSIDLRFNKLTK 502
Query: 395 SIPQL-ISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLP------FNKLAGSIPDQ 447
+ L L+ +DL N + P L+G + N+ P+
Sbjct: 503 LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEG 561
Query: 448 LCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDL 507
+ L L + N N++ L D+ N S+ S + + L
Sbjct: 562 ITLCPSLTQLQIGSNDIRKVNEKITPNISVL---DIKDNPNISIDLSYVCPYIEAGMYML 618
Query: 508 SSNSL 512
+
Sbjct: 619 FYDKT 623
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 260 bits (667), Expect = 2e-80
Identities = 87/289 (30%), Positives = 143/289 (49%), Gaps = 21/289 (7%)
Query: 326 NRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENI 385
+ G + T ++ LD+ + P +P+S+ NL L +
Sbjct: 36 RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYP-------------IPSSLANLP-YLNFL 81
Query: 386 YISNCN-IGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSI 444
YI N + G IP I+ L+ L L + ++G+IP +++ L L +N L+G++
Sbjct: 82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTL 141
Query: 445 PDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSP-DLGSNRLTSVLPSTFWNLKDIL 503
P + L L + GN+ SG+IP G+ + L + + NRLT +P TF NL +
Sbjct: 142 PPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LA 200
Query: 504 FFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGL 563
F DLS N L+G S+ G+ + I+L++N+ + D+ +G K+L + L N + G
Sbjct: 201 FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGT 259
Query: 564 IPESFG---YLTELNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLP 609
+P+ +L LN+SFN L GEIP+GG F ++ N+ LCG P
Sbjct: 260 LPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 3e-58
Identities = 83/339 (24%), Positives = 129/339 (38%), Gaps = 83/339 (24%)
Query: 55 TDQQALLALKAHISYDPTNLLAQNSTSNTSVCNWIGITCNV--NSHRVTALNISSLNLQG 112
D+QALL +K + +PT L + T++ W+G+ C+ ++RV L++S LNL
Sbjct: 6 QDKQALLQIKKDLG-NPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 113 T---------------------------IPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTM 145
IPP + L+ L L ++H +SG IP + +
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 146 HKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKN 205
L LDFS N LSG+ LP +I + L L + N
Sbjct: 125 KTLVTLDFSYNALSGT------------------------LPPSISS-LPNLVGITFDGN 159
Query: 206 MFHGQIPLALSKCKRL-QLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIG 264
G IP + +L + + +L+G IP +NL L + L N L G+ G
Sbjct: 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFG 218
Query: 265 YLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLG 324
N + + L N+L + +G N+ L+L
Sbjct: 219 SDKNTQKIHLAKNSLAFDLG-----------------------KVG---LSKNLNGLDLR 252
Query: 325 LNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLT 363
NR GT+P +T L L++ N+ G IP L
Sbjct: 253 NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQ 291
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 2e-75
Identities = 99/529 (18%), Positives = 187/529 (35%), Gaps = 44/529 (8%)
Query: 100 VTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLS 159
+T LN++ L+ S LT+L++ N +S P + LK L+ N+LS
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 160 GSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCK 219
+++ ++ L S+ + L L L+ N + +
Sbjct: 87 QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK-QKNLITLDLSHNGLSSTKLGTQVQLE 145
Query: 220 RLQLLNLGFKKLSGAIPKEIS--NLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFN 277
LQ L L K+ +E+ + L+K+ L +N+++ P + L L L
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNV 205
Query: 278 NLVGVVPAAIF---NMSTVKKIYLLDNSLLG-SFSLGIDLSLPNVERLNLGLNRFSGTIP 333
L + + ++++ + L ++ L S + + L N+ L+L N +
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265
Query: 334 SFITNASKLVYLDMGTNSFSGIIPNTIG------------------LTGNPLDGVLPTSI 375
+L Y + N+ + +++ ++ L + S
Sbjct: 266 DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSF 325
Query: 376 GNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGS--IPVTFGRLQ--KLQ 431
L LE++ + + +I G + + L NL L L + + TF L L
Sbjct: 326 QWLK-CLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLH 384
Query: 432 GLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIP-SCLGNLTSLRSPDLGSNRLTS 490
L L NK++ D L L L L N+ + L ++ L N+
Sbjct: 385 ILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQ 444
Query: 491 VLPSTFWNLKDILFFDLSSNSLDGPLSLD--IGNLRVVIGINLSRNNFSGDIPSTIGDLK 548
+ ++F + + L +L S LR + ++LS NN + + L+
Sbjct: 445 LTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLE 504
Query: 549 DLQNISLACNGLEGLIPESFGY-----------LTELNLSFNKLEGEIP 586
L+ + L N L L + L LNL N +
Sbjct: 505 KLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPV 553
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 1e-69
Identities = 87/504 (17%), Positives = 160/504 (31%), Gaps = 59/504 (11%)
Query: 123 SLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKL 182
S + SH KL+ +P + T + L+ + NQL ++ S
Sbjct: 5 SHEVADCSHLKLT-QVPDDLPT--NITVLNLTHNQLRRLPAANFTRYSQ----------- 50
Query: 183 SGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNL 242
L L + N P K L++LNL +LS K +
Sbjct: 51 --------------LTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFC 96
Query: 243 TILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNS 302
T L ++ L +N ++ + NL L L N L + ++++ L +N
Sbjct: 97 TNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNK 156
Query: 303 LLG-SFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIG 361
+ + ++++L L N+ P +L L + + +
Sbjct: 157 IQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLC 216
Query: 362 ------------LTGNPLDGVLPTSIGNLS-MSLENIYISNCNIGGSIPQLISNLSNLLL 408
L+ + L T+ L +L + +S N+ + L L
Sbjct: 217 LELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEY 276
Query: 409 LDLEGNKLTGSIPVTFGRLQKLQGLYL---------PFNKLAGSIPDQLCHLARLNTLGL 459
LE N + + L ++ L L L L L L +
Sbjct: 277 FFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNM 336
Query: 460 AGNKFSGSIPSCLGNLTSLRSPDLGSNRL--TSVLPSTFWNL--KDILFFDLSSNSLDGP 515
N G + L +L+ L ++ ++ TF +L + +L+ N +
Sbjct: 337 EDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKI 396
Query: 516 LSLDIGNLRVVIGINLSRNNFSGDIP-STIGDLKDLQNISLACNGLEGLIPESFGYLT-- 572
S L + ++L N ++ L+++ I L+ N L SF +
Sbjct: 397 ESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSL 456
Query: 573 -ELNLSFNKLEGEIPRGGPFANFT 595
L L L+ PF
Sbjct: 457 QRLMLRRVALKNVDSSPSPFQPLR 480
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 1e-68
Identities = 110/536 (20%), Positives = 187/536 (34%), Gaps = 71/536 (13%)
Query: 103 LNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFT---MHKLKFLDFSDNQLS 159
L++S L T L +L L LS+NK+ + LK L+ S NQ+
Sbjct: 126 LDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA-LKSEELDIFANSSLKKLELSSNQIK 184
Query: 160 GSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLH--YLKVLFLAKNMFHGQIPLALSK 217
+ + + L++ +L L +C L ++ L L+ +
Sbjct: 185 EFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLG 244
Query: 218 CK--RLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLG 275
K L +L+L + L+ + L L L N ++ H + L N+ L L
Sbjct: 245 LKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLK 304
Query: 276 ---------FNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLN 326
+L + + + ++ + + DN + G S + L N++ L+L +
Sbjct: 305 RSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS-NMFTGLINLKYLSLSNS 363
Query: 327 RFSGTIPSFIT----NASKLVYLDMGTNSFSGIIPNTIG---------LTGNPLDGVLP- 372
S + T S L L++ N S I + L N + L
Sbjct: 364 FTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTG 423
Query: 373 TSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTG--SIPVTFGRLQKL 430
L ++ IY+S + + +L L L L S P F L+ L
Sbjct: 424 QEWRGLE-NIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNL 482
Query: 431 QGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFS--------GSIPSCLGNLTSLRSPD 482
L L N +A D L L +L L L N + G L L+ L +
Sbjct: 483 TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILN 542
Query: 483 LGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPS 542
L SN + F +L L++ I+L NN + S
Sbjct: 543 LESNGFDEIPVEVFKDLF---------------------ELKI---IDLGLNNLNTLPAS 578
Query: 543 TIGDLKDLQNISLACNGLEGLIPESFGY----LTELNLSFNKLEGEIPRGGPFANF 594
+ L++++L N + + + FG LTEL++ FN + F N+
Sbjct: 579 VFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNW 634
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 3e-56
Identities = 80/440 (18%), Positives = 144/440 (32%), Gaps = 45/440 (10%)
Query: 90 GITCNVNSHRVTALNISSLNLQGTIPPQLGNL--SSLTTLNLSHNKLSGDIPPSIFTMHK 147
+ + + + L++S+ L T L ++LT L+LS+N L+ S + +
Sbjct: 214 KLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQ 273
Query: 148 LKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMF 207
L++ N + S L +V + L ++
Sbjct: 274 LEYFFLEYNNIQHLFSHSLHGLFNVRYLNLK----------------RSFTKQSISLASL 317
Query: 208 HGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIG--- 264
+ K L+ LN+ + G + L L+ +SL N+
Sbjct: 318 PKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVS 377
Query: 265 -YLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNL 323
L L L N + + A + ++ + L N + + L N+ + L
Sbjct: 378 LAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYL 437
Query: 324 GLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLE 383
N++ + L L + + + + P+ L +L
Sbjct: 438 SYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSS-------------PSPFQPLR-NLT 483
Query: 384 NIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLT--------GSIPVTFGRLQKLQGLYL 435
+ +SN NI ++ L L +LDL+ N L G L L L L
Sbjct: 484 ILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNL 543
Query: 436 PFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPST 495
N + L L + L N + S N SL+S +L N +TSV
Sbjct: 544 ESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKV 603
Query: 496 FW-NLKDILFFDLSSNSLDG 514
F +++ D+ N D
Sbjct: 604 FGPAFRNLTELDMRFNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 3e-12
Identities = 27/128 (21%), Positives = 48/128 (37%), Gaps = 11/128 (8%)
Query: 471 CLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGIN 530
C + D +LT V N+ + +L+ N L + + + ++
Sbjct: 2 CTVSHEVA---DCSHLKLTQVPDDLPTNITVL---NLTHNQLRRLPAANFTRYSQLTSLD 55
Query: 531 LSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFGY---LTELNLSFNKLEGEIPR 587
+ N S P L L+ ++L N L L ++F + LTEL+L N ++
Sbjct: 56 VGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKN- 114
Query: 588 GGPFANFT 595
PF
Sbjct: 115 -NPFVKQK 121
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 5e-08
Identities = 19/105 (18%), Positives = 40/105 (38%), Gaps = 6/105 (5%)
Query: 96 NSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIF--TMHKLKFLDF 153
+ + +++ NL N SL +LNL N ++ + +F L LD
Sbjct: 558 DLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITS-VEKKVFGPAFRNLTELDM 616
Query: 154 SDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLK 198
N + S+ + ++ + + + +LS +CN +
Sbjct: 617 RFNPFDCTCESIAWFVNWINETHTNIPELSSHY---LCNTPPHYH 658
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 255 bits (652), Expect = 7e-73
Identities = 88/646 (13%), Positives = 197/646 (30%), Gaps = 103/646 (15%)
Query: 45 VAVAAASNITTDQQALLALKAHISYDPTNLLAQNSTSNTSVCNW------------IGIT 92
+ + + D +AL A+ + + + NW G+
Sbjct: 259 IQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVD 318
Query: 93 CNVNSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPP------------ 140
+ N+ RVT L+++ +G +P +G L+ L L+ + +
Sbjct: 319 LD-NNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSE 377
Query: 141 -------------SIFTMHKLKFLDFSDNQLS-----GSLSSVTFNLSSVLDIRLDSDKL 182
+ +L D + ++ + + I ++++
Sbjct: 378 ERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRI 437
Query: 183 SGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNL 242
+ + I L L++++ A + F + N + K SNL
Sbjct: 438 TF-ISKAIQR-LTKLQIIYFANSPFTYDNI-----AVDWEDANSDYAKQYENEELSWSNL 490
Query: 243 TILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGV---------VPAAIFNMSTV 293
L + L N ++P + LP L++L + N + + +
Sbjct: 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKI 550
Query: 294 KKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFS 353
+ Y+ N+L + + + L+ N+ + +F KL L + N
Sbjct: 551 QIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEAF-GTNVKLTDLKLDYNQIE 608
Query: 354 GIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQL--ISNLSNLLLLDL 411
I P + +E + S+ + IP + ++ + +D
Sbjct: 609 EI----------------PEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDF 651
Query: 412 EGNKLTGSIPVTFG-----RLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFS- 465
NK+ + + L +N++ + + ++T+ L+ N +
Sbjct: 652 SYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTS 711
Query: 466 ------GSIPSCLGNLTSLRSPDLGSNRLTSVLPS-TFWNLKDILFFDLSSNSLDGPLSL 518
N L + DL N+LTS+ L + D+S N
Sbjct: 712 IPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPT 770
Query: 519 DIGNLRVVIGINLSR------NNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFGYLT 572
N + + N P+ I L + + N + + + L
Sbjct: 771 QPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDEKLTPQLY 830
Query: 573 ELNLSFNKL-EGEIPRGGPFANFTAKSFMGN--EKLCGLPNLQFPK 615
L+++ N ++ P+ + + + + G L +
Sbjct: 831 ILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALGIER 876
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 2e-71
Identities = 99/509 (19%), Positives = 174/509 (34%), Gaps = 30/509 (5%)
Query: 103 LNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSL 162
L++S +Q +LS L+TL L+ N + + + L+ L + L+
Sbjct: 57 LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLE 116
Query: 163 SSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQ 222
+ +L ++ ++ + + + + L L+ L L+ N L ++
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP 176
Query: 223 L----LNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGY-LPNLENLVL--- 274
L L+L ++ P + L K++LRNN + L LE L
Sbjct: 177 LLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLG 235
Query: 275 ---GFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDL--SLPNVERLNLGLNRFS 329
NL +A+ + + L IDL L NV +L
Sbjct: 236 EFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE 295
Query: 330 GTIPSFITNASKLVYLDMGTNSFSGIIPNTIG----LTGNPLDGVLPTSIGNLSMSLENI 385
+ +L++ F + LT G S +L SLE +
Sbjct: 296 RVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLP-SLEFL 352
Query: 386 YISNCNIG--GSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGS 443
+S + G Q ++L LDL N + + F L++L+ L + L
Sbjct: 353 DLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQM 411
Query: 444 IPDQ-LCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLT-SVLPSTFWNLKD 501
L L L ++ + L+SL + N + LP F L++
Sbjct: 412 SEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN 471
Query: 502 ILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLE 561
+ F DLS L+ +L + +N+S NNF L LQ + + N +
Sbjct: 472 LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 531
Query: 562 GLIPESFGY----LTELNLSFNKLEGEIP 586
+ + L LNL+ N
Sbjct: 532 TSKKQELQHFPSSLAFLNLTQNDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 1e-64
Identities = 104/519 (20%), Positives = 181/519 (34%), Gaps = 40/519 (7%)
Query: 104 NISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLS 163
LN IP L S L+LS N L S F+ +L+ LD S ++
Sbjct: 13 QCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69
Query: 164 SVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQL 223
+LS + + L + + L L+ L + + K L+
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSG-LSSLQKLVAVETNLASLENFPIGHLKTLKE 128
Query: 224 LNLGFKKL-SGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLEN----LVLGFNN 278
LN+ + S +P+ SNLT L + L +NK++ ++ L + L L N
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188
Query: 279 LVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITN 338
+ + P A + K+ L +N + L +E L L F +
Sbjct: 189 MNFIQPGAFKEIRL-HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD 247
Query: 339 AS-------------KLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSM--SLE 383
S +L YLD + + ++ L V + + S +
Sbjct: 248 KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQ 307
Query: 384 NIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLA-- 441
++ + NC G + +L L +G + L L+ L L N L+
Sbjct: 308 HLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAF-----SEVDLPSLEFLDLSRNGLSFK 362
Query: 442 GSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLP-STFWNLK 500
G L L L+ N + S L L D + L + S F +L+
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 421
Query: 501 DILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDI-PSTIGDLKDLQNISLACNG 559
++++ D+S + L + + ++ N+F + P +L++L + L+
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 481
Query: 560 LEGLIPESFG---YLTELNLSFNKLEGEIPRGGPFANFT 595
LE L P +F L LN+S N P+
Sbjct: 482 LEQLSPTAFNSLSSLQVLNMSHNNFFSLDT--FPYKCLN 518
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 2e-56
Identities = 90/484 (18%), Positives = 164/484 (33%), Gaps = 51/484 (10%)
Query: 96 NSHRVTALNISSLNLQGTIPPQLGNLSSLT----TLNLSHNKLSGDIPPSIFTMHKLKFL 151
N + L++SS +Q L L + +L+LS N ++ I P F +L L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKL 205
Query: 152 DFSDNQLSGSLSSVTFNLSSVLDI-RLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQ 210
+N S ++ + L++ RL + E
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE-------------------GNLEKF 246
Query: 211 IPLALSKCKRLQLLNLGFKKLS---GAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLP 267
AL L + L I + LT + SL + + Y
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNF 304
Query: 268 NLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNR 327
++L L + ++ K++ N +FS + LP++E L+L N
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKSL---KRLTFTSNKGGNAFSE---VDLPSLEFLDLSRNG 358
Query: 328 --FSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLT--------GNPLDGVLPTSIGN 377
F G + L YLD+ N + N +GL + L + S+
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418
Query: 378 LSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSI-PVTFGRLQKLQGLYLP 436
+L + IS+ + + + + LS+L +L + GN + P F L+ L L L
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478
Query: 437 FNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTF 496
+L P L+ L L ++ N F L SL+ D N + +
Sbjct: 479 QCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQEL 538
Query: 497 WNLKDIL-FFDLSSNSLDG--PLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNI 553
+ L F +L+ N + ++ + + PS + + ++
Sbjct: 539 QHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP-VLSL 597
Query: 554 SLAC 557
++ C
Sbjct: 598 NITC 601
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 1e-61
Identities = 95/510 (18%), Positives = 171/510 (33%), Gaps = 50/510 (9%)
Query: 100 VTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLS 159
L S L L +LT L+L+ ++ + + H+L L + N L
Sbjct: 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94
Query: 160 GSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCK 219
+ + LK LF + + L K
Sbjct: 95 F-------------------------MAETALSGPKALKHLFFIQTGISSIDFIPLHNQK 129
Query: 220 RLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFN-N 278
L+ L LG +S + L+ + +NN + ++ L NL L N N
Sbjct: 130 TLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGN 189
Query: 279 LVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGID-LSLPNVERLNLGLNRFSGTIPSFIT 337
+ + F+ + + + L G+ ++ ++ P+
Sbjct: 190 DIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFE 249
Query: 338 N--ASKLVYLDMGTNSFSGIIPNTIG---------LTGNPLDGVLPTSIGNLSMSLENIY 386
+ +++ + F I NT LT L LP+ + LS +L+ +
Sbjct: 250 GLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLS-TLKKLV 307
Query: 387 ISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSI-PVTFGRLQKLQGLYLPFNKLAGS-- 443
+S SN +L L ++GN + L+ L+ L L + + S
Sbjct: 308 LSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDC 367
Query: 444 IPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLP-STFWNLKDI 502
QL +L+ L +L L+ N+ L DL RL S F NL +
Sbjct: 368 CNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLL 427
Query: 503 LFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDI---PSTIGDLKDLQNISLACNG 559
+LS + LD L + +NL N+F +++ L L+ + L+
Sbjct: 428 KVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCD 487
Query: 560 LEGLIPESFG---YLTELNLSFNKLEGEIP 586
L + +F + ++LS N+L
Sbjct: 488 LSSIDQHAFTSLKMMNHVDLSHNRLTSSSI 517
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 3e-59
Identities = 91/505 (18%), Positives = 172/505 (34%), Gaps = 25/505 (4%)
Query: 101 TALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSG 160
T L+++ + + L TL L+ N L ++ LK L F +S
Sbjct: 60 TFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISS 119
Query: 161 SLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKR 220
N ++ + L S+ +S + + LKVL N H +S ++
Sbjct: 120 IDFIPLHNQKTLESLYLGSNHISS-IKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQ 178
Query: 221 LQLLNLGFKKLS-GAIPKEISNLTILRKISLRNNKLRGEIPHEIGY--LPNLENLVLGFN 277
L+L I + + + ++ + I + + +L
Sbjct: 179 ATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM 238
Query: 278 NLVGVVPAAIFNMSTVKKIYL-LDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFI 336
+ + PA + + + L + S ++ L+L S +PS +
Sbjct: 239 DDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGL 297
Query: 337 TNASKLVYLDMGTNSFSGIIPNTIG---------LTGNPLDGVLPTSIGNLSMSLENIYI 387
S L L + N F + + + GN L T +L + +
Sbjct: 298 VGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDL 357
Query: 388 SNCNIGGS--IPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIP 445
S+ +I S + NLS+L L+L N+ F +L+ L L F +L
Sbjct: 358 SHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDA 417
Query: 446 D-QLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSV---LPSTFWNLKD 501
+L L L L+ + S L +L+ +L N ++ L
Sbjct: 418 QSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGR 477
Query: 502 ILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLE 561
+ LS L +L+++ ++LS N + + LK + ++LA N +
Sbjct: 478 LEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHIS 536
Query: 562 GLIPESFGY---LTELNLSFNKLEG 583
++P +NL N L+
Sbjct: 537 IILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 1e-56
Identities = 77/438 (17%), Positives = 151/438 (34%), Gaps = 22/438 (5%)
Query: 96 NSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLK--FLDF 153
N + +L + S ++ P+ L L+ +N + + ++ + L+
Sbjct: 127 NQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNL 186
Query: 154 SDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNY-LHYLKVLFLAKNMFHGQIP 212
+ N ++ + F+ + + + + + N + L + P
Sbjct: 187 NGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISP 245
Query: 213 LALSKCKRLQL--LNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLE 270
+ + +NL + L+++ L L E+P + L L+
Sbjct: 246 AVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLK 304
Query: 271 NLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNR--F 328
LVL N + + N ++ + + N+ G +L N+ L+L +
Sbjct: 305 KLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIET 364
Query: 329 SGTIPSFITNASKLVYLDMGTNSFSGIIPNTIG---------LTGNPLDGVLPTSIGNLS 379
S + N S L L++ N + L L S
Sbjct: 365 SDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNL 424
Query: 380 MSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPV---TFGRLQKLQGLYLP 436
L+ + +S+ + S QL L L L+L+GN + L +L+ L L
Sbjct: 425 HLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLS 484
Query: 437 FNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTF 496
F L+ L +N + L+ N+ + S L +L + +L SN ++ +LPS
Sbjct: 485 FCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYL-NLASNHISIILPSLL 543
Query: 497 WNLKDILFFDLSSNSLDG 514
L +L N LD
Sbjct: 544 PILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 4e-53
Identities = 91/481 (18%), Positives = 154/481 (32%), Gaps = 50/481 (10%)
Query: 126 TLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGE 185
T N + L+ +IP ++ + L+FS N L + + S
Sbjct: 16 TYNCENLGLN-EIPGTLPN--STECLEFSFNVLPT----------------IQNTTFSR- 55
Query: 186 LPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTIL 245
L L L L + + RL L L L +S L
Sbjct: 56 --------LINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKAL 107
Query: 246 RKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLG 305
+ + + + LE+L LG N++ + F +K + +N+ +
Sbjct: 108 KHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNA-IH 166
Query: 306 SFSLGIDLSLPNVERLNLGLNR-FSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIG--- 361
S SL L+L LN I +++ L+ G +I +
Sbjct: 167 YLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNST 226
Query: 362 --------LTGNPLDGVLPTSIGNLS-MSLENIYISNCNIGGSIPQLISNLSNLLLLDLE 412
+ + P L MS+E+I + S L LDL
Sbjct: 227 IQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLT 286
Query: 413 GNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPS-C 471
L+ +P L L+ L L NK + L L + GN + + C
Sbjct: 287 ATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGC 345
Query: 472 LGNLTSLRSPDLGSNRLTSV--LPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGI 529
L NL +LR DL + + + NL + +LS N + + +
Sbjct: 346 LENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELL 405
Query: 530 NLSRNNFSG-DIPSTIGDLKDLQNISLACNGLEGLIPESFGY---LTELNLSFNKLEGEI 585
+L+ D S +L L+ ++L+ + L+ + F L LNL N
Sbjct: 406 DLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGN 465
Query: 586 P 586
Sbjct: 466 I 466
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 3e-44
Identities = 74/380 (19%), Positives = 141/380 (37%), Gaps = 25/380 (6%)
Query: 96 NSHRVTALNISSLNLQGTIPPQLGN--LSSLTTLNLSHNKLSGDIPPSIFTMHK---LKF 150
+S +LN I L N + SL DI P++F ++
Sbjct: 200 DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDE-DISPAVFEGLCEMSVES 258
Query: 151 LDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQ 210
++ + S+ S + ++ L + LS ELP + L LK L L+ N F
Sbjct: 259 INLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVG-LSTLKKLVLSANKFENL 316
Query: 211 IPLALSKCKRLQLLNLGFKKLSGAIPKE-ISNLTILRKISLRNNKLR--GEIPHEIGYLP 267
++ S L L++ + + NL LR++ L ++ + ++ L
Sbjct: 317 CQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLS 376
Query: 268 NLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNR 327
+L++L L +N + + A ++ + L L + +L ++ LNL +
Sbjct: 377 HLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSL 436
Query: 328 FSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYI 387
+ L +L++ N F S+ L LE + +
Sbjct: 437 LDISSEQLFDGLPALQHLNLQGNHFPKGNI------------QKTNSLQTLG-RLEILVL 483
Query: 388 SNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQ 447
S C++ ++L + +DL N+LT S L+ + L L N ++ +P
Sbjct: 484 SFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSL 542
Query: 448 LCHLARLNTLGLAGNKFSGS 467
L L++ T+ L N +
Sbjct: 543 LPILSQQRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 18/110 (16%), Positives = 47/110 (42%), Gaps = 6/110 (5%)
Query: 96 NSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSD 155
+ + +++S L + L +L + LNL+ N +S +P + + + + ++
Sbjct: 498 SLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQ 556
Query: 156 NQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKN 205
N L + S++ F L+ ++ + + +C L+ + L+
Sbjct: 557 NPLDCTCSNIYF-----LEWYKENMQKLEDTEDTLCENPPLLRGVRLSDV 601
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 5e-56
Identities = 90/510 (17%), Positives = 165/510 (32%), Gaps = 28/510 (5%)
Query: 100 VTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLS 159
+++S L+ N S L L+LS ++ + +H L L + N +
Sbjct: 34 TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93
Query: 160 GSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHG-QIPLALSKC 218
L+S+ ++ KL+ I L LK L +A N H ++P S
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLASLESFPIGQ-LITLKKLNVAHNFIHSCKLPAYFSNL 152
Query: 219 KRLQLLNLGFKKLSGAIPKEISNLTILR----KISLRNNKLRGEIPHEIGYLPNLENLVL 274
L ++L + + ++ L + + N + I + L L L
Sbjct: 153 TNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTL 211
Query: 275 GFNNLVGVVPAAIF-NMSTVKKIYLLDNSLLGSFSLGI-------DLSLPNVERLNLGLN 326
N + N++ + L+ +L I L ++ L
Sbjct: 212 RGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYT 271
Query: 327 RFSGTIPSFITNASKLVYLDMGTNSFSGI--IPNTIGLTGNPLDGVLPTSIGNLSMS-LE 383
+ + + + S + +P + L + L+
Sbjct: 272 NDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLK 331
Query: 384 NIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQ--KLQGLYLPFNKLA 441
++ ++ SI L +L LDL N L+ S ++ L L+ L L FN
Sbjct: 332 SLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGA- 388
Query: 442 GSIPDQLCHLARLNTLGLAGNKFSGSIP-SCLGNLTSLRSPDLGSNRLTSVLPSTFWNLK 500
+ L L L + S +L L D+ F L
Sbjct: 389 IIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLT 448
Query: 501 DILFFDLSSNSL-DGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNG 559
+ ++ NS D LS N + ++LS+ L LQ ++++ N
Sbjct: 449 SLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNN 508
Query: 560 LEGLIPESFGY---LTELNLSFNKLEGEIP 586
L L + L+ L+ SFN++E
Sbjct: 509 LLFLDSSHYNQLYSLSTLDCSFNRIETSKG 538
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-48
Identities = 89/495 (17%), Positives = 167/495 (33%), Gaps = 31/495 (6%)
Query: 103 LNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSL 162
L +P + SS ++LS N L S +L++LD S ++
Sbjct: 16 YQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIE 72
Query: 163 SSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQ 222
L + ++ L + + + L L+ L + + + L+
Sbjct: 73 DKAWHGLHHLSNLILTGNPIQS-FSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLK 131
Query: 223 LLNLGFKKLSGA-IPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFN---N 278
LN+ + +P SNLT L + L N ++ +++ +L + L + N
Sbjct: 132 KLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191
Query: 279 LVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITN 338
+ + F + ++ L N + +L + L L F I
Sbjct: 192 PIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFE 251
Query: 339 ASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQ 398
S + L + + LT L+ ++ + ++ +I +
Sbjct: 252 PSIMEGL-------CDVTIDEFRLTYTNDFSDDIVKFHCLA-NVSAMSLAGVSI--KYLE 301
Query: 399 LISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLG 458
+ L + +L L L+ L L NK SI + L L+ L
Sbjct: 302 DVPKHFKWQSLSIIRCQLKQ---FPTLDLPFLKSLTLTMNKG--SISFKKVALPSLSYLD 356
Query: 459 LAGNKFSGSIPSCLGNL--TSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPL 516
L+ N S S +L SLR DL N + + F L+++ D ++L
Sbjct: 357 LSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVT 415
Query: 517 SLD-IGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFGY----L 571
+L ++ +++S N D L L + +A N + + L
Sbjct: 416 EFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNL 475
Query: 572 TELNLSFNKLEGEIP 586
T L+LS +LE
Sbjct: 476 TFLDLSKCQLEQISW 490
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 9e-48
Identities = 82/443 (18%), Positives = 150/443 (33%), Gaps = 35/443 (7%)
Query: 96 NSHRVTALNISSLNLQG-TIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTM-----HKLK 149
+ LN++ + +P NL++L ++LS+N + I +
Sbjct: 126 QLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT-ITVNDLQFLRENPQVNL 184
Query: 150 FLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHG 209
LD S N + + F + ++ L + S + L L V L F
Sbjct: 185 SLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKD 243
Query: 210 QIPLALSKCK--------RLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPH 261
+ L + + + L + + L + +SL + +
Sbjct: 244 ERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLE 301
Query: 262 EIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERL 321
++ ++L + L ++ +K + L N SF +LP++ L
Sbjct: 302 DVPKHFKWQSLSIIRCQLKQFPTL---DLPFLKSLTLTMNKGSISFKKV---ALPSLSYL 355
Query: 322 NLGLNRFSGTIPSFITN--ASKLVYLDMGTNSFSGIIPNTIGLT--------GNPLDGVL 371
+L N S + ++ + L +LD+ N + N +GL + L V
Sbjct: 356 DLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVT 415
Query: 372 PTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPV-TFGRLQKL 430
S L + IS N + L++L L + GN + F L
Sbjct: 416 EFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNL 475
Query: 431 QGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTS 490
L L +L L RL L ++ N S L SL + D NR+ +
Sbjct: 476 TFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET 535
Query: 491 VLPSTFWNLKDILFFDLSSNSLD 513
K + FF+L++NS+
Sbjct: 536 SKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-39
Identities = 90/539 (16%), Positives = 163/539 (30%), Gaps = 100/539 (18%)
Query: 112 GTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSS 171
G++ P + + ++T KLS +P I + K +D S N L
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLS-KVPDDIPS--STKNIDLSFNPLKIL---------- 47
Query: 172 VLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKL 231
+ S LQ L+L ++
Sbjct: 48 ---------------------------------------KSYSFSNFSELQWLDLSRCEI 68
Query: 232 SGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMS 291
K L L + L N ++ P L +LENLV L + I +
Sbjct: 69 ETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLI 128
Query: 292 TVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKL----VYLDM 347
T+KK+ + N + +L N+ ++L N + + + + LDM
Sbjct: 129 TLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDM 188
Query: 348 GTNSFSGIIPNTIG--------LTGNPLDGVLPTSIGNLSMSLE------NIYISNCNIG 393
N I L GN + + L + N+
Sbjct: 189 SLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLE 248
Query: 394 GSIPQLISNLSNL--LLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHL 451
P ++ L ++ L V F L + + L + + +
Sbjct: 249 IFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKH 306
Query: 452 ARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNS 511
+ +L + + L L SL L N+ + + L + + DLS N+
Sbjct: 307 FKWQSLSIIRCQLKQFPTLDLPFLKSL---TLTMNKGS--ISFKKVALPSLSYLDLSRNA 361
Query: 512 LD--GPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESF- 568
L G S + ++LS N + + L++LQ++ + L+ + S
Sbjct: 362 LSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAF 420
Query: 569 ---GYLTELNLSFNKLEGEIPRGGPFANFTA-----------KSFMGNEKLCGLPNLQF 613
L L++S+ + + G F T+ K + NL F
Sbjct: 421 LSLEKLLYLDISYTNTKIDFD--GIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTF 477
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-23
Identities = 35/187 (18%), Positives = 65/187 (34%), Gaps = 2/187 (1%)
Query: 94 NVNSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFT-MHKLKFLD 152
++ ++ + L++S N + L L L+ H+ L S F + KL +LD
Sbjct: 372 DLGTNSLRHLDLSF-NGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLD 430
Query: 153 FSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIP 212
S + L+S+ +++ + N+ L L L+K
Sbjct: 431 ISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISW 490
Query: 213 LALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENL 272
RLQLLN+ L + L L + N++ + +L
Sbjct: 491 GVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFF 550
Query: 273 VLGFNNL 279
L N++
Sbjct: 551 NLTNNSV 557
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 5e-46
Identities = 105/509 (20%), Positives = 191/509 (37%), Gaps = 40/509 (7%)
Query: 101 TALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFT-MHKLKFLDFSDNQLS 159
LN IP L S L+LS N L + F +L+ LD S ++
Sbjct: 10 ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ 65
Query: 160 GSLSSVTF-NLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKC 218
++ + +LS + + L + + L + + L L+ L + +
Sbjct: 66 -TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHL 123
Query: 219 KRLQLLNLGFKKL-SGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFN 277
K L+ LN+ + S +P+ SNLT L + L +NK++ ++ L + L L +
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183
Query: 278 ---NLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGT--- 331
N + + F + K+ L +N + L +E L L F
Sbjct: 184 LSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNL 243
Query: 332 ----------IPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSM- 380
+ + +L YLD + + ++ L V + + S
Sbjct: 244 EKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN 303
Query: 381 -SLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNK 439
+++ + NC G P L L +L L NK + + L L+ L L N
Sbjct: 304 FGWQHLELVNCKF-GQFPTL--KLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNG 358
Query: 440 LA--GSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLP-STF 496
L+ G L L L+ N ++ S L L D + L + S F
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 417
Query: 497 WNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTI-GDLKDLQNISL 555
+L+++++ D+S + L + + ++ N+F + I +L++L + L
Sbjct: 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 477
Query: 556 ACNGLEGLIPESFGYLT---ELNLSFNKL 581
+ LE L P +F L+ LN++ N+L
Sbjct: 478 SQCQLEQLSPTAFNSLSSLQVLNMASNQL 506
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 6e-44
Identities = 96/521 (18%), Positives = 173/521 (33%), Gaps = 33/521 (6%)
Query: 100 VTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIF-TMHKLKFLDFSDNQL 158
L++S L+ + L L+LS ++ I + ++ L L + N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPI 88
Query: 159 SGSLSSVTF-NLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMF-HGQIPLALS 216
SL+ F LSS+ + L+ L +L LK L +A N+ ++P S
Sbjct: 89 Q-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 217 KCKRLQLLNLGFKKLSGAIPKEISNLTILR----KISLRNNKLRGEIPHEIGYLPNLENL 272
L+ L+L K+ ++ L + + L N + I L L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKL 205
Query: 273 VLGFNNLVGVVPAAIFNMSTVKKI------YLLDNSLLGSFSLGIDLSLPNVERLNLGLN 326
L N V ++ + L F L N+ L
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265
Query: 327 R---FSGTIPSFITNASKLVYLDMGTNSFSGI--IPNTIGLTGNPLDGVLPTSIGNLSM- 380
+ I + + + + + + G L L +
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLK 325
Query: 381 SLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLT--GSIPVTFGRLQKLQGLYLPFN 438
SL+ + ++ G + +L +L LDL N L+ G + L+ L L FN
Sbjct: 326 SLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN 383
Query: 439 KLAGSIPDQLCHLARLNTLGLAGNKFSGSIP-SCLGNLTSLRSPDLGSNRLTSVLPSTFW 497
+ ++ L +L L + S +L +L D+ F
Sbjct: 384 GVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 442
Query: 498 NLKDILFFDLSSNSLDGPLSLDI-GNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLA 556
L + ++ NS DI LR + ++LS+ P+ L LQ +++A
Sbjct: 443 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMA 502
Query: 557 CNGLEGLIPESFGYLT---ELNLSFNKLEGEIPRGGPFANF 594
N L+ + F LT ++ L N + PR + +
Sbjct: 503 SNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRW 543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-37
Identities = 90/436 (20%), Positives = 159/436 (36%), Gaps = 44/436 (10%)
Query: 96 NSHRVTALNISSLNLQ-GTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKF---- 150
+ + LN++ +Q +P NL++L L+LS NK+ + +H++
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS 181
Query: 151 LDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQ 210
LD S N ++ + F + + L ++ S + L L+V L F +
Sbjct: 182 LDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE 240
Query: 211 IPL------ALSKCKRLQLLNLGFKKLSG---AIPKEISNLTILRKISLRNNKLRGEIPH 261
L AL L + L I + LT + SL + + +
Sbjct: 241 GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKD 299
Query: 262 EIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERL 321
++L L + ++K++ N +FS + LP++E L
Sbjct: 300 FSY-NFGWQHLELVNCKFGQFPT---LKLKSLKRLTFTSNKGGNAFSE---VDLPSLEFL 352
Query: 322 NLGLNR--FSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLS 379
+L N F G + L YLD+ N + N +GL
Sbjct: 353 DLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLE---------------- 396
Query: 380 MSLENIYISNCNIGGSIPQ-LISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFN 438
LE++ + N+ + +L NL+ LD+ + F L L+ L + N
Sbjct: 397 -QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 455
Query: 439 KLAGSI-PDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFW 497
+ PD L L L L+ + P+ +L+SL+ ++ SN+L SV F
Sbjct: 456 SFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFD 515
Query: 498 NLKDILFFDLSSNSLD 513
L + L +N D
Sbjct: 516 RLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-23
Identities = 50/235 (21%), Positives = 84/235 (35%), Gaps = 8/235 (3%)
Query: 377 NLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLP 436
NL S +N+ +S + + L +LDL ++ + L L L L
Sbjct: 25 NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84
Query: 437 FNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSV-LPST 495
N + L+ L L + +G+L +L+ ++ N + S LP
Sbjct: 85 GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 496 FWNLKDILFFDLSSNSLDGPLSLDIGNLR----VVIGINLSRNNFSGDIPSTIGDLKDLQ 551
F NL ++ DLSSN + D+ L + + ++LS N + I L
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLH 203
Query: 552 NISLACNGLEGLIPE-SFGYLTELNLSFNKLEGEIPRGGPFANFTAKSFMGNEKL 605
++L N + + L L + L GE G F + G L
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVL-GEFRNEGNLEKFDKSALEGLCNL 257
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 8e-45
Identities = 92/494 (18%), Positives = 185/494 (37%), Gaps = 71/494 (14%)
Query: 99 RVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQL 158
+ + I+ I L+ L ++ + + ++ L +
Sbjct: 2 PLGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI 58
Query: 159 SGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKC 218
S+ V YL+ L + + N P L
Sbjct: 59 K-SIDGV--------------------------EYLNNLTQINFSNNQLTDITP--LKNL 89
Query: 219 KRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNN 278
+L + + +++ P ++NLT L ++L NN++ P + L NL L L N
Sbjct: 90 TKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNT 145
Query: 279 LVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITN 338
+ + + +++++++ N + L +L +ERL++ N+ S S +
Sbjct: 146 ISDISA--LSGLTSLQQLS-FGNQVTDLKPLA---NLTTLERLDISSNKVSD--ISVLAK 197
Query: 339 ASKLVYLDMGTNSFSGIIP-------NTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCN 391
+ L L N S I P + + L GN L + ++ +L+ +L ++ ++N
Sbjct: 198 LTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDI--GTLASLT-NLTDLDLANNQ 254
Query: 392 IGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHL 451
I P +S L+ L L L N+++ P L L L L N+L P + +L
Sbjct: 255 ISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNL 308
Query: 452 ARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNS 511
L L L N S P + +LT L+ +N+++ S+ NL +I + N
Sbjct: 309 KNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQ 364
Query: 512 LDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESF--- 568
+ + NL + + L+ ++ + ++ + L + P +
Sbjct: 365 ISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL--IAPATISDG 420
Query: 569 GYLTELNLSFNKLE 582
G TE ++++N
Sbjct: 421 GSYTEPDITWNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-42
Identities = 102/490 (20%), Positives = 175/490 (35%), Gaps = 79/490 (16%)
Query: 100 VTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLS 159
VT L L + + L++LT +N S+N+L+ DI P + + KL + ++NQ++
Sbjct: 48 VTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLT-DITP-LKNLTKLVDILMNNNQIA 103
Query: 160 GSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCK 219
+ N L L L L N P L
Sbjct: 104 D--------------------------ITPLAN-LTNLTGLTLFNNQITDIDP--LKNLT 134
Query: 220 RLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNL 279
L L L +S +S LT L+++S N + L LE L + N +
Sbjct: 135 NLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD---LKPLANLTTLERLDISSNKV 189
Query: 280 VGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNA 339
+ + ++ ++ + +N + LG L N++ L+L N+ + +
Sbjct: 190 SD--ISVLAKLTNLESLIATNNQISDITPLG---ILTNLDELSLNGNQLKD--IGTLASL 242
Query: 340 SKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQL 399
+ L LD+ N S + P + L+ L + + I P
Sbjct: 243 TNLTDLDLANNQISNLAP-----------------LSGLT-KLTELKLGANQISNISP-- 282
Query: 400 ISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGL 459
++ L+ L L+L N+L P L+ L L L FN ++ P + L +L L
Sbjct: 283 LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFF 338
Query: 460 AGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLD 519
NK S S L NLT++ G N+++ + P NL I L+ + +
Sbjct: 339 YNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT---NAP 391
Query: 520 IGNLRVVIGINLSRNNFSGDI-PSTIGDLKDLQNISLACNGLEGL--IPESFGYLTELNL 576
+ V N +N I P+TI D + N + +F +
Sbjct: 392 VNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGK 451
Query: 577 SFNKLEGEIP 586
G +
Sbjct: 452 GTTTFSGTVT 461
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 5e-43
Identities = 90/492 (18%), Positives = 188/492 (38%), Gaps = 27/492 (5%)
Query: 103 LNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFT-MHKLKFLDFSDNQLSGS 161
+ S + +IP L +++ +L+LS NK++ I L+ L ++++ +
Sbjct: 10 CDGRSRSFT-SIPSGL--TAAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRIN-T 64
Query: 162 LSSVTF-NLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHG-QIPLALSKCK 219
+ F +L S+ + L + LS L + L LK L L N + +
Sbjct: 65 IEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLT 123
Query: 220 RLQLLNLGFKKLSGAIPKE-ISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNN 278
LQ L +G + I + + LT L ++ ++ LR + + ++ +L L +
Sbjct: 124 NLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSE 183
Query: 279 LVGVVPAAIFNMSTVKKIYLLDNSL--LGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFI 336
++ +S+V+ + L D +L L +D +++L + + + +
Sbjct: 184 SAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNEL 243
Query: 337 TNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSI 396
+ L++ F N +G V+ ++++ ++I + +
Sbjct: 244 LKLLRY-ILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDL 302
Query: 397 PQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQ---LCHLAR 453
+ S L + + +E +K+ L+ L+ L L N +
Sbjct: 303 STVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPS 362
Query: 454 LNTLGLAGNKFS--GSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNS 511
L TL L+ N L L +L S D+ N +P + + + F +LSS
Sbjct: 363 LQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTG 421
Query: 512 LDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESF-GY 570
+ + + + +++S NN L LQ + ++ N L+ L S
Sbjct: 422 IR---VVKTCIPQTLEVLDVSNNNLD-SFSL---FLPRLQELYISRNKLKTLPDASLFPV 474
Query: 571 LTELNLSFNKLE 582
L + +S N+L+
Sbjct: 475 LLVMKISRNQLK 486
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 5e-38
Identities = 96/494 (19%), Positives = 170/494 (34%), Gaps = 51/494 (10%)
Query: 104 NISSLNLQG----TIPPQ-LGNLSSLTTLNLSHNKLSGDIPPSIFT-MHKLKFLDFSDNQ 157
N+ L L+ TI +L SL L+LS N LS + S F + LK+L+ N
Sbjct: 51 NLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNP 109
Query: 158 LSGSLSSVTF-NLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALS 216
+ F NL+++ +R+ + + E+ L L L + +L
Sbjct: 110 YQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLK 169
Query: 217 KCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGF 276
+ + L L + + + L+ +R + LR+ L + +
Sbjct: 170 SIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLA 229
Query: 277 NNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNL-GLNRFSGTIPSF 335
+ + N LL ++LS + L GL F+ +
Sbjct: 230 FRGSVLTDESF-------------NELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDV 276
Query: 336 ITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGS 395
++ K+ + + + L L T L ++ I + N +
Sbjct: 277 VSELGKVETVTIRRLH----------IPQFYLFYDLSTVYSLLE-KVKRITVENSKVFLV 325
Query: 396 IPQLISNLSNLLLLDLEGNKLTGSIPVT---FGRLQKLQGLYLPFNKLA--GSIPDQLCH 450
+L +L LDL N + G LQ L L N L + L
Sbjct: 326 PCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLT 385
Query: 451 LARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSN 510
L L +L ++ N F +P +R +L S + V L+ D+S+N
Sbjct: 386 LKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLE---VLDVSNN 441
Query: 511 SLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFGY 570
+LD SL + L+ + +SRN +P L + ++ N L+ + F
Sbjct: 442 NLDS-FSLFLPRLQE---LYISRNKLK-TLPDASL-FPVLLVMKISRNQLKSVPDGIFDR 495
Query: 571 ---LTELNLSFNKL 581
L ++ L N
Sbjct: 496 LTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 3e-17
Identities = 40/194 (20%), Positives = 76/194 (39%), Gaps = 7/194 (3%)
Query: 395 SIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARL 454
SIP ++ + + LDL NK+T LQ L L +++ D L L
Sbjct: 19 SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSL 76
Query: 455 NTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSV-LPSTFWNLKDILFFDLSS-NSL 512
L L+ N S S G L+SL+ +L N ++ + S F NL ++ + + +
Sbjct: 77 EHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETF 136
Query: 513 DGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFGYLT 572
+D L + + + + ++ ++D+ +++L + L+ L+
Sbjct: 137 SEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILS 196
Query: 573 ---ELNLSFNKLEG 583
L L L
Sbjct: 197 SVRYLELRDTNLAR 210
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 4e-42
Identities = 101/529 (19%), Positives = 175/529 (33%), Gaps = 59/529 (11%)
Query: 97 SHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFT-MHKLKFLDFSD 155
S NL +P L++ L LS N + + S F + +L+ L+
Sbjct: 3 SFDGRIAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIR-TVTASSFPFLEQLQLLELGS 57
Query: 156 NQLSGSLSSVTF-NLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQI--P 212
++ F NL ++ + L S K+ L + L +L L L +
Sbjct: 58 QYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKD 116
Query: 213 LALSKCKRLQLLNLGFKKLSG-AIPKEISNLTILRKISLRNNKLRGEIPHEIGYL--PNL 269
K L L+L ++ + L L+ I +N++ HE+ L L
Sbjct: 117 GYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTL 176
Query: 270 ENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFS 329
L N+L V + +L+ + V+ N S
Sbjct: 177 SFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGW-------TVDITGNFSNAIS 229
Query: 330 GTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISN 389
+ + A ++ G ++ NT G S+ ++ +S+
Sbjct: 230 KSQAFSLILAHHIMGAGFGFHNIKDPDQNTFA--------------GLARSSVRHLDLSH 275
Query: 390 CNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLC 449
+ ++ L +L +L+L NK+ F L LQ L L +N L
Sbjct: 276 GFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFY 335
Query: 450 HLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSS 509
L ++ + L N + L L++ DL N LT++ ++ DI LS
Sbjct: 336 GLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI--HFIPSIPDI---FLSG 390
Query: 510 NSLDGPLSLDIGNLRVVIGINLSRNNFSG-DIPSTIGDLKDLQNISLACNGLEGLIPESF 568
N L +++ I+LS N DI + + LQ + L N +
Sbjct: 391 NKLVTLPKINLTANL----IHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQT 446
Query: 569 GY----LTELNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPNLQF 613
L +L L N L+ + F GL +LQ
Sbjct: 447 PSENPSLEQLFLGENMLQLAWETELCWDVFE-----------GLSHLQV 484
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-41
Identities = 106/535 (19%), Positives = 183/535 (34%), Gaps = 61/535 (11%)
Query: 104 NISSLNLQG----TIPPQ-LGNLSSLTTLNLSHNKLSGD-IPPSIFT-MHKLKFLDFSDN 156
N+ L+L + P L L L L LS + F + L LD S N
Sbjct: 74 NLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKN 133
Query: 157 QLSGSLSSVTF-NLSSVLDIRLDSDKLSGELPVNICNYLH--YLKVLFLAKNMFHGQIPL 213
Q+ +F L+S+ I S+++ + + L L LA N + ++ +
Sbjct: 134 QIRSLYLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEPLQGKTLSFFSLAANSLYSRVSV 192
Query: 214 ALSKC-KRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENL 272
KC + + L +SG N + +N + + ++
Sbjct: 193 DWGKCMNPFRNMVLEILDVSG-------NGWTVDITGNFSNAISKSQAFSLILAHHIMGA 245
Query: 273 VLGFNNLVGVVPAAIFNM--STVKKIYLLDNSLLGSFSLGIDL--SLPNVERLNLGLNRF 328
GF+N+ + S+V+ + L + FSL + +L +++ LNL N+
Sbjct: 246 GFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFV---FSLNSRVFETLKDLKVLNLAYNKI 302
Query: 329 SGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYIS 388
+ L L+ L+ N L + ++ L + I +
Sbjct: 303 NKIADEAFYGLDNLQVLN---------------LSYNLLGELYSSNFYGLP-KVAYIDLQ 346
Query: 389 NCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQL 448
+I Q L L LDL N LT T + + ++L NKL ++P
Sbjct: 347 KNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV-TLPKIN 400
Query: 449 CHLARLNTLGLAGNKFSG-SIPSCLGNLTSLRSPDLGSNRLTSVLPS-TFWNLKDILFFD 506
N + L+ N+ I L + L+ L NR +S T +
Sbjct: 401 L---TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLF 457
Query: 507 LSSNSLDGPLSLDI-----GNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLE 561
L N L ++ L + + L+ N + P L L+ +SL N L
Sbjct: 458 LGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT 517
Query: 562 GLIPESF-GYLTELNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPNLQFPK 615
L L L++S N+L P F + + N+ +C F
Sbjct: 518 VLSHNDLPANLEILDISRNQL--LAPNPDVFVSLSVLDITHNKFICECELSTFIN 570
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-28
Identities = 94/439 (21%), Positives = 150/439 (34%), Gaps = 60/439 (13%)
Query: 103 LNISSLNLQGTIPPQLGNLS------SLTTLNLSHNKLSGDIP------------PSIFT 144
++++ +L + G L L++S N + DI S+
Sbjct: 179 FSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLIL 238
Query: 145 MHKLKFLDFSDNQLSGSLSSVTF---NLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLF 201
H + F + + TF SSV + L + L + L LKVL
Sbjct: 239 AHHIMGAGFGFHNIK-DPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLN 296
Query: 202 LAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPH 261
LA N + A LQ+LNL + L L + I L+ N +
Sbjct: 297 LAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQ 356
Query: 262 EIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERL 321
+L L+ L L N L I + ++ I+L N L+ + + +
Sbjct: 357 TFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINLTA-----NLI 406
Query: 322 NLGLNRFSG-TIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSM 380
+L NR I F+ L L + N FS + + NP
Sbjct: 407 HLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQT-PSENP-------------- 451
Query: 381 SLENIYISNCNIGGSI-----PQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYL 435
SLE +++ + + + LS+L +L L N L P F L L+GL L
Sbjct: 452 SLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSL 511
Query: 436 PFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLP-S 494
N+L + L A L L ++ N+ P SL D+ N+ S
Sbjct: 512 NSNRLTVLSHNDL--PANLEILDISRNQLLAPNPD---VFVSLSVLDITHNKFICECELS 566
Query: 495 TFWNLKDILFFDLSSNSLD 513
TF N + ++ D
Sbjct: 567 TFINWLNHTNVTIAGPPAD 585
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 2e-40
Identities = 72/371 (19%), Positives = 148/371 (39%), Gaps = 45/371 (12%)
Query: 215 LSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVL 274
+ L ++ + L + K+ + K+ I I YL NLE L L
Sbjct: 18 DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNL 73
Query: 275 GFNNLVGVVPAAIFNMSTVKKIYLLDNSL--LGSFSLGIDLSLPNVERLNLGLNRFSGTI 332
N + + P + N+ + +Y+ N + + + +L N+ L L + S
Sbjct: 74 NGNQITDISP--LSNLVKLTNLYIGTNKITDISALQ-----NLTNLRELYLNEDNISD-- 124
Query: 333 PSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNI 392
S + N +K+ L++G N + + N++ L + ++ +
Sbjct: 125 ISPLANLTKMYSLNLGANHNLSDLSP----------------LSNMT-GLNYLTVTESKV 167
Query: 393 GGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLA 452
P I+NL++L L L N++ P L L N++ P + ++
Sbjct: 168 KDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMT 221
Query: 453 RLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSL 512
RLN+L + NK + P L NL+ L ++G+N+++ + + +L + ++ SN +
Sbjct: 222 RLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQI 277
Query: 513 DGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIP-ESFGYL 571
+ NL + + L+ N + IG L +L + L+ N + + P S +
Sbjct: 278 SDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKM 335
Query: 572 TELNLSFNKLE 582
+ + ++
Sbjct: 336 DSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 5e-39
Identities = 79/412 (19%), Positives = 157/412 (38%), Gaps = 69/412 (16%)
Query: 101 TALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSG 160
L + P +L+ L ++ + + L + +++
Sbjct: 3 ATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQEELE--SITKLVVAGEKVA- 57
Query: 161 SLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKR 220
S+ + YL L+ L L N PL S +
Sbjct: 58 SIQGI--------------------------EYLTNLEYLNLNGNQITDISPL--SNLVK 89
Query: 221 LQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLV 280
L L +G K++ + NLT LR++ L + + P + L + +L LG N+ +
Sbjct: 90 LTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNL 145
Query: 281 GVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNAS 340
+ + NM+ + + + ++ + + +L ++ L+L N+ P + + +
Sbjct: 146 SD-LSPLSNMTGLNYLTVTESKVKDVTPIA---NLTDLYSLSLNYNQIEDISP--LASLT 199
Query: 341 KLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLI 400
L Y N + I P + N++ L ++ I N I P +
Sbjct: 200 SLHYFTAYVNQITDITP-----------------VANMT-RLNSLKIGNNKITDLSP--L 239
Query: 401 SNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLA 460
+NLS L L++ N+++ I L KL+ L + N++ S L +L++LN+L L
Sbjct: 240 ANLSQLTWLEIGTNQIS-DIN-AVKDLTKLKMLNVGSNQI--SDISVLNNLSQLNSLFLN 295
Query: 461 GNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSL 512
N+ +G LT+L + L N +T + P +L + D ++ +
Sbjct: 296 NNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-34
Identities = 75/366 (20%), Positives = 161/366 (43%), Gaps = 43/366 (11%)
Query: 100 VTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLS 159
+ ++ + L S+T L ++ K++ I I + L++L+ + NQ++
Sbjct: 24 GIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQIT 79
Query: 160 GSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCK 219
+S ++ NL + ++ + ++K++ + N L L+ L+L ++ PL +
Sbjct: 80 -DISPLS-NLVKLTNLYIGTNKITD--ISALQN-LTNLRELYLNEDNISDISPL--ANLT 132
Query: 220 RLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNL 279
++ LNLG +SN+T L +++ +K++ P I L +L +L L +N +
Sbjct: 133 KMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQI 189
Query: 280 VGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNA 339
+ P + +++++ N + + ++ + L +G N+ + P + N
Sbjct: 190 EDISP--LASLTSLHYFTAYVNQITDITPVA---NMTRLNSLKIGNNKITDLSP--LANL 242
Query: 340 SKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQL 399
S+L +L++GTN S I ++ +L+ L+ + + + I S +
Sbjct: 243 SQLTWLEIGTNQISDI-----------------NAVKDLT-KLKMLNVGSNQI--SDISV 282
Query: 400 ISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGL 459
++NLS L L L N+L G L L L+L N + P L L+++++
Sbjct: 283 LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADF 340
Query: 460 AGNKFS 465
A
Sbjct: 341 ANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 6e-31
Identities = 70/344 (20%), Positives = 134/344 (38%), Gaps = 41/344 (11%)
Query: 245 LRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLL 304
++ + P L VL ++ VV + ++ K+ + +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 305 GSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTG 364
+ L N+E LNL N+ + P ++N KL L +GTN + I
Sbjct: 58 SIQGIE---YLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--------- 103
Query: 365 NPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTF 424
+++ NL+ +L +Y++ NI P ++NL+ + L+L N +
Sbjct: 104 --------SALQNLT-NLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PL 151
Query: 425 GRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLG 484
+ L L + +K+ P + +L L +L L N+ P L +LTSL
Sbjct: 152 SNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAY 207
Query: 485 SNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTI 544
N++T + P N+ + + +N + L NL + + + N S + +
Sbjct: 208 VNQITDITP--VANMTRLNSLKIGNNKITDLSPL--ANLSQLTWLEIGTNQISD--INAV 261
Query: 545 GDLKDLQNISLACNGLEGLIP-ESFGYLTELNLSFNKLEGEIPR 587
DL L+ +++ N + + + L L L+ N+L E
Sbjct: 262 KDLTKLKMLNVGSNQISDISVLNNLSQLNSLFLNNNQLGNEDME 305
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-37
Identities = 87/487 (17%), Positives = 167/487 (34%), Gaps = 80/487 (16%)
Query: 114 IPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVL 173
I P+ + + L + L+ ++P + + ++ + +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 174 DIRLDSDKLSG------------ELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRL 221
RL LP + L+ L + N ++P K L
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLSSLPELPPH----LESLVASCNSLT-ELPELPQSLKSL 116
Query: 222 QLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVG 281
+ N K LS P L + + NN+L ++P E+ L+ + + N+L
Sbjct: 117 LVDNNNLKALSDLPPL-------LEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK- 166
Query: 282 VVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASK 341
+P ++ + I +N L L +LP + + N +P +
Sbjct: 167 KLPDLPPSL---EFIAAGNNQLEELPELQ---NLPFLTAIYADNNSLK-KLPDLPLS--- 216
Query: 342 LVYLDMGTNSFSGI--IPN-----TIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGG 394
L + G N + + N TI N L LP +L E + + + +
Sbjct: 217 LESIVAGNNILEELPELQNLPFLTTIYADNNLL-KTLPDLPPSL----EALNVRDNYLT- 270
Query: 395 SIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARL 454
+P+L +L+ L + + + L+ P L L N++ S+ D L L
Sbjct: 271 DLPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEIR-SLCDLPPSLEEL 322
Query: 455 NTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDG 514
N ++ NK +P+ L L N L +P NLK + + N L
Sbjct: 323 N---VSNNKLI-ELPALPPRLERL---IASFNHLAE-VPELPQNLKQL---HVEYNPLRE 371
Query: 515 PLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFGYLTEL 574
++ +L N+ ++P +LK L + N L P+ + +L
Sbjct: 372 -FPDIPESVE-----DLRMNSHLAEVPELPQNLKQL---HVETNPLREF-PDIPESVEDL 421
Query: 575 NLSFNKL 581
++ ++
Sbjct: 422 RMNSERV 428
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-32
Identities = 78/432 (18%), Positives = 146/432 (33%), Gaps = 73/432 (16%)
Query: 99 RVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQL 158
+ L +++L L ++P +L +L S N L+ ++P ++ L + + L
Sbjct: 72 QAHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL 126
Query: 159 SGSLSSVT---------------FNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLA 203
S + N S + I +D++ L +LP + L+ +
Sbjct: 127 SDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPS----LEFIAAG 181
Query: 204 KNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEI 263
N ++P L L + L +P +L + NN L E E+
Sbjct: 182 NNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLSLESI---VAGNNIL--EELPEL 233
Query: 264 GYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNL 323
LP L + N L +P ++ + + + DN L + ++ L++
Sbjct: 234 QNLPFLTTIYADNNLLK-TLPDLPPSL---EALNVRDNYLTD-----LPELPQSLTFLDV 284
Query: 324 GLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLT-----GNPLDGVLPTSIGNL 378
N FS + N L YL+ +N + L N L LP L
Sbjct: 285 SENIFS-GLSELPPN---LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL 339
Query: 379 SMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFN 438
E + S ++ +P+L NL L +E N L P ++ L+ N
Sbjct: 340 ----ERLIASFNHLA-EVPELPQNLKQL---HVEYNPLR-EFPDIPESVEDLR-----MN 385
Query: 439 KLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWN 498
+P+ +L +L+ + N P ++ L + S R+
Sbjct: 386 SHLAEVPELPQNLKQLH---VETNPLR-EFPDIPESVEDL---RMNSERVVDPYEFAHET 438
Query: 499 LKDILFFDLSSN 510
+ +
Sbjct: 439 TDKLEDDVFEHH 450
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-24
Identities = 64/356 (17%), Positives = 124/356 (34%), Gaps = 55/356 (15%)
Query: 116 PQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDI 175
P+L N S L +++ +N L +P L+F+ +NQL L + NL + I
Sbjct: 147 PELQNSSFLKIIDVDNNSLK-KLPDLP---PSLEFIAAGNNQLE-ELPELQ-NLPFLTAI 200
Query: 176 RLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAI 235
D++ L +LP + L+ + N+ L L + L +
Sbjct: 201 YADNNSLK-KLPDLPLS----LESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TL 252
Query: 236 PKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKK 295
P +L L ++R+N L ++P L L+ F+ L + P +
Sbjct: 253 PDLPPSLEAL---NVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP-------NLYY 301
Query: 296 IYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGI 355
+ N + L P++E LN+ N+ +P+ L L N + +
Sbjct: 302 LNASSNEIRSLCDL-----PPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLAEV 352
Query: 356 IPNTIG------LTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLL 409
P + NPL P ++ E++ +++ + ++ NL L
Sbjct: 353 -PELPQNLKQLHVEYNPLR-EFPDIPESV----EDLRMNS-----HLAEVPELPQNLKQL 401
Query: 410 DLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFS 465
+E N L P + ++ L + ++ +L +
Sbjct: 402 HVETNPLR-EFPDI---PESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-24
Identities = 67/349 (19%), Positives = 109/349 (31%), Gaps = 60/349 (17%)
Query: 235 IPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVK 294
I + T L++ ++ L E+P E + + ++ P +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 295 KIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSG 354
L D L L S ++P + L L NS +
Sbjct: 62 VSRLRDCLD------------RQAHELELNNLGLS-SLPELPPH---LESLVASCNSLT- 104
Query: 355 IIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGN 414
LP +L SL + + P L L + N
Sbjct: 105 ---------------ELPELPQSLK-SLLVDNNNLKALSDLPPLLEY-------LGVSNN 141
Query: 415 KLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGN 474
+L +P L+ + + N L +PD L + N+ +P L N
Sbjct: 142 QLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIA---AGNNQLE-ELPE-LQN 193
Query: 475 LTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRN 534
L L + +N L LP +L+ I +N L+ ++ NL + I N
Sbjct: 194 LPFLTAIYADNNSLKK-LPDLPLSLESI---VAGNNILEELP--ELQNLPFLTTIYADNN 247
Query: 535 NFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFGYLTELNLSFNKLEG 583
+P L+ L + N L L PE LT L++S N G
Sbjct: 248 LLK-TLPDLPPSLEALN---VRDNYLTDL-PELPQSLTFLDVSENIFSG 291
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-20
Identities = 56/340 (16%), Positives = 106/340 (31%), Gaps = 63/340 (18%)
Query: 101 TALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSG 160
+ + L P+L NL LT + +N L +P L+ + +N L
Sbjct: 176 EFIAAGNNQL--EELPELQNLPFLTAIYADNNSLK-KLPDLP---LSLESIVAGNNILE- 228
Query: 161 SLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKR 220
L + NL + I D++ L LP + L+ L + N +P
Sbjct: 229 ELPELQ-NLPFLTTIYADNNLLK-TLPDLPPS----LEALNVRDNYLT-DLPELPQSLTF 281
Query: 221 LQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLV 280
L + F L + NL L + +N++R + P+LE L + N L+
Sbjct: 282 LDVSENIFSGL----SELPPNLYYL---NASSNEIR-SLCDL---PPSLEELNVSNNKLI 330
Query: 281 GVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNAS 340
+ P +ERL N + +P N
Sbjct: 331 E-----------------------------LPALPPRLERLIASFNHLA-EVPELPQN-- 358
Query: 341 KLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLI 400
L L + N P+ + + L +L+ +++ + P +
Sbjct: 359 -LKQLHVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIP 415
Query: 401 SNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKL 440
++ +L + ++ KL+ +
Sbjct: 416 ESVEDL---RMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-36
Identities = 57/188 (30%), Positives = 86/188 (45%), Gaps = 25/188 (13%)
Query: 662 LRRFSYQDLFRATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKS-FEA 720
L+RFS ++L A++ FS +N++G G FG VYKGRL DG VA+K + + F+
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 721 ECEVMKNIRHRNHVKRISSCSNEDFKAL-----------DCLHSTNCSLNIFD---KLNI 766
E E++ HRN ++ C + L CL S D + I
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 767 MIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETL 816
+ A L YLH +IH D+K N+ DFG+ +L+ + + T
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196
Query: 817 VTIGYMAP 824
TIG++AP
Sbjct: 197 GTIGHIAP 204
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 57/197 (28%), Positives = 80/197 (40%), Gaps = 28/197 (14%)
Query: 653 SIRGGKSKTLRRFSYQDLFRATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCA 712
S R DL AT F + LIG G FG VYKG L DG +VA+K +
Sbjct: 17 SSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS 76
Query: 713 MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL-----------DCLHSTNCSLNIF 761
++ FE E E + RH + V I C + L L+ ++
Sbjct: 77 QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSM 136
Query: 762 D---KLNIMIDVASALEYLHFSHSTPVIHCDLKPKN----------VFDFGIGRL-LTGD 807
+L I I A L YL H+ +IH D+K N + DFGI + D
Sbjct: 137 SWEQRLEICIGAARGLHYL---HTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD 193
Query: 808 RSMIQTETLVTIGYMAP 824
++ + T T+GY+ P
Sbjct: 194 QTHLSTVVKGTLGYIDP 210
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 53/337 (15%), Positives = 109/337 (32%), Gaps = 41/337 (12%)
Query: 260 PHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVE 319
H + ENL + + + ++ Y D + S + + P +E
Sbjct: 5 HHHHHHSSGRENLYFQGSTALRPYHDVLSQW---QRHYNADRNRWHSAWRQANSNNPQIE 61
Query: 320 RLNLGLNRFSGTIPSFITNAS--KLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGN 377
+ + +A+ V L++ + P
Sbjct: 62 TRTGRALK---ATADLLEDATQPGRVALELRSVPLP----------------QFPDQAFR 102
Query: 378 LSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPF 437
LS L+++ I + +P + + L L L N L ++P + L +L+ L +
Sbjct: 103 LS-HLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRA 159
Query: 438 NKLAGSIPDQLC---------HLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRL 488
+P+ L L L +L L S+P+ + NL +L+S + ++ L
Sbjct: 160 CPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPL 218
Query: 489 TSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLK 548
++ L +L + DL + G + + L + +P I L
Sbjct: 219 SA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLT 277
Query: 549 DLQNISLACNGLEGLIPESFGYLT---ELNLSFNKLE 582
L+ + L +P L + + +
Sbjct: 278 QLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 56/320 (17%), Positives = 103/320 (32%), Gaps = 22/320 (6%)
Query: 197 LKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLR 256
+ L+ + LS+ +R + +N + + L+
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGRALK 69
Query: 257 GEIPHEIGYL--PNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLG-SFSLGIDL 313
+ P L L L P F +S ++ + + L+ ++
Sbjct: 70 -ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLMELPDTMQ--- 124
Query: 314 SLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPT 373
+E L L N +P+ I + ++L L + +P +
Sbjct: 125 QFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLA------STDASG 177
Query: 374 SIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGL 433
L +L+++ + I S+P I+NL NL L + + L+ ++ L KL+ L
Sbjct: 178 EHQGLV-NLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEEL 234
Query: 434 YLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLP 493
L + P A L L L ++P + LT L DL S LP
Sbjct: 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLP 294
Query: 494 STFWNLKDILFFDLSSNSLD 513
S L + +
Sbjct: 295 SLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 64/385 (16%), Positives = 117/385 (30%), Gaps = 71/385 (18%)
Query: 112 GTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSS 171
G+ + S L + + + D + + + N ++
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNN 57
Query: 172 VLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQL--LNLGFK 229
++ L L + L L
Sbjct: 58 P------------QIETRTGRALKAT--------------ADLLEDATQPGRVALELRSV 91
Query: 230 KLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFN 289
L P + L+ L+ +++ L E+P + LE L L N L +PA+I +
Sbjct: 92 PLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIAS 148
Query: 290 MSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGT 349
++ ++++ + L LP L S L L +
Sbjct: 149 LNRLRELSIRACPELTE--------LPE----PLA----STDASGEHQGLVNLQSLRLEW 192
Query: 350 NSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLL 409
LP SI NL +L+++ I N + ++ I +L L L
Sbjct: 193 TGIR----------------SLPASIANLQ-NLKSLKIRNSPLS-ALGPAIHHLPKLEEL 234
Query: 410 DLEGNKLTGSIPVTFGRLQKLQGLYLP-FNKLAGSIPDQLCHLARLNTLGLAGNKFSGSI 468
DL G + P FG L+ L L + L ++P + L +L L L G +
Sbjct: 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRL 293
Query: 469 PSCLGNLTSLRSPDLGSNRLTSVLP 493
PS + L + + + +
Sbjct: 294 PSLIAQLPANCIILVPPHLQAQLDQ 318
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 52/378 (13%), Positives = 102/378 (26%), Gaps = 69/378 (18%)
Query: 103 LNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSL 162
L L + + + S + + + L
Sbjct: 17 LYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANS----NNPQIETRTGRALK--- 69
Query: 163 SSVTFNLSSVLDIRLDSDKLSGELPVNICN-YLHYLKVLFLAKNMFHGQIPLALSKCKRL 221
+ + L L Q P + L
Sbjct: 70 ----------------------ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHL 106
Query: 222 QLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVG 281
Q + + L +P + L ++L N LR +P I L L L + +
Sbjct: 107 QHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELT 164
Query: 282 VVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASK 341
+P + + + L N++ L L ++P+ I N
Sbjct: 165 ELPEPLASTDASGEHQ----------------GLVNLQSLRLEWTGIR-SLPASIANLQN 207
Query: 342 LVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLIS 401
L L + + S L +I +L LE + + C + P +
Sbjct: 208 LKSLKIRNSPLSA----------------LGPAIHHLP-KLEELDLRGCTALRNYPPIFG 250
Query: 402 NLSNLLLLDLEG-NKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLA 460
+ L L L+ + L ++P+ RL +L+ L L +P + L + +
Sbjct: 251 GRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVP 309
Query: 461 GNKFSGSIPSCLGNLTSL 478
+ + +
Sbjct: 310 PHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 21/146 (14%), Positives = 37/146 (25%), Gaps = 29/146 (19%)
Query: 466 GSIPSCLGNLTSLRSPDL-GSNRLTSVLPSTFWNLKDILFFDLSSNSLDG---------- 514
GS + + + GS L + D +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRP-YHDVLSQWQRHYNADRNRWHSAWRQANSNNPQI 60
Query: 515 -----------PLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGL 563
L+ + + L P L LQ++++ GL L
Sbjct: 61 ETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLMEL 119
Query: 564 IPESFGYLT---ELNLSFNKLEGEIP 586
P++ L L+ N L +P
Sbjct: 120 -PDTMQQFAGLETLTLARNPLR-ALP 143
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-33
Identities = 71/400 (17%), Positives = 144/400 (36%), Gaps = 35/400 (8%)
Query: 211 IPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLE 270
I L +++ + E L + ++ +N+ +R + +E
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 271 NLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSG 330
L L + + A T++K+Y+ N++ + ++P + L L N S
Sbjct: 73 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAI-RYLPPHVFQNVPLLTVLVLERNDLS- 130
Query: 331 TIPSFI-TNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISN 389
++P I N KL L ++ N L+ + + + SL+N+ +S+
Sbjct: 131 SLPRGIFHNTPKLTTLS---------------MSNNNLERIEDDTFQATT-SLQNLQLSS 174
Query: 390 CNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLC 449
+ + +S + +L ++ N L+ T ++ L N + + +
Sbjct: 175 NRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV- 224
Query: 450 HLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSS 509
L L L N + L N L DL N L ++ F ++ + +S+
Sbjct: 225 -NVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN 281
Query: 510 NSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFG 569
N L L+L + + ++LS N+ + L+N+ L N + L +
Sbjct: 282 NRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHH 339
Query: 570 YLTELNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLP 609
L L LS N + F N + ++ C +
Sbjct: 340 TLKNLTLSHNDWD-CNSLRALFRNVARPAVDDADQHCKID 378
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-32
Identities = 68/414 (16%), Positives = 141/414 (34%), Gaps = 90/414 (21%)
Query: 103 LNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFT-MHKLKFLDFSDNQLSGS 161
++I + L++ + ++ + +P ++ +++ L+ +D Q+
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-- 82
Query: 162 LSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRL 221
E+ Y H ++ L++ N
Sbjct: 83 -----------------------EIDTYAFAYAHTIQKLYMGFNAIR------------- 106
Query: 222 QLLNLGFKKLSGAIPKEI-SNLTILRKISLRNNKLRGEIPHEI-GYLPNLENLVLGFNNL 279
+P + N+ +L + L N L +P I P L L + NNL
Sbjct: 107 ------------YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNL 153
Query: 280 VGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNA 339
+ ++++ + L N L L + +P++ N+ N S +
Sbjct: 154 ERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL---IPSLFHANVSYNLL-----STLAIP 204
Query: 340 SKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQL 399
+ LD NS + + +++ L + + + N+ L
Sbjct: 205 IAVEELDASHNSINVVRG-------------------PVNVELTILKLQHNNL-TDTAWL 244
Query: 400 ISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGL 459
N L+ +DL N+L + F ++Q+L+ LY+ N+L ++ + L L L
Sbjct: 245 -LNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDL 302
Query: 460 AGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLD 513
+ N + L + L N + ++ ST LK++ LS N D
Sbjct: 303 SHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNL---TLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-28
Identities = 71/402 (17%), Positives = 131/402 (32%), Gaps = 70/402 (17%)
Query: 71 PTNLLAQNSTSNTSVCNWIGITCNVNSHRVTALNISSLNLQG----TIPPQ-LGNLSSLT 125
+NL + + + +T N + + +P L + +
Sbjct: 14 DSNLQYDCVFYDVHI-DMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 126 TLNLSHNKLSGDIPPSIFT-MHKLKFLDFSDNQLSGSLSSVTF-NLSSVLDIRLDSDKLS 183
LNL+ ++ +I F H ++ L N + L F N+ + + L+ + LS
Sbjct: 73 LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 130
Query: 184 GELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLT 243
LP I + L L ++ N LQ L L +L+ + +S +
Sbjct: 131 -SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIP 186
Query: 244 ILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSL 303
L ++ N L + +E L N++ VV +
Sbjct: 187 SLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPVN--------------- 225
Query: 304 LGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLT 363
+ L L N + N LV +D L+
Sbjct: 226 ------------VELTILKLQHNNLT-DTAWL-LNYPGLVEVD---------------LS 256
Query: 364 GNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVT 423
N L+ ++ + LE +YISN + ++ + L +LDL N L +
Sbjct: 257 YNELEKIMYHPFVKMQ-RLERLYISNNRL-VALNLYGQPIPTLKVLDLSHNHLL-HVERN 313
Query: 424 FGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFS 465
+ +L+ LYL N + ++ L L L+ N +
Sbjct: 314 QPQFDRLENLYLDHNSIV-TLKLST--HHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 26/199 (13%), Positives = 60/199 (30%), Gaps = 7/199 (3%)
Query: 419 SIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSL 478
I +++ + L + + + L + +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 479 RSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSG 538
+L ++ + F I + N++ N+ ++ + L RN+ S
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 131
Query: 539 DIPSTIGDLKDLQNISLACNGLEGLIPESFGYLT---ELNLSFNKLEGEIPRGGPFANFT 595
+ L +S++ N LE + ++F T L LS N+L + +
Sbjct: 132 LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL-IPSLF 189
Query: 596 AKSFMGN--EKLCGLPNLQ 612
+ N L ++
Sbjct: 190 HANVSYNLLSTLAIPIAVE 208
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 7e-09
Identities = 18/150 (12%), Positives = 44/150 (29%), Gaps = 3/150 (2%)
Query: 436 PFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPST 495
P I L + + + L + + ++ + + +
Sbjct: 5 PRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAAL 64
Query: 496 FWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISL 555
+ + + +L+ ++ + + + + N P ++ L + L
Sbjct: 65 LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124
Query: 556 ACNGLEGLIPESFGYLT---ELNLSFNKLE 582
N L L F L++S N LE
Sbjct: 125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLE 154
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-32
Identities = 71/517 (13%), Positives = 161/517 (31%), Gaps = 48/517 (9%)
Query: 96 NSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSD 155
N +R ++ +L+ + + ++ L+LS N LS + KL+ L+ S
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 156 NQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLAL 215
N L + +LS++ + L+++ + EL V ++ L A N ++
Sbjct: 68 NVLY-ETLDLE-SLSTLRTLDLNNNYVQ-ELLV-----GPSIETLHAANNNISR---VSC 116
Query: 216 SKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRG-EIPHEIGYLPNLENLVL 274
S+ + + + L K++ + + ++ + L+ N++ LE+L L
Sbjct: 117 SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 275 GFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLS-LPNVERLNLGLNRFSGTIP 333
+N + V + + +K + L N L +G + V ++L N+ I
Sbjct: 177 QYNFIY-DVKGQVV-FAKLKTLDLSSNKLA---FMGPEFQSAAGVTWISLRNNKLV-LIE 230
Query: 334 SFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIG 393
+ + L + D L GN + + ++ + +
Sbjct: 231 KALRFSQNLEHFD---------------LRGNGFHCGTLRDFFSKNQRVQTVAKQ--TVK 273
Query: 394 GSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGS----IPDQLC 449
Q + L RL L+ GS + +
Sbjct: 274 KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERE 333
Query: 450 HLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSS 509
+ AR + ++ I + + + L + + ++ +
Sbjct: 334 NQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQA 393
Query: 510 NSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFG 569
+ + + + + +++ + + L E
Sbjct: 394 VGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEE--- 450
Query: 570 YLTELNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLC 606
N KL GE AN T + + E+
Sbjct: 451 -----NARLKKLNGEADLALASANATLQELVVREQNL 482
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-30
Identities = 61/368 (16%), Positives = 117/368 (31%), Gaps = 27/368 (7%)
Query: 234 AIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTV 293
AI + N + + ++ L+ + N++ L L N L + A + + +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 294 KKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFS 353
+ + L N L + L SL + L+L N + + L N+ S
Sbjct: 61 ELLNLSSNVLYETLDLE---SLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNIS 112
Query: 354 GIIPNT------IGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGG-SIPQLISNLSNL 406
+ + I L N + + G S ++ + + I + +L ++ L
Sbjct: 113 RVSCSRGQGKKNIYLANNKITMLRDLDEGCRS-RVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 407 LLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSG 466
L+L+ N + KL+ L L NKLA + + A + + L NK
Sbjct: 172 EHLNLQYNFIYDVKGQVV--FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV- 227
Query: 467 SIPSCLGNLTSLRSPDLGSNRLTSV-LPSTFWNLKDILFFDLSSNS-LDGPLSLDIGNLR 524
I L +L DL N L F + + + L G +
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 525 VVIGINLSRNNFSGDIPSTIG--DLKDLQNISLACNGLEGLIPESFGY--LTELNLSFNK 580
+ + + K+ +S + E L E E++ +
Sbjct: 288 LGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQ 347
Query: 581 LEGEIPRG 588
+
Sbjct: 348 YR-TVIDQ 354
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-32
Identities = 76/406 (18%), Positives = 131/406 (32%), Gaps = 95/406 (23%)
Query: 121 LSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSD 180
+ LN+ + L+ +P + + L DN L+
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT--------------------- 74
Query: 181 KLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEIS 240
LP L+ L ++ N +P+ L + + L P S
Sbjct: 75 ----SLPALPPE----LRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHL----PALPS 121
Query: 241 NLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLD 300
L L + N+L +P L+ L + N L +PA + K++ +
Sbjct: 122 GLCKL---WIFGNQLT-SLPVLPP---GLQELSVSDNQL-ASLPALPSEL---CKLWAYN 170
Query: 301 NSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTI 360
N L + + ++ L++ N+ + ++P+ + L L N +
Sbjct: 171 NQL-----TSLPMLPSGLQELSVSDNQLA-SLPTLPSE---LYKLWAYNNRLT------- 214
Query: 361 GLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSI 420
LP L+ + +S + S+P L S L L + GN+LT S+
Sbjct: 215 ---------SLPALPSG----LKELIVSGNRL-TSLPVLPSELKE---LMVSGNRLT-SL 256
Query: 421 PVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRS 480
P+ L L + N+L +P+ L HL+ T+ L GN S L +TS
Sbjct: 257 PMLPSGLLS---LSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSA-- 310
Query: 481 PDLGSNRLTSV------LPSTFWNLKDILFFDLSSNSLDGPLSLDI 520
S + P L L P D
Sbjct: 311 -PGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADR 355
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-31
Identities = 69/340 (20%), Positives = 130/340 (38%), Gaps = 43/340 (12%)
Query: 246 RKISLRNNKLRGEIPHEIG--YLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSL 303
R ++ R + ++ L +G + L +P + + + + DN+L
Sbjct: 17 RAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGL-TTLPDCLPA--HITTLVIPDNNL 73
Query: 304 LGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPN--TIG 361
+ P + L + N+ + ++P +L + +
Sbjct: 74 TS-----LPALPPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLW 127
Query: 362 LTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIP 421
+ GN L LP L + + +S+ + S+P L S L L + N+LT S+P
Sbjct: 128 IFGNQL-TSLPVLPPGL----QELSVSDNQLA-SLPALPSELCKLWAYN---NQLT-SLP 177
Query: 422 VTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSP 481
+ LQ+L + N+LA S+P L +L N+ + S+P+ L L
Sbjct: 178 MLPSGLQEL---SVSDNQLA-SLPTLPSELYKLWAYN---NRLT-SLPALPSGLKEL--- 226
Query: 482 DLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIP 541
+ NRLTS LP LK++ +S N L L + L +++ RN + +P
Sbjct: 227 IVSGNRLTS-LPVLPSELKEL---MVSGNRLTS-LPMLPSGLLS---LSVYRNQLT-RLP 277
Query: 542 STIGDLKDLQNISLACNGLEGLIPESFGYLTELNLSFNKL 581
++ L ++L N L ++ +T +
Sbjct: 278 ESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPI 317
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-24
Identities = 56/243 (23%), Positives = 95/243 (39%), Gaps = 48/243 (19%)
Query: 362 LTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIP 421
+ + L LP + + + I + N+ S+P L L L ++ GN+LT S+P
Sbjct: 47 VGESGL-TTLPDCLPA---HITTLVIPDNNLT-SLPALPPELRTL---EVSGNQLT-SLP 97
Query: 422 VTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSP 481
V L +L P L P L +L + GN+ + S+P L L
Sbjct: 98 VLPPGLLELSIFSNPLTHL----PALPSGLCKLW---IFGNQLT-SLPVLPPGLQEL--- 146
Query: 482 DLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIP 541
+ N+L S LP+ L + +N L L + L+ +++S N + +P
Sbjct: 147 SVSDNQLAS-LPALPSELCKL---WAYNNQLTS-LPMLPSGLQE---LSVSDNQLA-SLP 197
Query: 542 STIGDLKDL-----------------QNISLACNGLEGLIPESFGYLTELNLSFNKLEGE 584
+ +L L + + ++ N L L P L EL +S N+L
Sbjct: 198 TLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTSL-PVLPSELKELMVSGNRLT-S 255
Query: 585 IPR 587
+P
Sbjct: 256 LPM 258
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-24
Identities = 67/276 (24%), Positives = 109/276 (39%), Gaps = 45/276 (16%)
Query: 317 NVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIG------LTGNPLDGV 370
LN+G + + T+P + + L + N+ + +P ++GN L
Sbjct: 41 GNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPELRTLEVSGNQLT-S 95
Query: 371 LPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKL 430
LP L L +P L S L L + GN+LT S+PV LQ+L
Sbjct: 96 LPVLPPGLL-ELSIFSNPLT----HLPALPSGLCKL---WIFGNQLT-SLPVLPPGLQEL 146
Query: 431 QGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTS 490
+ N+LA S+P L +L N+ + S+P L L + N+L S
Sbjct: 147 ---SVSDNQLA-SLPALPSELCKLW---AYNNQLT-SLPMLPSGLQEL---SVSDNQLAS 195
Query: 491 VLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDL 550
LP+ L + +N L L L+ + +S N + +P +LK+L
Sbjct: 196 -LPTLPSELYKL---WAYNNRLT-SLPALPSGLKE---LIVSGNRLT-SLPVLPSELKEL 246
Query: 551 QNISLACNGLEGLIPESFGYLTELNLSFNKLEGEIP 586
++ N L L P L L++ N+L +P
Sbjct: 247 ---MVSGNRLTSL-PMLPSGLLSLSVYRNQLT-RLP 277
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 5e-19
Identities = 40/184 (21%), Positives = 72/184 (39%), Gaps = 25/184 (13%)
Query: 403 LSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGN 462
+ +L++ + LT ++P + L +P N L S+P L L ++GN
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALPPELRTLE---VSGN 91
Query: 463 KFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGN 522
+ + S+P L L L ++ L + + N L L +
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHLPALPS----GLCKL---WIFGNQLTS-LPVLPPG 142
Query: 523 LRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFGYLTELNLSFNKLE 582
L+ +++S N + +P+ +L L N L L P L EL++S N+L
Sbjct: 143 LQE---LSVSDNQLA-SLPALPSELCKLW---AYNNQLTSL-PMLPSGLQELSVSDNQLA 194
Query: 583 GEIP 586
+P
Sbjct: 195 -SLP 197
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 3e-13
Identities = 41/237 (17%), Positives = 85/237 (35%), Gaps = 28/237 (11%)
Query: 101 TALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSG 160
L + L ++P L L++S N+L+ +P +L L +N+L+
Sbjct: 164 CKLWAYNNQLT-SLPMLPSGL---QELSVSDNQLA-SLPTLP---SELYKLWAYNNRLT- 214
Query: 161 SLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKR 220
S+ S + ++ + ++L+ LPV LK L ++ N +P+ S
Sbjct: 215 ---SLPALPSGLKELIVSGNRLT-SLPVLPSE----LKELMVSGNRL-TSLPMLPSG--- 262
Query: 221 LQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFN--- 277
L L++ +L+ +P+ + +L+ ++L N L + + +
Sbjct: 263 LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFD 321
Query: 278 NLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSL---PNVERLNLGLNRFSGT 331
P + +L+ N + +L L+R S T
Sbjct: 322 MAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLSET 378
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-30
Identities = 74/488 (15%), Positives = 166/488 (34%), Gaps = 55/488 (11%)
Query: 103 LNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFT-MHKLKFLDFSDNQLSGS 161
++I + L++ + ++ + +P ++ +++ L+ +D Q+
Sbjct: 32 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-E 89
Query: 162 LSSVTF-NLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKR 220
+ + F ++ + + + + LP ++ + L VL L +N +
Sbjct: 90 IDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPK 148
Query: 221 LQLLNLGFKKLSGAIPKEI-SNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNL 279
L L++ L I + T L+ + L +N+L + + +P+L + + +N L
Sbjct: 149 LTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL 204
Query: 280 VGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNA 339
+ + V+++ NS + + + L L N + N
Sbjct: 205 -----STLAIPIAVEELDASHNS-INVVRGPV---NVELTILKLQHNNLT-DTAWL-LNY 253
Query: 340 SKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQL 399
LV +D+ N I+ + + LE +YISN + ++
Sbjct: 254 PGLVEVDLSYNELEKIMYHP---------------FVKMQ-RLERLYISNNRL-VALNLY 296
Query: 400 ISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGL 459
+ L +LDL N L + + +L+ LYL N + ++ L L L
Sbjct: 297 GQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLS--THHTLKNLTL 352
Query: 460 AGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLD 519
+ N + + L ++ P + + L+ L S L
Sbjct: 353 SHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDY---QLEHGLCCKESDKPYLDRLLQY 407
Query: 520 IGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFGYLTELNLSFN 579
I VV + ++ S + ++ + + +L N
Sbjct: 408 IALTSVVEKVQRAQGRCSA--------TDTINSVQSLSHYITQQGGVPLQGNEQLEAEVN 459
Query: 580 KLEGEIPR 587
+L E+ +
Sbjct: 460 ELRAEVQQ 467
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-30
Identities = 72/401 (17%), Positives = 147/401 (36%), Gaps = 37/401 (9%)
Query: 211 IPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEI-GYLPNL 269
I L +++ + E L + ++ +N+ +R ++P + +
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 77
Query: 270 ENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFS 329
E L L + + A T++K+Y+ N++ + ++P + L L N S
Sbjct: 78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAI-RYLPPHVFQNVPLLTVLVLERNDLS 136
Query: 330 GTIPSFI-TNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYIS 388
++P I N KL L ++ N L+ + + + SL+N+ +S
Sbjct: 137 -SLPRGIFHNTPKLTTLS---------------MSNNNLERIEDDTFQATT-SLQNLQLS 179
Query: 389 NCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQL 448
+ + + +S + +L ++ N L+ T ++ L N + + +
Sbjct: 180 SNRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV 230
Query: 449 CHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLS 508
L L L N + L N L DL N L ++ F ++ + +S
Sbjct: 231 N--VELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYIS 286
Query: 509 SNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESF 568
+N L L+L + + ++LS N+ + L+N+ L N + L +
Sbjct: 287 NNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTH 344
Query: 569 GYLTELNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLP 609
L L LS N + F N + ++ C +
Sbjct: 345 HTLKNLTLSHNDWD-CNSLRALFRNVARPAVDDADQHCKID 384
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 4e-15
Identities = 30/191 (15%), Positives = 59/191 (30%), Gaps = 6/191 (3%)
Query: 395 SIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARL 454
I + + ++ L + + + + L ++
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 455 NTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSN---S 511
L L + +++ +G N + + P F N+ + L N S
Sbjct: 78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 137
Query: 512 LDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFGYL 571
L + + L +++S NN T LQN+ L+ N L + L
Sbjct: 138 LPRGIFHNTPKLTT---LSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSL 194
Query: 572 TELNLSFNKLE 582
N+S+N L
Sbjct: 195 FHANVSYNLLS 205
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 44/171 (25%), Positives = 73/171 (42%), Gaps = 31/171 (18%)
Query: 680 ENLIGVGSFGSVYKGRLHDGIEVAIKVFH--QNCAMALKSFEAECEVMKNIRHRNHVKRI 737
LIG G FG VY GR H EVAI++ ++ LK+F+ E + RH N V +
Sbjct: 38 GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 738 SSCSNEDFKAL-----------DCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHSTPVI 786
+C + A+ + L++ I ++ + YL H+ ++
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL---HAKGIL 152
Query: 787 HCDLKPKNVF---------DFGIGRLLTGDRSMIQTETLV----TIGYMAP 824
H DLK KNVF DFG+ + ++ + + L + ++AP
Sbjct: 153 HKDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 45/175 (25%), Positives = 78/175 (44%), Gaps = 28/175 (16%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRN 732
+ + IG GSFG+V++ H G +VA+K+ + A + F E +MK +RH N
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 733 HVKRISSCSNEDFKAL-----------DCLHSTNC--SLNIFDKLNIMIDVASALEYLHF 779
V + + + ++ LH + L+ +L++ DVA + YLH
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH- 154
Query: 780 SHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
+ + P++H +LK N+ DFG+ RL ++ T +MAP
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA-GTPEWMAP 208
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-30
Identities = 79/479 (16%), Positives = 168/479 (35%), Gaps = 21/479 (4%)
Query: 125 TTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSG 184
++ S N L +P + K L+ S N +S +S +LS + + + +++
Sbjct: 3 FLVDRSKNGLI-HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ- 58
Query: 185 ELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKL-SGAIPKEISNLT 243
L +++ + L+ L L+ N ++ L+ L+L F + I KE N++
Sbjct: 59 YLDISVFKFNQELEYLDLSHNKLVK---ISCHPTVNLKHLDLSFNAFDALPICKEFGNMS 115
Query: 244 ILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKK--IYLLDN 301
L+ + L L I +L + L++ + I N
Sbjct: 116 QLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTN 175
Query: 302 SLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIG 361
++ N+E N+ F++ +KL +N I T
Sbjct: 176 KEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWN 235
Query: 362 LTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIP 421
L V T++ S + N+ + ++L L + + +
Sbjct: 236 SFIRILQLVWHTTVWYFS--ISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQS 293
Query: 422 VTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSP 481
+ + + ++ L + N + ++ G+LT L +
Sbjct: 294 YIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETL 353
Query: 482 DLGSNRLTSV--LPSTFWNLKDILFFDLSSNSLDGPLSLDI-GNLRVVIGINLSRNNFSG 538
L N+L + + +K + D+S NS+ + ++ +N+S N +
Sbjct: 354 ILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTD 413
Query: 539 DIPSTIGDLKDLQNISLACNGLEGLIPESFG--YLTELNLSFNKLEGEIPRGGPFANFT 595
I + ++ + L N ++ + + L ELN++ N+L+ +P G F T
Sbjct: 414 TIFRCL--PPRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLK-SVPD-GIFDRLT 468
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 5e-28
Identities = 78/416 (18%), Positives = 139/416 (33%), Gaps = 42/416 (10%)
Query: 119 GNLSSLTTLNLSHNKLSGDIPPSIFT-MHKLKFLDFSDNQL-SGSLSSVTFNLSSVLDIR 176
+L L+LS N F M +LKFL S L S+ + S + +
Sbjct: 87 HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLV 146
Query: 177 LDSDKLSGELPVNICN-YLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAI 235
L E P + + L ++F FH + +++ L+L N+
Sbjct: 147 LGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKC 206
Query: 236 PKEISNLT------ILRKISLRNNKLRGEIPHEIG---YLPNLENLVLGFNNLVGVVPAA 286
+S L L ++L N + I + + + L G +
Sbjct: 207 SYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFR 266
Query: 287 IFNMSTVK----KIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKL 342
F+ S I+ + + + G I N+ N ++ + S
Sbjct: 267 DFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPF 326
Query: 343 VYLDMGTNSFSGIIPNTI-GLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLIS 401
++LD N + + LT LE + + + + ++
Sbjct: 327 LHLDFSNNLLTDTVFENCGHLT-----------------ELETLILQMNQLK-ELSKIAE 368
Query: 402 ---NLSNLLLLDLEGNKLTGSIP-VTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTL 457
+ +L LD+ N ++ + L L + N L +I L R+ L
Sbjct: 369 MTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVL 426
Query: 458 GLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLD 513
L NK SIP + L +L+ ++ SN+L SV F L + L +N D
Sbjct: 427 DLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 8e-16
Identities = 37/188 (19%), Positives = 84/188 (44%), Gaps = 13/188 (6%)
Query: 98 HRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIF-TMHKLKFLDFSDN 156
+ N + + +S L+ S+N L+ D + +L+ L N
Sbjct: 300 SNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLT-DTVFENCGHLTELETLILQMN 358
Query: 157 QLS--GSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLA 214
QL ++ +T + S+ + + + +S + C++ L L ++ N +
Sbjct: 359 QLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSN----ILTDT 414
Query: 215 LSKC--KRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEI-GYLPNLEN 271
+ +C R+++L+L K+ +IPK++ L L+++++ +N+L+ +P I L +L+
Sbjct: 415 IFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQK 472
Query: 272 LVLGFNNL 279
+ L N
Sbjct: 473 IWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 8e-12
Identities = 43/240 (17%), Positives = 94/240 (39%), Gaps = 10/240 (4%)
Query: 70 DPTNLLAQNSTSNTSVCNWIGITCNVNSHRVTALNISSLNLQGTIPPQLG---NLSSLTT 126
T + + ++ + + + AL+I + PQ S++
Sbjct: 245 WHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNI 304
Query: 127 LNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSG-E 185
N + + + LDFS+N L+ ++ +L+ + + L ++L
Sbjct: 305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELS 364
Query: 186 LPVNICNYLHYLKVLFLAKNMF-HGQIPLALSKCKRLQLLNLGFKKLSGAIPKEI-SNLT 243
+ + L+ L +++N + + S K L LN+ L+ I + + +
Sbjct: 365 KIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIK 424
Query: 244 ILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSL 303
+L L +NK++ IP ++ L L+ L + N L V +++++KI+L N
Sbjct: 425 VL---DLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 54/305 (17%), Positives = 106/305 (34%), Gaps = 33/305 (10%)
Query: 234 AIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTV 293
AI + N + + ++ L+ + N++ L L N L + A + + +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 294 KKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFS 353
+ + L N L + L SL + L+L N + + L N+ S
Sbjct: 61 ELLNLSSNVLYETLDLE---SLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS 112
Query: 354 GIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEG 413
+ S G +NIY++N I S + LDL+
Sbjct: 113 RV----------------SCSRGQ---GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKL 153
Query: 414 NKLTG-SIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCL 472
N++ + L+ L L +N + + Q+ A+L TL L+ NK + +
Sbjct: 154 NEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEF 210
Query: 473 GNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLS 532
+ + L +N+L + +++ FDL N +L + ++
Sbjct: 211 QSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHC-GTLRDFFSKNQRVQTVA 268
Query: 533 RNNFS 537
+
Sbjct: 269 KQTVK 273
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 50/312 (16%), Positives = 103/312 (33%), Gaps = 37/312 (11%)
Query: 311 IDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGV 370
I + + + + + S +A + LD L+GNPL +
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELD---------------LSGNPLSQI 49
Query: 371 LPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKL 430
+ + LE + +S+ + ++ + +LS L LDL N + +
Sbjct: 50 SAADLAPFT-KLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSI 101
Query: 431 QGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTS 490
+ L+ N ++ + + LA NK + G + ++ DL N + +
Sbjct: 102 ETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT 158
Query: 491 V-LPSTFWNLKDILFFDLSSNSLDG-PLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLK 548
V + + +L N + + L+ ++LS N + +
Sbjct: 159 VNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKT---LDLSSNKLA-FMGPEFQSAA 214
Query: 549 DLQNISLACNGLEGLIPESFGY---LTELNLSFNKLEGEIPRGGPFANFTAKSFMGNEKL 605
+ ISL N L I ++ + L +L N R F+ + + +
Sbjct: 215 GVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTV 272
Query: 606 CGLPNLQFPKCK 617
L +C
Sbjct: 273 KKLTGQNEEECT 284
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 48/214 (22%), Positives = 83/214 (38%), Gaps = 13/214 (6%)
Query: 371 LPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKL 430
+ N + + +++ ++ ++ L + N+ LDL GN L+ KL
Sbjct: 2 IHEIKQNGN-RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 431 QGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTS 490
+ L L N L D L L+ L TL L N L S+ + +N ++
Sbjct: 61 ELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR 113
Query: 491 VLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSG-DIPSTIGDLKD 549
V S K+I L++N + LD G V ++L N +
Sbjct: 114 VSCSRGQGKKNI---YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 550 LQNISLACNGLEGLIPESF-GYLTELNLSFNKLE 582
L++++L N + + + L L+LS NKL
Sbjct: 171 LEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLA 204
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 56/326 (17%), Positives = 110/326 (33%), Gaps = 31/326 (9%)
Query: 211 IPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLE 270
I ++ K ++ + K+ ++ + N+ L L N L ++ LE
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKEL---DLSGNPLSQISAADLAPFTKLE 61
Query: 271 NLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSG 330
L L N L + ++ST++ + L +N + L P++E L+ N S
Sbjct: 62 LLNLSSNVLYET--LDLESLSTLRTLDLNNNYVQ---ELL---VGPSIETLHAANNNIS- 112
Query: 331 TIPSFITNASKLVYLDMGTNSFSGIIPNTIG---------LTGNPLDGV-LPTSIGNLSM 380
+ + + + N + + G L N +D V +
Sbjct: 113 RVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD- 169
Query: 381 SLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKL 440
+LE++ + I + + + L LDL NKL + F + + L NKL
Sbjct: 170 TLEHLNLQYNFI-YDVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
Query: 441 AGSIPDQLCHLARLNTLGLAGNKFS-GSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNL 499
I L L L GN F G++ +++ + + + +
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285
Query: 500 KDILFFD-LSSNSLDGPLSLDIGNLR 524
+ + L P + + L
Sbjct: 286 PTLGHYGAYCCEDLPAPFADRLIALG 311
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 64/365 (17%), Positives = 117/365 (32%), Gaps = 82/365 (22%)
Query: 96 NSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFT-MHKLKFLDFS 154
N +R ++ +L+ + + ++ L+LS N LS I + KL+ L+ S
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKLELLNLS 66
Query: 155 DNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLA 214
N L + +LS+ L+ L L N
Sbjct: 67 SNVLY-ETLDLE-SLST-------------------------LRTLDLNNNYVQ-----E 94
Query: 215 LSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVL 274
L ++ L+ +S + + I L NNK+ + G ++ L L
Sbjct: 95 LLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151
Query: 275 GFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPS 334
N + V A + S +E LNL N +
Sbjct: 152 KLNEIDTVNFAELAA------------------------SSDTLEHLNLQYNFIY-DVKG 186
Query: 335 FITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGG 394
+ +KL LD+ +N + + + + + I + N +
Sbjct: 187 QV-VFAKLKTLDLSSNKLA----------------FMGPEFQSAA-GVTWISLRNNKL-V 227
Query: 395 SIPQLISNLSNLLLLDLEGNKLT-GSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLAR 453
I + + NL DL GN G++ F + Q++Q + K ++ C +
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 454 LNTLG 458
L G
Sbjct: 288 LGHYG 292
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 45/255 (17%), Positives = 87/255 (34%), Gaps = 33/255 (12%)
Query: 332 IPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCN 391
I N ++ +T + L L + + +++ + +S
Sbjct: 2 IHEIKQNGNRYKIEK---------------VTDSSLKQALASLRQSAW-NVKELDLSGNP 45
Query: 392 IGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHL 451
+ ++ + L LL+L N L L L+ L L N + +L
Sbjct: 46 LSQISAADLAPFTKLELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVG 98
Query: 452 ARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNS 511
+ TL A N S S ++ L +N++T + + + DL N
Sbjct: 99 PSIETLHAANNNISRVSCSRGQGKKNI---YLANNKITMLRDLDEGCRSRVQYLDLKLNE 155
Query: 512 LDG-PLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFGY 570
+D + + + +NL N D+ + L+ + L+ N L + F
Sbjct: 156 IDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLAF-MGPEFQS 212
Query: 571 ---LTELNLSFNKLE 582
+T ++L NKL
Sbjct: 213 AAGVTWISLRNNKLV 227
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 9e-29
Identities = 41/178 (23%), Positives = 65/178 (36%), Gaps = 39/178 (21%)
Query: 680 ENLIGVGSFGSVYKGRLHDGIEVAIKVFH----QNCAMALKSFEAECEVMKNIRHRNHVK 735
E +IG+G FG VY+ G EVA+K ++ + +++ E ++ ++H N +
Sbjct: 12 EEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 736 RISSCSNEDFKAL-----------DCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHSTP 784
C E L L +I +N + +A + YLH P
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDI--LVNWAVQIARGMNYLHDEAIVP 128
Query: 785 VIHCDLKPKNVF------------------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
+IH DLK N+ DFG+ R M +MAP
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAG---AYAWMAP 183
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 43/196 (21%), Positives = 72/196 (36%), Gaps = 37/196 (18%)
Query: 665 FSYQDLFRATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEV 724
++L+ + + G FG V+K + VA+K+F +S++ E EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQ---DKQSWQNEYEV 69
Query: 725 --MKNIRHRNHVKRISSCSNEDFKALDCL-------------HSTNCSLNIFDKLNIMID 769
+ ++H N ++ I + +D ++ + +I
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAET 129
Query: 770 VASALEYLH-------FSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812
+A L YLH H + H D+K KNV DFG+ +S
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 813 TETLV-TIGYMAPGLL 827
T V T YMAP +L
Sbjct: 190 THGQVGTRRYMAPEVL 205
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-28
Identities = 67/349 (19%), Positives = 137/349 (39%), Gaps = 31/349 (8%)
Query: 97 SHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFT-MHKLKFLDFSD 155
S + A+ +P + + L+L N++ + F L+ L+ ++
Sbjct: 10 SAQDRAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNE 65
Query: 156 NQLSGSLSSVTF-NLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLA 214
N +S ++ F NL ++ + L S++L +P+ + L L L +++N +
Sbjct: 66 NIVS-AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYM 123
Query: 215 LSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEI-GYLPNLENLV 273
L+ L +G L + S L L +++L L IP E +L L L
Sbjct: 124 FQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLR 182
Query: 274 LGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIP 333
L N+ + + + +K + + L + + L N+ L++ + +P
Sbjct: 183 LRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNC-LYGLNLTSLSITHCNLT-AVP 240
Query: 334 SF-ITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNI 392
+ + L +L+ L+ NP+ + + + L L+ I + +
Sbjct: 241 YLAVRHLVYLRFLN---------------LSYNPISTIEGSMLHELL-RLQEIQLVGGQL 284
Query: 393 GGSIPQLISNLSNLLLLDLEGNKLTGSIPV-TFGRLQKLQGLYLPFNKL 440
P L+ L +L++ GN+LT ++ F + L+ L L N L
Sbjct: 285 AVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-27
Identities = 67/340 (19%), Positives = 117/340 (34%), Gaps = 25/340 (7%)
Query: 246 RKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLG 305
R + + +P I L LG N + + + ++++ L +N +
Sbjct: 14 RAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV-S 69
Query: 306 SFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGN 365
+ G +L N+ L L NR T S L LD+ N ++
Sbjct: 70 AVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYM--FQDL 127
Query: 366 PLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPV-TF 424
+L+++ + + ++ + S L++L L LE LT SIP
Sbjct: 128 Y--------------NLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEAL 172
Query: 425 GRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLG 484
L L L L + L RL L ++ + ++ +L S +
Sbjct: 173 SHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSIT 232
Query: 485 SNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTI 544
LT+V +L + F +LS N + + L + I L + P
Sbjct: 233 HCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAF 292
Query: 545 GDLKDLQNISLACNGLEGLIPESFGY---LTELNLSFNKL 581
L L+ ++++ N L L F L L L N L
Sbjct: 293 RGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-25
Identities = 51/287 (17%), Positives = 98/287 (34%), Gaps = 27/287 (9%)
Query: 316 PNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNT-IGLTGNPLDGVLPTS 374
L+LG NR + L L++ N S + P L
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLF----------- 80
Query: 375 IGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLY 434
+L + + + + + + LSNL LD+ NK+ + F L L+ L
Sbjct: 81 ------NLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLE 134
Query: 435 LPFNKLAGSIPDQ-LCHLARLNTLGLAGNKFSGSIPS-CLGNLTSLRSPDLGSNRLTSVL 492
+ N L I + L L L L + SIP+ L +L L L + ++
Sbjct: 135 VGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIR 192
Query: 493 PSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQN 552
+F L + ++S ++ + + ++++ N + + L L+
Sbjct: 193 DYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRF 252
Query: 553 ISLACNGLEGLIPESF---GYLTELNLSFNKLEGEIPRGGPFANFTA 596
++L+ N + + L E+ L +L + F
Sbjct: 253 LNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEP-YAFRGLNY 297
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 6e-13
Identities = 37/182 (20%), Positives = 61/182 (33%), Gaps = 29/182 (15%)
Query: 101 TALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSG 160
L + LN+ L L L +SH + P+ L L + L+
Sbjct: 179 IVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT- 237
Query: 161 SLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKR 220
+P +L YL+ L L+ N L + R
Sbjct: 238 ------------------------AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLR 273
Query: 221 LQLLNLGFKKLSGAIPKEI-SNLTILRKISLRNNKLRGEIPHEI-GYLPNLENLVLGFNN 278
LQ + L +L+ + L LR +++ N+L + + + NLE L+L N
Sbjct: 274 LQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNP 331
Query: 279 LV 280
L
Sbjct: 332 LA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 22/122 (18%), Positives = 44/122 (36%), Gaps = 10/122 (8%)
Query: 470 SCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGI 529
C ++ R +V + + DL N + + + + +
Sbjct: 8 ECSAQDRAV---LCHRKRFVAVPEGIPTETRLL---DLGKNRIKTLNQDEFASFPHLEEL 61
Query: 530 NLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFGY---LTELNLSFNKLEGEIP 586
L+ N S P +L +L+ + L N L+ + F LT+L++S NK+ +
Sbjct: 62 ELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILL 120
Query: 587 RG 588
Sbjct: 121 DY 122
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 47/184 (25%), Positives = 71/184 (38%), Gaps = 41/184 (22%)
Query: 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNC-------AMALKSFEAECEVMK 726
+ E IG G FG V+KGR + D VAIK + F+ E +M
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 727 NIRHRNHVKRISSCSNE-----------DFKALDCLHSTNCSLNIFDKLNIMIDVASALE 775
N+ H N VK N D L + KL +M+D+A +E
Sbjct: 79 NLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHR--LLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 776 YLHFSHSTPVIHCDLKPKNVF---------------DFGIGRLLTGDRSMIQTETLVTIG 820
Y+ + + P++H DL+ N+F DFG+ + S+ + L
Sbjct: 137 YMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSV--SGLLGNFQ 191
Query: 821 YMAP 824
+MAP
Sbjct: 192 WMAP 195
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 45/173 (26%), Positives = 75/173 (43%), Gaps = 28/173 (16%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRN 732
+ + IG GSFG+VYKG+ H +VA+K+ + L++F+ E V++ RH N
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 733 HVKRISSCSNEDF----------KALDCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHS 782
+ + + LH++ + ++I A ++YL H+
Sbjct: 82 ILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL---HA 138
Query: 783 TPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-TIGYMAP 824
+IH DLK N+F DFG+ + Q E L +I +MAP
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 7e-28
Identities = 27/174 (15%), Positives = 56/174 (32%), Gaps = 34/174 (19%)
Query: 680 ENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRI 737
+ G ++KGR G ++ +KV + F EC ++ H N + +
Sbjct: 15 LTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 738 SSCSNEDFKAL-------------DCLHS-TNCSLNIFDKLNIMIDVASALEYLHFSHST 783
+C + + LH TN ++ + +D+A + +LH +
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEP 132
Query: 784 PVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827
+ L ++V + S + ++AP L
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVK------FSFQSPGRMYAPAWVAPEAL 180
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 48/199 (24%), Positives = 69/199 (34%), Gaps = 43/199 (21%)
Query: 665 FSYQDLFRATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEV 724
+ + + LIG G +G+VYKG L VA+KVF ++F E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFA---NRQNFINEKNI 58
Query: 725 MK--NIRHRNHVKRISSCSNEDFKALD--CL------------HSTNCSLNIFDKLNIMI 768
+ + H N + I L + + + + +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAH 118
Query: 769 DVASALEYLH-----FSHSTPVI-HCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812
V L YLH H P I H DL +NV DFG+ LTG+R +
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178
Query: 813 TETLV-------TIGYMAP 824
E TI YMAP
Sbjct: 179 GEEDNAAISEVGTIRYMAP 197
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-27
Identities = 48/197 (24%), Positives = 79/197 (40%), Gaps = 38/197 (19%)
Query: 662 LRRFSYQDLFRATEKFSKE------NLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMA- 714
FS+ +L T F + N +G G FG VYKG + + VA+K +
Sbjct: 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITT 70
Query: 715 ---LKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL-----------DCLHSTNCS--L 758
+ F+ E +VM +H N V+ + S+ D L D L + + L
Sbjct: 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130
Query: 759 NIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLL-TGD 807
+ + I A+ + +L H IH D+K N+ DFG+ R
Sbjct: 131 SWHMRCKIAQGAANGINFL---HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 808 RSMIQTETLVTIGYMAP 824
++++ + + T YMAP
Sbjct: 188 QTVMTSRIVGTTAYMAP 204
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 41/172 (23%), Positives = 65/172 (37%), Gaps = 29/172 (16%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHV 734
++ E ++G G+FG V K + +VAIK K+F E + + H N V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIV 64
Query: 735 KRISSCSNE--------DFKAL-DCLHSTN--CSLNIFDKLNIMIDVASALEYLHFSHST 783
K +C N + +L + LH ++ + + + YLH
Sbjct: 65 KLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 784 PVIHCDLKPKNVF-----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
+IH DLKP N+ DFG + M T + +MAP
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT--HM--TNNKGSAAWMAP 172
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-26
Identities = 88/444 (19%), Positives = 162/444 (36%), Gaps = 64/444 (14%)
Query: 92 TCNVNSHRVTALNISSLNLQG--TIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFT-MHKL 148
C+V + + L +P + ++LS N ++ ++ + F+ + L
Sbjct: 7 ECSVIGYNA---ICINRGLHQVPELPA------HVNYVDLSLNSIA-ELNETSFSRLQDL 56
Query: 149 KFLDFSDNQLSGSLSSVTF-NLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMF 207
+FL + + TF LSS++ ++LD ++ +L N L L+VL L +
Sbjct: 57 QFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNL 115
Query: 208 HGQI--PLALSKCKRLQLLNLGFKKLSGAIPKEI-SNLTILRKISLRNNKLRGEIPHEIG 264
G + L++L L + P N+ + L NK++ I E
Sbjct: 116 DGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDL 174
Query: 265 Y-----------LPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDL 313
L ++ + L F +++ + L N S +
Sbjct: 175 LNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFD 234
Query: 314 SLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPN---TIGLTGNPLDGV 370
++ + +L L+ SF K D +F G+ + T L+ + + +
Sbjct: 235 AIAGTKIQSLILSNSYNMGSSFGHTNFK----DPDNFTFKGLEASGVKTCDLSKSKIFAL 290
Query: 371 LPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPV-TFGRLQK 429
L + + + LE + ++ I L++LL L+L N L SI F L K
Sbjct: 291 LKSVFSHFT-DLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDK 348
Query: 430 LQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLT 489
L+ L L +N + ++ DQ F G L +L+ L +N+L
Sbjct: 349 LEVLDLSYNHI-RALGDQS---------------FLG--------LPNLKELALDTNQLK 384
Query: 490 SVLPSTFWNLKDILFFDLSSNSLD 513
SV F L + L +N D
Sbjct: 385 SVPDGIFDRLTSLQKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 5e-21
Identities = 66/402 (16%), Positives = 125/402 (31%), Gaps = 78/402 (19%)
Query: 221 LQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEI-GYLPNLENLVLGFNNL 279
+ ++L ++ S L L+ + + I + L +L L L +N
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 280 VGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRF-SGTIPSFI-T 337
+ + FN L N+E L L +
Sbjct: 92 L-QLETGAFN------------------------GLANLEVLTLTQCNLDGAVLSGNFFK 126
Query: 338 NASKLVYLDMGTNSFSGIIPN----------TIGLTGNPLDGVLPTSIGNLSMSLENIYI 387
+ L L + N+ I P + LT N + + + N
Sbjct: 127 PLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQ-------- 178
Query: 388 SNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQ 447
+ LS++ L D+ L + + L L N S+ +
Sbjct: 179 -------GKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKR 231
Query: 448 LCHLARLNTL-------------GLAGNKFSGSIPSCLGNL--TSLRSPDLGSNRLTSVL 492
+ F L + +++ DL +++ ++L
Sbjct: 232 FFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALL 291
Query: 493 PSTFWNLKDILFFDLSSNSLDGPLSLDIG---NLRVVIGINLSRNNFSGDIPSTIGDLKD 549
S F + D+ L+ N ++ +D L ++ +NLS+N +L
Sbjct: 292 KSVFSHFTDLEQLTLAQNEIN---KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDK 348
Query: 550 LQNISLACNGLEGLIPESFGYLT---ELNLSFNKLEGEIPRG 588
L+ + L+ N + L +SF L EL L N+L+ +P G
Sbjct: 349 LEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SVPDG 389
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-17
Identities = 56/319 (17%), Positives = 114/319 (35%), Gaps = 53/319 (16%)
Query: 316 PNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIP----------NTIGLTGN 365
+V ++L LN + + + L +L + + +I + L N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 366 PLDGVLPTSIGNLSMSLENIYISNCNIGGSI--PQLISNLSNLLLLDLEGNKLTGSIPVT 423
+ + L+ +LE + ++ CN+ G++ L++L +L L N + P +
Sbjct: 90 QFLQLETGAFNGLA-NLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148
Query: 424 -FGRLQKLQGLYLPFNKLAGSIPD-----------QLCHLARLNTLGLAGNKFSGSIPSC 471
F +++ L L FNK+ SI + L L+ + +
Sbjct: 149 FFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGN 207
Query: 472 LGNLTSLRSPDLGSNRLTSVLPSTFWNL-------------KDILFFDLSSNSLDGP--- 515
TS+ + DL N + F++ + + P
Sbjct: 208 PFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNF 267
Query: 516 --LSLDIGNLRVVIGINLSRNNFSGDIPSTI-GDLKDLQNISLACNGLEGLIPESF---G 569
L+ ++ +LS++ + ++ DL+ ++LA N + + +F
Sbjct: 268 TFKGLEASGVKTC---DLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLT 323
Query: 570 YLTELNLSFNKLEGEIPRG 588
+L +LNLS N L G I
Sbjct: 324 HLLKLNLSQNFL-GSIDSR 341
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 23/132 (17%), Positives = 42/132 (31%), Gaps = 29/132 (21%)
Query: 467 SIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVV 526
+P ++ + DL N + + ++F L+D+ F + + +
Sbjct: 24 QVPELPAHVNYV---DLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIR--------- 71
Query: 527 IGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESF---GYLTELNLSFNKLEG 583
+T L L + L N L +F L L L+ L+G
Sbjct: 72 --------------NNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDG 117
Query: 584 EIPRGGPFANFT 595
+ G F T
Sbjct: 118 AVLSGNFFKPLT 129
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-25
Identities = 75/418 (17%), Positives = 157/418 (37%), Gaps = 51/418 (12%)
Query: 103 LNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSL 162
++ +Q T L++LT+L+ ++ ++ D+ I + L L + N ++ +L
Sbjct: 23 EVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNIT-TL 79
Query: 163 SSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQ 222
+++ + DS+KL+ L V L L L N L +S+ L
Sbjct: 80 D--LSQNTNLTYLACDSNKLT-NLDVT---PLTKLTYLNCDTNKL---TKLDVSQNPLLT 130
Query: 223 LLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGV 282
LN L+ ++S+ T L ++ NK ++ + L L FN + +
Sbjct: 131 YLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITEL 185
Query: 283 VPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLS-LPNVERLNLGLNRFSGTIPSFITNASK 341
+ + ++ N++ +DL+ + L+ N+ + I +T ++
Sbjct: 186 ---DVSQNKLLNRLNCDTNNITK-----LDLNQNIQLTFLDCSSNKLT-EID--VTPLTQ 234
Query: 342 LVYLDMGTNSFSGIIPN------TIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGS 395
L Y D N + + + T+ L + + + + L C
Sbjct: 235 LTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEI---DLTHNT-QLIYFQAEGCRKIKE 290
Query: 396 IPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLN 455
+ +++ + L LLD + +T + + KL LYL +L + + H +L
Sbjct: 291 LD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLK 342
Query: 456 TLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLD 513
+L S +G + +L + + ++ T N L +S + LD
Sbjct: 343 SLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTITMPKETLTNNS--LTIAVSPDLLD 396
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 55/348 (15%), Positives = 114/348 (32%), Gaps = 37/348 (10%)
Query: 239 ISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYL 298
L L + N+ + ++ I L L L+ NN+ + + + + +
Sbjct: 38 EEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNITTL---DLSQNTNLTYLAC 92
Query: 299 LDNSLLGSFSLGIDLS-LPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGI-I 356
N L +D++ L + LN N+ + + ++ L YL+ N+ + I +
Sbjct: 93 DSNKLTN-----LDVTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLTEIDV 144
Query: 357 PNTIGLTGNPLDGVLPTSIGNLSM--SLENIYISNCNIGGSIPQLISNLSNLLLLDLEGN 414
+ LT + +++ L + S I + +S L L+ + N
Sbjct: 145 SHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTN 201
Query: 415 KLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGN 474
+T + + +L L NKL I + L +L + N + S L
Sbjct: 202 NITK---LDLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLTELDVSTLSK 255
Query: 475 LTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRN 534
LT+L L + + L LD+ + + ++
Sbjct: 256 LTTL---HCIQTDLLEIDLTHNTQLIYFQAEGCRKIK-----ELDVTHNTQLYLLDCQAA 307
Query: 535 NFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFGYLTELNLSFNKLE 582
+ ++ + L + L L L L L+ ++
Sbjct: 308 GIT-ELD--LSQNPKLVYLYLNNTELTELDVSHNTKLKSLSCVNAHIQ 352
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-18
Identities = 56/339 (16%), Positives = 110/339 (32%), Gaps = 50/339 (14%)
Query: 267 PNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSL-----------LGSFSLG----- 310
N + V + + ++T+ + ++S+ L
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIEKLTGLTKLICTSNNIT 77
Query: 311 -IDLS-LPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPN------TIGL 362
+DLS N+ L N+ + + +T +KL YL+ TN + + + +
Sbjct: 78 TLDLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKLDVSQNPLLTYLNC 134
Query: 363 TGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPV 422
N L + + + + L + + ++ + L LD NK+T +
Sbjct: 135 ARNTLTEI---DVSHNT-QLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE---L 185
Query: 423 TFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPD 482
+ + L L N + + L +L L + NK + I + LT L D
Sbjct: 186 DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFD 239
Query: 483 LGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPS 542
N LT + ST L + L +D+ + +I ++
Sbjct: 240 CSVNPLTELDVSTLSKLTTL---HCIQTDLL---EIDLTHNTQLIYFQAEGCRKIKELD- 292
Query: 543 TIGDLKDLQNISLACNGLEGLIPESFGYLTELNLSFNKL 581
+ L + G+ L L L L+ +L
Sbjct: 293 -VTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTEL 330
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-16
Identities = 45/289 (15%), Positives = 98/289 (33%), Gaps = 42/289 (14%)
Query: 294 KKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFS 353
+ + ++ + L + L+ + + + I + L L +N+ +
Sbjct: 21 ASEVAAAFEMQATDTISEE-QLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNIT 77
Query: 354 GIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEG 413
+ + + +L + + + ++ ++ L+ L L+ +
Sbjct: 78 TL------------------DLSQNT-NLTYLACDSNKLT-NLD--VTPLTKLTYLNCDT 115
Query: 414 NKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLG 473
NKLT + + L L N L I + H +L L NK + +
Sbjct: 116 NKLT---KLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VT 167
Query: 474 NLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSR 533
T L + D N++T + K + + +N++ LD+ + ++ S
Sbjct: 168 PQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNIT---KLDLNQNIQLTFLDCSS 221
Query: 534 NNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFGYLTELNLSFNKLE 582
N + +I + L L + N L L + LT L+ L
Sbjct: 222 NKLT-EID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLL 267
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-14
Identities = 31/201 (15%), Positives = 68/201 (33%), Gaps = 16/201 (7%)
Query: 382 LENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLA 441
+ + + + L+ L LD + +T + +L L L N +
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT 77
Query: 442 GSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKD 501
++ L L L NK + ++ + LT L + +N+LT +
Sbjct: 78 -TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKL---DVSQNPL 128
Query: 502 ILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLE 561
+ + + + N+L +D+ + + ++ N + + L + + N +
Sbjct: 129 LTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT 183
Query: 562 GLIPESFGYLTELNLSFNKLE 582
L L LN N +
Sbjct: 184 ELDVSQNKLLNRLNCDTNNIT 204
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 42/180 (23%), Positives = 68/180 (37%), Gaps = 41/180 (22%)
Query: 680 ENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEV--MKNIRHRNHVKRI 737
+G G +G V++G G VA+K+F KS+ E E+ +RH N + I
Sbjct: 13 LECVGKGRYGEVWRGSWQ-GENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFI 68
Query: 738 SSCSNEDFKALDC---------------LHSTNCSLNIFDKLNIMIDVASALEYLH---- 778
+S + L T +L+ L I++ +AS L +LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 779 -FSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIG---YMAP 824
+ H DLK KN+ D G+ + + + + +G YMAP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 37/185 (20%), Positives = 67/185 (36%), Gaps = 38/185 (20%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHD-GIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNH 733
++G G FG K + G + +K + ++F E +VM+ + H N
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69
Query: 734 VKRISSCSNED-------FKA----LDCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHS 782
+K I + + + S + +++ D+AS + YL HS
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL---HS 126
Query: 783 TPVIHCDLKPKN----------VFDFGIGRLLTGDRSMIQTETLV-------------TI 819
+IH DL N V DFG+ RL+ +++ + +
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 820 GYMAP 824
+MAP
Sbjct: 187 YWMAP 191
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 41/185 (22%), Positives = 64/185 (34%), Gaps = 41/185 (22%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEV--MKNIRHRN 732
++ IG G +G V+ G+ G +VA+KVF S+ E E+ +RH N
Sbjct: 37 KQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHEN 92
Query: 733 HVKRISSCSNEDFKALDC---------------LHSTNCSLNIFDKLNIMIDVASALEYL 777
+ I++ L ST +L+ L + S L +L
Sbjct: 93 ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHL 150
Query: 778 H-----FSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIG-- 820
H + H DLK KN+ D G+ D + + +G
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
Query: 821 -YMAP 824
YM P
Sbjct: 211 RYMPP 215
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 40/180 (22%), Positives = 67/180 (37%), Gaps = 41/180 (22%)
Query: 680 ENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEV--MKNIRHRNHVKRI 737
+ IG G FG V++G+ G EVA+K+F +S+ E E+ +RH N + I
Sbjct: 47 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFI 102
Query: 738 SSCSNEDFKALDC---------------LHSTNCSLNIFDKLNIMIDVASALEYLH---- 778
++ + ++ L+ ++ + + + AS L +LH
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE--GMIKLALSTASGLAHLHMEIV 160
Query: 779 -FSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIG---YMAP 824
+ H DLK KN+ D G+ I +G YMAP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-22
Identities = 83/525 (15%), Positives = 177/525 (33%), Gaps = 57/525 (10%)
Query: 84 SVCNWIGITCNVNSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIF 143
++ +G ++ + ++ S+ NL +P L+LS N +S ++
Sbjct: 17 ALALIVGSMTPFSNELESMVDYSNRNLT-HVPK--DLPPRTKALSLSQNSIS-ELRMPDI 72
Query: 144 T-MHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFL 202
+ + +L+ L S N++ L ++ + L+ L +
Sbjct: 73 SFLSELRVLRLSHNRIR-------------------------SLDFHVFLFNQDLEYLDV 107
Query: 203 AKNMFHGQIPLALSKCKRLQLLNLGFKKL-SGAIPKEISNLTILRKISLRNNKLRGEIPH 261
+ N ++ L+ L+L F + KE NLT L + L K R
Sbjct: 108 SHNRLQN---ISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLL 164
Query: 262 EIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERL 321
+ +L L+ + + + ++L+ + FS+ +++S+ + L
Sbjct: 165 PVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNS-LFSVQVNMSVNALGHL 223
Query: 322 NLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMS 381
L + + + + + + I T +
Sbjct: 224 QLSNIKLNDENCQRLMTFLSELTRGPTLLNVTL---QHIETTWKCSVKLFQF---FWPRP 277
Query: 382 LENIYISNCNIGGSIPQLI-----SNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLP 436
+E + I N I I + + L +L++ ++ S + ++ L
Sbjct: 278 VEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLS 337
Query: 437 FNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTF 496
+ + L N F+ S+ L L++ L N L +
Sbjct: 338 ISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVAL 397
Query: 497 W--NLKDILFFDLSSNSL-DGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNI 553
N+ + D+S NSL ++ +NLS N +G + + ++ +
Sbjct: 398 MTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVL 455
Query: 554 SLACNGLEGLIPESF---GYLTELNLSFNKLEGEIPRGGPFANFT 595
L N + + P+ L ELN++ N+L+ +P G F T
Sbjct: 456 DLHNNRIMSI-PKDVTHLQALQELNVASNQLK-SVPD-GVFDRLT 497
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-22
Identities = 75/431 (17%), Positives = 149/431 (34%), Gaps = 41/431 (9%)
Query: 101 TALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFT-MHKLKFLDFSDNQL- 158
L++S LQ I ++SL L+LS N F + KL FL S +
Sbjct: 103 EYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR 159
Query: 159 SGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICN-YLHYLKVLFLAKNMFHGQIPLALSK 217
L V S + + L S + G ++ L ++F ++F Q+ ++++
Sbjct: 160 QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNA 219
Query: 218 CKRLQLLNLGFKKLSGA----IPKEISNLTILRKISLRNNKLRGEIPHEIG---YLPNLE 270
LQL N+ + E++ L ++L++ + + ++ + +E
Sbjct: 220 LGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVE 279
Query: 271 NLVLGFNNLVGVVPAAIFNMSTVK----KIYLLDNSLLGSFSLGIDLSLPNVERLNLGLN 326
L + + + F S I + N + + + L ++
Sbjct: 280 YLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSIS 339
Query: 327 RFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIY 386
+ S +L+ N F+ + L+ +
Sbjct: 340 DTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKR----------------LQTLI 383
Query: 387 ISNCNIGGSIPQLISNLSNLLLLDLEGNKLT----GSIPVTFGRLQKLQGLYLPFNKLAG 442
+ + + ++ N+ L+ L + T + + L L N L G
Sbjct: 384 LQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTG 442
Query: 443 SIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDI 502
S+ L ++ L L N+ SIP + +L +L+ ++ SN+L SV F L +
Sbjct: 443 SVFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSL 499
Query: 503 LFFDLSSNSLD 513
+ L N D
Sbjct: 500 QYIWLHDNPWD 510
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 2e-20
Identities = 91/502 (18%), Positives = 162/502 (32%), Gaps = 70/502 (13%)
Query: 100 VTALNISSLNLQGTIPPQ-LGNLSSLTTLNLSHNKLSGDIPPSIF-TMHKLKFLDFSDNQ 157
AL++S ++ + + LS L L LSHN++ + +F L++LD S N+
Sbjct: 54 TKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNR 111
Query: 158 LSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLA--L 215
L ++S C + L+ L L+ N F +P+
Sbjct: 112 LQ-NIS---------------------------CCPMASLRHLDLSFNDFD-VLPVCKEF 142
Query: 216 SKCKRLQLLNLGFKKLSGAIPKEISNL-TILRKISLRNNKLRGEIPHEIGYLPNLENLVL 274
+L L L K +++L + L + ++G + N L L
Sbjct: 143 GNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIP-NTTVLHL 201
Query: 275 GFNNLVGVVPAAIFNMSTVKKIYLLDNSL----LGSFSLGIDLSLPNVERLNLGLNRFSG 330
F+ +++ + + L + L + LN+ L
Sbjct: 202 VFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIET 261
Query: 331 TIPSFI-----TNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENI 385
T + + YL++ + + I D T SL
Sbjct: 262 TWKCSVKLFQFFWPRPVEYLNIYNLTITERI-----------DREEFTYSETALKSLMIE 310
Query: 386 YISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIP 445
++ N S L S + + + L + V L N S+
Sbjct: 311 HVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVF 370
Query: 446 DQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNL----KD 501
L RL TL L N + ++ S + L S+ + +
Sbjct: 371 QGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429
Query: 502 ILFFDLSSNSL-DGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGL 560
IL +LSSN L ++V ++L N IP + L+ LQ +++A N L
Sbjct: 430 ILVLNLSSNMLTGSVFRCLPPKVKV---LDLHNNRIM-SIPKDVTHLQALQELNVASNQL 485
Query: 561 EGLIPESFGY---LTELNLSFN 579
+ + F L + L N
Sbjct: 486 KSVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 3e-13
Identities = 37/184 (20%), Positives = 81/184 (44%), Gaps = 11/184 (5%)
Query: 100 VTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIF-TMHKLKFLDFSDNQL 158
+ +S + + SS T LN + N + D T+ +L+ L N L
Sbjct: 331 MNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFT-DSVFQGCSTLKRLQTLILQRNGL 389
Query: 159 SGSLSSVTFNLSSVLDIRLDS---DKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLAL 215
+ V ++ + + L+ C + + VL L+ NM G + L
Sbjct: 390 K-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL 448
Query: 216 SKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEI-GYLPNLENLVL 274
++++L+L ++ +IPK++++L L+++++ +N+L+ +P + L +L+ + L
Sbjct: 449 P--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWL 504
Query: 275 GFNN 278
N
Sbjct: 505 HDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 4e-11
Identities = 42/282 (14%), Positives = 97/282 (34%), Gaps = 7/282 (2%)
Query: 23 ITTSNLLSFHVPLTHCLLLYLVVAVAAASNITTDQQALLALKAHISYDPTNLLAQNSTSN 82
+ N L+ ++ V TT + ++ + L N T
Sbjct: 230 LNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTIT 289
Query: 83 TSVCNWIGITCNVNSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSI 142
+ + ++ + + + + LS +
Sbjct: 290 ERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCP 349
Query: 143 FTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKL-SGELPVNICNYLHYLKVLF 201
+ FL+F+ N + S+ L + + L + L + + + L+ L
Sbjct: 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLD 409
Query: 202 LAKNMF-HGQIPLALSKCKRLQLLNLGFKKLSGAIPKEI-SNLTILRKISLRNNKLRGEI 259
++ N + + + +LNL L+G++ + + + +L L NN++ I
Sbjct: 410 VSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVL---DLHNNRIM-SI 465
Query: 260 PHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDN 301
P ++ +L L+ L + N L V +++++ I+L DN
Sbjct: 466 PKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-22
Identities = 61/275 (22%), Positives = 92/275 (33%), Gaps = 33/275 (12%)
Query: 245 LRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSL- 303
K+ LR E+P I N L L N + + + ++ ++ + L N +
Sbjct: 45 FSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR 101
Query: 304 ---LGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNT- 359
+G+F+ L N+ L L NR + SKL L + N I
Sbjct: 102 TIEIGAFN-----GLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAF 156
Query: 360 IGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLI-SNLSNLLLLDLEGNKLTG 418
+ SL + + I + LSNL L+L L
Sbjct: 157 NRIP-----------------SLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR- 198
Query: 419 SIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSL 478
IP L KL L L N L+ P L L L + ++ + NL SL
Sbjct: 199 EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSL 257
Query: 479 RSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLD 513
+L N LT + F L + L N +
Sbjct: 258 VEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 7e-21
Identities = 58/281 (20%), Positives = 102/281 (36%), Gaps = 42/281 (14%)
Query: 85 VCNWIGITCNVNSHRVTAL------NISSLNLQG----TIPP-QLGNLSSLTTLNLSHNK 133
C+ + + N LNL I +L L L LS N
Sbjct: 40 SCSNQFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 134 LSGDIPPSIFT-MHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICN 192
+ I F + L L+ DN+L+ ++ + F
Sbjct: 100 IR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAF------------------------V 133
Query: 193 YLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEI-SNLTILRKISLR 251
YL LK L+L N A ++ L+ L+LG K I + L+ LR ++L
Sbjct: 134 YLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLA 193
Query: 252 NNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGI 311
LR EIP+ + L L+ L L N+L + P + + ++K++++ + +
Sbjct: 194 MCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQ-IQVIERNA 250
Query: 312 DLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSF 352
+L ++ +NL N + T L + + N +
Sbjct: 251 FDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 5e-19
Identities = 51/218 (23%), Positives = 89/218 (40%), Gaps = 11/218 (5%)
Query: 377 NLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLP 436
+S + + + I +L +L +L L N + F L L L L
Sbjct: 61 GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120
Query: 437 FNKLAGSIPDQ-LCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGS-NRLTSVLPS 494
N+L +IP+ +L++L L L N + SLR DLG RL+ +
Sbjct: 121 DNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEG 179
Query: 495 TFWNLKDILFFDLSSNSLDG-PLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNI 553
F L ++ + +L+ +L P + L ++LS N+ S P + L LQ +
Sbjct: 180 AFEGLSNLRYLNLAMCNLREIPNLTPLIKLDE---LDLSGNHLSAIRPGSFQGLMHLQKL 236
Query: 554 SLACNGLEGLIPESF---GYLTELNLSFNKLEGEIPRG 588
+ + ++ + +F L E+NL+ N L +P
Sbjct: 237 WMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHD 273
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-18
Identities = 56/246 (22%), Positives = 86/246 (34%), Gaps = 23/246 (9%)
Query: 316 PNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNT-IGLTGNPLDGVLPTS 374
N LNL N+ + + L L + N I GL
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLA----------- 112
Query: 375 IGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPV-TFGRLQKLQGL 433
+L + + + + LS L L L N + SIP F R+ L+ L
Sbjct: 113 ------NLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRL 165
Query: 434 YLP-FNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVL 492
L +L+ L+ L L LA IP+ L L L DL N L+++
Sbjct: 166 DLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIR 223
Query: 493 PSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQN 552
P +F L + + + + NL+ ++ INL+ NN + L L+
Sbjct: 224 PGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLER 283
Query: 553 ISLACN 558
I L N
Sbjct: 284 IHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 1e-17
Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 18/210 (8%)
Query: 395 SIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARL 454
+P IS +N LL+L N++ +F L+ L+ L L N + LA L
Sbjct: 57 EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114
Query: 455 NTLGLAGNKFSGSIPS-CLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSS-NSL 512
NTL L N+ + +IP+ L+ L+ L +N + S+ F + + DL L
Sbjct: 115 NTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRL 173
Query: 513 DGPLSLDIG---NLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESF- 568
+ G L + +NL+ N +IP + L L + L+ N L + P SF
Sbjct: 174 S---YISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQ 228
Query: 569 --GYLTELNLSFNKLEGEIPRGGPFANFTA 596
+L +L + ++++ I R F N +
Sbjct: 229 GLMHLQKLWMIQSQIQ-VIER-NAFDNLQS 256
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 4e-13
Identities = 49/186 (26%), Positives = 76/186 (40%), Gaps = 15/186 (8%)
Query: 104 NISSLNLQG----TIPPQ-LGNLSSLTTLNLSHNKLSGDIPPSIFT-MHKLKFLDFSD-N 156
N+++L L TIP LS L L L +N + IP F + L+ LD +
Sbjct: 113 NLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELK 171
Query: 157 QLSGSLSSVTF-NLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLAL 215
+LS +S F LS++ + L L + L L L L+ N P +
Sbjct: 172 RLS-YISEGAFEGLSNLRYLNLAMCNLRE---IPNLTPLIKLDELDLSGNHLSAIRPGSF 227
Query: 216 SKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEI-GYLPNLENLVL 274
LQ L + ++ NL L +I+L +N L +PH++ L +LE + L
Sbjct: 228 QGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHL 286
Query: 275 GFNNLV 280
N
Sbjct: 287 HHNPWN 292
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 51/298 (17%), Positives = 96/298 (32%), Gaps = 52/298 (17%)
Query: 246 RKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSL-L 304
+I + L +P I + L L N L + ++ + K+ L N L
Sbjct: 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 305 GSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTG 364
D +++ L+L N T+ S +L +LD ++ +
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSE------- 118
Query: 365 NPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTF 424
+ +L NL+ LD+ + F
Sbjct: 119 --------------------------------FSVFLSLRNLIYLDISHTHTRVAFNGIF 146
Query: 425 GRLQKLQGLYLPFNKLAGSIPDQ-LCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDL 483
L L+ L + N + L L L L+ + P+ +L+SL+ ++
Sbjct: 147 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM 206
Query: 484 GSNRLTSVLPSTFWNLKDILFFDLSSNSL----DGPLSLDIGNLRVVIGINLSRNNFS 537
N S+ + L + D S N + L +L +NL++N+F+
Sbjct: 207 SHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAF---LNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 52/272 (19%), Positives = 87/272 (31%), Gaps = 45/272 (16%)
Query: 316 PNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSI 375
+ RL L N+ ++L L + +N S + G
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT--------- 78
Query: 376 GNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPV-TFGRLQKLQGLY 434
SL+ + +S + ++ L L LD + + L F L+ L L
Sbjct: 79 -----SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 132
Query: 435 LPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPS-CLGNLTSLRSPDLGSNRLTSVLP 493
+ + L+ L L +AGN F + L +L DL +L + P
Sbjct: 133 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 192
Query: 494 STFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNI 553
+ F +L +L+V +N+S NNF L LQ +
Sbjct: 193 TAFNSLS---------------------SLQV---LNMSHNNFFSLDTFPYKCLNSLQVL 228
Query: 554 SLACNGLEGLIPESF----GYLTELNLSFNKL 581
+ N + + L LNL+ N
Sbjct: 229 DYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 39/223 (17%), Positives = 73/223 (32%), Gaps = 17/223 (7%)
Query: 377 NLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLT--GSIPVTFGRLQKLQGLY 434
+ S + + + + + L+ L L L N L+ G + L+ L
Sbjct: 25 GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD 84
Query: 435 LPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSC--LGNLTSLRSPDLGSNRLTSVL 492
L FN + ++ L +L L + + +L +L D+
Sbjct: 85 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAF 142
Query: 493 PSTFWNLKDILFFDLSSNSLDGPLSLDI----GNLRVVIGINLSRNNFSGDIPSTIGDLK 548
F L + ++ NS DI NL ++LS+ P+ L
Sbjct: 143 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF---LDLSQCQLEQLSPTAFNSLS 199
Query: 549 DLQNISLACNGLEGLIPESFGY---LTELNLSFNKLEGEIPRG 588
LQ ++++ N L + L L+ S N + +
Sbjct: 200 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQ 241
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 55/261 (21%), Positives = 99/261 (37%), Gaps = 17/261 (6%)
Query: 101 TALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFT-MHKLKFLDFSDNQLS 159
T + +S L ++P + SS T L L NKL +P +F + +L L S N LS
Sbjct: 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLS 65
Query: 160 -GSLSSVTF-NLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPL-ALS 216
S + +S+ + L + + + N L L+ L +
Sbjct: 66 FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLG-LEQLEHLDFQHSNLKQMSEFSVFL 123
Query: 217 KCKRLQLLNLGFKKLSGAIPKEI-SNLTILRKISLRNNKLRGEIPHEI-GYLPNLENLVL 274
+ L L++ I + L+ L + + N + +I L NL L L
Sbjct: 124 SLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 182
Query: 275 GFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIP- 333
L + P A ++S+++ + + N+ S L +++ L+ LN T
Sbjct: 183 SQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM-TSKK 240
Query: 334 -SFITNASKLVYLDMGTNSFS 353
S L +L++ N F+
Sbjct: 241 QELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 42/212 (19%), Positives = 89/212 (41%), Gaps = 9/212 (4%)
Query: 98 HRVTALNISS--LNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSD 155
++T L++SS L+ +G +SL L+LS N + + + + +L+ LDF
Sbjct: 52 TQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQH 110
Query: 156 NQLSGSLSSVTF-NLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQI-PL 213
+ L F +L +++ + + I N L L+VL +A N F P
Sbjct: 111 SNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPD 169
Query: 214 ALSKCKRLQLLNLGFKKLSGAIPKEI-SNLTILRKISLRNNKLRGEIPHEIGYLPNLENL 272
++ + L L+L +L + ++L+ L+ +++ +N L +L+ L
Sbjct: 170 IFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL 228
Query: 273 VLGFNNLVGVVPAAIFNMST-VKKIYLLDNSL 303
N+++ + + + + + L N
Sbjct: 229 DYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 5e-22
Identities = 54/275 (19%), Positives = 92/275 (33%), Gaps = 33/275 (12%)
Query: 245 LRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSL- 303
K+ L E+P I N L L NN+ + ++ ++ + L NS+
Sbjct: 56 FSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR 112
Query: 304 ---LGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNT- 359
+G+F+ L ++ L L N + SKL L + N I
Sbjct: 113 QIEVGAFN-----GLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAF 167
Query: 360 IGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLI-SNLSNLLLLDLEGNKLTG 418
+ SL + + I + L NL L+L +
Sbjct: 168 NRVP-----------------SLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK- 209
Query: 419 SIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSL 478
+P L L+ L + N P L+ L L + ++ S + L SL
Sbjct: 210 DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASL 268
Query: 479 RSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLD 513
+L N L+S+ F L+ ++ L N +
Sbjct: 269 VELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-20
Identities = 57/281 (20%), Positives = 100/281 (35%), Gaps = 42/281 (14%)
Query: 85 VCNWIGITCNVNSHRVTAL------NISSLNLQG----TIPP-QLGNLSSLTTLNLSHNK 133
C+ ++ + N LNL I +L L L L N
Sbjct: 51 SCSNQFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 134 LSGDIPPSIFT-MHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICN 192
+ I F + L L+ DN L+ + S F
Sbjct: 111 IR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAF------------------------E 144
Query: 193 YLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEI-SNLTILRKISLR 251
YL L+ L+L N A ++ L L+LG K I + L L+ ++L
Sbjct: 145 YLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLG 204
Query: 252 NNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGI 311
++ ++P+ + L LE L + N+ + P + +S++KK++++++ +
Sbjct: 205 MCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQ-VSLIERNA 261
Query: 312 DLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSF 352
L ++ LNL N S T LV L + N +
Sbjct: 262 FDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-20
Identities = 49/219 (22%), Positives = 83/219 (37%), Gaps = 13/219 (5%)
Query: 377 NLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPV-TFGRLQKLQGLYL 435
+ + + + NI +L +L +L L N + I V F L L L L
Sbjct: 72 GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLEL 130
Query: 436 PFNKLAGSIPDQ-LCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGS-NRLTSVLP 493
N L IP +L++L L L N + SL DLG +L +
Sbjct: 131 FDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISE 189
Query: 494 STFWNLKDILFFDLSSNSLDG-PLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQN 552
F L ++ + +L ++ P + L + +S N+F P + L L+
Sbjct: 190 GAFEGLFNLKYLNLGMCNIKDMPNLTPLVGLEE---LEMSGNHFPEIRPGSFHGLSSLKK 246
Query: 553 ISLACNGLEGLIPESF---GYLTELNLSFNKLEGEIPRG 588
+ + + + + +F L ELNL+ N L +P
Sbjct: 247 LWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHD 284
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 53/224 (23%), Positives = 85/224 (37%), Gaps = 11/224 (4%)
Query: 362 LTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIP 421
L N + + + +L LE + + +I + L++L L+L N LT IP
Sbjct: 82 LMENNIQMIQADTFRHLH-HLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIP 139
Query: 422 V-TFGRLQKLQGLYLPFNKLAGSIPDQ-LCHLARLNTLGLAGNKFSGSIPS-CLGNLTSL 478
F L KL+ L+L N + SIP + L L L K I L +L
Sbjct: 140 SGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNL 198
Query: 479 RSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSG 538
+ +LG + + L + ++S N L + + + + S
Sbjct: 199 KYLNLGMCNIKDM--PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSL 256
Query: 539 DIPSTIGDLKDLQNISLACNGLEGLIPESF---GYLTELNLSFN 579
+ L L ++LA N L L + F YL EL+L N
Sbjct: 257 IERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 7e-10
Identities = 33/110 (30%), Positives = 51/110 (46%), Gaps = 8/110 (7%)
Query: 104 NISSLNLQG---TIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFT-MHKLKFLDFSDNQLS 159
N+ LNL P L L L L +S N +I P F + LK L ++Q+S
Sbjct: 197 NLKYLNLGMCNIKDMPNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVS 255
Query: 160 GSLSSVTF-NLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFH 208
+ F L+S++++ L + LS LP ++ L YL L L N ++
Sbjct: 256 -LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPWN 303
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 56/296 (18%), Positives = 106/296 (35%), Gaps = 57/296 (19%)
Query: 316 PNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPN---------TIGLTGNP 366
P+ L+L N+ + N L L + N S I P + L+ N
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111
Query: 367 LDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLI-SNLSNLLLLDLEGNKLTGSI--PVT 423
L LP + +L+ + + I + + + + L+ +++++L N L S
Sbjct: 112 LK-ELPE---KMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGA 166
Query: 424 FGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPS-CLGNLTSLRSPD 482
F ++KL + + + +IP L L L L GNK + + + L L +L
Sbjct: 167 FQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLG 222
Query: 483 LGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPS 542
L N +++V + N + L++N L +P
Sbjct: 223 LSFNSISAVDNGSLANTPHLRELHLNNNKLV-------------------------KVPG 257
Query: 543 TIGDLKDLQNISLACNGLEGLIPESFGY---------LTELNLSFNKLE-GEIPRG 588
+ D K +Q + L N + + F + ++L N ++ EI
Sbjct: 258 GLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 313
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-21
Identities = 65/345 (18%), Positives = 124/345 (35%), Gaps = 54/345 (15%)
Query: 101 TALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFT-MHKLKFLDFSDNQLS 159
+ S L L+ +P L L+L +NK++ +I F + L L +N++S
Sbjct: 34 RVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKIS 89
Query: 160 GSLSSVTF-NLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKC 218
+S F L + + L ++L ELP + L+ L + +N +
Sbjct: 90 -KISPGAFAPLVKLERLYLSKNQLK-ELPEKM---PKTLQELRVHENEITKVRKSVFNGL 144
Query: 219 KRLQLLNLGFKKL-SGAIPKEI-SNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGF 276
++ ++ LG L S I + L I + + + IP G P+L L L
Sbjct: 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDG 201
Query: 277 NNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFI 336
N + V A++ ++ + K+ L NS + + G + P++ L+L N+ +P +
Sbjct: 202 NKITKVDAASLKGLNNLAKLGLSFNS-ISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL 259
Query: 337 TNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSI 396
+ + + + N+ S I N G
Sbjct: 260 ADHKYIQVVYLHNNNISAIGSNDFCPPG-------------------------------- 287
Query: 397 PQLISNLSNLLLLDLEGNKLTGSI--PVTFGRLQKLQGLYLPFNK 439
+ ++ + L N + P TF + + L K
Sbjct: 288 --YNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 52/255 (20%), Positives = 98/255 (38%), Gaps = 26/255 (10%)
Query: 377 NLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLP 436
+L + + N I NL NL L L NK++ P F L KL+ LYL
Sbjct: 49 DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108
Query: 437 FNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVL--PS 494
N+L +P+++ L L + N+ + S L + +LG+N L S
Sbjct: 109 KNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENG 165
Query: 495 TFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNIS 554
F +K + + ++ ++ ++ G + ++L N + +++ L +L +
Sbjct: 166 AFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLG 222
Query: 555 LACNGLEGLIPESF---GYLTELNLSFNKLEGEIPRG--------------GPFANFTAK 597
L+ N + + S +L EL+L+ NKL ++P G + +
Sbjct: 223 LSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSN 281
Query: 598 SFMGNEKLCGLPNLQ 612
F +
Sbjct: 282 DFCPPGYNTKKASYS 296
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 14/199 (7%)
Query: 395 SIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARL 454
+P+ + + LLDL+ NK+T F L+ L L L NK++ P L +L
Sbjct: 45 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102
Query: 455 NTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSL-D 513
L L+ N+ +P + +L+ + N +T V S F L ++ +L +N L
Sbjct: 103 ERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS 159
Query: 514 GPLSLDI-GNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESF---G 569
+ ++ + I ++ N + IP G L + L N + + S
Sbjct: 160 SGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLN 216
Query: 570 YLTELNLSFNKLEGEIPRG 588
L +L LSFN + + G
Sbjct: 217 NLAKLGLSFNSIS-AVDNG 234
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 38/186 (20%), Positives = 62/186 (33%), Gaps = 9/186 (4%)
Query: 405 NLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKF 464
+L ++ L +P L L NK+ +L L+TL L NK
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 465 SGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLR 524
S P L L L N+L + L+++ + N + L
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQEL---RVHENEITKVRKSVFNGLN 145
Query: 525 VVIGINLSRNNFSGDI--PSTIGDLKDLQNISLACNGLEGLIPESFGYLTELNLSFNKLE 582
+I + L N +K L I +A + + LTEL+L NK+
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKIT 205
Query: 583 GEIPRG 588
++
Sbjct: 206 -KVDAA 210
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 96.6 bits (240), Expect = 6e-21
Identities = 51/212 (24%), Positives = 78/212 (36%), Gaps = 23/212 (10%)
Query: 377 NLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLP 436
N S+S + Y + L N+ + + + L L
Sbjct: 10 NFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLN 67
Query: 437 FNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTF 496
L+ S+PD L ++ L + N S+P +L L D NRL++ LP
Sbjct: 68 RLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPASLEYL---DACDNRLST-LPELP 119
Query: 497 WNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLA 556
+LK + D+ +N L L L IN N + +P L+ L S+
Sbjct: 120 ASLKHL---DVDNNQLTM-LPELPALLEY---INADNNQLT-MLPELPTSLEVL---SVR 168
Query: 557 CNGLEGLIPESFGYLTELNLSFNKLEGEIPRG 588
N L L PE L L++S N LE +P
Sbjct: 169 NNQLTFL-PELPESLEALDVSTNLLE-SLPAV 198
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 91.2 bits (226), Expect = 4e-19
Identities = 49/282 (17%), Positives = 100/282 (35%), Gaps = 51/282 (18%)
Query: 311 IDLSLPNVERLNLGLNRFSGTIPS----FITNASKLVYLDMGTNSFSGIIPNTIGLTGNP 366
+ + LP +L N F TI + + K + + N
Sbjct: 1 MSIMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENR------------NE 48
Query: 367 LDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGR 426
+L + N + ++ N+ S+P + + +L++ N L S+P
Sbjct: 49 AVSLLKECLIN---QFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPELPAS 101
Query: 427 LQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSN 486
L+ L N+L+ ++P+ L L+ + N+ + +P L + + +N
Sbjct: 102 LEYL---DACDNRLS-TLPELPASLKHLD---VDNNQLT-MLPELPALLEYI---NADNN 150
Query: 487 RLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGD 546
+LT LP +L+ + + +N L L +L +++S N +P+
Sbjct: 151 QLTM-LPELPTSLEVL---SVRNNQL-TFLPELPESLEA---LDVSTNLLE-SLPAVPVR 201
Query: 547 LKDLQN----ISLACNGLEGLIPESFGYLT---ELNLSFNKL 581
+ N + + PE+ L + L N L
Sbjct: 202 NHHSEETEIFFRCRENRITHI-PENILSLDPTCTIILEDNPL 242
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 89.3 bits (221), Expect = 1e-18
Identities = 80/474 (16%), Positives = 145/474 (30%), Gaps = 89/474 (18%)
Query: 113 TIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFT----MHKLKFLDFSDNQLSGSLSSVTFN 168
+I + N SL+ N +N +S F+ K + N+ L N
Sbjct: 2 SIMLPINNNFSLS-QNSFYNTIS-GTYADYFSAWDKWEKQALPGENRNEAVSLLKECLIN 59
Query: 169 LSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGF 228
S L L+ LS LP N+ + VL + +N +P + + L +
Sbjct: 60 QFSELQ--LNRLNLS-SLPDNLPPQI---TVLEITQNALI-SLPELPASLEYLDACDNRL 112
Query: 229 KKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIF 288
L P+ ++L L + NN+L +P LE + N L ++P
Sbjct: 113 STL----PELPASLKHLD---VDNNQLT-MLPELPA---LLEYINADNNQLT-MLPE--- 157
Query: 289 NMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMG 348
++E L++ N+ + +P + L LD
Sbjct: 158 -------------------------LPTSLEVLSVRNNQLT-FLPELPES---LEALD-- 186
Query: 349 TNSFSGIIPNTIGLTGNPLDGVLPTSIG---NLSMSLENIYISNCNIGGSIPQLISNLSN 405
++ N L+ LP + + I IP+ I +L
Sbjct: 187 -------------VSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDP 231
Query: 406 LLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFS 465
+ LE N L+ I + + + P S+ D + F
Sbjct: 232 TCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF--SMSDGQQNTLHRPLADAVTAWFP 289
Query: 466 GSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRV 525
+ S + + + +N ++ L L D + +S ++ + L
Sbjct: 290 ENKQSDVSQIWHAFEHEEHANTFSAFL----DRLSDTVSARNTS-GFREQVAAWLEKLSA 344
Query: 526 VIGINLSRNNFSGDIPSTIGD-----LKDLQNISLACNGLEGLIPESFGYLTEL 574
+ + D + D +L+ L EGL G L L
Sbjct: 345 SAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQASEGLFDNDTGALLSL 398
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 7e-18
Identities = 55/380 (14%), Positives = 108/380 (28%), Gaps = 72/380 (18%)
Query: 103 LNISSLNL-QGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGS 161
+ N + + ++ + L L+ LS +P ++ ++ L+ + N L
Sbjct: 39 QALPGENRNEAVSLLKECLINQFSELQLNRLNLS-SLPDNLPP--QITVLEITQNALI-- 93
Query: 162 LSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRL 221
LP + L+ L N +P + K L
Sbjct: 94 -----------------------SLPELPAS----LEYLDACDNRLS-TLPELPASLKHL 125
Query: 222 QLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVG 281
+ N L P+ + L + + NN+L +P +LE L + N L
Sbjct: 126 DVDNNQLTML----PELPALLEYI---NADNNQLT-MLPELPT---SLEVLSVRNNQL-T 173
Query: 282 VVPAAIFNMSTVKKIYLLDNSL--LGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNA 339
+P ++ + + + N L L + + S NR + IP I +
Sbjct: 174 FLPELPESL---EALDVSTNLLESLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSL 229
Query: 340 SKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQL 399
+ L NPL + + + + I S+
Sbjct: 230 DPTCTII---------------LEDNPLS-SRIRESLSQQTAQPDYH--GPRIYFSMSDG 271
Query: 400 ISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGL 459
N + L D + ++ N + + D+L
Sbjct: 272 QQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFS-AFLDRLSDTVSARNTSG 330
Query: 460 AGNKFSGSIPSCLGNLTSLR 479
+ + + L LR
Sbjct: 331 FREQVA-AWLEKLSASAELR 349
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 3e-12
Identities = 31/183 (16%), Positives = 70/183 (38%), Gaps = 23/183 (12%)
Query: 101 TALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSG 160
L+ L T+P +L L++ +N+L+ +P L++++ +NQL+
Sbjct: 103 EYLDACDNRLS-TLPELPASL---KHLDVDNNQLT-MLPELP---ALLEYINADNNQLT- 153
Query: 161 SLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKR 220
L + +L + + +++L+ LP + L+ L ++ N+ +P +
Sbjct: 154 MLPELPTSLEV---LSVRNNQLT-FLPELPES----LEALDVSTNLLE-SLPAVPVRNHH 204
Query: 221 LQ----LLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGF 276
+ +++ IP+ I +L I L +N L I + +
Sbjct: 205 SEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPR 263
Query: 277 NNL 279
Sbjct: 264 IYF 266
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 28/140 (20%), Positives = 46/140 (32%), Gaps = 19/140 (13%)
Query: 451 LARLNTLGLAGNKFSGSIP-------SCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDIL 503
L N L+ N F +I S P N S+L +
Sbjct: 5 LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFS 62
Query: 504 FFDLSSNSLDGPLSLDIG-NLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEG 562
L+ +L L ++ + V + +++N +P L+ L N L
Sbjct: 63 ELQLNRLNLSS-LPDNLPPQITV---LEITQNALI-SLPELPASLEYL---DACDNRLST 114
Query: 563 LIPESFGYLTELNLSFNKLE 582
L PE L L++ N+L
Sbjct: 115 L-PELPASLKHLDVDNNQLT 133
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 25/117 (21%), Positives = 42/117 (35%), Gaps = 6/117 (5%)
Query: 467 SIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLS-LDIGNLRV 525
SI + N SL S + N ++ F L + + +S L +
Sbjct: 2 SIMLPINNNFSL-SQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQ 60
Query: 526 VIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFGYLTELNLSFNKLE 582
+ L+R N S +P + + + + N L L PE L L+ N+L
Sbjct: 61 FSELQLNRLNLS-SLPDNLP--PQITVLEITQNALISL-PELPASLEYLDACDNRLS 113
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 9e-21
Identities = 57/332 (17%), Positives = 116/332 (34%), Gaps = 35/332 (10%)
Query: 194 LHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNN 253
+ + A C R + L+ +IP ++ ++ + L NN
Sbjct: 6 WMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNN 62
Query: 254 KLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDL 313
++ ++ NL+ LVL N + + + ++ +++ + L N L + S
Sbjct: 63 RITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYN-YLSNLSSSWFK 121
Query: 314 SLPNVERLNLGLNRFSGTIP--SFITNASKLVYLDMGTNSFSGIIPNTI--GLTGNPLDG 369
L ++ LNL N + T+ S ++ +KL L +G I GLT
Sbjct: 122 PLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLT------ 174
Query: 370 VLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQK 429
LE + I ++ P+ + ++ N+ L L + + +
Sbjct: 175 -----------FLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSS 223
Query: 430 LQGLYL--------PFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSP 481
++ L L F++L+ + L + + + L ++ L
Sbjct: 224 VECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLEL 282
Query: 482 DLGSNRLTSVLPSTFWNLKDILFFDLSSNSLD 513
+ N+L SV F L + L +N D
Sbjct: 283 EFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 6e-18
Identities = 50/279 (17%), Positives = 91/279 (32%), Gaps = 41/279 (14%)
Query: 316 PNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNT-IGLTGNPLDGVLPTS 374
V+ L+L NR + S + L L + +N + I ++ L
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLG----------- 100
Query: 375 IGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIP--VTFGRLQKLQG 432
SLE++ +S + LS+L L+L GN ++ F L KLQ
Sbjct: 101 ------SLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQI 153
Query: 433 LYLPFNKLAGSIPDQ-LCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSV 491
L + I + L L L + + P L ++ ++ L + +
Sbjct: 154 LRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILL 213
Query: 492 LPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQ 551
L + +L LD + S +++ +
Sbjct: 214 LEIFVDVTSSVECLELRDTDLD----------------TFHFSELSTGETNSLIKKFTFR 257
Query: 552 NISLACNGLEGLIPESFG--YLTELNLSFNKLEGEIPRG 588
N+ + L ++ L EL S N+L+ +P G
Sbjct: 258 NVKITDESLFQVMKLLNQISGLLELEFSRNQLKS-VPDG 295
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 58/307 (18%), Positives = 109/307 (35%), Gaps = 57/307 (18%)
Query: 92 TCNVNSHRVTAL------NISSLNLQG----TIPP-QLGNLSSLTTLNLSHNKLSGDIPP 140
C +S + ++ + SL+L I L +L L L+ N ++ I
Sbjct: 35 ICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEE 93
Query: 141 SIFT-MHKLKFLDFSDNQLSGSLSSVTF-NLSSVLDIRLDSDKLSGELPVNICNYLHYLK 198
F+ + L+ LD S N LS +LSS F LSS+ + L + ++ ++L L+
Sbjct: 94 DSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQ 152
Query: 199 VLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGE 258
+L + +I K+ + LT L ++ + + L+
Sbjct: 153 ILRVGNMDTFTKIQ-----------------------RKDFAGLTFLEELEIDASDLQ-S 188
Query: 259 IPHEI-GYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSL----LGSFSLGIDL 313
+ + N+ +L+L + ++ + S+V+ + L D L S G
Sbjct: 189 YEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETN 248
Query: 314 SLPNV---ERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPN---------TIG 361
SL + + + + S L+ L+ N + I
Sbjct: 249 SLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIW 307
Query: 362 LTGNPLD 368
L NP D
Sbjct: 308 LHTNPWD 314
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 51/184 (27%), Positives = 76/184 (41%), Gaps = 44/184 (23%)
Query: 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIK---VFHQNCAMALKSFEAECEVMKNIRH 730
F E IG G F VY+ L DG+ VA+K +F A A E +++K + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 731 RNHVKRISSCSNEDFKALDCLH---------STNCSLNIFDK----------LNIMIDVA 771
N +K +S F + L+ + + F K + +
Sbjct: 92 PNVIKYYAS-----FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLC 146
Query: 772 SALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-TIG 820
SALE++ HS V+H D+KP NVF D G+GR + + +LV T
Sbjct: 147 SALEHM---HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPY 201
Query: 821 YMAP 824
YM+P
Sbjct: 202 YMSP 205
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 45/185 (24%), Positives = 68/185 (36%), Gaps = 34/185 (18%)
Query: 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKV--FHQNCAMALKSFEAECEVMKNIRHR 731
E + IG GS+G K R DG + K + + +E +++ ++H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 732 NHVKRISS---------------CSNED-FKALDCLHSTNCSLNIFDKLNIMIDVASALE 775
N V+ C D + L+ L +M + AL+
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 776 YLHFSHSTP--VIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-TIGYM 822
H V+H DLKP NVF DFG+ R+L D S +T V T YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKTFVGTPYYM 183
Query: 823 APGLL 827
+P +
Sbjct: 184 SPEQM 188
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 36/187 (19%), Positives = 62/187 (33%), Gaps = 40/187 (21%)
Query: 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNH 733
+ + +G G F V LHDG A+K + + + E ++ + H N
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88
Query: 734 VKRISSCSNED------------------FKALDCLHSTNCSLNIFDKLNIMIDVASALE 775
++ ++ C E + ++ L L L +++ + LE
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 776 YLHFSHSTPVIHCDLKPKNVF----------DFGIGRLL----TGDRSMIQTETLV---- 817
+ H+ H DLKP N+ D G G R + +
Sbjct: 149 AI---HAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 818 TIGYMAP 824
TI Y AP
Sbjct: 206 TISYRAP 212
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 66/295 (22%), Positives = 98/295 (33%), Gaps = 56/295 (18%)
Query: 316 PNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIG---------LTGNP 366
P+ L+L N S L L + N S I ++ N
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113
Query: 367 LDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSI--PVTF 424
L + P NL SL + I + I + S L N+ +++ GN L S P F
Sbjct: 114 LVEIPP----NLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAF 169
Query: 425 GRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPS-CLGNLTSLRSPDL 483
L KL L + KL IP L LN L L NK +I L + L L
Sbjct: 170 DGL-KLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGL 224
Query: 484 GSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPST 543
G N++ + + L + L +N L +P+
Sbjct: 225 GHNQIRMIENGSLSFLPTLRELHLDNNKLS-------------------------RVPAG 259
Query: 544 IGDLKDLQNISLACNGLEGLIPESFG---------YLTELNLSFNKLE-GEIPRG 588
+ DLK LQ + L N + + F Y ++L N + E+
Sbjct: 260 LPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPA 314
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 65/321 (20%), Positives = 121/321 (37%), Gaps = 53/321 (16%)
Query: 104 NISSLNLQG----TIPP-QLGNLSSLTTLNLSHNKLSGDIPPSIFT-MHKLKFLDFSDNQ 157
+ + L+LQ + L L L L +NK+S I F+ + KL+ L S N
Sbjct: 55 DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNH 113
Query: 158 LSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKN-MFHGQIPLALS 216
L + SS++++R+ +++ ++P + + L + + + N + +
Sbjct: 114 LV-EIPPNLP--SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAF 169
Query: 217 KCKRLQLLNLGFKKLSGAIPKEI-SNLTILRKISLRNNKLRGEIPHEI-GYLPNLENLVL 274
+L L + KL+ IPK++ L L L +NK++ I E L L L
Sbjct: 170 DGLKLNYLRISEAKLT-GIPKDLPETLNELH---LDHNKIQ-AIELEDLLRYSKLYRLGL 224
Query: 275 GFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPS 334
G N + + GS S LP + L+L N+ S +P+
Sbjct: 225 GHNQIRMIEN--------------------GSLS-----FLPTLRELHLDNNKLS-RVPA 258
Query: 335 FITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGG 394
+ + L + + TN+ + + N G + I SL N + +
Sbjct: 259 GLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGI-----SLFNNPVPYWEVQ- 312
Query: 395 SIPQLISNLSNLLLLDLEGNK 415
P +++ L + K
Sbjct: 313 --PATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 49/217 (22%), Positives = 79/217 (36%), Gaps = 13/217 (5%)
Query: 377 NLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLP 436
+S + + N +I L +L L L NK++ F L+KLQ LY+
Sbjct: 51 EISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110
Query: 437 FNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVL--PS 494
N L IP L + L L + N+ L ++ ++G N L + P
Sbjct: 111 KNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPG 167
Query: 495 TFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNIS 554
F LK + + +S L + + ++L N + L +
Sbjct: 168 AFDGLK-LNYLRISEAKLT---GIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLG 223
Query: 555 LACNGLEGLIPESF---GYLTELNLSFNKLEGEIPRG 588
L N + + S L EL+L NKL +P G
Sbjct: 224 LGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAG 259
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 36/185 (19%), Positives = 63/185 (34%), Gaps = 8/185 (4%)
Query: 405 NLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKF 464
+L ++ L ++P L L N ++ D L L L L NK
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 465 SGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLR 524
S L L+ + N L + P+ +L ++ + N + LR
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLVEIPPNLPSSLVEL---RIHDNRIRKVPKGVFSGLR 147
Query: 525 VVIGINLSRNNF-SGDIPSTIGDLKDLQNISLACNGLEGLIPESFGYLTELNLSFNKLEG 583
+ I + N + D L + ++ L G+ + L EL+L NK++
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQ- 206
Query: 584 EIPRG 588
I
Sbjct: 207 AIELE 211
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 15/88 (17%), Positives = 33/88 (37%), Gaps = 11/88 (12%)
Query: 103 LNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFT-------MHKLKFLDFSD 155
L++ + L +P L +L L + L N ++ + + F + +
Sbjct: 246 LHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFN 303
Query: 156 NQLS-GSLSSVTF-NLSSVLDIRLDSDK 181
N + + TF ++ L I+ + K
Sbjct: 304 NPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 45/217 (20%), Positives = 70/217 (32%), Gaps = 31/217 (14%)
Query: 377 NLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLP 436
+ + + I++ I NL +L L N L F L L+ L L
Sbjct: 29 GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88
Query: 437 FNKLAGSIPDQ-LCHLARLNTLGLAGNKFSGSIPS-CLGNLTSLRSPDLGSNRLTSVLPS 494
N S+ L RL+TL L + L +L+ L N L ++
Sbjct: 89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDD 147
Query: 495 TFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNIS 554
TF +L ++ L N + ++ F G L L +
Sbjct: 148 TFRDLGNLTHLFLHGNRIS----------------SVPERAFRG--------LHSLDRLL 183
Query: 555 LACNGLEGLIPESFGYLT---ELNLSFNKLEGEIPRG 588
L N + + P +F L L L N L +P
Sbjct: 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTE 219
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 45/211 (21%), Positives = 84/211 (39%), Gaps = 17/211 (8%)
Query: 316 PNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNT---------IGLTGNP 366
+R+ L NR S + L L + +N + I + L+ N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 367 LDGVLPTSI-GNLSMSLENIYISNCNIGGSIPQ-LISNLSNLLLLDLEGNKLTGSIPV-T 423
+ + L L +++ C + + L L+ L L L+ N L ++P T
Sbjct: 92 QLRSVDPATFHGLG-RLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDT 148
Query: 424 FGRLQKLQGLYLPFNKLAGSIPDQ-LCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPD 482
F L L L+L N+++ S+P++ L L+ L L N+ + P +L L +
Sbjct: 149 FRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207
Query: 483 LGSNRLTSVLPSTFWNLKDILFFDLSSNSLD 513
L +N L+++ L+ + + L+ N
Sbjct: 208 LFANNLSALPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 53/207 (25%), Positives = 79/207 (38%), Gaps = 9/207 (4%)
Query: 104 NISSLNLQG----TIPPQ-LGNLSSLTTLNLSHNKLSGDIPPSIFT-MHKLKFLDFSDNQ 157
+ L G +P +LT L L N L+ I + FT + L+ LD SDN
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNA 91
Query: 158 LSGSLSSVTF-NLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALS 216
S+ TF L + + LD L EL + L L+ L+L N
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150
Query: 217 KCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGF 276
L L L ++S + L L ++ L N++ PH L L L L
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210
Query: 277 NNLVGVVPAAIFNMSTVKKIYLLDNSL 303
NNL + A+ + ++ + L DN
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 45/186 (24%), Positives = 67/186 (36%), Gaps = 13/186 (6%)
Query: 104 NISSLNLQG----TIPPQ-LGNLSSLTTLNLSHNKLSGDIPPSIFT-MHKLKFLDFSDNQ 157
N++ L L I L+ L L+LS N + P+ F + +L L
Sbjct: 57 NLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG 116
Query: 158 LSGSLSSVTF-NLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALS 216
L L F L+++ + L + L LP + L L LFL N A
Sbjct: 117 LQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFR 174
Query: 217 KCKRLQLLNLGFKKLSGAIPKEI-SNLTILRKISLRNNKLRGEIPHEI-GYLPNLENLVL 274
L L L +++ + +L L + L N L +P E L L+ L L
Sbjct: 175 GLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRL 232
Query: 275 GFNNLV 280
N V
Sbjct: 233 NDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 49/238 (20%), Positives = 89/238 (37%), Gaps = 12/238 (5%)
Query: 93 CNVNSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFT-MHKLKFL 151
C + + LQ +P + ++ + L N++S +P + F L L
Sbjct: 6 CVCYNEPKVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRIS-HVPAASFRACRNLTIL 61
Query: 152 DFSDNQLSGSLSSVTF-NLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQ 210
N L+ + + F L+ + + L + + + L L L L +
Sbjct: 62 WLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQEL 120
Query: 211 IPLALSKCKRLQLLNLGFKKLSGAIPKEI-SNLTILRKISLRNNKLRGEIPHEI-GYLPN 268
P LQ L L L A+P + +L L + L N++ +P L +
Sbjct: 121 GPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHS 178
Query: 269 LENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLN 326
L+ L+L N + V P A ++ + +YL N+ L + L ++ L L N
Sbjct: 179 LDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN-LSALPTEALAPLRALQYLRLNDN 235
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 33/178 (18%), Positives = 61/178 (34%), Gaps = 36/178 (20%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKV--FHQNCAMALKSFEAECEVMKNIRHRN 732
+S IG G V++ AIK + L S+ E + ++ +
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 733 H--VKRISSCSNED--FKALDCLHSTNCSLNIFDKL------------NIMIDVASALEY 776
++ + + ++C N L L + ++ A+
Sbjct: 88 DKIIRLYDYEITDQYIYMVMEC---GNIDL--NSWLKKKKSIDPWERKSYWKNMLEAVHT 142
Query: 777 LHFSHSTPVIHCDLKPKNVF---------DFGIGRLLTGDRSMIQTETLV-TIGYMAP 824
+H ++H DLKP N DFGI + D + + ++ V T+ YM P
Sbjct: 143 IHQHG---IVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 6e-19
Identities = 43/201 (21%), Positives = 70/201 (34%), Gaps = 51/201 (25%)
Query: 672 RATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIK-VFHQNCAMALKSFEAECEVMKNIR 729
R F +G G FG V++ + D AIK + N +A + E + + +
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 730 HRNHVKRISSCSNEDFKALDCLHSTNCSLNI----------FDKLN-------------- 765
H V+ ++ ++ S L I D +N
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 766 -IMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTE 814
I + +A A+E+LH S ++H DLKP N+F DFG+ + D
Sbjct: 122 HIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 815 TLVTIG-----------YMAP 824
T + YM+P
Sbjct: 179 TPMPAYARHTGQVGTKLYMSP 199
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 8e-19
Identities = 34/173 (19%), Positives = 68/173 (39%), Gaps = 26/173 (15%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKV--FHQNCAMALKSFEAECEVMKNIRHRN 732
+S IG G V++ AIK + L S+ E + ++ +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 733 H--VKRISSCSNED--FKALDC----LHS---TNCSLNIFDKLNIMIDVASALEYLHFSH 781
++ + + ++C L+S S++ +++ + ++ A+ +H H
Sbjct: 69 DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH-QH 127
Query: 782 STPVIHCDLKPKNVF---------DFGIGRLLTGDRSMIQTETLV-TIGYMAP 824
++H DLKP N DFGI + D + + ++ V T+ YM P
Sbjct: 128 G--IVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 2e-18
Identities = 43/171 (25%), Positives = 66/171 (38%), Gaps = 25/171 (14%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHV 734
+ + IG G FG V+ G + +VAIK + AM+ + F E EVM + H V
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLV 66
Query: 735 KRISSCSNED-------FKA----LDCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHST 783
+ C + F D L + L + +DV + YL +
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC-- 124
Query: 784 PVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
VIH DL +N DFG+ R + D+ T T + + +P
Sbjct: 125 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 174
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-18
Identities = 38/171 (22%), Positives = 68/171 (39%), Gaps = 25/171 (14%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHV 734
E E +G G FG V+ + +VA+K +M++++F AE VMK ++H V
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLV 246
Query: 735 KRISSCSNEDF----------KALDCLHST-NCSLNIFDKLNIMIDVASALEYLHFSHST 783
K + + E LD L S + ++ +A + ++ +
Sbjct: 247 KLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN-- 304
Query: 784 PVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
IH DL+ N+ DFG+ R++ + + I + AP
Sbjct: 305 -YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 354
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 2e-18
Identities = 41/171 (23%), Positives = 66/171 (38%), Gaps = 25/171 (14%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHV 734
E+ + +G G FG V G+ +VA+K+ + +M+ F E + M + H V
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLV 66
Query: 735 KRISSCSNED-------FKA----LDCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHST 783
K CS E + + L+ L S L L + DV + +L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ-- 124
Query: 784 PVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
IH DL +N DFG+ R + D+ + T + + AP
Sbjct: 125 -FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAP 174
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 2e-18
Identities = 32/173 (18%), Positives = 66/173 (38%), Gaps = 26/173 (15%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKV--FHQNCAMALKSFEAECEVMKNIRHRN 732
+S IG G V++ AIK + L S+ E + ++ +
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 733 H--VKRISSCSNED--FKALDC----LHS---TNCSLNIFDKLNIMIDVASALEYLHFSH 781
++ + + ++C L+S S++ +++ + ++ A+ +H
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 175
Query: 782 STPVIHCDLKPKNVF---------DFGIGRLLTGDRSMIQTETLV-TIGYMAP 824
++H DLKP N DFGI + D + + ++ V + YM P
Sbjct: 176 ---IVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 39/171 (22%), Positives = 71/171 (41%), Gaps = 25/171 (14%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHV 734
E +G G FG V+ G + +VA+K Q +M+ +F AE +MK ++H+ V
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV 71
Query: 735 KRISSCSNEDF----------KALDCLHSTN-CSLNIFDKLNIMIDVASALEYLHFSHST 783
+ + + E +D L + + L I L++ +A + ++ +
Sbjct: 72 RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN-- 129
Query: 784 PVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
IH DL+ N+ DFG+ RL+ + + I + AP
Sbjct: 130 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 179
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 40/184 (21%), Positives = 70/184 (38%), Gaps = 41/184 (22%)
Query: 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKV--FHQNCAMALKSFEAECEVMKNIRHR 731
EK+ + IG GSFG + DG + IK + + + E V+ N++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 732 NHVKRISSCSNEDFKALDCLH-----STNCSLNIFDK------------LNIMIDVASAL 774
N V+ S F+ L+ L L+ + + AL
Sbjct: 84 NIVQYRES-----FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLAL 138
Query: 775 EYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-TIGYMA 823
+++H ++H D+K +N+F DFGI R+L + + T Y++
Sbjct: 139 KHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL--ARACIGTPYYLS 193
Query: 824 PGLL 827
P +
Sbjct: 194 PEIC 197
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 4e-18
Identities = 42/171 (24%), Positives = 68/171 (39%), Gaps = 25/171 (14%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHV 734
E E +G G FG V+ G + VAIK M+ ++F E +VMK +RH V
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLV 242
Query: 735 KRISSCSNEDF----------KALDCLHSTN-CSLNIFDKLNIMIDVASALEYLHFSHST 783
+ + S E LD L L + +++ +AS + Y+ +
Sbjct: 243 QLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN-- 300
Query: 784 PVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
+H DL+ N+ DFG+ RL+ + + I + AP
Sbjct: 301 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 350
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 8e-18
Identities = 42/171 (24%), Positives = 68/171 (39%), Gaps = 25/171 (14%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHV 734
E E +G G FG V+ G + VAIK M+ ++F E +VMK +RH V
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLV 325
Query: 735 KRISSCSNEDF----------KALDCLHSTN-CSLNIFDKLNIMIDVASALEYLHFSHST 783
+ + S E LD L L + +++ +AS + Y+ +
Sbjct: 326 QLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN-- 383
Query: 784 PVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
+H DL+ N+ DFG+ RL+ + + I + AP
Sbjct: 384 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 433
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 9e-18
Identities = 39/171 (22%), Positives = 64/171 (37%), Gaps = 25/171 (14%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHV 734
+ + +G G FG V G+ +VAIK+ + +M+ F E +VM N+ H V
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLV 82
Query: 735 KRISSCSNED-------FKA----LDCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHST 783
+ C+ + + A L+ L L + DV A+EYL
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ-- 140
Query: 784 PVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
+H DL +N DFG+ R + D + + + P
Sbjct: 141 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 190
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 46/205 (22%), Positives = 72/205 (35%), Gaps = 44/205 (21%)
Query: 653 SIRGGKSKTLRRFSYQDLFRAT---EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFH 708
S RG S+TL+ Y + + F + + +G GS+G V+K R DG A+K
Sbjct: 32 SFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSM 91
Query: 709 QNCAMALKSFEAECEV---MKNIRHRNHVKRISSCSNEDFKALDCLHSTN--CSLNIFDK 763
EV K +H V+ + ++ L+ C ++
Sbjct: 92 SPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA-----WEEGGILYLQTELCGPSLQQH 146
Query: 764 L-------------NIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGI 800
+ D AL +LH ++H D+KP N+F DFG+
Sbjct: 147 CEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGL 203
Query: 801 GRLLTGDRSMIQTETLV-TIGYMAP 824
L + E YMAP
Sbjct: 204 LVELG---TAGAGEVQEGDPRYMAP 225
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 44/172 (25%), Positives = 71/172 (41%), Gaps = 31/172 (18%)
Query: 679 KENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRI 737
++G G++G VY GR L + + +AIK + + + E + K+++H+N V+ +
Sbjct: 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 738 SSCSNEDF-----------KALDCLHSTNCSLNIFDKL--NIMIDVASALEYLHFSHSTP 784
S S F L S L ++ + L+YLH +
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--- 142
Query: 785 VIHCDLKPKNVF-----------DFGIGRLLTGDRSMIQTETLV-TIGYMAP 824
++H D+K NV DFG + L G TET T+ YMAP
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC--TETFTGTLQYMAP 192
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 45/193 (23%), Positives = 67/193 (34%), Gaps = 50/193 (25%)
Query: 672 RATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRH 730
R F + LIG G FG V+K + DG IK N A + E + + + H
Sbjct: 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDH 63
Query: 731 RNHVKRISS----CSNEDFKALDCLHSTNCSLNI---------------------FDK-- 763
N V + + + + S L I DK
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 764 -LNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812
L + + ++Y+ HS +I+ DLKP N+F DFG+ L D
Sbjct: 124 ALELFEQITKGVDYI---HSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR-- 178
Query: 813 TETLV-TIGYMAP 824
T+ YM+P
Sbjct: 179 -TRSKGTLRYMSP 190
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 41/189 (21%), Positives = 69/189 (36%), Gaps = 51/189 (26%)
Query: 674 TEKFSKEN-LIGVGSFGSVYKGR-LHDGIEVAIKVF--HQNCAMALKSFEAECEVMKNIR 729
+F K + IG GSF +VYKG +EVA + + F+ E E++K ++
Sbjct: 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ 83
Query: 730 HRNHVKRISSCSNEDFKALDCLHSTNCSLNIF----------DKL------------NIM 767
H N V+ S + + + L +
Sbjct: 84 HPNIVRFYDSWESTV--------KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWC 135
Query: 768 IDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRLLTGDRSMIQTETL 816
+ L++LH + + P+IH DLK N+F D G+ L + +
Sbjct: 136 RQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAV 190
Query: 817 V-TIGYMAP 824
+ T +MAP
Sbjct: 191 IGTPEFMAP 199
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-17
Identities = 44/173 (25%), Positives = 72/173 (41%), Gaps = 27/173 (15%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHD-GIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNH 733
+ ++ +G G +G VY+G + VA+K ++ M ++ F E VMK I+H N
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 278
Query: 734 VKRISSCSNED-------FKALDCLHS-----TNCSLNIFDKLNIMIDVASALEYLHFSH 781
V+ + C+ E F L ++ L + ++SA+EYL +
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338
Query: 782 STPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
IH +L +N DFG+ RL+TGD I + AP
Sbjct: 339 ---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 388
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 35/180 (19%), Positives = 75/180 (41%), Gaps = 34/180 (18%)
Query: 676 KFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNI-RHRNHV 734
F ++++G G+ G++ + D +VA+K C + E ++++ H N +
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81
Query: 735 KRISSCSNEDFKAL----------DCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHSTP 784
+ + + F+ + + + + + + + ++ S L +L HS
Sbjct: 82 RYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL---HSLN 138
Query: 785 VIHCDLKPKNVF---------------DFGIGRLLTGDR-SMIQTETLV-TIGYMAPGLL 827
++H DLKP N+ DFG+ + L R S + + T G++AP +L
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 39/201 (19%), Positives = 71/201 (35%), Gaps = 52/201 (25%)
Query: 672 RATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRH 730
R F + ++G G+FG V K R D AIK L + +E ++ ++ H
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNH 61
Query: 731 RNHVKRISS-CSNEDFKALDCLHSTNCSLNI----------FDKL-------------NI 766
+ V+ ++ +F +L I +D + +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 767 MIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETL 816
+ AL Y+H +IH DLKP N+F DFG+ + + +++ ++
Sbjct: 122 FRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 817 VTIG-------------YMAP 824
G Y+A
Sbjct: 179 NLPGSSDNLTSAIGTAMYVAT 199
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 45/173 (26%), Positives = 72/173 (41%), Gaps = 27/173 (15%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDG-IEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNH 733
+ ++ +G G +G VY+G + VA+K ++ M ++ F E VMK I+H N
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 71
Query: 734 VKRISSCSNED-------FKALDCLHS-----TNCSLNIFDKLNIMIDVASALEYLHFSH 781
V+ + C+ E F L ++ L + ++SA+EYL +
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 131
Query: 782 STPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
IH DL +N DFG+ RL+TGD I + AP
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 181
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 4e-17
Identities = 52/285 (18%), Positives = 92/285 (32%), Gaps = 32/285 (11%)
Query: 268 NLENLVLGFNNLVGVVPAA-IFNMSTVKKIYLLDNSLLGSFSLGI--DLSLPNVERLNLG 324
+LE L+ + + I ++K++ + + G L + ++ L L
Sbjct: 44 SLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLE 103
Query: 325 LNRFSGTIPSFITNAS--KLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSL 382
+GT P + A+ L L++ S++ D L L L
Sbjct: 104 NLEVTGTAPPPLLEATGPDLNILNLRNVSWAT------------RDAWLAELQQWLKPGL 151
Query: 383 ENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVT----FGRLQKLQGLYLPFN 438
+ + I+ + + + L LDL N G + + LQ L L
Sbjct: 152 KVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNA 211
Query: 439 KLA---GSIPDQLCHLARLNTLGLAGNKFSGSIP-SCLGNLTSLRSPDLGSNRLTSVLPS 494
+ G +L L L+ N + + L S +L L V
Sbjct: 212 GMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKG 271
Query: 495 TFWNLKDILFFDLSSNSLDG-PLSLDIGNLRVVIGINLSRNNFSG 538
L + DLS N LD P ++ + ++L N F
Sbjct: 272 LPAKLSVL---DLSYNRLDRNPSPDELPQVGN---LSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 5e-16
Identities = 51/333 (15%), Positives = 91/333 (27%), Gaps = 60/333 (18%)
Query: 185 ELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTI 244
EL + + LK + ++ + KRL + + ++
Sbjct: 37 ELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISG 96
Query: 245 LRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLL 304
L++++L N ++ G P + + +L N+ +
Sbjct: 97 LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSW-------------------ATRD 137
Query: 305 GSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTG 364
+ P ++ L++ + L LD+ N G L
Sbjct: 138 AWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISAL-- 195
Query: 365 NPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTF 424
P L L L + +G
Sbjct: 196 -------------------------------CPLKFPTLQVLALRNAGMETPSGVCSALA 224
Query: 425 GRLQKLQGLYLPFNKLAGSIPDQLC-HLARLNTLGLAGNKFSGSIPSCLG-NLTSLRSPD 482
+LQGL L N L + C ++LN+L L+ +P L L+ L D
Sbjct: 225 AARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPAKLSVL---D 280
Query: 483 LGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGP 515
L NRL + L + L N
Sbjct: 281 LSYNRLDRN--PSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 4e-15
Identities = 56/290 (19%), Positives = 95/290 (32%), Gaps = 25/290 (8%)
Query: 58 QALLALKAHISYDPTNLLAQNSTSNTSVCNWIGITCNVNSHRVTALNISSLNLQGTIPPQ 117
L A + +L +T + T + S + L + + + I
Sbjct: 29 NCLGAADVELYGGGRSLEYLLKRVDTE-ADLGQFTDIIKSLSLKRLTVRAARIPSRILFG 87
Query: 118 ---LGNLSSLTTLNLSHNKLSGDIPPSIF--TMHKLKFLDFSDNQLSGSLSSVTFNLSSV 172
+ +S L L L + +++G PP + T L L+ + + + + L
Sbjct: 88 ALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLA-ELQQW 146
Query: 173 LDIRLDSDKLSG----ELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKC-------KRL 221
L L ++ L L L+ N G+ L + C + L
Sbjct: 147 LKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVL 206
Query: 222 QLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEI-GYLPNLENLVLGFNNLV 280
L N G + SG + L+ + L +N LR + L +L L F L
Sbjct: 207 ALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266
Query: 281 GVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSG 330
VP + + + + L N L LP V L+L N F
Sbjct: 267 Q-VPKGLP--AKLSVLDLSYNRLD---RNPSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 8e-15
Identities = 43/222 (19%), Positives = 80/222 (36%), Gaps = 17/222 (7%)
Query: 379 SMSLENIYISNCNIGGSIPQLIS---NLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYL 435
S+SL+ + + I I +S L L LE ++TG+ P L
Sbjct: 67 SLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNIL 126
Query: 436 PFNKLAGSIPD------QLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLT 489
++ + D Q L L +A + +L + DL N
Sbjct: 127 NLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPEL 186
Query: 490 -------SVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPS 542
++ P F L+ + + + G S + G++LS N+ +
Sbjct: 187 GERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA 246
Query: 543 TIGD-LKDLQNISLACNGLEGLIPESFGYLTELNLSFNKLEG 583
D L +++L+ GL+ + L+ L+LS+N+L+
Sbjct: 247 PSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSVLDLSYNRLDR 288
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 44/303 (14%), Positives = 72/303 (23%), Gaps = 57/303 (18%)
Query: 297 YLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPS---FITNASKLVYLDMGTNSFS 353
++ + +++RL + R I + S L L + +
Sbjct: 49 LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108
Query: 354 GIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLL----- 408
G P + P L + + N + ++ L L
Sbjct: 109 GTAPPPLLEATGP--------------DLNILNLRNVSWAT-RDAWLAELQQWLKPGLKV 153
Query: 409 LDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSI-------PDQLCHLARLNTLGLAG 461
L + L L L N G P + L L
Sbjct: 154 LSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM 213
Query: 462 NKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLP-STFWNLKDILFFDLSSNSLDGPLSLDI 520
SG + L+ DL N L + + +LS L
Sbjct: 214 ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLP 273
Query: 521 GNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFGYLTELNLSFNK 580
L V ++LS N PS P+ + L+L N
Sbjct: 274 AKLSV---LDLSYNRLDR-NPS----------------------PDELPQVGNLSLKGNP 307
Query: 581 LEG 583
Sbjct: 308 FLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 49/331 (14%), Positives = 96/331 (29%), Gaps = 62/331 (18%)
Query: 117 QLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSL---SSVTFNLSSVL 173
G S L + I LK L ++ + + +S +
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98
Query: 174 DIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSG 233
++ L++ +++G P + + L L N+ +
Sbjct: 99 ELTLENLEVTGTAPPPL--------------------LEATGPDLNILNLRNVSWATRDA 138
Query: 234 AIPKEISNL-TILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMST 292
+ + L L+ +S+ ++ P L L L N +G
Sbjct: 139 WLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELG----------- 187
Query: 293 VKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSF 352
+ L+ + +L + N G+ SG + +L LD+ NS
Sbjct: 188 -------ERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSL 240
Query: 353 SGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLE 412
L ++ +S + +P+ + + L +LDL
Sbjct: 241 RDAAGAPSCD---------------WPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLS 282
Query: 413 GNKLTGSIPVTFGRLQKLQGLYLPFNKLAGS 443
N+L P L ++ L L N S
Sbjct: 283 YNRLD-RNPS-PDELPQVGNLSLKGNPFLDS 311
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 38/174 (21%), Positives = 65/174 (37%), Gaps = 35/174 (20%)
Query: 680 ENLIGVGSFGSVYKGRLHDG---IEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVK 735
+ +G G+FGSV +G I+VAIKV Q + E ++M + + V+
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 736 RISSCSNEDFKA----------LDCLHSTNCSLNIFDKLNIMIDVASALEYL---HFSHS 782
I C E L + + + ++ V+ ++YL +F
Sbjct: 75 LIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF--- 131
Query: 783 TPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTET--LVTIGYMAP 824
+H DL +NV DFG+ + L D S + + + AP
Sbjct: 132 ---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 182
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 36/180 (20%), Positives = 62/180 (34%), Gaps = 33/180 (18%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLH-----DGIEVAIKVFHQNCAMALKSFEAECEVMKNIR 729
+ +G G+FGSV R G VA+K + + F+ E +++K +
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 730 HRNHVKRISSCSNEDFKA-------------LDCLHSTNCSLNIFDKLNIMIDVASALEY 776
VK ++ D L L+ L + +EY
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEY 142
Query: 777 LHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS--MIQTETLVTIGYMAP 824
L +H DL +N+ DFG+ +LL D+ +++ I + AP
Sbjct: 143 LGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 199
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 41/217 (18%), Positives = 70/217 (32%), Gaps = 46/217 (21%)
Query: 652 KSIRGGKSKTLRRFSYQDLFRATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQN 710
S+ G + F Q + + ++ G F VY+ + + G E A+K N
Sbjct: 5 GSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN 64
Query: 711 CAMALKSFEAECEVMKNIR-HRNHVKRISS---------------------CSNEDFKAL 748
++ E MK + H N V+ S+ C + + L
Sbjct: 65 EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFL 124
Query: 749 DCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DF 798
+ S L+ L I A++++H P+IH DLK +N+ DF
Sbjct: 125 KKMESRG-PLSCDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDF 182
Query: 799 GIGRLLTGDRSMIQTETLV-----------TIGYMAP 824
G ++ + T Y P
Sbjct: 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTP 219
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 37/180 (20%), Positives = 62/180 (34%), Gaps = 36/180 (20%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDG-----IEVAIKVFHQNC-AMALKSFEAECEVMKNI 728
+ K ++G G FG+V+KG I V IKV + ++ + ++
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 729 RHRNHVKRISSCSNEDF----------KALDCLHSTNCSLNIFDKLNIMIDVASALEYL- 777
H + V+ + C LD + +L LN + +A + YL
Sbjct: 73 DHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE 132
Query: 778 --HFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTE-TLVTIGYMAP 824
+H +L +NV DFG+ LL D + I +MA
Sbjct: 133 EHGM------VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-16
Identities = 43/180 (23%), Positives = 67/180 (37%), Gaps = 36/180 (20%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDG-----IEVAIKVFHQNC-AMALKSFEAECEVMKNI 728
+F K ++G G+FG+VYKG I VAIK + A K E VM ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 729 RHRNHVKRISSCSNEDF----------KALDCLHSTNCSLNIFDKLNIMIDVASALEYL- 777
+ + + + C LD + ++ LN + +A + YL
Sbjct: 75 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 778 --HFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTE-TLVTIGYMAP 824
+H DL +NV DFG+ +LL + E V I +MA
Sbjct: 135 DRRL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 8e-16
Identities = 41/156 (26%), Positives = 58/156 (37%), Gaps = 26/156 (16%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRN 732
E IG G+FG V+ GRL D VA+K + F E ++K H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 733 HVKRISSCSNED-------FKA----LDCLHSTNCSLNIFDKLNIMIDVASALEYLHFSH 781
V+ I C+ + L L + L + L ++ D A+ +EYL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL---E 230
Query: 782 STPVIHCDLKPKNVF----------DFGIGRLLTGD 807
S IH DL +N DFG+ R
Sbjct: 231 SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 9e-16
Identities = 33/173 (19%), Positives = 55/173 (31%), Gaps = 46/173 (26%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHD--------GIEVAIKVFHQNCAMALKSFEAECEVMK 726
E +G G+F ++KG + EV +KV + +SF +M
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 727 NIRHRNHVKRISSCSNED-------FKA----LDCLHSTNCSLNIFDKLNIMIDVASALE 775
+ H++ V C D F L +NI KL + +A+A+
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMH 127
Query: 776 YL---HFSHSTPVIHCDLKPKNVF------------------DFGIGRLLTGD 807
+L IH ++ KN+ D GI +
Sbjct: 128 FLEENTL------IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 34/181 (18%), Positives = 65/181 (35%), Gaps = 34/181 (18%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLH-----DGIEVAIKVFHQNC-AMALKSFEAECEVMKNI 728
+ +G G FG V R G +VA+K + + E E+++N+
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 729 RHRNHVKRISSCSNEDFKA-------------LDCLHSTNCSLNIFDKLNIMIDVASALE 775
H N VK C+ + + L +N+ +L + + ++
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMD 140
Query: 776 YLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS--MIQTETLVTIGYMA 823
YL +H DL +NV DFG+ + + D+ ++ + + + A
Sbjct: 141 YLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYA 197
Query: 824 P 824
P
Sbjct: 198 P 198
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 38/181 (20%), Positives = 64/181 (35%), Gaps = 44/181 (24%)
Query: 665 FSYQDLFRATEKFSKE---------NLIGVGSFGSVYKGRLHDG----IEVAIKVFHQNC 711
+Y++ RA F++E +IG G G V GRL + VAIK
Sbjct: 30 HTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY 89
Query: 712 -AMALKSFEAECEVMKNIRHRNHVKRISSCSNED-------FKALDCLHS----TNCSLN 759
+ F +E +M H N ++ + + L + +
Sbjct: 90 TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFT 149
Query: 760 IFDKLNIMIDVASALEYL---HFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806
I + ++ V + + YL + +H DL +NV DFG+ R+L
Sbjct: 150 IMQLVGMLRGVGAGMRYLSDLGY------VHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203
Query: 807 D 807
D
Sbjct: 204 D 204
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 1e-15
Identities = 34/176 (19%), Positives = 58/176 (32%), Gaps = 49/176 (27%)
Query: 682 LIGVGSFGSVYKG---RLHDGIEVAIKVFH-QNCAMALKSFEAECEVMKNIRHRNHVKRI 737
I G G +Y + +G V +K A A AE + + + H + V+
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 738 SSCSNEDFKALDCLHSTNCS-------------------LNIFDKLNIMIDVASALEYLH 778
+F H L + + + ++++ AL YLH
Sbjct: 146 ------NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLH 199
Query: 779 FSHSTPVIHCDLKPKNVF---------DFGIGRLLTGDRSMIQTETLV-TIGYMAP 824
S +++ DLKP+N+ D G + L T G+ AP
Sbjct: 200 ---SIGLVYNDLKPENIMLTEEQLKLIDLGAVSRIN------SFGYLYGTPGFQAP 246
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 41/180 (22%), Positives = 66/180 (36%), Gaps = 33/180 (18%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLH-----DGIEVAIKVFHQNCAMALKSFEAECEVMKNIR 729
+G G+FGSV R G VA+K + L+ FE E E++K+++
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 730 HRNHVKRISSCSNEDFKA-------------LDCLHSTNCSLNIFDKLNIMIDVASALEY 776
H N VK C + + D L ++ L + +EY
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 129
Query: 777 LHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS--MIQTETLVTIGYMAP 824
L IH DL +N+ DFG+ ++L D+ ++ I + AP
Sbjct: 130 LGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAP 186
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 79.6 bits (196), Expect = 1e-15
Identities = 37/174 (21%), Positives = 65/174 (37%), Gaps = 35/174 (20%)
Query: 680 ENLIGVGSFGSVYKGRLHDG---IEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVK 735
+ +G G+FGSV +G I+VAIKV Q + E ++M + + V+
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 736 RISSCSNEDFK----------ALDCLHSTNCSLNIFDKLNIMIDVASALEYL---HFSHS 782
I C E L + + + ++ V+ ++YL +F
Sbjct: 401 LIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF--- 457
Query: 783 TPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTET--LVTIGYMAP 824
+H +L +NV DFG+ + L D S + + + AP
Sbjct: 458 ---VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 508
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 41/183 (22%), Positives = 71/183 (38%), Gaps = 40/183 (21%)
Query: 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFH-QNCAMALKSFEAECEVMKNIRHRN 732
+ +++G G+ +V++GR G AIKVF+ + + E EV+K + H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 733 HVKRISS---------------CSN-EDFKALDCLHSTNCSLNIFDKLNIMIDVASALEY 776
VK + C + L+ S L + L ++ DV + +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 777 LHFSHSTPVIHCDLKPKNVF--------------DFGIGRLLTGDRSMIQTETLV-TIGY 821
L + ++H ++KP N+ DFG R L D +L T Y
Sbjct: 128 LR-ENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VSLYGTEEY 181
Query: 822 MAP 824
+ P
Sbjct: 182 LHP 184
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 39/198 (19%), Positives = 69/198 (34%), Gaps = 48/198 (24%)
Query: 669 DLFRATEKFSKE---------NLIGVGSFGSVYKGRLHDG----IEVAIKVFHQNC-AMA 714
+L +A + +IG G FG VY G L D I A+K ++
Sbjct: 10 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 69
Query: 715 LKSFEAECEVMKNIRHRNHVKRISSCSNEDFKA------------LDCLHSTNCSLNIFD 762
+ F E +MK+ H N + + C + + + + + + D
Sbjct: 70 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 129
Query: 763 KLNIMIDVASALEYL---HFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGD-- 807
+ + VA ++YL F +H DL +N DFG+ R +
Sbjct: 130 LIGFGLQVAKGMKYLASKKF------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183
Query: 808 -RSMIQTETLVTIGYMAP 824
+T + + +MA
Sbjct: 184 YSVHNKTGAKLPVKWMAL 201
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 48/237 (20%), Positives = 85/237 (35%), Gaps = 24/237 (10%)
Query: 84 SVCNWIGITCNVNSHRVTAL------NISSLNLQG----TIPP-QLGNLSSLTTLNLSHN 132
V IT + + +L+L + + L L+LS
Sbjct: 3 CVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRC 62
Query: 133 KLSGDIPPSIFT-MHKLKFLDFSDNQLSGSLSSVTF-NLSSVLDIRLDSDKLSGELPVNI 190
++ I + + L L + N + SL+ F LSS+ + L+ L
Sbjct: 63 EIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFP 119
Query: 191 CNYLHYLKVLFLAKNMFHG-QIPLALSKCKRLQLLNLGFKKLSGAIPKEI----SNLTIL 245
+L LK L +A N+ ++P S L+ L+L K+ +I + +L
Sbjct: 120 IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLL 178
Query: 246 R-KISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDN 301
+ L N + I L+ L L N L V +++++KI+L N
Sbjct: 179 NLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 52/210 (24%), Positives = 84/210 (40%), Gaps = 28/210 (13%)
Query: 395 SIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLC-HLAR 453
IP + + LDL N L +F +LQ L L ++ +I D L+
Sbjct: 21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77
Query: 454 LNTLGLAGNKFSGSIPS-CLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSL 512
L+TL L GN S+ L+SL+ L S+ +LK + +++ N +
Sbjct: 78 LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136
Query: 513 -----DGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQN-------ISLACNGL 560
S ++ NL ++LS N I DL+ L + L+ N +
Sbjct: 137 QSFKLPEYFS-NLTNLEH---LDLSSNKIQ-SIYC--TDLRVLHQMPLLNLSLDLSLNPM 189
Query: 561 EGLIPESFGY--LTELNLSFNKLEGEIPRG 588
+ P +F L EL L N+L+ +P G
Sbjct: 190 NFIQPGAFKEIRLKELALDTNQLK-SVPDG 218
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 52/215 (24%), Positives = 83/215 (38%), Gaps = 22/215 (10%)
Query: 316 PNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIP---------NTIGLTGNP 366
+ + L+L N + +L LD+ I +T+ LTGNP
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 367 LDGVLPTSIGNLSMSLENIYISNCNIGGSIP-QLISNLSNLLLLDLEGNKLTGSIPV--T 423
+ + + LS SL+ + N+ S+ I +L L L++ N + S +
Sbjct: 88 IQSLALGAFSGLS-SLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLPEY 144
Query: 424 FGRLQKLQGLYLPFNKLAGSIP----DQLCHLARLN-TLGLAGNKFSGSIPSCLGNLTSL 478
F L L+ L L NK+ SI L + LN +L L+ N + I L
Sbjct: 145 FSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRL 202
Query: 479 RSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLD 513
+ L +N+L SV F L + L +N D
Sbjct: 203 KELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 237
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 43/222 (19%), Positives = 90/222 (40%), Gaps = 21/222 (9%)
Query: 197 LKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEI-SNLTILRKISLRNNKL 255
K L L+ N + LQ+L+L ++ I +L+ L + L N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPI 88
Query: 256 RGEIPHEI-GYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLS 314
+ + L +L+ LV NL + I ++ T+K++ + N + +
Sbjct: 89 Q-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 315 LPNVERLNLGLNRFSGTIPSFI-TNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPT 373
L N+E L+L N+ +I ++ L++ ++ L+ NP++ + P
Sbjct: 148 LTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNL-----------SLDLSLNPMNFIQPG 195
Query: 374 SIGNLSMSLENIYISNCNIGGSIPQLI-SNLSNLLLLDLEGN 414
+ + L+ + + + S+P I L++L + L N
Sbjct: 196 AFKEI--RLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTN 234
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 41/180 (22%), Positives = 71/180 (39%), Gaps = 38/180 (21%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDG----IEVAIKVFHQNCAMALKS-FEAECEVMKNIR 729
E ++G G FG VY+G + I VA+K ++C + K F +E +MKN+
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 730 HRNHVKRISSCSNE------------DFKALDCLHSTNCSLNIFDKLNIMIDVASALEYL 777
H + VK I E + L SL + + + + A+ YL
Sbjct: 72 HPHIVKLIGIIEEEPTWIIMELYPYGEL--GHYLERNKNSLKVLTLVLYSLQICKAMAYL 129
Query: 778 ---HFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
+ +H D+ +N+ DFG+ R + + + T + I +M+P
Sbjct: 130 ESINC------VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSP 183
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 41/178 (23%), Positives = 68/178 (38%), Gaps = 34/178 (19%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDG----IEVAIKVFHQNCAMALKS-FEAECEVMKNIR 729
E+ IG G FG V++G + VAIK + +++ F E M+
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 730 HRNHVKRISSCSNE------DFKALDCLHS---TNC-SLNIFDKLNIMIDVASALEYL-- 777
H + VK I + + L L S SL++ + +++AL YL
Sbjct: 75 HPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 134
Query: 778 -HFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
F +H D+ +NV DFG+ R + ++ + I +MAP
Sbjct: 135 KRF------VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 186
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 37/186 (19%), Positives = 63/186 (33%), Gaps = 39/186 (20%)
Query: 672 RATEKFSKENLIGVGSFGSVYKGRLHDG----IEVAIKVFHQNC-AMALKSFEAECEVMK 726
+ +IG G FG VY G D I+ AIK + +++F E +M+
Sbjct: 18 HERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMR 77
Query: 727 NIRHRNHVKRISSCSNEDFKA------------LDCLHSTNCSLNIFDKLNIMIDVASAL 774
+ H N + I + L + S + + D ++ + VA +
Sbjct: 78 GLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGM 137
Query: 775 EYL---HFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGD---RSMIQTETLVT 818
EYL F +H DL +N DFG+ R + +
Sbjct: 138 EYLAEQKF------VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP 191
Query: 819 IGYMAP 824
+ + A
Sbjct: 192 VKWTAL 197
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 41/180 (22%), Positives = 66/180 (36%), Gaps = 33/180 (18%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLH-----DGIEVAIKVFHQNCAMALKSFEAECEVMKNIR 729
+G G+FGSV R G VA+K + L+ FE E E++K+++
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 730 HRNHVKRISSCSNEDFKA-------------LDCLHSTNCSLNIFDKLNIMIDVASALEY 776
H N VK C + + D L ++ L + +EY
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY 160
Query: 777 LHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS--MIQTETLVTIGYMAP 824
L IH DL +N+ DFG+ ++L D+ ++ I + AP
Sbjct: 161 LGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAP 217
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 57/309 (18%), Positives = 107/309 (34%), Gaps = 42/309 (13%)
Query: 239 ISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYL 298
L KI+ + + + L + L + + + ++ + + L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEG--VQYLNNLIGLEL 70
Query: 299 LDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPN 358
DN + L +L + L L N S I + LD+ + + + P
Sbjct: 71 KDNQITDLAPLK---NLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTP- 124
Query: 359 TIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTG 418
+ LS +L+ +Y+ I P ++ L+NL L + +++
Sbjct: 125 ----------------LAGLS-NLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD 165
Query: 419 SIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSL 478
P L KL L NK++ I L L L + L N+ S P L N ++L
Sbjct: 166 LTP--LANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDVSP--LANTSNL 219
Query: 479 RSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSG 538
L + +T+ NL + N + GP I + + N +
Sbjct: 220 FIVTLTNQTITNQPVFYNNNL-------VVPNVVKGPSGAPIAPATISDNGTYASPNLTW 272
Query: 539 DIPSTIGDL 547
++ S I ++
Sbjct: 273 NLTSFINNV 281
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 49/268 (18%), Positives = 101/268 (37%), Gaps = 34/268 (12%)
Query: 312 DLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVL 371
D +L N ++ G + + T+ + + L + I
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEG-------------- 58
Query: 372 PTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQ 431
+ L+ +L + + + I + L NL+ + L+L GN L ++ LQ ++
Sbjct: 59 ---VQYLN-NLIGLELKDNQIT-DLAPL-KNLTKITELELSGNPLK-NVS-AIAGLQSIK 110
Query: 432 GLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSV 491
L L ++ P L L+ L L L N+ + +I L LT+L+ +G+ +++ +
Sbjct: 111 TLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDL 166
Query: 492 LPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQ 551
+ NL + N + L +L +I ++L N S D+ + + +L
Sbjct: 167 --TPLANLSKLTTLKADDNKISDISPLA--SLPNLIEVHLKNNQIS-DVSP-LANTSNLF 220
Query: 552 NISLACNGLEGLIPESFGYLTELNLSFN 579
++L + L N+
Sbjct: 221 IVTLTNQTITNQPVFYNNNLVVPNVVKG 248
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 50/289 (17%), Positives = 123/289 (42%), Gaps = 23/289 (7%)
Query: 118 LGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRL 177
L++ + + ++ + + + L ++ ++ V L++++ + L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVTQADLD--GITTLSAFGTGVT-TIEGVQ-YLNNLIGLEL 70
Query: 178 DSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPK 237
++++ + L + L L+ N + A++ + ++ L+L +++ P
Sbjct: 71 KDNQITD---LAPLKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTP- 124
Query: 238 EISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIY 297
++ L+ L+ + L N++ I + L NL+ L +G + + P + N+S + +
Sbjct: 125 -LAGLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLK 179
Query: 298 LLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIP 357
DN + L SLPN+ ++L N+ S P + N S L + + + +
Sbjct: 180 ADDNKISDISPLA---SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPV 234
Query: 358 --NTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLS 404
N + N + G I ++S +N ++ N+ ++ I+N+S
Sbjct: 235 FYNNNLVVPNVVKGPSGAPIAPATIS-DNGTYASPNLTWNLTSFINNVS 282
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 42/203 (20%), Positives = 88/203 (43%), Gaps = 15/203 (7%)
Query: 381 SLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKL 440
+ I N+ ++ ++L + L G +T +I L L GL L N++
Sbjct: 20 NAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQI 75
Query: 441 AGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLK 500
+ L +L ++ L L+GN ++ + + L S+++ DL S ++T V + L
Sbjct: 76 T-DLAP-LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDV--TPLAGLS 129
Query: 501 DILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGL 560
++ L N + +S + L + +++ S D+ + + +L L + N +
Sbjct: 130 NLQVLYLDLNQITN-IS-PLAGLTNLQYLSIGNAQVS-DL-TPLANLSKLTTLKADDNKI 185
Query: 561 EGLIP-ESFGYLTELNLSFNKLE 582
+ P S L E++L N++
Sbjct: 186 SDISPLASLPNLIEVHLKNNQIS 208
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 46/254 (18%), Positives = 93/254 (36%), Gaps = 25/254 (9%)
Query: 194 LHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNN 253
L + K+ + + + L+ ++ + + L L + L++N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQ--ADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 254 KLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDL 313
++ ++ + L + L L N L V I + ++K + L + L
Sbjct: 74 QIT-DLA-PLKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITDVTPLA--- 126
Query: 314 SLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIP-------NTIGLTGNP 366
L N++ L L LN+ + P + + L YL +G S + P T+ N
Sbjct: 127 GLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNK 184
Query: 367 LDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGR 426
+ + P + +L +L +++ N I P ++N SNL ++ L +T
Sbjct: 185 ISDISP--LASLP-NLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNN 239
Query: 427 LQKLQGLYLPFNKL 440
L + P
Sbjct: 240 LVVPNVVKGPSGAP 253
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 54/283 (19%), Positives = 104/283 (36%), Gaps = 44/283 (15%)
Query: 99 RVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQL 158
+T L+ + TI + L++L L L N+++ D+ P + + K+ L+ S N L
Sbjct: 42 GITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPL 97
Query: 159 SGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKC 218
N+S++ L +K L L P L+
Sbjct: 98 K--------NVSAI-------------------AGLQSIKTLDLTSTQITDVTP--LAGL 128
Query: 219 KRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNN 278
LQ+L L +++ P ++ LT L+ +S+ N ++ P + L L L N
Sbjct: 129 SNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNK 184
Query: 279 LVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITN 338
+ + P + ++ + +++L +N + L + N+ + L + + N
Sbjct: 185 ISDISP--LASLPNLIEVHLKNNQISDVSPLA---NTSNLFIVTLTNQTITNQPVFYNNN 239
Query: 339 ASKL--VYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLS 379
V G I + L L + I N+S
Sbjct: 240 LVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVS 282
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 37/184 (20%), Positives = 65/184 (35%), Gaps = 35/184 (19%)
Query: 400 ISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGL 459
L+N + + + +T VT L + L + +I + +L L L L
Sbjct: 15 DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLEL 70
Query: 460 AGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLD 519
N+ + + L NLT + +L N L +V S L+ I DL+S + D
Sbjct: 71 KDNQITD--LAPLKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQI-----TD 121
Query: 520 IGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIP-ESFGYLTELNLSF 578
+ L L +LQ + L N + + P L L++
Sbjct: 122 VTPL---------------------AGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGN 160
Query: 579 NKLE 582
++
Sbjct: 161 AQVS 164
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 36/190 (18%), Positives = 61/190 (32%), Gaps = 60/190 (31%)
Query: 674 TEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEA-ECEVMKNIRHR 731
+ + +G GSFG V++ + G + A+K + L+ F E +
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKK------VRLEVFRVEELVACAGLSSP 110
Query: 732 NHVKRISSCSNEDFKALDCLHSTNCSLNIF----------DKL------------NIMID 769
V + +NIF + +
Sbjct: 111 RIVPLYGAVREGP------------WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQ 158
Query: 770 VASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRLLTGD---RSMIQTET 815
LEYL H+ ++H D+K NV DFG L D +S++ +
Sbjct: 159 ALEGLEYL---HTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215
Query: 816 LV-TIGYMAP 824
+ T +MAP
Sbjct: 216 IPGTETHMAP 225
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 43/200 (21%), Positives = 74/200 (37%), Gaps = 46/200 (23%)
Query: 665 FSYQDLFRATEKFSKE---------NLIGVGSFGSVYKGRLH----DGIEVAIKVFHQNC 711
+++D + +F+KE ++G G FG V GRL I VAIK
Sbjct: 26 HTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY 85
Query: 712 -AMALKSFEAECEVMKNIRHRNHVKRISSCSNED----------FKALDC-LHSTNCSLN 759
+ F E +M H N ++ + +LD L +
Sbjct: 86 TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 760 IFDKLNIMIDVASALEYL---HFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806
+ + ++ +AS ++YL + +H DL +N+ DFG+GR+L
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMGY------VHRDLAARNILINSNLVCKVSDFGLGRVLED 199
Query: 807 DRSMIQTET--LVTIGYMAP 824
D T + I + +P
Sbjct: 200 DPEAAYTTRGGKIPIRWTSP 219
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 5e-15
Identities = 35/160 (21%), Positives = 53/160 (33%), Gaps = 30/160 (18%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLH----DGIEVAIKVFHQNC---AMALKSFEAECEVMKN 727
+ +G GSFG V +G + VA+K + A+ F E M +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 728 IRHRNHVKRISSCSNEDFK----------ALDCLHSTNCSLNIFDKLNIMIDVASALEYL 777
+ HRN ++ K LD L + + VA + YL
Sbjct: 78 LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 137
Query: 778 HFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGD 807
IH DL +N+ DFG+ R L +
Sbjct: 138 ESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 7e-15
Identities = 41/183 (22%), Positives = 71/183 (38%), Gaps = 40/183 (21%)
Query: 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFH-QNCAMALKSFEAECEVMKNIRHRN 732
+ +++G G+ +V++GR G AIKVF+ + + E EV+K + H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 733 HVKRISS---------------CSN-EDFKALDCLHSTNCSLNIFDKLNIMIDVASALEY 776
VK + C + L+ S L + L ++ DV + +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 777 LHFSHSTPVIHCDLKPKNVF--------------DFGIGRLLTGDRSMIQTETLV-TIGY 821
L + ++H ++KP N+ DFG R L D +L T Y
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VSLYGTEEY 181
Query: 822 MAP 824
+ P
Sbjct: 182 LHP 184
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 7e-15
Identities = 35/156 (22%), Positives = 61/156 (39%), Gaps = 33/156 (21%)
Query: 679 KENLIGVGSFGSVYKGRLHDG---IEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNH 733
++ +G G+FG+V KG VA+K+ AE VM+ + +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 734 VKRISSCSNE------DFKALDCLHS---TNCSLNIFDKLNIMIDVASALEYL---HFSH 781
V+ I C E + L L+ N + + + ++ V+ ++YL +F
Sbjct: 81 VRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF-- 138
Query: 782 STPVIHCDLKPKNVF----------DFGIGRLLTGD 807
+H DL +NV DFG+ + L D
Sbjct: 139 ----VHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 8e-15
Identities = 34/199 (17%), Positives = 69/199 (34%), Gaps = 26/199 (13%)
Query: 312 DLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVL 371
D + LG + + + + L Y+ + + + +
Sbjct: 19 DSTFKAYLNGLLGQSSTANITEA---QMNSLTYITLANINVTDL---------------- 59
Query: 372 PTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQ 431
T I +++++ I+N + P IS LSNL L + G +T L L
Sbjct: 60 -TGIEYAH-NIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115
Query: 432 GLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSV 491
L + + SI ++ L ++N++ L+ N I L L L+S ++ + +
Sbjct: 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDY 174
Query: 492 LPSTFWNLKDILFFDLSSN 510
+ + S
Sbjct: 175 RG--IEDFPKLNQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 7e-13
Identities = 30/186 (16%), Positives = 63/186 (33%), Gaps = 30/186 (16%)
Query: 400 ISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGL 459
+ +++L + L +T + + ++ L + P + L+ L L +
Sbjct: 40 EAQMNSLTYITLANINVTDLTGIEY--AHNIKDLTINNIHATNYNP--ISGLSNLERLRI 95
Query: 460 AGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLD 519
G + L LTSL D+ + + + L
Sbjct: 96 MGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLP------------------- 136
Query: 520 IGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIP-ESFGYLTELNLSF 578
+ I+LS N DI + L +L+++++ +G+ E F L +L
Sbjct: 137 --KVNS---IDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFS 190
Query: 579 NKLEGE 584
+ G+
Sbjct: 191 QTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 7e-13
Identities = 28/179 (15%), Positives = 72/179 (40%), Gaps = 8/179 (4%)
Query: 101 TALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSG 160
A L T ++SLT + L++ ++ D+ I H +K L ++ +
Sbjct: 23 KAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHAT- 79
Query: 161 SLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKR 220
+ + ++ LS++ +R+ ++ + N+ L L +L ++ + I ++ +
Sbjct: 80 NYNPIS-GLSNLERLRIMGKDVTSDKIPNLSG-LTSLTLLDISHSAHDDSILTKINTLPK 137
Query: 221 LQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNL 279
+ ++L + I + L L+ ++++ + + I P L L +
Sbjct: 138 VNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 22/159 (13%), Positives = 58/159 (36%), Gaps = 8/159 (5%)
Query: 100 VTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLS 159
+T + ++++N+ + ++ L +++ + + P I + L+ L ++
Sbjct: 46 LTYITLANINVTDLTG--IEYAHNIKDLTINNIHAT-NYNP-ISGLSNLERLRIMGKDVT 101
Query: 160 GSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCK 219
L+S+ + + + I L + + L+ N I L
Sbjct: 102 SDKIPNLSGLTSLTLLDISHSAHDDSILTKINT-LPKVNSIDLSYNGAITDIM-PLKTLP 159
Query: 220 RLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGE 258
L+ LN+ F + I + L ++ + + G+
Sbjct: 160 ELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-10
Identities = 29/182 (15%), Positives = 71/182 (39%), Gaps = 11/182 (6%)
Query: 120 NLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDS 179
+ L + + +I + M+ L ++ ++ ++ L+ + ++ D+ +++
Sbjct: 21 TFKAYLNGLLGQSSTA-NITEA--QMNSLTYITLANINVT-DLTGIE-YAHNIKDLTINN 75
Query: 180 DKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEI 239
+ P+ + L L+ L + LS L LL++ +I +I
Sbjct: 76 IHATNYNPI---SGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
Query: 240 SNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLL 299
+ L + I L N +I + LP L++L + F+ + I + + ++Y
Sbjct: 133 NTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAF 189
Query: 300 DN 301
Sbjct: 190 SQ 191
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 77.1 bits (189), Expect = 9e-15
Identities = 51/235 (21%), Positives = 94/235 (40%), Gaps = 27/235 (11%)
Query: 215 LSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVL 274
NL K ++ A+ + L + +I N+ ++ + I YLPN+ L L
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFL 72
Query: 275 GFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPS 334
N L + P + N+ + ++L +N + SL L ++ L+L N S I +
Sbjct: 73 NGNKLTDIKP--LTNLKNLGWLFLDENKIKDLSSLK---DLKKLKSLSLEHNGIS-DI-N 125
Query: 335 FITNASKLVYLDMGTNSFSGIIP-------NTIGLTGNPLDGVLPTSIGNLSM--SLENI 385
+ + +L L +G N + I +T+ L N + + I L+ L+N+
Sbjct: 126 GLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQI-----SDIVPLAGLTKLQNL 180
Query: 386 YISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKL 440
Y+S +I + L + L NL +L+L + L + L
Sbjct: 181 YLSKNHIS-DLRAL-AGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 74.8 bits (183), Expect = 6e-14
Identities = 52/234 (22%), Positives = 103/234 (44%), Gaps = 25/234 (10%)
Query: 100 VTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLS 159
+ + ++ +++ ++ + L ++T L L+ NKL+ DI P + + L +L +N++
Sbjct: 45 IDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIK 100
Query: 160 GSLSSVTFNLSSVLDIRLDSDKLSGELPVNICN--YLHYLKVLFLAKNMFHGQI--PLAL 215
LSS+ +L + + L+ + +S +I +L L+ L+L N +I L
Sbjct: 101 -DLSSLK-DLKKLKSLSLEHNGIS-----DINGLVHLPQLESLYLGNN----KITDITVL 149
Query: 216 SKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLG 275
S+ +L L+L ++S +P ++ LT L+ + L N + ++ + L NL+ L L
Sbjct: 150 SRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELF 205
Query: 276 FNNLVGVVPAAIFNMSTVKKIYLLDNSL--LGSFSLGIDLSLPNVERLNLGLNR 327
+ N+ + D SL S D PNV+
Sbjct: 206 SQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTN 259
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 73.6 bits (180), Expect = 1e-13
Identities = 51/274 (18%), Positives = 97/274 (35%), Gaps = 37/274 (13%)
Query: 312 DLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVL 371
D + + NL + + + + + + +
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV---------------- 58
Query: 372 PTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQ 431
I L ++ ++++ + I L +NL NL L L+ NK+ + + L+KL+
Sbjct: 59 -QGIQYLP-NVTKLFLNGNKLT-DIKPL-TNLKNLGWLFLDENKIK-DLS-SLKDLKKLK 112
Query: 432 GLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSV 491
L L N ++ I L HL +L +L L NK + + L LT L + L N+++ +
Sbjct: 113 SLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISDI 168
Query: 492 LPSTFWNLKDILFFDLSSNSLD--GPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKD 549
L + LS N + L+ + NL V + L + +L
Sbjct: 169 --VPLAGLTKLQNLYLSKNHISDLRALA-GLKNLDV---LELFSQECLNKPINHQSNLVV 222
Query: 550 LQNISLACNGLEGLIPES-FGYLTELNLSFNKLE 582
+ L S G + N+ ++ E
Sbjct: 223 PNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPE 256
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 72.1 bits (176), Expect = 4e-13
Identities = 51/294 (17%), Positives = 103/294 (35%), Gaps = 28/294 (9%)
Query: 118 LGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRL 177
+ NL ++ + + + + +++ + S+ + L +V + L
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVTQNELN--SIDQIIANNSDIK-SVQGIQ-YLPNVTKLFL 72
Query: 178 DSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPK 237
+ +KL+ P+ L L LFL +N + +L K+L+ L+L +S
Sbjct: 73 NGNKLTDIKPL---TNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGISDING- 126
Query: 238 EISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIY 297
+ +L L + L NNK+ + L L+ L L N + +VP + ++ ++ +Y
Sbjct: 127 -LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLY 181
Query: 298 LLDNSLLGSFSLGIDLS----LPNVERLNLGLNRFSGTIPSFITNASKLVYLDM--GTNS 351
L N + DL L N++ L L + +N + G+
Sbjct: 182 LSKNHI-------SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 234
Query: 352 FSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSN 405
II + + LP +S ++ L
Sbjct: 235 TPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKE 288
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 59.0 bits (142), Expect = 5e-09
Identities = 46/258 (17%), Positives = 96/258 (37%), Gaps = 18/258 (6%)
Query: 104 NISSLNLQG----TIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLS 159
N+ L L + L +L L +L+L HN +S DI + + +L+ L +N+++
Sbjct: 88 NLGWLFLDENKIKDLSS-LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT 144
Query: 160 GSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIP--LALSK 217
++ ++ L+ + + L+ +++S + L L+ L+L+KN I AL+
Sbjct: 145 -DITVLS-RLTKLDTLSLEDNQISD---IVPLAGLTKLQNLYLSKN----HISDLRALAG 195
Query: 218 CKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFN 277
K L +L L ++ SNL + + + L N+
Sbjct: 196 LKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLP 255
Query: 278 NLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFIT 337
V + T+ K + + + +V+ + +GT +
Sbjct: 256 EFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKTKVEAGTRITAPK 315
Query: 338 NASKLVYLDMGTNSFSGI 355
+K Y+ G +
Sbjct: 316 PPTKQGYVFKGWYTEKNG 333
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 77.4 bits (190), Expect = 9e-15
Identities = 45/191 (23%), Positives = 72/191 (37%), Gaps = 41/191 (21%)
Query: 672 RATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALK-SFEAECEVMKNIR 729
+ + + +G G FG V + G +VAIK Q + + + E ++MK +
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70
Query: 730 HRNHVK---------RISS----------CSNEDFKALDCLHSTNCSLNIFDKLNIMIDV 770
H N V +++ C D + C L ++ D+
Sbjct: 71 HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130
Query: 771 ASALEYLHFSHSTPVIHCDLKPKNVF-------------DFGIGRLLTGDRSMIQTETLV 817
+SAL YLH + +IH DLKP+N+ D G + L V
Sbjct: 131 SSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC---TEFV 184
Query: 818 -TIGYMAPGLL 827
T+ Y+AP LL
Sbjct: 185 GTLQYLAPELL 195
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 1e-14
Identities = 39/180 (21%), Positives = 66/180 (36%), Gaps = 38/180 (21%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDG----IEVAIKVFHQNCAMALKS-FEAECEVMKNIR 729
E+ IG G FG V++G + VAIK + +++ F E M+
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 730 HRNHVKRISSCSNE------------DFKALDCLHSTNCSLNIFDKLNIMIDVASALEYL 777
H + VK I + + L SL++ + +++AL YL
Sbjct: 450 HPHIVKLIGVITENPVWIIMELCTLGEL--RSFLQVRKFSLDLASLILYAYQLSTALAYL 507
Query: 778 ---HFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
F +H D+ +NV DFG+ R + ++ + I +MAP
Sbjct: 508 ESKRF------VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 561
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 33/181 (18%), Positives = 59/181 (32%), Gaps = 36/181 (19%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHD-----GIEVAIKVFHQNC-AMALKSFEAECEVMKNI 728
K +G G FG V G VA+K + ++ E ++++ +
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 729 RHRNHVKRISSCSNEDFKA-------------LDCLHSTNCSLNIFDKLNIMIDVASALE 775
H + +K C + + D L + L L + +
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLA--QLLLFAQQICEGMA 148
Query: 776 YLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS--MIQTETLVTIGYMA 823
YLH H IH DL +NV DFG+ + + ++ + + + A
Sbjct: 149 YLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 205
Query: 824 P 824
P
Sbjct: 206 P 206
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 42/236 (17%), Positives = 77/236 (32%), Gaps = 54/236 (22%)
Query: 617 KRRTRRKSKKKMLLLVIVLPLSTALIIAVPLALKYKSIRGGKSKTLRRFSYQ-------- 668
RR S +L+ P + L+ G ++ + +
Sbjct: 13 HHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALN 72
Query: 669 -DLFRATEKFSKE---------NLIGVGSFGSVYKGRLHDG----IEVAIKVFHQNC-AM 713
+L +A + +IG G FG VY G L D I A+K ++
Sbjct: 73 PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG 132
Query: 714 ALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKA------------LDCLHSTNCSLNIF 761
+ F E +MK+ H N + + C + + + + + +
Sbjct: 133 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 192
Query: 762 DKLNIMIDVASALEYL---HFSHSTPVIHCDLKPKNVF----------DFGIGRLL 804
D + + VA +++L F +H DL +N DFG+ R +
Sbjct: 193 DLIGFGLQVAKGMKFLASKKF------VHRDLAARNCMLDEKFTVKVADFGLARDM 242
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 75.9 bits (186), Expect = 1e-14
Identities = 28/234 (11%), Positives = 59/234 (25%), Gaps = 75/234 (32%)
Query: 648 ALKYKSIRGGKSKTLRRFSYQDLFRATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKV 706
+ +S G + +TL R ++G + + G + V
Sbjct: 66 PFRVESELGERPRTLVR---------------GTVLGQEDPYAYLEATDQETGESFEVHV 110
Query: 707 FH---QNCAMALKSFEAECEVMKNIRHRNHVKRIS------------------------- 738
+ + + A+K + E ++ +R + K+
Sbjct: 111 PYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRL 170
Query: 739 -----------------SCSNED-FKALDCLHSTNCSLNIFDKLNIMIDVASALEYLHFS 780
+ + + L ST+ SL +L + + V L LH
Sbjct: 171 DERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH-- 228
Query: 781 HSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
++H L+P ++ F A
Sbjct: 229 -HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAE 281
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 39/181 (21%), Positives = 65/181 (35%), Gaps = 45/181 (24%)
Query: 666 SYQDLFRATEKFSKE---------NLIGVGSFGSVYKGRLHDG-----IEVAIKVFHQNC 711
D +A KF+ E +IG G FG VYKG L + VAIK
Sbjct: 26 MGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY 85
Query: 712 AMALKS-FEAECEVMKNIRHRNHVKRISSCSNED-------FKALDCLHS----TNCSLN 759
+ F E +M H N ++ S + L + +
Sbjct: 86 TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFS 145
Query: 760 IFDKLNIMIDVASALEYL---HFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806
+ + ++ +A+ ++YL ++ +H DL +N+ DFG+ R+L
Sbjct: 146 VLQLVGMLRGIAAGMKYLANMNY------VHRDLAARNILVNSNLVCKVSDFGLSRVLED 199
Query: 807 D 807
D
Sbjct: 200 D 200
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 43/180 (23%), Positives = 67/180 (37%), Gaps = 36/180 (20%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDG-----IEVAIKVFHQNC-AMALKSFEAECEVMKNI 728
+F K ++G G+FG+VYKG I VAIK + A K E VM ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 729 RHRNHVKRISSCSNEDF----------KALDCLHSTNCSLNIFDKLNIMIDVASALEYL- 777
+ + + + C LD + ++ LN + +A + YL
Sbjct: 75 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 778 --HFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTE-TLVTIGYMAP 824
+H DL +NV DFG+ +LL + E V I +MA
Sbjct: 135 DRRL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 36/186 (19%), Positives = 70/186 (37%), Gaps = 47/186 (25%)
Query: 680 ENLIGVGSFGSVYKGRLHDG----IEVAIKVFHQNCA--MALKSFEAECEVMKNIRHRNH 733
++G G FGSV +G L ++VA+K + + ++ F +E MK+ H N
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 734 VKRISSCSNEDFKALDCL---------------------HSTNCSLNIFDKLNIMIDVAS 772
++ + C + + + + + L M+D+A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 773 ALEYL---HFSHSTPVIHCDLKPKNVF----------DFGIGRLL-TGDRSMIQTETLVT 818
+EYL +F +H DL +N DFG+ + + +GD +
Sbjct: 159 GMEYLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 212
Query: 819 IGYMAP 824
+ ++A
Sbjct: 213 VKWIAI 218
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 44/269 (16%), Positives = 68/269 (25%), Gaps = 47/269 (17%)
Query: 316 PNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSI 375
N L L + + L +++ N +I
Sbjct: 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIE--------------ADVF 75
Query: 376 GNLSMSLENIYISNCNIGGSIP-QLISNLSNLLLLDLEGNKLTGSIP-VTFGRLQKLQGL 433
NL L I I N I + NL NL L + + +P V + L
Sbjct: 76 SNLP-KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLL 133
Query: 434 YLPFNKLAGSIPDQ-LCHL-ARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSV 491
+ N +I L L L N S +N L +
Sbjct: 134 DIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEEL 193
Query: 492 LPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQ 551
F + D+S + +L LK L+
Sbjct: 194 PNDVFHGASGPVILDISRTRIH----------------SLPSYGLEN--------LKKLR 229
Query: 552 NISLACNGLEGLIP-ESFGYLTELNLSFN 579
S L+ L E L E +L++
Sbjct: 230 ARST--YNLKKLPTLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 40/261 (15%), Positives = 83/261 (31%), Gaps = 27/261 (10%)
Query: 85 VCNWIGITCNVNSHRVTAL------NISSLNLQG----TIPPQ-LGNLSSLTTLNLSHNK 133
+C+ +VT + N L I L + +S N
Sbjct: 6 ICHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQND 65
Query: 134 LSGDIPPSIFT-MHKLKFLDFSD-NQLSGSLSSVTF-NLSSVLDIRLDSDKLSGELPVNI 190
+ I +F+ + KL + N L ++ F NL ++ + + + + LP
Sbjct: 66 VLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVH 123
Query: 191 CNYLHYLKVLFLAKNMFHGQIPLALSK--CKRLQLLNLGFKKLSGAIPKEISNLTILRKI 248
+ +L + N+ I +L L + I N T L ++
Sbjct: 124 KIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDEL 182
Query: 249 SL-RNNKLRGEIPHEI-GYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGS 306
+L NN L E+P+++ L + + + + N+ ++ + L +
Sbjct: 183 NLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKLPT 241
Query: 307 FSLGIDLSLPNVERLNLGLNR 327
L + +L
Sbjct: 242 LE-----KLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 35/228 (15%), Positives = 68/228 (29%), Gaps = 17/228 (7%)
Query: 395 SIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQ-LCHLAR 453
IP + N + L KL F L+ + + N + I +L +
Sbjct: 23 EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 454 LNTLGLAGNKFSGSIPS-CLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSL 512
L+ + + I NL +L+ + + + + + + D+ N
Sbjct: 81 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 140
Query: 513 -----DGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPES 567
+ + L++N S + + N LE L +
Sbjct: 141 IHTIERNSFVGLSFESVI---LWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDV 197
Query: 568 F---GYLTELNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPNLQ 612
F L++S ++ +P G N L LP L+
Sbjct: 198 FHGASGPVILDISRTRIH-SLPSYG-LENLKKLRARSTYNLKKLPTLE 243
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 45/272 (16%), Positives = 84/272 (30%), Gaps = 35/272 (12%)
Query: 101 TALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFT-MHKLKFLDFSDNQLS 159
+ IP L + L KL I F+ L+ ++ S N +
Sbjct: 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVL 67
Query: 160 GSLSSVTF-NLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKC 218
+ + F NL + +IR++ + L L+ L ++ +P + K
Sbjct: 68 EVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLP-DVHKI 125
Query: 219 KRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEI--GYLPNLENLVLGF 276
LQ + L +++N I G L L
Sbjct: 126 HSLQKVLL----------------------DIQDNINIHTIERNSFVGLSFESVILWLNK 163
Query: 277 NNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFI 336
N + + + FN + + ++ L DN+ L + L++ R ++PS+
Sbjct: 164 NGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYG 221
Query: 337 -TNASKLVYLDMGTNSFSGIIPNTIGLTGNPL 367
N KL + + L L
Sbjct: 222 LENLKKLRARSTYNLKKLPTLEKLVALMEASL 253
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 39/172 (22%), Positives = 66/172 (38%), Gaps = 15/172 (8%)
Query: 353 SGIIPNT--IGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLI-SNLSNLLLL 409
+ T + L+ N L + +L ++ +S+ ++ I + NL L
Sbjct: 35 QSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYL 93
Query: 410 DLEGNKLTGSIPV-TFGRLQKLQGLYLPFNKLAGSIP-DQLCHLARLNTLGLAGNKFSGS 467
DL N L ++ F LQ L+ L L N + + + +A+L L L+ N+ S
Sbjct: 94 DLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-R 150
Query: 468 IP----SCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDI--LFFDLSSNSLD 513
P L L DL SN+L + + L L +N L+
Sbjct: 151 FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 40/184 (21%), Positives = 75/184 (40%), Gaps = 31/184 (16%)
Query: 100 VTALNISSLNLQGTIPPQ--LGNLSSLTTLNLSHNKLSGDIPPSIFT-MHKLKFLDFSDN 156
L++S NL + + L++L +L LSHN L+ I F + L++LD S N
Sbjct: 41 TALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSN 98
Query: 157 QLSGSLSSVTF-NLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLAL 215
L +L F +L ++ + L ++ + + N + L+ L+L++N
Sbjct: 99 HLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQN---------- 146
Query: 216 SKCKRLQLLNLG-FKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVL 274
++ + K + L L + L +NKL+ ++ LP L
Sbjct: 147 ----QISRFPVELIKDGN--------KLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194
Query: 275 GFNN 278
+N
Sbjct: 195 YLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 43/223 (19%), Positives = 63/223 (28%), Gaps = 73/223 (32%)
Query: 267 PNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLN 326
L L NNL + L N+ L L N
Sbjct: 39 SYTALLDLSHNNLSRLRAEWTPT------------------------RLTNLHSLLLSHN 74
Query: 327 RFSGTIPSFI-TNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENI 385
+ I S L YLD L+ N L ++
Sbjct: 75 HLN-FISSEAFVPVPNLRYLD---------------LSSNHL-----HTLD--------- 104
Query: 386 YISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPV-TFGRLQKLQGLYLPFNKLAGSI 444
L S+L L +L L N + + F + +LQ LYL N+++
Sbjct: 105 -----------EFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RF 151
Query: 445 PDQ----LCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDL 483
P + L +L L L+ NK + L L + L
Sbjct: 152 PVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 36/159 (22%), Positives = 61/159 (38%), Gaps = 19/159 (11%)
Query: 214 ALSKCKRLQLLNLGFKKLSGAIPKEI-SNLTILRKISLRNNKLRGEIPHEI-GYLPNLEN 271
++ L L L L+ I E + LR + L +N L + + L LE
Sbjct: 59 TPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEV 116
Query: 272 LVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSL--LGSFSLGIDLSLPNVERLNLGLNRFS 329
L+L N++V V A +M+ ++K+YL N + + LP + L+L N+
Sbjct: 117 LLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176
Query: 330 GTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLD 368
+ + V N + L NPL+
Sbjct: 177 KLPLTDLQKLPAWVK-------------NGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 39/144 (27%), Positives = 61/144 (42%), Gaps = 16/144 (11%)
Query: 456 TLGLAGNKFSGSIPS--CLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSN--- 510
L L+ N S + + LT+L S L N L + F + ++ + DLSSN
Sbjct: 43 LLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLH 101
Query: 511 SLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFGY 570
+LD L D+ L V + L N+ + D+ LQ + L+ N + E
Sbjct: 102 TLDEFLFSDLQALEV---LLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKD 158
Query: 571 ------LTELNLSFNKLEGEIPRG 588
L L+LS NKL+ ++P
Sbjct: 159 GNKLPKLMLLDLSSNKLK-KLPLT 181
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 4e-14
Identities = 47/173 (27%), Positives = 68/173 (39%), Gaps = 33/173 (19%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHV 734
++ IG G FG V G G +VA+K + A A ++F AE VM +RH N V
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-ATA-QAFLAEASVMTQLRHSNLV 249
Query: 735 KRISSCSNED--------FKALDCLHS-----TNCSLNIFDKLNIMIDVASALEYLHFSH 781
+ + E + A L L L +DV A+EYL ++
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 309
Query: 782 STPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
+H DL +NV DFG LT + S Q + + + AP
Sbjct: 310 ---FVHRDLAARNVLVSEDNVAKVSDFG----LTKEASSTQDTGKLPVKWTAP 355
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 43/186 (23%), Positives = 71/186 (38%), Gaps = 12/186 (6%)
Query: 377 NLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLP 436
+L +++S + + + L L+L+ +LT + V G L L L L
Sbjct: 28 DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLS 85
Query: 437 FNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPS-CLGNLTSLRSPDLGSNRLTSVLPST 495
N+L S+P L L L ++ N+ + S+P L L L+ L N L ++ P
Sbjct: 86 HNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGL 143
Query: 496 FWNLKDILFFDLSSNSLDGPLSLDIG---NLRVVIGINLSRNNFSGDIPSTIGDLKDLQN 552
+ L++N+L L G L + + L N+ IP L
Sbjct: 144 LTPTPKLEKLSLANNNLT---ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPF 199
Query: 553 ISLACN 558
L N
Sbjct: 200 AFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 8e-14
Identities = 46/197 (23%), Positives = 66/197 (33%), Gaps = 33/197 (16%)
Query: 395 SIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARL 454
++P + + +L L N L T +L L L +L + L L
Sbjct: 24 ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVL 79
Query: 455 NTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDG 514
TL L+ N+ S+P L +L D+ NRLTS+ L ++ L N L
Sbjct: 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK- 137
Query: 515 PLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESF---GYL 571
L + L+ +SLA N L L L
Sbjct: 138 ---------------TLPPGLLTP--------TPKLEKLSLANNNLTELPAGLLNGLENL 174
Query: 572 TELNLSFNKLEGEIPRG 588
L L N L IP+G
Sbjct: 175 DTLLLQENSLYT-IPKG 190
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 46/187 (24%), Positives = 84/187 (44%), Gaps = 13/187 (6%)
Query: 120 NLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDS 179
++S +N L+ +PP + L S+N L + + + + LD
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 180 DKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEI 239
+L+ +L V+ L L L L+ N +PL L +L++ F +L+ ++P
Sbjct: 65 AELT-KLQVD--GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGA 119
Query: 240 -SNLTILRKISLRNNKLRGEIPHEI-GYLPNLENLVLGFNNLVGVVPAAIF-NMSTVKKI 296
L L+++ L+ N+L+ +P + P LE L L NNL +PA + + + +
Sbjct: 120 LRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTL 177
Query: 297 YLLDNSL 303
L +NSL
Sbjct: 178 LLQENSL 184
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 9e-13
Identities = 51/249 (20%), Positives = 82/249 (32%), Gaps = 52/249 (20%)
Query: 240 SNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLL 299
S + +++ L +P ++ + L L N L A + + + ++ L
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 300 DNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNT 359
L L +D +LP + L+L N+ ++P L LD+ N + +
Sbjct: 64 RAELT---KLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPL-- 117
Query: 360 IGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGS 419
G L L L L L+GN+L +
Sbjct: 118 ---------GAL-----------------------------RGLGELQELYLKGNELK-T 138
Query: 420 IPV-TFGRLQKLQGLYLPFNKLAGSIPDQLC-HLARLNTLGLAGNKFSGSIPSCLGNLTS 477
+P KL+ L L N L +P L L L+TL L N +IP
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHL 196
Query: 478 LRSPDLGSN 486
L L N
Sbjct: 197 LPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 8e-12
Identities = 47/194 (24%), Positives = 70/194 (36%), Gaps = 40/194 (20%)
Query: 401 SNLSNLLLLDLEGNKLT---GSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTL 457
S +++ L ++ + LT +P L+L N L L RL L
Sbjct: 7 SKVASHLEVNCDKRNLTALPPDLPKD------TTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 458 GLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLS 517
L + + + G L L + DL N+L S LP L + D+S N L
Sbjct: 61 NLDRAELT-KLQV-DGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT---- 113
Query: 518 LDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESF---GYLTEL 574
+L G L +LQ + L N L+ L P L +L
Sbjct: 114 ------------SLPLGALRG--------LGELQELYLKGNELKTLPPGLLTPTPKLEKL 153
Query: 575 NLSFNKLEGEIPRG 588
+L+ N L E+P G
Sbjct: 154 SLANNNLT-ELPAG 166
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 27/108 (25%), Positives = 50/108 (46%), Gaps = 9/108 (8%)
Query: 104 NISSLNLQG----TIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFT-MHKLKFLDFSDNQL 158
+ +L+L ++P L +LT L++S N+L+ +P + +L+ L N+L
Sbjct: 78 VLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNEL 136
Query: 159 SGSLSSVTF-NLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKN 205
+L + + L ++ L+ ELP + N L L L L +N
Sbjct: 137 K-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQEN 182
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 27/146 (18%), Positives = 47/146 (32%), Gaps = 31/146 (21%)
Query: 469 PSC-LGNLTSLRSPDLGSNRLTSV---------------------LPSTFWNLKDILFFD 506
P C + + S + LT++ +T + +
Sbjct: 2 PICEVSKVASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 507 LSSNSLDG-PLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIP 565
L L + + L + +LS N +P L L + ++ N L L
Sbjct: 62 LDRAELTKLQVDGTLPVLGTL---DLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPL 117
Query: 566 ESF---GYLTELNLSFNKLEGEIPRG 588
+ G L EL L N+L+ +P G
Sbjct: 118 GALRGLGELQELYLKGNELK-TLPPG 142
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 6e-14
Identities = 38/174 (21%), Positives = 64/174 (36%), Gaps = 30/174 (17%)
Query: 674 TEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRN 732
IG GS G V R H G +VA+K+ + E +M++ +H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 733 HVKRISSCSNEDF-----------KALDCLHSTNCSLNIFDKLNIMIDVASALEYLHFSH 781
V+ S + D + ++ I + L+ L + H
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLH 158
Query: 782 STPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-TIGYMAP 824
+ VIH D+K ++ DFG ++ D + ++LV T +MAP
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAP 210
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 7e-14
Identities = 45/174 (25%), Positives = 70/174 (40%), Gaps = 30/174 (17%)
Query: 674 TEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRN 732
+K+++ IG G+ G+VY + G EVAI+ + + E VM+ ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 733 HVKRISSCSNEDF-----------KALDCLHSTNCSLNIFDKLNIMIDVASALEYLHFSH 781
V + S D D + T D+ I L+ L F H
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLH 133
Query: 782 STPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-TIGYMAP 824
S VIH D+K N+ DFG +T ++S + T+V T +MAP
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAP 185
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 8e-14
Identities = 41/151 (27%), Positives = 60/151 (39%), Gaps = 29/151 (19%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHV 734
++ IG G FG V G G +VA+K + A A ++F AE VM +RH N V
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-ATA-QAFLAEASVMTQLRHSNLV 77
Query: 735 KRISSCSNED--------FKALDCLHS-----TNCSLNIFDKLNIMIDVASALEYLHFSH 781
+ + E + A L L L +DV A+EYL ++
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 137
Query: 782 STPVIHCDLKPKNVF----------DFGIGR 802
+H DL +NV DFG+ +
Sbjct: 138 ---FVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 37/193 (19%), Positives = 71/193 (36%), Gaps = 49/193 (25%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVM-KNIRHRNH 733
E ++G GS G+V G VA+K + E +++ ++ H N
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71
Query: 734 VKRISSCSNEDF----------------KALDCLHSTNCSLNIFDKLNIMIDVASALEYL 777
++ S + + F ++ + ++ ++++ +AS + +L
Sbjct: 72 IRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 778 HFSHSTPVIHCDLKPKNVF-----------------------DFGIGRLLTGDRSMIQTE 814
HS +IH DLKP+N+ DFG+ + L +S +T
Sbjct: 132 ---HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 815 --TLV-TIGYMAP 824
T G+ AP
Sbjct: 189 LNNPSGTSGWRAP 201
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 39/184 (21%), Positives = 68/184 (36%), Gaps = 48/184 (26%)
Query: 683 IGVGSFGSVYKGRLHDG----IEVAIKVFHQNCA--MALKSFEAECEVMKNIRHRNHVKR 736
+G G FGSV + +L ++VA+K+ + ++ F E MK H + K
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 737 ISSCSNEDFKALDC-------------LHS---------TNCSLNIFDKLNIMIDVASAL 774
+ K LH+ +L + + M+D+A +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 775 EYL---HFSHSTPVIHCDLKPKNVF----------DFGIGRLL-TGDRSMIQTETLVTIG 820
EYL +F IH DL +N DFG+ R + +GD + + +
Sbjct: 151 EYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 821 YMAP 824
++A
Sbjct: 205 WLAL 208
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 55/199 (27%), Positives = 84/199 (42%), Gaps = 34/199 (17%)
Query: 395 SIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCH-LAR 453
+IP I ++ LDL+ NKL+ F RL KL+ LYL NKL ++P + L
Sbjct: 30 AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKN 86
Query: 454 LNTLGLAGNKFSGSIPSCL-GNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSL 512
L TL + NK ++P + L +L L N+L S+ P F +L + + L N L
Sbjct: 87 LETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNEL 145
Query: 513 DGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESF---G 569
+L + F L L+ + L N L+ + +F
Sbjct: 146 Q----------------SLPKGVFDK--------LTSLKELRLYNNQLKRVPEGAFDKLT 181
Query: 570 YLTELNLSFNKLEGEIPRG 588
L L L N+L+ +P G
Sbjct: 182 ELKTLKLDNNQLK-RVPEG 199
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 7e-13
Identities = 49/202 (24%), Positives = 83/202 (41%), Gaps = 26/202 (12%)
Query: 317 NVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNT-IGLTGNPLDGVLPTSI 375
+ ++L+L N+ S +KL L + N + L
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELK------------ 85
Query: 376 GNLSMSLENIYISNCNIGGSIPQLI-SNLSNLLLLDLEGNKLTGSIPV-TFGRLQKLQGL 433
+LE +++++ + ++P + L NL L L+ N+L S+P F L KL L
Sbjct: 86 -----NLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYL 138
Query: 434 YLPFNKLAGSIPDQLC-HLARLNTLGLAGNKFSGSIPSCL-GNLTSLRSPDLGSNRLTSV 491
L +N+L S+P + L L L L N+ +P LT L++ L +N+L V
Sbjct: 139 SLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRV 196
Query: 492 LPSTFWNLKDILFFDLSSNSLD 513
F +L+ + L N D
Sbjct: 197 PEGAFDSLEKLKMLQLQENPWD 218
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 59/234 (25%), Positives = 101/234 (43%), Gaps = 50/234 (21%)
Query: 86 CNWIGITCNVNSHRVTAL------NISSLNLQG----TIPPQ-LGNLSSLTTLNLSHNKL 134
CN + + +S ++TA+ + L+LQ ++P + L+ L L L+ NKL
Sbjct: 14 CNNNKNSVDCSSKKLTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL 73
Query: 135 SGDIPPSIFT-MHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNY 193
+P IF + L+ L +DN+L LP+ + +
Sbjct: 74 Q-TLPAGIFKELKNLETLWVTDNKLQ-------------------------ALPIGVFDQ 107
Query: 194 LHYLKVLFLAKNMFHGQI----PLALSKCKRLQLLNLGFKKLSGAIPKEI-SNLTILRKI 248
L L L L +N Q+ P +L L+LG+ +L ++PK + LT L+++
Sbjct: 108 LVNLAELRLDRN----QLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKEL 162
Query: 249 SLRNNKLRGEIPHEI-GYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDN 301
L NN+L+ +P L L+ L L N L V A ++ +K + L +N
Sbjct: 163 RLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 6e-08
Identities = 59/239 (24%), Positives = 94/239 (39%), Gaps = 54/239 (22%)
Query: 229 KKLSGAIPKEI-SNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAI 287
KKL+ AIP I ++ L L++NKL L L L L N L +PA I
Sbjct: 26 KKLT-AIPSNIPADTKKLD---LQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGI 80
Query: 288 FN-MSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFI-TNASKLVYL 345
F + ++ +++ DN L + +G+ L N+ L L N+ ++P + + +KL YL
Sbjct: 81 FKELKNLETLWVTDNKL-QALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYL 138
Query: 346 DMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQ-LISNLS 404
+G N S+P+ + L+
Sbjct: 139 SLGYNELQ-----------------------------------------SLPKGVFDKLT 157
Query: 405 NLLLLDLEGNKLTGSIPV-TFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGN 462
+L L L N+L +P F +L +L+ L L N+L L +L L L N
Sbjct: 158 SLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 41/170 (24%), Positives = 70/170 (41%), Gaps = 33/170 (19%)
Query: 682 LIGVGSFGSVYKGRLHDGI---EVAIKVFHQNCAM---ALKSFEAECEVMKNIRHRNHVK 735
+G G +VY D I +VAIK LK FE E + H+N V
Sbjct: 18 KLGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 736 RISSCSNEDF----------KALDCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHSTPV 785
I +D L ++ L++ +N + +++ +H +
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKH---AHDMRI 132
Query: 786 IHCDLKPKN----------VFDFGIGRLLTGDRSMIQTETLV-TIGYMAP 824
+H D+KP+N +FDFGI + L+ + S+ QT ++ T+ Y +P
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSP 181
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 40/205 (19%), Positives = 69/205 (33%), Gaps = 65/205 (31%)
Query: 672 RATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEV---MKN 727
R T +F + IG G FGSV+K DG AIK + A ++ A EV
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 728 IRHRNHVKRISS-------------CSNEDFKALDCLHSTNCSLNIFDK---LNIMIDVA 771
+H + V+ S+ C+ D + ++ F + ++++ V
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSL--ADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 772 SALEYLHFSHSTPVIHCDLKPKNVF-----------------------------DFGIGR 802
L Y+H ++H D+KP N+F D G
Sbjct: 126 RGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182
Query: 803 LLTGDRSMIQTETLVTIG---YMAP 824
++ + G ++A
Sbjct: 183 RISSPQVE--------EGDSRFLAN 199
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 47/197 (23%), Positives = 72/197 (36%), Gaps = 35/197 (17%)
Query: 655 RGGKSKTLRRFSYQDLFRA---TEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKV---F 707
GG++ +L+ +LF + FS IG GSFG+VY R + + VAIK
Sbjct: 31 AGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS 90
Query: 708 HQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF----------KALDCLHSTNCS 757
+ + E ++ +RH N ++ E A D L
Sbjct: 91 GKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP 150
Query: 758 LNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGD 807
L + + L YL HS +IH D+K N+ DFG ++
Sbjct: 151 LQEVEIAAVTHGALQGLAYL---HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207
Query: 808 RSMIQTETLVTIGYMAP 824
S + T +MAP
Sbjct: 208 NSFVGTPY-----WMAP 219
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 27/196 (13%), Positives = 53/196 (27%), Gaps = 50/196 (25%)
Query: 674 TEKFSKENLIGVGSFGSVYKGR------LHDGIEVAIKVFHQNCAMALKSFEAECEVMKN 727
++ +L+G G+F VY+ + + +KV E +K
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 728 IRHRNHVKRISSCSNEDFKALDCLHSTNCSLNIFDKLN-----------------IMIDV 770
+K S+ ++ L + +L + +N + +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTL--LNAINLYKNTPEKVMPQGLVISFAMRM 181
Query: 771 ASALEYLHFSHSTPVIHCDLKPKNVF---------------------DFGIGRLLTGDRS 809
+E +H +IH D+KP N D G +
Sbjct: 182 LYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238
Query: 810 MIQTETLV-TIGYMAP 824
T G+
Sbjct: 239 GTIFTAKCETSGFQCV 254
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 70.5 bits (172), Expect = 5e-13
Identities = 26/214 (12%), Positives = 45/214 (21%), Gaps = 63/214 (29%)
Query: 670 LFRATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQ---NCAMALKSFEAECEVM 725
L + K + VG V+ R + + A+KVF N L+
Sbjct: 57 LSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAA 116
Query: 726 KNIRHRNHVKRIS-----------------------------------------SCSNED 744
+ + + S E
Sbjct: 117 ARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLEL 176
Query: 745 -FKALDCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------- 796
F LD ++ I + + L ++H P N+F
Sbjct: 177 LFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRL 233
Query: 797 ---DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827
D + + Y L
Sbjct: 234 MLGDVSALWKVGTRGPASSV----PVTYAPREFL 263
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 7e-13
Identities = 37/174 (21%), Positives = 64/174 (36%), Gaps = 28/174 (16%)
Query: 674 TEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRN 732
E + +G G+FG VYK + G A KV L+ + E E++ H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 733 HVKRISSCSNEDF-----------KALDCLHSTNCSLNIFDKLNIMIDVASALEYLHFSH 781
VK + + ++ + + L + + AL +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137
Query: 782 STPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-TIGYMAP 824
+IH DLK NV DFG+ +++ + ++ + T +MAP
Sbjct: 138 ---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNL--KTLQKRDSFIGTPYWMAP 186
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 8e-13
Identities = 43/186 (23%), Positives = 75/186 (40%), Gaps = 52/186 (27%)
Query: 674 TEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRN 732
+ F ++G G+F V+ + G A+K ++ A S E E V+K I+H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 733 HVKRISSCSNEDFKALDCLH-----STNCSLNIFDKL------------NIMIDVASALE 775
V + +++ + + L FD++ ++ V SA++
Sbjct: 68 IVTLE-----DIYESTTHYYLVMQLVSGGEL--FDRILERGVYTEKDASLVIQQVLSAVK 120
Query: 776 YLHFSHSTPVIHCDLKPKN-------------VFDFGIGRLLTGDRSMIQTETLVTI--- 819
YLH + ++H DLKP+N + DFG+ + M Q + T
Sbjct: 121 YLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSK-------MEQNGIMSTACGT 170
Query: 820 -GYMAP 824
GY+AP
Sbjct: 171 PGYVAP 176
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 32/248 (12%), Positives = 67/248 (27%), Gaps = 69/248 (27%)
Query: 634 VLPLSTALIIAVPLALKYKSIRGGKSKTLRRFSYQDLFRATEKFSKENLIGVGSFGSVYK 693
V S + A + G+ + +L + ++G + +
Sbjct: 36 VRTTSEYMQSAADSLVSTSLWNTGQPFRVES----ELGERPRTLVRGTVLGQEDPYAYLE 91
Query: 694 GR-LHDGIEVAIKVF----------------------------HQNCAMALKSFEAECEV 724
G + V +Q A F ++
Sbjct: 92 ATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151
Query: 725 MKNIRHRNHVK------------------RISSCSNEDFKALDCLHSTNCSLNIFDKLNI 766
+K+ + + ++ R+ S + L ST+ SL +L +
Sbjct: 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQL 211
Query: 767 MIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETL 816
+ V L LH ++H L+P ++ F R + +
Sbjct: 212 TLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV-----RDGARVVSS 263
Query: 817 VTIGYMAP 824
V+ G+ P
Sbjct: 264 VSRGFEPP 271
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 39/173 (22%), Positives = 64/173 (36%), Gaps = 35/173 (20%)
Query: 680 ENLIGVGSFGSVYKGRLHDGI---EVAIKVFHQNCA---MALKSFEAECEVMKNIRHRNH 733
L+G G G VY+ D + VA+K+ + + + + E ++ +
Sbjct: 39 RRLVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHV 96
Query: 734 VKRISSCSNEDFKA-----------LDCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHS 782
V I D + L + L + I+ + SAL+ +H+
Sbjct: 97 V-PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDA---AHA 152
Query: 783 TPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-TIGYMAP 824
H D+KP+N+ DFGI T D + Q V T+ YMAP
Sbjct: 153 AGATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAP 204
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 44/174 (25%), Positives = 63/174 (36%), Gaps = 30/174 (17%)
Query: 674 TEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRN 732
E F +G GS+GSVYK G VAIK L+ E +M+ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPH 85
Query: 733 HVKRISSCSNEDF-----------KALDCLHSTNCSLNIFDKLNIMIDVASALEYLHFSH 781
VK S D + N + I + S L+ L + H
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLH 142
Query: 782 STPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-TIGYMAP 824
IH D+K N+ DFG+ LT +M + T++ T +MAP
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT--DTMAKRNTVIGTPFWMAP 194
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 35/206 (16%), Positives = 72/206 (34%), Gaps = 17/206 (8%)
Query: 395 SIPQLISNLSNLLLLDLEGNKLTGSIPV-TFGRLQKLQGLYLPFNKLAGSIPDQL-CHLA 452
IP L + L L L +IP F L + +Y+ + + +L+
Sbjct: 25 RIPSL---PPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLS 80
Query: 453 RLNTLGLAGNKFSGSIPS-CLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILF-FDLSSN 510
++ + + + I L L L+ + + L T DI F +++ N
Sbjct: 81 KVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDN 140
Query: 511 SLDGPLSLDI--GNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLA-CNGLEGLIPES 567
+ ++ G + + L N F+ + + L + L L + ++
Sbjct: 141 PYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDA 199
Query: 568 FG----YLTELNLSFNKLEGEIPRGG 589
FG + L++S + +P G
Sbjct: 200 FGGVYSGPSLLDVSQTSVT-ALPSKG 224
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 45/241 (18%), Positives = 78/241 (32%), Gaps = 47/241 (19%)
Query: 266 LPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGL 325
P+ + L L +L + A N+ + +IY+ + L +L V + +
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 326 NRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENI 385
R L Y+D LP L+ +
Sbjct: 90 TR-------------NLTYIDPDA--LKE----------------LP--------LLKFL 110
Query: 386 YISNCNIGGSIPQL--ISNLSNLLLLDLEGNKLTGSIPV-TFGRLQK-LQGLYLPFNKLA 441
I N + P L + + +L++ N SIPV F L L L N
Sbjct: 111 GIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT 169
Query: 442 GSIPDQLCHLARLNTLGLAGNKFSGSIPS-CLGNLTS-LRSPDLGSNRLTSVLPSTFWNL 499
S+ + +L+ + L NK+ I G + S D+ +T++ +L
Sbjct: 170 -SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHL 228
Query: 500 K 500
K
Sbjct: 229 K 229
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 6e-09
Identities = 30/213 (14%), Positives = 67/213 (31%), Gaps = 18/213 (8%)
Query: 92 TCNVNSHRVTAL-----NISSLNLQG----TIPPQ-LGNLSSLTTLNLSHNKLSGDIPPS 141
V + + + +L L TIP NL +++ + +S + +
Sbjct: 15 DFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESH 74
Query: 142 IFT-MHKLKFLDFSDNQLSGSLSSVTF-NLSSVLDIRLDSDKLSGELPVNICNYLHYLKV 199
F + K+ ++ + + + L + + + + L + +
Sbjct: 75 SFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFI 134
Query: 200 LFLAKNMFHGQIPLAL--SKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRG 257
L + N + IP+ C L L + ++ N T L + L NK
Sbjct: 135 LEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLT 193
Query: 258 EIPHEI--GYLPNLENLVLGFNNLVGVVPAAIF 288
I + G L + ++ +P+
Sbjct: 194 VIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGL 225
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 39/183 (21%), Positives = 66/183 (36%), Gaps = 47/183 (25%)
Query: 683 IGVGSFGSVYKGRLHDG------IEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVK 735
+G G+FG VY+G++ ++VA+K + C F E ++ H+N V+
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 736 RISSCSNE----------------DF-KALDCLHSTNCSLNIFDKLNIMIDVASALEYL- 777
I F + S SL + D L++ D+A +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 778 --HFSHSTPVIHCDLKPKNVF-------------DFGIGRLL-TGDRSMIQTETLVTIGY 821
HF IH D+ +N DFG+ R + ++ + +
Sbjct: 158 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 822 MAP 824
M P
Sbjct: 212 MPP 214
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 28/116 (24%), Positives = 51/116 (43%), Gaps = 6/116 (5%)
Query: 401 SNLSNLLLLDLEGNKLTGSIPV-TFGRLQKLQGLYLPFNKLAGSIPDQLC-HLARLNTLG 458
L L ++ NK+T I F + + L N+L ++ ++ L L TL
Sbjct: 54 KKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLM 111
Query: 459 LAGNKFSGSIPS-CLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLD 513
L N+ + + + L+S+R L N++T+V P F L + +L +N +
Sbjct: 112 LRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 29/121 (23%), Positives = 49/121 (40%), Gaps = 7/121 (5%)
Query: 395 SIPQLISNLSNLLLLDLEGNKLTGSIPVT--FGRLQKLQGLYLPFNKLAGSIPDQLCHLA 452
IP+ I L L N+ T + T F +L +L+ + NK+ +
Sbjct: 25 KIPEHIP--QYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGAS 81
Query: 453 RLNTLGLAGNKFSGSIPS-CLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNS 511
+N + L N+ ++ L SL++ L SNR+T V +F L + L N
Sbjct: 82 GVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQ 140
Query: 512 L 512
+
Sbjct: 141 I 141
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 7e-07
Identities = 33/161 (20%), Positives = 63/161 (39%), Gaps = 33/161 (20%)
Query: 122 SSLTTLNLSHNKLSGDIPPSIFT-MHKLKFLDFSDNQLSGSLSSVTFN-LSSVLDIRLDS 179
L L++N+ + IF + +L+ ++FS+N+++ + F S V +I L S
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTS 90
Query: 180 DKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEI 239
++L + + L LK L L N R+ + +
Sbjct: 91 NRLE-NVQHKMFKGLESLKTLMLRSN--------------RIT-----------CVGNDS 124
Query: 240 -SNLTILRKISLRNNKLRGEIPHEI-GYLPNLENLVLGFNN 278
L+ +R +SL +N++ + L +L L L N
Sbjct: 125 FIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNL-LAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 17/83 (20%), Positives = 38/83 (45%), Gaps = 9/83 (10%)
Query: 104 NISSLNLQG----TIPPQL-GNLSSLTTLNLSHNKLSGDIPPSIFT-MHKLKFLDFSDNQ 157
++ + L + ++ L SL TL L N+++ + F + ++ L DNQ
Sbjct: 82 GVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQ 140
Query: 158 LSGSLSSVTF-NLSSVLDIRLDS 179
++ +++ F L S+ + L +
Sbjct: 141 IT-TVAPGAFDTLHSLSTLNLLA 162
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 29/177 (16%), Positives = 49/177 (27%), Gaps = 56/177 (31%)
Query: 267 PNLENLVLGFNNLVGVVPAAIF-NMSTVKKIYLLDNSL----LGSFSLGIDLSLPNVERL 321
L L N + IF + ++KI +N + G+F V +
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFE-----GASGVNEI 86
Query: 322 NLGLNRFSGTIPSFI-TNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSM 380
L NR + + L L + +N +
Sbjct: 87 LLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT--------------------------- 118
Query: 381 SLENIYISNCNIGGSIPQLI-SNLSNLLLLDLEGNKLTGSIPV-TFGRLQKLQGLYL 435
+ LS++ LL L N++T ++ F L L L L
Sbjct: 119 --------------CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNL 160
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 4e-12
Identities = 31/116 (26%), Positives = 48/116 (41%), Gaps = 6/116 (5%)
Query: 401 SNLSNLLLLDLEGNKLTGSIPV-TFGRLQKLQGLYLPFNKLAGSIPDQL-CHLARLNTLG 458
S L +DL N+++ + F L+ L L L NK+ +P L L L L
Sbjct: 53 SPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLL 110
Query: 459 LAGNKFSGSIPS-CLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLD 513
L NK + + +L +L L N+L ++ TF L+ I L+ N
Sbjct: 111 LNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 32/119 (26%), Positives = 53/119 (44%), Gaps = 4/119 (3%)
Query: 395 SIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARL 454
IP + + + LE N + P F +KL+ + L N+++ PD L L
Sbjct: 25 EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSL 82
Query: 455 NTLGLAGNKFSGSIPS-CLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSL 512
N+L L GNK + +P L SL+ L +N++ + F +L ++ L N L
Sbjct: 83 NSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKL 140
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 38/159 (23%), Positives = 59/159 (37%), Gaps = 31/159 (19%)
Query: 122 SSLTTLNLSHNKLSGDIPPSIFT-MHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSD 180
++T + L N + IPP F+ KL+ +D S+NQ+S
Sbjct: 32 ETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS--------------------- 69
Query: 181 KLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEI- 239
EL + L L L L N LQLL L K++ + +
Sbjct: 70 ----ELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAF 124
Query: 240 SNLTILRKISLRNNKLRGEIPHEI-GYLPNLENLVLGFN 277
+L L +SL +NKL+ I L ++ + L N
Sbjct: 125 QDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 37/150 (24%), Positives = 54/150 (36%), Gaps = 22/150 (14%)
Query: 316 PNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTI-GLTGNPLDGVLPTS 374
+ + L N P + KL +D+ N S + P+ GL
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLR----------- 80
Query: 375 IGNLSMSLENIYISNCNIGGSIPQ-LISNLSNLLLLDLEGNKLTGSIPV-TFGRLQKLQG 432
SL ++ + I +P+ L L +L LL L NK+ + V F L L
Sbjct: 81 ------SLNSLVLYGNKI-TELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNL 132
Query: 433 LYLPFNKLAGSIPDQLCHLARLNTLGLAGN 462
L L NKL L + T+ LA N
Sbjct: 133 LSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 8e-08
Identities = 32/130 (24%), Positives = 59/130 (45%), Gaps = 10/130 (7%)
Query: 104 NISSLNLQG----TIPPQ-LGNLSSLTTLNLSHNKLSGDIPPSIFT-MHKLKFLDFSDNQ 157
I+ + L+ IPP L ++LS+N++S ++ P F + L L N+
Sbjct: 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNK 91
Query: 158 LSGSLSSVTF-NLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALS 216
++ L F L S+ + L+++K++ L V+ LH L +L L N S
Sbjct: 92 IT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS 149
Query: 217 KCKRLQLLNL 226
+ +Q ++L
Sbjct: 150 PLRAIQTMHL 159
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 30/132 (22%), Positives = 59/132 (44%), Gaps = 7/132 (5%)
Query: 198 KVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEI-SNLTILRKISLRNNKLR 256
+ L +N P A S K+L+ ++L ++S + + L L + L NK+
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT 93
Query: 257 GEIPHEI-GYLPNLENLVLGFNNLVGVVPAAIF-NMSTVKKIYLLDNSLLGSFSLGIDLS 314
E+P + L +L+ L+L N + + F ++ + + L DN L + + G
Sbjct: 94 -ELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNK-LQTIAKGTFSP 150
Query: 315 LPNVERLNLGLN 326
L ++ ++L N
Sbjct: 151 LRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 6e-05
Identities = 26/122 (21%), Positives = 45/122 (36%), Gaps = 6/122 (4%)
Query: 456 TLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGP 515
+ L N P LR DL +N+++ + P F L+ + L N +
Sbjct: 36 EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-- 93
Query: 516 LSLDIG---NLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFGYLT 572
L L + + L+ N + DL +L +SL N L+ + +F L
Sbjct: 94 -ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR 152
Query: 573 EL 574
+
Sbjct: 153 AI 154
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 30/117 (25%), Positives = 49/117 (41%), Gaps = 18/117 (15%)
Query: 482 DLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIG------NLRVVIGINLSRNN 535
L N + + P F K + DLS+N + L +L + L N
Sbjct: 38 RLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS---ELAPDAFQGLRSLNS---LVLYGNK 91
Query: 536 FSGDIPSTIGD-LKDLQNISLACNGLEGLIPESFGYLTELN---LSFNKLEGEIPRG 588
+ ++P ++ + L LQ + L N + L ++F L LN L NKL+ I +G
Sbjct: 92 IT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKG 146
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 42/205 (20%), Positives = 78/205 (38%), Gaps = 45/205 (21%)
Query: 656 GGKSKTLRRFSYQDLFRATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMAL 715
K + + + ++ +IG GSFG V++ +L + EVAIK Q+
Sbjct: 21 PNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN 80
Query: 716 KSFEAECEVMKNIRHRNHVK----RISSCSNEDFKAL--------DCLHSTNCSLNIFDK 763
+ E ++M+ ++H N V S+ +D L + ++ + K
Sbjct: 81 R----ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRA---SRHYAK 133
Query: 764 LNIMIDVA----------SALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGR 802
L + + +L Y+ HS + H D+KP+N+ DFG +
Sbjct: 134 LKQTMPMLLIKLYMYQLLRSLAYI---HSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190
Query: 803 LLTGDRSMIQTETLVTIGYMAPGLL 827
+L + + Y AP L+
Sbjct: 191 ILIAGEPN--VSYICSRYYRAPELI 213
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 36/191 (18%), Positives = 70/191 (36%), Gaps = 46/191 (24%)
Query: 677 FSKENL-----IGVGSFGSVYKGRLHDGIE------VAIKVFHQNCAMALKS-FEAECEV 724
++E + +G GSFG VY+G ++ VAIK ++ +M + F E V
Sbjct: 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 725 MKNIRHRNHVKRISSCSNED--------------------FKALDCLHSTNCSLNIFDKL 764
MK + V+ + S + + ++ +
Sbjct: 82 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 765 NIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLL-TGDRSMIQT 813
+ ++A + YL ++ +H DL +N DFG+ R + D
Sbjct: 142 QMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 198
Query: 814 ETLVTIGYMAP 824
+ L+ + +M+P
Sbjct: 199 KGLLPVRWMSP 209
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 6e-12
Identities = 61/276 (22%), Positives = 97/276 (35%), Gaps = 57/276 (20%)
Query: 215 LSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVL 274
NL K ++ A+ + L + +I N+ ++ + I YLPN+ L L
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFL 75
Query: 275 GFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPS 334
N L I L N L N+ L L N+ S
Sbjct: 76 NGNKL--------------TDIKPLAN-------------LKNLGWLFLDENKVKDL--S 106
Query: 335 FITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGG 394
+ + KL L + N S I + +L LE++Y+ N I
Sbjct: 107 SLKDLKKLKSLSLEHNGISDING-----------------LVHLP-QLESLYLGNNKI-- 146
Query: 395 SIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARL 454
+ ++S L+ L L LE N+++ I L KLQ LYL N ++ + L L L
Sbjct: 147 TDITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS-DLRA-LAGLKNL 202
Query: 455 NTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTS 490
+ L L + + NL + L +
Sbjct: 203 DVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT 238
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 44/201 (21%), Positives = 79/201 (39%), Gaps = 15/201 (7%)
Query: 382 LENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLA 441
+ ++ ++ Q + L+++ + + + S+ L + L+L NKL
Sbjct: 26 TIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLT 81
Query: 442 GSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKD 501
I L +L L L L NK + S L +L L+S L N ++ + + +L
Sbjct: 82 -DIKP-LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQ 135
Query: 502 ILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLE 561
+ L +N + L L + ++L N S DI + L LQN+ L+ N +
Sbjct: 136 LESLYLGNNKITDITVLS--RLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS 191
Query: 562 GLIP-ESFGYLTELNLSFNKL 581
L L L L +
Sbjct: 192 DLRALAGLKNLDVLELFSQEC 212
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 40/185 (21%), Positives = 76/185 (41%), Gaps = 15/185 (8%)
Query: 400 ISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGL 459
+ + +L+ +T VT L + + + + S+ + +L + L L
Sbjct: 20 DDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFL 75
Query: 460 AGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLD 519
GNK + I L NL +L L N++ + S+ +LK + L N + ++
Sbjct: 76 NGNKLT-DI-KPLANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEHNGIS---DIN 128
Query: 520 -IGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIP-ESFGYLTELNLS 577
+ +L + + L N + DI + + L L +SL N + ++P L L LS
Sbjct: 129 GLVHLPQLESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLS 186
Query: 578 FNKLE 582
N +
Sbjct: 187 KNHIS 191
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 52/231 (22%), Positives = 103/231 (44%), Gaps = 21/231 (9%)
Query: 100 VTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLS 159
+ + ++ +++ ++ + L ++T L L+ NKL+ DI P + + L +L +N++
Sbjct: 48 IDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVK 103
Query: 160 GSLSSVTFNLSSVLDIRLDSDKLSGELPVNICN--YLHYLKVLFLAKNMFHGQIPLALSK 217
LSS+ +L + + L+ + +S +I +L L+ L+L N I LS+
Sbjct: 104 -DLSSLK-DLKKLKSLSLEHNGIS-----DINGLVHLPQLESLYLGNNKIT-DIT-VLSR 154
Query: 218 CKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFN 277
+L L+L ++S +P ++ LT L+ + L N + ++ + L NL+ L L
Sbjct: 155 LTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFSQ 210
Query: 278 NLVGVVPAAIFNMSTVKKIYLLDNSLLG--SFSLGIDLSLPNVERLNLGLN 326
+ N+ + D SL+ S D PNV+
Sbjct: 211 ECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFT 261
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 7e-10
Identities = 48/264 (18%), Positives = 99/264 (37%), Gaps = 20/264 (7%)
Query: 118 LGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRL 177
+ NL ++ + + ++ + + +++ + S+ + L +V + L
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQGIQ-YLPNVTKLFL 75
Query: 178 DSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPK 237
+ +KL+ P+ L L LFL +N + +L K+L+ L+L +S
Sbjct: 76 NGNKLTDIKPL---ANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGISDING- 129
Query: 238 EISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIY 297
+ +L L + L NNK+ + L L+ L L N + +VP + ++ ++ +Y
Sbjct: 130 -LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLY 184
Query: 298 LLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGI-- 355
L N + L L N++ L L + +N + S
Sbjct: 185 LSKNHIS---DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEI 241
Query: 356 IPNTIGLTGNPLDGVLPTSIGNLS 379
I + + LP +S
Sbjct: 242 ISDDGDYEKPNVKWHLPEFTNEVS 265
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 6e-12
Identities = 42/183 (22%), Positives = 74/183 (40%), Gaps = 42/183 (22%)
Query: 674 TEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQN---CAMALKSFEAECEVMKNIR 729
++++ + ++G GSFG V + G E A+KV + +S E +++K +
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 730 HRNHVKRISSCSNEDFKALDCLHSTNCS---LNIFDKL------------NIMIDVASAL 774
H N +K ED L + L FD++ I+ V S +
Sbjct: 85 HPNIMKLYEFF--EDKGYF-YLVGEVYTGGEL--FDEIISRKRFSEVDAARIIRQVLSGI 139
Query: 775 EYLHFSHSTPVIHCDLKPKN-------------VFDFGIGRLLTGDRSMIQTETLVTIGY 821
Y+H + ++H DLKP+N + DFG+ + M + + T Y
Sbjct: 140 TYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--KDKIGTAYY 194
Query: 822 MAP 824
+AP
Sbjct: 195 IAP 197
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 6e-12
Identities = 71/431 (16%), Positives = 140/431 (32%), Gaps = 85/431 (19%)
Query: 122 SSLTTLNLSHNKLSGD-IPPSIFTMHKLKFLDFSDNQLS----GSLSSVTFNLSSVLDIR 176
+ +L++ +LS + + + + + D L+ +SS ++ ++
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 177 LDSDKLSGELPVNICNYLHY----LKVLFLAKNMFHGQ----IPLALSKCKRLQLLNL-- 226
L S++L + L ++ L L G + L LQ L+L
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 227 ------GFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYL----PNLENLVLGF 276
G + L + + L K+ L L + + P+ + L +
Sbjct: 123 NLLGDAGLQLLCEGL---LDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSN 179
Query: 277 NNL--VGV---VPAAIFNMSTVKKIYLLDNSL--LGSFSLGIDL-SLPNVERLNLGLNRF 328
N++ GV + ++ + L + L + S ++ L LG N+
Sbjct: 180 NDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKL 239
Query: 329 SGT-----IPSFITNASKLVYLDMGTNSF---------SGIIPNT----IGLTGNPL--D 368
P + +S+L L + + + L GN L +
Sbjct: 240 GDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE 299
Query: 369 GV--LPTSIGNLSMSLENIYISNCNIGG----SIPQLISNLSNLLLLDLEGNKLTGSIPV 422
G L ++ LE++++ +C+ +++ LL L + N+L +
Sbjct: 300 GARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA--- 356
Query: 423 TFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFS----GSIPSCLGNLTSL 478
G+ L + L L LA S S+ + L SL
Sbjct: 357 ---------GVRE----LCQGLGQPGSV---LRVLWLADCDVSDSSCSSLAATLLANHSL 400
Query: 479 RSPDLGSNRLT 489
R DL +N L
Sbjct: 401 RELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 6e-09
Identities = 73/425 (17%), Positives = 138/425 (32%), Gaps = 79/425 (18%)
Query: 118 LGNLSSLTTLNLSHNKLSGDIPPSIFTM-----HKLKFLDFSDNQLS----GSLSSVTFN 168
L +L LNL N+L + K++ L + L+ G LSS
Sbjct: 52 LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRT 111
Query: 169 LSSVLDIRLDSDKLSGELPVNICNYLHY----LKVLFLAKNMFHGQ----IPLALSKCKR 220
L ++ ++ L + L +C L L+ L L + L
Sbjct: 112 LPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPD 171
Query: 221 LQLLNLGFKKLSGAIPKEIS-----NLTILRKISLRNNKLRGE----IPHEIGYLPNLEN 271
+ L + ++ A + + + L + L + + + + + +L
Sbjct: 172 FKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRE 231
Query: 272 LVLGFNNL--VGVV---PAAIFNMSTVKKIYLLDNSL--LGSFSLGIDL-SLPNVERLNL 323
L LG N L VG+ P + S ++ +++ + + G L L + +++ L+L
Sbjct: 232 LALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSL 291
Query: 324 GLNRFSGT-----IPSFITNASKLVYLDMGTNSFS--GIIPNTIGLTGNPLDGVLPTSIG 376
N + + +L L + + SF+ + L N
Sbjct: 292 AGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNR---------- 341
Query: 377 NLSMSLENIYISNCNIGGSIPQLIS-----NLSNLLLLDLEGNKLT----GSIPVTFGRL 427
L + ISN + + + + S L +L L ++ S+ T
Sbjct: 342 ----FLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLAN 397
Query: 428 QKLQGLYLPFNK--------LAGSIPDQLCHLARLNTLGLAGNKFS----GSIPSCLGNL 475
L+ L L N L S+ C L L L +S + + +
Sbjct: 398 HSLRELDLSNNCLGDAGILQLVESVRQPGC---LLEQLVLYDIYWSEEMEDRLQALEKDK 454
Query: 476 TSLRS 480
SLR
Sbjct: 455 PSLRV 459
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 68/410 (16%), Positives = 128/410 (31%), Gaps = 75/410 (18%)
Query: 245 LRKISLRNNKLRGE-IPHEIGYLPNLENLVLGFNNL----VGVVPAAIFNMSTVKKIYLL 299
++ + ++ +L + L + + L L + +A+ + ++ L
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 300 DNSL--LGSFSLGIDLSLPN--VERLNLGLNRFSGT----IPSFITNASKLVYLDMGTNS 351
N L +G + L P+ +++L+L +G + S + L L + N
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124
Query: 352 FS---------GIIPNTIGLTGNPLDGVLPTSIGNLSM--------SLENIYISNCNIGG 394
G++ L L+ ++ + + + +SN +I
Sbjct: 125 LGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINE 184
Query: 395 S-----IPQLISNLSNLLLLDLEGNKLT----GSIPVTFGRLQKLQGLYLPFNKLAGS-- 443
+ L + L L LE +T + L+ L L NKL
Sbjct: 185 AGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGM 244
Query: 444 ---IPDQLCHLARLNTLGLAGNKFS----GSIPSCLGNLTSLRSPDLGSNR--------L 488
P L +RL TL + + G + L SL+ L N L
Sbjct: 245 AELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLL 304
Query: 489 TSVLPSTFWNLKDILFFDLSSNSLDG----PLSLDIGNLRVVIGINLSRNNFSGDIPSTI 544
L L+ + + S S S + R ++ + +S N +
Sbjct: 305 CETLLEPGCQLESL---WVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVREL 361
Query: 545 GD-LKD----LQNISLACNGL--EGLIP-----ESFGYLTELNLSFNKLE 582
L L+ + LA + + L EL+LS N L
Sbjct: 362 CQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 45/245 (18%), Positives = 77/245 (31%), Gaps = 41/245 (16%)
Query: 378 LSMSLENIYISNCNIG-GSIPQLISNLSNLLLLDLEGNKLT----GSIPVTFGRLQKLQG 432
+S+ ++++ I + +L+ L ++ L+ LT I L
Sbjct: 1 MSLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 60
Query: 433 LYLPFNKLAGSIPDQLCHL-----ARLNTLGLAGNKFS----GSIPSCLGNLTSLRSPDL 483
L L N+L + ++ L L + G + S L L +L+ L
Sbjct: 61 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHL 120
Query: 484 GSNRLT--------SVLPSTFWNLKDILFFDLSSNSLD----GPLSLDIGNLRVVIGINL 531
N L L L+ + L SL PL+ + + +
Sbjct: 121 SDNLLGDAGLQLLCEGLLDPQCRLEKL---QLEYCSLSAASCEPLASVLRAKPDFKELTV 177
Query: 532 SRNNFSGDIPSTIGD-LKD----LQNISLACNGLEGLIPESFGY-------LTELNLSFN 579
S N+ + + LKD L+ + L G+ L EL L N
Sbjct: 178 SNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSN 237
Query: 580 KLEGE 584
KL
Sbjct: 238 KLGDV 242
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 7e-12
Identities = 37/187 (19%), Positives = 67/187 (35%), Gaps = 51/187 (27%)
Query: 683 IGVGSFGSVYKGRLHDGIE------VAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKR 736
+G G+FG V+ H+ + VA+K + A + F+ E E++ ++H++ V+
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 737 ISSCSNED-------------------------FKALDCLHSTNCSLNIFDKLNIMIDVA 771
C+ L + L + VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 772 SALEYL---HFSHSTPVIHCDLKPKNVF----------DFGIGRLL-TGDRSMIQTETLV 817
+ + YL HF +H DL +N DFG+ R + + D + T++
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 818 TIGYMAP 824
I +M P
Sbjct: 223 PIRWMPP 229
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 9e-12
Identities = 41/188 (21%), Positives = 68/188 (36%), Gaps = 52/188 (27%)
Query: 683 IGVGSFGSVYKGRLHDG------IEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKR 736
+G G+FG V+ ++ + VA+K A K F+ E E++ N++H + VK
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 737 ISSCSNED--------------------------FKALDCLHSTNCSLNIFDKLNIMIDV 770
C + D L + L+I +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 771 ASALEYL---HFSHSTPVIHCDLKPKNVF----------DFGIGRLL-TGDRSMIQTETL 816
AS + YL HF +H DL +N DFG+ R + + D + T+
Sbjct: 143 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 817 VTIGYMAP 824
+ I +M P
Sbjct: 197 LPIRWMPP 204
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-11
Identities = 44/198 (22%), Positives = 71/198 (35%), Gaps = 43/198 (21%)
Query: 658 KSKTLRRFSYQDLFRATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVF--HQNCAMA 714
S +Q F +G GSFG V K + E A+KV
Sbjct: 7 HSSGRENLYFQGTFAERYNIVCM--LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD 64
Query: 715 LKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHSTNCS---LNIFDKL------- 764
+ E E++K + H N +K ED + + + L FD++
Sbjct: 65 TSTILREVELLKKLDHPNIMKLFEIL--EDSSSF-YIVGELYTGGEL--FDEIIKRKRFS 119
Query: 765 -----NIMIDVASALEYLHFSHSTPVIHCDLKPKN-------------VFDFGIGRLLTG 806
I+ V S + Y+H + ++H DLKP+N + DFG+
Sbjct: 120 EHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
Query: 807 DRSMIQTETLVTIGYMAP 824
+ M + + T Y+AP
Sbjct: 177 NTKM--KDRIGTAYYIAP 192
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 35/173 (20%), Positives = 68/173 (39%), Gaps = 29/173 (16%)
Query: 676 KFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHV 734
SK ++G G FG V+K G+++A K+ + + E VM + H N +
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 735 KRISSCSNEDFKAL-----------DCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHST 783
+ + +++ L D + + +L D + M + + ++H +
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY-- 207
Query: 784 PVIHCDLKPKN------------VFDFGIGRLLTGDRSMIQTETLVTIGYMAP 824
++H DLKP+N + DFG+ R + T ++AP
Sbjct: 208 -ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL--KVNFGTPEFLAP 257
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 30/175 (17%), Positives = 64/175 (36%), Gaps = 29/175 (16%)
Query: 674 TEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRN 732
+ + +G G+FG V++ G K + + + + E +M + H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 733 HVKRISSCSNEDFKAL-----------DCLHSTNCSLNIFDKLNIMIDVASALEYLHFSH 781
+ + ++ L D + + + ++ + +N M L+++H
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 782 STPVIHCDLKPKN------------VFDFGIGRLLTGDRSMIQTETLVTIGYMAP 824
++H D+KP+N + DFG+ L D + T T + AP
Sbjct: 170 ---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV--KVTTATAEFAAP 219
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 39/183 (21%), Positives = 66/183 (36%), Gaps = 47/183 (25%)
Query: 683 IGVGSFGSVYKGRLHDG------IEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVK 735
+G G+FG VY+G++ ++VA+K + C F E ++ H+N V+
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 736 RISSCSNE----------------DF-KALDCLHSTNCSLNIFDKLNIMIDVASALEYL- 777
I F + S SL + D L++ D+A +YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 778 --HFSHSTPVIHCDLKPKNVF-------------DFGIGRLL-TGDRSMIQTETLVTIGY 821
HF IH D+ +N DFG+ R + ++ + +
Sbjct: 199 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252
Query: 822 MAP 824
M P
Sbjct: 253 MPP 255
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 39/183 (21%), Positives = 60/183 (32%), Gaps = 53/183 (28%)
Query: 682 LIGVGSFGSVYKGRLHDGI---EVAIKVFHQNCA---MALKSFEAECEVMKNIRHRNHVK 735
++G G V+ D +VA+KV + A F E + + H V
Sbjct: 19 ILGFGGMSEVHLA--RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV- 75
Query: 736 RISSCSN-----EDFKALDCLH----------------STNCSLNIFDKLNIMIDVASAL 774
E L T + + ++ D AL
Sbjct: 76 ------AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 775 EYLHFSHSTPVIHCDLKPKN----------VFDFGIGRLLTGDRSMIQTETLVTIG---Y 821
+ SH +IH D+KP N V DFGI R + + + T+T IG Y
Sbjct: 130 NF---SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV-TQTAAVIGTAQY 185
Query: 822 MAP 824
++P
Sbjct: 186 LSP 188
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 48/175 (27%), Positives = 66/175 (37%), Gaps = 31/175 (17%)
Query: 674 TEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFH-QNCAMALKSFEAECEVMKNIRHR 731
E F+K IG GSFG V+KG VAIK+ + ++ + E V+
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 732 NHVKRISSCSNEDF-----------KALDCLHSTNCSLNIFDKLNIMIDVASALEYLHFS 780
K S + ALD L D+ I + L+ L +
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYL 135
Query: 781 HSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-TIGYMAP 824
HS IH D+K NV DFG+ LT + I+ T V T +MAP
Sbjct: 136 HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAP 188
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 2e-11
Identities = 40/192 (20%), Positives = 66/192 (34%), Gaps = 53/192 (27%)
Query: 680 ENLIGVGSFGSVYKGRLHDG------IEVAIKVFHQNCAMALKS-FEAECEVMKNIRHRN 732
+G FG VYKG L VAIK L+ F E + ++H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 733 HVKRISSCSNED--------------------------FKALDCLHSTNCSLNIFDKLNI 766
V + + + + D + +L D +++
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 767 MIDVASALEYL---HFSHSTPVIHCDLKPKNVF----------DFGIGRLL-TGDRSMIQ 812
+ +A+ +EYL H +H DL +NV D G+ R + D +
Sbjct: 134 VAQIAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLL 187
Query: 813 TETLVTIGYMAP 824
+L+ I +MAP
Sbjct: 188 GNSLLPIRWMAP 199
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 35/190 (18%), Positives = 67/190 (35%), Gaps = 56/190 (29%)
Query: 674 TEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVF--HQNCAMALKSFEAECEVMKNIRH 730
TE++ +G G+F V + + G E A + + A + E E + + ++H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 731 RNHVKRISSCSNEDFKALDCLHSTNCSLNI----------FDKL------------NIMI 768
N V+ S S E + F+ + + +
Sbjct: 70 PNIVRLHDSISEEGH------------HYLIFDLVTGGELFEDIVAREYYSEADASHCIQ 117
Query: 769 DVASALEYLHFSHSTPVIHCDLKPKN-------------VFDFGIGRLLTGDRSMIQTET 815
+ A+ + H V+H +LKP+N + DFG+ + G++
Sbjct: 118 QILEAVLHCH-QMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF--G 172
Query: 816 LV-TIGYMAP 824
T GY++P
Sbjct: 173 FAGTPGYLSP 182
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 39/193 (20%), Positives = 75/193 (38%), Gaps = 52/193 (26%)
Query: 674 TEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKV-------------FHQNCAMALKSFE 719
E + K +G G++G V + + E AIKV ++N +
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 720 AECEVMKNIRHRNHVKRISSCSNEDFKALDCLH--STNCS-LNIFDKL------------ 764
E ++K++ H N +K ++ + + + +F+++
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKY-----FYLVTEFYEGGELFEQIINRHKFDECDAA 149
Query: 765 NIMIDVASALEYLHFSHSTPVIHCDLKPKN-------------VFDFGIGRLLTGDRSMI 811
NIM + S + YLH + ++H D+KP+N + DFG+ + D +
Sbjct: 150 NIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL- 205
Query: 812 QTETLVTIGYMAP 824
+ L T Y+AP
Sbjct: 206 -RDRLGTAYYIAP 217
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 42/205 (20%), Positives = 68/205 (33%), Gaps = 57/205 (27%)
Query: 658 KSKTLRRFSYQDLFRATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFH--QNCAMA 714
S +Q F +G GSFG V K + E A+KV +
Sbjct: 7 HSSGRENLYFQGTFAERYNIVCM--LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD 64
Query: 715 LKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHSTNCSLNI----------FDKL 764
+ E E++K + H N +K + I FD++
Sbjct: 65 TSTILREVELLKKLDHPNIMKLFEILEDSSS------------FYIVGELYTGGELFDEI 112
Query: 765 ------------NIMIDVASALEYLHFSHSTPVIHCDLKPKN-------------VFDFG 799
I+ V S + Y+H + ++H DLKP+N + DFG
Sbjct: 113 IKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFG 169
Query: 800 IGRLLTGDRSMIQTETLVTIGYMAP 824
+ + M + + T Y+AP
Sbjct: 170 LSTCFQQNTKM--KDRIGTAYYIAP 192
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 44/182 (24%), Positives = 70/182 (38%), Gaps = 41/182 (22%)
Query: 674 TEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVF--HQNCAMALKSFEAECEVMKNIRH 730
+E + + +G G++G V R +E AIK+ + E V+K + H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 731 RNHVKRISSCSNEDFKALDCLHSTNCS---LNIFDKL------------NIMIDVASALE 775
N +K ED + L L FD++ I+ V S +
Sbjct: 96 PNIMKLYDFF--EDKRNY-YLVMECYKGGEL--FDEIIHRMKFNEVDAAVIIKQVLSGVT 150
Query: 776 YLHFSHSTPVIHCDLKPKN-------------VFDFGIGRLLTGDRSMIQTETLVTIGYM 822
YLH + ++H DLKP+N + DFG+ + + M E L T Y+
Sbjct: 151 YLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM--KERLGTAYYI 205
Query: 823 AP 824
AP
Sbjct: 206 AP 207
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 38/206 (18%), Positives = 72/206 (34%), Gaps = 41/206 (19%)
Query: 653 SIRGGKSKTLRRFSYQDLFRATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKV----- 706
I GG L LF + + IG G F V + G + A+K+
Sbjct: 4 GISGGGGGILDMADDDVLFEDVYELCEV--IGKGPFSVVRRCINRETGQQFAVKIVDVAK 61
Query: 707 FHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL-----------DCLHSTN 755
F + ++ + + E + ++H + V+ + + S++ + +
Sbjct: 62 FTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA 121
Query: 756 CSLNIF---DKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------DFG 799
+ ++ + M + AL Y H ++ +IH D+KP V FG
Sbjct: 122 DAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG 178
Query: 800 IGRLLTGDRSMIQTETLV-TIGYMAP 824
+ L + V T +MAP
Sbjct: 179 VAIQLGESGLVAG--GRVGTPHFMAP 202
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 25/176 (14%), Positives = 51/176 (28%), Gaps = 53/176 (30%)
Query: 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKS---FEAECEVMKNIRH 730
++ + +G G F ++ A K+ ++ + E + +++ H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 731 RNHVKRISSCSNEDFKALDCLHSTNC-----------SLNIFDKL------------NIM 767
++ V + SL + +
Sbjct: 101 QHVVGFH-----------GFFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARYYL 147
Query: 768 IDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQT 813
+ +YLH + VIH DLK N+F DFG+ + D +
Sbjct: 148 RQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV 200
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 44/198 (22%), Positives = 71/198 (35%), Gaps = 38/198 (19%)
Query: 658 KSKTLRRFSYQDLFRAT-EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMA- 714
+S + S + + T E IG G++GSV K G +A+K
Sbjct: 4 ESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE 63
Query: 715 LKSFEAECEV-MKNIRHRNHVK---------RISSC-------SNEDFKALDCLHSTNCS 757
K + +V M++ V+ C ++ +K + +
Sbjct: 64 QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIP 123
Query: 758 LNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGI-GRLLTG 806
I K I + AL +L + +IH D+KP N+ DFGI G+L
Sbjct: 124 EEILGK--ITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL--- 176
Query: 807 DRSMIQTETLVTIGYMAP 824
S+ +T YMAP
Sbjct: 177 VDSIAKTRDAGCRPYMAP 194
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 3e-11
Identities = 26/177 (14%), Positives = 49/177 (27%), Gaps = 55/177 (31%)
Query: 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFH----QNCAMALKSFEAECEVMKNIR 729
++ + +G G F ++ A K+ K E + +++
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLA 73
Query: 730 HRNHVKRISSCSNEDFKALDCLHSTNC-----------SLNIFDKL------------NI 766
H++ V + SL +
Sbjct: 74 HQHVVGFH-----------GFFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARYY 120
Query: 767 MIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQT 813
+ + +YLH + VIH DLK N+F DFG+ + D +
Sbjct: 121 LRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV 174
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 48/203 (23%), Positives = 73/203 (35%), Gaps = 45/203 (22%)
Query: 657 GKSKTLRRFSYQDLFRATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMAL 715
+++L L F L+G G++G VYKGR + G AIKV M +
Sbjct: 6 SPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKV------MDV 59
Query: 716 -----KSFEAECEVMKNI-RHRNHVK-----RISSCSNEDFK------------ALDCLH 752
+ + E ++K HRN + D + D +
Sbjct: 60 TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119
Query: 753 STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGR 802
+T N + I L L H VIH D+K +NV DFG+
Sbjct: 120 NTKG--NTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177
Query: 803 LLTGDRSMIQTETLV-TIGYMAP 824
L R++ + T + T +MAP
Sbjct: 178 QLD--RTVGRRNTFIGTPYWMAP 198
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 5e-11
Identities = 46/194 (23%), Positives = 72/194 (37%), Gaps = 42/194 (21%)
Query: 663 RRFSYQDLFRATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFH-QNCAMALKSFEA 720
+Q F ++ +G G+FG V+ G+E IK + + ++ EA
Sbjct: 12 ENLYFQGTIDDLFIFKRK--LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEA 69
Query: 721 ECEVMKNIRHRNHVKRISSCSNEDFKAL-------------DCLHSTNCSLNIF---DKL 764
E EV+K++ H N +K ED+ + + + S
Sbjct: 70 EIEVLKSLDHPNIIKIFEVF--EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA 127
Query: 765 NIMIDVASALEYLHFSHSTPVIHCDLKPKN-------------VFDFGIGRLLTGDRSMI 811
+M + +AL Y H H V+H DLKP+N + DFG+ L D
Sbjct: 128 ELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS- 183
Query: 812 QTETLV-TIGYMAP 824
T YMAP
Sbjct: 184 --TNAAGTALYMAP 195
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 5e-11
Identities = 32/175 (18%), Positives = 65/175 (37%), Gaps = 29/175 (16%)
Query: 674 TEKFSKENLIGVGSFGSVYKGRLHD-GIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRN 732
+ + +G G+FG V++ G A K ++ E + M +RH
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 733 HVKRISSCSNEDFKAL-----------DCLHSTNCSLNIFDKLNIMIDVASALEYLHFSH 781
V + +++ + + + + ++ + + M V L ++H ++
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 782 STPVIHCDLKPKN------------VFDFGIGRLLTGDRSMIQTETLVTIGYMAP 824
+H DLKP+N + DFG+ L +S+ T T + AP
Sbjct: 276 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV--KVTTGTAEFAAP 325
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 64.4 bits (156), Expect = 8e-11
Identities = 48/344 (13%), Positives = 95/344 (27%), Gaps = 32/344 (9%)
Query: 1 YLYFLMAHYLFSGIESPYITKLITTSNLLSFHVPLTHCLLLYLVVAVAAASNITTDQQAL 60
Y +L+ + + F PLT + ++ + + ++ + +
Sbjct: 231 YHRWLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTP 290
Query: 61 LALKAHISYDPTNLLAQNSTSNTSVCNWIGITCNVNSHRVTALNISSLNLQGTIPPQLGN 120
+L A + + +
Sbjct: 291 DGRNRPSHVWLCDLPAASLNDQ---LPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSAT 347
Query: 121 LSSLTTLNLSHNKLSG------------DIPP--------SIFTMHKLKFLDFSDNQLSG 160
L LS K + ++ P I M L L + L
Sbjct: 348 DEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQ- 406
Query: 161 SLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKR 220
S++ D + ++VL LA + L +
Sbjct: 407 YFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQLLL 464
Query: 221 LQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLV 280
+ L+L +L A+P ++ L L + +N L + + LP L+ L+L N L
Sbjct: 465 VTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQ 521
Query: 281 GV-VPAAIFNMSTVKKIYLLDNSL--LGSFSLGIDLSLPNVERL 321
+ + + + L NSL + LP+V +
Sbjct: 522 QSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 565
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 37/256 (14%), Positives = 80/256 (31%), Gaps = 18/256 (7%)
Query: 218 CKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFN 277
L +L + + ++ L ++ + L L
Sbjct: 301 LCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECW-CRDSATDEQLFRCELSVE 359
Query: 278 NLVGVVPAAIFNMSTVKKIYL-----LDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTI 332
V+ + + + ++++ L +L +L L + L
Sbjct: 360 KST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMR 418
Query: 333 PSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSM--SLENIYISNC 390
+++ + L+ + L L T + +L + ++ +S+
Sbjct: 419 AAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL-----TVLCHLEQLLLVTHLDLSHN 473
Query: 391 NIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAG-SIPDQLC 449
+ ++P ++ L L +L N L ++ L +LQ L L N+L + L
Sbjct: 474 RLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLV 530
Query: 450 HLARLNTLGLAGNKFS 465
RL L L GN
Sbjct: 531 SCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 2e-07
Identities = 29/163 (17%), Positives = 56/163 (34%), Gaps = 15/163 (9%)
Query: 397 PQLISNLSNLLLLD--------LEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQL 448
+ + S L +D +K V ++ L+L L ++ L
Sbjct: 402 KETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHL 459
Query: 449 CHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLS 508
L + L L+ N+ ++P L L L N L +V NL + L
Sbjct: 460 EQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVDG--VANLPRLQELLLC 516
Query: 509 SNSLDGPLSLD-IGNLRVVIGINLSRNNFSGDIPSTIGDLKDL 550
+N L ++ + + ++ +NL N+ L ++
Sbjct: 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 40/219 (18%), Positives = 68/219 (31%), Gaps = 27/219 (12%)
Query: 397 PQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNT 456
+ + L +L K T + ++LQ L +I + L L
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400
Query: 457 LGLAGNKFSGSIPSCLGNLTSLRSPDLGSNR--LTSVLPSTFWNLKDILFFDLSSNSLDG 514
FS L + +R+ L R D+ L+ L
Sbjct: 401 EKETLQYFST-----LKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV 455
Query: 515 PLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIP-ESFGYLTE 573
L+ L +V ++LS N +P + L+ L+ + + N LE + + L E
Sbjct: 456 LCHLE--QLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVDGVANLPRLQE 512
Query: 574 LNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPNLQ 612
L L N+L+ + L P L
Sbjct: 513 LLLCNNRLQ---------------QSAAIQPLVSCPRLV 536
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 47.1 bits (111), Expect = 2e-05
Identities = 28/201 (13%), Positives = 60/201 (29%), Gaps = 8/201 (3%)
Query: 384 NIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGS 443
N + ++I S+ + ++L L K
Sbjct: 305 PAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-V 363
Query: 444 IPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDIL 503
+ +L L L +I + L L +++ +
Sbjct: 364 LQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD 423
Query: 504 FFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGL 563
+ L ++ ++RV+ +L+ + + + + L + ++ L+ N L L
Sbjct: 424 DLRSKFLLENSVLKMEYADVRVL---HLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLRAL 478
Query: 564 IP--ESFGYLTELNLSFNKLE 582
P + L L S N LE
Sbjct: 479 PPALAALRCLEVLQASDNALE 499
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 9e-11
Identities = 38/197 (19%), Positives = 61/197 (30%), Gaps = 41/197 (20%)
Query: 667 YQDLFRATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIK--VFHQNCAMALKSFEA---- 720
+L ++ + I GS+G+V G +GI VAIK + +
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 721 -----ECEVMKNIRHRNHVK---RISSCSNEDFKAL-------DC-----LHSTNCSLNI 760
E ++ + H N + L +H ++
Sbjct: 74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISP 133
Query: 761 FDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810
M + L LH V+H DL P N+ DF + R T D +
Sbjct: 134 QHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK 190
Query: 811 IQTETLVTIGYMAPGLL 827
T + Y AP L+
Sbjct: 191 --THYVTHRWYRAPELV 205
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 1e-10
Identities = 38/190 (20%), Positives = 65/190 (34%), Gaps = 59/190 (31%)
Query: 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFH----QNCAMALKSFEAECEVMKNIR 729
E F NL+G GSF VY+ +H G+EVAIK+ M + + E ++ ++
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLK 69
Query: 730 HRNHVKRISSCSNEDFKALDCLHSTNCSLNI------------FDKL------------- 764
H + + + + +N + L
Sbjct: 70 HPSIL-----------ELYNYFEDSN---YVYLVLEMCHNGEMNRYLKNRVKPFSENEAR 115
Query: 765 NIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTE 814
+ M + + + YLH ++H DL N+ DFG+ L T
Sbjct: 116 HFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT- 171
Query: 815 TLVTIGYMAP 824
T Y++P
Sbjct: 172 LCGTPNYISP 181
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 47/187 (25%), Positives = 74/187 (39%), Gaps = 54/187 (28%)
Query: 679 KENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIR-HRNHVKR 736
+E+++G G+ V L E A+K+ + E E++ + HRN ++
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 737 ISSCSNEDFKALDCLHSTNCSL--------NIFDKL------------NIMIDVASALEY 776
I E F+ D + L +I + ++ DVASAL++
Sbjct: 77 I-----EFFEEEDRFY-----LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDF 126
Query: 777 LHFSHSTPVIHCDLKPKN-------------VFDFGIGRLLT--GDRSMIQTETLVTI-- 819
LH + H DLKP+N + DF +G + GD S I T L+T
Sbjct: 127 LHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG 183
Query: 820 --GYMAP 824
YMAP
Sbjct: 184 SAEYMAP 190
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 1e-10
Identities = 41/187 (21%), Positives = 69/187 (36%), Gaps = 53/187 (28%)
Query: 674 TEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRN 732
+ ++ EN IG GS+G V I A K + + F+ E E+MK++ H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 733 HVKRISSCSNEDFKALDCLHSTNCSLNI----------FDKL------------NIMIDV 770
++ + + + + F+++ IM DV
Sbjct: 68 IIRLYETFEDNTD------------IYLVMELCTGGELFERVVHKRVFRESDAARIMKDV 115
Query: 771 ASALEYLHFSHSTPVIHCDLKPKN-------------VFDFGIGRLLTGDRSMIQTETLV 817
SA+ Y H + V H DLKP+N + DFG+ + M +
Sbjct: 116 LSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVG 170
Query: 818 TIGYMAP 824
T Y++P
Sbjct: 171 TPYYVSP 177
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 1e-10
Identities = 32/190 (16%), Positives = 67/190 (35%), Gaps = 57/190 (30%)
Query: 674 TEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRH 730
++ + + +G G+F V + G+E A K+ + A + E E + + ++H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 731 RNHVKRISSCSNEDFKALDCLHSTNCSLNI----------FDKL------------NIMI 768
N V+ S E F + F+ + + +
Sbjct: 65 PNIVRLHDSIQEESF------------HYLVFDLVTGGELFEDIVAREFYSEADASHCIQ 112
Query: 769 DVASALEYLHFSHSTPVIHCDLKPKN-------------VFDFGIGRLLTGDRSMIQTET 815
+ ++ Y H + ++H +LKP+N + DFG+ + +
Sbjct: 113 QILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---HG 166
Query: 816 LV-TIGYMAP 824
T GY++P
Sbjct: 167 FAGTPGYLSP 176
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 39/208 (18%), Positives = 66/208 (31%), Gaps = 66/208 (31%)
Query: 677 FSKENL-----IGVGSFGSVYKGRLHDGIE------VAIKVFHQNC-AMALKSFEAECEV 724
+ + N+ IG G+FG V++ R + VA+K+ + A F+ E +
Sbjct: 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 103
Query: 725 MKNIRHRNHVKRISSCSNED----------------------------------FKALDC 750
M + N VK + C+
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 751 LHSTNCSLNIFDKLNIMIDVASALEYL---HFSHSTPVIHCDLKPKNVF----------D 797
L+ ++L I VA+ + YL F +H DL +N D
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIAD 217
Query: 798 FGIGR-LLTGDRSMIQTETLVTIGYMAP 824
FG+ R + + D + I +M P
Sbjct: 218 FGLSRNIYSADYYKADGNDAIPIRWMPP 245
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 34/207 (16%), Positives = 71/207 (34%), Gaps = 55/207 (26%)
Query: 656 GGKSKTLRRFSYQDLFRATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQN--CA 712
G + F + ++ + + +G G+F V + G+E A K+ + A
Sbjct: 10 GQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA 69
Query: 713 MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHSTNCSLNI----------FD 762
+ E E + + ++H N V+ S E F + F+
Sbjct: 70 RDFQKLEREARICRKLQHPNIVRLHDSIQEESF------------HYLVFDLVTGGELFE 117
Query: 763 KL------------NIMIDVASALEYLHFSHSTPVIHCDLKPKN-------------VFD 797
+ + + + ++ Y H + ++H +LKP+N + D
Sbjct: 118 DIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLAD 174
Query: 798 FGIGRLLTGDRSMIQTETLVTIGYMAP 824
FG+ + + T GY++P
Sbjct: 175 FGLAIEVNDSEAW--HGFAGTPGYLSP 199
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 28/188 (14%), Positives = 58/188 (30%), Gaps = 53/188 (28%)
Query: 683 IGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEA-----------------ECEVM 725
+ G F + D A+K + ++ + F E +++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 726 KNIRHRNHVKRISSCSNED--------------FKALDCLH----STNCSLNIFDKLNIM 767
+I++ + +N D K + + C + I I+
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 768 IDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV 817
V ++ Y+H + + H D+KP N+ DFG + + +
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK----IKGSR 211
Query: 818 -TIGYMAP 824
T +M P
Sbjct: 212 GTYEFMPP 219
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 40/186 (21%), Positives = 68/186 (36%), Gaps = 54/186 (29%)
Query: 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFE---AECEVMKNIRH 730
E F +G G FG+VY R +A+KV + E E+ ++RH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 731 RNHVK---------RISSCSNEDFKALDCLHSTNCSLNIFDKL------------NIMID 769
N ++ R+ + L+ ++ ++ + +L + +
Sbjct: 69 PNILRLYGYFHDATRV-------YLILE--YAPLGTV--YRELQKLSKFDEQRTATYITE 117
Query: 770 VASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-T 818
+A+AL Y H VIH D+KP+N+ DFG R L T
Sbjct: 118 LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGT 170
Query: 819 IGYMAP 824
+ Y+ P
Sbjct: 171 LDYLPP 176
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 39/190 (20%), Positives = 64/190 (33%), Gaps = 49/190 (25%)
Query: 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECE-------VMK 726
+ + + +IG G+ V +VAIK + L+ + + M
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKR------INLEKCQTSMDELLKEIQAMS 68
Query: 727 NIRHRNHVKRISSCSNEDF-----------KALDCLHST----NCSLNIFDKLNIMI--- 768
H N V +S +D LD + + D+ I
Sbjct: 69 QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128
Query: 769 DVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVT 818
+V LEYLH + IH D+K N+ DFG+ L + + + T
Sbjct: 129 EVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 819 -IG---YMAP 824
+G +MAP
Sbjct: 186 FVGTPCWMAP 195
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 40/182 (21%), Positives = 66/182 (36%), Gaps = 46/182 (25%)
Query: 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIR-HRN 732
+ K+ +G GSF K A+K+ + + + E +K H N
Sbjct: 11 DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPN 67
Query: 733 HVKRISSCSNEDFKAL--DCLHSTNCS---LNIFDKL------------NIMIDVASALE 775
VK ++ L + + L F+++ IM + SA+
Sbjct: 68 IVKLHEVFHDQLHTFLVMEL-----LNGGEL--FERIKKKKHFSETEASYIMRKLVSAVS 120
Query: 776 YLHFSHSTPVIHCDLKPKN-------------VFDFGIGRLLTGDRSMIQTETLVTIGYM 822
++H V+H DLKP+N + DFG RL D ++T T+ Y
Sbjct: 121 HMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTLHYA 176
Query: 823 AP 824
AP
Sbjct: 177 AP 178
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 49/185 (26%), Positives = 80/185 (43%), Gaps = 37/185 (20%)
Query: 671 FRATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNC------AMALKSFEAECE 723
F++ EK+ L+G GS+G V K R G VAIK F ++ +A++ E +
Sbjct: 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR----EIK 76
Query: 724 VMKNIRHRNHVKRISSCSNED-----FKALDC-----LHSTNCSLNIFDKLNIMIDVASA 773
++K +RH N V + C + F+ +D L L+ + + +
Sbjct: 77 LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIING 136
Query: 774 LEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG-DRSMIQTETLVTIGYM 822
+ + H SH+ +IH D+KP+N+ DFG R L + + T Y
Sbjct: 137 IGFCH-SHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--DDEVATRWYR 191
Query: 823 APGLL 827
AP LL
Sbjct: 192 APELL 196
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 47/212 (22%), Positives = 74/212 (34%), Gaps = 59/212 (27%)
Query: 660 KTLRRFSYQDLFRATEKFSKENL---------IGVGSFGSVYKGR-LHDGIEVAIKVFH- 708
+ F + DL + + L +G G+ G V +VAI++
Sbjct: 111 SRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISK 170
Query: 709 -------QNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHSTNCS---L 758
A + E E E++K + H +K + ED+ + L
Sbjct: 171 RKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY----YIVLELMEGGEL 226
Query: 759 NIFDKL------------NIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---------- 796
FDK+ + A++YLH + +IH DLKP+NV
Sbjct: 227 --FDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLI 281
Query: 797 ---DFGIGRLLTGDRSMIQTETLV-TIGYMAP 824
DFG ++L M TL T Y+AP
Sbjct: 282 KITDFGHSKILGETSLM---RTLCGTPTYLAP 310
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 39/200 (19%), Positives = 69/200 (34%), Gaps = 56/200 (28%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHD--------GIEVAIKVFHQNC-AMALKSFEAECEVM 725
+K + +G G FG V + VA+K+ + L +E E+M
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 726 KNI-RHRNHVKRISSCSNE----------------DF----------KALDCLHSTNCSL 758
K I +H+N + + +C+ + ++ + D +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 759 NIFDKLNIMIDVASALEYL---HFSHSTPVIHCDLKPKNVF----------DFGIGRLL- 804
D ++ +A +EYL IH DL +NV DFG+ R +
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDIN 254
Query: 805 TGDRSMIQTETLVTIGYMAP 824
D T + + +MAP
Sbjct: 255 NIDYYKKTTNGRLPVKWMAP 274
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 4e-10
Identities = 34/197 (17%), Positives = 71/197 (36%), Gaps = 50/197 (25%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDGIE------VAIKVFHQNC-AMALKSFEAECEVMKN 727
+ S +G G+FG V + + I+ VA+K+ + ++ +E +V+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 728 I-RHRNHVKRISSCSNED----------------------------FKALDCLHSTNCSL 758
+ H N V + +C+ + + +L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 759 NIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLL-TGD 807
++ D L+ VA + +L + IH DL +N+ DFG+ R +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 808 RSMIQTETLVTIGYMAP 824
+++ + + +MAP
Sbjct: 200 NYVVKGNARLPVKWMAP 216
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 5e-10
Identities = 34/111 (30%), Positives = 49/111 (44%), Gaps = 5/111 (4%)
Query: 402 NLSNLLLLDLEGNKLTGSIPV-TFGRLQKLQGLYLPFNKLAGSIPDQLC-HLARLNTLGL 459
+L NL L L N+L ++PV F L +L L L N+L +P + L L L +
Sbjct: 62 SLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFM 119
Query: 460 AGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSN 510
NK + +P + LT L L N+L S+ F L + L N
Sbjct: 120 CCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 34/112 (30%), Positives = 47/112 (41%), Gaps = 17/112 (15%)
Query: 409 LDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKL----AGSIPDQLCHLARLNTLGLAGNKF 464
L L N++T P F L L+ LYL N+L G + D L +L L L N+
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVG-VFD---SLTQLTVLDLGTNQL 100
Query: 465 SGSIPS----CLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSL 512
+ +PS L +L L + N+LT LP L + L N L
Sbjct: 101 T-VLPSAVFDRLVHLKEL---FMCCNKLTE-LPRGIERLTHLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 47/181 (25%), Positives = 76/181 (41%), Gaps = 31/181 (17%)
Query: 122 SSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDK 181
S TT++ + + +P I T + L DNQ++ V +L ++ ++ L S++
Sbjct: 19 CSGTTVDCRSKRHAS-VPAGIPT--NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQ 75
Query: 182 LSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLG-FKKLSGAIPKEIS 240
L LPV + + L L VL L N +L +L F +L
Sbjct: 76 LG-ALPVGVFDSLTQLTVLDLGTN--------------QLTVLPSAVFDRLV-------- 112
Query: 241 NLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLD 300
+L L + NKL E+P I L +L +L L N L + A +S++ YL
Sbjct: 113 HLKEL---FMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFG 168
Query: 301 N 301
N
Sbjct: 169 N 169
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 6e-10
Identities = 39/197 (19%), Positives = 70/197 (35%), Gaps = 50/197 (25%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHD--------GIEVAIKVFHQNC-AMALKSFEAECEVM 725
+K + +G G+FG V + VA+K+ + L +E E+M
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 726 KNI-RHRNHVKRISSCSNE----------------DF----------KALDCLHSTNCSL 758
K I +H+N + + +C+ + ++ + D +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 759 NIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLL-TGD 807
D ++ +A +EYL IH DL +NV DFG+ R + D
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 808 RSMIQTETLVTIGYMAP 824
T + + +MAP
Sbjct: 212 YYKKTTNGRLPVKWMAP 228
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 7e-10
Identities = 28/107 (26%), Positives = 50/107 (46%), Gaps = 5/107 (4%)
Query: 409 LDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLC-HLARLNTLGLAGNKFSGS 467
L L+GN+ T +P + L + L N+++ ++ +Q ++ +L TL L+ N+
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-C 92
Query: 468 IPS-CLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLD 513
IP L SLR L N ++ V F +L + + +N L
Sbjct: 93 IPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 7e-08
Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 395 SIPQLISNLSNLLLLDLEGNKLTGSIPV-TFGRLQKLQGLYLPFNKLAGSIPDQLCH-LA 452
+P+ +SN +L L+DL N+++ ++ +F + +L L L +N+L IP + L
Sbjct: 45 LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLK 102
Query: 453 RLNTLGLAGNKFSGSIPSCLG---NLTSLRSPDLGSN 486
L L L GN S +P G +L++L +G+N
Sbjct: 103 SLRLLSLHGNDIS-VVPE--GAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 31/108 (28%), Positives = 52/108 (48%), Gaps = 9/108 (8%)
Query: 104 NISSLNLQG----TIPPQLGNLSSLTTLNLSHNKLSGDIPPSIF-TMHKLKFLDFSDNQL 158
+++ L L G +P +L N LT ++LS+N++S + F M +L L S N+L
Sbjct: 32 DVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRL 90
Query: 159 SGSLSSVTFN-LSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKN 205
+ TF+ L S+ + L + +S +P N L L L + N
Sbjct: 91 R-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 7e-10
Identities = 41/200 (20%), Positives = 71/200 (35%), Gaps = 55/200 (27%)
Query: 677 FSKENL-----IGVGSFGSVYKGRLHD--------GIEVAIKVFHQNCAM-ALKSFEAEC 722
++ L +G G+FG V +VA+K+ + L +E
Sbjct: 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 125
Query: 723 EVMKNI-RHRNHVKRISSCSNED--------------------------FKALDCLHSTN 755
E+MK I +H+N + + +C+ + + + H+
Sbjct: 126 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185
Query: 756 CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLL- 804
L+ D ++ VA +EYL IH DL +NV DFG+ R +
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIH 242
Query: 805 TGDRSMIQTETLVTIGYMAP 824
D T + + +MAP
Sbjct: 243 HIDYYKKTTNGRLPVKWMAP 262
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 8e-10
Identities = 39/194 (20%), Positives = 71/194 (36%), Gaps = 52/194 (26%)
Query: 668 QDLFRATEKFSKE----NLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAEC 722
Q L R + +F+ IGVGS+ + +E A+K+ ++ E E
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKS---KRDPTE-EI 66
Query: 723 EVM-KNIRHRNHVKRISSCSNEDFKAL--DCLHSTNCS---LNIFDKL------------ 764
E++ + +H N + + + + + L DK+
Sbjct: 67 EILLRYGQHPNIITLKDVYDDGKYVYVVTEL-----MKGGEL--LDKILRQKFFSEREAS 119
Query: 765 NIMIDVASALEYLHFSHSTPVIHCDLKPKN--------------VFDFGIGRLLTGDRSM 810
++ + +EYLH V+H DLKP N + DFG + L + +
Sbjct: 120 AVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176
Query: 811 IQTETLVTIGYMAP 824
+ T T ++AP
Sbjct: 177 LMT-PCYTANFVAP 189
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 9e-10
Identities = 32/175 (18%), Positives = 62/175 (35%), Gaps = 30/175 (17%)
Query: 674 TEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRN 732
EK+ +G G FG V++ K + E ++ RHRN
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRN 62
Query: 733 HVKRISSCSNEDFKAL-----------DCLHSTNCSLNIFDKLNIMIDVASALEYLHFSH 781
+ S + + + + ++++ LN + ++ + V AL++LH +
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 782 STPVIHCDLKPKN------------VFDFGIGRLLTGDRSMIQTETLVTIGYMAP 824
+ H D++P+N + +FG R L + Y AP
Sbjct: 123 ---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAP 172
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 9e-10
Identities = 41/246 (16%), Positives = 64/246 (26%), Gaps = 96/246 (39%)
Query: 672 RATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAI-----------------------KVF 707
R F +G G FG V++ + D AI K+
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 708 HQNCAMALKSFEAECEVMKNIRHRNH-----------------------VKRISSCSNED 744
H ++ ++R+ S ++
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122
Query: 745 FKALDCLHSTNCSLNI-------------------------FDKLNIMIDVASALEYLHF 779
S L I L+I I +A A+E+LH
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182
Query: 780 SHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-----------T 818
++H DLKP N+F DFG+ + D T + T
Sbjct: 183 KG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
Query: 819 IGYMAP 824
YM+P
Sbjct: 240 KLYMSP 245
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 9e-10
Identities = 37/205 (18%), Positives = 73/205 (35%), Gaps = 60/205 (29%)
Query: 677 FSKENL-----IGVGSFGSVYKGRLHDG------IEVAIKVFHQNC-AMALKSFEAECEV 724
F ++NL +G G FG V K VA+K+ +N L+ +E V
Sbjct: 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNV 79
Query: 725 MKNIRHRNHVKRISSCSNED----------------------------------FKALDC 750
+K + H + +K +CS + +
Sbjct: 80 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 751 LHSTNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGI 800
H +L + D ++ ++ ++YL ++H DL +N+ DFG+
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGL 196
Query: 801 GRLL-TGDRSMIQTETLVTIGYMAP 824
R + D + +++ + + +MA
Sbjct: 197 SRDVYEEDSYVKRSQGRIPVKWMAI 221
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 36/196 (18%), Positives = 72/196 (36%), Gaps = 51/196 (26%)
Query: 677 FSKENL-----IGVGSFGSVYKGRLHDGIE------VAIKVFHQNC-AMALKSFEAECEV 724
F + NL +G G+FG V + + VA+K+ A ++ +E ++
Sbjct: 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 725 MKNI-RHRNHVKRISSCSNED------------------------FKALDCLHSTNCSLN 759
M ++ +H N V + +C++ + N + +
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 760 IFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLL-TGDR 808
D L+ VA + +L + IH D+ +NV DFG+ R +
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219
Query: 809 SMIQTETLVTIGYMAP 824
+++ + + +MAP
Sbjct: 220 YIVKGNARLPVKWMAP 235
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 31/196 (15%), Positives = 64/196 (32%), Gaps = 49/196 (25%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHD------GIEVAIKVFHQNC-AMALKSFEAECEVMKN 727
++ +G G+FG V + VA+K+ + ++ +E +++ +
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 728 I-RHRNHVKRISSCSNED---------------------------FKALDCLHSTNCSLN 759
I H N V + +C+ + L
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 760 IFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLL-TGDR 808
+ + VA +E+L IH DL +N+ DFG+ R +
Sbjct: 147 LEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 809 SMIQTETLVTIGYMAP 824
+ + + + + +MAP
Sbjct: 204 YVRKGDARLPLKWMAP 219
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 40/116 (34%), Positives = 57/116 (49%), Gaps = 10/116 (8%)
Query: 403 LSNLLLLDLEGNKLTGSIPV-TFGRLQKLQGLYLPFNKLAGSIPDQLC-HLARLNTLGLA 460
L+ L L L N+L S+P+ F L +L LYL N+L S+P + L +L L L
Sbjct: 82 LTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLN 139
Query: 461 GNKFSGSIPSCLG---NLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLD 513
N+ SIP+ G LT+L++ L +N+L SV F L + L N D
Sbjct: 140 TNQLQ-SIPA--GAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFD 192
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 40/136 (29%), Positives = 64/136 (47%), Gaps = 12/136 (8%)
Query: 383 ENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPV-TFGRLQKLQGLYLPFNKLA 441
E + + + + L+ L L+L+ N+L ++ F L +L L L N+LA
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 442 GSIPDQL-CHLARLNTLGLAGNKFSGSIPS----CLGNLTSLRSPDLGSNRLTSVLPSTF 496
S+P + HL +L+ L L GN+ S+PS L L L L +N+L S+ F
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKEL---RLNTNQLQSIPAGAF 151
Query: 497 WNLKDILFFDLSSNSL 512
L ++ LS+N L
Sbjct: 152 DKLTNLQTLSLSTNQL 167
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 8e-08
Identities = 54/216 (25%), Positives = 92/216 (42%), Gaps = 39/216 (18%)
Query: 90 GITCNVNSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFT-MHKL 148
G TCN ++ +L ++P G + L+L L+ + + F + KL
Sbjct: 9 GCTCNEGK---KEVDCQGKSLD-SVPS--GIPADTEKLDLQSTGLA-TLSDATFRGLTKL 61
Query: 149 KFLDFSDNQLSGSLSSVTFN-LSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMF 207
+L+ NQL +LS+ F+ L+ + + L +++L+ LP+ + ++L L L+L N
Sbjct: 62 TWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGN-- 117
Query: 208 HGQIPLALSKCKRLQLLNLG-FKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEI-GY 265
+L+ L G F +L+ L L L N+L+ IP
Sbjct: 118 ------------QLKSLPSGVFDRLT--------KLKEL---RLNTNQLQ-SIPAGAFDK 153
Query: 266 LPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDN 301
L NL+ L L N L V A + ++ I L N
Sbjct: 154 LTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 6e-04
Identities = 52/213 (24%), Positives = 77/213 (36%), Gaps = 50/213 (23%)
Query: 229 KKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIF 288
K L ++P I T K+ L++ L L L L L +N L + A +F
Sbjct: 24 KSLD-SVPSGIPADT--EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVF 79
Query: 289 N-MSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDM 347
+ ++ + + L +N L S LG+ L +++L LG N+ +KL L +
Sbjct: 80 DDLTELGTLGLANNQ-LASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRL 138
Query: 348 GTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQ-LISNLSNL 406
TN SIP L+NL
Sbjct: 139 NTNQLQ-----------------------------------------SIPAGAFDKLTNL 157
Query: 407 LLLDLEGNKLTGSIPV-TFGRLQKLQGLYLPFN 438
L L N+L S+P F RL KLQ + L N
Sbjct: 158 QTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 9e-04
Identities = 36/139 (25%), Positives = 62/139 (44%), Gaps = 12/139 (8%)
Query: 457 LGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPL 516
L L + + LT L +L N+L ++ F +L ++ L++N L
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA--- 96
Query: 517 SLDIG---NLRVVIGINLSRNNFSGDIPSTIGD-LKDLQNISLACNGLEGLIPESF---G 569
SL +G +L + + L N +PS + D L L+ + L N L+ + +F
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLT 155
Query: 570 YLTELNLSFNKLEGEIPRG 588
L L+LS N+L+ +P G
Sbjct: 156 NLQTLSLSTNQLQS-VPHG 173
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 43/194 (22%), Positives = 73/194 (37%), Gaps = 52/194 (26%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDG---IEVAIKVFHQNC-AMALKSFEAECEVMKNI-R 729
+++IG G+FG V K R+ ++ AIK + + F E EV+ +
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 730 HRNHVKRISSCSNE----------------DF----------KALDCLHSTNCSLNIFDK 763
H N + + +C + DF A +ST +L+
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 764 LNIMIDVASALEYL---HFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810
L+ DVA ++YL F IH DL +N+ DFG+ R + +
Sbjct: 145 LHFAADVARGMDYLSQKQF------IHRDLAARNILVGENYVAKIADFGLSR--GQEVYV 196
Query: 811 IQTETLVTIGYMAP 824
+T + + +MA
Sbjct: 197 KKTMGRLPVRWMAI 210
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 2e-09
Identities = 50/181 (27%), Positives = 75/181 (41%), Gaps = 37/181 (20%)
Query: 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNC------AMALKSFEAECEVMKN 727
EK+ K IG GS+G V+K R G VAIK F ++ +AL+ E ++K
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR----EIRMLKQ 58
Query: 728 IRHRNHVKRISSCSNED-----FKALDC-----LHSTNCSLNIFDKLNIMIDVASALEYL 777
++H N V + + F+ D L + +I A+ +
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 778 HFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG-DRSMIQTETLVTIGYMAPGL 826
H H+ IH D+KP+N+ DFG RLLTG + + T Y +P L
Sbjct: 119 H-KHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY--DDEVATRWYRSPEL 173
Query: 827 L 827
L
Sbjct: 174 L 174
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 41/198 (20%), Positives = 67/198 (33%), Gaps = 68/198 (34%)
Query: 674 TEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFH--------QNCAMALKSFEAECEV 724
+++ +G G+ G V +VAIK+ A + E E E+
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 725 MKNIRHRNHVKRISSCSNEDFKALDCLHSTNCSLNI------------FDKL-------- 764
+K + H +K + + + + FDK+
Sbjct: 69 LKKLNHPCIIK---------------IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKE 113
Query: 765 ----NIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------DFGIGRLLTGD 807
+ A++YLH + +IH DLKP+NV DFG ++L
Sbjct: 114 ATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
Query: 808 RSMIQTETLV-TIGYMAP 824
M TL T Y+AP
Sbjct: 171 SLM---RTLCGTPTYLAP 185
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 36/187 (19%), Positives = 67/187 (35%), Gaps = 55/187 (29%)
Query: 674 TEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRN 732
++ F E+ +G G+ VY+ + A+KV + + K E V+ + H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPN 109
Query: 733 HVKRISSCSNEDFKALDCLHSTNCSLNI----------FDKL------------NIMIDV 770
+K +++ FD++ + + +
Sbjct: 110 IIKLKEIFETPT------------EISLVLELVTGGELFDRIVEKGYYSERDAADAVKQI 157
Query: 771 ASALEYLHFSHSTPVIHCDLKPKN-------------VFDFGIGRLLTGDRSMIQTETLV 817
A+ YLH + ++H DLKP+N + DFG+ +++ M
Sbjct: 158 LEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVCG 212
Query: 818 TIGYMAP 824
T GY AP
Sbjct: 213 TPGYCAP 219
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 4e-09
Identities = 41/179 (22%), Positives = 62/179 (34%), Gaps = 36/179 (20%)
Query: 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMA-LKSFEAECEV-MKNIRHR 731
+ +G G++G V K R + G +A+K K + ++ M+ +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 732 NHVK---------RISSC------SNEDFKALDCLHSTNCSLNIFDKLNIMIDVASALEY 776
V + C S + F +I K I + + ALE+
Sbjct: 67 FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGK--IAVSIVKALEH 124
Query: 777 LHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-TIGYMAP 824
LH S VIH D+KP NV DFGI L + + YMAP
Sbjct: 125 LHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKD-IDAGCKPYMAP 178
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 40/173 (23%), Positives = 64/173 (36%), Gaps = 29/173 (16%)
Query: 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMA-LKSFEAECEVMKNIRHRN 732
+ F K + +G G+ G V+K G+ +A K+ H A E +V+
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 733 HVKRISSCSNE----------DFKALDCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHS 782
V + ++ D +LD + + + I V L YL H
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152
Query: 783 TPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-TIGYMAP 824
++H D+KP N+ DFG+ L SM + V T YM+P
Sbjct: 153 --IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSM--ANSFVGTRSYMSP 199
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 5e-09
Identities = 43/188 (22%), Positives = 70/188 (37%), Gaps = 40/188 (21%)
Query: 671 FRATEKFSKENLIGVGSFGSVYKGRLHD-GIEVAIKVFHQNCAMALKSFEAECEVMKNIR 729
++ +IG GSFG VY+ +L D G VAIK Q+ + E ++M+ +
Sbjct: 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLD 105
Query: 730 HRNHVK----RISSCSNEDF---------------KALDCLHSTNCSLNIFDKLNIMIDV 770
H N V+ SS +D + +L + M +
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 771 ASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRLLTGDRSMIQTETLVTI 819
+L Y+ HS + H D+KP+N+ DFG + L + +
Sbjct: 166 FRSLAYI---HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSR 220
Query: 820 GYMAPGLL 827
Y AP L+
Sbjct: 221 YYRAPELI 228
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 36/192 (18%), Positives = 67/192 (34%), Gaps = 42/192 (21%)
Query: 671 FRATEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIR 729
+ ++F E + G G+FG+V G+ G+ VAIK Q+ + E ++M+++
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNR----ELQIMQDLA 74
Query: 730 HRNHVKRIS------SCSNEDF-----------------KALDCLHSTNCSLNIFDKLNI 766
+H + + D + + +
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVF 134
Query: 767 MIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRLLTGDRSMIQTET 815
+ + ++ LH S V H D+KP NV DFG + L+
Sbjct: 135 LFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN--VAY 191
Query: 816 LVTIGYMAPGLL 827
+ + Y AP L+
Sbjct: 192 ICSRYYRAPELI 203
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 5e-09
Identities = 42/187 (22%), Positives = 68/187 (36%), Gaps = 56/187 (29%)
Query: 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFH----QNCAMALKSFEAECEVMKNIR 729
+ F +G G FG+VY R + +A+KV + + E E+ ++R
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVE-HQLRREIEIQSHLR 72
Query: 730 HRNHVK---------RISSCSNEDFKALDCLHSTNCSLNIFDKL------------NIMI 768
H N ++ RI + L+ + L + +L M
Sbjct: 73 HPNILRMYNYFHDRKRI-------YLMLE--FAPRGEL--YKELQKHGRFDEQRSATFME 121
Query: 769 DVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV- 817
++A AL Y H VIH D+KP+N+ DFG R T+
Sbjct: 122 ELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCG 174
Query: 818 TIGYMAP 824
T+ Y+ P
Sbjct: 175 TLDYLPP 181
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 5e-09
Identities = 33/201 (16%), Positives = 62/201 (30%), Gaps = 66/201 (32%)
Query: 672 RATEKFSKE----NLIGVGSFGSVYKGR-LHDGIEVAIKVF---------HQNCAMALKS 717
+T F + ++G G V + E A+K+ + ++
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 718 FEAECEVMKNI-RHRNHVKRISSCSNEDFKALDCLHSTNCSLNI----------FDKL-- 764
E ++++ + H N ++ + F + FD L
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTF------------FFLVFDLMKKGELFDYLTE 117
Query: 765 ----------NIMIDVASALEYLHFSHSTPVIHCDLKPKN----------VFDFGIGRLL 804
IM + + LH + ++H DLKP+N + DFG L
Sbjct: 118 KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL 174
Query: 805 TGDRSMIQTETLV-TIGYMAP 824
+ + T Y+AP
Sbjct: 175 DPGEKL---REVCGTPSYLAP 192
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 33/141 (23%), Positives = 58/141 (41%), Gaps = 20/141 (14%)
Query: 683 IGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSC- 740
IG G+FG + G+ L+ VAIK+ E K + + + ++
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 741 SNEDFKAL----------DCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDL 790
+ A+ D + + ++ L I I + S +EY+H S +I+ D+
Sbjct: 75 PCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDV 131
Query: 791 KPKNVFDFGIGRLLTGDRSMI 811
KP+N F IGR + +I
Sbjct: 132 KPEN---FLIGRPGNKTQQVI 149
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 6e-09
Identities = 31/109 (28%), Positives = 49/109 (44%), Gaps = 7/109 (6%)
Query: 409 LDLEGNKLTGSIPVT--FGRLQKLQGLYLPFNKLAGSIPDQLC-HLARLNTLGLAGNKFS 465
L L N+L I FGRL L L L N+L I + + L L NK
Sbjct: 34 LLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK 91
Query: 466 GSIPS-CLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLD 513
I + L L++ +L N+++ V+P +F +L + +L+SN +
Sbjct: 92 -EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 10/90 (11%)
Query: 402 NLSNLLLLDLEGNKLTGSIPV-TFGRLQKLQGLYLPFNKLAGSIPDQLC-HLARLNTLGL 459
L +L+ L+L+ N+LT I F +Q L L NK+ I +++ L +L TL L
Sbjct: 52 RLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNL 109
Query: 460 AGNKFSGSIPSCLG---NLTSLRSPDLGSN 486
N+ S + G +L SL S +L SN
Sbjct: 110 YDNQIS-CVMP--GSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 20/62 (32%), Positives = 34/62 (54%), Gaps = 4/62 (6%)
Query: 120 NLSSLTTLNLSHNKLSGDIPPSIFT-MHKLKFLDFSDNQLSGSLSSVTF-NLSSVLDIRL 177
S + L L NK+ +I +F +H+LK L+ DNQ+S + +F +L+S+ + L
Sbjct: 76 GASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNL 133
Query: 178 DS 179
S
Sbjct: 134 AS 135
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 57.1 bits (139), Expect = 6e-09
Identities = 46/184 (25%), Positives = 71/184 (38%), Gaps = 44/184 (23%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECE----------- 723
EK+ IG G++G VYK + + G A+K E E E
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR---------LEKEDEGIPSTTIREIS 52
Query: 724 VMKNIRHRNHVKRISSCSNED-----FKALDC-----LHSTNCSLNIFDKLNIMIDVASA 773
++K ++H N VK + F+ LD L L + ++ + +
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 774 LEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMA 823
+ Y H V+H DLKP+N+ DFG+ R G T +VT+ Y A
Sbjct: 113 IAYCH-DRR--VLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIVTLWYRA 168
Query: 824 PGLL 827
P +L
Sbjct: 169 PDVL 172
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 7e-09
Identities = 50/202 (24%), Positives = 83/202 (41%), Gaps = 39/202 (19%)
Query: 658 KSKTLRRFSYQDLFRAT----EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIK----VFH 708
KSK +F ++ +T +++ IG G+ G V VAIK F
Sbjct: 41 KSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF- 99
Query: 709 QNCAMALKSFEAECEVMKNIRHRNHVK----RISSCSNEDFKAL---DCLHSTNCSLNIF 761
QN A +++ E +MK + H+N + + E+F+ + L N I
Sbjct: 100 QNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ 158
Query: 762 DKLN------IMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLT 805
+L+ ++ + +++LH S +IH DLKP N+ DFG+ R
Sbjct: 159 MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215
Query: 806 GDRSMIQTETLVTIGYMAPGLL 827
M T +VT Y AP ++
Sbjct: 216 TSFMM--TPYVVTRYYRAPEVI 235
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 8e-09
Identities = 27/190 (14%), Positives = 58/190 (30%), Gaps = 48/190 (25%)
Query: 674 TEKFSKENLIGVG--SFGSVYKGR-LHDGIEVAIKVF---HQNCAMALKSFEAECEVMKN 727
+ +IG G +V R G V ++ + M + + E V K
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEM-VTFLQGELHVSKL 82
Query: 728 IRHRNHVKRISSCSNEDF-----------KALDCLHSTNCSLNIFDKLN------IMIDV 770
H N V ++ ++ A D + + D +N I+ V
Sbjct: 83 FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTH-----FMDGMNELAIAYILQGV 137
Query: 771 ASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGD---RSMIQTETLV 817
AL+Y+H +H +K ++ + + ++
Sbjct: 138 LKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194
Query: 818 TIG---YMAP 824
++ +++P
Sbjct: 195 SVKVLPWLSP 204
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 9e-09
Identities = 34/194 (17%), Positives = 61/194 (31%), Gaps = 60/194 (30%)
Query: 674 TEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFH------QNCAMALKSFEAECEVMK 726
+ + +G G F V K R G++ A K ++ + E E ++K
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 727 NIRHRNHVKRISSCSNEDFKALDCLHSTNCSLNI----------FDKL------------ 764
I+H N + L ++ + + FD L
Sbjct: 70 EIQHPNVIT------------LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 765 NIMIDVASALEYLHFSHSTPVIHCDLKPKN--------------VFDFGIGRLLTGDRSM 810
+ + + + YLH + H DLKP+N + DFG+ +
Sbjct: 118 EFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 811 IQTETLVTIGYMAP 824
T ++AP
Sbjct: 175 --KNIFGTPEFVAP 186
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 9e-09
Identities = 38/193 (19%), Positives = 58/193 (30%), Gaps = 58/193 (30%)
Query: 674 TEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFH------QNCAMALKSFEAECEVMK 726
+ + +G G F V K R G E A K ++ + E E +++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 727 NIRHRNHVKRISSCSNEDFKALDCLHSTNCSLNI---------FDKL------------N 765
IRH N + N+ L I FD L
Sbjct: 64 EIRHPNIITLHDIFENKTDVVL-----------ILELVSGGELFDFLAEKESLTEDEATQ 112
Query: 766 IMIDVASALEYLHFSHSTPVIHCDLKPKN--------------VFDFGIGRLLTGDRSMI 811
+ + + YLH + H DLKP+N + DFGI +
Sbjct: 113 FLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF- 168
Query: 812 QTETLVTIGYMAP 824
T ++AP
Sbjct: 169 -KNIFGTPEFVAP 180
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 41/198 (20%), Positives = 72/198 (36%), Gaps = 49/198 (24%)
Query: 672 RATEKFSKENL-IGVGSFGSVYKGRLHD---GIEVAIKVFHQNCAMALKSFEAECEV--M 725
R + F E +G G++G VYK + D + A+K S A E+ +
Sbjct: 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----SMSACREIALL 72
Query: 726 KNIRHRN--HVKRISSCSNE------------DFKALDCLHSTNCSLNIFDKLN------ 765
+ ++H N ++++ + D + H + + +L
Sbjct: 73 RELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKS 132
Query: 766 IMIDVASALEYLHFSHSTPVIHCDLKPKNVF--------------DFGIGRLLTG-DRSM 810
++ + + YLH + V+H DLKP N+ D G RL + +
Sbjct: 133 LLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 189
Query: 811 IQ-TETLVTIGYMAPGLL 827
+VT Y AP LL
Sbjct: 190 ADLDPVVVTFWYRAPELL 207
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 1e-08
Identities = 46/188 (24%), Positives = 72/188 (38%), Gaps = 46/188 (24%)
Query: 672 RATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECE-------- 723
EK+ K +G G++G VYK + G VA+K +AE E
Sbjct: 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR---------LDAEDEGIPSTAIR 68
Query: 724 ---VMKNIRHRNHVKRISSCSNED-----FKALDC-----LHSTNCSLNIFDKLNIMIDV 770
++K + H N V I +E F+ ++ L L + +
Sbjct: 69 EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQL 128
Query: 771 ASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG-DRSMIQTETLVTI 819
+ + H H ++H DLKP+N+ DFG+ R RS T +VT+
Sbjct: 129 LRGVAHCH-QHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTL 183
Query: 820 GYMAPGLL 827
Y AP +L
Sbjct: 184 WYRAPDVL 191
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 57.9 bits (139), Expect = 1e-08
Identities = 91/599 (15%), Positives = 164/599 (27%), Gaps = 165/599 (27%)
Query: 257 GEIPHEIGY---LP-NLENLVLGFN-NLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGI 311
GE + Y L + V F+ V +P +I + + I + +++ G+ L
Sbjct: 12 GEHQY--QYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRL-F 68
Query: 312 DLSLPNVERLNLGLNRFSGTIP----SFITNASKLVYLD--MGTNSFSGIIPNTIGLTGN 365
L E + +F + F+ + K M T + N
Sbjct: 69 WTLLSKQEE---MVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRL--YNDN 123
Query: 366 PL---DGVL-PTSIGNLSMSLENI----YISNCNIGGSIPQLISNLSNLLLLDLEGNKLT 417
+ V L +L + + + GS + ++ + L K+
Sbjct: 124 QVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGK---TWVALDVCLS---YKVQ 177
Query: 418 GSIP-----VTFGR-------LQKLQGLYLPFNKLAGSIPDQLCHL--------ARLNTL 457
+ + L+ LQ L + S D ++ A L L
Sbjct: 178 CKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL 237
Query: 458 GLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLS 517
L + +CL L L ++ N K F+LS
Sbjct: 238 -LKSKPY----ENCL--LV-LL--NV-------------QNAKAWNAFNLSC-------- 266
Query: 518 LDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIP-ESFGYLTE-LN 575
++++ +R D S +ISL + L P E L + L+
Sbjct: 267 ------KILL---TTRFKQVTDFLSA----ATTTHISLD-HHSMTLTPDEVKSLLLKYLD 312
Query: 576 LSFNKLEGEIPRGGPFA-NFTAKSFMGNEKLCGLPNLQFPKCKR--RTRRKS-------- 624
L E+ P + A+S + L N + C + S
Sbjct: 313 CRPQDLPREVLTTNPRRLSIIAESI--RDGLATWDNWKHVNCDKLTTIIESSLNVLEPAE 370
Query: 625 KKKMLLLVIVLPLSTALIIAVPLALKYKSIRGGKSKTLRRF----SYQDLFRATEKFSKE 680
+KM + V P S +P + L D+ K K
Sbjct: 371 YRKMFDRLSVFPPSA----HIP------------TILLSLIWFDVIKSDVMVVVNKLHKY 414
Query: 681 NLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSC 740
+L+ S + + LK + E + HR+ V
Sbjct: 415 SLVEKQPKESTI--SIPS------------IYLELK---VKLENEYAL-HRSIV------ 450
Query: 741 SNEDFKALDCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVFDFG 799
+ + S + D+ S + + H + L DF
Sbjct: 451 --DHYNIPKTFDSDDLIPPYLDQY-----FYSHIGH-HLKNIEHPERMTLFRMVFLDFR 501
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 1e-05
Identities = 102/602 (16%), Positives = 170/602 (28%), Gaps = 208/602 (34%)
Query: 3 Y-FLMAHYLF-----SGIESPYIT---KLITTSNLLS-FHVPLTHCLLLYLVVAVAAASN 52
Y FLM+ S + YI +L + + + ++V L
Sbjct: 91 YKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYL-----------K 139
Query: 53 ITTDQQALLALKAHISYDPTNL------------LAQNSTSNTSVCNWIGITCNVNSHRV 100
+ +QALL L+ N+ +A VC + C ++ +
Sbjct: 140 L---RQALLELRPA-----KNVLIDGVLGSGKTWVA------LDVCLSYKVQCKMDFK-I 184
Query: 101 TALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIF--TMHKLKFLDFSDNQL 158
LN+ + N T+ L L N + +L+ L
Sbjct: 185 FWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL-LKSKPY 243
Query: 159 SGSL--------SSV--TFNLSS-VL----DIRLDSDKLSGELPVNICNYLHYLKVL--- 200
L + FNLS +L ++ +D LS +I H+ L
Sbjct: 244 ENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQV-TDFLSAATTTHIS-LDHHSMTLTPD 301
Query: 201 ----FLAK--NM--------FHGQIPLALSKCKRL---------QLLNLGFKKLSGAI-- 235
L K + P LS ++ KL+ I
Sbjct: 302 EVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIES 361
Query: 236 ------PKEIS----NLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPA 285
P E L++ + IP + L L + +++
Sbjct: 362 SLNVLEPAEYRKMFDRLSVFPP----SAH----IPTIL--------LSLIWFDVIKSDV- 404
Query: 286 AIFNMSTVKKIYLLDNSLL------GSFSL-GIDLSLPNVERLNLG-LNRFSGTIPSFIT 337
M V K L SL+ + S+ I L L V+ N L+R S +
Sbjct: 405 ----MVVVNK--LHKYSLVEKQPKESTISIPSIYLEL-KVKLENEYALHR------SIVD 451
Query: 338 NASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIY-ISNCNIGGSI 396
+ + D L LD + IG + + N +
Sbjct: 452 HYNIPKTFDSD------------DLIPPYLDQYFYSHIG---------HHLKNIEHPERM 490
Query: 397 PQLISNLSNLLLLDLE--GNKL---------TGSIPVTFGRLQKLQGLYLPFNKLAGSIP 445
L ++ LD K+ +GSI T +L+ Y P+ I
Sbjct: 491 -----TLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKF----YKPY------IC 535
Query: 446 DQLCHLARL-NTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILF 504
D RL N + F +P NL + S T +L + +F
Sbjct: 536 DNDPKYERLVNAIL----DF---LPKIEENL--ICSKY------TDLLRIALMAEDEAIF 580
Query: 505 FD 506
+
Sbjct: 581 EE 582
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 35/193 (18%), Positives = 57/193 (29%), Gaps = 58/193 (30%)
Query: 674 TEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFH------QNCAMALKSFEAECEVMK 726
+ + +G G F V K R G+E A K + + E E +++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 727 NIRHRNHVKRISSCSNEDFKALDCLHSTNCSLNI---------FDKL------------N 765
+ H N + N L I FD L +
Sbjct: 71 QVLHPNIITLHDVYENRTDVVL-----------ILELVSGGELFDFLAQKESLSEEEATS 119
Query: 766 IMIDVASALEYLHFSHSTPVIHCDLKPKN--------------VFDFGIGRLLTGDRSMI 811
+ + + YLH + H DLKP+N + DFG+ +
Sbjct: 120 FIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF- 175
Query: 812 QTETLVTIGYMAP 824
T ++AP
Sbjct: 176 -KNIFGTPEFVAP 187
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-08
Identities = 36/106 (33%), Positives = 51/106 (48%), Gaps = 8/106 (7%)
Query: 409 LDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLC-HLARLNTLGLAGNKFSGS 467
L+LE NKL F +L +L L L N++ S+PD + L +L L L NK S
Sbjct: 33 LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-S 90
Query: 468 IPSCLG---NLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSN 510
+P+ G LT L+ L +N+L SV F L + L +N
Sbjct: 91 LPN--GVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 5e-05
Identities = 32/87 (36%), Positives = 45/87 (51%), Gaps = 6/87 (6%)
Query: 403 LSNLLLLDLEGNKLTGSIPV-TFGRLQKLQGLYLPFNKLAGSIPDQLC-HLARLNTLGLA 460
L+ L L L N++ S+P F +L KL LYL NKL S+P+ + L +L L L
Sbjct: 51 LTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALD 108
Query: 461 GNKFSGSIPS-CLGNLTSLRSPDLGSN 486
N+ S+P LTSL+ L +N
Sbjct: 109 TNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 37/175 (21%), Positives = 58/175 (33%), Gaps = 31/175 (17%)
Query: 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMA-LKSFEAECEV-MKNIRHR 731
+G G+ G V+K R G +A+K ++ K + +V +K+
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 732 NHVKRISSCSNEDFKALDCLHSTNCSLNIFDKL-----------NIMIDVASALEYLHFS 780
V+ + + K + + + AL YL
Sbjct: 85 YIVQCFGTFITNT-DVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143
Query: 781 HSTPVIHCDLKPKNVF----------DFGI-GRLLTGDRSMIQTETLVTIGYMAP 824
H VIH D+KP N+ DFGI GRL + + YMAP
Sbjct: 144 HG--VIHRDVKPSNILLDERGQIKLCDFGISGRL---VDDKAKDRSAGCAAYMAP 193
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 64/338 (18%), Positives = 103/338 (30%), Gaps = 87/338 (25%)
Query: 118 LGNLSSLTTLNLSHNKLSGD----IPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVL 173
L S+ + LS N + + + +I + L+ +FSD + L
Sbjct: 28 LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRL-- 85
Query: 174 DIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMF--HGQIPLA--LSKCKRLQLLNL--- 226
L L L + L+ N F Q PL LSK L+ L L
Sbjct: 86 --------LLQALLKC-----PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNN 132
Query: 227 -----GFKKLSGAIP-----KEISNLTILRKISLRNNKLRGE----IPHEIGYLPNLENL 272
K++ A+ K+ N LR I N+L L +
Sbjct: 133 GLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTV 192
Query: 273 VLGFNNL--VGVVPA---AIFNMSTVKKIYLLDNSL--LGSFSLGIDL-SLPNVERLNLG 324
+ N + G+ + +K + L DN+ LGS +L I L S PN+ L L
Sbjct: 193 KMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN 252
Query: 325 LNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLEN 384
S G + + N L+
Sbjct: 253 DCLLS----------------ARGAAAVV----DAFSKLENI--------------GLQT 278
Query: 385 IYISNCNIGGS-----IPQLISNLSNLLLLDLEGNKLT 417
+ + I + + +LL L+L GN+ +
Sbjct: 279 LRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 60/348 (17%), Positives = 106/348 (30%), Gaps = 73/348 (20%)
Query: 269 LENLVLGFNNL----VGVVPAAIFNMSTVKKIYLLDNSL--LGSFSLGIDL-SLPNVERL 321
+E L + + V A + +VK+I L N++ + L ++ S ++E
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 322 NLG---LNRFSGTIP-------SFITNASKLVYLDMGTNSFS--GIIPNTIGLTGNPLDG 369
R IP + KL + + N+F P L+ +
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHT--- 122
Query: 370 VLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQK 429
LE++Y+ N +G PQ + ++ L K +
Sbjct: 123 -----------PLEHLYLHNNGLG---PQAGAKIARALQELAVNKKAKNA--------PP 160
Query: 430 LQGLYLPFNKL----AGSIPDQLCHLARLNTLGLAGNKF-----SGSIPSCLGNLTSLRS 480
L+ + N+L L+T+ + N + L L+
Sbjct: 161 LRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKV 220
Query: 481 PDLGSNRLT----SVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNF 536
DL N T S L + ++ L+ L G VV + N
Sbjct: 221 LDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS-----ARGAAAVVDAFSKLEN-- 273
Query: 537 SGDIPSTIGDLKDLQNISLACNGLEGL---IPESFGYLTELNLSFNKL 581
+ L LQ + + + L I E L L L+ N+
Sbjct: 274 -----IGLQTL-RLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 39/205 (19%), Positives = 71/205 (34%), Gaps = 60/205 (29%)
Query: 677 FSKENL-----IGVGSFGSVYKGRLHDG------IEVAIKVFHQNC-AMALKSFEAECEV 724
F +ENL +G G+FG V + I+VA+K+ + + ++ +E ++
Sbjct: 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 101
Query: 725 MKNI-RHRNHVKRISSCSNED---------------------------------FKALDC 750
M + H N V + +C+ +
Sbjct: 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161
Query: 751 LHSTNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGI 800
L D L VA +E+L F +H DL +NV DFG+
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGL 218
Query: 801 GRLL-TGDRSMIQTETLVTIGYMAP 824
R + + +++ + + +MAP
Sbjct: 219 ARDIMSDSNYVVRGNARLPVKWMAP 243
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 48/199 (24%), Positives = 77/199 (38%), Gaps = 30/199 (15%)
Query: 655 RGGKSKTLRRFSYQD-LFRATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIK----VFH 708
R + D F +++ IG G+ G V VAIK F
Sbjct: 4 RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF- 62
Query: 709 QNCAMALKSFEAECEVMKNIRHRNHVK----RISSCSNEDFKAL-DCLHSTNCSLNIFDK 763
QN A +++ E +MK + H+N + S E+F+ + + + +L +
Sbjct: 63 QNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ 121
Query: 764 LNIMIDVASALEY-----LHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808
+ + + S L Y + HS +IH DLKP N+ DFG+ R
Sbjct: 122 MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181
Query: 809 SMIQTETLVTIGYMAPGLL 827
M T +VT Y AP ++
Sbjct: 182 MM--TPYVVTRYYRAPEVI 198
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 35/188 (18%), Positives = 75/188 (39%), Gaps = 20/188 (10%)
Query: 118 LGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRL 177
L++ NL ++ D+ + ++ + ++ + SL+ + +++ ++ L
Sbjct: 15 DPGLANAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQ-SLAGMQ-FFTNLKELHL 70
Query: 178 DSDKLSGELPVNICN--YLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAI 235
+++S ++ L L+ L + +N + + RL L N +
Sbjct: 71 SHNQIS-----DLSPLKDLTKLEELSVNRNRLKNLNGIPSACLSRLFLDNNELRDTDS-- 123
Query: 236 PKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKK 295
+ +L L +S+RNNKL+ I +G+L LE L L N + + + V
Sbjct: 124 ---LIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNW 176
Query: 296 IYLLDNSL 303
I L
Sbjct: 177 IDLTGQKC 184
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 36/227 (15%), Positives = 78/227 (34%), Gaps = 34/227 (14%)
Query: 215 LSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVL 274
NLG + ++ + L+ ++ + N+ ++ + + + NL+ L L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHL 70
Query: 275 GFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGID-LSLPNVERLNLGLNRFSGTIP 333
N + + P + +++ ++++ + N L ++ + + RL L N T
Sbjct: 71 SHNQISDLSP--LKDLTKLEELSVNRNRLKN-----LNGIPSACLSRLFLDNNELRDT-- 121
Query: 334 SFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIG 393
+ + L L + N I +G LS LE + + I
Sbjct: 122 DSLIHLKNLEILSIRNNKLKSI-----------------VMLGFLS-KLEVLDLHGNEIT 163
Query: 394 GSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKL 440
+ L + L + +DL G K L + P +
Sbjct: 164 -NTGGL-TRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW 208
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 8e-07
Identities = 38/213 (17%), Positives = 72/213 (33%), Gaps = 16/213 (7%)
Query: 373 TSIGNLSM--SLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKL 430
T + + ++N N NI + +NL L L N+++ + L KL
Sbjct: 32 TDLVSQKELSGVQNFNGDNSNI--QSLAGMQFFTNLKELHLSHNQIS-DLS-PLKDLTKL 87
Query: 431 QGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTS 490
+ L + N+L L+RL L N+ L +L +L + +N+L S
Sbjct: 88 EELSVNRNRLKNLNGIPSACLSRLF---LDNNELRD--TDSLIHLKNLEILSIRNNKLKS 142
Query: 491 VLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDL 550
+ L + DL N + L L+ V I+L+ + +L
Sbjct: 143 I--VMLGFLSKLEVLDLHGNEITNTGGLT--RLKKVNWIDLTGQKCVNEPVKYQPELYIT 198
Query: 551 QNIS-LACNGLEGLIPESFGYLTELNLSFNKLE 582
+ + + G + + +
Sbjct: 199 NTVKDPDGRWISPYYISNGGSYVDGCVLWELPV 231
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 39/205 (19%), Positives = 74/205 (36%), Gaps = 38/205 (18%)
Query: 100 VTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLS 159
V N + N+Q ++ + ++L L+LSHN++S D+ P + + KL+ L + N+L
Sbjct: 43 VQNFNGDNSNIQ-SLAG-MQFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLK 98
Query: 160 GSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCK 219
L+G L LFL N + +L K
Sbjct: 99 ---------------------NLNGIPSAC-------LSRLFLDNNEL--RDTDSLIHLK 128
Query: 220 RLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNL 279
L++L++ KL + + L+ L + L N++ + L + + L
Sbjct: 129 NLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKC 184
Query: 280 VGVVPAAIFNMSTVKKIYLLDNSLL 304
V + + D +
Sbjct: 185 VNEPVKYQPELYITNTVKDPDGRWI 209
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 55.2 bits (134), Expect = 3e-08
Identities = 40/186 (21%), Positives = 74/186 (39%), Gaps = 47/186 (25%)
Query: 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECE---------- 723
+K+ K IG G++G+V+K + VA+K + + E
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR---------LDDDDEGVPSSALREI 52
Query: 724 -VMKNIRHRNHVKRISSCSNED-----FKALDC-----LHSTNCSLNIFDKLNIMIDVAS 772
++K ++H+N V+ ++ F+ D S N L+ + + +
Sbjct: 53 CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLK 112
Query: 773 ALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG-DRSMIQTETLVTIGY 821
L + H S + V+H DLKP+N+ +FG+ R R + +VT+ Y
Sbjct: 113 GLGFCH-SRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWY 167
Query: 822 MAPGLL 827
P +L
Sbjct: 168 RPPDVL 173
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 46/194 (23%), Positives = 74/194 (38%), Gaps = 32/194 (16%)
Query: 409 LDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLA--GSIPDQLCHLARLNTLGLAGNKFSG 466
+L+ +T T L + + + + I +L + L L GNK
Sbjct: 24 ANLKKKSVT-DAV-TQNELNSIDQIIANNSDIKSVQGIQ----YLPNVRYLALGGNKLH- 76
Query: 467 SIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSL--------DGPLSL 518
I + L LT+L L N+L S+ F L ++ L N L D +L
Sbjct: 77 DISA-LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNL 135
Query: 519 DIGNLRVVIGINLSRNNFSGDIPSTIGD-LKDLQNISLACNGLEGLIPESF---GYLTEL 574
+NL+ N +P + D L +L + L+ N L+ L F L +L
Sbjct: 136 TY--------LNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDL 186
Query: 575 NLSFNKLEGEIPRG 588
L N+L+ +P G
Sbjct: 187 RLYQNQLKS-VPDG 199
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 48/201 (23%), Positives = 78/201 (38%), Gaps = 16/201 (7%)
Query: 319 ERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGI--IPNTIGLTGNPLDGVLPTSIG 376
+ NL + + + + + + + I + L G I
Sbjct: 22 IKANLKKKSVT-DAVTQN-ELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLHDIS 79
Query: 377 ---NLSMSLENIYISNCNIGGSIPQLI-SNLSNLLLLDLEGNKLTGSIPV-TFGRLQKLQ 431
L+ +L + ++ N S+P + L+NL L L N+L S+P F +L L
Sbjct: 80 ALKELT-NLTYLILTG-NQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLT 136
Query: 432 GLYLPFNKLAGSIPDQLC-HLARLNTLGLAGNKFSGSIPS-CLGNLTSLRSPDLGSNRLT 489
L L N+L S+P + L L L L+ N+ S+P LT L+ L N+L
Sbjct: 137 YLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK 194
Query: 490 SVLPSTFWNLKDILFFDLSSN 510
SV F L + + L N
Sbjct: 195 SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 46/221 (20%), Positives = 91/221 (41%), Gaps = 33/221 (14%)
Query: 229 KKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIF 288
P + T K +L+ + + + L +++ ++ +++ V I
Sbjct: 8 PIKQ-IFPDDAFAET--IKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIKSV--QGIQ 60
Query: 289 NMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNA-SKLVYLDM 347
+ V+ + L N L + L N+ L L N+ ++P+ + + + L L +
Sbjct: 61 YLPNVRYLALGGNKLH---DISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVL 116
Query: 348 GTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLI-SNLSNL 406
N LP + + +L + +++ N S+P+ + L+NL
Sbjct: 117 VENQLQ----------------SLPDGVFDKLTNLTYLNLAH-NQLQSLPKGVFDKLTNL 159
Query: 407 LLLDLEGNKLTGSIPV-TFGRLQKLQGLYLPFNKLAGSIPD 446
LDL N+L S+P F +L +L+ L L N+L S+PD
Sbjct: 160 TELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK-SVPD 198
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 40/162 (24%), Positives = 67/162 (41%), Gaps = 32/162 (19%)
Query: 120 NLSSLTTLNLSHNKLSGDIPPSIF-TMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLD 178
L++LT L L+ N+L +P +F + LK L +NQL
Sbjct: 83 ELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQ------------------- 122
Query: 179 SDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKE 238
LP + + L L L LA N K L L+L + +L ++P+
Sbjct: 123 ------SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEG 175
Query: 239 I-SNLTILRKISLRNNKLRGEIPHEI-GYLPNLENLVLGFNN 278
+ LT L+ + L N+L+ +P + L +L+ + L +N
Sbjct: 176 VFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWL-HDN 215
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 4e-08
Identities = 16/76 (21%), Positives = 25/76 (32%), Gaps = 1/76 (1%)
Query: 438 NKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPS-CLGNLTSLRSPDLGSNRLTSVLPSTF 496
A L L L + + + L L LR+ + + L V P F
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 497 WNLKDILFFDLSSNSL 512
+ +LS N+L
Sbjct: 77 HFTPRLSRLNLSFNAL 92
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 53.2 bits (127), Expect = 2e-07
Identities = 21/96 (21%), Positives = 33/96 (34%), Gaps = 2/96 (2%)
Query: 395 SIPQLISNLSNLLLLDLEGNKLTGSIP-VTFGRLQKLQGLYLPFNKLAGSIPDQLCHLAR 453
+ NL L +E + + L +L+ L + + L PD R
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 454 LNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLT 489
L+ L L+ N S+ SL+ L N L
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.8 bits (126), Expect = 2e-07
Identities = 19/101 (18%), Positives = 29/101 (28%), Gaps = 2/101 (1%)
Query: 414 NKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQ-LCHLARLNTLGLAGNKFSGSIPSCL 472
+ L LY+ + + + L L L L + + P
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 473 GNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLD 513
L +L N L S+ T L + LS N L
Sbjct: 77 HFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 21/95 (22%), Positives = 34/95 (35%), Gaps = 5/95 (5%)
Query: 372 PTSIGNLSMSLENIYISNCNIGGSIP-QLISNLSNLLLLDLEGNKLTGSIPV-TFGRLQK 429
+ +L +YI N + + + L L L + + L + F +
Sbjct: 24 LHHLPGAE-NLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81
Query: 430 LQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKF 464
L L L FN L S+ + L L L+GN
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.7 bits (110), Expect = 2e-05
Identities = 17/98 (17%), Positives = 33/98 (33%), Gaps = 5/98 (5%)
Query: 113 TIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFT-MHKLKFLDFSDNQLSGSLSSVTF-NLS 170
L +LT L + + + + + +L+ L + L ++ F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 171 SVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFH 208
+ + L + L L L L+ L L+ N H
Sbjct: 81 RLSRLNLSFNALE-SLSWKTVQGLS-LQELVLSGNPLH 116
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 34/132 (25%), Positives = 55/132 (41%), Gaps = 20/132 (15%)
Query: 683 IGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSC- 740
IG GSFG +Y G + G EVAIK+ E ++ K ++ + I C
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 741 SNEDFKAL----------DCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDL 790
+ D+ + D + + ++ L + + S +EY+H S IH D+
Sbjct: 75 AEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDV 131
Query: 791 KPKNVFDFGIGR 802
KP N F +G
Sbjct: 132 KPDN---FLMGL 140
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 5e-08
Identities = 35/193 (18%), Positives = 58/193 (30%), Gaps = 58/193 (30%)
Query: 674 TEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFH------QNCAMALKSFEAECEVMK 726
+ + +G G F V K R G+E A K ++ + E E +++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 727 NIRHRNHVKRISSCSNEDFKALDCLHSTNCSLNI---------FDKL------------N 765
+ H N + N L I FD L +
Sbjct: 71 QVLHHNVITLHDVYENRTDVVL-----------ILELVSGGELFDFLAQKESLSEEEATS 119
Query: 766 IMIDVASALEYLHFSHSTPVIHCDLKPKN--------------VFDFGIGRLLTGDRSMI 811
+ + + YLH + H DLKP+N + DFG+ +
Sbjct: 120 FIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF- 175
Query: 812 QTETLVTIGYMAP 824
T ++AP
Sbjct: 176 -KNIFGTPEFVAP 187
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 36/186 (19%), Positives = 62/186 (33%), Gaps = 61/186 (32%)
Query: 680 ENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNI-RHRNHVKRI 737
++G+G G V + + A+K+ E E+ + + V+ +
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIV 121
Query: 738 SSCSNEDFKALD-CLHSTNCSLNI----------FDKL--------------NIMIDVAS 772
E+ A CL I F ++ IM +
Sbjct: 122 DVY--ENLYAGRKCLL-------IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 773 ALEYLHFSHSTPVIHCDLKPKN-------------VFDFGIGRLLTGDRSMIQTETLV-T 818
A++YLH + + H D+KP+N + DFG + T S+ T T
Sbjct: 173 AIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL---TTPCYT 226
Query: 819 IGYMAP 824
Y+AP
Sbjct: 227 PYYVAP 232
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 5e-08
Identities = 45/183 (24%), Positives = 73/183 (39%), Gaps = 31/183 (16%)
Query: 670 LFRATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIK----VFHQNCAMALKSFEAECEV 724
+ + + +G G++GSV G +VAIK F Q+ A +++ E +
Sbjct: 19 AWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYR-ELLL 76
Query: 725 MKNIRHRNHVK----RISSCSNEDFKALDC-LHSTNCSLNIFDKLNIMIDVASALEY--- 776
+K+++H N + + S +F + L L + L Y
Sbjct: 77 LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQML 136
Query: 777 --LHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
L + HS V+H DLKP N+ DFG+ R D M T +VT Y AP
Sbjct: 137 KGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR--HADAEM--TGYVVTRWYRAP 192
Query: 825 GLL 827
++
Sbjct: 193 EVI 195
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 36/188 (19%), Positives = 69/188 (36%), Gaps = 59/188 (31%)
Query: 676 KFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVM-KNIRHRNH 733
+ SK+ L G+G G V + G + A+K+ + + E + + +
Sbjct: 31 QLSKQVL-GLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHI 84
Query: 734 VKRISSCSNEDFKALDCLHSTNCSLNIFDKL-----------------------NIMIDV 770
V + + ++ + H C L I + + IM D+
Sbjct: 85 VCIL-----DVYE--NMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDI 137
Query: 771 ASALEYLHFSHSTPVIHCDLKPKN-------------VFDFGIGRLLTGDRSMIQTETLV 817
+A+++LH + + H D+KP+N + DFG + T + +T
Sbjct: 138 GTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN----ALQTPC 190
Query: 818 -TIGYMAP 824
T Y+AP
Sbjct: 191 YTPYYVAP 198
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 6e-08
Identities = 51/187 (27%), Positives = 73/187 (39%), Gaps = 48/187 (25%)
Query: 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECE---------- 723
E F K IG G++G VYK R G VA+K + E E
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR---------LDTETEGVPSTAIREI 53
Query: 724 -VMKNIRHRNHVKRISSCSNED-----FKALDC-LHS--TNCSLNIFDKLNI---MIDVA 771
++K + H N VK + E+ F+ L L +L I + +
Sbjct: 54 SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 772 SALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG-DRSMIQTETLVTIG 820
L + H SH V+H DLKP+N+ DFG+ R R+ T +VT+
Sbjct: 114 QGLAFCH-SHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLW 168
Query: 821 YMAPGLL 827
Y AP +L
Sbjct: 169 YRAPEIL 175
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 7e-08
Identities = 40/211 (18%), Positives = 69/211 (32%), Gaps = 63/211 (29%)
Query: 657 GKSKTLRRFSYQDLFRATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVF-------- 707
G L ++ F IG G V + G E A+K+
Sbjct: 78 GPEDELPDWAAAKEFYQKYDPKDV--IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLS 135
Query: 708 HQNCAMALKSFEAECEVMKNIR-HRNHVKRISSCSNEDFKALDCLHSTNCSLNI------ 760
+ ++ E +++ + H + + I S + F + +
Sbjct: 136 PEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF------------MFLVFDLMR 183
Query: 761 ----FDKL------------NIMIDVASALEYLHFSHSTPVIHCDLKPKN---------- 794
FD L +IM + A+ +LH ++ ++H DLKP+N
Sbjct: 184 KGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR 240
Query: 795 VFDFGIGRLLTGDRSMIQTETLV-TIGYMAP 824
+ DFG L + L T GY+AP
Sbjct: 241 LSDFGFSCHLEPGEKL---RELCGTPGYLAP 268
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 7e-08
Identities = 44/183 (24%), Positives = 69/183 (37%), Gaps = 42/183 (22%)
Query: 677 FSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFE---AECEVMKNIRHRN 732
F ++G GSF +V R E AIK+ + + E +VM + H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 733 HVKRISSCSNED--FKALDCL-------HSTNCSLNIFDKLNIMIDVA--------SALE 775
VK + +++ + L + FD SALE
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFD-----ETCTRFYTAEIVSALE 144
Query: 776 YLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-TIGYMAP 824
YLH +IH DLKP+N+ DFG ++L+ + + + V T Y++P
Sbjct: 145 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201
Query: 825 GLL 827
LL
Sbjct: 202 ELL 204
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 1e-07
Identities = 43/194 (22%), Positives = 74/194 (38%), Gaps = 48/194 (24%)
Query: 669 DLFRATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECE---- 723
D+ +++ K + +G G F +VYK R + VAIK L +
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIK------LGHRSEAKDGINR 57
Query: 724 -------VMKNIRHRNHVKRISSCSNE------------DFKALDCLHSTNCSLNIFDKL 764
+++ + H N + + + ++ D + + + + L
Sbjct: 58 TALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVI--IKDNSLVLTPSHIK 115
Query: 765 NIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG-DRSMIQT 813
M+ LEYLH H ++H DLKP N+ DFG+ + +R+ T
Sbjct: 116 AYMLMTLQGLEYLH-QHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--T 170
Query: 814 ETLVTIGYMAPGLL 827
+VT Y AP LL
Sbjct: 171 HQVVTRWYRAPELL 184
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 43/195 (22%), Positives = 71/195 (36%), Gaps = 43/195 (22%)
Query: 671 FRATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIK--VFHQNCAMALKSFEAECEVMKN 727
F ++ +G G G V+ VAIK V + + E ++++
Sbjct: 7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVL-TDPQSVKHALR-EIKIIRR 64
Query: 728 IRHRNHVK------------RISSCSNEDFKAL-------DC-LHSTNCSLNIFD--KLN 765
+ H N VK S + ++ + L + + +
Sbjct: 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL 124
Query: 766 IMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRLLTGDRSMIQ-- 812
M + L+Y+H S V+H DLKP N+F DFG+ R++ S
Sbjct: 125 FMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL 181
Query: 813 TETLVTIGYMAPGLL 827
+E LVT Y +P LL
Sbjct: 182 SEGLVTKWYRSPRLL 196
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 38/117 (32%), Positives = 54/117 (46%), Gaps = 6/117 (5%)
Query: 397 PQLISNLSNLLLLDLEGNKLTGSIPV-TFGRLQKLQGLYLPFNKLAGSIPDQLC-HLARL 454
+ L++L L L GNKL S+P F +L L L L N+L S+P+ + L +L
Sbjct: 45 NGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQL 102
Query: 455 NTLGLAGNKFSGSIPS-CLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSN 510
L L N+ S+P LT L+ L N+L SV F L + + L N
Sbjct: 103 KELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 7e-07
Identities = 34/108 (31%), Positives = 42/108 (38%), Gaps = 8/108 (7%)
Query: 409 LDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSI 468
LDLE N L F L L LYL NKL L L L L+ N+ S+
Sbjct: 33 LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-SL 91
Query: 469 PS----CLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSL 512
P+ L L L L +N+L S+ F L + L N L
Sbjct: 92 PNGVFDKLTQLKEL---ALNTNQLQSLPDGVFDKLTQLKDLRLYQNQL 136
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 47/182 (25%), Positives = 74/182 (40%), Gaps = 32/182 (17%)
Query: 122 SSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDK 181
S TT+ + +P I + +LD N L + V L+S+ + L +K
Sbjct: 7 CSGTTVECYSQGRTS-VPTGIPA--QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNK 63
Query: 182 LSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLG-FKKLSGAIPKEIS 240
L LP + N L L L L+ N +LQ L G F KL+
Sbjct: 64 LQ-SLPNGVFNKLTSLTYLNLSTN--------------QLQSLPNGVFDKLT-------- 100
Query: 241 NLTILRKISLRNNKLRGEIPHEI-GYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLL 299
L L +L N+L+ +P + L L++L L N L V +++++ I+L
Sbjct: 101 QLKEL---ALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLH 156
Query: 300 DN 301
DN
Sbjct: 157 DN 158
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 28/141 (19%), Positives = 51/141 (36%), Gaps = 20/141 (14%)
Query: 683 IGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSC- 740
IG GSFG +++G L + +VAIK + E K + + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 741 SNEDFKAL----------DCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDL 790
L D L ++ + + ++ +H +++ D+
Sbjct: 76 QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDI 132
Query: 791 KPKNVFDFGIGRLLTGDRSMI 811
KP N F IGR + + +MI
Sbjct: 133 KPDN---FLIGRPNSKNANMI 150
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 41/182 (22%), Positives = 62/182 (34%), Gaps = 41/182 (22%)
Query: 676 KFSKENLIGVGSFGSVYKGR-LHDGIEVAIKV--------FHQNCAMALKSFEAECEVMK 726
K+S + +G G+FG V+ EV +K L E ++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 727 NIRHRNHVKRISSCSNEDFKALDC-LHSTNCSLNIFDKL------------NIMIDVASA 773
+ H N +K + N+ F L H + L F + I + SA
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDL--FAFIDRHPRLDEPLASYIFRQLVSA 142
Query: 774 LEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-TIGYM 822
+ YL +IH D+K +N+ DFG L + T TI Y
Sbjct: 143 VGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF---YTFCGTIEYC 196
Query: 823 AP 824
AP
Sbjct: 197 AP 198
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 31/157 (19%), Positives = 62/157 (39%), Gaps = 33/157 (21%)
Query: 682 LIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEA----ECEVMKNIRHRNHVKR 736
L+G GS+G V + A+K+ + + + EA E ++++ +RH+N ++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 737 ISSCSNEDFKALDCL---HSTNCSLNIFDKLN---IMIDVA--------SALEYLHFSHS 782
+ NE+ + + + + + D + + A LEYLH S
Sbjct: 72 VDVLYNEEKQKM-YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH-SQG 129
Query: 783 TPVIHCDLKPKN----------VFDFGIGRLLTGDRS 809
++H D+KP N + G+ L +
Sbjct: 130 --IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA 164
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 2e-07
Identities = 39/192 (20%), Positives = 69/192 (35%), Gaps = 49/192 (25%)
Query: 672 RATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECE------- 723
+ +++ + +G G++G VYK VAIK E E E
Sbjct: 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR---------LEHEEEGVPGTAI 81
Query: 724 ----VMKNIRHRNHVKRISSCSNED-----FKALDC-LHSTNCSLNIFDKLNI---MIDV 770
++K ++HRN ++ S + F+ + L I + +
Sbjct: 82 REVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQL 141
Query: 771 ASALEYLHFSHSTPVIHCDLKPKNVF---------------DFGIGRLLTGDRSMIQTET 815
+ + + H S +H DLKP+N+ DFG+ R G T
Sbjct: 142 INGVNFCH-SRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGIPIRQFTHE 197
Query: 816 LVTIGYMAPGLL 827
++T+ Y P +L
Sbjct: 198 IITLWYRPPEIL 209
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 36/161 (22%), Positives = 63/161 (39%), Gaps = 34/161 (21%)
Query: 671 FRATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIK----VFHQNCAMALKSFEAECEVM 725
++ +++ +LIG GS+G V + + VAIK VF ++ + E ++
Sbjct: 49 WQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILR-EIAIL 106
Query: 726 KNIRHRNHVKR---ISSCSNEDFKAL-------DC-LHS---TNCSLNIFDKLNIMIDVA 771
+ H + VK + E F L D T L ++ ++
Sbjct: 107 NRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLL 166
Query: 772 SALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGR 802
++Y+H S ++H DLKP N DFG+ R
Sbjct: 167 VGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLAR 204
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 41/187 (21%), Positives = 78/187 (41%), Gaps = 34/187 (18%)
Query: 670 LFRATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIK---VFHQNCAMALKSFEAECEVM 725
+F +++ + IG G++G V + + VAIK F ++ ++ E +++
Sbjct: 22 VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLR-EIKIL 79
Query: 726 KNIRHRNHVK---RISSCSNEDFKAL-------DC-LHSTNCSLNIFD--KLNIMIDVAS 772
RH N + I + + E K + + L+ + ++ + + +
Sbjct: 80 LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR 139
Query: 773 ALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ--TETLVTIG 820
L+Y+H S V+H DLKP N+ DFG+ R+ D TE + T
Sbjct: 140 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 821 YMAPGLL 827
Y AP ++
Sbjct: 197 YRAPEIM 203
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 30/132 (22%), Positives = 55/132 (41%), Gaps = 18/132 (13%)
Query: 683 IGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSC- 740
IG GSFG +Y G + EVAIK+ + E ++ + ++ + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 741 SNEDFKAL----------DCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDL 790
D+ L D + + L++ L + + + +E++H +H D+
Sbjct: 73 VEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDI 129
Query: 791 KPKNVFDFGIGR 802
KP N F G+GR
Sbjct: 130 KPDN-FLMGLGR 140
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 37/214 (17%), Positives = 66/214 (30%), Gaps = 66/214 (30%)
Query: 674 TEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRN 732
++K+S +G GSFG V + + G A+K Q+ + E ++MK + H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVN 61
Query: 733 HVK--------------RISSCSNEDFKALDCLHSTNCSLNIFDKLNIMIDVASALEY-- 776
+K + + N ++ + + +EY
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 777 --------------------------------LHFSHSTPVIHCDLKPKNVF-------- 796
+ F HS + H D+KP+N+
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTL 181
Query: 797 ---DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827
DFG + L + + Y AP L+
Sbjct: 182 KLCDFGSAKKLIPSEPS--VAYICSRFYRAPELM 213
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 4e-07
Identities = 42/187 (22%), Positives = 79/187 (42%), Gaps = 38/187 (20%)
Query: 670 LFRATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIK----VFHQNCAMALKSFEAECEV 724
++ E++ + +G G++GSV G+ VA+K F Q+ A +++ E +
Sbjct: 24 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYR-ELRL 81
Query: 725 MKNIRHRNHVK----RISSCSNEDFKAL-------DC-LHSTNCS--LNIFDKLNIMIDV 770
+K+++H N + + S E+F + L++ L ++ +
Sbjct: 82 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 141
Query: 771 ASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIG 820
L+Y+H S +IH DLKP N+ DFG+ R + T + T
Sbjct: 142 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYVATRW 194
Query: 821 YMAPGLL 827
Y AP ++
Sbjct: 195 YRAPEIM 201
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 46/194 (23%), Positives = 76/194 (39%), Gaps = 43/194 (22%)
Query: 671 FRATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIK---VFHQNCAMALKSFEAECEVMK 726
+ + F ++L+G G++G V G VAIK F AL++ E +++K
Sbjct: 7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLR-EIKILK 64
Query: 727 NIRHRNHVKR---ISSCSNEDFKAL-------DC-LH---STNCSLNIFDKLNIMIDVAS 772
+ +H N + S E+F + LH ST L+ +
Sbjct: 65 HFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQ-MLSDDHIQYFIYQTLR 123
Query: 773 ALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ---------T 813
A++ LH + VIH DLKP N+ DFG+ R++ +
Sbjct: 124 AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 814 ETLVTIGYMAPGLL 827
E + T Y AP ++
Sbjct: 181 EFVATRWYRAPEVM 194
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 39/209 (18%), Positives = 61/209 (29%), Gaps = 88/209 (42%)
Query: 682 LIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEA-------------------- 720
IG GS+G V +D A+KV + + F
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 721 ------ECEVMKNIRHRNHVKRISSCSNEDFKALDCLH-----STNCSL----------N 759
E ++K + H N VK L L
Sbjct: 80 IEQVYQEIAILKKLDHPNVVK---------------LVEVLDDPNEDHLYMVFELVNQGP 124
Query: 760 IFDKLN-----------IMIDVASALEYLHFSHSTPVIHCDLKPKN----------VFDF 798
+ + D+ +EYLH+ +IH D+KP N + DF
Sbjct: 125 VMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADF 181
Query: 799 GIGRLLTGDRSMIQTETLVTIG---YMAP 824
G+ G +++ T+G +MAP
Sbjct: 182 GVSNEFKGSDALLSN----TVGTPAFMAP 206
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 5e-07
Identities = 43/186 (23%), Positives = 72/186 (38%), Gaps = 39/186 (20%)
Query: 673 ATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEA-------ECEV 724
++ +F + +G G++ +VYKG G+ VA+K L S E E +
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK------LDSEEGTPSTAIREISL 56
Query: 725 MKNIRHRNHVKRISSCSNE------------DFKALDCLHSTNCSLNIFDKLNIMIDVAS 772
MK ++H N V+ E D K + + + +
Sbjct: 57 MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 773 ALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG-DRSMIQTETLVTIGY 821
L+ L F H ++H DLKP+N+ DFG+ R + + +VT+ Y
Sbjct: 117 LLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--SSEVVTLWY 174
Query: 822 MAPGLL 827
AP +L
Sbjct: 175 RAPDVL 180
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 5e-07
Identities = 31/188 (16%), Positives = 70/188 (37%), Gaps = 38/188 (20%)
Query: 666 SYQDLFRATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEA---- 720
S+ + + + +G G + V++ + + +V +K+ LK +
Sbjct: 27 SHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI--------LKPVKKKKIK 78
Query: 721 -ECEVMKNIR-HRNHVKRI----SSCSNEDFKALDCLHSTNCSLNIFDKLNIMIDVAS-- 772
E ++++N+R N + S + +++T+ ++ L D+
Sbjct: 79 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFK-QLYQTLTDY-DIRFYM 136
Query: 773 --ALEYLHFSHSTPVIHCDLKPKNV-----------FDFGIGRLLTGDRSMIQTETLVTI 819
L+ L + HS ++H D+KP NV D+G+ + + +
Sbjct: 137 YEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASR 194
Query: 820 GYMAPGLL 827
+ P LL
Sbjct: 195 YFKGPELL 202
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 6e-07
Identities = 43/201 (21%), Positives = 71/201 (35%), Gaps = 59/201 (29%)
Query: 672 RATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECE------- 723
K+ K IG G+FG V+K R G +VA+K E E E
Sbjct: 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL---------MENEKEGFPITAL 64
Query: 724 ----VMKNIRHRN--------HVKRISSCSNE------------DFKALDCLHSTNCSLN 759
+++ ++H N K + D L L +
Sbjct: 65 REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGL--LSNVLVKFT 122
Query: 760 IFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809
+ + +M + + L Y+H + ++H D+K NV DFG+ R + ++
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179
Query: 810 MIQ---TETLVTIGYMAPGLL 827
T +VT+ Y P LL
Sbjct: 180 SQPNRYTNRVVTLWYRPPELL 200
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 36/167 (21%), Positives = 59/167 (35%), Gaps = 44/167 (26%)
Query: 676 KFSKENLIGVGSFGSVYKGR-LHDGIEVAIK------VFHQNCAMALKSFEAECEVMKNI 728
++ L+G G FGSVY G + D + VAIK + E ++K +
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 729 RHRN-HVKRISSCSNEDFKALDCL-----HSTNCSLNIFDKL------------NIMIDV 770
V R+ + F+ D ++FD + + V
Sbjct: 104 SSGFSGVIRLL----DWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQV 158
Query: 771 ASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRLLTG 806
A+ + H + V+H D+K +N+ DFG G LL
Sbjct: 159 LEAVRHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKD 202
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 6e-07
Identities = 42/201 (20%), Positives = 70/201 (34%), Gaps = 58/201 (28%)
Query: 671 FRATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECE------ 723
AT ++ IGVG++G+VYK R H G VA+K
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR---------VPNGGGGGGGLP 55
Query: 724 -----------VMKNIRHRNHVKRISSCSNEDFKALDCLH-------------STNCSLN 759
++ H N V+ + C+ +
Sbjct: 56 ISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPP 115
Query: 760 IFDKLNI---MIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806
I M L++LH ++ ++H DLKP+N+ DFG+ R+ +
Sbjct: 116 GLPAETIKDLMRQFLRGLDFLH-ANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSY 172
Query: 807 DRSMIQTETLVTIGYMAPGLL 827
++ T +VT+ Y AP +L
Sbjct: 173 QMAL--TPVVVTLWYRAPEVL 191
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 7e-07
Identities = 43/186 (23%), Positives = 73/186 (39%), Gaps = 38/186 (20%)
Query: 671 FRATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIK----VFHQNCAMALKSFEAECEVM 725
+ + +G G++G+V G +VAIK F Q+ A +++ E ++
Sbjct: 21 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYR-ELRLL 78
Query: 726 KNIRHRNHVK----RISSCSNEDFKAL-------DC-LHS--TNCSLNIFDKLNIMIDVA 771
K++RH N + + +DF L + L ++ +
Sbjct: 79 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML 138
Query: 772 SALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGY 821
L Y+H + +IH DLKP N+ DFG+ R D M T +VT Y
Sbjct: 139 KGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QADSEM--TGYVVTRWY 191
Query: 822 MAPGLL 827
AP ++
Sbjct: 192 RAPEVI 197
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 7e-07
Identities = 36/198 (18%), Positives = 65/198 (32%), Gaps = 57/198 (28%)
Query: 670 LFRATEKFSK-----ENLIGVGSFGSVYKGR-LHDGIEVAIKVFH--QNCAMALKSFEAE 721
F++ E F+ +G G F V + G E A K + E
Sbjct: 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHE 78
Query: 722 CEVMKNIRHRNHVKRISSCSNEDFKALDCLHSTNCSL--------NIFDKL--------- 764
V++ + V + +E ++ + L IF
Sbjct: 79 IAVLELAKSCPRVINL----HEVYENTSEII-----LILEYAAGGEIFSLCLPELAEMVS 129
Query: 765 -----NIMIDVASALEYLHFSHSTPVIHCDLKPKN-------------VFDFGIGRLLTG 806
++ + + YLH ++ ++H DLKP+N + DFG+ R +
Sbjct: 130 ENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186
Query: 807 DRSMIQTETLVTIGYMAP 824
+ E + T Y+AP
Sbjct: 187 ACEL--REIMGTPEYLAP 202
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 8e-07
Identities = 43/181 (23%), Positives = 71/181 (39%), Gaps = 38/181 (20%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHD-GIEVAIKVFHQNCAMALKSFEA-------ECEVMK 726
E + K + +G G++ +VYKG+ VA+K L+ E E ++K
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR------LEHEEGAPCTAIREVSLLK 55
Query: 727 NIRHRNHVKRISSCSNED-----FKALDC-----LHSTNCSLNIFDKLNIMIDVASALEY 776
+++H N V E F+ LD L +N+ + + + L Y
Sbjct: 56 DLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115
Query: 777 LHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGL 826
H V+H DLKP+N+ DFG+ R + +VT+ Y P +
Sbjct: 116 CH-RQK--VLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVVTLWYRPPDI 171
Query: 827 L 827
L
Sbjct: 172 L 172
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 9e-07
Identities = 28/141 (19%), Positives = 55/141 (39%), Gaps = 30/141 (21%)
Query: 682 LIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSC 740
+G G F +V+ + + + VA+K+ + ++ E E ++++ + ++ K S
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 741 SNEDFKALD------------CLHSTNCSLNIFD--KLN------------IMIDVASAL 774
+N K LD + N+ K I + L
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 144
Query: 775 EYLHFSHSTPVIHCDLKPKNV 795
+Y+H +IH D+KP+NV
Sbjct: 145 DYMHRRCG--IIHTDIKPENV 163
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 34/165 (20%), Positives = 62/165 (37%), Gaps = 38/165 (23%)
Query: 676 KFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEA------ECEVMKNI 728
++ L+G G FG+V+ G L D ++VAIKV +N + E ++ +
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 729 R----HRNHVKRISSCSNEDFKALDCLHSTNCSLNIFDKL------------NIMIDVAS 772
H ++ + ++ L ++FD + V +
Sbjct: 92 GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQ-DLFDYITEKGPLGEGPSRCFFGQVVA 150
Query: 773 ALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRLLTG 806
A+++ H V+H D+K +N+ DFG G LL
Sbjct: 151 AIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHD 192
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 46/203 (22%), Positives = 73/203 (35%), Gaps = 66/203 (32%)
Query: 672 RATEKFSKENLIGVGSFGSVYKGR--LHDGIEVAIKVFHQNCAMALKSFEAECE------ 723
RA +++ IG G++G V+K R + G VA+K + E
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR---------VQTGEEGMPLST 58
Query: 724 --------VMKNIRHRN--------HVKRISSCSN---------EDFKA-LDCLHSTNCS 757
++ H N V R + +D LD
Sbjct: 59 IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLD-----KVP 113
Query: 758 LNIFDKLNI---MIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLL 804
I M + L++LH SH V+H DLKP+N+ DFG+ R+
Sbjct: 114 EPGVPTETIKDMMFQLLRGLDFLH-SHR--VVHRDLKPQNILVTSSGQIKLADFGLARIY 170
Query: 805 TGDRSMIQTETLVTIGYMAPGLL 827
+ ++ T +VT+ Y AP +L
Sbjct: 171 SFQMAL--TSVVVTLWYRAPEVL 191
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 38/186 (20%), Positives = 64/186 (34%), Gaps = 67/186 (36%)
Query: 682 LIGVGSFGSVYKGRLHDGIEV-AIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSC 740
IG GSFG V + +D ++ A+K ++ +C +R+ +I
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNK----------QKCVERNEVRNVFKELQIMQG 71
Query: 741 SNEDFKALDCLHSTNCSLNIF---DKLNIMID---------------------------- 769
F L L + F + + +++D
Sbjct: 72 LEHPF--LVNLWYS------FQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICE 123
Query: 770 VASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-T 818
+ AL+YL + +IH D+KP N+ DF I +L + T+ T
Sbjct: 124 LVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGT 177
Query: 819 IGYMAP 824
YMAP
Sbjct: 178 KPYMAP 183
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 36/222 (16%), Positives = 58/222 (26%), Gaps = 74/222 (33%)
Query: 674 TEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVF-----HQNCAMALKSFEAECEVMKN 727
+K+ + IG GS+G V AIK+ Q ++ + E +MK
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 728 ----------------------------------IRHRNHVKRISSCSNEDFKALDCLHS 753
+ + +
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 754 TNCSLNIFDKL----------------NIMIDVASALEYLHFSHSTPVIHCDLKPKN--- 794
N NIM + SAL YLH + H D+KP+N
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLF 201
Query: 795 ---------VFDFGIGRLLTGDRSMIQTE--TLV-TIGYMAP 824
+ DFG+ + + T T ++AP
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 2e-06
Identities = 37/165 (22%), Positives = 62/165 (37%), Gaps = 57/165 (34%)
Query: 682 LIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEA---ECEVMKNIRHRNHVKRI 737
+GVG+FG V G G +VA+K+ ++ +L E + +K RH + +K
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK-- 75
Query: 738 SSCSNEDFKALDCLH---STNCSLNI----------FDKL----NIMIDVA--------S 772
L+ ST + FD + + A S
Sbjct: 76 -------------LYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS 122
Query: 773 ALEYLHFSHSTPVIHCDLKPKN----------VFDFGIGRLLTGD 807
A++Y H V+H DLKP+N + DFG+ +++
Sbjct: 123 AVDYC---HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 37/190 (19%), Positives = 64/190 (33%), Gaps = 34/190 (17%)
Query: 665 FSYQDLFRATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIK----VFHQNCAMALKSFE 719
F + + ++LIG GS+G VY + VAIK +F ++ +
Sbjct: 16 FQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILR 74
Query: 720 AECEVMKNIRHRNHVKR---ISSCSNEDFKAL-------DC-LHS---TNCSLNIFDKLN 765
E ++ ++ ++ I F L D L T L
Sbjct: 75 -EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKT 133
Query: 766 IMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTET 815
I+ ++ ++H + +IH DLKP N DFG+ R + ++
Sbjct: 134 ILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190
Query: 816 LVTIGYMAPG 825
L P
Sbjct: 191 LEENEEPGPH 200
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 30/147 (20%), Positives = 51/147 (34%), Gaps = 52/147 (35%)
Query: 682 LIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIR----------- 729
+IG GSFG V K VA+K+ + E +++++R
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF-HRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 730 -------HRNHVKRISSCSNEDFKALDCLHSTNCSLNIFDKL--------------NIMI 768
RNH+ C+ S+N+++ +
Sbjct: 163 HMLENFTFRNHI---------------CMTFELLSMNLYELIKKNKFQGFSLPLVRKFAH 207
Query: 769 DVASALEYLHFSHSTPVIHCDLKPKNV 795
+ L+ LH +IHCDLKP+N+
Sbjct: 208 SILQCLDALH---KNRIIHCDLKPENI 231
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 33/164 (20%), Positives = 55/164 (33%), Gaps = 56/164 (34%)
Query: 682 LIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEA---ECEVMKNIRHRNHVKRI 737
+G GSFG V +VA+K + E +K +RH + +K
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIK-- 73
Query: 738 SSCSNEDFKALDCLH---STNCSL---------NIFDKLN----IMIDVA--------SA 773
L+ +T + +FD + + D A
Sbjct: 74 -------------LYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICA 120
Query: 774 LEYLHFSHSTPVIHCDLKPKN----------VFDFGIGRLLTGD 807
+EY H ++H DLKP+N + DFG+ ++T
Sbjct: 121 IEYC---HRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 3e-06
Identities = 33/112 (29%), Positives = 49/112 (43%), Gaps = 4/112 (3%)
Query: 381 SLENIYISNCNIG-GSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNK 439
++ + + NC G I L + NL L L L S+ +L KL+ L L N+
Sbjct: 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENR 82
Query: 440 LAGSIPDQLCHLARLNTLGLAGNKFSG-SIPSCLGNLTSLRSPDLGSNRLTS 490
+ G + L L L L+GNK S L L L+S DL + +T+
Sbjct: 83 IFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTN 134
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 22/91 (24%), Positives = 35/91 (38%), Gaps = 3/91 (3%)
Query: 402 NLSNLLLLDLEGNKLT-GSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLA 460
+ + L L+ K G I L+ L L L S+ L L +L L L+
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELS 79
Query: 461 GNKFSGSIPSCLGNLTSLRSPDLGSNRLTSV 491
N+ G + L +L +L N+L +
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDI 110
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 35/165 (21%), Positives = 63/165 (38%), Gaps = 57/165 (34%)
Query: 682 LIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEA---ECEVMKNIRHRNHVKRI 737
+GVG+FG V G+ G +VA+K+ ++ +L E + +K RH + +K
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK-- 80
Query: 738 SSCSNEDFKALDCLH---STNCSLNI----------FDKL----NIMIDVA--------S 772
L+ ST + + FD + + + S
Sbjct: 81 -------------LYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS 127
Query: 773 ALEYLHFSHSTPVIHCDLKPKN----------VFDFGIGRLLTGD 807
++Y H V+H DLKP+N + DFG+ +++
Sbjct: 128 GVDYC---HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 4e-06
Identities = 30/111 (27%), Positives = 46/111 (41%), Gaps = 4/111 (3%)
Query: 381 SLENIYISNCNIG-GSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNK 439
++ + + N G + L L L LT SI +L KL+ L L N+
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNR 75
Query: 440 LAGSIPDQLCHLARLNTLGLAGNKFSG-SIPSCLGNLTSLRSPDLGSNRLT 489
++G + L L L+GNK S L L +L+S DL + +T
Sbjct: 76 VSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 8e-05
Identities = 20/91 (21%), Positives = 38/91 (41%), Gaps = 3/91 (3%)
Query: 402 NLSNLLLLDLEGNKLT-GSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLA 460
S++ L L+ ++ G + ++L+ L L SI L L +L L L+
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 461 GNKFSGSIPSCLGNLTSLRSPDLGSNRLTSV 491
N+ SG + +L +L N++ +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDL 103
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 6e-06
Identities = 22/95 (23%), Positives = 32/95 (33%), Gaps = 4/95 (4%)
Query: 396 IPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLN 455
Q +N LDL G K+ I L + + N++ + D L RL
Sbjct: 12 AAQY-TNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLK 67
Query: 456 TLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTS 490
TL + N+ L L L +N L
Sbjct: 68 TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE 102
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 32/164 (19%), Positives = 49/164 (29%), Gaps = 38/164 (23%)
Query: 116 PQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDI 175
Q N L+L K+ I T+ + +DFSDN++
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR---------------- 55
Query: 176 RLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSG-A 234
KL G P L LK L + N L L L L
Sbjct: 56 -----KLDG-FP-----LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELG 104
Query: 235 IPKEISNLTILRKISLRNNKL------RGEIPHEIGYLPNLENL 272
+++L L + + N + R + I +P + L
Sbjct: 105 DLDPLASLKSLTYLCILRNPVTNKKHYRLYV---IYKVPQVRVL 145
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 7e-06
Identities = 39/163 (23%), Positives = 57/163 (34%), Gaps = 56/163 (34%)
Query: 683 IGVGSFGSVYKGR-LHDGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISS 739
IG G+F V R + G EVAIK+ + +L+ E +MK + H N VK
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVK---- 78
Query: 740 CSNEDFKALDCLH---STNCSLNI----------FDKL------------NIMIDVASAL 774
L T +L + FD L + + SA+
Sbjct: 79 -----------LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAV 127
Query: 775 EYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGD 807
+Y H ++H DLK +N+ DFG T
Sbjct: 128 QYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 43/218 (19%), Positives = 72/218 (33%), Gaps = 72/218 (33%)
Query: 659 SKTLRRFSYQDLFRATEKFSKEN-----LIGVGSFGSVYKGRLHDGIEV-AIKVFHQNCA 712
S RF + + +IG G FG VY R D ++ A+K
Sbjct: 168 SDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKC------ 221
Query: 713 MALKSFEAECEVMKNIRHRNHVKRI-SSCSNEDFKALDCLHSTNCSLNIF---DKLNIMI 768
L + ++ + + + + S S D + C+ F DKL+ ++
Sbjct: 222 --LD--KKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA------FHTPDKLSFIL 271
Query: 769 D----------------------------VASALEYLHFSHSTPVIHCDLKPKNVF---- 796
D + LE++H + V++ DLKP N+
Sbjct: 272 DLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEH 328
Query: 797 ------DFGIGRLLTGDRSMIQTETLV-TIGYMAPGLL 827
D G+ + + V T GYMAP +L
Sbjct: 329 GHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVL 362
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 26/136 (19%), Positives = 51/136 (37%), Gaps = 31/136 (22%)
Query: 682 LIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEA---ECEVMKNIR----HRNH 733
+G G+FG V + + + A+KV + E +++K I+ + N+
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKY----TRSAKIEADILKKIQNDDINNNN 97
Query: 734 VKRISSCSNEDFKALDCLHSTNCSLNIFD--KLN------------IMIDVASALEYLHF 779
+ + + CL ++++ N I++ AL YL
Sbjct: 98 IVKYHGKF--MYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR- 154
Query: 780 SHSTPVIHCDLKPKNV 795
+ H DLKP+N+
Sbjct: 155 --KMSLTHTDLKPENI 168
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 36/185 (19%), Positives = 69/185 (37%), Gaps = 39/185 (21%)
Query: 668 QDLFRATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMK 726
+ ++++ IG G+FG R VA+K + A+ ++ + E +
Sbjct: 13 MPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID-ENVQREIINHR 71
Query: 727 NIRHRNHVKRISSCSNEDFKALDCLHSTNCSLNIFDKL----NIMIDVA--------SAL 774
++RH N V+ A+ +++ L ++++ D A S +
Sbjct: 72 SLRHPNIVRFKEVILTPTHLAIIMEYASGGEL--YERICNAGRFSEDEARFFFQQLLSGV 129
Query: 775 EYLHFSHSTPVIHCDLKPKN------------VFDFGIGRLLTGDRSMIQTETLVTIG-- 820
Y H + H DLK +N + DFG + S ++ T+G
Sbjct: 130 SYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS----TVGTP 181
Query: 821 -YMAP 824
Y+AP
Sbjct: 182 AYIAP 186
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 2e-05
Identities = 32/181 (17%), Positives = 58/181 (32%), Gaps = 56/181 (30%)
Query: 682 LIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKS-FEAECEVMKNIRHRNHVKRISS 739
+G G++G V VA+K+ A+ + E + K + H N VK
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK---- 69
Query: 740 CSNEDFKALDCLH---STNCSLNI----------FDKL----NIMIDVA--------SAL 774
+ + FD++ + A + +
Sbjct: 70 -----------FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 775 EYLHFSHSTPVIHCDLKPKN----------VFDFGIGRLLTGDRSMIQTETLV-TIGYMA 823
YL H + H D+KP+N + DFG+ + + + T+ Y+A
Sbjct: 119 VYL---HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 824 P 824
P
Sbjct: 176 P 176
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 35/177 (19%), Positives = 67/177 (37%), Gaps = 38/177 (21%)
Query: 677 FSKENLIGVGSFGSVYKGRLHDGIEV-AIKVFHQNCAMALKS---FEAECEVMKNIRHRN 732
+ +IG G+FG V R +V A+K+ + + F E ++M
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 733 HVKRISSCSNED--FKALDCLHSTNCS----LNIFDKLNIMIDVA--------SALEYLH 778
V+ + ++ + ++ +N+ ++ A AL+ +H
Sbjct: 131 VVQLFYAFQDDRYLYMVMEY-----MPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIH 185
Query: 779 FSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-TIGYMAP 824
S IH D+KP N+ DFG + + M++ +T V T Y++P
Sbjct: 186 ---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE-GMVRCDTAVGTPDYISP 238
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 2e-05
Identities = 34/194 (17%), Positives = 52/194 (26%), Gaps = 62/194 (31%)
Query: 659 SKTLRRFSYQDLFRATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKV--------FHQN 710
K FS+ TEK + IG G FG V++ D VAIK+ + +
Sbjct: 7 QKGPVPFSH---CLPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGS 62
Query: 711 CAMALKSFEAECEVMKNIRHRNHVKRISS---------------CSNEDFKALDCLHSTN 755
+ E + K + + + KA D +ST
Sbjct: 63 HQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTK 122
Query: 756 CSLNIFDK---------------------------------LNIMIDVASALEYLHFSHS 782
S N +I+ + ++L S
Sbjct: 123 GSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR 182
Query: 783 TPVIHCDLKPKNVF 796
H DL NV
Sbjct: 183 --FEHRDLHWGNVL 194
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 32/180 (17%), Positives = 59/180 (32%), Gaps = 49/180 (27%)
Query: 656 GGKSKTLRRFSYQDLFRATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMA 714
G K+ + + + S+ +G+G G V + + A+K+
Sbjct: 1 GPHVKSGLQIKKNAIIDDYKVTSQV--LGLGINGKVLQIFNKRTQEKFALKMLQDC---- 54
Query: 715 LKSFEAECEVMKNI-RHRNHVKRISSCSNEDFKAL-DCLH--STNCS---LNIFDKL--- 764
E E+ + + V+ + E+ A CL L F ++
Sbjct: 55 -PKARREVELHWRASQCPHIVRIVDVY--ENLYAGRKCLLIVMECLDGGEL--FSRIQDR 109
Query: 765 -----------NIMIDVASALEYLHFSHSTPVIHCDLKPKN-------------VFDFGI 800
IM + A++YLH + + H D+KP+N + DFG
Sbjct: 110 GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 34/135 (25%), Positives = 56/135 (41%), Gaps = 24/135 (17%)
Query: 681 NLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIR-----HRNHV 734
+LIG GSFG V K + VAIK+ A L + E +++ + + ++
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF-LNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 735 KRISSCSNEDFKALDCLHSTNCSLNIFDKL--------------NIMIDVASALEYLHFS 780
+ F+ CL S N++D L + +AL +L
Sbjct: 119 VHLKRHF--MFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP 176
Query: 781 HSTPVIHCDLKPKNV 795
+ +IHCDLKP+N+
Sbjct: 177 ELS-IIHCDLKPENI 190
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 32/181 (17%), Positives = 60/181 (33%), Gaps = 56/181 (30%)
Query: 682 LIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAM-ALKSFEAECEVMKNIRHRNHVKRISS 739
+G G++G V VA+K+ A+ ++ + E + K + H N VK
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK---- 69
Query: 740 CSNEDFKALDCLH---STNCSLNI----------FDKL----NIMIDVA--------SAL 774
+ + FD++ + A + +
Sbjct: 70 -----------FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 775 EYLHFSHSTPVIHCDLKPKN----------VFDFGIGRLLTGDRSMIQTETLV-TIGYMA 823
YL H + H D+KP+N + DFG+ + + + T+ Y+A
Sbjct: 119 VYL---HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 824 P 824
P
Sbjct: 176 P 176
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 17/160 (10%), Positives = 40/160 (25%), Gaps = 36/160 (22%)
Query: 682 LIGVGSFGSVYKGRLHDGI---EVAIKVFHQNCAMA---LKSFEAECEVMKNIRHRNHVK 735
G ++ D +VA+ + L+ + + I +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 736 RISSCSNEDFKAL-----------DCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHSTP 784
+ + + + S + + M +A+A + +H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADT---SPSPVGAIRAMQSLAAAADA---AHRAG 149
Query: 785 VIHCDLKPKNVFDFGIGRLLTGDRSMIQTETLVTIGYMAP 824
V P V ++ D ++ L M
Sbjct: 150 VALSIDHPSRV-------RVSIDGDVV----LAYPATMPD 178
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 37/333 (11%), Positives = 96/333 (28%), Gaps = 39/333 (11%)
Query: 104 NISSLNLQGTIPPQLG---------NLSSLTTLNLS--HNKLSGDIPPSIFT-MHKLKFL 151
N+ L+L+ + + +SL +LN+S +++S + T LK L
Sbjct: 157 NLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSL 216
Query: 152 DFSDNQLSGSLSSVTFNLSSVLDIRL-----DSDKLSGELPVNICNYLHYLKVLFLAKNM 206
+ L+++ + ++ + + L+ L +
Sbjct: 217 KLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDA 276
Query: 207 FHGQIPLALSKCKRLQLLNLGFKKLSG-AIPKEISNLTILRKISLRNNKLRGEIPHEIGY 265
+P S C RL LNL + + + K + L+++ + + +
Sbjct: 277 VPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLAST 336
Query: 266 LPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGL 325
+L L + + + P + + + P +E +
Sbjct: 337 CKDLRELRVFPSEPFVMEPNVALTEQGLVSV---------------SMGCPKLESVLYFC 381
Query: 326 NRFSG-TIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLEN 384
+ + + + N + + T+ +I L
Sbjct: 382 RQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGF-----GAIVEHCKDLRR 436
Query: 385 IYISNCNIGGSIPQLISNLSNLLLLDLEGNKLT 417
+ +S + + + +L + +
Sbjct: 437 LSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDS 469
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 21/96 (21%), Positives = 42/96 (43%), Gaps = 5/96 (5%)
Query: 396 IPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLN 455
+ +S L L L N + I + ++ L+ L L N + I + L
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96
Query: 456 TLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSV 491
L ++ N+ + S+ S + L +LR + +N++T+
Sbjct: 97 ELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNW 130
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 31/138 (22%), Positives = 52/138 (37%), Gaps = 33/138 (23%)
Query: 682 LIGVGSFGSVYKGRLH--DGIEVAIKVFHQNCAMALKSFEA---ECEVMKNIRH-----R 731
+G G+FG V + H +VA+K+ EA E V+K I+ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKY----REAARLEINVLKKIKEKDKENK 81
Query: 732 NHVKRISSCSNEDFKALDCLHSTNCSLNIFDKL--------------NIMIDVASALEYL 777
+S +F C+ N F+ L ++ + AL +L
Sbjct: 82 FLCVLMSDWF--NFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFL 139
Query: 778 HFSHSTPVIHCDLKPKNV 795
H + + H DLKP+N+
Sbjct: 140 HENQ---LTHTDLKPENI 154
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 5e-05
Identities = 27/138 (19%), Positives = 52/138 (37%), Gaps = 33/138 (23%)
Query: 682 LIGVGSFGSVYKGRLH--DGIEVAIKVFHQNCAMALKSFEA---ECEVMKNIR-----HR 731
+G G+FG V + H G VA+K+ EA E +V++++
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRY----CEAARSEIQVLEHLNTTDPNST 76
Query: 732 NHVKRISSCSNEDFKALDCLHSTNCSLNIFD--KLN------------IMIDVASALEYL 777
++ + C+ L+ +D K N + + ++ +L
Sbjct: 77 FRCVQMLEWF--EHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFL 134
Query: 778 HFSHSTPVIHCDLKPKNV 795
H + + H DLKP+N+
Sbjct: 135 HSNK---LTHTDLKPENI 149
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 9e-05
Identities = 35/183 (19%), Positives = 70/183 (38%), Gaps = 42/183 (22%)
Query: 677 FSKENLIGVGSFGSVYKGRLHDGIEV-AIKVFHQNCAMALKS---FEAECEVMKNIRHRN 732
F +IG G+FG V +L + +V A+K+ ++ + F E +V+ N +
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 733 HVKRISSCSNED--FKALDCL-------HSTNCSLNIFDKLNIMIDVA--------SALE 775
+ +++ + +D + + + ++A A++
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPE-----EMARFYLAEMVIAID 189
Query: 776 YLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-TIGYMAP 824
+H +H D+KP N+ DFG L D +Q+ V T Y++P
Sbjct: 190 SVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQSSVAVGTPDYISP 245
Query: 825 GLL 827
+L
Sbjct: 246 EIL 248
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 9e-05
Identities = 62/395 (15%), Positives = 121/395 (30%), Gaps = 78/395 (19%)
Query: 224 LNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYL-----PNLENLVLGFNN 278
L S + + S + + L N L E+ ++ +L L N+
Sbjct: 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNS 62
Query: 279 LVGVVPAAIFNM-----STVKKIYLLDNSL--LGSFSLGIDLSLPN--VERLNLGLNRFS 329
L + + + V + L N L S L L+ + L+LG N FS
Sbjct: 63 LGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS 122
Query: 330 GT-----IPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLEN 384
+F + + L++ N +G+ L + + ++ +
Sbjct: 123 SKSSSEFKQAFSNLPASITSLNLRGND--------LGIKS---SDELIQILAAIPANVNS 171
Query: 385 IYISNCNIGGS-----IPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNK 439
+ + N+ L S +++ LDL N L K
Sbjct: 172 LNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLG--------------------LK 211
Query: 440 LAGSIPDQLCHL-ARLNTLGLAGNKFSGS----IPSCLGNLTSLRSPDLGSNRLTSV--- 491
+ + + +L L N G + +L L++ L + + ++
Sbjct: 212 SYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKE 271
Query: 492 ----LPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDL 547
L + F N++ I+ D + + S+ I NL + + D+PS L
Sbjct: 272 QCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNL-------IRELSGKADVPS----L 320
Query: 548 KDLQNISLACNGLEGLIPESFGYLTELNLSFNKLE 582
+ I + L E + L
Sbjct: 321 LNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPLL 355
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 8e-04
Identities = 51/318 (16%), Positives = 102/318 (32%), Gaps = 73/318 (22%)
Query: 321 LNLGLNRFSGT--IPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGV--LPTSIG 376
+N L G+ + F + + LD+ N+ L +
Sbjct: 1 MNYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYS-------------ISTVELIQAFA 47
Query: 377 NLSMSLENIYISNCNIGGSIPQ-----LISNLSNLLLLDLEGNKLTGSIPVTFGRL---- 427
N S+ ++ +S ++G L + +N+ L+L GN L+ +
Sbjct: 48 NTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAI 107
Query: 428 -QKLQGLYLPFNK--------LAGSIPDQLCHLARL----NTLGLAGNK-FSGSIPSCLG 473
+ L L +N + + + L N LG+ + + +
Sbjct: 108 PFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPA 167
Query: 474 NLTSLRSPDLGSNRLT--------SVLPSTFWNLKDILFFDLSSNSLDGPLSLDIG---- 521
N+ SL +L N L L S ++ + DLS+N L ++
Sbjct: 168 NVNSL---NLRGNNLASKNCAELAKFLASIPASVTSL---DLSANLLGLKSYAELAYIFS 221
Query: 522 -NLRVVIGINLSRNNFSGDIPSTIGDLKD----LQNISLACNGLEGLIPESFGY------ 570
V+ +NL N G + LKD LQ + L + ++ + E
Sbjct: 222 SIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFP 281
Query: 571 ----LTELNLSFNKLEGE 584
+ ++ + ++
Sbjct: 282 NIQKIILVDKNGKEIHPS 299
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 34/180 (18%), Positives = 66/180 (36%), Gaps = 47/180 (26%)
Query: 682 LIGVGSFGSVYKGRLHDGIEV-AIKVF---------HQNCAMALKSFEAECEVMKNIRHR 731
++G G FG V ++ ++ A K + A+ E ++++ + R
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN------EKQILEKVNSR 244
Query: 732 NHVKRISSCSNED--FKALDCL-------HSTNCSLNIFDKLNIMI---DVASALEYLHF 779
V + +D L + H + F + + ++ LE LH
Sbjct: 245 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH- 303
Query: 780 SHSTPVIHCDLKPKNVF----------DFGIGR-LLTGDRSMIQTETLV-TIGYMAPGLL 827
+++ DLKP+N+ D G+ + G + V T+GYMAP ++
Sbjct: 304 --RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT----IKGRVGTVGYMAPEVV 357
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 54/357 (15%), Positives = 105/357 (29%), Gaps = 50/357 (14%)
Query: 158 LSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMF--HGQIPLAL 215
L G + FNL I + I N L LK + + + LA
Sbjct: 80 LKGKPRAAMFNL-----IPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAK 134
Query: 216 SKCKRLQLLNL-GFKKLSGAIPKEI-SNLTILRKISLRNNKLRGEIPHEIGYL----PNL 269
++ L+ L L + I ++ ++ + + + + + L +L
Sbjct: 135 ARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSL 194
Query: 270 ENLVLGFNNLVGVVPAAIF----NMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGL 325
E L + P + N ++ + + D +L + N+E G
Sbjct: 195 EVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFF--KAAANLEEFCGGS 252
Query: 326 NRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENI 385
+P N L S + PN + + + + +
Sbjct: 253 LNEDIGMPEKYMNLVFPRKLCR--LGLSYMGPNEM------------PILFPFAAQIRKL 298
Query: 386 YISNCN-IGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYL-------PF 437
+ LI NL +L+ + V ++L+ L +
Sbjct: 299 DLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGM 358
Query: 438 NKLAGSIPDQ-LCHLAR----LNTLGLAGNKFS----GSIPSCLGNLTSLRSPDLGS 485
G + + L LA+ L + + + + SI + L NL R L
Sbjct: 359 EDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDR 415
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 38/172 (22%), Positives = 67/172 (38%), Gaps = 33/172 (19%)
Query: 671 FRATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIK----VFHQNCAMALKSFEAECEVM 725
K+ +G G++G V+K G VA+K F QN A ++F E ++
Sbjct: 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFR-EIMIL 62
Query: 726 KNIR-HRNHVKRISSCSNEDFKAL-------DC-LH---STNCSLNIFDKLNIMIDVASA 773
+ H N V ++ ++ + + + LH N L K ++ +
Sbjct: 63 TELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRAN-ILEPVHKQYVVYQLIKV 121
Query: 774 LEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTET 815
++YLH S ++H D+KP N+ DFG+ R R +
Sbjct: 122 IKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 36/182 (19%), Positives = 68/182 (37%), Gaps = 40/182 (21%)
Query: 677 FSKENLIGVGSFGSVYKGRLHDGIEV-AIKVFHQNCAMALK---SFEAECEVMKNIRHRN 732
F +IG G+F V ++ +V A+K+ ++ + F E +V+ N R
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 733 HVKRISSCSNEDFKAL--------DCLHSTNCSLNIFDKLNIMIDVA--------SALEY 776
+ + +E++ L D L + ++A A++
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPA-----EMARFYLAEIVMAIDS 177
Query: 777 LHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-TIGYMAPG 825
+H +H D+KP N+ DFG L D +++ V T Y++P
Sbjct: 178 VH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD-GTVRSLVAVGTPDYLSPE 233
Query: 826 LL 827
+L
Sbjct: 234 IL 235
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 14/78 (17%), Positives = 32/78 (41%), Gaps = 8/78 (10%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHD------GIEVAIKVFHQN-CAMALKSFEAECEVMKN 727
++ +G G+FG V + VA+K+ + ++ +E +++ +
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 728 I-RHRNHVKRISSCSNED 744
I H N V + +C+
Sbjct: 82 IGHHLNVVNLLGACTKPG 99
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 23/69 (33%), Positives = 34/69 (49%), Gaps = 16/69 (23%)
Query: 770 VASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-T 818
+ S LE+LH +I+ DLKP+NV D G+ L ++ +T+ T
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGT 352
Query: 819 IGYMAPGLL 827
G+MAP LL
Sbjct: 353 PGFMAPELL 361
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 7e-04
Identities = 33/99 (33%), Positives = 44/99 (44%), Gaps = 16/99 (16%)
Query: 395 SIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIP----DQLCH 450
S+P I + +L L N++T P F RL +L L L N+L +P D
Sbjct: 23 SVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFD---K 76
Query: 451 LARLNTLGLAGNKFSGSIPSCLG---NLTSLRSPDLGSN 486
L +L L L N+ SIP G NL SL L +N
Sbjct: 77 LTQLTQLSLNDNQLK-SIPR--GAFDNLKSLTHIWLLNN 112
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 827 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.98 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.98 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.98 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.98 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.97 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 99.95 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.94 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.94 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.94 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.94 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.94 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.94 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 99.94 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.94 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.94 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 99.94 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.93 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 99.93 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 99.93 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 99.92 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.92 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 99.92 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.91 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.89 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.89 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.87 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.87 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.87 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.87 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.86 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.85 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.85 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.85 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.85 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.84 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.84 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.84 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.84 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.84 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.84 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.84 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.84 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.84 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.84 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.83 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.83 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.83 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.83 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.83 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.83 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.83 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.83 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.83 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.82 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.82 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.82 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.82 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.82 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.82 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.82 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.82 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.82 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.82 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.82 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.82 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.82 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.82 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.82 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.82 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.82 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.82 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.82 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.82 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.82 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.82 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.81 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.81 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.81 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.81 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.81 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.81 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.81 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.81 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.81 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.81 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.81 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.81 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.81 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.81 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.81 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.81 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.81 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.8 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.8 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.8 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.8 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.8 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.8 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.8 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.8 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.8 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.8 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.8 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.8 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.8 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.8 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.8 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.8 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.8 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.8 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.8 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.79 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.79 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.79 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.79 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.79 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.79 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.79 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.79 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.79 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.79 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.79 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.79 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.79 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.79 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.79 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.79 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.79 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.79 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.79 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.79 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.79 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.79 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.79 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.79 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.79 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.79 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.79 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.78 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.78 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.78 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.78 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.78 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.78 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.78 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.78 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.78 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.78 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.78 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.78 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.78 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.78 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.78 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.78 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.78 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.78 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.78 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.78 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.78 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.78 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.78 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.78 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.78 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.78 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.78 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.78 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.78 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.78 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.78 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.78 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.78 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.78 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.78 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.78 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.78 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.78 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.77 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.77 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.77 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.77 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.77 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.77 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.77 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.77 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.77 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.77 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.77 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.77 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.77 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.77 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.77 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.77 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.77 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.77 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.77 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.77 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.77 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.77 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.77 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.77 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.77 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.76 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.76 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.76 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.76 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.76 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.76 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.76 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.76 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.76 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.76 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.76 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.76 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.76 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.76 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.76 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.76 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.76 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.76 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.76 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.76 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.76 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.76 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.76 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.76 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.76 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.76 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.76 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.76 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.76 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.76 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.76 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.75 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.75 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.75 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.75 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.75 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.75 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.75 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.75 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.75 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.75 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.75 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.75 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.75 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.75 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.75 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.74 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.74 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.74 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.74 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.74 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.74 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.74 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.74 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.74 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.73 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.73 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.73 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.73 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.73 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.73 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.73 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.73 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.73 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.73 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.72 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.72 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.72 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.72 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.72 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.72 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.71 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.71 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.71 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.71 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.71 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.71 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.7 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.7 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.7 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.69 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.69 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.69 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.69 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.69 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.68 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.67 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.66 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.64 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.62 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.62 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.62 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.61 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.61 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.59 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.59 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.59 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.59 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.58 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.52 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.52 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.51 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.5 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.46 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.43 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.42 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.41 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.4 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.4 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.37 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.37 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.33 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.33 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.27 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.22 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.18 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.18 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.11 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.1 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.99 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.89 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.85 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.7 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.61 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.59 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.34 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.32 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.3 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.2 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.17 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 97.8 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.16 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.15 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 96.93 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 96.39 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.39 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.37 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.34 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.16 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.16 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.0 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 95.27 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 95.09 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 94.99 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 94.93 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 93.76 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 90.46 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 87.95 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 87.43 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 86.81 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 83.21 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 82.23 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-81 Score=754.18 Aligned_cols=563 Identities=34% Similarity=0.550 Sum_probs=443.9
Q ss_pred hccCCCHHHHHHHHHHHhhcCCCCCCcCCCCCCCCCCCCcccceecCCCCCcEEEEEcCCCCCccc---cC---------
Q 047196 48 AAASNITTDQQALLALKAHISYDPTNLLAQNSTSNTSVCNWIGITCNVNSHRVTALNISSLNLQGT---IP--------- 115 (827)
Q Consensus 48 ~~~~~~~~~~~aLl~~k~~~~~~~~~~l~~w~~~~~~~C~W~gv~C~~~~~~v~~L~L~~~~l~g~---~~--------- 115 (827)
+++++.++|++||++||+++. ||. .+++|. .++|||+|.||+|+ +++|+.|||+++++.|. +|
T Consensus 5 ~~~~~~~~~~~all~~k~~~~-~~~-~l~~W~-~~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L 79 (768)
T 3rgz_A 5 SPSQSLYREIHQLISFKDVLP-DKN-LLPDWS-SNKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGL 79 (768)
T ss_dssp ---CCHHHHHHHHHHHHTTCS-CTT-SSTTCC-TTSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTC
T ss_pred ccccCCHHHHHHHHHHHhhCC-Ccc-cccCCC-CCCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCcc
Confidence 445557899999999999995 887 899998 67899999999998 58999999999999886 43
Q ss_pred --------------ccccCCCCCCEEECCCCCCCccCCh--hhhhccccceEEecCCCCCCcccccc-CCCCCCcEEEcC
Q 047196 116 --------------PQLGNLSSLTTLNLSHNKLSGDIPP--SIFTMHKLKFLDFSDNQLSGSLSSVT-FNLSSVLDIRLD 178 (827)
Q Consensus 116 --------------~~l~~L~~L~~L~Ls~N~l~g~~p~--~~~~l~~L~~LdLs~N~l~g~~p~~~-~~l~~L~~L~L~ 178 (827)
+.++++++|++|||++|.++|.+|. .++++++|++|||++|.+++.+|..+ .++++|++|+|+
T Consensus 80 ~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls 159 (768)
T 3rgz_A 80 ESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLS 159 (768)
T ss_dssp CEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECC
T ss_pred cccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECC
Confidence 5788899999999999999999998 89999999999999999988877765 667777777777
Q ss_pred CCCCCCCcchhH---h---------------------hccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCccc
Q 047196 179 SDKLSGELPVNI---C---------------------NYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGA 234 (827)
Q Consensus 179 ~n~l~g~ip~~~---~---------------------~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~ 234 (827)
+|.+++..|..+ . ..+++|++|++++|.+++.+|. ++++++|++|++++|.+++.
T Consensus 160 ~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~ 238 (768)
T 3rgz_A 160 ANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGD 238 (768)
T ss_dssp SSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSC
T ss_pred CCccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCc
Confidence 777665555431 0 1234566666666666665555 66666666666666666555
Q ss_pred CCCcCcCCccccEEEcccc----------------------cccccccccccCc-CCCcEEEeecccCcccCchhhhcCC
Q 047196 235 IPKEISNLTILRKISLRNN----------------------KLRGEIPHEIGYL-PNLENLVLGFNNLVGVVPAAIFNMS 291 (827)
Q Consensus 235 ~p~~~~~l~~L~~L~Ls~N----------------------~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~ 291 (827)
+|..++++++|++|++++| +++|.+|..+..+ ++|++|+|++|++++.+|..+.+++
T Consensus 239 ~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~ 318 (768)
T 3rgz_A 239 FSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCS 318 (768)
T ss_dssp HHHHTTTCSSCCEEECCSSCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCT
T ss_pred ccHHHhcCCCCCEEECCCCcccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCC
Confidence 5555555544444444444 4444566666554 7788888888888777787788888
Q ss_pred CccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCC-CCcEEEcCCCccee----------------
Q 047196 292 TVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNAS-KLVYLDMGTNSFSG---------------- 354 (827)
Q Consensus 292 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~g---------------- 354 (827)
+|++|++++|.+.|.+|......+++|++|++++|++++.+|..+.+++ +|+.|++++|.++|
T Consensus 319 ~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~ 398 (768)
T 3rgz_A 319 LLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQE 398 (768)
T ss_dssp TCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCE
T ss_pred CccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccE
Confidence 8888888888887777766444677777777777777777776665554 55555555555554
Q ss_pred ----------ecCCCc---------cCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCcc
Q 047196 355 ----------IIPNTI---------GLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNK 415 (827)
Q Consensus 355 ----------~~p~~~---------~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~ 415 (827)
.+|..+ .+++|.+++.+|..+..++ +|++|++++|++++.+|..+..+++|+.|++++|+
T Consensus 399 L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~ 477 (768)
T 3rgz_A 399 LYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLS-KLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND 477 (768)
T ss_dssp EECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCT-TCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSC
T ss_pred EECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCC-CCCEEECCCCcccCcCCHHHcCCCCceEEEecCCc
Confidence 444322 2556666666777776665 77788888888887888888888888888888888
Q ss_pred ccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCccccCCCcccccCCcc
Q 047196 416 LTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPST 495 (827)
Q Consensus 416 l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 495 (827)
++|.+|..+.++++|++|+|++|++++.+|.++..+++|++|++++|+++|.+|..++++++|++||+++|+++|.+|..
T Consensus 478 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~ 557 (768)
T 3rgz_A 478 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAA 557 (768)
T ss_dssp CCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGG
T ss_pred ccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChH
Confidence 88888888888888888888888888888888888889999999999998889998999999999999999888877765
Q ss_pred cc----------------------------------------------------------------------cccccccc
Q 047196 496 FW----------------------------------------------------------------------NLKDILFF 505 (827)
Q Consensus 496 ~~----------------------------------------------------------------------~l~~L~~L 505 (827)
+. .+++|++|
T Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~L 637 (768)
T 3rgz_A 558 MFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFL 637 (768)
T ss_dssp GGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEE
T ss_pred HhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEE
Confidence 43 34678899
Q ss_pred CCCCCCCCCCCcccccccccCceEEcccceeeecccccccCCCCCCEEECCCCcceeecCCCCc---CCceEeCcCCcCe
Q 047196 506 DLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFG---YLTELNLSFNKLE 582 (827)
Q Consensus 506 dLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~---~L~~L~ls~N~l~ 582 (827)
||++|+++|.+|.++++++.|+.|||++|+++|.||..++++++|+.|||++|+++|.||..++ .|++||+|+|+++
T Consensus 638 dLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~ 717 (768)
T 3rgz_A 638 DMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLS 717 (768)
T ss_dssp ECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEE
T ss_pred ECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCccc
Confidence 9999999999999999999999999999999999999999999999999999999999998775 7899999999999
Q ss_pred ecCCCCCCCCCCcccccccCccccCCCCCCCccccccc
Q 047196 583 GEIPRGGPFANFTAKSFMGNEKLCGLPNLQFPKCKRRT 620 (827)
Q Consensus 583 g~ip~~~~~~~~~~~~~~~n~~lc~~p~~~~~~c~~~~ 620 (827)
|+||.+++|.+++..+|.||+++||.| .++|....
T Consensus 718 g~iP~~~~~~~~~~~~~~gN~~Lcg~~---l~~C~~~~ 752 (768)
T 3rgz_A 718 GPIPEMGQFETFPPAKFLNNPGLCGYP---LPRCDPSN 752 (768)
T ss_dssp EECCSSSSGGGSCGGGGCSCTEEESTT---SCCCCSCC
T ss_pred ccCCCchhhccCCHHHhcCCchhcCCC---CcCCCCCc
Confidence 999999999999999999999999965 24787544
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-63 Score=598.54 Aligned_cols=479 Identities=31% Similarity=0.477 Sum_probs=422.8
Q ss_pred cEEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcC
Q 047196 99 RVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLD 178 (827)
Q Consensus 99 ~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~ 178 (827)
+++.|+|++|.+.+.++ +.++++|++|+|++|++++.+|. ++++++|++|+|++|.+++.+|..+.++++|++|+++
T Consensus 179 ~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls 255 (768)
T 3rgz_A 179 ELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNIS 255 (768)
T ss_dssp TCCEEECCSSEEESCCB--CTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECC
T ss_pred CCCEEECCCCcccccCC--cccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECC
Confidence 56666666666655443 36778888888888888877776 8888888888888888888888888888888888888
Q ss_pred CCCCCCCcchhHhhccccccEEEeecccccccCCccCCCC-CCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccc
Q 047196 179 SDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKC-KRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRG 257 (827)
Q Consensus 179 ~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l-~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 257 (827)
+|.+.|.+|.. .+++|++|++++|.++|.+|..+.+. ++|++|++++|.+++.+|..++++++|++|++++|+++|
T Consensus 256 ~n~l~~~~~~~---~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~ 332 (768)
T 3rgz_A 256 SNQFVGPIPPL---PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSG 332 (768)
T ss_dssp SSCCEESCCCC---CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEE
T ss_pred CCcccCccCcc---ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccC
Confidence 88888877765 35588999999999988888888775 899999999999999999999999999999999999988
Q ss_pred ccccc-ccCcCCCcEEEeecccCcccCchhhhcCC-CccEEEecCCccccccChhhhc-CCCCccEEeCcCCccccccCc
Q 047196 258 EIPHE-IGYLPNLENLVLGFNNLVGVVPAAIFNMS-TVKKIYLLDNSLLGSFSLGIDL-SLPNVERLNLGLNRFSGTIPS 334 (827)
Q Consensus 258 ~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~ 334 (827)
.+|.. ++.+++|++|+|++|++++.+|..+.++. +|+.|++++|.+.|.+|..+.. .+++|++|++++|++++.+|.
T Consensus 333 ~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~ 412 (768)
T 3rgz_A 333 ELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPP 412 (768)
T ss_dssp ECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCG
T ss_pred cCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCH
Confidence 88876 88999999999999999999999988887 8999999999998888876652 278899999999999999999
Q ss_pred cccCCCCCcEEEcCCCcceeecCCCc---------cCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCC
Q 047196 335 FITNASKLVYLDMGTNSFSGIIPNTI---------GLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSN 405 (827)
Q Consensus 335 ~~~~l~~L~~L~Ls~N~l~g~~p~~~---------~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~ 405 (827)
.+.++++|+.|++++|++++.+|..+ .+++|.+++.+|..+..+. +|++|++++|+++|.+|..+.++++
T Consensus 413 ~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~ 491 (768)
T 3rgz_A 413 TLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVK-TLETLILDFNDLTGEIPSGLSNCTN 491 (768)
T ss_dssp GGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCT-TCCEEECCSSCCCSCCCGGGGGCTT
T ss_pred HHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCC-CceEEEecCCcccCcCCHHHhcCCC
Confidence 99999999999999999999888643 4789999999999998887 8999999999999999999999999
Q ss_pred CceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCccc-------------
Q 047196 406 LLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCL------------- 472 (827)
Q Consensus 406 L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~------------- 472 (827)
|++|+|++|++++.+|.+++.+++|++|+|++|+++|.+|..+.++++|++|++++|+++|.+|..+
T Consensus 492 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~ 571 (768)
T 3rgz_A 492 LNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIA 571 (768)
T ss_dssp CCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTC
T ss_pred CCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccc
Confidence 9999999999999999999999999999999999999999999999999999999999998887654
Q ss_pred ---------------------------------------------------------cCCCCCCccccCCCcccccCCcc
Q 047196 473 ---------------------------------------------------------GNLTSLRSPDLGSNRLTSVLPST 495 (827)
Q Consensus 473 ---------------------------------------------------------~~l~~L~~L~Ls~N~l~~~~p~~ 495 (827)
+.+++|++|||++|+++|.+|.+
T Consensus 572 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~ 651 (768)
T 3rgz_A 572 GKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKE 651 (768)
T ss_dssp SCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGG
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHH
Confidence 33567899999999999999999
Q ss_pred ccccccccccCCCCCCCCCCCcccccccccCceEEcccceeeecccccccCCCCCCEEECCCCcceeecCCC--CcCCce
Q 047196 496 FWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPES--FGYLTE 573 (827)
Q Consensus 496 ~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~--~~~L~~ 573 (827)
+++++.|+.|||++|+++|.+|..+++++.|+.||||+|+++|.||..+++++.|+.||+++|+++|.||+. |..+..
T Consensus 652 l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~ 731 (768)
T 3rgz_A 652 IGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPP 731 (768)
T ss_dssp GGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCG
T ss_pred HhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCH
Confidence 999999999999999999999999999999999999999999999999999999999999999999999974 445666
Q ss_pred EeCcCCc-Ceec
Q 047196 574 LNLSFNK-LEGE 584 (827)
Q Consensus 574 L~ls~N~-l~g~ 584 (827)
..+.+|. ++|.
T Consensus 732 ~~~~gN~~Lcg~ 743 (768)
T 3rgz_A 732 AKFLNNPGLCGY 743 (768)
T ss_dssp GGGCSCTEEEST
T ss_pred HHhcCCchhcCC
Confidence 6677774 6764
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-60 Score=560.35 Aligned_cols=494 Identities=19% Similarity=0.277 Sum_probs=362.9
Q ss_pred CCCHHHHHHHHHHHhhcCCCCCC-------cCCCCCCCCCCCCcc---cceecCCCCCcEEEEEcCCCCCccccCccccC
Q 047196 51 SNITTDQQALLALKAHISYDPTN-------LLAQNSTSNTSVCNW---IGITCNVNSHRVTALNISSLNLQGTIPPQLGN 120 (827)
Q Consensus 51 ~~~~~~~~aLl~~k~~~~~~~~~-------~l~~w~~~~~~~C~W---~gv~C~~~~~~v~~L~L~~~~l~g~~~~~l~~ 120 (827)
+....|++||.+++.++..+... ...+|. .+.|||.| .||+|+.. ++|+.|+|++++++|.+|+++++
T Consensus 26 ~~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~-~~~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~~ 103 (636)
T 4eco_A 26 AEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWN-FNKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQ 103 (636)
T ss_dssp CHHHHHHHHHHHHHHHTTGGGCCCCC------CCCC-CSSCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGGG
T ss_pred hhHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCC-CCCCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHhc
Confidence 34457999999999997433222 234787 56899999 99999865 89999999999999999999999
Q ss_pred CCCCCEEECCCCCC------Cc------cCChhhhhccccceEEecCCCCCCccccccCCC-CCCcEEEcCCCCCCCCcc
Q 047196 121 LSSLTTLNLSHNKL------SG------DIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNL-SSVLDIRLDSDKLSGELP 187 (827)
Q Consensus 121 L~~L~~L~Ls~N~l------~g------~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l-~~L~~L~L~~n~l~g~ip 187 (827)
|++|++|||++|.+ .| .+|.+. +.+|+ +++++|.+.+.+|..+..+ ..+..+++....+...
T Consensus 104 L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~-- 178 (636)
T 4eco_A 104 LTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKS-- 178 (636)
T ss_dssp CTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCC--
T ss_pred CccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCccccccccc--
Confidence 99999999999976 44 567666 77888 9999999998887765521 1111122221111100
Q ss_pred hhHhhccccccEEEe--ecccccccCCccCCCCCCCcEEEccCCCCccc-----------------CCCcCc--CCcccc
Q 047196 188 VNICNYLHYLKVLFL--AKNMFHGQIPLALSKCKRLQLLNLGFKKLSGA-----------------IPKEIS--NLTILR 246 (827)
Q Consensus 188 ~~~~~~~~~L~~L~L--s~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~-----------------~p~~~~--~l~~L~ 246 (827)
....++.+.+ ..|+++| +|..++++++|++|+|++|.+++. +|..++ ++++|+
T Consensus 179 -----~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~ 252 (636)
T 4eco_A 179 -----SRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLT 252 (636)
T ss_dssp -----CCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCC
T ss_pred -----cccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCC
Confidence 0001222222 2566777 777777777777777777777775 777777 777777
Q ss_pred EEEcccccccccccccccCcCCCcEEEeeccc-Ccc-cCchhhhcC------CCccEEEecCCccccccCh--hhhcCCC
Q 047196 247 KISLRNNKLRGEIPHEIGYLPNLENLVLGFNN-LVG-VVPAAIFNM------STVKKIYLLDNSLLGSFSL--GIDLSLP 316 (827)
Q Consensus 247 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~-~~p~~~~~l------~~L~~L~l~~n~l~~~~~~--~~~~~l~ 316 (827)
+|+|++|++.+.+|..++++++|++|+|++|+ ++| .+|..+.++ ++|++|++++|.+. .+|. .+. .++
T Consensus 253 ~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~-~l~ 330 (636)
T 4eco_A 253 DVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQ-KMK 330 (636)
T ss_dssp EEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHT-TCT
T ss_pred EEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhc-cCC
Confidence 77777777777777777777777777777777 777 777777665 77777777777777 6665 444 677
Q ss_pred CccEEeCcCCccccccCccccCCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhccccc-ccEEEccCCcCccc
Q 047196 317 NVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMS-LENIYISNCNIGGS 395 (827)
Q Consensus 317 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~-L~~L~Ls~N~l~g~ 395 (827)
+|++|++++|+++|.+| .+..+++|+.|++++|+++ .+ |..+..+. + |++|++++|+++ .
T Consensus 331 ~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~l---------------p~~l~~l~-~~L~~L~Ls~N~l~-~ 391 (636)
T 4eco_A 331 KLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EI---------------PANFCGFT-EQVENLSFAHNKLK-Y 391 (636)
T ss_dssp TCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-EC---------------CTTSEEEC-TTCCEEECCSSCCS-S
T ss_pred CCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cc---------------cHhhhhhc-ccCcEEEccCCcCc-c
Confidence 77888888888777777 7777777888888777776 32 33445554 4 788888888877 6
Q ss_pred cCccccCCC--CCceEeccCcccccccccccc-------CCCCCcEEECCCCCCCCCCCcc-ccccccccEEecCCCccc
Q 047196 396 IPQLISNLS--NLLLLDLEGNKLTGSIPVTFG-------RLQKLQGLYLPFNKLAGSIPDQ-LCHLARLNTLGLAGNKFS 465 (827)
Q Consensus 396 ~p~~~~~l~--~L~~L~Ls~N~l~g~~p~~~~-------~l~~L~~L~Ls~N~l~g~~p~~-~~~l~~L~~L~Ls~N~l~ 465 (827)
+|..+..++ +|+.|++++|++++.+|..+. .+++|++|+|++|+++ .+|.. +..+++|+.|+|++|+++
T Consensus 392 lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~L~~L~Ls~N~l~ 470 (636)
T 4eco_A 392 IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS-KFPKELFSTGSPLSSINLMGNMLT 470 (636)
T ss_dssp CCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCC-SCCTHHHHTTCCCSEEECCSSCCS
T ss_pred cchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccC-cCCHHHHccCCCCCEEECCCCCCC
Confidence 777766654 788888888888877777777 6778888888888887 44444 445778888888888887
Q ss_pred ccCCccccC-C-------CCCCccccCCCcccccCCcccc--ccccccccCCCCCCCCCCCcccccccccCceEEc----
Q 047196 466 GSIPSCLGN-L-------TSLRSPDLGSNRLTSVLPSTFW--NLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINL---- 531 (827)
Q Consensus 466 ~~~p~~~~~-l-------~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L---- 531 (827)
.+|..+.. . ++|++|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..++.++.|+.|++
T Consensus 471 -~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~ 547 (636)
T 4eco_A 471 -EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQR 547 (636)
T ss_dssp -BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCB
T ss_pred -CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCc
Confidence 55554332 2 27888888888887 5666665 78888888888888887 7778888888888888
Q ss_pred --ccceeeecccccccCCCCCCEEECCCCcceeecCCCC-cCCceEeCcCCcCee
Q 047196 532 --SRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESF-GYLTELNLSFNKLEG 583 (827)
Q Consensus 532 --s~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~-~~L~~L~ls~N~l~g 583 (827)
++|++.+.+|..++++++|+.|+|++|++ +.+|..+ .+|+.||+++|++..
T Consensus 548 ~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~~~L~~L~Ls~N~l~~ 601 (636)
T 4eco_A 548 DAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKITPNISVLDIKDNPNIS 601 (636)
T ss_dssp CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCCTTCCEEECCSCTTCE
T ss_pred ccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHhCcCCEEECcCCCCcc
Confidence 56888999999999999999999999999 6777655 589999999998764
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-58 Score=548.63 Aligned_cols=475 Identities=19% Similarity=0.239 Sum_probs=352.0
Q ss_pred hccCCCHHHHHHHHHHHhhcCCCCCCcCCCCCCCC----CCC--Ccc------------cceecCCCCCcEEEEEcCCCC
Q 047196 48 AAASNITTDQQALLALKAHISYDPTNLLAQNSTSN----TSV--CNW------------IGITCNVNSHRVTALNISSLN 109 (827)
Q Consensus 48 ~~~~~~~~~~~aLl~~k~~~~~~~~~~l~~w~~~~----~~~--C~W------------~gv~C~~~~~~v~~L~L~~~~ 109 (827)
.++++..+|++||++||+++ .+| +|...+ .+| |.| .||+|+. .++|+.|+|++++
T Consensus 262 ~~~~~~~~d~~ALl~~k~~l-~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~ 334 (876)
T 4ecn_A 262 KETAEYIKDYKALKAIWEAL-DGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFG 334 (876)
T ss_dssp CCCCHHHHHHHHHHHHHHHT-TGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTC
T ss_pred cccccchHHHHHHHHHHHHc-CCC-----CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCC
Confidence 34455678999999999998 455 675333 355 999 9999986 5899999999999
Q ss_pred CccccCccccCCCCCCEEEC-CCCCCCccCChhhhhc-------------------------------------------
Q 047196 110 LQGTIPPQLGNLSSLTTLNL-SHNKLSGDIPPSIFTM------------------------------------------- 145 (827)
Q Consensus 110 l~g~~~~~l~~L~~L~~L~L-s~N~l~g~~p~~~~~l------------------------------------------- 145 (827)
+.|.+|++|++|++|++||| ++|.++|..|-.....
T Consensus 335 L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~ 414 (876)
T 4ecn_A 335 AKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEM 414 (876)
T ss_dssp CEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTS
T ss_pred CCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccc
Confidence 99999999999999999999 9998887744221100
Q ss_pred --------cccceEEec--CCCCCCccccccCCCCCCcEEEcCCCCCCC-CcchhHhhccccccEEEeecccccccCCcc
Q 047196 146 --------HKLKFLDFS--DNQLSGSLSSVTFNLSSVLDIRLDSDKLSG-ELPVNICNYLHYLKVLFLAKNMFHGQIPLA 214 (827)
Q Consensus 146 --------~~L~~LdLs--~N~l~g~~p~~~~~l~~L~~L~L~~n~l~g-~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~ 214 (827)
..++.+.++ .|+++| +|..+.++++|++|+|++|.++| .+|..+.. .+.|.++|.+|..
T Consensus 415 ~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~---------~s~n~~~g~iP~~ 484 (876)
T 4ecn_A 415 KPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWED---------ANSDYAKQYENEE 484 (876)
T ss_dssp CCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSC---------TTSHHHHHHTTSC
T ss_pred cccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccc---------cccccccccCChh
Confidence 111112221 144444 44444444444444444444443 12211110 1113333368999
Q ss_pred CC--CCCCCcEEEccCCCCcccCCCcCcCCccccEEEccccc-ccc-cccccccCcC-------CCcEEEeecccCcccC
Q 047196 215 LS--KCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNK-LRG-EIPHEIGYLP-------NLENLVLGFNNLVGVV 283 (827)
Q Consensus 215 l~--~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~-~~p~~~~~l~-------~L~~L~Ls~N~l~~~~ 283 (827)
++ ++++|++|+|++|.+.+.+|..++++++|++|+|++|+ ++| .+|..++.++ +|++|+|++|+++ .+
T Consensus 485 l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~i 563 (876)
T 4ecn_A 485 LSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EF 563 (876)
T ss_dssp CCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BC
T ss_pred hhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-cc
Confidence 88 99999999999999999999999999999999999998 888 8898777666 9999999999999 78
Q ss_pred ch--hhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCC-CcEEEcCCCcceeecCCCc
Q 047196 284 PA--AIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASK-LVYLDMGTNSFSGIIPNTI 360 (827)
Q Consensus 284 p~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~g~~p~~~ 360 (827)
|. .+.++++|+.|++++|.+. .+| .+ ..+++|+.|+|++|+++ .+|..+..+++ |+.|++++|.++ .+|.
T Consensus 564 p~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~-~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~-- 636 (876)
T 4ecn_A 564 PASASLQKMVKLGLLDCVHNKVR-HLE-AF-GTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPN-- 636 (876)
T ss_dssp CCHHHHTTCTTCCEEECTTSCCC-BCC-CC-CTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCS--
T ss_pred CChhhhhcCCCCCEEECCCCCcc-cch-hh-cCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCch--
Confidence 88 8999999999999999988 777 44 37899999999999999 88888999998 999999999987 4443
Q ss_pred cCCCCCCcccCCCchhccc-ccccEEEccCCcCccccCccc---c--CCCCCceEeccCccccccccccccCCCCCcEEE
Q 047196 361 GLTGNPLDGVLPTSIGNLS-MSLENIYISNCNIGGSIPQLI---S--NLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLY 434 (827)
Q Consensus 361 ~l~~n~l~g~~p~~~~~~~-~~L~~L~Ls~N~l~g~~p~~~---~--~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 434 (827)
.+.... .+|+.|++++|+++|.+|... . .+++|+.|+|++|+++...+..+..+++|+.|+
T Consensus 637 -------------~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~ 703 (876)
T 4ecn_A 637 -------------IFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTII 703 (876)
T ss_dssp -------------CCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEE
T ss_pred -------------hhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEE
Confidence 222222 149999999999998777543 2 345899999999999954334456899999999
Q ss_pred CCCCCCCCCCCccccc--------cccccEEecCCCcccccCCcccc--CCCCCCccccCCCcccccCCccccccccccc
Q 047196 435 LPFNKLAGSIPDQLCH--------LARLNTLGLAGNKFSGSIPSCLG--NLTSLRSPDLGSNRLTSVLPSTFWNLKDILF 504 (827)
Q Consensus 435 Ls~N~l~g~~p~~~~~--------l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 504 (827)
|++|+++ .+|..+.. +++|+.|+|++|+++ .+|..+. .+++|+.|+|++|.+++ +|..+..+++|+.
T Consensus 704 Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~ 780 (876)
T 4ecn_A 704 LSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKA 780 (876)
T ss_dssp CCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCE
T ss_pred CCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCE
Confidence 9999998 66765543 338999999999999 7888887 89999999999999998 7888999999999
Q ss_pred cCCCCCCCCCCCcccccccccCceEEcccceeeecccccccCCCCCCEEECCCCcceeecCCCC-cCCceEeCcCCcCe
Q 047196 505 FDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESF-GYLTELNLSFNKLE 582 (827)
Q Consensus 505 LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~-~~L~~L~ls~N~l~ 582 (827)
|+|++|. ++++|++.+.+|..++++++|+.|+|++|++ +.+|..+ .+|+.|||++|++.
T Consensus 781 L~Ls~N~------------------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~~~L~~LdLs~N~l~ 840 (876)
T 4ecn_A 781 FGIRHQR------------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLTPQLYILDIADNPNI 840 (876)
T ss_dssp EECCCCB------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCCSSSCEEECCSCTTC
T ss_pred EECCCCC------------------CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhcCCCCEEECCCCCCC
Confidence 9998854 3445555555555555555555555555555 4444433 24555555555544
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-55 Score=526.05 Aligned_cols=510 Identities=21% Similarity=0.232 Sum_probs=411.7
Q ss_pred CcEEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEc
Q 047196 98 HRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRL 177 (827)
Q Consensus 98 ~~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L 177 (827)
.+|+.|+|++|++++..+..|.++++|++|||++|.+++..|..|+++++|++|||++|++++..+..+.++++|++|+|
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 57999999999999988888999999999999999999999999999999999999999999877778999999999999
Q ss_pred CCCCCCCCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCc--CCccccEEEcccccc
Q 047196 178 DSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEIS--NLTILRKISLRNNKL 255 (827)
Q Consensus 178 ~~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~--~l~~L~~L~Ls~N~l 255 (827)
++|.+++..|..+. .+++|++|++++|.+++..|..++++++|++|++++|.+++..|..+. .+++|++|++++|++
T Consensus 105 ~~n~l~~~~~~~~~-~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l 183 (680)
T 1ziw_A 105 MSNSIQKIKNNPFV-KQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI 183 (680)
T ss_dssp CSSCCCCCCSCTTT-TCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCC
T ss_pred CCCccCccChhHcc-ccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcc
Confidence 99999854444444 456999999999999999999999999999999999999987776654 558899999999999
Q ss_pred cccccccccCc---------------------------CCCcEEEeecccCcccCchhhhcCCC--ccEEEecCCccccc
Q 047196 256 RGEIPHEIGYL---------------------------PNLENLVLGFNNLVGVVPAAIFNMST--VKKIYLLDNSLLGS 306 (827)
Q Consensus 256 ~~~~p~~~~~l---------------------------~~L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~l~~n~l~~~ 306 (827)
++..|..+..+ ++|++|++++|.+++..|..+.+++. |+.|++++|.+.+.
T Consensus 184 ~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~ 263 (680)
T 1ziw_A 184 KEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVV 263 (680)
T ss_dssp CCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEE
T ss_pred cccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCcc
Confidence 88877766544 45677777777777777777777654 88888888887766
Q ss_pred cChhhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceee-----cCC-------------CccCCCCCCc
Q 047196 307 FSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGI-----IPN-------------TIGLTGNPLD 368 (827)
Q Consensus 307 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~-----~p~-------------~~~l~~n~l~ 368 (827)
.+..+. .+++|++|++++|++++..|..+.++++|+.|++++|...+. +|. .+.+++|.+.
T Consensus 264 ~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~ 342 (680)
T 1ziw_A 264 GNDSFA-WLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIP 342 (680)
T ss_dssp CTTTTT-TCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBC
T ss_pred Cccccc-CcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccC
Confidence 655544 677888888888888777776666666666666655433321 110 1124444444
Q ss_pred ccCCCchhccc---------------------------ccccEEEccCCcCccccCccccCCCCCceEeccCcccccccc
Q 047196 369 GVLPTSIGNLS---------------------------MSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIP 421 (827)
Q Consensus 369 g~~p~~~~~~~---------------------------~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p 421 (827)
+..|..+..++ .+|+.|++++|++++..|..|..+++|+.|++++|++++.+|
T Consensus 343 ~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 422 (680)
T 1ziw_A 343 GIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELT 422 (680)
T ss_dssp CCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECC
T ss_pred CCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccC
Confidence 43333332221 257777777888888888888888999999999999887665
Q ss_pred -ccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCccc--ccCCccccCCCCCCccccCCCcccccCCccccc
Q 047196 422 -VTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFS--GSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWN 498 (827)
Q Consensus 422 -~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 498 (827)
..|.++++|++|++++|++.+..+..+..+++|+.|++++|.++ +.+|..+.++++|++|++++|++++..|..|.+
T Consensus 423 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~ 502 (680)
T 1ziw_A 423 GQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEG 502 (680)
T ss_dssp SGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred cccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhcc
Confidence 67888899999999999988888888888999999999999887 578889999999999999999999988888999
Q ss_pred cccccccCCCCCCCCCCCc--------ccccccccCceEEcccceeeecccccccCCCCCCEEECCCCcceeecCCCC--
Q 047196 499 LKDILFFDLSSNSLDGPLS--------LDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESF-- 568 (827)
Q Consensus 499 l~~L~~LdLs~N~l~g~~p--------~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~-- 568 (827)
+++|+.|+|++|++++..+ ..+++++.|+.|++++|+++...+..|+++++|+.|+|++|++++..+..|
T Consensus 503 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~ 582 (680)
T 1ziw_A 503 LEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNN 582 (680)
T ss_dssp CTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred ccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCC
Confidence 9999999999999986422 347889999999999999995444579999999999999999998777655
Q ss_pred -cCCceEeCcCCcCeecCCCC-C-CCCCCcccccccCccccCCC
Q 047196 569 -GYLTELNLSFNKLEGEIPRG-G-PFANFTAKSFMGNEKLCGLP 609 (827)
Q Consensus 569 -~~L~~L~ls~N~l~g~ip~~-~-~~~~~~~~~~~~n~~lc~~p 609 (827)
.+|+.|++++|++++..|.. + .+.++....+.|||..|.++
T Consensus 583 l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 583 QVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp CTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred CCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 47999999999999876642 1 35667778889999999864
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-55 Score=516.70 Aligned_cols=490 Identities=19% Similarity=0.191 Sum_probs=368.8
Q ss_pred CcEEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEc
Q 047196 98 HRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRL 177 (827)
Q Consensus 98 ~~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L 177 (827)
..++.|||++|.+++..|.+|.++++|++|+|++|++++..|.+|.++++|++|+|++|++++..|..+.++++|++|++
T Consensus 33 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 112 (606)
T 3t6q_A 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF 112 (606)
T ss_dssp TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEEC
T ss_pred CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeec
Confidence 47999999999999998999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCcccc--EEEcccccc
Q 047196 178 DSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILR--KISLRNNKL 255 (827)
Q Consensus 178 ~~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~--~L~Ls~N~l 255 (827)
++|.+++..|..+. .+++|++|++++|.+++..+..+..+++|++|++++|.+++..|..++.+++|+ .|++++|.+
T Consensus 113 ~~n~i~~l~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l 191 (606)
T 3t6q_A 113 IQTGISSIDFIPLH-NQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191 (606)
T ss_dssp TTSCCSCGGGSCCT-TCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCC
T ss_pred cccCcccCCcchhc-cCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCcc
Confidence 99999964344444 456999999999999985545555699999999999999998888899999999 899999999
Q ss_pred cccccccccCcCCCcEEEeecccCc--------------------------ccCchhhhcCC--CccEEEecCCcccccc
Q 047196 256 RGEIPHEIGYLPNLENLVLGFNNLV--------------------------GVVPAAIFNMS--TVKKIYLLDNSLLGSF 307 (827)
Q Consensus 256 ~~~~p~~~~~l~~L~~L~Ls~N~l~--------------------------~~~p~~~~~l~--~L~~L~l~~n~l~~~~ 307 (827)
++..|..+.. .+|++|++++|... ...+..+..+. +++.|++++|.+.+..
T Consensus 192 ~~~~~~~~~~-~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~ 270 (606)
T 3t6q_A 192 AGIEPGAFDS-AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNIS 270 (606)
T ss_dssp CEECTTTTTT-CEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCC
T ss_pred CccChhHhhh-ccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccC
Confidence 9877776654 57888888776411 01111222222 6788888888876654
Q ss_pred ChhhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEc
Q 047196 308 SLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYI 387 (827)
Q Consensus 308 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~L 387 (827)
+..+. .+++|++|++++|+++ .+|..+..+++|++|++++|.+++..|. .+..++ +|++|++
T Consensus 271 ~~~~~-~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~---------------~~~~l~-~L~~L~l 332 (606)
T 3t6q_A 271 SNTFH-CFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQI---------------SASNFP-SLTHLSI 332 (606)
T ss_dssp TTTTT-TCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGG---------------CGGGCT-TCSEEEC
T ss_pred HHHhc-cccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchh---------------hhhccC-cCCEEEC
Confidence 44343 7788888888888887 6777788888888888888887755442 333443 6777777
Q ss_pred cCCcCccccCc-cccCCCCCceEeccCccccccc--cccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcc
Q 047196 388 SNCNIGGSIPQ-LISNLSNLLLLDLEGNKLTGSI--PVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKF 464 (827)
Q Consensus 388 s~N~l~g~~p~-~~~~l~~L~~L~Ls~N~l~g~~--p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l 464 (827)
++|.+.+.+|. .+..+++|+.|++++|++++.. |..+..+++|++|++++|++.+..|..+..+++|+.|++++|++
T Consensus 333 ~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 412 (606)
T 3t6q_A 333 KGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRL 412 (606)
T ss_dssp CSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCE
T ss_pred CCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcC
Confidence 77777765554 3677777777777777777655 56677777777777777777766677777777777777777777
Q ss_pred cccCCcc-ccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCC---CCcccccccccCceEEcccceeeecc
Q 047196 465 SGSIPSC-LGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDG---PLSLDIGNLRVVIGINLSRNNFSGDI 540 (827)
Q Consensus 465 ~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g---~~p~~~~~l~~L~~L~Ls~N~l~g~i 540 (827)
++..|.. +..+++|++|++++|.+++..|..+..+++|+.|++++|.+++ ..+..++.++.|+.|++++|++++.+
T Consensus 413 ~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 492 (606)
T 3t6q_A 413 KVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSID 492 (606)
T ss_dssp ECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEEC
T ss_pred CCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccC
Confidence 7665543 6677777777777777777777777777777777777777766 22345677777777777777777777
Q ss_pred cccccCCCCCCEEECCCCcceeecCCCCc---CCceEeCcCCcCeecCCCC-CCCCCCcccccccCccccCC
Q 047196 541 PSTIGDLKDLQNISLACNGLEGLIPESFG---YLTELNLSFNKLEGEIPRG-GPFANFTAKSFMGNEKLCGL 608 (827)
Q Consensus 541 p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~---~L~~L~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~lc~~ 608 (827)
|..|+++++|+.|+|++|++++.+|..+. .| .||+++|++++.+|.. ..+..+....+.||+..|.+
T Consensus 493 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 563 (606)
T 3t6q_A 493 QHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC 563 (606)
T ss_dssp TTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSG
T ss_pred hhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccC
Confidence 77777777777777777777777776654 44 6777777777655542 23344555666777766653
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-54 Score=508.12 Aligned_cols=483 Identities=22% Similarity=0.224 Sum_probs=413.3
Q ss_pred EEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcCCCCC
Q 047196 103 LNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKL 182 (827)
Q Consensus 103 L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~l 182 (827)
++.++.+++ .+|..+.. .+++|||++|.+++..|..|.++++|++|||++|++++..|..|.++++|++|+|++|.+
T Consensus 17 ~~c~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 17 YNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp EECTTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EECCCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 444555555 45655543 789999999999999899999999999999999999999999999999999999999999
Q ss_pred CCCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEccccccccccccc
Q 047196 183 SGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHE 262 (827)
Q Consensus 183 ~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 262 (827)
++..|..+.. +++|++|++++|.+++..|..++++++|++|++++|.+++..+..+..+++|++|++++|++++..|..
T Consensus 94 ~~~~~~~~~~-l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 172 (606)
T 3t6q_A 94 IFMAETALSG-PKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED 172 (606)
T ss_dssp SEECTTTTSS-CTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHH
T ss_pred cccChhhhcc-cccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhh
Confidence 9766666555 559999999999999888889999999999999999999855445556999999999999999888999
Q ss_pred ccCcCCCc--EEEeecccCcccCchhhhcCCCccEEEecCCcccc-------------------------ccChhhhcCC
Q 047196 263 IGYLPNLE--NLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLG-------------------------SFSLGIDLSL 315 (827)
Q Consensus 263 ~~~l~~L~--~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~-------------------------~~~~~~~~~l 315 (827)
++.+++|+ +|++++|.+++..|..+. ..+|+.|++++|.... .++...+..+
T Consensus 173 ~~~l~~L~~l~L~l~~n~l~~~~~~~~~-~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l 251 (606)
T 3t6q_A 173 MSSLQQATNLSLNLNGNDIAGIEPGAFD-SAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251 (606)
T ss_dssp HHTTTTCCSEEEECTTCCCCEECTTTTT-TCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGG
T ss_pred hhhhcccceeEEecCCCccCccChhHhh-hccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchh
Confidence 99999999 999999999998877654 4689999998875211 1111111111
Q ss_pred --CCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCc
Q 047196 316 --PNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIG 393 (827)
Q Consensus 316 --~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~ 393 (827)
.+|+.|++++|++++..+..+..+++|++|++++|+++. +|..+..++ +|++|++++|+++
T Consensus 252 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~----------------lp~~l~~l~-~L~~L~l~~n~l~ 314 (606)
T 3t6q_A 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE----------------LPSGLVGLS-TLKKLVLSANKFE 314 (606)
T ss_dssp GGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCSC----------------CCSSCCSCT-TCCEEECTTCCCS
T ss_pred hcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccCC----------------CChhhcccc-cCCEEECccCCcC
Confidence 278999999999999888889999999999999999872 344455555 8999999999999
Q ss_pred cccCccccCCCCCceEeccCcccccccccc-ccCCCCCcEEECCCCCCCCCC--CccccccccccEEecCCCcccccCCc
Q 047196 394 GSIPQLISNLSNLLLLDLEGNKLTGSIPVT-FGRLQKLQGLYLPFNKLAGSI--PDQLCHLARLNTLGLAGNKFSGSIPS 470 (827)
Q Consensus 394 g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~-~~~l~~L~~L~Ls~N~l~g~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~ 470 (827)
+..|..+..+++|+.|++++|.+.+.+|.. +..+++|++|++++|.+.+.. |..+..+++|++|++++|++++..|.
T Consensus 315 ~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 394 (606)
T 3t6q_A 315 NLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTE 394 (606)
T ss_dssp BGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTT
T ss_pred cCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHH
Confidence 998999999999999999999999877664 899999999999999999776 78899999999999999999999999
Q ss_pred cccCCCCCCccccCCCcccccCCcc-ccccccccccCCCCCCCCCCCcccccccccCceEEcccceeeec---ccccccC
Q 047196 471 CLGNLTSLRSPDLGSNRLTSVLPST-FWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGD---IPSTIGD 546 (827)
Q Consensus 471 ~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~---ip~~~~~ 546 (827)
.+..+++|++|++++|.+++..|.. +..+++|+.|++++|.+++..|..++.++.|+.|++++|++++. .+..+..
T Consensus 395 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~ 474 (606)
T 3t6q_A 395 AFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQT 474 (606)
T ss_dssp TTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGG
T ss_pred HhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhcc
Confidence 9999999999999999999887654 89999999999999999999999999999999999999999873 3367999
Q ss_pred CCCCCEEECCCCcceeecCCCCc---CCceEeCcCCcCeecCCCC-CCCCCCcccccccCccccCCC
Q 047196 547 LKDLQNISLACNGLEGLIPESFG---YLTELNLSFNKLEGEIPRG-GPFANFTAKSFMGNEKLCGLP 609 (827)
Q Consensus 547 l~~L~~L~Ls~N~l~g~ip~~~~---~L~~L~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~lc~~p 609 (827)
+++|+.|++++|++++.+|..|+ +|+.|++++|++++.+|.. ..+..+ ...+.+|. +.+.+
T Consensus 475 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~-l~~~~ 539 (606)
T 3t6q_A 475 LGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNH-ISIIL 539 (606)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSC-CCCCC
T ss_pred CCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCc-ccccC
Confidence 99999999999999999998765 7899999999999988753 234444 44555553 33443
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-53 Score=503.97 Aligned_cols=489 Identities=22% Similarity=0.229 Sum_probs=425.1
Q ss_pred CcEEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEc
Q 047196 98 HRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRL 177 (827)
Q Consensus 98 ~~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L 177 (827)
.+++.|+|++|.+++..+.+|+++++|++|+|++|++++..|..|+++++|++|||++|.+++..|..+.++++|++|++
T Consensus 73 ~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 152 (680)
T 1ziw_A 73 PMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLL 152 (680)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEEC
T ss_pred cCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEc
Confidence 46888999999888766667999999999999999998777788999999999999999999888888889999999999
Q ss_pred CCCCCCCCcchhHhh-ccccccEEEeecccccccCCccCCCC---------------------------CCCcEEEccCC
Q 047196 178 DSDKLSGELPVNICN-YLHYLKVLFLAKNMFHGQIPLALSKC---------------------------KRLQLLNLGFK 229 (827)
Q Consensus 178 ~~n~l~g~ip~~~~~-~~~~L~~L~Ls~N~l~~~~p~~l~~l---------------------------~~L~~L~L~~n 229 (827)
+.|.+++..|..+.. ..++|++|++++|.+++..|..+..+ ++|+.|++++|
T Consensus 153 ~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n 232 (680)
T 1ziw_A 153 SNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNS 232 (680)
T ss_dssp CSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTS
T ss_pred cCCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCC
Confidence 999998766655432 23589999999999998888766544 56788888999
Q ss_pred CCcccCCCcCcCCcc--ccEEEcccccccccccccccCcCCCcEEEeecccCcccCchhhhcCCCccEEEecCCccccc-
Q 047196 230 KLSGAIPKEISNLTI--LRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGS- 306 (827)
Q Consensus 230 ~l~~~~p~~~~~l~~--L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~- 306 (827)
.+++..|..+.+++. |++|++++|++++..|..|+.+++|++|+|++|++++..|..+.++++|+.|++++|...+.
T Consensus 233 ~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~ 312 (680)
T 1ziw_A 233 QLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSI 312 (680)
T ss_dssp CCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC--
T ss_pred cccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhccc
Confidence 999988999988866 99999999999988889999999999999999999999999999999999999998765542
Q ss_pred ----cCh---hhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceeec-C------------CCccCCCCC
Q 047196 307 ----FSL---GIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGII-P------------NTIGLTGNP 366 (827)
Q Consensus 307 ----~~~---~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~-p------------~~~~l~~n~ 366 (827)
+|. ..+..+++|++|++++|++++..|..+.++++|++|++++|.+++.. + ..+.+++|.
T Consensus 313 ~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~ 392 (680)
T 1ziw_A 313 SLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNK 392 (680)
T ss_dssp ----CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSC
T ss_pred ccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCC
Confidence 221 12337899999999999999999999999999999999999865322 1 123478899
Q ss_pred CcccCCCchhcccccccEEEccCCcCccccC-ccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCC--CC
Q 047196 367 LDGVLPTSIGNLSMSLENIYISNCNIGGSIP-QLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLA--GS 443 (827)
Q Consensus 367 l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~--g~ 443 (827)
+++..|..+..+. +|++|++++|.+++.+| ..|.++++|+.|++++|++++..+..|..+++|+.|++++|.+. +.
T Consensus 393 l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~ 471 (680)
T 1ziw_A 393 ISKIESDAFSWLG-HLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDS 471 (680)
T ss_dssp CCEECTTTTTTCT-TCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTC
T ss_pred CCeEChhhhhCCC-CCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhcccccccccc
Confidence 9998898888887 89999999999998776 68999999999999999999999999999999999999999987 67
Q ss_pred CCccccccccccEEecCCCcccccCCccccCCCCCCccccCCCcccccCC--------ccccccccccccCCCCCCCCCC
Q 047196 444 IPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLP--------STFWNLKDILFFDLSSNSLDGP 515 (827)
Q Consensus 444 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~LdLs~N~l~g~ 515 (827)
+|..+.++++|+.|++++|++++..|..+.++++|++|++++|.+++..+ ..+.++++|+.|+|++|+++..
T Consensus 472 ~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i 551 (680)
T 1ziw_A 472 SPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEI 551 (680)
T ss_dssp SSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCC
T ss_pred CCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCC
Confidence 89999999999999999999998888889999999999999999987532 2478899999999999999965
Q ss_pred CcccccccccCceEEcccceeeecccccccCCCCCCEEECCCCcceeecCCC----CcCCceEeCcCCcCeecCCC
Q 047196 516 LSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPES----FGYLTELNLSFNKLEGEIPR 587 (827)
Q Consensus 516 ~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~----~~~L~~L~ls~N~l~g~ip~ 587 (827)
.+..+++++.|+.|++++|++++..+..|.++++|+.|+|++|++++.+|.. +.+|+.+++++|.+.+..+.
T Consensus 552 ~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 552 PVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred CHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 5567999999999999999999877778899999999999999999988864 56899999999999887653
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=504.01 Aligned_cols=483 Identities=19% Similarity=0.174 Sum_probs=389.9
Q ss_pred CcEEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEc
Q 047196 98 HRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRL 177 (827)
Q Consensus 98 ~~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L 177 (827)
.+++.|+|++|.+++..+..|.++++|++|||++|++++..|.+|.++++|++|||++|.+++..|..+.++++|++|++
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 57999999999999998889999999999999999999988999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhHhhccccccEEEeecccccc-cCCccCCCCCCCcEEEccCCCCcccCCCcCcCCcccc----EEEccc
Q 047196 178 DSDKLSGELPVNICNYLHYLKVLFLAKNMFHG-QIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILR----KISLRN 252 (827)
Q Consensus 178 ~~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~----~L~Ls~ 252 (827)
++|.+++..|..+.. +++|++|++++|.+++ .+|..++++++|++|++++|.+++..|..++.+++|+ +|++++
T Consensus 112 ~~n~l~~~~~~~~~~-l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~ 190 (606)
T 3vq2_A 112 VETKLASLESFPIGQ-LITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL 190 (606)
T ss_dssp TTSCCCCSSSSCCTT-CTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTT
T ss_pred cCCccccccccccCC-CCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccC
Confidence 999998655455544 5599999999999986 6799999999999999999999999999898888776 899999
Q ss_pred ccccccccccccCcCCCcEEEeecccCc-ccCchhhhcCCCccEEEe---------------------------------
Q 047196 253 NKLRGEIPHEIGYLPNLENLVLGFNNLV-GVVPAAIFNMSTVKKIYL--------------------------------- 298 (827)
Q Consensus 253 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~l--------------------------------- 298 (827)
|.+++..+..+.. .+|++|++++|.++ +.+|..+.+++.++.+++
T Consensus 191 n~l~~~~~~~~~~-~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~ 269 (606)
T 3vq2_A 191 NPIDFIQDQAFQG-IKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLT 269 (606)
T ss_dssp CCCCEECTTTTTT-CEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEEC
T ss_pred CCcceeCcccccC-ceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheecc
Confidence 9999665555554 48999999999987 456777888888887776
Q ss_pred cCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcc
Q 047196 299 LDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNL 378 (827)
Q Consensus 299 ~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~ 378 (827)
..|.+.+.+|. + ..+++|+.|++++|.+.. +| .+..+++|+.|++++|.+ +. +|. + .+
T Consensus 270 ~~~~~~~~~~~-~-~~l~~L~~L~l~~~~~~~-l~-~l~~~~~L~~L~l~~n~l-~~---------------lp~-~-~l 327 (606)
T 3vq2_A 270 YTNDFSDDIVK-F-HCLANVSAMSLAGVSIKY-LE-DVPKHFKWQSLSIIRCQL-KQ---------------FPT-L-DL 327 (606)
T ss_dssp CCTTCCGGGGS-C-GGGTTCSEEEEESCCCCC-CC-CCCTTCCCSEEEEESCCC-SS---------------CCC-C-CC
T ss_pred ccccccccccc-c-ccCCCCCEEEecCccchh-hh-hccccccCCEEEcccccC-cc---------------ccc-C-CC
Confidence 34444444443 2 255667777777776643 44 566666777777776666 33 332 2 33
Q ss_pred cccccEEEccCCcCccccCccccCCCCCceEeccCcccccc--ccccccCCCCCcEEECCCCCCCCCCCccccccccccE
Q 047196 379 SMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGS--IPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNT 456 (827)
Q Consensus 379 ~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~--~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 456 (827)
+ +|++|++++|...+.+ .+..+++|+.|++++|++++. +|..+..+++|++|++++|.+.+ +|..+..+++|+.
T Consensus 328 ~-~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~ 403 (606)
T 3vq2_A 328 P-FLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQH 403 (606)
T ss_dssp S-SCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCE
T ss_pred C-ccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCe
Confidence 3 7888888888665544 566788888888888888876 37778888888888888888874 6677888888888
Q ss_pred EecCCCcccccCC-ccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCC-CCcccccccccCceEEcccc
Q 047196 457 LGLAGNKFSGSIP-SCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDG-PLSLDIGNLRVVIGINLSRN 534 (827)
Q Consensus 457 L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g-~~p~~~~~l~~L~~L~Ls~N 534 (827)
|++++|++++..| ..+..+++|++|++++|.+++..|..+..+++|+.|++++|.+++ .+|..++.++.|+.|++++|
T Consensus 404 L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n 483 (606)
T 3vq2_A 404 LDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKC 483 (606)
T ss_dssp EECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTS
T ss_pred eECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCC
Confidence 8888888887777 678888888888888888888888888888888888888888887 46888888888888888888
Q ss_pred eeeecccccccCCCCCCEEECCCCcceeecCCCCc---CCceEeCcCCcCeecCCCC-CCCC-CCcccccccCccccCCC
Q 047196 535 NFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFG---YLTELNLSFNKLEGEIPRG-GPFA-NFTAKSFMGNEKLCGLP 609 (827)
Q Consensus 535 ~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~---~L~~L~ls~N~l~g~ip~~-~~~~-~~~~~~~~~n~~lc~~p 609 (827)
++++.+|..++++++|+.|+|++|++++.+|..++ +|+.||+++|+++ .+|.. ..+. ++....+.+|+..|.++
T Consensus 484 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 484 QLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred cCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 88888888888888888888888888888887664 6788888888888 56654 2222 35556677888887653
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-54 Score=522.69 Aligned_cols=509 Identities=20% Similarity=0.179 Sum_probs=360.4
Q ss_pred CcccceecCCCCCcEEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccC-ChhhhhccccceEEecCCCCCCcccc
Q 047196 86 CNWIGITCNVNSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDI-PPSIFTMHKLKFLDFSDNQLSGSLSS 164 (827)
Q Consensus 86 C~W~gv~C~~~~~~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~-p~~~~~l~~L~~LdLs~N~l~g~~p~ 164 (827)
|+|..|-+ ...+++.|||++|.+++..+.+|.++++|++|||++|.+.+.+ |.+|.++++|++|+|++|.+++..|.
T Consensus 14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~ 91 (844)
T 3j0a_A 14 CNLTQVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD 91 (844)
T ss_dssp CCSSCCCS--SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred CCCCCCCC--CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence 67888888 3468999999999999999999999999999999999777666 78899999999999999999999999
Q ss_pred ccCCCCCCcEEEcCCCCCCCCcchh-HhhccccccEEEeecccccccCC-ccCCCCCCCcEEEccCCCCcccCCCcCcCC
Q 047196 165 VTFNLSSVLDIRLDSDKLSGELPVN-ICNYLHYLKVLFLAKNMFHGQIP-LALSKCKRLQLLNLGFKKLSGAIPKEISNL 242 (827)
Q Consensus 165 ~~~~l~~L~~L~L~~n~l~g~ip~~-~~~~~~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l 242 (827)
.+.++++|++|+|++|.+++.+|.. .+..+++|++|+|++|.+++..+ ..|+++++|++|++++|.+++..|..+..+
T Consensus 92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l 171 (844)
T 3j0a_A 92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL 171 (844)
T ss_dssp SSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHH
T ss_pred HccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccc
Confidence 9999999999999999999877765 34456699999999999998765 579999999999999999999999999888
Q ss_pred --ccccEEEcccccccccccccccCcCC------CcEEEeecccCcccCchhhhcC---CCccEEEecCCcccc------
Q 047196 243 --TILRKISLRNNKLRGEIPHEIGYLPN------LENLVLGFNNLVGVVPAAIFNM---STVKKIYLLDNSLLG------ 305 (827)
Q Consensus 243 --~~L~~L~Ls~N~l~~~~p~~~~~l~~------L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~l~~n~l~~------ 305 (827)
++|+.|++++|.+.+..|..++.+++ |++|++++|.+++.+|..+... .+++.+.+..+....
T Consensus 172 ~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~ 251 (844)
T 3j0a_A 172 QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHN 251 (844)
T ss_dssp HHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSS
T ss_pred cCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccc
Confidence 89999999999999999988887776 9999999999998888776643 456666665332211
Q ss_pred ---ccChhhh-cCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceeecCCCcc---------CCCCCCcccCC
Q 047196 306 ---SFSLGID-LSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIG---------LTGNPLDGVLP 372 (827)
Q Consensus 306 ---~~~~~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~---------l~~n~l~g~~p 372 (827)
.....+. ...++|+.|++++|.+.+..|..+..+++|+.|++++|++++..|..+. +++|.+++..|
T Consensus 252 l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 331 (844)
T 3j0a_A 252 IKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYS 331 (844)
T ss_dssp STTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCS
T ss_pred cCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCH
Confidence 1111111 1135677777777777777777777777777777777777666553221 23333333333
Q ss_pred CchhcccccccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccc
Q 047196 373 TSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLA 452 (827)
Q Consensus 373 ~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~ 452 (827)
..+..++ +|+.|++++|++++..+..|..+++|+.|+|++|.+++.. .+++|+.|++++|+++ .+|.. ..
T Consensus 332 ~~~~~l~-~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~-----~~~~L~~L~l~~N~l~-~l~~~---~~ 401 (844)
T 3j0a_A 332 SNFYGLP-KVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIH-----FIPSIPDIFLSGNKLV-TLPKI---NL 401 (844)
T ss_dssp CSCSSCT-TCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCS-----SCCSCSEEEEESCCCC-CCCCC---CT
T ss_pred HHhcCCC-CCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCccc-----CCCCcchhccCCCCcc-ccccc---cc
Confidence 3444443 4555555555555444445555555555555555554311 1444444444444444 23322 23
Q ss_pred cccEEecCCCcccccC-CccccCCCCCCccccCCCcccccCCc-cccccccccccCCCCCCCC-----CCCccccccccc
Q 047196 453 RLNTLGLAGNKFSGSI-PSCLGNLTSLRSPDLGSNRLTSVLPS-TFWNLKDILFFDLSSNSLD-----GPLSLDIGNLRV 525 (827)
Q Consensus 453 ~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~LdLs~N~l~-----g~~p~~~~~l~~ 525 (827)
+++.|++++|++++.- +..+.++++|++|+|++|++++..+. .+..+++|+.|+|++|.++ +..+..+.+++.
T Consensus 402 ~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~ 481 (844)
T 3j0a_A 402 TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSH 481 (844)
T ss_dssp TCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCC
T ss_pred ccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCccc
Confidence 4455555555555321 12244667777777777777765443 3455677777777777776 334455667777
Q ss_pred CceEEcccceeeecccccccCCCCCCEEECCCCcceeecCCCC-cCCceEeCcCCcCeecCCCCCCCCCCcccccccCcc
Q 047196 526 VIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESF-GYLTELNLSFNKLEGEIPRGGPFANFTAKSFMGNEK 604 (827)
Q Consensus 526 L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~-~~L~~L~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~ 604 (827)
|+.|+|++|+|++.+|..|..+++|+.|+|++|++++.+|..+ .+|+.||+++|+++|.+|. .|..+....+.||+.
T Consensus 482 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~~L~~L~Ls~N~l~~~~~~--~~~~L~~l~l~~Np~ 559 (844)
T 3j0a_A 482 LQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPD--VFVSLSVLDITHNKF 559 (844)
T ss_dssp EECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCCSCCCEEEEEEECCCCCCSC--CCSSCCEEEEEEECC
T ss_pred ccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhhccccEEECCCCcCCCCChh--HhCCcCEEEecCCCc
Confidence 7777777777777777777777777777777777777666555 3677777777777777764 355666666777777
Q ss_pred ccCC
Q 047196 605 LCGL 608 (827)
Q Consensus 605 lc~~ 608 (827)
.|.+
T Consensus 560 ~C~c 563 (844)
T 3j0a_A 560 ICEC 563 (844)
T ss_dssp CCSS
T ss_pred cccc
Confidence 7744
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=483.70 Aligned_cols=461 Identities=18% Similarity=0.146 Sum_probs=412.1
Q ss_pred CcEEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEc
Q 047196 98 HRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRL 177 (827)
Q Consensus 98 ~~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L 177 (827)
.+++.|+|++|.+++..|.+|.++++|++|+|++|.+++..|.+|+++++|++|+|++|.+++..+..+.++++|++|++
T Consensus 56 ~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 135 (606)
T 3vq2_A 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNV 135 (606)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEEC
T ss_pred ccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeC
Confidence 57999999999999999999999999999999999999998999999999999999999999988888999999999999
Q ss_pred CCCCCCC-CcchhHhhccccccEEEeecccccccCCccCCCCCCCc----EEEccCCCCcccCCCcCcCCccccEEEccc
Q 047196 178 DSDKLSG-ELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQ----LLNLGFKKLSGAIPKEISNLTILRKISLRN 252 (827)
Q Consensus 178 ~~n~l~g-~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~----~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~ 252 (827)
++|.+.+ .+|..+.++ ++|++|++++|.+++..|..++.+++|+ +|++++|.+++..+..+... +|++|++++
T Consensus 136 ~~n~l~~~~lp~~~~~l-~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~ 213 (606)
T 3vq2_A 136 AHNFIHSCKLPAYFSNL-TNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRG 213 (606)
T ss_dssp CSSCCCCCCCCGGGGTC-TTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEES
T ss_pred CCCcccceechHhHhhc-CCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccC
Confidence 9999986 678887775 5999999999999999898888877665 89999999997777666655 899999999
Q ss_pred cccc-ccccccccCcCCCcEEEe---------------------------------ecccCcccCchhhhcCCCccEEEe
Q 047196 253 NKLR-GEIPHEIGYLPNLENLVL---------------------------------GFNNLVGVVPAAIFNMSTVKKIYL 298 (827)
Q Consensus 253 N~l~-~~~p~~~~~l~~L~~L~L---------------------------------s~N~l~~~~p~~~~~l~~L~~L~l 298 (827)
|.++ +..|..++++++|+.+++ ..|.+++.+|. +..+++|+.|++
T Consensus 214 n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l 292 (606)
T 3vq2_A 214 NFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSL 292 (606)
T ss_dssp CCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEE
T ss_pred CccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEe
Confidence 9987 466778888888887776 66777777777 889999999999
Q ss_pred cCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcc
Q 047196 299 LDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNL 378 (827)
Q Consensus 299 ~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~ 378 (827)
++|.+. .+| .+. .+++|+.|++++|++ +.+|. + .+++|+.|++++|...+.++ +..+
T Consensus 293 ~~~~~~-~l~-~l~-~~~~L~~L~l~~n~l-~~lp~-~-~l~~L~~L~l~~n~~~~~~~-----------------~~~l 349 (606)
T 3vq2_A 293 AGVSIK-YLE-DVP-KHFKWQSLSIIRCQL-KQFPT-L-DLPFLKSLTLTMNKGSISFK-----------------KVAL 349 (606)
T ss_dssp ESCCCC-CCC-CCC-TTCCCSEEEEESCCC-SSCCC-C-CCSSCCEEEEESCSSCEECC-----------------CCCC
T ss_pred cCccch-hhh-hcc-ccccCCEEEcccccC-ccccc-C-CCCccceeeccCCcCccchh-----------------hccC
Confidence 999985 455 333 788999999999999 78884 4 99999999999996654432 2233
Q ss_pred cccccEEEccCCcCccc--cCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCC-cccccccccc
Q 047196 379 SMSLENIYISNCNIGGS--IPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIP-DQLCHLARLN 455 (827)
Q Consensus 379 ~~~L~~L~Ls~N~l~g~--~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p-~~~~~l~~L~ 455 (827)
+ +|++|++++|++++. +|..+..+++|+.|++++|.+++ +|..+..+++|+.|++++|++.+..| ..+.++++|+
T Consensus 350 ~-~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~ 427 (606)
T 3vq2_A 350 P-SLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLL 427 (606)
T ss_dssp T-TCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCC
T ss_pred C-CCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCC
Confidence 3 899999999999976 48899999999999999999986 66889999999999999999998888 6899999999
Q ss_pred EEecCCCcccccCCccccCCCCCCccccCCCcccc-cCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccc
Q 047196 456 TLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTS-VLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRN 534 (827)
Q Consensus 456 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N 534 (827)
.|++++|++++..|..+..+++|++|++++|.+++ .+|..+..+++|+.|+|++|++++.+|..++.++.|+.|++++|
T Consensus 428 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 507 (606)
T 3vq2_A 428 YLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHN 507 (606)
T ss_dssp EEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCC
Confidence 99999999999999999999999999999999998 57999999999999999999999999999999999999999999
Q ss_pred eeeecccccccCCCCCCEEECCCCcceeecCCCCc----CCceEeCcCCcCeecCCC
Q 047196 535 NFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFG----YLTELNLSFNKLEGEIPR 587 (827)
Q Consensus 535 ~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~----~L~~L~ls~N~l~g~ip~ 587 (827)
++++.+|..++++++|+.|||++|+++. +|..+. +|+.|++++|++.+..+.
T Consensus 508 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 508 NLLFLDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp CCSCEEGGGTTTCTTCCEEECTTSCCCC-EESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred cCCCcCHHHccCCCcCCEEECCCCcCcc-cCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 9999999999999999999999999994 565443 599999999999986664
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=470.47 Aligned_cols=478 Identities=20% Similarity=0.206 Sum_probs=306.3
Q ss_pred CCcccceecCCCC-----------CcEEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEe
Q 047196 85 VCNWIGITCNVNS-----------HRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDF 153 (827)
Q Consensus 85 ~C~W~gv~C~~~~-----------~~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdL 153 (827)
.|.|.|| |+... .+++.|+|++|.+++..|.+|.++++|++|+|++|++++..|.+|.++++|++|||
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 4899998 86431 24555566665555555555555666666666666555555555555566666666
Q ss_pred cCCCCCCccccccCCCCCCcEEEcCCCCCCC-CcchhHhhccccccEEEeecccccccCC-ccCCCCCCCcEEEccCCCC
Q 047196 154 SDNQLSGSLSSVTFNLSSVLDIRLDSDKLSG-ELPVNICNYLHYLKVLFLAKNMFHGQIP-LALSKCKRLQLLNLGFKKL 231 (827)
Q Consensus 154 s~N~l~g~~p~~~~~l~~L~~L~L~~n~l~g-~ip~~~~~~~~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~L~~n~l 231 (827)
++|++++..|..+.++++|++|++++|.+++ .+|..+.. +++|++|++++|.+.+.+| ..+.++++|++|++++|.+
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~-l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l 160 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPN-LTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL 160 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTT-CTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhc-cCCccEEECCCCccccccCHhhhhcccccCeeeccCCcc
Confidence 6666555555555555555555555555553 23333322 3355555555555333333 3555555555555555555
Q ss_pred cccCCCcCcCCccccEEEccccccccccccc-ccCcCCCcEEEeecccCcccC--ch-hhhcCCCccEEEecCCcccccc
Q 047196 232 SGAIPKEISNLTILRKISLRNNKLRGEIPHE-IGYLPNLENLVLGFNNLVGVV--PA-AIFNMSTVKKIYLLDNSLLGSF 307 (827)
Q Consensus 232 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~--p~-~~~~l~~L~~L~l~~n~l~~~~ 307 (827)
++.+|..++++++|++|++++|.+. .+|.. +..+++|++|++++|++++.. |. ....+++|+.|++++|.+.+..
T Consensus 161 ~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~ 239 (549)
T 2z81_A 161 RNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDES 239 (549)
T ss_dssp CEECTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHH
T ss_pred cccChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhH
Confidence 5555555555555555555555554 23332 234555555555555555431 11 1123445555555555554433
Q ss_pred Chhhh---cCCCCccEEeCcCCcccccc------CccccCCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcc
Q 047196 308 SLGID---LSLPNVERLNLGLNRFSGTI------PSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNL 378 (827)
Q Consensus 308 ~~~~~---~~l~~L~~L~L~~N~l~~~~------p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~ 378 (827)
+..+. ..+++|+.+++++|.+.+.. ...+..+.+|+.|++.++.+..... ...++... ..
T Consensus 240 ~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~----------~~~l~~~~-~~ 308 (549)
T 2z81_A 240 FNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYL----------FYDLSTVY-SL 308 (549)
T ss_dssp HHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGG----------SCCCCHHH-HH
T ss_pred HHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhh----------cccchhhh-hh
Confidence 32221 13445555555555554421 1123344555555555554322100 00111111 22
Q ss_pred cccccEEEccCCcCccccCccc-cCCCCCceEeccCccccccccc---cccCCCCCcEEECCCCCCCCCCC--ccccccc
Q 047196 379 SMSLENIYISNCNIGGSIPQLI-SNLSNLLLLDLEGNKLTGSIPV---TFGRLQKLQGLYLPFNKLAGSIP--DQLCHLA 452 (827)
Q Consensus 379 ~~~L~~L~Ls~N~l~g~~p~~~-~~l~~L~~L~Ls~N~l~g~~p~---~~~~l~~L~~L~Ls~N~l~g~~p--~~~~~l~ 452 (827)
..+|+.|++++|+++ .+|..+ ..+++|++|++++|++++.+|. .++.+++|++|+|++|++++..+ ..+..++
T Consensus 309 ~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~ 387 (549)
T 2z81_A 309 LEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLK 387 (549)
T ss_dssp STTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCT
T ss_pred cccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCC
Confidence 237999999999987 566655 5799999999999999987753 47889999999999999986533 4588899
Q ss_pred cccEEecCCCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcc
Q 047196 453 RLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLS 532 (827)
Q Consensus 453 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls 532 (827)
+|++|++++|+++ .+|..+..+++|++|++++|.+++. |..+ .++|++|||++|++++.+ +.++.|+.|+++
T Consensus 388 ~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~l-~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls 459 (549)
T 2z81_A 388 NLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVV-KTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQELYIS 459 (549)
T ss_dssp TCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSCC-CTTS--CTTCSEEECCSSCCSCCC----CCCTTCCEEECC
T ss_pred CCCEEECCCCCCc-cCChhhcccccccEEECCCCCcccc-cchh--cCCceEEECCCCChhhhc----ccCChhcEEECC
Confidence 9999999999998 6888899999999999999998853 4333 258899999999999854 578899999999
Q ss_pred cceeeecccccccCCCCCCEEECCCCcceeecCCCC---cCCceEeCcCCcCeecCCC
Q 047196 533 RNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESF---GYLTELNLSFNKLEGEIPR 587 (827)
Q Consensus 533 ~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~---~~L~~L~ls~N~l~g~ip~ 587 (827)
+|+|+ .+|. .+.+++|+.|||++|++++.+|..+ .+|+.|++++|+++|..|.
T Consensus 460 ~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 515 (549)
T 2z81_A 460 RNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 515 (549)
T ss_dssp SSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHH
T ss_pred CCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCcc
Confidence 99998 6776 5678999999999999999888765 4789999999999887773
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=486.92 Aligned_cols=461 Identities=20% Similarity=0.187 Sum_probs=393.8
Q ss_pred CcEEEEEcCCCCCcccc-CccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccc--cCCCCCCcE
Q 047196 98 HRVTALNISSLNLQGTI-PPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSV--TFNLSSVLD 174 (827)
Q Consensus 98 ~~v~~L~L~~~~l~g~~-~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~--~~~l~~L~~ 174 (827)
.+++.|||++|...+.+ |.+|.++++|++|+|++|.+++..|.+|.++++|++|||++|.+++.+|.. +.++++|++
T Consensus 48 ~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~ 127 (844)
T 3j0a_A 48 EQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTR 127 (844)
T ss_dssp CSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCE
T ss_pred ccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCE
Confidence 57899999999777777 678999999999999999999999999999999999999999999877665 889999999
Q ss_pred EEcCCCCCCCCcchhHhhccccccEEEeecccccccCCccCCCC--CCCcEEEccCCCCcccCCCcCcCCcc------cc
Q 047196 175 IRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKC--KRLQLLNLGFKKLSGAIPKEISNLTI------LR 246 (827)
Q Consensus 175 L~L~~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~------L~ 246 (827)
|+|++|.+++..|...+..+++|++|+|++|.+++..|..+..+ ++|+.|+++.|.+++..|..++.+.+ |+
T Consensus 128 L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~ 207 (844)
T 3j0a_A 128 LDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLE 207 (844)
T ss_dssp EEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBS
T ss_pred EECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCcee
Confidence 99999999987665555556699999999999999999999888 89999999999999999888877766 99
Q ss_pred EEEcccccccccccccccCc--------------------------------------CCCcEEEeecccCcccCchhhh
Q 047196 247 KISLRNNKLRGEIPHEIGYL--------------------------------------PNLENLVLGFNNLVGVVPAAIF 288 (827)
Q Consensus 247 ~L~Ls~N~l~~~~p~~~~~l--------------------------------------~~L~~L~Ls~N~l~~~~p~~~~ 288 (827)
+|++++|.+++..|..+... ++|++|+|++|.+++..|..+.
T Consensus 208 ~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~ 287 (844)
T 3j0a_A 208 ILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFE 287 (844)
T ss_dssp EEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSS
T ss_pred EEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhh
Confidence 99999998887776655422 5788888888888888888888
Q ss_pred cCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceeecCCCccCCCCCCc
Q 047196 289 NMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLD 368 (827)
Q Consensus 289 ~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~ 368 (827)
.+++|+.|++++|.+.+..+..+. .+++|++|+|++|++++..|..+..+++|+.|++++|.+++..+
T Consensus 288 ~l~~L~~L~L~~n~i~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~----------- 355 (844)
T 3j0a_A 288 TLKDLKVLNLAYNKINKIADEAFY-GLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQD----------- 355 (844)
T ss_dssp SCCCCCEEEEESCCCCEECTTTTT-TCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCS-----------
T ss_pred cCCCCCEEECCCCcCCCCChHHhc-CCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccCh-----------
Confidence 888888888888888776665554 77888888888888888778888888888888888888765443
Q ss_pred ccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCC-Ccc
Q 047196 369 GVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSI-PDQ 447 (827)
Q Consensus 369 g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~-p~~ 447 (827)
..+..++ +|++|++++|.+++. ..+++|+.|++++|+++. +|.. ..+++.|++++|++++.. +..
T Consensus 356 ----~~~~~l~-~L~~L~Ls~N~l~~i-----~~~~~L~~L~l~~N~l~~-l~~~---~~~l~~L~ls~N~l~~l~~~~~ 421 (844)
T 3j0a_A 356 ----QTFKFLE-KLQTLDLRDNALTTI-----HFIPSIPDIFLSGNKLVT-LPKI---NLTANLIHLSENRLENLDILYF 421 (844)
T ss_dssp ----SCSCSCC-CCCEEEEETCCSCCC-----SSCCSCSEEEEESCCCCC-CCCC---CTTCCEEECCSCCCCSSTTHHH
T ss_pred ----hhhcCCC-CCCEEECCCCCCCcc-----cCCCCcchhccCCCCccc-cccc---ccccceeecccCccccCchhhh
Confidence 2344444 899999999999853 237899999999999984 4543 568999999999998643 234
Q ss_pred ccccccccEEecCCCcccccCCc-cccCCCCCCccccCCCccc-----ccCCccccccccccccCCCCCCCCCCCccccc
Q 047196 448 LCHLARLNTLGLAGNKFSGSIPS-CLGNLTSLRSPDLGSNRLT-----SVLPSTFWNLKDILFFDLSSNSLDGPLSLDIG 521 (827)
Q Consensus 448 ~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~ 521 (827)
+.++++|+.|+|++|++++..+. .+..+++|+.|+|++|.++ +..|..|.++++|+.|||++|++++.+|..+.
T Consensus 422 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 501 (844)
T 3j0a_A 422 LLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFS 501 (844)
T ss_dssp HTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSS
T ss_pred hhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHcc
Confidence 56899999999999999975543 4567899999999999997 45567789999999999999999999999999
Q ss_pred ccccCceEEcccceeeecccccccCCCCCCEEECCCCcceeecCCCCcCCceEeCcCCcCeecCC
Q 047196 522 NLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFGYLTELNLSFNKLEGEIP 586 (827)
Q Consensus 522 ~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~L~~L~ls~N~l~g~ip 586 (827)
.++.|+.|+|++|+|++..|..+. ++|+.|||++|++++.+|..|.+|+.|++++|.+.+..+
T Consensus 502 ~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 502 HLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECE 564 (844)
T ss_dssp SCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSS
T ss_pred chhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhCCcCEEEecCCCcccccc
Confidence 999999999999999988777776 899999999999999999999999999999999987665
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=465.19 Aligned_cols=464 Identities=20% Similarity=0.195 Sum_probs=358.6
Q ss_pred CcEEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEc
Q 047196 98 HRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRL 177 (827)
Q Consensus 98 ~~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L 177 (827)
.+++.|||++|.+++..+.+|.++++|++|||++|++++..|..|.++++|++|+|++|++++..|..+.++++|++|++
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 47899999999999988889999999999999999999888888999999999999999999888889999999999999
Q ss_pred CCCCCCCCcchhHhhccccccEEEeecccccc-cCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccc----cEEEccc
Q 047196 178 DSDKLSGELPVNICNYLHYLKVLFLAKNMFHG-QIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTIL----RKISLRN 252 (827)
Q Consensus 178 ~~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L----~~L~Ls~ 252 (827)
++|.+++ +|...+..+++|++|++++|.+++ .+|..++++++|++|++++|.+++..|..++.+++| +.|++++
T Consensus 108 ~~n~l~~-l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~ 186 (570)
T 2z63_A 108 VETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186 (570)
T ss_dssp TTSCCCC-STTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred ccccccc-CCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCC
Confidence 9999985 444223445699999999999987 579999999999999999999998888889888888 8999999
Q ss_pred ccccccccccccCcCCCcEEEeecccCcc-cCchhhhcCCCccE--------------------------------EEec
Q 047196 253 NKLRGEIPHEIGYLPNLENLVLGFNNLVG-VVPAAIFNMSTVKK--------------------------------IYLL 299 (827)
Q Consensus 253 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~--------------------------------L~l~ 299 (827)
|.+++..|..+..+ +|++|++++|.... .+|..+.+++.++. +++.
T Consensus 187 n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~ 265 (570)
T 2z63_A 187 NPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265 (570)
T ss_dssp CCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEE
T ss_pred CCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhh
Confidence 99998888777766 79999999885432 23344444444443 3333
Q ss_pred CC-ccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcc
Q 047196 300 DN-SLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNL 378 (827)
Q Consensus 300 ~n-~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~ 378 (827)
.+ .+.+.++..+. .+++|+.|++++|+++ .+|..+..+ +|+.|++++|.+. . +|. ..+
T Consensus 266 ~~~~~~~~~~~~~~-~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~---------------l~~--~~l 324 (570)
T 2z63_A 266 YLDYYLDDIIDLFN-CLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-Q---------------FPT--LKL 324 (570)
T ss_dssp ETTEEESCSTTTTG-GGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-S---------------CCB--CBC
T ss_pred cchhhhhhchhhhc-CcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-c---------------cCc--ccc
Confidence 33 33333443333 4566677777776666 356666666 6777777666654 2 222 122
Q ss_pred cccccEEEccCCcCccccCccccCCCCCceEeccCccccccc--cccccCCCCCcEEECCCCCCCCCCCccccccccccE
Q 047196 379 SMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSI--PVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNT 456 (827)
Q Consensus 379 ~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~--p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 456 (827)
+ +|+.|++++|.+.+.++. ..+++|+.|++++|++++.. |..+..+++|++|++++|.+.+..+ .+..+++|+.
T Consensus 325 ~-~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~l~~L~~ 400 (570)
T 2z63_A 325 K-SLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSS-NFLGLEQLEH 400 (570)
T ss_dssp S-SCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEE-EEETCTTCCE
T ss_pred c-ccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccc-cccccCCCCE
Confidence 2 678888888887776665 66788888888888887654 6677788888888888888875443 3777888888
Q ss_pred EecCCCcccccCC-ccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCC-CCCcccccccccCceEEcccc
Q 047196 457 LGLAGNKFSGSIP-SCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLD-GPLSLDIGNLRVVIGINLSRN 534 (827)
Q Consensus 457 L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~-g~~p~~~~~l~~L~~L~Ls~N 534 (827)
|++++|++++..| ..+.++++|++|++++|.+.+..|..+.++++|+.|++++|.++ +.+|..++.++.|+.|++++|
T Consensus 401 L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n 480 (570)
T 2z63_A 401 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480 (570)
T ss_dssp EECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTS
T ss_pred EEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCC
Confidence 8888888877665 46777888888888888888888888888888888888888887 567778888888888888888
Q ss_pred eeeecccccccCCCCCCEEECCCCcceeecCCCC---cCCceEeCcCCcCeecCCCC
Q 047196 535 NFSGDIPSTIGDLKDLQNISLACNGLEGLIPESF---GYLTELNLSFNKLEGEIPRG 588 (827)
Q Consensus 535 ~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~---~~L~~L~ls~N~l~g~ip~~ 588 (827)
++++..|..++++++|+.|++++|++++.+|..+ .+|+.|++++|+++|.+|..
T Consensus 481 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~ 537 (570)
T 2z63_A 481 QLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537 (570)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred ccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcch
Confidence 8888778888888888888888888888777655 36778888888888777753
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=452.79 Aligned_cols=478 Identities=21% Similarity=0.258 Sum_probs=405.9
Q ss_pred EEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcCCCCC
Q 047196 103 LNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKL 182 (827)
Q Consensus 103 L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~l 182 (827)
++-++.+++ .+|..+. +++++|||++|++++..+.+|.++++|++|||++|++++..|..+.++++|++|+|++|.+
T Consensus 12 ~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 88 (570)
T 2z63_A 12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88 (570)
T ss_dssp EECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcC
Confidence 344444554 3455443 5799999999999988888999999999999999999998888999999999999999999
Q ss_pred CCCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcc-cCCCcCcCCccccEEEcccccccccccc
Q 047196 183 SGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSG-AIPKEISNLTILRKISLRNNKLRGEIPH 261 (827)
Q Consensus 183 ~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 261 (827)
++ +|+..+..+++|++|++++|.+++..+..++++++|++|++++|.+++ .+|..++++++|++|++++|++++..|.
T Consensus 89 ~~-~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~ 167 (570)
T 2z63_A 89 QS-LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 167 (570)
T ss_dssp CE-ECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGG
T ss_pred Cc-cCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHH
Confidence 86 444444446699999999999998777789999999999999999987 5799999999999999999999988889
Q ss_pred cccCcCCC----cEEEeecccCcccCchhhhcCCCccEEEecCCccccc-cChhhhcCCC--------------------
Q 047196 262 EIGYLPNL----ENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGS-FSLGIDLSLP-------------------- 316 (827)
Q Consensus 262 ~~~~l~~L----~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~~l~-------------------- 316 (827)
.++.+++| +.|++++|.+++..|..+... +|+.|++++|..... ++..+ ..++
T Consensus 168 ~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~-~~l~~l~~~~l~~~~~~~~~~l~~ 245 (570)
T 2z63_A 168 DLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCI-QGLAGLEVHRLVLGEFRNEGNLEK 245 (570)
T ss_dssp GGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHH-HTTTTCEEEEEEEEECCCCSSCEE
T ss_pred HccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhh-cCccccceeeeccccccCchhhhh
Confidence 99999999 899999999999888877665 899999998843221 11111 0111
Q ss_pred ------------CccEEeCcCC-ccccccCccccCCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhccccccc
Q 047196 317 ------------NVERLNLGLN-RFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLE 383 (827)
Q Consensus 317 ------------~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~ 383 (827)
.++.++++.+ .+.+.+|..+..+++|+.|++++|.+++ +|..+... +|+
T Consensus 246 ~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~----------------l~~~~~~~--~L~ 307 (570)
T 2z63_A 246 FDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER----------------VKDFSYNF--GWQ 307 (570)
T ss_dssp CCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEECS----------------CCBCCSCC--CCS
T ss_pred cchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccchh----------------hhhhhccC--Ccc
Confidence 2456666666 7778888899999999999999998863 33344444 799
Q ss_pred EEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCC--CccccccccccEEecCC
Q 047196 384 NIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSI--PDQLCHLARLNTLGLAG 461 (827)
Q Consensus 384 ~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~--p~~~~~l~~L~~L~Ls~ 461 (827)
+|++++|.+. .+|. ..+++|+.|++++|.+.+..+. ..+++|+.|++++|++++.. |..+.++++|++|++++
T Consensus 308 ~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~ 382 (570)
T 2z63_A 308 HLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSF 382 (570)
T ss_dssp EEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCS
T ss_pred EEeeccCccc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCC
Confidence 9999999998 6665 4789999999999999887765 78999999999999998654 77888999999999999
Q ss_pred CcccccCCccccCCCCCCccccCCCcccccCC-ccccccccccccCCCCCCCCCCCcccccccccCceEEcccceee-ec
Q 047196 462 NKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLP-STFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFS-GD 539 (827)
Q Consensus 462 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~-g~ 539 (827)
|++++..+. +..+++|+.|++++|.+.+..| ..+.++++|++|++++|.+++.+|..+..++.|+.|++++|+++ +.
T Consensus 383 n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 461 (570)
T 2z63_A 383 NGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 461 (570)
T ss_dssp CSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGE
T ss_pred Ccccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCcccc
Confidence 999965554 9999999999999999998877 57899999999999999999999999999999999999999998 68
Q ss_pred ccccccCCCCCCEEECCCCcceeecCCCCc---CCceEeCcCCcCeecCCCC-CCCCCCcccccccCccccCCCC
Q 047196 540 IPSTIGDLKDLQNISLACNGLEGLIPESFG---YLTELNLSFNKLEGEIPRG-GPFANFTAKSFMGNEKLCGLPN 610 (827)
Q Consensus 540 ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~---~L~~L~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~lc~~p~ 610 (827)
+|..++.+++|+.|++++|++++.+|..+. +|++|++++|++++.+|.. ..+..+....+.+|+..|.+|.
T Consensus 462 ~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 462 LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp ECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred chhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 999999999999999999999999998765 7999999999999877753 4566777788899998887654
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-49 Score=470.87 Aligned_cols=436 Identities=20% Similarity=0.223 Sum_probs=355.5
Q ss_pred CCCCEEECCCCCCCccCChhhhhccccceEEe-cCCCCCCccccccCCC----CCCc--EEE----------cCCCCCCC
Q 047196 122 SSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDF-SDNQLSGSLSSVTFNL----SSVL--DIR----------LDSDKLSG 184 (827)
Q Consensus 122 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdL-s~N~l~g~~p~~~~~l----~~L~--~L~----------L~~n~l~g 184 (827)
.+++.|+|++|+++|.+|+++++|++|++||| ++|.++|..|...... +..+ .++ .....+++
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 57899999999999999999999999999999 9999988744332111 0000 000 00001111
Q ss_pred CcchhHh----------hccccccEEEee--cccccccCCccCCCCCCCcEEEccCCCCcc-----------------cC
Q 047196 185 ELPVNIC----------NYLHYLKVLFLA--KNMFHGQIPLALSKCKRLQLLNLGFKKLSG-----------------AI 235 (827)
Q Consensus 185 ~ip~~~~----------~~~~~L~~L~Ls--~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~-----------------~~ 235 (827)
.++..+. .....++.+.+. .|.+++ +|..++++++|++|+|++|.+++ .+
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i 481 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence 1111111 001134444444 488888 89999999999999999999998 49
Q ss_pred CCcCc--CCccccEEEcccccccccccccccCcCCCcEEEeeccc-Ccc-cCchhhhcCC-------CccEEEecCCccc
Q 047196 236 PKEIS--NLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNN-LVG-VVPAAIFNMS-------TVKKIYLLDNSLL 304 (827)
Q Consensus 236 p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~-~~p~~~~~l~-------~L~~L~l~~n~l~ 304 (827)
|..++ ++++|++|+|++|++.+.+|..++++++|++|+|++|+ ++| .+|..+.+++ +|+.|++++|.+.
T Consensus 482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~ 561 (876)
T 4ecn_A 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561 (876)
T ss_dssp TSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred ChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence 99988 99999999999999999999999999999999999998 999 8999888776 9999999999999
Q ss_pred cccCh--hhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhccccc-
Q 047196 305 GSFSL--GIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMS- 381 (827)
Q Consensus 305 ~~~~~--~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~- 381 (827)
.+|. .+. .+++|+.|+|++|+++ .+| .+..+++|+.|++++|.++ . +|..+..+. +
T Consensus 562 -~ip~~~~l~-~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~---------------lp~~l~~l~-~~ 620 (876)
T 4ecn_A 562 -EFPASASLQ-KMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-E---------------IPEDFCAFT-DQ 620 (876)
T ss_dssp -BCCCHHHHT-TCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-C---------------CCTTSCEEC-TT
T ss_pred -ccCChhhhh-cCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-c---------------chHHHhhcc-cc
Confidence 8887 555 8999999999999999 888 8999999999999999987 3 344556665 5
Q ss_pred ccEEEccCCcCccccCccccCCCC--CceEeccCccccccccccc---c--CCCCCcEEECCCCCCCCCCCccc-ccccc
Q 047196 382 LENIYISNCNIGGSIPQLISNLSN--LLLLDLEGNKLTGSIPVTF---G--RLQKLQGLYLPFNKLAGSIPDQL-CHLAR 453 (827)
Q Consensus 382 L~~L~Ls~N~l~g~~p~~~~~l~~--L~~L~Ls~N~l~g~~p~~~---~--~l~~L~~L~Ls~N~l~g~~p~~~-~~l~~ 453 (827)
|+.|+|++|+++ .+|..+..++. |+.|+|++|+++|.+|... . .+++|+.|+|++|+++ .+|..+ ..+++
T Consensus 621 L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~ 698 (876)
T 4ecn_A 621 VEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSP 698 (876)
T ss_dssp CCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCC
T ss_pred CCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCC
Confidence 999999999999 78988887765 9999999999999876433 2 3458999999999999 667665 47899
Q ss_pred ccEEecCCCcccccCCccccCC--------CCCCccccCCCcccccCCcccc--ccccccccCCCCCCCCCCCccccccc
Q 047196 454 LNTLGLAGNKFSGSIPSCLGNL--------TSLRSPDLGSNRLTSVLPSTFW--NLKDILFFDLSSNSLDGPLSLDIGNL 523 (827)
Q Consensus 454 L~~L~Ls~N~l~~~~p~~~~~l--------~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~LdLs~N~l~g~~p~~~~~l 523 (827)
|+.|+|++|+++ .+|..+... ++|+.|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..++.+
T Consensus 699 L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L 775 (876)
T 4ecn_A 699 ISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNS 775 (876)
T ss_dssp CSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGC
T ss_pred CCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcC
Confidence 999999999999 777765443 38999999999999 6788887 89999999999999998 78888899
Q ss_pred ccCceEEcccceeeecccccccCCCCCCEEECCCCcceeecCCCCc---CCceEeCcCCcCeecCCCCCCCCCCcccccc
Q 047196 524 RVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFG---YLTELNLSFNKLEGEIPRGGPFANFTAKSFM 600 (827)
Q Consensus 524 ~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~---~L~~L~ls~N~l~g~ip~~~~~~~~~~~~~~ 600 (827)
++|+.|+|++|+ ++++|++.+.+|..+. +|+.|++++|++ +.||.. .+..+....+.
T Consensus 776 ~~L~~L~Ls~N~------------------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~-l~~~L~~LdLs 835 (876)
T 4ecn_A 776 SQLKAFGIRHQR------------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEK-LTPQLYILDIA 835 (876)
T ss_dssp TTCCEEECCCCB------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-CCSSSCEEECC
T ss_pred CCCCEEECCCCC------------------CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHh-hcCCCCEEECC
Confidence 999999999988 7889999999998775 789999999999 899986 34566667777
Q ss_pred cCcc
Q 047196 601 GNEK 604 (827)
Q Consensus 601 ~n~~ 604 (827)
+|+.
T Consensus 836 ~N~l 839 (876)
T 4ecn_A 836 DNPN 839 (876)
T ss_dssp SCTT
T ss_pred CCCC
Confidence 7753
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=467.91 Aligned_cols=492 Identities=20% Similarity=0.246 Sum_probs=388.2
Q ss_pred CCHHHHHHHHHHHhhcCCCCCCcCCCCCCCCC---CCCcccc-eecCCC--CCcEEEEEcCCCCCccccCccccCCCCCC
Q 047196 52 NITTDQQALLALKAHISYDPTNLLAQNSTSNT---SVCNWIG-ITCNVN--SHRVTALNISSLNLQGTIPPQLGNLSSLT 125 (827)
Q Consensus 52 ~~~~~~~aLl~~k~~~~~~~~~~l~~w~~~~~---~~C~W~g-v~C~~~--~~~v~~L~L~~~~l~g~~~~~l~~L~~L~ 125 (827)
....+.+.-.++++-...- + -..|...+. ..|.|.. ..|+.. ...|+. .. . .+++
T Consensus 24 ~~~~~~~d~~aL~~~~~~~--~-~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C---~~---------~----~~V~ 84 (636)
T 4eco_A 24 RTAEYIKDYLALKEIWDAL--N-GKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSL---NS---------N----GRVT 84 (636)
T ss_dssp CCCHHHHHHHHHHHHHHHT--T-GGGCCCCC------CCCCCSSCGGGTTCCTTEEE---CT---------T----CCEE
T ss_pred hhhhHHHHHHHHHHHHHHc--C-CCCcccCCcCCccCCCCCCCCCcccccCCCCeEE---cC---------C----CCEE
Confidence 3445556677777665221 1 235763332 2358963 333322 134553 00 0 4788
Q ss_pred EEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcCCCCCCCCcchhHhhccccccEEEeecc
Q 047196 126 TLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKN 205 (827)
Q Consensus 126 ~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~~L~Ls~N 205 (827)
.|+|++|+++|.+|+++++|++|++|||++|.+.... ..++.. .+...+|... ...|+ ++++.|
T Consensus 85 ~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~-~~~~~~-----------~~~~~~~~~~---~~~l~-l~l~~~ 148 (636)
T 4eco_A 85 GLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNE-RLFGPK-----------GISANMSDEQ---KQKMR-MHYQKT 148 (636)
T ss_dssp EEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTC-CSBSTT-----------SBCTTCCHHH---HHHHH-THHHHH
T ss_pred EEEecCcccCCcCChHHhcCccceEEECcCCccccCC-cccccc-----------ccccCchHHH---HHHHH-hhHHHh
Confidence 9999999999999999999999999999999872110 000000 0001234433 12344 555555
Q ss_pred cccccCCccCC-------------------CCCCCcEEEcc--CCCCcccCCCcCcCCccccEEEccccccccc------
Q 047196 206 MFHGQIPLALS-------------------KCKRLQLLNLG--FKKLSGAIPKEISNLTILRKISLRNNKLRGE------ 258 (827)
Q Consensus 206 ~l~~~~p~~l~-------------------~l~~L~~L~L~--~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~------ 258 (827)
.+.+.+|..+. ....++.+.++ .|+++| +|.+++++++|++|+|++|+++|.
T Consensus 149 ~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~ 227 (636)
T 4eco_A 149 FVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAW 227 (636)
T ss_dssp HTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSC
T ss_pred hhccCchhhHHHHHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccc
Confidence 55555544443 12233333333 588999 999999999999999999999986
Q ss_pred -----------cccccc--CcCCCcEEEeecccCcccCchhhhcCCCccEEEecCCc-ccc-ccChhhhcCC------CC
Q 047196 259 -----------IPHEIG--YLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNS-LLG-SFSLGIDLSL------PN 317 (827)
Q Consensus 259 -----------~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~-l~~-~~~~~~~~~l------~~ 317 (827)
+|..++ ++++|++|+|++|++.+.+|..+.++++|+.|++++|. ++| .+|..+. .+ ++
T Consensus 228 ~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~-~L~~~~~l~~ 306 (636)
T 4eco_A 228 ENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQ-ALADAPVGEK 306 (636)
T ss_dssp SCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHH-HHHHSGGGGT
T ss_pred cccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHH-hhhccccCCC
Confidence 999999 99999999999999999999999999999999999998 998 8888776 44 89
Q ss_pred ccEEeCcCCccccccCc--cccCCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccc
Q 047196 318 VERLNLGLNRFSGTIPS--FITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGS 395 (827)
Q Consensus 318 L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~ 395 (827)
|++|++++|+++ .+|. .++++++|+.|++++|+++|.+| .+..+. +|++|++++|+++ .
T Consensus 307 L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip----------------~~~~l~-~L~~L~L~~N~l~-~ 367 (636)
T 4eco_A 307 IQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP----------------AFGSEI-KLASLNLAYNQIT-E 367 (636)
T ss_dssp CCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC----------------CCEEEE-EESEEECCSSEEE-E
T ss_pred CCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh----------------hhCCCC-CCCEEECCCCccc-c
Confidence 999999999999 8998 99999999999999999987766 233444 8999999999999 8
Q ss_pred cCccccCCCC-CceEeccCccccccccccccCCC--CCcEEECCCCCCCCCCCcccc-------ccccccEEecCCCccc
Q 047196 396 IPQLISNLSN-LLLLDLEGNKLTGSIPVTFGRLQ--KLQGLYLPFNKLAGSIPDQLC-------HLARLNTLGLAGNKFS 465 (827)
Q Consensus 396 ~p~~~~~l~~-L~~L~Ls~N~l~g~~p~~~~~l~--~L~~L~Ls~N~l~g~~p~~~~-------~l~~L~~L~Ls~N~l~ 465 (827)
+|..+..+++ |+.|++++|+++ .+|..+..++ +|+.|++++|++++.+|..+. .+++|+.|++++|+++
T Consensus 368 lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~ 446 (636)
T 4eco_A 368 IPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS 446 (636)
T ss_dssp CCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCC
T ss_pred ccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccC
Confidence 8999999999 999999999999 7888887765 999999999999999999988 8889999999999999
Q ss_pred ccCCcc-ccCCCCCCccccCCCcccccCCcc-cccc-------ccccccCCCCCCCCCCCccccc--ccccCceEEcccc
Q 047196 466 GSIPSC-LGNLTSLRSPDLGSNRLTSVLPST-FWNL-------KDILFFDLSSNSLDGPLSLDIG--NLRVVIGINLSRN 534 (827)
Q Consensus 466 ~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l-------~~L~~LdLs~N~l~g~~p~~~~--~l~~L~~L~Ls~N 534 (827)
.+|.. +..+++|++|+|++|.++ .+|.. +... ++|+.|+|++|+++ .+|..+. .++.|+.|+|++|
T Consensus 447 -~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N 523 (636)
T 4eco_A 447 -KFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYN 523 (636)
T ss_dssp -SCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSS
T ss_pred -cCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCC
Confidence 56654 556999999999999999 45544 4333 39999999999999 7888887 9999999999999
Q ss_pred eeeecccccccCCCCCCEEEC------CCCcceeecCCCCc---CCceEeCcCCcCeecCCCCCCCCCCcccccccCccc
Q 047196 535 NFSGDIPSTIGDLKDLQNISL------ACNGLEGLIPESFG---YLTELNLSFNKLEGEIPRGGPFANFTAKSFMGNEKL 605 (827)
Q Consensus 535 ~l~g~ip~~~~~l~~L~~L~L------s~N~l~g~ip~~~~---~L~~L~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~l 605 (827)
+|++ +|..++++++|+.|+| ++|++.+.+|..+. +|+.|++++|++ +.||.. .+..+....+.+|+..
T Consensus 524 ~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~-~~~~L~~L~Ls~N~l~ 600 (636)
T 4eco_A 524 SFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEK-ITPNISVLDIKDNPNI 600 (636)
T ss_dssp CCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-CCTTCCEEECCSCTTC
T ss_pred CCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHh-HhCcCCEEECcCCCCc
Confidence 9998 9999999999999999 56889999998775 789999999999 899976 3367777778888766
Q ss_pred c
Q 047196 606 C 606 (827)
Q Consensus 606 c 606 (827)
|
T Consensus 601 ~ 601 (636)
T 4eco_A 601 S 601 (636)
T ss_dssp E
T ss_pred c
Confidence 5
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=448.81 Aligned_cols=490 Identities=19% Similarity=0.228 Sum_probs=401.2
Q ss_pred ecCCCCCcEEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCC
Q 047196 92 TCNVNSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSS 171 (827)
Q Consensus 92 ~C~~~~~~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~ 171 (827)
.|... .| .|.++++++ .+|+.+. ++|++|||++|++++..|.+|.++++|++|+|++|++++..|..+.++++
T Consensus 3 ~C~~~--~~--c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~ 75 (549)
T 2z81_A 3 SCDAS--GV--CDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGS 75 (549)
T ss_dssp EECTT--SE--EECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred cCCCC--ce--EECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhcccccc
Confidence 57542 34 689999998 4566554 79999999999999999999999999999999999999999999999999
Q ss_pred CcEEEcCCCCCCCCcchhHhhccccccEEEeecccccc-cCCccCCCCCCCcEEEccCCCCcccCC-CcCcCCccccEEE
Q 047196 172 VLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHG-QIPLALSKCKRLQLLNLGFKKLSGAIP-KEISNLTILRKIS 249 (827)
Q Consensus 172 L~~L~L~~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~ 249 (827)
|++|+|++|.+++..|..+.. +++|++|++++|.+++ .+|..++++++|++|++++|.+.+.+| ..++++++|++|+
T Consensus 76 L~~L~Ls~n~l~~~~~~~~~~-l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~ 154 (549)
T 2z81_A 76 LEHLDLSDNHLSSLSSSWFGP-LSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELE 154 (549)
T ss_dssp CCEEECTTSCCCSCCHHHHTT-CTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEE
T ss_pred CCEEECCCCccCccCHHHhcc-CCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeee
Confidence 999999999999755554554 5699999999999987 467899999999999999999555555 6899999999999
Q ss_pred cccccccccccccccCcCCCcEEEeecccCcccCchhhhcCCCccEEEecCCcccccc--ChhhhcCCCCccEEeCcCCc
Q 047196 250 LRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSF--SLGIDLSLPNVERLNLGLNR 327 (827)
Q Consensus 250 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~--~~~~~~~l~~L~~L~L~~N~ 327 (827)
+++|++++..|..++.+++|++|+++.|.+....+..+..+++|+.|++++|.+.+.. +..+...+++|+.|++++|+
T Consensus 155 L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~ 234 (549)
T 2z81_A 155 IKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSV 234 (549)
T ss_dssp EEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCE
T ss_pred ccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccc
Confidence 9999999999999999999999999999986543334457999999999999998742 22333457899999999999
Q ss_pred cccccC----ccccCCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccc-----cCc
Q 047196 328 FSGTIP----SFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGS-----IPQ 398 (827)
Q Consensus 328 l~~~~p----~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~-----~p~ 398 (827)
+++..+ ..+..+++|+.+++++|.+.+...-.. . ....+..+. +++.|++.++.+... ++.
T Consensus 235 l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~------~---~~~~~~~l~-~L~~L~l~~~~i~~~~~~~~l~~ 304 (549)
T 2z81_A 235 LTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNP------S---ESDVVSELG-KVETVTIRRLHIPQFYLFYDLST 304 (549)
T ss_dssp EEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCC------C---TTTCCCCCT-TCCEEEEESCBCSCGGGSCCCCH
T ss_pred cchhHHHHHHHHhhhhccccccccccccccccccccc------c---chhhhhhhc-ccccccccccccchhhhcccchh
Confidence 987544 345678999999999999887422100 0 001122333 789999999887642 233
Q ss_pred cccCCCCCceEeccCccccccccccc-cCCCCCcEEECCCCCCCCCCCc---cccccccccEEecCCCcccccCC--ccc
Q 047196 399 LISNLSNLLLLDLEGNKLTGSIPVTF-GRLQKLQGLYLPFNKLAGSIPD---QLCHLARLNTLGLAGNKFSGSIP--SCL 472 (827)
Q Consensus 399 ~~~~l~~L~~L~Ls~N~l~g~~p~~~-~~l~~L~~L~Ls~N~l~g~~p~---~~~~l~~L~~L~Ls~N~l~~~~p--~~~ 472 (827)
.+....+|+.|++++|++. .+|..+ ..+++|++|++++|++++.+|. .+..+++|++|++++|++++..+ ..+
T Consensus 305 ~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 383 (549)
T 2z81_A 305 VYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEIL 383 (549)
T ss_dssp HHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHG
T ss_pred hhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhh
Confidence 3445678999999999997 566665 6899999999999999987753 47889999999999999986533 458
Q ss_pred cCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccceeeecccccccCCCCCCE
Q 047196 473 GNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQN 552 (827)
Q Consensus 473 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~ 552 (827)
..+++|++||+++|+++ .+|..+..+++|++|++++|.+++ +|..+ .+.|+.|++++|+|++.+ +.+++|+.
T Consensus 384 ~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~ 455 (549)
T 2z81_A 384 LTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQE 455 (549)
T ss_dssp GGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSC-CCTTS--CTTCSEEECCSSCCSCCC----CCCTTCCE
T ss_pred hcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCccc-ccchh--cCCceEEECCCCChhhhc----ccCChhcE
Confidence 89999999999999999 578889999999999999999985 34333 268999999999999753 57899999
Q ss_pred EECCCCcceeecCCC--CcCCceEeCcCCcCeecCCCC-CCCCCCcccccccCccccCCC
Q 047196 553 ISLACNGLEGLIPES--FGYLTELNLSFNKLEGEIPRG-GPFANFTAKSFMGNEKLCGLP 609 (827)
Q Consensus 553 L~Ls~N~l~g~ip~~--~~~L~~L~ls~N~l~g~ip~~-~~~~~~~~~~~~~n~~lc~~p 609 (827)
|+|++|+++ .+|.. +.+|++||+++|++++.+|.. ..+..+....+.+|+..|.+|
T Consensus 456 L~Ls~N~l~-~ip~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 456 LYISRNKLK-TLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp EECCSSCCS-SCCCGGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred EECCCCccC-cCCCcccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 999999998 56653 458999999999999987763 456677778889999888653
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=450.73 Aligned_cols=455 Identities=20% Similarity=0.217 Sum_probs=370.3
Q ss_pred EEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcCCC
Q 047196 101 TALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSD 180 (827)
Q Consensus 101 ~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n 180 (827)
+.||+++|+++ .+|..+. ++|++|||++|++++..|..|.++++|++|||++|++++..|..+.++++|++|+|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 46899999999 4777666 89999999999999888889999999999999999999998999999999999999999
Q ss_pred CCCCCcchhHhhccccccEEEeecccccc-cCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccc--cEEEcccccc--
Q 047196 181 KLSGELPVNICNYLHYLKVLFLAKNMFHG-QIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTIL--RKISLRNNKL-- 255 (827)
Q Consensus 181 ~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L--~~L~Ls~N~l-- 255 (827)
+++ .+|.. .+++|++|+|++|.+++ .+|..|+++++|++|++++|.+++ ..+..+++| ++|++++|.+
T Consensus 80 ~l~-~lp~~---~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~ 152 (520)
T 2z7x_B 80 KLV-KISCH---PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYG 152 (520)
T ss_dssp CCC-EEECC---CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTT
T ss_pred cee-ecCcc---ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccc
Confidence 998 68876 46699999999999987 578899999999999999999886 356777777 9999999999
Q ss_pred cccccccccCcC-CCcEEEeecccCcccCch-hhhcCCCccEEEecCCc-------cccccChhhhcCCCCccEEeCcCC
Q 047196 256 RGEIPHEIGYLP-NLENLVLGFNNLVGVVPA-AIFNMSTVKKIYLLDNS-------LLGSFSLGIDLSLPNVERLNLGLN 326 (827)
Q Consensus 256 ~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~l~~n~-------l~~~~~~~~~~~l~~L~~L~L~~N 326 (827)
.+..|..+..++ +...+++++|++.+.++. .+.++++|+.+++++|. +.+.++ .+. .+++|+.|++++|
T Consensus 153 ~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~-~l~~L~~L~l~~~ 230 (520)
T 2z7x_B 153 EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQ-TNPKLSNLTLNNI 230 (520)
T ss_dssp SSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGG-GCTTCCEEEEEEE
T ss_pred cccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhc-cccchhhcccccc
Confidence 788888887766 344677888888776654 56778889999998887 666555 333 6888999999888
Q ss_pred ccccccCcccc---CCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccC-ccccC
Q 047196 327 RFSGTIPSFIT---NASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIP-QLISN 402 (827)
Q Consensus 327 ~l~~~~p~~~~---~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p-~~~~~ 402 (827)
.+++..+..+. ..++|++|++++|+++|.+|..+... ....+. +|+.+++++|.+ .+| ..+..
T Consensus 231 ~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~----------~~~~l~-~L~~l~l~~n~~--~~p~~~~~~ 297 (520)
T 2z7x_B 231 ETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDY----------SGTSLK-ALSIHQVVSDVF--GFPQSYIYE 297 (520)
T ss_dssp EEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCC----------CSCCCC-EEEEEEEEECCC--CSCTHHHHH
T ss_pred ccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhc----------ccccCc-eeEeccccccce--ecchhhhhc
Confidence 88764332221 24588999999988887766533100 003343 788899999998 555 45554
Q ss_pred C---CCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccc--cCCccccCCCC
Q 047196 403 L---SNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSG--SIPSCLGNLTS 477 (827)
Q Consensus 403 l---~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~ 477 (827)
+ .+|+.|++++|.+.+.. .+..+++|++|++++|++++.+|..+.++++|++|++++|++++ .+|..+..+++
T Consensus 298 ~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~ 375 (520)
T 2z7x_B 298 IFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKS 375 (520)
T ss_dssp HHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTT
T ss_pred ccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCC
Confidence 4 67999999999886432 12688999999999999999899999999999999999999986 56778899999
Q ss_pred CCccccCCCcccccCCc-cccccccccccCCCCCCCCCCCcccccccccCceEEcccceeeecccccccCCCCCCEEECC
Q 047196 478 LRSPDLGSNRLTSVLPS-TFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLA 556 (827)
Q Consensus 478 L~~L~Ls~N~l~~~~p~-~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls 556 (827)
|++||+++|.+++.+|. .+..+++|+.|++++|.+++.+|..+. +.|+.|++++|+|+ .+|..+..+++|+.|+|+
T Consensus 376 L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~ 452 (520)
T 2z7x_B 376 LQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVA 452 (520)
T ss_dssp CCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECC
T ss_pred CCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECC
Confidence 99999999999985555 488889999999999999988887765 78999999999998 888888899999999999
Q ss_pred CCcceeecCCC-C---cCCceEeCcCCcCeecCC
Q 047196 557 CNGLEGLIPES-F---GYLTELNLSFNKLEGEIP 586 (827)
Q Consensus 557 ~N~l~g~ip~~-~---~~L~~L~ls~N~l~g~ip 586 (827)
+|++++ +|.. + .+|+.|++++|++++..+
T Consensus 453 ~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 453 SNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp SSCCCC-CCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCcCCc-cCHHHhccCCcccEEECcCCCCcccCC
Confidence 999985 5543 4 478899999999987654
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=436.64 Aligned_cols=452 Identities=17% Similarity=0.200 Sum_probs=387.4
Q ss_pred CEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcCCCCCCCCcchhHhhccccccEEEeec
Q 047196 125 TTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAK 204 (827)
Q Consensus 125 ~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~~L~Ls~ 204 (827)
++||+++|+++ .+|..+. ++|++|||++|.+++..|..+.++++|++|+|++|++++..|..+.. +++|++|+|++
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~-l~~L~~L~Ls~ 78 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKF-NQELEYLDLSH 78 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTT-CTTCCEEECCS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhc-ccCCCEEecCC
Confidence 68999999999 6887776 89999999999999999999999999999999999999766666655 55999999999
Q ss_pred ccccccCCccCCCCCCCcEEEccCCCCcc-cCCCcCcCCccccEEEcccccccccccccccCcCCC--cEEEeecccC--
Q 047196 205 NMFHGQIPLALSKCKRLQLLNLGFKKLSG-AIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNL--ENLVLGFNNL-- 279 (827)
Q Consensus 205 N~l~~~~p~~l~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L--~~L~Ls~N~l-- 279 (827)
|+++ .+|.. .+++|++|++++|.+++ .+|..++++++|++|++++|++++ ..+..+++| ++|++++|.+
T Consensus 79 N~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~ 152 (520)
T 2z7x_B 79 NKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYG 152 (520)
T ss_dssp SCCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTT
T ss_pred Ccee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccc
Confidence 9998 56666 89999999999999998 578999999999999999999986 467778888 9999999999
Q ss_pred cccCchhhhcCC-CccEEEecCCccccccChhhhcCCCCccEEeCcCCc-------cccccCccccCCCCCcEEEcCCCc
Q 047196 280 VGVVPAAIFNMS-TVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNR-------FSGTIPSFITNASKLVYLDMGTNS 351 (827)
Q Consensus 280 ~~~~p~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~-------l~~~~p~~~~~l~~L~~L~Ls~N~ 351 (827)
.+..|..+..+. ....+++++|.+.+.++......+++|+.|++++|. +.+.+| .+..+++|+.|++++|.
T Consensus 153 ~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~ 231 (520)
T 2z7x_B 153 EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIE 231 (520)
T ss_dssp SSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEE
T ss_pred cccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccc
Confidence 888898888776 455778899999988887666689999999999998 888777 78999999999999998
Q ss_pred ceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccc-----cCCCCCceEeccCcccccccc-cccc
Q 047196 352 FSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLI-----SNLSNLLLLDLEGNKLTGSIP-VTFG 425 (827)
Q Consensus 352 l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~-----~~l~~L~~L~Ls~N~l~g~~p-~~~~ 425 (827)
+++..+.. . +.... . .+|++|++++|+++|.+|..+ ..+++|+.+++++|.+ .+| ..+.
T Consensus 232 l~~~~~~~----------~-~~~~~-~-~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~ 296 (520)
T 2z7x_B 232 TTWNSFIR----------I-LQLVW-H-TTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIY 296 (520)
T ss_dssp EEHHHHHH----------H-HHHHH-T-SSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHH
T ss_pred cCHHHHHH----------H-HHHhh-h-CcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhh
Confidence 87542211 0 11111 1 279999999999999999998 9999999999999999 455 4555
Q ss_pred CC---CCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCccccCCCcccc--cCCccccccc
Q 047196 426 RL---QKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTS--VLPSTFWNLK 500 (827)
Q Consensus 426 ~l---~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~ 500 (827)
.+ .+|+.|++++|.+.+.. .+..+++|++|++++|++++.+|..++.+++|++|++++|++++ .+|..+..++
T Consensus 297 ~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~ 374 (520)
T 2z7x_B 297 EIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMK 374 (520)
T ss_dssp HHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCT
T ss_pred cccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCC
Confidence 44 68999999999987532 12678999999999999999999999999999999999999997 5678899999
Q ss_pred cccccCCCCCCCCCCCccc-ccccccCceEEcccceeeecccccccCCCCCCEEECCCCcceeecCCCC---cCCceEeC
Q 047196 501 DILFFDLSSNSLDGPLSLD-IGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESF---GYLTELNL 576 (827)
Q Consensus 501 ~L~~LdLs~N~l~g~~p~~-~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~---~~L~~L~l 576 (827)
+|+.||+++|.+++.+|.. +..++.|+.|++++|++++.+|..+. ++|+.|++++|+++ .+|..+ .+|++|++
T Consensus 375 ~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L 451 (520)
T 2z7x_B 375 SLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNV 451 (520)
T ss_dssp TCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEEC
T ss_pred CCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEEC
Confidence 9999999999999977765 88899999999999999999998876 79999999999999 677644 58999999
Q ss_pred cCCcCeecCCCC--CCCCCCcccccccCccccCC
Q 047196 577 SFNKLEGEIPRG--GPFANFTAKSFMGNEKLCGL 608 (827)
Q Consensus 577 s~N~l~g~ip~~--~~~~~~~~~~~~~n~~lc~~ 608 (827)
++|+++ .+|.. ..+..+....+.+|+..|.+
T Consensus 452 ~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c 484 (520)
T 2z7x_B 452 ASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSC 484 (520)
T ss_dssp CSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred CCCcCC-ccCHHHhccCCcccEEECcCCCCcccC
Confidence 999999 57764 34556667778899887753
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=426.53 Aligned_cols=476 Identities=20% Similarity=0.159 Sum_probs=255.7
Q ss_pred cEEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcC
Q 047196 99 RVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLD 178 (827)
Q Consensus 99 ~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~ 178 (827)
.++.|||++|+|++..+.+|.++++|++|||++|+|++..|.+|.++++|++|||++|+|++..+..|.++++|++|+|+
T Consensus 53 ~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls 132 (635)
T 4g8a_A 53 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 132 (635)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECT
T ss_pred CCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECC
Confidence 57788888888877777778888888888888888877767777888888888888888877666777788888888888
Q ss_pred CCCCCCCcchhHhhccccccEEEeecccccc-cCCccCCCCCCCcEEEccCCCCcccCCCcCcCCcccc----EEEcccc
Q 047196 179 SDKLSGELPVNICNYLHYLKVLFLAKNMFHG-QIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILR----KISLRNN 253 (827)
Q Consensus 179 ~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~----~L~Ls~N 253 (827)
+|++++ +|...+..+++|++|+|++|.+++ .+|..++++++|++|++++|++++..|..+..+.+++ .++++.|
T Consensus 133 ~N~l~~-l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n 211 (635)
T 4g8a_A 133 ETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 211 (635)
T ss_dssp TSCCCC-STTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred CCcCCC-CChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccC
Confidence 887774 554444445578888888887765 4567777778888888888887777777766655443 5777777
Q ss_pred cccccccccccCcCCCcEEEeecccCcccC-chhhhcCCCccEEEecCCcccccc------Chh----------------
Q 047196 254 KLRGEIPHEIGYLPNLENLVLGFNNLVGVV-PAAIFNMSTVKKIYLLDNSLLGSF------SLG---------------- 310 (827)
Q Consensus 254 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~l~~n~l~~~~------~~~---------------- 310 (827)
.++...+..+ ....++.+++..|.....+ +..+..+..++...+..+...+.. ...
T Consensus 212 ~l~~i~~~~~-~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~ 290 (635)
T 4g8a_A 212 PMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 290 (635)
T ss_dssp CCCEECTTTT-TTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEEC
T ss_pred cccccCcccc-cchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhh
Confidence 7765444333 3445667777777655332 344556666665555332211100 000
Q ss_pred ----------hhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceeecCCCc------cCCCCCCcccCCCc
Q 047196 311 ----------IDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTI------GLTGNPLDGVLPTS 374 (827)
Q Consensus 311 ----------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~------~l~~n~l~g~~p~~ 374 (827)
......+++.+++..+.+.... .+.....|+.|++.+|.+.+..+..+ .+..|..... ..
T Consensus 291 ~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~--~~ 366 (635)
T 4g8a_A 291 LDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--DFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNA--FS 366 (635)
T ss_dssp CCSCEEECTTTTGGGTTCSEEEEESCEEEECG--GGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCB--CC
T ss_pred hcccccchhhhhhhhccccccccccccccccc--ccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCC--cc
Confidence 0012234455555555544322 23444566666666666554332211 0111111111 11
Q ss_pred hhcccccccEEEccCCcCcc--ccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCC-cccccc
Q 047196 375 IGNLSMSLENIYISNCNIGG--SIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIP-DQLCHL 451 (827)
Q Consensus 375 ~~~~~~~L~~L~Ls~N~l~g--~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p-~~~~~l 451 (827)
...++ +|+.+++++|.+.. ..+..+..+.+|+.++++.|.+.+ .+..+..+++|+.++++.|......+ ..+..+
T Consensus 367 ~~~l~-~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l 444 (635)
T 4g8a_A 367 EVDLP-SLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 444 (635)
T ss_dssp CCBCT-TCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTC
T ss_pred ccccc-ccccchhhccccccccccccchhhhhhhhhhhcccccccc-ccccccccccccchhhhhccccccccccccccc
Confidence 11222 34444444444431 233333444444444444444432 22334444444444444444333222 233444
Q ss_pred ccccEEecCCCcccccCCccccCCCCCCccccCCCcc-cccCCccccccccccccCCCCCCCCCCCcccccccccCceEE
Q 047196 452 ARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRL-TSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGIN 530 (827)
Q Consensus 452 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l-~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~ 530 (827)
.+++.+++++|++.+..|..+..++.|+.|++++|.+ .+.+|..|..+++|++|||++|++++.+|..|+++++|+.|+
T Consensus 445 ~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~ 524 (635)
T 4g8a_A 445 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 524 (635)
T ss_dssp TTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred cccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEE
Confidence 4444444444444444444444444444444444442 223344444444444444444444444444444444444444
Q ss_pred cccceeeecccccccCCCCCCEEECCCCcceeecCCCCc----CCceEeCcCCcCe
Q 047196 531 LSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFG----YLTELNLSFNKLE 582 (827)
Q Consensus 531 Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~----~L~~L~ls~N~l~ 582 (827)
|++|+|++..|..|+++++|+.|||++|+|++.+|..+. +|+.|++++|+++
T Consensus 525 Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~ 580 (635)
T 4g8a_A 525 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 580 (635)
T ss_dssp CTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBC
T ss_pred CCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCc
Confidence 444444444444444444444444444444444444332 3444444444443
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=419.47 Aligned_cols=455 Identities=20% Similarity=0.194 Sum_probs=362.8
Q ss_pred EEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcCCC
Q 047196 101 TALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSD 180 (827)
Q Consensus 101 ~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n 180 (827)
+.+|++++++++ +|..+. ++|++|||++|.+++..|.+|.++++|++|+|++|++++..|..+.++++|++|+|++|
T Consensus 34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 789999999996 676654 89999999999999888889999999999999999999988999999999999999999
Q ss_pred CCCCCcchhHhhccccccEEEeecccccc-cCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccc--cEEEcccccc--
Q 047196 181 KLSGELPVNICNYLHYLKVLFLAKNMFHG-QIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTIL--RKISLRNNKL-- 255 (827)
Q Consensus 181 ~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L--~~L~Ls~N~l-- 255 (827)
.++ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|++++|.+++. .+..+++| ++|++++|++
T Consensus 111 ~l~-~lp~~---~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~ 183 (562)
T 3a79_B 111 RLQ-NISCC---PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHI 183 (562)
T ss_dssp CCC-EECSC---CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCC
T ss_pred cCC-ccCcc---ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccc
Confidence 998 68877 46799999999999987 4678999999999999999999863 45555666 9999999999
Q ss_pred cccccccccCcC--CCcEEEeecccCcccCch-hhhcCCCccEEEecCCcc-----ccccChhhhcCCCCccEEeCcCCc
Q 047196 256 RGEIPHEIGYLP--NLENLVLGFNNLVGVVPA-AIFNMSTVKKIYLLDNSL-----LGSFSLGIDLSLPNVERLNLGLNR 327 (827)
Q Consensus 256 ~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~l~~n~l-----~~~~~~~~~~~l~~L~~L~L~~N~ 327 (827)
++..|..+..++ .| .++++.|.+.+.++. .+.++++|+.+++++|.. .+.+ ..+ ..+++|+.++++++.
T Consensus 184 ~~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~-~~l-~~l~~L~~L~L~~~~ 260 (562)
T 3a79_B 184 KGGETESLQIPNTTVL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFL-SEL-TRGPTLLNVTLQHIE 260 (562)
T ss_dssp CSSSCCEEEECCEEEE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHH-HHH-HSCSSCEEEEEEEEE
T ss_pred cccCcccccccCcceE-EEEecCccchhhhhhhcccccceEEEecccccccccchHHHHH-HHH-hccCcceEEEecCCc
Confidence 888898888765 33 568889998886654 456788999999999852 2222 122 267888888888877
Q ss_pred ccccc----CccccCCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccC-ccccC
Q 047196 328 FSGTI----PSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIP-QLISN 402 (827)
Q Consensus 328 l~~~~----p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p-~~~~~ 402 (827)
+++.. +..+ ..++|++|++++|.++|.+|..+... ....+. .|+.++++.|.+ .+| ..+..
T Consensus 261 l~~~~~~~~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~----------~~~~L~-~L~~~~~~~~~~--~~p~~~~~~ 326 (562)
T 3a79_B 261 TTWKCSVKLFQFF-WPRPVEYLNIYNLTITERIDREEFTY----------SETALK-SLMIEHVKNQVF--LFSKEALYS 326 (562)
T ss_dssp ECHHHHHHHHHHH-TTSSEEEEEEEEEEECSCCCCCCCCC----------CSCSCC-EEEEEEEEECCC--SSCHHHHHH
T ss_pred CcHHHHHHHHHhh-hcccccEEEEeccEeeccccchhhhc----------ccccch-heehhhccccee--ecChhhhhh
Confidence 66432 2222 23589999999999988777542100 002222 566666777776 445 22222
Q ss_pred ---CCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccc--cCCccccCCCC
Q 047196 403 ---LSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSG--SIPSCLGNLTS 477 (827)
Q Consensus 403 ---l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~ 477 (827)
..+|+.|++++|.+.... ....+++|++|++++|++++.+|..+.++++|++|++++|++++ .+|..+..+++
T Consensus 327 ~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~ 404 (562)
T 3a79_B 327 VFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSS 404 (562)
T ss_dssp HHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTT
T ss_pred hhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCC
Confidence 267999999999886432 12688999999999999999899999999999999999999986 34577899999
Q ss_pred CCccccCCCcccccCCc-cccccccccccCCCCCCCCCCCcccccccccCceEEcccceeeecccccccCCCCCCEEECC
Q 047196 478 LRSPDLGSNRLTSVLPS-TFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLA 556 (827)
Q Consensus 478 L~~L~Ls~N~l~~~~p~-~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls 556 (827)
|++|++++|.+++.+|. .+..+++|+.|++++|++++.+|..+. +.|+.|++++|+|+ .+|..+..+++|+.|+|+
T Consensus 405 L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~ 481 (562)
T 3a79_B 405 LETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVA 481 (562)
T ss_dssp CCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECC
T ss_pred CCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECC
Confidence 99999999999985554 588899999999999999988887665 78999999999998 788888899999999999
Q ss_pred CCcceeecCCCC---cCCceEeCcCCcCeecCCC
Q 047196 557 CNGLEGLIPESF---GYLTELNLSFNKLEGEIPR 587 (827)
Q Consensus 557 ~N~l~g~ip~~~---~~L~~L~ls~N~l~g~ip~ 587 (827)
+|++++..+..+ .+|+.|++++|++++..|.
T Consensus 482 ~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 515 (562)
T 3a79_B 482 SNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG 515 (562)
T ss_dssp SSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHHH
T ss_pred CCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcch
Confidence 999995433324 4788999999999887663
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=414.06 Aligned_cols=445 Identities=19% Similarity=0.180 Sum_probs=341.5
Q ss_pred CcEEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEc
Q 047196 98 HRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRL 177 (827)
Q Consensus 98 ~~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L 177 (827)
.+++.|||++|+|++..+.+|.+|++|++|+|++|+|++..|..|.++++|++|+|++|++++..+..+.++++|++|+|
T Consensus 76 ~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~L 155 (635)
T 4g8a_A 76 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 155 (635)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeecc
Confidence 47999999999999988889999999999999999999877788999999999999999999988888999999999999
Q ss_pred CCCCCCC-CcchhHhhccccccEEEeecccccccCCccCCCCCCC----cEEEccCCCCcccCCCcCcCCccccEEEccc
Q 047196 178 DSDKLSG-ELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRL----QLLNLGFKKLSGAIPKEISNLTILRKISLRN 252 (827)
Q Consensus 178 ~~n~l~g-~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L----~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~ 252 (827)
++|.+++ .+|..+.. +++|++|++++|++++..|..+..+.++ ..++++.|.++...+..+. ...++.+++++
T Consensus 156 s~N~l~~~~~~~~~~~-l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~-~~~~~~l~l~~ 233 (635)
T 4g8a_A 156 AHNLIQSFKLPEYFSN-LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLHKLTLRN 233 (635)
T ss_dssp CSSCCCCCCCCGGGGG-CTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTT-TCEEEEEEEES
T ss_pred ccCccccCCCchhhcc-chhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCccccc-chhhhhhhhhc
Confidence 9999976 34555444 5699999999999999988888766554 4789999999876665554 44577888888
Q ss_pred ccccccc-cccccCcCCCcEEEeecccCc---------------------------------ccCchhhhcCCCccEEEe
Q 047196 253 NKLRGEI-PHEIGYLPNLENLVLGFNNLV---------------------------------GVVPAAIFNMSTVKKIYL 298 (827)
Q Consensus 253 N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~---------------------------------~~~p~~~~~l~~L~~L~l 298 (827)
|..+..+ +..+..++.++...+..+... ..++..+..+.+++.+.+
T Consensus 234 n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~ 313 (635)
T 4g8a_A 234 NFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSL 313 (635)
T ss_dssp CCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEE
T ss_pred ccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccc
Confidence 7654322 223344444443333221110 011112223334444444
Q ss_pred cCCccccccChhhhcCCCCccEEeCcCCccccccC-------------------ccccCCCCCcEEEcCCCcceeecCCC
Q 047196 299 LDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIP-------------------SFITNASKLVYLDMGTNSFSGIIPNT 359 (827)
Q Consensus 299 ~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-------------------~~~~~l~~L~~L~Ls~N~l~g~~p~~ 359 (827)
.++.+.+..+. ....+++.|++.+|++.+..+ .....+++|+.|+++.|.+...
T Consensus 314 ~~~~~~~~~~~---~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~---- 386 (635)
T 4g8a_A 314 VSVTIERVKDF---SYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFK---- 386 (635)
T ss_dssp ESCEEEECGGG---GSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEE----
T ss_pred ccccccccccc---ccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccccccchhhccccccc----
Confidence 44443322111 122344444444444433221 1233456666666666655432
Q ss_pred ccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCcccccccc-ccccCCCCCcEEECCCC
Q 047196 360 IGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIP-VTFGRLQKLQGLYLPFN 438 (827)
Q Consensus 360 ~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p-~~~~~l~~L~~L~Ls~N 438 (827)
+..+....... +++.+++..|.+.+ ++..+..+++|+.++++.|+.....+ ..|..+++++.++++.|
T Consensus 387 ---------~~~~~~~~~~~-~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n 455 (635)
T 4g8a_A 387 ---------GCCSQSDFGTI-SLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 455 (635)
T ss_dssp ---------EECCHHHHSCS-CCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTS
T ss_pred ---------cccccchhhhh-hhhhhhcccccccc-ccccccccccccchhhhhcccccccccccccccccccccccccc
Confidence 12233344444 79999999999875 55668889999999999998877665 45789999999999999
Q ss_pred CCCCCCCccccccccccEEecCCCccc-ccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCc
Q 047196 439 KLAGSIPDQLCHLARLNTLGLAGNKFS-GSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLS 517 (827)
Q Consensus 439 ~l~g~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p 517 (827)
.+.+..|..+..++.|+.|++++|++. +.+|..+..+++|++|||++|++++..|..|.++++|++|+|++|+|++..|
T Consensus 456 ~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~ 535 (635)
T 4g8a_A 456 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 535 (635)
T ss_dssp CCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCC
T ss_pred ccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCCh
Confidence 999999999999999999999999854 4678899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCceEEcccceeeecccccccCC-CCCCEEECCCCccee
Q 047196 518 LDIGNLRVVIGINLSRNNFSGDIPSTIGDL-KDLQNISLACNGLEG 562 (827)
Q Consensus 518 ~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l-~~L~~L~Ls~N~l~g 562 (827)
..++++++|+.|||++|+|++.+|..+..+ ++|+.|+|++|.++-
T Consensus 536 ~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C 581 (635)
T 4g8a_A 536 FPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 581 (635)
T ss_dssp GGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCC
T ss_pred hHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcc
Confidence 999999999999999999999999999998 689999999999864
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=415.34 Aligned_cols=454 Identities=19% Similarity=0.183 Sum_probs=372.7
Q ss_pred CCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcCCCCCCCCcchhHhhccccccEEEe
Q 047196 123 SLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFL 202 (827)
Q Consensus 123 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~~L~L 202 (827)
..+++|+++|++++ +|..+. ++|++|||++|.+++..|..+.++++|++|+|++|.+++..|..+.. +++|++|+|
T Consensus 32 ~~~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~L 107 (562)
T 3a79_B 32 LESMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLF-NQDLEYLDV 107 (562)
T ss_dssp -CCEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTT-CTTCCEEEC
T ss_pred CCcEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCC-CCCCCEEEC
Confidence 34899999999995 787664 89999999999999999999999999999999999999655555544 569999999
Q ss_pred ecccccccCCccCCCCCCCcEEEccCCCCcc-cCCCcCcCCccccEEEcccccccccccccccCcCCC--cEEEeecccC
Q 047196 203 AKNMFHGQIPLALSKCKRLQLLNLGFKKLSG-AIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNL--ENLVLGFNNL 279 (827)
Q Consensus 203 s~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L--~~L~Ls~N~l 279 (827)
++|.++ .+|.. .+++|++|++++|++++ .+|..|+++++|++|++++|++++. .+..+++| ++|++++|.+
T Consensus 108 s~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l 181 (562)
T 3a79_B 108 SHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSY 181 (562)
T ss_dssp TTSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSC
T ss_pred CCCcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccc
Confidence 999998 56766 89999999999999997 4578999999999999999999863 45666666 9999999999
Q ss_pred --cccCchhhhcCC-CccEEEecCCccccccChhhhcCCCCccEEeCcCCc-----cccccCccccCCCCCcEEEcCCCc
Q 047196 280 --VGVVPAAIFNMS-TVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNR-----FSGTIPSFITNASKLVYLDMGTNS 351 (827)
Q Consensus 280 --~~~~p~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~-----l~~~~p~~~~~l~~L~~L~Ls~N~ 351 (827)
++..|..+..+. ....+++++|.+.+.++......+++|+.+++++|+ +.+.+ ..+..+++|+.++++++.
T Consensus 182 ~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~-~~l~~l~~L~~L~L~~~~ 260 (562)
T 3a79_B 182 HIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFL-SELTRGPTLLNVTLQHIE 260 (562)
T ss_dssp CCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHH-HHHHSCSSCEEEEEEEEE
T ss_pred cccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHH-HHHhccCcceEEEecCCc
Confidence 898998888765 233668899999888777666678899999999985 33332 357788999999998887
Q ss_pred ceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccc-----cCCCCCceEeccCcccccccc-cccc
Q 047196 352 FSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLI-----SNLSNLLLLDLEGNKLTGSIP-VTFG 425 (827)
Q Consensus 352 l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~-----~~l~~L~~L~Ls~N~l~g~~p-~~~~ 425 (827)
+++... .+ ++..+. . .+|++|++++|+++|.+|..+ .+++.|+.++++.|.+ .+| ..+.
T Consensus 261 l~~~~~----------~~-~~~~~~-~-~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~ 325 (562)
T 3a79_B 261 TTWKCS----------VK-LFQFFW-P-RPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALY 325 (562)
T ss_dssp ECHHHH----------HH-HHHHHT-T-SSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHH
T ss_pred CcHHHH----------HH-HHHhhh-c-ccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhh
Confidence 654211 11 111111 1 279999999999999999987 7788888888888887 344 2332
Q ss_pred C---CCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCccccCCCccccc--CCccccccc
Q 047196 426 R---LQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSV--LPSTFWNLK 500 (827)
Q Consensus 426 ~---l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~ 500 (827)
. ..+|+.|++++|.+.... ....+++|++|++++|++++.+|..++++++|++|++++|++++. +|..+.+++
T Consensus 326 ~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~ 403 (562)
T 3a79_B 326 SVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMS 403 (562)
T ss_dssp HHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCT
T ss_pred hhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCC
Confidence 2 267999999999986432 126789999999999999999999999999999999999999984 457789999
Q ss_pred cccccCCCCCCCCCCCcc-cccccccCceEEcccceeeecccccccCCCCCCEEECCCCcceeecCCCC---cCCceEeC
Q 047196 501 DILFFDLSSNSLDGPLSL-DIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESF---GYLTELNL 576 (827)
Q Consensus 501 ~L~~LdLs~N~l~g~~p~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~---~~L~~L~l 576 (827)
+|+.||+++|.+++.+|. .+..++.|+.|++++|++++.+|..+. ++|+.|+|++|+++ .+|..+ .+|+.|++
T Consensus 404 ~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L 480 (562)
T 3a79_B 404 SLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNV 480 (562)
T ss_dssp TCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEEC
T ss_pred CCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEEC
Confidence 999999999999996665 488899999999999999999888776 78999999999998 566544 48999999
Q ss_pred cCCcCeecCCCC--CCCCCCcccccccCccccCC
Q 047196 577 SFNKLEGEIPRG--GPFANFTAKSFMGNEKLCGL 608 (827)
Q Consensus 577 s~N~l~g~ip~~--~~~~~~~~~~~~~n~~lc~~ 608 (827)
++|+++ .+|.. ..+..+....+.+|+..|.+
T Consensus 481 ~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c 513 (562)
T 3a79_B 481 ASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTC 513 (562)
T ss_dssp CSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCH
T ss_pred CCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCc
Confidence 999999 57764 45566677788999988864
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=383.53 Aligned_cols=293 Identities=27% Similarity=0.455 Sum_probs=224.2
Q ss_pred CCCHHHHHHHHHHHhhcCCCCCCcCCCCCCCCCCCCc--ccceecCCCC--CcEEEEEcCCCCCcc--ccCccccCCCCC
Q 047196 51 SNITTDQQALLALKAHISYDPTNLLAQNSTSNTSVCN--WIGITCNVNS--HRVTALNISSLNLQG--TIPPQLGNLSSL 124 (827)
Q Consensus 51 ~~~~~~~~aLl~~k~~~~~~~~~~l~~w~~~~~~~C~--W~gv~C~~~~--~~v~~L~L~~~~l~g--~~~~~l~~L~~L 124 (827)
.|.++|++||++||+++ .||. .+.+|. .+.|||. |.||+|+..+ ++|+.|+|+++++.| .+|+.+.++++|
T Consensus 2 ~c~~~~~~aL~~~k~~~-~~~~-~l~~W~-~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L 78 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDL-GNPT-TLSSWL-PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp CSCHHHHHHHHHHHHHT-TCCG-GGTTCC-TTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCCHHHHHHHHHHHHhc-CCcc-cccCCC-CCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCC
Confidence 58899999999999998 5665 778897 5679998 9999998755 799999999999999 899999999999
Q ss_pred CEEECCC-CCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcCCCCCCCCcchhHhhccccccEEEee
Q 047196 125 TTLNLSH-NKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLA 203 (827)
Q Consensus 125 ~~L~Ls~-N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~~L~Ls 203 (827)
++|+|++ |.+.+.+|..|+++++|++|+|++|++++.+|..+.++++|++|++++|.+++.+|..+..+ ++|++|+++
T Consensus 79 ~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~ 157 (313)
T 1ogq_A 79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSL-PNLVGITFD 157 (313)
T ss_dssp SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGC-TTCCEEECC
T ss_pred CeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcC-CCCCeEECc
Confidence 9999995 99999999999999999999999999999988888888888888888887777777666553 477777777
Q ss_pred cccccccCCccCCCCC-CCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEeecccCccc
Q 047196 204 KNMFHGQIPLALSKCK-RLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGV 282 (827)
Q Consensus 204 ~N~l~~~~p~~l~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 282 (827)
+|.+++.+|..+++++ +|++|++++|.+++.+|..+..++ |++|++++|++++..|..+..+++|++|+|++|++++.
T Consensus 158 ~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 236 (313)
T 1ogq_A 158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD 236 (313)
T ss_dssp SSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCB
T ss_pred CCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeee
Confidence 7777777777777776 777777777777777777777766 77777777777777777777777777777777777665
Q ss_pred CchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCc
Q 047196 283 VPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNS 351 (827)
Q Consensus 283 ~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 351 (827)
+|. +..+++|++|++++|.+.+.+|..+. .+++|++|++++|+++|.+|.. ..+++|+.+++++|.
T Consensus 237 ~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 237 LGK-VGLSKNLNGLDLRNNRIYGTLPQGLT-QLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302 (313)
T ss_dssp GGG-CCCCTTCCEEECCSSCCEECCCGGGG-GCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred cCc-ccccCCCCEEECcCCcccCcCChHHh-cCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence 554 45555555555555555555554443 4555555555555555555544 445555555555554
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=397.28 Aligned_cols=406 Identities=22% Similarity=0.301 Sum_probs=236.6
Q ss_pred CcEEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhcccc-------------ceEEecCCCCCCcccc
Q 047196 98 HRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKL-------------KFLDFSDNQLSGSLSS 164 (827)
Q Consensus 98 ~~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L-------------~~LdLs~N~l~g~~p~ 164 (827)
.+++.|++++|++ |.+|++++++++|++|++++|++.|.+|.+++++++| ++|++++|.+++. |.
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~l-p~ 88 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSL-PE 88 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCC-CS
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccC-CC
Confidence 4788899999988 8888889999999999999999988899888887765 8888888888763 32
Q ss_pred ccCCCCCCcEEEcCCCCCCCCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCcc
Q 047196 165 VTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTI 244 (827)
Q Consensus 165 ~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~ 244 (827)
-.++|++|+++.|.+++ +|.. ..+|++|++++|.+++ +|.. .++|++|++++|++++ +| +++++++
T Consensus 89 ---~~~~L~~L~l~~n~l~~-lp~~----~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~ 154 (454)
T 1jl5_A 89 ---LPPHLESLVASCNSLTE-LPEL----PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSF 154 (454)
T ss_dssp ---CCTTCSEEECCSSCCSS-CCCC----CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTT
T ss_pred ---CcCCCCEEEccCCcCCc-cccc----cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCC
Confidence 13678888888888886 6643 2578888888888875 2221 1678888888888886 66 5888888
Q ss_pred ccEEEcccccccccccccccCcCCCcEEEeecccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCc
Q 047196 245 LRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLG 324 (827)
Q Consensus 245 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~ 324 (827)
|++|++++|++++ +|..+ ++|++|++++|++++ +| .+.++++|+.|++++|.+.+ +|. ..++|++|+++
T Consensus 155 L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~----~~~~L~~L~l~ 223 (454)
T 1jl5_A 155 LKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPD----LPLSLESIVAG 223 (454)
T ss_dssp CCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCC----CCTTCCEEECC
T ss_pred CCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCC----CcCcccEEECc
Confidence 8888888888875 56543 478888888888887 45 57788888888888888765 332 23578888888
Q ss_pred CCccccccCccccCCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCC
Q 047196 325 LNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLS 404 (827)
Q Consensus 325 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~ 404 (827)
+|+++ .+|. ++.+++|++|++++|++++. |. . ..+|++|++++|++++ +|.. .+
T Consensus 224 ~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~l-~~---------------~----~~~L~~L~l~~N~l~~-l~~~---~~ 277 (454)
T 1jl5_A 224 NNILE-ELPE-LQNLPFLTTIYADNNLLKTL-PD---------------L----PPSLEALNVRDNYLTD-LPEL---PQ 277 (454)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCSSC-CS---------------C----CTTCCEEECCSSCCSC-CCCC---CT
T ss_pred CCcCC-cccc-cCCCCCCCEEECCCCcCCcc-cc---------------c----ccccCEEECCCCcccc-cCcc---cC
Confidence 88887 5664 77788888888888877642 21 1 1267788888888775 4443 36
Q ss_pred CCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCccccC
Q 047196 405 NLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLG 484 (827)
Q Consensus 405 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 484 (827)
+|+.|++++|++++. |.. .++|+.|++++|++++ ++.. .++|+.|++++|++++ +|.. +++|++|+++
T Consensus 278 ~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~-i~~~---~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~ 345 (454)
T 1jl5_A 278 SLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRS-LCDL---PPSLEELNVSNNKLIE-LPAL---PPRLERLIAS 345 (454)
T ss_dssp TCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSE-ECCC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECC
T ss_pred cCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCc-ccCC---cCcCCEEECCCCcccc-cccc---CCcCCEEECC
Confidence 777888888877762 211 2577777777777764 2211 1467777777777775 5543 4667777777
Q ss_pred CCcccccCCccccccccccccCCCCCCCCC--CCcccccccccCceEEcccceeeecccccccCCCCCCEEECCCCccee
Q 047196 485 SNRLTSVLPSTFWNLKDILFFDLSSNSLDG--PLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEG 562 (827)
Q Consensus 485 ~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g--~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g 562 (827)
+|.+++ +|. .+++|++|++++|++++ .+|.+++. ++.|++.|.+|.. +++|+.||+++|++++
T Consensus 346 ~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~---~~~L~~L~ls~N~l~~ 410 (454)
T 1jl5_A 346 FNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPEL---PQNLKQLHVETNPLRE 410 (454)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC---------------------------
T ss_pred CCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHh--------hhhcccccccccc---cCcCCEEECCCCcCCc
Confidence 777774 444 35667777777777776 56655432 3346666666653 3566777777777766
Q ss_pred --ecCCCCcCCceEeCcCCcCeecCC
Q 047196 563 --LIPESFGYLTELNLSFNKLEGEIP 586 (827)
Q Consensus 563 --~ip~~~~~L~~L~ls~N~l~g~ip 586 (827)
.+|.+ ++.|.+++|.+.+.+|
T Consensus 411 ~~~iP~s---l~~L~~~~~~~~~~~~ 433 (454)
T 1jl5_A 411 FPDIPES---VEDLRMNSERVVDPYE 433 (454)
T ss_dssp --------------------------
T ss_pred cccchhh---HhheeCcCcccCCccc
Confidence 55543 3445566666665554
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=392.72 Aligned_cols=396 Identities=21% Similarity=0.246 Sum_probs=215.5
Q ss_pred ccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCC-------------cEEEcCCCCC
Q 047196 116 PQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSV-------------LDIRLDSDKL 182 (827)
Q Consensus 116 ~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L-------------~~L~L~~n~l 182 (827)
+.-...++|++|++++|.+ |.+|++++++++|++|++++|.++|.+|..++++.+| ++|++++|.+
T Consensus 5 p~~~~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l 83 (454)
T 1jl5_A 5 PRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGL 83 (454)
T ss_dssp ------------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCC
T ss_pred ccccccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcc
Confidence 3334568999999999999 8999999999999999999999999999999998875 7777777777
Q ss_pred CCCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEccccccccccccc
Q 047196 183 SGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHE 262 (827)
Q Consensus 183 ~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 262 (827)
++ +|. ..++|++|++++|.+++ +|.. +++|++|++++|.+++ +|.. .++|++|++++|++++ +| +
T Consensus 84 ~~-lp~----~~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~ 148 (454)
T 1jl5_A 84 SS-LPE----LPPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-E 148 (454)
T ss_dssp SC-CCS----CCTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-C
T ss_pred cc-CCC----CcCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-c
Confidence 75 443 12467777777777776 5543 3677777777777764 2221 1567777777777775 56 4
Q ss_pred ccCcCCCcEEEeecccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCC
Q 047196 263 IGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKL 342 (827)
Q Consensus 263 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 342 (827)
++.+++|++|++++|++++ +|..+ .+|++|++++|.+.+ +| .+ ..+++|++|++++|++++ +|... ++|
T Consensus 149 ~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~-~~l~~L~~L~l~~N~l~~-l~~~~---~~L 217 (454)
T 1jl5_A 149 LQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-EL-QNLPFLTAIYADNNSLKK-LPDLP---LSL 217 (454)
T ss_dssp CTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CC-TTCTTCCEEECCSSCCSS-CCCCC---TTC
T ss_pred cCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cc-cCCCCCCEEECCCCcCCc-CCCCc---Ccc
Confidence 7777777777777777775 44332 366777777776665 44 23 256677777777777665 33322 466
Q ss_pred cEEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCccccccccc
Q 047196 343 VYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPV 422 (827)
Q Consensus 343 ~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 422 (827)
++|++++|.++ .+|. ++.++ +|++|++++|++++ +|.. +++|+.|++++|++++ +|.
T Consensus 218 ~~L~l~~n~l~-~lp~----------------~~~l~-~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~ 274 (454)
T 1jl5_A 218 ESIVAGNNILE-ELPE----------------LQNLP-FLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPE 274 (454)
T ss_dssp CEEECCSSCCS-SCCC----------------CTTCT-TCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCC
T ss_pred cEEECcCCcCC-cccc----------------cCCCC-CCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCc
Confidence 67777666655 2221 22333 67777777777764 3432 3567777777777765 343
Q ss_pred cccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCccccCCCcccccCCccccccccc
Q 047196 423 TFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDI 502 (827)
Q Consensus 423 ~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 502 (827)
. +++|+.|++++|++++ +|.. .++|+.|++++|++++ ++.. .++|++|++++|++++ +|.. +++|
T Consensus 275 ~---~~~L~~L~ls~N~l~~-l~~~---~~~L~~L~l~~N~l~~-i~~~---~~~L~~L~Ls~N~l~~-lp~~---~~~L 339 (454)
T 1jl5_A 275 L---PQSLTFLDVSENIFSG-LSEL---PPNLYYLNASSNEIRS-LCDL---PPSLEELNVSNNKLIE-LPAL---PPRL 339 (454)
T ss_dssp C---CTTCCEEECCSSCCSE-ESCC---CTTCCEEECCSSCCSE-ECCC---CTTCCEEECCSSCCSC-CCCC---CTTC
T ss_pred c---cCcCCEEECcCCccCc-ccCc---CCcCCEEECcCCcCCc-ccCC---cCcCCEEECCCCcccc-cccc---CCcC
Confidence 2 3667777777777765 2211 1466777777777764 2211 1467777777777765 4443 3566
Q ss_pred cccCCCCCCCCCCCcccccccccCceEEcccceeee--cccccccCCCCCCEEECCCCcceeecCCCCcCCceEeCcCCc
Q 047196 503 LFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSG--DIPSTIGDLKDLQNISLACNGLEGLIPESFGYLTELNLSFNK 580 (827)
Q Consensus 503 ~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g--~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~L~~L~ls~N~ 580 (827)
+.|++++|++++ +|. .++.|+.|++++|++++ .+|.++++ |+.|++.|.+|..+.+|+.||+++|+
T Consensus 340 ~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~~~~L~~L~ls~N~ 407 (454)
T 1jl5_A 340 ERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPELPQNLKQLHVETNP 407 (454)
T ss_dssp CEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC---------------------
T ss_pred CEEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHh--------hhhcccccccccccCcCCEEECCCCc
Confidence 677777777763 444 35667777777777776 56655443 23466667777666789999999999
Q ss_pred Cee--cCCCC
Q 047196 581 LEG--EIPRG 588 (827)
Q Consensus 581 l~g--~ip~~ 588 (827)
++| .+|..
T Consensus 408 l~~~~~iP~s 417 (454)
T 1jl5_A 408 LREFPDIPES 417 (454)
T ss_dssp ----------
T ss_pred CCccccchhh
Confidence 998 78853
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=390.66 Aligned_cols=391 Identities=21% Similarity=0.247 Sum_probs=228.1
Q ss_pred CCCCCcccc--eecCCCCCcEEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCC
Q 047196 82 NTSVCNWIG--ITCNVNSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLS 159 (827)
Q Consensus 82 ~~~~C~W~g--v~C~~~~~~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~ 159 (827)
+.+.|.|.+ |.|+. ++++ .+|. + .++|++|||++|.+++..|..|.++++|++|+|++|.+.
T Consensus 4 ~~~~c~~~~~~~~c~~------------~~l~-~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~ 67 (455)
T 3v47_A 4 GTSECSVIGYNAICIN------------RGLH-QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPG 67 (455)
T ss_dssp ---CCEEETTEEECCS------------SCCS-SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTT
T ss_pred ccceeEEEccccCcCC------------CCcc-cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCccc
Confidence 345577766 66653 2333 3344 2 278999999999999888999999999999999999998
Q ss_pred Cccc-cccCCCCCCcEEEcCCCCCCCCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCc
Q 047196 160 GSLS-SVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKE 238 (827)
Q Consensus 160 g~~p-~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~ 238 (827)
+.++ ..+.++++|++|+|++|.++ +..|..|+++++|++|++++|.+++.+|..
T Consensus 68 ~~i~~~~~~~l~~L~~L~Ls~n~l~-------------------------~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 122 (455)
T 3v47_A 68 LVIRNNTFRGLSSLIILKLDYNQFL-------------------------QLETGAFNGLANLEVLTLTQCNLDGAVLSG 122 (455)
T ss_dssp CEECTTTTTTCTTCCEEECTTCTTC-------------------------EECTTTTTTCTTCCEEECTTSCCBTHHHHS
T ss_pred ceECcccccccccCCEEeCCCCccC-------------------------ccChhhccCcccCCEEeCCCCCCCccccCc
Confidence 6653 34555555555555555554 444455555555555555555555433322
Q ss_pred --CcCCccccEEEccccccccccccc-ccCcCCCcEEEeecccCcccCchhhhcC--CCccEEEecCCccccccChhh--
Q 047196 239 --ISNLTILRKISLRNNKLRGEIPHE-IGYLPNLENLVLGFNNLVGVVPAAIFNM--STVKKIYLLDNSLLGSFSLGI-- 311 (827)
Q Consensus 239 --~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l--~~L~~L~l~~n~l~~~~~~~~-- 311 (827)
++++++|++|+|++|++++..|.. +..+++|++|+|++|++++..|..+.++ .+++.|++++|.+.+..+..+
T Consensus 123 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~ 202 (455)
T 3v47_A 123 NFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGW 202 (455)
T ss_dssp STTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTH
T ss_pred ccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccc
Confidence 555555555555555555444443 4555555555555555555555544443 445555555555443222111
Q ss_pred -----hcCCCCccEEeCcCCccccccCccccCC---CCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhccccccc
Q 047196 312 -----DLSLPNVERLNLGLNRFSGTIPSFITNA---SKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLE 383 (827)
Q Consensus 312 -----~~~l~~L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~ 383 (827)
...+++|++|++++|++++..|..+... ++|+.|++++|.+.+.... .+.+.+..+..+..+
T Consensus 203 ~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~-----~~~~~~~~~~~~~~~----- 272 (455)
T 3v47_A 203 EKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFG-----HTNFKDPDNFTFKGL----- 272 (455)
T ss_dssp HHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTT-----CCSSCCCCTTTTGGG-----
T ss_pred cccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccc-----hhhhccCcccccccc-----
Confidence 1145677888888888877777666543 7778888887765543111 111111111111111
Q ss_pred EEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCc
Q 047196 384 NIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNK 463 (827)
Q Consensus 384 ~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~ 463 (827)
..++|+.|++++|++++.+|..++.+++|++|+|++|++++..|..+.++++|++|+|++|+
T Consensus 273 ------------------~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 334 (455)
T 3v47_A 273 ------------------EASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNF 334 (455)
T ss_dssp ------------------TTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred ------------------cccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCc
Confidence 12455555555555555555555555666666666666655555555566666666666666
Q ss_pred ccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccceeeeccc
Q 047196 464 FSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIP 541 (827)
Q Consensus 464 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip 541 (827)
+++..|..+.++++|++|+|++|.+++..|..|..+++|++|+|++|++++..+..+..++.|+.|++++|++++.+|
T Consensus 335 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 335 LGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred cCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 655555556666666666666666666666666666666666666666665555555666667777777777776665
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=389.96 Aligned_cols=383 Identities=19% Similarity=0.197 Sum_probs=281.5
Q ss_pred CCcccceecCCC-CCcEEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccC-ChhhhhccccceEEecCCCCCCcc
Q 047196 85 VCNWIGITCNVN-SHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDI-PPSIFTMHKLKFLDFSDNQLSGSL 162 (827)
Q Consensus 85 ~C~W~gv~C~~~-~~~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~-p~~~~~l~~L~~LdLs~N~l~g~~ 162 (827)
.|.+.|++.-.. ..+++.|||++|.+++..|..|.++++|++|+|++|.+.+.+ |..|.++++|++|||++|++++..
T Consensus 16 ~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~ 95 (455)
T 3v47_A 16 ICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLE 95 (455)
T ss_dssp ECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEEC
T ss_pred CcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccC
Confidence 366666654322 357999999999999999999999999999999999998766 567999999999999999999999
Q ss_pred ccccCCCCCCcEEEcCCCCCCCCcchh-HhhccccccEEEeecccccccCCcc-CCCCCCCcEEEccCCCCcccCCCcCc
Q 047196 163 SSVTFNLSSVLDIRLDSDKLSGELPVN-ICNYLHYLKVLFLAKNMFHGQIPLA-LSKCKRLQLLNLGFKKLSGAIPKEIS 240 (827)
Q Consensus 163 p~~~~~l~~L~~L~L~~n~l~g~ip~~-~~~~~~~L~~L~Ls~N~l~~~~p~~-l~~l~~L~~L~L~~n~l~~~~p~~~~ 240 (827)
|..+.++++|++|+|++|.+++.+|.. .+..+++|++|+|++|.+++..|.. +.++++|++|++++|.+++..|..+.
T Consensus 96 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~ 175 (455)
T 3v47_A 96 TGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLL 175 (455)
T ss_dssp TTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSG
T ss_pred hhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhh
Confidence 999999999999999999998766654 2334558888888888888777766 77888888888888888888887777
Q ss_pred CC--ccccEEEcccccccccccccc--------cCcCCCcEEEeecccCcccCchhhhcCCCccEEEecCCccccccChh
Q 047196 241 NL--TILRKISLRNNKLRGEIPHEI--------GYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLG 310 (827)
Q Consensus 241 ~l--~~L~~L~Ls~N~l~~~~p~~~--------~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~ 310 (827)
++ .+|+.|++++|.+.+..+..+ ..+++|++|++++|++++..|..+...
T Consensus 176 ~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~-------------------- 235 (455)
T 3v47_A 176 NFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDA-------------------- 235 (455)
T ss_dssp GGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHH--------------------
T ss_pred ccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhcc--------------------
Confidence 66 678888888888876544332 355677777777777777777666543
Q ss_pred hhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccCC
Q 047196 311 IDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNC 390 (827)
Q Consensus 311 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N 390 (827)
...++|+.|++++|.+.+... ..+.+.+..+.. +.+.... +|++|++++|
T Consensus 236 --~~~~~L~~L~l~~~~~~~~~~--------------~~~~~~~~~~~~-------~~~~~~~-------~L~~L~l~~n 285 (455)
T 3v47_A 236 --IAGTKIQSLILSNSYNMGSSF--------------GHTNFKDPDNFT-------FKGLEAS-------GVKTCDLSKS 285 (455)
T ss_dssp --TTTCCEEEEECTTCTTTSCCT--------------TCCSSCCCCTTT-------TGGGTTS-------CCCEEECCSS
T ss_pred --ccccceeeEeecccccccccc--------------chhhhccCcccc-------ccccccc-------CceEEEecCc
Confidence 012344444444444332110 011111110000 0000000 4677777777
Q ss_pred cCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCc
Q 047196 391 NIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPS 470 (827)
Q Consensus 391 ~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 470 (827)
++++.+|..+..+++|+.|++++|++++..|..|.++++|++|+|++|++++..|..+.++++|++|+|++|++++..|.
T Consensus 286 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 365 (455)
T 3v47_A 286 KIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQ 365 (455)
T ss_dssp CCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTT
T ss_pred cccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChh
Confidence 77777777777777888888888888777777777788888888888888777777777788888888888888777777
Q ss_pred cccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCc
Q 047196 471 CLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLS 517 (827)
Q Consensus 471 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p 517 (827)
.+..+++|++|+|++|++++..+..+..+++|+.|++++|.+++..|
T Consensus 366 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 366 SFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred hccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 78888888888888888887666677778888888888888887766
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=371.15 Aligned_cols=353 Identities=16% Similarity=0.181 Sum_probs=209.3
Q ss_pred cEEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcC
Q 047196 99 RVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLD 178 (827)
Q Consensus 99 ~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~ 178 (827)
+++.|++++|.+++. | .+..+++|++|+|++|++++. | ++.+++|++|||++|++++. + +.++++|++|+++
T Consensus 43 ~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~ 114 (457)
T 3bz5_A 43 TLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCD 114 (457)
T ss_dssp TCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECC
T ss_pred CCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECC
Confidence 567777777777764 3 567777777777777777653 3 66777777777777777664 2 6666666666666
Q ss_pred CCCCCCCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEccccccccc
Q 047196 179 SDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGE 258 (827)
Q Consensus 179 ~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 258 (827)
+|.+++ +| + ..+++|++|++++|++++. .++++++|++|++++|...+.+ .++.+++|++|++++|++++
T Consensus 115 ~N~l~~-l~--~-~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~- 184 (457)
T 3bz5_A 115 TNKLTK-LD--V-SQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE- 184 (457)
T ss_dssp SSCCSC-CC--C-TTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-
T ss_pred CCcCCe-ec--C-CCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-
Confidence 666664 43 2 2234666666666666652 2556666666666666544444 35566666666666666664
Q ss_pred ccccccCcCCCcEEEeecccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccC
Q 047196 259 IPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITN 338 (827)
Q Consensus 259 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 338 (827)
+| ++.+++|++|++++|++++. .+..+++|+.|++++|.+.+ +| + ..+++|+.|++++|++++.. +..
T Consensus 185 l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~-~~l~~L~~L~l~~N~l~~~~---~~~ 252 (457)
T 3bz5_A 185 LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--V-TPLTQLTYFDCSVNPLTELD---VST 252 (457)
T ss_dssp CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--C-TTCTTCSEEECCSSCCSCCC---CTT
T ss_pred ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--c-cccCCCCEEEeeCCcCCCcC---HHH
Confidence 33 55666666666666666654 25555555556665555554 33 2 24555555555555555432 234
Q ss_pred CCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCccccc
Q 047196 339 ASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTG 418 (827)
Q Consensus 339 l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g 418 (827)
+++|+.|+++.| +|+.|++++|.+.|.+| ++.+++|+.|++++|...+
T Consensus 253 l~~L~~L~l~~n------------------------------~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~ 300 (457)
T 3bz5_A 253 LSKLTTLHCIQT------------------------------DLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLY 300 (457)
T ss_dssp CTTCCEEECTTC------------------------------CCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCC
T ss_pred CCCCCEEeccCC------------------------------CCCEEECCCCccCCccc--ccccccCCEEECCCCcccc
Confidence 445555555443 24455566666555555 3455666666666666655
Q ss_pred cccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCccccCCCcccccCCccccc
Q 047196 419 SIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWN 498 (827)
Q Consensus 419 ~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 498 (827)
.+|. ...+|+.|++++| ++|+.|++++|++++ ++ ++++++|+.||+++|++++
T Consensus 301 ~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~-l~--l~~l~~L~~L~l~~N~l~~-------- 353 (457)
T 3bz5_A 301 LLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQD-------- 353 (457)
T ss_dssp EEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSC-CC--CTTCTTCSEEECCSSCCCB--------
T ss_pred eecc---CCCcceEechhhc-------------ccCCEEECCCCcccc-cc--cccCCcCcEEECCCCCCCC--------
Confidence 5553 2344444444433 456667777777765 22 6666667777777776665
Q ss_pred cccccccCCCCCCCCCCCcccccccccCceEEcccceeeeccccccc
Q 047196 499 LKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIG 545 (827)
Q Consensus 499 l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~ 545 (827)
++.|..|++++|.++|. +.+..+..+++++|+++|.||..+.
T Consensus 354 l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~~ 395 (457)
T 3bz5_A 354 FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDLL 395 (457)
T ss_dssp CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTCB
T ss_pred ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChhHh
Confidence 23455666666666664 2445556666666777766666543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=371.44 Aligned_cols=362 Identities=18% Similarity=0.187 Sum_probs=221.3
Q ss_pred ccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcCCCCCCCCcchhH
Q 047196 111 QGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNI 190 (827)
Q Consensus 111 ~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~l~g~ip~~~ 190 (827)
.+..+.+++++++|++|||++|.+++. | ++..+++|++|+|++|++++. | +..+++|++|++++|.+++ +| +
T Consensus 31 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~-~~--~ 102 (457)
T 3bz5_A 31 QATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTN-LD--V 102 (457)
T ss_dssp CTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSC-CC--C
T ss_pred CcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCce-ee--c
Confidence 334455788899999999999999965 5 799999999999999999985 3 7788888888888888876 34 3
Q ss_pred hhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCc
Q 047196 191 CNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLE 270 (827)
Q Consensus 191 ~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 270 (827)
. .+++|++|++++|.+++ +| ++++++|++|++++|++++. + ++++++|++|++++|+..+.+ .++.+++|+
T Consensus 103 ~-~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~ 173 (457)
T 3bz5_A 103 T-PLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLT 173 (457)
T ss_dssp T-TCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCC
T ss_pred C-CCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCC
Confidence 3 34577777777777776 33 77777777777777777763 2 667777777777777655555 366777777
Q ss_pred EEEeecccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCC
Q 047196 271 NLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTN 350 (827)
Q Consensus 271 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 350 (827)
+|++++|++++ +| +..+++|+.|++++|.+.+. + + ..+++|++|++++|++++ +| +..+++|+.|++++|
T Consensus 174 ~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~-~--l-~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N 243 (457)
T 3bz5_A 174 TLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL-D--L-NQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVN 243 (457)
T ss_dssp EEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC-C--C-TTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSS
T ss_pred EEECCCCccce-ec--cccCCCCCEEECcCCcCCee-c--c-ccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCC
Confidence 77777777776 33 55555666666666555543 1 1 144555555555555554 33 444555555555555
Q ss_pred cceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCC
Q 047196 351 SFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKL 430 (827)
Q Consensus 351 ~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L 430 (827)
++ ++.. ++.+++|+.|++++| +|
T Consensus 244 ~l----------------------------------------~~~~---~~~l~~L~~L~l~~n--------------~L 266 (457)
T 3bz5_A 244 PL----------------------------------------TELD---VSTLSKLTTLHCIQT--------------DL 266 (457)
T ss_dssp CC----------------------------------------SCCC---CTTCTTCCEEECTTC--------------CC
T ss_pred cC----------------------------------------CCcC---HHHCCCCCEEeccCC--------------CC
Confidence 44 4322 223344444444433 23
Q ss_pred cEEECCCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCC
Q 047196 431 QGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSN 510 (827)
Q Consensus 431 ~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N 510 (827)
+.|++++|.+.|.+| +..+++|+.|++++|++.+.+|. ...+|+.|++++| ++|+.|++++|
T Consensus 267 ~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N 328 (457)
T 3bz5_A 267 LEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNT 328 (457)
T ss_dssp SCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTC
T ss_pred CEEECCCCccCCccc--ccccccCCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECCCC
Confidence 344445555444444 23445555555555555555443 2334444444444 34555555555
Q ss_pred CCCCCCcccccccccCceEEcccceeeecccccccCCCCCCEEECCCCcceeecCCCCcCCceEeCcCCcCeecCCC
Q 047196 511 SLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFGYLTELNLSFNKLEGEIPR 587 (827)
Q Consensus 511 ~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~L~~L~ls~N~l~g~ip~ 587 (827)
++++. .++.++.|+.|++++|+|++ ++.|+.|++++|+++|. ..+..|..+++++|+++|.||.
T Consensus 329 ~l~~l---~l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~--~~~~~l~~l~l~~N~l~g~ip~ 392 (457)
T 3bz5_A 329 ELTEL---DVSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE--GQTITMPKETLTNNSLTIAVSP 392 (457)
T ss_dssp CCSCC---CCTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE--EEEEECCCBCCBTTBEEEECCT
T ss_pred ccccc---ccccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec--ceeeecCccccccCcEEEEcCh
Confidence 55552 25555566666666666554 13344555666666655 2333556666677777777665
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=351.95 Aligned_cols=347 Identities=24% Similarity=0.374 Sum_probs=215.8
Q ss_pred cCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcCCCCCCCCcchhHhhcccccc
Q 047196 119 GNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLK 198 (827)
Q Consensus 119 ~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~ 198 (827)
..+++|+.|++++|.+.. +| .+..+++|++|||++|.+++. |. + ..+++|+
T Consensus 43 ~~l~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~-------------------------~~-~-~~l~~L~ 93 (466)
T 1o6v_A 43 TDLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDI-------------------------TP-L-KNLTKLV 93 (466)
T ss_dssp HHHHTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-------------------------GG-G-TTCTTCC
T ss_pred hHhccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCc-------------------------hh-h-hccccCC
Confidence 345677777777777763 44 366777777777777777632 22 2 2234777
Q ss_pred EEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEeeccc
Q 047196 199 VLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNN 278 (827)
Q Consensus 199 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 278 (827)
+|++++|.+++..| ++++++|++|++++|.+++..+ +.++++|++|++++|++++ +| .++.+++|++|+++ |.
T Consensus 94 ~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~ 166 (466)
T 1o6v_A 94 DILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQ 166 (466)
T ss_dssp EEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ES
T ss_pred EEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-Cc
Confidence 77777777776544 7777777777777777775433 6777777777777777764 33 36677777777775 44
Q ss_pred CcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceeecCC
Q 047196 279 LVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPN 358 (827)
Q Consensus 279 l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 358 (827)
+.+..+ +.++++|+.|++++|. +++. ..+..+++|++|++++|.+++..|
T Consensus 167 ~~~~~~--~~~l~~L~~L~l~~n~-------------------------l~~~--~~l~~l~~L~~L~l~~n~l~~~~~- 216 (466)
T 1o6v_A 167 VTDLKP--LANLTTLERLDISSNK-------------------------VSDI--SVLAKLTNLESLIATNNQISDITP- 216 (466)
T ss_dssp CCCCGG--GTTCTTCCEEECCSSC-------------------------CCCC--GGGGGCTTCSEEECCSSCCCCCGG-
T ss_pred ccCchh--hccCCCCCEEECcCCc-------------------------CCCC--hhhccCCCCCEEEecCCccccccc-
Confidence 443222 4445555555555544 4332 124445555555555555443222
Q ss_pred CccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCC
Q 047196 359 TIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFN 438 (827)
Q Consensus 359 ~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 438 (827)
++.+. +|++|++++|++++. ..+..+++|+.|++++|++++..| +..+++|+.|++++|
T Consensus 217 ----------------~~~l~-~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n 275 (466)
T 1o6v_A 217 ----------------LGILT-NLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGAN 275 (466)
T ss_dssp ----------------GGGCT-TCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSS
T ss_pred ----------------ccccC-CCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCC
Confidence 11122 455566666655542 245566666666666666665544 666666777777777
Q ss_pred CCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcc
Q 047196 439 KLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSL 518 (827)
Q Consensus 439 ~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~ 518 (827)
.+++..| +..+++|+.|++++|++++..| +..+++|+.|++++|++++..| +..+++|+.|++++|.+++. .
T Consensus 276 ~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~ 347 (466)
T 1o6v_A 276 QISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--S 347 (466)
T ss_dssp CCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--G
T ss_pred ccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--h
Confidence 6665433 5666667777777777665433 5666777777777777766555 56667777777777777664 3
Q ss_pred cccccccCceEEcccceeeecccccccCCCCCCEEECCCCccee
Q 047196 519 DIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEG 562 (827)
Q Consensus 519 ~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g 562 (827)
.+..++.|+.|++++|++++.+| +..+++|+.|++++|.+++
T Consensus 348 ~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 348 SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp GGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred hhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence 56677777777777777777666 6777777777777777776
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=350.02 Aligned_cols=344 Identities=24% Similarity=0.350 Sum_probs=256.8
Q ss_pred CcEEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEc
Q 047196 98 HRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRL 177 (827)
Q Consensus 98 ~~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L 177 (827)
.+++.|+++++++.. +| .+..+++|++|||++|.+++..| +.++++|++|++++|.+++..
T Consensus 46 ~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~--------------- 106 (466)
T 1o6v_A 46 DQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT--------------- 106 (466)
T ss_dssp HTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG---------------
T ss_pred ccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccCh---------------
Confidence 468999999999875 44 48899999999999999996644 999999999999999998542
Q ss_pred CCCCCCCCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccc
Q 047196 178 DSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRG 257 (827)
Q Consensus 178 ~~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 257 (827)
. ...+++|++|++++|.+++..+ +.++++|++|++++|.+++. | .++++++|++|+++ |.+.+
T Consensus 107 ----------~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~ 169 (466)
T 1o6v_A 107 ----------P--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTD 169 (466)
T ss_dssp ----------G--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCC
T ss_pred ----------h--hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccC
Confidence 2 2234589999999999987644 89999999999999999863 3 48999999999997 56654
Q ss_pred cccccccCcCCCcEEEeecccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCcccc
Q 047196 258 EIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFIT 337 (827)
Q Consensus 258 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 337 (827)
.. .+..+++|++|++++|.+++. ..+..+++|+.|++++|.+.+..+ ++
T Consensus 170 ~~--~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~---------------------------~~ 218 (466)
T 1o6v_A 170 LK--PLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP---------------------------LG 218 (466)
T ss_dssp CG--GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG---------------------------GG
T ss_pred ch--hhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc---------------------------cc
Confidence 43 389999999999999998764 235555555555555555544333 33
Q ss_pred CCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCcccc
Q 047196 338 NASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLT 417 (827)
Q Consensus 338 ~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 417 (827)
.+++|+.|++++|.+++. ..+..++ +|+.|++++|.+++..| +..+++|+.|++++|+++
T Consensus 219 ~l~~L~~L~l~~n~l~~~-----------------~~l~~l~-~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~ 278 (466)
T 1o6v_A 219 ILTNLDELSLNGNQLKDI-----------------GTLASLT-NLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS 278 (466)
T ss_dssp GCTTCCEEECCSSCCCCC-----------------GGGGGCT-TCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCC
T ss_pred ccCCCCEEECCCCCcccc-----------------hhhhcCC-CCCEEECCCCccccchh--hhcCCCCCEEECCCCccC
Confidence 444555555555544321 0122222 56666666666665544 667777777777777777
Q ss_pred ccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCccccCCCcccccCCcccc
Q 047196 418 GSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFW 497 (827)
Q Consensus 418 g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 497 (827)
+..+ +..+++|+.|++++|++.+..| +..+++|+.|++++|++++..| +..+++|+.|++++|.+++. ..+.
T Consensus 279 ~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~ 350 (466)
T 1o6v_A 279 NISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLA 350 (466)
T ss_dssp CCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGT
T ss_pred cccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhc
Confidence 6544 6777888888888888776544 6777888888888888876655 67788888888888888775 4677
Q ss_pred ccccccccCCCCCCCCCCCcccccccccCceEEcccceeee
Q 047196 498 NLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSG 538 (827)
Q Consensus 498 ~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g 538 (827)
.+++|+.|++++|++++..| +..++.|+.|++++|.+++
T Consensus 351 ~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 351 NLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp TCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred cCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence 88888888888888888777 7788888889999998886
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=351.14 Aligned_cols=173 Identities=14% Similarity=0.135 Sum_probs=89.6
Q ss_pred cCCCCCCCCCCCCc----ccceecCCCCCcEEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccc
Q 047196 74 LLAQNSTSNTSVCN----WIGITCNVNSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLK 149 (827)
Q Consensus 74 ~l~~w~~~~~~~C~----W~gv~C~~~~~~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~ 149 (827)
.+.+|. .+.+||. |.++.|+. + ++-....... ...-..+++++.|++++|.+....+..|..+++|+
T Consensus 8 ~l~~~~-~~~~C~~~~~~~~c~~~~~---~---i~~~~~~~~~--~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~ 78 (597)
T 3oja_B 8 NVKPRQ-PEYKCIDSNLQYDCVFYDV---H---IDMQTQDVYF--GFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78 (597)
T ss_dssp ---CCC-SEECCCCC--CCSEEECSC---E---ECSSCCCCEE--SCSSGGGCCCSEEEESSCEESEECTHHHHHCCCCS
T ss_pred cccCCC-CCCcCcccCcCceeEecCc---e---eccccccccc--CcccccCCCceEEEeeCCCCCCcCHHHHccCCCCc
Confidence 456776 5567774 66666652 1 1111111111 11223467888888888888766556677788888
Q ss_pred eEEecCCCCCCccccccCCCCCCcEEEcCCCCCCCCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCC
Q 047196 150 FLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFK 229 (827)
Q Consensus 150 ~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n 229 (827)
+|+|++|.+++..|..+..++ +|++|+|++|.+++..|..|+++++|++|+|++|
T Consensus 79 ~L~L~~n~l~~~~~~~~~~l~-------------------------~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 133 (597)
T 3oja_B 79 LLNLNDLQIEEIDTYAFAYAH-------------------------TIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERN 133 (597)
T ss_dssp EEECTTSCCCEECTTTTTTCT-------------------------TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred EEECCCCCCCCCChHHhcCCC-------------------------CCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCC
Confidence 888888877654333333222 3333333333333444444455555555555555
Q ss_pred CCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEeecccCc
Q 047196 230 KLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLV 280 (827)
Q Consensus 230 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 280 (827)
.+++..+..|+++++|++|+|++|.+++..|..|+.+++|++|+|++|.++
T Consensus 134 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 184 (597)
T 3oja_B 134 DLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 184 (597)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCS
T ss_pred CCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCC
Confidence 555433333455555555555555555444444444555555555444443
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=339.23 Aligned_cols=313 Identities=18% Similarity=0.180 Sum_probs=210.5
Q ss_pred CCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcCCCCCCCCcc
Q 047196 108 LNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELP 187 (827)
Q Consensus 108 ~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~l~g~ip 187 (827)
++++ .+|..+. +++++|||++|++++..|..|.++++|++|+|++|.+++..|..+.++++|++|+|++|.++ .+|
T Consensus 21 ~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~ 96 (477)
T 2id5_A 21 KRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIP 96 (477)
T ss_dssp CCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-SCC
T ss_pred CCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCC-ccC
Confidence 3443 3455443 58899999999999888889999999999999999999888888888888888888888887 466
Q ss_pred hhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcC
Q 047196 188 VNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLP 267 (827)
Q Consensus 188 ~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 267 (827)
...+..+++|++|+|++|.+++..|..|.++++|++|++++|.+++..|..|.++++|++|+|++|++++..+..+..++
T Consensus 97 ~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~ 176 (477)
T 2id5_A 97 LGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLH 176 (477)
T ss_dssp TTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCT
T ss_pred cccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccC
Confidence 65555556888888888888877777888888888888888888877777788888888888888888766666777888
Q ss_pred CCcEEEeecccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEc
Q 047196 268 NLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDM 347 (827)
Q Consensus 268 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 347 (827)
+|++|+|++|.+++..+..+.++++|+.|++++|...+.++.... ...+|+.|++++|+++...+..+..++
T Consensus 177 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~-~~~~L~~L~l~~n~l~~~~~~~~~~l~------- 248 (477)
T 2id5_A 177 GLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCL-YGLNLTSLSITHCNLTAVPYLAVRHLV------- 248 (477)
T ss_dssp TCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTT-TTCCCSEEEEESSCCCSCCHHHHTTCT-------
T ss_pred CCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccc-cCccccEEECcCCcccccCHHHhcCcc-------
Confidence 888888888888777666666666666666666655555444333 223444444444444422222233333
Q ss_pred CCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCC
Q 047196 348 GTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRL 427 (827)
Q Consensus 348 s~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l 427 (827)
+|+.|+|++|.+++..+..|..+++|+.|+|++|++++..|..|..+
T Consensus 249 ---------------------------------~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 295 (477)
T 2id5_A 249 ---------------------------------YLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGL 295 (477)
T ss_dssp ---------------------------------TCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTC
T ss_pred ---------------------------------ccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCc
Confidence 34444444444444444445555555555555555555555555555
Q ss_pred CCCcEEECCCCCCCCCCCccccccccccEEecCCCccc
Q 047196 428 QKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFS 465 (827)
Q Consensus 428 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 465 (827)
++|+.|+|++|++++..+..|..+++|+.|++++|.+.
T Consensus 296 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 333 (477)
T 2id5_A 296 NYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333 (477)
T ss_dssp TTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEE
T ss_pred ccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCcc
Confidence 55666666666555544445555555556666655554
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=341.07 Aligned_cols=300 Identities=23% Similarity=0.224 Sum_probs=153.5
Q ss_pred cccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEee
Q 047196 196 YLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLG 275 (827)
Q Consensus 196 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 275 (827)
++++|+|++|.+++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|++++..+..|..+++|++|+|+
T Consensus 33 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 112 (477)
T 2id5_A 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDIS 112 (477)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECT
T ss_pred CCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECC
Confidence 56777777777776666677777777777777777776667777777777777777777765555556677777777777
Q ss_pred cccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceee
Q 047196 276 FNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGI 355 (827)
Q Consensus 276 ~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 355 (827)
+|++++..|..+.++++|+.|++++|.+.+..+..+. .+++|+.|++++|++++..+..+.++++|+.|++++|.+.+.
T Consensus 113 ~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~ 191 (477)
T 2id5_A 113 ENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFS-GLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAI 191 (477)
T ss_dssp TSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSST-TCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEE
T ss_pred CCccccCChhHccccccCCEEECCCCccceeChhhcc-CCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEe
Confidence 7777666666665555555555555555443333322 444555555555555444334444444444444444444332
Q ss_pred cCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEEC
Q 047196 356 IPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYL 435 (827)
Q Consensus 356 ~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 435 (827)
.+. .+..+. +|++|++++|.+.+.+|.......+|+.|++++|++++..+..+..+++|+.|+|
T Consensus 192 ~~~---------------~~~~l~-~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 255 (477)
T 2id5_A 192 RDY---------------SFKRLY-RLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNL 255 (477)
T ss_dssp CTT---------------CSCSCT-TCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEEC
T ss_pred Chh---------------hcccCc-ccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeEC
Confidence 221 111111 3444444444444333333333334444444444444333233444444444444
Q ss_pred CCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCC
Q 047196 436 PFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSL 512 (827)
Q Consensus 436 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l 512 (827)
++|.+++..+..+.++++|+.|+|++|++++..|..+..+++|+.|+|++|++++..+..|..+++|+.|+|++|.+
T Consensus 256 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l 332 (477)
T 2id5_A 256 SYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332 (477)
T ss_dssp CSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCE
T ss_pred CCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCc
Confidence 44444433333444444444444444444444444444444444444444444443333334444444444444443
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=326.25 Aligned_cols=349 Identities=16% Similarity=0.148 Sum_probs=170.3
Q ss_pred CCCCCCCCCCCCc-ccceecCCCCCcEEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEe
Q 047196 75 LAQNSTSNTSVCN-WIGITCNVNSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDF 153 (827)
Q Consensus 75 l~~w~~~~~~~C~-W~gv~C~~~~~~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdL 153 (827)
+++|. .+.+||. |.+..|.....++ ............-..++++++|++++|.++...+..+..+++|++|+|
T Consensus 3 ~~~~~-~~~~C~~~~~~~~c~~~~~~i-----~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L 76 (390)
T 3o6n_A 3 VKPRQ-PEYKCIDSNLQYDCVFYDVHI-----DMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNL 76 (390)
T ss_dssp ----C-CEECBCC------EEEESCEE-----CSSCCCCEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEEC
T ss_pred cCCCC-Cccceehhhhhhccceeeeee-----ecccccccccccccccCCceEEEecCCchhhCChhHhcccccCcEEEC
Confidence 45676 5567774 5555553221122 221111122222345789999999999998655556788999999999
Q ss_pred cCCCCCCccccccCCCCCCcEEEcCCCCCCCCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcc
Q 047196 154 SDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSG 233 (827)
Q Consensus 154 s~N~l~g~~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~ 233 (827)
++|.+++..+..+..+++|++|+|++|.++ +..|..++++++|++|++++|.++.
T Consensus 77 ~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-------------------------~~~~~~~~~l~~L~~L~L~~n~l~~ 131 (390)
T 3o6n_A 77 NDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-------------------------YLPPHVFQNVPLLTVLVLERNDLSS 131 (390)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECCSSCCC-------------------------CCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CCCcccccChhhccCCCCcCEEECCCCCCC-------------------------cCCHHHhcCCCCCCEEECCCCccCc
Confidence 999998665556665555555555555544 3344444555555555555555553
Q ss_pred cCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEeecccCcccCchhhhcCCCccEEEecCCccccccChhhhc
Q 047196 234 AIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDL 313 (827)
Q Consensus 234 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 313 (827)
..+..++++++|++|++++|++++..|..+..+++|++|++++|++++.. +..+++|+.|++++|.+.+. .
T Consensus 132 l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---~~~l~~L~~L~l~~n~l~~~------~ 202 (390)
T 3o6n_A 132 LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTL------A 202 (390)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC---GGGCTTCSEEECCSSCCSEE------E
T ss_pred CCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc---cccccccceeeccccccccc------C
Confidence 33333455555555555555555444445555555555555555554421 22233333333333333211 0
Q ss_pred CCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCc
Q 047196 314 SLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIG 393 (827)
Q Consensus 314 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~ 393 (827)
..++|+.|++++|+++.. |.. ..++ |+.|++++|+++
T Consensus 203 ~~~~L~~L~l~~n~l~~~-~~~--~~~~----------------------------------------L~~L~l~~n~l~ 239 (390)
T 3o6n_A 203 IPIAVEELDASHNSINVV-RGP--VNVE----------------------------------------LTILKLQHNNLT 239 (390)
T ss_dssp CCSSCSEEECCSSCCCEE-ECC--CCSS----------------------------------------CCEEECCSSCCC
T ss_pred CCCcceEEECCCCeeeec-ccc--cccc----------------------------------------ccEEECCCCCCc
Confidence 123344444444444432 111 1234 444444444444
Q ss_pred cccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCcccc
Q 047196 394 GSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLG 473 (827)
Q Consensus 394 g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 473 (827)
+. ..+..+++|+.|++++|++++..|..|..+++|+.|+|++|++++ +|..+..+++|+.|++++|+++ .+|..+.
T Consensus 240 ~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~ 315 (390)
T 3o6n_A 240 DT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQP 315 (390)
T ss_dssp CC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHH
T ss_pred cc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCcccc
Confidence 32 234444444444444444444444444444445555555444442 3333344444555555555444 3344444
Q ss_pred CCCCCCccccCCCcccccCCccccccccccccCCCCCCCC
Q 047196 474 NLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLD 513 (827)
Q Consensus 474 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~ 513 (827)
.+++|++|++++|.++... +..+++|+.|++++|.++
T Consensus 316 ~l~~L~~L~L~~N~i~~~~---~~~~~~L~~L~l~~N~~~ 352 (390)
T 3o6n_A 316 QFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWD 352 (390)
T ss_dssp HHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCEE
T ss_pred ccCcCCEEECCCCccceeC---chhhccCCEEEcCCCCcc
Confidence 4445555555555544331 334444555555555544
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-36 Score=323.16 Aligned_cols=282 Identities=21% Similarity=0.267 Sum_probs=204.4
Q ss_pred cCCCHHHHHHHHHHHhhcCCCCCCcCCCCC---CCCCCCCcccceecCC--------CCCcEEEEEcCCCCCccccCccc
Q 047196 50 ASNITTDQQALLALKAHISYDPTNLLAQNS---TSNTSVCNWIGITCNV--------NSHRVTALNISSLNLQGTIPPQL 118 (827)
Q Consensus 50 ~~~~~~~~~aLl~~k~~~~~~~~~~l~~w~---~~~~~~C~W~gv~C~~--------~~~~v~~L~L~~~~l~g~~~~~l 118 (827)
+++..+|++||++||+++..|+.+.+.+|. ....++|.|.|+.|+. ...+|+.|+|++|+++ .+|+.+
T Consensus 22 ~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l 100 (328)
T 4fcg_A 22 STALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQA 100 (328)
T ss_dssp -CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCG
T ss_pred cccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhh
Confidence 345678999999999998778877778883 2567899999999952 3468999999999998 778889
Q ss_pred cCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcCCCCCCCCcchhHhhcccccc
Q 047196 119 GNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLK 198 (827)
Q Consensus 119 ~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~ 198 (827)
+++++|++|+|++|.++ .+|..++.+++|++|||++|.++ .+|..+.++++|++|++++|++.+.+|..+...
T Consensus 101 ~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~----- 173 (328)
T 4fcg_A 101 FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST----- 173 (328)
T ss_dssp GGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEE-----
T ss_pred hhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhc-----
Confidence 99999999999999999 89999999999999999999998 667777788777777777777777777654320
Q ss_pred EEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEeeccc
Q 047196 199 VLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNN 278 (827)
Q Consensus 199 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 278 (827)
.++..++++++|++|++++|.++ .+|..++++++|++|+|++|++++ +|..++.+++|++|+|++|+
T Consensus 174 -----------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~ 240 (328)
T 4fcg_A 174 -----------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCT 240 (328)
T ss_dssp -----------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCT
T ss_pred -----------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCc
Confidence 01122334556666666666665 555556666666666666666653 44456666666666666666
Q ss_pred CcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcce
Q 047196 279 LVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFS 353 (827)
Q Consensus 279 l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 353 (827)
+.+.+|..+.++++|+.|++++|.+.+.+|..+. .+++|++|++++|++.+.+|..++++++|+.+++..+.+.
T Consensus 241 ~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~-~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 241 ALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIH-RLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp TCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGG-GCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred chhhhHHHhcCCCCCCEEECCCCCchhhcchhhh-cCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 6666666666666666666666666666665554 6677777777777777777777777777777777766554
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=310.99 Aligned_cols=227 Identities=34% Similarity=0.626 Sum_probs=143.7
Q ss_pred cccEEEccC-CcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEec
Q 047196 381 SLENIYISN-CNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGL 459 (827)
Q Consensus 381 ~L~~L~Ls~-N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 459 (827)
+|++|++++ |++.+.+|..|.++++|++|+|++|++++.+|..|.++++|++|+|++|.+++.+|..+..+++|++|++
T Consensus 77 ~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 156 (313)
T 1ogq_A 77 YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITF 156 (313)
T ss_dssp TCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEEC
T ss_pred CCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEEC
Confidence 344444442 4444455555555555555555555555555555555555555555555555555555555556666666
Q ss_pred CCCcccccCCccccCCC-CCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccceeee
Q 047196 460 AGNKFSGSIPSCLGNLT-SLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSG 538 (827)
Q Consensus 460 s~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g 538 (827)
++|++++.+|..+..++ +|++|++++|.+++.+|..+..++ |+.|++++|.+++.+|..++.++.|+.|++++|++++
T Consensus 157 ~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 235 (313)
T 1ogq_A 157 DGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235 (313)
T ss_dssp CSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECC
T ss_pred cCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceee
Confidence 66666555565555555 566666666666666666665555 6666666666666666666666666666666666666
Q ss_pred cccccccCCCCCCEEECCCCcceeecCCCCc---CCceEeCcCCcCeecCCCCCCCCCCcccccccCccccCCC
Q 047196 539 DIPSTIGDLKDLQNISLACNGLEGLIPESFG---YLTELNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLP 609 (827)
Q Consensus 539 ~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~---~L~~L~ls~N~l~g~ip~~~~~~~~~~~~~~~n~~lc~~p 609 (827)
.+|. +..+++|+.|+|++|+++|.+|..+. +|+.|++++|+++|.+|..+.+..+....+.+|+.+||.|
T Consensus 236 ~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p 308 (313)
T 1ogq_A 236 DLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp BGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred ecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCC
Confidence 5554 56666677777777777766666543 5677777777777777777777788888888999999964
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=312.14 Aligned_cols=309 Identities=18% Similarity=0.173 Sum_probs=156.3
Q ss_pred cccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEee
Q 047196 196 YLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLG 275 (827)
Q Consensus 196 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 275 (827)
++++|++++|.++...+..+.++++|++|++++|.+++..|..|+++++|++|+|++|++++..|..++.+++|++|+|+
T Consensus 46 ~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 125 (390)
T 3o6n_A 46 NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 125 (390)
T ss_dssp CCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECC
Confidence 45555555555443333334445555555555555554444455555555555555555554444445555555555555
Q ss_pred cccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceee
Q 047196 276 FNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGI 355 (827)
Q Consensus 276 ~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 355 (827)
+|+++...+..+.++++|++|++++|.+.+..+..+. .+++|++|++++|++++. .+..+++|+.|++++|.+++.
T Consensus 126 ~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~~ 201 (390)
T 3o6n_A 126 RNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQ-ATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL 201 (390)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTS-SCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSEE
T ss_pred CCccCcCCHHHhcCCCCCcEEECCCCccCccChhhcc-CCCCCCEEECCCCcCCcc---ccccccccceeeccccccccc
Confidence 5555432222223333333333333332222111111 333344444444444322 123334444444444443321
Q ss_pred cCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEEC
Q 047196 356 IPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYL 435 (827)
Q Consensus 356 ~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 435 (827)
...++|+.|++++|++... |.. ..++|+.|++
T Consensus 202 ---------------------------------------------~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l 233 (390)
T 3o6n_A 202 ---------------------------------------------AIPIAVEELDASHNSINVV-RGP--VNVELTILKL 233 (390)
T ss_dssp ---------------------------------------------ECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEEC
T ss_pred ---------------------------------------------CCCCcceEEECCCCeeeec-ccc--ccccccEEEC
Confidence 1123444444444444432 111 1245555555
Q ss_pred CCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCC
Q 047196 436 PFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGP 515 (827)
Q Consensus 436 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~ 515 (827)
++|.+++. ..+..+++|+.|++++|++++..|..+..+++|++|+|++|.+++ +|..+..+++|+.|+|++|+++ .
T Consensus 234 ~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~ 309 (390)
T 3o6n_A 234 QHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-H 309 (390)
T ss_dssp CSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-C
T ss_pred CCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-e
Confidence 55555542 345555566666666666665556666666666666666666655 3444455666666666666666 3
Q ss_pred CcccccccccCceEEcccceeeecccccccCCCCCCEEECCCCcceee
Q 047196 516 LSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGL 563 (827)
Q Consensus 516 ~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ 563 (827)
+|..++.++.|+.|++++|+|+.. | +..+++|+.|++++|.++..
T Consensus 310 ~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~ 354 (390)
T 3o6n_A 310 VERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCN 354 (390)
T ss_dssp CGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHH
T ss_pred cCccccccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccch
Confidence 455566677777777777777643 3 66777888888888887764
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-33 Score=324.49 Aligned_cols=287 Identities=17% Similarity=0.185 Sum_probs=186.3
Q ss_pred CcEEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEc
Q 047196 98 HRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRL 177 (827)
Q Consensus 98 ~~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L 177 (827)
..++.++++++.+....+..+.++++|++|+|++|.+++..|..|..+++|++|+|++|.+++..|..+.+++
T Consensus 51 ~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~------- 123 (597)
T 3oja_B 51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVP------- 123 (597)
T ss_dssp CCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT-------
T ss_pred CCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCC-------
Confidence 3578899999999877666789999999999999999998888999999999999999999976666555554
Q ss_pred CCCCCCCCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccc
Q 047196 178 DSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRG 257 (827)
Q Consensus 178 ~~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 257 (827)
+|++|+|++|.+++..+..|+++++|++|+|++|.+++..|..|+++++|++|+|++|.+++
T Consensus 124 ------------------~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 185 (597)
T 3oja_B 124 ------------------LLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH 185 (597)
T ss_dssp ------------------TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSB
T ss_pred ------------------CCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCC
Confidence 45555555555555455557899999999999999999999999999999999999999986
Q ss_pred cccccccCcCCCcEEEeecccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCcccc
Q 047196 258 EIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFIT 337 (827)
Q Consensus 258 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 337 (827)
. .++.+++|+.|++++|.+++. . ..++|+.|++++|.++...+..
T Consensus 186 ~---~~~~l~~L~~L~l~~n~l~~l-----~-------------------------~~~~L~~L~ls~n~l~~~~~~~-- 230 (597)
T 3oja_B 186 V---DLSLIPSLFHANVSYNLLSTL-----A-------------------------IPIAVEELDASHNSINVVRGPV-- 230 (597)
T ss_dssp C---CGGGCTTCSEEECCSSCCSEE-----E-------------------------CCTTCSEEECCSSCCCEEECSC--
T ss_pred c---ChhhhhhhhhhhcccCccccc-----c-------------------------CCchhheeeccCCccccccccc--
Confidence 5 256678899999998887642 1 1224555555555554322211
Q ss_pred CCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCcccc
Q 047196 338 NASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLT 417 (827)
Q Consensus 338 ~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 417 (827)
.++|+.|++++|.+++. ..+..++ +|+.|+|++|.+++.+|..|..+++|+.|+|++|+++
T Consensus 231 -~~~L~~L~L~~n~l~~~-----------------~~l~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 291 (597)
T 3oja_B 231 -NVELTILKLQHNNLTDT-----------------AWLLNYP-GLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 291 (597)
T ss_dssp -CSCCCEEECCSSCCCCC-----------------GGGGGCT-TCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCC
T ss_pred -CCCCCEEECCCCCCCCC-----------------hhhccCC-CCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCC
Confidence 12344444444443321 1122222 3444444444444444444444444555555554444
Q ss_pred ccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCccc
Q 047196 418 GSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFS 465 (827)
Q Consensus 418 g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 465 (827)
+ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|+++
T Consensus 292 ~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~ 337 (597)
T 3oja_B 292 A-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 337 (597)
T ss_dssp E-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCC
T ss_pred C-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCC
Confidence 3 2333344444444444444444 33444444444444444444443
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-32 Score=295.98 Aligned_cols=302 Identities=23% Similarity=0.392 Sum_probs=146.2
Q ss_pred cEEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcC
Q 047196 99 RVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLD 178 (827)
Q Consensus 99 ~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~ 178 (827)
+++.|+++++.+... + .+..+++|++|+|++|++++. |. +..+++|++|+|++|.+++. +.+.+++
T Consensus 45 ~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~~--~~~~~l~-------- 110 (347)
T 4fmz_A 45 SITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITDI--SALQNLT-------- 110 (347)
T ss_dssp TCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCC--GGGTTCT--------
T ss_pred cccEEEEeCCccccc-h-hhhhcCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccCc--hHHcCCC--------
Confidence 455566665555432 2 355555666666666655532 22 55555566666655555432 1233344
Q ss_pred CCCCCCCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEccccccccc
Q 047196 179 SDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGE 258 (827)
Q Consensus 179 ~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 258 (827)
+|++|++++|.+++..+ +..+++|+.|++++|.....++ .+..+++|++|++++|.+.+.
T Consensus 111 -----------------~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~ 170 (347)
T 4fmz_A 111 -----------------NLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDV 170 (347)
T ss_dssp -----------------TCSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCC
T ss_pred -----------------cCCEEECcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCc
Confidence 44444444444433221 4455555555555554333222 245555555555555555433
Q ss_pred ccccccCcCCCcEEEeecccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccC
Q 047196 259 IPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITN 338 (827)
Q Consensus 259 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 338 (827)
.+ +..+++|++|++++|.+++..+ +..+++|+.+++++|.+.+..+ + ..+++|++|++++|++++..+ +..
T Consensus 171 ~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~-~~~~~L~~L~l~~n~l~~~~~--~~~ 241 (347)
T 4fmz_A 171 TP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--V-ANMTRLNSLKIGNNKITDLSP--LAN 241 (347)
T ss_dssp GG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--G-GGCTTCCEEECCSSCCCCCGG--GTT
T ss_pred hh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--h-hcCCcCCEEEccCCccCCCcc--hhc
Confidence 22 4555555555555555544322 3344444444444443332221 1 134444444444444443222 344
Q ss_pred CCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCccccc
Q 047196 339 ASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTG 418 (827)
Q Consensus 339 l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g 418 (827)
+++|+. |++++|.+++. ..+..+++|+.|++++|++++
T Consensus 242 l~~L~~----------------------------------------L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~ 279 (347)
T 4fmz_A 242 LSQLTW----------------------------------------LEIGTNQISDI--NAVKDLTKLKMLNVGSNQISD 279 (347)
T ss_dssp CTTCCE----------------------------------------EECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC
T ss_pred CCCCCE----------------------------------------EECCCCccCCC--hhHhcCCCcCEEEccCCccCC
Confidence 444444 44444444432 234445555555555555554
Q ss_pred cccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCccccCCCccc
Q 047196 419 SIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLT 489 (827)
Q Consensus 419 ~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 489 (827)
. +.+..+++|+.|++++|.+++..|..+..+++|+.|++++|++++..| +..+++|++||+++|.++
T Consensus 280 ~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 280 I--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp C--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred C--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 3 234555555555555555555555555555566666666666554444 555566666666666553
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-32 Score=294.79 Aligned_cols=301 Identities=25% Similarity=0.387 Sum_probs=136.6
Q ss_pred cccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEee
Q 047196 196 YLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLG 275 (827)
Q Consensus 196 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 275 (827)
+|++|++++|.+.. +| .+..+++|++|++++|.+++..+ +.++++|++|++++|.++. +| .+..+++|++|+++
T Consensus 45 ~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~~L~l~ 118 (347)
T 4fmz_A 45 SITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLRELYLN 118 (347)
T ss_dssp TCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECT
T ss_pred cccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC-ch-HHcCCCcCCEEECc
Confidence 55555555555542 22 24455555555555555543322 4455555555555555543 22 34455555555555
Q ss_pred cccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceee
Q 047196 276 FNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGI 355 (827)
Q Consensus 276 ~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 355 (827)
+|.+++..+ +. .+++|+.|++++|.....++ .+..+++|++|++++|.+.+.
T Consensus 119 ~n~i~~~~~--~~-------------------------~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~ 170 (347)
T 4fmz_A 119 EDNISDISP--LA-------------------------NLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDV 170 (347)
T ss_dssp TSCCCCCGG--GT-------------------------TCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCC
T ss_pred CCcccCchh--hc-------------------------cCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCc
Confidence 555443221 33 34444444444443332222 244444455555444444321
Q ss_pred cCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEEC
Q 047196 356 IPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYL 435 (827)
Q Consensus 356 ~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 435 (827)
.+ +..+. +|++|++++|.+.+..+ +..+++|+.|++++|.+.+..+ +..+++|+.|++
T Consensus 171 ~~-----------------~~~l~-~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l 228 (347)
T 4fmz_A 171 TP-----------------IANLT-DLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKI 228 (347)
T ss_dssp GG-----------------GGGCT-TCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEEC
T ss_pred hh-----------------hccCC-CCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEc
Confidence 11 11222 34444444444443222 4444555555555555544332 444555555555
Q ss_pred CCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCC
Q 047196 436 PFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGP 515 (827)
Q Consensus 436 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~ 515 (827)
++|++++..+ +..+++|++|++++|++++. +.+..+++|++|++++|.+++. +.+..+++|+.|++++|.+++.
T Consensus 229 ~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~ 302 (347)
T 4fmz_A 229 GNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNE 302 (347)
T ss_dssp CSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGG
T ss_pred cCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCc
Confidence 5555543222 44455555555555555431 2344445555555555555442 2244444444444444444444
Q ss_pred CcccccccccCceEEcccceeeecccccccCCCCCCEEECCCCcc
Q 047196 516 LSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGL 560 (827)
Q Consensus 516 ~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l 560 (827)
.|..++.++.|+.|++++|++++..| +..+++|+.|++++|.+
T Consensus 303 ~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i 345 (347)
T 4fmz_A 303 DMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345 (347)
T ss_dssp GHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC--
T ss_pred ChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhcc
Confidence 44444444444445555554444333 44444444444444444
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=332.56 Aligned_cols=390 Identities=17% Similarity=0.185 Sum_probs=224.8
Q ss_pred CCCCEEECCCCCCCccCChh-hhhccccceEEecCCCCCC----ccccccCCCCCCcEEEcCCCCCCCCcchhHhhccc-
Q 047196 122 SSLTTLNLSHNKLSGDIPPS-IFTMHKLKFLDFSDNQLSG----SLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLH- 195 (827)
Q Consensus 122 ~~L~~L~Ls~N~l~g~~p~~-~~~l~~L~~LdLs~N~l~g----~~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~- 195 (827)
++|++|||++|+++...... +..+++|++|+|++|.+++ .++..+..+++|++|+|++|.+.+..+..++..+.
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 34556666666655333222 5556666666666666653 23444555555555555555554434444444443
Q ss_pred ---cccEEEeecccccc----cCCccCCCCCCCcEEEccCCCCcccCCCcCc-----CCccccEEEccccccccc----c
Q 047196 196 ---YLKVLFLAKNMFHG----QIPLALSKCKRLQLLNLGFKKLSGAIPKEIS-----NLTILRKISLRNNKLRGE----I 259 (827)
Q Consensus 196 ---~L~~L~Ls~N~l~~----~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~~----~ 259 (827)
+|++|+|++|.++. .+|..+.++++|++|++++|.++...+..+. ..++|++|++++|++++. +
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l 162 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence 47777777776663 4466666677777777777766543332222 234566666666666543 2
Q ss_pred cccccCcCCCcEEEeecccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccc----cCcc
Q 047196 260 PHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGT----IPSF 335 (827)
Q Consensus 260 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~ 335 (827)
+..+..+++|++|+|++|.++...+..+.. .+....++|++|++++|+++.. ++..
T Consensus 163 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~--------------------~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 222 (461)
T 1z7x_W 163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQ--------------------GLKDSPCQLEALKLESCGVTSDNCRDLCGI 222 (461)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHH--------------------HHHHSCCCCCEEECTTSCCBTTHHHHHHHH
T ss_pred HHHHhhCCCCCEEECcCCCcchHHHHHHHH--------------------HHhcCCCCceEEEccCCCCcHHHHHHHHHH
Confidence 444555566666666666655433332221 1111234566666666665542 3555
Q ss_pred ccCCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchh-cccccccEEEccCCcCccc----cCccccCCCCCceEe
Q 047196 336 ITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIG-NLSMSLENIYISNCNIGGS----IPQLISNLSNLLLLD 410 (827)
Q Consensus 336 ~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~-~~~~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~ 410 (827)
+..+++|+.|++++|.+++..... +...+. .. .+|++|++++|++++. ++..+..+++|+.|+
T Consensus 223 l~~~~~L~~L~Ls~n~l~~~~~~~-----------l~~~~~~~~-~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~ 290 (461)
T 1z7x_W 223 VASKASLRELALGSNKLGDVGMAE-----------LCPGLLHPS-SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELS 290 (461)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHHH-----------HHHHHTSTT-CCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEE
T ss_pred HHhCCCccEEeccCCcCChHHHHH-----------HHHHHhcCC-CCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEE
Confidence 556666666666666654321000 000111 11 2677777777777654 566666677778888
Q ss_pred ccCcccccccccccc-----CCCCCcEEECCCCCCCCC----CCccccccccccEEecCCCcccccCCccccC-----CC
Q 047196 411 LEGNKLTGSIPVTFG-----RLQKLQGLYLPFNKLAGS----IPDQLCHLARLNTLGLAGNKFSGSIPSCLGN-----LT 476 (827)
Q Consensus 411 Ls~N~l~g~~p~~~~-----~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~ 476 (827)
+++|.+++..+..+. ..++|+.|++++|.+++. +|..+..+++|+.|++++|++++..+..+.. .+
T Consensus 291 Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~ 370 (461)
T 1z7x_W 291 LAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGS 370 (461)
T ss_dssp CTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTC
T ss_pred CCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCC
Confidence 887777654443332 235788888888877754 4555666778888888888777654443332 56
Q ss_pred CCCccccCCCcccc----cCCccccccccccccCCCCCCCCCCCccccc-----ccccCceEEcccceeeeccccc
Q 047196 477 SLRSPDLGSNRLTS----VLPSTFWNLKDILFFDLSSNSLDGPLSLDIG-----NLRVVIGINLSRNNFSGDIPST 543 (827)
Q Consensus 477 ~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~-----~l~~L~~L~Ls~N~l~g~ip~~ 543 (827)
+|++|++++|.+++ .+|..+..+++|++||+++|.+++.-...+. ....|+.|++.++.+....+..
T Consensus 371 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~~~~~~ 446 (461)
T 1z7x_W 371 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDR 446 (461)
T ss_dssp CCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHH
T ss_pred ceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCHHHHHH
Confidence 78888888888875 6677777778888888888887753211111 1234666777666666554443
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-31 Score=289.91 Aligned_cols=290 Identities=23% Similarity=0.278 Sum_probs=165.3
Q ss_pred cccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEee
Q 047196 196 YLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLG 275 (827)
Q Consensus 196 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 275 (827)
+++++++++|.++ .+|..+. ++|+.|++++|.+++..|..|.++++|++|++++|++++..|..|+.+++|++|+|+
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 4666666666655 4454442 456666666666665555566666666666666666665556666666666666666
Q ss_pred cccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceee
Q 047196 276 FNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGI 355 (827)
Q Consensus 276 ~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 355 (827)
+|+++. +|..+. ++|++|++++|++++..+..+..+++|+.|++++|.++..
T Consensus 111 ~n~l~~-l~~~~~---------------------------~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~ 162 (332)
T 2ft3_A 111 KNHLVE-IPPNLP---------------------------SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENS 162 (332)
T ss_dssp SSCCCS-CCSSCC---------------------------TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGG
T ss_pred CCcCCc-cCcccc---------------------------ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccC
Confidence 666552 332221 3444455555555444444445555555555555544310
Q ss_pred cCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEEC
Q 047196 356 IPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYL 435 (827)
Q Consensus 356 ~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 435 (827)
+..|..+..+ +|++|++++|++++ +|..+. ++|+.|++++|++++..|..+..+++|+.|+|
T Consensus 163 -------------~~~~~~~~~l--~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L 224 (332)
T 2ft3_A 163 -------------GFEPGAFDGL--KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGL 224 (332)
T ss_dssp -------------GSCTTSSCSC--CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBC
T ss_pred -------------CCCcccccCC--ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence 0011122222 35555555555554 333322 45666666666666655566666666666666
Q ss_pred CCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCccccCCCcccccCCcccccc------ccccccCCCC
Q 047196 436 PFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNL------KDILFFDLSS 509 (827)
Q Consensus 436 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l------~~L~~LdLs~ 509 (827)
++|++++..|..+..+++|+.|++++|+++ .+|..+..+++|++|++++|.+++..+..|..+ ..|+.|++++
T Consensus 225 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~ 303 (332)
T 2ft3_A 225 GHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFN 303 (332)
T ss_dssp CSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCS
T ss_pred CCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeec
Confidence 666666655556666666666666666666 566666666666666666666666555555432 4566777777
Q ss_pred CCCC--CCCcccccccccCceEEcccce
Q 047196 510 NSLD--GPLSLDIGNLRVVIGINLSRNN 535 (827)
Q Consensus 510 N~l~--g~~p~~~~~l~~L~~L~Ls~N~ 535 (827)
|.+. +..|..+..++.|+.+++++|+
T Consensus 304 N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 304 NPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp SSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred CcccccccCcccccccchhhhhhccccc
Confidence 7776 5566667777777777777764
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.98 E-value=4.1e-35 Score=333.72 Aligned_cols=383 Identities=20% Similarity=0.195 Sum_probs=256.6
Q ss_pred CCCcEEEcCCCCCCCCcchhHhhccccccEEEeecccccc----cCCccCCCCCCCcEEEccCCCCcccCCCcCc-CCc-
Q 047196 170 SSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHG----QIPLALSKCKRLQLLNLGFKKLSGAIPKEIS-NLT- 243 (827)
Q Consensus 170 ~~L~~L~L~~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~----~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~-~l~- 243 (827)
++|++|+|+.|.++......++..+++|++|+|++|.++. .++..+..+++|++|++++|.++...+..+. .+.
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 3466777777776644334444455567777777776653 3455556666666777766666543332221 233
Q ss_pred ---cccEEEcccccccc----cccccccCcCCCcEEEeecccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCC
Q 047196 244 ---ILRKISLRNNKLRG----EIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLP 316 (827)
Q Consensus 244 ---~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~ 316 (827)
+|++|+|++|+++. .+|..+..+++|++|+|++|.+++..+..+.. .+....+
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~--------------------~l~~~~~ 142 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCE--------------------GLLDPQC 142 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHH--------------------HHTSTTC
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHH--------------------HHhcCCC
Confidence 46666666666652 44566666666666666666665443333221 1111345
Q ss_pred CccEEeCcCCccccc----cCccccCCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcC
Q 047196 317 NVERLNLGLNRFSGT----IPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNI 392 (827)
Q Consensus 317 ~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l 392 (827)
+|++|++++|++++. ++..+..+++|+.|++++|.+++..+.. +...+.....+|++|++++|++
T Consensus 143 ~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~-----------l~~~l~~~~~~L~~L~L~~n~l 211 (461)
T 1z7x_W 143 RLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRV-----------LCQGLKDSPCQLEALKLESCGV 211 (461)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHH-----------HHHHHHHSCCCCCEEECTTSCC
T ss_pred cceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHH-----------HHHHHhcCCCCceEEEccCCCC
Confidence 677777777777653 3455566778888888877765432210 0011111112688888888888
Q ss_pred ccc----cCccccCCCCCceEeccCccccccc-----cccccCCCCCcEEECCCCCCCCC----CCccccccccccEEec
Q 047196 393 GGS----IPQLISNLSNLLLLDLEGNKLTGSI-----PVTFGRLQKLQGLYLPFNKLAGS----IPDQLCHLARLNTLGL 459 (827)
Q Consensus 393 ~g~----~p~~~~~l~~L~~L~Ls~N~l~g~~-----p~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~L 459 (827)
++. ++..+..+++|+.|++++|++++.. +..+..+++|+.|++++|.+++. ++..+..+++|+.|++
T Consensus 212 ~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L 291 (461)
T 1z7x_W 212 TSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSL 291 (461)
T ss_dssp BTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEEC
T ss_pred cHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEEC
Confidence 763 5777778889999999999887542 33344688999999999988754 5677777889999999
Q ss_pred CCCcccccCCcccc-----CCCCCCccccCCCccccc----CCccccccccccccCCCCCCCCCCCcccccc-----ccc
Q 047196 460 AGNKFSGSIPSCLG-----NLTSLRSPDLGSNRLTSV----LPSTFWNLKDILFFDLSSNSLDGPLSLDIGN-----LRV 525 (827)
Q Consensus 460 s~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~-----l~~ 525 (827)
++|++++..+..+. ..++|++|++++|.+++. +|..+..+++|+.||+++|.+++..+..+.. .+.
T Consensus 292 s~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~ 371 (461)
T 1z7x_W 292 AGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSV 371 (461)
T ss_dssp TTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCC
T ss_pred CCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCc
Confidence 99988755443333 236899999999998865 4666777889999999999888765555543 568
Q ss_pred CceEEcccceeee----cccccccCCCCCCEEECCCCcceee--------cCCCCcCCceEeCcCCcCee
Q 047196 526 VIGINLSRNNFSG----DIPSTIGDLKDLQNISLACNGLEGL--------IPESFGYLTELNLSFNKLEG 583 (827)
Q Consensus 526 L~~L~Ls~N~l~g----~ip~~~~~l~~L~~L~Ls~N~l~g~--------ip~~~~~L~~L~ls~N~l~g 583 (827)
|+.|++++|++++ .+|..+..+++|+.|++++|++++. +|.....|+.|++.++.+..
T Consensus 372 L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~ 441 (461)
T 1z7x_W 372 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 441 (461)
T ss_dssp CCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred eEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCH
Confidence 9999999999987 7888898999999999999998764 56656678888888776654
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.98 E-value=3e-31 Score=288.19 Aligned_cols=288 Identities=25% Similarity=0.302 Sum_probs=228.9
Q ss_pred CCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEeecccCcccCchhhhcCCCccEEEec
Q 047196 220 RLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLL 299 (827)
Q Consensus 220 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 299 (827)
+++.++++++.++ .+|..+. ++|++|++++|++++..|..|..+++|++|+|++|++++..|..+.
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~----------- 99 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFS----------- 99 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGST-----------
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhh-----------
Confidence 5677777777766 4555443 5677777777777666666677777777777777777666555554
Q ss_pred CCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhccc
Q 047196 300 DNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLS 379 (827)
Q Consensus 300 ~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~ 379 (827)
.+++|++|++++|+++ .+|..+. ++|++|++++|++++..+. .+..+.
T Consensus 100 --------------~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~---------------~~~~l~ 147 (332)
T 2ft3_A 100 --------------PLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKG---------------VFSGLR 147 (332)
T ss_dssp --------------TCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSG---------------GGSSCS
T ss_pred --------------CcCCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHh---------------HhCCCc
Confidence 4556666666667666 4454444 7999999999998754332 344454
Q ss_pred ccccEEEccCCcCc--cccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEE
Q 047196 380 MSLENIYISNCNIG--GSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTL 457 (827)
Q Consensus 380 ~~L~~L~Ls~N~l~--g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 457 (827)
+|++|++++|.++ +..|..+..+ +|+.|++++|++++ +|..+. ++|+.|++++|++++..|..+..+++|+.|
T Consensus 148 -~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L 222 (332)
T 2ft3_A 148 -NMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRL 222 (332)
T ss_dssp -SCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCC
T ss_pred -cCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEE
Confidence 8999999999996 4778888888 99999999999996 555543 799999999999999888999999999999
Q ss_pred ecCCCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCccccccc------ccCceEEc
Q 047196 458 GLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNL------RVVIGINL 531 (827)
Q Consensus 458 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l------~~L~~L~L 531 (827)
++++|++++..|..+..+++|++|++++|.++ .+|..+..+++|+.|++++|++++..+..+... ..|+.|++
T Consensus 223 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l 301 (332)
T 2ft3_A 223 GLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISL 301 (332)
T ss_dssp BCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEEC
T ss_pred ECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEe
Confidence 99999999888889999999999999999999 678889999999999999999998777777653 56899999
Q ss_pred ccceee--ecccccccCCCCCCEEECCCCc
Q 047196 532 SRNNFS--GDIPSTIGDLKDLQNISLACNG 559 (827)
Q Consensus 532 s~N~l~--g~ip~~~~~l~~L~~L~Ls~N~ 559 (827)
++|.+. +..|..|..+++|+.+++++|+
T Consensus 302 ~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 302 FNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ecCcccccccCcccccccchhhhhhccccc
Confidence 999998 6778889999999999999985
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7e-31 Score=285.03 Aligned_cols=267 Identities=23% Similarity=0.248 Sum_probs=139.9
Q ss_pred CCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEeecccCcccCchhhhcCCCccEEEec
Q 047196 220 RLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLL 299 (827)
Q Consensus 220 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 299 (827)
+|++|++++|++++..+..|+++++|++|+|++|++++..|..|+.+++|++|+|++|+++. +|..+. ++|++|+++
T Consensus 53 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-l~~~~~--~~L~~L~l~ 129 (330)
T 1xku_A 53 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKMP--KTLQELRVH 129 (330)
T ss_dssp TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSB-CCSSCC--TTCCEEECC
T ss_pred CCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCCc-cChhhc--ccccEEECC
Confidence 44444444444444444444444444444444444444444444444444444444444442 222221 334444444
Q ss_pred CCccccccChhhhcCCCCccEEeCcCCccc--cccCccccCCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhc
Q 047196 300 DNSLLGSFSLGIDLSLPNVERLNLGLNRFS--GTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGN 377 (827)
Q Consensus 300 ~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~ 377 (827)
+|.+.+..+..+ ..+++|+.|++++|++. +..+..+..+++|++|++++|.++.. | ..+.
T Consensus 130 ~n~l~~~~~~~~-~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l-~---------------~~~~- 191 (330)
T 1xku_A 130 ENEITKVRKSVF-NGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTI-P---------------QGLP- 191 (330)
T ss_dssp SSCCCBBCHHHH-TTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSC-C---------------SSCC-
T ss_pred CCcccccCHhHh-cCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccC-C---------------cccc-
Confidence 443332222111 24555555555555553 24555666677777777777666531 1 1111
Q ss_pred ccccccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEE
Q 047196 378 LSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTL 457 (827)
Q Consensus 378 ~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 457 (827)
.+|++|++++|++++..|..+..+++|+.|++++|++++..+..+..+++|+.|+|++|+++ .+|..+..+++|++|
T Consensus 192 --~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L 268 (330)
T 1xku_A 192 --PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVV 268 (330)
T ss_dssp --TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEE
T ss_pred --ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEE
Confidence 25677777777777666666777777777777777777666666666777777777777666 566666666666777
Q ss_pred ecCCCcccccCCccccCC------CCCCccccCCCcccc--cCCccccccccccccCCCCC
Q 047196 458 GLAGNKFSGSIPSCLGNL------TSLRSPDLGSNRLTS--VLPSTFWNLKDILFFDLSSN 510 (827)
Q Consensus 458 ~Ls~N~l~~~~p~~~~~l------~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~LdLs~N 510 (827)
++++|++++..+..|... ..|+.+++++|.+.. ..|..|..+.+++.++|++|
T Consensus 269 ~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N 329 (330)
T 1xku_A 269 YLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329 (330)
T ss_dssp ECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC---
T ss_pred ECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEeccc
Confidence 777766665444444322 344555555555432 33344444444444444444
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=283.22 Aligned_cols=298 Identities=22% Similarity=0.300 Sum_probs=215.6
Q ss_pred CCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEeecccCcccCchhhhcCCCccEEEe
Q 047196 219 KRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYL 298 (827)
Q Consensus 219 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 298 (827)
.+++.++++++.++ .+|..+. +.|++|++++|++++..+..|+.+++|++|+|++|++++..|..+.++++|++|++
T Consensus 31 c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (330)
T 1xku_A 31 CHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 107 (330)
T ss_dssp EETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence 36778888888877 4565554 68999999999999887778999999999999999999998999999999999999
Q ss_pred cCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcc
Q 047196 299 LDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNL 378 (827)
Q Consensus 299 ~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~ 378 (827)
++|.+. .+|..+. ++|++|++++|++++..+..+.++++|+.|++++|.+... +..+..+..+
T Consensus 108 s~n~l~-~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-------------~~~~~~~~~l 170 (330)
T 1xku_A 108 SKNQLK-ELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS-------------GIENGAFQGM 170 (330)
T ss_dssp CSSCCS-BCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGG-------------GBCTTGGGGC
T ss_pred CCCcCC-ccChhhc---ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCcc-------------CcChhhccCC
Confidence 999886 4555433 6899999999999888777888889999999888877531 1223344444
Q ss_pred cccccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEe
Q 047196 379 SMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLG 458 (827)
Q Consensus 379 ~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 458 (827)
. +|++|++++|+++. +|..+. ++|+.|++++|++++..|..|..+++|+.|+|++|++++..+..+..+++|+.|+
T Consensus 171 ~-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 246 (330)
T 1xku_A 171 K-KLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH 246 (330)
T ss_dssp T-TCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEE
T ss_pred C-CcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEE
Confidence 4 67777777777774 444332 6777777777777776677777777777777777777766666677777777777
Q ss_pred cCCCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccceeee
Q 047196 459 LAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSG 538 (827)
Q Consensus 459 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g 538 (827)
+++|+++ .+|..+..+++|++|++++|++++..+..|..... ......+..+++++|.+..
T Consensus 247 L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~------------------~~~~~~l~~l~l~~N~~~~ 307 (330)
T 1xku_A 247 LNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGY------------------NTKKASYSGVSLFSNPVQY 307 (330)
T ss_dssp CCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSC------------------CTTSCCCSEEECCSSSSCG
T ss_pred CCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCccc------------------ccccccccceEeecCcccc
Confidence 7777776 56666777777777777777777655554432210 0112455667777776653
Q ss_pred --cccccccCCCCCCEEECCCCc
Q 047196 539 --DIPSTIGDLKDLQNISLACNG 559 (827)
Q Consensus 539 --~ip~~~~~l~~L~~L~Ls~N~ 559 (827)
..|..|..+..++.++|++|+
T Consensus 308 ~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 308 WEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp GGSCGGGGTTCCCGGGEEC----
T ss_pred cccCccccccccceeEEEecccC
Confidence 445677777778888887774
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-33 Score=331.20 Aligned_cols=256 Identities=13% Similarity=0.120 Sum_probs=125.1
Q ss_pred CCcccceecCCCCCcEEEEEcCCCCCccccCccccCCCCCCEEECCCCCC---CccCChhhh------------hccccc
Q 047196 85 VCNWIGITCNVNSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKL---SGDIPPSIF------------TMHKLK 149 (827)
Q Consensus 85 ~C~W~gv~C~~~~~~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l---~g~~p~~~~------------~l~~L~ 149 (827)
|++|.++.+... .+ +.+.+ ......+..+..+++|++|+|+++.. .+.+|..++ .+++|+
T Consensus 41 ck~W~~~~~~~~-~~---l~~~~-~~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~ 115 (592)
T 3ogk_B 41 CRRWFKIDSETR-EH---VTMAL-CYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLK 115 (592)
T ss_dssp CHHHHHHHHHHC-CE---EEESC-GGGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCC
T ss_pred hHHHHHhhhccc-cE---EEEee-ccccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCC
Confidence 457998865422 12 22222 22233334466778888888877532 123332222 677888
Q ss_pred eEEecCCCCCCccccccCCC--CCCcEEEcCCCC-CCCCcchhHhhccccccEEEeeccccccc----CCccCCCCCCCc
Q 047196 150 FLDFSDNQLSGSLSSVTFNL--SSVLDIRLDSDK-LSGELPVNICNYLHYLKVLFLAKNMFHGQ----IPLALSKCKRLQ 222 (827)
Q Consensus 150 ~LdLs~N~l~g~~p~~~~~l--~~L~~L~L~~n~-l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~ 222 (827)
+|+|++|.+++..+..+... .+|++|+|+.+. ++..--..+...+++|++|+|++|.+++. ++..+.++++|+
T Consensus 116 ~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~ 195 (592)
T 3ogk_B 116 SVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLE 195 (592)
T ss_dssp EEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCC
T ss_pred eEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCcc
Confidence 88888887776555444432 236666665554 11000011122234566666666655443 222334455666
Q ss_pred EEEccCCCCc----ccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEeecccCc---ccCchhhhcCCCccE
Q 047196 223 LLNLGFKKLS----GAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLV---GVVPAAIFNMSTVKK 295 (827)
Q Consensus 223 ~L~L~~n~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~---~~~p~~~~~l~~L~~ 295 (827)
.|++++|.++ +.++..+.++++|++|++++|.+.+ +|..+..+++|++|+++.+... +..+..+..+++|+.
T Consensus 196 ~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~ 274 (592)
T 3ogk_B 196 VLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCR 274 (592)
T ss_dssp EEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCE
T ss_pred EEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccc
Confidence 6666666554 2233334455556666666655553 4555555666666666542221 122233444455555
Q ss_pred EEecCCccccccChhhhcCCCCccEEeCcCCccccccC-ccccCCCCCcEEEcC
Q 047196 296 IYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIP-SFITNASKLVYLDMG 348 (827)
Q Consensus 296 L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls 348 (827)
++++++. .+.+|..+. .+++|++|++++|.+++... ..+..+++|+.|+++
T Consensus 275 L~l~~~~-~~~l~~~~~-~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~ 326 (592)
T 3ogk_B 275 LGLSYMG-PNEMPILFP-FAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR 326 (592)
T ss_dssp EEETTCC-TTTGGGGGG-GGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE
T ss_pred cCccccc-hhHHHHHHh-hcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc
Confidence 5554431 122222221 34455555555555433222 223445555555554
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-32 Score=320.76 Aligned_cols=412 Identities=13% Similarity=0.047 Sum_probs=280.4
Q ss_pred CCccCChhhhhccccceEEecCCCC---CCccccccC------------CCCCCcEEEcCCCCCCCCcchhHhhcccc-c
Q 047196 134 LSGDIPPSIFTMHKLKFLDFSDNQL---SGSLSSVTF------------NLSSVLDIRLDSDKLSGELPVNICNYLHY-L 197 (827)
Q Consensus 134 l~g~~p~~~~~l~~L~~LdLs~N~l---~g~~p~~~~------------~l~~L~~L~L~~n~l~g~ip~~~~~~~~~-L 197 (827)
+....+..+..+++|++|+|+++.. .+.+|..+. .+++|++|+|++|.+++..+..+....+. |
T Consensus 61 ~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L 140 (592)
T 3ogk_B 61 YTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDL 140 (592)
T ss_dssp GGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGC
T ss_pred cccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccC
Confidence 3334455677899999999988643 133333322 68899999999998887777766664334 9
Q ss_pred cEEEeeccc-ccc-cCCccCCCCCCCcEEEccCCCCccc----CCCcCcCCccccEEEccccccc----ccccccccCcC
Q 047196 198 KVLFLAKNM-FHG-QIPLALSKCKRLQLLNLGFKKLSGA----IPKEISNLTILRKISLRNNKLR----GEIPHEIGYLP 267 (827)
Q Consensus 198 ~~L~Ls~N~-l~~-~~p~~l~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~l~ 267 (827)
++|+|++|. ++. .++....++++|++|+|++|.+++. ++..+.++++|++|++++|.++ +.++..+..++
T Consensus 141 ~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~ 220 (592)
T 3ogk_B 141 ETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCR 220 (592)
T ss_dssp CEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCT
T ss_pred cEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCC
Confidence 999999886 221 2233345788999999999988765 3334567889999999999987 45566667889
Q ss_pred CCcEEEeecccCcccCchhhhcCCCccEEEecCCccc---cccChhhhcCCCCccEEeCcCCccccccCccccCCCCCcE
Q 047196 268 NLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLL---GSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVY 344 (827)
Q Consensus 268 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~---~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 344 (827)
+|++|+|++|.+.+ +|..+.++++|+.|+++..... +..+..+. .+++|+.|+++++. .+.+|..+..+++|++
T Consensus 221 ~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~-~~~~L~~L~l~~~~-~~~l~~~~~~~~~L~~ 297 (592)
T 3ogk_B 221 SLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLV-FPRKLCRLGLSYMG-PNEMPILFPFAAQIRK 297 (592)
T ss_dssp TCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCC-CCTTCCEEEETTCC-TTTGGGGGGGGGGCCE
T ss_pred CCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhh-ccccccccCccccc-hhHHHHHHhhcCCCcE
Confidence 99999999998887 6788888999999999864322 11222222 56788888887753 3456777777888888
Q ss_pred EEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEecc-----------C
Q 047196 345 LDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLE-----------G 413 (827)
Q Consensus 345 L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls-----------~ 413 (827)
|++++|.+++... +..+..++ +|++|+++++-..+.++..+..+++|+.|+++ .
T Consensus 298 L~Ls~~~l~~~~~--------------~~~~~~~~-~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~ 362 (592)
T 3ogk_B 298 LDLLYALLETEDH--------------CTLIQKCP-NLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEE 362 (592)
T ss_dssp EEETTCCCCHHHH--------------HHHHTTCT-TCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTT
T ss_pred EecCCCcCCHHHH--------------HHHHHhCc-CCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCcccccccccc
Confidence 8888887653211 11122333 78888888443334455555677888888888 3
Q ss_pred ccccccc-cccccCCCCCcEEECCCCCCCCCCCccccc-cccccEEecC----CCccccc-----CCccccCCCCCCccc
Q 047196 414 NKLTGSI-PVTFGRLQKLQGLYLPFNKLAGSIPDQLCH-LARLNTLGLA----GNKFSGS-----IPSCLGNLTSLRSPD 482 (827)
Q Consensus 414 N~l~g~~-p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~-l~~L~~L~Ls----~N~l~~~-----~p~~~~~l~~L~~L~ 482 (827)
|.+++.. +.....+++|++|+++.|.+++..+..+.. +++|+.|+++ .|++++. ++..+.++++|++|+
T Consensus 363 ~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~ 442 (592)
T 3ogk_B 363 GLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFA 442 (592)
T ss_dssp CCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEE
T ss_pred CccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEE
Confidence 5665432 223455788888888878887766666554 7778888885 6677653 334456678888888
Q ss_pred cCCCc--ccccCCcccc-ccccccccCCCCCCCCC-CCcccccccccCceEEcccceeeec-ccccccCCCCCCEEECCC
Q 047196 483 LGSNR--LTSVLPSTFW-NLKDILFFDLSSNSLDG-PLSLDIGNLRVVIGINLSRNNFSGD-IPSTIGDLKDLQNISLAC 557 (827)
Q Consensus 483 Ls~N~--l~~~~p~~~~-~l~~L~~LdLs~N~l~g-~~p~~~~~l~~L~~L~Ls~N~l~g~-ip~~~~~l~~L~~L~Ls~ 557 (827)
++++. +++..+..+. .+++|+.|++++|.+++ .++..+..+++|+.|++++|.|++. ++..+..+++|+.|+|++
T Consensus 443 L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~ 522 (592)
T 3ogk_B 443 FYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQG 522 (592)
T ss_dssp EECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEES
T ss_pred EecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcC
Confidence 86433 5554444443 36778888888888776 3455556777888888888887655 344456677888888888
Q ss_pred Ccceee
Q 047196 558 NGLEGL 563 (827)
Q Consensus 558 N~l~g~ 563 (827)
|++++.
T Consensus 523 n~it~~ 528 (592)
T 3ogk_B 523 YRASMT 528 (592)
T ss_dssp CBCCTT
T ss_pred CcCCHH
Confidence 887654
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=276.52 Aligned_cols=285 Identities=21% Similarity=0.289 Sum_probs=212.1
Q ss_pred CCCCCcccceecCCCCCcEEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCc
Q 047196 82 NTSVCNWIGITCNVNSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGS 161 (827)
Q Consensus 82 ~~~~C~W~gv~C~~~~~~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~ 161 (827)
...+|.|.|+ |+ +++++++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|++++.
T Consensus 26 ~~~~C~~~~~-c~----------~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~ 91 (353)
T 2z80_A 26 ASLSCDRNGI-CK----------GSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTI 91 (353)
T ss_dssp -CCEECTTSE-EE----------CCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEE
T ss_pred cCCCCCCCeE-ee----------CCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCcc
Confidence 4567999988 75 3455555 3455444 4788888888888876666788888888888888888877
Q ss_pred cccccCCCCCCcEEEcCCCCCCCCcchhHhhccccccEEEeecccccccCC-ccCCCCCCCcEEEccCC-CCcccCCCcC
Q 047196 162 LSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIP-LALSKCKRLQLLNLGFK-KLSGAIPKEI 239 (827)
Q Consensus 162 ~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~L~~n-~l~~~~p~~~ 239 (827)
.|..+.++++|++|++++|.++ .+|...+..+++|++|++++|.+++..+ ..+.++++|++|++++| .+++..|..+
T Consensus 92 ~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~ 170 (353)
T 2z80_A 92 EEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170 (353)
T ss_dssp CTTTTTTCTTCCEEECCSSCCS-SCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTT
T ss_pred CHhhcCCCCCCCEEECCCCcCC-cCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHc
Confidence 7777888888888888888887 4666655556688888888888875433 47788888888888888 4666667778
Q ss_pred cCCccccEEEcccccccccccccccCcCCCcEEEeecccCcccCchhhhcCCCccEEEecCCccccccChhhh--cCCCC
Q 047196 240 SNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGID--LSLPN 317 (827)
Q Consensus 240 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~--~~l~~ 317 (827)
+++++|++|++++|++++..|..+..+++|++|++++|+++...+..+..+++|+.|++++|.+.+..+..+. ...+.
T Consensus 171 ~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~ 250 (353)
T 2z80_A 171 AGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSL 250 (353)
T ss_dssp TTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCC
T ss_pred cCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccch
Confidence 8888888888888888888888888888888888888888654444455688888888888888765433221 23566
Q ss_pred ccEEeCcCCcccc----ccCccccCCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCch-hcccccccEEEccCCcC
Q 047196 318 VERLNLGLNRFSG----TIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSI-GNLSMSLENIYISNCNI 392 (827)
Q Consensus 318 L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~-~~~~~~L~~L~Ls~N~l 392 (827)
++.++++.+.+++ .+|..+..+++|+.|++++|+++. +| ..+ ..++ +|++|++++|.+
T Consensus 251 l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~-i~---------------~~~~~~l~-~L~~L~L~~N~~ 313 (353)
T 2z80_A 251 IKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKS-VP---------------DGIFDRLT-SLQKIWLHTNPW 313 (353)
T ss_dssp CCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCC-CC---------------TTTTTTCT-TCCEEECCSSCB
T ss_pred hhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCc-cC---------------HHHHhcCC-CCCEEEeeCCCc
Confidence 7888888888776 467778888889999998888873 22 222 3444 788899999998
Q ss_pred ccccCc
Q 047196 393 GGSIPQ 398 (827)
Q Consensus 393 ~g~~p~ 398 (827)
.+..|.
T Consensus 314 ~~~~~~ 319 (353)
T 2z80_A 314 DCSCPR 319 (353)
T ss_dssp CCCHHH
T ss_pred cCcCCC
Confidence 888774
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=272.21 Aligned_cols=283 Identities=19% Similarity=0.209 Sum_probs=213.3
Q ss_pred CCCCcCCCCCCC-CCCCCcccceecCCCCCcEEEEEcCCCCCccc----cCcc--ccCCCCCCEEECCCCCCCccCChhh
Q 047196 70 DPTNLLAQNSTS-NTSVCNWIGITCNVNSHRVTALNISSLNLQGT----IPPQ--LGNLSSLTTLNLSHNKLSGDIPPSI 142 (827)
Q Consensus 70 ~~~~~l~~w~~~-~~~~C~W~gv~C~~~~~~v~~L~L~~~~l~g~----~~~~--l~~L~~L~~L~Ls~N~l~g~~p~~~ 142 (827)
|+...+..|... ..|+|.|.++.|...... -.-....|. ++.. -...+++++|+|++|+++ .+|+.+
T Consensus 27 ~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~-----~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l 100 (328)
T 4fcg_A 27 PYHDVLSQWQRHYNADRNRWHSAWRQANSNN-----PQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQA 100 (328)
T ss_dssp CHHHHHHHHHHHHHHCCTTHHHHHHHHTTTC-----TTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCG
T ss_pred hHHHHHHHHHHhccCCchhhhhhhccccccc-----ccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhh
Confidence 333456667521 247899999998422110 001112221 1111 123578999999999998 888889
Q ss_pred hhccccceEEecCCCCCCccccccCCCCCCcEEEcCCCCCCCCcchhHhhccccccEEEeecccccccCCccCCCCCCCc
Q 047196 143 FTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQ 222 (827)
Q Consensus 143 ~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 222 (827)
+++++|++|+|++|.++ .+|..+..+++|++|+|++|.++ .+|..+..+ ++|++|++++|++.+.+|..++..
T Consensus 101 ~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l-~~L~~L~L~~n~~~~~~p~~~~~~---- 173 (328)
T 4fcg_A 101 FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASL-NRLRELSIRACPELTELPEPLAST---- 173 (328)
T ss_dssp GGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGC-TTCCEEEEEEETTCCCCCSCSEEE----
T ss_pred hhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcC-cCCCEEECCCCCCccccChhHhhc----
Confidence 99999999999999998 77777777777777777666666 566555443 356666666665555555443321
Q ss_pred EEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEeecccCcccCchhhhcCCCccEEEecCCc
Q 047196 223 LLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNS 302 (827)
Q Consensus 223 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~ 302 (827)
.++..+.++++|++|+|++|+++ .+|..++.+++|++|+|++|++++ +|..+..+++|+.|++++|.
T Consensus 174 -----------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~ 240 (328)
T 4fcg_A 174 -----------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCT 240 (328)
T ss_dssp -----------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCT
T ss_pred -----------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCc
Confidence 12233556999999999999999 889999999999999999999996 56679999999999999999
Q ss_pred cccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccc
Q 047196 303 LLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSL 382 (827)
Q Consensus 303 l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L 382 (827)
+.+.+|..+. .+++|++|++++|++.+.+|..+.++++|+.|++++|++.+.+ |..++.++ ++
T Consensus 241 ~~~~~p~~~~-~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~i---------------P~~l~~L~-~L 303 (328)
T 4fcg_A 241 ALRNYPPIFG-GRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRL---------------PSLIAQLP-AN 303 (328)
T ss_dssp TCCBCCCCTT-CCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCC---------------CGGGGGSC-TT
T ss_pred chhhhHHHhc-CCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhc---------------cHHHhhcc-Cc
Confidence 9999998776 8999999999999999999999999999999999998877654 45667776 79
Q ss_pred cEEEccCCcCccc
Q 047196 383 ENIYISNCNIGGS 395 (827)
Q Consensus 383 ~~L~Ls~N~l~g~ 395 (827)
+.+++..+.+...
T Consensus 304 ~~l~l~~~~~~~l 316 (328)
T 4fcg_A 304 CIILVPPHLQAQL 316 (328)
T ss_dssp CEEECCGGGSCC-
T ss_pred eEEeCCHHHHHHH
Confidence 9999999888764
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.2e-29 Score=266.12 Aligned_cols=252 Identities=21% Similarity=0.268 Sum_probs=175.9
Q ss_pred CCcccceecCCCCCcEEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCC--cc
Q 047196 85 VCNWIGITCNVNSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSG--SL 162 (827)
Q Consensus 85 ~C~W~gv~C~~~~~~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g--~~ 162 (827)
.|.|.+|.|+.. +++ .+|..+. ++|++|+|++|+++...+..|.++++|++|+|++|.++. ..
T Consensus 6 ~C~~~~l~c~~~------------~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~ 70 (306)
T 2z66_A 6 SCSGTEIRCNSK------------GLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCC 70 (306)
T ss_dssp EEETTEEECCSS------------CCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEE
T ss_pred eeCCCEEEcCCC------------Ccc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCc
Confidence 389999999753 222 2333332 567777777777774444446777777777777777763 33
Q ss_pred ccccCCCCCCcEEEcCCCCCCCCcchhHhhccccccEEEeecccccccCC-ccCCCCCCCcEEEccCCCCcccCCCcCcC
Q 047196 163 SSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIP-LALSKCKRLQLLNLGFKKLSGAIPKEISN 241 (827)
Q Consensus 163 p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~L~~n~l~~~~p~~~~~ 241 (827)
+..+..+++|++|++++|.+. .+|..+.. +++|++|++++|.+++..+ ..+.++++|++|++++|.+++..|..+.+
T Consensus 71 ~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~-l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 148 (306)
T 2z66_A 71 SQSDFGTTSLKYLDLSFNGVI-TMSSNFLG-LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 148 (306)
T ss_dssp EHHHHSCSCCCEEECCSCSEE-EEEEEEET-CTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTT
T ss_pred ccccccccccCEEECCCCccc-cChhhcCC-CCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhccc
Confidence 555556677777777777666 35555443 4477777777777776554 56777888888888888887777777788
Q ss_pred CccccEEEcccccccc-cccccccCcCCCcEEEeecccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccE
Q 047196 242 LTILRKISLRNNKLRG-EIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVER 320 (827)
Q Consensus 242 l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 320 (827)
+++|++|++++|.+++ .+|..+..+++|++|+|++|++++..|..+.++++|+.|++++|.+.+..+..+. .+++|+.
T Consensus 149 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~ 227 (306)
T 2z66_A 149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK-CLNSLQV 227 (306)
T ss_dssp CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGT-TCTTCCE
T ss_pred CcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhcc-CcccCCE
Confidence 8888888888888776 5677778888888888888888877777777777777777777776654443333 5677777
Q ss_pred EeCcCCccccccCccccCCC-CCcEEEcCCCccee
Q 047196 321 LNLGLNRFSGTIPSFITNAS-KLVYLDMGTNSFSG 354 (827)
Q Consensus 321 L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~g 354 (827)
|++++|++++..|..+..++ +|++|++++|.+++
T Consensus 228 L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~ 262 (306)
T 2z66_A 228 LDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 262 (306)
T ss_dssp EECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEEC
T ss_pred eECCCCCCcccCHHHHHhhhccCCEEEccCCCeec
Confidence 77777777777777777663 77777777777664
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-28 Score=260.27 Aligned_cols=281 Identities=20% Similarity=0.225 Sum_probs=160.0
Q ss_pred cEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEeecccCccc--CchhhhcCCCccEEEec
Q 047196 222 QLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGV--VPAAIFNMSTVKKIYLL 299 (827)
Q Consensus 222 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~l~ 299 (827)
+.++++++.++ .+|..+. ++|++|+|++|+++...+..|..+++|++|+|++|+++.. .|..+..
T Consensus 10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~---------- 76 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFG---------- 76 (306)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHS----------
T ss_pred CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCccccccc----------
Confidence 46777777776 4455443 5677888888887744444467777788888877777632 2444443
Q ss_pred CCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhccc
Q 047196 300 DNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLS 379 (827)
Q Consensus 300 ~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~ 379 (827)
+++|++|++++|+++. +|..+..+++|++|++++|.+++..+. ..+..+.
T Consensus 77 ---------------~~~L~~L~Ls~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~--------------~~~~~l~ 126 (306)
T 2z66_A 77 ---------------TTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEF--------------SVFLSLR 126 (306)
T ss_dssp ---------------CSCCCEEECCSCSEEE-EEEEEETCTTCCEEECTTSEEESSTTT--------------TTTTTCT
T ss_pred ---------------ccccCEEECCCCcccc-ChhhcCCCCCCCEEECCCCcccccccc--------------hhhhhcc
Confidence 4455555555555552 444455666666666666665543220 1122222
Q ss_pred ccccEEEccCCcCccccCccccCCCCCceEeccCccccc-cccccccCCCCCcEEECCCCCCCCCCCccccccccccEEe
Q 047196 380 MSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTG-SIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLG 458 (827)
Q Consensus 380 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g-~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 458 (827)
+|++|++++|.+++..|..+..+++|+.|++++|++++ .+|..+..+++|++|++++|++++..|..+..+++|+.|+
T Consensus 127 -~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 205 (306)
T 2z66_A 127 -NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 205 (306)
T ss_dssp -TCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred -CCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEE
Confidence 56666666666666666666666666666666666665 4556666666666666666666655566666666666666
Q ss_pred cCCCcccccCCccccCCCCCCccccCCCcccccCCcccccc-ccccccCCCCCCCCCCCcc--cccccccCceEEcccce
Q 047196 459 LAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNL-KDILFFDLSSNSLDGPLSL--DIGNLRVVIGINLSRNN 535 (827)
Q Consensus 459 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~LdLs~N~l~g~~p~--~~~~l~~L~~L~Ls~N~ 535 (827)
+++|++++..+..+..+++|++||+++|.+++..|..+..+ ++|++|+|++|.+++..+. ....++..+.+....+.
T Consensus 206 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~ 285 (306)
T 2z66_A 206 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVER 285 (306)
T ss_dssp CTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGG
T ss_pred CCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccc
Confidence 66666665444455556666666666666666555555555 2555555555555543211 11122223333444455
Q ss_pred eeecccccccC
Q 047196 536 FSGDIPSTIGD 546 (827)
Q Consensus 536 l~g~ip~~~~~ 546 (827)
+.+..|+.+.+
T Consensus 286 ~~C~~p~~~~g 296 (306)
T 2z66_A 286 MECATPSDKQG 296 (306)
T ss_dssp CBEEESGGGTT
T ss_pred cccCCchhhCC
Confidence 55555554443
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.7e-30 Score=276.88 Aligned_cols=267 Identities=16% Similarity=0.135 Sum_probs=173.1
Q ss_pred CCCCCCCCCCCCcccceecCCCCCcEEEEEcCCCCCccccCccccCCCCCCEEECCCCCC-CccCChhhh-------hcc
Q 047196 75 LAQNSTSNTSVCNWIGITCNVNSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKL-SGDIPPSIF-------TMH 146 (827)
Q Consensus 75 l~~w~~~~~~~C~W~gv~C~~~~~~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l-~g~~p~~~~-------~l~ 146 (827)
...|. ....|+.|..+.......+++.|++++|.+ .+|..+... |++|+|++|.+ .+.+|..+. +++
T Consensus 21 ~~~~~-~~~~c~~~~~~~~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~ 95 (312)
T 1wwl_A 21 KPDWS-SAFNCLGAADVELYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGIS 95 (312)
T ss_dssp SCCGG-GGGGSSSCSEEEEEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTS
T ss_pred ccchH-HHhhhhccccEEEEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcC
Confidence 34565 344566665544322234677777888887 666655544 77888888888 456777665 678
Q ss_pred ccceEEecCCCCCCcccccc--CCCCCCcEEEcCCCCCCCCcchhHhhc----cccccEEEeecccccccCCccCCCCCC
Q 047196 147 KLKFLDFSDNQLSGSLSSVT--FNLSSVLDIRLDSDKLSGELPVNICNY----LHYLKVLFLAKNMFHGQIPLALSKCKR 220 (827)
Q Consensus 147 ~L~~LdLs~N~l~g~~p~~~--~~l~~L~~L~L~~n~l~g~ip~~~~~~----~~~L~~L~Ls~N~l~~~~p~~l~~l~~ 220 (827)
+|++|+|++|++++.+|..+ ..+++|++|+|++|.+++. |..+... .++|++|+|++|++++..|..|+++++
T Consensus 96 ~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~ 174 (312)
T 1wwl_A 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPA 174 (312)
T ss_dssp CCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSS
T ss_pred CccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCC
Confidence 88888888888888777765 7788888888888888765 6555543 157777777777777777777777777
Q ss_pred CcEEEccCCCCccc--CCCcC--cCCccccEEEcccccccc--ccc-ccccCcCCCcEEEeecccCcccCc-hhhhcCCC
Q 047196 221 LQLLNLGFKKLSGA--IPKEI--SNLTILRKISLRNNKLRG--EIP-HEIGYLPNLENLVLGFNNLVGVVP-AAIFNMST 292 (827)
Q Consensus 221 L~~L~L~~n~l~~~--~p~~~--~~l~~L~~L~Ls~N~l~~--~~p-~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~ 292 (827)
|++|++++|++.+. +|..+ +++++|++|+|++|++++ .++ ..+..+++|++|+|++|++++..| ..+..+++
T Consensus 175 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~ 254 (312)
T 1wwl_A 175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQ 254 (312)
T ss_dssp CCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTT
T ss_pred CCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCC
Confidence 77777777776654 23333 667777777777777762 222 233566777777777777776654 33444566
Q ss_pred ccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcce
Q 047196 293 VKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFS 353 (827)
Q Consensus 293 L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 353 (827)
|++|++++|.++ .+|..+. ++|++|+|++|++++. |. +..+++|++|++++|.++
T Consensus 255 L~~L~Ls~N~l~-~ip~~~~---~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~ 309 (312)
T 1wwl_A 255 LNSLNLSFTGLK-QVPKGLP---AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFL 309 (312)
T ss_dssp CCEEECTTSCCS-SCCSSCC---SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTT
T ss_pred CCEEECCCCccC-hhhhhcc---CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCC
Confidence 666666666665 4444332 5566666666666554 43 555566666666655554
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-28 Score=284.62 Aligned_cols=107 Identities=26% Similarity=0.364 Sum_probs=61.2
Q ss_pred cccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecC
Q 047196 381 SLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLA 460 (827)
Q Consensus 381 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 460 (827)
+|+.|++++|.++. +|.. +++|+.|++++|++++ +| ..+++|+.|+|++|+++ .+|. .+++|+.|+|+
T Consensus 202 ~L~~L~L~~N~l~~-l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls 269 (622)
T 3g06_A 202 ELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVY 269 (622)
T ss_dssp TCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECC
T ss_pred hhhEEECcCCcccc-cCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCC
Confidence 45555555555552 3322 3556666666666664 33 33456666666666665 3444 34566666666
Q ss_pred CCcccccCCccccCCCCCCccccCCCcccccCCccccccc
Q 047196 461 GNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLK 500 (827)
Q Consensus 461 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 500 (827)
+|+++ .+|..+.++++|+.|+|++|.+++..|..+..++
T Consensus 270 ~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 270 RNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp SSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred CCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 66666 5566666666666666666666666555544443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-28 Score=267.34 Aligned_cols=258 Identities=16% Similarity=0.117 Sum_probs=147.5
Q ss_pred cccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEee
Q 047196 196 YLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLG 275 (827)
Q Consensus 196 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 275 (827)
+|++|++++|.+++..+..+.++++|++|++++|.+++..|..|+++++|++|++++|++++..+..++.+++|++|+|+
T Consensus 53 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 132 (353)
T 2z80_A 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLL 132 (353)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECT
T ss_pred cCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECC
Confidence 67777777777776666677778888888888888877777777778888888888888775555557777888888888
Q ss_pred cccCcccCc-hhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCccee
Q 047196 276 FNNLVGVVP-AAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSG 354 (827)
Q Consensus 276 ~N~l~~~~p-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g 354 (827)
+|++++..+ ..+.++++|++|++++|...+.++......+++|++|++++|++++..|..+..+++|++|++++|.++.
T Consensus 133 ~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~ 212 (353)
T 2z80_A 133 GNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHIL 212 (353)
T ss_dssp TCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTT
T ss_pred CCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCcccc
Confidence 887775433 3566666666666666643333332222355566666666666665556566555555555555555431
Q ss_pred ecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEE
Q 047196 355 IIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLY 434 (827)
Q Consensus 355 ~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 434 (827)
. |..+.....+|++|++++|++++..+..+.. ......++.++
T Consensus 213 ~----------------~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~---------------------~~~~~~l~~l~ 255 (353)
T 2z80_A 213 L----------------LEIFVDVTSSVECLELRDTDLDTFHFSELST---------------------GETNSLIKKFT 255 (353)
T ss_dssp H----------------HHHHHHHTTTEEEEEEESCBCTTCCCC---------------------------CCCCCCEEE
T ss_pred c----------------hhhhhhhcccccEEECCCCcccccccccccc---------------------ccccchhhccc
Confidence 1 1111111114555555555554433322211 11233444444
Q ss_pred CCCCCCCC----CCCccccccccccEEecCCCcccccCCcc-ccCCCCCCccccCCCccccc
Q 047196 435 LPFNKLAG----SIPDQLCHLARLNTLGLAGNKFSGSIPSC-LGNLTSLRSPDLGSNRLTSV 491 (827)
Q Consensus 435 Ls~N~l~g----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~ 491 (827)
|++|.+++ .+|..+..+++|+.|++++|+++ .+|.. +..+++|++|++++|.+.+.
T Consensus 256 L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~ 316 (353)
T 2z80_A 256 FRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCS 316 (353)
T ss_dssp EESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred cccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCc
Confidence 44444443 24444555555555555555555 34433 35555666666666655543
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-29 Score=270.85 Aligned_cols=252 Identities=19% Similarity=0.199 Sum_probs=159.5
Q ss_pred ccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcCCCCCCCCcchhHh------
Q 047196 118 LGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNIC------ 191 (827)
Q Consensus 118 l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~------ 191 (827)
++..++|++|++++|.+ .+|..+... |++|+|++|++... .+|..+.
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~-----------------------~~~~~~~~~~~~~ 91 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAA-----------------------RIPSRILFGALRV 91 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEE-----------------------ECBHHHHHHHHHH
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCC-----------------------CcCHHHHHHHHHh
Confidence 56677888999999998 788877766 88889998888421 2343332
Q ss_pred hccccccEEEeecccccccCCccC--CCCCCCcEEEccCCCCcccCCCcCcCC-----ccccEEEccccccccccccccc
Q 047196 192 NYLHYLKVLFLAKNMFHGQIPLAL--SKCKRLQLLNLGFKKLSGAIPKEISNL-----TILRKISLRNNKLRGEIPHEIG 264 (827)
Q Consensus 192 ~~~~~L~~L~Ls~N~l~~~~p~~l--~~l~~L~~L~L~~n~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~ 264 (827)
..+++|++|+|++|.+++.+|..+ +.+++|++|++++|.+++. |..++.+ ++|++|+|++|++++..|..|+
T Consensus 92 ~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~ 170 (312)
T 1wwl_A 92 LGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVR 170 (312)
T ss_dssp HTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCC
T ss_pred cCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhc
Confidence 013477788888888777777765 7777888888888887766 6666666 7777777777777776667777
Q ss_pred CcCCCcEEEeecccCcccC--chhh--hcCCCccEEEecCCcccc--ccChhhhcCCCCccEEeCcCCccccccC-cccc
Q 047196 265 YLPNLENLVLGFNNLVGVV--PAAI--FNMSTVKKIYLLDNSLLG--SFSLGIDLSLPNVERLNLGLNRFSGTIP-SFIT 337 (827)
Q Consensus 265 ~l~~L~~L~Ls~N~l~~~~--p~~~--~~l~~L~~L~l~~n~l~~--~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~ 337 (827)
.+++|++|+|++|++.+.+ |..+ .++++|++|++++|.+.+ .++..++..+++|++|++++|++++.+| ..+.
T Consensus 171 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 250 (312)
T 1wwl_A 171 VFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD 250 (312)
T ss_dssp CCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCC
T ss_pred cCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhh
Confidence 7777777777777776542 2233 445555555555555442 2222222234444555555444444332 2222
Q ss_pred CCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCcccc
Q 047196 338 NASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLT 417 (827)
Q Consensus 338 ~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 417 (827)
.++ +|++|++++|+++ .+|..+. ++|+.|||++|+++
T Consensus 251 ~l~----------------------------------------~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~ 287 (312)
T 1wwl_A 251 WPS----------------------------------------QLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLD 287 (312)
T ss_dssp CCT----------------------------------------TCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCC
T ss_pred hcC----------------------------------------CCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCC
Confidence 333 4556666666665 4555444 66666777777666
Q ss_pred ccccccccCCCCCcEEECCCCCCCC
Q 047196 418 GSIPVTFGRLQKLQGLYLPFNKLAG 442 (827)
Q Consensus 418 g~~p~~~~~l~~L~~L~Ls~N~l~g 442 (827)
+. |. +..+++|++|+|++|.+++
T Consensus 288 ~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 288 RN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp SC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred CC-hh-HhhCCCCCEEeccCCCCCC
Confidence 55 44 6667777777777776664
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=4.9e-27 Score=266.20 Aligned_cols=234 Identities=23% Similarity=0.305 Sum_probs=183.2
Q ss_pred cCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcCCCCCCCCcchhHhhc
Q 047196 114 IPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNY 193 (827)
Q Consensus 114 ~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~ 193 (827)
+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|++++..+..+.++++|++|+|++|.++ .+|...+..
T Consensus 69 iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~ 145 (452)
T 3zyi_A 69 VPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEY 145 (452)
T ss_dssp CCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCS-BCCTTTSSS
T ss_pred cCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCC-ccChhhhcc
Confidence 444443 57888888888888877888888888888888888888877778888888888888888887 466655555
Q ss_pred cccccEEEeecccccccCCccCCCCCCCcEEEccCC-CCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEE
Q 047196 194 LHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFK-KLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENL 272 (827)
Q Consensus 194 ~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 272 (827)
+++|++|+|++|.++...+..|.++++|+.|++++| .+....+..|.++++|++|+|++|++++ +| .+..+++|++|
T Consensus 146 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L 223 (452)
T 3zyi_A 146 LSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEEL 223 (452)
T ss_dssp CTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEE
T ss_pred cCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cc-cccccccccEE
Confidence 668888888888888777778888888888888884 4444444568888888888888888874 34 57788888888
Q ss_pred EeecccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcc
Q 047196 273 VLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSF 352 (827)
Q Consensus 273 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 352 (827)
+|++|++++..|..+.++++|+.|++++|.+.+..+..+. .+++|+.|+|++|++++..+..+..+++|+.|++++|.+
T Consensus 224 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~ 302 (452)
T 3zyi_A 224 EMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFD-GLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302 (452)
T ss_dssp ECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTT-TCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCE
T ss_pred ECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhc-CCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCc
Confidence 8888888888888888888888888888887766555544 678888888888888877777778888888888888876
Q ss_pred e
Q 047196 353 S 353 (827)
Q Consensus 353 ~ 353 (827)
.
T Consensus 303 ~ 303 (452)
T 3zyi_A 303 N 303 (452)
T ss_dssp E
T ss_pred C
Confidence 5
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-28 Score=261.60 Aligned_cols=150 Identities=23% Similarity=0.430 Sum_probs=113.6
Q ss_pred hcccccceEecCCceEEEEEEec------CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH------DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l 748 (827)
++|...++||+|+||+||+|+++ +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45667789999999999999864 478899999987766677889999999999999999999999988775544
Q ss_pred --eeeccC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------
Q 047196 749 --DCLHST-----------------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------- 796 (827)
Q Consensus 749 --~~l~~~-----------------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------- 796 (827)
+++..+ ...++|.+++.|+.|||+||+||| +++||||||||+|||
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence 333211 124788999999999999999996 467999999999998
Q ss_pred ---eecccccccCCCcc-ccccceecccccccccC
Q 047196 797 ---DFGIGRLLTGDRSM-IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 ---DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l 827 (827)
|||+|+.+...... ..+..+||++|||||++
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~ 232 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI 232 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhh
Confidence 99999977543322 22335699999999974
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-28 Score=257.86 Aligned_cols=150 Identities=27% Similarity=0.432 Sum_probs=119.5
Q ss_pred hcccccceEecCCceEEEEEEec------CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH------DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l 748 (827)
++|...+.||+|+||+||+|++. +|+.||||+++.......++|.+|+++|++++|||||+++|+|.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 45777889999999999999863 478899999987666677889999999999999999999999988765544
Q ss_pred --eeeccC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------
Q 047196 749 --DCLHST---------------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF--------- 796 (827)
Q Consensus 749 --~~l~~~---------------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl--------- 796 (827)
+++..+ ...++|.++..|+.|||+||+||| +++||||||||+|||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence 333221 135788999999999999999996 568999999999998
Q ss_pred -eecccccccCCCccc-cccceecccccccccC
Q 047196 797 -DFGIGRLLTGDRSMI-QTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 -DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l 827 (827)
|||+|+......... .....||++|||||++
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~ 202 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI 202 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHH
Confidence 999999765433222 2234599999999974
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.7e-29 Score=266.44 Aligned_cols=169 Identities=21% Similarity=0.188 Sum_probs=90.6
Q ss_pred cccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCcccc-ccccccEEec
Q 047196 381 SLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLC-HLARLNTLGL 459 (827)
Q Consensus 381 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~-~l~~L~~L~L 459 (827)
+|++|++++|++++..+.. +++|+.|++++|++++..|..++.+++|++|+|++|++++..|..+. .+++|++|++
T Consensus 100 ~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L 176 (317)
T 3o53_A 100 SIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176 (317)
T ss_dssp TCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEEC
T ss_pred CcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEEC
Confidence 4555555555555433322 34555666666666555555555555666666666655554444442 4555666666
Q ss_pred CCCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccceee-e
Q 047196 460 AGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFS-G 538 (827)
Q Consensus 460 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~-g 538 (827)
++|++++. |. ...+++|++|+|++|.+++..+ .+..+++|+.|+|++|.+++ +|..+..++.|+.|++++|+++ +
T Consensus 177 ~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~~-~~~~l~~L~~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N~~~~~ 252 (317)
T 3o53_A 177 QYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCG 252 (317)
T ss_dssp TTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCCBHH
T ss_pred CCCcCccc-cc-ccccccCCEEECCCCcCCcchh-hhcccCcccEEECcCCcccc-hhhHhhcCCCCCEEEccCCCccCc
Confidence 66665543 21 2235566666666666654332 35555555555555555552 4445555555555555555555 4
Q ss_pred cccccccCCCCCCEEECC
Q 047196 539 DIPSTIGDLKDLQNISLA 556 (827)
Q Consensus 539 ~ip~~~~~l~~L~~L~Ls 556 (827)
.+|..++.++.|+.|+++
T Consensus 253 ~~~~~~~~~~~L~~l~l~ 270 (317)
T 3o53_A 253 TLRDFFSKNQRVQTVAKQ 270 (317)
T ss_dssp HHHHHHHTCHHHHHHHHH
T ss_pred CHHHHHhccccceEEECC
Confidence 555555555555555554
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-26 Score=261.07 Aligned_cols=228 Identities=21% Similarity=0.215 Sum_probs=146.5
Q ss_pred ccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEe
Q 047196 195 HYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVL 274 (827)
Q Consensus 195 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 274 (827)
+++++|+|++|.+++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|++++..+..|..+++|++|+|
T Consensus 75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 154 (452)
T 3zyi_A 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL 154 (452)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence 37889999999998888888999999999999999999888888999999999999999998777777888999999999
Q ss_pred ecccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCccee
Q 047196 275 GFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSG 354 (827)
Q Consensus 275 s~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g 354 (827)
++|+++...+..+.++++|+.|++++|+..+.++. ..+.++++|++|++++|++++
T Consensus 155 ~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~------------------------~~~~~l~~L~~L~L~~n~l~~ 210 (452)
T 3zyi_A 155 RNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISE------------------------GAFEGLFNLKYLNLGMCNIKD 210 (452)
T ss_dssp CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECT------------------------TTTTTCTTCCEEECTTSCCSS
T ss_pred CCCCcceeCHhHHhcCCcccEEeCCCCCCccccCh------------------------hhccCCCCCCEEECCCCcccc
Confidence 99998876666666666666666665444333333 234445555555555554432
Q ss_pred ecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEE
Q 047196 355 IIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLY 434 (827)
Q Consensus 355 ~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 434 (827)
. | .+..+. +|++|+|++|++++..|..|.++++|+.|+|++|++++..|..|.++++|+.|+
T Consensus 211 ~-~----------------~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 272 (452)
T 3zyi_A 211 M-P----------------NLTPLV-GLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELN 272 (452)
T ss_dssp C-C----------------CCTTCT-TCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred c-c----------------cccccc-cccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEE
Confidence 1 1 011111 445555555555544455555555555555555555555455555555555555
Q ss_pred CCCCCCCCCCCccccccccccEEecCCCcc
Q 047196 435 LPFNKLAGSIPDQLCHLARLNTLGLAGNKF 464 (827)
Q Consensus 435 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l 464 (827)
|++|++++..+..+..+++|+.|+|++|.+
T Consensus 273 L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~ 302 (452)
T 3zyi_A 273 LAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302 (452)
T ss_dssp CCSSCCSCCCTTSSTTCTTCCEEECCSSCE
T ss_pred CCCCcCCccChHHhccccCCCEEEccCCCc
Confidence 555555444444444444444444444444
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-28 Score=263.28 Aligned_cols=267 Identities=19% Similarity=0.144 Sum_probs=132.5
Q ss_pred cEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEeecc
Q 047196 198 KVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFN 277 (827)
Q Consensus 198 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 277 (827)
+..+++.+.+...++..+..+++|++|++++|.+++..|..+.++++|++|+|++|++++..| +..+++|++|+|++|
T Consensus 13 ~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n 90 (317)
T 3o53_A 13 KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNN 90 (317)
T ss_dssp EEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSS
T ss_pred eEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCC
Confidence 333444444433333333344445555555555554444445555555555555555544332 445555555555555
Q ss_pred cCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceeecC
Q 047196 278 NLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIP 357 (827)
Q Consensus 278 ~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p 357 (827)
++++.. ..++|+.|++++|.+.+..+. .+++|+.|++++|++++..|..+..+++|++|++++|
T Consensus 91 ~l~~l~-----~~~~L~~L~l~~n~l~~~~~~----~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N------- 154 (317)
T 3o53_A 91 YVQELL-----VGPSIETLHAANNNISRVSCS----RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLN------- 154 (317)
T ss_dssp EEEEEE-----ECTTCCEEECCSSCCSEEEEC----CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTS-------
T ss_pred cccccc-----CCCCcCEEECCCCccCCcCcc----ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCC-------
Confidence 544321 113333333333333322111 2344555555555555544444444444444444444
Q ss_pred CCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccc-cCCCCCceEeccCccccccccccccCCCCCcEEECC
Q 047196 358 NTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLI-SNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLP 436 (827)
Q Consensus 358 ~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~-~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 436 (827)
.+++..|..+ ..+++|++|+|++|++++.. ....+++|++|+|+
T Consensus 155 ---------------------------------~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~l~~L~~L~Ls 199 (317)
T 3o53_A 155 ---------------------------------EIDTVNFAELAASSDTLEHLNLQYNFIYDVK--GQVVFAKLKTLDLS 199 (317)
T ss_dssp ---------------------------------CCCEEEGGGGGGGTTTCCEEECTTSCCCEEE--CCCCCTTCCEEECC
T ss_pred ---------------------------------CCCcccHHHHhhccCcCCEEECCCCcCcccc--cccccccCCEEECC
Confidence 4444433333 24555555555555555432 12235566666666
Q ss_pred CCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCccccCCCccc-ccCCccccccccccccCCC-CCCCCC
Q 047196 437 FNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLT-SVLPSTFWNLKDILFFDLS-SNSLDG 514 (827)
Q Consensus 437 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~LdLs-~N~l~g 514 (827)
+|++++ +|..+..+++|+.|++++|+++ .+|..+..+++|+.|++++|.+. +.+|..+..++.|+.++++ .+.++|
T Consensus 200 ~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~ 277 (317)
T 3o53_A 200 SNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTG 277 (317)
T ss_dssp SSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHS
T ss_pred CCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccC
Confidence 666653 3334556666666666666665 35555666666666666666666 5556666666666666666 334455
Q ss_pred CCccc
Q 047196 515 PLSLD 519 (827)
Q Consensus 515 ~~p~~ 519 (827)
..|..
T Consensus 278 ~~~~~ 282 (317)
T 3o53_A 278 QNEEE 282 (317)
T ss_dssp SSSCC
T ss_pred Cchhc
Confidence 44433
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-26 Score=258.74 Aligned_cols=242 Identities=23% Similarity=0.307 Sum_probs=190.3
Q ss_pred cCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcCCCCCCC
Q 047196 105 ISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSG 184 (827)
Q Consensus 105 L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~l~g 184 (827)
.++.+++ .+|..+. +++++|+|++|++++..+..|.++++|++|+|++|.+++..+..+.++++|++|+|++|+++
T Consensus 50 c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~- 125 (440)
T 3zyj_A 50 CVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT- 125 (440)
T ss_dssp CCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCS-
T ss_pred eCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCC-
Confidence 3344454 3455444 67888899999888888888888889999999999888877788888888888888888887
Q ss_pred CcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCC-CCcccCCCcCcCCccccEEEcccccccccccccc
Q 047196 185 ELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFK-KLSGAIPKEISNLTILRKISLRNNKLRGEIPHEI 263 (827)
Q Consensus 185 ~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 263 (827)
.+|...+..+++|++|+|++|.++...+..|.++++|+.|++++| .++...+..|.++++|++|+|++|+++ .+| .+
T Consensus 126 ~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~ 203 (440)
T 3zyj_A 126 TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NL 203 (440)
T ss_dssp SCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CC
T ss_pred eeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-cc
Confidence 466655555668888888888888777778888899999999884 444444456888889999999999887 455 47
Q ss_pred cCcCCCcEEEeecccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCc
Q 047196 264 GYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLV 343 (827)
Q Consensus 264 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 343 (827)
..+++|++|+|++|++++..|..|.++++|+.|++++|.+.+..+..+. .+++|+.|+|++|++++..+..+..+++|+
T Consensus 204 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 282 (440)
T 3zyj_A 204 TPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFD-NLQSLVEINLAHNNLTLLPHDLFTPLHHLE 282 (440)
T ss_dssp TTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSST-TCTTCCEEECTTSCCCCCCTTTTSSCTTCC
T ss_pred CCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhc-CCCCCCEEECCCCCCCccChhHhccccCCC
Confidence 8888899999999988888888888888888888888887766554443 678888888888888877777778888888
Q ss_pred EEEcCCCcce
Q 047196 344 YLDMGTNSFS 353 (827)
Q Consensus 344 ~L~Ls~N~l~ 353 (827)
.|++++|.+.
T Consensus 283 ~L~L~~Np~~ 292 (440)
T 3zyj_A 283 RIHLHHNPWN 292 (440)
T ss_dssp EEECCSSCEE
T ss_pred EEEcCCCCcc
Confidence 8888888764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.5e-28 Score=255.06 Aligned_cols=148 Identities=26% Similarity=0.503 Sum_probs=113.8
Q ss_pred hcccccceEecCCceEEEEEEecCCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc-eeeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF-KALDCL 751 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~-~~l~~l 751 (827)
+++...+.||+|+||+||+|++++ .||||+++.. .....++|.+|++++++++|||||+++|+|.++.. .+++++
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVmEy~ 113 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWC 113 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEEEcC
Confidence 456777899999999999998764 6999998643 34556789999999999999999999999976553 233333
Q ss_pred cc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc-c
Q 047196 752 HS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM-I 811 (827)
Q Consensus 752 ~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~-~ 811 (827)
.. ....++|.++..|+.|||+||+||| +++||||||||+||| |||+|+........ .
T Consensus 114 ~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~ 190 (307)
T 3omv_A 114 EGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQ 190 (307)
T ss_dssp SSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---------
T ss_pred CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCccee
Confidence 22 2346889999999999999999996 468999999999998 99999876543222 2
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
....+||++|||||++
T Consensus 191 ~~~~~GT~~ymAPE~l 206 (307)
T 3omv_A 191 VEQPTGSVLWMAPEVI 206 (307)
T ss_dssp ---CCCCTTSCCHHHH
T ss_pred ecccccCCCccCHHHh
Confidence 2335699999999974
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.6e-27 Score=247.66 Aligned_cols=207 Identities=23% Similarity=0.227 Sum_probs=118.2
Q ss_pred cccEEEccCCcCccccCccccCCCCCceEeccCcc-ccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEec
Q 047196 381 SLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNK-LTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGL 459 (827)
Q Consensus 381 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~-l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 459 (827)
+|++|++++|.+++..|..|..+++|++|++++|+ +.+..|..|..+++|++|++++|.+++..|..+.++++|++|++
T Consensus 57 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 136 (285)
T 1ozn_A 57 NLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYL 136 (285)
T ss_dssp TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEEC
Confidence 34444444444444444455555555555555554 44444555555555555555555555555555555555666666
Q ss_pred CCCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccceeeec
Q 047196 460 AGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGD 539 (827)
Q Consensus 460 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ 539 (827)
++|++++..+..+..+++|++|++++|.+++..+..+..+++|+.|++++|.+++..|..++.++.|+.|++++|++++.
T Consensus 137 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 216 (285)
T 1ozn_A 137 QDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSAL 216 (285)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcC
Confidence 66655544444455556666666666666555555555566666666666666665566666666666666666666655
Q ss_pred ccccccCCCCCCEEECCCCcceeecCCC--CcCCceEeCcCCcCeecCCC
Q 047196 540 IPSTIGDLKDLQNISLACNGLEGLIPES--FGYLTELNLSFNKLEGEIPR 587 (827)
Q Consensus 540 ip~~~~~l~~L~~L~Ls~N~l~g~ip~~--~~~L~~L~ls~N~l~g~ip~ 587 (827)
.+..+..+++|+.|++++|.+....+.. +..++.++.+.|.+.+..|.
T Consensus 217 ~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~~l~~~~~~~~~~~c~~p~ 266 (285)
T 1ozn_A 217 PTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQ 266 (285)
T ss_dssp CHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEESG
T ss_pred CHHHcccCcccCEEeccCCCccCCCCcHHHHHHHHhcccccCccccCCch
Confidence 5555666666666666666665543321 12344455666777766665
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.3e-27 Score=248.83 Aligned_cols=254 Identities=18% Similarity=0.162 Sum_probs=180.4
Q ss_pred EEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcCCC
Q 047196 101 TALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSD 180 (827)
Q Consensus 101 ~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n 180 (827)
+.++.++++++. +|..+ .++|++|+|++|++++..+..|..+++|++|+|++|.+++..|..+.++++|++|++++|
T Consensus 14 ~~~~c~~~~l~~-ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQA-VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCSS-CCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCccc-CCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 455666666653 34333 457888888888888766677888888888888888888777777888888888888888
Q ss_pred CCCCCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEccccccccccc
Q 047196 181 KLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIP 260 (827)
Q Consensus 181 ~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 260 (827)
...+.++...+..+++|++|++++|.+++..|..+.++++|++|++++|.+++..+..++++++|++|++++|++++..+
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 170 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCH
Confidence 73334544334445588888888888887777778888888888888888887666677888888888888888876666
Q ss_pred ccccCcCCCcEEEeecccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCC
Q 047196 261 HEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNAS 340 (827)
Q Consensus 261 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 340 (827)
..+..+++|++|+|++|.+++..|..+.++++|+.|++++|.+.+..+..+ ..+++|+.|++++|.+....+.. .-..
T Consensus 171 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~l~~N~~~c~~~~~-~~~~ 248 (285)
T 1ozn_A 171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEAL-APLRALQYLRLNDNPWVCDCRAR-PLWA 248 (285)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHH-TTCTTCCEEECCSSCEECSGGGH-HHHH
T ss_pred HHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHc-ccCcccCEEeccCCCccCCCCcH-HHHH
Confidence 667888888888888888888878888888888888888888776433333 37788888888888877543321 1111
Q ss_pred CCcEEEcCCCcceeecCCC
Q 047196 341 KLVYLDMGTNSFSGIIPNT 359 (827)
Q Consensus 341 ~L~~L~Ls~N~l~g~~p~~ 359 (827)
.++.+..+.+.+....|..
T Consensus 249 ~l~~~~~~~~~~~c~~p~~ 267 (285)
T 1ozn_A 249 WLQKFRGSSSEVPCSLPQR 267 (285)
T ss_dssp HHHHCCSEECCCBEEESGG
T ss_pred HHHhcccccCccccCCchH
Confidence 2333345556666666643
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.7e-26 Score=255.92 Aligned_cols=107 Identities=26% Similarity=0.335 Sum_probs=63.1
Q ss_pred cccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecC
Q 047196 381 SLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLA 460 (827)
Q Consensus 381 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 460 (827)
+|++|++++|+++ .+| .+..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|..|.++++|+.|+|+
T Consensus 186 ~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 263 (440)
T 3zyj_A 186 NLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLA 263 (440)
T ss_dssp SCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECT
T ss_pred ccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECC
Confidence 3444444444444 222 24455566666666666665556666666666666666666665556666666666666666
Q ss_pred CCcccccCCccccCCCCCCccccCCCccc
Q 047196 461 GNKFSGSIPSCLGNLTSLRSPDLGSNRLT 489 (827)
Q Consensus 461 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 489 (827)
+|++++..+..+..+++|+.|+|++|.+.
T Consensus 264 ~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 264 HNNLTLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp TSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred CCCCCccChhHhccccCCCEEEcCCCCcc
Confidence 66666555555666666666666666654
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.4e-26 Score=264.69 Aligned_cols=265 Identities=24% Similarity=0.321 Sum_probs=140.6
Q ss_pred cccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEee
Q 047196 196 YLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLG 275 (827)
Q Consensus 196 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 275 (827)
++++|++++|.++ .+|..+. ++|++|++++|.++. +|. .+++|++|+|++|+++ .+|. .+++|++|+|+
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~-lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls 109 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIF 109 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSC-CCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEEC
T ss_pred CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCC-CCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECc
Confidence 5888888888887 6676655 678888888888773 444 4677777777777776 3554 56777777777
Q ss_pred cccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceee
Q 047196 276 FNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGI 355 (827)
Q Consensus 276 ~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 355 (827)
+|++++. |. . +++|+.|++++|++++ +|.. +++|++|++++|++++.
T Consensus 110 ~N~l~~l-~~---~-------------------------l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~l 156 (622)
T 3g06_A 110 SNPLTHL-PA---L-------------------------PSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLASL 156 (622)
T ss_dssp SCCCCCC-CC---C-------------------------CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCC
T ss_pred CCcCCCC-CC---C-------------------------CCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCCc
Confidence 7776653 22 2 2345555555555543 3322 24555555555555431
Q ss_pred cCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEEC
Q 047196 356 IPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYL 435 (827)
Q Consensus 356 ~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 435 (827)
| .. ..+|+.|++++|++++ +| ..+++|+.|++++|++++ +|. .+++|+.|++
T Consensus 157 -~---------------~~----~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L 208 (622)
T 3g06_A 157 -P---------------AL----PSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPT---LPSELYKLWA 208 (622)
T ss_dssp -C---------------CC----CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEEC
T ss_pred -C---------------Cc----cCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCC---ccchhhEEEC
Confidence 1 00 0145556666666653 33 234556666666666554 222 1345555555
Q ss_pred CCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCC
Q 047196 436 PFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGP 515 (827)
Q Consensus 436 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~ 515 (827)
++|.++ .+|.. +++|+.|++++|++++ +| ..+++|+.|+|++|.|++ +|. .+++|+.|+|++|+++ .
T Consensus 209 ~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~ 275 (622)
T 3g06_A 209 YNNRLT-SLPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-R 275 (622)
T ss_dssp CSSCCS-SCCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-S
T ss_pred cCCccc-ccCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-c
Confidence 555555 23322 2445555555555553 33 233445555555555543 222 2334444444444444 3
Q ss_pred CcccccccccCceEEcccceeeeccccccc
Q 047196 516 LSLDIGNLRVVIGINLSRNNFSGDIPSTIG 545 (827)
Q Consensus 516 ~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~ 545 (827)
+|..+.++++|+.|+|++|++++.+|..+.
T Consensus 276 lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~ 305 (622)
T 3g06_A 276 LPESLIHLSSETTVNLEGNPLSERTLQALR 305 (622)
T ss_dssp CCGGGGGSCTTCEEECCSCCCCHHHHHHHH
T ss_pred CCHHHhhccccCEEEecCCCCCCcCHHHHH
Confidence 344444444444444444444444444333
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-27 Score=253.18 Aligned_cols=149 Identities=26% Similarity=0.400 Sum_probs=115.9
Q ss_pred cccccceEecCCceEEEEEEec------CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH------DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL 748 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l 748 (827)
+++..+.||+|+||+||+|++. +++.||||+++... ....++|.+|++++++++|||||+++|+|.+++..++
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3455678999999999999863 46889999996543 2345789999999999999999999999987665443
Q ss_pred --eeeccC------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee------
Q 047196 749 --DCLHST------------------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------ 796 (827)
Q Consensus 749 --~~l~~~------------------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------ 796 (827)
+++..+ ...++|.++++|+.|||+||+||| +++||||||||+|||
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCCC
Confidence 332211 124788899999999999999996 567999999999998
Q ss_pred ----eecccccccCCCcc-ccccceecccccccccC
Q 047196 797 ----DFGIGRLLTGDRSM-IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 ----DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l 827 (827)
|||+|+.+...... ..+..+||++|||||++
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l 219 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAI 219 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHH
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHH
Confidence 99999977543322 22345699999999974
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-27 Score=253.58 Aligned_cols=149 Identities=24% Similarity=0.259 Sum_probs=122.0
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
+.|+..+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..++...+.
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 45888899999999999999864 69999999997654444567899999999999999999999998887655533332
Q ss_pred C---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccccc
Q 047196 754 T---------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTE 814 (827)
Q Consensus 754 ~---------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~ 814 (827)
. ...+.+.+...++.|++.||+||| +++||||||||+||| |||+|+.+...... ...
T Consensus 154 ~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~~~ 229 (346)
T 4fih_A 154 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKS 229 (346)
T ss_dssp TTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC-BCC
T ss_pred CCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc-ccc
Confidence 2 245777888899999999999996 568999999999998 99999987654332 234
Q ss_pred ceecccccccccC
Q 047196 815 TLVTIGYMAPGLL 827 (827)
Q Consensus 815 ~~gt~~Y~APE~l 827 (827)
.+||+.|||||++
T Consensus 230 ~~GTp~YmAPEvl 242 (346)
T 4fih_A 230 LVGTPYWMAPELI 242 (346)
T ss_dssp CCSCGGGCCHHHH
T ss_pred cccCcCcCCHHHH
Confidence 6799999999974
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-26 Score=240.40 Aligned_cols=218 Identities=25% Similarity=0.364 Sum_probs=166.7
Q ss_pred CCCCcccceecCCCCCcEEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCcc
Q 047196 83 TSVCNWIGITCNVNSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSL 162 (827)
Q Consensus 83 ~~~C~W~gv~C~~~~~~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~ 162 (827)
.++|.|.|+.|+-. +.++.+++++++++. +|..+. ++|++|+|++|++++..+..|.++++|++|+|++|.++...
T Consensus 2 ~~~C~~~~~~C~c~-~~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~ 77 (270)
T 2o6q_A 2 EALCKKDGGVCSCN-NNKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLP 77 (270)
T ss_dssp CCCBGGGTCSBEEE-TTTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCC
T ss_pred CccCCCCCCCCEeC-CCCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeC
Confidence 47999999999643 356789999999985 666554 68999999999999877778999999999999999999766
Q ss_pred ccccCCCCCCcEEEcCCCCCCCCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCC
Q 047196 163 SSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNL 242 (827)
Q Consensus 163 p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l 242 (827)
+..+.++++|++|++++|.+++ +|...+..+++|++|++++|.+++..|..|+++++|++|++++|.+++..+..+..+
T Consensus 78 ~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 156 (270)
T 2o6q_A 78 AGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKL 156 (270)
T ss_dssp TTTTSSCTTCCEEECCSSCCCC-CCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred hhhhcCCCCCCEEECCCCcCCc-CCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCC
Confidence 6667788888888888888874 555555445577888888777777777777777777777777777776666667777
Q ss_pred ccccEEEcccccccccccccccCcCCCcEEEeecccCcccCchhhhcCCCccEEEecCCcccc
Q 047196 243 TILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLG 305 (827)
Q Consensus 243 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~ 305 (827)
++|++|+|++|++++..+..|..+++|++|+|++|++++..+..+..+++|+.|++++|.+..
T Consensus 157 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 219 (270)
T 2o6q_A 157 TSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC 219 (270)
T ss_dssp TTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred cccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence 777777777777776666667777777777777777776555556666666666666665543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=243.50 Aligned_cols=146 Identities=27% Similarity=0.387 Sum_probs=113.9
Q ss_pred cccceEecCCceEEEEEEec-CCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecC----C--ceee
Q 047196 678 SKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNE----D--FKAL 748 (827)
Q Consensus 678 ~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~----~--~~~l 748 (827)
...++||+|+||+||+|+.. +++.||||++... .....++|.+|++++++++|||||++++++... . +.++
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45567999999999999865 6899999999643 234567899999999999999999999998542 2 2333
Q ss_pred eeeccC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------eecccccccCCCc
Q 047196 749 DCLHST--------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRLLTGDRS 809 (827)
Q Consensus 749 ~~l~~~--------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGla~~~~~~~~ 809 (827)
+++..+ ...+++.....++.||++||+|||. +.++||||||||+||| |||+|+......
T Consensus 109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~-~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~- 186 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF- 186 (290)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTTS-
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCCc-
Confidence 444332 2356777888999999999999974 3456999999999998 999998654322
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
....+||++|||||++
T Consensus 187 --~~~~~GTp~YmAPE~~ 202 (290)
T 3fpq_A 187 --AKAVIGTPEFMAPEMY 202 (290)
T ss_dssp --BEESCSSCCCCCGGGG
T ss_pred --cCCcccCccccCHHHc
Confidence 2345699999999974
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.4e-27 Score=249.50 Aligned_cols=151 Identities=27% Similarity=0.406 Sum_probs=114.6
Q ss_pred hcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC------ceee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNED------FKAL 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~------~~~l 748 (827)
++|...+.||+|+||+||+|++ +|+.||||++..... ....+++|+..+.+++|||||+++|+|.+++ +.++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 3566778999999999999998 489999999965432 2233456777778899999999999998654 2334
Q ss_pred eeeccC-------CCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEEccCCCccee----------eecccccccC
Q 047196 749 DCLHST-------NCSLNIFDKLNIMIDVASALEYLHFS-----HSTPVIHCDLKPKNVF----------DFGIGRLLTG 806 (827)
Q Consensus 749 ~~l~~~-------~~~l~~~~~~~i~~~ia~~L~~Lh~~-----h~~~iiHrDlK~~NIl----------DFGla~~~~~ 806 (827)
+++..+ ...++|.++.+++.++|+||+|||.. |.++||||||||+||| |||+|+....
T Consensus 81 Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 160 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp ECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred cCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence 444322 23578889999999999999999954 5779999999999999 9999998755
Q ss_pred CCccc---cccceecccccccccC
Q 047196 807 DRSMI---QTETLVTIGYMAPGLL 827 (827)
Q Consensus 807 ~~~~~---~~~~~gt~~Y~APE~l 827 (827)
..... ....+||++|||||++
T Consensus 161 ~~~~~~~~~~~~~GT~~ymAPE~l 184 (303)
T 3hmm_A 161 ATDTIDIAPNHRVGTKRYMAPEVL 184 (303)
T ss_dssp TTTEESCC-----CCGGGCCHHHH
T ss_pred CCCceeeecccccccccccCHHHh
Confidence 43321 1234699999999974
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=8.4e-27 Score=246.37 Aligned_cols=150 Identities=28% Similarity=0.392 Sum_probs=121.3
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
++|+..++||+|+||+||+|+. .+|+.||||++.+.. ....+.+.+|+++|++++|||||++++++.+++..++..
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999986 469999999997532 223567999999999999999999999998887655433
Q ss_pred eccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 751 LHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 751 l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
.+.. ...++..+...++.|++.||+||| +++|+||||||+||| |||+|+.+......
T Consensus 112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 3322 235677777889999999999996 578999999999999 99999987544332
Q ss_pred -ccccceecccccccccC
Q 047196 811 -IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 -~~~~~~gt~~Y~APE~l 827 (827)
...+.+||+.|||||++
T Consensus 189 ~~~~~~~GTp~YmAPEvl 206 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELL 206 (311)
T ss_dssp CCBCCCCSCGGGCCHHHH
T ss_pred ccccCcccCcccCCHHHH
Confidence 22345799999999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=254.38 Aligned_cols=149 Identities=24% Similarity=0.259 Sum_probs=122.3
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
+.|+..+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++..++..++...+.
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 46888899999999999999864 69999999997654444567899999999999999999999998887655533332
Q ss_pred C---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccccc
Q 047196 754 T---------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTE 814 (827)
Q Consensus 754 ~---------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~ 814 (827)
. ...+.+.+...|+.|+++||+||| +++||||||||+||| |||+|+.+...... ...
T Consensus 231 ~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~~~ 306 (423)
T 4fie_A 231 EGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKS 306 (423)
T ss_dssp TTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC-BCC
T ss_pred CCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc-ccc
Confidence 2 234677788899999999999996 568999999999998 99999987554332 244
Q ss_pred ceecccccccccC
Q 047196 815 TLVTIGYMAPGLL 827 (827)
Q Consensus 815 ~~gt~~Y~APE~l 827 (827)
.+||+.|||||++
T Consensus 307 ~~GTp~YmAPEvl 319 (423)
T 4fie_A 307 LVGTPYWMAPELI 319 (423)
T ss_dssp CEECTTTCCHHHH
T ss_pred cccCcCcCCHHHH
Confidence 6799999999974
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-29 Score=295.50 Aligned_cols=426 Identities=12% Similarity=0.083 Sum_probs=226.6
Q ss_pred CCcccceecCCCCCcEEEEEcCCCCCccccC-ccccCCCCCCEEECCCCCCCc---cCC------------hhhhhcccc
Q 047196 85 VCNWIGITCNVNSHRVTALNISSLNLQGTIP-PQLGNLSSLTTLNLSHNKLSG---DIP------------PSIFTMHKL 148 (827)
Q Consensus 85 ~C~W~gv~C~~~~~~v~~L~L~~~~l~g~~~-~~l~~L~~L~~L~Ls~N~l~g---~~p------------~~~~~l~~L 148 (827)
|++|.++... ..+.++++... +..+ ..+..+++|++|+|+++.... ..| .....+++|
T Consensus 34 ck~W~~~~~~----~~~~l~~~~~~--~~~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L 107 (594)
T 2p1m_B 34 CKSWYEIERW----CRRKVFIGNCY--AVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWL 107 (594)
T ss_dssp CHHHHHHHHH----HCCEEEESSTT--SSCHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTC
T ss_pred HHHHHHhhhh----hceEEeecccc--ccCHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCC
Confidence 5578887322 23345554432 2222 236677889999999875321 122 123467889
Q ss_pred ceEEecCCCCCCccccccC-CCCCCcEEEcCCC-CCCCCcchhHhhccccccEEEeecccccccCCccC----CCCCCCc
Q 047196 149 KFLDFSDNQLSGSLSSVTF-NLSSVLDIRLDSD-KLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLAL----SKCKRLQ 222 (827)
Q Consensus 149 ~~LdLs~N~l~g~~p~~~~-~l~~L~~L~L~~n-~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l----~~l~~L~ 222 (827)
++|+|++|.+++..+..+. .+++|++|+|++| .++......+...+++|++|+|++|.+++..+..+ ..+++|+
T Consensus 108 ~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~ 187 (594)
T 2p1m_B 108 EEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLV 187 (594)
T ss_dssp CEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCC
T ss_pred CeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCc
Confidence 9999999988877666654 5778888888877 44432233344345688888888888776544333 3667888
Q ss_pred EEEccCCC--Cccc-CCCcCcCCccccEEEcccccccccccccccCcCCCcEEEeecc-------cCcccCchhhhcCCC
Q 047196 223 LLNLGFKK--LSGA-IPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFN-------NLVGVVPAAIFNMST 292 (827)
Q Consensus 223 ~L~L~~n~--l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-------~l~~~~p~~~~~l~~ 292 (827)
.|++++|. ++.. ++..+.++++|++|++++|...+.+|..+..+++|++|+++.+ .+.+ ++..+.++++
T Consensus 188 ~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~~ 266 (594)
T 2p1m_B 188 SLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCKE 266 (594)
T ss_dssp EEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCTT
T ss_pred EEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccccCccchhhHHH-HHHHHhcCCC
Confidence 88888876 2211 1112234678888888887332337777778888888885443 3443 3346677777
Q ss_pred ccEEE-ecCCccccccChhhhcCCCCccEEeCcCCcccccc-CccccCCCCCcEEEcCCCcceeecCCCccCCCCCCccc
Q 047196 293 VKKIY-LLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTI-PSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGV 370 (827)
Q Consensus 293 L~~L~-l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~ 370 (827)
|+.+. +.+.. .+.++.... .+++|+.|++++|.+++.. +..+..+++|+.|++++| ++.. .
T Consensus 267 L~~Ls~~~~~~-~~~l~~~~~-~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~--------------~ 329 (594)
T 2p1m_B 267 LRCLSGFWDAV-PAYLPAVYS-VCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDA--------------G 329 (594)
T ss_dssp CCEEECCBTCC-GGGGGGGHH-HHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHH--------------H
T ss_pred cccccCCcccc-hhhHHHHHH-hhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHH--------------H
Confidence 77773 22221 122332221 4567777777777765432 222456677777777665 2210 0
Q ss_pred CCCchhcccccccEEEccC---------CcCccccCccc-cCCCCCceEeccCcccccccccccc-CCCCCcEEECC--C
Q 047196 371 LPTSIGNLSMSLENIYISN---------CNIGGSIPQLI-SNLSNLLLLDLEGNKLTGSIPVTFG-RLQKLQGLYLP--F 437 (827)
Q Consensus 371 ~p~~~~~~~~~L~~L~Ls~---------N~l~g~~p~~~-~~l~~L~~L~Ls~N~l~g~~p~~~~-~l~~L~~L~Ls--~ 437 (827)
++.....++ +|++|++++ +.+++.....+ ..+++|+.|+++.|.+++..+..+. .+++|+.|+++ +
T Consensus 330 l~~l~~~~~-~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~ 408 (594)
T 2p1m_B 330 LEVLASTCK-DLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIE 408 (594)
T ss_dssp HHHHHHHCT-TCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESS
T ss_pred HHHHHHhCC-CCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeeccc
Confidence 001111122 566666632 34433222222 2356666666666666554444443 35666666665 2
Q ss_pred ----CCCCCCC-----CccccccccccEEecCCCcccccCCccccC-CCCCCccccCCCcccccCCccccccccccccCC
Q 047196 438 ----NKLAGSI-----PDQLCHLARLNTLGLAGNKFSGSIPSCLGN-LTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDL 507 (827)
Q Consensus 438 ----N~l~g~~-----p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdL 507 (827)
|.+++.. +..+..+++|+.|++++ .+++..+..+.. +++|++|+|++|.
T Consensus 409 ~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~-------------------- 467 (594)
T 2p1m_B 409 PKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAG-------------------- 467 (594)
T ss_dssp TTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCC--------------------
T ss_pred CCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCC--------------------
Confidence 3333111 11133344555555544 333333333322 4445555555444
Q ss_pred CCCCCCCCCcccc-cccccCceEEcccceeeecccc-cccCCCCCCEEECCCCcc
Q 047196 508 SSNSLDGPLSLDI-GNLRVVIGINLSRNNFSGDIPS-TIGDLKDLQNISLACNGL 560 (827)
Q Consensus 508 s~N~l~g~~p~~~-~~l~~L~~L~Ls~N~l~g~ip~-~~~~l~~L~~L~Ls~N~l 560 (827)
+++..+..+ ..+++|+.|++++|.+++..+. .+..+++|+.|++++|++
T Consensus 468 ----i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 468 ----DSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp ----SSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred ----CcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence 443322222 3345555555555555433332 223355555555555555
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.7e-27 Score=251.86 Aligned_cols=149 Identities=26% Similarity=0.399 Sum_probs=113.5
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee--e
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL--D 749 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l--~ 749 (827)
++|+..+.||+|+||+||+|+. .+|+.||||++... .....++|.+|++++++++|||||++++++.+++..++ +
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6789999999999999999986 46999999999654 23456789999999999999999999999988775554 3
Q ss_pred eeccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 750 CLHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 750 ~l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
++..+ ...+++.+...|+.||+.||+||| +++||||||||+||| |||+|+.+.....
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 180 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence 33221 123456677889999999999996 578999999999998 9999987643222
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
. .+..+||+.|||||++
T Consensus 181 ~-~~~~~GT~~YmAPE~l 197 (350)
T 4b9d_A 181 L-ARACIGTPYYLSPEIC 197 (350)
T ss_dssp H-HHHHHSCCTTCCHHHH
T ss_pred c-ccccCCCccccCHHHH
Confidence 1 2335699999999974
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=241.17 Aligned_cols=148 Identities=23% Similarity=0.371 Sum_probs=107.5
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
++|+..+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..++..
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999986 469999999997542 223467999999999999999999999998877655432
Q ss_pred eccC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 751 LHST---------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 751 l~~~---------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
.+.+ ...++..+...++.|++.||+||| +++|+||||||+||| |||+|+.......
T Consensus 93 Ey~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~-- 167 (275)
T 3hyh_A 93 EYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF-- 167 (275)
T ss_dssp ECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCc--
Confidence 2221 245777788899999999999996 578999999999998 9999987654332
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
....+||+.|||||++
T Consensus 168 ~~~~~GT~~Y~APE~~ 183 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVI 183 (275)
T ss_dssp -------CTTSCHHHH
T ss_pred cCCeeECcccCChhhh
Confidence 2345799999999974
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=7e-27 Score=266.65 Aligned_cols=30 Identities=17% Similarity=0.086 Sum_probs=25.9
Q ss_pred HHHHHHHHHHHHhcCCCCceEEEeeeecCC
Q 047196 715 LKSFEAECEVMKNIRHRNHVKRISSCSNED 744 (827)
Q Consensus 715 ~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~ 744 (827)
.++|.+|++.+++++|+|+|+++|||....
T Consensus 323 ~~eF~~Eve~L~~i~HrNLV~L~gyC~s~~ 352 (487)
T 3oja_A 323 SETERLECERENQARQREIDALKEQYRTVI 352 (487)
T ss_dssp --CHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred HHHHHHHHHHHhcccccchhhHHHHhcChH
Confidence 356999999999999999999999997754
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-26 Score=263.41 Aligned_cols=124 Identities=20% Similarity=0.115 Sum_probs=72.2
Q ss_pred cccEEEccCCcCccccCcccc-CCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEec
Q 047196 381 SLENIYISNCNIGGSIPQLIS-NLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGL 459 (827)
Q Consensus 381 ~L~~L~Ls~N~l~g~~p~~~~-~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 459 (827)
+|+.|+|++|.+++.+|..+. .+++|+.|+|++|.+++..+ +..+++|+.|+|++|.+++ +|..+..+++|+.|+|
T Consensus 145 ~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~L 221 (487)
T 3oja_A 145 RVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISL 221 (487)
T ss_dssp SEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEEC
T ss_pred CCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEe
Confidence 444445555555544444443 45666666666666665422 2246666666666666664 3334666666666666
Q ss_pred CCCcccccCCccccCCCCCCccccCCCccc-ccCCccccccccccccCCC
Q 047196 460 AGNKFSGSIPSCLGNLTSLRSPDLGSNRLT-SVLPSTFWNLKDILFFDLS 508 (827)
Q Consensus 460 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~LdLs 508 (827)
++|++++ +|..+..+++|+.|++++|.+. +.+|.++..++.|+.++++
T Consensus 222 s~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 222 RNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp TTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred cCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 6666664 5656666666666666666665 4555556666666655553
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-26 Score=244.30 Aligned_cols=150 Identities=26% Similarity=0.424 Sum_probs=106.5
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC--------
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNED-------- 744 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~-------- 744 (827)
++|+..+.||+|+||+||+|+.+ +|+.||||+++... ....+++.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 56889999999999999999864 68999999996543 344578999999999999999999999986543
Q ss_pred ------ceeeeeeccCC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------e
Q 047196 745 ------FKALDCLHSTN-----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------D 797 (827)
Q Consensus 745 ------~~~l~~l~~~~-----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------D 797 (827)
+..++++..+. ....+.....|+.|+++||+||| +++||||||||+||| |
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence 22333332211 11234446789999999999996 568999999999998 9
Q ss_pred ecccccccCCCcc-----------ccccceecccccccccC
Q 047196 798 FGIGRLLTGDRSM-----------IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 798 FGla~~~~~~~~~-----------~~~~~~gt~~Y~APE~l 827 (827)
||+|+.+..+... ..+..+||+.|||||++
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~ 202 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQI 202 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHH
Confidence 9999987543221 11234699999999974
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.2e-26 Score=242.19 Aligned_cols=145 Identities=23% Similarity=0.256 Sum_probs=113.6
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee--eee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL--DCL 751 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l--~~l 751 (827)
+.|...++||+|+||+||+|+.+ +|+.||||+++.... ..+|++++++++|||||++++++.+++..++ +++
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 56777889999999999999864 699999999975422 2479999999999999999999988776544 443
Q ss_pred ccC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------eecccccccCCCcc--
Q 047196 752 HST--------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRLLTGDRSM-- 810 (827)
Q Consensus 752 ~~~--------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGla~~~~~~~~~-- 810 (827)
... ...+++.+...++.|++.||+||| +++||||||||+||| |||+|+.+..+...
T Consensus 133 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 133 EGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp TTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence 321 235778888899999999999995 678999999999998 99999987543321
Q ss_pred --ccccceecccccccccC
Q 047196 811 --IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 --~~~~~~gt~~Y~APE~l 827 (827)
.....+||+.|||||++
T Consensus 210 ~~~~~~~~GT~~YmAPE~~ 228 (336)
T 4g3f_A 210 LLTGDYIPGTETHMAPEVV 228 (336)
T ss_dssp ----CCCCCCGGGCCHHHH
T ss_pred eecCCccccCccccCHHHH
Confidence 11224699999999974
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-27 Score=281.70 Aligned_cols=418 Identities=13% Similarity=0.114 Sum_probs=251.9
Q ss_pred CEEECCCCCCCccCC-hhhhhccccceEEecCCCCCCcc---c------------cccCCCCCCcEEEcCCCCCCCCcch
Q 047196 125 TTLNLSHNKLSGDIP-PSIFTMHKLKFLDFSDNQLSGSL---S------------SVTFNLSSVLDIRLDSDKLSGELPV 188 (827)
Q Consensus 125 ~~L~Ls~N~l~g~~p-~~~~~l~~L~~LdLs~N~l~g~~---p------------~~~~~l~~L~~L~L~~n~l~g~ip~ 188 (827)
+.+++++.. ...| ..+..+++|++|+|+++.....+ | .....+++|++|+|++|.+++..+.
T Consensus 46 ~~l~~~~~~--~~~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~ 123 (594)
T 2p1m_B 46 RKVFIGNCY--AVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLE 123 (594)
T ss_dssp CEEEESSTT--SSCHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHH
T ss_pred eEEeecccc--ccCHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHH
Confidence 355665433 2333 34678999999999998643211 1 1123455666666666666655555
Q ss_pred hHhhccccccEEEeecc-ccccc-CCccCCCCCCCcEEEccCCCCcccCCCcCc----CCccccEEEccccc--ccc-cc
Q 047196 189 NICNYLHYLKVLFLAKN-MFHGQ-IPLALSKCKRLQLLNLGFKKLSGAIPKEIS----NLTILRKISLRNNK--LRG-EI 259 (827)
Q Consensus 189 ~~~~~~~~L~~L~Ls~N-~l~~~-~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~----~l~~L~~L~Ls~N~--l~~-~~ 259 (827)
.+...+++|++|+|++| .++.. ++..+.++++|++|++++|.+++..+..+. .+++|++|++++|. ++. .+
T Consensus 124 ~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l 203 (594)
T 2p1m_B 124 LIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSAL 203 (594)
T ss_dssp HHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHH
T ss_pred HHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHH
Confidence 55433446666666666 33322 333333556666666666665543332222 44456666666554 211 11
Q ss_pred cccccCcCCCcEEEeecccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCC
Q 047196 260 PHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNA 339 (827)
Q Consensus 260 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 339 (827)
+..+..+++|++|+|++|...+.+|..+.++++|+.|++..+.. ++..|.+.+ ++..+.++
T Consensus 204 ~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~------------------~~~~~~~~~-l~~~l~~~ 264 (594)
T 2p1m_B 204 ERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTA------------------EVRPDVYSG-LSVALSGC 264 (594)
T ss_dssp HHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCC------------------CCCHHHHHH-HHHHHHTC
T ss_pred HHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccccC------------------ccchhhHHH-HHHHHhcC
Confidence 11123345566666655522222444455555555554433221 022333443 33456777
Q ss_pred CCCcEE-EcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCcccc-CccccCCCCCceEeccCcccc
Q 047196 340 SKLVYL-DMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSI-PQLISNLSNLLLLDLEGNKLT 417 (827)
Q Consensus 340 ~~L~~L-~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~-p~~~~~l~~L~~L~Ls~N~l~ 417 (827)
++|+.| .+.+... +.+|..+..++ +|++|++++|.+++.. +..+..+++|+.|++++| +.
T Consensus 265 ~~L~~Ls~~~~~~~----------------~~l~~~~~~~~-~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~ 326 (594)
T 2p1m_B 265 KELRCLSGFWDAVP----------------AYLPAVYSVCS-RLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IE 326 (594)
T ss_dssp TTCCEEECCBTCCG----------------GGGGGGHHHHT-TCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GH
T ss_pred CCcccccCCcccch----------------hhHHHHHHhhC-CCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cC
Confidence 777777 2222111 12233333344 7888888888876543 334567888889988888 43
Q ss_pred c-cccccccCCCCCcEEECC---------CCCCCCCCCcccc-ccccccEEecCCCcccccCCcccc-CCCCCCccccC-
Q 047196 418 G-SIPVTFGRLQKLQGLYLP---------FNKLAGSIPDQLC-HLARLNTLGLAGNKFSGSIPSCLG-NLTSLRSPDLG- 484 (827)
Q Consensus 418 g-~~p~~~~~l~~L~~L~Ls---------~N~l~g~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls- 484 (827)
. .++.....+++|+.|+++ .+.+++.....+. .+++|+.|+++.|++++..+..+. .+++|+.|+++
T Consensus 327 ~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~ 406 (594)
T 2p1m_B 327 DAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCI 406 (594)
T ss_dssp HHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEE
T ss_pred HHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeec
Confidence 2 233333457888888883 3455433222232 478899998888888876655554 58899999998
Q ss_pred -C----Cccccc-----CCccccccccccccCCCCCCCCCCCcccccc-cccCceEEcccceeeecccccc-cCCCCCCE
Q 047196 485 -S----NRLTSV-----LPSTFWNLKDILFFDLSSNSLDGPLSLDIGN-LRVVIGINLSRNNFSGDIPSTI-GDLKDLQN 552 (827)
Q Consensus 485 -~----N~l~~~-----~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~-l~~L~~L~Ls~N~l~g~ip~~~-~~l~~L~~ 552 (827)
+ |.++.. ++..+..+++|+.|+|++ .+++..+..++. +++|+.|++++|.+++..+..+ ..+++|+.
T Consensus 407 ~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~ 485 (594)
T 2p1m_B 407 IEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRK 485 (594)
T ss_dssp SSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCE
T ss_pred ccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCE
Confidence 4 556532 222366788999999987 777666666665 8899999999999988766666 67999999
Q ss_pred EECCCCcceeecCC----CCcCCceEeCcCCcCe
Q 047196 553 ISLACNGLEGLIPE----SFGYLTELNLSFNKLE 582 (827)
Q Consensus 553 L~Ls~N~l~g~ip~----~~~~L~~L~ls~N~l~ 582 (827)
|+|++|.+++..+. .+.+|+.|++++|+++
T Consensus 486 L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~ 519 (594)
T 2p1m_B 486 LEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519 (594)
T ss_dssp EEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCB
T ss_pred EECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCC
Confidence 99999999654432 3568999999999885
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.1e-26 Score=241.12 Aligned_cols=149 Identities=25% Similarity=0.287 Sum_probs=110.8
Q ss_pred hcccccceEecCCceEEEEEEec----CCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH----DGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l 748 (827)
++|+..+.||+|+||+||+|+.. +++.||||+++... .....++.+|++++++++|||||++++++.+++..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999752 47899999996532 1223468899999999999999999999988776554
Q ss_pred eeeccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 749 DCLHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 749 ~~l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
...+.. ...++..+...++.|++.||+||| +++|+||||||+||| |||+|+......
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 333322 235677778889999999999996 578999999999998 999998764433
Q ss_pred ccccccceecccccccccC
Q 047196 809 SMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~~~~~~gt~~Y~APE~l 827 (827)
.. ....+||+.|||||++
T Consensus 181 ~~-~~~~~GT~~YmAPE~~ 198 (304)
T 3ubd_A 181 KK-AYSFCGTVEYMAPEVV 198 (304)
T ss_dssp CC-CCSCCCCGGGCCHHHH
T ss_pred cc-ccccccCcccCCHHHh
Confidence 22 2345699999999974
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.2e-25 Score=239.15 Aligned_cols=152 Identities=22% Similarity=0.409 Sum_probs=119.1
Q ss_pred HhhcccccceEecCCceEEEEEEecC------CcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCC-CCceEEEeeeecCC
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLHD------GIEVAIKVFHQNC-AMALKSFEAECEVMKNIRH-RNHVKRISSCSNED 744 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~~------g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H-~niv~~~~~~~~~~ 744 (827)
..++|+..+.||+|+||+||+|++.. ++.||||++.... ....++|.+|+++|++++| ||||+++|+|.+++
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 44678888999999999999998642 3689999997643 3445789999999999976 89999999997643
Q ss_pred ---ceeeeeeccC------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-
Q 047196 745 ---FKALDCLHST------------------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF- 796 (827)
Q Consensus 745 ---~~~l~~l~~~------------------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl- 796 (827)
+.+++++..+ ...+++.++..++.|||+||+||| +++||||||||+|||
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~~NILl 218 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILL 218 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCccceee
Confidence 2334443221 123788889999999999999996 567999999999999
Q ss_pred ---------eecccccccCCCccc-cccceecccccccccC
Q 047196 797 ---------DFGIGRLLTGDRSMI-QTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 ---------DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l 827 (827)
|||+|+.+..+.... .+..+||++|||||++
T Consensus 219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l 259 (353)
T 4ase_A 219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 259 (353)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHH
T ss_pred CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHH
Confidence 999999875544332 2345699999999974
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-24 Score=228.01 Aligned_cols=206 Identities=22% Similarity=0.262 Sum_probs=161.6
Q ss_pred cccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecC
Q 047196 381 SLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLA 460 (827)
Q Consensus 381 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 460 (827)
++++|++++|++++..+..|.++++|++|++++|++++..+..|.++++|++|+|++|++++..|..+.++++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 67888888888887777777888888888888888887777778888888888888888887777778888888888888
Q ss_pred CCcccccCCccccCCCCCCccccCCCccccc-CCccccccccccccCCCCCCCCCCCcccccccccCc----eEEcccce
Q 047196 461 GNKFSGSIPSCLGNLTSLRSPDLGSNRLTSV-LPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVI----GINLSRNN 535 (827)
Q Consensus 461 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~----~L~Ls~N~ 535 (827)
+|++++..+..+..+++|++|++++|.+++. +|..+..+++|+.|++++|++++..+..+..+..|+ .|++++|+
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~ 188 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence 8888876666788888888888888888764 577888888888888888888877777777777766 78888888
Q ss_pred eeecccccccCCCCCCEEECCCCcceeecCCCC---cCCceEeCcCCcCeecCCC
Q 047196 536 FSGDIPSTIGDLKDLQNISLACNGLEGLIPESF---GYLTELNLSFNKLEGEIPR 587 (827)
Q Consensus 536 l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~---~~L~~L~ls~N~l~g~ip~ 587 (827)
+++..+..+.. .+|+.|+|++|++++..+..+ .+|+.|++++|++++..|.
T Consensus 189 l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 242 (276)
T 2z62_A 189 MNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 242 (276)
T ss_dssp CCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTT
T ss_pred ccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCc
Confidence 88665555544 478888888888887766544 4788888888888876654
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.6e-24 Score=224.43 Aligned_cols=184 Identities=26% Similarity=0.272 Sum_probs=138.9
Q ss_pred cccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecC
Q 047196 381 SLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLA 460 (827)
Q Consensus 381 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 460 (827)
+|++|++++|++++..+..|..+++|++|++++|++++..+..|.++++|++|++++|.+.+..+..+.++++|++|+++
T Consensus 53 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 132 (276)
T 2z62_A 53 ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 132 (276)
T ss_dssp TCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECC
T ss_pred CCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECc
Confidence 56666666666666566667777777777777777777766777777777777777777776666667777778888888
Q ss_pred CCccccc-CCccccCCCCCCccccCCCcccccCCcccccccccc----ccCCCCCCCCCCCcccccccccCceEEcccce
Q 047196 461 GNKFSGS-IPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDIL----FFDLSSNSLDGPLSLDIGNLRVVIGINLSRNN 535 (827)
Q Consensus 461 ~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~ 535 (827)
+|++++. +|..+..+++|++|++++|.+++..+..+..+.+|+ .|++++|.+++..+..+.. ..|+.|++++|+
T Consensus 133 ~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~ 211 (276)
T 2z62_A 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQ 211 (276)
T ss_dssp SSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSC
T ss_pred CCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCc
Confidence 8877753 577777888888888888888777777777776666 7788888888655544443 478889999999
Q ss_pred eeecccccccCCCCCCEEECCCCcceeecC
Q 047196 536 FSGDIPSTIGDLKDLQNISLACNGLEGLIP 565 (827)
Q Consensus 536 l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip 565 (827)
+++..+..+..+++|+.|++++|.+++..|
T Consensus 212 l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 212 LKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp CSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred eeecCHhHhcccccccEEEccCCcccccCC
Confidence 887777778889999999999999987655
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=240.16 Aligned_cols=150 Identities=29% Similarity=0.440 Sum_probs=117.3
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecC------C-
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNE------D- 744 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~------~- 744 (827)
++|+..+.||+|+||+||+|+. .+|+.||||++... .....+++.+|+++|++++|||||++++++... .
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5689999999999999999986 47999999999653 234456789999999999999999999987542 1
Q ss_pred -ceeeeeecc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccC
Q 047196 745 -FKALDCLHS-------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806 (827)
Q Consensus 745 -~~~l~~l~~-------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~ 806 (827)
+.+++++.. ....+++.+...++.|++.||+||| +++||||||||+||| |||+|+.+..
T Consensus 134 ~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 134 VYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp EEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 234444422 2346788888899999999999996 578999999999998 9999987643
Q ss_pred CCc---cccccceecccccccccC
Q 047196 807 DRS---MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 807 ~~~---~~~~~~~gt~~Y~APE~l 827 (827)
... ...+..+||+.|||||++
T Consensus 211 ~~~~~~~~~~~~~GT~~Y~APEv~ 234 (398)
T 4b99_A 211 SPAEHQYFMTEYVATRWYRAPELM 234 (398)
T ss_dssp -----CCCCCSSCCCCTTCCHHHH
T ss_pred CccccccccccceeChHhcCHHHh
Confidence 321 122345799999999973
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.6e-24 Score=225.27 Aligned_cols=200 Identities=27% Similarity=0.274 Sum_probs=166.0
Q ss_pred cccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecC
Q 047196 381 SLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLA 460 (827)
Q Consensus 381 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 460 (827)
+|+.|++++|.++. + ..+..+++|++|++++|++++. ..+..+++|++|++++|.+++..+..+.++++|++|+++
T Consensus 42 ~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 117 (272)
T 3rfs_A 42 SIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLV 117 (272)
T ss_dssp TCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred ceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECC
Confidence 57777777777663 2 2467788888888888888763 367788888888888888887777778888888888888
Q ss_pred CCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccceeeecc
Q 047196 461 GNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDI 540 (827)
Q Consensus 461 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~i 540 (827)
+|++++..|..+..+++|++|++++|.+++..|..+..+++|+.|++++|++++..+..++.+++|+.|++++|++++..
T Consensus 118 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 197 (272)
T 3rfs_A 118 ENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVP 197 (272)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccC
Confidence 88888777777888888888888888888877777888888889999999888877777888899999999999999888
Q ss_pred cccccCCCCCCEEECCCCcceeecCCCCcCCceEeCcCCcCeecCCCC
Q 047196 541 PSTIGDLKDLQNISLACNGLEGLIPESFGYLTELNLSFNKLEGEIPRG 588 (827)
Q Consensus 541 p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~L~~L~ls~N~l~g~ip~~ 588 (827)
|..++.+++|+.|++++|.+.+..| .|+.++++.|+++|.+|..
T Consensus 198 ~~~~~~l~~L~~L~l~~N~~~~~~~----~l~~l~~~~n~~~g~ip~~ 241 (272)
T 3rfs_A 198 DGVFDRLTSLQYIWLHDNPWDCTCP----GIRYLSEWINKHSGVVRNS 241 (272)
T ss_dssp TTTTTTCTTCCEEECCSSCBCCCTT----TTHHHHHHHHHTGGGBBCT
T ss_pred HHHHhCCcCCCEEEccCCCccccCc----HHHHHHHHHHhCCCcccCc
Confidence 8888999999999999999888766 5788999999999999974
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.91 E-value=8e-24 Score=219.88 Aligned_cols=192 Identities=21% Similarity=0.287 Sum_probs=138.9
Q ss_pred CCCcccceecCCCCCcEEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccc
Q 047196 84 SVCNWIGITCNVNSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLS 163 (827)
Q Consensus 84 ~~C~W~gv~C~~~~~~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p 163 (827)
+||.|.|++|.. ..+.+++++++++ .+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|.+++..+
T Consensus 3 ~Cp~~~gC~C~~---~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 76 (251)
T 3m19_A 3 TCETVTGCTCNE---GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSA 76 (251)
T ss_dssp -CHHHHSSEEEG---GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCT
T ss_pred cCCCCCceEcCC---CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCH
Confidence 688999999963 3456899999998 4566555 689999999999999888899999999999999999998887
Q ss_pred cccCCCCCCcEEEcCCCCCCCCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCc
Q 047196 164 SVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLT 243 (827)
Q Consensus 164 ~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~ 243 (827)
..+.++++|++|+|++|.+++ +|...+..+++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..|++++
T Consensus 77 ~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 155 (251)
T 3m19_A 77 GVFDDLTELGTLGLANNQLAS-LPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLT 155 (251)
T ss_dssp TTTTTCTTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred hHhccCCcCCEEECCCCcccc-cChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCc
Confidence 778888888888877777773 4444444445666666666666655555566666666666666666655555566666
Q ss_pred cccEEEcccccccccccccccCcCCCcEEEeecccCccc
Q 047196 244 ILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGV 282 (827)
Q Consensus 244 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 282 (827)
+|++|+|++|++++..+..+..+++|++|+|++|.+++.
T Consensus 156 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 156 NLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 666666666666655555566666666666666666544
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=4.5e-24 Score=224.59 Aligned_cols=210 Identities=22% Similarity=0.298 Sum_probs=136.4
Q ss_pred ccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcCCCCCCCCcchhHhhccccc
Q 047196 118 LGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYL 197 (827)
Q Consensus 118 l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~~L 197 (827)
+..+++|+.|++++|.++. + +.+..+++|++|+|++|.+++. ..+..+++|++|++++|.+++ +|...+..+++|
T Consensus 37 ~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L 111 (272)
T 3rfs_A 37 QNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQS-LPNGVFDKLTNL 111 (272)
T ss_dssp HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCC-CCTTTTTTCTTC
T ss_pred cccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCc-cChhHhcCCcCC
Confidence 4455566666666666552 2 2355666666666666666542 245555555555555555553 333333334467
Q ss_pred cEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEeecc
Q 047196 198 KVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFN 277 (827)
Q Consensus 198 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 277 (827)
++|++++|.+++..+..++++++|++|++++|.+++..|..++++++|++|++++|++++..+..++.+++|++|+|++|
T Consensus 112 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N 191 (272)
T 3rfs_A 112 KELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQN 191 (272)
T ss_dssp CEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCC
Confidence 77777777776666666777777777777777777666666777777777777777777666666777777777777777
Q ss_pred cCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCC
Q 047196 278 NLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNAS 340 (827)
Q Consensus 278 ~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 340 (827)
++++..|..+.++++|+.|++++|.+.+ .+++|+.|+++.|+++|.+|.+++.+.
T Consensus 192 ~l~~~~~~~~~~l~~L~~L~l~~N~~~~--------~~~~l~~l~~~~n~~~g~ip~~~~~~~ 246 (272)
T 3rfs_A 192 QLKSVPDGVFDRLTSLQYIWLHDNPWDC--------TCPGIRYLSEWINKHSGVVRNSAGSVA 246 (272)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCBCC--------CTTTTHHHHHHHHHTGGGBBCTTSCBC
T ss_pred cCCccCHHHHhCCcCCCEEEccCCCccc--------cCcHHHHHHHHHHhCCCcccCcccccC
Confidence 7777666666777777777777776654 244566677777777777777665543
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.9e-23 Score=217.20 Aligned_cols=181 Identities=23% Similarity=0.259 Sum_probs=100.0
Q ss_pred cccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecC
Q 047196 381 SLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLA 460 (827)
Q Consensus 381 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 460 (827)
++++|++++|++++..+..|..+++|++|++++|++++..+..|.++++|++|++++|++++..+..+..+++|++|+++
T Consensus 38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 117 (270)
T 2o6q_A 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD 117 (270)
T ss_dssp TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence 45555566665555544555556666666666666654444445555666666666666655444455555556666666
Q ss_pred CCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccceeeecc
Q 047196 461 GNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDI 540 (827)
Q Consensus 461 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~i 540 (827)
+|++++..|..+..+++|++|+|++|.+++..+..|..+++|+.|+|++|.+++..+..+..++.|+.|++++|++++..
T Consensus 118 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 197 (270)
T 2o6q_A 118 RNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVP 197 (270)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCC
Confidence 66555554555555555555555555555544444555555555555555555544444555555555555555555444
Q ss_pred cccccCCCCCCEEECCCCcce
Q 047196 541 PSTIGDLKDLQNISLACNGLE 561 (827)
Q Consensus 541 p~~~~~l~~L~~L~Ls~N~l~ 561 (827)
+..+..+++|+.|+|++|.+.
T Consensus 198 ~~~~~~l~~L~~L~l~~N~~~ 218 (270)
T 2o6q_A 198 EGAFDSLEKLKMLQLQENPWD 218 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCBC
T ss_pred HHHhccccCCCEEEecCCCee
Confidence 444555555555555555443
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1e-23 Score=226.35 Aligned_cols=200 Identities=18% Similarity=0.189 Sum_probs=170.6
Q ss_pred cccEEEccCCcCccccCccc--cCCCCCceEeccCcccccccc----ccccCCCCCcEEECCCCCCCCCCCccccccccc
Q 047196 381 SLENIYISNCNIGGSIPQLI--SNLSNLLLLDLEGNKLTGSIP----VTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARL 454 (827)
Q Consensus 381 ~L~~L~Ls~N~l~g~~p~~~--~~l~~L~~L~Ls~N~l~g~~p----~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L 454 (827)
+|++|++++|++++..|..+ ..+++|++|+|++|++++..+ ..+..+++|++|+|++|++.+..|..+..+++|
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 171 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL 171 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence 58999999999999888888 889999999999999998655 345678999999999999998888999999999
Q ss_pred cEEecCCCccccc--C--CccccCCCCCCccccCCCcccccCC--c-cccccccccccCCCCCCCCCCCccccccc---c
Q 047196 455 NTLGLAGNKFSGS--I--PSCLGNLTSLRSPDLGSNRLTSVLP--S-TFWNLKDILFFDLSSNSLDGPLSLDIGNL---R 524 (827)
Q Consensus 455 ~~L~Ls~N~l~~~--~--p~~~~~l~~L~~L~Ls~N~l~~~~p--~-~~~~l~~L~~LdLs~N~l~g~~p~~~~~l---~ 524 (827)
++|+|++|++.+. + +..+..+++|++|+|++|+++...+ . .+..+++|++|||++|++++.+|..++.+ +
T Consensus 172 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~ 251 (310)
T 4glp_A 172 TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSS 251 (310)
T ss_dssp CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCT
T ss_pred CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcC
Confidence 9999999998753 2 3345788999999999999974222 1 25678999999999999999888888777 6
Q ss_pred cCceEEcccceeeecccccccCCCCCCEEECCCCccee-ecCCCCcCCceEeCcCCcCee
Q 047196 525 VVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEG-LIPESFGYLTELNLSFNKLEG 583 (827)
Q Consensus 525 ~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g-~ip~~~~~L~~L~ls~N~l~g 583 (827)
.|+.|+|++|+|+ .+|..+. ++|+.|||++|++++ .++..+.+|+.|++++|+++.
T Consensus 252 ~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 252 ALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRAPQPDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp TCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSCCCTTSCCCCSCEECSSTTTSC
T ss_pred cCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCCchhhhCCCccEEECcCCCCCC
Confidence 9999999999999 7788775 799999999999998 567778899999999999863
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=7.1e-23 Score=217.25 Aligned_cols=203 Identities=19% Similarity=0.160 Sum_probs=147.9
Q ss_pred ccCCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCcc
Q 047196 336 ITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNK 415 (827)
Q Consensus 336 ~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~ 415 (827)
+.++++++.+++++|.++.. |..+. .+++.|++++|++++..|..|..+++|+.|+|++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~~i----------------p~~~~---~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~ 66 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLTAL----------------PPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66 (290)
T ss_dssp EECSTTCCEEECTTSCCSSC----------------CSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSC
T ss_pred ccccCCccEEECCCCCCCcC----------------CCCCC---CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCc
Confidence 44556666666666665522 11111 267778888888877777778888888888888888
Q ss_pred ccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCccccCCCcccccCCcc
Q 047196 416 LTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPST 495 (827)
Q Consensus 416 l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 495 (827)
+++..+. +.+++|++|+|++|+++ .+|..+..+++|++|++++|++++..|..|..+++|++|+|++|++++..+..
T Consensus 67 l~~~~~~--~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 143 (290)
T 1p9a_G 67 LTKLQVD--GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGL 143 (290)
T ss_dssp CCEEECC--SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTT
T ss_pred cCcccCC--CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhh
Confidence 8765432 67788888888888887 66777777888888888888887666677778888888888888888777777
Q ss_pred ccccccccccCCCCCCCCCCCcccccccccCceEEcccceeeecccccccCCCCCCEEECCCCcce
Q 047196 496 FWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLE 561 (827)
Q Consensus 496 ~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~ 561 (827)
|..+++|+.|+|++|++++..+..+..++.|+.|+|++|+|+ .+|..+..+.+|+.|+|++|.+.
T Consensus 144 ~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 144 LTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp TTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred cccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence 777778888888888887655556677777777777777777 66777777777777777777664
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=6e-25 Score=241.38 Aligned_cols=254 Identities=18% Similarity=0.153 Sum_probs=193.6
Q ss_pred EEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCC----hhhhhcc-ccceEEecCCCCCCccccccCCC-----CC
Q 047196 102 ALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIP----PSIFTMH-KLKFLDFSDNQLSGSLSSVTFNL-----SS 171 (827)
Q Consensus 102 ~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p----~~~~~l~-~L~~LdLs~N~l~g~~p~~~~~l-----~~ 171 (827)
..+|+.++++|.+|..+...++|++|||++|.+++..+ ..+..++ +|++|+|++|.+++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 36788999999988888888889999999999987766 6778888 89999999999998777666654 89
Q ss_pred CcEEEcCCCCCCCCcchhHhhcc----ccccEEEeecccccccCCccC----CC-CCCCcEEEccCCCCccc----CCCc
Q 047196 172 VLDIRLDSDKLSGELPVNICNYL----HYLKVLFLAKNMFHGQIPLAL----SK-CKRLQLLNLGFKKLSGA----IPKE 238 (827)
Q Consensus 172 L~~L~L~~n~l~g~ip~~~~~~~----~~L~~L~Ls~N~l~~~~p~~l----~~-l~~L~~L~L~~n~l~~~----~p~~ 238 (827)
|++|+|++|.+++..+..+...+ ++|++|+|++|.+++..+..+ .. .++|++|+|++|.++.. ++..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 99999999999877777655532 589999999999987665443 34 36899999999998853 3334
Q ss_pred CcCCc-cccEEEcccccccccccccccC----c-CCCcEEEeecccCccc----Cchhhhc-CCCccEEEecCCcccccc
Q 047196 239 ISNLT-ILRKISLRNNKLRGEIPHEIGY----L-PNLENLVLGFNNLVGV----VPAAIFN-MSTVKKIYLLDNSLLGSF 307 (827)
Q Consensus 239 ~~~l~-~L~~L~Ls~N~l~~~~p~~~~~----l-~~L~~L~Ls~N~l~~~----~p~~~~~-l~~L~~L~l~~n~l~~~~ 307 (827)
+..++ +|++|+|++|++++..+..+.. . ++|++|||++|.+++. ++..+.. .++|++|++++|.+.+..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 45555 8999999999998777655543 4 5899999999998873 4455555 358999999998887643
Q ss_pred Ch---hhhcCCCCccEEeCcCCccccc-------cCccccCCCCCcEEEcCCCcceee
Q 047196 308 SL---GIDLSLPNVERLNLGLNRFSGT-------IPSFITNASKLVYLDMGTNSFSGI 355 (827)
Q Consensus 308 ~~---~~~~~l~~L~~L~L~~N~l~~~-------~p~~~~~l~~L~~L~Ls~N~l~g~ 355 (827)
+. .....+++|+.|+|++|++.+. ++..+..+++|+.||+++|.+.+.
T Consensus 242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred HHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence 32 2223677888999988884432 334567788888888888887654
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.3e-23 Score=214.66 Aligned_cols=196 Identities=18% Similarity=0.165 Sum_probs=174.3
Q ss_pred cccEEEccCCcCccccCccccCCCCCceEeccCcc-ccccccccccCCCCCcEEECCC-CCCCCCCCccccccccccEEe
Q 047196 381 SLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNK-LTGSIPVTFGRLQKLQGLYLPF-NKLAGSIPDQLCHLARLNTLG 458 (827)
Q Consensus 381 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~-l~g~~p~~~~~l~~L~~L~Ls~-N~l~g~~p~~~~~l~~L~~L~ 458 (827)
++++|++++|++++..+..|.++++|+.|++++|+ +++..+..|.++++|++|++++ |++++..+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 79999999999998888889999999999999997 8877777899999999999998 999977778899999999999
Q ss_pred cCCCcccccCCccccCCCCCC---ccccCCC-cccccCCcccccccccc-ccCCCCCCCCCCCcccccccccCceEEccc
Q 047196 459 LAGNKFSGSIPSCLGNLTSLR---SPDLGSN-RLTSVLPSTFWNLKDIL-FFDLSSNSLDGPLSLDIGNLRVVIGINLSR 533 (827)
Q Consensus 459 Ls~N~l~~~~p~~~~~l~~L~---~L~Ls~N-~l~~~~p~~~~~l~~L~-~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~ 533 (827)
+++|++++ +|. +..+++|+ +|++++| .+++..+..|.++++|+ .|++++|+++ .+|......+.|+.|++++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~ 188 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNK 188 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTT
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCC
Confidence 99999986 776 88888888 9999999 99988888899999999 9999999998 5555444448899999999
Q ss_pred ce-eeecccccccCC-CCCCEEECCCCcceeecCCCCcCCceEeCcCC
Q 047196 534 NN-FSGDIPSTIGDL-KDLQNISLACNGLEGLIPESFGYLTELNLSFN 579 (827)
Q Consensus 534 N~-l~g~ip~~~~~l-~~L~~L~Ls~N~l~g~ip~~~~~L~~L~ls~N 579 (827)
|+ +++..+..|..+ ++|+.|++++|++++..+..|.+|+.|+++++
T Consensus 189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARNT 236 (239)
T ss_dssp CTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCTTCTTCSEEECTTC
T ss_pred CCCcccCCHHHhhccccCCcEEECCCCccccCChhHhccCceeeccCc
Confidence 95 997778889999 99999999999999877777899999999876
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=4.9e-25 Score=242.09 Aligned_cols=233 Identities=18% Similarity=0.176 Sum_probs=108.3
Q ss_pred EEeecccccccCCccCCCCCCCcEEEccCCCCcccCC----CcCcCCc-cccEEEcccccccccccccccCc-----CCC
Q 047196 200 LFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIP----KEISNLT-ILRKISLRNNKLRGEIPHEIGYL-----PNL 269 (827)
Q Consensus 200 L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~L 269 (827)
++++.|.++|.+|..+...++|++|+|++|.+++..+ ..+.+++ +|++|+|++|++++..+..+..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 4555555555555555555555555555555554443 3444454 55555555555554444444443 555
Q ss_pred cEEEeecccCcccCchhhhcCCCccEEEecCCccccccChhhhcCC-CCccEEeCcCCccccccCcccc----C-CCCCc
Q 047196 270 ENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSL-PNVERLNLGLNRFSGTIPSFIT----N-ASKLV 343 (827)
Q Consensus 270 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l-~~L~~L~L~~N~l~~~~p~~~~----~-l~~L~ 343 (827)
++|+|++|.+++..+..+... +. .. ++|++|+|++|++++..+..+. . .++|+
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~--------------------l~-~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~ 141 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKT--------------------LA-AIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASIT 141 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHH--------------------HH-TSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCC
T ss_pred cEEECcCCcCChHHHHHHHHH--------------------HH-hCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCcee
Confidence 555555555554444333221 00 22 4555555555555544333222 2 23555
Q ss_pred EEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccc----cCC-CCCceEeccCccccc
Q 047196 344 YLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLI----SNL-SNLLLLDLEGNKLTG 418 (827)
Q Consensus 344 ~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~----~~l-~~L~~L~Ls~N~l~g 418 (827)
+|++++|.+++..+. .++..+.....+|++|+|++|++++..+..+ ..+ ++|+.|||++|++++
T Consensus 142 ~L~Ls~N~l~~~~~~-----------~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~ 210 (362)
T 3goz_A 142 SLNLRGNDLGIKSSD-----------ELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGL 210 (362)
T ss_dssp EEECTTSCGGGSCHH-----------HHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGG
T ss_pred EEEccCCcCCHHHHH-----------HHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCCh
Confidence 555555555421110 0111112222245555555555554444322 223 356666666666554
Q ss_pred c----ccccccC-CCCCcEEECCCCCCCCCCC----ccccccccccEEecCCCcc
Q 047196 419 S----IPVTFGR-LQKLQGLYLPFNKLAGSIP----DQLCHLARLNTLGLAGNKF 464 (827)
Q Consensus 419 ~----~p~~~~~-l~~L~~L~Ls~N~l~g~~p----~~~~~l~~L~~L~Ls~N~l 464 (827)
. ++..+.. .++|+.|+|++|.+++..+ ..+..+++|+.|++++|.+
T Consensus 211 ~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l 265 (362)
T 3goz_A 211 KSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIV 265 (362)
T ss_dssp SCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHH
T ss_pred hHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCc
Confidence 2 2333333 2355555555555554332 1223344455555555553
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-23 Score=229.21 Aligned_cols=150 Identities=23% Similarity=0.307 Sum_probs=115.7
Q ss_pred HhhcccccceEecCCceEEEEEEec----CCcEEEEEEEcccchHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCcee
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLH----DGIEVAIKVFHQNCAMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFKA 747 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~ 747 (827)
..+.|+..+.||+|+||+||+|+.+ +++.||||++.... ...++.+|+++++++ +|||||++++++.+.+..+
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 3467999999999999999999753 46889999986543 234678999999998 6999999999998877655
Q ss_pred eeeeccCC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------eecccccccCCCc
Q 047196 748 LDCLHSTN-------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRLLTGDRS 809 (827)
Q Consensus 748 l~~l~~~~-------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGla~~~~~~~~ 809 (827)
+...+... ..++..+...++.|++.||+||| +.+|+||||||+||| |||+|+.......
T Consensus 97 lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~ 173 (361)
T 4f9c_A 97 IAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI 173 (361)
T ss_dssp EEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred EEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence 53333222 34677778889999999999996 678999999999998 9999986543211
Q ss_pred c---------------------------ccccceecccccccccC
Q 047196 810 M---------------------------IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~---------------------------~~~~~~gt~~Y~APE~l 827 (827)
. ..+..+||++|||||++
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l 218 (361)
T 4f9c_A 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVL 218 (361)
T ss_dssp GGGGGC--------------------------CCCCGGGCCHHHH
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHH
Confidence 0 11234699999999974
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.89 E-value=4.4e-25 Score=239.86 Aligned_cols=269 Identities=17% Similarity=0.208 Sum_probs=151.3
Q ss_pred CCCcccceecCCCCCcEEEEEcCCCCCccccCccccCC--CCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCc
Q 047196 84 SVCNWIGITCNVNSHRVTALNISSLNLQGTIPPQLGNL--SSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGS 161 (827)
Q Consensus 84 ~~C~W~gv~C~~~~~~v~~L~L~~~~l~g~~~~~l~~L--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~ 161 (827)
-|..|.++.|+. ..++.+|++++.+. +..+..+ +++++|++++|.+.+..|. +..+++|++|+|++|.+++.
T Consensus 35 vc~~W~~~~~~~--~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~ 108 (336)
T 2ast_B 35 VCKRWYRLASDE--SLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVS 108 (336)
T ss_dssp SCHHHHHHHTCS--TTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHH
T ss_pred HHHHHHHHhcCc--hhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHH
Confidence 356899999874 35778888888776 3456666 7888888888888766554 55788888888888887755
Q ss_pred -cccccCCCCCCcEEEcCCCCCCCCcchhHhhccccccEEEeecc-ccccc-CCccCCCCCCCcEEEccCC-CCcccCCC
Q 047196 162 -LSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKN-MFHGQ-IPLALSKCKRLQLLNLGFK-KLSGAIPK 237 (827)
Q Consensus 162 -~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~~L~Ls~N-~l~~~-~p~~l~~l~~L~~L~L~~n-~l~~~~p~ 237 (827)
+|..+..+++|++|++++|.+++..|..+.. +++|++|++++| .+++. ++..+.++++|++|++++| .+++.
T Consensus 109 ~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~-~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~--- 184 (336)
T 2ast_B 109 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAK-NSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEK--- 184 (336)
T ss_dssp HHHHHHTTBCCCSEEECTTCBCCHHHHHHHTT-CTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHH---
T ss_pred HHHHHHhhCCCCCEEeCcCcccCHHHHHHHhc-CCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChH---
Confidence 6666666666666666666555444444443 335555555555 34431 3333444444444444444 44432
Q ss_pred cCcCCccccEEEcccccccccccccccCcC-CCcEEEeecc--cCc-ccCchhhhcCCCccEEEecCCc-cccccChhhh
Q 047196 238 EISNLTILRKISLRNNKLRGEIPHEIGYLP-NLENLVLGFN--NLV-GVVPAAIFNMSTVKKIYLLDNS-LLGSFSLGID 312 (827)
Q Consensus 238 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N--~l~-~~~p~~~~~l~~L~~L~l~~n~-l~~~~~~~~~ 312 (827)
.++..+..++ +|++|+|++| .++ +.+|..+.++++|+.|++++|. +++..+..+.
T Consensus 185 --------------------~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~ 244 (336)
T 2ast_B 185 --------------------HVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFF 244 (336)
T ss_dssp --------------------HHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGG
T ss_pred --------------------HHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHh
Confidence 1344444444 5555555554 233 3334444445555555555554 3333333332
Q ss_pred cCCCCccEEeCcCCc-cccccCccccCCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCc
Q 047196 313 LSLPNVERLNLGLNR-FSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCN 391 (827)
Q Consensus 313 ~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~ 391 (827)
.+++|+.|++++|. +.......+.++++|+.|++++| ++ . ..+..+...+..|++++|+
T Consensus 245 -~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~----~--------------~~~~~l~~~l~~L~l~~n~ 304 (336)
T 2ast_B 245 -QLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP----D--------------GTLQLLKEALPHLQINCSH 304 (336)
T ss_dssp -GCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC----T--------------TCHHHHHHHSTTSEESCCC
T ss_pred -CCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cC----H--------------HHHHHHHhhCcceEEeccc
Confidence 44556666666553 22111124556667777777666 21 1 1222222246666677777
Q ss_pred CccccCccccC
Q 047196 392 IGGSIPQLISN 402 (827)
Q Consensus 392 l~g~~p~~~~~ 402 (827)
+++..|..+++
T Consensus 305 l~~~~~~~~~~ 315 (336)
T 2ast_B 305 FTTIARPTIGN 315 (336)
T ss_dssp SCCTTCSSCSS
T ss_pred CccccCCcccc
Confidence 77777777666
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=5.2e-23 Score=220.84 Aligned_cols=224 Identities=17% Similarity=0.178 Sum_probs=167.3
Q ss_pred CCCCEEECCCCCCCccCCh---hhhhccccceEEecCCCCCCcccccc--CCCCCCcEEEcCCCCCCCCcc----hhHhh
Q 047196 122 SSLTTLNLSHNKLSGDIPP---SIFTMHKLKFLDFSDNQLSGSLSSVT--FNLSSVLDIRLDSDKLSGELP----VNICN 192 (827)
Q Consensus 122 ~~L~~L~Ls~N~l~g~~p~---~~~~l~~L~~LdLs~N~l~g~~p~~~--~~l~~L~~L~L~~n~l~g~ip----~~~~~ 192 (827)
..++.|++.++.++...-. .+..+++|++|+|++|.+++..|..+ ..+++|++|+|++|.+++..| ..+.
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~- 142 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQW- 142 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTT-
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhh-
Confidence 3578899998887632111 23346789999999999999999888 899999999999999998665 2223
Q ss_pred ccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCccc--C--CCcCcCCccccEEEcccccccccccc----ccc
Q 047196 193 YLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGA--I--PKEISNLTILRKISLRNNKLRGEIPH----EIG 264 (827)
Q Consensus 193 ~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~--~--p~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~ 264 (827)
.+++|++|+|++|.+++..|..++++++|++|+|++|++.+. + +..++++++|++|+|++|+++ .+|. .++
T Consensus 143 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~ 221 (310)
T 4glp_A 143 LKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAA 221 (310)
T ss_dssp BCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHH
T ss_pred hccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHh
Confidence 466899999999999888888999999999999999998752 2 233578889999999999986 3333 256
Q ss_pred CcCCCcEEEeecccCcccCchhhhcC---CCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCC
Q 047196 265 YLPNLENLVLGFNNLVGVVPAAIFNM---STVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASK 341 (827)
Q Consensus 265 ~l~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 341 (827)
.+++|++|+|++|++++..|..+..+ ++|++|++++|.+. .+|..+. ++|++|+|++|++++. |. +..+++
T Consensus 222 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~---~~L~~L~Ls~N~l~~~-~~-~~~l~~ 295 (310)
T 4glp_A 222 AGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP---AKLRVLDLSSNRLNRA-PQ-PDELPE 295 (310)
T ss_dssp HTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC---SCCSCEECCSCCCCSC-CC-TTSCCC
T ss_pred cCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc---CCCCEEECCCCcCCCC-ch-hhhCCC
Confidence 78899999999999998878777665 47777777777766 4554432 5677777777777653 22 455666
Q ss_pred CcEEEcCCCcce
Q 047196 342 LVYLDMGTNSFS 353 (827)
Q Consensus 342 L~~L~Ls~N~l~ 353 (827)
|+.|++++|.++
T Consensus 296 L~~L~L~~N~l~ 307 (310)
T 4glp_A 296 VDNLTLDGNPFL 307 (310)
T ss_dssp CSCEECSSTTTS
T ss_pred ccEEECcCCCCC
Confidence 666666666654
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2e-22 Score=213.80 Aligned_cols=152 Identities=26% Similarity=0.340 Sum_probs=76.5
Q ss_pred cEEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcC
Q 047196 99 RVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLD 178 (827)
Q Consensus 99 ~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~ 178 (827)
.++.+++++++++. +|..+. +++++|+|++|.+++..|..|..+++|++|+|++|.+++..+. ..++
T Consensus 11 ~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~-------- 77 (290)
T 1p9a_G 11 SHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLP-------- 77 (290)
T ss_dssp TCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCT--------
T ss_pred CccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCC--------
Confidence 45555555555552 333332 4555566666665555555555555666666665555532211 2333
Q ss_pred CCCCCCCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEccccccccc
Q 047196 179 SDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGE 258 (827)
Q Consensus 179 ~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 258 (827)
+|++|++++|.++ .+|..+.++++|++|++++|++++..|..|.++++|++|+|++|++++.
T Consensus 78 -----------------~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~ 139 (290)
T 1p9a_G 78 -----------------VLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTL 139 (290)
T ss_dssp -----------------TCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCC
T ss_pred -----------------cCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCcc
Confidence 4444444444444 3444445555555555555555544444455555555555555555544
Q ss_pred ccccccCcCCCcEEEeecccCcc
Q 047196 259 IPHEIGYLPNLENLVLGFNNLVG 281 (827)
Q Consensus 259 ~p~~~~~l~~L~~L~Ls~N~l~~ 281 (827)
.+..|..+++|++|+|++|++++
T Consensus 140 ~~~~~~~l~~L~~L~L~~N~l~~ 162 (290)
T 1p9a_G 140 PPGLLTPTPKLEKLSLANNNLTE 162 (290)
T ss_dssp CTTTTTTCTTCCEEECTTSCCSC
T ss_pred ChhhcccccCCCEEECCCCcCCc
Confidence 44444455555555555555543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2.8e-23 Score=240.29 Aligned_cols=148 Identities=22% Similarity=0.321 Sum_probs=121.9
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
++|+..+.||+|+||+||+|+.+ +|+.||||++........+.+.+|+++|++++|||||++++++.+....++...+.
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 57899999999999999999864 69999999997766556678999999999999999999999998877655533322
Q ss_pred C-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee------------eecccccccCCCcc
Q 047196 754 T-----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------------DFGIGRLLTGDRSM 810 (827)
Q Consensus 754 ~-----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------------DFGla~~~~~~~~~ 810 (827)
. ...+++.+...++.||++||+||| +++|+||||||+||| |||+|+.+......
T Consensus 237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~ 313 (573)
T 3uto_A 237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 313 (573)
T ss_dssp CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEE
T ss_pred CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCce
Confidence 1 234567778889999999999996 568999999999998 99999987544332
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
...+||+.|||||++
T Consensus 314 --~~~~GT~~y~APEv~ 328 (573)
T 3uto_A 314 --KVTTGTAEFAAPEVA 328 (573)
T ss_dssp --EEECSSGGGCCHHHH
T ss_pred --eeeEECccccCHHHh
Confidence 335699999999974
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.88 E-value=8.4e-23 Score=234.64 Aligned_cols=147 Identities=23% Similarity=0.261 Sum_probs=114.8
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccch------HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCcee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA------MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKA 747 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~------~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~ 747 (827)
++|+..++||+|+||+||+|+.+ +|+.||||++.+... ....+..+|+++++.++|||||++++++.+++..+
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 57999999999999999999865 699999999964321 11122334567777889999999999998887665
Q ss_pred eeeeccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCC
Q 047196 748 LDCLHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGD 807 (827)
Q Consensus 748 l~~l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~ 807 (827)
+...+..+ +.++......++.+|+.||+||| +++||||||||+||| |||+|+.+...
T Consensus 269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence 53333222 34667777889999999999995 678999999999999 99999877544
Q ss_pred CccccccceecccccccccC
Q 047196 808 RSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 808 ~~~~~~~~~gt~~Y~APE~l 827 (827)
.. .+.+||+.|||||++
T Consensus 346 ~~---~t~~GTp~YmAPEvl 362 (689)
T 3v5w_A 346 KP---HASVGTHGYMAPEVL 362 (689)
T ss_dssp CC---CSCCSCGGGCCHHHH
T ss_pred CC---CCccCCcCccCHHHH
Confidence 32 345799999999974
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=5.5e-22 Score=205.98 Aligned_cols=181 Identities=26% Similarity=0.295 Sum_probs=147.9
Q ss_pred cccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecC
Q 047196 381 SLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLA 460 (827)
Q Consensus 381 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 460 (827)
+.++++++++.++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|++++..|..+..+++|++|+|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 5677888888887 4555544 578888888888888888888888888888888888888777778888888888888
Q ss_pred CCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccceeeecc
Q 047196 461 GNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDI 540 (827)
Q Consensus 461 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~i 540 (827)
+|++++..+..+..+++|++|+|++|.+++..+..|..+++|+.|+|++|++++..+..++.+++|+.|+|++|+|++..
T Consensus 92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 171 (251)
T 3m19_A 92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVP 171 (251)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccC
Confidence 88888777777888888888888888888777777788888888888888888777767888888888888888888777
Q ss_pred cccccCCCCCCEEECCCCcceeec
Q 047196 541 PSTIGDLKDLQNISLACNGLEGLI 564 (827)
Q Consensus 541 p~~~~~l~~L~~L~Ls~N~l~g~i 564 (827)
|..+..+++|+.|+|++|.+++..
T Consensus 172 ~~~~~~l~~L~~L~l~~N~~~c~~ 195 (251)
T 3m19_A 172 HGAFDRLGKLQTITLFGNQFDCSR 195 (251)
T ss_dssp TTTTTTCTTCCEEECCSCCBCTTS
T ss_pred HHHHhCCCCCCEEEeeCCceeCCc
Confidence 777888888888888888887653
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=3e-22 Score=206.33 Aligned_cols=196 Identities=18% Similarity=0.127 Sum_probs=143.2
Q ss_pred CCCEEECCCCCCCccCChhhhhccccceEEecCCC-CCCccccccCCCCCCcEEEcCC-CCCCCCcchhHhhccccccEE
Q 047196 123 SLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQ-LSGSLSSVTFNLSSVLDIRLDS-DKLSGELPVNICNYLHYLKVL 200 (827)
Q Consensus 123 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~-l~g~~p~~~~~l~~L~~L~L~~-n~l~g~ip~~~~~~~~~L~~L 200 (827)
+|++|+|++|++++..+..|.++++|++|++++|. +++..+..+.++++|++|++++ |.++ .+|...+..+++|++|
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~-~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLT-YIDPDALKELPLLKFL 110 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCC-EECTTSEECCTTCCEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCee-EcCHHHhCCCCCCCEE
Confidence 67777777777776666677777777777777776 6655555677777777777777 7776 4555544445678888
Q ss_pred EeecccccccCCccCCCCCCCc---EEEccCC-CCcccCCCcCcCCcccc-EEEcccccccccccccccCcCCCcEEEee
Q 047196 201 FLAKNMFHGQIPLALSKCKRLQ---LLNLGFK-KLSGAIPKEISNLTILR-KISLRNNKLRGEIPHEIGYLPNLENLVLG 275 (827)
Q Consensus 201 ~Ls~N~l~~~~p~~l~~l~~L~---~L~L~~n-~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 275 (827)
++++|.+++ +|. ++.+++|+ +|++++| .+++..+..|.++++|+ +|++++|+++ .+|......++|++|+|+
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~ 187 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLN 187 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECT
T ss_pred eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcC
Confidence 888888876 555 77777777 8888888 88777677788888888 8888888887 555544344788888888
Q ss_pred ccc-CcccCchhhhcC-CCccEEEecCCccccccChhhhcCCCCccEEeCcCC
Q 047196 276 FNN-LVGVVPAAIFNM-STVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLN 326 (827)
Q Consensus 276 ~N~-l~~~~p~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N 326 (827)
+|+ +++..+..+.++ ++|+.|++++|.+.+ +|.. .+++|+.|+++++
T Consensus 188 ~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~-l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSK---GLEHLKELIARNT 236 (239)
T ss_dssp TCTTCCEECTTTTTTCSBCCSEEECTTCCCCC-CCCT---TCTTCSEEECTTC
T ss_pred CCCCcccCCHHHhhccccCCcEEECCCCcccc-CChh---HhccCceeeccCc
Confidence 884 877767777777 888888888888764 4433 4678888888765
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.3e-23 Score=232.87 Aligned_cols=138 Identities=21% Similarity=0.308 Sum_probs=81.1
Q ss_pred CCCcEEEccCCCCc-ccCC---CcCcCCccccEEEccccccc--c---cccccccCcCCCcEEEeecccCc----ccCch
Q 047196 219 KRLQLLNLGFKKLS-GAIP---KEISNLTILRKISLRNNKLR--G---EIPHEIGYLPNLENLVLGFNNLV----GVVPA 285 (827)
Q Consensus 219 ~~L~~L~L~~n~l~-~~~p---~~~~~l~~L~~L~Ls~N~l~--~---~~p~~~~~l~~L~~L~Ls~N~l~----~~~p~ 285 (827)
++|++|++++|.++ +.+| ..+..+++|++|++++|+++ | ..|..+..+++|++|+|++|.++ +.+|.
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~ 238 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 238 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH
Confidence 55666666666654 2333 24445556666666666655 2 23335556666666666666664 44555
Q ss_pred hhhcCCCccEEEecCCccccc----cChhhh-cCCCCccEEeCcCCcccc----ccCccc-cCCCCCcEEEcCCCcceee
Q 047196 286 AIFNMSTVKKIYLLDNSLLGS----FSLGID-LSLPNVERLNLGLNRFSG----TIPSFI-TNASKLVYLDMGTNSFSGI 355 (827)
Q Consensus 286 ~~~~l~~L~~L~l~~n~l~~~----~~~~~~-~~l~~L~~L~L~~N~l~~----~~p~~~-~~l~~L~~L~Ls~N~l~g~ 355 (827)
.+..+++|+.|++++|.+.+. ++..+. ..+++|+.|+|++|++++ .+|..+ .++++|++|++++|.+++.
T Consensus 239 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~ 318 (386)
T 2ca6_A 239 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 318 (386)
T ss_dssp HGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred HHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcc
Confidence 566666666666666665543 222221 136677777777777776 366665 5577777777777777654
Q ss_pred c
Q 047196 356 I 356 (827)
Q Consensus 356 ~ 356 (827)
.
T Consensus 319 ~ 319 (386)
T 2ca6_A 319 D 319 (386)
T ss_dssp S
T ss_pred h
Confidence 3
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.87 E-value=5.7e-23 Score=223.18 Aligned_cols=255 Identities=19% Similarity=0.251 Sum_probs=200.5
Q ss_pred CCCEEECCCCCCCccCChhhhhc--cccceEEecCCCCCCccccccCCCCCCcEEEcCCCCCCCCcchhHhhccccccEE
Q 047196 123 SLTTLNLSHNKLSGDIPPSIFTM--HKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVL 200 (827)
Q Consensus 123 ~L~~L~Ls~N~l~g~~p~~~~~l--~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~~L 200 (827)
.++.||+++|.+. |..+..+ +++++|++++|.+.+..+. +..+ ++|++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~-------------------------~~L~~L 98 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSP-------------------------FRVQHM 98 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCC-------------------------BCCCEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccC-------------------------CCCCEE
Confidence 4789999999886 5677777 8999999999998876543 2222 367777
Q ss_pred Eeeccccccc-CCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccc-ccccc-ccccccCcCCCcEEEeecc
Q 047196 201 FLAKNMFHGQ-IPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNN-KLRGE-IPHEIGYLPNLENLVLGFN 277 (827)
Q Consensus 201 ~Ls~N~l~~~-~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L~~L~Ls~N 277 (827)
++++|.+++. +|..+..+++|++|++++|.+++..|..++.+++|++|++++| .+++. +|..+..+++|++|++++|
T Consensus 99 ~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~ 178 (336)
T 2ast_B 99 DLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWC 178 (336)
T ss_dssp ECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCC
T ss_pred EccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCC
Confidence 7777776655 6777788889999999999888888888888999999999999 67763 7777899999999999999
Q ss_pred -cCccc-CchhhhcCC-CccEEEecCC--ccc-cccChhhhcCCCCccEEeCcCCc-cccccCccccCCCCCcEEEcCCC
Q 047196 278 -NLVGV-VPAAIFNMS-TVKKIYLLDN--SLL-GSFSLGIDLSLPNVERLNLGLNR-FSGTIPSFITNASKLVYLDMGTN 350 (827)
Q Consensus 278 -~l~~~-~p~~~~~l~-~L~~L~l~~n--~l~-~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~N 350 (827)
.+++. ++..+..++ +|++|++++| .++ +.++..+. .+++|+.|++++|. +++..+..+..+++|+.|++++|
T Consensus 179 ~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~-~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~ 257 (336)
T 2ast_B 179 FDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVR-RCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRC 257 (336)
T ss_dssp TTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHH-HCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTC
T ss_pred CCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHh-hCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCC
Confidence 99875 678889999 9999999999 455 44554443 78999999999999 78788889999999999999999
Q ss_pred cceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCC-CCCceEeccCccccccccccccC
Q 047196 351 SFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNL-SNLLLLDLEGNKLTGSIPVTFGR 426 (827)
Q Consensus 351 ~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l-~~L~~L~Ls~N~l~g~~p~~~~~ 426 (827)
. +..+..+ ..+..++ +|++|++++| ++. ..+..+ .++..|++++|++++..|..++.
T Consensus 258 ~--~~~~~~~------------~~l~~~~-~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 258 Y--DIIPETL------------LELGEIP-TLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARPTIGN 315 (336)
T ss_dssp T--TCCGGGG------------GGGGGCT-TCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred C--CCCHHHH------------HHHhcCC-CCCEEeccCc-cCH---HHHHHHHhhCcceEEecccCccccCCcccc
Confidence 6 2211110 1344454 8999999999 432 234444 34788889999999999988765
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.5e-23 Score=232.55 Aligned_cols=110 Identities=20% Similarity=0.265 Sum_probs=51.0
Q ss_pred ccccEEEccccccc-cccc---ccccCcCCCcEEEeecccCc--c---cCchhhhcCCCccEEEecCCccc----cccCh
Q 047196 243 TILRKISLRNNKLR-GEIP---HEIGYLPNLENLVLGFNNLV--G---VVPAAIFNMSTVKKIYLLDNSLL----GSFSL 309 (827)
Q Consensus 243 ~~L~~L~Ls~N~l~-~~~p---~~~~~l~~L~~L~Ls~N~l~--~---~~p~~~~~l~~L~~L~l~~n~l~----~~~~~ 309 (827)
++|++|+|++|+++ +.+| ..+..+++|++|+|++|+++ | ..|..+..+++|+.|++++|.+. +.++.
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~ 238 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 238 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH
Confidence 45555555555554 2233 23444455555555555554 1 22324445555555555555543 33333
Q ss_pred hhhcCCCCccEEeCcCCccccc----cCccc--cCCCCCcEEEcCCCcce
Q 047196 310 GIDLSLPNVERLNLGLNRFSGT----IPSFI--TNASKLVYLDMGTNSFS 353 (827)
Q Consensus 310 ~~~~~l~~L~~L~L~~N~l~~~----~p~~~--~~l~~L~~L~Ls~N~l~ 353 (827)
.+. .+++|+.|+|++|++++. +|..+ +.+++|+.|++++|.++
T Consensus 239 ~l~-~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~ 287 (386)
T 2ca6_A 239 ALK-SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 287 (386)
T ss_dssp HGG-GCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCB
T ss_pred HHc-cCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCC
Confidence 332 445555555555555443 33333 22455555555555544
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.6e-22 Score=218.73 Aligned_cols=167 Identities=33% Similarity=0.542 Sum_probs=134.2
Q ss_pred cccccchhHHHHHhhcccccceEecCCceEEEEEEecCCcEEEEEEEcccchH-HHHHHHHHHHHHHhcCCCCceEEEee
Q 047196 661 TLRRFSYQDLFRATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAM-ALKSFEAECEVMKNIRHRNHVKRISS 739 (827)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~~~~~ 739 (827)
..+.+++.++...+++|...+.||+|+||.||+|+.++|+.||||++...... ....+.+|++++++++|||||+++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 34678889999999999999999999999999999888999999998654322 23368999999999999999999999
Q ss_pred eecCCceee--eeecc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------
Q 047196 740 CSNEDFKAL--DCLHS------------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF--------- 796 (827)
Q Consensus 740 ~~~~~~~~l--~~l~~------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl--------- 796 (827)
+......++ +++.. ....+++..+..|+.++++||+|||..+.++|+||||||+||+
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 987665443 32221 1123788889999999999999999877789999999999998
Q ss_pred -eecccccccCCCccccccceecccccccccC
Q 047196 797 -DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 -DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
|||+++..............||++|+|||++
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 207 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 207 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHH
T ss_pred ccCccccccCcccccccccccCCcCccCHHHh
Confidence 9999987754443333334589999999963
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.87 E-value=4.4e-22 Score=228.93 Aligned_cols=200 Identities=22% Similarity=0.333 Sum_probs=138.6
Q ss_pred CCCCCCCCCC-----cccce-ecCCCCCcEEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccce
Q 047196 77 QNSTSNTSVC-----NWIGI-TCNVNSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKF 150 (827)
Q Consensus 77 ~w~~~~~~~C-----~W~gv-~C~~~~~~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 150 (827)
+|. .+.++| .|.|+ .|.. ++|+.|+|++|++++ +|..+. ++|++|+|++|+|+ .+| ..+++|++
T Consensus 35 ~W~-~~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~ 104 (571)
T 3cvr_A 35 KWE-KQALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEY 104 (571)
T ss_dssp HHH-TTCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCE
T ss_pred HHh-ccCCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCE
Confidence 454 344567 79999 7863 479999999999998 777663 89999999999999 677 45799999
Q ss_pred EEecCCCCCCccccccCCCCCCcEEEcCCCCCCCCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCC
Q 047196 151 LDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKK 230 (827)
Q Consensus 151 LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~ 230 (827)
|+|++|+|++ +|. +.+ +|++|+|++|.+++ +|. .+++|++|+|++|.+++ +|. .+++|++|+|++|.
T Consensus 105 L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~----~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~ 171 (571)
T 3cvr_A 105 LDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE----LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQ 171 (571)
T ss_dssp EECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC----CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSC
T ss_pred EEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC----cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCC
Confidence 9999999998 666 544 78888888888876 665 34577777777777775 454 46677777777777
Q ss_pred CcccCCCcCcCCccccEEEcccccccccccccccCcCCC-------cEEEeecccCcccCchhhhcCCCccEEEecCCcc
Q 047196 231 LSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNL-------ENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSL 303 (827)
Q Consensus 231 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-------~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l 303 (827)
+++ +|. +. ++|++|+|++|+|+ .+|. +.. +| ++|+|++|+|+. +|..++.+++|+.|++++|.+
T Consensus 172 L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~L~~N~l 242 (571)
T 3cvr_A 172 LTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPL 242 (571)
T ss_dssp CSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCCC-CCGGGGGSCTTEEEECCSSSC
T ss_pred CCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCccee-cCHHHhcCCCCCEEEeeCCcC
Confidence 776 555 54 67777777777776 5555 443 55 666666666663 455444444444444444444
Q ss_pred ccccC
Q 047196 304 LGSFS 308 (827)
Q Consensus 304 ~~~~~ 308 (827)
++.+|
T Consensus 243 ~~~~p 247 (571)
T 3cvr_A 243 SSRIR 247 (571)
T ss_dssp CHHHH
T ss_pred CCcCH
Confidence 44433
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.86 E-value=1.3e-21 Score=209.49 Aligned_cols=168 Identities=23% Similarity=0.371 Sum_probs=91.4
Q ss_pred cccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecC
Q 047196 381 SLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLA 460 (827)
Q Consensus 381 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 460 (827)
+|++|++++|++++..+ +..+++|++|++++|++++. + .+..+++|+.|++++|++++. |. +..+++|+.|+++
T Consensus 64 ~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~ 137 (308)
T 1h6u_A 64 NLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV-S-AIAGLQSIKTLDLTSTQITDV-TP-LAGLSNLQVLYLD 137 (308)
T ss_dssp TCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC-G-GGTTCTTCCEEECTTSCCCCC-GG-GTTCTTCCEEECC
T ss_pred CCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc-h-hhcCCCCCCEEECCCCCCCCc-hh-hcCCCCCCEEECC
Confidence 44445555554443322 45555555555555555542 2 355555555555555555542 22 5555555555555
Q ss_pred CCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccceeeecc
Q 047196 461 GNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDI 540 (827)
Q Consensus 461 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~i 540 (827)
+|++++..+ +..+++|++|++++|.+++..+ +..+++|+.|++++|.+++..+ +..++.|+.|++++|++++..
T Consensus 138 ~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~ 211 (308)
T 1h6u_A 138 LNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS 211 (308)
T ss_dssp SSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG
T ss_pred CCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc
Confidence 555553322 5555556666666665554333 5555566666666666654433 555666666666666666443
Q ss_pred cccccCCCCCCEEECCCCccee
Q 047196 541 PSTIGDLKDLQNISLACNGLEG 562 (827)
Q Consensus 541 p~~~~~l~~L~~L~Ls~N~l~g 562 (827)
| +..+++|+.|++++|.+++
T Consensus 212 ~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 212 P--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp G--GTTCTTCCEEEEEEEEEEC
T ss_pred c--ccCCCCCCEEEccCCeeec
Confidence 2 5666666666666666654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=7.9e-22 Score=220.78 Aligned_cols=157 Identities=21% Similarity=0.258 Sum_probs=124.0
Q ss_pred hHHHHHhhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchH---HHHHHHHHHHHHHhcCCCCceEEEeeeecC
Q 047196 668 QDLFRATEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAM---ALKSFEAECEVMKNIRHRNHVKRISSCSNE 743 (827)
Q Consensus 668 ~~~~~~~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~---~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~ 743 (827)
.++...+++|+..++||+|+||+||+|+.+ +++.||||++...... ..+.+.+|+.+++.++|||||++++++.+.
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 344445678999999999999999999976 5889999999653221 223488999999999999999999999887
Q ss_pred CceeeeeeccC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccc
Q 047196 744 DFKALDCLHST-----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGR 802 (827)
Q Consensus 744 ~~~~l~~l~~~-----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~ 802 (827)
+..++...+.. ...+++.....++.+++.||+||| +.+|+||||||+||| |||+|+
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla~ 223 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCL 223 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhhh
Confidence 76554333221 245777888889999999999996 567999999999998 999998
Q ss_pred cccCCCccccccceecccccccccC
Q 047196 803 LLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 803 ~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
....+........+||++|||||++
T Consensus 224 ~~~~~~~~~~~~~~GT~~Y~APE~l 248 (437)
T 4aw2_A 224 KLMEDGTVQSSVAVGTPDYISPEIL 248 (437)
T ss_dssp ECCTTSCEECCSCCSCGGGCCHHHH
T ss_pred hcccCCCcccccccCCcCeeChHHH
Confidence 7765544333445699999999974
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.2e-21 Score=207.96 Aligned_cols=161 Identities=24% Similarity=0.254 Sum_probs=127.0
Q ss_pred cccchhHHHHHhhc----------ccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCC
Q 047196 663 RRFSYQDLFRATEK----------FSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHR 731 (827)
Q Consensus 663 ~~~~~~~~~~~~~~----------~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~ 731 (827)
+.++++++..+++. |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|++++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34667777766653 666789999999999999975 7999999999765545567789999999999999
Q ss_pred CceEEEeeeecCCceeeeeeccC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee------
Q 047196 732 NHVKRISSCSNEDFKALDCLHST---------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------ 796 (827)
Q Consensus 732 niv~~~~~~~~~~~~~l~~l~~~---------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------ 796 (827)
|||++++++...+..++...+.. ...+++.....++.++++||+||| +.+|+||||||+||+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~ 179 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGR 179 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCc
Confidence 99999999988765554333221 235788889999999999999996 468999999999998
Q ss_pred ----eecccccccCCCccccccceecccccccccC
Q 047196 797 ----DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 ----DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
|||+++........ .....||++|+|||++
T Consensus 180 ~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~ 213 (321)
T 2c30_A 180 VKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVI 213 (321)
T ss_dssp EEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHH
T ss_pred EEEeeeeeeeecccCccc-cccccCCccccCHhhh
Confidence 99999876544322 2334699999999963
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=6.9e-21 Score=203.93 Aligned_cols=189 Identities=21% Similarity=0.346 Sum_probs=166.9
Q ss_pred cccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecC
Q 047196 381 SLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLA 460 (827)
Q Consensus 381 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 460 (827)
+|++|++++|+++. +| .+..+++|+.|++++|++++..+ +..+++|++|+|++|++++. | .+..+++|+.|+++
T Consensus 42 ~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~l~ 115 (308)
T 1h6u_A 42 GITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV-S-AIAGLQSIKTLDLT 115 (308)
T ss_dssp TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC-G-GGTTCTTCCEEECT
T ss_pred CcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc-h-hhcCCCCCCEEECC
Confidence 78899999998875 45 58889999999999999997655 99999999999999999863 3 68899999999999
Q ss_pred CCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccceeeecc
Q 047196 461 GNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDI 540 (827)
Q Consensus 461 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~i 540 (827)
+|++++ +|. +..+++|++|++++|.+++..+ +..+++|+.|++++|.+++..+ +..++.|+.|++++|++++..
T Consensus 116 ~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~ 189 (308)
T 1h6u_A 116 STQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDIS 189 (308)
T ss_dssp TSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG
T ss_pred CCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcCh
Confidence 999986 443 8999999999999999998655 8899999999999999997555 889999999999999999765
Q ss_pred cccccCCCCCCEEECCCCcceeecC-CCCcCCceEeCcCCcCee
Q 047196 541 PSTIGDLKDLQNISLACNGLEGLIP-ESFGYLTELNLSFNKLEG 583 (827)
Q Consensus 541 p~~~~~l~~L~~L~Ls~N~l~g~ip-~~~~~L~~L~ls~N~l~g 583 (827)
+ +..+++|+.|+|++|++++..| ..+.+|+.|++++|++++
T Consensus 190 ~--l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 190 P--LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp G--GGGCTTCCEEECTTSCCCBCGGGTTCTTCCEEEEEEEEEEC
T ss_pred h--hcCCCCCCEEEccCCccCccccccCCCCCCEEEccCCeeec
Confidence 4 8999999999999999998765 334589999999999976
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=9.2e-22 Score=212.23 Aligned_cols=159 Identities=35% Similarity=0.532 Sum_probs=126.0
Q ss_pred cchhHHHHHhhcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC
Q 047196 665 FSYQDLFRATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNED 744 (827)
Q Consensus 665 ~~~~~~~~~~~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~ 744 (827)
+.+.++..++++|+..+.||+|+||.||+|+.++|+.||||++........+.+.+|++++++++|||||++++++...+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 34445556778999999999999999999998889999999987665556778999999999999999999999998766
Q ss_pred ceee--eeeccC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecc
Q 047196 745 FKAL--DCLHST------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGI 800 (827)
Q Consensus 745 ~~~l--~~l~~~------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGl 800 (827)
..++ ++.... ...+++.++..++.++++||+||| +++|+||||||+||+ |||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence 4443 322211 123778889999999999999996 468999999999998 9999
Q ss_pred cccccCCCcc-ccccceeccccccccc
Q 047196 801 GRLLTGDRSM-IQTETLVTIGYMAPGL 826 (827)
Q Consensus 801 a~~~~~~~~~-~~~~~~gt~~Y~APE~ 826 (827)
++........ ......||++|+|||+
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~ 212 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEY 212 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHH
T ss_pred ccccccccccccccccCCCccccCHHH
Confidence 9875432221 2233458999999996
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=6.6e-21 Score=191.76 Aligned_cols=161 Identities=23% Similarity=0.245 Sum_probs=97.4
Q ss_pred cccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecC
Q 047196 381 SLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLA 460 (827)
Q Consensus 381 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 460 (827)
++++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|+|++|++++..+..+..+++|++|+++
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 108 (208)
T 2o6s_A 29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALN 108 (208)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcC
Confidence 46666666666665555556666666666666666665555555666666666666666665555555666666666666
Q ss_pred CCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccceeeecc
Q 047196 461 GNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDI 540 (827)
Q Consensus 461 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~i 540 (827)
+|++++..+..+..+++|++|++++|.+++..+..+..+++|+.|++++|.+.+. ++.|+.|+++.|+++|.+
T Consensus 109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~L~~~~n~~~g~i 181 (208)
T 2o6s_A 109 TNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVV 181 (208)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC-------TTTTHHHHHHHHHCTTTB
T ss_pred CCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC-------CCCHHHHHHHHHhCCcee
Confidence 6666654454556666666666666666655555556666666666666655542 234555566666666666
Q ss_pred cccccCCC
Q 047196 541 PSTIGDLK 548 (827)
Q Consensus 541 p~~~~~l~ 548 (827)
|++++.++
T Consensus 182 p~~~~~l~ 189 (208)
T 2o6s_A 182 RNSAGSVA 189 (208)
T ss_dssp BCTTSSBC
T ss_pred eccCcccc
Confidence 66555544
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=3.6e-21 Score=193.70 Aligned_cols=152 Identities=25% Similarity=0.242 Sum_probs=91.0
Q ss_pred cEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCC
Q 047196 383 ENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGN 462 (827)
Q Consensus 383 ~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 462 (827)
+.++.+++.++. +|..+ .++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|++++|
T Consensus 10 ~~v~c~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRTS-VPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCccC-CCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 456666666663 34333 346777777777777666666667777777777777776555555666666666666666
Q ss_pred cccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccceee
Q 047196 463 KFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFS 537 (827)
Q Consensus 463 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 537 (827)
++++..+..+..+++|++|++++|.+++..+..|..+++|+.|++++|.+++..+..+..++.|+.|++++|.+.
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 161 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD 161 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCee
Confidence 666544445566666666666666666555555555555555555555555444434444444444444444443
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=6.6e-21 Score=204.42 Aligned_cols=150 Identities=23% Similarity=0.369 Sum_probs=119.6
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
++|...++||+|+||.||+|+.. +|+.||||++........+.|.+|++++++++|||||++++++.++...++...+.
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 57888899999999999999874 68999999987666667788999999999999999999999998876554432222
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc-
Q 047196 754 -----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI- 811 (827)
Q Consensus 754 -----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~- 811 (827)
....+.+.++..++.++++||+||| +.+|+||||||+||+ |||+++.........
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 1345778889999999999999996 567999999999998 999998764332211
Q ss_pred ------------cccceecccccccccC
Q 047196 812 ------------QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ------------~~~~~gt~~Y~APE~l 827 (827)
....+||++|+|||++
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 194 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMI 194 (310)
T ss_dssp -------------CCCCSCGGGCCHHHH
T ss_pred ccccccccccccccccCCCcceeCHHHh
Confidence 0134589999999963
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.84 E-value=7.6e-21 Score=205.35 Aligned_cols=149 Identities=26% Similarity=0.338 Sum_probs=120.3
Q ss_pred hhcccccceEecCCceEEEEEEe-cCCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
.++|...+.||+|+||.||+|+. .+|+.||||++... .....+++.+|+++++.++|||||++++++......++..
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46789999999999999999986 57999999999653 3345677899999999999999999999998776555433
Q ss_pred eccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 751 LHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 751 l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
.+.. ...++......++.++++|++||| +.+|+||||||+||+ |||+++.......
T Consensus 94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 169 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK- 169 (328)
T ss_dssp CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG-
T ss_pred ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc-
Confidence 3322 134667778899999999999996 568999999999998 9999987654332
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
....+||++|+|||++
T Consensus 170 -~~~~~gt~~y~aPE~~ 185 (328)
T 3fe3_A 170 -LDAFCGAPPYAAPELF 185 (328)
T ss_dssp -GGTTSSSGGGCCHHHH
T ss_pred -cccccCCcceeCcccc
Confidence 2345699999999963
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.84 E-value=2.5e-20 Score=203.49 Aligned_cols=204 Identities=16% Similarity=0.124 Sum_probs=132.9
Q ss_pred CcccceecCCCCCcEEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCcccc-
Q 047196 86 CNWIGITCNVNSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSS- 164 (827)
Q Consensus 86 C~W~gv~C~~~~~~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~- 164 (827)
|.|..|.|+. ++++ .+|..+ .+++++|+|++|+|+...+.+|.++++|++|||++|++.+.+|.
T Consensus 9 C~~~~v~C~~------------~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~ 73 (350)
T 4ay9_X 9 CSNRVFLCQE------------SKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD 73 (350)
T ss_dssp EETTEEEEES------------TTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTT
T ss_pred eeCCEEEecC------------CCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChh
Confidence 6777777763 3344 456555 36789999999999865556789999999999999998765543
Q ss_pred ccCCCCCCcEEEcCCCCCCCCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCcc
Q 047196 165 VTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTI 244 (827)
Q Consensus 165 ~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~ 244 (827)
.|.+++++ ++.+.++.|+++...|..|.++++|++|++++|++++..+..+....+
T Consensus 74 ~f~~L~~l------------------------~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~ 129 (350)
T 4ay9_X 74 VFSNLPKL------------------------HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQ 129 (350)
T ss_dssp SBCSCTTC------------------------CEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSS
T ss_pred Hhhcchhh------------------------hhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccch
Confidence 23333322 234556667777777777888888888888888887766666666777
Q ss_pred ccEEEccc-ccccccccccccCcC-CCcEEEeecccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEe
Q 047196 245 LRKISLRN-NKLRGEIPHEIGYLP-NLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLN 322 (827)
Q Consensus 245 L~~L~Ls~-N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ 322 (827)
+..|++.+ |++....+..|..+. .+++|+|++|+++.+ |...+...+|+++++++++..+.+|...+..+++|++|+
T Consensus 130 l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i-~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~Ld 208 (350)
T 4ay9_X 130 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEI-HNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILD 208 (350)
T ss_dssp CEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEE-CTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEE
T ss_pred hhhhhhccccccccccccchhhcchhhhhhccccccccCC-ChhhccccchhHHhhccCCcccCCCHHHhccCcccchhh
Confidence 77788765 456544445566654 577888888888754 333444455666666554444445444433444555555
Q ss_pred CcCCccc
Q 047196 323 LGLNRFS 329 (827)
Q Consensus 323 L~~N~l~ 329 (827)
|++|+++
T Consensus 209 Ls~N~l~ 215 (350)
T 4ay9_X 209 ISRTRIH 215 (350)
T ss_dssp CTTSCCC
T ss_pred cCCCCcC
Confidence 5555544
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=2.1e-21 Score=215.83 Aligned_cols=156 Identities=21% Similarity=0.277 Sum_probs=122.7
Q ss_pred HHHHHhhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC
Q 047196 669 DLFRATEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNED 744 (827)
Q Consensus 669 ~~~~~~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~ 744 (827)
+.....++|+..++||+|+||+||+|+.+ +|+.||||++.+.. ....+.+.+|++++.+++|||||++++++.+.+
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN 134 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 33445678999999999999999999875 69999999996532 122345889999999999999999999998877
Q ss_pred ceeeeeeccC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eeccccc
Q 047196 745 FKALDCLHST-----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRL 803 (827)
Q Consensus 745 ~~~l~~l~~~-----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~ 803 (827)
..++...+.. ...+.+.....++.+++.||+||| +.+|+||||||+||| |||+|+.
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla~~ 211 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLK 211 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhhee
Confidence 6554333221 135677777889999999999996 568999999999998 9999987
Q ss_pred ccCCCccccccceecccccccccC
Q 047196 804 LTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 804 ~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
...+........+||++|||||++
T Consensus 212 ~~~~~~~~~~~~~Gt~~Y~APE~l 235 (412)
T 2vd5_A 212 LRADGTVRSLVAVGTPDYLSPEIL 235 (412)
T ss_dssp CCTTSCEECSSCCSCGGGCCHHHH
T ss_pred ccCCCccccceeccccCcCCHHHH
Confidence 765443222335699999999974
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.84 E-value=6.3e-21 Score=219.30 Aligned_cols=166 Identities=27% Similarity=0.305 Sum_probs=124.2
Q ss_pred cccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecC
Q 047196 381 SLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLA 460 (827)
Q Consensus 381 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 460 (827)
+|++|+|++|+|+ .+| ..+++|+.|+|++|++++ +|. +.+ +|+.|+|++|++++ +|. .+++|+.|+|+
T Consensus 81 ~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls 148 (571)
T 3cvr_A 81 QITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINAD 148 (571)
T ss_dssp TCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECC
T ss_pred CCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCC
Confidence 6788888888887 566 446788888888888886 555 554 78888888888876 565 56778888888
Q ss_pred CCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccC-------ceEEccc
Q 047196 461 GNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVV-------IGINLSR 533 (827)
Q Consensus 461 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L-------~~L~Ls~ 533 (827)
+|++++ +|. .+++|++|+|++|.+++ +|. +. ++|+.|||++|+|+ .+|. +.. .| +.|+|++
T Consensus 149 ~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~ 216 (571)
T 3cvr_A 149 NNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRE 216 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCS
T ss_pred CCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCC
Confidence 888875 665 46778888888888877 555 54 78888888888887 5555 544 66 8888888
Q ss_pred ceeeecccccccCCCCCCEEECCCCcceeecCCCCcCC
Q 047196 534 NNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFGYL 571 (827)
Q Consensus 534 N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~L 571 (827)
|+|+ .+|..+..+++|+.|+|++|.+++.+|..+..+
T Consensus 217 N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l 253 (571)
T 3cvr_A 217 NRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ 253 (571)
T ss_dssp SCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHH
T ss_pred Ccce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHh
Confidence 8888 578888888888888888888888888766543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=6.8e-21 Score=204.39 Aligned_cols=150 Identities=27% Similarity=0.392 Sum_probs=117.4
Q ss_pred hhcccccceEecCCceEEEEEEecCCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee--e
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL--D 749 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l--~ 749 (827)
.++|+..+.||+|+||.||+|+..+|+.||||++.... ....+.+.+|++++++++|||||++++++..+...++ +
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 36788999999999999999998889999999986542 2234678999999999999999999999987765444 3
Q ss_pred eecc--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 750 CLHS--------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 750 ~l~~--------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
++.. ....+.+.....++.++++||+||| +.+|+||||||+||+ |||+|+........
T Consensus 100 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~- 175 (311)
T 3niz_A 100 FMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS- 175 (311)
T ss_dssp CCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC--
T ss_pred CCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCccc-
Confidence 2221 1234778888899999999999996 568999999999998 99999876433221
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
....+||++|+|||++
T Consensus 176 ~~~~~~t~~y~aPE~~ 191 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVL 191 (311)
T ss_dssp --CCCCCCTTCCHHHH
T ss_pred ccCCcccCCcCCHHHh
Confidence 2334589999999963
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=4.5e-21 Score=212.99 Aligned_cols=156 Identities=22% Similarity=0.241 Sum_probs=122.1
Q ss_pred HHHHHhhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceEEEeeeecCC
Q 047196 669 DLFRATEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA---MALKSFEAECEVMKNIRHRNHVKRISSCSNED 744 (827)
Q Consensus 669 ~~~~~~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~ 744 (827)
++....++|+..++||+|+||+||+|+.+ +|+.||||++..... ...+.+.+|+++++.++|||||++++++.++.
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 34445678999999999999999999875 589999999865321 12345889999999999999999999998877
Q ss_pred ceeeeeeccC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eeccccccc
Q 047196 745 FKALDCLHST---------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLT 805 (827)
Q Consensus 745 ~~~l~~l~~~---------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~ 805 (827)
..++...+.. ...+.+.....++.+++.||+||| +.+|+||||||+||| |||+|+...
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~ 219 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence 6554333322 134566777889999999999996 568999999999998 999998775
Q ss_pred CCCccccccceecccccccccC
Q 047196 806 GDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 806 ~~~~~~~~~~~gt~~Y~APE~l 827 (827)
..........+||+.|||||++
T Consensus 220 ~~~~~~~~~~~gt~~Y~APE~l 241 (410)
T 3v8s_A 220 KEGMVRCDTAVGTPDYISPEVL 241 (410)
T ss_dssp TTSEEECCSCCSCGGGCCHHHH
T ss_pred cCCcccccCCcCCccccCHHHh
Confidence 5433223345699999999974
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.2e-20 Score=201.08 Aligned_cols=150 Identities=27% Similarity=0.325 Sum_probs=120.2
Q ss_pred hhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
.++|+..+.||+|+||.||+|+. .+|+.||||++........+.+.+|+.++++++|||||++++++..++..++...+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 35788899999999999999985 56899999998755444456789999999999999999999999877755543333
Q ss_pred cCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccc
Q 047196 753 STN---------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQT 813 (827)
Q Consensus 753 ~~~---------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~ 813 (827)
... ..+++.+...++.++++||+||| +.+|+||||||+||+ |||+++........ ..
T Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~ 174 (297)
T 3fxz_A 99 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RS 174 (297)
T ss_dssp CTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-BC
T ss_pred CCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc-cC
Confidence 222 23667778899999999999996 568999999999998 99999876544332 23
Q ss_pred cceecccccccccC
Q 047196 814 ETLVTIGYMAPGLL 827 (827)
Q Consensus 814 ~~~gt~~Y~APE~l 827 (827)
..+||+.|+|||++
T Consensus 175 ~~~gt~~y~aPE~~ 188 (297)
T 3fxz_A 175 TMVGTPYWMAPEVV 188 (297)
T ss_dssp CCCSCGGGCCHHHH
T ss_pred CccCCcCccChhhh
Confidence 34699999999963
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=2.6e-20 Score=199.38 Aligned_cols=162 Identities=28% Similarity=0.437 Sum_probs=129.0
Q ss_pred cccccchhHHHHHhhccccc------ceEecCCceEEEEEEecCCcEEEEEEEccc----chHHHHHHHHHHHHHHhcCC
Q 047196 661 TLRRFSYQDLFRATEKFSKE------NLIGVGSFGSVYKGRLHDGIEVAIKVFHQN----CAMALKSFEAECEVMKNIRH 730 (827)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~~------~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~----~~~~~~~~~~Ei~~l~~l~H 730 (827)
..+.+++.++..++.+|... +.||+|+||.||+|+. +++.||||++... .....+.+.+|++++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34678999999999999888 8999999999999987 5789999998643 23345789999999999999
Q ss_pred CCceEEEeeeecCCceeeeeecc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-
Q 047196 731 RNHVKRISSCSNEDFKALDCLHS-------------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF- 796 (827)
Q Consensus 731 ~niv~~~~~~~~~~~~~l~~l~~-------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl- 796 (827)
|||+++++++...+..++...+. ....+++..+..++.++++||+||| +.+|+||||||+||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEE
Confidence 99999999998766444322221 1234778888999999999999996 568999999999998
Q ss_pred ---------eecccccccCCCccc-cccceeccccccccc
Q 047196 797 ---------DFGIGRLLTGDRSMI-QTETLVTIGYMAPGL 826 (827)
Q Consensus 797 ---------DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~ 826 (827)
|||+++......... .....||++|+|||+
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 206 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA 206 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHH
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHH
Confidence 999998765433221 222458999999996
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.83 E-value=1.6e-20 Score=203.40 Aligned_cols=149 Identities=26% Similarity=0.296 Sum_probs=118.2
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
++|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++...+..++..
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57889999999999999999865 68999999996532 223467889999999999999999999998877655433
Q ss_pred eccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 751 LHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 751 l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
.+... ..++......++.+++.||+||| +.+|+||||||+||+ |||+++........
T Consensus 85 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 161 (337)
T 1o6l_A 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence 33222 34566777889999999999996 568999999999998 99999864333222
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
....+||+.|||||++
T Consensus 162 -~~~~~gt~~y~aPE~~ 177 (337)
T 1o6l_A 162 -MKTFCGTPEYLAPEVL 177 (337)
T ss_dssp -BCCCEECGGGCCGGGG
T ss_pred -ccccccChhhCChhhh
Confidence 2335699999999974
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=5.3e-21 Score=205.27 Aligned_cols=148 Identities=28% Similarity=0.310 Sum_probs=113.8
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEccc--chHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN--CAMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~l~~ 750 (827)
++|+..++||+|+||+||+|+.. +|+.||||++... ......++.+|+..+.++ +|+|+|+++++|.+....++..
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999875 7999999998643 233344566677666665 8999999999998877655433
Q ss_pred eccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 751 LHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 751 l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
.+.. ...+++..+..++.+++.||+||| +.+|+||||||+||| |||+++.......
T Consensus 137 e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~- 212 (311)
T 3p1a_A 137 ELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA- 212 (311)
T ss_dssp ECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred eccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCC-
Confidence 3221 235788889999999999999996 467999999999998 9999887643322
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
.....||++|+|||++
T Consensus 213 -~~~~~gt~~y~aPE~~ 228 (311)
T 3p1a_A 213 -GEVQEGDPRYMAPELL 228 (311)
T ss_dssp ---CCCCCGGGCCGGGG
T ss_pred -CcccCCCccccCHhHh
Confidence 2334589999999974
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.83 E-value=5.5e-20 Score=200.74 Aligned_cols=106 Identities=17% Similarity=0.194 Sum_probs=62.6
Q ss_pred cEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEeecccCcccCchhhhcCCCccEEEecCC
Q 047196 222 QLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDN 301 (827)
Q Consensus 222 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n 301 (827)
+.++.++++++ .+|..+ .+++++|+|++|+|+...+.+|.++++|++|+|++|++.+.+|
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~----------------- 71 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIE----------------- 71 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEEC-----------------
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccC-----------------
Confidence 35566666665 445444 2456666666666664433456666666666666666554443
Q ss_pred ccccccChhhhcCCCCccE-EeCcCCccccccCccccCCCCCcEEEcCCCccee
Q 047196 302 SLLGSFSLGIDLSLPNVER-LNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSG 354 (827)
Q Consensus 302 ~l~~~~~~~~~~~l~~L~~-L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g 354 (827)
...+..++++++ +.++.|+++...|..|..+++|++|++++|++++
T Consensus 72 -------~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~ 118 (350)
T 4ay9_X 72 -------ADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH 118 (350)
T ss_dssp -------TTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSS
T ss_pred -------hhHhhcchhhhhhhcccCCcccccCchhhhhcccccccccccccccc
Confidence 322234455443 4556677777667777777777777777776654
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.83 E-value=5.3e-22 Score=236.61 Aligned_cols=258 Identities=18% Similarity=0.224 Sum_probs=90.1
Q ss_pred CCHHHHHHHHHHHhhcCCCCCCcCCCCCCCCCCCCcccceecCCCCCcEEEEEcCCCCCccccCccccCCCCCCEEECCC
Q 047196 52 NITTDQQALLALKAHISYDPTNLLAQNSTSNTSVCNWIGITCNVNSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSH 131 (827)
Q Consensus 52 ~~~~~~~aLl~~k~~~~~~~~~~l~~w~~~~~~~C~W~gv~C~~~~~~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~ 131 (827)
..+.++++|+++...........-..|....+..+.|.++.++. .+++.|+|..+++... +.. .|+.++|+.
T Consensus 129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~~-~~~-----~l~~l~Ls~ 200 (727)
T 4b8c_D 129 LVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST--PLTPKIELFANGKDEA-NQA-----LLQHKKLSQ 200 (727)
T ss_dssp ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred ccccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC--CccceEEeeCCCCCcc-hhh-----HhhcCccCc
Confidence 45678899999988763333333345654455678899998875 6899999999988763 332 334455555
Q ss_pred CCCCc---------cCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcCCCCCCCCcchhHhhccccccEEEe
Q 047196 132 NKLSG---------DIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFL 202 (827)
Q Consensus 132 N~l~g---------~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~~L~L 202 (827)
|.|.+ ..|..+..+++|++|||++|.+. .+|..+++++ +|++|+|
T Consensus 201 ~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~-------------------------~L~~L~L 254 (727)
T 4b8c_D 201 YSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYD-------------------------FLTRLYL 254 (727)
T ss_dssp ---------------------CCCCCCEEECTTSCCS-CCCGGGGGCC-------------------------SCSCCBC
T ss_pred ccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCC-------------------------CCCEEEe
Confidence 54442 34556666777777777777765 3444444444 4555555
Q ss_pred ecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEeecccCccc
Q 047196 203 AKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGV 282 (827)
Q Consensus 203 s~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 282 (827)
++|.++ .+|..|+++++|++|+|++|.|+ .+|..|++|++|++|+|++|.|+ .+|..|+.+++|++|+|++|.+++.
T Consensus 255 s~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~ 331 (727)
T 4b8c_D 255 NGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQ 331 (727)
T ss_dssp TTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSH
T ss_pred eCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCC
Confidence 555554 45555555555555555555555 44555555555666666665554 4555555566666666666666555
Q ss_pred CchhhhcCCC-ccEEEecCCccccccChhhhcCCCCccEEeCcCC--------ccccccCccccCCCCCcEEEcCCCcce
Q 047196 283 VPAAIFNMST-VKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLN--------RFSGTIPSFITNASKLVYLDMGTNSFS 353 (827)
Q Consensus 283 ~p~~~~~l~~-L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N--------~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 353 (827)
+|..+..+.. +..+++++|.+.|.+|. .|+.|+++.| .+.+..+..+.++.++....+++|-+.
T Consensus 332 ~p~~~~~~~~~~~~l~l~~N~l~~~~p~-------~l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~ 404 (727)
T 4b8c_D 332 FLKILTEKSVTGLIFYLRDNRPEIPLPH-------ERRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLC 404 (727)
T ss_dssp HHHHHHHHHHHHHHHHHHHCCCCCCCCC-------C-----------------------------------------CCC
T ss_pred ChHHHhhcchhhhHHhhccCcccCcCcc-------ccceeEeecccccccccCCccccccchhhcccccceeeeeccccc
Confidence 5555543321 12244555555544442 2334444444 233333344445555555566666554
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.83 E-value=2e-20 Score=205.14 Aligned_cols=150 Identities=24% Similarity=0.404 Sum_probs=120.2
Q ss_pred HhhcccccceEecCCceEEEEEEec-CCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeee
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALD 749 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~ 749 (827)
..++|...+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|++++++++|||||++++++.+.+..++.
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3467999999999999999999865 6899999999653 234457799999999999999999999999887765543
Q ss_pred eeccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------eecccccccC
Q 047196 750 CLHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------DFGIGRLLTG 806 (827)
Q Consensus 750 ~l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------------DFGla~~~~~ 806 (827)
..+.. ...+++.+...++.++++||+||| +.+|+||||||+||+ |||+++....
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 33221 234677888899999999999996 568999999999998 9999987653
Q ss_pred CCccccccceecccccccccC
Q 047196 807 DRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 807 ~~~~~~~~~~gt~~Y~APE~l 827 (827)
... ....+||++|+|||++
T Consensus 184 ~~~--~~~~~gt~~y~aPE~~ 202 (362)
T 2bdw_A 184 SEA--WHGFAGTPGYLSPEVL 202 (362)
T ss_dssp CCS--CCCSCSCTTTCCHHHH
T ss_pred Ccc--cccCCCCccccCHHHH
Confidence 322 2234699999999973
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.83 E-value=2.1e-20 Score=198.62 Aligned_cols=149 Identities=26% Similarity=0.359 Sum_probs=119.1
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l 751 (827)
++|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++..+...++...
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888899999999999999875 68999999996432 3345678899999999999999999999988775544322
Q ss_pred cc----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 752 HS----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 752 ~~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
+. ....+++.....++.++++||+||| +.+|+||||||+||+ |||+|+........
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 157 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC- 157 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC-
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc-
Confidence 21 1346778888999999999999996 568999999999998 99999876533222
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
.....||+.|+|||++
T Consensus 158 ~~~~~~t~~y~aPE~~ 173 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVL 173 (292)
T ss_dssp CCSCCSCGGGCCHHHH
T ss_pred ccCCccccCCcChHHH
Confidence 2334589999999963
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.83 E-value=1.9e-20 Score=206.01 Aligned_cols=150 Identities=26% Similarity=0.443 Sum_probs=116.2
Q ss_pred hcccccceEecCCceEEEEEEec--------CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCC
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH--------DGIEVAIKVFHQNC-AMALKSFEAECEVMKNI-RHRNHVKRISSCSNED 744 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~ 744 (827)
++|...+.||+|+||.||+|+.. ++..||||++.... ....+++.+|+++++++ +|||||+++++|...+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 57888899999999999999852 35679999997543 34567899999999999 8999999999998766
Q ss_pred ceeeeeeccCC--------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee--
Q 047196 745 FKALDCLHSTN--------------------------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-- 796 (827)
Q Consensus 745 ~~~l~~l~~~~--------------------------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-- 796 (827)
..++...+... ..+.+.+...++.++++||+||| +.+|+||||||+||+
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEEC
Confidence 54442222111 23577788899999999999996 568999999999998
Q ss_pred --------eecccccccCCCccc-cccceecccccccccC
Q 047196 797 --------DFGIGRLLTGDRSMI-QTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 --------DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l 827 (827)
|||+|+......... .....+|+.|||||++
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~ 277 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 277 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHH
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHh
Confidence 999998765433221 1223478999999963
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.82 E-value=1.8e-20 Score=204.67 Aligned_cols=149 Identities=20% Similarity=0.312 Sum_probs=117.4
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccch-----HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA-----MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-----~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l 748 (827)
+.|+..+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++|||||++++++...+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 56888999999999999999864 689999999864321 135679999999999999999999999988775544
Q ss_pred eeeccCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------eeccc
Q 047196 749 DCLHSTN--------------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------DFGIG 801 (827)
Q Consensus 749 ~~l~~~~--------------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------------DFGla 801 (827)
...+... ..+++.....++.++++||+||| +.+|+||||||+||+ |||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 3332221 13566777889999999999996 568999999999998 99999
Q ss_pred ccccCCCccccccceecccccccccC
Q 047196 802 RLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 802 ~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
+........ ....+||+.|+|||++
T Consensus 181 ~~~~~~~~~-~~~~~gt~~y~aPE~~ 205 (351)
T 3c0i_A 181 IQLGESGLV-AGGRVGTPHFMAPEVV 205 (351)
T ss_dssp EECCTTSCB-CCCCCSCGGGCCHHHH
T ss_pred eEecCCCee-ecCCcCCcCccCHHHH
Confidence 876543321 2335699999999973
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.3e-20 Score=201.90 Aligned_cols=151 Identities=26% Similarity=0.375 Sum_probs=112.1
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc------
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF------ 745 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~------ 745 (827)
.++|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467889999999999999999975 79999999997533 3355789999999999999999999998855321
Q ss_pred ---------------------------------------------------ee--eeeeccC-----------CCCCCHH
Q 047196 746 ---------------------------------------------------KA--LDCLHST-----------NCSLNIF 761 (827)
Q Consensus 746 ---------------------------------------------------~~--l~~l~~~-----------~~~l~~~ 761 (827)
.+ +++.... .....+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 11 2222111 0123344
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc-----------cccccceeccc
Q 047196 762 DKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS-----------MIQTETLVTIG 820 (827)
Q Consensus 762 ~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~-----------~~~~~~~gt~~ 820 (827)
....++.|+++||+||| +.+|+||||||+||+ |||+++....... ......+||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 56789999999999996 568999999999998 9999987754321 11123458999
Q ss_pred ccccccC
Q 047196 821 YMAPGLL 827 (827)
Q Consensus 821 Y~APE~l 827 (827)
|+|||++
T Consensus 242 y~aPE~~ 248 (332)
T 3qd2_B 242 YMSPEQI 248 (332)
T ss_dssp GSCHHHH
T ss_pred ccChHHh
Confidence 9999963
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.8e-20 Score=204.79 Aligned_cols=148 Identities=25% Similarity=0.335 Sum_probs=118.8
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++......++..
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 57888999999999999999865 58999999986532 123467889999999999999999999998877554432
Q ss_pred ecc----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 751 LHS----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 751 l~~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
.+. ....+++.....++.+++.||+||| +.+|+||||||+||+ |||+|+.......
T Consensus 95 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~- 170 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ- 170 (384)
T ss_dssp CCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC-
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCc-
Confidence 222 1235677788899999999999996 568999999999998 9999987654332
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
....+||++|+|||++
T Consensus 171 -~~~~~gt~~Y~aPE~~ 186 (384)
T 4fr4_A 171 -ITTMAGTKPYMAPEMF 186 (384)
T ss_dssp -BCCCCSCGGGCCGGGT
T ss_pred -eeccCCCccccCCeee
Confidence 2345699999999975
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=2.2e-20 Score=201.48 Aligned_cols=152 Identities=25% Similarity=0.302 Sum_probs=117.8
Q ss_pred hhcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc------ee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF------KA 747 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~------~~ 747 (827)
..+|+..++||+|+||.||+|+.. ++.||||++.... .....+++|+.++++++|||||++++++..... .+
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 357888999999999999999876 7899999996543 234456779999999999999999999977542 23
Q ss_pred eeeeccC-------CCCCCHHHHHHHHHHHHHHHHHHHhc-------CCCCeEEccCCCccee----------eeccccc
Q 047196 748 LDCLHST-------NCSLNIFDKLNIMIDVASALEYLHFS-------HSTPVIHCDLKPKNVF----------DFGIGRL 803 (827)
Q Consensus 748 l~~l~~~-------~~~l~~~~~~~i~~~ia~~L~~Lh~~-------h~~~iiHrDlK~~NIl----------DFGla~~ 803 (827)
+++.... ...+++.....++.++++||+|||.. |+++|+||||||+||+ |||+|+.
T Consensus 101 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~ 180 (322)
T 3soc_A 101 TAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180 (322)
T ss_dssp EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccc
Confidence 3333221 13477888899999999999999643 3459999999999998 9999987
Q ss_pred ccCCCccc-cccceecccccccccC
Q 047196 804 LTGDRSMI-QTETLVTIGYMAPGLL 827 (827)
Q Consensus 804 ~~~~~~~~-~~~~~gt~~Y~APE~l 827 (827)
........ .....||+.|+|||++
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~aPE~~ 205 (322)
T 3soc_A 181 FEAGKSAGDTHGQVGTRRYMAPEVL 205 (322)
T ss_dssp ECTTSCCCCCTTCCCCGGGCCHHHH
T ss_pred cccccCccccccCccCccccCHhhc
Confidence 75443322 2234589999999963
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=3e-20 Score=205.86 Aligned_cols=150 Identities=19% Similarity=0.322 Sum_probs=117.1
Q ss_pred hcccccceEecCCceEEEEEEecCCcEEEEEEEccc--chHHHHHHHHHHHHHHhcC--CCCceEEEeeeecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQN--CAMALKSFEAECEVMKNIR--HRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~--H~niv~~~~~~~~~~~~~l~~ 750 (827)
+.|...+.||+|+||.||+|...+++.||||++... .....+.+.+|++++++++ |+|||++++++..++..++..
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458889999999999999999878999999998643 3445678999999999997 499999999998877655433
Q ss_pred ecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------eecccccccCCCcc-c
Q 047196 751 LHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---------DFGIGRLLTGDRSM-I 811 (827)
Q Consensus 751 l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---------DFGla~~~~~~~~~-~ 811 (827)
... ....+++.++..++.++++||+||| +.+|+||||||+||| |||+|+.+...... .
T Consensus 136 E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~kl~DFG~a~~~~~~~~~~~ 212 (390)
T 2zmd_A 136 ECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVV 212 (390)
T ss_dssp ECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEESSSCEEECCCSSSCCC--------
T ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEECCeEEEEecCccccccCCCcccc
Confidence 221 1235677788899999999999995 678999999999998 99999876543322 1
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
....+||++|||||++
T Consensus 213 ~~~~~gt~~y~aPE~~ 228 (390)
T 2zmd_A 213 KDSQVGAVNYMPPEAI 228 (390)
T ss_dssp -CCSCCCGGGCCHHHH
T ss_pred CCCCCcCCCccChHHh
Confidence 2335699999999973
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=4e-20 Score=197.08 Aligned_cols=149 Identities=27% Similarity=0.420 Sum_probs=113.2
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccch--------------------------HHHHHHHHHHHHHHh
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA--------------------------MALKSFEAECEVMKN 727 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--------------------------~~~~~~~~Ei~~l~~ 727 (827)
++|...+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 57888999999999999999864 689999999864321 113568999999999
Q ss_pred cCCCCceEEEeeeecC--Cceee--eeecc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee
Q 047196 728 IRHRNHVKRISSCSNE--DFKAL--DCLHS-------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF 796 (827)
Q Consensus 728 l~H~niv~~~~~~~~~--~~~~l--~~l~~-------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl 796 (827)
++|||||++++++... ...++ ++... ....+++.+...++.++++||+||| +.+|+||||||+||+
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLL 169 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEE
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEE
Confidence 9999999999998763 33333 33221 1235678888999999999999996 568999999999998
Q ss_pred ----------eecccccccCCCccccccceecccccccccC
Q 047196 797 ----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 ----------DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
|||+++........ .....||+.|+|||++
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~ 209 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGSDAL-LSNTVGTPAFMAPESL 209 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSSSCE-ECCCCSCGGGCCGGGC
T ss_pred ECCCCCEEEecCCCcccccccccc-ccCCcCCccccChhhh
Confidence 99999876543322 2334689999999974
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.9e-20 Score=202.24 Aligned_cols=150 Identities=25% Similarity=0.464 Sum_probs=115.0
Q ss_pred hcccccceEecCCceEEEEEEec----CCcEEEEEEEccc-chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee-
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH----DGIEVAIKVFHQN-CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL- 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~----~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l- 748 (827)
++|...+.||+|+||.||+|+.. .+..||||++... .....+.|.+|++++++++|||||++++++......++
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 46788899999999999999874 3456999999764 34456789999999999999999999999987654443
Q ss_pred -eeecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 749 -DCLHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 749 -~~l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
+++.. ....+++.+...++.++++||+||| +.+|+||||||+||+ |||+++......
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 33321 2245778889999999999999996 568999999999998 999998775433
Q ss_pred ccc--cccceecccccccccC
Q 047196 809 SMI--QTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~--~~~~~gt~~Y~APE~l 827 (827)
... .....+|++|+|||++
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~ 226 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAI 226 (325)
T ss_dssp -CCEECC---CCGGGSCHHHH
T ss_pred cceeeccCCCCcccccCHhHh
Confidence 221 1222368899999963
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.5e-20 Score=212.82 Aligned_cols=149 Identities=24% Similarity=0.338 Sum_probs=112.7
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC------
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNED------ 744 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~------ 744 (827)
.++|+..+.||+|+||+||+|+.. +|+.||||++... .....+++.+|+++++.++|||||++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467889999999999999999864 6899999999754 3344578899999999999999999999986543
Q ss_pred --ceeeeeeccC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCC
Q 047196 745 --FKALDCLHST-----NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGD 807 (827)
Q Consensus 745 --~~~l~~l~~~-----~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~ 807 (827)
+.+++++... ...+++.+...++.|+++||+||| +.+|+||||||+||| |||+|+.....
T Consensus 141 ~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 217 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217 (464)
T ss_dssp EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC-----C
T ss_pred eEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC
Confidence 2233333221 234777888899999999999996 568999999999998 99999876543
Q ss_pred CccccccceecccccccccC
Q 047196 808 RSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 808 ~~~~~~~~~gt~~Y~APE~l 827 (827)
.. .+..+||++|+|||++
T Consensus 218 ~~--~~~~~gt~~y~aPE~~ 235 (464)
T 3ttj_A 218 FM--MTPYVVTRYYRAPEVI 235 (464)
T ss_dssp CC--C----CCCTTCCHHHH
T ss_pred cc--cCCCcccccccCHHHH
Confidence 22 2345699999999974
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.82 E-value=9.5e-21 Score=200.89 Aligned_cols=149 Identities=28% Similarity=0.406 Sum_probs=115.6
Q ss_pred hcccccceEecCCceEEEEEEecCCcEEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCA--MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
++|+..+.||+|+||.||+|+..+|+.||||++..... ...+.+.+|++++++++|||||++++++...+..++...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46888899999999999999988899999999865432 2246788999999999999999999999877654442222
Q ss_pred c----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 753 S----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 753 ~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
. ....+++.....++.++++||+||| +.+|+||||||+||+ |||+++........ .
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~ 157 (288)
T 1ob3_A 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-Y 157 (288)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred cCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccc-c
Confidence 1 2245778888899999999999996 568999999999998 99999876433221 2
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
....||+.|+|||++
T Consensus 158 ~~~~~t~~y~aPE~~ 172 (288)
T 1ob3_A 158 THEIVTLWYRAPDVL 172 (288)
T ss_dssp ----CCCTTCCHHHH
T ss_pred ccccccccccCchhe
Confidence 234589999999963
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.9e-20 Score=212.35 Aligned_cols=150 Identities=27% Similarity=0.392 Sum_probs=105.6
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC-----c
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNED-----F 745 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~-----~ 745 (827)
.++|+..++||+|+||+||+|+.. +|+.||||++... .....+++.+|++++++++|||||++++++.... .
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367999999999999999999864 6899999998653 3345578999999999999999999999985432 1
Q ss_pred ee--eeeecc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccC
Q 047196 746 KA--LDCLHS-------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806 (827)
Q Consensus 746 ~~--l~~l~~-------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~ 806 (827)
.+ +++... ....+++.....++.++++||+||| +.+|+||||||+||| |||+|+....
T Consensus 132 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 132 LYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp EEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred EEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 22 222211 1235778888899999999999996 568999999999998 9999987643
Q ss_pred CCc--------------------------cccccceeccccccccc
Q 047196 807 DRS--------------------------MIQTETLVTIGYMAPGL 826 (827)
Q Consensus 807 ~~~--------------------------~~~~~~~gt~~Y~APE~ 826 (827)
... ...+..+||++|||||+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~ 254 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPEL 254 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHH
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHH
Confidence 211 01233468999999996
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.5e-20 Score=202.91 Aligned_cols=150 Identities=19% Similarity=0.329 Sum_probs=116.7
Q ss_pred hcccccceEecCCceEEEEEEecCCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCC--CCceEEEeeeecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRH--RNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H--~niv~~~~~~~~~~~~~l~~ 750 (827)
+.|+..+.||+|+||.||+|...+++.||||++... .....+.+.+|++++++++| +|||++++++......++..
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 568889999999999999999888999999998643 34455789999999999987 99999999998877555433
Q ss_pred ecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------eecccccccCCCcc-c
Q 047196 751 LHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---------DFGIGRLLTGDRSM-I 811 (827)
Q Consensus 751 l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---------DFGla~~~~~~~~~-~ 811 (827)
... ....+++.++..++.++++||+||| +.+|+||||||+||| |||+|+........ .
T Consensus 89 e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~~~~~kl~DFG~a~~~~~~~~~~~ 165 (343)
T 3dbq_A 89 ECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVV 165 (343)
T ss_dssp CCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTEEEECCCSSSCCC--------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEECCcEEEeecccccccCccccccc
Confidence 221 1235678888999999999999996 568999999999998 99999877544322 1
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
....+||++|+|||++
T Consensus 166 ~~~~~gt~~y~aPE~~ 181 (343)
T 3dbq_A 166 KDSQVGTVNYMPPEAI 181 (343)
T ss_dssp ----CCCCSSCCHHHH
T ss_pred CCCCcCCcCcCCHHHH
Confidence 2334699999999973
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.7e-20 Score=197.99 Aligned_cols=149 Identities=26% Similarity=0.378 Sum_probs=113.6
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEccc---chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN---CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
++|+..+.||+|+||.||+|+.. +++.||||++... .....++|.+|++++++++|||||++++++...+..++..
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 56888999999999999999864 6899999998532 2345678999999999999999999999998877554433
Q ss_pred eccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 751 LHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 751 l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
.+.. ...+++.....++.++++||+||| +.+|+||||||+||+ |||+++........
T Consensus 91 e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 3222 134677888899999999999996 568999999999998 99999876543322
Q ss_pred ccccceeccccccccc
Q 047196 811 IQTETLVTIGYMAPGL 826 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~ 826 (827)
......||+.|+|||+
T Consensus 168 ~~~~~~gt~~y~aPE~ 183 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQ 183 (294)
T ss_dssp -------CCSSCCHHH
T ss_pred ccCccccCccccCHhH
Confidence 2233458999999996
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.5e-20 Score=203.34 Aligned_cols=150 Identities=23% Similarity=0.272 Sum_probs=114.5
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCceee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFKAL 748 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~l 748 (827)
.++|+..++||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|+++++.+ +|||||++++++...+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 467999999999999999999865 68999999997542 22345688999999998 69999999999988776554
Q ss_pred eeeccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 749 DCLHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 749 ~~l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
...+... ..+++.....++.+++.||+||| +.+|+||||||+||| |||+|+......
T Consensus 102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence 3333221 34677778889999999999996 568999999999998 999998643322
Q ss_pred ccccccceecccccccccC
Q 047196 809 SMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~~~~~~gt~~Y~APE~l 827 (827)
.. ....+||+.|||||++
T Consensus 179 ~~-~~~~~gt~~y~aPE~~ 196 (353)
T 3txo_A 179 VT-TATFCGTPDYIAPEIL 196 (353)
T ss_dssp --------CCGGGCCHHHH
T ss_pred cc-ccccCCCcCeEChhhc
Confidence 21 2335699999999973
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.7e-20 Score=205.60 Aligned_cols=150 Identities=23% Similarity=0.236 Sum_probs=116.9
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCceee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFKAL 748 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~l 748 (827)
.++|+..++||+|+||+||+|+.+ +++.||||++.... ....+.+.+|..+++++ +|||||++++++...+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 367899999999999999999875 58899999997542 22345688999999887 89999999999988775554
Q ss_pred eeeccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 749 DCLHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 749 ~~l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
...+... ..+++.....++.+++.||+||| +.+|+||||||+||| |||+|+......
T Consensus 131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence 3333222 34677778889999999999996 568999999999998 999998643322
Q ss_pred ccccccceecccccccccC
Q 047196 809 SMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~~~~~~gt~~Y~APE~l 827 (827)
.. ....+||+.|||||++
T Consensus 208 ~~-~~~~~gt~~Y~aPE~l 225 (396)
T 4dc2_A 208 DT-TSTFCGTPNYIAPEIL 225 (396)
T ss_dssp CC-BCCCCBCGGGCCHHHH
T ss_pred Cc-cccccCCcccCCchhh
Confidence 22 2345699999999974
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.82 E-value=2.7e-20 Score=205.53 Aligned_cols=149 Identities=19% Similarity=0.331 Sum_probs=120.6
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
.+.|+..+.||+|+||.||+|+.. +|+.||+|++..........+.+|++++++++|||||++++++.+....++...+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 357888999999999999999865 6899999999766555566899999999999999999999999877655443222
Q ss_pred c-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee------------eecccccccCCCc
Q 047196 753 S-----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------------DFGIGRLLTGDRS 809 (827)
Q Consensus 753 ~-----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------------DFGla~~~~~~~~ 809 (827)
. ....+++.+...++.++++||+||| +.+|+||||||+||+ |||+|+.......
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 1 1235678888999999999999996 568999999999998 9999987654332
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
. ....||++|+|||++
T Consensus 207 ~--~~~~gt~~y~aPE~~ 222 (387)
T 1kob_A 207 V--KVTTATAEFAAPEIV 222 (387)
T ss_dssp E--EEECSSGGGCCHHHH
T ss_pred e--eeeccCCCccCchhc
Confidence 1 234589999999973
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.5e-20 Score=206.76 Aligned_cols=146 Identities=23% Similarity=0.394 Sum_probs=112.7
Q ss_pred ccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeeccC-
Q 047196 677 FSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHST- 754 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~- 754 (827)
+...+.||+|+||.||+|+. .+|+.||||++........+++.+|++++++++|||||++++++...+..++...+..
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 44467899999999999986 4689999999987665667789999999999999999999999988775554333221
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee------------eecccccccCCCcccc
Q 047196 755 ----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 755 ----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------------DFGla~~~~~~~~~~~ 812 (827)
...+++.+...++.++++||+||| +.+|+||||||+||| |||+++....... .
T Consensus 171 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~ 245 (373)
T 2x4f_A 171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--L 245 (373)
T ss_dssp CEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--C
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--c
Confidence 234677788899999999999996 568999999999997 9999987654332 1
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
...+||++|+|||++
T Consensus 246 ~~~~gt~~y~aPE~~ 260 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVV 260 (373)
T ss_dssp CCCCSSCTTCCHHHH
T ss_pred ccccCCCcEeChhhc
Confidence 234599999999963
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.6e-20 Score=197.02 Aligned_cols=148 Identities=26% Similarity=0.408 Sum_probs=117.4
Q ss_pred hcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee--eeec
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL--DCLH 752 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l--~~l~ 752 (827)
++|+..+.||+|+||.||+|+..+++.||||++..... ..+++.+|++++++++||||+++++++.+....++ ++..
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 56888899999999999999988888999999975432 24578999999999999999999999987765443 3322
Q ss_pred c---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccc
Q 047196 753 S---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQT 813 (827)
Q Consensus 753 ~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~ 813 (827)
. ....+++.....++.++++|++||| +.+|+||||||+||+ |||+++...........
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (269)
T 4hcu_A 89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 165 (269)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccccccccccccccccc
Confidence 1 1234678888899999999999996 567999999999998 99999876443222223
Q ss_pred cceeccccccccc
Q 047196 814 ETLVTIGYMAPGL 826 (827)
Q Consensus 814 ~~~gt~~Y~APE~ 826 (827)
...+|+.|+|||+
T Consensus 166 ~~~~~~~y~aPE~ 178 (269)
T 4hcu_A 166 GTKFPVKWASPEV 178 (269)
T ss_dssp STTCCGGGCCHHH
T ss_pred CcccccccCCHHH
Confidence 3347889999996
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=3.3e-20 Score=202.89 Aligned_cols=149 Identities=22% Similarity=0.356 Sum_probs=118.8
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchH------HHHHHHHHHHHHHhcCCCCceEEEeeeecCCce
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAM------ALKSFEAECEVMKNIRHRNHVKRISSCSNEDFK 746 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~------~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~ 746 (827)
.+.|...+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|++++++++|||||++++++......
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 356888999999999999999865 6899999999754321 246789999999999999999999999887755
Q ss_pred eeeeeccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee--------------eecccc
Q 047196 747 ALDCLHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF--------------DFGIGR 802 (827)
Q Consensus 747 ~l~~l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl--------------DFGla~ 802 (827)
++...+.. ...+++.+...++.+++.||+||| +.+|+||||||+||+ |||+++
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 54333221 235678888999999999999996 568999999999987 899998
Q ss_pred cccCCCccccccceecccccccccC
Q 047196 803 LLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 803 ~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
....... ....+||++|+|||++
T Consensus 168 ~~~~~~~--~~~~~gt~~y~aPE~~ 190 (361)
T 2yab_A 168 EIEDGVE--FKNIFGTPEFVAPEIV 190 (361)
T ss_dssp ECCTTCC--CCCCCSCGGGCCHHHH
T ss_pred EcCCCCc--cccCCCCccEECchHH
Confidence 7654322 2334699999999973
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=4.6e-20 Score=193.30 Aligned_cols=150 Identities=25% Similarity=0.385 Sum_probs=119.0
Q ss_pred hhcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
.++|+..+.||+|+||.||+|+.+++..||||++..... ..+++.+|++++++++||||+++++++......++...+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 357888899999999999999988888999999975432 3467899999999999999999999998776544432222
Q ss_pred C-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 754 T-----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 754 ~-----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
. ...+++.+...++.++++|++||| +.+|+||||||+||+ |||+++..........
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 162 (268)
T 3sxs_A 86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS 162 (268)
T ss_dssp TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEEC
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcc
Confidence 1 124677888899999999999996 568999999999998 9999987655433322
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
....+|+.|+|||++
T Consensus 163 ~~~~~~~~y~aPE~~ 177 (268)
T 3sxs_A 163 VGTKFPVKWSAPEVF 177 (268)
T ss_dssp CSCCCCGGGCCHHHH
T ss_pred cCCCcCcccCCHHHH
Confidence 333467889999963
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=3.3e-20 Score=200.16 Aligned_cols=150 Identities=23% Similarity=0.333 Sum_probs=116.9
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA-MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
++|+..+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+++++.++|||||++++++.+++..++...+
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 57889999999999999999865 789999999865432 2346789999999999999999999999887755442222
Q ss_pred c----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc-c
Q 047196 753 S----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM-I 811 (827)
Q Consensus 753 ~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~-~ 811 (827)
. ....+++.+...++.++++||+||| +.+|+||||||+||+ |||+++.+...... .
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 163 (323)
T 3tki_A 87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (323)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred CCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence 1 1235778889999999999999996 578999999999998 99999876433221 1
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
....+||+.|+|||++
T Consensus 164 ~~~~~gt~~y~aPE~~ 179 (323)
T 3tki_A 164 LNKMCGTLPYVAPELL 179 (323)
T ss_dssp BCSCCSCGGGSCHHHH
T ss_pred cCCCccCcCccCcHHh
Confidence 2334699999999973
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=5e-20 Score=206.93 Aligned_cols=151 Identities=25% Similarity=0.310 Sum_probs=118.8
Q ss_pred HhhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeee
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALD 749 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~ 749 (827)
..++|+..+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|++++++++|||||++++++.+++..++.
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 356799999999999999999986 478999999986543 33456799999999999999999999999887765543
Q ss_pred eeccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------eecccccccC
Q 047196 750 CLHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------DFGIGRLLTG 806 (827)
Q Consensus 750 ~l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------------DFGla~~~~~ 806 (827)
..+.. ...+++.+...++.++++|++||| +.+|+||||||+||+ |||+|+....
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 33222 234677788899999999999996 568999999999998 9999987654
Q ss_pred CCccccccceecccccccccC
Q 047196 807 DRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 807 ~~~~~~~~~~gt~~Y~APE~l 827 (827)
.... ....+||++|||||++
T Consensus 166 ~~~~-~~~~~gt~~Y~APE~l 185 (444)
T 3soa_A 166 EQQA-WFGFAGTPGYLSPEVL 185 (444)
T ss_dssp TCCB-CCCSCSCGGGCCHHHH
T ss_pred CCce-eecccCCcccCCHHHh
Confidence 4322 2335699999999973
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.82 E-value=4e-20 Score=199.20 Aligned_cols=148 Identities=22% Similarity=0.279 Sum_probs=118.5
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
.++|...+.||+|+||.||+|+.. +|+.||+|++.... ...+.+.+|+++++.++|||||++++++.+.+..++...+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 357888999999999999999865 68999999987543 3446789999999999999999999999887655443222
Q ss_pred c-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee------------eecccccccCCCc
Q 047196 753 S-----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------------DFGIGRLLTGDRS 809 (827)
Q Consensus 753 ~-----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------------DFGla~~~~~~~~ 809 (827)
. ....+++.+...++.++++|++||| +.+|+||||||+||+ |||+++.......
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence 1 1234778888999999999999996 568999999999998 9999987654332
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
.....||++|+|||++
T Consensus 160 --~~~~~gt~~y~aPE~~ 175 (321)
T 1tki_A 160 --FRLLFTAPEYYAPEVH 175 (321)
T ss_dssp --EEEEESCGGGSCHHHH
T ss_pred --cccccCChhhcCcHHh
Confidence 2234589999999963
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.81 E-value=1.4e-20 Score=207.23 Aligned_cols=150 Identities=25% Similarity=0.493 Sum_probs=106.9
Q ss_pred hcccccceEecCCceEEEEEEec----CCcEEEEEEEccc-chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee-
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH----DGIEVAIKVFHQN-CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL- 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~----~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l- 748 (827)
.+|+..+.||+|+||.||+|+.. ++..||||++... .....++|.+|++++++++|||||++++++......++
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 46888899999999999999864 5778999999754 34456789999999999999999999999987665444
Q ss_pred -eeecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 749 -DCLHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 749 -~~l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
+++.. ....+++.+...++.++++||+||| +.+|+||||||+||+ |||+++......
T Consensus 125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 33321 1235778889999999999999996 568999999999998 999998775443
Q ss_pred ccccc--cceecccccccccC
Q 047196 809 SMIQT--ETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~~~--~~~gt~~Y~APE~l 827 (827)
..... ...+|++|+|||++
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~ 222 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAI 222 (373)
T ss_dssp ------------CTTSCHHHH
T ss_pred ccceeccCCCcCCCccChhhh
Confidence 22111 12257889999963
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=6.6e-20 Score=199.48 Aligned_cols=149 Identities=24% Similarity=0.238 Sum_probs=117.7
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEccc---chHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCceeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN---CAMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFKALD 749 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~l~ 749 (827)
++|+..+.||+|+||.||+|+.+ +|+.||||++... .....+.+.+|+++++++ +|||||++++++......++.
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57888999999999999999875 6899999999753 233456788999999998 899999999999887655543
Q ss_pred eeccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 750 CLHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 750 ~l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
..+... ..+++.....++.+++.||+||| +.+|+||||||+||+ |||+|+.......
T Consensus 89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~ 165 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165 (345)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence 333221 34667778889999999999996 568999999999998 9999986432222
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
. ....+||+.|+|||++
T Consensus 166 ~-~~~~~gt~~y~aPE~~ 182 (345)
T 3a8x_A 166 T-TSTFCGTPNYIAPEIL 182 (345)
T ss_dssp C-BCCCCSCGGGCCHHHH
T ss_pred c-ccccCCCccccCcccc
Confidence 1 2335699999999973
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.81 E-value=3.6e-20 Score=200.50 Aligned_cols=148 Identities=22% Similarity=0.317 Sum_probs=118.2
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCA---MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
++|...+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|+++++.++|||||++++++..+...++..
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5788899999999999999986 5789999999864321 12357899999999999999999999998877554432
Q ss_pred eccC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 751 LHST---------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 751 l~~~---------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
.+.. ...+++.+...++.+++.|++||| +.+|+||||||+||+ |||+++.......
T Consensus 89 E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~-- 163 (336)
T 3h4j_B 89 EYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF-- 163 (336)
T ss_dssp CCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT--
T ss_pred ECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc--
Confidence 2221 235677888899999999999996 457999999999998 9999987654322
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
....+||+.|+|||++
T Consensus 164 ~~~~~gt~~y~aPE~~ 179 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVI 179 (336)
T ss_dssp TCCCTTSTTTSCGGGS
T ss_pred cccccCCcCcCCHHHH
Confidence 2334699999999975
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=3.2e-20 Score=202.25 Aligned_cols=144 Identities=27% Similarity=0.365 Sum_probs=116.5
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee--
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL-- 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l-- 748 (827)
+.|...+.||+|+||.||+|+. .+|+.||||++.... ....+++.+|++++++++|||||++++++..++..++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588889999999999999986 578999999986432 3345679999999999999999999999987765444
Q ss_pred eeecc--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 749 DCLHS--------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 749 ~~l~~--------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
++... ....+++.+...++.++++||+||| +.+|+||||||+||+ |||+++.....
T Consensus 134 e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--- 207 (348)
T 1u5q_A 134 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 207 (348)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred ecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence 32211 1345778888999999999999996 468999999999998 99999765432
Q ss_pred ccccceeccccccccc
Q 047196 811 IQTETLVTIGYMAPGL 826 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~ 826 (827)
...+||++|+|||+
T Consensus 208 --~~~~gt~~y~aPE~ 221 (348)
T 1u5q_A 208 --NSFVGTPYWMAPEV 221 (348)
T ss_dssp --CCCCSCGGGCCHHH
T ss_pred --CcccCCcceeCHhh
Confidence 23458999999996
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.3e-19 Score=185.23 Aligned_cols=162 Identities=22% Similarity=0.245 Sum_probs=114.8
Q ss_pred CCCCCCcccceecCCCCCcEEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCC
Q 047196 81 SNTSVCNWIGITCNVNSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSG 160 (827)
Q Consensus 81 ~~~~~C~W~gv~C~~~~~~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g 160 (827)
.+.+.|+|.+|.|+.. ++. .+|..+. ++|++|+|++|++++..|..|..+++|++|+|++|+|++
T Consensus 14 ~~~~~Cs~~~v~c~~~------------~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 78 (229)
T 3e6j_A 14 PSQCSCSGTTVDCRSK------------RHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA 78 (229)
T ss_dssp CTTCEEETTEEECTTS------------CCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CCCCEEeCCEeEccCC------------CcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCC
Confidence 3567899999999753 222 4454443 789999999999998889899999999999999999864
Q ss_pred ccccccCCCCCCcEEEcCCCCCCCCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCc
Q 047196 161 SLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEIS 240 (827)
Q Consensus 161 ~~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~ 240 (827)
..+..+.. +++|++|+|++|.+++..+..|..+++|++|+|++|+++ .+|..+.
T Consensus 79 i~~~~~~~-------------------------l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~ 132 (229)
T 3e6j_A 79 LPVGVFDS-------------------------LTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIE 132 (229)
T ss_dssp CCTTTTTT-------------------------CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGG
T ss_pred cChhhccc-------------------------CCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccc
Confidence 43333333 335555555555555555555667777777777777776 5666677
Q ss_pred CCccccEEEcccccccccccccccCcCCCcEEEeecccCcccC
Q 047196 241 NLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVV 283 (827)
Q Consensus 241 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 283 (827)
++++|++|+|++|++++..+..+..+++|++|+|++|.+++..
T Consensus 133 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 133 RLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp GCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred cCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence 7777777777777777655566777777777777777776544
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=6.8e-20 Score=196.35 Aligned_cols=151 Identities=29% Similarity=0.470 Sum_probs=108.2
Q ss_pred hhcccccceEecCCceEEEEEEecCCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee--e
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL--D 749 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l--~ 749 (827)
.++|+..+.||+|+||.||+|+. +|+.||||++.... ....++|.+|++++++++|||||++++++......++ +
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 45788889999999999999987 57899999986543 3445789999999999999999999999987664443 3
Q ss_pred eeccC--------CC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 750 CLHST--------NC---SLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 750 ~l~~~--------~~---~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
++... .. .+++..+..++.++++||+|||. +.++|+||||||+||+ |||+++......
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~ 193 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT-SSSCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence 33221 11 26777888999999999999963 2233999999999998 999998654332
Q ss_pred ccccccceecccccccccC
Q 047196 809 SMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~~~~~~gt~~Y~APE~l 827 (827)
. ......||+.|+|||++
T Consensus 194 ~-~~~~~~gt~~y~aPE~~ 211 (309)
T 3p86_A 194 L-SSKSAAGTPEWMAPEVL 211 (309)
T ss_dssp ---------CCTTSCHHHH
T ss_pred c-ccccCCCCccccChhhh
Confidence 2 12234589999999963
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.81 E-value=7.1e-20 Score=196.83 Aligned_cols=146 Identities=24% Similarity=0.294 Sum_probs=117.0
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA---MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
++|+..+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|+.+++.++|||||++++++.+....++..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 57888999999999999999865 689999999965422 23467889999999999999999999998876555433
Q ss_pred eccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 751 LHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 751 l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
.+.. ...+++.....++.+++.||+||| +.+|+||||||+||+ |||+++......
T Consensus 86 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~-- 160 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-- 160 (318)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB--
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCcc--
Confidence 3222 234667777889999999999995 678999999999998 999998754321
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
...+||+.|+|||++
T Consensus 161 --~~~~gt~~y~aPE~~ 175 (318)
T 1fot_A 161 --YTLCGTPDYIAPEVV 175 (318)
T ss_dssp --CCCCSCTTTCCHHHH
T ss_pred --ccccCCccccCHhHh
Confidence 234699999999963
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.81 E-value=1.9e-20 Score=199.20 Aligned_cols=150 Identities=27% Similarity=0.446 Sum_probs=113.9
Q ss_pred hcccccceEecCCceEEEEEEe-----cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC----c
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-----HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNED----F 745 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~----~ 745 (827)
++|+..+.||+|+||.||+|++ .+|+.||||++........+.|.+|++++++++|||||++++++...+ +
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 5788889999999999999984 258899999998766666788999999999999999999999986532 2
Q ss_pred eeeeeecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccC
Q 047196 746 KALDCLHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806 (827)
Q Consensus 746 ~~l~~l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~ 806 (827)
.+++++.. ....+++.+...++.++++||+||| +.+|+||||||+||+ |||+++....
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp EEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred EEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 33343322 1234778888999999999999996 568999999999998 9999987754
Q ss_pred CCccc--cccceecccccccccC
Q 047196 807 DRSMI--QTETLVTIGYMAPGLL 827 (827)
Q Consensus 807 ~~~~~--~~~~~gt~~Y~APE~l 827 (827)
..... .....+|+.|+|||++
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~ 189 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESL 189 (295)
T ss_dssp ---------CTTCGGGGCCHHHH
T ss_pred CcceeeeccCCCCccceeCcHHh
Confidence 33221 1223378889999963
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=8.1e-20 Score=197.39 Aligned_cols=149 Identities=23% Similarity=0.359 Sum_probs=118.3
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchH------HHHHHHHHHHHHHhcCCCCceEEEeeeecCCce
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAM------ALKSFEAECEVMKNIRHRNHVKRISSCSNEDFK 746 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~------~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~ 746 (827)
.+.|...+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|++++++++|||||++++++......
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356888999999999999999865 6899999998653221 356799999999999999999999999887655
Q ss_pred eeeeeccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee--------------eecccc
Q 047196 747 ALDCLHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF--------------DFGIGR 802 (827)
Q Consensus 747 ~l~~l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl--------------DFGla~ 802 (827)
++...+.. ...+++.+...++.++++||+||| +.+|+||||||+||+ |||+++
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 44332221 234677888999999999999996 568999999999997 899998
Q ss_pred cccCCCccccccceecccccccccC
Q 047196 803 LLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 803 ~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
....... .....||+.|+|||++
T Consensus 167 ~~~~~~~--~~~~~gt~~y~aPE~~ 189 (326)
T 2y0a_A 167 KIDFGNE--FKNIFGTPEFVAPEIV 189 (326)
T ss_dssp ECCTTSC--CCCCCSCTTTCCHHHH
T ss_pred ECCCCCc--cccccCCcCcCCceee
Confidence 7643322 1234599999999963
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=5.8e-20 Score=199.63 Aligned_cols=151 Identities=20% Similarity=0.270 Sum_probs=118.0
Q ss_pred HhhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCcee
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFKA 747 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~ 747 (827)
..++|...++||+|+||.||+|+.+ +|+.||||++.... ....+.+.+|.++++++ +|||||++++++...+..+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 4578999999999999999999975 68999999997542 12345678899999987 9999999999998877655
Q ss_pred eeeeccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCC
Q 047196 748 LDCLHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGD 807 (827)
Q Consensus 748 l~~l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~ 807 (827)
+...+... ..+++.....++.+++.||+||| +.+|+||||||+||+ |||+|+.....
T Consensus 95 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 43333221 34677778889999999999996 568999999999998 99999865332
Q ss_pred CccccccceecccccccccC
Q 047196 808 RSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 808 ~~~~~~~~~gt~~Y~APE~l 827 (827)
... ....+||+.|+|||++
T Consensus 172 ~~~-~~~~~gt~~y~aPE~~ 190 (345)
T 1xjd_A 172 DAK-TNTFCGTPDYIAPEIL 190 (345)
T ss_dssp TCC-BCCCCSCGGGCCHHHH
T ss_pred CCc-ccCCCCCcccCChhhh
Confidence 221 2335699999999973
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=7.4e-20 Score=205.63 Aligned_cols=150 Identities=26% Similarity=0.368 Sum_probs=115.0
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC-----c
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNED-----F 745 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~-----~ 745 (827)
.++|...+.||+|+||.||+|+.. +|+.||||++... .....+++.+|++++++++|+|||++++++.... .
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 467999999999999999999864 6889999999653 2344578999999999999999999999987653 1
Q ss_pred ee--eeeecc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccC
Q 047196 746 KA--LDCLHS-------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806 (827)
Q Consensus 746 ~~--l~~l~~-------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~ 806 (827)
.+ +++... ....+++.....++.++++||+||| +.+|+||||||+||| |||+|+....
T Consensus 105 ~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 105 LYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp EEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred EEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 22 232211 1235788888999999999999996 568999999999998 9999987643
Q ss_pred CCcc---------------------ccccceeccccccccc
Q 047196 807 DRSM---------------------IQTETLVTIGYMAPGL 826 (827)
Q Consensus 807 ~~~~---------------------~~~~~~gt~~Y~APE~ 826 (827)
.... ..+..+||++|+|||+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 222 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPEL 222 (432)
T ss_dssp -----------------------------CCCCCTTCCHHH
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHH
Confidence 3211 1234568999999996
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=5.5e-20 Score=198.75 Aligned_cols=150 Identities=26% Similarity=0.330 Sum_probs=107.9
Q ss_pred hhcccccceEecCCceEEEEEEe----cCCcEEEEEEEcccc----hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRL----HDGIEVAIKVFHQNC----AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF 745 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~----~~g~~vAvK~l~~~~----~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~ 745 (827)
.++|+..+.||+|+||.||+|+. .+|+.||||++.... ......+.+|++++++++|||||++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 36788999999999999999986 468999999997542 2234568899999999999999999999988765
Q ss_pred eeeeeeccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eeccccccc
Q 047196 746 KALDCLHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLT 805 (827)
Q Consensus 746 ~~l~~l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~ 805 (827)
.++...+.. ...+.......++.+++.||+||| +.+|+||||||+||+ |||+++...
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 554333322 234566777889999999999996 568999999999998 999998654
Q ss_pred CCCccccccceecccccccccC
Q 047196 806 GDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 806 ~~~~~~~~~~~gt~~Y~APE~l 827 (827)
..... ....+||+.|+|||++
T Consensus 173 ~~~~~-~~~~~gt~~y~aPE~~ 193 (327)
T 3a62_A 173 HDGTV-THTFCGTIEYMAPEIL 193 (327)
T ss_dssp -------CTTSSCCTTSCHHHH
T ss_pred cCCcc-ccccCCCcCccCHhhC
Confidence 33221 2234589999999963
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.81 E-value=2.2e-20 Score=201.96 Aligned_cols=150 Identities=27% Similarity=0.449 Sum_probs=109.8
Q ss_pred hcccccceEecCCceEEEEEEec-CCc----EEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGI----EVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~----~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l 748 (827)
++|+..++||+|+||.||+|++. +|+ .||+|++.... ....++|.+|++++++++|||||+++++|......++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~v 94 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 94 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 56888899999999999999853 444 36888875432 3345789999999999999999999999987764332
Q ss_pred -eeec---------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 749 -DCLH---------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 749 -~~l~---------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
+++. .....+.+.....++.++++||+||| +.+|+||||||+||+ |||+|+......
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 171 (327)
T 3poz_A 95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp EECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence 2211 12345778888999999999999996 468999999999998 999998875443
Q ss_pred ccc-cccceecccccccccC
Q 047196 809 SMI-QTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~-~~~~~gt~~Y~APE~l 827 (827)
... .....||++|+|||++
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~ 191 (327)
T 3poz_A 172 KEYHAEGGKVPIKWMALESI 191 (327)
T ss_dssp C-------CCCGGGSCHHHH
T ss_pred ccccccCCCccccccChHHh
Confidence 322 2223368899999963
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=2.9e-20 Score=204.33 Aligned_cols=150 Identities=23% Similarity=0.405 Sum_probs=116.2
Q ss_pred hcccccceEecCCceEEEEEEec------CCcEEEEEEEccc-chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCcee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH------DGIEVAIKVFHQN-CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKA 747 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~------~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~ 747 (827)
++|...+.||+|+||+||+|++. +++.||||++... ......++.+|+.++++++|||||++++++......+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 56888899999999999999843 4678999998654 3445567999999999999999999999998765444
Q ss_pred e--eeeccC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------e
Q 047196 748 L--DCLHST---------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------D 797 (827)
Q Consensus 748 l--~~l~~~---------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------------D 797 (827)
+ +++... ...+.+.+...++.++++||+||| +.+|+||||||+||| |
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEECC
Confidence 3 332210 134778888999999999999996 568999999999998 9
Q ss_pred ecccccccCCCcc-ccccceecccccccccC
Q 047196 798 FGIGRLLTGDRSM-IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 798 FGla~~~~~~~~~-~~~~~~gt~~Y~APE~l 827 (827)
||+|+........ ......||+.|+|||++
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~ 258 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAF 258 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHH
T ss_pred CccccccccccccccCCCcCCcccEECHHHh
Confidence 9999865332221 12234479999999963
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.81 E-value=5.9e-20 Score=203.58 Aligned_cols=152 Identities=25% Similarity=0.421 Sum_probs=108.5
Q ss_pred HhhcccccceEecCCceEEEEEEe-cCCcEEEEEEEccc--chHHHHHHHHHHHHHHhcC-CCCceEEEeeeecCC----
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQN--CAMALKSFEAECEVMKNIR-HRNHVKRISSCSNED---- 744 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~---- 744 (827)
..++|+..+.||+|+||.||+|+. .+|+.||||++... .....+++.+|+.++++++ |||||++++++..++
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 456899999999999999999986 46899999998543 2345567889999999998 999999999987544
Q ss_pred ceeeeeecc------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 745 FKALDCLHS------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 745 ~~~l~~l~~------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
+.+++++.. ....+++.....++.++++||+||| +.+|+||||||+||| |||+|+.+....
T Consensus 87 ~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 87 YLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEEEECCSEEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EEEecccCcCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 222333321 1235677778889999999999996 568999999999998 999998763311
Q ss_pred --------------------ccccccceecccccccccC
Q 047196 809 --------------------SMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 --------------------~~~~~~~~gt~~Y~APE~l 827 (827)
....+..+||++|+|||++
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 202 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEIL 202 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHh
Confidence 1112334699999999963
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.3e-19 Score=193.34 Aligned_cols=150 Identities=27% Similarity=0.444 Sum_probs=113.9
Q ss_pred hhcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHh--cCCCCceEEEeeeecCC------c
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKN--IRHRNHVKRISSCSNED------F 745 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~--l~H~niv~~~~~~~~~~------~ 745 (827)
.++|...+.||+|+||.||+|+. +|+.||||++.... .+.+.+|.+++.. ++|||||++++++.... +
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 35788899999999999999987 58899999986542 3456677777777 79999999999875431 1
Q ss_pred eeeeeecc-------CCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEEccCCCccee----------eeccccc
Q 047196 746 KALDCLHS-------TNCSLNIFDKLNIMIDVASALEYLHFS-----HSTPVIHCDLKPKNVF----------DFGIGRL 803 (827)
Q Consensus 746 ~~l~~l~~-------~~~~l~~~~~~~i~~~ia~~L~~Lh~~-----h~~~iiHrDlK~~NIl----------DFGla~~ 803 (827)
.++++... ....+++.....++.++++||+|||.. ++++|+||||||+||+ |||+|+.
T Consensus 83 lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 162 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM 162 (301)
T ss_dssp EEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeee
Confidence 22232221 124578888999999999999999832 3889999999999998 9999987
Q ss_pred ccCCCccc---cccceecccccccccC
Q 047196 804 LTGDRSMI---QTETLVTIGYMAPGLL 827 (827)
Q Consensus 804 ~~~~~~~~---~~~~~gt~~Y~APE~l 827 (827)
........ .....||++|+|||++
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~ 189 (301)
T 3q4u_A 163 HSQSTNQLDVGNNPRVGTKRYMAPEVL 189 (301)
T ss_dssp EETTTTEEECCCCCCCCCGGGCCHHHH
T ss_pred cccccccccccccccccccceeChhhh
Confidence 65443321 1223689999999963
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=3.8e-20 Score=202.83 Aligned_cols=157 Identities=21% Similarity=0.359 Sum_probs=118.7
Q ss_pred hHHHHHhhcccccceEecCCceEEEEEEe------cCCcEEEEEEEcccc-hHHHHHHHHHHHHHHhc-CCCCceEEEee
Q 047196 668 QDLFRATEKFSKENLIGVGSFGSVYKGRL------HDGIEVAIKVFHQNC-AMALKSFEAECEVMKNI-RHRNHVKRISS 739 (827)
Q Consensus 668 ~~~~~~~~~~~~~~~iG~G~fg~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~~~~~ 739 (827)
.++....++|...+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|+++++++ +|||||+++++
T Consensus 15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~ 94 (359)
T 3vhe_A 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 94 (359)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeee
Confidence 34444567899999999999999999973 246889999997643 34457799999999999 78999999999
Q ss_pred eecCCc---eeeeeecc---------C-----------------------------------------------------
Q 047196 740 CSNEDF---KALDCLHS---------T----------------------------------------------------- 754 (827)
Q Consensus 740 ~~~~~~---~~l~~l~~---------~----------------------------------------------------- 754 (827)
|...+. .++++... .
T Consensus 95 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (359)
T 3vhe_A 95 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174 (359)
T ss_dssp ECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred eecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence 877543 22233211 0
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc-c
Q 047196 755 ------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM-I 811 (827)
Q Consensus 755 ------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~-~ 811 (827)
...+++.....++.++++||+||| +.+|+||||||+||+ |||+++........ .
T Consensus 175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 251 (359)
T 3vhe_A 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 251 (359)
T ss_dssp ---------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEE
T ss_pred hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchh
Confidence 011677788899999999999996 568999999999998 99999876443322 2
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
.....||++|+|||++
T Consensus 252 ~~~~~~t~~y~aPE~~ 267 (359)
T 3vhe_A 252 KGDARLPLKWMAPETI 267 (359)
T ss_dssp C--CEECGGGCCHHHH
T ss_pred ccccCCCceeEChhhh
Confidence 2334589999999963
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.80 E-value=6.8e-20 Score=199.36 Aligned_cols=151 Identities=25% Similarity=0.363 Sum_probs=116.6
Q ss_pred HhhcccccceEecCCceEEEEEEec------CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLH------DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF 745 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~ 745 (827)
..++|...+.||+|+||.||+|+.. +++.||||++.... ....+.|.+|++++++++|||||++++++...+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 3467888999999999999999874 34889999997543 3446789999999999999999999999987665
Q ss_pred eeeeeeccCC----------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCC
Q 047196 746 KALDCLHSTN----------------------------------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLK 791 (827)
Q Consensus 746 ~~l~~l~~~~----------------------------------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK 791 (827)
.++...+... ..+++.+...++.++++||+||| +.+|+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 4432222111 34677788899999999999996 5689999999
Q ss_pred Cccee----------eecccccccCCCcc-ccccceeccccccccc
Q 047196 792 PKNVF----------DFGIGRLLTGDRSM-IQTETLVTIGYMAPGL 826 (827)
Q Consensus 792 ~~NIl----------DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~ 826 (827)
|+||+ |||+++........ ......+|++|+|||+
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~ 247 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPES 247 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHH
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhh
Confidence 99998 99999876433211 1222347999999996
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=7.9e-20 Score=195.72 Aligned_cols=146 Identities=25% Similarity=0.415 Sum_probs=112.0
Q ss_pred hcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeeccC
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHST 754 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~ 754 (827)
++|+..+.||+|+||.||+|+.. ++.||||++... ...+.|.+|++++++++|||||++++++.+..+.++++....
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~~~ 84 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGG 84 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCTTC
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCCCC
Confidence 56888899999999999999875 688999998643 345679999999999999999999999886655555554321
Q ss_pred --------C---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------eecccccccCCCcccc
Q 047196 755 --------N---CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 755 --------~---~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGla~~~~~~~~~~~ 812 (827)
. ....+.....++.++++|++|||..|.++|+||||||+||+ |||+++......
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~---- 160 (307)
T 2eva_A 85 SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM---- 160 (307)
T ss_dssp BHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------
T ss_pred CHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc----
Confidence 1 12567778899999999999999877789999999999998 999887553221
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
....||++|+|||++
T Consensus 161 ~~~~gt~~y~aPE~~ 175 (307)
T 2eva_A 161 TNNKGSAAWMAPEVF 175 (307)
T ss_dssp ----CCTTSSCHHHH
T ss_pred ccCCCCCceEChhhh
Confidence 223589999999963
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.2e-19 Score=195.33 Aligned_cols=147 Identities=25% Similarity=0.403 Sum_probs=116.4
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC--c--eee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNED--F--KAL 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~--~--~~l 748 (827)
++|...++||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.... . .++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 56888999999999999999875 58999999997543 233567889999999999999999999987654 2 233
Q ss_pred eeeccC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee--------------eeccccc
Q 047196 749 DCLHST-----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF--------------DFGIGRL 803 (827)
Q Consensus 749 ~~l~~~-----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl--------------DFGla~~ 803 (827)
+++... ...+++.....++.++++||+||| +.+|+||||||+||+ |||+|+.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 333211 112788888999999999999996 568999999999996 9999987
Q ss_pred ccCCCccccccceeccccccccc
Q 047196 804 LTGDRSMIQTETLVTIGYMAPGL 826 (827)
Q Consensus 804 ~~~~~~~~~~~~~gt~~Y~APE~ 826 (827)
....... ....||+.|+|||+
T Consensus 166 ~~~~~~~--~~~~gt~~y~aPE~ 186 (319)
T 4euu_A 166 LEDDEQF--VSLYGTEEYLHPDM 186 (319)
T ss_dssp CCTTCCB--CCCCSCGGGCCHHH
T ss_pred cCCCCce--eecccCCCccCHHH
Confidence 6544322 23458999999996
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=2.3e-20 Score=205.97 Aligned_cols=151 Identities=28% Similarity=0.437 Sum_probs=117.0
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee--e
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL--D 749 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l--~ 749 (827)
.++|...+.||+|+||.||+|+.. +++.||||++.... ....++|.+|++++++++|||||+++++|...+..++ +
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 457888899999999999999976 68999999987542 3345678999999999999999999999987664443 3
Q ss_pred eeccC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 750 CLHST---------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 750 ~l~~~---------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
++... ...+++.....++.++++||+||| +.+|+||||||+||| |||+++........
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 33211 224677788899999999999996 568999999999998 99999865432211
Q ss_pred cc-ccceecccccccccC
Q 047196 811 IQ-TETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~-~~~~gt~~Y~APE~l 827 (827)
.. ....+++.|+|||++
T Consensus 270 ~~~~~~~~~~~y~aPE~~ 287 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEAL 287 (377)
T ss_dssp CCSSCCEEEGGGSCHHHH
T ss_pred ecCCCCCCCcCcCCHhHh
Confidence 11 112368899999963
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=6.2e-20 Score=197.50 Aligned_cols=150 Identities=25% Similarity=0.385 Sum_probs=104.3
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l 751 (827)
.++|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++..++..++...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 457888999999999999999864 68999999986543 2234678899999999999999999999987765544322
Q ss_pred ccC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccC
Q 047196 752 HST---------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806 (827)
Q Consensus 752 ~~~---------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~ 806 (827)
+.. ...+.+.....++.|+++||+||| +.+|+||||||+||+ |||+++....
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 84 FMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp CCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred ecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 211 123667777889999999999996 568999999999998 9999987643
Q ss_pred CCccccccceecccccccccC
Q 047196 807 DRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 807 ~~~~~~~~~~gt~~Y~APE~l 827 (827)
.... ....+||+.|+|||++
T Consensus 161 ~~~~-~~~~~~t~~y~aPE~~ 180 (317)
T 2pmi_A 161 PVNT-FSSEVVTLWYRAPDVL 180 (317)
T ss_dssp CCCC-CCCCCSCCTTCCHHHH
T ss_pred Cccc-CCCCcccccccCchHh
Confidence 3221 2234589999999963
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.80 E-value=6.9e-20 Score=199.54 Aligned_cols=156 Identities=26% Similarity=0.339 Sum_probs=116.7
Q ss_pred HHHHHhhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc-----hHHHHHHHHHHHHHHhcCCCCceEEEeeeec
Q 047196 669 DLFRATEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC-----AMALKSFEAECEVMKNIRHRNHVKRISSCSN 742 (827)
Q Consensus 669 ~~~~~~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~ 742 (827)
++....++|...+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++|||||++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 4556678899999999999999999986 468899999986432 2345789999999999999999999999988
Q ss_pred CCceeeeeeccCCCC--------------------------------------------------CCHHHHHHHHHHHHH
Q 047196 743 EDFKALDCLHSTNCS--------------------------------------------------LNIFDKLNIMIDVAS 772 (827)
Q Consensus 743 ~~~~~l~~l~~~~~~--------------------------------------------------l~~~~~~~i~~~ia~ 772 (827)
.+..++...+...+. +.+.....++.++++
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 775544322221111 123345679999999
Q ss_pred HHHHHHhcCCCCeEEccCCCccee------------eecccccccCCCcc---ccccceecccccccccC
Q 047196 773 ALEYLHFSHSTPVIHCDLKPKNVF------------DFGIGRLLTGDRSM---IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 773 ~L~~Lh~~h~~~iiHrDlK~~NIl------------DFGla~~~~~~~~~---~~~~~~gt~~Y~APE~l 827 (827)
||+||| +.+|+||||||+||+ |||+++.+...... ......||+.|+|||++
T Consensus 180 ~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 246 (345)
T 3hko_A 180 ALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVL 246 (345)
T ss_dssp HHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHH
T ss_pred HHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhh
Confidence 999996 568999999999998 99999876432211 12334589999999963
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.1e-19 Score=191.37 Aligned_cols=148 Identities=28% Similarity=0.369 Sum_probs=119.2
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
.++|...+.||+|+||.||+|+.. ++..||+|++........+.+.+|++++++++||||+++++++......++...+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 457888999999999999999865 5789999999765444567899999999999999999999999887755443332
Q ss_pred cC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------eecccccccCCCc
Q 047196 753 ST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------DFGIGRLLTGDRS 809 (827)
Q Consensus 753 ~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------------DFGla~~~~~~~~ 809 (827)
.. ...+++.+...++.++++|++||| +.+|+||||||+||+ |||+++.......
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~ 164 (277)
T 3f3z_A 88 CTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164 (277)
T ss_dssp CCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence 22 134677788899999999999996 568999999999997 9999987654332
Q ss_pred cccccceeccccccccc
Q 047196 810 MIQTETLVTIGYMAPGL 826 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~ 826 (827)
.....||++|+|||+
T Consensus 165 --~~~~~~t~~y~aPE~ 179 (277)
T 3f3z_A 165 --MRTKVGTPYYVSPQV 179 (277)
T ss_dssp --BCCCCSCTTTCCHHH
T ss_pred --hhccCCCCCccChHH
Confidence 223458999999996
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=9.9e-20 Score=208.82 Aligned_cols=149 Identities=21% Similarity=0.320 Sum_probs=118.4
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALD 749 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~ 749 (827)
.++|...++||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++...+..++.
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 356888999999999999999875 69999999996532 12345688999999999999999999999887655443
Q ss_pred eeccC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCC
Q 047196 750 CLHST------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGD 807 (827)
Q Consensus 750 ~l~~~------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~ 807 (827)
..+.. ...+++.....++.+++.||+||| +.+|+||||||+||| |||+|+.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 22221 123778888899999999999996 468999999999998 99999876543
Q ss_pred CccccccceecccccccccC
Q 047196 808 RSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 808 ~~~~~~~~~gt~~Y~APE~l 827 (827)
.. ....+||++|||||++
T Consensus 340 ~~--~~~~~GT~~Y~APEvl 357 (576)
T 2acx_A 340 QT--IKGRVGTVGYMAPEVV 357 (576)
T ss_dssp CC--EECCCSCGGGCCHHHH
T ss_pred cc--ccccCCCccccCHHHH
Confidence 32 1334699999999974
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.80 E-value=3.9e-20 Score=195.55 Aligned_cols=149 Identities=24% Similarity=0.433 Sum_probs=115.1
Q ss_pred hhcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee--eee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL--DCL 751 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l--~~l 751 (827)
.++|+..+.||+|+||.||+|+..++..||||++..... ..+++.+|++++++++|+||+++++++......++ ++.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 457888899999999999999998888999999975432 24678999999999999999999999987665444 322
Q ss_pred cc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 752 HS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 752 ~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
.. ....+++.+...++.++++|++||| +.+|+||||||+||+ |||+++..........
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (283)
T 3gen_A 102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 178 (283)
T ss_dssp TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHST
T ss_pred CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccccccccc
Confidence 21 1245778888999999999999996 568999999999998 9999987643322222
Q ss_pred ccceeccccccccc
Q 047196 813 TETLVTIGYMAPGL 826 (827)
Q Consensus 813 ~~~~gt~~Y~APE~ 826 (827)
....+|+.|+|||+
T Consensus 179 ~~~~~~~~y~aPE~ 192 (283)
T 3gen_A 179 VGSKFPVRWSPPEV 192 (283)
T ss_dssp TSTTSCGGGCCHHH
T ss_pred cCCccCcccCCHHH
Confidence 22346889999996
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=7.6e-20 Score=193.17 Aligned_cols=151 Identities=25% Similarity=0.396 Sum_probs=105.8
Q ss_pred hhcccccceEecCCceEEEEEEec----CCcEEEEEEEccc-chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc-ee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH----DGIEVAIKVFHQN-CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF-KA 747 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~----~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~-~~ 747 (827)
.++|+..+.||+|+||.||+|+.. .+..||||++... .....+.+.+|+.++++++|||||++++++.+... ..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~lv 93 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII 93 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccEEE
Confidence 357888899999999999999864 2567999998653 33445789999999999999999999999865443 22
Q ss_pred eeeecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 748 LDCLHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 748 l~~l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
+++... ....+++.....++.++++||+||| +.+|+||||||+||+ |||+++......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 94 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170 (281)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCccc
Confidence 333221 1235788888999999999999996 568999999999998 999998765433
Q ss_pred ccccccceecccccccccC
Q 047196 809 SMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~~~~~~gt~~Y~APE~l 827 (827)
........+|+.|+|||++
T Consensus 171 ~~~~~~~~~~~~y~aPE~~ 189 (281)
T 1mp8_A 171 YYKASKGKLPIKWMAPESI 189 (281)
T ss_dssp --------CCGGGCCHHHH
T ss_pred ccccccCCCcccccChhhc
Confidence 2222223468899999963
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.80 E-value=5.6e-20 Score=207.98 Aligned_cols=151 Identities=23% Similarity=0.436 Sum_probs=116.6
Q ss_pred HhhcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCce-eeeee
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFK-ALDCL 751 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~-~l~~l 751 (827)
..++|...+.||+|+||.||+|++.++..||||++.... ...++|.+|++++++++|||||++++++..+... +++++
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv~e~~ 264 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFM 264 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEECCC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEEEeec
Confidence 346788889999999999999999888899999997543 3457899999999999999999999998754322 22332
Q ss_pred ccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 752 HST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 752 ~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
... ...+.+.+...++.++++||+||| +.+|+||||||+||| |||+|+.........
T Consensus 265 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 341 (454)
T 1qcf_A 265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341 (454)
T ss_dssp TTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHT
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceec
Confidence 211 124566778889999999999996 567999999999998 999998764332222
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
.....+|+.|+|||++
T Consensus 342 ~~~~~~~~~y~aPE~~ 357 (454)
T 1qcf_A 342 REGAKFPIKWTAPEAI 357 (454)
T ss_dssp TCSSSSCGGGSCHHHH
T ss_pred cCCCcccccccCHHHh
Confidence 2223468899999963
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.80 E-value=1.2e-19 Score=197.76 Aligned_cols=146 Identities=22% Similarity=0.293 Sum_probs=117.5
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA---MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
++|+..+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++|||||++++++.+....++..
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57888999999999999999865 689999999965421 23467889999999999999999999998877555433
Q ss_pred eccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 751 LHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 751 l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
.+... ..++......++.+++.||+||| +.+|+||||||+||+ |||+++......
T Consensus 121 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~-- 195 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-- 195 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB--
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCCc--
Confidence 33221 34667778889999999999996 568999999999998 999998764332
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
...+||+.|+|||++
T Consensus 196 --~~~~gt~~y~aPE~~ 210 (350)
T 1rdq_E 196 --WTLCGTPEALAPEII 210 (350)
T ss_dssp --CCCEECGGGCCHHHH
T ss_pred --ccccCCccccCHHHh
Confidence 234699999999963
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.80 E-value=7e-20 Score=209.29 Aligned_cols=150 Identities=29% Similarity=0.519 Sum_probs=118.6
Q ss_pred hhcccccceEecCCceEEEEEEecC-CcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee--ee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLHD-GIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL--DC 750 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l--~~ 750 (827)
..+|...+.||+|+||.||+|++.. +..||||++.... ...++|.+|++++++++|||||+++++|......++ ++
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 3568888999999999999999764 8899999997543 235679999999999999999999999987664443 33
Q ss_pred ecc----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 751 LHS----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 751 l~~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
+.. ....+.+.....++.++++||+||| +++|+||||||+||| |||+++....+...
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 374 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence 221 1234677888899999999999996 568999999999998 99999887544332
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
......+|+.|+|||++
T Consensus 375 ~~~~~~~~~~y~aPE~~ 391 (495)
T 1opk_A 375 AHAGAKFPIKWTAPESL 391 (495)
T ss_dssp CCTTCCCCGGGCCHHHH
T ss_pred ecCCCcCCcceeCHhHH
Confidence 22333468899999963
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.80 E-value=8e-20 Score=204.43 Aligned_cols=150 Identities=26% Similarity=0.364 Sum_probs=110.9
Q ss_pred HhhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccch--------HHHHHHHHHHHHHHhcCCCCceEEEeeeecC
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA--------MALKSFEAECEVMKNIRHRNHVKRISSCSNE 743 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--------~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~ 743 (827)
..++|...+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++|||||++++++..+
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 212 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 212 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 4568999999999999999999864 689999999865321 1123588999999999999999999998665
Q ss_pred Cce-eeeeecc--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------eeccc
Q 047196 744 DFK-ALDCLHS--------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------DFGIG 801 (827)
Q Consensus 744 ~~~-~l~~l~~--------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------------DFGla 801 (827)
... +++++.. ....+.+.....++.++++||+||| +.+|+||||||+||| |||+|
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 432 2233321 1235678888999999999999996 467999999999998 99999
Q ss_pred ccccCCCccccccceecccccccccC
Q 047196 802 RLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 802 ~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
+....... ....+||++|+|||++
T Consensus 290 ~~~~~~~~--~~~~~gt~~y~aPE~~ 313 (419)
T 3i6u_A 290 KILGETSL--MRTLCGTPTYLAPEVL 313 (419)
T ss_dssp TSCC-------------CTTCCTTTT
T ss_pred eecCCCcc--ccccCCCCCccCceee
Confidence 87643322 2334599999999974
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.7e-19 Score=199.36 Aligned_cols=150 Identities=27% Similarity=0.421 Sum_probs=116.8
Q ss_pred hcccccceEecCCceEEEEEEec--------CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCC
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH--------DGIEVAIKVFHQNC-AMALKSFEAECEVMKNI-RHRNHVKRISSCSNED 744 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~ 744 (827)
++|...+.||+|+||.||+|+.. ++..||||++.... ....+++.+|+++++++ +|||||++++++...+
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 148 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 148 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence 57888899999999999999852 23679999997543 44557899999999999 9999999999998766
Q ss_pred ceee--eeeccC------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee--
Q 047196 745 FKAL--DCLHST------------------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-- 796 (827)
Q Consensus 745 ~~~l--~~l~~~------------------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-- 796 (827)
..++ ++.... ...+++.+...|+.++++||+||| +.+|+||||||+||+
T Consensus 149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT 225 (382)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEC
T ss_pred ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEEc
Confidence 5443 332210 123788889999999999999996 568999999999998
Q ss_pred --------eecccccccCCCcc-ccccceecccccccccC
Q 047196 797 --------DFGIGRLLTGDRSM-IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 --------DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l 827 (827)
|||+|+........ ......+|++|+|||++
T Consensus 226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~ 265 (382)
T 3tt0_A 226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 265 (382)
T ss_dssp TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHH
T ss_pred CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHh
Confidence 99999876543221 12223478999999963
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=3.3e-20 Score=201.21 Aligned_cols=150 Identities=26% Similarity=0.361 Sum_probs=118.3
Q ss_pred HhhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccch--------HHHHHHHHHHHHHHhcCCCCceEEEeeeecC
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCA--------MALKSFEAECEVMKNIRHRNHVKRISSCSNE 743 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~--------~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~ 743 (827)
..++|...+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|++++++++|||||++++++...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 346789999999999999999985 4689999999865421 1234578899999999999999999999887
Q ss_pred Cceeeeeecc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccc
Q 047196 744 DFKALDCLHS-----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGR 802 (827)
Q Consensus 744 ~~~~l~~l~~-----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~ 802 (827)
...++...+. ....+++.....|+.++++||+||| +.+|+||||||+||+ |||+++
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 7554433221 1235678888899999999999996 568999999999998 999998
Q ss_pred cccCCCccccccceecccccccccC
Q 047196 803 LLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 803 ~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
........ ...+||++|+|||++
T Consensus 179 ~~~~~~~~--~~~~gt~~y~aPE~~ 201 (335)
T 3dls_A 179 YLERGKLF--YTFCGTIEYCAPEVL 201 (335)
T ss_dssp ECCTTCCB--CEECSCGGGCCHHHH
T ss_pred ECCCCCce--eccCCCccccChhhh
Confidence 76543321 234589999999963
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=9.9e-20 Score=198.45 Aligned_cols=150 Identities=21% Similarity=0.189 Sum_probs=117.5
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCceee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFKAL 748 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~l 748 (827)
.++|+..++||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|.++++.+ +||+|+++++++...+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 467999999999999999999876 48899999997542 12345688999999988 79999999999988765554
Q ss_pred eeeccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 749 DCLHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 749 ~~l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
...+... ..+++.....++.+++.||+||| +.+|+||||||+||+ |||+|+......
T Consensus 99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence 3333221 34667778889999999999996 568999999999998 999998643322
Q ss_pred ccccccceecccccccccC
Q 047196 809 SMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~~~~~~gt~~Y~APE~l 827 (827)
.. ....+||+.|||||++
T Consensus 176 ~~-~~~~~gt~~y~aPE~~ 193 (353)
T 2i0e_A 176 VT-TKTFCGTPDYIAPEII 193 (353)
T ss_dssp CC-BCCCCSCGGGCCHHHH
T ss_pred cc-cccccCCccccChhhh
Confidence 21 2335699999999973
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.8e-19 Score=203.67 Aligned_cols=148 Identities=24% Similarity=0.393 Sum_probs=119.1
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA---MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
++|...+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+++++.++|||||++++++...+..++..
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56888899999999999999875 799999999965422 23467899999999999999999999998876554432
Q ss_pred ecc----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 751 LHS----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 751 l~~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
.+. ....+++.....++.|++.|++||| +.+|+||||||+||+ |||+++.......
T Consensus 96 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~- 171 (476)
T 2y94_A 96 EYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF- 171 (476)
T ss_dssp ECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC-
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhcccccc-
Confidence 222 1345778888999999999999995 678999999999998 9999987654322
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
....+||+.|+|||++
T Consensus 172 -~~~~~gt~~y~aPE~~ 187 (476)
T 2y94_A 172 -LRTSCGSPNYAAPEVI 187 (476)
T ss_dssp -BCCCCSCSTTCCHHHH
T ss_pred -ccccCCCcCeEChhhc
Confidence 2335699999999963
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1e-21 Score=227.07 Aligned_cols=220 Identities=20% Similarity=0.205 Sum_probs=132.3
Q ss_pred cccceecCCCCCcEEEEEcCCCCCcc-------------------------ccCc---cccCCCCCCEEECCCCCCCccC
Q 047196 87 NWIGITCNVNSHRVTALNISSLNLQG-------------------------TIPP---QLGNLSSLTTLNLSHNKLSGDI 138 (827)
Q Consensus 87 ~W~gv~C~~~~~~v~~L~L~~~~l~g-------------------------~~~~---~l~~L~~L~~L~Ls~N~l~g~~ 138 (827)
.|..+.|+....+|-.+++..-.+.- ..+. .+..+++|+.|+|++|+++ .+
T Consensus 286 ~W~~~~~~~~~~~vw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~L~~L~Ls~n~L~-~L 364 (567)
T 1dce_A 286 EWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VL 364 (567)
T ss_dssp CCBCTTSSCCSEEEEEEECCGGGTSTTSSEEEEEEEETTTTEEEEEEEETTCSEEEEECCSTTTTSSSCCCCHHHHH-HH
T ss_pred eeccCCcccccceeEEeecCccccccccccceEEEeeccCCCCccccccCCCchhhhcccccCccceeccCChhhHH-hh
Confidence 68888887766777777775433321 0011 2367899999999999997 88
Q ss_pred ChhhhhccccceEEecCCC-------------CCCccccccCCCCCCcEEE-cCCCCCCCCcchhHhhccccccEEEeec
Q 047196 139 PPSIFTMHKLKFLDFSDNQ-------------LSGSLSSVTFNLSSVLDIR-LDSDKLSGELPVNICNYLHYLKVLFLAK 204 (827)
Q Consensus 139 p~~~~~l~~L~~LdLs~N~-------------l~g~~p~~~~~l~~L~~L~-L~~n~l~g~ip~~~~~~~~~L~~L~Ls~ 204 (827)
|++++++++|+.||+++|. +.+.+|..+.++++|+.|+ ++.|.+ ..|+.+.+++
T Consensus 365 p~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~------------~~L~~l~l~~ 432 (567)
T 1dce_A 365 QSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL------------DDLRSKFLLE 432 (567)
T ss_dssp HHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH------------HHHHHHHHHH
T ss_pred HHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc------------chhhhhhhhc
Confidence 9999999999999998775 3444455555555555444 333221 1233344444
Q ss_pred ccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEeecccCcccCc
Q 047196 205 NMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVP 284 (827)
Q Consensus 205 N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 284 (827)
|.++...+ ..|+.|+|++|.+++ +|. ++++++|+.|+|++|+|+ .+|..++.+++|++|+|++|++++ +|
T Consensus 433 n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp 502 (567)
T 1dce_A 433 NSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD 502 (567)
T ss_dssp HHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG
T ss_pred ccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc
Confidence 44443222 136667777777765 454 666777777777777776 566667777777777777777665 44
Q ss_pred hhhhcCCCccEEEecCCcccccc-ChhhhcCCCCccEEeCcCCccccc
Q 047196 285 AAIFNMSTVKKIYLLDNSLLGSF-SLGIDLSLPNVERLNLGLNRFSGT 331 (827)
Q Consensus 285 ~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~~l~~L~~L~L~~N~l~~~ 331 (827)
.+.++++|+.|++++|.+.+.. |..+. .+++|+.|+|++|.+++.
T Consensus 503 -~l~~l~~L~~L~Ls~N~l~~~~~p~~l~-~l~~L~~L~L~~N~l~~~ 548 (567)
T 1dce_A 503 -GVANLPRLQELLLCNNRLQQSAAIQPLV-SCPRLVLLNLQGNSLCQE 548 (567)
T ss_dssp -GGTTCSSCCEEECCSSCCCSSSTTGGGG-GCTTCCEEECTTSGGGGS
T ss_pred -ccCCCCCCcEEECCCCCCCCCCCcHHHh-cCCCCCEEEecCCcCCCC
Confidence 4555555554444444444433 33332 344444444444444433
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=9e-20 Score=198.92 Aligned_cols=147 Identities=25% Similarity=0.359 Sum_probs=102.7
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
.+.|+..+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|++++++++|||||++++++...+..++...+
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 467888999999999999999975 58899999987542 345688999999999999999999999887655443322
Q ss_pred cC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------eecccccccCCCc
Q 047196 753 ST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------DFGIGRLLTGDRS 809 (827)
Q Consensus 753 ~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------------DFGla~~~~~~~~ 809 (827)
.. ...+++.+...++.++++||+||| +.+|+||||||+||+ |||+++.......
T Consensus 130 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 206 (349)
T 2w4o_A 130 VTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL 206 (349)
T ss_dssp CCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc
Confidence 21 234677888999999999999996 568999999999998 8999887643321
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
.....||++|+|||++
T Consensus 207 --~~~~~gt~~y~aPE~~ 222 (349)
T 2w4o_A 207 --MKTVCGTPGYCAPEIL 222 (349)
T ss_dssp --------CGGGSCHHHH
T ss_pred --cccccCCCCccCHHHh
Confidence 1234589999999963
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.79 E-value=9.4e-20 Score=197.81 Aligned_cols=145 Identities=22% Similarity=0.237 Sum_probs=109.1
Q ss_pred hhcccccceEecCCceEEEEEEecCCcEEEEEEEcccc--------hHHHHHHHHHHHHHHhcC---------CCCceEE
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNC--------AMALKSFEAECEVMKNIR---------HRNHVKR 736 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~--------~~~~~~~~~Ei~~l~~l~---------H~niv~~ 736 (827)
.++|+..+.||+|+||.||+|+. +|+.||||++.... ....+.+.+|++++++++ |+|+|++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35788899999999999999987 68999999997542 122467899999999996 8888888
Q ss_pred Eeeeec------------------------------CCce--eeeeeccC-------CCCCCHHHHHHHHHHHHHHHHHH
Q 047196 737 ISSCSN------------------------------EDFK--ALDCLHST-------NCSLNIFDKLNIMIDVASALEYL 777 (827)
Q Consensus 737 ~~~~~~------------------------------~~~~--~l~~l~~~-------~~~l~~~~~~~i~~~ia~~L~~L 777 (827)
.+.+.. .... ++++...+ ...+++.....|+.|++.||+||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~l 177 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA 177 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHH
Confidence 876431 2222 23333221 13467888899999999999999
Q ss_pred HhcCCCCeEEccCCCccee------------------------------eecccccccCCCccccccceecccccccccC
Q 047196 778 HFSHSTPVIHCDLKPKNVF------------------------------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 778 h~~h~~~iiHrDlK~~NIl------------------------------DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
| ++.+|+||||||+||| |||+|+.... ...+||+.|||||++
T Consensus 178 H--~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~~y~aPE~~ 249 (336)
T 2vuw_A 178 E--ASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFCDVSMDEDLF 249 (336)
T ss_dssp H--HHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECCCCTTCSGGG
T ss_pred H--HhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEeecccChhhh
Confidence 7 2567999999999987 5677665432 224699999999975
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.79 E-value=9.8e-20 Score=199.54 Aligned_cols=148 Identities=23% Similarity=0.263 Sum_probs=110.4
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
.++|...+.||+|+||.||+|+.. +|+.||||++..... ..+.+.+|+.++++++|||||++++++......++...+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 357888999999999999999875 789999999965432 235688999999999999999999999887755543333
Q ss_pred cC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee------------eecccccccCCCcc
Q 047196 753 ST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------------DFGIGRLLTGDRSM 810 (827)
Q Consensus 753 ~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------------DFGla~~~~~~~~~ 810 (827)
.. ...+++.....++.++++||+||| +.+|+||||||+||+ |||+|+.......
T Consensus 98 ~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~- 173 (361)
T 3uc3_A 98 ASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 173 (361)
T ss_dssp CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC-
Confidence 22 234677788899999999999996 568999999999998 9999875432221
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
....+||++|+|||++
T Consensus 174 -~~~~~gt~~y~aPE~~ 189 (361)
T 3uc3_A 174 -PKSTVGTPAYIAPEVL 189 (361)
T ss_dssp --------CTTSCHHHH
T ss_pred -CCCCcCCCCcCChhhh
Confidence 1234599999999963
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=4e-20 Score=208.83 Aligned_cols=151 Identities=25% Similarity=0.266 Sum_probs=109.0
Q ss_pred hhcccccceEecCCceEEEEEEe-cCCcEEEEEEEccc---chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQN---CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALD 749 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~ 749 (827)
.++|+..+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|++++++++|||||++++++...+..++.
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 35788899999999999999986 46899999999653 223345788999999999999999999999887765543
Q ss_pred eeccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 750 CLHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 750 ~l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
..+... ..+++.....++.++++||+|||. .++|+||||||+||| |||+|+.......
T Consensus 227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 304 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 304 (446)
T ss_dssp ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc
Confidence 333222 345677788899999999999974 268999999999998 9999986543322
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
. ....+||++|||||++
T Consensus 305 ~-~~~~~gt~~y~aPE~~ 321 (446)
T 4ejn_A 305 T-MKTFCGTPEYLAPEVL 321 (446)
T ss_dssp ---CCSSSCGGGCCHHHH
T ss_pred c-cccccCCccccCHhhc
Confidence 2 2335699999999973
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.5e-19 Score=206.43 Aligned_cols=149 Identities=26% Similarity=0.413 Sum_probs=117.8
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
.++|...++||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++......++..
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 467899999999999999999865 68999999986432 223467899999999999999999999998877555433
Q ss_pred eccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------eecccccccCC
Q 047196 751 LHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------DFGIGRLLTGD 807 (827)
Q Consensus 751 l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------------DFGla~~~~~~ 807 (827)
.+.. ...+++.....++.++++||.||| +.+|+||||||+||+ |||+|+.....
T Consensus 101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 2222 134677788899999999999996 568999999999998 99999876543
Q ss_pred CccccccceecccccccccC
Q 047196 808 RSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 808 ~~~~~~~~~gt~~Y~APE~l 827 (827)
.. ....+||++|+|||++
T Consensus 178 ~~--~~~~~gt~~y~aPE~~ 195 (486)
T 3mwu_A 178 TK--MKDRIGTAYYIAPEVL 195 (486)
T ss_dssp ------CCTTGGGGCCGGGG
T ss_pred Cc--cCCCcCCCCCCCHHHh
Confidence 32 2334599999999974
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.6e-19 Score=191.07 Aligned_cols=147 Identities=30% Similarity=0.442 Sum_probs=113.6
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++......++...+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 56888999999999999999864 68999999986543 22357799999999999999999999999877654443222
Q ss_pred cC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------eeccccccc
Q 047196 753 ST--------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------DFGIGRLLT 805 (827)
Q Consensus 753 ~~--------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------------DFGla~~~~ 805 (827)
.. ...+++.....++.++++||+||| +.+|+||||||+||+ |||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 21 134677788899999999999996 568999999999998 999997764
Q ss_pred CCCccccccceeccccccccc
Q 047196 806 GDRSMIQTETLVTIGYMAPGL 826 (827)
Q Consensus 806 ~~~~~~~~~~~gt~~Y~APE~ 826 (827)
.... .....||+.|+|||+
T Consensus 179 ~~~~--~~~~~~t~~y~aPE~ 197 (285)
T 3is5_A 179 SDEH--STNAAGTALYMAPEV 197 (285)
T ss_dssp ----------CTTGGGCCHHH
T ss_pred Cccc--CcCcccccCcCChHH
Confidence 4322 223458999999996
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.79 E-value=1.3e-19 Score=202.88 Aligned_cols=144 Identities=29% Similarity=0.448 Sum_probs=111.3
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecC----C--ce-
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNE----D--FK- 746 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~----~--~~- 746 (827)
.+|...++||+|+||.||+|+.. +|+.||||++..... .+.+|++++++++|+|||++++++... + +.
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 36888899999999999999975 689999999865422 235799999999999999999987542 1 11
Q ss_pred -eeeeecc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------eeccccc
Q 047196 747 -ALDCLHS-----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRL 803 (827)
Q Consensus 747 -~l~~l~~-----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGla~~ 803 (827)
+++++.. ....+.+.....++.|+++||+||| +.+|+||||||+||| |||+|+.
T Consensus 130 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 130 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred eehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 2222211 1245677778899999999999996 678999999999998 9999987
Q ss_pred ccCCCccccccceecccccccccC
Q 047196 804 LTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 804 ~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
+..... ....+||++|+|||++
T Consensus 207 ~~~~~~--~~~~~~t~~y~aPE~~ 228 (420)
T 1j1b_A 207 LVRGEP--NVSYICSRYYRAPELI 228 (420)
T ss_dssp CCTTCC--CCSCCSCTTSCCHHHH
T ss_pred cccCCC--ceeeeeCCCcCCHHHH
Confidence 644332 2335689999999963
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=6.7e-20 Score=196.67 Aligned_cols=150 Identities=22% Similarity=0.407 Sum_probs=110.8
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEccc---chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC------
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQN---CAMALKSFEAECEVMKNIRHRNHVKRISSCSNED------ 744 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~------ 744 (827)
++|+..+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|++++++++|||||++++++....
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 5788899999999999999986 57899999999754 2334567999999999999999999999986543
Q ss_pred ceeeeeecc--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccC
Q 047196 745 FKALDCLHS--------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806 (827)
Q Consensus 745 ~~~l~~l~~--------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~ 806 (827)
+.+++++.. ....+++.+...++.++++||+||| +.+|+||||||+||+ |||+++....
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 334444322 1235778888999999999999996 568999999999998 9999987654
Q ss_pred CCcc--ccccceecccccccccC
Q 047196 807 DRSM--IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 807 ~~~~--~~~~~~gt~~Y~APE~l 827 (827)
.... .....+||++|+|||++
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~ 191 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQA 191 (311)
T ss_dssp -------------CCTTCCHHHH
T ss_pred cccccccccccCcCcccCCHHHh
Confidence 3221 11224589999999963
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.79 E-value=2.5e-19 Score=198.59 Aligned_cols=151 Identities=16% Similarity=0.211 Sum_probs=118.1
Q ss_pred hhcccccceEecC--CceEEEEEEec-CCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee
Q 047196 674 TEKFSKENLIGVG--SFGSVYKGRLH-DGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL 748 (827)
Q Consensus 674 ~~~~~~~~~iG~G--~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l 748 (827)
.++|+..++||+| +||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++...+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4679999999999 99999999975 69999999996542 3445778999999999999999999999988775544
Q ss_pred eeeccC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccC
Q 047196 749 DCLHST------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806 (827)
Q Consensus 749 ~~l~~~------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~ 806 (827)
...+.. ...+++.....++.++++||+||| +.+|+||||||+||| |||.+.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 322221 144677888899999999999996 568999999999998 8998865432
Q ss_pred CCcc------ccccceecccccccccC
Q 047196 807 DRSM------IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 807 ~~~~------~~~~~~gt~~Y~APE~l 827 (827)
.... .....+||+.|+|||++
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~ 207 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVL 207 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHH
T ss_pred ccccccccccccccccccccccCHHHH
Confidence 2111 11223589999999973
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=3.5e-19 Score=188.22 Aligned_cols=148 Identities=24% Similarity=0.406 Sum_probs=117.9
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
.++|+..+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|++++++++||||+++++++..+...++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467888999999999999999865 6899999998653 2344577899999999999999999999998877554433
Q ss_pred eccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------eecccccccCC
Q 047196 751 LHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------DFGIGRLLTGD 807 (827)
Q Consensus 751 l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------------DFGla~~~~~~ 807 (827)
.+... ..+++.....++.+++.|++||| +.+|+||||||+||+ |||++......
T Consensus 85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 32221 23667778899999999999996 568999999999998 89998766433
Q ss_pred Cccccccceeccccccccc
Q 047196 808 RSMIQTETLVTIGYMAPGL 826 (827)
Q Consensus 808 ~~~~~~~~~gt~~Y~APE~ 826 (827)
.. .....||++|+|||+
T Consensus 162 ~~--~~~~~~~~~y~aPE~ 178 (284)
T 3kk8_A 162 EA--WHGFAGTPGYLSPEV 178 (284)
T ss_dssp CB--CCCSCSCGGGCCHHH
T ss_pred cc--ccCCCCCcCCcCchh
Confidence 22 123458999999996
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.79 E-value=2.1e-19 Score=195.63 Aligned_cols=151 Identities=25% Similarity=0.411 Sum_probs=114.7
Q ss_pred HhhcccccceEecCCceEEEEEEe------cCCcEEEEEEEcccc-hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCC
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRL------HDGIEVAIKVFHQNC-AMALKSFEAECEVMKNI-RHRNHVKRISSCSNED 744 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~ 744 (827)
..++|...+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 346788899999999999999985 245789999997542 33456899999999999 8999999999998766
Q ss_pred ceeeeeeccCC---------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCC
Q 047196 745 FKALDCLHSTN---------------------------------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLK 791 (827)
Q Consensus 745 ~~~l~~l~~~~---------------------------------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK 791 (827)
..++...+... ..+++.....++.++++||+||| +.+|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCC
Confidence 54432222111 12577788899999999999996 5689999999
Q ss_pred Cccee----------eecccccccCCCccc-cccceeccccccccc
Q 047196 792 PKNVF----------DFGIGRLLTGDRSMI-QTETLVTIGYMAPGL 826 (827)
Q Consensus 792 ~~NIl----------DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~ 826 (827)
|+||+ |||+++......... .....||++|+|||+
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~ 245 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPES 245 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHH
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHH
Confidence 99998 999998765443322 223447899999996
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.6e-19 Score=198.41 Aligned_cols=149 Identities=19% Similarity=0.217 Sum_probs=115.0
Q ss_pred HhhcccccceEecCCceEEEEEE------ecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcC---CCCceEEEeeeecC
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGR------LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIR---HRNHVKRISSCSNE 743 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~------~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~---H~niv~~~~~~~~~ 743 (827)
..++|...++||+|+||.||+|+ ..+++.||||++.... ..++.+|++++++++ |+|+|++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 34678889999999999999994 3468899999997543 346788898888888 99999999999877
Q ss_pred Cceeeeeecc---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee------------
Q 047196 744 DFKALDCLHS---------------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------------ 796 (827)
Q Consensus 744 ~~~~l~~l~~---------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------------ 796 (827)
+..++...+. ....+++.....|+.++++||+||| +.+|+||||||+|||
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccccc
Confidence 6554432221 1235778889999999999999996 578999999999997
Q ss_pred ---------eecccccccCCC-ccccccceecccccccccC
Q 047196 797 ---------DFGIGRLLTGDR-SMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 ---------DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~l 827 (827)
|||+|+.+.... .......+||++|||||++
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~ 257 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEML 257 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHH
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHh
Confidence 899987654221 1122345699999999973
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=2.2e-19 Score=192.76 Aligned_cols=150 Identities=23% Similarity=0.406 Sum_probs=116.2
Q ss_pred hhcccccceEecCCceEEEEEEe------cCCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCce
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRL------HDGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFK 746 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~ 746 (827)
.++|...+.||+|+||.||+|+. .+++.||||++.... ....+++.+|++++++++|||||++++++...+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 45788889999999999999975 235889999997543 44567899999999999999999999999876654
Q ss_pred eeeeeccCC----------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCC
Q 047196 747 ALDCLHSTN----------------------------------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKP 792 (827)
Q Consensus 747 ~l~~l~~~~----------------------------------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~ 792 (827)
++...+... ..+++.+...++.++++||+||| +.+|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccch
Confidence 442222111 12567778899999999999996 56899999999
Q ss_pred ccee----------eecccccccCCCccc-cccceeccccccccc
Q 047196 793 KNVF----------DFGIGRLLTGDRSMI-QTETLVTIGYMAPGL 826 (827)
Q Consensus 793 ~NIl----------DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~ 826 (827)
+||+ |||+++......... .....+|+.|+|||+
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 223 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIES 223 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHH
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhh
Confidence 9998 999998765433322 122347889999996
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.79 E-value=1.5e-19 Score=204.40 Aligned_cols=150 Identities=26% Similarity=0.448 Sum_probs=111.5
Q ss_pred hhcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCce-eeeeec
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFK-ALDCLH 752 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~-~l~~l~ 752 (827)
.++|...+.||+|+||.||+|++.++..||||++.... ...++|.+|++++++++|||||++++++.++... +++++.
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~e~~~ 261 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS 261 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCT
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEehhhc
Confidence 45688889999999999999999888889999987543 2346799999999999999999999998764322 223332
Q ss_pred cC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 753 ST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 753 ~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
.. ...+++.+...++.++++||+||| +++|+||||||+||| |||+++..........
T Consensus 262 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 338 (452)
T 1fmk_A 262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 338 (452)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecc
Confidence 21 124677788899999999999996 568999999999998 9999987654332222
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
....+|+.|+|||++
T Consensus 339 ~~~~~~~~y~aPE~~ 353 (452)
T 1fmk_A 339 QGAKFPIKWTAPEAA 353 (452)
T ss_dssp ----CCGGGSCHHHH
T ss_pred cCCcccccccCHhHH
Confidence 223468899999963
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.79 E-value=2.7e-19 Score=204.72 Aligned_cols=149 Identities=24% Similarity=0.334 Sum_probs=117.9
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee--
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA---MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL-- 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l-- 748 (827)
++|...++||+|+||.||+|+.+ +|+.||||++..... ...+.+.+|++++++++|||||++++++......++
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 56888899999999999999875 699999999965422 234678899999999999999999999887765444
Q ss_pred eeeccC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccC
Q 047196 749 DCLHST------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806 (827)
Q Consensus 749 ~~l~~~------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~ 806 (827)
+++... ...+.+.....++.+++.||+||| +.+|+||||||+||+ |||+++.+..
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 332211 124677788889999999999996 568999999999998 9999987654
Q ss_pred CCccccccceecccccccccC
Q 047196 807 DRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 807 ~~~~~~~~~~gt~~Y~APE~l 827 (827)
.... ....+||+.|||||++
T Consensus 342 ~~~~-~~~~~GT~~Y~APE~l 361 (543)
T 3c4z_A 342 GQTK-TKGYAGTPGFMAPELL 361 (543)
T ss_dssp TCCC-BCCCCSCTTTSCHHHH
T ss_pred CCcc-cccccCCccccChhhh
Confidence 4322 2234699999999974
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.6e-19 Score=206.56 Aligned_cols=149 Identities=28% Similarity=0.420 Sum_probs=115.2
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
.+.|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++|||||++++++......++..
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 356888999999999999999875 68999999987543 223567899999999999999999999998877555433
Q ss_pred eccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------eecccccccCC
Q 047196 751 LHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------DFGIGRLLTGD 807 (827)
Q Consensus 751 l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------------DFGla~~~~~~ 807 (827)
.+... ..+++.....++.++++||+||| +.+|+||||||+||+ |||+|+.....
T Consensus 116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 33221 34667778899999999999996 568999999999998 99999876543
Q ss_pred CccccccceecccccccccC
Q 047196 808 RSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 808 ~~~~~~~~~gt~~Y~APE~l 827 (827)
.. ....+||++|+|||++
T Consensus 193 ~~--~~~~~gt~~y~aPE~l 210 (494)
T 3lij_A 193 KK--MKERLGTAYYIAPEVL 210 (494)
T ss_dssp BC--BCCCCSCTTTCCHHHH
T ss_pred cc--ccccCCCcCeeCHHHH
Confidence 32 2335699999999973
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=3.9e-19 Score=190.62 Aligned_cols=149 Identities=31% Similarity=0.407 Sum_probs=113.2
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l 751 (827)
++|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++......++...
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 56888999999999999999875 58999999986543 3345678899999999999999999999988765444222
Q ss_pred cc----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 752 HS----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 752 ~~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
+. ....+++.....++.++++|++||| +.+|+||||||+||+ |||+++........
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 158 (311)
T 4agu_A 83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY- 158 (311)
T ss_dssp CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc-
Confidence 21 1345778888899999999999996 568999999999998 99999876533221
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
.....||++|+|||++
T Consensus 159 ~~~~~~~~~y~aPE~~ 174 (311)
T 4agu_A 159 YDDEVATRWYRSPELL 174 (311)
T ss_dssp -------GGGCCHHHH
T ss_pred cCCCcCCccccChHHH
Confidence 2334589999999963
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.79 E-value=9.9e-20 Score=198.48 Aligned_cols=151 Identities=27% Similarity=0.419 Sum_probs=112.0
Q ss_pred HhhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchH-----HHHHHHHHHHHHHhcCCCCceEEEeeeecCCce
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAM-----ALKSFEAECEVMKNIRHRNHVKRISSCSNEDFK 746 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~-----~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~ 746 (827)
..++|...+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|++++++++|||||++++++......
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4567999999999999999999875 6899999998643211 134688999999999999999999999776544
Q ss_pred ee--eeec--------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccC
Q 047196 747 AL--DCLH--------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806 (827)
Q Consensus 747 ~l--~~l~--------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~ 806 (827)
++ +++. .....+++.+...++.++++||+||| +.+|+||||||+||+ |||+++....
T Consensus 88 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 88 SLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp EEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred EEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 43 2221 11234667778899999999999996 567999999999998 9999987654
Q ss_pred CCccccccceecccccccccC
Q 047196 807 DRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 807 ~~~~~~~~~~gt~~Y~APE~l 827 (827)
.... ....+||++|+|||++
T Consensus 165 ~~~~-~~~~~~t~~y~aPE~~ 184 (346)
T 1ua2_A 165 PNRA-YTHQVVTRWYRAPELL 184 (346)
T ss_dssp CCCC-CCCSCCCCTTCCHHHH
T ss_pred Cccc-CCcccccccccCchHh
Confidence 3322 2335689999999963
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.79 E-value=9.9e-20 Score=191.98 Aligned_cols=150 Identities=25% Similarity=0.460 Sum_probs=117.3
Q ss_pred HhhcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCce-eeeee
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFK-ALDCL 751 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~-~l~~l 751 (827)
..++|+..+.||+|+||.||+|+..++..||||++.... ...+.+.+|++++++++|||++++++++..+... ++++.
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~ 89 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYM 89 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEecC
Confidence 346788899999999999999998888899999996543 2346789999999999999999999998755432 22333
Q ss_pred ccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 752 HST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 752 ~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
... ...+++.+...++.++++||+||| +.+|+||||||+||+ |||+++.........
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccccc
Confidence 211 114677888899999999999996 568999999999998 999998765433222
Q ss_pred cccceeccccccccc
Q 047196 812 QTETLVTIGYMAPGL 826 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~ 826 (827)
.....+|+.|+|||+
T Consensus 167 ~~~~~~~~~y~aPE~ 181 (279)
T 1qpc_A 167 REGAKFPIKWTAPEA 181 (279)
T ss_dssp CTTCCCCTTTSCHHH
T ss_pred ccCCCCccCccChhh
Confidence 223347889999996
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.79 E-value=3.8e-19 Score=191.96 Aligned_cols=141 Identities=27% Similarity=0.330 Sum_probs=99.3
Q ss_pred cceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcC-CCCceEEEeeeecCCceeeeeeccC---
Q 047196 680 ENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIR-HRNHVKRISSCSNEDFKALDCLHST--- 754 (827)
Q Consensus 680 ~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~l~~l~~~--- 754 (827)
.+.||+|+||.||+|+.. +|+.||||++... ....+.+|++++++++ |||||++++++.+....++...+..
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999875 6899999998643 3456789999999998 9999999999988775554332221
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------eecccccccCCCcccccc
Q 047196 755 -------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------DFGIGRLLTGDRSMIQTE 814 (827)
Q Consensus 755 -------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------------DFGla~~~~~~~~~~~~~ 814 (827)
...+++.+...++.++++||+||| +.+|+||||||+||+ |||+++........ ...
T Consensus 93 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~-~~~ 168 (325)
T 3kn6_A 93 LFERIKKKKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKT 168 (325)
T ss_dssp HHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc-ccc
Confidence 234677888899999999999996 568999999999998 99999866543322 233
Q ss_pred ceecccccccccC
Q 047196 815 TLVTIGYMAPGLL 827 (827)
Q Consensus 815 ~~gt~~Y~APE~l 827 (827)
.+||++|+|||++
T Consensus 169 ~~~t~~y~aPE~~ 181 (325)
T 3kn6_A 169 PCFTLHYAAPELL 181 (325)
T ss_dssp -------------
T ss_pred cCCCcCccCHHHh
Confidence 4589999999974
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.9e-19 Score=189.99 Aligned_cols=150 Identities=26% Similarity=0.440 Sum_probs=112.8
Q ss_pred hhcccccceEecCCceEEEEEEecC----CcEEEEEEEccc-chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCce-e
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLHD----GIEVAIKVFHQN-CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFK-A 747 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~~----g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~-~ 747 (827)
.++|...+.||+|+||.||+|+... +..||||++... .....++|.+|++++++++|||++++++++.+.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v 90 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWII 90 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEEE
Confidence 4678889999999999999998542 346999998754 344567899999999999999999999998765432 2
Q ss_pred eeeecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 748 LDCLHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 748 l~~l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
+++... ....+++.....++.++++|++||| +.+|+||||||+||+ |||+++......
T Consensus 91 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 167 (281)
T 3cc6_A 91 MELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167 (281)
T ss_dssp EECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred EecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence 233221 1234677888899999999999996 568999999999998 999998765433
Q ss_pred ccccccceeccccccccc
Q 047196 809 SMIQTETLVTIGYMAPGL 826 (827)
Q Consensus 809 ~~~~~~~~gt~~Y~APE~ 826 (827)
........+|++|+|||+
T Consensus 168 ~~~~~~~~~~~~y~aPE~ 185 (281)
T 3cc6_A 168 YYKASVTRLPIKWMSPES 185 (281)
T ss_dssp -----CCCCCGGGCCHHH
T ss_pred ccccccCCCCcceeCchh
Confidence 222223347889999996
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.79 E-value=2.4e-19 Score=197.39 Aligned_cols=148 Identities=24% Similarity=0.338 Sum_probs=107.5
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC-------
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNED------- 744 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~------- 744 (827)
++|...+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|++++++++|||||++++++....
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 57888999999999999999864 6899999998653 2344567899999999999999999999987654
Q ss_pred -ceeeeeeccC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 745 -FKALDCLHST-----NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 745 -~~~l~~l~~~-----~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
+.+++++... ...+++.....++.++++||+||| +.+|+||||||+||+ |||+|+......
T Consensus 105 ~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 181 (371)
T 2xrw_A 105 VYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181 (371)
T ss_dssp EEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC--------
T ss_pred eEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeeccccccccc
Confidence 2223333211 134677778889999999999996 568999999999998 999998764332
Q ss_pred ccccccceecccccccccC
Q 047196 809 SMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~~~~~~gt~~Y~APE~l 827 (827)
. ....+||+.|+|||++
T Consensus 182 ~--~~~~~gt~~y~aPE~~ 198 (371)
T 2xrw_A 182 M--MTPYVVTRYYRAPEVI 198 (371)
T ss_dssp ----------CTTCCHHHH
T ss_pred c--cCCceecCCccCHHHh
Confidence 1 2334689999999963
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.3e-19 Score=189.57 Aligned_cols=148 Identities=26% Similarity=0.408 Sum_probs=116.4
Q ss_pred hcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee--eeec
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL--DCLH 752 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l--~~l~ 752 (827)
++|...+.||+|+||.||+|+..+++.||||++..... ..+.+.+|++++++++|||++++++++...+..++ ++..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 56888899999999999999988888999999975432 23678999999999999999999999987654443 2221
Q ss_pred c---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccc
Q 047196 753 S---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQT 813 (827)
Q Consensus 753 ~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~ 813 (827)
. ....+++.....++.++++|++||| +.+|+||||||+||+ |||+++...........
T Consensus 87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 163 (267)
T 3t9t_A 87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 163 (267)
T ss_dssp TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccccccccc
Confidence 1 1234677788899999999999996 568999999999998 99999876432221122
Q ss_pred cceeccccccccc
Q 047196 814 ETLVTIGYMAPGL 826 (827)
Q Consensus 814 ~~~gt~~Y~APE~ 826 (827)
...+|+.|+|||+
T Consensus 164 ~~~~~~~y~aPE~ 176 (267)
T 3t9t_A 164 GTKFPVKWASPEV 176 (267)
T ss_dssp STTCCGGGCCHHH
T ss_pred cccccccccChhh
Confidence 2347889999996
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.79 E-value=3e-19 Score=193.98 Aligned_cols=147 Identities=22% Similarity=0.382 Sum_probs=115.5
Q ss_pred HhhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCceeeee
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~l~~ 750 (827)
..++|+..+.||+|+||.||+|+.+ +|+.||||++..... .+.+|++++.++ +|||||++++++.+.+..++..
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3467899999999999999999875 689999999965432 245788889888 7999999999998877555433
Q ss_pred eccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee--------------eecccccccC
Q 047196 751 LHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF--------------DFGIGRLLTG 806 (827)
Q Consensus 751 l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl--------------DFGla~~~~~ 806 (827)
.+.. ...+++.+...++.++++||+||| +.+|+||||||+||+ |||+++....
T Consensus 96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 2221 234677788899999999999996 568999999999997 9999987654
Q ss_pred CCccccccceecccccccccC
Q 047196 807 DRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 807 ~~~~~~~~~~gt~~Y~APE~l 827 (827)
.... ....+||+.|+|||++
T Consensus 173 ~~~~-~~~~~gt~~y~aPE~~ 192 (342)
T 2qr7_A 173 ENGL-LMTPCYTANFVAPEVL 192 (342)
T ss_dssp TTCC-BCCSSCCSSCCCHHHH
T ss_pred CCCc-eeccCCCccccCHHHh
Confidence 4332 2234689999999973
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.1e-19 Score=199.46 Aligned_cols=156 Identities=24% Similarity=0.352 Sum_probs=114.6
Q ss_pred chhHHHHHhhcccccceEecCCceEEEEEEecCCcEEEEEEEcccc-----------hHHHHHHHHHHHHHHhcCCCCce
Q 047196 666 SYQDLFRATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNC-----------AMALKSFEAECEVMKNIRHRNHV 734 (827)
Q Consensus 666 ~~~~~~~~~~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~-----------~~~~~~~~~Ei~~l~~l~H~niv 734 (827)
...++....++|...+.||+|+||.||+|+..+|+.||||++.... ....+.+.+|++++++++|||||
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 4566777788999999999999999999998889999999985321 12247899999999999999999
Q ss_pred EEEeeeecCC-------ceeeeeec--------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---
Q 047196 735 KRISSCSNED-------FKALDCLH--------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF--- 796 (827)
Q Consensus 735 ~~~~~~~~~~-------~~~l~~l~--------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl--- 796 (827)
++++++...+ +.++++.. .....+++.....++.++++||+||| +.+|+||||||+||+
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~ 169 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLAD 169 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECT
T ss_pred ceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEEcC
Confidence 9999885422 12223222 12235788889999999999999996 468999999999998
Q ss_pred -------eecccccccCCCccccccceeccccccccc
Q 047196 797 -------DFGIGRLLTGDRSMIQTETLVTIGYMAPGL 826 (827)
Q Consensus 797 -------DFGla~~~~~~~~~~~~~~~gt~~Y~APE~ 826 (827)
|||+++....... .....||+.|+|||+
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~ 204 (362)
T 3pg1_A 170 NNDITICDFNLAREDTADAN--KTHYVTHRWYRAPEL 204 (362)
T ss_dssp TCCEEECCTTC-----------------CGGGCCHHH
T ss_pred CCCEEEEecCcccccccccc--cceecccceecCcHH
Confidence 9999976543322 233458999999996
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1.4e-19 Score=195.86 Aligned_cols=152 Identities=23% Similarity=0.347 Sum_probs=112.0
Q ss_pred HHhhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee
Q 047196 672 RATEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCA--MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL 748 (827)
Q Consensus 672 ~~~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l 748 (827)
...++|...+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|++++++++|||||++++++......++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 3456899999999999999999985 4689999999865432 234568899999999999999999999988775544
Q ss_pred eeeccC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------------eecccccc
Q 047196 749 DCLHST---------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---------------DFGIGRLL 804 (827)
Q Consensus 749 ~~l~~~---------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---------------DFGla~~~ 804 (827)
...+.. ...+++.....|+.++++||+||| +.+|+||||||+||+ |||+|+..
T Consensus 111 v~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 111 IFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 332221 234677788899999999999996 568999999999987 89998876
Q ss_pred cCCCccccccceecccccccccC
Q 047196 805 TGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 805 ~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
...... ....+||++|+|||++
T Consensus 188 ~~~~~~-~~~~~~t~~y~aPE~~ 209 (329)
T 3gbz_A 188 GIPIRQ-FTHEIITLWYRPPEIL 209 (329)
T ss_dssp C------------CCTTCCHHHH
T ss_pred CCcccc-cCCCcCCccccCHHHh
Confidence 433221 2334589999999963
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.78 E-value=8.2e-19 Score=192.55 Aligned_cols=152 Identities=25% Similarity=0.387 Sum_probs=120.1
Q ss_pred HHHhhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc--------hHHHHHHHHHHHHHHhc-CCCCceEEEeee
Q 047196 671 FRATEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC--------AMALKSFEAECEVMKNI-RHRNHVKRISSC 740 (827)
Q Consensus 671 ~~~~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--------~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~ 740 (827)
....++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++++ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 344567999999999999999999975 79999999986432 12245788999999999 799999999999
Q ss_pred ecCCceeeeeeccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecc
Q 047196 741 SNEDFKALDCLHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGI 800 (827)
Q Consensus 741 ~~~~~~~l~~l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGl 800 (827)
......++...+... ..+++.....++.++++||.||| +.+|+||||||+||+ |||+
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~ 246 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGF 246 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEecCc
Confidence 877765553333222 34677778899999999999996 468999999999998 9999
Q ss_pred cccccCCCccccccceecccccccccC
Q 047196 801 GRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 801 a~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
++.+..... ....+||++|+|||++
T Consensus 247 ~~~~~~~~~--~~~~~gt~~y~aPE~~ 271 (365)
T 2y7j_A 247 SCHLEPGEK--LRELCGTPGYLAPEIL 271 (365)
T ss_dssp CEECCTTCC--BCCCCSCGGGCCHHHH
T ss_pred ccccCCCcc--cccCCCCCCccChhhc
Confidence 987654332 2334699999999963
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.78 E-value=1e-19 Score=199.04 Aligned_cols=151 Identities=25% Similarity=0.309 Sum_probs=117.2
Q ss_pred hhcccccceEecCCceEEEEEEe----cCCcEEEEEEEcccc----hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCC
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRL----HDGIEVAIKVFHQNC----AMALKSFEAECEVMKNI-RHRNHVKRISSCSNED 744 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~----~~g~~vAvK~l~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~ 744 (827)
.++|+..+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+++++++ +||||+++++++..+.
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36789999999999999999986 368999999986432 12345678899999999 6999999999998776
Q ss_pred ceeeeeeccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccc
Q 047196 745 FKALDCLHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLL 804 (827)
Q Consensus 745 ~~~l~~l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~ 804 (827)
..++...+... ..+++.....++.++++||+||| +.+|+||||||+||+ |||+++..
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 55443333221 34667778889999999999996 568999999999998 99999876
Q ss_pred cCCCccccccceecccccccccC
Q 047196 805 TGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 805 ~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
...........+||++|+|||++
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~ 232 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIV 232 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHH
T ss_pred ccCCCCcccCcccCcCccChhhh
Confidence 43333222334699999999973
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=2.5e-19 Score=193.63 Aligned_cols=150 Identities=25% Similarity=0.372 Sum_probs=118.0
Q ss_pred hcccccceEecCCceEEEEEEe-----cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC--cee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-----HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNED--FKA 747 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~--~~~ 747 (827)
++|+..+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++|+||+++++++..++ ..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5688889999999999999984 358899999998776666778999999999999999999999886432 222
Q ss_pred --eeeeccC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccC
Q 047196 748 --LDCLHST---------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806 (827)
Q Consensus 748 --l~~l~~~---------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~ 806 (827)
++++... ...+++.....++.++++||+||| +.+|+||||||+||+ |||+++....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 2333211 234678888999999999999996 568999999999998 9999987754
Q ss_pred CCcc--ccccceecccccccccC
Q 047196 807 DRSM--IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 807 ~~~~--~~~~~~gt~~Y~APE~l 827 (827)
.... ......||+.|+|||++
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~ 202 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESL 202 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHH
T ss_pred CCccceeeccCCccccccCHHHh
Confidence 4322 12223478899999963
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.78 E-value=4e-19 Score=203.84 Aligned_cols=149 Identities=27% Similarity=0.420 Sum_probs=116.5
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccch-------------HHHHHHHHHHHHHHhcCCCCceEEEee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA-------------MALKSFEAECEVMKNIRHRNHVKRISS 739 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-------------~~~~~~~~Ei~~l~~l~H~niv~~~~~ 739 (827)
.++|...+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++++++|||||+++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 467888999999999999999865 588999999865321 224678999999999999999999999
Q ss_pred eecCCceeeeeeccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------
Q 047196 740 CSNEDFKALDCLHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------------- 796 (827)
Q Consensus 740 ~~~~~~~~l~~l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------------- 796 (827)
+.+....++...+.. ...+++.....++.+++.||+||| +.+|+||||||+||+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 988776554333222 134677888899999999999996 568999999999998
Q ss_pred eecccccccCCCccccccceecccccccccC
Q 047196 797 DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
|||+|+....... ....+||++|+|||++
T Consensus 192 Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~ 220 (504)
T 3q5i_A 192 DFGLSSFFSKDYK--LRDRLGTAYYIAPEVL 220 (504)
T ss_dssp CCTTCEECCTTSC--BCCCCSCTTTCCHHHH
T ss_pred ECCCCEEcCCCCc--cccccCCcCCCCHHHh
Confidence 9999987654432 2335699999999973
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=3e-19 Score=189.15 Aligned_cols=148 Identities=30% Similarity=0.479 Sum_probs=117.1
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchH-------HHHHHHHHHHHHHhcCCCCceEEEeeeecCCce
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAM-------ALKSFEAECEVMKNIRHRNHVKRISSCSNEDFK 746 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~-------~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~ 746 (827)
++|+..+.||+|+||.||+|+. .+++.||||++...... ..+++.+|++++++++||||+++++++.+..+.
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~l 98 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRM 98 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTTEE
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCCeE
Confidence 5688889999999999999987 47899999998543211 126799999999999999999999999887766
Q ss_pred eeeeecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------------eecccc
Q 047196 747 ALDCLHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---------------DFGIGR 802 (827)
Q Consensus 747 ~l~~l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---------------DFGla~ 802 (827)
++++... ....+++.....++.++++|++|||. +.++|+||||||+||+ |||+++
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~ 177 (287)
T 4f0f_A 99 VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177 (287)
T ss_dssp EEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCB
T ss_pred EEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHh-CCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccc
Confidence 6655432 23457888889999999999999973 2233999999999987 888887
Q ss_pred cccCCCccccccceecccccccccC
Q 047196 803 LLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 803 ~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
..... .....||+.|+|||++
T Consensus 178 ~~~~~----~~~~~g~~~y~aPE~~ 198 (287)
T 4f0f_A 178 QSVHS----VSGLLGNFQWMAPETI 198 (287)
T ss_dssp CCSSC----EECCCCCCTTSCGGGS
T ss_pred ccccc----ccccCCCccccCchhh
Confidence 54322 2234589999999974
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.78 E-value=5e-19 Score=191.90 Aligned_cols=151 Identities=26% Similarity=0.455 Sum_probs=115.5
Q ss_pred hhcccccceEecCCceEEEEEEec--------CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecC
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH--------DGIEVAIKVFHQNC-AMALKSFEAECEVMKNI-RHRNHVKRISSCSNE 743 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~ 743 (827)
.++|...+.||+|+||.||+|+.. +++.||||++.... ....+++.+|+++++++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 367888899999999999999863 46789999997543 34567899999999999 899999999999876
Q ss_pred Cceee--eeeccC------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-
Q 047196 744 DFKAL--DCLHST------------------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF- 796 (827)
Q Consensus 744 ~~~~l--~~l~~~------------------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl- 796 (827)
+..++ ++.... ...+++.+...++.++++||+||| +.+|+||||||+||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence 65443 222110 113677888999999999999996 568999999999998
Q ss_pred ---------eecccccccCCCccc-cccceecccccccccC
Q 047196 797 ---------DFGIGRLLTGDRSMI-QTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 ---------DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l 827 (827)
|||+++......... .....+|++|+|||++
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 231 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 231 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHh
Confidence 999998765433221 1223478899999963
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=5.1e-19 Score=186.38 Aligned_cols=150 Identities=24% Similarity=0.402 Sum_probs=105.5
Q ss_pred hhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCA---MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALD 749 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~ 749 (827)
.++|...+.||+|+||.||+|+. .+|+.||||++..... ...+++.+|++++++++||||+++++++...+..++.
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35788899999999999999986 5789999999864322 1246789999999999999999999999887755443
Q ss_pred eecc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 750 CLHS-----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 750 ~l~~-----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
..+. ....+++.....++.++++|++||| +.+|+||||||+||+ |||+++......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 2221 1245778888999999999999996 568999999999998 999998764332
Q ss_pred ccccccceecccccccccC
Q 047196 809 SMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~~~~~~gt~~Y~APE~l 827 (827)
.. .....||+.|+|||++
T Consensus 167 ~~-~~~~~~~~~y~aPE~~ 184 (278)
T 3cok_A 167 EK-HYTLCGTPNYISPEIA 184 (278)
T ss_dssp -------------------
T ss_pred Cc-ceeccCCCCcCCcchh
Confidence 21 1224589999999974
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.6e-19 Score=194.72 Aligned_cols=151 Identities=24% Similarity=0.430 Sum_probs=102.8
Q ss_pred HhhcccccceEecCCceEEEEEEecC-C---cEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc-
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLHD-G---IEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF- 745 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~~-g---~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~- 745 (827)
..++|+..+.||+|+||.||+|+... + ..||||++... .....+++.+|++++++++|||||++++++.....
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 34678899999999999999998653 3 37999998654 23446789999999999999999999999876543
Q ss_pred -------eeeeeeccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee--------
Q 047196 746 -------KALDCLHST--------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------- 796 (827)
Q Consensus 746 -------~~l~~l~~~--------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------- 796 (827)
.++++.... ...+++.+...++.++++||+||| +.+|+||||||+||+
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEE
Confidence 223332221 014677888999999999999996 568999999999998
Q ss_pred --eecccccccCCCccc-cccceeccccccccc
Q 047196 797 --DFGIGRLLTGDRSMI-QTETLVTIGYMAPGL 826 (827)
Q Consensus 797 --DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~ 826 (827)
|||+|+......... .....+|+.|+|||+
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 210 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALES 210 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHH
T ss_pred EeeccccccccccccccccccccCcccccCchh
Confidence 999998764433221 122336889999996
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1.9e-19 Score=197.68 Aligned_cols=149 Identities=29% Similarity=0.330 Sum_probs=108.2
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHH-HHhcCCCCceEEEeeeecCCceeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEV-MKNIRHRNHVKRISSCSNEDFKALD 749 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~-l~~l~H~niv~~~~~~~~~~~~~l~ 749 (827)
++|+..++||+|+||+||+|+.+ +++.||||++.... ....+.+.+|..+ ++.++|||||++++++...+..++.
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 57889999999999999999875 58899999997543 2234556777776 5778999999999999887765543
Q ss_pred eeccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 750 CLHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 750 ~l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
..+... ..+.......++.+++.||+||| +.+|+||||||+||| |||+++.......
T Consensus 118 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~ 194 (373)
T 2r5t_A 118 LDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS 194 (373)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccCCC
Confidence 333222 23556667789999999999996 568999999999998 9999986543322
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
. ....+||+.|||||++
T Consensus 195 ~-~~~~~gt~~y~aPE~~ 211 (373)
T 2r5t_A 195 T-TSTFCGTPEYLAPEVL 211 (373)
T ss_dssp C-CCSBSCCCCCCCHHHH
T ss_pred c-cccccCCccccCHHHh
Confidence 2 2335699999999973
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=4.6e-19 Score=190.10 Aligned_cols=150 Identities=23% Similarity=0.438 Sum_probs=117.2
Q ss_pred hhcccccceEecCCceEEEEEEe------cCCcEEEEEEEcccc-hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCc
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRL------HDGIEVAIKVFHQNC-AMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDF 745 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~ 745 (827)
.++|...+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+++++++ +|||||++++++..++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 35788889999999999999984 246889999997543 34457899999999999 99999999999987664
Q ss_pred eee--eeecc---------C-----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-
Q 047196 746 KAL--DCLHS---------T-----------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF- 796 (827)
Q Consensus 746 ~~l--~~l~~---------~-----------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl- 796 (827)
.++ ++... . ...+++.+...++.++++||+||| +.+|+||||||+||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEE
Confidence 443 22211 0 113778888999999999999996 568999999999998
Q ss_pred ---------eecccccccCCCccc-cccceeccccccccc
Q 047196 797 ---------DFGIGRLLTGDRSMI-QTETLVTIGYMAPGL 826 (827)
Q Consensus 797 ---------DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~ 826 (827)
|||+++......... .....||++|+|||+
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 218 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPES 218 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHH
Confidence 999998775543322 223447899999996
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.78 E-value=1.3e-19 Score=191.93 Aligned_cols=150 Identities=29% Similarity=0.508 Sum_probs=119.8
Q ss_pred HhhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee--e
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL--D 749 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l--~ 749 (827)
..++|...+.||+|+||.||+|+.. ++..||||++.... ...+++.+|++++++++||||+++++++..+...++ +
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 4567888999999999999999875 48899999997543 345779999999999999999999999987765443 2
Q ss_pred eecc----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 750 CLHS----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 750 ~l~~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
+... ....+++.....++.++++|++||| +.+|+||||||+||+ |||+++.......
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence 2221 1234778888899999999999996 457999999999998 9999987765443
Q ss_pred cccccceeccccccccc
Q 047196 810 MIQTETLVTIGYMAPGL 826 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~ 826 (827)
.......+|+.|+|||+
T Consensus 167 ~~~~~~~~~~~y~aPE~ 183 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPES 183 (288)
T ss_dssp EEETTEEECGGGCCHHH
T ss_pred ccccCCccccCcCChhh
Confidence 33333457899999996
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.78 E-value=6.5e-19 Score=186.57 Aligned_cols=150 Identities=24% Similarity=0.443 Sum_probs=114.4
Q ss_pred hcccccc-eEecCCceEEEEEEec---CCcEEEEEEEccc-chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCcee-e
Q 047196 675 EKFSKEN-LIGVGSFGSVYKGRLH---DGIEVAIKVFHQN-CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKA-L 748 (827)
Q Consensus 675 ~~~~~~~-~iG~G~fg~Vy~~~~~---~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~-l 748 (827)
++|...+ .||+|+||.||+|+.. +++.||||++... .....+++.+|++++++++||||+++++++..+...+ +
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv~ 88 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 88 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEEE
Confidence 3455555 8999999999999853 5788999999764 3445678999999999999999999999995544322 2
Q ss_pred eeec---------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 749 DCLH---------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 749 ~~l~---------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
++.. .....+++.....++.++++||.||| +.+|+||||||+||+ |||+++.......
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 165 (287)
T 1u59_A 89 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165 (287)
T ss_dssp ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcc
Confidence 2221 12345788889999999999999996 568999999999998 9999987754332
Q ss_pred cc--cccceecccccccccC
Q 047196 810 MI--QTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~--~~~~~gt~~Y~APE~l 827 (827)
.. .....+|+.|+|||++
T Consensus 166 ~~~~~~~~~~~~~y~aPE~~ 185 (287)
T 1u59_A 166 YYTARSAGKWPLKWYAPECI 185 (287)
T ss_dssp EECCCCSSCCCGGGCCHHHH
T ss_pred eeeccccccccccccCHHHh
Confidence 21 1223368999999963
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=2e-19 Score=192.55 Aligned_cols=150 Identities=29% Similarity=0.481 Sum_probs=111.6
Q ss_pred HhhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc-----hHHHHHHHHHHHHHHhcC---CCCceEEEeeeecC
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC-----AMALKSFEAECEVMKNIR---HRNHVKRISSCSNE 743 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-----~~~~~~~~~Ei~~l~~l~---H~niv~~~~~~~~~ 743 (827)
..++|+..+.||+|+||.||+|+. .+|+.||||++.... ......+.+|++++++++ |||||++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 356899999999999999999996 568999999986322 111345677888777765 99999999998764
Q ss_pred Cc-----e--eeeeecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------e
Q 047196 744 DF-----K--ALDCLHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------D 797 (827)
Q Consensus 744 ~~-----~--~l~~l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------D 797 (827)
.. . ++++... ....+++.....++.++++||+||| +.+|+||||||+||+ |
T Consensus 87 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp CSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEECS
T ss_pred CCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEee
Confidence 41 1 2222221 1123788888999999999999996 567999999999998 9
Q ss_pred ecccccccCCCccccccceecccccccccC
Q 047196 798 FGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 798 FGla~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
||+|+....... .....||+.|+|||++
T Consensus 164 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~ 191 (308)
T 3g33_A 164 FGLARIYSYQMA--LTPVVVTLWYRAPEVL 191 (308)
T ss_dssp CSCTTTSTTCCC--SGGGGCCCSSCCHHHH
T ss_pred CccccccCCCcc--cCCccccccccCchHH
Confidence 999987643322 2335689999999963
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=7.3e-19 Score=178.33 Aligned_cols=133 Identities=20% Similarity=0.196 Sum_probs=67.3
Q ss_pred cEEECCCCCCCCCCC-ccccccccccEEecCCCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCC
Q 047196 431 QGLYLPFNKLAGSIP-DQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSS 509 (827)
Q Consensus 431 ~~L~Ls~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~ 509 (827)
+.|+|++|++++..| ..|..+++|+.|+|++|++++..|..|.++++|++|+|++|.+++..|..|..+++|++|+|++
T Consensus 35 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 114 (220)
T 2v70_A 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRS 114 (220)
T ss_dssp SEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTT
T ss_pred CEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCC
Confidence 344444444433322 2234444444444444444444444444455555555555555544444455555555555555
Q ss_pred CCCCCCCcccccccccCceEEcccceeeecccccccCCCCCCEEECCCCcceee
Q 047196 510 NSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGL 563 (827)
Q Consensus 510 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ 563 (827)
|++++..|..+..+++|+.|+|++|+|++..|..|..+++|+.|+|++|.+++.
T Consensus 115 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 115 NRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp SCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred CcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 555555555555555555555555555555555566666666666655555543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1.1e-19 Score=192.51 Aligned_cols=145 Identities=24% Similarity=0.387 Sum_probs=112.3
Q ss_pred hcccccceEecCCceEEEEEEec-CC-------cEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCce
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DG-------IEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFK 746 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g-------~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~ 746 (827)
++|...+.||+|+||.||+|+.. ++ ..||+|++........+.+.+|++++++++|||||++++++..++..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 57888899999999999999864 33 57999999766556667899999999999999999999999876654
Q ss_pred ee--eeecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee------------------e
Q 047196 747 AL--DCLHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------------------D 797 (827)
Q Consensus 747 ~l--~~l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------------------D 797 (827)
++ ++... ....+++..+..++.++++||+||| +++|+||||||+||+ |
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeecc
Confidence 44 33321 1123677788899999999999996 567999999999998 5
Q ss_pred ecccccccCCCccccccceecccccccccC
Q 047196 798 FGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 798 FGla~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
||+++.... .....||++|+|||++
T Consensus 165 fg~~~~~~~-----~~~~~~~~~y~aPE~~ 189 (289)
T 4fvq_A 165 PGISITVLP-----KDILQERIPWVPPECI 189 (289)
T ss_dssp CCSCTTTSC-----HHHHHHTTTTSCHHHH
T ss_pred CcccccccC-----ccccCCcCcccCHHHh
Confidence 555543321 1123479999999963
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=6.9e-19 Score=178.51 Aligned_cols=157 Identities=22% Similarity=0.250 Sum_probs=120.2
Q ss_pred ccEEEccCCcCccccCccccCCCCCceEeccCcccccccc-ccccCCCCCcEEECCCCCCCCCCCccccccccccEEecC
Q 047196 382 LENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIP-VTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLA 460 (827)
Q Consensus 382 L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 460 (827)
-+.+++++|.++. +|..+. ..++.|+|++|++++..| ..|..+++|+.|+|++|++++..+..|.++++|++|+|+
T Consensus 13 ~~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 89 (220)
T 2v70_A 13 GTTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLT 89 (220)
T ss_dssp TTEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECC
Confidence 3567777777764 555442 356778888888877654 346778888888888888877666677788888888888
Q ss_pred CCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccceeeecc
Q 047196 461 GNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDI 540 (827)
Q Consensus 461 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~i 540 (827)
+|++++..|..|..+++|++|+|++|.+++..|..|..+++|+.|+|++|++++..|..+..+++|+.|++++|.+++..
T Consensus 90 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 90 SNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp SSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred CCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCC
Confidence 88887766667778888888888888888877888888888888888888888877888888888888888888888755
Q ss_pred c
Q 047196 541 P 541 (827)
Q Consensus 541 p 541 (827)
+
T Consensus 170 ~ 170 (220)
T 2v70_A 170 Y 170 (220)
T ss_dssp G
T ss_pred c
Confidence 4
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=8.1e-19 Score=186.53 Aligned_cols=149 Identities=20% Similarity=0.275 Sum_probs=118.9
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEccc---chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN---CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALD 749 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~ 749 (827)
.++|...+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|++++++++|+|||++++++...+..++.
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 357888999999999999999875 5889999998653 234567899999999999999999999999887765543
Q ss_pred eeccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 750 CLHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 750 ~l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
..+.. ...+++.+...++.++++|++||| +.+|+||||||+||+ |||+++.......
T Consensus 94 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 94 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp EECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 33322 134677788899999999999996 568999999999998 9999987653332
Q ss_pred cccccceeccccccccc
Q 047196 810 MIQTETLVTIGYMAPGL 826 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~ 826 (827)
. .....||++|+|||+
T Consensus 171 ~-~~~~~~~~~y~aPE~ 186 (294)
T 2rku_A 171 R-KKVLCGTPNYIAPEV 186 (294)
T ss_dssp C-BCCCCSCCSSCCHHH
T ss_pred c-cccccCCCCcCCcch
Confidence 2 223458999999996
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.78 E-value=5.8e-19 Score=189.16 Aligned_cols=151 Identities=23% Similarity=0.297 Sum_probs=112.0
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALD 749 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~ 749 (827)
.++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++..++..++.
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 467899999999999999999865 68999999986542 23457899999999999999999999999877655443
Q ss_pred eeccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 750 CLHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 750 ~l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
..+.. ...+++.+...++.++++|++||| +.+|+||||||+||+ |||+++.......
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 32221 234677888899999999999996 568999999999998 9999887654332
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
.......||+.|+|||++
T Consensus 190 ~~~~~~~~~~~y~aPE~~ 207 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERF 207 (309)
T ss_dssp -------CCGGGCCGGGT
T ss_pred ccccccCCCcCccCHHHH
Confidence 222334589999999974
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=7.4e-19 Score=190.60 Aligned_cols=150 Identities=21% Similarity=0.282 Sum_probs=119.4
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEccc---chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN---CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALD 749 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~ 749 (827)
.++|...+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|++++++++|+|||++++++.+.+..++.
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 357888999999999999999875 5889999998653 234567899999999999999999999999887755543
Q ss_pred eeccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 750 CLHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 750 ~l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
..+.. ...+++.+...++.++++||+||| +.+|+||||||+||+ |||+++.......
T Consensus 120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196 (335)
T ss_dssp ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence 33222 134677788899999999999996 568999999999998 9999987653332
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
. .....||++|+|||++
T Consensus 197 ~-~~~~~gt~~y~aPE~~ 213 (335)
T 2owb_A 197 R-KKVLCGTPNYIAPEVL 213 (335)
T ss_dssp C-BCCCCSCCSSCCHHHH
T ss_pred c-ccccCCCccccCHHHh
Confidence 2 2234589999999963
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=2.7e-19 Score=195.44 Aligned_cols=151 Identities=27% Similarity=0.427 Sum_probs=116.5
Q ss_pred hhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc-----
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF----- 745 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~----- 745 (827)
.++|+..+.||+|+||.||+|+. .+|+.||||++.... ......+.+|++++++++|||||++++++.....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36788999999999999999987 578999999985432 2234578899999999999999999999876431
Q ss_pred -----eeeeeecc--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccc
Q 047196 746 -----KALDCLHS--------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGR 802 (827)
Q Consensus 746 -----~~l~~l~~--------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~ 802 (827)
.++++... ....+++.+...++.++++||+||| +.+|+||||||+||+ |||+|+
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 22333221 2245788889999999999999996 568999999999998 999998
Q ss_pred cccCCCcc---ccccceecccccccccC
Q 047196 803 LLTGDRSM---IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 803 ~~~~~~~~---~~~~~~gt~~Y~APE~l 827 (827)
.+...... .....+||++|+|||++
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 200 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELL 200 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHH
T ss_pred cccccccccccccCCcccccCccCchhh
Confidence 76432211 12334589999999963
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1.1e-19 Score=196.63 Aligned_cols=148 Identities=22% Similarity=0.297 Sum_probs=115.9
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCceee--ee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFKAL--DC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~l--~~ 750 (827)
++|...+.||+|+||.||+|+. .+|+.||||++..... .+.+.+|+++++++ +|+||+++++++...+..++ ++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 5788899999999999999986 5789999999865422 34588999999999 99999999999988765444 33
Q ss_pred ecc--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------------eecccccccCC
Q 047196 751 LHS--------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---------------DFGIGRLLTGD 807 (827)
Q Consensus 751 l~~--------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---------------DFGla~~~~~~ 807 (827)
+.. ....+++.....++.++++||+||| +.+|+||||||+||+ |||+|+.+...
T Consensus 87 ~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 87 LGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred CCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence 311 1245788888999999999999996 568999999999997 89999876443
Q ss_pred Cccc------cccceecccccccccC
Q 047196 808 RSMI------QTETLVTIGYMAPGLL 827 (827)
Q Consensus 808 ~~~~------~~~~~gt~~Y~APE~l 827 (827)
.... .....||+.|+|||++
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~ 189 (330)
T 2izr_A 164 ETKKHIPYREHKSLTGTARYMSINTH 189 (330)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHH
T ss_pred CCCccccccccCCcCCCccccChHHH
Confidence 2211 1234599999999963
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=3e-19 Score=190.60 Aligned_cols=150 Identities=25% Similarity=0.463 Sum_probs=113.9
Q ss_pred hcccccceEecCCceEEEEEEe-----cCCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecC--Cce
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-----HDGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNE--DFK 746 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-----~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~--~~~ 746 (827)
+.|+..+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4578889999999999999984 368999999997442 23356799999999999999999999998775 322
Q ss_pred --eeeeecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eeccccccc
Q 047196 747 --ALDCLHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLT 805 (827)
Q Consensus 747 --~l~~l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~ 805 (827)
.+++... ....+++.+...++.+++.||+||| +.+|+||||||+||+ |||+++...
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence 2333321 1234677888899999999999996 568999999999998 999998775
Q ss_pred CCCcc--ccccceecccccccccC
Q 047196 806 GDRSM--IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 806 ~~~~~--~~~~~~gt~~Y~APE~l 827 (827)
..... ......||..|+|||++
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~ 201 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECL 201 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHH
T ss_pred CCCcceeccCCCCCCccccCCeee
Confidence 44322 12233478899999963
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.78 E-value=1.6e-19 Score=194.64 Aligned_cols=156 Identities=24% Similarity=0.346 Sum_probs=119.2
Q ss_pred hHHHHHhhcccccceEecCCceEEEEEEec------CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeee
Q 047196 668 QDLFRATEKFSKENLIGVGSFGSVYKGRLH------DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSC 740 (827)
Q Consensus 668 ~~~~~~~~~~~~~~~iG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~ 740 (827)
+++....++|...+.||+|+||.||+|+.. +++.||||++.... .....+|.+|++++++++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 344445678999999999999999999754 36889999987543 34456799999999999999999999999
Q ss_pred ecCCceeeeeeccCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----
Q 047196 741 SNEDFKALDCLHSTN--------------------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---- 796 (827)
Q Consensus 741 ~~~~~~~l~~l~~~~--------------------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---- 796 (827)
...+..++...+... ..+++.....++.++++||+||| +.+|+||||||+||+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCC
Confidence 876654442222211 23466778889999999999996 568999999999998
Q ss_pred ------eecccccccCCCcc-ccccceeccccccccc
Q 047196 797 ------DFGIGRLLTGDRSM-IQTETLVTIGYMAPGL 826 (827)
Q Consensus 797 ------DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~ 826 (827)
|||+++........ ......||++|+|||+
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 211 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES 211 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHH
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhh
Confidence 99999866433221 1223357899999996
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.78 E-value=2.4e-19 Score=190.13 Aligned_cols=148 Identities=27% Similarity=0.475 Sum_probs=105.6
Q ss_pred hhcccccceEecCCceEEEEEEecCCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCcee-eee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKA-LDC 750 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~-l~~ 750 (827)
.++|...+.||+|+||.||+|+... .||||++... .....+.|.+|++++++++|+|++++++++......+ +++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~ 100 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQW 100 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEEEe
Confidence 3568888999999999999998653 5999998643 3445678999999999999999999999876554322 222
Q ss_pred ec---------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc-
Q 047196 751 LH---------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM- 810 (827)
Q Consensus 751 l~---------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~- 810 (827)
+. .....+++.+...++.++++||+||| +.+|+||||||+||+ |||+++........
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (289)
T 3og7_A 101 CEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177 (289)
T ss_dssp CCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred cCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccccccccc
Confidence 21 22345778888999999999999996 568999999999998 99999865432221
Q ss_pred ccccceeccccccccc
Q 047196 811 IQTETLVTIGYMAPGL 826 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~ 826 (827)
......||+.|+|||+
T Consensus 178 ~~~~~~gt~~y~aPE~ 193 (289)
T 3og7_A 178 QFEQLSGSILWMAPEV 193 (289)
T ss_dssp ------CCCTTCCHHH
T ss_pred cccccCCCccccCchh
Confidence 1222458999999996
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.78 E-value=2.2e-19 Score=197.27 Aligned_cols=147 Identities=24% Similarity=0.404 Sum_probs=109.7
Q ss_pred hhcccccceEecCCceEEEEEEe-cCCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC------
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNED------ 744 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~------ 744 (827)
.++|...+.||+|+||.||+|+. .+|+.||||++... .....+++.+|++++++++|||||++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 35688889999999999999986 46999999998543 2344567899999999999999999999986643
Q ss_pred --ceeeeeecc------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccC
Q 047196 745 --FKALDCLHS------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806 (827)
Q Consensus 745 --~~~l~~l~~------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~ 806 (827)
+.+++++.. ....+++.....++.|+++||+||| +.+|+||||||+||+ |||+|+....
T Consensus 104 ~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 104 DFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp CCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 223333211 1235677778889999999999996 568999999999998 9999987543
Q ss_pred CCccccccceecccccccccC
Q 047196 807 DRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 807 ~~~~~~~~~~gt~~Y~APE~l 827 (827)
. .+..+||++|+|||++
T Consensus 181 ~----~~~~~~t~~y~aPE~~ 197 (367)
T 1cm8_A 181 E----MTGYVVTRWYRAPEVI 197 (367)
T ss_dssp S----CCSSCSCGGGCCTHHH
T ss_pred c----cCcCcCCCCcCCHHHH
Confidence 2 2334689999999963
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.78 E-value=3.7e-19 Score=195.36 Aligned_cols=150 Identities=25% Similarity=0.366 Sum_probs=116.7
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC-------
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNED------- 744 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~------- 744 (827)
.++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++|||||++++++....
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 457999999999999999999864 68899999997432 344578999999999999999999999986543
Q ss_pred ceeeeeecc------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 745 FKALDCLHS------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 745 ~~~l~~l~~------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
+.+++++.. ....+++.....++.++++||+||| +.+|+||||||+||+ |||+++......
T Consensus 106 ~iv~e~~~~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 106 YIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEcccCcCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 122222221 1234677888899999999999996 568999999999998 999998764332
Q ss_pred ccc--cccceeccccccccc
Q 047196 809 SMI--QTETLVTIGYMAPGL 826 (827)
Q Consensus 809 ~~~--~~~~~gt~~Y~APE~ 826 (827)
... ....+||++|+|||+
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~ 202 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEI 202 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHH
T ss_pred CccccccccccccCCCCCHH
Confidence 211 233468999999996
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1.8e-19 Score=205.71 Aligned_cols=149 Identities=26% Similarity=0.446 Sum_probs=119.2
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALD 749 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~ 749 (827)
.++|...++||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++......++.
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 357888999999999999999875 78999999986432 23456799999999999999999999999887755543
Q ss_pred eecc----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------eecccccccC
Q 047196 750 CLHS----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------DFGIGRLLTG 806 (827)
Q Consensus 750 ~l~~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------------DFGla~~~~~ 806 (827)
..+. ....+++.....++.++++||+||| +.+|+||||||+||+ |||+|+....
T Consensus 105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 3222 1235677888899999999999996 568999999999998 9999987654
Q ss_pred CCccccccceecccccccccC
Q 047196 807 DRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 807 ~~~~~~~~~~gt~~Y~APE~l 827 (827)
... ....+||++|+|||++
T Consensus 182 ~~~--~~~~~gt~~y~aPE~~ 200 (484)
T 3nyv_A 182 SKK--MKDKIGTAYYIAPEVL 200 (484)
T ss_dssp CCS--HHHHTTGGGTCCHHHH
T ss_pred ccc--cccCCCCccccCceee
Confidence 332 2234599999999973
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=7.8e-20 Score=197.36 Aligned_cols=148 Identities=26% Similarity=0.376 Sum_probs=109.2
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchH-HHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAM-ALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
++|...+.||+|+||.||+|+.. +|+.||||++...... ....+.+|++++++++|||||++++++..+...++...+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888899999999999999875 6899999998654322 222456899999999999999999999877654442222
Q ss_pred c----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 753 S----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 753 ~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
. ....+++.....++.++++||+||| +.+|+||||||+||+ |||+++........ .
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~-~ 157 (324)
T 3mtl_A 82 LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT-Y 157 (324)
T ss_dssp CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred cccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc-c
Confidence 1 1234677788889999999999996 568999999999998 99999865433221 2
Q ss_pred ccceeccccccccc
Q 047196 813 TETLVTIGYMAPGL 826 (827)
Q Consensus 813 ~~~~gt~~Y~APE~ 826 (827)
....||++|+|||+
T Consensus 158 ~~~~~t~~y~aPE~ 171 (324)
T 3mtl_A 158 DNEVVTLWYRPPDI 171 (324)
T ss_dssp -----CGGGCCHHH
T ss_pred ccccCcccccChhh
Confidence 23458999999996
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=4.7e-19 Score=196.82 Aligned_cols=147 Identities=25% Similarity=0.393 Sum_probs=115.8
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC--c--eee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNED--F--KAL 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~--~--~~l 748 (827)
++|...++||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.... . .++
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 56888999999999999999875 58999999997543 233567889999999999999999999987654 2 223
Q ss_pred eeeccC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee--------------eeccccc
Q 047196 749 DCLHST-----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF--------------DFGIGRL 803 (827)
Q Consensus 749 ~~l~~~-----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl--------------DFGla~~ 803 (827)
+++... ...+++.....++.+++.||+||| +.+|+||||||+||+ |||+|+.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 333211 112788889999999999999996 568999999999996 9999987
Q ss_pred ccCCCccccccceeccccccccc
Q 047196 804 LTGDRSMIQTETLVTIGYMAPGL 826 (827)
Q Consensus 804 ~~~~~~~~~~~~~gt~~Y~APE~ 826 (827)
...... .....||+.|+|||+
T Consensus 166 ~~~~~~--~~~~~gt~~y~aPE~ 186 (396)
T 4eut_A 166 LEDDEQ--FVSLYGTEEYLHPDM 186 (396)
T ss_dssp CCCGGG--SSCSSSCCTTCCHHH
T ss_pred ccCCCc--cccccCCccccCHHH
Confidence 654322 223458999999996
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=8.5e-20 Score=197.15 Aligned_cols=150 Identities=25% Similarity=0.413 Sum_probs=110.7
Q ss_pred hcccccceEecCCceEEEEEEec-CCcE----EEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCcee-
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIE----VAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKA- 747 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~----vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~- 747 (827)
++|...+.||+|+||.||+|+.. +|+. ||+|++.... ....+++.+|+.++++++|||||+++++|.+....+
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v 92 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLV 92 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEEE
Confidence 46888899999999999999864 4543 7888875432 223356788999999999999999999987554322
Q ss_pred eeeecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 748 LDCLHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 748 l~~l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
++++.. ....+++.....++.++++||+||| +.+|+||||||+||+ |||+|+......
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 169 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169 (325)
T ss_dssp EECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred EEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence 222221 1235667778899999999999996 567999999999998 999999875443
Q ss_pred ccc-cccceecccccccccC
Q 047196 809 SMI-QTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~-~~~~~gt~~Y~APE~l 827 (827)
... .....||++|+|||++
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~ 189 (325)
T 3kex_A 170 KQLLYSEAKTPIKWMALESI 189 (325)
T ss_dssp TCCC-----CCTTTSCHHHH
T ss_pred ccccccCCCCcccccChHHh
Confidence 322 2233478899999963
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.78 E-value=6.8e-19 Score=184.62 Aligned_cols=148 Identities=26% Similarity=0.443 Sum_probs=106.7
Q ss_pred hcccccceEecCCceEEEEEEecCCcEEEEEEEcccch----HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee--
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCA----MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL-- 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~----~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l-- 748 (827)
++|+..+.||+|+||.||+|+.. |+.||||++..... ...+.+.+|++++++++||||+++++++..++..++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 57888899999999999999975 78999999864322 234678999999999999999999999987765444
Q ss_pred eeecc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee------------------eeccccc
Q 047196 749 DCLHS-------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------------------DFGIGRL 803 (827)
Q Consensus 749 ~~l~~-------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------------------DFGla~~ 803 (827)
++... ....+++.....++.++++|++|||.....+|+||||||+||+ |||+++.
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~ 165 (271)
T 3dtc_A 86 EFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE 165 (271)
T ss_dssp ECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---
T ss_pred EcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccc
Confidence 33221 1345778888999999999999998644445999999999997 7888876
Q ss_pred ccCCCccccccceeccccccccc
Q 047196 804 LTGDRSMIQTETLVTIGYMAPGL 826 (827)
Q Consensus 804 ~~~~~~~~~~~~~gt~~Y~APE~ 826 (827)
...... ....||++|+|||+
T Consensus 166 ~~~~~~---~~~~~~~~y~aPE~ 185 (271)
T 3dtc_A 166 WHRTTK---MSAAGAYAWMAPEV 185 (271)
T ss_dssp -------------CCGGGSCHHH
T ss_pred cccccc---cCCCCccceeCHHH
Confidence 543222 23458999999996
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.78 E-value=2.7e-19 Score=206.37 Aligned_cols=151 Identities=26% Similarity=0.446 Sum_probs=116.8
Q ss_pred HhhcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCce-eeeee
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFK-ALDCL 751 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~-~l~~l 751 (827)
..++|...+.||+|+||.||+|++.++..||||++.... ...++|.+|+++|++++|+|||++++++.++... +++++
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~e~~ 343 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYM 343 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEeeehh
Confidence 345688889999999999999999888889999997543 2346799999999999999999999998764432 22332
Q ss_pred ccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 752 HST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 752 ~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
... ...+.+.+...|+.++++||+||| +++|+||||||+||| |||+++.........
T Consensus 344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 420 (535)
T 2h8h_A 344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420 (535)
T ss_dssp TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT
T ss_pred cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec
Confidence 211 134677888999999999999996 568999999999998 999998764322111
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
.....++..|+|||++
T Consensus 421 ~~~~~~~~~y~aPE~~ 436 (535)
T 2h8h_A 421 RQGAKFPIKWTAPEAA 436 (535)
T ss_dssp TCSTTSCGGGSCHHHH
T ss_pred ccCCcCcccccCHHHh
Confidence 2223368899999963
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.78 E-value=6.1e-19 Score=190.09 Aligned_cols=148 Identities=22% Similarity=0.367 Sum_probs=117.1
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccch------HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCce
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA------MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFK 746 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~------~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~ 746 (827)
.+.|...+.||+|+||.||+|+.. +|+.||||++..... ...+++.+|++++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 356888999999999999999875 689999999865321 1356799999999999999999999999887655
Q ss_pred eeeeeccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee--------------eecccc
Q 047196 747 ALDCLHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF--------------DFGIGR 802 (827)
Q Consensus 747 ~l~~l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl--------------DFGla~ 802 (827)
++...+.. ...+++.....++.++++||+||| +.+|+||||||+||+ |||+++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 44333221 234567778899999999999996 568999999999997 899887
Q ss_pred cccCCCccccccceeccccccccc
Q 047196 803 LLTGDRSMIQTETLVTIGYMAPGL 826 (827)
Q Consensus 803 ~~~~~~~~~~~~~~gt~~Y~APE~ 826 (827)
....... .....||+.|+|||+
T Consensus 168 ~~~~~~~--~~~~~gt~~y~aPE~ 189 (321)
T 2a2a_A 168 EIEDGVE--FKNIFGTPEFVAPEI 189 (321)
T ss_dssp ECCTTCC--CCCCCSCGGGCCHHH
T ss_pred ecCcccc--ccccCCCCCccCccc
Confidence 7654322 123458999999996
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.78 E-value=4.1e-19 Score=196.45 Aligned_cols=146 Identities=24% Similarity=0.347 Sum_probs=111.2
Q ss_pred HHhhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC------
Q 047196 672 RATEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNED------ 744 (827)
Q Consensus 672 ~~~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~------ 744 (827)
...++|...+.||+|+||.||+|+. .+|+.||||++..... ...+|+++++.++|||||++++++....
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 3456899999999999999999986 5799999999865422 2347999999999999999999884421
Q ss_pred --------------------------------ce--eeeeecc-----------CCCCCCHHHHHHHHHHHHHHHHHHHh
Q 047196 745 --------------------------------FK--ALDCLHS-----------TNCSLNIFDKLNIMIDVASALEYLHF 779 (827)
Q Consensus 745 --------------------------------~~--~l~~l~~-----------~~~~l~~~~~~~i~~~ia~~L~~Lh~ 779 (827)
+. +++++.. ....+.+.....++.++++||+|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH- 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH- 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-
Confidence 11 2222221 1245677788899999999999996
Q ss_pred cCCCCeEEccCCCccee-----------eecccccccCCCccccccceeccccccccc
Q 047196 780 SHSTPVIHCDLKPKNVF-----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGL 826 (827)
Q Consensus 780 ~h~~~iiHrDlK~~NIl-----------DFGla~~~~~~~~~~~~~~~gt~~Y~APE~ 826 (827)
+.+|+||||||+||+ |||+|+........ ....||+.|+|||+
T Consensus 159 --~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~ 212 (383)
T 3eb0_A 159 --SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS--VAYICSRFYRAPEL 212 (383)
T ss_dssp --TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC--CCCCCCSSCCCHHH
T ss_pred --HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC--cCcccCCCccCHHH
Confidence 678999999999998 99999876544322 33458999999996
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1e-18 Score=184.73 Aligned_cols=147 Identities=24% Similarity=0.358 Sum_probs=115.0
Q ss_pred HhhcccccceEecCCceEEEEEEec-CCcEEEEEEEccc--chHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCceee
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN--CAMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFKAL 748 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~l 748 (827)
..++|+..+.||+|+||.||+|+.. +++.||||++... ......++.+|+..+.++ +|||||++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3467999999999999999999875 7899999998753 233456788999999999 99999999999988776554
Q ss_pred eeeccCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee------------------
Q 047196 749 DCLHSTN--------------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------------------ 796 (827)
Q Consensus 749 ~~l~~~~--------------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------------------ 796 (827)
...+... ..+++.....++.++++||+||| +.+|+||||||+||+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 3333221 34677788899999999999996 568999999999987
Q ss_pred -----------eecccccccCCCccccccceecccccccccC
Q 047196 797 -----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 -----------DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
|||.++..... ....||+.|+|||++
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~ 202 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVL 202 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHH
T ss_pred ccCCceEEEEcccccccccCCc-----cccCCCccccChhHh
Confidence 55655544322 123489999999963
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.78 E-value=8.3e-19 Score=184.94 Aligned_cols=147 Identities=27% Similarity=0.392 Sum_probs=113.6
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA---MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALD 749 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~ 749 (827)
.++|+..+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++++.+....++.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467899999999999999999865 578999999864321 2245789999999999999999999999887655443
Q ss_pred eeccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 750 CLHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 750 ~l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
..+.. ...+++.....++.+++.|++||| +.+|+||||||+||+ |||++........
T Consensus 88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 164 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 164 (279)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCcccc
Confidence 32221 134677788899999999999996 678999999999998 9998865433221
Q ss_pred cccccceeccccccccc
Q 047196 810 MIQTETLVTIGYMAPGL 826 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~ 826 (827)
....||+.|+|||+
T Consensus 165 ---~~~~~~~~y~aPE~ 178 (279)
T 3fdn_A 165 ---TDLCGTLDYLPPEM 178 (279)
T ss_dssp ------CCCCTTCCHHH
T ss_pred ---cccCCCCCccCHhH
Confidence 23458999999996
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.78 E-value=4.9e-19 Score=194.01 Aligned_cols=176 Identities=23% Similarity=0.211 Sum_probs=94.0
Q ss_pred cEEEccCCcCccccCccccCCCCCceEeccCcccccccccccc-CCCCCcEEECCCCCCCCCCCccccccccccEEecCC
Q 047196 383 ENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFG-RLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAG 461 (827)
Q Consensus 383 ~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~-~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 461 (827)
+.+++++++++. +|..+. +.++.|+|++|++++..+..|. ++++|+.|+|++|++++..|..|.++++|+.|+|++
T Consensus 21 ~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 445555555553 343322 3355556666655555555554 555566666665655554455555555566666666
Q ss_pred CcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccc---cccccCceEEcccceeee
Q 047196 462 NKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDI---GNLRVVIGINLSRNNFSG 538 (827)
Q Consensus 462 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~---~~l~~L~~L~Ls~N~l~g 538 (827)
|++++..+..|.++++|++|+|++|.+++..|..|.++++|+.|+|++|++++..+..+ ..++.|+.|||++|+|++
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 65555444455555556666666665555555555555555555555555554333333 345555555555555554
Q ss_pred cccccccCCCC--CCEEECCCCcce
Q 047196 539 DIPSTIGDLKD--LQNISLACNGLE 561 (827)
Q Consensus 539 ~ip~~~~~l~~--L~~L~Ls~N~l~ 561 (827)
..+..+..++. ++.|+|++|.+.
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred cCHHHhhhccHhhcceEEecCCCcc
Confidence 44444555444 245555555543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=6.9e-19 Score=190.65 Aligned_cols=151 Identities=25% Similarity=0.428 Sum_probs=116.2
Q ss_pred HhhcccccceEecCCceEEEEEEec-CC-----cEEEEEEEcccc-hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCC
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLH-DG-----IEVAIKVFHQNC-AMALKSFEAECEVMKNI-RHRNHVKRISSCSNED 744 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~g-----~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~ 744 (827)
..++|...+.||+|+||.||+|+.. ++ ..||||++.... ....+.+.+|+++++++ +|||||++++++...+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 3467888899999999999999864 23 479999997543 34557799999999999 8999999999998766
Q ss_pred ceeeeeeccC------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----
Q 047196 745 FKALDCLHST------------------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---- 796 (827)
Q Consensus 745 ~~~l~~l~~~------------------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---- 796 (827)
..++...+.. ...+++.....++.++++||+||| +.+|+||||||+||+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCC
Confidence 5444222211 123567778899999999999996 568999999999998
Q ss_pred ------eecccccccCCCccc-cccceeccccccccc
Q 047196 797 ------DFGIGRLLTGDRSMI-QTETLVTIGYMAPGL 826 (827)
Q Consensus 797 ------DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~ 826 (827)
|||+++......... .....||++|+|||+
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 237 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPES 237 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHH
Confidence 999998765443221 223447899999996
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.77 E-value=6.8e-19 Score=188.10 Aligned_cols=148 Identities=28% Similarity=0.403 Sum_probs=114.2
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
.++|...+.||+|+||.||+|+.. +|+.||||++........+.+.+|++++++++||||+++++++......++...+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 457888999999999999999865 6899999999765444456789999999999999999999999877655443322
Q ss_pred cC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------eecccccccCCCc
Q 047196 753 ST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------DFGIGRLLTGDRS 809 (827)
Q Consensus 753 ~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------------DFGla~~~~~~~~ 809 (827)
.. ...+++.....++.++++|++||| +.+|+||||||+||+ |||+++......
T Consensus 88 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~- 163 (304)
T 2jam_A 88 VSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI- 163 (304)
T ss_dssp CCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT-
T ss_pred CCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc-
Confidence 22 134567778889999999999996 568999999999987 899887543221
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
.....||++|+|||++
T Consensus 164 --~~~~~~~~~y~aPE~~ 179 (304)
T 2jam_A 164 --MSTACGTPGYVAPEVL 179 (304)
T ss_dssp --THHHHSCCCBCCTTTB
T ss_pred --cccccCCCCccChHHh
Confidence 1223589999999974
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.77 E-value=3.7e-19 Score=197.37 Aligned_cols=144 Identities=26% Similarity=0.412 Sum_probs=111.1
Q ss_pred hcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc------e--
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF------K-- 746 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~------~-- 746 (827)
.+|...++||+|+||.||+|+...+..||||++..... ...+|+++++.++|||||++++++..... .
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 46888999999999999999987767799998854322 22479999999999999999999854321 2
Q ss_pred eeeeecc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------eecccccc
Q 047196 747 ALDCLHS-----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRLL 804 (827)
Q Consensus 747 ~l~~l~~-----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGla~~~ 804 (827)
+++++.. ....+.+.....++.|+++||+||| +.+|+||||||+||+ |||+|+..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 2233221 1345677778889999999999996 568999999999998 99999876
Q ss_pred cCCCccccccceecccccccccC
Q 047196 805 TGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 805 ~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
..... ....+||++|+|||++
T Consensus 193 ~~~~~--~~~~~~t~~y~aPE~~ 213 (394)
T 4e7w_A 193 IAGEP--NVSYICSRYYRAPELI 213 (394)
T ss_dssp CTTCC--CCSSCSCGGGCCHHHH
T ss_pred cCCCC--CcccccCcCccCHHHH
Confidence 44332 2334689999999963
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.77 E-value=1.3e-18 Score=182.93 Aligned_cols=151 Identities=22% Similarity=0.325 Sum_probs=119.0
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l 751 (827)
.++|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+....++...
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467889999999999999999875 68999999986432 3345789999999999999999999999987765444222
Q ss_pred cc----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc-
Q 047196 752 HS----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM- 810 (827)
Q Consensus 752 ~~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~- 810 (827)
+. ....+++.....++.++++||+||| +.+|+||||||+||+ |||+++........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 21 1234678888999999999999996 568999999999998 99999876433221
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
......||+.|+|||++
T Consensus 163 ~~~~~~~~~~y~aPE~~ 179 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELL 179 (276)
T ss_dssp CBCCCCSCGGGCCGGGG
T ss_pred cccCCccccCccChHHH
Confidence 12234589999999974
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.77 E-value=6.5e-19 Score=198.92 Aligned_cols=144 Identities=28% Similarity=0.435 Sum_probs=111.8
Q ss_pred hhcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC-cee--eee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNED-FKA--LDC 750 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~-~~~--l~~ 750 (827)
.++|...+.||+|+||.||+|++. |+.||||+++... ..+.|.+|++++++++|||||+++++|...+ ..+ +++
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 356888899999999999999876 7899999997543 4567999999999999999999999987654 223 333
Q ss_pred eccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 751 LHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 751 l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
+... ...+++.....++.++++||+||| +.+|+||||||+||| |||+++......
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 343 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 343 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--
Confidence 3221 112577788899999999999996 568999999999998 999998543221
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
....+|+.|+|||++
T Consensus 344 --~~~~~~~~y~aPE~~ 358 (450)
T 1k9a_A 344 --DTGKLPVKWTAPEAL 358 (450)
T ss_dssp -----CCCTTTSCHHHH
T ss_pred --cCCCCCcceeCHHHh
Confidence 122478899999963
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.4e-18 Score=176.35 Aligned_cols=151 Identities=25% Similarity=0.324 Sum_probs=79.9
Q ss_pred cEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCC
Q 047196 383 ENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGN 462 (827)
Q Consensus 383 ~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 462 (827)
+.+++++++++ .+|..+. ++|+.|++++|++++..+..|..+++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 45666666666 3444332 45666666666666555555666666666666666666555555555555555555555
Q ss_pred cccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEccccee
Q 047196 463 KFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNF 536 (827)
Q Consensus 463 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l 536 (827)
+++...+..|..+++|++|+|++|.+++..|..|..+++|+.|+|++|++++..+..+..++.|+.|++++|.+
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~ 164 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCE
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCc
Confidence 55543333345555555555555555554444444444444444444444443333333333333344443333
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=1e-18 Score=188.79 Aligned_cols=149 Identities=27% Similarity=0.432 Sum_probs=116.5
Q ss_pred hcccccceEecCCceEEEEEEe-----cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC----c
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-----HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNED----F 745 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~----~ 745 (827)
++|+..+.||+|+||.||+|++ .+|+.||||++........+.+.+|++++++++|||||++++++...+ +
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4678889999999999999984 368999999998766666778999999999999999999999886543 2
Q ss_pred eeeeeecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccC
Q 047196 746 KALDCLHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806 (827)
Q Consensus 746 ~~l~~l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~ 806 (827)
.++++... ....+++.+...++.++++||+||| +.+|+||||||+||+ |||+++....
T Consensus 121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 23333321 1234778888999999999999996 568999999999998 9999987754
Q ss_pred CCccc--cccceeccccccccc
Q 047196 807 DRSMI--QTETLVTIGYMAPGL 826 (827)
Q Consensus 807 ~~~~~--~~~~~gt~~Y~APE~ 826 (827)
..... .....++..|+|||+
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~ 219 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPES 219 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHH
T ss_pred cccccccccCCCCceeEECchh
Confidence 43221 122336888999996
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.5e-18 Score=176.04 Aligned_cols=153 Identities=23% Similarity=0.279 Sum_probs=107.4
Q ss_pred ceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCccccCCC
Q 047196 407 LLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSN 486 (827)
Q Consensus 407 ~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 486 (827)
+.+++++|.++. +|..+. ++|+.|+|++|++++..+..|..+++|+.|+|++|++++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~~-iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLTE-IPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCSS-CCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcCc-CCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 466777777763 444433 56777777777777665666777777777777777777666777777777777777777
Q ss_pred cccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccceeeecccccccCCCCCCEEECCCCccee
Q 047196 487 RLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEG 562 (827)
Q Consensus 487 ~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g 562 (827)
.+++..+..|.++++|+.|+|++|++++..|..+..++.|+.|+|++|+|++..+..|..+++|+.|+|++|.+..
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 7776666666777777777777777777767777777777777777777776666667777777777777777654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.77 E-value=5.7e-19 Score=189.77 Aligned_cols=150 Identities=25% Similarity=0.334 Sum_probs=111.2
Q ss_pred hcccc-cceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCceeeeee
Q 047196 675 EKFSK-ENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 675 ~~~~~-~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~l~~l 751 (827)
+.|.. .++||+|+||.||+|+. .+|+.||||++........+.+.+|++++.++ +|||||++++++...+..++...
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 34665 37899999999999985 46899999999765444567789999999995 79999999999988775554333
Q ss_pred ccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------eecccccccCCC
Q 047196 752 HST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------DFGIGRLLTGDR 808 (827)
Q Consensus 752 ~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------------DFGla~~~~~~~ 808 (827)
+.. ...+++.....++.++++||+||| +.+|+||||||+||+ |||+++......
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 168 (316)
T 2ac3_A 92 KMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168 (316)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred cCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence 322 134677778889999999999996 468999999999998 899887654221
Q ss_pred cc------ccccceecccccccccC
Q 047196 809 SM------IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~------~~~~~~gt~~Y~APE~l 827 (827)
.. .....+||+.|+|||++
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~ 193 (316)
T 2ac3_A 169 DCSPISTPELLTPCGSAEYMAPEVV 193 (316)
T ss_dssp -------------CCSGGGCCHHHH
T ss_pred ccccccccccccccCCcCccChHHh
Confidence 10 11223489999999963
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=2.9e-19 Score=191.78 Aligned_cols=157 Identities=19% Similarity=0.316 Sum_probs=117.9
Q ss_pred hhHHHHHhhcccccceEecCCceEEEEEEecCCcEEEEEEEccc--chHHHHHHHHHHHHHHhcC--CCCceEEEeeeec
Q 047196 667 YQDLFRATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQN--CAMALKSFEAECEVMKNIR--HRNHVKRISSCSN 742 (827)
Q Consensus 667 ~~~~~~~~~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~--H~niv~~~~~~~~ 742 (827)
++.+....++|...+.||+|+||.||+|+..+|+.||||++... .....+.+.+|++++++++ |+|++++++++..
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 33333445679999999999999999999888999999998643 3445678999999999998 4999999999988
Q ss_pred CCceeeeeecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------eecccccc
Q 047196 743 EDFKALDCLHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---------DFGIGRLL 804 (827)
Q Consensus 743 ~~~~~l~~l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---------DFGla~~~ 804 (827)
....++..... ....+++..+..++.++++||+||| +.+|+||||||+||+ |||+++..
T Consensus 100 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 100 DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGMLKLIDFGIANQM 176 (313)
T ss_dssp SSEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTEEEECCCSSSCC-
T ss_pred CCEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEECCeEEEeeccccccc
Confidence 77654432221 1235677888899999999999996 568999999999998 99999876
Q ss_pred cCCCccc-cccceeccccccccc
Q 047196 805 TGDRSMI-QTETLVTIGYMAPGL 826 (827)
Q Consensus 805 ~~~~~~~-~~~~~gt~~Y~APE~ 826 (827)
....... .....||+.|+|||+
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~ 199 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEA 199 (313)
T ss_dssp -------------CCGGGCCHHH
T ss_pred cCccccccccCCCCCCCcCCHHH
Confidence 5433221 223458999999996
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.3e-18 Score=184.46 Aligned_cols=168 Identities=29% Similarity=0.398 Sum_probs=116.7
Q ss_pred cccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecC
Q 047196 381 SLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLA 460 (827)
Q Consensus 381 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 460 (827)
+|+.|++++|.++.. + .+..+++|+.|++++|++++..+ +..+++|+.|++++|++++ +| .+..+++|+.|+++
T Consensus 47 ~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~ 120 (291)
T 1h6t_A 47 SIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLE 120 (291)
T ss_dssp TCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECT
T ss_pred cccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECC
Confidence 566677777766643 3 36667777777777777776544 6777777777777777764 23 36677777777777
Q ss_pred CCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccceeeecc
Q 047196 461 GNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDI 540 (827)
Q Consensus 461 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~i 540 (827)
+|++++. +.+..+++|++|++++|.+++. ..+..+++|+.|++++|.+++..| +..++.|+.|++++|+|++ +
T Consensus 121 ~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l 193 (291)
T 1h6t_A 121 HNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-L 193 (291)
T ss_dssp TSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-C
T ss_pred CCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC-C
Confidence 7777642 3566777777777777777764 456777777777777777776554 6777777777777777775 3
Q ss_pred cccccCCCCCCEEECCCCccee
Q 047196 541 PSTIGDLKDLQNISLACNGLEG 562 (827)
Q Consensus 541 p~~~~~l~~L~~L~Ls~N~l~g 562 (827)
| .+..+++|+.|++++|+++.
T Consensus 194 ~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 194 R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp G-GGTTCTTCSEEEEEEEEEEC
T ss_pred h-hhccCCCCCEEECcCCcccC
Confidence 3 37777777777777777765
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=3e-19 Score=209.02 Aligned_cols=143 Identities=24% Similarity=0.456 Sum_probs=106.9
Q ss_pred eEecCCceEEEEEEec---CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCce-eeeeecc---
Q 047196 682 LIGVGSFGSVYKGRLH---DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFK-ALDCLHS--- 753 (827)
Q Consensus 682 ~iG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~-~l~~l~~--- 753 (827)
.||+|+||.||+|.++ ++..||||+++... ....++|.+|++++++++|||||+++++|..+... +++++..
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~E~~~~g~L 422 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPL 422 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEEECCTTCBH
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEEEeCCCCcH
Confidence 7999999999999764 46789999997543 33467899999999999999999999999765432 2232221
Q ss_pred ------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc--ccc
Q 047196 754 ------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ--TET 815 (827)
Q Consensus 754 ------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~--~~~ 815 (827)
....+++.+...++.++++||+||| +.+|+||||||+||| |||+|+.......... ...
T Consensus 423 ~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 499 (613)
T 2ozo_A 423 HKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 499 (613)
T ss_dssp HHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------------
T ss_pred HHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCC
Confidence 2345788889999999999999996 568999999999998 9999987654332211 122
Q ss_pred eecccccccccC
Q 047196 816 LVTIGYMAPGLL 827 (827)
Q Consensus 816 ~gt~~Y~APE~l 827 (827)
.+|+.|||||++
T Consensus 500 ~~~~~y~APE~~ 511 (613)
T 2ozo_A 500 KWPLKWYAPECI 511 (613)
T ss_dssp --CCTTSCHHHH
T ss_pred CCccceeCHhhh
Confidence 357899999974
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.77 E-value=1.2e-18 Score=189.02 Aligned_cols=151 Identities=27% Similarity=0.404 Sum_probs=110.1
Q ss_pred HhhcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhc--CCCCceEEEeeeecC----Cce
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNI--RHRNHVKRISSCSNE----DFK 746 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l--~H~niv~~~~~~~~~----~~~ 746 (827)
..++|+..+.||+|+||.||+|+.. |+.||||++.... ...+.+|.+++... +|||||++++++... ...
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred cccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 3467999999999999999999876 8899999986432 23345555555554 999999999998776 333
Q ss_pred ee--eeeccC-------CCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEEccCCCccee----------eecccc
Q 047196 747 AL--DCLHST-------NCSLNIFDKLNIMIDVASALEYLHFS-----HSTPVIHCDLKPKNVF----------DFGIGR 802 (827)
Q Consensus 747 ~l--~~l~~~-------~~~l~~~~~~~i~~~ia~~L~~Lh~~-----h~~~iiHrDlK~~NIl----------DFGla~ 802 (827)
++ ++.... ...+.+.....++.+++.||+|||.. |.++|+||||||+||+ |||+|+
T Consensus 111 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 190 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 190 (337)
T ss_dssp EEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCce
Confidence 33 322211 13467778889999999999999853 3559999999999998 999997
Q ss_pred cccCCCccc---cccceecccccccccC
Q 047196 803 LLTGDRSMI---QTETLVTIGYMAPGLL 827 (827)
Q Consensus 803 ~~~~~~~~~---~~~~~gt~~Y~APE~l 827 (827)
......... .....||++|+|||++
T Consensus 191 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 218 (337)
T 3mdy_A 191 KFISDTNEVDIPPNTRVGTKRYMPPEVL 218 (337)
T ss_dssp ECC---------CCSSCSCGGGCCHHHH
T ss_pred eeccccccccCCCCCCccCcceeChhhc
Confidence 764433221 1234589999999963
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.77 E-value=1.1e-18 Score=184.15 Aligned_cols=147 Identities=25% Similarity=0.390 Sum_probs=114.2
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccch------HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCcee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA------MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKA 747 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~------~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~ 747 (827)
++|...+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++......+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56888999999999999999875 689999999865321 13567999999999999999999999998876554
Q ss_pred eeeeccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee--------------eeccccc
Q 047196 748 LDCLHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF--------------DFGIGRL 803 (827)
Q Consensus 748 l~~l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl--------------DFGla~~ 803 (827)
+...+.. ...+++.+...++.++++||+||| +.+|+||||||+||+ |||+++.
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 4333221 234677888899999999999996 568999999999997 8888876
Q ss_pred ccCCCccccccceeccccccccc
Q 047196 804 LTGDRSMIQTETLVTIGYMAPGL 826 (827)
Q Consensus 804 ~~~~~~~~~~~~~gt~~Y~APE~ 826 (827)
...... .....||+.|+|||+
T Consensus 162 ~~~~~~--~~~~~~~~~y~aPE~ 182 (283)
T 3bhy_A 162 IEAGNE--FKNIFGTPEFVAPEI 182 (283)
T ss_dssp CC----------CCCGGGCCHHH
T ss_pred ccCCCc--ccccCCCcCccCcce
Confidence 543322 123458999999996
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.77 E-value=1.4e-18 Score=187.89 Aligned_cols=144 Identities=22% Similarity=0.385 Sum_probs=114.0
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcC-CCCceEEEeeeecC--Cceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIR-HRNHVKRISSCSNE--DFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~--~~~~l~~ 750 (827)
++|+..+.||+|+||.||+|+. .+++.||||++.... .+.+.+|++++++++ ||||+++++++... ...++..
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 5788899999999999999986 578999999986443 356889999999998 99999999999873 3333322
Q ss_pred eccCC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------eecccccccCCCcccc
Q 047196 751 LHSTN-------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 751 l~~~~-------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGla~~~~~~~~~~~ 812 (827)
.+... ..+...+...++.++++||+||| +.+|+||||||+||+ |||+|+....... .
T Consensus 113 e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~ 187 (330)
T 3nsz_A 113 EHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--Y 187 (330)
T ss_dssp ECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC--C
T ss_pred eccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc--c
Confidence 22221 23667778899999999999996 568999999999998 9999987654332 2
Q ss_pred ccceeccccccccc
Q 047196 813 TETLVTIGYMAPGL 826 (827)
Q Consensus 813 ~~~~gt~~Y~APE~ 826 (827)
....||+.|+|||+
T Consensus 188 ~~~~~~~~y~aPE~ 201 (330)
T 3nsz_A 188 NVRVASRYFKGPEL 201 (330)
T ss_dssp CSCCSCGGGCCHHH
T ss_pred ccccccccccChhh
Confidence 23458999999996
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=7.6e-19 Score=190.21 Aligned_cols=148 Identities=30% Similarity=0.444 Sum_probs=113.2
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l 751 (827)
++|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++......++...
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 57888999999999999999875 58999999985432 3345678899999999999999999999988775444222
Q ss_pred cc----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 752 HS----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 752 ~~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
+. ....+++.....++.++++|++||| +.+|+||||||+||+ |||+++........
T Consensus 105 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 180 (331)
T 4aaa_A 105 FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV- 180 (331)
T ss_dssp CCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred cCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc-
Confidence 21 1345778888999999999999996 568999999999998 99999876543322
Q ss_pred cccceeccccccccc
Q 047196 812 QTETLVTIGYMAPGL 826 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~ 826 (827)
.....||++|+|||+
T Consensus 181 ~~~~~~t~~y~aPE~ 195 (331)
T 4aaa_A 181 YDDEVATRWYRAPEL 195 (331)
T ss_dssp ---CCCCCTTCCHHH
T ss_pred cCCCcCCccccCccc
Confidence 223458999999996
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.9e-19 Score=194.47 Aligned_cols=149 Identities=27% Similarity=0.451 Sum_probs=106.7
Q ss_pred hcccccceEecCCceEEEEEEec-CCcE----EEEEEEccc-chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIE----VAIKVFHQN-CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~----vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l 748 (827)
++|+..+.||+|+||.||+|+.. +++. ||+|.+... .....+++.+|++++++++|||||++++++......++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~v 94 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 94 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceEE
Confidence 56888999999999999999864 4543 577777543 23345789999999999999999999999987664332
Q ss_pred -eeec---------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 749 -DCLH---------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 749 -~~l~---------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
+++. .....+.+.....++.++++||+||| +.+|+||||||+||+ |||+++......
T Consensus 95 ~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~ 171 (327)
T 3lzb_A 95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp ECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence 2111 12345677888999999999999996 568999999999998 999998765433
Q ss_pred ccc-cccceeccccccccc
Q 047196 809 SMI-QTETLVTIGYMAPGL 826 (827)
Q Consensus 809 ~~~-~~~~~gt~~Y~APE~ 826 (827)
... .....+|+.|+|||+
T Consensus 172 ~~~~~~~~~~t~~y~aPE~ 190 (327)
T 3lzb_A 172 KEYHAEGGKVPIKWMALES 190 (327)
T ss_dssp --------CCCGGGSCHHH
T ss_pred ccccccCCCccccccCHHH
Confidence 221 122336889999996
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=2.6e-19 Score=199.54 Aligned_cols=147 Identities=26% Similarity=0.364 Sum_probs=99.2
Q ss_pred cccc-cceEecCCceEEEEEEec---CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeec--CCceee-
Q 047196 676 KFSK-ENLIGVGSFGSVYKGRLH---DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSN--EDFKAL- 748 (827)
Q Consensus 676 ~~~~-~~~iG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~--~~~~~l- 748 (827)
.|+. .++||+|+||.||+|+.. +++.||||++.... ..+.+.+|++++++++|||||++++++.. ....++
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 3554 458999999999999865 57889999986542 23467899999999999999999999854 333332
Q ss_pred -eeeccC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee--------------e
Q 047196 749 -DCLHST----------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF--------------D 797 (827)
Q Consensus 749 -~~l~~~----------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl--------------D 797 (827)
++.... ...+.+.....|+.+++.||+||| +.+|+||||||+||| |
T Consensus 99 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 99 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 222110 113677778899999999999996 567999999999997 9
Q ss_pred ecccccccCCCcc--ccccceecccccccccC
Q 047196 798 FGIGRLLTGDRSM--IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 798 FGla~~~~~~~~~--~~~~~~gt~~Y~APE~l 827 (827)
||+|+........ .....+||++|+|||++
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 207 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELL 207 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhh
Confidence 9999876533211 12334589999999963
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.77 E-value=1e-18 Score=191.42 Aligned_cols=159 Identities=23% Similarity=0.194 Sum_probs=126.4
Q ss_pred cccEEEccCCcCccccCcccc-CCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEec
Q 047196 381 SLENIYISNCNIGGSIPQLIS-NLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGL 459 (827)
Q Consensus 381 ~L~~L~Ls~N~l~g~~p~~~~-~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 459 (827)
.++.|+|++|++++..+..+. ++++|+.|+|++|+|++..|..|.++++|++|+|++|++++..+..|.++++|+.|+|
T Consensus 40 ~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 119 (361)
T 2xot_A 40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLL 119 (361)
T ss_dssp TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEEC
Confidence 577788888888877777776 7888888888888888777777888888888888888888766777888888888888
Q ss_pred CCCcccccCCccccCCCCCCccccCCCcccccCCccc---cccccccccCCCCCCCCCCCccccccccc--CceEEcccc
Q 047196 460 AGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTF---WNLKDILFFDLSSNSLDGPLSLDIGNLRV--VIGINLSRN 534 (827)
Q Consensus 460 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~LdLs~N~l~g~~p~~~~~l~~--L~~L~Ls~N 534 (827)
++|++++..|..|..+++|+.|+|++|.+++..+..| ..+++|+.|||++|+|++..+..+..++. ++.|+|++|
T Consensus 120 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N 199 (361)
T 2xot_A 120 YNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199 (361)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSS
T ss_pred CCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCC
Confidence 8888887778888888888888888888887555555 56788888888888888766667777766 377889998
Q ss_pred eeeec
Q 047196 535 NFSGD 539 (827)
Q Consensus 535 ~l~g~ 539 (827)
.+...
T Consensus 200 ~~~C~ 204 (361)
T 2xot_A 200 PLECD 204 (361)
T ss_dssp CEECC
T ss_pred CccCC
Confidence 88753
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.1e-18 Score=186.33 Aligned_cols=150 Identities=19% Similarity=0.331 Sum_probs=115.4
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc----hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC--ce
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC----AMALKSFEAECEVMKNIRHRNHVKRISSCSNED--FK 746 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~----~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~--~~ 746 (827)
.++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 367999999999999999999864 68999999996532 234567999999999999999999999985432 22
Q ss_pred --eeeeecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eeccccccc
Q 047196 747 --ALDCLHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLT 805 (827)
Q Consensus 747 --~l~~l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~ 805 (827)
++++... ....+++.....++.++++||+||| +.+|+||||||+||+ |||+++...
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 84 YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp EEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 2333221 1345778888999999999999996 568999999999998 999998764
Q ss_pred CCCcc-ccccceeccccccccc
Q 047196 806 GDRSM-IQTETLVTIGYMAPGL 826 (827)
Q Consensus 806 ~~~~~-~~~~~~gt~~Y~APE~ 826 (827)
..... ......||+.|+|||+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~ 182 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEI 182 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHH
T ss_pred ccccccccccCCCCCCCcChhh
Confidence 32221 1223458999999996
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=6.9e-19 Score=189.20 Aligned_cols=150 Identities=23% Similarity=0.255 Sum_probs=113.8
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecC----Cc--ee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNE----DF--KA 747 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~----~~--~~ 747 (827)
++|+..+.||+|+||.||+|+. .+|+.||||++........+.+.+|++++++++|||||++++++... .. .+
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 108 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL 108 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence 5788999999999999999986 57899999998766666677899999999999999999999998632 11 22
Q ss_pred eeeecc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eeccccccc
Q 047196 748 LDCLHS------------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLT 805 (827)
Q Consensus 748 l~~l~~------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~ 805 (827)
+++... ....+++.+...++.++++||+||| +.+|+||||||+||+ |||+++...
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 232221 1245778888999999999999996 458999999999998 999887643
Q ss_pred CCCccc--------cccceecccccccccC
Q 047196 806 GDRSMI--------QTETLVTIGYMAPGLL 827 (827)
Q Consensus 806 ~~~~~~--------~~~~~gt~~Y~APE~l 827 (827)
...... .....||+.|+|||++
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 215 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELF 215 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGS
T ss_pred cccccccccccccccccccCCcccCCHhHh
Confidence 211100 0123379999999974
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.77 E-value=6.7e-19 Score=193.81 Aligned_cols=146 Identities=25% Similarity=0.382 Sum_probs=112.7
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc-----
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF----- 745 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~----- 745 (827)
.++|...+.||+|+||.||+|+.. +|+.||||++... .....+++.+|++++++++|||||++++++...+.
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 357888899999999999999864 6899999999753 23345788999999999999999999999876542
Q ss_pred ---eeeeeecc-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCC
Q 047196 746 ---KALDCLHS-----TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGD 807 (827)
Q Consensus 746 ---~~l~~l~~-----~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~ 807 (827)
..++++.. ....+++.....++.++++||+||| +.+|+||||||+||+ |||+++.....
T Consensus 121 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 197 (371)
T 4exu_A 121 DFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 197 (371)
T ss_dssp CCEEEEECCCEEHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred eEEEEEccccccHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC
Confidence 23333221 1234788888999999999999996 568999999999998 99999865432
Q ss_pred Cccccccceeccccccccc
Q 047196 808 RSMIQTETLVTIGYMAPGL 826 (827)
Q Consensus 808 ~~~~~~~~~gt~~Y~APE~ 826 (827)
. ...+||++|+|||+
T Consensus 198 ~----~~~~~t~~y~aPE~ 212 (371)
T 4exu_A 198 M----TGYVVTRWYRAPEV 212 (371)
T ss_dssp ------CTTCCCTTSCHHH
T ss_pred c----CCcccCccccCHHH
Confidence 1 23458999999996
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.2e-18 Score=185.04 Aligned_cols=148 Identities=26% Similarity=0.397 Sum_probs=111.7
Q ss_pred cccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeeccC
Q 047196 676 KFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHST 754 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~~ 754 (827)
+|....+||+|+||.||+|+. .+++.||||++........+.+.+|++++++++|||||++++++...+..++...+..
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 345556899999999999986 4689999999976655556789999999999999999999999987765444222211
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------eecccccccCCCcc
Q 047196 755 -------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 755 -------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGla~~~~~~~~~ 810 (827)
.....+.....++.++++||+||| +.+|+||||||+||+ |||+++........
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~ 179 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence 123456667789999999999996 568999999999998 89998766433221
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
.....||++|+|||++
T Consensus 180 -~~~~~~~~~y~aPE~~ 195 (295)
T 2clq_A 180 -TETFTGTLQYMAPEII 195 (295)
T ss_dssp --CCCCCCGGGCCHHHH
T ss_pred -ccccCCCccccChhhh
Confidence 1234589999999963
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.77 E-value=5.9e-19 Score=189.53 Aligned_cols=156 Identities=21% Similarity=0.371 Sum_probs=117.7
Q ss_pred HHHHHhhcccccceEecCCceEEEEEEe------cCCcEEEEEEEcccc-hHHHHHHHHHHHHHHhc-CCCCceEEEeee
Q 047196 669 DLFRATEKFSKENLIGVGSFGSVYKGRL------HDGIEVAIKVFHQNC-AMALKSFEAECEVMKNI-RHRNHVKRISSC 740 (827)
Q Consensus 669 ~~~~~~~~~~~~~~iG~G~fg~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~ 740 (827)
+.....++|...+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+++++++ +|||||++++++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 3333457899999999999999999974 246889999997643 33456799999999999 689999999998
Q ss_pred ecCCc-e--eeeeecc---------CC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCc
Q 047196 741 SNEDF-K--ALDCLHS---------TN---------------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPK 793 (827)
Q Consensus 741 ~~~~~-~--~l~~l~~---------~~---------------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~ 793 (827)
...+. . ++++... .. ..+++.....++.++++||+||| +.+|+||||||+
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~ 177 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAAR 177 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGG
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccCccc
Confidence 76542 2 2232221 01 11567788899999999999996 568999999999
Q ss_pred cee----------eecccccccCCCccc-cccceecccccccccC
Q 047196 794 NVF----------DFGIGRLLTGDRSMI-QTETLVTIGYMAPGLL 827 (827)
Q Consensus 794 NIl----------DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l 827 (827)
||+ |||+++......... .....||++|+|||++
T Consensus 178 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 222 (316)
T 2xir_A 178 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 222 (316)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHH
T ss_pred eEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhh
Confidence 998 999998765443322 2234589999999963
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=1.5e-18 Score=189.66 Aligned_cols=150 Identities=24% Similarity=0.336 Sum_probs=114.0
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEccc-chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC-----ce
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN-CAMALKSFEAECEVMKNIRHRNHVKRISSCSNED-----FK 746 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~-----~~ 746 (827)
.++|...+.||+|+||.||+|+.. +|+.||||++... ......++.+|++++++++|||||++++++.... ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 367888999999999999999865 6899999999643 3344567889999999999999999999886542 22
Q ss_pred e--eeeecc------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 747 A--LDCLHS------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 747 ~--l~~l~~------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
+ +++... ....+++.....++.++++||+||| +.+|+||||||+||+ |||+++......
T Consensus 90 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (353)
T 2b9h_A 90 YIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166 (353)
T ss_dssp EEEECCCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEEEeccCccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence 2 222211 1234677888899999999999996 568999999999998 999998764322
Q ss_pred cc---------ccccceeccccccccc
Q 047196 809 SM---------IQTETLVTIGYMAPGL 826 (827)
Q Consensus 809 ~~---------~~~~~~gt~~Y~APE~ 826 (827)
.. .....+||+.|+|||+
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~ 193 (353)
T 2b9h_A 167 ADNSEPTGQQSGMVEFVATRWYRAPEV 193 (353)
T ss_dssp -------------CCCCCCGGGCCHHH
T ss_pred ccccCccccccchhhccccccccCCee
Confidence 11 0122358999999996
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.9e-18 Score=187.29 Aligned_cols=152 Identities=23% Similarity=0.306 Sum_probs=104.7
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcC-CCCceEEEeeeecC-------C-
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIR-HRNHVKRISSCSNE-------D- 744 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~-------~- 744 (827)
.+|...++||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++ |||||++++++... .
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 47888999999999999999864 68999999987666666778999999999996 99999999998421 1
Q ss_pred --ceeeeeecc----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccc
Q 047196 745 --FKALDCLHS----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGR 802 (827)
Q Consensus 745 --~~~l~~l~~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~ 802 (827)
+.++++... ....+++.+...++.++++||+|||. +.++|+||||||+||+ |||+++
T Consensus 108 ~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 186 (337)
T 3ll6_A 108 EFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSAT 186 (337)
T ss_dssp EEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCCCCCGGGCEECTTSCEEBCCCTTCB
T ss_pred eEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEEccCCcccEEECCCCCEEEecCccce
Confidence 112222211 12457888899999999999999973 2234999999999998 999998
Q ss_pred cccCCCccc-----------cccceecccccccccC
Q 047196 803 LLTGDRSMI-----------QTETLVTIGYMAPGLL 827 (827)
Q Consensus 803 ~~~~~~~~~-----------~~~~~gt~~Y~APE~l 827 (827)
......... .....||+.|+|||++
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 222 (337)
T 3ll6_A 187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEII 222 (337)
T ss_dssp CCSSCC------------------------------
T ss_pred eccccCcccccccccccchhhccccCCCCcCChhhh
Confidence 765432210 1123489999999974
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=1e-18 Score=187.96 Aligned_cols=149 Identities=27% Similarity=0.364 Sum_probs=109.2
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecC----------
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNE---------- 743 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~---------- 743 (827)
++|...+.||+|+||.||+|+.. +|+.||||++........+++.+|++++++++|||+|++++++...
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 56888899999999999999875 5899999999776666678899999999999999999999987432
Q ss_pred ----Ccee--eeeecc------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------eecc
Q 047196 744 ----DFKA--LDCLHS------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGI 800 (827)
Q Consensus 744 ----~~~~--l~~l~~------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGl 800 (827)
...+ +++... ....+.+.....++.++++||+||| +.+|+||||||+||+ |||+
T Consensus 91 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~ 167 (320)
T 2i6l_A 91 LTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGL 167 (320)
T ss_dssp CCSCSEEEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEECCCTT
T ss_pred ccccCceeEEeeccCCCHHHHhhcCCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEccCcc
Confidence 2222 222221 1234677788899999999999996 568999999999998 9999
Q ss_pred cccccCCCcc--ccccceeccccccccc
Q 047196 801 GRLLTGDRSM--IQTETLVTIGYMAPGL 826 (827)
Q Consensus 801 a~~~~~~~~~--~~~~~~gt~~Y~APE~ 826 (827)
++........ ......+|..|+|||+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 195 (320)
T 2i6l_A 168 ARIMDPHYSHKGHLSEGLVTKWYRSPRL 195 (320)
T ss_dssp CBCC--------CCCGGGSCCTTCCHHH
T ss_pred ccccCCCcccccccccccccccccCcHH
Confidence 9876432211 1122347999999996
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.76 E-value=4.1e-19 Score=194.93 Aligned_cols=147 Identities=24% Similarity=0.416 Sum_probs=101.6
Q ss_pred hhcccccceEecCCceEEEEEEe-cCCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecC------C
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNE------D 744 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~------~ 744 (827)
.++|...+.||+|+||.||+|+. .+|+.||||++... .....+++.+|++++++++|||||++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 36788899999999999999985 46899999998643 234557789999999999999999999988643 1
Q ss_pred --ceeeeeecc------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccC
Q 047196 745 --FKALDCLHS------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806 (827)
Q Consensus 745 --~~~l~~l~~------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~ 806 (827)
+.++++... ....+++.....++.++++||+||| +.+|+||||||+||+ |||+|+....
T Consensus 108 ~~~lv~e~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 108 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp CCEEEEECCCEECC-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred eEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 112222111 1235778888999999999999996 568999999999998 9999987543
Q ss_pred CCccccccceecccccccccC
Q 047196 807 DRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 807 ~~~~~~~~~~gt~~Y~APE~l 827 (827)
. .+..+||++|+|||++
T Consensus 185 ~----~~~~~~t~~y~aPE~~ 201 (367)
T 2fst_X 185 E----MTGYVATRWYRAPEIM 201 (367)
T ss_dssp ----------CCCTTCCHHHH
T ss_pred c----CCCcCcCcCccChHHH
Confidence 2 1334689999999963
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.76 E-value=8.7e-19 Score=189.89 Aligned_cols=150 Identities=24% Similarity=0.437 Sum_probs=108.6
Q ss_pred hcccccceEecCCceEEEEEEecC-----CcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHD-----GIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~-----g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l 748 (827)
.+|...+.||+|+||.||+|+... +..||||++.... ......+.+|++++++++|||||++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 356667899999999999998642 3469999997543 3445679999999999999999999999987665444
Q ss_pred eeecc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCC
Q 047196 749 DCLHS-----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGD 807 (827)
Q Consensus 749 ~~l~~-----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~ 807 (827)
...+. ....+++.+...++.++++||+||| +.+|+||||||+||+ |||+++.....
T Consensus 124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 22221 2245788889999999999999996 568999999999998 99999876543
Q ss_pred Cccc--cccceecccccccccC
Q 047196 808 RSMI--QTETLVTIGYMAPGLL 827 (827)
Q Consensus 808 ~~~~--~~~~~gt~~Y~APE~l 827 (827)
.... .....+|+.|+|||++
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~ 222 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAI 222 (333)
T ss_dssp ----------CCCGGGSCHHHH
T ss_pred cccccccCCCCccccccCchhc
Confidence 2211 1122368899999963
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.76 E-value=6.8e-19 Score=208.01 Aligned_cols=150 Identities=21% Similarity=0.189 Sum_probs=117.5
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCceee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFKAL 748 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~l 748 (827)
.++|+..++||+|+||.||+|+.. +++.||||++.... ....+.+.+|.+++..+ +|++|+++.+++...+..++
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 467899999999999999999865 68899999997532 22345788899999987 69999999999887765544
Q ss_pred eeeccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 749 DCLHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 749 ~~l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
...+... ..+++.....++.+++.||+||| +.+|+||||||+||| |||+|+......
T Consensus 420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence 3333221 35677788899999999999996 568999999999998 999998654333
Q ss_pred ccccccceecccccccccC
Q 047196 809 SMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~~~~~~gt~~Y~APE~l 827 (827)
.. ....+||++|||||++
T Consensus 497 ~~-~~~~~GT~~Y~APE~l 514 (674)
T 3pfq_A 497 VT-TKTFCGTPDYIAPEII 514 (674)
T ss_dssp CC-BCCCCSCSSSCCHHHH
T ss_pred cc-cccccCCCcccCHhhh
Confidence 22 2335699999999974
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.9e-18 Score=200.91 Aligned_cols=171 Identities=25% Similarity=0.369 Sum_probs=79.5
Q ss_pred CCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCc
Q 047196 314 SLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIG 393 (827)
Q Consensus 314 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~ 393 (827)
.+++|+.|++++|.+... | .+..+++|+.|+|++|.+++..| +..+. +|+.|+|++|+++
T Consensus 41 ~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~-----------------l~~l~-~L~~L~Ls~N~l~ 100 (605)
T 1m9s_A 41 ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP-----------------LTNLK-NLGWLFLDENKIK 100 (605)
T ss_dssp HHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG-----------------GGGCT-TCCEEECCSSCCC
T ss_pred cCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh-----------------hccCC-CCCEEECcCCCCC
Confidence 345556666666655432 2 34555555555555555443211 12222 4555555555554
Q ss_pred cccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCcccc
Q 047196 394 GSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLG 473 (827)
Q Consensus 394 g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 473 (827)
+ +| .+..+++|+.|+|++|++++. ..+..+++|+.|+|++|++++. ..+..+++|+.|+|++|++++..| +.
T Consensus 101 ~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~ 172 (605)
T 1m9s_A 101 D-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LA 172 (605)
T ss_dssp C-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GT
T ss_pred C-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hc
Confidence 3 12 344445555555555555432 2344445555555555555432 334444445555555555444333 44
Q ss_pred CCCCCCccccCCCcccccCCccccccccccccCCCCCCCCC
Q 047196 474 NLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDG 514 (827)
Q Consensus 474 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g 514 (827)
.+++|+.|+|++|.+++. ..+..+++|+.|+|++|.+++
T Consensus 173 ~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 173 GLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp TCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEEC
T ss_pred cCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcC
Confidence 444445555554444442 124444444444444444443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=2.6e-18 Score=184.90 Aligned_cols=148 Identities=21% Similarity=0.391 Sum_probs=113.9
Q ss_pred ccccceEecCCceEEEEEEec-----CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC--ce--
Q 047196 677 FSKENLIGVGSFGSVYKGRLH-----DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNED--FK-- 746 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~~-----~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~--~~-- 746 (827)
|+..+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|++++++++|||||++++++...+ ..
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 478899999999999998653 57899999997543 345678999999999999999999999998743 22
Q ss_pred eeeeecc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 747 ALDCLHS-------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 747 ~l~~l~~-------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
++++... ....+++.....++.+++.||+||| +.+|+||||||+||+ |||+++.......
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 189 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189 (318)
T ss_dssp EECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS
T ss_pred EEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccccccc
Confidence 2233221 1234678888999999999999996 568999999999998 9999987754432
Q ss_pred c--ccccceecccccccccC
Q 047196 810 M--IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~--~~~~~~gt~~Y~APE~l 827 (827)
. ......||+.|+|||++
T Consensus 190 ~~~~~~~~~~~~~y~aPE~~ 209 (318)
T 3lxp_A 190 YYRVREDGDSPVFWYAPECL 209 (318)
T ss_dssp EEEC---CCCCGGGCCHHHH
T ss_pred ccccccCCCCCceeeChHHh
Confidence 1 12223478899999963
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=8.6e-19 Score=188.11 Aligned_cols=151 Identities=23% Similarity=0.411 Sum_probs=106.4
Q ss_pred HhhcccccceEecCCceEEEEEEec----CCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc-
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLH----DGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF- 745 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~----~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~- 745 (827)
..++|...+.||+|+||.||+|+.. +++.||||++... .....+.+.+|++++++++||||+++++++.....
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 4467888899999999999999754 3458999998643 34455789999999999999999999999876542
Q ss_pred ------eeeeeecc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------
Q 047196 746 ------KALDCLHS--------------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF--------- 796 (827)
Q Consensus 746 ------~~l~~l~~--------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl--------- 796 (827)
.++++... ....+++.....++.++++||.||| +.+|+||||||+||+
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEE
Confidence 22332221 1234778889999999999999995 678999999999998
Q ss_pred -eecccccccCCCccc-cccceeccccccccc
Q 047196 797 -DFGIGRLLTGDRSMI-QTETLVTIGYMAPGL 826 (827)
Q Consensus 797 -DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~ 826 (827)
|||+++......... .....+++.|+|||+
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 220 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIES 220 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHH
T ss_pred eecCcceecccccccCcccccCCCccccCchh
Confidence 999998764432211 122337889999996
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.4e-18 Score=190.38 Aligned_cols=156 Identities=23% Similarity=0.293 Sum_probs=109.0
Q ss_pred hHHHHHhhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc-
Q 047196 668 QDLFRATEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF- 745 (827)
Q Consensus 668 ~~~~~~~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~- 745 (827)
.......++|...+.||+|+||.||+|+.. +|+.||||++.... ....++.+|++.++.++|||||++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 344566788999999999999999999874 68999999985542 223456788899999999999999999855221
Q ss_pred ------e--eeeeecc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------
Q 047196 746 ------K--ALDCLHS-----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---------- 796 (827)
Q Consensus 746 ------~--~l~~l~~-----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---------- 796 (827)
. +++++.. ....+.+.....++.+++.|+.||| .|+++|+||||||+||+
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~~~ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHT-STTTCCBCSCCCGGGEEEETTTTEEEE
T ss_pred cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHh-CCCCCeecCcCCHHHEEEeCCCCcEEE
Confidence 2 2233221 1234566777889999999999997 35899999999999998
Q ss_pred -eecccccccCCCccccccceecccccccccC
Q 047196 797 -DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 -DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
|||+++........ ....||++|+|||++
T Consensus 174 ~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~ 203 (360)
T 3e3p_A 174 CDFGSAKKLSPSEPN--VAYICSRYYRAPELI 203 (360)
T ss_dssp CCCTTCBCCCTTSCC--CSTTSCGGGCCHHHH
T ss_pred eeCCCceecCCCCCc--ccccCCcceeCHHHH
Confidence 99999876543322 234589999999963
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.2e-18 Score=183.88 Aligned_cols=144 Identities=30% Similarity=0.488 Sum_probs=112.8
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC--------
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNED-------- 744 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~-------- 744 (827)
..+|+..+.||+|+||.||+|+.. +|+.||||++.... +.+.+|++++++++|||++++++++...+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 457889999999999999999875 78999999987543 34678999999999999999999875411
Q ss_pred ----------ceeeeeecc----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee--------
Q 047196 745 ----------FKALDCLHS----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------- 796 (827)
Q Consensus 745 ----------~~~l~~l~~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------- 796 (827)
+..+++... ....+++.....++.++++||.||| +.+|+||||||+||+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCEE
Confidence 112222221 1235678888899999999999996 568999999999998
Q ss_pred --eecccccccCCCccccccceeccccccccc
Q 047196 797 --DFGIGRLLTGDRSMIQTETLVTIGYMAPGL 826 (827)
Q Consensus 797 --DFGla~~~~~~~~~~~~~~~gt~~Y~APE~ 826 (827)
|||+++....... .....||++|+|||+
T Consensus 163 l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~ 192 (284)
T 2a19_B 163 IGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQ 192 (284)
T ss_dssp ECCCTTCEESSCCSC--CCCCCSCCTTSCHHH
T ss_pred ECcchhheecccccc--ccccCCcccccChhh
Confidence 9999987654432 123458999999996
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.76 E-value=2.9e-18 Score=181.20 Aligned_cols=146 Identities=25% Similarity=0.395 Sum_probs=115.6
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA---MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
++|...+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++++++|||++++++++...+..++..
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57888999999999999999875 588999999864321 12467899999999999999999999998776554433
Q ss_pred eccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 751 LHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 751 l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
.+.. ...+++.....++.++++|++||| +.+|+||||||+||+ |||++.......
T Consensus 94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 168 (284)
T 2vgo_A 94 EFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR-- 168 (284)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC--
T ss_pred EeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcccc--
Confidence 2221 134677788899999999999995 678999999999998 999987654322
Q ss_pred ccccceeccccccccc
Q 047196 811 IQTETLVTIGYMAPGL 826 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~ 826 (827)
.....||+.|+|||+
T Consensus 169 -~~~~~~~~~y~aPE~ 183 (284)
T 2vgo_A 169 -RRTMCGTLDYLPPEM 183 (284)
T ss_dssp -BCCCCSCGGGCCHHH
T ss_pred -cccccCCCCcCCHHH
Confidence 123458999999996
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=2.8e-18 Score=183.25 Aligned_cols=149 Identities=28% Similarity=0.344 Sum_probs=118.6
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
+.|...+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++|||++++++++......++...+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 5688889999999999999986 468999999986543 33457899999999999999999999999877654443222
Q ss_pred c---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccc
Q 047196 753 S---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQT 813 (827)
Q Consensus 753 ~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~ 813 (827)
. ....+++.....++.++++|+.||| +.+|+||||||+||+ |||+++........ ..
T Consensus 102 ~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~ 177 (303)
T 3a7i_A 102 LGGGSALDLLEPGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RN 177 (303)
T ss_dssp CTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC-BC
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCccccc-cC
Confidence 2 1245778888999999999999996 568999999999998 99999876543321 22
Q ss_pred cceecccccccccC
Q 047196 814 ETLVTIGYMAPGLL 827 (827)
Q Consensus 814 ~~~gt~~Y~APE~l 827 (827)
...||+.|+|||++
T Consensus 178 ~~~~~~~y~aPE~~ 191 (303)
T 3a7i_A 178 TFVGTPFWMAPEVI 191 (303)
T ss_dssp CCCSCGGGCCHHHH
T ss_pred ccCCCcCccCHHHH
Confidence 34589999999963
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.9e-18 Score=181.79 Aligned_cols=148 Identities=24% Similarity=0.391 Sum_probs=110.0
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA---MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
++|...+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++...+..++..
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 56888899999999999999875 789999999865322 23467899999999999999999999998876555433
Q ss_pred eccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 751 LHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 751 l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
.+... ..+++.....++.++++|++||| +.+|+||||||+||+ |||+++.......
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 166 (276)
T 2h6d_A 91 EYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF- 166 (276)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred eccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCCcc-
Confidence 33221 24567778899999999999996 457999999999998 9999887643322
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
.....||+.|+|||++
T Consensus 167 -~~~~~~~~~y~aPE~~ 182 (276)
T 2h6d_A 167 -LRTSCGSPNYAAPEVI 182 (276)
T ss_dssp -----------CCTGGG
T ss_pred -eecccCCccccCHHHH
Confidence 1234589999999974
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=9.5e-19 Score=189.08 Aligned_cols=150 Identities=23% Similarity=0.407 Sum_probs=112.1
Q ss_pred hhcccccceEecCCceEEEEEEe------cCCcEEEEEEEccc-chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCce
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRL------HDGIEVAIKVFHQN-CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFK 746 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~------~~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~ 746 (827)
.++|...+.||+|+||.||+|+. .+++.||||++... ......++.+|+.++++++|||||++++++......
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 35788899999999999999984 24788999999644 344556899999999999999999999999876544
Q ss_pred ee--eeecc---------C------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------
Q 047196 747 AL--DCLHS---------T------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------------- 796 (827)
Q Consensus 747 ~l--~~l~~---------~------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------------- 796 (827)
++ ++... . ...+.+.+...++.++++||+||| +.+|+||||||+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence 33 33211 0 124778888999999999999996 568999999999998
Q ss_pred eecccccccCCCccc-cccceeccccccccc
Q 047196 797 DFGIGRLLTGDRSMI-QTETLVTIGYMAPGL 826 (827)
Q Consensus 797 DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~ 826 (827)
|||+++......... .....||++|+|||+
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 216 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEA 216 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhH
Confidence 899887654332211 122347899999996
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.1e-18 Score=184.84 Aligned_cols=149 Identities=24% Similarity=0.261 Sum_probs=105.0
Q ss_pred hhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc-h-HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee--
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC-A-MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL-- 748 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-~-~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l-- 748 (827)
.++|+..+.||+|+||.||+|+. .+|+.||||++.... . ...+.+.+|...++.++||||+++++++..++..++
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 36788999999999999999986 578999999996542 2 223345555666888999999999999987765444
Q ss_pred eeecc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCC
Q 047196 749 DCLHS-----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGD 807 (827)
Q Consensus 749 ~~l~~-----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~ 807 (827)
++... ....+++.....++.++++|++|||.. .+|+||||||+||+ |||+++.....
T Consensus 86 e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 163 (290)
T 3fme_A 86 ELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD 163 (290)
T ss_dssp ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC---------
T ss_pred ehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCccccccc
Confidence 22211 124577888899999999999999742 37999999999998 99999876543
Q ss_pred Cccccccceeccccccccc
Q 047196 808 RSMIQTETLVTIGYMAPGL 826 (827)
Q Consensus 808 ~~~~~~~~~gt~~Y~APE~ 826 (827)
.. .....||+.|+|||+
T Consensus 164 ~~--~~~~~~t~~y~aPE~ 180 (290)
T 3fme_A 164 VA--KDIDAGCKPYMAPER 180 (290)
T ss_dssp --------CCCCCCSCHHH
T ss_pred cc--ccccCCCccccChhh
Confidence 22 122358999999997
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.2e-18 Score=207.28 Aligned_cols=145 Identities=22% Similarity=0.333 Sum_probs=116.9
Q ss_pred hcccccceEecCCceEEEEEEec--CCcEEEEEEEccc-chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc------
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH--DGIEVAIKVFHQN-CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF------ 745 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~--~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~------ 745 (827)
++|...+.||+|+||.||+|+.. +|+.||||++... .....+.|.+|++++++++|||||++++++...+.
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 57889999999999999999875 6899999998643 34455678999999999999999999999876543
Q ss_pred -eeeeeeccC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------eecccccccCCCc
Q 047196 746 -KALDCLHST------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---------DFGIGRLLTGDRS 809 (827)
Q Consensus 746 -~~l~~l~~~------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---------DFGla~~~~~~~~ 809 (827)
.+++++... ...+++.+...|+.++++||+||| +.+|+||||||+||+ |||+++.....
T Consensus 160 ~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~~~kl~DFG~a~~~~~~-- 234 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEEQLKLIDLGAVSRINSF-- 234 (681)
T ss_dssp EEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSCEEECCCTTCEETTCC--
T ss_pred EEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCCcEEEEecccchhcccC--
Confidence 333433221 225778889999999999999996 568999999999998 99999876433
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
....||++|||||++
T Consensus 235 ---~~~~gt~~y~aPE~~ 249 (681)
T 2pzi_A 235 ---GYLYGTPGFQAPEIV 249 (681)
T ss_dssp ---SCCCCCTTTSCTTHH
T ss_pred ---CccCCCccccCHHHH
Confidence 234599999999963
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.76 E-value=2.2e-19 Score=214.10 Aligned_cols=182 Identities=23% Similarity=0.244 Sum_probs=76.1
Q ss_pred cCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCccccCC
Q 047196 396 IPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNL 475 (827)
Q Consensus 396 ~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 475 (827)
.|..+..+++|+.|+|++|++. .+|..+.++++|++|+|++|.|+ .+|..+.++++|++|+|++|+|+ .+|..++++
T Consensus 216 ~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l 292 (727)
T 4b8c_D 216 PKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSC 292 (727)
T ss_dssp ------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGG
T ss_pred ChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCC
Confidence 3444555555555555555554 34444445555555555555555 45555555555555555555555 445555555
Q ss_pred CCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccC-ceEEcccceeeecccccccCCCCCCEEE
Q 047196 476 TSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVV-IGINLSRNNFSGDIPSTIGDLKDLQNIS 554 (827)
Q Consensus 476 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L-~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ 554 (827)
++|++|+|++|.|+ .+|..|..+++|+.|+|++|.|++.+|..+..+... ..++|++|.++|.+|.. |+.|+
T Consensus 293 ~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~ 365 (727)
T 4b8c_D 293 FQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIE 365 (727)
T ss_dssp TTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-----------
T ss_pred CCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeE
Confidence 55555555555554 344445555555555555555555555544433211 22455555555555543 23344
Q ss_pred CCCC--------cceeecCCCCc---CCceEeCcCCcCeecCCC
Q 047196 555 LACN--------GLEGLIPESFG---YLTELNLSFNKLEGEIPR 587 (827)
Q Consensus 555 Ls~N--------~l~g~ip~~~~---~L~~L~ls~N~l~g~ip~ 587 (827)
+++| .+.+.++..+. .+....+++|.+.+....
T Consensus 366 l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~~~~~ 409 (727)
T 4b8c_D 366 INTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLCQHYAT 409 (727)
T ss_dssp ------------------------------------CCCGGGCC
T ss_pred eecccccccccCCccccccchhhcccccceeeeeccccccccCc
Confidence 4444 22222222222 334556677776654443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=3.4e-18 Score=181.98 Aligned_cols=148 Identities=22% Similarity=0.309 Sum_probs=117.5
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---------hHHHHHHHHHHHHHHhcC-CCCceEEEeeeec
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---------AMALKSFEAECEVMKNIR-HRNHVKRISSCSN 742 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---------~~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~ 742 (827)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++ ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 467888999999999999999875 68999999986432 123467889999999996 9999999999987
Q ss_pred CCceeeeeeccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccc
Q 047196 743 EDFKALDCLHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGR 802 (827)
Q Consensus 743 ~~~~~l~~l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~ 802 (827)
....++...+.. ...+++.....++.++++||+||| +.+|+||||||+||+ |||+++
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence 765554333322 134677788899999999999996 568999999999998 999998
Q ss_pred cccCCCccccccceeccccccccc
Q 047196 803 LLTGDRSMIQTETLVTIGYMAPGL 826 (827)
Q Consensus 803 ~~~~~~~~~~~~~~gt~~Y~APE~ 826 (827)
....... .....||+.|+|||+
T Consensus 173 ~~~~~~~--~~~~~~~~~y~aPE~ 194 (298)
T 1phk_A 173 QLDPGEK--LREVCGTPSYLAPEI 194 (298)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHH
T ss_pred hcCCCcc--cccccCCccccCHHH
Confidence 7654322 123458999999996
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.2e-18 Score=204.60 Aligned_cols=144 Identities=25% Similarity=0.442 Sum_probs=107.8
Q ss_pred ceEecCCceEEEEEEec---CCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCce-eeeeecc-
Q 047196 681 NLIGVGSFGSVYKGRLH---DGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFK-ALDCLHS- 753 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~-~l~~l~~- 753 (827)
+.||+|+||.||+|.+. .++.||||+++... ....++|.+|++++++++|||||+++++|..+... +++++..
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g 454 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 454 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCC
Confidence 57999999999999653 46889999997543 23457899999999999999999999999765532 2233221
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc--cccc
Q 047196 754 -------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM--IQTE 814 (827)
Q Consensus 754 -------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~--~~~~ 814 (827)
....+.+.....|+.+|++||+||| +.+|+||||||+||| |||+|+.+..+... ..+.
T Consensus 455 ~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 531 (635)
T 4fl3_A 455 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 531 (635)
T ss_dssp EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----------
T ss_pred CHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccC
Confidence 1245778888999999999999996 568999999999998 99999887544322 1222
Q ss_pred ceecccccccccC
Q 047196 815 TLVTIGYMAPGLL 827 (827)
Q Consensus 815 ~~gt~~Y~APE~l 827 (827)
..+|+.|+|||++
T Consensus 532 ~~~t~~y~APE~~ 544 (635)
T 4fl3_A 532 GKWPVKWYAPECI 544 (635)
T ss_dssp ---CGGGSCHHHH
T ss_pred CCCceeeeChhhh
Confidence 3368899999974
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.3e-18 Score=190.72 Aligned_cols=156 Identities=26% Similarity=0.332 Sum_probs=119.6
Q ss_pred ccchhHHHHHhhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcC-----CCCceEEE
Q 047196 664 RFSYQDLFRATEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIR-----HRNHVKRI 737 (827)
Q Consensus 664 ~~~~~~~~~~~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-----H~niv~~~ 737 (827)
.+++.+-....++|...++||+|+||.||+|+. .+++.||||++... ....+.+.+|++++++++ |||||+++
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 344444444567899999999999999999987 46899999998643 334567888999999997 99999999
Q ss_pred eeeecCCceeeeeeccC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------
Q 047196 738 SSCSNEDFKALDCLHST-----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---------- 796 (827)
Q Consensus 738 ~~~~~~~~~~l~~l~~~-----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---------- 796 (827)
+++...+..++...+.. ...+++.+...++.++++||+||| +.+|+||||||+|||
T Consensus 103 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~ 179 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSL 179 (360)
T ss_dssp EEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEE
T ss_pred ceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccccccc
Confidence 99988775544322211 123677788899999999999996 578999999999985
Q ss_pred -------------------------eecccccccCCCccccccceecccccccccC
Q 047196 797 -------------------------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 -------------------------DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
|||+|+..... .....||+.|+|||++
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~ 231 (360)
T 3llt_A 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVI 231 (360)
T ss_dssp EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHH
T ss_pred cchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHH
Confidence 67777654322 1234589999999973
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=4.7e-19 Score=198.66 Aligned_cols=147 Identities=23% Similarity=0.424 Sum_probs=107.3
Q ss_pred hcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCceeeeeecc
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
.+|...++||+|+||+||.....+|+.||||++..... +.+.+|+++++++ +|||||++++++.+....++...+.
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 46888899999999986655556789999999864322 2356899999999 7999999999998877654432221
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------------eecccccccCCC
Q 047196 754 ----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---------------DFGIGRLLTGDR 808 (827)
Q Consensus 754 ----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---------------DFGla~~~~~~~ 808 (827)
........+...++.++++||+||| +.+|+||||||+||+ |||+|+......
T Consensus 101 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~ 177 (432)
T 3p23_A 101 AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177 (432)
T ss_dssp SEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred CCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence 1122333456789999999999996 567999999999987 999998765432
Q ss_pred cc--ccccceecccccccccC
Q 047196 809 SM--IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~--~~~~~~gt~~Y~APE~l 827 (827)
.. .....+||++|+|||++
T Consensus 178 ~~~~~~~~~~gt~~y~APE~l 198 (432)
T 3p23_A 178 HSFSRRSGVPGTEGWIAPEML 198 (432)
T ss_dssp --------CCSCTTSCCGGGT
T ss_pred cceeeccccCCCcCccChhhh
Confidence 21 12334599999999975
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.3e-18 Score=182.41 Aligned_cols=145 Identities=16% Similarity=0.316 Sum_probs=110.4
Q ss_pred hcccccceEecCCceEEEEEEecCCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecC--Cc--eee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNE--DF--KAL 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~--~~--~~l 748 (827)
++|...+.||+|+||.||+|+.+ |+.||||++... .....++|.+|++++++++|||||++++++... .. ..+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 56888899999999999999985 789999999754 234557899999999999999999999999775 33 233
Q ss_pred eeeccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 749 DCLHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 749 ~~l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
++.... ...+++.+...++.++++||+|||. +.++|+||||||+||+ |||++....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~--- 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ--- 164 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT-SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS---
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc-CCCceecCCCccceEEEcCCcceeEEeccceeeec---
Confidence 333221 1247888999999999999999953 2233999999999998 344432211
Q ss_pred ccccccceecccccccccC
Q 047196 809 SMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~~~~~~gt~~Y~APE~l 827 (827)
.....||+.|+|||++
T Consensus 165 ---~~~~~~t~~y~aPE~~ 180 (271)
T 3kmu_A 165 ---SPGRMYAPAWVAPEAL 180 (271)
T ss_dssp ---CTTCBSCGGGSCHHHH
T ss_pred ---ccCccCCccccChhhh
Confidence 1234589999999963
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.76 E-value=7.4e-19 Score=192.93 Aligned_cols=151 Identities=17% Similarity=0.224 Sum_probs=111.3
Q ss_pred hhcccccceEecCCceEEEEEEecC------CcEEEEEEEcccchHH-----------HHHHHHHHHHHHhcCCCCceEE
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLHD------GIEVAIKVFHQNCAMA-----------LKSFEAECEVMKNIRHRNHVKR 736 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~~------g~~vAvK~l~~~~~~~-----------~~~~~~Ei~~l~~l~H~niv~~ 736 (827)
.++|...+.||+|+||.||+|++.. ++.||||++....... ...+.+|+..++.++|+|||++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4579999999999999999998754 4789999986543211 1234456777888899999999
Q ss_pred EeeeecCC------ceeeeeec--------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee------
Q 047196 737 ISSCSNED------FKALDCLH--------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------ 796 (827)
Q Consensus 737 ~~~~~~~~------~~~l~~l~--------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------ 796 (827)
++++.... +.+++++. .....+++..+..|+.++++||+||| +.+|+||||||+|||
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESSCT
T ss_pred EeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecCCC
Confidence 99986641 22333331 12246889999999999999999996 458999999999998
Q ss_pred ------eecccccccCCCcc------ccccceecccccccccC
Q 047196 797 ------DFGIGRLLTGDRSM------IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 ------DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~l 827 (827)
|||+|+.+...... ......||+.|||||++
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 233 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAH 233 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHH
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHh
Confidence 99999876433211 11223499999999963
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.76 E-value=8.9e-19 Score=192.02 Aligned_cols=148 Identities=23% Similarity=0.297 Sum_probs=116.2
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEccc-chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN-CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
++|+..+.||+|+||.||+|+.. +|+.||+|++... .....+.+.+|++++++++|||||++++++...+..++...+
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 56888899999999999999875 6899999998754 344457899999999999999999999999887655443333
Q ss_pred cCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 753 STN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 753 ~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
... ..+++.....++.++++|++|||.. .+|+||||||+||+ |||+++...... .
T Consensus 113 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~ 187 (360)
T 3eqc_A 113 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---A 187 (360)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC----
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCccccccc---c
Confidence 221 2456677788999999999999743 27999999999998 999987653221 1
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
....||++|+|||++
T Consensus 188 ~~~~gt~~y~aPE~~ 202 (360)
T 3eqc_A 188 NSFVGTRSYMSPERL 202 (360)
T ss_dssp ---CCCCTTCCHHHH
T ss_pred cCCCCCCCeECHHHH
Confidence 234589999999963
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.3e-18 Score=190.10 Aligned_cols=145 Identities=25% Similarity=0.402 Sum_probs=112.2
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC-------
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNED------- 744 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~------- 744 (827)
++|...+.||+|+||.||+|+.. +|+.||||++... .....+++.+|+.++++++|||||++++++....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 56888899999999999999864 6899999999653 2334567899999999999999999999987653
Q ss_pred -ceeeeeecc-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 745 -FKALDCLHS-----TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 745 -~~~l~~l~~-----~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
+..+++... ....+++.....++.++++||+||| +.+|+||||||+||+ |||+++.....
T Consensus 104 ~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~- 179 (353)
T 3coi_A 104 FYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE- 179 (353)
T ss_dssp CEEEEECCSEEGGGTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-----
T ss_pred EEEEeccccCCHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC-
Confidence 223333221 1234678888999999999999996 568999999999998 99998765422
Q ss_pred ccccccceeccccccccc
Q 047196 809 SMIQTETLVTIGYMAPGL 826 (827)
Q Consensus 809 ~~~~~~~~gt~~Y~APE~ 826 (827)
.....||++|+|||+
T Consensus 180 ---~~~~~~t~~y~aPE~ 194 (353)
T 3coi_A 180 ---MTGYVVTRWYRAPEV 194 (353)
T ss_dssp -------CCSBCCSCHHH
T ss_pred ---ccccccCcCcCCHHH
Confidence 123458999999996
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.5e-18 Score=184.64 Aligned_cols=147 Identities=17% Similarity=0.198 Sum_probs=115.7
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCceeeeeec
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
++|...+.||+|+||.||+|+. .+|+.||||++.... ..+.+.+|+++++++ +|++++++++++......++...+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 5688899999999999999985 578999999986432 234578999999999 799999999998877654442222
Q ss_pred c----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------------eecccccccCC
Q 047196 753 S----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---------------DFGIGRLLTGD 807 (827)
Q Consensus 753 ~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---------------DFGla~~~~~~ 807 (827)
. ....+++.+...++.++++||+||| +.+|+||||||+||+ |||+++.....
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 88 LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred cCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 1 1234778888999999999999996 678999999999998 89999876543
Q ss_pred Ccc------ccccceeccccccccc
Q 047196 808 RSM------IQTETLVTIGYMAPGL 826 (827)
Q Consensus 808 ~~~------~~~~~~gt~~Y~APE~ 826 (827)
... ......||+.|+|||+
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~ 189 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINT 189 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHH
T ss_pred cccccccccCccCCCCCcccCCchh
Confidence 221 1223458999999996
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.76 E-value=4.6e-18 Score=180.28 Aligned_cols=148 Identities=28% Similarity=0.391 Sum_probs=111.9
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecC----Cceee
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNE----DFKAL 748 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~----~~~~l 748 (827)
.|...+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++|||||++++++... ...++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 3666778999999999999864 6889999998653 244567899999999999999999999987642 22222
Q ss_pred --eeeccC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------eecccccccCC
Q 047196 749 --DCLHST--------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRLLTGD 807 (827)
Q Consensus 749 --~~l~~~--------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGla~~~~~~ 807 (827)
++.... ...+++.....++.++++||+|||. +.++|+||||||+||+ |||+++.....
T Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~ 185 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred EEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc
Confidence 332211 1346777788999999999999973 2234999999999998 99998755433
Q ss_pred CccccccceecccccccccC
Q 047196 808 RSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 808 ~~~~~~~~~gt~~Y~APE~l 827 (827)
.. ....||++|+|||++
T Consensus 186 ~~---~~~~~t~~y~aPE~~ 202 (290)
T 1t4h_A 186 FA---KAVIGTPEFMAPEMY 202 (290)
T ss_dssp SB---EESCSSCCCCCGGGG
T ss_pred cc---ccccCCcCcCCHHHH
Confidence 21 234589999999974
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.76 E-value=1.5e-18 Score=184.87 Aligned_cols=148 Identities=29% Similarity=0.395 Sum_probs=114.0
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA--MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l 751 (827)
++|+..+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++..++..++...
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (299)
T 2r3i_A 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence 57888899999999999999875 689999999865432 224678899999999999999999999987765444222
Q ss_pred ccC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 752 HST-----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 752 ~~~-----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
+.. ...+.+.....++.++++||+||| +.+|+||||||+||+ |||+++........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 159 (299)
T 2r3i_A 83 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 159 (299)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred cccCCHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHeEEcCCCCEEECcchhhhhccCCccc
Confidence 211 134667778889999999999996 568999999999998 99999876433221
Q ss_pred ccccceeccccccccc
Q 047196 811 IQTETLVTIGYMAPGL 826 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~ 826 (827)
.....||+.|+|||+
T Consensus 160 -~~~~~~~~~y~aPE~ 174 (299)
T 2r3i_A 160 -YTHEVVTLWYRAPEI 174 (299)
T ss_dssp -TTSCBCCCTTCCHHH
T ss_pred -cCcccccccccCcHH
Confidence 233458999999996
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1e-18 Score=188.38 Aligned_cols=148 Identities=26% Similarity=0.361 Sum_probs=112.5
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccch--------HHHHHHHHHHHHHHhcCCCCceEEEeeeecCC
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA--------MALKSFEAECEVMKNIRHRNHVKRISSCSNED 744 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--------~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~ 744 (827)
.++|...+.||+|+||.||+|+.. +|+.||||++..... .....+.+|++++++++||||+++++++..+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 467899999999999999999865 689999999864321 12345889999999999999999999987665
Q ss_pred cee-eeeecc--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------eecccc
Q 047196 745 FKA-LDCLHS--------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------DFGIGR 802 (827)
Q Consensus 745 ~~~-l~~l~~--------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------------DFGla~ 802 (827)
..+ ++++.. ....+++.....++.++++||+||| +.+|+||||||+||+ |||+++
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 322 233221 1235677788899999999999996 568999999999998 899987
Q ss_pred cccCCCccccccceeccccccccc
Q 047196 803 LLTGDRSMIQTETLVTIGYMAPGL 826 (827)
Q Consensus 803 ~~~~~~~~~~~~~~gt~~Y~APE~ 826 (827)
....... .....||+.|+|||+
T Consensus 166 ~~~~~~~--~~~~~gt~~y~aPE~ 187 (322)
T 2ycf_A 166 ILGETSL--MRTLCGTPTYLAPEV 187 (322)
T ss_dssp ECCCCHH--HHHHHSCCTTCCHHH
T ss_pred ecccccc--cccccCCcCccCchh
Confidence 7643221 122358999999996
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=2.4e-18 Score=192.91 Aligned_cols=145 Identities=21% Similarity=0.322 Sum_probs=113.8
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhc------CCCCceEEEeeeecCCcee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNI------RHRNHVKRISSCSNEDFKA 747 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l------~H~niv~~~~~~~~~~~~~ 747 (827)
.+|+..++||+|+||.||+|+.. +++.||||++... ....+.+.+|+++++.+ .|+|++++++++......+
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 46888999999999999999865 5899999999654 33456788899999888 4669999999998776554
Q ss_pred eeeeccC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee------------eecccccc
Q 047196 748 LDCLHST-----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------------DFGIGRLL 804 (827)
Q Consensus 748 l~~l~~~-----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------------DFGla~~~ 804 (827)
+...+.. ...+++.....++.++++||+||| +.+|+||||||+||| |||+|+..
T Consensus 176 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~ 252 (429)
T 3kvw_A 176 MTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE 252 (429)
T ss_dssp EEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence 4322211 123778888999999999999997 458999999999998 99998764
Q ss_pred cCCCccccccceecccccccccC
Q 047196 805 TGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 805 ~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
.... ...+||++|||||++
T Consensus 253 ~~~~----~~~~gt~~y~aPE~~ 271 (429)
T 3kvw_A 253 HQRV----YTYIQSRFYRAPEVI 271 (429)
T ss_dssp TCCC----CSSCSCGGGCCHHHH
T ss_pred CCcc----cccCCCCCccChHHH
Confidence 3221 234689999999973
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=7.1e-19 Score=187.63 Aligned_cols=149 Identities=26% Similarity=0.324 Sum_probs=112.8
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
.++|+..+.||+|+||.||+|+.. +|+.||+|++........+.+.+|++++++++||||+++++++...+..++...+
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 467888999999999999999975 5899999999765555567899999999999999999999999876654442222
Q ss_pred c-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 753 S-----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 753 ~-----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
. ....+++.....++.++++|+.||| +.+|+||||||+||+ |||+++....... .
T Consensus 98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 173 (302)
T 2j7t_A 98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ-K 173 (302)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH-C
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc-c
Confidence 1 1245778888899999999999996 568999999999998 9998764321111 1
Q ss_pred cccceeccccccccc
Q 047196 812 QTETLVTIGYMAPGL 826 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~ 826 (827)
.....||+.|+|||+
T Consensus 174 ~~~~~~~~~y~aPE~ 188 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEV 188 (302)
T ss_dssp -----CCGGGCCHHH
T ss_pred cccccCChhhcCCee
Confidence 122458999999996
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.75 E-value=4.3e-18 Score=197.95 Aligned_cols=172 Identities=28% Similarity=0.383 Sum_probs=100.7
Q ss_pred cccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecC
Q 047196 381 SLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLA 460 (827)
Q Consensus 381 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 460 (827)
+|+.|++++|.+.. +| .+..+++|+.|+|++|++++..| +..+++|+.|+|++|.+.+ +| .+..+++|+.|+|+
T Consensus 44 ~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls 117 (605)
T 1m9s_A 44 SIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLE 117 (605)
T ss_dssp TCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECT
T ss_pred CCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEec
Confidence 45555555555543 22 35555666666666666655443 5556666666666666653 22 45556666666666
Q ss_pred CCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccceeeecc
Q 047196 461 GNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDI 540 (827)
Q Consensus 461 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~i 540 (827)
+|++++ + +.+..+++|+.|+|++|.+++. ..+..+++|+.|+|++|.+++..| +..++.|+.|+|++|+|++.
T Consensus 118 ~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l- 190 (605)
T 1m9s_A 118 HNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL- 190 (605)
T ss_dssp TSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-
T ss_pred CCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC-
Confidence 666653 2 3355666666666666666654 445566666666666666666555 56666666666666666653
Q ss_pred cccccCCCCCCEEECCCCcceeecCC
Q 047196 541 PSTIGDLKDLQNISLACNGLEGLIPE 566 (827)
Q Consensus 541 p~~~~~l~~L~~L~Ls~N~l~g~ip~ 566 (827)
+.+..+++|+.|+|++|++++....
T Consensus 191 -~~l~~l~~L~~L~L~~N~l~~~p~~ 215 (605)
T 1m9s_A 191 -RALAGLKNLDVLELFSQECLNKPIN 215 (605)
T ss_dssp -GGGTTCTTCSEEECCSEEEECCCCC
T ss_pred -hHHccCCCCCEEEccCCcCcCCccc
Confidence 2466666666666666666654333
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=2.3e-18 Score=186.05 Aligned_cols=158 Identities=21% Similarity=0.299 Sum_probs=117.4
Q ss_pred cchhHHHHHhhccccc-ceEecCCceEEEEEEec-CCcEEEEEEEcccch--HHHHHHHHHHHHHHhcC-CCCceEEEee
Q 047196 665 FSYQDLFRATEKFSKE-NLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA--MALKSFEAECEVMKNIR-HRNHVKRISS 739 (827)
Q Consensus 665 ~~~~~~~~~~~~~~~~-~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~-H~niv~~~~~ 739 (827)
..++......+.|... +.||+|+||.||+|+.. +|+.||||++..... ....++.+|++++++++ ||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3344445555667766 88999999999999865 689999999875432 23567899999999995 5999999999
Q ss_pred eecCCceee--eeecc----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------
Q 047196 740 CSNEDFKAL--DCLHS----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------- 796 (827)
Q Consensus 740 ~~~~~~~~l--~~l~~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------- 796 (827)
+......++ +++.. ....+++.+...++.++++||+||| +.+|+||||||+||+
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEE
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEE
Confidence 987765444 22211 1245778889999999999999996 568999999999998
Q ss_pred --eecccccccCCCccccccceecccccccccC
Q 047196 797 --DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 --DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
|||+++....... .....||++|+|||++
T Consensus 175 L~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~ 205 (327)
T 3lm5_A 175 IVDFGMSRKIGHACE--LREIMGTPEYLAPEIL 205 (327)
T ss_dssp ECCGGGCEEC-----------CCCGGGCCHHHH
T ss_pred EeeCccccccCCccc--cccccCCcCccCCeee
Confidence 8999887643322 1234589999999963
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.75 E-value=5.3e-18 Score=173.13 Aligned_cols=154 Identities=23% Similarity=0.250 Sum_probs=82.7
Q ss_pred ccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCC
Q 047196 382 LENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAG 461 (827)
Q Consensus 382 L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 461 (827)
.+.++.++++++ .+|..+. ++|+.|+|++|++++..|..|..+++|++|+|++|++.+..+..|..+++|++|+|++
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 456666666665 3444332 5566666666666665555566666666666666665544334445555555555555
Q ss_pred CcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccceeeeccc
Q 047196 462 NKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIP 541 (827)
Q Consensus 462 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip 541 (827)
|++++..+..+..+++|++|+|++|.++ .+|..+..+++|+.|+|++|+|++..+
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-------------------------~lp~~~~~l~~L~~L~L~~N~l~~~~~ 152 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-------------------------ELPRGIERLTHLTHLALDQNQLKSIPH 152 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC-------------------------SCCTTGGGCTTCSEEECCSSCCCCCCT
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc-------------------------ccCcccccCCCCCEEECCCCcCCccCH
Confidence 5555443444444444554444444444 334444455555555555555554444
Q ss_pred ccccCCCCCCEEECCCCcceee
Q 047196 542 STIGDLKDLQNISLACNGLEGL 563 (827)
Q Consensus 542 ~~~~~l~~L~~L~Ls~N~l~g~ 563 (827)
..+..+++|+.|+|++|.+.+.
T Consensus 153 ~~~~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 153 GAFDRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp TTTTTCTTCCEEECTTSCBCTT
T ss_pred HHHhCCCCCCEEEeeCCCccCC
Confidence 4555555555555555555443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.75 E-value=1.1e-18 Score=185.80 Aligned_cols=149 Identities=26% Similarity=0.400 Sum_probs=111.7
Q ss_pred hcccccceEecCCceEEEEEEecC----CcEEEEEEEccc-chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC-c--e
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHD----GIEVAIKVFHQN-CAMALKSFEAECEVMKNIRHRNHVKRISSCSNED-F--K 746 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~----g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~-~--~ 746 (827)
..|...++||+|+||.||+|+..+ +..||||++... .....+++.+|++++++++|||||+++++|...+ . .
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 357778999999999999998642 346899998753 3445678999999999999999999999975543 2 2
Q ss_pred eeeeecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCC
Q 047196 747 ALDCLHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGD 807 (827)
Q Consensus 747 ~l~~l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~ 807 (827)
+++++.. ....+++.+...++.++++||+||| +.+|+||||||+||+ |||+++.....
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 3333322 2334677888899999999999996 568999999999998 99999876433
Q ss_pred Ccc---ccccceeccccccccc
Q 047196 808 RSM---IQTETLVTIGYMAPGL 826 (827)
Q Consensus 808 ~~~---~~~~~~gt~~Y~APE~ 826 (827)
... ......||+.|+|||+
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~ 203 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALES 203 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHH
T ss_pred chhccccccCCCCCccccChHH
Confidence 211 1222347889999996
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.75 E-value=4.6e-18 Score=180.26 Aligned_cols=145 Identities=22% Similarity=0.372 Sum_probs=66.3
Q ss_pred cEEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcC
Q 047196 99 RVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLD 178 (827)
Q Consensus 99 ~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~ 178 (827)
+++.|+++++.+... +.+..+++|++|+|++|++++..| +..+++|++|+|++|.+++. | .+..+++|++|+++
T Consensus 47 ~L~~L~l~~~~i~~~--~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~L~ 120 (291)
T 1h6t_A 47 SIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL-S-SLKDLKKLKSLSLE 120 (291)
T ss_dssp TCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCG-G-GGTTCTTCCEEECT
T ss_pred cccEEEccCCCcccC--hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCC-h-hhccCCCCCEEECC
Confidence 455566666655543 235556666666666666654333 55566666666666665542 1 24445555555555
Q ss_pred CCCCCCCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEccccccc
Q 047196 179 SDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLR 256 (827)
Q Consensus 179 ~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 256 (827)
+|.+++ ++ .+. .+++|++|++++|.+++. ..++.+++|++|++++|.+++..| +..+++|++|++++|.++
T Consensus 121 ~n~i~~-~~-~l~-~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~ 191 (291)
T 1h6t_A 121 HNGISD-IN-GLV-HLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS 191 (291)
T ss_dssp TSCCCC-CG-GGG-GCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred CCcCCC-Ch-hhc-CCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCC
Confidence 554443 21 111 122444444444444332 233344444444444444433222 333444444444444443
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.75 E-value=2.9e-18 Score=190.46 Aligned_cols=143 Identities=24% Similarity=0.395 Sum_probs=102.5
Q ss_pred hccccc-ceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHH-hcCCCCceEEEeeeec----CCce-
Q 047196 675 EKFSKE-NLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMK-NIRHRNHVKRISSCSN----EDFK- 746 (827)
Q Consensus 675 ~~~~~~-~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~-~l~H~niv~~~~~~~~----~~~~- 746 (827)
++|... ++||+|+||+||+|+.. +|+.||||++... ..+.+|++++. ..+|||||++++++.. ....
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 455554 68999999999999865 6899999998643 34678888874 5589999999998754 2222
Q ss_pred -eeeeeccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------eecccc
Q 047196 747 -ALDCLHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------DFGIGR 802 (827)
Q Consensus 747 -~l~~l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------------DFGla~ 802 (827)
+++++... ...+++.....|+.++++||+||| +.+|+||||||+||| |||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 23333211 124778888999999999999996 468999999999998 999998
Q ss_pred cccCCCccccccceecccccccccC
Q 047196 803 LLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 803 ~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
....... ....+||++|+|||++
T Consensus 213 ~~~~~~~--~~~~~gt~~y~aPE~~ 235 (400)
T 1nxk_A 213 ETTSHNS--LTTPCYTPYYVAPEVL 235 (400)
T ss_dssp ECC-------------CTTCCGGGS
T ss_pred ccCCCCc--cccCCCCCCccCHhhc
Confidence 6543322 2335689999999985
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.75 E-value=1.9e-18 Score=184.23 Aligned_cols=149 Identities=26% Similarity=0.384 Sum_probs=109.1
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC--------
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNED-------- 744 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~-------- 744 (827)
.++|+..+.||+|+||.||+|+.. +|+.||||++... ....+.+.+|++++++++|||++++++++.+..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 467899999999999999999864 7899999998653 344578999999999999999999999886531
Q ss_pred -----ce--eeeeecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------ee
Q 047196 745 -----FK--ALDCLHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DF 798 (827)
Q Consensus 745 -----~~--~l~~l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DF 798 (827)
.. .+++... ......+.....++.++++|++||| +.+|+||||||+||+ ||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeC
Confidence 11 1222211 1223456677789999999999996 568999999999998 99
Q ss_pred cccccccCCC-------------ccccccceeccccccccc
Q 047196 799 GIGRLLTGDR-------------SMIQTETLVTIGYMAPGL 826 (827)
Q Consensus 799 Gla~~~~~~~-------------~~~~~~~~gt~~Y~APE~ 826 (827)
|+++...... ........||+.|+|||+
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 201 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEV 201 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHH
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCccc
Confidence 9998654221 011123458999999996
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.3e-18 Score=204.96 Aligned_cols=151 Identities=25% Similarity=0.395 Sum_probs=112.9
Q ss_pred hhcccccceEecCCceEEEEEEec----CCcEEEEEEEccc-chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc-ee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH----DGIEVAIKVFHQN-CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF-KA 747 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~----~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~-~~ 747 (827)
.++|...+.||+|+||.||+|++. .+..||||++... .....+.|.+|+.++++++|||||++++++.+... .+
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~lv 468 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII 468 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCceEEE
Confidence 356888899999999999999864 2567999998653 33445789999999999999999999999865442 22
Q ss_pred eeeecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 748 LDCLHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 748 l~~l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
++++.. ....+++.....++.++++||+||| +.+|+||||||+||| |||+++......
T Consensus 469 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~ 545 (656)
T 2j0j_A 469 MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545 (656)
T ss_dssp EECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred EEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence 333321 1235778888899999999999996 468999999999998 999998765433
Q ss_pred ccccccceecccccccccC
Q 047196 809 SMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~~~~~~gt~~Y~APE~l 827 (827)
........+|+.|||||++
T Consensus 546 ~~~~~~~~~t~~y~aPE~~ 564 (656)
T 2j0j_A 546 YYKASKGKLPIKWMAPESI 564 (656)
T ss_dssp --------CCGGGCCHHHH
T ss_pred ceeccCCCCCcceeCHHHh
Confidence 2222223478899999963
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=2.8e-18 Score=183.80 Aligned_cols=148 Identities=29% Similarity=0.413 Sum_probs=105.9
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEccc---chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQN---CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
++|...+.||+|+||.||+|+. .+|+.||||++... .....+++.+|++++++++||||+++++++...+..++..
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 5788899999999999999986 57899999998642 2445678999999999999999999999998776554432
Q ss_pred eccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccC
Q 047196 751 LHST--------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806 (827)
Q Consensus 751 l~~~--------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~ 806 (827)
.+.. ...+++.....++.++++||+||| +.+|+||||||+||+ |||+++....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 2221 233567778899999999999996 568999999999998 9999887644
Q ss_pred CCccccccceeccccccccc
Q 047196 807 DRSMIQTETLVTIGYMAPGL 826 (827)
Q Consensus 807 ~~~~~~~~~~gt~~Y~APE~ 826 (827)
.... .....||+.|+|||+
T Consensus 189 ~~~~-~~~~~~~~~y~aPE~ 207 (310)
T 2wqm_A 189 KTTA-AHSLVGTPYYMSPER 207 (310)
T ss_dssp -----------CCSSCCHHH
T ss_pred CCcc-ccccCCCeeEeChHH
Confidence 3221 122458999999996
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.7e-18 Score=188.84 Aligned_cols=147 Identities=18% Similarity=0.335 Sum_probs=117.1
Q ss_pred hcccccceEecCCceEEEEEEecCCcEEEEEEEcccchH-----------------HHHHHHHHHHHHHhcCCCCceEEE
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAM-----------------ALKSFEAECEVMKNIRHRNHVKRI 737 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~-----------------~~~~~~~Ei~~l~~l~H~niv~~~ 737 (827)
++|...+.||+|+||.||+|+. +|+.||||++...... ..+.+.+|++++++++||||++++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred CceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 5788899999999999999998 8999999998643211 117899999999999999999999
Q ss_pred eeeecCCceee--eeecc--------------C--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---
Q 047196 738 SSCSNEDFKAL--DCLHS--------------T--NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF--- 796 (827)
Q Consensus 738 ~~~~~~~~~~l--~~l~~--------------~--~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl--- 796 (827)
+++...+..++ ++... . ...+++.....++.++++|++|||. .++|+||||||+||+
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDK 187 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEECT
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEcC
Confidence 99987765443 22111 1 3456788889999999999999974 378999999999998
Q ss_pred -------eecccccccCCCccccccceecccccccccC
Q 047196 797 -------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 -------DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
|||+++...... .....||+.|+|||++
T Consensus 188 ~~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~ 222 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDKK---IKGSRGTYEFMPPEFF 222 (348)
T ss_dssp TSCEEECCCTTCEECBTTE---ECSSCSCGGGCCGGGG
T ss_pred CCcEEEecccccccccccc---ccCCCCCcCccCchhh
Confidence 999998764431 2334589999999974
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=5.1e-18 Score=184.45 Aligned_cols=152 Identities=27% Similarity=0.447 Sum_probs=117.4
Q ss_pred HHhhcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHh--cCCCCceEEEeeeecCC----c
Q 047196 672 RATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKN--IRHRNHVKRISSCSNED----F 745 (827)
Q Consensus 672 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~--l~H~niv~~~~~~~~~~----~ 745 (827)
...++|...+.||+|+||.||+|+. +|+.||||++... ..+.+.+|+++++. ++||||+++++++.... .
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 39 TIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred cccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 3456799999999999999999987 4899999998643 23567889999988 78999999999987764 2
Q ss_pred eee--eeeccC-------CCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEEccCCCccee----------eeccc
Q 047196 746 KAL--DCLHST-------NCSLNIFDKLNIMIDVASALEYLHFS-----HSTPVIHCDLKPKNVF----------DFGIG 801 (827)
Q Consensus 746 ~~l--~~l~~~-------~~~l~~~~~~~i~~~ia~~L~~Lh~~-----h~~~iiHrDlK~~NIl----------DFGla 801 (827)
.++ ++.... ...+++.+...++.++++|++|||.. ++++|+||||||+||+ |||++
T Consensus 115 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~ 194 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 194 (342)
T ss_dssp EEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred eEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCc
Confidence 233 322211 13467788899999999999999832 2789999999999998 99999
Q ss_pred ccccCCCcc---ccccceecccccccccC
Q 047196 802 RLLTGDRSM---IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 802 ~~~~~~~~~---~~~~~~gt~~Y~APE~l 827 (827)
+........ ......||+.|+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 223 (342)
T 1b6c_B 195 VRHDSATDTIDIAPNHRVGTKRYMAPEVL 223 (342)
T ss_dssp EEEETTTTEEEECCCSCCCCGGGCCHHHH
T ss_pred eeccccccccccccccCCcCcccCCHhhh
Confidence 877544322 12234589999999963
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.75 E-value=4.7e-19 Score=194.81 Aligned_cols=149 Identities=26% Similarity=0.418 Sum_probs=103.2
Q ss_pred cccccceEecCCceEEEEEEec--CC--cEEEEEEEccc-chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC-c--ee
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH--DG--IEVAIKVFHQN-CAMALKSFEAECEVMKNIRHRNHVKRISSCSNED-F--KA 747 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~--~g--~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~-~--~~ 747 (827)
.|...++||+|+||.||+|++. ++ ..||||++... .....++|.+|++++++++|||||+++++|...+ . .+
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3566789999999999999863 22 46899998643 3345678999999999999999999999976533 2 23
Q ss_pred eeeecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 748 LDCLHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 748 l~~l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
++++.. ....+++.+...++.++++||+||| +.+|+||||||+||+ |||+++......
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 333322 1234677788899999999999996 568999999999998 999998764332
Q ss_pred cc---ccccceecccccccccC
Q 047196 809 SM---IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~---~~~~~~gt~~Y~APE~l 827 (827)
.. ......+|++|+|||++
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~ 268 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESL 268 (373)
T ss_dssp -----------CCGGGSCHHHH
T ss_pred cccccccCCCCCcccccChHHh
Confidence 11 11223478899999963
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=2.6e-18 Score=186.35 Aligned_cols=149 Identities=30% Similarity=0.438 Sum_probs=106.3
Q ss_pred hcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHH--HHHHHHHhcCCCCceEEEeeeecC----C---c
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFE--AECEVMKNIRHRNHVKRISSCSNE----D---F 745 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~--~Ei~~l~~l~H~niv~~~~~~~~~----~---~ 745 (827)
++|...+.||+|+||.||+|+. +++.||||++..... +.+. .|+..++.++|+||+++++.+... . +
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 5788899999999999999976 578999999865432 2334 444445568999999999865431 1 1
Q ss_pred eeeeeeccC-------CCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEEccCCCccee----------eecccc
Q 047196 746 KALDCLHST-------NCSLNIFDKLNIMIDVASALEYLHFSH------STPVIHCDLKPKNVF----------DFGIGR 802 (827)
Q Consensus 746 ~~l~~l~~~-------~~~l~~~~~~~i~~~ia~~L~~Lh~~h------~~~iiHrDlK~~NIl----------DFGla~ 802 (827)
.+++++... .....+.....++.++++||+|||..+ .++|+||||||+||| |||+|+
T Consensus 89 lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~ 168 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSM 168 (336)
T ss_dssp EEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecccee
Confidence 223333221 123467778899999999999997542 339999999999998 999998
Q ss_pred cccCCCc-------cccccceecccccccccC
Q 047196 803 LLTGDRS-------MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 803 ~~~~~~~-------~~~~~~~gt~~Y~APE~l 827 (827)
.+..... ......+||+.|+|||++
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 200 (336)
T 3g2f_A 169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVL 200 (336)
T ss_dssp ECSSSSCC---------CCTTSCGGGCCHHHH
T ss_pred ecccccccCccccccccccCCCccceeCchhh
Confidence 7653321 111234589999999963
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.74 E-value=2.1e-18 Score=183.56 Aligned_cols=148 Identities=24% Similarity=0.356 Sum_probs=111.9
Q ss_pred cccccceEecCCceEEEEEEec-C---CcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCce---e
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-D---GIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFK---A 747 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~---g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~---~ 747 (827)
.|...++||+|+||.||+|+.. + +..||||++.... ....+.|.+|++++++++|||||++++++...+.. +
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4556689999999999999853 2 2379999987543 34567899999999999999999999999765432 2
Q ss_pred eeeec---------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 748 LDCLH---------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 748 l~~l~---------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
+++.. .....+++.+...++.++++||+||| +.+|+||||||+||+ |||+++......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 22221 11345677888899999999999996 568999999999998 999998654322
Q ss_pred cc---ccccceeccccccccc
Q 047196 809 SM---IQTETLVTIGYMAPGL 826 (827)
Q Consensus 809 ~~---~~~~~~gt~~Y~APE~ 826 (827)
.. ......+|+.|+|||+
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~ 199 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALES 199 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHH
T ss_pred ccccccCcCCCCCccccChhh
Confidence 11 1122347899999996
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.74 E-value=1.2e-18 Score=184.88 Aligned_cols=149 Identities=26% Similarity=0.385 Sum_probs=105.5
Q ss_pred hcccccceEecCCceEEEEEEec--CCc--EEEEEEEccc---chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCcee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH--DGI--EVAIKVFHQN---CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKA 747 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~--~g~--~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~ 747 (827)
++|+..+.||+|+||.||+|++. +++ .||||++... .....+.+.+|++++++++||||+++++++..+...+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 97 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCcee
Confidence 57888899999999999999853 333 6999998643 2334678999999999999999999999998765332
Q ss_pred -eeeecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCC
Q 047196 748 -LDCLHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGD 807 (827)
Q Consensus 748 -l~~l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~ 807 (827)
+++... ....+++.....++.++++||+||| +.+|+||||||+||+ |||+++.....
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 174 (291)
T 1u46_A 98 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174 (291)
T ss_dssp EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred eEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence 222221 1234677788899999999999996 568999999999998 99999877544
Q ss_pred Cccc--cccceeccccccccc
Q 047196 808 RSMI--QTETLVTIGYMAPGL 826 (827)
Q Consensus 808 ~~~~--~~~~~gt~~Y~APE~ 826 (827)
.... .....+|++|+|||+
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~ 195 (291)
T 1u46_A 175 DDHYVMQEHRKVPFAWCAPES 195 (291)
T ss_dssp CCEEEC-----CCGGGCCHHH
T ss_pred ccchhhhccCCCCceeeCchh
Confidence 3221 122347889999996
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=5e-18 Score=187.62 Aligned_cols=148 Identities=24% Similarity=0.336 Sum_probs=116.0
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcC-CCC-----ceEEEeeeecCCce
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIR-HRN-----HVKRISSCSNEDFK 746 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-H~n-----iv~~~~~~~~~~~~ 746 (827)
.++|...+.||+|+||.||+|+.. +|+.||||++... .....++.+|+++++.++ |++ +|++.+++...+..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 467899999999999999999865 6889999999754 334567888999999886 553 89999998776655
Q ss_pred eeeeeccC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee------------eeccccc
Q 047196 747 ALDCLHST-----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------------DFGIGRL 803 (827)
Q Consensus 747 ~l~~l~~~-----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------------DFGla~~ 803 (827)
++...+.. ...+++.....++.+++.||+|||. |+.+|+||||||+||| |||+|+.
T Consensus 132 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~ 210 (382)
T 2vx3_A 132 CLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 210 (382)
T ss_dssp EEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence 44322211 1346788888999999999999974 5789999999999998 9999987
Q ss_pred ccCCCccccccceecccccccccC
Q 047196 804 LTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 804 ~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
..... ...+||+.|+|||++
T Consensus 211 ~~~~~----~~~~~t~~y~aPE~~ 230 (382)
T 2vx3_A 211 LGQRI----YQYIQSRFYRSPEVL 230 (382)
T ss_dssp TTCCC----CSSCSCGGGCCHHHH
T ss_pred ccccc----ccccCCccccChHHH
Confidence 64321 234689999999973
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=3.2e-18 Score=181.63 Aligned_cols=150 Identities=24% Similarity=0.433 Sum_probs=111.3
Q ss_pred hcccccc-eEecCCceEEEEEEe---cCCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCce-e
Q 047196 675 EKFSKEN-LIGVGSFGSVYKGRL---HDGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFK-A 747 (827)
Q Consensus 675 ~~~~~~~-~iG~G~fg~Vy~~~~---~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~-~ 747 (827)
++|...+ .||+|+||.||+|.+ .+++.||||++.... ....+++.+|++++++++||||+++++++..+... +
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv 95 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLV 95 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcEEE
Confidence 4567666 899999999999964 246889999986542 23457899999999999999999999999554432 2
Q ss_pred eeeecc--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 748 LDCLHS--------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 748 l~~l~~--------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
+++... ....+++.....++.++++||+||| +.+|+||||||+||+ |||+++.......
T Consensus 96 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (291)
T 1xbb_A 96 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172 (291)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred EEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCC
Confidence 222221 1234778888999999999999996 568999999999998 9999987654433
Q ss_pred ccc--ccceecccccccccC
Q 047196 810 MIQ--TETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~--~~~~gt~~Y~APE~l 827 (827)
... ....+|+.|+|||++
T Consensus 173 ~~~~~~~~~~~~~y~aPE~~ 192 (291)
T 1xbb_A 173 YYKAQTHGKWPVKWYAPECI 192 (291)
T ss_dssp EEEC----CCCGGGCCHHHH
T ss_pred cccccccCCCCceeeChHHh
Confidence 211 122367899999963
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=3.7e-18 Score=179.80 Aligned_cols=152 Identities=27% Similarity=0.369 Sum_probs=113.0
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecC--Ccee-
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNE--DFKA- 747 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~--~~~~- 747 (827)
.++|+..+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|++++++++||||+++++++... ...+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 367888999999999999999875 6899999999653 234567899999999999999999999987542 2222
Q ss_pred -eeeeccC------------CCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEEccCCCccee----------eecccc
Q 047196 748 -LDCLHST------------NCSLNIFDKLNIMIDVASALEYLHFSH--STPVIHCDLKPKNVF----------DFGIGR 802 (827)
Q Consensus 748 -l~~l~~~------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h--~~~iiHrDlK~~NIl----------DFGla~ 802 (827)
+++.... ...+++.....++.++++||+|||... ..+|+||||||+||+ |||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 2332211 123778888999999999999998643 244999999999998 999988
Q ss_pred cccCCCccccccceeccccccccc
Q 047196 803 LLTGDRSMIQTETLVTIGYMAPGL 826 (827)
Q Consensus 803 ~~~~~~~~~~~~~~gt~~Y~APE~ 826 (827)
........ .....||+.|+|||+
T Consensus 165 ~~~~~~~~-~~~~~~~~~y~aPE~ 187 (279)
T 2w5a_A 165 ILNHDTSF-AKTFVGTPYYMSPEQ 187 (279)
T ss_dssp HC---CHH-HHHHHSCCTTCCHHH
T ss_pred eecccccc-ccccCCCccccChHH
Confidence 76543221 122358999999996
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=3.1e-18 Score=181.38 Aligned_cols=149 Identities=26% Similarity=0.411 Sum_probs=117.9
Q ss_pred HhhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeee
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALD 749 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~ 749 (827)
..++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++......++.
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3467999999999999999999875 68999999986432 23456789999999999999999999999877655443
Q ss_pred eeccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------eecccccccC
Q 047196 750 CLHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------DFGIGRLLTG 806 (827)
Q Consensus 750 ~l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------------DFGla~~~~~ 806 (827)
..+.. ...+++.+...++.++++||+||| +.+|+||||||+||+ |||+++....
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 32221 134677788899999999999996 568999999999998 8998876643
Q ss_pred CCccccccceeccccccccc
Q 047196 807 DRSMIQTETLVTIGYMAPGL 826 (827)
Q Consensus 807 ~~~~~~~~~~gt~~Y~APE~ 826 (827)
.... ....||+.|+|||+
T Consensus 177 ~~~~--~~~~~~~~y~aPE~ 194 (287)
T 2wei_A 177 NTKM--KDRIGTAYYIAPEV 194 (287)
T ss_dssp CSSC--SCHHHHHTTCCHHH
T ss_pred CCcc--ccccCcccccChHH
Confidence 3221 22348999999996
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.74 E-value=4.3e-19 Score=195.81 Aligned_cols=146 Identities=16% Similarity=0.216 Sum_probs=105.1
Q ss_pred hhcccccceEecCCceEEEEEEe-cCCcEEEEEEEccc---chHHHHHHHHHH---HHHHhcCCCCceEEE-------ee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQN---CAMALKSFEAEC---EVMKNIRHRNHVKRI-------SS 739 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~~~~Ei---~~l~~l~H~niv~~~-------~~ 739 (827)
.++|...+.||+|+||.||+|+. .+|+.||||++... .....+.|.+|+ +++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 45788889999999999999996 56999999998632 334567899999 566666899999987 44
Q ss_pred eecCC-------------------ceeeeeeccC-------CC-------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 047196 740 CSNED-------------------FKALDCLHST-------NC-------SLNIFDKLNIMIDVASALEYLHFSHSTPVI 786 (827)
Q Consensus 740 ~~~~~-------------------~~~l~~l~~~-------~~-------~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ii 786 (827)
+..++ +..+++.... .. .+.+..+..|+.|+++||+||| +.+|+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iv 228 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLV 228 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCee
Confidence 43331 1112222110 00 1113556779999999999996 46899
Q ss_pred EccCCCccee----------eecccccccCCCccccccceecccccccccC
Q 047196 787 HCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 787 HrDlK~~NIl----------DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
||||||+||| |||+|+.... .....+| ++|+|||++
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~ 274 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELE 274 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhh
Confidence 9999999998 9999985322 1223457 999999974
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.6e-18 Score=187.04 Aligned_cols=158 Identities=27% Similarity=0.352 Sum_probs=113.8
Q ss_pred cchhHHHHHhhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhc-CCCCceEEEeeeec
Q 047196 665 FSYQDLFRATEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNI-RHRNHVKRISSCSN 742 (827)
Q Consensus 665 ~~~~~~~~~~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~ 742 (827)
+...++....++|+..+.||+|+||.||+|+. .+|+.||||++.... ...+.+.+|+++++++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 33444445667899999999999999999986 478999999986543 2346789999999999 79999999999876
Q ss_pred C------Ccee--eeeecc----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee--------
Q 047196 743 E------DFKA--LDCLHS----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------- 796 (827)
Q Consensus 743 ~------~~~~--l~~l~~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------- 796 (827)
. ...+ +++... ....++......++.+++.||+||| +.+|+||||||+||+
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEE
Confidence 3 2222 233221 1134667778889999999999996 568999999999998
Q ss_pred --eecccccccCCCccccccceecccccccccC
Q 047196 797 --DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 --DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
|||+++........ .....||+.|+|||++
T Consensus 170 l~Dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~ 201 (326)
T 2x7f_A 170 LVDFGVSAQLDRTVGR-RNTFIGTPYWMAPEVI 201 (326)
T ss_dssp ECCCTTTC--------------CCGGGCCHHHH
T ss_pred EeeCcCceecCcCccc-cccccCCccccChhhh
Confidence 99998776432221 1234589999999963
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=6.2e-18 Score=182.66 Aligned_cols=149 Identities=24% Similarity=0.273 Sum_probs=99.7
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc-hHHHHHHHHHHH-HHHhcCCCCceEEEeeeecCCceee--e
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC-AMALKSFEAECE-VMKNIRHRNHVKRISSCSNEDFKAL--D 749 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~-~l~~l~H~niv~~~~~~~~~~~~~l--~ 749 (827)
++|...+.||+|+||.||+|+.. +|+.||||++.... .....++.+|+. +++.++|||||++++++...+..++ +
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 57888899999999999999874 68999999997543 334455666666 7788899999999999987765443 2
Q ss_pred eecc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCC
Q 047196 750 CLHS------------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGD 807 (827)
Q Consensus 750 ~l~~------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~ 807 (827)
+... ....+.+.....++.++++|+.|||.. .+|+||||||+||+ |||+++.....
T Consensus 102 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 179 (327)
T 3aln_A 102 LMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS 179 (327)
T ss_dssp CCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC----
T ss_pred ecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceecccc
Confidence 2221 134567778889999999999999742 27999999999998 99999876543
Q ss_pred CccccccceecccccccccC
Q 047196 808 RSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 808 ~~~~~~~~~gt~~Y~APE~l 827 (827)
.. .....||+.|+|||++
T Consensus 180 ~~--~~~~~gt~~y~aPE~~ 197 (327)
T 3aln_A 180 IA--KTRDAGCRPYMAPERI 197 (327)
T ss_dssp --------------------
T ss_pred cc--cccCCCCccccCceee
Confidence 22 1223589999999974
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.1e-19 Score=210.24 Aligned_cols=216 Identities=16% Similarity=0.119 Sum_probs=125.0
Q ss_pred CCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEE-ccCCcC
Q 047196 314 SLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIY-ISNCNI 392 (827)
Q Consensus 314 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~-Ls~N~l 392 (827)
..++|+.|+|+.|+++ .+|..++++++|+.|++++|......|.. +..+...+..|..++.+. +|+.|+ ++.|.+
T Consensus 347 ~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~l--l~~~~~~~~~~~~l~~l~-~L~~L~~l~~n~~ 422 (567)
T 1dce_A 347 TDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILL--MRALDPLLYEKETLQYFS-TLKAVDPMRAAYL 422 (567)
T ss_dssp TTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHH--HHHHCTGGGHHHHHHHHH-HHHHHCGGGHHHH
T ss_pred cCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHH--HHhcccccCCHHHHHHHH-hcccCcchhhccc
Confidence 5677888888888886 67888888888888887665421111100 001111222333333332 333333 222221
Q ss_pred ccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCccc
Q 047196 393 GGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCL 472 (827)
Q Consensus 393 ~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 472 (827)
.+|..+.+++|.+++..+ ..|+.|+|++|++++ +|. +..+++|+.|+|++|+++ .+|..+
T Consensus 423 -----------~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~ 482 (567)
T 1dce_A 423 -----------DDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPAL 482 (567)
T ss_dssp -----------HHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGG
T ss_pred -----------chhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhh
Confidence 123333344445443222 246777777777775 555 777777777777777777 667777
Q ss_pred cCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCC-cccccccccCceEEcccceeeeccccc---ccCCC
Q 047196 473 GNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPL-SLDIGNLRVVIGINLSRNNFSGDIPST---IGDLK 548 (827)
Q Consensus 473 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~-p~~~~~l~~L~~L~Ls~N~l~g~ip~~---~~~l~ 548 (827)
+.+++|+.|+|++|.+++ +| .+..+++|+.|+|++|++++.+ |..++.++.|+.|+|++|+|++.+|.. +..++
T Consensus 483 ~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp 560 (567)
T 1dce_A 483 AALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 560 (567)
T ss_dssp GGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCT
T ss_pred hcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCc
Confidence 777777777777777776 45 5666666666666666666665 666666666666666666666554422 22355
Q ss_pred CCCEEEC
Q 047196 549 DLQNISL 555 (827)
Q Consensus 549 ~L~~L~L 555 (827)
+|+.||+
T Consensus 561 ~L~~L~l 567 (567)
T 1dce_A 561 SVSSILT 567 (567)
T ss_dssp TCSEEEC
T ss_pred ccCccCC
Confidence 5555543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=6.9e-18 Score=181.09 Aligned_cols=148 Identities=29% Similarity=0.335 Sum_probs=112.4
Q ss_pred HhhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeee
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l 751 (827)
..++|+..+.||+|+||.||+|+.. +|+.||||++.... ..+++.+|++++++++||||+++++++......++...
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 3467888999999999999999875 58999999986543 24578999999999999999999999987765444222
Q ss_pred cc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 752 HS-----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 752 ~~-----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
+. ....+++.....++.+++.|+.||| +.+|+||||||+||+ |||+++........
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 181 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK 181 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSC
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccc
Confidence 21 1345778888999999999999996 568999999999998 99999876543221
Q ss_pred ccccceeccccccccc
Q 047196 811 IQTETLVTIGYMAPGL 826 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~ 826 (827)
.....||+.|+|||+
T Consensus 182 -~~~~~~~~~y~aPE~ 196 (314)
T 3com_A 182 -RNTVIGTPFWMAPEV 196 (314)
T ss_dssp -BCCCCSCGGGCCHHH
T ss_pred -cCccCCCCCccChhh
Confidence 223458999999996
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.73 E-value=3.2e-18 Score=181.89 Aligned_cols=149 Identities=26% Similarity=0.409 Sum_probs=110.7
Q ss_pred HhhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecC-Cceee--
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNE-DFKAL-- 748 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~-~~~~l-- 748 (827)
..++|+..+.||+|+||.||+|+. .+++.||||++.... ..+++.+|++++++++|++++..++.+... +..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 456799999999999999999986 578999999875432 224578999999999999988888777543 33232
Q ss_pred eeec--------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------eecccccccCC
Q 047196 749 DCLH--------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------DFGIGRLLTGD 807 (827)
Q Consensus 749 ~~l~--------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------------DFGla~~~~~~ 807 (827)
++.. .....+++.....++.++++||+||| +.+|+||||||+||+ |||+++.....
T Consensus 85 e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 85 ELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp ECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 3221 11345788889999999999999996 568999999999998 99999876543
Q ss_pred Ccc------ccccceeccccccccc
Q 047196 808 RSM------IQTETLVTIGYMAPGL 826 (827)
Q Consensus 808 ~~~------~~~~~~gt~~Y~APE~ 826 (827)
... ......||+.|+|||+
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~ 186 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINT 186 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHH
T ss_pred ccCccCCCCcccccCCCccccchHH
Confidence 321 1123458999999996
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.73 E-value=3.9e-18 Score=181.30 Aligned_cols=148 Identities=26% Similarity=0.411 Sum_probs=113.6
Q ss_pred hhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecC-Ccee--ee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNE-DFKA--LD 749 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~-~~~~--l~ 749 (827)
.++|...+.||+|+||.||+|+. .+|+.||||++..... .+++.+|++++++++|+++++.+.++... ...+ ++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46788999999999999999986 5789999999865432 24688999999999999988877776443 3222 23
Q ss_pred eec--------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------eecccccccCCC
Q 047196 750 CLH--------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------DFGIGRLLTGDR 808 (827)
Q Consensus 750 ~l~--------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------------DFGla~~~~~~~ 808 (827)
+.. .....+++.+...++.++++||+||| +.+|+||||||+||+ |||+++......
T Consensus 86 ~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 86 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred ecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 321 11345778888999999999999996 568999999999998 999998765443
Q ss_pred cc------ccccceeccccccccc
Q 047196 809 SM------IQTETLVTIGYMAPGL 826 (827)
Q Consensus 809 ~~------~~~~~~gt~~Y~APE~ 826 (827)
.. ......||+.|+|||+
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~ 186 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINT 186 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHH
T ss_pred cccccccccccccccccccCChhh
Confidence 21 1123458999999996
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.9e-18 Score=186.77 Aligned_cols=150 Identities=19% Similarity=0.221 Sum_probs=107.5
Q ss_pred hcccccceEecCCceEEEEEEec----CCcEEEEEEEcccchH-----------HHHHHHHHHHHHHhcCCCCceEEEee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH----DGIEVAIKVFHQNCAM-----------ALKSFEAECEVMKNIRHRNHVKRISS 739 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~~~-----------~~~~~~~Ei~~l~~l~H~niv~~~~~ 739 (827)
++|...+.||+|+||.||+|+.. ++..||||+....... ..+.+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 56888999999999999999875 5788999998654311 12347789999999999999999999
Q ss_pred eec----CCceee--eeecc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------
Q 047196 740 CSN----EDFKAL--DCLHS-------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---------- 796 (827)
Q Consensus 740 ~~~----~~~~~l--~~l~~-------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---------- 796 (827)
+.. ....++ ++... ....+++.+...++.++++||+||| +.+|+||||||+||+
T Consensus 117 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEESSSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTTSEE
T ss_pred cccccCCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCCcEE
Confidence 876 333332 33210 1225788899999999999999996 568999999999998
Q ss_pred --eecccccccCCCcc------ccccceecccccccccC
Q 047196 797 --DFGIGRLLTGDRSM------IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 --DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~l 827 (827)
|||+|+.+...... ......||+.|+|||++
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 232 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAH 232 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHh
Confidence 99999876432211 11234589999999963
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=5.2e-18 Score=183.27 Aligned_cols=148 Identities=28% Similarity=0.462 Sum_probs=110.4
Q ss_pred hcccccceEecCCceEEEEEEec-CCcE--EEEEEEcccc-hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCceeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIE--VAIKVFHQNC-AMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFKALD 749 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~--vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~l~ 749 (827)
++|...+.||+|+||.||+|+.. +|.. ||||++.... ....+.+.+|+++++++ +||||+++++++...+..++.
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57888899999999999999864 5664 4999986532 33456789999999999 899999999999887755443
Q ss_pred eeccC--------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------
Q 047196 750 CLHST--------------------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------- 796 (827)
Q Consensus 750 ~l~~~--------------------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------- 796 (827)
..+.. ...+++.+...++.++++||+||| +.+|+||||||+||+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence 22211 124677888999999999999996 578999999999998
Q ss_pred ---eecccccccCCCccccccceecccccccccC
Q 047196 797 ---DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 ---DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
|||+++....... .....+|+.|+|||++
T Consensus 182 kL~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~ 213 (327)
T 1fvr_A 182 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESL 213 (327)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHH
T ss_pred EEcccCcCcccccccc--ccCCCCCccccChhhh
Confidence 9999874322111 1223468899999963
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=5.1e-18 Score=178.74 Aligned_cols=143 Identities=27% Similarity=0.430 Sum_probs=104.3
Q ss_pred hhcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC-cee--eee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNED-FKA--LDC 750 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~-~~~--l~~ 750 (827)
.++|+..+.||+|+||.||+|+.. |+.||||++.... ..+.+.+|++++++++|||+|++++++.+.. ..+ +++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 357888999999999999999875 7899999986543 4567899999999999999999999976543 222 232
Q ss_pred eccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 751 LHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 751 l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
..... ..+++.....++.++++|++||| +.+|+||||||+||+ |||+++......
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence 22110 11566677889999999999996 568999999999998 999987654321
Q ss_pred ccccceeccccccccc
Q 047196 811 IQTETLVTIGYMAPGL 826 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~ 826 (827)
....+++.|+|||+
T Consensus 172 --~~~~~~~~y~aPE~ 185 (278)
T 1byg_A 172 --DTGKLPVKWTAPEA 185 (278)
T ss_dssp ------CCTTTSCHHH
T ss_pred --cCCCccccccCHHH
Confidence 12347889999996
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.73 E-value=2.9e-18 Score=184.66 Aligned_cols=148 Identities=25% Similarity=0.315 Sum_probs=115.5
Q ss_pred hhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccch------HHHHHHHHHHHHHHhcC--CCCceEEEeeeecCC
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCA------MALKSFEAECEVMKNIR--HRNHVKRISSCSNED 744 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~------~~~~~~~~Ei~~l~~l~--H~niv~~~~~~~~~~ 744 (827)
.++|...+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|++++++++ |+|++++++++..++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~ 121 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence 45688899999999999999986 4689999999865321 12245778999999997 599999999998876
Q ss_pred ceeeeeeccC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------eecccc
Q 047196 745 FKALDCLHST-----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGR 802 (827)
Q Consensus 745 ~~~l~~l~~~-----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGla~ 802 (827)
..++...+.. ...+++.....++.++++||+||| +.+|+||||||+||+ |||+++
T Consensus 122 ~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 122 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred cEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 5544332221 235677788899999999999996 568999999999998 999998
Q ss_pred cccCCCccccccceecccccccccC
Q 047196 803 LLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 803 ~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
....... ....||+.|+|||++
T Consensus 199 ~~~~~~~---~~~~gt~~y~aPE~~ 220 (320)
T 3a99_A 199 LLKDTVY---TDFDGTRVYSPPEWI 220 (320)
T ss_dssp ECCSSCB---CCCCSCGGGSCHHHH
T ss_pred ccccccc---cCCCCCccCCChHHh
Confidence 7653321 234589999999963
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.1e-18 Score=186.16 Aligned_cols=150 Identities=25% Similarity=0.318 Sum_probs=99.3
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l 751 (827)
.++|...+.||+|+||.||+|+.. +++.||||++.... ....+++.+|++++++++||||+++++++...+..++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 467888999999999999999864 68999999986432 3345678999999999999999999999987765544222
Q ss_pred ccC------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eeccccc
Q 047196 752 HST------------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRL 803 (827)
Q Consensus 752 ~~~------------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~ 803 (827)
+.. ...+++.....++.++++|++||| +.+|+||||||+||+ |||+++.
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 211 234678888999999999999996 568999999999998 9999877
Q ss_pred ccCCCcc----ccccceeccccccccc
Q 047196 804 LTGDRSM----IQTETLVTIGYMAPGL 826 (827)
Q Consensus 804 ~~~~~~~----~~~~~~gt~~Y~APE~ 826 (827)
....... ......||+.|+|||+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~ 197 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEV 197 (303)
T ss_dssp CC---------------CCCTTCCHHH
T ss_pred eccCCCccchhhhcccCCCccccCHHH
Confidence 6433211 1122458999999996
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=1.9e-18 Score=190.25 Aligned_cols=147 Identities=14% Similarity=0.157 Sum_probs=94.3
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhc--CCCCceEEEe-------ee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNI--RHRNHVKRIS-------SC 740 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l--~H~niv~~~~-------~~ 740 (827)
...|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++++.+ +|||+|+++. .+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345888899999999999999965 78999999997643 23456788885555444 6999888553 22
Q ss_pred ecCC-------------------ceeeeeecc--------CCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCCeEE
Q 047196 741 SNED-------------------FKALDCLHS--------TNCSLNIFDK------LNIMIDVASALEYLHFSHSTPVIH 787 (827)
Q Consensus 741 ~~~~-------------------~~~l~~l~~--------~~~~l~~~~~------~~i~~~ia~~L~~Lh~~h~~~iiH 787 (827)
.... +.+++++.. ....+.+..+ ..++.++++||+||| +.+|+|
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~ivH 217 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVH 217 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCcc
Confidence 2111 122222221 0111233334 677899999999996 568999
Q ss_pred ccCCCccee----------eecccccccCCCccccccceecccccccccC
Q 047196 788 CDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 788 rDlK~~NIl----------DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
|||||+||| |||+|+...... ....+|+.|+|||++
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~ 263 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFL 263 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHH
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhc
Confidence 999999998 999998654221 134477999999973
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.72 E-value=4.8e-18 Score=183.30 Aligned_cols=149 Identities=28% Similarity=0.451 Sum_probs=111.1
Q ss_pred HhhcccccceEecCCceEEEEEEe--cCCcEEEEEEEcccch--HHHHHHHHHHHHHHhc---CCCCceEEEeeeec---
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRL--HDGIEVAIKVFHQNCA--MALKSFEAECEVMKNI---RHRNHVKRISSCSN--- 742 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~--~~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l---~H~niv~~~~~~~~--- 742 (827)
+.++|+..+.||+|+||.||+|+. .+|+.||||++..... .....+.+|+++++++ +||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999987 3688999999864321 1223567788877776 89999999999862
Q ss_pred --CCcee--eeeecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eec
Q 047196 743 --EDFKA--LDCLHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFG 799 (827)
Q Consensus 743 --~~~~~--l~~l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFG 799 (827)
....+ +++... ....+.+.....++.++++||+||| +.+|+||||||+||+ |||
T Consensus 89 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Dfg 165 (326)
T 1blx_A 89 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFG 165 (326)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred CCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecCc
Confidence 22222 222221 1123677888899999999999996 568999999999998 999
Q ss_pred ccccccCCCccccccceeccccccccc
Q 047196 800 IGRLLTGDRSMIQTETLVTIGYMAPGL 826 (827)
Q Consensus 800 la~~~~~~~~~~~~~~~gt~~Y~APE~ 826 (827)
+++...... ......||+.|+|||+
T Consensus 166 ~~~~~~~~~--~~~~~~~~~~y~aPE~ 190 (326)
T 1blx_A 166 LARIYSFQM--ALTSVVVTLWYRAPEV 190 (326)
T ss_dssp SCCCCCGGG--GGCCCCCCCTTCCHHH
T ss_pred ccccccCCC--CccccccccceeCHHH
Confidence 998654322 1233458999999996
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.72 E-value=2.2e-18 Score=188.29 Aligned_cols=144 Identities=13% Similarity=0.232 Sum_probs=108.6
Q ss_pred hcccccceEecCCceEEEEEEecC---------CcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceE----------
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHD---------GIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVK---------- 735 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~---------g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~---------- 735 (827)
++|...+.||+|+||.||+|+... ++.||||++... +.+.+|++++++++|||+|+
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 578889999999999999998753 789999998654 35789999999999999987
Q ss_pred -----EEeeeec-CCceee--eeecc--------C-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee--
Q 047196 736 -----RISSCSN-EDFKAL--DCLHS--------T-NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-- 796 (827)
Q Consensus 736 -----~~~~~~~-~~~~~l--~~l~~--------~-~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-- 796 (827)
+++++.. ....++ ++... . ...+++.+...++.++++||+||| +.+|+||||||+||+
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVD 193 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEEEE
T ss_pred cCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEEc
Confidence 4556554 333222 33210 1 245788889999999999999996 568999999999998
Q ss_pred ----------eecccccccCCCcc------ccccceeccccccccc
Q 047196 797 ----------DFGIGRLLTGDRSM------IQTETLVTIGYMAPGL 826 (827)
Q Consensus 797 ----------DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~ 826 (827)
|||+++.+...... ......||+.|+|||+
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 239 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDL 239 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHH
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHH
Confidence 99999876432211 1123358999999996
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.3e-17 Score=179.23 Aligned_cols=150 Identities=22% Similarity=0.278 Sum_probs=102.0
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc-hH-HHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC-AM-ALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~-~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
.++|+..+.||+|+||.||+|+.. +|+.||||++.... .. ..+.+..+..+++.++||||+++++++...+..++..
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 357888899999999999999875 68999999996542 22 2334455566788999999999999998877554432
Q ss_pred eccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 751 LHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 751 l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
.+.. ...+.+.....++.++++||+|||.. .+|+||||||+||+ |||+++.......
T Consensus 104 e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 180 (318)
T 2dyl_A 104 ELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA- 180 (318)
T ss_dssp CCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred eccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc-
Confidence 2211 24567778889999999999999742 27999999999998 9999876644322
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
.....||+.|+|||++
T Consensus 181 -~~~~~~~~~y~aPE~~ 196 (318)
T 2dyl_A 181 -KDRSAGCAAYMAPERI 196 (318)
T ss_dssp -------CCTTCCHHHH
T ss_pred -ccccCCCccccChhhc
Confidence 1234589999999973
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.72 E-value=3.9e-18 Score=182.92 Aligned_cols=149 Identities=25% Similarity=0.320 Sum_probs=109.0
Q ss_pred HHhhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccch------HHHHHHHHHHHHHHhc----CCCCceEEEeee
Q 047196 672 RATEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCA------MALKSFEAECEVMKNI----RHRNHVKRISSC 740 (827)
Q Consensus 672 ~~~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~------~~~~~~~~Ei~~l~~l----~H~niv~~~~~~ 740 (827)
...++|...+.||+|+||.||+|+. .+|+.||||++..... .....+.+|+++++++ +|+||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 3456799999999999999999986 4689999999865432 1223467899999999 899999999998
Q ss_pred ecCCceeeeeec-c----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------ee
Q 047196 741 SNEDFKALDCLH-S----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DF 798 (827)
Q Consensus 741 ~~~~~~~l~~l~-~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DF 798 (827)
...+..++...+ . ....+++.....++.++++||+||| +.+|+||||||+||+ ||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~df 184 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDF 184 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence 766544432222 1 1234778888999999999999997 457999999999998 99
Q ss_pred cccccccCCCccccccceeccccccccc
Q 047196 799 GIGRLLTGDRSMIQTETLVTIGYMAPGL 826 (827)
Q Consensus 799 Gla~~~~~~~~~~~~~~~gt~~Y~APE~ 826 (827)
|+++....... ....||++|+|||+
T Consensus 185 g~~~~~~~~~~---~~~~~~~~y~aPE~ 209 (312)
T 2iwi_A 185 GSGALLHDEPY---TDFDGTRVYSPPEW 209 (312)
T ss_dssp SSCEECCSSCB---CCCCSCTTTSCHHH
T ss_pred chhhhcccCcc---cccCCcccccCcee
Confidence 99887654322 23458999999996
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=6.6e-18 Score=189.76 Aligned_cols=145 Identities=26% Similarity=0.375 Sum_probs=102.4
Q ss_pred ccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCceeeeeeccCC
Q 047196 677 FSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFKALDCLHSTN 755 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~l~~l~~~~ 755 (827)
|...++||+|+||+||.+...+|+.||||++.... .+.+.+|+++++++ +|||||++++++......++...+...
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~g 93 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNL 93 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCSE
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCCC
Confidence 44567899999999987766679999999986532 34678999999987 899999999998877755443222110
Q ss_pred ---------CC-------CCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------------------
Q 047196 756 ---------CS-------LNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------------------- 796 (827)
Q Consensus 756 ---------~~-------l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------------------- 796 (827)
.. ..+.....++.++++||+||| +.+|+||||||+||+
T Consensus 94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp EHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 00 112234679999999999996 568999999999986
Q ss_pred eecccccccCCCccc---cccceecccccccccC
Q 047196 797 DFGIGRLLTGDRSMI---QTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 DFGla~~~~~~~~~~---~~~~~gt~~Y~APE~l 827 (827)
|||+|+......... ....+||++|+|||++
T Consensus 171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 204 (434)
T 2rio_A 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELL 204 (434)
T ss_dssp CCTTCEECCC--------------CCTTSCHHHH
T ss_pred ccccceecCCCCccceeeecCCCCCCCccCHHHh
Confidence 789888765433211 1234599999999963
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.72 E-value=7.7e-18 Score=167.71 Aligned_cols=154 Identities=16% Similarity=0.200 Sum_probs=86.2
Q ss_pred cCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCc
Q 047196 401 SNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRS 480 (827)
Q Consensus 401 ~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 480 (827)
..+++|+.|++++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|++++..|..+..+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 34455555555555555 233 3555555555555555443 2234555566666666666665555555666666666
Q ss_pred cccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccceeeecccccccCCCCCCEEECCCCcc
Q 047196 481 PDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGL 560 (827)
Q Consensus 481 L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l 560 (827)
|++++|.+++..|..+..+++|+.|++++|.+.+.+| .+..++.|+.|++++|++++ ++ .+..+++|+.|++++|++
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i 193 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTI 193 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC--
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCccc
Confidence 6666666665555556666666666666665223334 45566666666666666664 33 556666666666666665
Q ss_pred e
Q 047196 561 E 561 (827)
Q Consensus 561 ~ 561 (827)
.
T Consensus 194 ~ 194 (197)
T 4ezg_A 194 G 194 (197)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.7e-17 Score=173.05 Aligned_cols=167 Identities=19% Similarity=0.249 Sum_probs=119.6
Q ss_pred EEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcCC
Q 047196 100 VTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDS 179 (827)
Q Consensus 100 v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~ 179 (827)
++.++++.+.+++.. .+..+++|++|++++|+++ .+| .+..+++|++|+|++|++++..+ +..+++|++|++++
T Consensus 21 l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~ 94 (263)
T 1xeu_A 21 AVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNR 94 (263)
T ss_dssp HHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCS
T ss_pred HHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCC
Confidence 445566677766543 5777888888888888887 445 67888888888888888887655 77778888888888
Q ss_pred CCCCCCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccc
Q 047196 180 DKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEI 259 (827)
Q Consensus 180 n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 259 (827)
|++++ +|.... ++|++|++++|.+++. ..+.++++|+.|++++|++++. | .++.+++|++|++++|++++.
T Consensus 95 N~l~~-l~~~~~---~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~- 165 (263)
T 1xeu_A 95 NRLKN-LNGIPS---ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT- 165 (263)
T ss_dssp SCCSC-CTTCCC---SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC-
T ss_pred CccCC-cCcccc---CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch-
Confidence 87774 443222 4777777777777753 2477777777777777777754 3 567777777777777777755
Q ss_pred cccccCcCCCcEEEeecccCccc
Q 047196 260 PHEIGYLPNLENLVLGFNNLVGV 282 (827)
Q Consensus 260 p~~~~~l~~L~~L~Ls~N~l~~~ 282 (827)
..+..+++|++|++++|.+++.
T Consensus 166 -~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 166 -GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp -TTSTTCCCCCEEEEEEEEEECC
T ss_pred -HHhccCCCCCEEeCCCCcccCC
Confidence 5677777777777777777654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=1.4e-17 Score=184.89 Aligned_cols=118 Identities=22% Similarity=0.322 Sum_probs=93.2
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcC--------CCCceEEEeeeec---
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIR--------HRNHVKRISSCSN--- 742 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~--------H~niv~~~~~~~~--- 742 (827)
++|...+.||+|+||.||+|+. .+|+.||||++... ....+.+.+|++++++++ |+|||++++++..
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 5788899999999999999986 46899999999654 344567899999999997 7789999998862
Q ss_pred -CCceee--eeecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEEccCCCccee
Q 047196 743 -EDFKAL--DCLHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHST-PVIHCDLKPKNVF 796 (827)
Q Consensus 743 -~~~~~l--~~l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~-~iiHrDlK~~NIl 796 (827)
....++ +++.. ....+++.....|+.|+++||+|||. + +|+||||||+|||
T Consensus 116 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIl 179 (397)
T 1wak_A 116 NGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENIL 179 (397)
T ss_dssp TEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEE
T ss_pred CCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHee
Confidence 222222 22211 11347788889999999999999974 4 8999999999986
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.3e-17 Score=164.26 Aligned_cols=155 Identities=17% Similarity=0.196 Sum_probs=131.0
Q ss_pred hcccccccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCcccccccccc
Q 047196 376 GNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLN 455 (827)
Q Consensus 376 ~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~ 455 (827)
..+. +|+.|++++|.++ .+| .+..+++|+.|++++|.++. +..+..+++|++|++++|++++..|..+..+++|+
T Consensus 41 ~~l~-~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 115 (197)
T 4ezg_A 41 AQMN-SLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115 (197)
T ss_dssp HHHH-TCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred hhcC-CccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence 3444 7999999999998 566 68889999999999997753 34788999999999999999988888999999999
Q ss_pred EEecCCCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccce
Q 047196 456 TLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNN 535 (827)
Q Consensus 456 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~ 535 (827)
+|++++|++++..|..+..+++|++|++++|.+.+.+| .+..+++|+.|++++|.+++. + .+..++.|+.|++++|+
T Consensus 116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC-
T ss_pred EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCcc
Confidence 99999999998888899999999999999998434455 688999999999999999874 3 78899999999999999
Q ss_pred eee
Q 047196 536 FSG 538 (827)
Q Consensus 536 l~g 538 (827)
|.+
T Consensus 193 i~~ 195 (197)
T 4ezg_A 193 IGG 195 (197)
T ss_dssp ---
T ss_pred cCC
Confidence 864
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=3.5e-18 Score=197.61 Aligned_cols=138 Identities=17% Similarity=0.098 Sum_probs=96.9
Q ss_pred EecCCceEEEEEEe-cCCcEEEEEEEcccc----------hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCceeeee
Q 047196 683 IGVGSFGSVYKGRL-HDGIEVAIKVFHQNC----------AMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 683 iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~----------~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~l~~ 750 (827)
.+.|+.|.++.++. -.|+.||||++.... ....++|.+|+++|+++ .|+||+++++++.++...++..
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 56677777666653 358999999996431 22356799999999999 6999999999998887665543
Q ss_pred eccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 751 LHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 751 l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
.+..+ +.++ ..+|+.||+.||+|+| +++||||||||+||| |||+|+....+...
T Consensus 322 Eyv~G~~L~d~i~~~~~l~---~~~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~ 395 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEEID---REKILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSW 395 (569)
T ss_dssp ECCCSEEHHHHHHTTCCCC---HHHHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CC
T ss_pred ecCCCCcHHHHHHhCCCCC---HHHHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcc
Confidence 33322 2233 3469999999999995 678999999999998 99999987654332
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
....+||++|||||++
T Consensus 396 -~~t~vGTp~YmAPE~l 411 (569)
T 4azs_A 396 -PTNLVQSFFVFVNELF 411 (569)
T ss_dssp -SHHHHHHHHHHHHHHC
T ss_pred -ccCceechhhccHHHh
Confidence 2335699999999974
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.71 E-value=1.6e-17 Score=182.73 Aligned_cols=145 Identities=19% Similarity=0.337 Sum_probs=112.3
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcC-----------CCCceEEEeeeec
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIR-----------HRNHVKRISSCSN 742 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-----------H~niv~~~~~~~~ 742 (827)
++|...+.||+|+||.||+|+. .+|+.||||++... ....+.+.+|++++++++ |+||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 5788899999999999999986 56899999999754 334567889999999887 8899999998865
Q ss_pred CC----ceeeeeecc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEEccCCCccee----------
Q 047196 743 ED----FKALDCLHS-----------TNCSLNIFDKLNIMIDVASALEYLHFSHST-PVIHCDLKPKNVF---------- 796 (827)
Q Consensus 743 ~~----~~~l~~l~~-----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~-~iiHrDlK~~NIl---------- 796 (827)
.. ..++...+. ....+++.....++.+++.||+|||. + +|+||||||+||+
T Consensus 98 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTTTE
T ss_pred cCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCcCc
Confidence 32 222211111 12347788888999999999999974 4 8999999999987
Q ss_pred ------eecccccccCCCccccccceecccccccccC
Q 047196 797 ------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 ------DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
|||+|+...... ....||++|+|||++
T Consensus 175 ~~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~ 207 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEHY----TNSIQTREYRSPEVL 207 (373)
T ss_dssp EEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHH
T ss_pred ceEEEcccccccccCCCC----CCCCCCccccCcHHH
Confidence 899887664321 234589999999963
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.9e-17 Score=187.48 Aligned_cols=149 Identities=23% Similarity=0.364 Sum_probs=111.2
Q ss_pred hhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEee-eecCCceee--e
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISS-CSNEDFKAL--D 749 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~-~~~~~~~~l--~ 749 (827)
.++|...++||+|+||.||+|+. .+|+.||||++..... .+++.+|+++++.++|++.+..+.+ +...+..++ +
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 35789999999999999999986 5689999998764432 2357899999999998665554444 444443333 3
Q ss_pred eecc--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------eecccccccCCC
Q 047196 750 CLHS--------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------DFGIGRLLTGDR 808 (827)
Q Consensus 750 ~l~~--------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------------DFGla~~~~~~~ 808 (827)
++.. ....+++.....|+.+++.||+||| +.+|+||||||+||| |||+|+.+....
T Consensus 84 ~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 3311 1345788889999999999999996 568999999999998 999998775433
Q ss_pred ccc------cccceecccccccccC
Q 047196 809 SMI------QTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~------~~~~~gt~~Y~APE~l 827 (827)
... .....||+.|+|||++
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~ 185 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTH 185 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHH
T ss_pred cccccccccccccCCCccccCHHHh
Confidence 211 1234589999999963
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.70 E-value=9.7e-18 Score=174.96 Aligned_cols=168 Identities=17% Similarity=0.246 Sum_probs=112.0
Q ss_pred cccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecC
Q 047196 381 SLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLA 460 (827)
Q Consensus 381 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 460 (827)
.+..+++++|.+++.. .+..+++|+.|++++|.++. +| .+..+++|+.|+|++|++++..| +..+++|+.|+++
T Consensus 20 ~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~ 93 (263)
T 1xeu_A 20 NAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVN 93 (263)
T ss_dssp HHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECC
T ss_pred HHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECC
Confidence 4556667777776433 45667777777777777764 34 56677777777777777775443 6777777777777
Q ss_pred CCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccceeeecc
Q 047196 461 GNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDI 540 (827)
Q Consensus 461 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~i 540 (827)
+|++++ +|.... ++|++|++++|.+++. +.+..+++|+.||+++|++++. + .++.++.|+.|++++|++++.
T Consensus 94 ~N~l~~-l~~~~~--~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~- 165 (263)
T 1xeu_A 94 RNRLKN-LNGIPS--ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT- 165 (263)
T ss_dssp SSCCSC-CTTCCC--SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC-
T ss_pred CCccCC-cCcccc--CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch-
Confidence 777764 343222 6777777777777663 2466677777777777777664 2 466677777777777777765
Q ss_pred cccccCCCCCCEEECCCCcceee
Q 047196 541 PSTIGDLKDLQNISLACNGLEGL 563 (827)
Q Consensus 541 p~~~~~l~~L~~L~Ls~N~l~g~ 563 (827)
..+..+++|+.|++++|.+++.
T Consensus 166 -~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 166 -GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp -TTSTTCCCCCEEEEEEEEEECC
T ss_pred -HHhccCCCCCEEeCCCCcccCC
Confidence 5566777777777777776654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=3.6e-17 Score=177.26 Aligned_cols=145 Identities=19% Similarity=0.328 Sum_probs=111.9
Q ss_pred hcccccceEecCCceEEEEEEe--cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCC------ceEEEeeeecCCce
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL--HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRN------HVKRISSCSNEDFK 746 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~--~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~n------iv~~~~~~~~~~~~ 746 (827)
++|+..+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|+++++.++|++ ++++++++...+..
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 5788899999999999999986 36889999999654 334567899999999998765 89999998877655
Q ss_pred eeeeeccC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------------
Q 047196 747 ALDCLHST-----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------------------- 796 (827)
Q Consensus 747 ~l~~l~~~-----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------------------- 796 (827)
++...+.. ...+++.....++.++++||+||| +.+|+||||||+||+
T Consensus 93 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~ 169 (339)
T 1z57_A 93 CIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169 (339)
T ss_dssp EEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCccccccc
Confidence 44322211 124667788899999999999996 568999999999986
Q ss_pred ----------eecccccccCCCccccccceecccccccccC
Q 047196 797 ----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 ----------DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
|||+++..... .....||++|+|||++
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~ 206 (339)
T 1z57_A 170 TLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVI 206 (339)
T ss_dssp EESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHH
T ss_pred cccCCCceEeeCcccccCccc----cccccCCccccChHHh
Confidence 67777654322 1234589999999963
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.70 E-value=1.7e-17 Score=164.49 Aligned_cols=130 Identities=25% Similarity=0.339 Sum_probs=74.0
Q ss_pred cEEEccCCcCccccCccccCCCCCceEeccCccccccccc-cccCCCCCcEEECCCCCCCCCCCccccccccccEEecCC
Q 047196 383 ENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPV-TFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAG 461 (827)
Q Consensus 383 ~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 461 (827)
+.+++++|+++ .+|..+. .+|+.|++++|++++..+. .|..+++|++|+|++|++++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 55666666664 4444332 2566666666666554443 355566666666666666655555565666666666666
Q ss_pred CcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCC
Q 047196 462 NKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGP 515 (827)
Q Consensus 462 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~ 515 (827)
|++++..|..|.++++|++|+|++|++++..|..+..+++|++|+|++|.+++.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 141 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence 666555555555555555555555555555555555555555555555555543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=6.4e-17 Score=176.53 Aligned_cols=145 Identities=23% Similarity=0.343 Sum_probs=112.2
Q ss_pred hcccccceEecCCceEEEEEEec-CC-cEEEEEEEcccchHHHHHHHHHHHHHHhcCCCC------ceEEEeeeecCCce
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DG-IEVAIKVFHQNCAMALKSFEAECEVMKNIRHRN------HVKRISSCSNEDFK 746 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g-~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~n------iv~~~~~~~~~~~~ 746 (827)
++|...+.||+|+||.||+|+.. ++ +.||||++... ....+.+.+|++++++++|++ ++.+.+++......
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 57888999999999999999864 44 78999999654 334567889999999998877 88888888776654
Q ss_pred eeeeeccC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------------
Q 047196 747 ALDCLHST-----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------------------- 796 (827)
Q Consensus 747 ~l~~l~~~-----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------------------- 796 (827)
++...+.. ...+++.+...++.++++||+||| +.+|+||||||+||+
T Consensus 98 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~ 174 (355)
T 2eu9_A 98 CIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174 (355)
T ss_dssp EEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred EEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccccccc
Confidence 44222211 134778888999999999999996 678999999999985
Q ss_pred ----------eecccccccCCCccccccceecccccccccC
Q 047196 797 ----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 ----------DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
|||+++...... ....||+.|+|||++
T Consensus 175 ~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~ 211 (355)
T 2eu9_A 175 SVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVI 211 (355)
T ss_dssp EESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHH
T ss_pred ccCCCcEEEeecCccccccccc----cCCcCCCcccCCeee
Confidence 788876543221 234589999999963
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=3.1e-18 Score=184.15 Aligned_cols=149 Identities=30% Similarity=0.433 Sum_probs=111.2
Q ss_pred HhhcccccceEecCCceEEEEEEecCCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
..++|+..+.||+|+||.||+|+..+ .||||++.... ....+.|.+|++++++++|+||+++++++...+..++..
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 34678889999999999999998754 49999986432 223456789999999999999999999998876544422
Q ss_pred ecc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------eecccccccCCCc-
Q 047196 751 LHS-----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---------DFGIGRLLTGDRS- 809 (827)
Q Consensus 751 l~~-----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---------DFGla~~~~~~~~- 809 (827)
.+. ....+++.+...++.++++||+||| +.+|+||||||+||+ |||+++.......
T Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDNGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp BCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC--CCEECCCSCCC--------
T ss_pred ecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEeCCCEEEeecCCcccccccccc
Confidence 221 1234677888999999999999996 568999999999998 9999876532111
Q ss_pred ---cccccceeccccccccc
Q 047196 810 ---MIQTETLVTIGYMAPGL 826 (827)
Q Consensus 810 ---~~~~~~~gt~~Y~APE~ 826 (827)
.......||++|+|||+
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~ 205 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEI 205 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHH
T ss_pred ccccccccCCCcccccChHH
Confidence 11122348999999996
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=1.3e-17 Score=193.19 Aligned_cols=149 Identities=31% Similarity=0.460 Sum_probs=113.6
Q ss_pred hhcccccceEecCCceEEEEEEe-cCCcEEEEEEEccc-chHHHHHHHHHHHHHHhcCCCCceEEEeeeec------CCc
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQN-CAMALKSFEAECEVMKNIRHRNHVKRISSCSN------EDF 745 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~------~~~ 745 (827)
.++|...+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|++++++++|||||++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 36799999999999999999986 46899999998654 34456789999999999999999999998754 222
Q ss_pred --eeeeeeccC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------eec
Q 047196 746 --KALDCLHST-----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------DFG 799 (827)
Q Consensus 746 --~~l~~l~~~-----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------------DFG 799 (827)
.+++++... ...+++.....++.+++.|++||| +.+|+||||||+||+ |||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 233333211 124667778899999999999996 468999999999997 899
Q ss_pred ccccccCCCccccccceecccccccccC
Q 047196 800 IGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 800 la~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
+++....... .....||++|+|||++
T Consensus 170 ~a~~~~~~~~--~~~~~gt~~Y~APE~l 195 (676)
T 3qa8_A 170 YAKELDQGEL--CTEFVGTLQYLAPELL 195 (676)
T ss_dssp CCCBTTSCCC--CCCCCSCCTTCSSCSS
T ss_pred cccccccccc--cccccCCcccCChHHh
Confidence 9987654332 2334689999999974
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=7.5e-17 Score=174.83 Aligned_cols=144 Identities=23% Similarity=0.383 Sum_probs=92.5
Q ss_pred hhccccc-ceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeec----CC--c
Q 047196 674 TEKFSKE-NLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSN----ED--F 745 (827)
Q Consensus 674 ~~~~~~~-~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~----~~--~ 745 (827)
.++|... ++||+|+||.||+|+.. +|+.||||++..... .. ......++.++|||++++++++.. .. +
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-AR---QEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-HH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-HH---HHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 4567774 57999999999999875 689999999865321 11 222334677799999999999865 22 2
Q ss_pred eeeeeecc----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------eecccc
Q 047196 746 KALDCLHS----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------DFGIGR 802 (827)
Q Consensus 746 ~~l~~l~~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------------DFGla~ 802 (827)
.+++++.. ....+++.+...++.++++||+||| +.+|+||||||+||+ |||+++
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 22333322 1125788889999999999999996 568999999999998 899887
Q ss_pred cccCCCccccccceecccccccccC
Q 047196 803 LLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 803 ~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
...... .....||++|+|||++
T Consensus 180 ~~~~~~---~~~~~~t~~y~aPE~~ 201 (336)
T 3fhr_A 180 ETTQNA---LQTPCYTPYYVAPEVL 201 (336)
T ss_dssp EC-----------------------
T ss_pred eccccc---cccCCCCcCccChhhh
Confidence 654322 1234589999999974
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.69 E-value=6.6e-17 Score=160.17 Aligned_cols=113 Identities=23% Similarity=0.272 Sum_probs=58.5
Q ss_pred cccEEecCCCcccccCCc-cccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEc
Q 047196 453 RLNTLGLAGNKFSGSIPS-CLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINL 531 (827)
Q Consensus 453 ~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L 531 (827)
+|++|++++|++++..+. .+..+++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..++.++.|+.|+|
T Consensus 30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 109 (192)
T 1w8a_A 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence 344444444444433332 2444444455555555554444444445555555555555555444444555555555555
Q ss_pred ccceeeecccccccCCCCCCEEECCCCcceeecC
Q 047196 532 SRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIP 565 (827)
Q Consensus 532 s~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip 565 (827)
++|+|++.+|..+..+++|+.|+|++|.+++..+
T Consensus 110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 5555555556566666666666666666655443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.4e-17 Score=185.91 Aligned_cols=147 Identities=16% Similarity=0.169 Sum_probs=99.8
Q ss_pred HhhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCC-CCce---------EEEe
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRH-RNHV---------KRIS 738 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H-~niv---------~~~~ 738 (827)
.++.|...++||+|+||.||+|++ .+|+.||||++.... ....+.|.+|+.+++.++| +|.. ....
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 345677889999999999999995 579999999987332 2235789999999999988 2211 1000
Q ss_pred e------------eecCC------ce-eeeeec--------------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 047196 739 S------------CSNED------FK-ALDCLH--------------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPV 785 (827)
Q Consensus 739 ~------------~~~~~------~~-~l~~l~--------------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~i 785 (827)
. ..... .. ++.... .....+.+..+..|+.|+++||+||| +++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i 232 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL 232 (413)
T ss_dssp EEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred hcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence 1 01100 00 000000 01122455677889999999999996 5689
Q ss_pred EEccCCCccee----------eecccccccCCCccccccceecccccccccC
Q 047196 786 IHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 786 iHrDlK~~NIl----------DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
+||||||+||| |||+++..... ....+| ++|||||++
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~ 279 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETT 279 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhh
Confidence 99999999998 99998865432 233457 999999974
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=1.1e-17 Score=192.27 Aligned_cols=144 Identities=19% Similarity=0.203 Sum_probs=95.1
Q ss_pred cccceEecCCceEEEEEEecCCcEEEEEEEcccc--------hHHHHHHHHHHHHHHhcCCCCceEEEeeeecC--Ccee
Q 047196 678 SKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNC--------AMALKSFEAECEVMKNIRHRNHVKRISSCSNE--DFKA 747 (827)
Q Consensus 678 ~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~--------~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~--~~~~ 747 (827)
...++||+|+||.||+|+. .++.+|+|+..... ....++|.+|++++++++|||||++..++... .+..
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 46889999864321 11245689999999999999999444444343 3344
Q ss_pred eeeeccCCCCCCHH--HHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee--------eecccccccCCCccc------
Q 047196 748 LDCLHSTNCSLNIF--DKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF--------DFGIGRLLTGDRSMI------ 811 (827)
Q Consensus 748 l~~l~~~~~~l~~~--~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl--------DFGla~~~~~~~~~~------ 811 (827)
++++.. +.+... .+..++.|+++||+||| +++|+||||||+||| |||+|+.........
T Consensus 418 mE~~~g--gsL~~~l~~~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~~~kL~DFGla~~~~~~~~~~~~~~~~ 492 (540)
T 3en9_A 418 MSYING--KLAKDVIEDNLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDKDLYIIDFGLGKISNLDEDKAVDLIVF 492 (540)
T ss_dssp EECCCS--EEHHHHSTTCTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESSSEEECCCTTCEECCCHHHHHHHHHHH
T ss_pred EECCCC--CCHHHHHHHHHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECCeEEEEECccCEECCCccccccchhhh
Confidence 444432 221111 14589999999999996 568999999999997 999999875432211
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
....+||+.|||||++
T Consensus 493 ~~~~~GT~~y~APEv~ 508 (540)
T 3en9_A 493 KKAVLSTHHEKFDEIW 508 (540)
T ss_dssp HHHHHHHCGGGHHHHH
T ss_pred hhhhcCCCCcCCHHHH
Confidence 1234599999999974
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.66 E-value=5.2e-17 Score=175.55 Aligned_cols=134 Identities=15% Similarity=0.106 Sum_probs=67.0
Q ss_pred CCCCCCEEECCCCCCCccCChhhhh-ccccceEEecCCCCCCccccccCCCCCCcEEEcCCCCCCCCcchhHhhcccccc
Q 047196 120 NLSSLTTLNLSHNKLSGDIPPSIFT-MHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLK 198 (827)
Q Consensus 120 ~L~~L~~L~Ls~N~l~g~~p~~~~~-l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~ 198 (827)
.+.+++.|+++++ +....-..+.. +++|++|||++|++..... ..+.+..+..+.+..| .||..
T Consensus 23 ~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~-~~~~~~~~~~~~~~~~----~I~~~--------- 87 (329)
T 3sb4_A 23 EANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSG-KAGTYPNGKFYIYMAN----FVPAY--------- 87 (329)
T ss_dssp HHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEE-SSSSSGGGCCEEECTT----EECTT---------
T ss_pred hhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecC-cccccccccccccccc----ccCHH---------
Confidence 3678888888864 22222234444 6779999999998871100 0000000111111111 12211
Q ss_pred EEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEeec
Q 047196 199 VLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGF 276 (827)
Q Consensus 199 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 276 (827)
.|.+..|..+.++++|+.++|.. .++..-+..|.++++|+.|++++|.+....+..|..+.++..+.+..
T Consensus 88 -------aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~ 157 (329)
T 3sb4_A 88 -------AFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGS 157 (329)
T ss_dssp -------TTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTC
T ss_pred -------HhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcc
Confidence 12222222222366666666666 56555555566666666666666666555555565555555544443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.64 E-value=6.9e-16 Score=163.08 Aligned_cols=119 Identities=11% Similarity=0.003 Sum_probs=96.1
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
++|...+.||+|+||.||+|+.. +|+.||||++.... ....++|.+|++++++++|||||++++++...+..++..
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 56888999999999999999875 58999999996542 344578999999999999999999999998876554432
Q ss_pred eccC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee
Q 047196 751 LHST--------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF 796 (827)
Q Consensus 751 l~~~--------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl 796 (827)
.+.. .......+...|+.++++||+||| +.+|+||||||+||+
T Consensus 111 e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIl 161 (286)
T 3uqc_A 111 EWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVR 161 (286)
T ss_dssp ECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEE
T ss_pred EecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEE
Confidence 2221 112345567889999999999996 568999999999998
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.62 E-value=5e-16 Score=150.22 Aligned_cols=133 Identities=20% Similarity=0.153 Sum_probs=78.4
Q ss_pred CCCcEEECCCCCCC-CCCCccccccccccEEecCCCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccC
Q 047196 428 QKLQGLYLPFNKLA-GSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFD 506 (827)
Q Consensus 428 ~~L~~L~Ls~N~l~-g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~Ld 506 (827)
++|+.|++++|.++ +.+|..+..+++|++|++++|++++. ..+..+++|++|++++|.+++.+|..+..+++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 44555555555554 45555555555555555555555543 4455556666666666666555555555566666666
Q ss_pred CCCCCCCCCC-cccccccccCceEEcccceeeeccc---ccccCCCCCCEEECCCCccee
Q 047196 507 LSSNSLDGPL-SLDIGNLRVVIGINLSRNNFSGDIP---STIGDLKDLQNISLACNGLEG 562 (827)
Q Consensus 507 Ls~N~l~g~~-p~~~~~l~~L~~L~Ls~N~l~g~ip---~~~~~l~~L~~L~Ls~N~l~g 562 (827)
+++|.+++.. +..+..++.|+.|++++|++++..+ ..+..+++|+.|++++|.+..
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~ 161 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQE 161 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCB
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhh
Confidence 6666665532 2456666666777777777665444 366677777777777766643
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.62 E-value=4.3e-16 Score=168.30 Aligned_cols=101 Identities=22% Similarity=0.193 Sum_probs=58.7
Q ss_pred CCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCcccccccccc-EEecCCCcccccCCccccCCCCCCcc
Q 047196 403 LSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLN-TLGLAGNKFSGSIPSCLGNLTSLRSP 481 (827)
Q Consensus 403 l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L 481 (827)
+++|+.++|++|+++...+..|.++++|+.|+|++| +...-+..|.++++|+ .+++.+ +++..-+..|.+|++|+.+
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 566666666666666555555666666666666665 4433344555666666 666655 4444444555566666666
Q ss_pred ccCCCcccccCCcccccccccccc
Q 047196 482 DLGSNRLTSVLPSTFWNLKDILFF 505 (827)
Q Consensus 482 ~Ls~N~l~~~~p~~~~~l~~L~~L 505 (827)
++++|+++...+..|.++++|+.+
T Consensus 303 ~l~~n~i~~I~~~aF~~~~~L~~l 326 (329)
T 3sb4_A 303 LATGDKITTLGDELFGNGVPSKLI 326 (329)
T ss_dssp EECSSCCCEECTTTTCTTCCCCEE
T ss_pred EeCCCccCccchhhhcCCcchhhh
Confidence 665566655555555555555544
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1.4e-15 Score=147.17 Aligned_cols=134 Identities=20% Similarity=0.174 Sum_probs=75.9
Q ss_pred CCCCCEEECCCCCCC-ccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcCCCCCCCCcchhHhhccccccE
Q 047196 121 LSSLTTLNLSHNKLS-GDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKV 199 (827)
Q Consensus 121 L~~L~~L~Ls~N~l~-g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~~ 199 (827)
.++|++|+|++|.++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|++++|.+++.+|..+.. +++|++
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~ 99 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEK-LPNLTH 99 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHH-CTTCCE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhh-CCCCCE
Confidence 367788888888887 67777778888888888888887755 44555555555555555555443333222 224445
Q ss_pred EEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEccccccccccc---ccccCcCCCcEEEeec
Q 047196 200 LFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIP---HEIGYLPNLENLVLGF 276 (827)
Q Consensus 200 L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~ 276 (827)
|++++|.+++.. .+..+..+++|++|++++|.+++..+ ..+..+++|++|+++.
T Consensus 100 L~Ls~N~l~~~~-----------------------~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~ 156 (168)
T 2ell_A 100 LNLSGNKLKDIS-----------------------TLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYD 156 (168)
T ss_dssp EECBSSSCCSSG-----------------------GGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEE
T ss_pred EeccCCccCcch-----------------------hHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCC
Confidence 554444444321 11344455555555555555553332 2455555555555555
Q ss_pred ccCc
Q 047196 277 NNLV 280 (827)
Q Consensus 277 N~l~ 280 (827)
|.+.
T Consensus 157 n~~~ 160 (168)
T 2ell_A 157 REDQ 160 (168)
T ss_dssp TTSC
T ss_pred CChh
Confidence 5544
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.61 E-value=4.8e-16 Score=147.12 Aligned_cols=126 Identities=24% Similarity=0.306 Sum_probs=96.7
Q ss_pred cccEEEccCCcCc-cccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEec
Q 047196 381 SLENIYISNCNIG-GSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGL 459 (827)
Q Consensus 381 ~L~~L~Ls~N~l~-g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 459 (827)
+++.|++++|+++ +.+|..+..+++|+.|++++|++++. ..++.+++|++|++++|++++.+|..+..+++|++|++
T Consensus 18 ~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 95 (149)
T 2je0_A 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95 (149)
T ss_dssp GCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred cCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence 6888888888887 77787778888888888888888765 66777888888888888888777777777788888888
Q ss_pred CCCccccc-CCccccCCCCCCccccCCCcccccCC---ccccccccccccCCC
Q 047196 460 AGNKFSGS-IPSCLGNLTSLRSPDLGSNRLTSVLP---STFWNLKDILFFDLS 508 (827)
Q Consensus 460 s~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~LdLs 508 (827)
++|++++. .|..+..+++|++|++++|.+++..+ ..+..+++|+.||++
T Consensus 96 s~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 96 SGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp TTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 88888753 34667777788888888887777655 456677777777765
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.61 E-value=3.7e-16 Score=147.91 Aligned_cols=126 Identities=15% Similarity=0.152 Sum_probs=64.3
Q ss_pred CCcEEECCCCCCC-CCCCccccccccccEEecCCCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCC
Q 047196 429 KLQGLYLPFNKLA-GSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDL 507 (827)
Q Consensus 429 ~L~~L~Ls~N~l~-g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdL 507 (827)
+|+.|++++|.++ +.+|..+..+++|++|++++|++++. ..+..+++|++|++++|.+++.+|..+..+++|+.|++
T Consensus 18 ~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 95 (149)
T 2je0_A 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95 (149)
T ss_dssp GCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred cCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence 3344444444443 33444444444444444444444432 33444455555555555555444444444555555555
Q ss_pred CCCCCCCC-CcccccccccCceEEcccceeeeccc---ccccCCCCCCEEECC
Q 047196 508 SSNSLDGP-LSLDIGNLRVVIGINLSRNNFSGDIP---STIGDLKDLQNISLA 556 (827)
Q Consensus 508 s~N~l~g~-~p~~~~~l~~L~~L~Ls~N~l~g~ip---~~~~~l~~L~~L~Ls 556 (827)
++|.+++. .+..++.++.|+.|++++|++++..+ ..++.+++|+.||++
T Consensus 96 s~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 96 SGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp TTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 55555542 23455566666666666666665544 456666666666665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=2.5e-15 Score=158.09 Aligned_cols=127 Identities=13% Similarity=0.166 Sum_probs=89.6
Q ss_pred HHHhhcccccceEecCCceEEEEEEecCCcEEEEEEEcccch------------------HHHHHHHHHHHHHHhcCCCC
Q 047196 671 FRATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCA------------------MALKSFEAECEVMKNIRHRN 732 (827)
Q Consensus 671 ~~~~~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~------------------~~~~~~~~Ei~~l~~l~H~n 732 (827)
......|...+.||+|+||.||+|+..+|+.||||+++.... .....+.+|++++++++|.+
T Consensus 86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~~~ 165 (282)
T 1zar_A 86 VRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLA 165 (282)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSS
T ss_pred HhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccCCC
Confidence 334445667799999999999999987799999999864321 23467899999999999544
Q ss_pred ceEEEeeeec-CCceeeeeeccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------eeccc
Q 047196 733 HVKRISSCSN-EDFKALDCLHSTN-CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---------DFGIG 801 (827)
Q Consensus 733 iv~~~~~~~~-~~~~~l~~l~~~~-~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---------DFGla 801 (827)
+. +++.. ..+..++++.... ..+...+...++.++++|++||| +.+|+||||||+||| |||+|
T Consensus 166 v~---~~~~~~~~~lvmE~~~g~~L~~l~~~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~~~~vkl~DFG~a 239 (282)
T 1zar_A 166 VP---KVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEEGIWIIDFPQS 239 (282)
T ss_dssp SC---CEEEEETTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETTEEEECCCTTC
T ss_pred cC---eEEeccceEEEEEecCCCcHHHcchhhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEECCcEEEEECCCC
Confidence 44 43322 2333444443211 11222345679999999999996 678999999999998 77776
Q ss_pred cc
Q 047196 802 RL 803 (827)
Q Consensus 802 ~~ 803 (827)
+.
T Consensus 240 ~~ 241 (282)
T 1zar_A 240 VE 241 (282)
T ss_dssp EE
T ss_pred eE
Confidence 53
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=4.5e-15 Score=146.95 Aligned_cols=108 Identities=27% Similarity=0.362 Sum_probs=56.7
Q ss_pred cccEEecCCCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcc
Q 047196 453 RLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLS 532 (827)
Q Consensus 453 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls 532 (827)
+|+.|++++|+++ .+|..+.++++|++|+|++|.+++..|..|.++++|+.|+|++|++++..|..+..+++|+.|+|+
T Consensus 32 ~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~ 110 (193)
T 2wfh_A 32 DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLH 110 (193)
T ss_dssp TCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECC
Confidence 4444455555444 344444455555555555555554444445555555555555555555444455555555555555
Q ss_pred cceeeecccccccCCCCCCEEECCCCcce
Q 047196 533 RNNFSGDIPSTIGDLKDLQNISLACNGLE 561 (827)
Q Consensus 533 ~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~ 561 (827)
+|+|++..+..|..+++|+.|+|++|.+.
T Consensus 111 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 111 GNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp SSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 55555444445555666666666655554
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.59 E-value=5.2e-15 Score=144.40 Aligned_cols=132 Identities=27% Similarity=0.268 Sum_probs=82.4
Q ss_pred ccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCC
Q 047196 382 LENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAG 461 (827)
Q Consensus 382 L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 461 (827)
.+.+++++|+++. +|..+ .++|+.|++++|++++..+..|..+++|++|++++|++++..+..+..+++|++|++++
T Consensus 9 ~~~l~~~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCSS-CCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCcc-CCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 4566777777663 34322 25677777777777665555666677777777777777655555566666666666666
Q ss_pred CcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCC
Q 047196 462 NKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPL 516 (827)
Q Consensus 462 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~ 516 (827)
|++++..+..+..+++|++|++++|.+++..+..+..+++|+.|++++|.+++..
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence 6666555555666666666666666666555544555566666666666555543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.59 E-value=4.7e-15 Score=144.70 Aligned_cols=113 Identities=22% Similarity=0.241 Sum_probs=56.6
Q ss_pred cccEEecCCCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcc
Q 047196 453 RLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLS 532 (827)
Q Consensus 453 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls 532 (827)
+|+.|++++|++++..+..+..+++|++|++++|.+++..+..|..+++|+.|++++|++++..+..++.++.|+.|+++
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 108 (177)
T 2o6r_A 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALD 108 (177)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECc
Confidence 44444444444443333334444455555555555544444444445555555555555554444444555555555555
Q ss_pred cceeeecccccccCCCCCCEEECCCCcceeecC
Q 047196 533 RNNFSGDIPSTIGDLKDLQNISLACNGLEGLIP 565 (827)
Q Consensus 533 ~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip 565 (827)
+|+|++..+..+..+++|+.|+|++|.+++..|
T Consensus 109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 109 TNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 555554444444555555655555555554433
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=7.9e-15 Score=145.16 Aligned_cols=126 Identities=24% Similarity=0.336 Sum_probs=64.0
Q ss_pred cEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCC
Q 047196 383 ENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGN 462 (827)
Q Consensus 383 ~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 462 (827)
+.+++++|+++ .+|..+. ++|+.|+|++|+++ .+|..|.++++|+.|+|++|++++..+..|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 45666666665 3443332 35555666655555 34455555555555555555555544445555555555555555
Q ss_pred cccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCC
Q 047196 463 KFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSL 512 (827)
Q Consensus 463 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l 512 (827)
++++..|..|..+++|++|+|++|.+++..+..|..+++|+.|+|++|.+
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~ 138 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPL 138 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCE
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCe
Confidence 55544444455555555555555555444333344444444444444433
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.52 E-value=4.7e-17 Score=162.12 Aligned_cols=137 Identities=20% Similarity=0.224 Sum_probs=69.5
Q ss_pred cCCCCCceEeccCccccccccc------cccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCccccC
Q 047196 401 SNLSNLLLLDLEGNKLTGSIPV------TFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGN 474 (827)
Q Consensus 401 ~~l~~L~~L~Ls~N~l~g~~p~------~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 474 (827)
.....++.++++.|.++|.+|. .+..+++|++|++++|.+++ +| .+..+++|++|++++|+++ .+|..+..
T Consensus 15 ~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~ 91 (198)
T 1ds9_A 15 EERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAV 91 (198)
T ss_dssp HHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHH
T ss_pred HhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhc
Confidence 3345556666666666665554 45555555555555555554 34 4555555555555555554 34444444
Q ss_pred CCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCc-ccccccccCceEEcccceeeecccc
Q 047196 475 LTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLS-LDIGNLRVVIGINLSRNNFSGDIPS 542 (827)
Q Consensus 475 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~g~ip~ 542 (827)
+++|++|++++|.+++. | .+..+++|+.|++++|++++..+ ..+..++.|+.|++++|++++.+|.
T Consensus 92 ~~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 92 ADTLEELWISYNQIASL-S-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp HHHCSEEEEEEEECCCH-H-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred CCcCCEEECcCCcCCcC-C-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 45555555555555442 2 34444455555555555443211 2344455555555555555544443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=3.7e-14 Score=150.84 Aligned_cols=124 Identities=23% Similarity=0.427 Sum_probs=96.0
Q ss_pred hccccc-ceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHH-HhcCCCCceEEEeeeec----CCcee
Q 047196 675 EKFSKE-NLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVM-KNIRHRNHVKRISSCSN----EDFKA 747 (827)
Q Consensus 675 ~~~~~~-~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l-~~l~H~niv~~~~~~~~----~~~~~ 747 (827)
++|... ++||+|+||.||+|+. .+|+.||||++... ..+.+|++++ +..+||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 456665 7899999999999986 46899999998643 3467889888 66699999999998865 22222
Q ss_pred --eeeeccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------eecccc
Q 047196 748 --LDCLHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------DFGIGR 802 (827)
Q Consensus 748 --l~~l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------------DFGla~ 802 (827)
+++.... ...+++.....++.+++.||+||| +.+|+||||||+||+ |||+|+
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 2332211 124778888999999999999996 568999999999998 899987
Q ss_pred cccC
Q 047196 803 LLTG 806 (827)
Q Consensus 803 ~~~~ 806 (827)
....
T Consensus 169 ~~~~ 172 (299)
T 3m2w_A 169 ETTG 172 (299)
T ss_dssp ECTT
T ss_pred cccc
Confidence 6543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.51 E-value=1.5e-16 Score=158.48 Aligned_cols=59 Identities=32% Similarity=0.524 Sum_probs=28.5
Q ss_pred cEEEEEcCCCCCccccCc------cccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCC
Q 047196 99 RVTALNISSLNLQGTIPP------QLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLS 159 (827)
Q Consensus 99 ~v~~L~L~~~~l~g~~~~------~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~ 159 (827)
+|+.++++.+.+.|.+|. .+..+++|++|+|++|.+++ +| .+..+++|++|+|++|.++
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~ 83 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK 83 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc
Confidence 344444555555554443 44445555555555555443 33 4444555555555554443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.50 E-value=1.9e-14 Score=140.16 Aligned_cols=132 Identities=17% Similarity=0.168 Sum_probs=84.3
Q ss_pred ccCCCCCcEEECCCCCCCCCCCccccccc-cccEEecCCCcccccCCccccCCCCCCccccCCCcccccCCccccccccc
Q 047196 424 FGRLQKLQGLYLPFNKLAGSIPDQLCHLA-RLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDI 502 (827)
Q Consensus 424 ~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 502 (827)
+.++.+|+.|++++|+++. +|. +..+. +|+.|++++|++++. ..+..+++|++|++++|.+++..|..+..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 4455666666666666653 343 33333 666777777766653 456667777777777777776555555667777
Q ss_pred cccCCCCCCCCCCCcc--cccccccCceEEcccceeeeccccc----ccCCCCCCEEECCCCcce
Q 047196 503 LFFDLSSNSLDGPLSL--DIGNLRVVIGINLSRNNFSGDIPST----IGDLKDLQNISLACNGLE 561 (827)
Q Consensus 503 ~~LdLs~N~l~g~~p~--~~~~l~~L~~L~Ls~N~l~g~ip~~----~~~l~~L~~L~Ls~N~l~ 561 (827)
++|+|++|.++. +|. .++.++.|+.|++++|.++ .+|.. +..+++|+.||++.|.+.
T Consensus 91 ~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 91 TELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CEEECCCCcCCc-chhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 777777777743 444 5667777777777777776 44553 677777777777776654
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.46 E-value=3.7e-14 Score=138.14 Aligned_cols=127 Identities=19% Similarity=0.196 Sum_probs=68.2
Q ss_pred cccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecC
Q 047196 381 SLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLA 460 (827)
Q Consensus 381 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 460 (827)
+|++|++++|+++. +|......++|+.|++++|++++. ..+..+++|++|+|++|++++..|..+..+++|++|+++
T Consensus 20 ~L~~L~l~~n~l~~-i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 96 (176)
T 1a9n_A 20 RDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT 96 (176)
T ss_dssp SCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECC
T ss_pred CceEEEeeCCCCch-hHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECC
Confidence 56666666666663 343333233666666666666653 455566666666666666654333334556666666666
Q ss_pred CCcccccCCc--cccCCCCCCccccCCCcccccCCcc----ccccccccccCCCCCCC
Q 047196 461 GNKFSGSIPS--CLGNLTSLRSPDLGSNRLTSVLPST----FWNLKDILFFDLSSNSL 512 (827)
Q Consensus 461 ~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~LdLs~N~l 512 (827)
+|+++ .+|. .+..+++|+.|++++|.++. +|.. +..+++|+.||++.|..
T Consensus 97 ~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 97 NNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp SCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCH
T ss_pred CCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCH
Confidence 66663 3443 45555555555555555553 2332 44444455555444443
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.43 E-value=3.4e-12 Score=140.89 Aligned_cols=168 Identities=11% Similarity=0.123 Sum_probs=84.2
Q ss_pred CccEEeCcCCccccccCccccCCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCcccc
Q 047196 317 NVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSI 396 (827)
Q Consensus 317 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~ 396 (827)
+|+.+.+.. .++..-+..|.++.+|+.++++.|+++...... +.. .+|+.+.+.++ ++..-
T Consensus 158 ~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~a----------------F~~-~~L~~l~lp~~-l~~I~ 218 (401)
T 4fdw_A 158 TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPAST----------------FVY-AGIEEVLLPVT-LKEIG 218 (401)
T ss_dssp CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTT----------------TTT-CCCSEEECCTT-CCEEC
T ss_pred CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhh----------------Eee-cccCEEEeCCc-hheeh
Confidence 455555543 444444556666666666666666555322211 111 15666666533 54444
Q ss_pred CccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCccc-----ccCCcc
Q 047196 397 PQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFS-----GSIPSC 471 (827)
Q Consensus 397 p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~-----~~~p~~ 471 (827)
...|.++++|+.+++..| ++..-...|.+ .+|+.+++ .|.++..-+..|.++++|+.+++.+|.+. ..-+..
T Consensus 219 ~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~a 295 (401)
T 4fdw_A 219 SQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYC 295 (401)
T ss_dssp TTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTT
T ss_pred hhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHH
Confidence 556666666666666653 34333444554 45666666 23344333445555555665555555443 222334
Q ss_pred ccCCCCCCccccCCCcccccCCccccccccccccCC
Q 047196 472 LGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDL 507 (827)
Q Consensus 472 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdL 507 (827)
|.+|++|+.++|. |.++..-..+|.++++|+.++|
T Consensus 296 F~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~l 330 (401)
T 4fdw_A 296 LEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTI 330 (401)
T ss_dssp TTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEE
T ss_pred hhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEE
Confidence 4555555555554 2344444444444444444444
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=1.5e-13 Score=142.70 Aligned_cols=125 Identities=18% Similarity=0.253 Sum_probs=88.9
Q ss_pred ccccceEecCCceEEEEEEe-cCCcE--EEEEEEcccch------------------------HHHHHHHHHHHHHHhcC
Q 047196 677 FSKENLIGVGSFGSVYKGRL-HDGIE--VAIKVFHQNCA------------------------MALKSFEAECEVMKNIR 729 (827)
Q Consensus 677 ~~~~~~iG~G~fg~Vy~~~~-~~g~~--vAvK~l~~~~~------------------------~~~~~~~~Ei~~l~~l~ 729 (827)
|+..+.||+|+||.||+|+. .+|+. ||||+++.... .....+.+|++++++++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 55678899999999999987 68888 99998754311 11236889999999999
Q ss_pred CCCc--eEEEeeeecCCceeeeeeccCC---CCC-------CHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-
Q 047196 730 HRNH--VKRISSCSNEDFKALDCLHSTN---CSL-------NIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF- 796 (827)
Q Consensus 730 H~ni--v~~~~~~~~~~~~~l~~l~~~~---~~l-------~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl- 796 (827)
|+++ ...+. ....+.+++++.... ..+ .+.+...++.++++++.|||. +.+|+||||||+|||
T Consensus 129 ~~~i~~p~~~~--~~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlkp~NILl 204 (258)
T 1zth_A 129 EAGVSVPQPYT--YMKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQ--EAELVHADLSEYNIMY 204 (258)
T ss_dssp HTTCCCCCEEE--EETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCSTTSEEE
T ss_pred hCCCCCCeEEE--cCCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCCHHHEEE
Confidence 8864 23332 234445555552100 011 122457899999999999962 678999999999987
Q ss_pred -------eeccccccc
Q 047196 797 -------DFGIGRLLT 805 (827)
Q Consensus 797 -------DFGla~~~~ 805 (827)
|||+|....
T Consensus 205 ~~~~~liDFG~a~~~~ 220 (258)
T 1zth_A 205 IDKVYFIDMGQAVTLR 220 (258)
T ss_dssp SSSEEECCCTTCEETT
T ss_pred cCcEEEEECcccccCC
Confidence 999997654
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.41 E-value=6.1e-12 Score=138.89 Aligned_cols=161 Identities=12% Similarity=0.143 Sum_probs=88.7
Q ss_pred CCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccc
Q 047196 316 PNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGS 395 (827)
Q Consensus 316 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~ 395 (827)
.+|+.+.+..+ ++..-...|.++++|+.+++..| ++.+-. ..+.. .+|+.+++ .++++..
T Consensus 203 ~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~---------------~aF~~--~~L~~i~l-p~~i~~I 262 (401)
T 4fdw_A 203 AGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQ---------------EAFRE--SGITTVKL-PNGVTNI 262 (401)
T ss_dssp CCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECT---------------TTTTT--CCCSEEEE-ETTCCEE
T ss_pred cccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCccc---------------ccccc--CCccEEEe-CCCccEE
Confidence 45555555532 44444556666667777666543 221111 11111 15666766 3445545
Q ss_pred cCccccCCCCCceEeccCcccc-----ccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCc
Q 047196 396 IPQLISNLSNLLLLDLEGNKLT-----GSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPS 470 (827)
Q Consensus 396 ~p~~~~~l~~L~~L~Ls~N~l~-----g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 470 (827)
-+..|.++++|+.+++.+|.+. ...+..|.+|++|+.++|. +.+...-...|.++++|+.++|.+| ++..-+.
T Consensus 263 ~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~ 340 (401)
T 4fdw_A 263 ASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFS 340 (401)
T ss_dssp CTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTT
T ss_pred ChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHH
Confidence 5667777777777777776654 2344556666777777666 3354333455666666666666443 4433445
Q ss_pred cccCCCCCCccccCCCcccccCCcccccc
Q 047196 471 CLGNLTSLRSPDLGSNRLTSVLPSTFWNL 499 (827)
Q Consensus 471 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 499 (827)
.|.++ +|+.+++++|.+....+..|.++
T Consensus 341 aF~~~-~L~~l~l~~n~~~~l~~~~F~~~ 368 (401)
T 4fdw_A 341 AFNNT-GIKEVKVEGTTPPQVFEKVWYGF 368 (401)
T ss_dssp SSSSS-CCCEEEECCSSCCBCCCSSCCCS
T ss_pred hCCCC-CCCEEEEcCCCCcccccccccCC
Confidence 56666 66666666665555444444444
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.40 E-value=4.5e-13 Score=129.60 Aligned_cols=107 Identities=22% Similarity=0.264 Sum_probs=64.0
Q ss_pred ccEEecCCCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEccc
Q 047196 454 LNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSR 533 (827)
Q Consensus 454 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~ 533 (827)
.+.+++++|+++ .+|..+. ++|++|+|++|.|++..|..|..+++|++|||++|+|++..+..+..+++|+.|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 345555555555 3444432 4556666666666665555566666666666666666655555556666666666666
Q ss_pred ceeeecccccccCCCCCCEEECCCCcceee
Q 047196 534 NNFSGDIPSTIGDLKDLQNISLACNGLEGL 563 (827)
Q Consensus 534 N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ 563 (827)
|+|++..|..|..+++|+.|+|++|.++..
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 666655555666666666666666666544
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.40 E-value=9.1e-13 Score=127.41 Aligned_cols=106 Identities=25% Similarity=0.238 Sum_probs=66.2
Q ss_pred ccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCC
Q 047196 382 LENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAG 461 (827)
Q Consensus 382 L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 461 (827)
.+.+++++|+++. +|..+ .++|+.|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++
T Consensus 11 ~~~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcCc-cCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 5667777777764 44443 25666677777776666666666666666666666666655555556666666666666
Q ss_pred CcccccCCccccCCCCCCccccCCCcccc
Q 047196 462 NKFSGSIPSCLGNLTSLRSPDLGSNRLTS 490 (827)
Q Consensus 462 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 490 (827)
|++++..+..|..+++|++|+|++|.+..
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence 66665444456666666666666665554
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.37 E-value=1e-12 Score=127.46 Aligned_cols=105 Identities=20% Similarity=0.249 Sum_probs=58.9
Q ss_pred cEEecCCCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccc
Q 047196 455 NTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRN 534 (827)
Q Consensus 455 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N 534 (827)
+.+++++|+++ .+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|+|++..+..+..+++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 34555555553 3444332 45555555555555555555555555555555555555544444555666666666666
Q ss_pred eeeecccccccCCCCCCEEECCCCccee
Q 047196 535 NFSGDIPSTIGDLKDLQNISLACNGLEG 562 (827)
Q Consensus 535 ~l~g~ip~~~~~l~~L~~L~Ls~N~l~g 562 (827)
+|++..+..|..+++|+.|+|++|.+..
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred ccceeCHHHhccccCCCEEEeCCCCccc
Confidence 6665444456666666666666666653
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.8e-12 Score=125.72 Aligned_cols=106 Identities=27% Similarity=0.295 Sum_probs=62.9
Q ss_pred ccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCC
Q 047196 382 LENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAG 461 (827)
Q Consensus 382 L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 461 (827)
-+.+++++|+++ .+|..+. ++|+.|+|++|++++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 355666666664 4454432 5666666666666666666666666666666666666654444455666666666666
Q ss_pred CcccccCCccccCCCCCCccccCCCcccc
Q 047196 462 NKFSGSIPSCLGNLTSLRSPDLGSNRLTS 490 (827)
Q Consensus 462 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 490 (827)
|++++..+..+..+++|++|+|++|.+..
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred CccceeCHHHhccccCCCEEEeCCCCccc
Confidence 66654434445555566666666555543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.33 E-value=4.9e-11 Score=131.92 Aligned_cols=238 Identities=12% Similarity=0.068 Sum_probs=133.9
Q ss_pred hhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceeecCCCccCCC
Q 047196 285 AAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTG 364 (827)
Q Consensus 285 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~ 364 (827)
.+|.++++|+.+.+.++- ..++...+..+++|+.+.+..| ++......|.++..|+.+.+..+...-
T Consensus 156 ~aF~~c~~L~~i~l~~~~--~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~i---------- 222 (394)
T 4fs7_A 156 EAFATCESLEYVSLPDSM--ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYYL---------- 222 (394)
T ss_dssp TTTTTCTTCCEEECCTTC--CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCEE----------
T ss_pred hhhcccCCCcEEecCCcc--ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceEe----------
Confidence 345555555555554332 1233333334555555555444 333334455666666665554432210
Q ss_pred CCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCC
Q 047196 365 NPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSI 444 (827)
Q Consensus 365 n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~ 444 (827)
........ +|+.+.+..+ ++..-...|..+..|+.+.+..+... .....|..+..++.+....+.+.
T Consensus 223 -------~~~~~~~~-~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~--- 289 (394)
T 4fs7_A 223 -------GDFALSKT-GVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP--- 289 (394)
T ss_dssp -------CTTTTTTC-CCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---
T ss_pred -------ehhhcccC-CCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---
Confidence 01111111 4566655432 23233455667777777777766443 44556777777777776654322
Q ss_pred CccccccccccEEecCCCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccc
Q 047196 445 PDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLR 524 (827)
Q Consensus 445 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~ 524 (827)
...|..+.+|+.+.+.++ ++..-...|.++++|+.+++.++ ++..-..+|.++.+|+.+++..| ++..-...|.++.
T Consensus 290 ~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~ 366 (394)
T 4fs7_A 290 EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCI 366 (394)
T ss_dssp TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCT
T ss_pred cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCC
Confidence 234666777777777654 44344556777788888887644 66555677777788877777665 5544455677777
Q ss_pred cCceEEcccceeeecccccccCCCCCCEE
Q 047196 525 VVIGINLSRNNFSGDIPSTIGDLKDLQNI 553 (827)
Q Consensus 525 ~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L 553 (827)
+|+.+++..+ ++ .+...|.++++|+.+
T Consensus 367 ~L~~i~lp~~-~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 367 NLKKVELPKR-LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp TCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred CCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence 7777777654 22 234556666666543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.33 E-value=4.8e-11 Score=132.01 Aligned_cols=329 Identities=13% Similarity=0.073 Sum_probs=159.9
Q ss_pred CccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcCCCCCCCCcchhHhhcc
Q 047196 115 PPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYL 194 (827)
Q Consensus 115 ~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~ 194 (827)
..+|.++++|+.++|.. .++.+-..+|.++++|+.++|..+ ++..-...|.+..+|+.+.+..+ +. .+....+...
T Consensus 64 ~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~-~i~~~aF~~~ 139 (394)
T 4fs7_A 64 YAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LK-SIGVEAFKGC 139 (394)
T ss_dssp TTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CC-EECTTTTTTC
T ss_pred HHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-ee-eecceeeecc
Confidence 45788888899999874 466555667888899999988754 54333455666666666554432 11 2222223222
Q ss_pred ccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEe
Q 047196 195 HYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVL 274 (827)
Q Consensus 195 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 274 (827)
..++...... .......+|.++++|+.+.+..+. ...-...|.++++|+.+++..| ++..-...|.+++.|+.+.+
T Consensus 140 ~~~~~~~~~~--~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~ 215 (394)
T 4fs7_A 140 DFKEITIPEG--VTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEF 215 (394)
T ss_dssp CCSEEECCTT--CCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCC
T ss_pred cccccccCcc--ccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeec
Confidence 1122111111 111223445566666666665432 2233344555566665555544 33233344555555555554
Q ss_pred ecccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCccee
Q 047196 275 GFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSG 354 (827)
Q Consensus 275 s~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g 354 (827)
..+... +...... ..+|+.+.+..+ ++..-...+.++..|+.+.+..+...
T Consensus 216 ~~~~~~--i~~~~~~-------------------------~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~- 266 (394)
T 4fs7_A 216 PNSLYY--LGDFALS-------------------------KTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR- 266 (394)
T ss_dssp CTTCCE--ECTTTTT-------------------------TCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-
T ss_pred CCCceE--eehhhcc-------------------------cCCCceEEECCC-ceecccccccccccceeEEcCCCcce-
Confidence 443221 1122222 234444444322 22222344555666666665544321
Q ss_pred ecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEE
Q 047196 355 IIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLY 434 (827)
Q Consensus 355 ~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 434 (827)
+.. ..+.... .++.+....+.+ ....|..+.+|+.+.+..+ ++..-...|.++.+|+.++
T Consensus 267 -i~~--------------~~F~~~~-~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~ 326 (394)
T 4fs7_A 267 -IGG--------------SLFYNCS-GLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSID 326 (394)
T ss_dssp -ECS--------------CTTTTCT-TCCEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEEC
T ss_pred -eec--------------ccccccc-ccceeccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEE
Confidence 000 0111111 344444433322 1234555666666666543 4433345566666666666
Q ss_pred CCCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCccccCCCcccccCCccccccccccc
Q 047196 435 LPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILF 504 (827)
Q Consensus 435 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 504 (827)
+..+ ++..-...|.++.+|+.+++..| ++..-...|.+|++|+.+++..+ +. .+...|.++++|+.
T Consensus 327 lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~ 392 (394)
T 4fs7_A 327 LPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKW 392 (394)
T ss_dssp CCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEE
T ss_pred eCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcE
Confidence 6533 44233445566666666666554 44333445666666666666543 21 12334555555443
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.27 E-value=2.1e-13 Score=149.16 Aligned_cols=161 Identities=19% Similarity=0.181 Sum_probs=68.6
Q ss_pred CCCCEEECCCCCCCccCChhhhhc-----cccceEEecCCCCCCccccc-cCCCCCCcEEEcCCCCCCCCcchhHhhc--
Q 047196 122 SSLTTLNLSHNKLSGDIPPSIFTM-----HKLKFLDFSDNQLSGSLSSV-TFNLSSVLDIRLDSDKLSGELPVNICNY-- 193 (827)
Q Consensus 122 ~~L~~L~Ls~N~l~g~~p~~~~~l-----~~L~~LdLs~N~l~g~~p~~-~~~l~~L~~L~L~~n~l~g~ip~~~~~~-- 193 (827)
+.|++|+|++|.++......+..+ ++|++|||++|.++...... ...+.+|++|+|++|.++..-...+...
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 345555555555554333333332 45555555555554221111 1122233334444443332212222211
Q ss_pred --cccccEEEeecccccc----cCCccCCCCCCCcEEEccCCCCccc----CCCcCcCCccccEEEccccccccc----c
Q 047196 194 --LHYLKVLFLAKNMFHG----QIPLALSKCKRLQLLNLGFKKLSGA----IPKEISNLTILRKISLRNNKLRGE----I 259 (827)
Q Consensus 194 --~~~L~~L~Ls~N~l~~----~~p~~l~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~ 259 (827)
..+|++|+|++|.++. .++..+..+++|++|+|++|.++.. ++..+...++|++|+|++|.|+.. +
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 1245555555555442 1222334445555555555555421 233344444555555555555432 2
Q ss_pred cccccCcCCCcEEEeecccCccc
Q 047196 260 PHEIGYLPNLENLVLGFNNLVGV 282 (827)
Q Consensus 260 p~~~~~l~~L~~L~Ls~N~l~~~ 282 (827)
+..+...++|++|+|++|.|+..
T Consensus 232 ~~~L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 232 ARAAREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp HHHHHHCSSCCEEECTTSSCCHH
T ss_pred HHHHHhCCCCCEEeccCCCCCHH
Confidence 22333345555555555555443
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.22 E-value=9.6e-13 Score=143.92 Aligned_cols=137 Identities=15% Similarity=0.153 Sum_probs=88.7
Q ss_pred ccccceEEecCCCCCCcccccc----C-CCCCCcEEEcCCCCCCCCcchhHhhccccccEEEeecccccccCCccC----
Q 047196 145 MHKLKFLDFSDNQLSGSLSSVT----F-NLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLAL---- 215 (827)
Q Consensus 145 l~~L~~LdLs~N~l~g~~p~~~----~-~l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l---- 215 (827)
++.|++|+|++|.++......+ . ...+|++|+|++|.++..-...+...+.+|++|+|++|.++......+
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 5789999999999986433332 2 236888888888888754445555555678888888887765433333
Q ss_pred -CCCCCCcEEEccCCCCcc----cCCCcCcCCccccEEEccccccccc----ccccccCcCCCcEEEeecccCcc
Q 047196 216 -SKCKRLQLLNLGFKKLSG----AIPKEISNLTILRKISLRNNKLRGE----IPHEIGYLPNLENLVLGFNNLVG 281 (827)
Q Consensus 216 -~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~ 281 (827)
...++|+.|+|++|.++. .++..+..+++|++|+|++|.|+.. ++..+...++|++|+|++|.++.
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~ 225 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGD 225 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCH
T ss_pred HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCH
Confidence 245667777777777753 2333445566677777777776532 24445556667777777776654
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.18 E-value=2.3e-11 Score=132.09 Aligned_cols=105 Identities=20% Similarity=0.196 Sum_probs=77.5
Q ss_pred cEEEccCC-cCccccCccccCCCCCceEeccC-ccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecC
Q 047196 383 ENIYISNC-NIGGSIPQLISNLSNLLLLDLEG-NKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLA 460 (827)
Q Consensus 383 ~~L~Ls~N-~l~g~~p~~~~~l~~L~~L~Ls~-N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 460 (827)
..++.+++ ++++ +|. +..+++|+.|+|++ |+|++..|..|.++++|+.|+|++|+|++..|..|.++++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 34677777 7774 666 77788888888885 88887777778888888888888888887777777778888888888
Q ss_pred CCcccccCCccccCCCCCCccccCCCcccc
Q 047196 461 GNKFSGSIPSCLGNLTSLRSPDLGSNRLTS 490 (827)
Q Consensus 461 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 490 (827)
+|+|++..+..+..++ |+.|+|++|.+..
T Consensus 89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 89 FNALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp SSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred CCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 8888755455555544 7777777777654
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.18 E-value=3.5e-11 Score=130.70 Aligned_cols=104 Identities=21% Similarity=0.169 Sum_probs=59.1
Q ss_pred eEeccCc-cccccccccccCCCCCcEEECCC-CCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCccccCC
Q 047196 408 LLDLEGN-KLTGSIPVTFGRLQKLQGLYLPF-NKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGS 485 (827)
Q Consensus 408 ~L~Ls~N-~l~g~~p~~~~~l~~L~~L~Ls~-N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 485 (827)
.++.+++ ++++ +|. +..+++|+.|+|++ |+|++..|..|.++++|+.|+|++|+|++..|..|.++++|++|||++
T Consensus 12 ~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 3455555 5553 444 55556666666653 666555555556666666666666666655555556666666666666
Q ss_pred CcccccCCccccccccccccCCCCCCCCC
Q 047196 486 NRLTSVLPSTFWNLKDILFFDLSSNSLDG 514 (827)
Q Consensus 486 N~l~~~~p~~~~~l~~L~~LdLs~N~l~g 514 (827)
|+|++..+..|..++ |+.|+|++|.+..
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 666554444444444 5666666665553
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.11 E-value=1e-10 Score=126.29 Aligned_cols=118 Identities=14% Similarity=0.129 Sum_probs=78.2
Q ss_pred cccccceEecCCceEEEEEEecCCcEEEEEEEcccch-----------------H-----HHHHHHHHHHHHHhcCCCCc
Q 047196 676 KFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCA-----------------M-----ALKSFEAECEVMKNIRHRNH 733 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~-----------------~-----~~~~~~~Ei~~l~~l~H~ni 733 (827)
-|+..+.||+|+||.||+|...+|+.||||+++.... . ......+|...|.++.+..+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3788899999999999999988999999998753210 0 01123567888888865543
Q ss_pred eEEEeeeecCCceeeeeeccCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee
Q 047196 734 VKRISSCSNEDFKALDCLHSTN--CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF 796 (827)
Q Consensus 734 v~~~~~~~~~~~~~l~~l~~~~--~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl 796 (827)
.....+.......+|+++.... ......+...++.+++.++.|+| +.+||||||||.|||
T Consensus 176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~~~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NIL 237 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVDALPMRQVSSVPDPASLYADLIALILRLA---KHGLIHGDFNEFNIL 237 (397)
T ss_dssp SCCCEEEEETTEEEEECCSCEEGGGCCCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEE
T ss_pred CCCeeeeccCceEEEEecCCccHhhhcccHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEE
Confidence 2211122223344555543211 01122234568889999999996 467999999999999
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.10 E-value=5.1e-09 Score=115.60 Aligned_cols=309 Identities=12% Similarity=0.104 Sum_probs=135.4
Q ss_pred CCccCCCCCCCcEEEccCCC---CcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEeecccCcccCchhh
Q 047196 211 IPLALSKCKRLQLLNLGFKK---LSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAI 287 (827)
Q Consensus 211 ~p~~l~~l~~L~~L~L~~n~---l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 287 (827)
-..+|.++++|+.+.+..|. ++..-...|.++.+|+.+.+..+ ++..-...|..+.+|+.+.+..+ +.......|
T Consensus 79 g~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~lp~~-~~~I~~~~F 156 (394)
T 4gt6_A 79 GSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTVTIPEG-VTSVADGMF 156 (394)
T ss_dssp CTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEECCTT-CCEECTTTT
T ss_pred hHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhcccccccccce-eeeecccce
Confidence 34455566666666655442 33233344555555655554433 33233345555666666666532 333334455
Q ss_pred hcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceeecCCCccCCCCCC
Q 047196 288 FNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPL 367 (827)
Q Consensus 288 ~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l 367 (827)
.++.+|+.+.+.++- ..+....+ ....|+.+.+..+- ...-...+.++.++.......+.....- .
T Consensus 157 ~~c~~L~~i~~~~~~--~~I~~~aF-~~~~l~~i~ip~~~-~~i~~~af~~c~~l~~~~~~~~~~~~~~-~--------- 222 (394)
T 4gt6_A 157 SYCYSLHTVTLPDSV--TAIEERAF-TGTALTQIHIPAKV-TRIGTNAFSECFALSTITSDSESYPAID-N--------- 222 (394)
T ss_dssp TTCTTCCEEECCTTC--CEECTTTT-TTCCCSEEEECTTC-CEECTTTTTTCTTCCEEEECCSSSCBSS-S---------
T ss_pred eccccccccccccee--eEeccccc-cccceeEEEECCcc-cccccchhhhccccceeccccccccccc-c---------
Confidence 555666665554431 12222222 22345555554332 2223345556666665554433321100 0
Q ss_pred cccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCcc
Q 047196 368 DGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQ 447 (827)
Q Consensus 368 ~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~ 447 (827)
.+... +.........+.....+..+.+. +.++..-...|.++..|+.+.+..+... .-...
T Consensus 223 ------~~~~~-----------~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~a 283 (394)
T 4gt6_A 223 ------VLYEK-----------SANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVS-IGTGA 283 (394)
T ss_dssp ------CEEEE-----------CTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTT
T ss_pred ------eeecc-----------cccccccccccccccccceEEcC-CcceEcccceeeecccccEEecccccce-ecCcc
Confidence 00000 00000000000011122222221 1122222334555555666555443321 22334
Q ss_pred ccccccccEEecCCCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCc
Q 047196 448 LCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVI 527 (827)
Q Consensus 448 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~ 527 (827)
|.+++.|+.+.+. +.++..-...|.+|.+|+.++|..+ ++..-..+|.++.+|+.+.+..+ ++..-...|.++++|+
T Consensus 284 F~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~ 360 (394)
T 4gt6_A 284 FMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALN 360 (394)
T ss_dssp TTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCC
T ss_pred cccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCC
Confidence 5555666666654 2333333445666666666666543 44444556666666666666433 4433345566666677
Q ss_pred eEEcccceeeecccccccCCCCCCEEECCCCcc
Q 047196 528 GINLSRNNFSGDIPSTIGDLKDLQNISLACNGL 560 (827)
Q Consensus 528 ~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l 560 (827)
.+++.+|.... ..+..+.+|+.+.+..|.+
T Consensus 361 ~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 361 NIEYSGSRSQW---NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp EEEESSCHHHH---HTCBCCCCC----------
T ss_pred EEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence 77776665432 3455666677666655543
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.99 E-value=8.2e-08 Score=105.87 Aligned_cols=318 Identities=12% Similarity=0.110 Sum_probs=147.2
Q ss_pred CccccCCC-CCCEEECCCCCCCccCChhhhhccccceEEecCCC---CCCccccccCCCCCCcEEEcCCCCCCCCcchhH
Q 047196 115 PPQLGNLS-SLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQ---LSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNI 190 (827)
Q Consensus 115 ~~~l~~L~-~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~---l~g~~p~~~~~l~~L~~L~L~~n~l~g~ip~~~ 190 (827)
..+|.+.+ .|+.+.+..+ ++.+-..+|.++++|+.+.++.|. ++..-...|.+..+|+.+.+..+
T Consensus 56 ~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~---------- 124 (394)
T 4gt6_A 56 DRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS---------- 124 (394)
T ss_dssp TTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT----------
T ss_pred HhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc----------
Confidence 34677764 5888888754 665666788889999999988774 33222334555555554433322
Q ss_pred hhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCc
Q 047196 191 CNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLE 270 (827)
Q Consensus 191 ~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 270 (827)
++......|.++.+|+.+.+..+ +...-...|.++..|+.+.+..+ ++..-...|. ..+|+
T Consensus 125 ----------------~~~I~~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~-~~~l~ 185 (394)
T 4gt6_A 125 ----------------VTEIDSEAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFT-GTALT 185 (394)
T ss_dssp ----------------CSEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTT-TCCCS
T ss_pred ----------------cceehhhhhhhhcccccccccce-eeeecccceecccccccccccce-eeEecccccc-cccee
Confidence 11122334455555555555432 22223334555555555555443 2212222332 24555
Q ss_pred EEEeecccCcccCchhhhcCCCccEEEecCCccccccChhhh-------------cCCCCccEEeCcCCccccccCcccc
Q 047196 271 NLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGID-------------LSLPNVERLNLGLNRFSGTIPSFIT 337 (827)
Q Consensus 271 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~-------------~~l~~L~~L~L~~N~l~~~~p~~~~ 337 (827)
.+.+..+- +......+.++.++.......+..... ...+. .....+..+.+. +.++..-...|.
T Consensus 186 ~i~ip~~~-~~i~~~af~~c~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~ 262 (394)
T 4gt6_A 186 QIHIPAKV-TRIGTNAFSECFALSTITSDSESYPAI-DNVLYEKSANGDYALIRYPSQREDPAFKIP-NGVARIETHAFD 262 (394)
T ss_dssp EEEECTTC-CEECTTTTTTCTTCCEEEECCSSSCBS-SSCEEEECTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTT
T ss_pred EEEECCcc-cccccchhhhccccceecccccccccc-cceeecccccccccccccccccccceEEcC-CcceEcccceee
Confidence 55554432 223334455555555554433322100 00000 000111111111 111111222334
Q ss_pred CCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCcccc
Q 047196 338 NASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLT 417 (827)
Q Consensus 338 ~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 417 (827)
++.+| +.+.+.++.. ..-...|.++++|+.+.+. +.++
T Consensus 263 ~c~~L----------------------------------------~~i~lp~~~~-~I~~~aF~~c~~L~~i~l~-~~i~ 300 (394)
T 4gt6_A 263 SCAYL----------------------------------------ASVKMPDSVV-SIGTGAFMNCPALQDIEFS-SRIT 300 (394)
T ss_dssp TCSSC----------------------------------------CEEECCTTCC-EECTTTTTTCTTCCEEECC-TTCC
T ss_pred ecccc----------------------------------------cEEecccccc-eecCcccccccccccccCC-Cccc
Confidence 44444 4444433222 1223445556666666664 3344
Q ss_pred ccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCccccCCCcccccCCcccc
Q 047196 418 GSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFW 497 (827)
Q Consensus 418 g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 497 (827)
......|.++.+|+.+++..+ ++..-...|.++.+|+.+.+..+ ++..-...|.+|++|+.+++.+|.... ..+.
T Consensus 301 ~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~ 375 (394)
T 4gt6_A 301 ELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAIS 375 (394)
T ss_dssp EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCB
T ss_pred ccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhh
Confidence 344455666666666666543 43233445666666666666543 443334456667777777776664432 2455
Q ss_pred ccccccccCCCCCCC
Q 047196 498 NLKDILFFDLSSNSL 512 (827)
Q Consensus 498 ~l~~L~~LdLs~N~l 512 (827)
.+.+|+.+.+..|.+
T Consensus 376 ~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 376 TDSGLQNLPVAPGSI 390 (394)
T ss_dssp CCCCC----------
T ss_pred ccCCCCEEEeCCCCE
Confidence 556666666655544
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.89 E-value=1.1e-09 Score=118.54 Aligned_cols=181 Identities=14% Similarity=0.167 Sum_probs=97.7
Q ss_pred CCcEEEEEcCCCCCcc-c-------cCccccCCCCCCEEECCCCCCC---------ccCChhhhhccccceEEecCCCCC
Q 047196 97 SHRVTALNISSLNLQG-T-------IPPQLGNLSSLTTLNLSHNKLS---------GDIPPSIFTMHKLKFLDFSDNQLS 159 (827)
Q Consensus 97 ~~~v~~L~L~~~~l~g-~-------~~~~l~~L~~L~~L~Ls~N~l~---------g~~p~~~~~l~~L~~LdLs~N~l~ 159 (827)
..+|+.|.+......| . +..+...+++|+.|.+..+... +.++..+..+++|+.|+|++|.-.
T Consensus 106 ~~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l 185 (362)
T 2ra8_A 106 LPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL 185 (362)
T ss_dssp GGGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC
T ss_pred chhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc
Confidence 3578888888766553 2 2334667889999999776431 235566778899999999887311
Q ss_pred CccccccCCCCCCcEEEcCCCCCCCCcchhHhh-ccccccEEEeec--ccccccC-----CccC--CCCCCCcEEEccCC
Q 047196 160 GSLSSVTFNLSSVLDIRLDSDKLSGELPVNICN-YLHYLKVLFLAK--NMFHGQI-----PLAL--SKCKRLQLLNLGFK 229 (827)
Q Consensus 160 g~~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~-~~~~L~~L~Ls~--N~l~~~~-----p~~l--~~l~~L~~L~L~~n 229 (827)
.++. + .+++|+.|+|..+.+....-..+.. .+++|+.|+|+. |...+.. ...+ ..+++|++|+|.+|
T Consensus 186 -~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~ 262 (362)
T 2ra8_A 186 -SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDA 262 (362)
T ss_dssp -BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESC
T ss_pred -eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCC
Confidence 2232 2 3677888888777654332223331 355777777753 2221110 0111 23455555555555
Q ss_pred CCcccCCCcC---cCCccccEEEccccccccc----ccccccCcCCCcEEEeecccCc
Q 047196 230 KLSGAIPKEI---SNLTILRKISLRNNKLRGE----IPHEIGYLPNLENLVLGFNNLV 280 (827)
Q Consensus 230 ~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 280 (827)
.++...+..+ ..+++|++|+|+.|.+.+. ++..+..+++|+.|+|++|.++
T Consensus 263 ~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 263 EEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp TTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred CCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 5543221111 1345555555555555432 2222233455555555555444
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.85 E-value=3.4e-11 Score=123.83 Aligned_cols=24 Identities=13% Similarity=-0.013 Sum_probs=17.9
Q ss_pred CCCcccceecCCCCCcEEEEEcCC
Q 047196 84 SVCNWIGITCNVNSHRVTALNISS 107 (827)
Q Consensus 84 ~~C~W~gv~C~~~~~~v~~L~L~~ 107 (827)
..|+|.|+.|+....+|+.+...+
T Consensus 76 ~l~~~~g~i~~~~~~ki~~~v~~~ 99 (267)
T 3rw6_A 76 ALKAVNYKILDRENRRISIIINSS 99 (267)
T ss_dssp HHHHTTSSCBCTTSCBCCCEEEEC
T ss_pred HHHhcCcEEECCCCCEEEEEEecC
Confidence 468999999997666776665544
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.70 E-value=1.1e-08 Score=110.72 Aligned_cols=211 Identities=15% Similarity=0.103 Sum_probs=112.3
Q ss_pred CCCCCEEECCCCCCCc-cC-------ChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcCCCCCCCCcchhHhh
Q 047196 121 LSSLTTLNLSHNKLSG-DI-------PPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICN 192 (827)
Q Consensus 121 L~~L~~L~Ls~N~l~g-~~-------p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~ 192 (827)
++.++.|.+....+.| .. ..+...+++|+.|.+..+.....--.+.. .+.++ .+..
T Consensus 106 ~~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~---------------~~~L~-~ll~ 169 (362)
T 2ra8_A 106 LPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIE---------------QVDLS-PVLD 169 (362)
T ss_dssp GGGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCB---------------CCBCH-HHHH
T ss_pred chhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhccccccc---------------ccCHH-HHHh
Confidence 3467788887666543 21 33456788999999977644210000000 01122 2223
Q ss_pred ccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCc--CCccccEEEccc--cccccc-----ccccc
Q 047196 193 YLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEIS--NLTILRKISLRN--NKLRGE-----IPHEI 263 (827)
Q Consensus 193 ~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~--~l~~L~~L~Ls~--N~l~~~-----~p~~~ 263 (827)
..++|+.|+|++|.-. .++. + .+++|+.|++..+.++......+. .+++|++|+|+. |...+. +...+
T Consensus 170 ~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l 246 (362)
T 2ra8_A 170 AMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLF 246 (362)
T ss_dssp TCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGS
T ss_pred cCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHH
Confidence 3446666666665211 1222 2 256777777766665433222232 566777777653 221111 11112
Q ss_pred --cCcCCCcEEEeecccCcccCchhhh---cCCCccEEEecCCccccccChhhh---cCCCCccEEeCcCCccccccCcc
Q 047196 264 --GYLPNLENLVLGFNNLVGVVPAAIF---NMSTVKKIYLLDNSLLGSFSLGID---LSLPNVERLNLGLNRFSGTIPSF 335 (827)
Q Consensus 264 --~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~l~~n~l~~~~~~~~~---~~l~~L~~L~L~~N~l~~~~p~~ 335 (827)
..+++|++|+|.+|.++...+..+. .+++|++|+++.|.+.+.-...+. ..+++|+.|+|+.|.++...-..
T Consensus 247 ~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~ 326 (362)
T 2ra8_A 247 SKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKE 326 (362)
T ss_dssp CTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHH
T ss_pred hcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHH
Confidence 2467777777777777654444443 366778888877776653211111 14678888888888876543333
Q ss_pred ccCCCCCcEEEcCCCc
Q 047196 336 ITNASKLVYLDMGTNS 351 (827)
Q Consensus 336 ~~~l~~L~~L~Ls~N~ 351 (827)
+...- ...++++.++
T Consensus 327 l~~al-g~~~~~~~~~ 341 (362)
T 2ra8_A 327 LQKSL-PMKIDVSDSQ 341 (362)
T ss_dssp HHHHC-CSEEECCSBC
T ss_pred HHHHc-CCEEEecCCc
Confidence 33211 4567888776
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.61 E-value=2.6e-06 Score=93.17 Aligned_cols=80 Identities=4% Similarity=-0.020 Sum_probs=43.5
Q ss_pred ccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEE
Q 047196 193 YLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENL 272 (827)
Q Consensus 193 ~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 272 (827)
...+|+.+.+..+ ++..-..+|.+|.+|+.+++..+ ++..-...|.++ +|+.+.+..+ ++..-...|.. .+|+.+
T Consensus 44 ~~~~i~~v~ip~~-vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~~i 118 (379)
T 4h09_A 44 DRDRISEVRVNSG-ITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDLDDF 118 (379)
T ss_dssp GGGGCSEEEECTT-EEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCCSEE
T ss_pred cccCCEEEEeCCC-ccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CCcccc
Confidence 3446777777543 44444566777777777777543 544444556655 4555555433 33222233333 356666
Q ss_pred Eeecc
Q 047196 273 VLGFN 277 (827)
Q Consensus 273 ~Ls~N 277 (827)
++..+
T Consensus 119 ~lp~~ 123 (379)
T 4h09_A 119 EFPGA 123 (379)
T ss_dssp ECCTT
T ss_pred cCCCc
Confidence 66543
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.59 E-value=9.5e-06 Score=88.69 Aligned_cols=107 Identities=13% Similarity=0.065 Sum_probs=48.7
Q ss_pred ccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCC
Q 047196 398 QLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTS 477 (827)
Q Consensus 398 ~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 477 (827)
..|.++..|+.+.+..+ ++..-...|.++.+|+.+.+..+ +...-...|.++++|+.+.+.++.++..-...|.+|.+
T Consensus 234 ~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~ 311 (379)
T 4h09_A 234 GAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVK 311 (379)
T ss_dssp TTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTT
T ss_pred ccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCC
Confidence 34444555555555433 33233334455555555555332 22222234444555555555555444333444555555
Q ss_pred CCccccCCCcccccCCccccccccccccCC
Q 047196 478 LRSPDLGSNRLTSVLPSTFWNLKDILFFDL 507 (827)
Q Consensus 478 L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdL 507 (827)
|+.++|..+ ++.+-..+|.++++|+.+.+
T Consensus 312 L~~i~lp~~-l~~I~~~aF~~C~~L~~i~i 340 (379)
T 4h09_A 312 LSSVTLPTA-LKTIQVYAFKNCKALSTISY 340 (379)
T ss_dssp CCEEECCTT-CCEECTTTTTTCTTCCCCCC
T ss_pred CCEEEcCcc-ccEEHHHHhhCCCCCCEEEE
Confidence 555555432 33333444555555554444
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=1.3e-06 Score=90.16 Aligned_cols=107 Identities=14% Similarity=0.049 Sum_probs=72.4
Q ss_pred HHhhcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcC-CCCceEEEeeeecCCcee--e
Q 047196 672 RATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIR-HRNHVKRISSCSNEDFKA--L 748 (827)
Q Consensus 672 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~~~~--l 748 (827)
.....|......+.|+.+.||+.... |..+++|+...........+.+|+++++.++ |..+.++++++......+ +
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 34456777777888889999999754 6789999986432222346889999999995 556667888777655433 3
Q ss_pred eeeccCCC---CCCHHHHHHHHHHHHHHHHHHHh
Q 047196 749 DCLHSTNC---SLNIFDKLNIMIDVASALEYLHF 779 (827)
Q Consensus 749 ~~l~~~~~---~l~~~~~~~i~~~ia~~L~~Lh~ 779 (827)
+++..... ..+..+...++.+++++++.||.
T Consensus 90 e~i~G~~l~~~~~~~~~~~~~~~~l~~~l~~LH~ 123 (263)
T 3tm0_A 90 SEADGVLCSEEYEDEQSPEKIIELYAECIRLFHS 123 (263)
T ss_dssp ECCSSEEHHHHCCTTTCHHHHHHHHHHHHHHHHH
T ss_pred EecCCeehhhccCCcccHHHHHHHHHHHHHHHhC
Confidence 44332210 00112345788999999999997
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.32 E-value=6.2e-08 Score=94.56 Aligned_cols=46 Identities=13% Similarity=0.103 Sum_probs=29.3
Q ss_pred cCccccCCCCCCEEECCCC-CCCcc----CChhhhhccccceEEecCCCCC
Q 047196 114 IPPQLGNLSSLTTLNLSHN-KLSGD----IPPSIFTMHKLKFLDFSDNQLS 159 (827)
Q Consensus 114 ~~~~l~~L~~L~~L~Ls~N-~l~g~----~p~~~~~l~~L~~LdLs~N~l~ 159 (827)
+...+...+.|++|+|++| .+... +...+...++|++|||++|.+.
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~ 78 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSN 78 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCC
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCC
Confidence 3445666777778888877 76532 3334445567777777777765
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.30 E-value=8.8e-08 Score=98.37 Aligned_cols=67 Identities=22% Similarity=0.309 Sum_probs=38.9
Q ss_pred cCCCCCcEEECCCCCCCC--CCCccccccccccEEecCCCcccccCCccccCCC--CCCccccCCCcccccCC
Q 047196 425 GRLQKLQGLYLPFNKLAG--SIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLT--SLRSPDLGSNRLTSVLP 493 (827)
Q Consensus 425 ~~l~~L~~L~Ls~N~l~g--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p 493 (827)
.++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|++++. ..+..+. +|++|+|++|.+.+.+|
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccC
Confidence 456666666666666665 3445555666666666666666643 2222222 56666666666665444
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.20 E-value=1.7e-07 Score=91.48 Aligned_cols=44 Identities=9% Similarity=0.075 Sum_probs=23.2
Q ss_pred ccccCCCCCcEEECCCC-CCCCC----CCccccccccccEEecCCCccc
Q 047196 422 VTFGRLQKLQGLYLPFN-KLAGS----IPDQLCHLARLNTLGLAGNKFS 465 (827)
Q Consensus 422 ~~~~~l~~L~~L~Ls~N-~l~g~----~p~~~~~l~~L~~L~Ls~N~l~ 465 (827)
..+...+.|+.|+|++| .+... +...+...++|++|+|++|++.
T Consensus 30 ~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~ 78 (185)
T 1io0_A 30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSN 78 (185)
T ss_dssp HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCC
T ss_pred HHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCC
Confidence 34555667777777776 66421 1222333445555555555554
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.17 E-value=1.9e-06 Score=88.72 Aligned_cols=93 Identities=12% Similarity=0.052 Sum_probs=61.0
Q ss_pred ecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCc-e-EEEeeeecCC--ceeeeeeccCCCCCC
Q 047196 684 GVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNH-V-KRISSCSNED--FKALDCLHSTNCSLN 759 (827)
Q Consensus 684 G~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v-~~~~~~~~~~--~~~l~~l~~~~~~l~ 759 (827)
+.|..+.||+....+|..++||+.... ....+.+|+++++.+++.++ | +++++...++ +.+++++........
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~~~ 105 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSS 105 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTS
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccCcC
Confidence 456679999998777888999997543 22457889999999976554 4 4677665544 334444433221111
Q ss_pred HHHHHHHHHHHHHHHHHHHh
Q 047196 760 IFDKLNIMIDVASALEYLHF 779 (827)
Q Consensus 760 ~~~~~~i~~~ia~~L~~Lh~ 779 (827)
..+...++.++++.++.||.
T Consensus 106 ~~~~~~~~~~l~~~l~~lh~ 125 (264)
T 1nd4_A 106 HLAPAEKVSIMADAMRRLHT 125 (264)
T ss_dssp CCCHHHHHHHHHHHHHHHTT
T ss_pred cCCHhHHHHHHHHHHHHHhC
Confidence 11234678888899999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=97.80 E-value=5.5e-05 Score=81.91 Aligned_cols=99 Identities=12% Similarity=0.142 Sum_probs=67.1
Q ss_pred cceEecCCceEEEEEEecCCcEEEEEEEc--ccc-hHHHHHHHHHHHHHHhcCC--CCceEEEeeeecC-----Cceeee
Q 047196 680 ENLIGVGSFGSVYKGRLHDGIEVAIKVFH--QNC-AMALKSFEAECEVMKNIRH--RNHVKRISSCSNE-----DFKALD 749 (827)
Q Consensus 680 ~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~--~~~-~~~~~~~~~Ei~~l~~l~H--~niv~~~~~~~~~-----~~~~l~ 749 (827)
.+.++.|.++.||+.+..+ ..+++|+.. ... ......+.+|+++++.+++ ..+.+.+.++.+. .+.+++
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 4568899999999988764 578888765 322 1223468899999999984 4567788887665 344555
Q ss_pred eeccCC------CCCCHHHHHHHHHHHHHHHHHHHh
Q 047196 750 CLHSTN------CSLNIFDKLNIMIDVASALEYLHF 779 (827)
Q Consensus 750 ~l~~~~------~~l~~~~~~~i~~~ia~~L~~Lh~ 779 (827)
++.... ..++..++..++.++++.|+.||.
T Consensus 122 ~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~ 157 (359)
T 3dxp_A 122 FVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHT 157 (359)
T ss_dssp CCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhC
Confidence 554322 124566778899999999999996
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.16 E-value=0.00015 Score=69.00 Aligned_cols=34 Identities=3% Similarity=-0.133 Sum_probs=17.2
Q ss_pred cccEEEeecccccccCCccCCCCCCCcEEEccCC
Q 047196 196 YLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFK 229 (827)
Q Consensus 196 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n 229 (827)
+|+.||++++.++..--..+.++++|+.|+|+++
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C 95 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC 95 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence 4566666655554332333445555555555554
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0003 Score=66.88 Aligned_cols=84 Identities=12% Similarity=0.118 Sum_probs=49.6
Q ss_pred CCCcEEEccCCCCcccCCCcCcCCccccEEEccccc-ccccccccccCc----CCCcEEEeeccc-CcccCchhhhcCCC
Q 047196 219 KRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNK-LRGEIPHEIGYL----PNLENLVLGFNN-LVGVVPAAIFNMST 292 (827)
Q Consensus 219 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~ 292 (827)
.+|+.||++++.++..--..+.++++|++|+|++|. ++..-=..+..+ ++|++|+|++|. +|..--..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 467777777777664333445667777777777774 553322334443 357777777763 55433334555666
Q ss_pred ccEEEecCCc
Q 047196 293 VKKIYLLDNS 302 (827)
Q Consensus 293 L~~L~l~~n~ 302 (827)
|+.|+++++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 6666666654
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=96.39 E-value=0.017 Score=60.38 Aligned_cols=94 Identities=15% Similarity=0.132 Sum_probs=58.2
Q ss_pred cceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCC-CC--ceEEEeeeecCC-----ceeeeee
Q 047196 680 ENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRH-RN--HVKRISSCSNED-----FKALDCL 751 (827)
Q Consensus 680 ~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H-~n--iv~~~~~~~~~~-----~~~l~~l 751 (827)
.+.++.|....||+.. ..+++|+-... .....+.+|+++++.+.+ .. +.+.+..+...+ +.+++++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3568999999999853 46888885432 345678999999999843 22 223444433322 2233334
Q ss_pred ccCCC------CCCHHHHHHHHHHHHHHHHHHHh
Q 047196 752 HSTNC------SLNIFDKLNIMIDVASALEYLHF 779 (827)
Q Consensus 752 ~~~~~------~l~~~~~~~i~~~ia~~L~~Lh~ 779 (827)
..... .++..++..++.++++.++.||.
T Consensus 99 ~G~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~ 132 (304)
T 3sg8_A 99 KGVPLTPLLLNNLPKQSQNQAAKDLARFLSELHS 132 (304)
T ss_dssp CCEECCHHHHHTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCeECCccccccCCHHHHHHHHHHHHHHHHHHHc
Confidence 32211 23344566788888888888885
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.39 E-value=0.011 Score=61.35 Aligned_cols=54 Identities=17% Similarity=0.161 Sum_probs=42.6
Q ss_pred cccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcC
Q 047196 676 KFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIR 729 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~ 729 (827)
.....+.+|.|..+.||+.+..+|+.|.||+-..........|.+|++.|+.+.
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~ 69 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLG 69 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHT
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHH
Confidence 345557789999999999999999999999865443333346889999999885
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.34 E-value=0.00059 Score=66.10 Aligned_cols=41 Identities=10% Similarity=0.255 Sum_probs=19.7
Q ss_pred cCCCCCCEEECCCC-CCCc----cCChhhhhccccceEEecCCCCC
Q 047196 119 GNLSSLTTLNLSHN-KLSG----DIPPSIFTMHKLKFLDFSDNQLS 159 (827)
Q Consensus 119 ~~L~~L~~L~Ls~N-~l~g----~~p~~~~~l~~L~~LdLs~N~l~ 159 (827)
.+-+.|++|+|++| +|.. .+-..+..-+.|+.|+|++|++.
T Consensus 38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~ig 83 (197)
T 1pgv_A 38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAIS 83 (197)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCB
T ss_pred hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCC
Confidence 34455556666553 4431 12233334455555555555554
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.16 E-value=0.0089 Score=53.87 Aligned_cols=56 Identities=18% Similarity=0.239 Sum_probs=43.1
Q ss_pred EEEcCCCCCc-cccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCC
Q 047196 102 ALNISSLNLQ-GTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLS 159 (827)
Q Consensus 102 ~L~L~~~~l~-g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~ 159 (827)
.++.++++++ ..+|..+. .+|++|+|++|+|+...+..|..+++|++|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5677777776 35554432 36899999999999766677888999999999999875
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.16 E-value=0.0029 Score=61.22 Aligned_cols=83 Identities=18% Similarity=0.287 Sum_probs=59.0
Q ss_pred CcEEEEEcCCC-CCcc----ccCccccCCCCCCEEECCCCCCCc----cCChhhhhccccceEEecCCCCCCc----ccc
Q 047196 98 HRVTALNISSL-NLQG----TIPPQLGNLSSLTTLNLSHNKLSG----DIPPSIFTMHKLKFLDFSDNQLSGS----LSS 164 (827)
Q Consensus 98 ~~v~~L~L~~~-~l~g----~~~~~l~~L~~L~~L~Ls~N~l~g----~~p~~~~~l~~L~~LdLs~N~l~g~----~p~ 164 (827)
..++.|+|+++ +|.. .+..++..-+.|+.|+|++|.|.. .+...+..-+.|++|+|++|.|... +-.
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~ 120 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 120 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHH
Confidence 46899999985 7753 244567778899999999999973 3445566778999999999999743 223
Q ss_pred ccCCCCCCcEEEcCCC
Q 047196 165 VTFNLSSVLDIRLDSD 180 (827)
Q Consensus 165 ~~~~l~~L~~L~L~~n 180 (827)
.+..-+.|++|+|+.|
T Consensus 121 aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 121 STLVTQSIVEFKADNQ 136 (197)
T ss_dssp HTTTTCCCSEEECCCC
T ss_pred HHhhCCceeEEECCCC
Confidence 3444445666666543
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.00 E-value=0.0096 Score=53.63 Aligned_cols=56 Identities=25% Similarity=0.367 Sum_probs=34.1
Q ss_pred EEEccCCCCc-ccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEeecccCc
Q 047196 223 LLNLGFKKLS-GAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLV 280 (827)
Q Consensus 223 ~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 280 (827)
.++.+++.++ ..+|..+. .+|++|+|++|+|+...+..|..+++|++|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4556666654 23444332 34667777777776555556666777777777777654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=95.09 E-value=0.021 Score=62.22 Aligned_cols=60 Identities=15% Similarity=0.112 Sum_probs=38.3
Q ss_pred cceEecCCceEEEEEEec-CCcEEEEEEEcccch-------HHHHHHHHHHHHHHhcCC--CCce-EEEee
Q 047196 680 ENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA-------MALKSFEAECEVMKNIRH--RNHV-KRISS 739 (827)
Q Consensus 680 ~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-------~~~~~~~~Ei~~l~~l~H--~niv-~~~~~ 739 (827)
.+.+|.|..+.||+++.. +++.|+||....... ....++..|+++++.+++ +..| +.+.+
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~ 105 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS 105 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE
Confidence 357899999999999754 468899998643211 123456789999988743 3444 34433
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=94.99 E-value=0.036 Score=59.30 Aligned_cols=64 Identities=8% Similarity=-0.034 Sum_probs=41.1
Q ss_pred cceE-ecCCceEEEEEEec-------CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCC---CCceEEEeeeecC
Q 047196 680 ENLI-GVGSFGSVYKGRLH-------DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRH---RNHVKRISSCSNE 743 (827)
Q Consensus 680 ~~~i-G~G~fg~Vy~~~~~-------~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H---~niv~~~~~~~~~ 743 (827)
.+.+ +.|..+.+|+.+.. +|+.+++|+-.... ......+.+|+++++.++. -.+.+.+.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 3567 78889999998754 25678888754322 0012457789888888753 2355566666543
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=94.93 E-value=0.15 Score=53.13 Aligned_cols=94 Identities=9% Similarity=-0.003 Sum_probs=54.5
Q ss_pred cceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCC---ceEEEeeeec-C--Cceeeeeecc
Q 047196 680 ENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRN---HVKRISSCSN-E--DFKALDCLHS 753 (827)
Q Consensus 680 ~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~n---iv~~~~~~~~-~--~~~~l~~l~~ 753 (827)
.+.++.|....||+. |..++||+-. .......+.+|+++++.+++.. +-+.+.++.. . .+.+++++..
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356888999999987 5678888743 2234567899999999998632 3344444432 1 2333443332
Q ss_pred CC------CCCCHHHHHHHHHHHHHHHHHHHh
Q 047196 754 TN------CSLNIFDKLNIMIDVASALEYLHF 779 (827)
Q Consensus 754 ~~------~~l~~~~~~~i~~~ia~~L~~Lh~ 779 (827)
.. ..++..++..++.++++.++.||.
T Consensus 98 ~~l~~~~~~~l~~~~~~~~~~~lg~~La~LH~ 129 (306)
T 3tdw_A 98 QILGEDGMAVLPDDAKDRLALQLAEFMNELSA 129 (306)
T ss_dssp EECHHHHHTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred eECchhhhhhCCHHHHHHHHHHHHHHHHHHhc
Confidence 11 112333445555666666655553
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=93.76 E-value=0.38 Score=48.86 Aligned_cols=61 Identities=13% Similarity=0.012 Sum_probs=39.7
Q ss_pred eEecCCce-EEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCC-CCceEEEeeeecCCc
Q 047196 682 LIGVGSFG-SVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRH-RNHVKRISSCSNEDF 745 (827)
Q Consensus 682 ~iG~G~fg-~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H-~niv~~~~~~~~~~~ 745 (827)
.+..|..| .||+.... ++..+.||+-... ....+.+|.+.|+.+.. -.+-+.++++.+++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~ 94 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDD 94 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCe
Confidence 35556555 69987754 4677889986433 34567889999998853 223456666665543
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=90.46 E-value=0.38 Score=49.89 Aligned_cols=93 Identities=6% Similarity=-0.050 Sum_probs=49.7
Q ss_pred cceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCce-EEEeeeecCCceeeeeeccCCCCC
Q 047196 680 ENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHV-KRISSCSNEDFKALDCLHSTNCSL 758 (827)
Q Consensus 680 ~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv-~~~~~~~~~~~~~l~~l~~~~~~l 758 (827)
.+.++.|....+|+. ..+.+|+-...... .....+|+++++.+....+. ++++.+.+.....++++. ....+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~~~~~~v~e~i~-~g~~l 95 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDPATGVMVTRYIA-GAQTM 95 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECTTTCCEEEECCT-TCEEC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEECCCCEEEEeecC-CCccC
Confidence 567899999999998 45788886543211 11235688777777543343 444444333445555551 11222
Q ss_pred CHHHH---HHHHHHHHHHHHHHHh
Q 047196 759 NIFDK---LNIMIDVASALEYLHF 779 (827)
Q Consensus 759 ~~~~~---~~i~~~ia~~L~~Lh~ 779 (827)
+.... -.+...+++.|+-+|.
T Consensus 96 ~~~~~~~~~~~~~~~~~~La~lH~ 119 (301)
T 3dxq_A 96 SPEKFKTRPGSPARAGEAFRKLHG 119 (301)
T ss_dssp CHHHHHHSTTHHHHHHHHHHHHHT
T ss_pred CHhhHhhhHHHHHHHHHHHHHHhC
Confidence 22111 1245556666666653
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=87.95 E-value=1.4 Score=48.04 Aligned_cols=26 Identities=19% Similarity=0.132 Sum_probs=20.9
Q ss_pred cceEecCCceEEEEEEecCCcEEEEEE
Q 047196 680 ENLIGVGSFGSVYKGRLHDGIEVAIKV 706 (827)
Q Consensus 680 ~~~iG~G~fg~Vy~~~~~~g~~vAvK~ 706 (827)
.+.+|.|..+.||+... +++.++||.
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~ 64 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQ 64 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEE
Confidence 35688999999999964 467899994
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=87.43 E-value=2.1 Score=44.81 Aligned_cols=43 Identities=19% Similarity=0.204 Sum_probs=24.0
Q ss_pred ceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhc
Q 047196 681 NLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNI 728 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l 728 (827)
+.++.|..+.||+....+| .+++|+.... . .+...|+++++.+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L 80 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYL 80 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHH
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHH
Confidence 3456677899999987655 4889988652 1 2233445545444
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=86.81 E-value=1.5 Score=45.59 Aligned_cols=62 Identities=8% Similarity=0.102 Sum_probs=35.3
Q ss_pred cchhHHHHHhhcccc-----cceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcC
Q 047196 665 FSYQDLFRATEKFSK-----ENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIR 729 (827)
Q Consensus 665 ~~~~~~~~~~~~~~~-----~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~ 729 (827)
++.+++....+.|.. .+.++.|....+|+.+..+| .+++|+..... ..+.+..|+++++.++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~ 73 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLA 73 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHH
Confidence 344455544444543 23466788899999987666 57789876521 1234566777777664
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=83.21 E-value=1.2 Score=47.40 Aligned_cols=53 Identities=17% Similarity=0.239 Sum_probs=30.1
Q ss_pred ceEecCCceEEEEEEecC---------CcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCce
Q 047196 681 NLIGVGSFGSVYKGRLHD---------GIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHV 734 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~~---------g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv 734 (827)
..++.|....+|+....+ ++.+.+|+...... .......|.++++.+....++
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~ 100 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIA 100 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSS
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCC
Confidence 456778888999998654 26788888654322 111235788888777533444
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=82.23 E-value=3 Score=43.35 Aligned_cols=47 Identities=11% Similarity=0.103 Sum_probs=32.5
Q ss_pred ceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcC
Q 047196 681 NLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIR 729 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~ 729 (827)
..++ |....||+....+|+.+++|+..... .....+..|.++++.++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~ 78 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLV 78 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHH
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHH
Confidence 3466 77889999877778789999985321 12345667888777764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 827 | ||||
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-30 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-29 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-28 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-27 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-27 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-26 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-26 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-26 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-26 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-26 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-25 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-25 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-25 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-24 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-24 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-24 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-23 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-23 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-23 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-23 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-23 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-23 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-23 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-22 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-07 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-22 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-22 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-22 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-22 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-21 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-21 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-20 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-20 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-20 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-20 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-20 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-20 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-20 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-19 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.003 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-19 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 9e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-08 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-06 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-19 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-19 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-19 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-18 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-18 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-18 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-18 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-18 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-18 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-18 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-17 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-17 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-17 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-17 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-17 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-17 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-17 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-17 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-17 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-16 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-16 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-16 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-16 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-15 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-15 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-14 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-14 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 9e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 9e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.003 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 5e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.002 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.004 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 8e-04 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.002 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 1e-30
Identities = 39/174 (22%), Positives = 71/174 (40%), Gaps = 25/174 (14%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHV 734
E +G G FG V+ G + +VA+K Q +M+ +F AE +MK ++H+ V
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV 71
Query: 735 KRISSCSNEDF----------KALDCLHS-TNCSLNIFDKLNIMIDVASALEYLHFSHST 783
+ + + E +D L + + L I L++ +A + ++
Sbjct: 72 RLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EER 128
Query: 784 PVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827
IH DL+ N+ DFG+ RL+ + + I + AP +
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 114 bits (287), Expect = 9e-29
Identities = 45/199 (22%), Positives = 74/199 (37%), Gaps = 42/199 (21%)
Query: 665 FSYQDLFRATEKFSKE---------NLIGVGSFGSVYKGRLH----DGIEVAIKVFHQNC 711
F+++D A +F+KE +IG G FG V G L I VAIK
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 712 AM-ALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHSTNCSLNIFDK------- 763
+ F +E +M H N + + + N SL+ F +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 764 ----LNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809
+ ++ +A+ ++YL + +H DL +N+ DFG+ R L D S
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 810 MIQTETLV----TIGYMAP 824
+ + I + AP
Sbjct: 184 DPTYTSALGGKIPIRWTAP 202
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 2e-28
Identities = 45/173 (26%), Positives = 73/173 (42%), Gaps = 28/173 (16%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMA--LKSFEAECEVMKNIRHRN 732
+ + IG GSFG+VYKG+ H +VA+K+ + L++F+ E V++ RH N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 733 HVKRISSCSNEDF----------KALDCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHS 782
+ + + LH + ++I A ++YLH
Sbjct: 66 ILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK-- 123
Query: 783 TPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-TIGYMAP 824
+IH DLK N+F DFG+ + + Q E L +I +MAP
Sbjct: 124 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 1e-27
Identities = 40/174 (22%), Positives = 66/174 (37%), Gaps = 25/174 (14%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHV 734
E E +G G FG V+ G + VAIK M+ ++F E +VMK +RH V
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLV 75
Query: 735 KRISSCSNEDF-----------KALDCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHST 783
+ + S E T L + +++ +AS + Y+ +
Sbjct: 76 QLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN-- 133
Query: 784 PVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827
+H DL+ N+ DFG+ RL+ + + I + AP
Sbjct: 134 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 110 bits (275), Expect = 3e-27
Identities = 49/188 (26%), Positives = 76/188 (40%), Gaps = 27/188 (14%)
Query: 663 RRFSYQDLFRATEKFSKENLIGVGSFGSVYKGRLHD-GIEVAIKVFHQNCAMALKSFEAE 721
+Y + ++ +G G +G VY+G + VA+K ++ M ++ F E
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKE 63
Query: 722 CEVMKNIRHRNHVKRISSCSNEDF-----------KALDCLHSTN-CSLNIFDKLNIMID 769
VMK I+H N V+ + C+ E LD L N ++ L +
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123
Query: 770 VASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTI 819
++SA+EYL IH DL +N DFG+ RL+TGD I
Sbjct: 124 ISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180
Query: 820 GYMAPGLL 827
+ AP L
Sbjct: 181 KWTAPESL 188
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 1e-26
Identities = 38/174 (21%), Positives = 64/174 (36%), Gaps = 25/174 (14%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHV 734
+ + +G G FG V G+ +VAIK+ + +M+ F E +VM N+ H V
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLV 62
Query: 735 KRISSCSNEDFKAL-----------DCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHST 783
+ C+ + + + L L + DV A+EYL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ-- 120
Query: 784 PVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827
+H DL +N DFG+ R + D + + + P +L
Sbjct: 121 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 3e-26
Identities = 36/177 (20%), Positives = 62/177 (35%), Gaps = 27/177 (15%)
Query: 673 ATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFH-QNCAMALKSFEAECEVMKNIRH 730
+ F K + +G G+ G V+K G+ +A K+ H + E +V+
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 731 RNHVKRISSCSNEDF----------KALDCLHSTNCSLNIFDKLNIMIDVASALEYLHFS 780
V + ++ +LD + + + I V L YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 781 HSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827
H ++H D+KP N+ DFG+ L + + T YM+P L
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERL 175
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 3e-26
Identities = 39/187 (20%), Positives = 69/187 (36%), Gaps = 30/187 (16%)
Query: 668 QDLFRATEKFSKENL-IGVGSFGSVYKGRLH---DGIEVAIKVFHQN-CAMALKSFEAEC 722
+ LF + ++ +G G+FGSV +G I+VAIKV Q + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 723 EVMKNIRHRNHVKRISSCSNEDF----------KALDCLHSTNCSLNIFDKLNIMIDVAS 772
++M + + V+ I C E L + + + ++ V+
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120
Query: 773 ALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV--TIG 820
++YL +H DL +NV DFG+ + L D S + +
Sbjct: 121 GMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177
Query: 821 YMAPGLL 827
+ AP +
Sbjct: 178 WYAPECI 184
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (264), Expect = 6e-26
Identities = 42/171 (24%), Positives = 67/171 (39%), Gaps = 25/171 (14%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHV 734
+ + IG G FG V+ G + +VAIK + AM+ + F E EVM + H V
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLV 63
Query: 735 KRISSCSNEDFKALDCLHSTNCSLNIFDK-----------LNIMIDVASALEYLHFSHST 783
+ C + L + L+ + + L + +DV + YL
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEA 120
Query: 784 PVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
VIH DL +N DFG+ R + D+ T T + + +P
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 171
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 107 bits (267), Expect = 6e-26
Identities = 42/175 (24%), Positives = 62/175 (35%), Gaps = 32/175 (18%)
Query: 674 TEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAM---ALKSFEAECEVMKNIR 729
+ FS IG GSFG+VY R + + VAIK + + E ++ +R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 730 HRNHVKRISSCSNEDF----------KALDCLHSTNCSLNIFDKLNIMIDVASALEYLHF 779
H N ++ E A D L L + + L YL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL-- 131
Query: 780 SHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
HS +IH D+K N+ DFG ++ S + T +MAP
Sbjct: 132 -HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVG-----TPYWMAP 180
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 5e-25
Identities = 34/177 (19%), Positives = 64/177 (36%), Gaps = 28/177 (15%)
Query: 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFH-QNCAMALKSFEAECEVMKNIRHRN 732
E + +G G++G V VA+K+ + ++ + E + K + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 733 HVKRISSCSNEDFKAL-----------DCLHSTNCSLNIFDKLNIMIDVASALEYLHFSH 781
VK + + L D + + + D + + + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH--- 120
Query: 782 STPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-TIGYMAPGLL 827
+ H D+KP+N+ DFG+ + + + T+ Y+AP LL
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 6e-25
Identities = 38/172 (22%), Positives = 69/172 (40%), Gaps = 29/172 (16%)
Query: 679 KENLIGVGSFGSVYKGRLHD---GIEVAIKVFHQ--NCAMALKSFEAECEVMKNIRHRNH 733
++ +G G+FG+V KG VA+K+ N AE VM+ + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 734 VKRISSCSNEDF---------KALDCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHSTP 784
V+ I C E + L+ N + + + ++ V+ ++YL S+
Sbjct: 71 VRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--- 127
Query: 785 VIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV--TIGYMAP 824
+H DL +NV DFG+ + L D + + +T + + AP
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 179
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 7e-25
Identities = 42/178 (23%), Positives = 71/178 (39%), Gaps = 22/178 (12%)
Query: 672 RATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAM---ALKSFEAECEVMKN 727
+ E F ++G GSF +V R L E AIK+ + + + E +VM
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 728 IRHRNHVKRISSCSNEDFKAL-------DCLHSTNCSLNIFDKLNIMIDVASALEYLHFS 780
+ H VK + +++ L + FD+ A + L +
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 124
Query: 781 HSTPVIHCDLKPKN----------VFDFGIGRLLTGDRSMIQTETLV-TIGYMAPGLL 827
H +IH DLKP+N + DFG ++L+ + + + V T Y++P LL
Sbjct: 125 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (254), Expect = 1e-24
Identities = 43/180 (23%), Positives = 69/180 (38%), Gaps = 34/180 (18%)
Query: 676 KFSKENLIGVGSFGSVYKGRLHD-GIEVAIKVFH--QNCAMALKSFEAECEVMKNIRHRN 732
KF E IG GSF +VYKG + +EVA + + F+ E E++K ++H N
Sbjct: 12 KFDIE--IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69
Query: 733 HVKRISSCSNE--------------DFKALDCLHSTNCSLNIFDKLNIMIDVASALEYLH 778
V+ S + L + I + + L++LH
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 779 FSHSTPVIHCDLKPKNVF-----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827
+ + P+IH DLK N+F D G+ L + + T +MAP +
Sbjct: 130 -TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEMY 185
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (254), Expect = 2e-24
Identities = 37/176 (21%), Positives = 64/176 (36%), Gaps = 26/176 (14%)
Query: 674 TEKFSKENLIGVGSFGSVYKGRLHD-GIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRN 732
+ + +G G+FG VYK + + + A KV L+ + E +++ + H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 733 HVKRISSCSNEDFKAL-----------DCLHSTNCSLNIFDKLNIMIDVASALEYLHFSH 781
VK + + E+ + + L + AL YL H
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL---H 127
Query: 782 STPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827
+IH DLK N+ DFG+ T + + T +MAP ++
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPYWMAPEVV 182
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.7 bits (248), Expect = 8e-24
Identities = 41/184 (22%), Positives = 64/184 (34%), Gaps = 32/184 (17%)
Query: 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAM--ALKSFEAECEVMKNIRHR 731
E + IG GS+G K R DG + K + +E +++ ++H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 732 NHVKRISSCSNED----------------FKALDCLHSTNCSLNIFDKLNIMIDVASALE 775
N V+ + + L+ L +M + AL+
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 776 YLHFSH--STPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMA 823
H V+H DLKP NVF DFG+ R+L D S + T YM+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV-GTPYYMS 182
Query: 824 PGLL 827
P +
Sbjct: 183 PEQM 186
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.3 bits (247), Expect = 1e-23
Identities = 44/176 (25%), Positives = 67/176 (38%), Gaps = 33/176 (18%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHV 734
++ IG G FG V G + G +VA+K + ++F AE VM +RH N V
Sbjct: 7 KELKLLQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 735 KRISSCSNEDFK------------ALDCLHSTNCS-LNIFDKLNIMIDVASALEYLHFSH 781
+ + E +D L S S L L +DV A+EYL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---E 120
Query: 782 STPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827
+H DL +NV DFG+ + + + + + + AP L
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL----PVKWTAPEAL 172
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 99 bits (248), Expect = 1e-23
Identities = 36/179 (20%), Positives = 64/179 (35%), Gaps = 32/179 (17%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDG-----IEVAIKVFHQNCAM-ALKSFEAECEVMKNI 728
+++ +IG G FG VYKG L + VAIK F E +M
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 729 RHRNHVKRISSCSNEDFKAL-----------DCLHSTNCSLNIFDKLNIMIDVASALEYL 777
H N ++ S + L + ++ + ++ +A+ +
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG---M 123
Query: 778 HFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTET--LVTIGYMAP 824
+ + +H DL +N+ DFG+ R+L D T + + I + AP
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 1e-23
Identities = 42/171 (24%), Positives = 70/171 (40%), Gaps = 24/171 (14%)
Query: 674 TEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRN 732
+K+++ IG G+ G+VY + G EVAI+ + + E VM+ ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 733 HVKRISSCSNEDFKALDCLHSTNCSLNIF---------DKLNIMIDVASALEYLHFSHST 783
V + S D + + SL + + ALE+L HS
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFL---HSN 135
Query: 784 PVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
VIH D+K N+ DFG +T ++S ++ + T +MAP
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAP 185
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 1e-23
Identities = 45/182 (24%), Positives = 72/182 (39%), Gaps = 31/182 (17%)
Query: 670 LFRATEKFSKENLIGVGSFGSVYKGRLHD-----GIEVAIKVFHQ-NCAMALKSFEAECE 723
+ + TE F K ++G G+FG+VYKG I VAIK + A K E
Sbjct: 5 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 724 VMKNIRHRNHVKRISSCSNEDFKALDCLHSTNCSLNIFDK----------LNIMIDVASA 773
VM ++ + + + + C + + L C L+ + LN + +A
Sbjct: 64 VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123
Query: 774 LEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV-TIGYM 822
+ YL ++H DL +NV DFG+ +LL + E I +M
Sbjct: 124 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
Query: 823 AP 824
A
Sbjct: 181 AL 182
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 100 bits (251), Expect = 1e-23
Identities = 32/174 (18%), Positives = 63/174 (36%), Gaps = 29/174 (16%)
Query: 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNH 733
+ + +G G+FG V++ G A K ++ E + M +RH
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 734 VKRISSCSNEDFKAL-----------DCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHS 782
V + +++ + + + + ++ + + M V L ++ H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM---HE 142
Query: 783 TPVIHCDLKPKNVF------------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
+H DLKP+N+ DFG+ L +S+ T T + AP
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG--TAEFAAP 194
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.1 bits (244), Expect = 2e-23
Identities = 39/174 (22%), Positives = 63/174 (36%), Gaps = 30/174 (17%)
Query: 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQ---NCAMALKSFEAECEVMKNIRH 730
E F +G G FG+VY R +A+KV + A E E+ ++RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 731 RNHVKRISSCSNEDFKALDCLHSTNCSLNIF----------DKLNIMIDVASALEYLHFS 780
N ++ + L ++ ++ + ++A+AL Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH-- 123
Query: 781 HSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
S VIH D+KP+N+ DFG R T+ Y+ P
Sbjct: 124 -SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC---GTLDYLPP 173
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 99.0 bits (246), Expect = 6e-23
Identities = 30/177 (16%), Positives = 66/177 (37%), Gaps = 29/177 (16%)
Query: 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNH 733
+ + +G G+FG V++ G K + + + + E +M + H
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 734 VKRISSCSNEDFKAL-----------DCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHS 782
+ + ++ L D + + + ++ + +N M L+++ H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM---HE 145
Query: 783 TPVIHCDLKPKNVF------------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827
++H D+KP+N+ DFG+ L D + T T + AP ++
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV--TTATAEFAAPEIV 200
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 96.4 bits (238), Expect = 3e-22
Identities = 75/315 (23%), Positives = 126/315 (40%), Gaps = 35/315 (11%)
Query: 55 TDQQALLALKAHISYDPTNLLAQNSTSNTSVCNWIGITCNVNS--HRVTALNISSLNLQG 112
D+QALL +K + +PT L + T++ W+G+ C+ ++ +RV L++S LNL
Sbjct: 6 QDKQALLQIKKDLG-NPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 113 --TIPPQLGNLSSLTTLNLSHN-KLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNL 169
IP L NL L L + L G IPP+I + +L +L +
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTN------------ 112
Query: 170 SSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFK 229
+ + + L L + N G +P ++S L +
Sbjct: 113 -------------VSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159
Query: 230 KLSGAIPKEISNLTILRK-ISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIF 288
++SGAIP + + L +++ N+L G+IP L +
Sbjct: 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGS 219
Query: 289 NMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMG 348
+ +T K ++ +F LG N+ L+L NR GT+P +T L L++
Sbjct: 220 DKNTQKIHLAKNSL---AFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVS 276
Query: 349 TNSFSGIIPNTIGLT 363
N+ G IP L
Sbjct: 277 FNNLCGEIPQGGNLQ 291
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 85.2 bits (209), Expect = 1e-18
Identities = 78/285 (27%), Positives = 125/285 (43%), Gaps = 24/285 (8%)
Query: 337 TNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNC-NIGGS 395
T ++ LD+ + P +P+S+ NL L +YI N+ G
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYP-------------IPSSLANLP-YLNFLYIGGINNLVGP 92
Query: 396 IPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLN 455
IP I+ L+ L L + ++G+IP +++ L L +N L+G++P + L L
Sbjct: 93 IPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLV 152
Query: 456 TLGLAGNKFSGSIPSCLGNLTSLRS-PDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDG 514
+ GN+ SG+IP G+ + L + + NRLT +P TF N L F S ++
Sbjct: 153 GITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN--LNLAFVDLSRNMLE 210
Query: 515 PLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFG---YL 571
+ + N +G K+L + L N + G +P+ +L
Sbjct: 211 GDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFL 270
Query: 572 TELNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPNLQFPKC 616
LN+SFN L GEIP+GG F ++ N+ LCG P P C
Sbjct: 271 HSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 60.1 bits (144), Expect = 3e-10
Identities = 20/77 (25%), Positives = 36/77 (46%), Gaps = 2/77 (2%)
Query: 86 CNWIGITCNVNSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTM 145
+ S + L++ + + GT+P L L L +LN+S N L G+I P +
Sbjct: 232 SLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNL 290
Query: 146 HKLKFLDFSDNQ-LSGS 161
+ +++N+ L GS
Sbjct: 291 QRFDVSAYANNKCLCGS 307
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 50.1 bits (118), Expect = 5e-07
Identities = 17/70 (24%), Positives = 30/70 (42%), Gaps = 1/70 (1%)
Query: 122 SSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDK 181
+L L+L +N++ G +P + + L L+ S N L G + NL ++K
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG-NLQRFDVSAYANNK 302
Query: 182 LSGELPVNIC 191
P+ C
Sbjct: 303 CLCGSPLPAC 312
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.2 bits (236), Expect = 3e-22
Identities = 39/182 (21%), Positives = 59/182 (32%), Gaps = 32/182 (17%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLH----DGIEVAIKVFHQNCAM---ALKSFEAECEVMKN 727
+ +G GSFG V +G + VA+K + A+ F E M +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 728 IRHRNHVKRISSCSNEDFK----------ALDCLHSTNCSLNIFDKLNIMIDVASALEYL 777
+ HRN ++ K LD L + + VA + YL
Sbjct: 68 LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 778 HFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV--TIGYMAPG 825
S IH DL +N+ DFG+ R L + + + AP
Sbjct: 128 ---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 826 LL 827
L
Sbjct: 185 SL 186
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 95.3 bits (236), Expect = 4e-22
Identities = 40/172 (23%), Positives = 64/172 (37%), Gaps = 20/172 (11%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFH--QNCAMALKSFEAECEVMKNIRHRN 732
EK+ IG G++G VYK + + G A+K + + E ++K ++H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 733 HVKRISSCSNEDFKALDCLHSTNCSLNIFDKLN-------IMIDVASALEYLHFSHSTPV 785
VK + L H + D + L + + H V
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 786 IHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827
+H DLKP+N+ DFG+ R +VT+ Y AP +L
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH-EIVTLWYRAPDVL 172
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.4 bits (234), Expect = 6e-22
Identities = 39/178 (21%), Positives = 67/178 (37%), Gaps = 28/178 (15%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHD----GIEVAIKVFHQNCAMALKS-FEAECEVMKNIR 729
E+ IG G FG V++G + VAIK + +++ F E M+
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 730 HRNHVKRISSCSNEDF----------KALDCLHSTNCSLNIFDKLNIMIDVASALEYLHF 779
H + VK I + + L SL++ + +++AL YL
Sbjct: 67 HPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL-- 124
Query: 780 SHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827
S +H D+ +NV DFG+ R + ++ + I +MAP +
Sbjct: 125 -ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.3 bits (236), Expect = 9e-22
Identities = 37/182 (20%), Positives = 66/182 (36%), Gaps = 24/182 (13%)
Query: 670 LFRATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQ-NCAMALKSFEAECEVMKN 727
+F +++ + IG G++G V + + VAIK + E +++
Sbjct: 3 VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 62
Query: 728 IRHRNHVKRISSCSNEDFKALDCLHSTN--CSLNIFDKLN--------IMIDVASALEYL 777
RH N + + + ++ +++ L I + L L
Sbjct: 63 FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGL 122
Query: 778 HFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV--TIGYMAPG 825
+ HS V+H DLKP N+ DFG+ R+ D T T Y AP
Sbjct: 123 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 826 LL 827
++
Sbjct: 183 IM 184
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.5 bits (234), Expect = 1e-21
Identities = 40/179 (22%), Positives = 67/179 (37%), Gaps = 33/179 (18%)
Query: 680 ENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISS 739
+ IG G FG V++G+ G EVA+K+F + EAE +RH N + I++
Sbjct: 8 QESIGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAA 65
Query: 740 CSNEDFKALDCL-------------HSTNCSLNIFDKLNIMIDVASALEYLH-----FSH 781
+ ++ + ++ + + + + AS L +LH
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 782 STPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTET---LVTIGYMAPGLL 827
+ H DLK KN+ D G+ I + T YMAP +L
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 93.8 bits (232), Expect = 2e-21
Identities = 38/185 (20%), Positives = 62/185 (33%), Gaps = 36/185 (19%)
Query: 671 FRATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIR 729
R ++ IG GSFG +Y G + G EVAIK+ E ++ K ++
Sbjct: 3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQ 60
Query: 730 HRNHVKRISSCSNEDFK-----------ALDCLHSTNCSLNIFDKLNIMIDVASALEYLH 778
+ I C E D + + ++ L + + S +EY+H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 779 FSHSTPVIHCDLKPKNVF-------------DFGIGRLLTGDRSMIQ------TETLVTI 819
+ IH D+KP N DFG+ + R+ T
Sbjct: 121 SKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 820 GYMAP 824
Y +
Sbjct: 178 RYASI 182
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.4 bits (226), Expect = 1e-20
Identities = 39/202 (19%), Positives = 68/202 (33%), Gaps = 55/202 (27%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHD------GIEVAIKVFHQNC-AMALKSFEAECEVMKN 727
E ++G G+FG V + I+VA+K+ + + ++ +E ++M
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 728 I-RHRNHVKRISSCSNEDFKAL-----------DCLHSTN-------------------- 755
+ H N V + +C+ L + L S
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 756 --CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRL 803
L D L VA +E+L +H DL +NV DFG+ R
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 804 LTGDRSMIQTETLV-TIGYMAP 824
+ D + + + +MAP
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAP 235
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 89.8 bits (222), Expect = 3e-20
Identities = 37/181 (20%), Positives = 63/181 (34%), Gaps = 33/181 (18%)
Query: 674 TEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAM---ALKSFEAECEVMKNIR 729
++++ ++G G V+ R L +VA+KV + A F E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 730 HRNHVKRISSCSNEDFKA--------------LDCLHSTNCSLNIFDKLNIMIDVASALE 775
H V + E L + T + + ++ D AL
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125
Query: 776 YLHFSHSTPVIHCDLKPKN----------VFDFGIGRLLTGDRSMIQTETLV--TIGYMA 823
+ H +IH D+KP N V DFGI R + + + V T Y++
Sbjct: 126 FS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 824 P 824
P
Sbjct: 183 P 183
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 89.9 bits (222), Expect = 3e-20
Identities = 29/183 (15%), Positives = 56/183 (30%), Gaps = 38/183 (20%)
Query: 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNH 733
+ IG GSFG +++G L + +VAIK + E K +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTG 62
Query: 734 VKRISSCSNED-----------FKALDCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHS 782
+ + E D L ++ + + ++ +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS- 121
Query: 783 TPVIHCDLKPKNVF---------------DFGIGRLLTGDRS-----MIQTETLV-TIGY 821
+++ D+KP N DFG+ + + + + L T Y
Sbjct: 122 --LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 822 MAP 824
M+
Sbjct: 180 MSI 182
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 89.8 bits (222), Expect = 4e-20
Identities = 38/177 (21%), Positives = 66/177 (37%), Gaps = 31/177 (17%)
Query: 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAM---ALKSFEAECEVMKNIRH 730
+ F +G GSFG V+ R H+G A+KV + + ++ E ++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 731 RNHVKRISSCSNEDF----------KALDCLHSTNCSLNIFDKLNIMIDVASALEYLHFS 780
++ + + L L + +V ALEYLH
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH-- 121
Query: 781 HSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827
S +I+ DLKP+N+ DFG + + + T Y+AP ++
Sbjct: 122 -SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG----TPDYIAPEVV 173
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.5 bits (221), Expect = 5e-20
Identities = 35/200 (17%), Positives = 74/200 (37%), Gaps = 50/200 (25%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLH------DGIEVAIKVFHQNCAMA-LKSFEAECEVMKN 727
+ S +G G+FG V + + + VA+K+ + + ++ +E +V+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 728 I-RHRNHVKRISSCSNEDFKAL----------------------------DCLHSTNCSL 758
+ H N V + +C+ + + +L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 759 NIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808
++ D L+ VA + +L S IH DL +N+ DFG+ R + D
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 809 S-MIQTETLVTIGYMAPGLL 827
+ +++ + + +MAP +
Sbjct: 200 NYVVKGNARLPVKWMAPESI 219
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.9 bits (219), Expect = 6e-20
Identities = 42/173 (24%), Positives = 71/173 (41%), Gaps = 21/173 (12%)
Query: 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFH--QNCAMALKSFEAECEVMKNIRHR 731
+K+ K IG G++G+V+K + VA+K + S E ++K ++H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 732 NHVKRISSCSNEDFKALDCLHSTNCSLNIFDKLNIMID-------VASALEYLHFSHSTP 784
N V+ ++ L FD N +D + L+ L F HS
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 785 VIHCDLKPKN----------VFDFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827
V+H DLKP+N + +FG+ R + +VT+ Y P +L
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-YSAEVVTLWYRPPDVL 173
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 88.4 bits (218), Expect = 9e-20
Identities = 40/214 (18%), Positives = 67/214 (31%), Gaps = 55/214 (25%)
Query: 666 SYQDLFRATEKFSKENLIGVGSFGSVYKGRL------HDGIEVAIKVFHQNCAM-ALKSF 718
L IG G+FG V++ R VA+K+ + + F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 719 EAECEVMKNIRHRNHVKRISSCSNEDFKAL-----------DCLHSTNCS---------- 757
+ E +M + N VK + C+ L + L S +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 758 -------------LNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------- 796
L+ ++L I VA+ + YL +H DL +N
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVK 180
Query: 797 --DFGIGRLL-TGDRSMIQTETLVTIGYMAPGLL 827
DFG+ R + + D + I +M P +
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESI 214
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.3 bits (218), Expect = 1e-19
Identities = 34/191 (17%), Positives = 64/191 (33%), Gaps = 33/191 (17%)
Query: 665 FSYQDLFRATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFH------QNCAMALKS 717
F +++ + + +G G F V K R G++ A K ++ +
Sbjct: 3 FRQENV---DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 59
Query: 718 FEAECEVMKNIRHRNHVKRISSCSNEDFKAL-------DCLHSTNCSLNIFDKLNIMIDV 770
E E ++K I+H N + N+ L L + +
Sbjct: 60 IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 119
Query: 771 ASALEYLHFSHSTPVIHCDLKPKNVF--------------DFGIGRLLTGDRSMIQTETL 816
L +++ HS + H DLKP+N+ DFG+ +
Sbjct: 120 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIF 177
Query: 817 VTIGYMAPGLL 827
T ++AP ++
Sbjct: 178 GTPEFVAPEIV 188
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.1 bits (220), Expect = 1e-19
Identities = 38/174 (21%), Positives = 66/174 (37%), Gaps = 22/174 (12%)
Query: 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMA---LKSFEAECEVMKNIRH 730
F L+G G+FG V R G A+K+ + +A + E V++N RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 731 RNHVKRISSCSNEDFKALDCLHSTNCSL-------NIFDKLNIMIDVASALEYLHFSHST 783
+ D ++ L +F + A + L + HS
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 784 PVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827
V++ D+K +N+ DFG+ + D + ++T T Y+AP +L
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVL 177
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 89.7 bits (221), Expect = 1e-19
Identities = 86/388 (22%), Positives = 148/388 (38%), Gaps = 49/388 (12%)
Query: 99 RVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQL 158
+VT L L ++ +I + L++LT +N S+N+L+ P + + KL + ++NQ+
Sbjct: 45 QVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI 100
Query: 159 SGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKC 218
+ + L + + L L ++ +
Sbjct: 101 ADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLS 160
Query: 219 KRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNN 278
Q+ + K ++NLT L ++ + +N + + L NLE+L+ N
Sbjct: 161 FGNQVTD----------LKPLANLTTLERLDISSN--KVSDISVLAKLTNLESLIATNNQ 208
Query: 279 LVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITN 338
+ + P + ++ + ++ L N L +L SL N+ L+L N+ S P ++
Sbjct: 209 ISDITP--LGILTNLDELSLNGNQLKDIGTLA---SLTNLTDLDLANNQISNLAP--LSG 261
Query: 339 ASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQ 398
+KL L +G N S I P + L+ N
Sbjct: 262 LTKLTELKLGANQISNISP-----------------LAGLTALTNLELNENQLE---DIS 301
Query: 399 LISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLG 458
ISNL NL L L N ++ P L KLQ L+ NK+ S L +L +N L
Sbjct: 302 PISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKV--SDVSSLANLTNINWLS 357
Query: 459 LAGNKFSGSIPSCLGNLTSLRSPDLGSN 486
N+ S P L NLT + L
Sbjct: 358 AGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 83.5 bits (205), Expect = 1e-17
Identities = 84/381 (22%), Positives = 145/381 (38%), Gaps = 29/381 (7%)
Query: 202 LAKNMFHGQIPLA-LSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIP 260
L K + L + LQ LG K + G + L L +I+ NN+L P
Sbjct: 29 LGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSNNQLTDITP 83
Query: 261 HEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVER 320
+ L L ++++ N A I ++ + + L + +L N+ R
Sbjct: 84 --LKNLTKLVDILMNNNQ-----IADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 136
Query: 321 LNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIG-LTGNPLDGVLPTSIGNLS 379
L L N S + + + + T + V S+
Sbjct: 137 LELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKL 196
Query: 380 MSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNK 439
+LE++ +N I P I +NL L L GN+L T L L L L N+
Sbjct: 197 TNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQ 252
Query: 440 LAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNL 499
++ P L L +L L L N+ S P LT+L + +L N+L S NL
Sbjct: 253 ISNLAP--LSGLTKLTELKLGANQISNISPLA--GLTALTNLELNENQLED--ISPISNL 306
Query: 500 KDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNG 559
K++ + L N++ + +L + + + N S S++ +L ++ +S N
Sbjct: 307 KNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQ 362
Query: 560 LEGLIP-ESFGYLTELNLSFN 579
+ L P + +T+L L+
Sbjct: 363 ISDLTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 75.4 bits (184), Expect = 5e-15
Identities = 42/212 (19%), Positives = 79/212 (37%), Gaps = 15/212 (7%)
Query: 66 HISYDPTNLLAQNSTSNTSVCNWIGITCNVNSHRVTALNISSLNLQGTIPPQLGNLSSLT 125
L + + IT + L+++ L+ L +L++LT
Sbjct: 187 VSDISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLT 244
Query: 126 TLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGE 185
L+L++N++S P + + KL L NQ+S L+ + + +
Sbjct: 245 DLDLANNQISNLAP--LSGLTKLTELKLGANQISNI-----SPLAGLTALTNLELNENQL 297
Query: 186 LPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTIL 245
++ + L L L L N P+ S +LQ L K+S ++NLT +
Sbjct: 298 EDISPISNLKNLTYLTLYFNNISDISPV--SSLTKLQRLFFANNKVSD--VSSLANLTNI 353
Query: 246 RKISLRNNKLRGEIPHEIGYLPNLENLVLGFN 277
+S +N++ P + L + L L
Sbjct: 354 NWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 71.2 bits (173), Expect = 1e-13
Identities = 60/387 (15%), Positives = 123/387 (31%), Gaps = 43/387 (11%)
Query: 168 NLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLG 227
L+ + L ++ + + + L+ L G + L +N
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 74
Query: 228 FKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAI 287
+L+ P + NLT L I + NN++ P L + +
Sbjct: 75 NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 288 FNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDM 347
+ + S G+ + + + + +
Sbjct: 133 NLNRLELSSNTISDI---SALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD 189
Query: 348 GTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLL 407
+ ++ T N + + P I +L+ + ++ + +++L+NL
Sbjct: 190 ISVLAKLTNLESLIATNNQISDITPLGI---LTNLDELSLNGNQLKD--IGTLASLTNLT 244
Query: 408 LLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIP--------------------DQ 447
LDL N+++ P L KL L L N+++ P
Sbjct: 245 DLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISP 302
Query: 448 LCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDL 507
+ +L L L L N S P + +LT L+ +N+++ S+ NL +I +
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSA 358
Query: 508 SSNSLDGPLSLDIGNLRVVIGINLSRN 534
N + L NL + + L+
Sbjct: 359 GHNQISDLTPL--ANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 43.8 bits (102), Expect = 5e-05
Identities = 60/335 (17%), Positives = 104/335 (31%), Gaps = 51/335 (15%)
Query: 289 NMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMG 348
++ K L ++ + S L V L + + L ++
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT---DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFS 74
Query: 349 TNSFSGIIP--NTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNL 406
N + I P N L ++ I L+ ++ N + + NL+NL
Sbjct: 75 NNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 407 LLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFN-----------------KLAGSIPDQLC 449
L+L N ++ ++ + S L
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194
Query: 450 HLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSS 509
L L +L N+ S P LT+L L N+L T +L ++ DL++
Sbjct: 195 KLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLAN 250
Query: 510 NSLDGPLSLDIGNLRVVIGINLSRNNFSGDIP--------------------STIGDLKD 549
N + L L + + L N S P S I +LK+
Sbjct: 251 NQISNLAPL--SGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKN 308
Query: 550 LQNISLACNGLEGLIP-ESFGYLTELNLSFNKLEG 583
L ++L N + + P S L L + NK+
Sbjct: 309 LTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSD 343
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 38.4 bits (88), Expect = 0.003
Identities = 14/68 (20%), Positives = 28/68 (41%), Gaps = 7/68 (10%)
Query: 522 NLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFGY---LTELNLSF 578
L + L + N + + + DL + + G++ + + Y LT++N S
Sbjct: 20 ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 75
Query: 579 NKLEGEIP 586
N+L P
Sbjct: 76 NQLTDITP 83
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.2 bits (214), Expect = 2e-19
Identities = 60/268 (22%), Positives = 92/268 (34%), Gaps = 16/268 (5%)
Query: 316 PNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSI 375
+R+ L NR S + L L + +N + I
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFT-------------- 77
Query: 376 GNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYL 435
L++ + N + P L L L L+ L P F L LQ LYL
Sbjct: 78 -GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYL 136
Query: 436 PFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPST 495
N L D L L L L GN+ S L SL L NR+ V P
Sbjct: 137 QDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196
Query: 496 FWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISL 555
F +L ++ L +N+L + + LR + + L+ N + D + LQ
Sbjct: 197 FRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRG 255
Query: 556 ACNGLEGLIPESFGYLTELNLSFNKLEG 583
+ + + +P+ L+ N L+G
Sbjct: 256 SSSEVPCSLPQRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.4 bits (186), Expect = 9e-16
Identities = 51/297 (17%), Positives = 89/297 (29%), Gaps = 24/297 (8%)
Query: 122 SSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDK 181
T + L +P I + + N++S ++ ++ + L S+
Sbjct: 11 EPKVTTSCPQQGLQ-AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV 67
Query: 182 LSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISN 241
L+ ++ P RL L+L L P
Sbjct: 68 LARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRG 127
Query: 242 LTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDN 301
L L+ + L++N L+ L NL +L L N + V A + ++ ++ L N
Sbjct: 128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN 187
Query: 302 SLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIG 361
+ L + L L N S + L YL + N +
Sbjct: 188 RVAHVHPHAFR-DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR---- 242
Query: 362 LTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTG 418
L L+ S+ + S+P L+ L L N L G
Sbjct: 243 -------------ARPLWAWLQKFRGSSSEVPCSLP---QRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.4 bits (160), Expect = 2e-12
Identities = 54/237 (22%), Positives = 81/237 (34%), Gaps = 4/237 (1%)
Query: 377 NLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLP 436
+ + + I++ I NL +L L N L F L L+ L L
Sbjct: 29 GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88
Query: 437 FNKLAGSI-PDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPST 495
N S+ P L RL+TL L P L +L+ L N L ++ T
Sbjct: 89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT 148
Query: 496 FWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISL 555
F +L ++ L N + L + + L +N + P DL L + L
Sbjct: 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208
Query: 556 ACNGLEGLIPESFG---YLTELNLSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLP 609
N L L E+ L L L+ N + +A +E C LP
Sbjct: 209 FANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLP 265
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.8 bits (130), Expect = 1e-08
Identities = 39/217 (17%), Positives = 69/217 (31%), Gaps = 2/217 (0%)
Query: 75 LAQNSTSNTSVCNWIGITCNVNSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKL 134
L + + + + L+ P L L TL+L L
Sbjct: 58 LTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL 117
Query: 135 SGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYL 194
P + L++L DN L +L ++ + L +++S +P L
Sbjct: 118 QELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS-VPERAFRGL 176
Query: 195 HYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNK 254
H L L L +N P A RL L L LS + ++ L L+ + L +N
Sbjct: 177 HSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNP 236
Query: 255 LRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMS 291
+ L+ + + +P +
Sbjct: 237 WVCDC-RARPLWAWLQKFRGSSSEVPCSLPQRLAGRD 272
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.9 bits (112), Expect = 2e-06
Identities = 30/193 (15%), Positives = 58/193 (30%), Gaps = 27/193 (13%)
Query: 88 WIGITCNVNSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHK 147
+ R+ L++ LQ P L++L L L N L + +
Sbjct: 95 SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGN 154
Query: 148 LKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHY----------- 196
L L N++S L S+ + L ++++ P +
Sbjct: 155 LTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS 214
Query: 197 ------------LKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTI 244
L+ L L N + LQ ++ ++P+ ++ +
Sbjct: 215 ALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAGRDL 273
Query: 245 LRKISLRNNKLRG 257
L N L+G
Sbjct: 274 K---RLAANDLQG 283
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.5 bits (216), Expect = 2e-19
Identities = 38/175 (21%), Positives = 65/175 (37%), Gaps = 33/175 (18%)
Query: 680 ENLIGVGSFGSVYKGRLHD----GIEVAIKVFHQNCAMA-LKSFEAECEVMKNIRHRNHV 734
+IG G FG VY G L D I A+K ++ + + F E +MK+ H N +
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 735 KRISSCSNEDFKAL------------DCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHS 782
+ C + L + + + + + D + + VA + F S
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG---MKFLAS 148
Query: 783 TPVIHCDLKPKNVF----------DFGIGRLLTG---DRSMIQTETLVTIGYMAP 824
+H DL +N DFG+ R + D +T + + +MA
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.9 bits (217), Expect = 3e-19
Identities = 40/182 (21%), Positives = 68/182 (37%), Gaps = 40/182 (21%)
Query: 677 FSKENLIGVGSFGSVYKGRLHD-GIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVK 735
++ +IG GSFG VY+ +L D G VAIK Q+ + E ++M+ + H N V+
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVR 77
Query: 736 RISS-------------------CSNEDFKALDCLHSTNCSLNIFDKLNIMIDVASALEY 776
++ +L + M + +L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 777 LHFSHSTPVIHCDLKPKN-----------VFDFGIGRLLTGDRSMIQTETLVTIGYMAPG 825
+ HS + H D+KP+N + DFG + L + + + Y AP
Sbjct: 138 I---HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRAPE 192
Query: 826 LL 827
L+
Sbjct: 193 LI 194
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.5 bits (213), Expect = 5e-19
Identities = 40/191 (20%), Positives = 69/191 (36%), Gaps = 41/191 (21%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLH------DGIEVAIKVFHQNCAM-ALKSFEAECEVMKN 727
EK + +G GSFG VY+G VAIK ++ +M F E VMK
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 728 IRHRNHVKRISSCSNEDFKALDCLHSTNCSLNIFDK--------------------LNIM 767
+ V+ + S + T L + + + +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 768 IDVASALEYLHFSHSTPVIHCDLKPKN----------VFDFGIGRLLT-GDRSMIQTETL 816
++A + YL ++ +H DL +N + DFG+ R + D + L
Sbjct: 140 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 817 VTIGYMAPGLL 827
+ + +M+P L
Sbjct: 197 LPVRWMSPESL 207
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.9 bits (212), Expect = 1e-18
Identities = 34/181 (18%), Positives = 66/181 (36%), Gaps = 33/181 (18%)
Query: 668 QDLFRATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMK 726
++L+ EK+ +G G FG V++ K + E ++
Sbjct: 1 KELY---EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILN 56
Query: 727 NIRHRNHVKRISSCSNEDFKAL-----------DCLHSTNCSLNIFDKLNIMIDVASALE 775
RHRN + S + + + + ++++ LN + ++ + V AL+
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 776 YLHFSHSTPVIHCDLKPKNV------------FDFGIGRLLTGDRSMIQTETLVTIGYMA 823
+L HS + H D++P+N+ +FG R L + Y A
Sbjct: 117 FL---HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYA 171
Query: 824 P 824
P
Sbjct: 172 P 172
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.3 bits (210), Expect = 1e-18
Identities = 45/189 (23%), Positives = 73/189 (38%), Gaps = 38/189 (20%)
Query: 672 RATEKFSKENLIGVGSFGSVYKGR--LHDGIEVAIKVFHQNCA--MALKSFEAECEVMKN 727
RA +++ IG G++G V+K R + G VA+K S E V+++
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 728 I---RHRNHVKRISSCSNEDFKALDCL----------------HSTNCSLNIFDKLNIMI 768
+ H N V+ C+ L + ++M
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 769 DVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVT 818
+ L++LH S V+H DLKP+N+ DFG+ R+ M T +VT
Sbjct: 124 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVT 178
Query: 819 IGYMAPGLL 827
+ Y AP +L
Sbjct: 179 LWYRAPEVL 187
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.1 bits (207), Expect = 2e-18
Identities = 38/173 (21%), Positives = 64/173 (36%), Gaps = 30/173 (17%)
Query: 681 NLIGVGSFGSVYKGR-LHDGIEVAIKVFH-----QNCAMALKSFEAECEVMKNIRHRNHV 734
+ +G G F +VYK R + VAIK + ++ E ++++ + H N +
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 735 KRISSCSNEDF----------KALDCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHSTP 784
+ + ++ + + L M+ LEYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHW 120
Query: 785 VIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827
++H DLKP N+ DFG+ + T +VT Y AP LL
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-YTHQVVTRWYRAPELL 172
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.8 bits (206), Expect = 4e-18
Identities = 45/177 (25%), Positives = 66/177 (37%), Gaps = 28/177 (15%)
Query: 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAM--ALKSFEAECEVMKNIRHR 731
E F K IG G++G VYK R G VA+K + + E ++K + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 732 NHVKRISSCSNEDFKALDCLHSTNCSLNIFDK-----------LNIMIDVASALEYLHFS 780
N VK + E+ L D + + + L +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC--- 118
Query: 781 HSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827
HS V+H DLKP+N+ DFG+ R T +VT+ Y AP +L
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEIL 174
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 83.9 bits (207), Expect = 4e-18
Identities = 38/179 (21%), Positives = 63/179 (35%), Gaps = 30/179 (16%)
Query: 674 TEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAM-ALKSFEAECEVMKNIRHR 731
+ + +++G G+F V VAIK + S E E V+ I+H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 732 NHVKRISSCSNEDF----------KALDCLHSTNCSLNIFDKLNIMIDVASALEYLHFSH 781
N V + L D ++ V A++YL H
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL---H 124
Query: 782 STPVIHCDLKPKNVF-------------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827
++H DLKP+N+ DFG+ ++ + + T GY+AP +L
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL--STACGTPGYVAPEVL 181
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.7 bits (206), Expect = 7e-18
Identities = 38/190 (20%), Positives = 76/190 (40%), Gaps = 30/190 (15%)
Query: 665 FSYQDLFRAT----EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCA--MALKS 717
F Q++ + + +G G++G+V G +VAIK ++ + K
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 718 FEAECEVMKNIRHRNHVKRISSCSNED--------FKALDCLHSTNCSLNIFDKLN---- 765
E ++K++RH N + + + ++ + + + + L +KL
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 766 --IMIDVASALEYLHFSHSTPVIHCDLKPKNVFDFGIGRLLTGDRSMIQ------TETLV 817
++ + L Y+H + +IH DLKP N+ L D + + T +V
Sbjct: 124 QFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVV 180
Query: 818 TIGYMAPGLL 827
T Y AP ++
Sbjct: 181 TRWYRAPEVI 190
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.8 bits (206), Expect = 7e-18
Identities = 37/190 (19%), Positives = 67/190 (35%), Gaps = 30/190 (15%)
Query: 665 FSYQDL----FRATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCA--MALKS 717
F Q+L + E++ + +G G++GSV G+ VA+K + + K
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 718 FEAECEVMKNIRHRNHVKRISSCSNEDFKALDCL--------------HSTNCSLNIFDK 763
E ++K+++H N + + + L
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV 123
Query: 764 LNIMIDVASALEYLHFSHSTPVIHCDLKPKNVFDFGIGRLLTGDR------SMIQTETLV 817
++ + L+Y+ HS +IH DLKP N+ L D T +
Sbjct: 124 QFLIYQILRGLKYI---HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA 180
Query: 818 TIGYMAPGLL 827
T Y AP ++
Sbjct: 181 TRWYRAPEIM 190
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.2 bits (202), Expect = 1e-17
Identities = 34/199 (17%), Positives = 66/199 (33%), Gaps = 49/199 (24%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLH------DGIEVAIKVFHQNCAMA-LKSFEAECEVMKN 727
++ +G G+FG V + VA+K+ + + ++ +E +++ +
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 728 IRHRNHVKRISSCSNEDFKAL-------------DCLHSTNCS---------------LN 759
I H +V + + L L S L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 760 IFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809
+ + VA +E+L S IH DL +N+ DFG+ R + D
Sbjct: 133 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 810 MIQTETLV-TIGYMAPGLL 827
++ + +MAP +
Sbjct: 190 YVRKGDARLPLKWMAPETI 208
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.1 bits (202), Expect = 2e-17
Identities = 31/178 (17%), Positives = 59/178 (33%), Gaps = 29/178 (16%)
Query: 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAM---ALKSFEAECEVM-KNIR 729
E F ++G GSFG V+ AIK ++ + ++ E V+
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 730 HRNHVKRISSCSNEDFKALDCLHSTNCSL----------NIFDKLNIMIDVASALEYLHF 779
H + ++ + L ++ ++ L++LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 780 SHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827
+++ DLK N+ DFG+ + + T T Y+AP +L
Sbjct: 122 KG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEIL 175
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.8 bits (201), Expect = 2e-17
Identities = 41/194 (21%), Positives = 70/194 (36%), Gaps = 46/194 (23%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHDG---IEVAIKVFHQNCAM-ALKSFEAECEVMKNI-R 729
+++IG G+FG V K R+ ++ AIK + + + F E EV+ +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 730 HRNHVKRISSCSNEDF--------------------------KALDCLHSTNCSLNIFDK 763
H N + + +C + + A +ST +L+
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 764 LNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQT 813
L+ DVA ++YL IH DL +N+ DFG+ R T
Sbjct: 130 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--T 184
Query: 814 ETLVTIGYMAPGLL 827
+ + +MA L
Sbjct: 185 MGRLPVRWMAIESL 198
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.8 bits (201), Expect = 2e-17
Identities = 37/175 (21%), Positives = 65/175 (37%), Gaps = 26/175 (14%)
Query: 675 EKFSKENLIGVGSFGSVYKGRL----HDGIEVAIKVFHQ----NCAMALKSFEAECEVMK 726
E F ++G G++G V+ R G A+KV + A + E +V++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 727 NIRHRNHVKRI-SSCSNEDFKALDCLHSTNCSL-------NIFDKLNIMIDVASALEYLH 778
+IR + + + E L + L F + + I V + L
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 779 FSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMA 823
H +I+ D+K +N+ DFG+ + D + + TI YMA
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 198
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 80.9 bits (199), Expect = 2e-17
Identities = 32/181 (17%), Positives = 62/181 (34%), Gaps = 36/181 (19%)
Query: 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFH---------QNCAMALKSFEAECEV 724
E + + ++G G V + E A+K+ + ++ E ++
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 725 MKNIR-HRNHVKRISSCSNEDF----------KALDCLHSTNCSLNIFDKLNIMIDVASA 773
++ + H N ++ + F L + +L+ + IM +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 774 LEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMA 823
+ L H ++H DLKP+N+ DFG L + E T Y+A
Sbjct: 123 ICAL---HKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSYLA 177
Query: 824 P 824
P
Sbjct: 178 P 178
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.5 bits (200), Expect = 2e-17
Identities = 43/187 (22%), Positives = 69/187 (36%), Gaps = 31/187 (16%)
Query: 672 RATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFH--QNCAMALKSFEAECEVMKNI 728
K+ K IG G+FG V+K R G +VA+K + E ++++ +
Sbjct: 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66
Query: 729 RHRNHVKRISSCSNEDFKALDC---------------LHSTNCSLNIFDKLNIMIDVASA 773
+H N V I C + C + L F I +
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126
Query: 774 LEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS---MIQTETLVTIG 820
L L++ H ++H D+K NV DFG+ R + ++ T +VT+
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 821 YMAPGLL 827
Y P LL
Sbjct: 187 YRPPELL 193
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.5 bits (198), Expect = 3e-17
Identities = 37/183 (20%), Positives = 62/183 (33%), Gaps = 37/183 (20%)
Query: 676 KFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMA------LKSFEAECEVMKNI 728
++ L+G G FGSVY G + D + VAIK ++ E ++K +
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 729 R--HRNHVKRISSCSNEDFKA-----------LDCLHSTNCSLNIFDKLNIMIDVASALE 775
++ + D L + +L + V A+
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 776 YLHFSHSTPVIHCDLKPKNVF-----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
+ H+ V+H D+K +N+ DFG G LL T+ T Y P
Sbjct: 125 HC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPP 178
Query: 825 GLL 827
+
Sbjct: 179 EWI 181
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 81.7 bits (201), Expect = 4e-17
Identities = 30/170 (17%), Positives = 53/170 (31%), Gaps = 30/170 (17%)
Query: 675 EKFSKENLIGVGSFGSVYKGRLHD-GIEVAIKVFH------QNCAMALKSFEAECEVMKN 727
FS +IG G FG VY R D G A+K + + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 728 IRHRNHVKRISSCSNED--FKALDCLHSTNCSLNIFDK--------LNIMIDVASALEYL 777
V + D LD ++ + ++ ++ LE++
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 778 HFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLV 817
H+ V++ DLKP N+ D G+ + + T
Sbjct: 124 ---HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG 170
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.5 bits (195), Expect = 9e-17
Identities = 40/200 (20%), Positives = 73/200 (36%), Gaps = 50/200 (25%)
Query: 675 EKFSKENLIGVGSFGSVYKGRL--------HDGIEVAIKVFHQNCAM-ALKSFEAECEVM 725
++ +G G+FG V + +VA+K+ + L +E E+M
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 726 KNI-RHRNHVKRISSCSNEDFKAL--------------------------DCLHSTNCSL 758
K I +H+N + + +C+ + + + H+ L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 759 NIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKN----------VFDFGIGRLLTGDR 808
+ D ++ VA +EYL S IH DL +N + DFG+ R +
Sbjct: 133 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 809 SMIQTET-LVTIGYMAPGLL 827
+T + + +MAP L
Sbjct: 190 YYKKTTNGRLPVKWMAPEAL 209
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 76.7 bits (188), Expect = 1e-16
Identities = 19/149 (12%), Positives = 40/149 (26%), Gaps = 31/149 (20%)
Query: 681 NLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCA------------------MALKSFEAEC 722
L+G G +V+ E +K +A++S E
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 723 EVMKNIRHRNHVKRISSCSNEDFKALDCLHSTNCSLNIFDKLNIMIDVASALEYLHFSHS 782
++ ++ K + N L + + ++ + + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV-RVENPDEVLDMILEEVAKF---YH 121
Query: 783 TPVIHCDLKPKNVF---------DFGIGR 802
++H DL NV DF
Sbjct: 122 RGIVHGDLSQYNVLVSEEGIWIIDFPQSV 150
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 79.8 bits (196), Expect = 2e-16
Identities = 27/136 (19%), Positives = 48/136 (35%), Gaps = 17/136 (12%)
Query: 675 EKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALK---SFEAECEVMKNIRH 730
++F + +G GSFG V + G A+K+ + + LK E +++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 731 RNHVKRISSCSNEDFKA----------LDCLHSTNCSLNIFDKLNIMIDVASALEYLHFS 780
VK S + + + + EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-- 158
Query: 781 HSTPVIHCDLKPKNVF 796
S +I+ DLKP+N+
Sbjct: 159 -SLDLIYRDLKPENLL 173
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.6 bits (195), Expect = 2e-16
Identities = 38/180 (21%), Positives = 63/180 (35%), Gaps = 31/180 (17%)
Query: 671 FRATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCA--MALKSFEAECEVMKN 727
F +++ IG G+ G V VAIK + K E +MK
Sbjct: 13 FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC 72
Query: 728 IRHRNHVKRISSCSNED-------------FKALDCLHSTNCSLNIFDKLNIMIDVASAL 774
+ H+N + ++ + + + L+ ++ + +
Sbjct: 73 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 132
Query: 775 EYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
++L HS +IH DLKP N+ DFG+ R M T +VT Y AP
Sbjct: 133 KHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYYRAP 187
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.8 bits (191), Expect = 5e-16
Identities = 32/179 (17%), Positives = 59/179 (32%), Gaps = 41/179 (22%)
Query: 680 ENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNI-RHRNHVKRI 737
++G+G G V + + A+K+ E E+ + + V+ +
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIV 71
Query: 738 SSCSNEDFKA---------------LDCLHS-TNCSLNIFDKLNIMIDVASALEYLHFSH 781
N + + + + IM + A++YLH
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--- 128
Query: 782 STPVIHCDLKPKNVF-------------DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827
S + H D+KP+N+ DFG + T S+ T Y+AP +L
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVL 185
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 76.8 bits (188), Expect = 1e-15
Identities = 26/176 (14%), Positives = 61/176 (34%), Gaps = 30/176 (17%)
Query: 671 FRATEKFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIR 729
+ + + +G G + V++ + + +V +K+ K + E ++++N+R
Sbjct: 31 WGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLR 87
Query: 730 -HRNHVKRISSCSNEDFKALDC---------LHSTNCSLNIFDKLNIMIDVASALEYLHF 779
N + + + +L +D M ++ AL+Y H
Sbjct: 88 GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHS 147
Query: 780 SHSTPVIHCDLKPKNVF-----------DFGIGRLLTGDRSMIQTETLVTIGYMAP 824
++H D+KP NV D+G+ + + + + P
Sbjct: 148 MG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGP 198
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 73.9 bits (180), Expect = 7e-15
Identities = 45/262 (17%), Positives = 82/262 (31%), Gaps = 40/262 (15%)
Query: 377 NLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLP 436
+L + + N I NL NL L L NK++ P F L KL+ LYL
Sbjct: 28 DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87
Query: 437 FNKLAGSIPDQLCH------------------------LARLNTLGLAGNKFSGSIPSCL 472
N+L +P+++ + LG K SG
Sbjct: 88 KNQL-KELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 146
Query: 473 GNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLS 532
+ L + +T++ +L ++ L N + + + L + + LS
Sbjct: 147 QGMKKLSYIRIADTNITTIPQGLPPSLTEL---HLDGNKITKVDAASLKGLNNLAKLGLS 203
Query: 533 RNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFG--YLTELNLSFNKLEGEIPRGGP 590
N+ S ++ + L+ + L N L + Y+ + L N +
Sbjct: 204 FNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNIS-------- 255
Query: 591 FANFTAKSFMGNEKLCGLPNLQ 612
+ F +
Sbjct: 256 --AIGSNDFCPPGYNTKKASYS 275
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 72.4 bits (176), Expect = 2e-14
Identities = 52/279 (18%), Positives = 100/279 (35%), Gaps = 27/279 (9%)
Query: 316 PNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIG---------LTGNP 366
P+ L+L N+ + N L L + N S I P L+ N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 367 LDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEG--NKLTGSIPVTF 424
L + + +L+ + + I + + L+ +++++L K +G F
Sbjct: 91 LKELPE----KMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 146
Query: 425 GRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLG 484
++KL + + + +IP L L L L GNK + + L L +L L
Sbjct: 147 QGMKKLSYIRIADTNI-TTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLS 203
Query: 485 SNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSG------ 538
N +++V + N + L++N L + + + + + L NN S
Sbjct: 204 FNSISAVDNGSLANTPHLRELHLNNNKLVKVPG-GLADHKYIQVVYLHNNNISAIGSNDF 262
Query: 539 DIPSTIGDLKDLQNISLACNGLE--GLIPESFGYLTELN 575
P +SL N ++ + P +F +
Sbjct: 263 CPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRA 301
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 71.2 bits (173), Expect = 6e-14
Identities = 55/291 (18%), Positives = 102/291 (35%), Gaps = 24/291 (8%)
Query: 86 CNWIGITCNVNSHR---------VTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSG 136
C+ + C+ L++ + + NL +L TL L +NK+S
Sbjct: 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 137 DIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHY 196
P + + KL+ L S NQL + L + + K+ +
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVF--NGLNQMI 127
Query: 197 LKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLR 256
+ L G A K+L + + ++ +LT L L NK+
Sbjct: 128 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTEL---HLDGNKIT 184
Query: 257 GEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLP 316
+ L NL L L FN++ V ++ N +++++L +N L G
Sbjct: 185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL--VKVPGGLADHK 242
Query: 317 NVERLNLGLNRFSG------TIPSFITNASKLVYLDMGTN--SFSGIIPNT 359
++ + L N S P + T + + + +N + I P+T
Sbjct: 243 YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPST 293
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 73.9 bits (180), Expect = 1e-14
Identities = 26/148 (17%), Positives = 57/148 (38%), Gaps = 30/148 (20%)
Query: 676 KFSKENLIGVGSFGSVYKGR-LHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHV 734
++ +G G F +V+ + + + VA+K+ + + ++ E E ++++ + ++
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNT 72
Query: 735 KRISSCSNEDFKALDC--------------------------LHSTNCSLNIFDKLNIMI 768
K S +N K LD + + + I
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 769 DVASALEYLHFSHSTPVIHCDLKPKNVF 796
+ L+Y+H +IH D+KP+NV
Sbjct: 133 QLLLGLDYMHRRCG--IIHTDIKPENVL 158
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.1 bits (131), Expect = 9e-09
Identities = 37/207 (17%), Positives = 70/207 (33%), Gaps = 8/207 (3%)
Query: 238 EISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIY 297
E+S + +++ L +P ++ + L L N L A + + + ++
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 298 LLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTN----SFS 353
L L G L ++ + L + V + T+ +
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 354 GIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEG 413
G+ LP + + LE + ++N N+ L++ L NL L L+
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 414 NKLTGSIPVTFGRLQKLQGLYLPFNKL 440
N L +IP F L +L N
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.7 bits (130), Expect = 1e-08
Identities = 47/209 (22%), Positives = 74/209 (35%), Gaps = 8/209 (3%)
Query: 96 NSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSD 155
+N NL +PP L T L+LS N L ++ +L L+
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 156 NQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLAL 215
+L+ T + LD+ + + L + ++ N AL
Sbjct: 65 AELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVL----DVSFNRLTSLPLGAL 120
Query: 216 SKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLG 275
LQ L L +L P ++ L K+SL NN L + L NL+ L+L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 276 FNNLVGVVPAAIFNMSTVKKIYLLDNSLL 304
N+L +P F + +L N L
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.1 bits (118), Expect = 4e-07
Identities = 42/203 (20%), Positives = 70/203 (34%), Gaps = 8/203 (3%)
Query: 381 SLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKL 440
S + N+ ++P + + +L L N L T +L L L +
Sbjct: 11 SHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE- 66
Query: 441 AGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLK 500
+ L L TL L+ N+ L +L D+ NRLTS+ L
Sbjct: 67 -LTKLQVDGTLPVLGTLDLSHNQLQSLPLLG-QTLPALTVLDVSFNRLTSLPLGALRGLG 124
Query: 501 DILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGL 560
++ L N L + + ++L+ NN + + L++L + L N L
Sbjct: 125 ELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184
Query: 561 EGLIPESFG--YLTELNLSFNKL 581
+ FG L L N
Sbjct: 185 YTIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.4 bits (111), Expect = 3e-06
Identities = 36/178 (20%), Positives = 58/178 (32%), Gaps = 6/178 (3%)
Query: 316 PNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGII-----PNTIGLTGNPLDGV 370
+ L+L N + + ++L L++ + + P L +
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQ 90
Query: 371 LPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKL 430
+G +L + +S + + L L L L+GN+L P KL
Sbjct: 91 SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKL 150
Query: 431 QGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRL 488
+ L L N L L L L+TL L N +IP L L N
Sbjct: 151 EKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.5 bits (106), Expect = 1e-05
Identities = 18/73 (24%), Positives = 27/73 (36%), Gaps = 1/73 (1%)
Query: 86 CNWIGITCNVNSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTM 145
+ + ++ L++++ NL L L +L TL L N L IP F
Sbjct: 136 LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGS 194
Query: 146 HKLKFLDFSDNQL 158
H L F N
Sbjct: 195 HLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.3 bits (90), Expect = 0.001
Identities = 38/209 (18%), Positives = 69/209 (33%), Gaps = 16/209 (7%)
Query: 168 NLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLG 227
++S L++ D L+ LP ++ +L L++N+ + L RL LNL
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDLPKDT---TILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 228 FKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAI 287
+L+ + +S + + + L L+ +L P
Sbjct: 64 RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSL----PLGA 119
Query: 288 FNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDM 347
+ L + L + G+ P +E+L+L N + + L L +
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179
Query: 348 GTNSFSGIIPN--------TIGLTGNPLD 368
NS I L GNP
Sbjct: 180 QENSLYTIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.5 bits (124), Expect = 1e-07
Identities = 21/94 (22%), Positives = 35/94 (37%), Gaps = 9/94 (9%)
Query: 386 YISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIP 445
I L +L L++ NKL +P RL++ L FN L +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHL-AEVP 320
Query: 446 DQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLR 479
+ +L +L+ + N P ++ LR
Sbjct: 321 ELPQNLKQLH---VEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.2 bits (118), Expect = 6e-07
Identities = 52/334 (15%), Positives = 96/334 (28%), Gaps = 25/334 (7%)
Query: 100 VTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLS 159
L +++L L ++P +L +L S N L+ ++P LK L +N L
Sbjct: 40 AHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK 91
Query: 160 GSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCK 219
+L +L+ S+ +LP + + + +P +L
Sbjct: 92 A-----LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIA 146
Query: 220 RLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNL 279
+L L + L E + + L
Sbjct: 147 AGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFL 206
Query: 280 VGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNA 339
+ + L+ + L LP + N
Sbjct: 207 TTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNL 266
Query: 340 SKLVYLDMGTNSFSGIIPN--TIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIP 397
L S + P+ + ++ N L LP L E + S ++ +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRL----ERLIASFNHLA-EVP 320
Query: 398 QLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQ 431
+L NL L +E N L P ++ L+
Sbjct: 321 ELPQNLKQL---HVEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.8 bits (104), Expect = 2e-05
Identities = 21/94 (22%), Positives = 33/94 (35%), Gaps = 12/94 (12%)
Query: 86 CNWIGITCNVNSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTM 145
+ + + LN+S+ L +P L L S N L+ ++P
Sbjct: 272 SSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHLA-EVPELP--- 323
Query: 146 HKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDS 179
LK L N L SV D+R++S
Sbjct: 324 QNLKQLHVEYNP----LREFPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.4 bits (103), Expect = 3e-05
Identities = 20/90 (22%), Positives = 35/90 (38%), Gaps = 9/90 (10%)
Query: 462 NKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIG 521
N S I S SL ++ +N+L LP+ L+ + S N L +
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERL---IASFNHLAE-VPELPQ 324
Query: 522 NLRVVIGINLSRNNFSGDIPSTIGDLKDLQ 551
NL+ +++ N P ++DL+
Sbjct: 325 NLKQ---LHVEYNPLRE-FPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.0 bits (94), Expect = 5e-04
Identities = 21/114 (18%), Positives = 40/114 (35%), Gaps = 10/114 (8%)
Query: 86 CNWIGITCNVNSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTM 145
+ + I SL LN+S+NKL ++P
Sbjct: 248 FLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP--- 303
Query: 146 HKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKV 199
+L+ L S N L+ + + NL + ++ + L E P + + L++
Sbjct: 304 PRLERLIASFNHLA-EVPELPQNLKQ---LHVEYNPLR-EFPDIPES-VEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.8 bits (91), Expect = 0.001
Identities = 13/94 (13%), Positives = 31/94 (32%), Gaps = 25/94 (26%)
Query: 315 LPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTS 374
P++E LN+ N+ +P+ L L N
Sbjct: 283 PPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHL--------------------AE 318
Query: 375 IGNLSMSLENIYISNCNIGGSIPQLISNLSNLLL 408
+ L +L+ +++ + P + ++ +L +
Sbjct: 319 VPELPQNLKQLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 9e-06
Identities = 34/219 (15%), Positives = 81/219 (36%), Gaps = 15/219 (6%)
Query: 219 KRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNN 278
+ G ++ + + ++L + +S + + YL NL L L N
Sbjct: 19 ANAIKIAAGKSNVTDTVTQ--ADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQ 74
Query: 279 LVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITN 338
+ + + + KI L+ S ++ L +++ L+L + + P +
Sbjct: 75 ITD-----LAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLS 129
Query: 339 ASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLS--MSLENIYISNCNIGGSI 396
+++YLD+ + + L + + + L+ L + + I
Sbjct: 130 NLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDIS 189
Query: 397 PQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYL 435
P +++L NL+ + L+ N+++ P L + L
Sbjct: 190 P--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.6 bits (96), Expect = 2e-04
Identities = 41/219 (18%), Positives = 76/219 (34%), Gaps = 11/219 (5%)
Query: 241 NLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLD 300
L KI+ + + + L + L + + + ++ + + L D
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 301 NSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTI 360
N + L +L + L L N + K + L + +
Sbjct: 73 NQITDLAPLK---NLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLS 129
Query: 361 GLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSI 420
L LD T+I L+ Y+S N S ++NLS L L + NK++
Sbjct: 130 NLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDIS 189
Query: 421 PVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGL 459
P L L ++L N+++ P L + + L + L
Sbjct: 190 P--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 36/212 (16%), Positives = 70/212 (33%), Gaps = 21/212 (9%)
Query: 100 VTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLS 159
+ N+ T+ +L +TTL+ ++ I + ++ L L+ DNQ++
Sbjct: 21 AIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQIT 76
Query: 160 GSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAK-------------NM 206
+ L++ + K + L + +
Sbjct: 77 DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYL 136
Query: 207 FHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYL 266
QI L L + ++NL+ L + +NK+ P + L
Sbjct: 137 DLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASL 194
Query: 267 PNLENLVLGFNNLVGVVPAAIFNMSTVKKIYL 298
PNL + L N + V P + N S + + L
Sbjct: 195 PNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 4e-04
Identities = 13/70 (18%), Positives = 28/70 (40%), Gaps = 4/70 (5%)
Query: 86 CNWIGITCNVNSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTM 145
+T N ++T L + P L +L +L ++L +N++S P +
Sbjct: 161 AQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANT 216
Query: 146 HKLKFLDFSD 155
L + ++
Sbjct: 217 SNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.003
Identities = 35/217 (16%), Positives = 69/217 (31%), Gaps = 19/217 (8%)
Query: 71 PTNLLAQNSTSNTSVCNWIGITCNVNSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLS 130
P LA N + +T L+ + TI + L++L L L
Sbjct: 14 PDPALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELK 71
Query: 131 HNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNI 190
N+++ P T L + + +++ + + L +D N+
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 191 CNYLHYLKVLFLAKNMFHGQI-------------PLALSKCKRLQLLNLGFKKLSGAIPK 237
L + + L+ +L L K+S P
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190
Query: 238 EISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVL 274
+++L L ++ L+NN++ P + NL + L
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.2 bits (101), Expect = 1e-05
Identities = 23/126 (18%), Positives = 44/126 (34%), Gaps = 12/126 (9%)
Query: 385 IYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSI 444
+++++ ++ ++ + L + LDL N+L P L+ L+ L N L
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59
Query: 445 PDQLCHLARLNTLGLAGNKF-SGSIPSCLGNLTSLRSPDLGSNRLTSV------LPSTFW 497
+ L L N+ + L + L +L N L L
Sbjct: 60 GVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 498 NLKDIL 503
++ IL
Sbjct: 118 SVSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.2 bits (96), Expect = 5e-05
Identities = 26/121 (21%), Positives = 44/121 (36%), Gaps = 8/121 (6%)
Query: 126 TLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGE 185
L+L+H L+ + + + + LD S N+L + L+++ + + +
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA----LAALRCLEVLQASDNAL 55
Query: 186 LPVNICNYLHYLKVLFLAKNMF-HGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTI 244
V+ L L+ L L N L C RL LLNL L L
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAE 114
Query: 245 L 245
+
Sbjct: 115 M 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.2 bits (88), Expect = 7e-04
Identities = 26/122 (21%), Positives = 55/122 (45%), Gaps = 6/122 (4%)
Query: 222 QLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVG 281
++L+L K L+ + + L ++ + L +N+LR P + L LE VL ++
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLE--VLQASDNAL 55
Query: 282 VVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASK 341
+ N+ ++++ L +N L S ++ +S P + LNL N ++
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAE 114
Query: 342 LV 343
++
Sbjct: 115 ML 116
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 44.0 bits (102), Expect = 2e-05
Identities = 41/168 (24%), Positives = 68/168 (40%), Gaps = 6/168 (3%)
Query: 395 SIPQLISNLSNLLLLDLEGNKLTGSIPVTF-GRLQKLQGLYLPFNKLAGSIPDQLCHLAR 453
IP+ I + L L N+L GRL L L L N+L G P+ +
Sbjct: 22 EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79
Query: 454 LNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLD 513
+ L L NK L L++ +L N+++ V+P +F +L + +L+SN +
Sbjct: 80 IQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139
Query: 514 GPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGD--LKDLQNISLACNG 559
L + +L+ PS + D +KDL + C+
Sbjct: 140 CNCHLA-WFAEWLRKKSLNGGAARCGAPSKVRDVQIKDLPHSEFKCSS 186
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 39.8 bits (91), Expect = 5e-04
Identities = 33/184 (17%), Positives = 63/184 (34%), Gaps = 7/184 (3%)
Query: 246 RKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLG 305
+ L+ EIP +I + L+L N L + +F L + L
Sbjct: 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 306 SFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIG---- 361
+++ L LG N+ +L L++ N S ++P +
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 362 LTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIP 421
LT L +L+ E + + N G + S + ++ + DL ++ S
Sbjct: 128 LTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQIKDLPHSEFKCSSE 187
Query: 422 VTFG 425
+ G
Sbjct: 188 NSEG 191
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 37.9 bits (86), Expect = 0.002
Identities = 19/112 (16%), Positives = 36/112 (32%), Gaps = 4/112 (3%)
Query: 384 NIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGS 443
+ + I ++ L L L+L N+++ +P +F L L L L +
Sbjct: 82 ELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNL-ASNPFNC 140
Query: 444 IPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPST 495
L L G PS + ++ DL + ++
Sbjct: 141 NCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQIK---DLPHSEFKCSSENS 189
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (101), Expect = 2e-05
Identities = 25/138 (18%), Positives = 41/138 (29%), Gaps = 10/138 (7%)
Query: 116 PQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQL-----SGSLSSVTFNLS 170
Q N L+L K+ I T+ + +DFSDN++ L + L
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLV 70
Query: 171 SVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKK 230
+ I + L LP L ++ L L L +L
Sbjct: 71 NNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLAS----LKSLTYLCILRNPVTN 126
Query: 231 LSGAIPKEISNLTILRKI 248
I + +R +
Sbjct: 127 KKHYRLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (95), Expect = 1e-04
Identities = 21/97 (21%), Positives = 31/97 (31%), Gaps = 3/97 (3%)
Query: 401 SNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLA 460
+N LDL G K+ I L + + N++ D L RL TL +
Sbjct: 15 TNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVN 71
Query: 461 GNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFW 497
N+ L L L +N L +
Sbjct: 72 NNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPL 108
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 2e-05
Identities = 13/86 (15%), Positives = 30/86 (34%), Gaps = 5/86 (5%)
Query: 379 SMSLENIYISNCNIGGS-IPQLISNLSNLLLLDLEGNKLTG----SIPVTFGRLQKLQGL 433
S+ ++++ I + + +L+ L ++ L+ LT I L L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 434 YLPFNKLAGSIPDQLCHLARLNTLGL 459
L N+L + + + +
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKI 86
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 3e-05
Identities = 14/69 (20%), Positives = 23/69 (33%), Gaps = 10/69 (14%)
Query: 103 LNISSLNLQGT------IPPQLGNLSSLTTLNLSHNKLSGD----IPPSIFTMHKLKFLD 152
L+I SL++Q L L + L L+ I ++ L L+
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 153 FSDNQLSGS 161
N+L
Sbjct: 62 LRSNELGDV 70
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 5e-05
Identities = 15/85 (17%), Positives = 33/85 (38%), Gaps = 9/85 (10%)
Query: 380 MSLENIYISNCNIGG----SIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQK-----L 430
L +++++C++ S+ + +L LDL N L + + + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 431 QGLYLPFNKLAGSIPDQLCHLARLN 455
+ L L + + D+L L +
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 3e-04
Identities = 13/84 (15%), Positives = 25/84 (29%), Gaps = 9/84 (10%)
Query: 86 CNWIGITCNVNSHRVTALNISSLNLQGT----IPPQLGNLSSLTTLNLSHNKLSGDIPPS 141
+ + L ++ ++ + + L SL L+LS+N L
Sbjct: 357 VRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQ 416
Query: 142 IFT-----MHKLKFLDFSDNQLSG 160
+ L+ L D S
Sbjct: 417 LVESVRQPGCLLEQLVLYDIYWSE 440
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 4e-04
Identities = 19/88 (21%), Positives = 31/88 (35%), Gaps = 5/88 (5%)
Query: 221 LQLLNLGFKKLSGAIPKEI-SNLTILRKISLRNNKLRGE----IPHEIGYLPNLENLVLG 275
+Q L++ ++LS A E+ L + + L + L I + P L L L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 276 FNNLVGVVPAAIFNMSTVKKIYLLDNSL 303
N L V + + SL
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 5e-04
Identities = 10/96 (10%), Positives = 25/96 (26%), Gaps = 4/96 (4%)
Query: 359 TIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGG----SIPQLISNLSNLLLLDLEGN 414
++ + L + L + + + +C + I + L L+L N
Sbjct: 6 SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN 65
Query: 415 KLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCH 450
+L + + + L
Sbjct: 66 ELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGC 101
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 6e-04
Identities = 19/84 (22%), Positives = 27/84 (32%), Gaps = 9/84 (10%)
Query: 401 SNLSNLLLLDLEGNKLTG----SIPVTFGRLQKLQGLYLPFNKLAGSIPDQLC-----HL 451
S L +L L ++ S+ T L+ L L N L + QL
Sbjct: 366 QPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPG 425
Query: 452 ARLNTLGLAGNKFSGSIPSCLGNL 475
L L L +S + L L
Sbjct: 426 CLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 17/77 (22%), Positives = 29/77 (37%), Gaps = 9/77 (11%)
Query: 120 NLSSLTTLNLSHNKLSGD----IPPSIFTMHKLKFLDFSDNQLSGS-----LSSVTFNLS 170
S L L L+ +S + ++ H L+ LD S+N L + + SV
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 171 SVLDIRLDSDKLSGELP 187
+ + L S E+
Sbjct: 427 LLEQLVLYDIYWSEEME 443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.001
Identities = 17/100 (17%), Positives = 31/100 (31%), Gaps = 7/100 (7%)
Query: 166 TFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQ----IPLALSKCKRL 221
+ ++ S LD + ++LS + L +V+ L I AL L
Sbjct: 1 SLDIQS-LD--IQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPAL 57
Query: 222 QLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPH 261
LNL +L + ++ L+
Sbjct: 58 AELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.003
Identities = 14/66 (21%), Positives = 25/66 (37%), Gaps = 5/66 (7%)
Query: 430 LQGLYLPFNKLAGSIPDQLC-HLARLNTLGLAGNKFSG----SIPSCLGNLTSLRSPDLG 484
+Q L + +L+ + +L L + + L + I S L +L +L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 485 SNRLTS 490
SN L
Sbjct: 64 SNELGD 69
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 4e-05
Identities = 42/209 (20%), Positives = 77/209 (36%), Gaps = 15/209 (7%)
Query: 259 IPHEIGYL---PNLENLV---LGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGID 312
+P I + + L ++ V ++++ +I ++ + +
Sbjct: 10 VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQ-- 65
Query: 313 LSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLP 372
LPNV +L L N+ + P ++LD + + L L+
Sbjct: 66 -YLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGI 124
Query: 373 TSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQG 432
+ I L + + N + ++S L+ L L LE N+++ +P L KLQ
Sbjct: 125 SDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQN 182
Query: 433 LYLPFNKLAGSIPDQLCHLARLNTLGLAG 461
LYL N + S L L L+ L L
Sbjct: 183 LYLSKNHI--SDLRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 3e-04
Identities = 40/193 (20%), Positives = 74/193 (38%), Gaps = 9/193 (4%)
Query: 219 KRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNN 278
NL K ++ A+ + + L + +I N+ ++ I YLPN+ L L N
Sbjct: 24 AETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNK 79
Query: 279 LVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITN 338
L + P A + L S L ++E + +P +
Sbjct: 80 LTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESL 139
Query: 339 ASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQ 398
+ T +T+ L N + ++P + L+ L+N+Y+S +I +
Sbjct: 140 YLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLT-KLQNLYLSKNHI-SDLRA 195
Query: 399 LISNLSNLLLLDL 411
L + L NL +L+L
Sbjct: 196 L-AGLKNLDVLEL 207
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 32/191 (16%), Positives = 67/191 (35%), Gaps = 23/191 (12%)
Query: 99 RVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQL 158
N+ ++ + L+S+ + +++ + I + + L + N+L
Sbjct: 25 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKL 80
Query: 159 SG---------------SLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLA 203
+ + V S +L S L +I +H ++ L
Sbjct: 81 TDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLY 140
Query: 204 KNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEI 263
LS+ +L L+L ++S +P ++ LT L+ + L N + +
Sbjct: 141 LGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD--LRAL 196
Query: 264 GYLPNLENLVL 274
L NL+ L L
Sbjct: 197 AGLKNLDVLEL 207
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (101), Expect = 6e-05
Identities = 19/101 (18%), Positives = 35/101 (34%), Gaps = 2/101 (1%)
Query: 125 TTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSG 184
TL+L+ L D+ + + + + + L+ F+ V + L + +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEV 60
Query: 185 ELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLN 225
I + L+ L L I L+K L LN
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.6 bits (96), Expect = 3e-04
Identities = 34/259 (13%), Positives = 86/259 (33%), Gaps = 15/259 (5%)
Query: 90 GITCNVNSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFT-MHKL 148
+T + S V A + + + ++LS++ + I + KL
Sbjct: 15 DVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVSTLHGILSQCSKL 73
Query: 149 KFLDFSDNQLSGSLSSVTFNLSSVLDIRLDS----DKLSGELPVNICNYLHYLKVLFLAK 204
+ L +LS + + S+++ + L + + + ++ C+ L L + +
Sbjct: 74 QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFD 133
Query: 205 NMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKI----SLRNNKLRGEIP 260
+ + LNL + + + + + + L+ +
Sbjct: 134 FTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCF 193
Query: 261 HEIGYLPNLENLVL-GFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVE 319
E L L++L L +++ + + T+K + + G + L +
Sbjct: 194 QEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDG----TLQLLKEALP 249
Query: 320 RLNLGLNRFSGTIPSFITN 338
L + + F+ I N
Sbjct: 250 HLQINCSHFTTIARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.4 bits (85), Expect = 0.004
Identities = 33/277 (11%), Positives = 82/277 (29%), Gaps = 27/277 (9%)
Query: 320 RLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIG--------LTGNPLDGVL 371
L+L + + + ++ + + L+ + ++
Sbjct: 4 TLDLTGKNLHPDVTGRLL-SQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVST 62
Query: 372 PTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQ 431
I + L+N+ + + I ++ SNL+ L+ L
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN----------------LSGCS 106
Query: 432 GLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSV 491
G + S +L L ++ +T L N S
Sbjct: 107 GFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSD 166
Query: 492 LPSTFWNLKDILFFDLSSNSL-DGPLSLDIGNLRVVIGINLSR-NNFSGDIPSTIGDLKD 549
L + +++ DLS + + + L + ++LSR + + +G++
Sbjct: 167 LSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPT 226
Query: 550 LQNISLACNGLEGLIPESFGYLTELNLSFNKLEGEIP 586
L+ + + +G + L L ++ +
Sbjct: 227 LKTLQVFGIVPDGTLQLLKEALPHLQINCSHFTTIAR 263
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (94), Expect = 3e-04
Identities = 10/60 (16%), Positives = 19/60 (31%)
Query: 380 MSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNK 439
E N N+ + S ++LD+ ++ L+KL+ K
Sbjct: 177 QLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.002
Identities = 13/74 (17%), Positives = 26/74 (35%), Gaps = 3/74 (4%)
Query: 86 CNWIGITCNVNSHRVTALNISSLNLQGTIPPQ-LGNLSSLTTLNLSHNKLSGDIPPSIFT 144
C N ++ LN+S N +P S L++S ++ +P
Sbjct: 164 GIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS-LPSYGLE 222
Query: 145 -MHKLKFLDFSDNQ 157
+ KL+ + +
Sbjct: 223 NLKKLRARSTYNLK 236
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.3 bits (90), Expect = 8e-04
Identities = 37/192 (19%), Positives = 73/192 (38%), Gaps = 23/192 (11%)
Query: 96 NSHRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSD 155
+ N+ T+ +L +TTL + I + ++ L ++FS+
Sbjct: 16 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 71
Query: 156 NQLSG--SLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYL-------------HYLKVL 200
NQL+ L ++T + +++ +D N+ + +
Sbjct: 72 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131
Query: 201 FLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIP 260
L + ALS LQ LN +++ P ++NLT L ++ + +NK+
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSD--I 187
Query: 261 HEIGYLPNLENL 272
+ L NLE+L
Sbjct: 188 SVLAKLTNLESL 199
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 38.1 bits (87), Expect = 0.002
Identities = 29/181 (16%), Positives = 49/181 (27%), Gaps = 25/181 (13%)
Query: 98 HRVTALNISSLNLQGTIPP------QLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFL 151
V A + L G IPP L L + L LS N + I + ++ L
Sbjct: 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KISS----LSGMENL 72
Query: 152 DFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQI 211
+ + + L I ++ + + +
Sbjct: 73 RILSLGRNLIKKIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLYMSNNKITNWGE 132
Query: 212 PLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLEN 271
L+ +L+ L L L + NN + LPNL+
Sbjct: 133 IDKLAALDKLEDLLLAGNPLYNDYKE--------------NNATSEYRIEVVKRLPNLKK 178
Query: 272 L 272
L
Sbjct: 179 L 179
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.002
Identities = 47/334 (14%), Positives = 94/334 (28%), Gaps = 24/334 (7%)
Query: 103 LNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGD----IPPSIFTMHKLKFLDFSDNQL 158
L+ + + ++ L S+ + LS N + + + +I + L+ +FSD
Sbjct: 12 LDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT 71
Query: 159 SGSLSSVTFNLSSVLDIRLDSDKLS--GELPVNICNYLHYLKVLFLAKNMFHGQIPLALS 216
+ L +L L KL + FL+K+ + L +
Sbjct: 72 GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNN 131
Query: 217 KCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGF 276
+ A+ K+ N LR I N+L E
Sbjct: 132 GLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ-------S 184
Query: 277 NNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFI 336
+ L+ V + +LL L L + N
Sbjct: 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 244
Query: 337 TNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSI 396
L + + ++ L L ++ L+ I +
Sbjct: 245 LRELGLNDCLLSARGAAAVVDAFSKLENIGL----------QTLRLQYNEIELDAVRTLK 294
Query: 397 PQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKL 430
+ + +LL L+L GN+ ++++
Sbjct: 295 TVIDEKMPDLLFLELNGNRF-SEEDDVVDEIREV 327
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (86), Expect = 0.002
Identities = 19/105 (18%), Positives = 43/105 (40%), Gaps = 2/105 (1%)
Query: 378 LSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTG--SIPVTFGRLQKLQGLYL 435
++ +++ + ++ ++ + N+ LL L+L N+L + + L+ L L
Sbjct: 39 VAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNL 98
Query: 436 PFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRS 480
N+L +L L L GN S + ++++R
Sbjct: 99 SGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRE 143
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 827 | |||
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.98 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.93 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 99.93 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.93 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.93 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.93 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 99.93 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.92 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.92 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.92 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.92 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.92 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.92 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.92 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.92 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.92 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.92 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.91 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.91 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.91 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.91 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.91 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.91 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.91 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.91 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.9 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.9 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.9 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.9 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.9 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.9 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.9 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.9 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.89 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.89 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.89 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.89 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.89 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.89 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.88 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.88 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.88 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.88 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.88 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.88 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.88 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.88 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.88 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.87 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.87 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.87 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.87 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.86 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.86 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.86 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.86 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.86 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.86 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.86 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.85 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.85 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.85 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.85 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.83 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.82 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.81 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.81 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.81 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.77 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.73 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.73 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.72 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.72 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.71 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.71 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.67 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.66 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.66 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.64 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.63 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.47 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.44 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.43 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.42 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.41 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.4 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.38 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.37 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.21 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.19 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.14 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.13 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.3 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.22 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.05 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.79 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 95.82 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 95.77 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 94.74 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 91.65 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 86.44 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 82.57 |
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=4.7e-43 Score=375.50 Aligned_cols=293 Identities=27% Similarity=0.461 Sum_probs=207.8
Q ss_pred CCCHHHHHHHHHHHhhcCCCCCCcCCCCCCCCCCCC--cccceecCCCC--CcEEEEEcCCCCCcc--ccCccccCCCCC
Q 047196 51 SNITTDQQALLALKAHISYDPTNLLAQNSTSNTSVC--NWIGITCNVNS--HRVTALNISSLNLQG--TIPPQLGNLSSL 124 (827)
Q Consensus 51 ~~~~~~~~aLl~~k~~~~~~~~~~l~~w~~~~~~~C--~W~gv~C~~~~--~~v~~L~L~~~~l~g--~~~~~l~~L~~L 124 (827)
-|.++||+||++||+++. ||. .+++|+ .++||| .|.||+|+..+ +||+.|||+++++.| .+|+++++|++|
T Consensus 2 ~c~~~e~~aLl~~k~~~~-~~~-~l~sW~-~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L 78 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLG-NPT-TLSSWL-PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp CSCHHHHHHHHHHHHHTT-CCG-GGTTCC-TTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCCHHHHHHHHHHHHHCC-CCC-cCCCCC-CCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccc
Confidence 388999999999999994 553 688897 678999 49999998754 489999999999998 578999999999
Q ss_pred CEEECCC-CCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcCCCCCCCCcchhHhhccccccEEEee
Q 047196 125 TTLNLSH-NKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLA 203 (827)
Q Consensus 125 ~~L~Ls~-N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~~L~Ls 203 (827)
++|||++ |+++|.+|++|+++++|++|||++|++.+..+..+..+..|+.++++.|.+.+.+|..+.++. .|++++++
T Consensus 79 ~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~-~L~~l~l~ 157 (313)
T d1ogqa_ 79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLP-NLVGITFD 157 (313)
T ss_dssp SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCT-TCCEEECC
T ss_pred cccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCc-ccceeecc
Confidence 9999997 899999999999999999999999999988877777777777777777766666666655433 66666666
Q ss_pred cccccccCCccCCCCCCC-cEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEeecccCccc
Q 047196 204 KNMFHGQIPLALSKCKRL-QLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGV 282 (827)
Q Consensus 204 ~N~l~~~~p~~l~~l~~L-~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 282 (827)
+|.++|.+|..+..+..+ +.++++.|++++..|..+.++..+ .++++++.+.+.+|..++.+++|+.+++++|.+++.
T Consensus 158 ~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~ 236 (313)
T d1ogqa_ 158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD 236 (313)
T ss_dssp SSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCB
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccc
Confidence 666666666666665554 566666666666666666555433 466666666666666666666666666666666654
Q ss_pred CchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCc
Q 047196 283 VPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNS 351 (827)
Q Consensus 283 ~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 351 (827)
+| .+..+++++.|++++|+++|.+|..+. .+++|++|+|++|+++|.+|. ++++++|+.+++++|+
T Consensus 237 ~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~-~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 237 LG-KVGLSKNLNGLDLRNNRIYGTLPQGLT-QLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302 (313)
T ss_dssp GG-GCCCCTTCCEEECCSSCCEECCCGGGG-GCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred cc-ccccccccccccCccCeecccCChHHh-CCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCc
Confidence 43 344555555555555555555555443 455555555555555555553 3444555555555554
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.98 E-value=7.8e-33 Score=295.50 Aligned_cols=257 Identities=34% Similarity=0.618 Sum_probs=206.1
Q ss_pred CCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccC-CcCccccCccccCCCCCceEeccCcccccc
Q 047196 341 KLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISN-CNIGGSIPQLISNLSNLLLLDLEGNKLTGS 419 (827)
Q Consensus 341 ~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~-N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ 419 (827)
+++.|+|++|.++|.. .+|..+++++ +|++|+|++ |+++|.+|..|+++++|++|+|++|++.+.
T Consensus 51 ~v~~L~L~~~~l~g~~-------------~lp~~l~~L~-~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~ 116 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPY-------------PIPSSLANLP-YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA 116 (313)
T ss_dssp CEEEEEEECCCCSSCE-------------ECCGGGGGCT-TCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEE
T ss_pred EEEEEECCCCCCCCCC-------------CCChHHhcCc-cccccccccccccccccccccccccccchhhhcccccccc
Confidence 4566666666555421 2455666665 677777775 677778888888888888888888888888
Q ss_pred ccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCC-CccccCCCcccccCCccccc
Q 047196 420 IPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSL-RSPDLGSNRLTSVLPSTFWN 498 (827)
Q Consensus 420 ~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-~~L~Ls~N~l~~~~p~~~~~ 498 (827)
.|..+..+.+|+.+++++|.+.+.+|..+.+++.|+.+++++|++++.+|..+..+..+ +.+++++|++++..|..+..
T Consensus 117 ~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~ 196 (313)
T d1ogqa_ 117 IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN 196 (313)
T ss_dssp CCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGG
T ss_pred ccccccchhhhcccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccc
Confidence 88888888888888888888888888888888888888888888888888888777775 77888888888888887777
Q ss_pred cccccccCCCCCCCCCCCcccccccccCceEEcccceeeecccccccCCCCCCEEECCCCcceeecCCCCc---CCceEe
Q 047196 499 LKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLACNGLEGLIPESFG---YLTELN 575 (827)
Q Consensus 499 l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~---~L~~L~ 575 (827)
+..+ .+++++|...|.+|..++.++.++.+++++|.+++.+| .++.+++|+.|+|++|+++|.+|+.++ +|++||
T Consensus 197 l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~ 274 (313)
T d1ogqa_ 197 LNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLN 274 (313)
T ss_dssp CCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEE
T ss_pred cccc-cccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEE
Confidence 6554 68888888888888888888888888888888887765 578888888888888888888888764 688889
Q ss_pred CcCCcCeecCCCCCCCCCCcccccccCccccCCCCCCCccc
Q 047196 576 LSFNKLEGEIPRGGPFANFTAKSFMGNEKLCGLPNLQFPKC 616 (827)
Q Consensus 576 ls~N~l~g~ip~~~~~~~~~~~~~~~n~~lc~~p~~~~~~c 616 (827)
|++|+|+|.||..+.++.+....+.||+.+||.| .|.|
T Consensus 275 Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~p---lp~c 312 (313)
T d1ogqa_ 275 VSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312 (313)
T ss_dssp CCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTT---SSCC
T ss_pred CcCCcccccCCCcccCCCCCHHHhCCCccccCCC---CCCC
Confidence 9999999999988888888889999999999965 3567
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=1.7e-27 Score=261.13 Aligned_cols=207 Identities=26% Similarity=0.360 Sum_probs=137.0
Q ss_pred ccEEeCcCCccccccCccccCCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccC
Q 047196 318 VERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIP 397 (827)
Q Consensus 318 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p 397 (827)
........|... ....+..++++..+++++|.+++..|. ... .+|++|++++|+++. +
T Consensus 177 ~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~~-----------------~~~-~~L~~L~l~~n~l~~-~- 234 (384)
T d2omza2 177 LERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITPL-----------------GIL-TNLDELSLNGNQLKD-I- 234 (384)
T ss_dssp CCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGGG-----------------GGC-TTCCEEECCSSCCCC-C-
T ss_pred cccccccccccc--cccccccccccceeeccCCccCCCCcc-----------------ccc-CCCCEEECCCCCCCC-c-
Confidence 334444444432 234455666777777777766644321 111 267777777777764 2
Q ss_pred ccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCC
Q 047196 398 QLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTS 477 (827)
Q Consensus 398 ~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 477 (827)
..+..+++|+.|++++|++++..+ +..+++|+.|++++|++++.. .+..+..++.+++++|++++ +..+..+++
T Consensus 235 ~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~ 308 (384)
T d2omza2 235 GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKN 308 (384)
T ss_dssp GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTT
T ss_pred chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--cccccccccccccccccccc--ccccchhcc
Confidence 356677778888888887776543 667777888888887777543 25567777777787777764 234667777
Q ss_pred CCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccceeeecccccccCCCCCCEEECCC
Q 047196 478 LRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNISLAC 557 (827)
Q Consensus 478 L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~ 557 (827)
++.|++++|++++..| +..+++|+.|++++|++++ ++ .++++++|++|++++|+|++.+| +.++++|+.|+|++
T Consensus 309 l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~ 382 (384)
T d2omza2 309 LTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLND 382 (384)
T ss_dssp CSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCC
T ss_pred cCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCC
Confidence 7777787777776533 6677777777777777765 33 46777777777777777776554 67777777777777
Q ss_pred C
Q 047196 558 N 558 (827)
Q Consensus 558 N 558 (827)
|
T Consensus 383 N 383 (384)
T d2omza2 383 Q 383 (384)
T ss_dssp E
T ss_pred C
Confidence 6
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=7.3e-27 Score=255.95 Aligned_cols=340 Identities=25% Similarity=0.353 Sum_probs=195.1
Q ss_pred CcEEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEc
Q 047196 98 HRVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRL 177 (827)
Q Consensus 98 ~~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L 177 (827)
..++.|++++++++.. +.+..|++|++|||++|+|++. | .++++++|++|++++|++.+..+ +..+++|+.|++
T Consensus 44 ~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i~~i~~--l~~l~~L~~L~~ 117 (384)
T d2omza2 44 DQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTL 117 (384)
T ss_dssp TTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred CCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCC-c-cccCCcccccccccccccccccc--cccccccccccc
Confidence 4689999999998753 4688899999999999999864 3 39999999999999999987543 788999999999
Q ss_pred CCCCCCCCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccc
Q 047196 178 DSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRG 257 (827)
Q Consensus 178 ~~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 257 (827)
+.+.+++..+.. ....+..+....|.+....+..................+ ..+...+.........|...
T Consensus 118 ~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~- 188 (384)
T d2omza2 118 FNNQITDIDPLK---NLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDL-----KPLANLTTLERLDISSNKVS- 188 (384)
T ss_dssp CSSCCCCCGGGT---TCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCC-----GGGTTCTTCCEEECCSSCCC-
T ss_pred cccccccccccc---ccccccccccccccccccccccccccccccccccccchh-----hhhccccccccccccccccc-
Confidence 999888644322 223677778887777654443333333333333322222 22334444455555555443
Q ss_pred cccccccCcCCCcEEEeecccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCcccc
Q 047196 258 EIPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFIT 337 (827)
Q Consensus 258 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 337 (827)
.+..+..+++++.+++++|.+++..| +..+.+|++|++++|.+... + .+ ..+++|+.|++++|++++..+ +.
T Consensus 189 -~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~-~-~l-~~l~~L~~L~l~~n~l~~~~~--~~ 260 (384)
T d2omza2 189 -DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI-G-TL-ASLTNLTDLDLANNQISNLAP--LS 260 (384)
T ss_dssp -CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-G-GG-GGCTTCSEEECCSSCCCCCGG--GT
T ss_pred -cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc-c-hh-hcccccchhccccCccCCCCc--cc
Confidence 34455667777777777777766543 23445555555555554431 1 11 134555555555555554322 44
Q ss_pred CCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCcccc
Q 047196 338 NASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLT 417 (827)
Q Consensus 338 ~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 417 (827)
.+++|+.|++++|++ ++.. .+..++.++.++++.|+++
T Consensus 261 ~~~~L~~L~l~~~~l----------------------------------------~~~~--~~~~~~~l~~l~~~~n~l~ 298 (384)
T d2omza2 261 GLTKLTELKLGANQI----------------------------------------SNIS--PLAGLTALTNLELNENQLE 298 (384)
T ss_dssp TCTTCSEEECCSSCC----------------------------------------CCCG--GGTTCTTCSEEECCSSCCS
T ss_pred ccccCCEeeccCccc----------------------------------------CCCC--ccccccccccccccccccc
Confidence 445555555555444 3321 1334444445555555444
Q ss_pred ccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCccccCCCcccccCCcccc
Q 047196 418 GSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFW 497 (827)
Q Consensus 418 g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 497 (827)
+. ..+..+++++.|++++|++++.. .+..+++|+.|++++|++++ +| .+.++++|++|++++|++++..| +.
T Consensus 299 ~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~ 370 (384)
T d2omza2 299 DI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LA 370 (384)
T ss_dssp CC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GT
T ss_pred cc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hc
Confidence 32 12444455555555555554332 14445555555555555542 22 34555555555555555554433 45
Q ss_pred ccccccccCCCCC
Q 047196 498 NLKDILFFDLSSN 510 (827)
Q Consensus 498 ~l~~L~~LdLs~N 510 (827)
++++|+.|+|++|
T Consensus 371 ~l~~L~~L~L~~N 383 (384)
T d2omza2 371 NLTRITQLGLNDQ 383 (384)
T ss_dssp TCTTCSEEECCCE
T ss_pred cCCCCCEeeCCCC
Confidence 5555555555554
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=7.7e-27 Score=242.58 Aligned_cols=150 Identities=25% Similarity=0.466 Sum_probs=121.1
Q ss_pred hhcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCce-eeeeec
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFK-ALDCLH 752 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~-~l~~l~ 752 (827)
.++|+..+.||+|+||.||+|++++++.||||+++... ...++|.+|++++++++|||||+++|+|.++... ++++..
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~~ 90 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYME 90 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCT
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEEeCC
Confidence 35788889999999999999999888999999997543 2346799999999999999999999998765532 333333
Q ss_pred cC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 753 ST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 753 ~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
.+ ...+++.++..|+.|||+||+||| +++|+||||||+||| |||+|+.+........
T Consensus 91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (272)
T d1qpca_ 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (272)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCccccc
Confidence 21 124788889999999999999996 568999999999998 9999998765443333
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
....||++|||||++
T Consensus 168 ~~~~gt~~y~APE~~ 182 (272)
T d1qpca_ 168 EGAKFPIKWTAPEAI 182 (272)
T ss_dssp TTCCCCTTTSCHHHH
T ss_pred cccCCcccccChHHH
Confidence 445689999999974
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=2.1e-26 Score=238.44 Aligned_cols=151 Identities=22% Similarity=0.351 Sum_probs=119.4
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee--e
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL--D 749 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l--~ 749 (827)
.++|+..+.||+|+||+||+|+.+ +|+.||||++.... ....+++.+|++++++++|||||++++++.+++..++ +
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 357889999999999999999864 69999999997543 2334679999999999999999999999988876544 3
Q ss_pred eecc--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc-
Q 047196 750 CLHS--------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM- 810 (827)
Q Consensus 750 ~l~~--------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~- 810 (827)
+... ....+++.+...++.|+++||+||| +++|+||||||+||| |||+|+.+......
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 3221 1245778888899999999999996 568999999999998 99999987544322
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
..+..+||+.|||||++
T Consensus 161 ~~~~~~GT~~Y~APE~~ 177 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELL 177 (271)
T ss_dssp CBCCCCSCGGGSCTHHH
T ss_pred cccceeeCcCccCHhHh
Confidence 23345699999999974
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.2e-26 Score=241.14 Aligned_cols=148 Identities=27% Similarity=0.493 Sum_probs=113.9
Q ss_pred hcccccceEecCCceEEEEEEecCCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCce-eeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFK-ALDCL 751 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~-~l~~l 751 (827)
++|...+.||+|+||+||+|++++ .||||+++.. .....++|.+|++++++++|||||++++++.++... +++++
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~Ey~ 85 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWC 85 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred ccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEEecC
Confidence 568888999999999999998753 5999998643 344567899999999999999999999998765532 23332
Q ss_pred c---------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc-c
Q 047196 752 H---------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM-I 811 (827)
Q Consensus 752 ~---------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~-~ 811 (827)
. .....+++.++..|+.|+|+||+||| +++||||||||+||| |||+|+........ .
T Consensus 86 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~ 162 (276)
T d1uwha_ 86 EGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 162 (276)
T ss_dssp CEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---------
T ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCccc
Confidence 2 22346889999999999999999996 568999999999998 99999877543322 2
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
.....||+.|||||++
T Consensus 163 ~~~~~gt~~y~APE~l 178 (276)
T d1uwha_ 163 FEQLSGSILWMAPEVI 178 (276)
T ss_dssp ---CCCCGGGCCHHHH
T ss_pred ccccccCcccCCHHHH
Confidence 2334589999999973
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=9.1e-27 Score=240.89 Aligned_cols=149 Identities=27% Similarity=0.421 Sum_probs=110.3
Q ss_pred hcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee--eeec
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL--DCLH 752 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l--~~l~ 752 (827)
.+|+..+.||+|+||.||+|++.+++.||||+++... ...++|.+|++++++++|||||+++|+|..++..++ ++..
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 4677889999999999999999888899999997543 234679999999999999999999999987665444 3322
Q ss_pred c---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccc
Q 047196 753 S---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQT 813 (827)
Q Consensus 753 ~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~ 813 (827)
. ....+.+..+..|+.|+|+||+||| +++|+||||||+||| |||+|+...........
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 1 2245678888999999999999996 567999999999998 99999887554433333
Q ss_pred cceecccccccccC
Q 047196 814 ETLVTIGYMAPGLL 827 (827)
Q Consensus 814 ~~~gt~~Y~APE~l 827 (827)
...||+.|||||++
T Consensus 161 ~~~gt~~y~aPE~l 174 (263)
T d1sm2a_ 161 GTKFPVKWASPEVF 174 (263)
T ss_dssp ----CTTSCCHHHH
T ss_pred ceecCcccCChHHh
Confidence 34589999999974
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.93 E-value=7.7e-27 Score=244.32 Aligned_cols=151 Identities=29% Similarity=0.513 Sum_probs=122.2
Q ss_pred HhhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee--e
Q 047196 673 ATEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL--D 749 (827)
Q Consensus 673 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l--~ 749 (827)
..++|+..+.||+|+||+||+|++. +|+.||||+++... ...++|.+|++++++++|||||+++++|.+++..++ +
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 3457888899999999999999875 58999999987543 235679999999999999999999999988765544 3
Q ss_pred eecc----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 750 CLHS----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 750 ~l~~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
+... ....+++..+..|+.|+|+||+||| +++|+||||||+||| |||+|+....+..
T Consensus 94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 3221 1235678888999999999999996 468999999999999 9999998765544
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
...+...||+.|||||++
T Consensus 171 ~~~~~~~g~~~y~aPE~~ 188 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESL 188 (287)
T ss_dssp EEETTEEECGGGCCHHHH
T ss_pred eeeccccccccccChHHH
Confidence 434445589999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=4.9e-26 Score=238.22 Aligned_cols=149 Identities=27% Similarity=0.327 Sum_probs=121.4
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeecc
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLHS 753 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~~ 753 (827)
++|+..+.||+|+||+||+|+. .+|+.||||++........+.+.+|++++++++|||||++++++..++..++...+.
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4689999999999999999986 469999999997654444577999999999999999999999998887655533332
Q ss_pred CC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccccc
Q 047196 754 TN---------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQTE 814 (827)
Q Consensus 754 ~~---------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~~ 814 (827)
.. ..++..+...++.|++.||+||| +++|+||||||+||| |||+|+.+..+... ...
T Consensus 100 ~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~-~~~ 175 (293)
T d1yhwa1 100 AGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RST 175 (293)
T ss_dssp TTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-BCC
T ss_pred CCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecccccc-ccc
Confidence 22 34667778899999999999996 578999999999998 99999987544332 234
Q ss_pred ceecccccccccC
Q 047196 815 TLVTIGYMAPGLL 827 (827)
Q Consensus 815 ~~gt~~Y~APE~l 827 (827)
.+||+.|||||++
T Consensus 176 ~~gt~~Y~aPE~~ 188 (293)
T d1yhwa1 176 MVGTPYWMAPEVV 188 (293)
T ss_dssp CCSCGGGCCHHHH
T ss_pred cccCCCccChhhh
Confidence 5699999999974
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.92 E-value=3.9e-24 Score=226.56 Aligned_cols=244 Identities=26% Similarity=0.332 Sum_probs=128.8
Q ss_pred cccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEee
Q 047196 196 YLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLG 275 (827)
Q Consensus 196 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 275 (827)
.++++|=+++.++ .+|..+. +++++|+|++|+++...+.+|.++++|++|++++|.+....|..|.++++|++|+++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 4566666666666 4565553 567777777777776555567777777777777777776666677777777777777
Q ss_pred cccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccc--cccCccccCCCCCcEEEcCCCcce
Q 047196 276 FNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFS--GTIPSFITNASKLVYLDMGTNSFS 353 (827)
Q Consensus 276 ~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~ 353 (827)
+|+++.. |..+ ...++.|++.+|.+.+. +...+.....++.++...|... ...+..+..+++
T Consensus 88 ~n~l~~l-~~~~--~~~l~~L~~~~n~l~~l-~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~------------ 151 (305)
T d1xkua_ 88 KNQLKEL-PEKM--PKTLQELRVHENEITKV-RKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKK------------ 151 (305)
T ss_dssp SSCCSBC-CSSC--CTTCCEEECCSSCCCBB-CHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTT------------
T ss_pred CCccCcC-ccch--hhhhhhhhccccchhhh-hhhhhhccccccccccccccccccCCCccccccccc------------
Confidence 7777643 3222 23445555555544332 2222223333444444443221 122233333444
Q ss_pred eecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEE
Q 047196 354 GIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGL 433 (827)
Q Consensus 354 g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 433 (827)
|+.+++++|+++. +|..+ +++|+.|++++|..++..+..|.+++.+++|
T Consensus 152 ----------------------------L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L 200 (305)
T d1xkua_ 152 ----------------------------LSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKL 200 (305)
T ss_dssp ----------------------------CCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEE
T ss_pred ----------------------------cCccccccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhcccccccc
Confidence 4444444444432 22221 3445555555555554445555555555555
Q ss_pred ECCCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCccccCCCcccc
Q 047196 434 YLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTS 490 (827)
Q Consensus 434 ~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 490 (827)
++++|.+.+..+..+.++++|++|+|++|+++ .+|.++..+++|++|+|++|+|+.
T Consensus 201 ~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~ 256 (305)
T d1xkua_ 201 GLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 256 (305)
T ss_dssp ECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCC
T ss_pred ccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCc
Confidence 55555555444445555555555555555554 344455555555555555555554
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.92 E-value=4.5e-24 Score=226.09 Aligned_cols=255 Identities=21% Similarity=0.215 Sum_probs=181.2
Q ss_pred CcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEccccccccccccccc
Q 047196 185 ELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIG 264 (827)
Q Consensus 185 ~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 264 (827)
++|.++. +++++|+|++|+++...+.+|.++++|++|++++|.++...|..|.++++|++|++++|+++ .+|..+
T Consensus 24 ~lP~~l~---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~-~l~~~~- 98 (305)
T d1xkua_ 24 KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM- 98 (305)
T ss_dssp SCCCSCC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSC-
T ss_pred ccCCCCC---CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccC-cCccch-
Confidence 5665543 47899999999998766678999999999999999999888888999999999999999998 456543
Q ss_pred CcCCCcEEEeecccCcccCchhhhcCCCccEEEecCCccccc-cChhhhcCCCCccEEeCcCCccccccCccccCCCCCc
Q 047196 265 YLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGS-FSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLV 343 (827)
Q Consensus 265 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 343 (827)
...++.|+++.|.+.+..+..+.....+..++...|..... ........+++|+.+++++|+++. +|..+ .+
T Consensus 99 -~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~-l~~~~--~~--- 171 (305)
T d1xkua_ 99 -PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGL--PP--- 171 (305)
T ss_dssp -CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSC--CT---
T ss_pred -hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccc-cCccc--CC---
Confidence 46789999999999988777788888888888888754322 222233468899999999998763 33221 23
Q ss_pred EEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCcccccccccc
Q 047196 344 YLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVT 423 (827)
Q Consensus 344 ~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~ 423 (827)
+++.|++++|..++..+..|..++.++.|++++|.+++..+..
T Consensus 172 -------------------------------------~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~ 214 (305)
T d1xkua_ 172 -------------------------------------SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGS 214 (305)
T ss_dssp -------------------------------------TCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTT
T ss_pred -------------------------------------ccCEEECCCCcCCCCChhHhhcccccccccccccccccccccc
Confidence 4555666666666666666666667777777777777666666
Q ss_pred ccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCcc------ccCCCCCCccccCCCccc
Q 047196 424 FGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSC------LGNLTSLRSPDLGSNRLT 489 (827)
Q Consensus 424 ~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~------~~~l~~L~~L~Ls~N~l~ 489 (827)
+.++++|++|+|++|+|+ .+|.++.++++|++|+|++|+++..-... ...+.+|+.|+|++|.+.
T Consensus 215 ~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 215 LANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp GGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred ccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 667777777777777776 45666777777777777777776322222 223455666666666553
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=5.2e-26 Score=237.83 Aligned_cols=150 Identities=24% Similarity=0.476 Sum_probs=111.3
Q ss_pred hcccccceEecCCceEEEEEEecC-C----cEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHD-G----IEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~-g----~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l 748 (827)
..|+..++||+|+||.||+|+++. + ..||||++.... .....+|.+|++++++++|||||+++|+|.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 468888999999999999998753 2 479999996543 3445679999999999999999999999987665443
Q ss_pred --eeec---------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCC
Q 047196 749 --DCLH---------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGD 807 (827)
Q Consensus 749 --~~l~---------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~ 807 (827)
+++. .....+++.++..++.|+|+|++||| +++|+||||||+||| |||+|+.+...
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 2221 12346889999999999999999996 578999999999998 99999987544
Q ss_pred Cccc--cccceecccccccccC
Q 047196 808 RSMI--QTETLVTIGYMAPGLL 827 (827)
Q Consensus 808 ~~~~--~~~~~gt~~Y~APE~l 827 (827)
.... .....||+.|||||++
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l 185 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAI 185 (283)
T ss_dssp ----------CCCGGGSCHHHH
T ss_pred CccceEeccCCCCccccCHHHH
Confidence 3221 2223489999999963
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.92 E-value=1e-25 Score=237.83 Aligned_cols=145 Identities=27% Similarity=0.356 Sum_probs=118.7
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeee-
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALD- 749 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~- 749 (827)
+.|+..+.||+|+||+||+|+. .+|+.||||++.... ....+.|.+|++++++++|||||++++++.+++..++.
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4588899999999999999986 578999999997543 33456799999999999999999999999887755543
Q ss_pred -eecc--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 750 -CLHS--------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 750 -~l~~--------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
+... ....+++.+...++.|+++||.||| +++|+||||||+||| |||+|+.....
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--- 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCCC---
Confidence 3221 2345788889999999999999996 568999999999998 99999865432
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
...+||++|||||++
T Consensus 169 --~~~~GT~~Y~APE~~ 183 (309)
T d1u5ra_ 169 --NSFVGTPYWMAPEVI 183 (309)
T ss_dssp --CCCCSCGGGCCHHHH
T ss_pred --CccccCccccCHHHH
Confidence 234699999999973
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.92 E-value=5.8e-26 Score=239.05 Aligned_cols=161 Identities=25% Similarity=0.481 Sum_probs=113.4
Q ss_pred ccchhHHHHHhhccc---------ccceEecCCceEEEEEEec-CC---cEEEEEEEccc-chHHHHHHHHHHHHHHhcC
Q 047196 664 RFSYQDLFRATEKFS---------KENLIGVGSFGSVYKGRLH-DG---IEVAIKVFHQN-CAMALKSFEAECEVMKNIR 729 (827)
Q Consensus 664 ~~~~~~~~~~~~~~~---------~~~~iG~G~fg~Vy~~~~~-~g---~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~ 729 (827)
.++++|+.+++.+|. ..++||+|+||+||+|+++ +| ..||||++... .....++|.+|+++|++++
T Consensus 6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 85 (299)
T d1jpaa_ 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85 (299)
T ss_dssp GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence 456777777766554 4578999999999999864 23 36899998654 3445678999999999999
Q ss_pred CCCceEEEeeeecCCceee--eeecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee--
Q 047196 730 HRNHVKRISSCSNEDFKAL--DCLHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-- 796 (827)
Q Consensus 730 H~niv~~~~~~~~~~~~~l--~~l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-- 796 (827)
|||||+++|+|..++..++ +++.. ....+++.++..|+.|+|+||+||| +++|+||||||+|||
T Consensus 86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~ 162 (299)
T d1jpaa_ 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVN 162 (299)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEC
T ss_pred CCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEEC
Confidence 9999999999987665444 33221 2345789999999999999999996 568999999999999
Q ss_pred --------eecccccccCCCccc----cccceecccccccccC
Q 047196 797 --------DFGIGRLLTGDRSMI----QTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 --------DFGla~~~~~~~~~~----~~~~~gt~~Y~APE~l 827 (827)
|||+|+.+....... .....||+.|||||++
T Consensus 163 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 205 (299)
T d1jpaa_ 163 SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 205 (299)
T ss_dssp TTCCEEECCC-----------------------CGGGSCHHHH
T ss_pred CCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHH
Confidence 999999875443221 1123479999999963
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.8e-25 Score=230.44 Aligned_cols=147 Identities=27% Similarity=0.403 Sum_probs=119.0
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
++|+..+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..++..
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57888999999999999999875 68999999986432 223467899999999999999999999998887655433
Q ss_pred eccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 751 LHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 751 l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
.+.. ...+++.+...++.|+++||+||| +++|+||||||+||| |||+|+.......
T Consensus 86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~- 161 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR- 161 (263)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCC-
T ss_pred eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCCcc-
Confidence 3322 235677788899999999999996 578999999999998 9999987654322
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
...+||+.|||||++
T Consensus 162 --~~~~Gt~~Y~APE~~ 176 (263)
T d2j4za1 162 --TTLCGTLDYLPPEMI 176 (263)
T ss_dssp --EETTEEGGGCCHHHH
T ss_pred --cccCCCCcccCHHHH
Confidence 234599999999974
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=9e-26 Score=232.13 Aligned_cols=149 Identities=25% Similarity=0.440 Sum_probs=121.3
Q ss_pred hcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee--eeec
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL--DCLH 752 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l--~~l~ 752 (827)
++|+..+.||+|+||+||+|++++++.||||+++.... ..++|.+|++++++++|||||+++|+|.+.+..++ ++..
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 46888899999999999999998888999999976433 34679999999999999999999999987665443 3222
Q ss_pred ---------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccc
Q 047196 753 ---------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQT 813 (827)
Q Consensus 753 ---------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~ 813 (827)
.....+.+..+.+++.|+|+||+||| +++|+||||||+||+ |||+|+...........
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 12345678889999999999999996 468999999999998 99999877554433333
Q ss_pred cceecccccccccC
Q 047196 814 ETLVTIGYMAPGLL 827 (827)
Q Consensus 814 ~~~gt~~Y~APE~l 827 (827)
...||+.|||||++
T Consensus 160 ~~~~t~~y~aPE~~ 173 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVL 173 (258)
T ss_dssp CSCCCGGGCCHHHH
T ss_pred ccCCCCCcCCcHHh
Confidence 45589999999974
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=3.6e-26 Score=238.97 Aligned_cols=149 Identities=25% Similarity=0.348 Sum_probs=120.3
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee--eee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL--DCL 751 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l--~~l 751 (827)
+.|+..+.||+|+||+||+|+.. +|+.||||+++.......++|.+|++++++++|||||++++++.+++..++ +++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 45788899999999999999864 689999999977655566789999999999999999999999988775544 332
Q ss_pred cc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 752 HS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 752 ~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
.. ....+++.+...++.|+++||+||| +++|+||||||+||| |||+|+....... ..
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-~~ 167 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RR 167 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-HH
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCcc-cc
Confidence 21 1235778888999999999999996 568999999999998 9999976543221 12
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
...+||+.|||||++
T Consensus 168 ~~~~Gt~~y~APE~l 182 (288)
T d2jfla1 168 DSFIGTPYWMAPEVV 182 (288)
T ss_dssp TCCCSCCTTCCHHHH
T ss_pred cccccccccCCHHHH
Confidence 235699999999973
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.6e-25 Score=231.72 Aligned_cols=152 Identities=27% Similarity=0.395 Sum_probs=108.9
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC----cee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNED----FKA 747 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~----~~~ 747 (827)
++|+..+.||+|+||+||+|+. .+|+.||||++.... ....+.|.+|++++++++|||||++++++.+.. +..
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 6799999999999999999986 469999999996542 344577999999999999999999999986532 223
Q ss_pred eeeeccC------------CCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEEccCCCccee----------eeccccc
Q 047196 748 LDCLHST------------NCSLNIFDKLNIMIDVASALEYLHFSH--STPVIHCDLKPKNVF----------DFGIGRL 803 (827)
Q Consensus 748 l~~l~~~------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h--~~~iiHrDlK~~NIl----------DFGla~~ 803 (827)
+++...+ ...+++.....++.|+++||+|||... ..+|+||||||+||| |||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 4443321 234777888899999999999999754 356999999999998 9999998
Q ss_pred ccCCCccccccceecccccccccC
Q 047196 804 LTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 804 ~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
+..+... ....+||++|||||++
T Consensus 164 ~~~~~~~-~~~~~gt~~Y~APE~l 186 (269)
T d2java1 164 LNHDTSF-AKAFVGTPYYMSPEQM 186 (269)
T ss_dssp C------------CCCSCCCHHHH
T ss_pred cccCCCc-cccCCCCcccCCHHHH
Confidence 7544332 2335699999999974
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.9e-24 Score=226.51 Aligned_cols=223 Identities=20% Similarity=0.208 Sum_probs=141.0
Q ss_pred EcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcCCCCCC
Q 047196 104 NISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLS 183 (827)
Q Consensus 104 ~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~l~ 183 (827)
+.++.+++ .+|..+. +++++|+|++|+|+...+.+|.++++|++||+++|++.+..+..+.++..+..++...+...
T Consensus 17 ~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~ 93 (284)
T d1ozna_ 17 SCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93 (284)
T ss_dssp ECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTC
T ss_pred EcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccccc
Confidence 44555666 4565543 57899999999999777778999999999999999998777766666666666655433332
Q ss_pred CCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccc
Q 047196 184 GELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEI 263 (827)
Q Consensus 184 g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 263 (827)
..++ |..|.++++|++|++++|.+....+..+..+++|+.+++++|++++..+..|
T Consensus 94 ~~l~------------------------~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f 149 (284)
T d1ozna_ 94 RSVD------------------------PATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTF 149 (284)
T ss_dssp CCCC------------------------TTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred cccc------------------------chhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHh
Confidence 2333 4444455555555555555544444444455555555555555554444445
Q ss_pred cCcCCCcEEEeecccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCc
Q 047196 264 GYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLV 343 (827)
Q Consensus 264 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 343 (827)
..+++|++|++++|++++..+..|.++++|+.+++++|.+.+..|..+. .+++|++|++++|++.+..|..|.++++|+
T Consensus 150 ~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~-~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~ 228 (284)
T d1ozna_ 150 RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFR-DLGRLMTLYLFANNLSALPTEALAPLRALQ 228 (284)
T ss_dssp TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTT-TCTTCCEEECCSSCCSCCCHHHHTTCTTCC
T ss_pred ccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhh-hhhhcccccccccccccccccccccccccC
Confidence 5555555555555555555455555555555555555555544443333 566777777777777777777788888888
Q ss_pred EEEcCCCccee
Q 047196 344 YLDMGTNSFSG 354 (827)
Q Consensus 344 ~L~Ls~N~l~g 354 (827)
+|++++|.+..
T Consensus 229 ~L~l~~N~l~C 239 (284)
T d1ozna_ 229 YLRLNDNPWVC 239 (284)
T ss_dssp EEECCSSCEEC
T ss_pred EEEecCCCCCC
Confidence 88888887764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=5.9e-26 Score=241.91 Aligned_cols=149 Identities=23% Similarity=0.289 Sum_probs=119.5
Q ss_pred hhcccccceEecCCceEEEEEEe-cCCcEEEEEEEccc-chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQN-CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l 751 (827)
.++|+..+.||+|+||+||+|+. .+|+.||||+++.. .....+++.+|+++|++++|||||++++++.+++..++...
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 46799999999999999999986 46899999999754 23345689999999999999999999999988876554333
Q ss_pred ccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 752 HST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 752 ~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
+.. ...+++.....++.|+++||.|||+. .+|+||||||+||| |||+|+.+....
T Consensus 85 y~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--- 159 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 159 (322)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT---
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc---
Confidence 222 23577778889999999999999853 36999999999999 999999765332
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
....+||++|||||++
T Consensus 160 ~~~~~GT~~Y~APEvl 175 (322)
T d1s9ja_ 160 ANSFVGTRSYMSPERL 175 (322)
T ss_dssp C---CCSSCCCCHHHH
T ss_pred cccccCCccccCchHH
Confidence 2335799999999974
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.92 E-value=2.4e-25 Score=239.01 Aligned_cols=149 Identities=21% Similarity=0.310 Sum_probs=122.8
Q ss_pred hhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
.++|+..+.||+|+||+||+|+. .+|+.||||++........+.+.+|++++++++|||||++++++.+++..++...+
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35799999999999999999986 46999999999776666667899999999999999999999999887765543222
Q ss_pred c-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee------------eecccccccCCCc
Q 047196 753 S-----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------------DFGIGRLLTGDRS 809 (827)
Q Consensus 753 ~-----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------------DFGla~~~~~~~~ 809 (827)
. ....+++.....|+.|++.||+||| +.+||||||||+||| |||+|+.+.....
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 1 2235778888999999999999996 578999999999997 9999987754433
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
. ....||+.|||||++
T Consensus 182 ~--~~~~gT~~Y~aPEv~ 197 (350)
T d1koaa2 182 V--KVTTGTAEFAAPEVA 197 (350)
T ss_dssp E--EEECSCTTTCCHHHH
T ss_pred c--ceecCcccccCHHHH
Confidence 2 334599999999974
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=2.6e-25 Score=232.29 Aligned_cols=150 Identities=28% Similarity=0.392 Sum_probs=117.1
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
++|+..+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..++..
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5799999999999999999986 469999999996432 223467999999999999999999999998877555433
Q ss_pred eccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 751 LHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 751 l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
.+.. ...+++.....++.|++.||+||| +++|+||||||+||+ |||+|+.+......
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 2222 235677778889999999999995 678999999999998 99999987543322
Q ss_pred -ccccceecccccccccC
Q 047196 811 -IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 -~~~~~~gt~~Y~APE~l 827 (827)
.....+||+.|||||++
T Consensus 165 ~~~~~~~GT~~Y~APE~~ 182 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELL 182 (288)
T ss_dssp -----CCCCGGGCCHHHH
T ss_pred cccccccCCccccCceee
Confidence 22335699999999974
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=4.5e-25 Score=230.24 Aligned_cols=150 Identities=24% Similarity=0.463 Sum_probs=116.8
Q ss_pred hcccccce-EecCCceEEEEEEec---CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCce-ee
Q 047196 675 EKFSKENL-IGVGSFGSVYKGRLH---DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFK-AL 748 (827)
Q Consensus 675 ~~~~~~~~-iG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~-~l 748 (827)
++|...+. ||+|+||+||+|.++ ++..||||+++... ....++|.+|++++++++|||||+++|+|..+... ++
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvm 87 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 87 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEEE
Confidence 34555564 999999999999764 35689999997543 44567899999999999999999999999765532 23
Q ss_pred eeec---------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 749 DCLH---------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 749 ~~l~---------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
+++. .....+++.++..++.|+|+||+||| +++|+||||||+||+ |||+|+.+.....
T Consensus 88 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 88 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164 (285)
T ss_dssp ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence 3322 12345788899999999999999996 578999999999998 9999998755433
Q ss_pred cc--cccceecccccccccC
Q 047196 810 MI--QTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~--~~~~~gt~~Y~APE~l 827 (827)
.. .....||+.|||||++
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~ 184 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECI 184 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHH
T ss_pred ccccccccccCccccChHHH
Confidence 21 2234589999999974
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1.4e-25 Score=233.95 Aligned_cols=149 Identities=26% Similarity=0.450 Sum_probs=113.6
Q ss_pred hcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCcee-eeeecc
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKA-LDCLHS 753 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~-l~~l~~ 753 (827)
++|+..+.||+|+||.||+|++++++.||||++.... ...+.|.+|++++++++|||||+++|+|.+++..+ +++...
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEEecCC
Confidence 5788899999999999999999888889999996543 23467999999999999999999999997655332 233222
Q ss_pred C----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccccc
Q 047196 754 T----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQT 813 (827)
Q Consensus 754 ~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~~ 813 (827)
+ ...++|.++..|+.+||+||+||| +.+|+||||||+||| |||+|+.+........+
T Consensus 96 g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 172 (285)
T d1fmka3 96 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 172 (285)
T ss_dssp CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred CchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCCceeec
Confidence 1 134789999999999999999996 568999999999998 99999887544433334
Q ss_pred cceecccccccccC
Q 047196 814 ETLVTIGYMAPGLL 827 (827)
Q Consensus 814 ~~~gt~~Y~APE~l 827 (827)
...||+.|||||++
T Consensus 173 ~~~gt~~y~aPE~~ 186 (285)
T d1fmka3 173 GAKFPIKWTAPEAA 186 (285)
T ss_dssp ---CCGGGSCHHHH
T ss_pred cccccccccChHHH
Confidence 45589999999974
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1.1e-24 Score=228.18 Aligned_cols=251 Identities=25% Similarity=0.259 Sum_probs=177.3
Q ss_pred CCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEc-cCCcCcc
Q 047196 316 PNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYI-SNCNIGG 394 (827)
Q Consensus 316 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~L-s~N~l~g 394 (827)
+++++|+|++|+|+...+..|.++++|++|++++|++.+..+..+ .... .++.++. ..|.++.
T Consensus 32 ~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~---------------~~~~-~~~~l~~~~~~~~~~ 95 (284)
T d1ozna_ 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAF---------------TGLA-LLEQLDLSDNAQLRS 95 (284)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTT---------------TTCT-TCCEEECCSCTTCCC
T ss_pred CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccc---------------cccc-ccccccccccccccc
Confidence 457788888888887666778888888888888888776544321 1122 4555554 3555666
Q ss_pred ccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCccccC
Q 047196 395 SIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGN 474 (827)
Q Consensus 395 ~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 474 (827)
..|..|.++++|++|++++|.+.+..+..+..+.+|+.+++++|++++..+..|..++.|+.|++++|++++..|..|.+
T Consensus 96 l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~ 175 (284)
T d1ozna_ 96 VDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRG 175 (284)
T ss_dssp CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTT
T ss_pred ccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhcc
Confidence 66777788888888888888877766777777788888888888887666667777777888888888887777777777
Q ss_pred CCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccceeeecccccccCCCCCCEEE
Q 047196 475 LTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDIPSTIGDLKDLQNIS 554 (827)
Q Consensus 475 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ 554 (827)
+++|+++++++|++++..|..|.++++|++||+++|.+++..|..++.+.+|+.|++++|.+.+.-+.. .-...++.+.
T Consensus 176 l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~-~l~~~l~~~~ 254 (284)
T d1ozna_ 176 LHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFR 254 (284)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHHHHHHCC
T ss_pred ccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccch-HHHHHHHhCc
Confidence 888888888888888777777777778888888888887777777777777777777777777654321 1112244455
Q ss_pred CCCCcceeecCCCCcCCceEeCcCCcCee
Q 047196 555 LACNGLEGLIPESFGYLTELNLSFNKLEG 583 (827)
Q Consensus 555 Ls~N~l~g~ip~~~~~L~~L~ls~N~l~g 583 (827)
...+++....|..+......+++.++|+|
T Consensus 255 ~~~~~~~C~~p~~l~g~~l~~l~~~~l~g 283 (284)
T d1ozna_ 255 GSSSEVPCSLPQRLAGRDLKRLAANDLQG 283 (284)
T ss_dssp SEECCCBEEESGGGTTCBGGGSCGGGSCC
T ss_pred CCCCceEeCCchHHcCCccccCCHHHCCC
Confidence 55566666667666666666666666665
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1e-24 Score=225.65 Aligned_cols=146 Identities=27% Similarity=0.390 Sum_probs=112.6
Q ss_pred cccceEecCCceEEEEEEec-CCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecC----C--ceee
Q 047196 678 SKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNE----D--FKAL 748 (827)
Q Consensus 678 ~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~----~--~~~l 748 (827)
+..++||+|+||+||+|+.. +++.||||++... .....+.|.+|++++++++|||||++++++... . +..+
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 44567999999999999865 6899999998653 234457899999999999999999999998642 1 2233
Q ss_pred eeeccC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------eecccccccCCCc
Q 047196 749 DCLHST--------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRLLTGDRS 809 (827)
Q Consensus 749 ~~l~~~--------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGla~~~~~~~~ 809 (827)
+++... ...+++.....++.|+++||+|||. +.++|+||||||+||| |||+|+.......
T Consensus 92 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~-~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~~ 170 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA 170 (270)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSB
T ss_pred eCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHH-CCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCcc
Confidence 433321 2356777788899999999999973 3345999999999998 9999986543322
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
...+||+.|||||++
T Consensus 171 ---~~~~GT~~Y~aPE~~ 185 (270)
T d1t4ha_ 171 ---KAVIGTPEFMAPEMY 185 (270)
T ss_dssp ---EESCSSCCCCCGGGG
T ss_pred ---CCcccCccccCHHHh
Confidence 235699999999974
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=3.9e-25 Score=230.03 Aligned_cols=144 Identities=25% Similarity=0.434 Sum_probs=110.6
Q ss_pred ceEecCCceEEEEEEec---CCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCce-eeeeecc-
Q 047196 681 NLIGVGSFGSVYKGRLH---DGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFK-ALDCLHS- 753 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~---~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~-~l~~l~~- 753 (827)
++||+|+||+||+|.++ .++.||||+++.. .....++|.+|++++++++|||||+++|+|..+... ++++...
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g 92 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 92 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence 57999999999999864 3578999999643 233457899999999999999999999999765532 2333322
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc--ccc
Q 047196 754 -------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI--QTE 814 (827)
Q Consensus 754 -------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~--~~~ 814 (827)
....+++.++..|+.|||+||+||| +++|+||||||+||| |||+|+.+....... ...
T Consensus 93 ~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 169 (277)
T d1xbba_ 93 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169 (277)
T ss_dssp EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC---
T ss_pred cHHHHHhhccCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccc
Confidence 1345788899999999999999996 568999999999998 999999875443322 222
Q ss_pred ceecccccccccC
Q 047196 815 TLVTIGYMAPGLL 827 (827)
Q Consensus 815 ~~gt~~Y~APE~l 827 (827)
..||++|||||++
T Consensus 170 ~~gt~~y~APE~l 182 (277)
T d1xbba_ 170 GKWPVKWYAPECI 182 (277)
T ss_dssp -CCCGGGCCHHHH
T ss_pred cCCCceecCchhh
Confidence 3489999999963
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=3.2e-25 Score=235.73 Aligned_cols=150 Identities=27% Similarity=0.450 Sum_probs=113.4
Q ss_pred hcccccceEecCCceEEEEEEec-CCc----EEEEEEEccc-chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGI----EVAIKVFHQN-CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~----~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l 748 (827)
.+|+..++||+|+||+||+|++. +|+ .||||++... .....++|.+|++++++++|||||+++|+|.+++...+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v 88 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 88 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEE
Confidence 35889999999999999999864 443 5899988643 23446789999999999999999999999988765433
Q ss_pred -eeec---------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 749 -DCLH---------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 749 -~~l~---------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
+++. .....+++..+..++.|||+||+||| +++|+||||||+||| |||+|+......
T Consensus 89 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred EEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 2111 12345778889999999999999996 468999999999998 999999875543
Q ss_pred ccc-cccceecccccccccC
Q 047196 809 SMI-QTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~-~~~~~gt~~Y~APE~l 827 (827)
... .....||+.|||||++
T Consensus 166 ~~~~~~~~~gt~~y~APE~l 185 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESI 185 (317)
T ss_dssp C--------CCTTTSCHHHH
T ss_pred ccccccccccCccccChHHH
Confidence 322 2223489999999974
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.91 E-value=1.3e-24 Score=230.27 Aligned_cols=146 Identities=25% Similarity=0.303 Sum_probs=118.0
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
++|+..+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.++++++|||||++++++.+++..++..
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5788899999999999999986 469999999996532 223567999999999999999999999998887655533
Q ss_pred eccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 751 LHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 751 l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
.+.. ...+.......++.|++.|++||| +++|+||||||+||| |||+|+......
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~-- 158 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-- 158 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB--
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEecccc--
Confidence 3322 233456666779999999999995 778999999999998 999998765332
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
...+||+.|||||++
T Consensus 159 --~~~~Gt~~Y~APE~l 173 (316)
T d1fota_ 159 --YTLCGTPDYIAPEVV 173 (316)
T ss_dssp --CCCCSCTTTCCHHHH
T ss_pred --ccccCcccccCHHHH
Confidence 235699999999974
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.90 E-value=1.1e-24 Score=234.09 Aligned_cols=148 Identities=20% Similarity=0.371 Sum_probs=121.7
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceee--eee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKAL--DCL 751 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l--~~l 751 (827)
+.|+..+.||+|+||+||+|+. .+|+.||||++........+.+.+|++++++++|||||++++++.+++..++ +++
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4688999999999999999986 4799999999987655556788999999999999999999999988775544 333
Q ss_pred cc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee------------eecccccccCCCcc
Q 047196 752 HS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------------DFGIGRLLTGDRSM 810 (827)
Q Consensus 752 ~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------------DFGla~~~~~~~~~ 810 (827)
.. ....++..+...|+.||++||+||| +.+|+||||||+||| |||+|+.+..+...
T Consensus 109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~ 185 (352)
T d1koba_ 109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 185 (352)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCCce
Confidence 21 1234778888999999999999996 578999999999998 99999887654332
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
....||+.|||||++
T Consensus 186 --~~~~gt~~y~aPE~~ 200 (352)
T d1koba_ 186 --KVTTATAEFAAPEIV 200 (352)
T ss_dssp --EEECSSGGGCCHHHH
T ss_pred --eeccCcccccCHHHH
Confidence 334589999999974
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=2.3e-24 Score=229.96 Aligned_cols=149 Identities=26% Similarity=0.293 Sum_probs=120.1
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
++|+..++||+|+||+||+|+. .+|+.||||+++... ....+++.+|+++|++++|||||++++++.+++..++..
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5799999999999999999986 579999999997542 223567899999999999999999999999887665544
Q ss_pred eccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 751 LHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 751 l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
.+... ..+.......++.|++.||+||| +++|+||||||+||| |||+|+........
T Consensus 85 ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~ 161 (337)
T d1o6la_ 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred eccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCCcc
Confidence 43332 23555666779999999999995 678999999999998 99999876543332
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
....+||+.|||||++
T Consensus 162 -~~~~~GT~~Y~aPE~~ 177 (337)
T d1o6la_ 162 -MKTFCGTPEYLAPEVL 177 (337)
T ss_dssp -BCCCEECGGGCCGGGG
T ss_pred -cccceeCHHHhhhhhc
Confidence 2345799999999985
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=2.7e-24 Score=225.97 Aligned_cols=148 Identities=24% Similarity=0.367 Sum_probs=119.4
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc------hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCcee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC------AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKA 747 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~------~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~ 747 (827)
+.|+..+.||+|+||+||+|+. .+|+.||||++.... ....+.|.+|++++++++|||||++++++.+++..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5689999999999999999986 479999999986432 123568999999999999999999999998887655
Q ss_pred eeeeccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee--------------eeccccc
Q 047196 748 LDCLHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF--------------DFGIGRL 803 (827)
Q Consensus 748 l~~l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl--------------DFGla~~ 803 (827)
+...+.. ...+++.....++.|++.||+||| +++|+||||||+||+ |||+|+.
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 5333322 234677778899999999999996 568999999999997 9999987
Q ss_pred ccCCCccccccceecccccccccC
Q 047196 804 LTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 804 ~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
...... .....||+.|||||++
T Consensus 167 ~~~~~~--~~~~~~t~~y~APE~~ 188 (293)
T d1jksa_ 167 IDFGNE--FKNIFGTPEFVAPEIV 188 (293)
T ss_dssp CTTSCB--CSCCCCCGGGCCHHHH
T ss_pred cCCCcc--ccccCCCCcccCHHHH
Confidence 654332 2334689999999974
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=2.2e-24 Score=229.92 Aligned_cols=150 Identities=25% Similarity=0.438 Sum_probs=114.5
Q ss_pred hcccccceEecCCceEEEEEEecC-C-----cEEEEEEEcccc-hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCce
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHD-G-----IEVAIKVFHQNC-AMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFK 746 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~-g-----~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~ 746 (827)
++|+..++||+|+||+||+|+... + ..||||++.... ....+.|.+|+++++++ +|||||+++++|...+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 568888999999999999998642 2 369999986542 33456799999999998 899999999999887654
Q ss_pred ee--eeeccC-------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCc
Q 047196 747 AL--DCLHST-------------------------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPK 793 (827)
Q Consensus 747 ~l--~~l~~~-------------------------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~ 793 (827)
++ ++...+ ...+++..+..|+.|+|+||+||| +++||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCchh
Confidence 44 332211 123677888999999999999996 568999999999
Q ss_pred cee----------eecccccccCCCccc-cccceecccccccccC
Q 047196 794 NVF----------DFGIGRLLTGDRSMI-QTETLVTIGYMAPGLL 827 (827)
Q Consensus 794 NIl----------DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l 827 (827)
||+ |||+|+......... .....||++|||||++
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l 238 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL 238 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHH
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHH
Confidence 998 999998775544322 2334589999999974
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.90 E-value=6.6e-25 Score=231.54 Aligned_cols=149 Identities=26% Similarity=0.360 Sum_probs=104.4
Q ss_pred hhcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeee
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l 751 (827)
.+.|+..+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..++...
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 356888999999999999999865 68999999997543 2234578899999999999999999999988776554332
Q ss_pred ccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------eecccccccCCC
Q 047196 752 HST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------DFGIGRLLTGDR 808 (827)
Q Consensus 752 ~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------------DFGla~~~~~~~ 808 (827)
+.. ...+++.+...++.|++.||+||| +++|+||||||+||+ |||+|+......
T Consensus 88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 221 235778888899999999999996 578999999999998 999998765433
Q ss_pred ccccccceecccccccccC
Q 047196 809 SMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~~~~~~gt~~Y~APE~l 827 (827)
. ....+||+.|||||++
T Consensus 165 ~--~~~~~GT~~y~APE~~ 181 (307)
T d1a06a_ 165 V--LSTACGTPGYVAPEVL 181 (307)
T ss_dssp ----------CTTSCHHHH
T ss_pred e--eeeeeeCccccCcHHH
Confidence 2 2335699999999974
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.90 E-value=1.2e-24 Score=229.55 Aligned_cols=155 Identities=25% Similarity=0.354 Sum_probs=119.0
Q ss_pred HHHHhhcccccceEecCCceEEEEEEec------CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceEEEeeeec
Q 047196 670 LFRATEKFSKENLIGVGSFGSVYKGRLH------DGIEVAIKVFHQNC-AMALKSFEAECEVMKNIRHRNHVKRISSCSN 742 (827)
Q Consensus 670 ~~~~~~~~~~~~~iG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~ 742 (827)
++-..++|+..+.||+|+||+||+|+++ +++.||||++.... ....++|.+|++++++++|||+|+++++|..
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 3334568999999999999999999864 35789999997543 3446789999999999999999999999987
Q ss_pred CCceeeeeeccC----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEc
Q 047196 743 EDFKALDCLHST----------------------------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHC 788 (827)
Q Consensus 743 ~~~~~l~~l~~~----------------------------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHr 788 (827)
.+...+...+.. ...+++..++.|+.|+|+||+||| +++||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHr 164 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHR 164 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEee
Confidence 654433221111 123677889999999999999996 6789999
Q ss_pred cCCCccee----------eecccccccCCCccc-cccceecccccccccC
Q 047196 789 DLKPKNVF----------DFGIGRLLTGDRSMI-QTETLVTIGYMAPGLL 827 (827)
Q Consensus 789 DlK~~NIl----------DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l 827 (827)
||||+||| |||+|+......... .+...||+.|||||++
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~ 214 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI 214 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHH
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHH
Confidence 99999999 999998765433222 2234589999999963
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.90 E-value=3.9e-24 Score=229.68 Aligned_cols=146 Identities=22% Similarity=0.283 Sum_probs=118.2
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~ 750 (827)
++|+..+.||+|+||.||+|+.+ +|+.||||++.... ....+.+.+|++++++++|||||++++++......++..
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999864 79999999986432 223467899999999999999999999998877654433
Q ss_pred eccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 751 LHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 751 l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
.+.. ...++......++.|++.||.||| +.+||||||||+||| |||+|+.+....
T Consensus 121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~-- 195 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-- 195 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB--
T ss_pred ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc--
Confidence 2222 234667778889999999999996 567999999999998 999998775332
Q ss_pred ccccceecccccccccC
Q 047196 811 IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~l 827 (827)
....||+.|||||++
T Consensus 196 --~~~~Gt~~Y~APE~~ 210 (350)
T d1rdqe_ 196 --WTLCGTPEALAPEII 210 (350)
T ss_dssp --CCCEECGGGCCHHHH
T ss_pred --ccccCccccCCHHHH
Confidence 235699999999974
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=3.2e-24 Score=223.01 Aligned_cols=150 Identities=25% Similarity=0.402 Sum_probs=106.5
Q ss_pred hcccccceEecCCceEEEEEEecC----CcEEEEEEEccc-chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc-eee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHD----GIEVAIKVFHQN-CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF-KAL 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~----g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~-~~l 748 (827)
++|+..+.||+|+||.||+|++.. +..||||+++.. .....+.|.+|++++++++|||||++++++.+... .++
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv~ 86 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM 86 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEEEE
Confidence 578888999999999999998642 467999998653 33445789999999999999999999999965442 223
Q ss_pred eeecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 749 DCLHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 749 ~~l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
++... ....+++.++..++.|+++||+||| +++|+||||||+||+ |||+|+.......
T Consensus 87 E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~ 163 (273)
T d1mp8a_ 87 ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 163 (273)
T ss_dssp ECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred EeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence 33221 2345788889999999999999995 578999999999998 9999987654433
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
...+...||+.|||||++
T Consensus 164 ~~~~~~~gt~~y~apE~l 181 (273)
T d1mp8a_ 164 YKASKGKLPIKWMAPESI 181 (273)
T ss_dssp -------CCGGGCCHHHH
T ss_pred eeccceecCcccchhhHh
Confidence 333334589999999974
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=8.2e-24 Score=223.01 Aligned_cols=151 Identities=27% Similarity=0.386 Sum_probs=113.8
Q ss_pred hcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc------eee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF------KAL 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~------~~l 748 (827)
++|...+.||+|+||.||+|++ +|+.||||+++.... ....+++|+..+++++|||||+++++|..++. .++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4566778999999999999986 578999999965432 22234456666678899999999999976542 233
Q ss_pred eeeccC-------CCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEEccCCCccee----------eecccccccC
Q 047196 749 DCLHST-------NCSLNIFDKLNIMIDVASALEYLHFS-----HSTPVIHCDLKPKNVF----------DFGIGRLLTG 806 (827)
Q Consensus 749 ~~l~~~-------~~~l~~~~~~~i~~~ia~~L~~Lh~~-----h~~~iiHrDlK~~NIl----------DFGla~~~~~ 806 (827)
++...+ ...++|.++.+++.++|.|++|+|.. |+++||||||||+||| |||+++....
T Consensus 81 Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~ 160 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp ECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred ecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccC
Confidence 433321 23578889999999999999999953 6789999999999998 9999998755
Q ss_pred CCccc---cccceecccccccccC
Q 047196 807 DRSMI---QTETLVTIGYMAPGLL 827 (827)
Q Consensus 807 ~~~~~---~~~~~gt~~Y~APE~l 827 (827)
..... ....+||++|||||++
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~ 184 (303)
T d1vjya_ 161 ATDTIDIAPNHRVGTKRYMAPEVL 184 (303)
T ss_dssp TTTEECC----CCSCGGGCCHHHH
T ss_pred CCcceeccccceecccCcCChhhc
Confidence 43221 2234599999999973
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=5.8e-24 Score=224.30 Aligned_cols=145 Identities=28% Similarity=0.376 Sum_probs=112.0
Q ss_pred ccceEecCCceEEEEEEec-CCcEEEEEEEcccchH-----HHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 679 KENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAM-----ALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 679 ~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~-----~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
..++||+|+||+||+|+.+ +|+.||||+++..... ..+.+.+|++++++++|||||++++++..++..++...+
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999964 6999999998643221 134689999999999999999999999887755543322
Q ss_pred c----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 753 S----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 753 ~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
. ....++..+...++.|+++||+||| +++|+||||||+||| |||+|+........ .
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~-~ 157 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-Y 157 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-C
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCccc-c
Confidence 1 2345667778899999999999996 678999999999998 99999876544332 2
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
...+||+.|||||++
T Consensus 158 ~~~~gt~~y~aPE~~ 172 (299)
T d1ua2a_ 158 THQVVTRWYRAPELL 172 (299)
T ss_dssp CCSCCCCTTCCHHHH
T ss_pred cceecChhhccHHHH
Confidence 335699999999973
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=7.8e-24 Score=223.07 Aligned_cols=148 Identities=29% Similarity=0.391 Sum_probs=118.8
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCA--MALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l 751 (827)
++|+..+.||+|+||+||+|+. .+|+.||||+++.... ...+++.+|++++++++|||||++++++.+++..++...
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5788999999999999999986 5799999999965432 235679999999999999999999999988776554322
Q ss_pred cc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcc
Q 047196 752 HS-----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSM 810 (827)
Q Consensus 752 ~~-----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~ 810 (827)
+. ....+++.....++.|++.||+||| +++||||||||+||| |||+|+........
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence 21 1345788889999999999999996 577999999999999 99999877544332
Q ss_pred ccccceeccccccccc
Q 047196 811 IQTETLVTIGYMAPGL 826 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~ 826 (827)
.....||+.|+|||+
T Consensus 159 -~~~~~gt~~y~apE~ 173 (298)
T d1gz8a_ 159 -YTHEVVTLWYRAPEI 173 (298)
T ss_dssp -TTCCBCCCTTCCHHH
T ss_pred -ceeecccceeeehhh
Confidence 233569999999996
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.89 E-value=1.1e-23 Score=219.61 Aligned_cols=150 Identities=21% Similarity=0.392 Sum_probs=111.7
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC------
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC---AMALKSFEAECEVMKNIRHRNHVKRISSCSNED------ 744 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~------ 744 (827)
++|+..+.||+|+||+||+|+. .+|+.||||+++... ....++|.+|++++++++|||||++++++...+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 5688899999999999999986 579999999996532 344568999999999999999999999987643
Q ss_pred ceeeeeecc--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccC
Q 047196 745 FKALDCLHS--------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806 (827)
Q Consensus 745 ~~~l~~l~~--------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~ 806 (827)
+.++++... ....+++.+...++.|+++||+||| +++|+||||||+||| |||.++....
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 233444332 1245788888999999999999996 578999999999998 8998876543
Q ss_pred CCcc--ccccceecccccccccC
Q 047196 807 DRSM--IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 807 ~~~~--~~~~~~gt~~Y~APE~l 827 (827)
.... .....+||+.|||||++
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~ 186 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQA 186 (277)
T ss_dssp ---------------TTCCHHHH
T ss_pred ccccccccccccCcccccCHHHH
Confidence 3221 22334699999999974
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=5.3e-24 Score=220.86 Aligned_cols=150 Identities=25% Similarity=0.386 Sum_probs=108.0
Q ss_pred hcccccceEecCCceEEEEEEec--C--CcEEEEEEEccc---chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCcee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH--D--GIEVAIKVFHQN---CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKA 747 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~--~--g~~vAvK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~ 747 (827)
++|+..+.||+|+||.||+|++. + +..||||++... .....++|.+|++++++++|||||+++|+|.++...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~l 87 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 87 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchhe
Confidence 56888899999999999999863 2 247999998643 2334578999999999999999999999997764432
Q ss_pred -eeeecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCC
Q 047196 748 -LDCLHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGD 807 (827)
Q Consensus 748 -l~~l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~ 807 (827)
+++... ....+++..+..++.|+|+||.||| +++|+||||||+||+ |||+++.+...
T Consensus 88 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred eeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 233221 1245788889999999999999996 578999999999998 99999987554
Q ss_pred Cccc--cccceecccccccccC
Q 047196 808 RSMI--QTETLVTIGYMAPGLL 827 (827)
Q Consensus 808 ~~~~--~~~~~gt~~Y~APE~l 827 (827)
.... .....||.+|||||++
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~ 186 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESL 186 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHH
T ss_pred CCcceecCccccCcccCCHHHH
Confidence 3321 2223478999999964
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=7e-24 Score=220.26 Aligned_cols=147 Identities=25% Similarity=0.318 Sum_probs=116.0
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccch------HHHHHHHHHHHHHHhcC--CCCceEEEeeeecCCc
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCA------MALKSFEAECEVMKNIR--HRNHVKRISSCSNEDF 745 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~------~~~~~~~~Ei~~l~~l~--H~niv~~~~~~~~~~~ 745 (827)
++|+..++||+|+||+||+|+. .+|+.||||++..... ...+++.+|++++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 4688899999999999999986 5799999999864321 12234778999999997 8999999999988775
Q ss_pred eeeeeecc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------eeccccc
Q 047196 746 KALDCLHS-----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRL 803 (827)
Q Consensus 746 ~~l~~l~~-----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGla~~ 803 (827)
.++...+. ....+++.+...++.|+++||+||| +++|+||||||+||| |||+|+.
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECcccccee
Confidence 54432221 1235677778899999999999996 678999999999998 9999987
Q ss_pred ccCCCccccccceecccccccccC
Q 047196 804 LTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 804 ~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
..... .+..+||+.|||||++
T Consensus 161 ~~~~~---~~~~~GT~~y~aPE~~ 181 (273)
T d1xwsa_ 161 LKDTV---YTDFDGTRVYSPPEWI 181 (273)
T ss_dssp CCSSC---BCCCCSCGGGSCHHHH
T ss_pred ccccc---ccccccCCCcCCHHHH
Confidence 54332 2345699999999973
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.88 E-value=7.9e-24 Score=221.80 Aligned_cols=149 Identities=28% Similarity=0.408 Sum_probs=118.3
Q ss_pred hcccccceEecCCceEEEEEEecCCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeeec
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCLH 752 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l~ 752 (827)
++|+..++||+|+||+||+|+.++|+.||||++.... ....+++.+|+.++++++|||||++++++..++..++...+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5788899999999999999999899999999996543 22356899999999999999999999999887765553222
Q ss_pred ----------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCcccc
Q 047196 753 ----------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 753 ----------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~~ 812 (827)
.....++......++.|+++||+||| +.+||||||||+||| |||.|......... .
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~-~ 157 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-Y 157 (286)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCccc-c
Confidence 22456788888999999999999996 468999999999998 99999876543221 2
Q ss_pred ccceecccccccccC
Q 047196 813 TETLVTIGYMAPGLL 827 (827)
Q Consensus 813 ~~~~gt~~Y~APE~l 827 (827)
....|++.|+|||++
T Consensus 158 ~~~~~~~~y~~pE~~ 172 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVL 172 (286)
T ss_dssp ----CCCTTCCHHHH
T ss_pred ceecccchhhhHHHH
Confidence 334589999999963
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=2.5e-23 Score=220.37 Aligned_cols=151 Identities=23% Similarity=0.420 Sum_probs=119.0
Q ss_pred hhcccccceEecCCceEEEEEEec------CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCc
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH------DGIEVAIKVFHQNC-AMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDF 745 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~ 745 (827)
.++|+..++||+|+||.||+|++. +++.||||+++... .....+|.+|+++++++ +|||||+++++|.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 367888899999999999999852 46789999997543 34556899999999999 69999999999988765
Q ss_pred eeeeeeccC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-
Q 047196 746 KALDCLHST----------------------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF- 796 (827)
Q Consensus 746 ~~l~~l~~~----------------------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl- 796 (827)
.++...+.. ...+++.++..++.|||+|++||| +++||||||||+||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccccc
Confidence 444222211 124678889999999999999996 567999999999998
Q ss_pred ---------eecccccccCCCcc-ccccceecccccccccC
Q 047196 797 ---------DFGIGRLLTGDRSM-IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 ---------DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~l 827 (827)
|||+++........ ..+...||+.|||||++
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 219 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI 219 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHh
Confidence 99999987654332 23345689999999963
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=3.8e-23 Score=219.49 Aligned_cols=146 Identities=23% Similarity=0.312 Sum_probs=118.1
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeee--ee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALD--CL 751 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~--~l 751 (827)
++|...+.||+|+||+||+|+.. +|+.||||+++.... ..+.+.+|+++|++++|||||++++++.+++..++. ++
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 57888999999999999999865 689999999976543 345688999999999999999999999887755543 22
Q ss_pred cc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee------------eecccccccCCCcc
Q 047196 752 HS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------------DFGIGRLLTGDRSM 810 (827)
Q Consensus 752 ~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------------DFGla~~~~~~~~~ 810 (827)
.. ....+++.+...++.|+++|++||| +.+|+||||||+||| |||+++.......
T Consensus 84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~- 159 (321)
T d1tkia_ 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN- 159 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE-
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccCCc-
Confidence 21 1235778888899999999999996 578999999999998 9999987654332
Q ss_pred ccccceeccccccccc
Q 047196 811 IQTETLVTIGYMAPGL 826 (827)
Q Consensus 811 ~~~~~~gt~~Y~APE~ 826 (827)
.....||+.|+|||+
T Consensus 160 -~~~~~~t~~y~ape~ 174 (321)
T d1tkia_ 160 -FRLLFTAPEYYAPEV 174 (321)
T ss_dssp -EEEEESCGGGSCHHH
T ss_pred -ccccccccccccchh
Confidence 223458999999996
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.88 E-value=6.8e-23 Score=212.62 Aligned_cols=148 Identities=22% Similarity=0.352 Sum_probs=119.3
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc---------hHHHHHHHHHHHHHHhcC-CCCceEEEeeeecC
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC---------AMALKSFEAECEVMKNIR-HRNHVKRISSCSNE 743 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---------~~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~ 743 (827)
++|+..+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++ |||||++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5788899999999999999986 478999999986532 112356889999999997 99999999999887
Q ss_pred Cceee--eeeccC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eeccccc
Q 047196 744 DFKAL--DCLHST--------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRL 803 (827)
Q Consensus 744 ~~~~l--~~l~~~--------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~ 803 (827)
+..++ +++..+ ...+++.+...++.|+++||+||| +++|+||||||+||+ |||+|+.
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchheeE
Confidence 76554 333221 245788888999999999999996 567999999999998 9999988
Q ss_pred ccCCCccccccceecccccccccC
Q 047196 804 LTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 804 ~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
+..... .+..+||+.|+|||++
T Consensus 160 ~~~~~~--~~~~~gt~~y~~PE~~ 181 (277)
T d1phka_ 160 LDPGEK--LREVCGTPSYLAPEII 181 (277)
T ss_dssp CCTTCC--BCCCCSCGGGCCHHHH
T ss_pred ccCCCc--eeeeeccCCCCCHHHh
Confidence 754332 2335699999999963
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.88 E-value=4.3e-23 Score=222.77 Aligned_cols=147 Identities=23% Similarity=0.255 Sum_probs=113.0
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccch---HHHHHHH---HHHHHHHhcCCCCceEEEeeeecCCcee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCA---MALKSFE---AECEVMKNIRHRNHVKRISSCSNEDFKA 747 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~---~Ei~~l~~l~H~niv~~~~~~~~~~~~~ 747 (827)
++|+..++||+|+||.||+|+.. +|+.||||++..... .....+. +|+++++.++|||||++++++..++..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57889999999999999999864 699999999864321 1122333 4467777888999999999998877555
Q ss_pred eeeeccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCC
Q 047196 748 LDCLHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGD 807 (827)
Q Consensus 748 l~~l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~ 807 (827)
+...+... ..+.+.+...++.+++.||+||| +++||||||||+||| |||+|+.+...
T Consensus 84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 43333222 23556677889999999999996 678999999999999 99999876543
Q ss_pred CccccccceecccccccccC
Q 047196 808 RSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 808 ~~~~~~~~~gt~~Y~APE~l 827 (827)
.. ...+||+.|||||++
T Consensus 161 ~~---~~~~GT~~y~APE~~ 177 (364)
T d1omwa3 161 KP---HASVGTHGYMAPEVL 177 (364)
T ss_dssp CC---CSCCSCGGGCCHHHH
T ss_pred cc---cccccccccchhHHh
Confidence 32 234699999999974
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=2.6e-23 Score=219.84 Aligned_cols=151 Identities=25% Similarity=0.366 Sum_probs=118.6
Q ss_pred hhcccccceEecCCceEEEEEEec------CCcEEEEEEEccc-chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCce
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRLH------DGIEVAIKVFHQN-CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFK 746 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~~------~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~ 746 (827)
.++|...+.||+|+||.||+|+++ +++.||||+++.. ..+....|.+|++++++++|||||+++++|..++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 367888899999999999999863 3578999999754 344556799999999999999999999999876655
Q ss_pred eeeeeccCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------
Q 047196 747 ALDCLHSTN--------------------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---------- 796 (827)
Q Consensus 747 ~l~~l~~~~--------------------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---------- 796 (827)
++...+... ..+++..+..|+.++|+||.||| +++|+||||||+|||
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEe
Confidence 543333221 23567778899999999999996 468999999999998
Q ss_pred eecccccccCCCccc-cccceecccccccccC
Q 047196 797 DFGIGRLLTGDRSMI-QTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l 827 (827)
|||+|+.+....... .....||+.|||||++
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l 207 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESL 207 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHH
T ss_pred ecccceeccCCcceeeccceecccccCCHHHH
Confidence 999999775443322 2334589999999963
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=3e-23 Score=219.21 Aligned_cols=145 Identities=26% Similarity=0.437 Sum_probs=112.1
Q ss_pred cceEecCCceEEEEEEecC----CcEEEEEEEcc-cchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC-ce--eeeee
Q 047196 680 ENLIGVGSFGSVYKGRLHD----GIEVAIKVFHQ-NCAMALKSFEAECEVMKNIRHRNHVKRISSCSNED-FK--ALDCL 751 (827)
Q Consensus 680 ~~~iG~G~fg~Vy~~~~~~----g~~vAvK~l~~-~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~-~~--~l~~l 751 (827)
.++||+|+||+||+|++.+ +..||||+++. ......++|.+|++++++++|||||+++|+|...+ .. ++++.
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4689999999999998743 24699999974 34556688999999999999999999999987644 22 23333
Q ss_pred cc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc-
Q 047196 752 HS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI- 811 (827)
Q Consensus 752 ~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~- 811 (827)
.. ......+.+++.++.|+|+||.|+| +++|+||||||+||| |||+++.........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 22 2234567788999999999999995 678999999999999 999999875443221
Q ss_pred --cccceecccccccccC
Q 047196 812 --QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 --~~~~~gt~~Y~APE~l 827 (827)
.....||+.|+|||++
T Consensus 189 ~~~~~~~gt~~y~aPE~~ 206 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESL 206 (311)
T ss_dssp TCTTCSSCCGGGSCHHHH
T ss_pred eecccccccccccChHHH
Confidence 2234589999999963
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=4.2e-22 Score=206.15 Aligned_cols=177 Identities=20% Similarity=0.149 Sum_probs=125.8
Q ss_pred cccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecC
Q 047196 381 SLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLA 460 (827)
Q Consensus 381 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 460 (827)
++++|+|++|+|++..+..|.++++|++|+|++|+|+. +| .++.+++|++|+|++|++++ ++..+.++++|++|+++
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~ 108 (266)
T d1p9ag_ 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVS 108 (266)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECC
T ss_pred CCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-cccccccccccccccccccc-ccccccccccccccccc
Confidence 56777777777776666677777777777777777764 33 34567777777777777763 45566777777777777
Q ss_pred CCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccceeeecc
Q 047196 461 GNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDI 540 (827)
Q Consensus 461 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~i 540 (827)
+|++.+..+..+..+.+++.|++++|.+++..+..+..+++++.+++++|++++..+..++.+++|+.|||++|+|+ .+
T Consensus 109 ~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~l 187 (266)
T d1p9ag_ 109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TI 187 (266)
T ss_dssp SSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CC
T ss_pred ccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-cc
Confidence 77777666666677777777777777777766666677777777777777777766666777777777777777777 66
Q ss_pred cccccCCCCCCEEECCCCcce
Q 047196 541 PSTIGDLKDLQNISLACNGLE 561 (827)
Q Consensus 541 p~~~~~l~~L~~L~Ls~N~l~ 561 (827)
|+.+..+++|+.|+|++|.+.
T Consensus 188 p~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 188 PKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp CTTTTTTCCCSEEECCSCCBC
T ss_pred ChhHCCCCCCCEEEecCCCCC
Confidence 777777777777777777553
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=5e-23 Score=217.02 Aligned_cols=150 Identities=22% Similarity=0.403 Sum_probs=106.9
Q ss_pred hcccccceEecCCceEEEEEEec------CCcEEEEEEEcccc-hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCc-
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH------DGIEVAIKVFHQNC-AMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDF- 745 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~- 745 (827)
++|+..+.||+|+||+||+|+.. +++.||||++.... ....+++.+|++++.++ +|+|||++++++...+.
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 57888999999999999999853 34689999986543 34456788899888887 58899999999876542
Q ss_pred --eeeeeeccC------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---
Q 047196 746 --KALDCLHST------------------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF--- 796 (827)
Q Consensus 746 --~~l~~l~~~------------------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl--- 796 (827)
..+++...+ ...+++.++..++.|+|+||+||| +++||||||||+|||
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeECC
Confidence 223333211 123678888999999999999996 568999999999998
Q ss_pred -------eecccccccCCCccc-cccceecccccccccC
Q 047196 797 -------DFGIGRLLTGDRSMI-QTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 -------DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l 827 (827)
|||+|+......... .....||+.|||||++
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l 208 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 208 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHh
Confidence 999998765443332 2334599999999974
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=3.8e-23 Score=212.68 Aligned_cols=143 Identities=28% Similarity=0.449 Sum_probs=106.4
Q ss_pred hcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC-ceee--eee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNED-FKAL--DCL 751 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~-~~~l--~~l 751 (827)
++|+..+.||+|+||.||+|+++ |+.||||+++... ..++|.+|++++++++|||||+++|+|.+++ ..++ ++.
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 56777899999999999999985 7889999996543 3467999999999999999999999986543 2223 333
Q ss_pred ccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 752 HST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 752 ~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
..+ ...++|..+++|+.|||.|++||| +++|+||||||+||+ |||+++......
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--- 157 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 157 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCCC---
Confidence 221 123678889999999999999996 568999999999998 999998654332
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
....+|+.|||||++
T Consensus 158 -~~~~~~~~y~aPE~l 172 (262)
T d1byga_ 158 -DTGKLPVKWTAPEAL 172 (262)
T ss_dssp -----CCTTTSCHHHH
T ss_pred -ccccccccCCChHHH
Confidence 223479999999974
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=8.1e-23 Score=216.69 Aligned_cols=149 Identities=20% Similarity=0.280 Sum_probs=117.0
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccc---hHHHHHHHHHHHHHH-hcCCCCceEEEeeeecCCceeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNC---AMALKSFEAECEVMK-NIRHRNHVKRISSCSNEDFKALD 749 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~Ei~~l~-~l~H~niv~~~~~~~~~~~~~l~ 749 (827)
++|...+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+.++. .++|||||++++++.+++..++.
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57888999999999999999864 68999999996532 223456777887765 68999999999999988766554
Q ss_pred eeccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCc
Q 047196 750 CLHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRS 809 (827)
Q Consensus 750 ~l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~ 809 (827)
..+... ..++..+...++.||+.||+||| +++|+||||||+||| |||+|+.......
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 433322 34566777889999999999996 567999999999999 9999987654332
Q ss_pred cccccceecccccccccC
Q 047196 810 MIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 810 ~~~~~~~gt~~Y~APE~l 827 (827)
. .+..+||+.|||||++
T Consensus 159 ~-~~~~~gt~~y~aPE~~ 175 (320)
T d1xjda_ 159 K-TNTFCGTPDYIAPEIL 175 (320)
T ss_dssp C-BCCCCSCGGGCCHHHH
T ss_pred c-ccccCCCCCcCCHHHH
Confidence 2 2335699999999974
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=4.4e-23 Score=218.22 Aligned_cols=148 Identities=28% Similarity=0.467 Sum_probs=112.5
Q ss_pred hcccccceEecCCceEEEEEEec-CCc--EEEEEEEccc-chHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCCceeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGI--EVAIKVFHQN-CAMALKSFEAECEVMKNI-RHRNHVKRISSCSNEDFKALD 749 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~--~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~~~~l~ 749 (827)
++|+..++||+|+||+||+|+++ +|. .||||++... .....++|.+|+++++++ +|||||+++|+|.+++..++.
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 56788899999999999999875 454 5788888643 333456899999999999 799999999999987765543
Q ss_pred eeccC--------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------
Q 047196 750 CLHST--------------------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------- 796 (827)
Q Consensus 750 ~l~~~--------------------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------- 796 (827)
..+.. ...+++.++..++.|||+|+.|+| +++|+||||||+|||
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence 32211 245788889999999999999996 568999999999998
Q ss_pred ---eecccccccCCCccccccceecccccccccC
Q 047196 797 ---DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 ---DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
|||+|+....... .....||+.|+|||++
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l 198 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESL 198 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHH
T ss_pred EEcccccccccccccc--ccceecCCcccchHHh
Confidence 9999986543222 1223489999999964
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=5.7e-22 Score=205.17 Aligned_cols=195 Identities=23% Similarity=0.216 Sum_probs=173.0
Q ss_pred cccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecC
Q 047196 381 SLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLA 460 (827)
Q Consensus 381 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 460 (827)
.+.+++.++++++ .+|..+. +++++|||++|+|++..+..|.++++|++|+|++|+|+ .+| .+..+++|++|+|+
T Consensus 11 ~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls 85 (266)
T d1p9ag_ 11 SHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLS 85 (266)
T ss_dssp TCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECC
T ss_pred CCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-cccccccccccccc
Confidence 5667899999998 4676553 58999999999999888889999999999999999998 444 35789999999999
Q ss_pred CCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccceeeecc
Q 047196 461 GNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDI 540 (827)
Q Consensus 461 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~i 540 (827)
+|++++ +|..+..+++|+.|++++|.+.+..+..+..+.++..|++++|.++...+..+..++.++.+++++|+|++..
T Consensus 86 ~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~ 164 (266)
T d1p9ag_ 86 HNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELP 164 (266)
T ss_dssp SSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCC
T ss_pred cccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccC
Confidence 999984 6778999999999999999999999999999999999999999999888888899999999999999999988
Q ss_pred cccccCCCCCCEEECCCCcceeecCCCC---cCCceEeCcCCcCe
Q 047196 541 PSTIGDLKDLQNISLACNGLEGLIPESF---GYLTELNLSFNKLE 582 (827)
Q Consensus 541 p~~~~~l~~L~~L~Ls~N~l~g~ip~~~---~~L~~L~ls~N~l~ 582 (827)
+..|..+++|+.|||++|+|+ .+|+.+ .+|+.|+|++|.+.
T Consensus 165 ~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 165 AGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp TTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred ccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 899999999999999999999 677654 37888998888764
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=1.9e-22 Score=216.91 Aligned_cols=151 Identities=25% Similarity=0.352 Sum_probs=115.0
Q ss_pred hhcccccceEecCCceEEEEEEe-cCCcEEEEEEEccc-chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc------
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQN-CAMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF------ 745 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~------ 745 (827)
+.+|+..+.||+|+||+||+|+. .+|+.||||+++.. .....+++.+|+++|++++|||+|++++++....+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35688899999999999999985 57999999999753 34456789999999999999999999999876542
Q ss_pred eeeeeecc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 746 KALDCLHS-------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 746 ~~l~~l~~-------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
.+++.+.. ....+++.....++.|+++||+||| +++||||||||+||| |||+|+......
T Consensus 87 ~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp EEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 12222221 1235677788899999999999996 568999999999998 999998764332
Q ss_pred cc--ccccceecccccccccC
Q 047196 809 SM--IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~--~~~~~~gt~~Y~APE~l 827 (827)
.. .....+||+.|+|||++
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l 184 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIM 184 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGT
T ss_pred ccceeeccccccceechHHHh
Confidence 21 12335589999999975
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=1.4e-22 Score=213.27 Aligned_cols=150 Identities=27% Similarity=0.422 Sum_probs=112.3
Q ss_pred hcccccceEecCCceEEEEEEecC--------CcEEEEEEEcccc-hHHHHHHHHHHHHHHhc-CCCCceEEEeeeecCC
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLHD--------GIEVAIKVFHQNC-AMALKSFEAECEVMKNI-RHRNHVKRISSCSNED 744 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~~--------g~~vAvK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~~ 744 (827)
++|...+.||+|+||.||+|+... +..||||+++... .....++.+|+..+.++ +|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 578888999999999999998532 3579999997654 34457899999999998 8999999999998876
Q ss_pred ceee--eeeccC------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee--
Q 047196 745 FKAL--DCLHST------------------------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-- 796 (827)
Q Consensus 745 ~~~l--~~l~~~------------------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-- 796 (827)
..++ +++..+ ...+++.++..++.|+|+||+||| +++||||||||+|||
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceeec
Confidence 5443 222111 124688889999999999999995 678999999999998
Q ss_pred --------eecccccccCCCccc-cccceecccccccccC
Q 047196 797 --------DFGIGRLLTGDRSMI-QTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 --------DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~l 827 (827)
|||+++......... .....||+.|||||++
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l 209 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 209 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHH
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHh
Confidence 999998876544332 2234589999999963
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=1.4e-22 Score=218.37 Aligned_cols=147 Identities=24% Similarity=0.403 Sum_probs=111.7
Q ss_pred hhcccccceEecCCceEEEEEEe-cCCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC------
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNED------ 744 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~------ 744 (827)
.++|+..+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+++|++++|||+|++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 35788899999999999999986 46999999999743 3344578899999999999999999999987654
Q ss_pred --ceeeeeecc------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccC
Q 047196 745 --FKALDCLHS------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806 (827)
Q Consensus 745 --~~~l~~l~~------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~ 806 (827)
+..++++.. ....+++.....++.|++.||+||| +.+|+||||||+||| |||+|+....
T Consensus 97 ~~~lv~e~~~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 97 DFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp CCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eEEEEEecccccHHHHHHhccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceeccCC
Confidence 222333211 1245788888999999999999996 578999999999999 9999987643
Q ss_pred CCccccccceecccccccccC
Q 047196 807 DRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 807 ~~~~~~~~~~gt~~Y~APE~l 827 (827)
.. +..+||+.|||||++
T Consensus 174 ~~----~~~~~t~~y~aPE~~ 190 (346)
T d1cm8a_ 174 EM----TGYVVTRWYRAPEVI 190 (346)
T ss_dssp SC----CSSCSCGGGCCTHHH
T ss_pred cc----ccccccccccCHHHH
Confidence 32 335689999999963
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=3.1e-22 Score=213.53 Aligned_cols=143 Identities=24% Similarity=0.408 Sum_probs=110.8
Q ss_pred hccccc-ceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhc-CCCCceEEEeeeecC----C--c
Q 047196 675 EKFSKE-NLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNI-RHRNHVKRISSCSNE----D--F 745 (827)
Q Consensus 675 ~~~~~~-~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~~~~~~~~~----~--~ 745 (827)
++|... ++||+|+||+||+|+. .+|+.||||+++.. +.+.+|++++.++ +|||||++++++.+. . +
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 567765 4699999999999986 57899999998643 3467899987655 899999999987541 2 2
Q ss_pred eeeeeeccC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------eecccc
Q 047196 746 KALDCLHST----------NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------DFGIGR 802 (827)
Q Consensus 746 ~~l~~l~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------------DFGla~ 802 (827)
.+++++..+ ...+++.+...|+.|++.||+||| +.+|+||||||+||| |||+|+
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccceee
Confidence 233333221 234778888999999999999996 678999999999998 999998
Q ss_pred cccCCCccccccceecccccccccC
Q 047196 803 LLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 803 ~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
........ ...+||++|||||++
T Consensus 163 ~~~~~~~~--~~~~gt~~y~aPE~~ 185 (335)
T d2ozaa1 163 ETTSHNSL--TTPCYTPYYVAPEVL 185 (335)
T ss_dssp ECCCCCCC--CCCSCCCSSCCCCCC
T ss_pred eccCCCcc--ccccCCcccCCcHHH
Confidence 77544332 335699999999985
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.86 E-value=4.5e-22 Score=212.60 Aligned_cols=144 Identities=21% Similarity=0.383 Sum_probs=114.9
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcC-CCCceEEEeeeecCC--cee--e
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIR-HRNHVKRISSCSNED--FKA--L 748 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~--~~~--l 748 (827)
++|+..++||+|+||+||+|+. .+|+.||||+++... .+++.+|+++|++++ |||||++++++.... ..+ +
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5789999999999999999986 568999999996543 356889999999996 999999999986542 222 2
Q ss_pred eeeccC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------eecccccccCCCcccc
Q 047196 749 DCLHST-----NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRLLTGDRSMIQ 812 (827)
Q Consensus 749 ~~l~~~-----~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGla~~~~~~~~~~~ 812 (827)
+++... ...++..+...++.|+++||+||| +++|+||||||+||| |||+|+....... .
T Consensus 112 e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~--~ 186 (328)
T d3bqca1 112 EHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--Y 186 (328)
T ss_dssp ECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC--C
T ss_pred eecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCCc--c
Confidence 332221 235677888899999999999996 678999999999998 9999987654432 2
Q ss_pred ccceeccccccccc
Q 047196 813 TETLVTIGYMAPGL 826 (827)
Q Consensus 813 ~~~~gt~~Y~APE~ 826 (827)
...+||+.|+|||+
T Consensus 187 ~~~~~t~~y~aPE~ 200 (328)
T d3bqca1 187 NVRVASRYFKGPEL 200 (328)
T ss_dssp CSCCSCGGGCCHHH
T ss_pred cccccCccccCccc
Confidence 33468999999996
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=1.7e-22 Score=213.78 Aligned_cols=149 Identities=28% Similarity=0.458 Sum_probs=110.0
Q ss_pred hhcccccceEecCCceEEEEEEe-cC-CcEEEEEEEcccch--HHHHHHHHHHHHHHhc---CCCCceEEEeeeecCC--
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRL-HD-GIEVAIKVFHQNCA--MALKSFEAECEVMKNI---RHRNHVKRISSCSNED-- 744 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~-~~-g~~vAvK~l~~~~~--~~~~~~~~Ei~~l~~l---~H~niv~~~~~~~~~~-- 744 (827)
.++|+..+.||+|+||+||+|+. ++ ++.||||+++.... .....+.+|+++++.+ +|||||++++++....
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46799999999999999999986 34 67899999864321 1233566788877766 7999999999885321
Q ss_pred ---ceee--eeecc---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecc
Q 047196 745 ---FKAL--DCLHS---------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGI 800 (827)
Q Consensus 745 ---~~~l--~~l~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGl 800 (827)
..++ +++.. ....+++.....++.|++.||+||| +++|+||||||+||| |||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchhh
Confidence 1122 22211 1234667777889999999999996 578999999999999 9999
Q ss_pred cccccCCCccccccceecccccccccC
Q 047196 801 GRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 801 a~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
++....... ....+||+.|||||++
T Consensus 163 ~~~~~~~~~--~~~~~gT~~Y~APE~~ 187 (305)
T d1blxa_ 163 ARIYSFQMA--LTSVVVTLWYRAPEVL 187 (305)
T ss_dssp CCCCCGGGG--GCCCCCCCTTCCHHHH
T ss_pred hhhhccccc--CCCcccChhhcCcchh
Confidence 886543322 2345699999999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=4.2e-22 Score=214.58 Aligned_cols=142 Identities=29% Similarity=0.434 Sum_probs=111.5
Q ss_pred cccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC------cee-
Q 047196 676 KFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSNED------FKA- 747 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~------~~~- 747 (827)
+|+..++||+|+||+||+|+.. +|+.||||++..... .+.+|+++|++++|+|||++++++.... +.+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5888899999999999999974 699999999965432 2357999999999999999999985422 122
Q ss_pred -eeeecc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-----------eecccccc
Q 047196 748 -LDCLHS-----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-----------DFGIGRLL 804 (827)
Q Consensus 748 -l~~l~~-----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-----------DFGla~~~ 804 (827)
++++.. ....+++.+...++.|+++||+||| +++|+||||||+||| |||+|+..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 233211 1235778888899999999999995 689999999999998 99999876
Q ss_pred cCCCccccccceeccccccccc
Q 047196 805 TGDRSMIQTETLVTIGYMAPGL 826 (827)
Q Consensus 805 ~~~~~~~~~~~~gt~~Y~APE~ 826 (827)
...... ...+||+.|+|||+
T Consensus 174 ~~~~~~--~~~~gt~~y~aPE~ 193 (350)
T d1q5ka_ 174 VRGEPN--VSYICSRYYRAPEL 193 (350)
T ss_dssp CTTSCC--CSCCSCTTSCCHHH
T ss_pred cCCccc--ccccccccccChHH
Confidence 544322 33569999999996
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.85 E-value=2.3e-22 Score=211.90 Aligned_cols=147 Identities=26% Similarity=0.414 Sum_probs=112.5
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceEEEeeeec-CCceee--ee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNHVKRISSCSN-EDFKAL--DC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~-~~~~~l--~~ 750 (827)
++|+..+.||+|+||+||+|+. .+|+.||||++..... .+++.+|++++++++|+|+|..++.|.. .+..++ ++
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 4688899999999999999986 4689999999865432 2457899999999999887777666644 343332 22
Q ss_pred ecc--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee-------------eecccccccCCCc
Q 047196 751 LHS--------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF-------------DFGIGRLLTGDRS 809 (827)
Q Consensus 751 l~~--------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl-------------DFGla~~~~~~~~ 809 (827)
+.. ....+++.....++.|+++||+||| +++|+||||||+||+ |||+|+.+.....
T Consensus 85 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 85 LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred cCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 211 2345788888999999999999996 577999999999996 9999998754332
Q ss_pred c------ccccceeccccccccc
Q 047196 810 M------IQTETLVTIGYMAPGL 826 (827)
Q Consensus 810 ~------~~~~~~gt~~Y~APE~ 826 (827)
. .....+||+.|||||+
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~ 184 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINT 184 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHH
T ss_pred ccceeccccCCcCCCccccCHHH
Confidence 1 1223459999999996
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.85 E-value=3.2e-22 Score=212.89 Aligned_cols=151 Identities=27% Similarity=0.427 Sum_probs=111.6
Q ss_pred hhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCc-----
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDF----- 745 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~----- 745 (827)
.++|+..+.||+|+||+||+|+. .+|+.||||++.... ....+++.+|+++|++++|||++++++.+.....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 36899999999999999999986 579999999985432 2234678999999999999999999998865321
Q ss_pred ---e--eeeeecc--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccc
Q 047196 746 ---K--ALDCLHS--------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGR 802 (827)
Q Consensus 746 ---~--~l~~l~~--------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~ 802 (827)
. .+++... ............|+.|+++|+.||| +.+|+||||||+||| |||+|+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecceee
Confidence 1 1222211 1234556677889999999999996 678999999999999 999998
Q ss_pred cccCCCcc---ccccceecccccccccC
Q 047196 803 LLTGDRSM---IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 803 ~~~~~~~~---~~~~~~gt~~Y~APE~l 827 (827)
.+...... .....+||++|+|||++
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~ 193 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELL 193 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHH
T ss_pred ecccccccccccccceecCHHHhhHHHH
Confidence 76543221 12234689999999963
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.85 E-value=6.8e-22 Score=207.68 Aligned_cols=149 Identities=26% Similarity=0.358 Sum_probs=119.1
Q ss_pred hcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCCceeeeee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNEDFKALDCL 751 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~~~~l~~l 751 (827)
++|+..+.||+|+||+||+|+. .+|+.||||+++... ....+++.+|++++++++|||||++.+++...+...+...
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 4788899999999999999986 478999999986432 3346789999999999999999999999988876554322
Q ss_pred cc----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCCccc
Q 047196 752 HS----------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDRSMI 811 (827)
Q Consensus 752 ~~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~~~~ 811 (827)
.. ......+.....++.|+++||+||| +.+|+||||||+||| |||.|+........
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~- 157 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC- 157 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC-
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCcc-
Confidence 21 2345677788899999999999996 568999999999998 99999887544332
Q ss_pred cccceecccccccccC
Q 047196 812 QTETLVTIGYMAPGLL 827 (827)
Q Consensus 812 ~~~~~gt~~Y~APE~l 827 (827)
.....+++.|+|||++
T Consensus 158 ~~~~~~~~~~~~pe~~ 173 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVL 173 (292)
T ss_dssp CCSCCSCGGGCCHHHH
T ss_pred ceeeccccchhhhhHh
Confidence 2223478899999963
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.85 E-value=7.2e-22 Score=207.15 Aligned_cols=148 Identities=18% Similarity=0.229 Sum_probs=113.8
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEcccchHHHHHHHHHHHHHHhcCC-CCceEEEeeeecCCceee--ee
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQNCAMALKSFEAECEVMKNIRH-RNHVKRISSCSNEDFKAL--DC 750 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H-~niv~~~~~~~~~~~~~l--~~ 750 (827)
++|+..+.||+|+||+||+|+.. +|+.||||++.... ..+.+.+|+++++.++| +|++.+.+++......++ ++
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 57888999999999999999864 68999999986532 22357789999999986 788888888877664443 22
Q ss_pred ec--------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------------eecccccccCC
Q 047196 751 LH--------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---------------DFGIGRLLTGD 807 (827)
Q Consensus 751 l~--------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---------------DFGla~~~~~~ 807 (827)
+. .....+...+...++.+++.||+||| +.+|+||||||+||+ |||+|+.+...
T Consensus 83 ~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 83 LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred cCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 21 11235677888899999999999995 788999999999987 99999987543
Q ss_pred Ccc------ccccceecccccccccC
Q 047196 808 RSM------IQTETLVTIGYMAPGLL 827 (827)
Q Consensus 808 ~~~------~~~~~~gt~~Y~APE~l 827 (827)
... .....+||+.|||||++
T Consensus 160 ~~~~~~~~~~~~~~~GT~~y~aPE~~ 185 (293)
T d1csna_ 160 VTKQHIPYREKKNLSGTARYMSINTH 185 (293)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHH
T ss_pred ccccceeecccCceEEchhhcCHHHh
Confidence 221 12234599999999963
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=2e-21 Score=209.68 Aligned_cols=148 Identities=24% Similarity=0.321 Sum_probs=107.0
Q ss_pred hcccccceEecCCceEEEEEEec-CCcEEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC------c
Q 047196 675 EKFSKENLIGVGSFGSVYKGRLH-DGIEVAIKVFHQN--CAMALKSFEAECEVMKNIRHRNHVKRISSCSNED------F 745 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~------~ 745 (827)
++|+..++||+|+||+||+|+.. +|+.||||++... .....+++.+|+.++++++|||||++++++...+ .
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 56888999999999999999865 6999999999753 2344567899999999999999999999986432 2
Q ss_pred --eeeeeeccC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccCCC
Q 047196 746 --KALDCLHST-----NCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTGDR 808 (827)
Q Consensus 746 --~~l~~l~~~-----~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~~~ 808 (827)
..++++... ...+++.+...++.|++.|++||| +.+|+||||||+||| |||+++......
T Consensus 97 ~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~ 173 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173 (355)
T ss_dssp EEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred eEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhcccccc
Confidence 233333221 245677888899999999999996 568999999999999 899888764432
Q ss_pred ccccccceecccccccccC
Q 047196 809 SMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 809 ~~~~~~~~gt~~Y~APE~l 827 (827)
. .+..+||+.|+|||++
T Consensus 174 ~--~~~~~~t~~y~aPE~l 190 (355)
T d2b1pa1 174 M--MTPYVVTRYYRAPEVI 190 (355)
T ss_dssp ---------CCTTCCHHHH
T ss_pred c--cccccccccccChhhh
Confidence 2 2334589999999974
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.82 E-value=1.8e-18 Score=185.77 Aligned_cols=309 Identities=23% Similarity=0.272 Sum_probs=178.2
Q ss_pred cEEEEEcCCCCCccccCccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcC
Q 047196 99 RVTALNISSLNLQGTIPPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLD 178 (827)
Q Consensus 99 ~v~~L~L~~~~l~g~~~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~ 178 (827)
+++.|||++++++. +|+. +++|++|+|++|+|+ .+|+. +.+|+.|++++|+++.. +
T Consensus 39 ~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~~l-~--------------- 94 (353)
T d1jl5a_ 39 QAHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLKAL-S--------------- 94 (353)
T ss_dssp TCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSCC-C---------------
T ss_pred CCCEEEeCCCCCCC-CCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccchh-h---------------
Confidence 46678888888874 5643 467888888888887 66754 35678888888877621 1
Q ss_pred CCCCCCCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEccccccccc
Q 047196 179 SDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGE 258 (827)
Q Consensus 179 ~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 258 (827)
.+ .+.|++|++++|.+. .+|. ++++++|++|++++|.++... . ....+..+.+.++...
T Consensus 95 ------~l-------p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~-~---~~~~l~~l~~~~~~~~-- 153 (353)
T d1jl5a_ 95 ------DL-------PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLP-D---LPPSLEFIAAGNNQLE-- 153 (353)
T ss_dssp ------SC-------CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSCCC-C---CCTTCCEEECCSSCCS--
T ss_pred ------hh-------ccccccccccccccc-cccc-hhhhccceeeccccccccccc-c---ccccccchhhcccccc--
Confidence 11 125777777777776 3443 567777888888777776432 2 2345566666655543
Q ss_pred ccccccCcCCCcEEEeecccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccC
Q 047196 259 IPHEIGYLPNLENLVLGFNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITN 338 (827)
Q Consensus 259 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 338 (827)
.+..+..++.++.++++.|.+...... ....+.+....+.+ ..++.. ..++.|+.+++++|.... +|. .
T Consensus 154 ~~~~l~~l~~l~~L~l~~n~~~~~~~~----~~~~~~l~~~~~~~-~~~~~~--~~l~~L~~l~l~~n~~~~-~~~---~ 222 (353)
T d1jl5a_ 154 ELPELQNLPFLTAIYADNNSLKKLPDL----PLSLESIVAGNNIL-EELPEL--QNLPFLTTIYADNNLLKT-LPD---L 222 (353)
T ss_dssp SCCCCTTCTTCCEEECCSSCCSSCCCC----CTTCCEEECCSSCC-SSCCCC--TTCTTCCEEECCSSCCSS-CCS---C
T ss_pred ccccccccccceecccccccccccccc----cccccccccccccc-cccccc--cccccccccccccccccc-ccc---c
Confidence 344566777778888877776543211 12233444443332 222221 256777888887776653 332 2
Q ss_pred CCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCccccc
Q 047196 339 ASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTG 418 (827)
Q Consensus 339 l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g 418 (827)
..++..+++.++.+..... ....+...++..+.+.+. +.. .......++..|.+.+
T Consensus 223 ~~~l~~~~~~~~~~~~~~~--------------------~~~~l~~~~~~~~~~~~l-~~l---~~~~~~~~~~~~~~~~ 278 (353)
T d1jl5a_ 223 PPSLEALNVRDNYLTDLPE--------------------LPQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRS 278 (353)
T ss_dssp CTTCCEEECCSSCCSCCCC--------------------CCTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSE
T ss_pred ccccccccccccccccccc--------------------cccccccccccccccccc-ccc---cchhcccccccCcccc
Confidence 3456677777766543211 011344555555554431 110 1233455555555543
Q ss_pred cccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCccccCCCcccccCCccccc
Q 047196 419 SIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWN 498 (827)
Q Consensus 419 ~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 498 (827)
. ...+++|++|+|++|+++ .+|.. +++|+.|+|++|+++ .+|.. +++|++|++++|+++. +|.....
T Consensus 279 ~----~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~~-lp~~~~~ 345 (353)
T d1jl5a_ 279 L----CDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLRE-FPDIPES 345 (353)
T ss_dssp E----CCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSS-CCCCCTT
T ss_pred c----cccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCCC-CCccccc
Confidence 2 233566777777777776 45543 456777777777776 45543 3567777777777763 4544333
Q ss_pred cc
Q 047196 499 LK 500 (827)
Q Consensus 499 l~ 500 (827)
+.
T Consensus 346 L~ 347 (353)
T d1jl5a_ 346 VE 347 (353)
T ss_dssp CC
T ss_pred cC
Confidence 33
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.81 E-value=6e-21 Score=205.63 Aligned_cols=146 Identities=25% Similarity=0.397 Sum_probs=110.7
Q ss_pred hhcccccceEecCCceEEEEEEe-cCCcEEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceEEEeeeecCC------
Q 047196 674 TEKFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNC--AMALKSFEAECEVMKNIRHRNHVKRISSCSNED------ 744 (827)
Q Consensus 674 ~~~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~~~~~~~~~~------ 744 (827)
.++|+..+.||+|+||+||+|+. .+|+.||||+++... ....+++.+|++++++++|||+|++++++....
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46799999999999999999985 579999999997542 334567899999999999999999998875321
Q ss_pred -ceeeeeecc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eecccccccC
Q 047196 745 -FKALDCLHS-------TNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLTG 806 (827)
Q Consensus 745 -~~~l~~l~~-------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~~ 806 (827)
..+++++.. ....++..+...++.|++.||+||| +++|+||||||+||| |||+|.....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred eEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhcccCc
Confidence 122222221 1235778888899999999999996 568999999999998 8888865432
Q ss_pred CCccccccceeccccccccc
Q 047196 807 DRSMIQTETLVTIGYMAPGL 826 (827)
Q Consensus 807 ~~~~~~~~~~gt~~Y~APE~ 826 (827)
. .....||+.|+|||+
T Consensus 174 ~----~~~~~g~~~y~apE~ 189 (348)
T d2gfsa1 174 E----MTGYVATRWYRAPEI 189 (348)
T ss_dssp G----GSSSCHHHHTSCHHH
T ss_pred c----cccccccccccCchh
Confidence 2 233458999999996
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.81 E-value=5.4e-21 Score=202.78 Aligned_cols=149 Identities=26% Similarity=0.320 Sum_probs=115.2
Q ss_pred hcccccceEecCCceEEEEEEe----cCCcEEEEEEEcccc----hHHHHHHHHHHHHHHhcCC-CCceEEEeeeecCCc
Q 047196 675 EKFSKENLIGVGSFGSVYKGRL----HDGIEVAIKVFHQNC----AMALKSFEAECEVMKNIRH-RNHVKRISSCSNEDF 745 (827)
Q Consensus 675 ~~~~~~~~iG~G~fg~Vy~~~~----~~g~~vAvK~l~~~~----~~~~~~~~~Ei~~l~~l~H-~niv~~~~~~~~~~~ 745 (827)
++|+..+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++| ||||++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6799999999999999999975 248999999986432 2234568899999999987 799999999888776
Q ss_pred eeeeeeccCC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee----------eeccccccc
Q 047196 746 KALDCLHSTN----------CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF----------DFGIGRLLT 805 (827)
Q Consensus 746 ~~l~~l~~~~----------~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl----------DFGla~~~~ 805 (827)
.++...+... ..........++.|++.|++|+| +.+|+||||||+||+ |||+|+.+.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 5554333222 23445556778899999999996 578999999999998 999998765
Q ss_pred CCCccccccceeccccccccc
Q 047196 806 GDRSMIQTETLVTIGYMAPGL 826 (827)
Q Consensus 806 ~~~~~~~~~~~gt~~Y~APE~ 826 (827)
...........||+.|+|||+
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~ 201 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDI 201 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHH
T ss_pred ccccccccccccccccchhHH
Confidence 433333334558999999996
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.81 E-value=5.5e-18 Score=181.87 Aligned_cols=199 Identities=25% Similarity=0.243 Sum_probs=108.4
Q ss_pred cccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEee
Q 047196 196 YLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLG 275 (827)
Q Consensus 196 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 275 (827)
++++|||++|.++ .+|+. +++|++|++++|+|+ .+|..+ .+|+.|++++|+++ .++.. .+.|++|+++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---cccccccccc
Confidence 5667777777665 35543 356677777777776 455543 45666777777665 23321 1357777777
Q ss_pred cccCcccCchhhhcCCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceee
Q 047196 276 FNNLVGVVPAAIFNMSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGI 355 (827)
Q Consensus 276 ~N~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 355 (827)
+|.++. +|. +..+++|+.|+++++.+..... ....+..+.+..+... .+..+..++.++.++++.|.+...
T Consensus 107 ~n~l~~-lp~-~~~l~~L~~L~l~~~~~~~~~~-----~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~~ 177 (353)
T d1jl5a_ 107 NNQLEK-LPE-LQNSSFLKIIDVDNNSLKKLPD-----LPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKL 177 (353)
T ss_dssp SSCCSS-CCC-CTTCTTCCEEECCSSCCSCCCC-----CCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSSC
T ss_pred cccccc-ccc-hhhhccceeecccccccccccc-----ccccccchhhcccccc--ccccccccccceeccccccccccc
Confidence 777664 343 4566667777766666543221 2345666666555443 234456667777777777665432
Q ss_pred cCCCccCCCCCCcccCCCchhcccccccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEEC
Q 047196 356 IPNTIGLTGNPLDGVLPTSIGNLSMSLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYL 435 (827)
Q Consensus 356 ~p~~~~l~~n~l~g~~p~~~~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 435 (827)
... ....+.+...++.+. .+| .+..++.|+.+++++|.... +|. ...++..+.+
T Consensus 178 ~~~--------------------~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~-~~~---~~~~l~~~~~ 231 (353)
T d1jl5a_ 178 PDL--------------------PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNV 231 (353)
T ss_dssp CCC--------------------CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEEC
T ss_pred ccc--------------------ccccccccccccccc-ccc-cccccccccccccccccccc-ccc---cccccccccc
Confidence 110 012334444444443 222 23456666666666665542 222 2344555666
Q ss_pred CCCCCC
Q 047196 436 PFNKLA 441 (827)
Q Consensus 436 s~N~l~ 441 (827)
.+|.+.
T Consensus 232 ~~~~~~ 237 (353)
T d1jl5a_ 232 RDNYLT 237 (353)
T ss_dssp CSSCCS
T ss_pred cccccc
Confidence 665554
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.77 E-value=2.2e-19 Score=194.44 Aligned_cols=145 Identities=19% Similarity=0.318 Sum_probs=108.6
Q ss_pred cccccceEecCCceEEEEEEe-cCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCC-----------CCceEEEeeeecC
Q 047196 676 KFSKENLIGVGSFGSVYKGRL-HDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRH-----------RNHVKRISSCSNE 743 (827)
Q Consensus 676 ~~~~~~~iG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H-----------~niv~~~~~~~~~ 743 (827)
+|+..++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|++++++++| +|+|++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 488899999999999999986 579999999997653 334678899999988865 6788888877543
Q ss_pred C--ceee--eeec-----------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee------------
Q 047196 744 D--FKAL--DCLH-----------STNCSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF------------ 796 (827)
Q Consensus 744 ~--~~~l--~~l~-----------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl------------ 796 (827)
. ...+ .... .............++.+++.|++|||+ ..+|+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccce
Confidence 2 1111 1111 122345667778899999999999984 468999999999998
Q ss_pred ----eecccccccCCCccccccceecccccccccC
Q 047196 797 ----DFGIGRLLTGDRSMIQTETLVTIGYMAPGLL 827 (827)
Q Consensus 797 ----DFGla~~~~~~~~~~~~~~~gt~~Y~APE~l 827 (827)
|||.|+...... ...+||+.|+|||++
T Consensus 171 ~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~ 201 (362)
T d1q8ya_ 171 IKIADLGNACWYDEHY----TNSIQTREYRSPEVL 201 (362)
T ss_dssp EEECCCTTCEETTBCC----CSCCSCGGGCCHHHH
T ss_pred eeEeeccccccccccc----ccccccccccChhhc
Confidence 788876543222 235699999999963
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=6.3e-20 Score=204.65 Aligned_cols=382 Identities=21% Similarity=0.188 Sum_probs=193.0
Q ss_pred ccceEEecCCCCCCccccccCCCCCCcEEEcCCCCCCCCcchhHhhccccccEEEeecccccc----cCCccCCCCCCCc
Q 047196 147 KLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHG----QIPLALSKCKRLQ 222 (827)
Q Consensus 147 ~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~----~~p~~l~~l~~L~ 222 (827)
+|++||+++|++++.. =..+...++++++|+|++|.++. .++..+..+++|+
T Consensus 3 ~l~~ld~~~~~i~~~~------------------------~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~ 58 (460)
T d1z7xw1 3 DIQSLDIQCEELSDAR------------------------WAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALA 58 (460)
T ss_dssp EEEEEEEESCCCCHHH------------------------HHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCC
T ss_pred CCCEEEeeCCcCChHH------------------------HHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCC
Confidence 5778888888876421 01223334567777777776652 3344566778888
Q ss_pred EEEccCCCCccc----CCCcCc-CCccccEEEccccccccc----ccccccCcCCCcEEEeecccCcccCchhhhc----
Q 047196 223 LLNLGFKKLSGA----IPKEIS-NLTILRKISLRNNKLRGE----IPHEIGYLPNLENLVLGFNNLVGVVPAAIFN---- 289 (827)
Q Consensus 223 ~L~L~~n~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~---- 289 (827)
+|+|++|.++.. +...+. ...+|++|+|++|+++.. ++..+..+++|++|+|++|.++......+..
T Consensus 59 ~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~ 138 (460)
T d1z7xw1 59 ELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLD 138 (460)
T ss_dssp EEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTS
T ss_pred EEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccc
Confidence 888888877521 222222 234688888888888643 4556777888888888888876432222211
Q ss_pred -CCCccEEEecCCccccccChhhhcCCCCccEEeCcCCccccccCccccCCCCCcEEEcCCCcceeecCCCccCCCCCCc
Q 047196 290 -MSTVKKIYLLDNSLLGSFSLGIDLSLPNVERLNLGLNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLD 368 (827)
Q Consensus 290 -l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~ 368 (827)
.................-.. ..-..+.....++.++++.+......-.
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~l~~~~~~~~~~ls~~~~~~~~~~---------- 187 (460)
T d1z7xw1 139 PQCRLEKLQLEYCSLSAASCE---------------------PLASVLRAKPDFKELTVSNNDINEAGVR---------- 187 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHH---------------------HHHHHHHHCTTCCEEECCSSBCHHHHHH----------
T ss_pred cccccccccccccccchhhhc---------------------cccccccccccccccccccccccccccc----------
Confidence 11122222222211110000 0001112223344444443332210000
Q ss_pred ccCCCchhcccccccEEEccCCcCccc----cCccccCCCCCceEeccCccccc-----cccccccCCCCCcEEECCCCC
Q 047196 369 GVLPTSIGNLSMSLENIYISNCNIGGS----IPQLISNLSNLLLLDLEGNKLTG-----SIPVTFGRLQKLQGLYLPFNK 439 (827)
Q Consensus 369 g~~p~~~~~~~~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g-----~~p~~~~~l~~L~~L~Ls~N~ 439 (827)
.....+.........+++..+.+... ....+...+.++.+++++|++.. ..+........++.+++++|.
T Consensus 188 -~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~ 266 (460)
T d1z7xw1 188 -VLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECG 266 (460)
T ss_dssp -HHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSC
T ss_pred -ccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccccchhhccccccccccccccccccc
Confidence 00000000011233444444433211 11122334555566666655432 122233445566666666666
Q ss_pred CCCCC----CccccccccccEEecCCCcccccCCcc-----ccCCCCCCccccCCCcccccCCcc----ccccccccccC
Q 047196 440 LAGSI----PDQLCHLARLNTLGLAGNKFSGSIPSC-----LGNLTSLRSPDLGSNRLTSVLPST----FWNLKDILFFD 506 (827)
Q Consensus 440 l~g~~----p~~~~~l~~L~~L~Ls~N~l~~~~p~~-----~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~Ld 506 (827)
+.... ...+...+.++.+++++|.++...... ......|+.+++++|.++...... +....+|+.||
T Consensus 267 i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~ 346 (460)
T d1z7xw1 267 ITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQ 346 (460)
T ss_dssp CCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEE
T ss_pred ccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhh
Confidence 54221 122334556666666666664321111 112345677777777665432222 23345677777
Q ss_pred CCCCCCCCC----Cccccc-ccccCceEEcccceeeec----ccccccCCCCCCEEECCCCcceeecCC--------CCc
Q 047196 507 LSSNSLDGP----LSLDIG-NLRVVIGINLSRNNFSGD----IPSTIGDLKDLQNISLACNGLEGLIPE--------SFG 569 (827)
Q Consensus 507 Ls~N~l~g~----~p~~~~-~l~~L~~L~Ls~N~l~g~----ip~~~~~l~~L~~L~Ls~N~l~g~ip~--------~~~ 569 (827)
|++|++++. ++..+. ..+.|+.|+|++|+|+.. ++..+..+++|++|||++|+++..... .-.
T Consensus 347 Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~ 426 (460)
T d1z7xw1 347 ISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426 (460)
T ss_dssp CCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTC
T ss_pred eeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCC
Confidence 777777542 222332 345677788888887643 455566677888888888887653221 122
Q ss_pred CCceEeCcCCcCeec
Q 047196 570 YLTELNLSFNKLEGE 584 (827)
Q Consensus 570 ~L~~L~ls~N~l~g~ 584 (827)
.|+.|++++|.+..+
T Consensus 427 ~L~~l~l~~~~~~~~ 441 (460)
T d1z7xw1 427 LLEQLVLYDIYWSEE 441 (460)
T ss_dssp CCCEEECTTCCCCHH
T ss_pred ccCEEECCCCCCCHH
Confidence 578888888877643
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=8.9e-20 Score=203.39 Aligned_cols=133 Identities=20% Similarity=0.266 Sum_probs=63.7
Q ss_pred cccEEEccCCcCccc----cCccccCCCCCceEeccCccccccccccc-----cCCCCCcEEECCCCCCCCCCCccc---
Q 047196 381 SLENIYISNCNIGGS----IPQLISNLSNLLLLDLEGNKLTGSIPVTF-----GRLQKLQGLYLPFNKLAGSIPDQL--- 448 (827)
Q Consensus 381 ~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~-----~~l~~L~~L~Ls~N~l~g~~p~~~--- 448 (827)
.++.+++++|.+... ....+...+.++.+++++|.+.......+ .....|+.+++++|.++......+
T Consensus 256 ~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~ 335 (460)
T d1z7xw1 256 RLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSV 335 (460)
T ss_dssp CCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccc
Confidence 466666666666532 22233445666667777666643221111 223456666666666653322222
Q ss_pred -cccccccEEecCCCccccc----CCcccc-CCCCCCccccCCCccccc----CCccccccccccccCCCCCCCC
Q 047196 449 -CHLARLNTLGLAGNKFSGS----IPSCLG-NLTSLRSPDLGSNRLTSV----LPSTFWNLKDILFFDLSSNSLD 513 (827)
Q Consensus 449 -~~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~LdLs~N~l~ 513 (827)
...++|++|+|++|+++.. ++..+. ..+.|++|+|++|.|+.. ++..+..+++|++|||++|+++
T Consensus 336 ~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~ 410 (460)
T d1z7xw1 336 LAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 410 (460)
T ss_dssp HHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred cccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCC
Confidence 2334566666666665432 222222 234455555555555431 2223333444444445444444
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.72 E-value=2.3e-18 Score=168.33 Aligned_cols=132 Identities=25% Similarity=0.315 Sum_probs=99.0
Q ss_pred ccEEEccCCcCccccCccccCCCCCceEeccCccccccc-cccccCCCCCcEEECCCCCCCCCCCccccccccccEEecC
Q 047196 382 LENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSI-PVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLA 460 (827)
Q Consensus 382 L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~-p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 460 (827)
.+.++.++++++ .+|..+. +++++|+|++|+|++.+ +..|.++++|+.|+|++|.+.+..+..+..+++|+.|+|+
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 567888888887 5665542 57888888888887644 5567778888888888888887777777778888888888
Q ss_pred CCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCC
Q 047196 461 GNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPL 516 (827)
Q Consensus 461 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~ 516 (827)
+|++++..|..|.++++|++|+|++|+|++..|.+|..+++|++|+|++|.+....
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~ 142 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccccc
Confidence 88887766777777888888888888887777777777777777777777776543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.72 E-value=3.9e-18 Score=166.67 Aligned_cols=110 Identities=29% Similarity=0.397 Sum_probs=57.3
Q ss_pred cccEEEccCCcCcccc-CccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEec
Q 047196 381 SLENIYISNCNIGGSI-PQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGL 459 (827)
Q Consensus 381 ~L~~L~Ls~N~l~g~~-p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 459 (827)
++++|+|++|+|++.+ +..|.++++|+.|+|++|++.+.++..|..+++|++|+|++|++++..|..|.++++|++|+|
T Consensus 30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L 109 (192)
T d1w8aa_ 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCccccccc
Confidence 4555555555554422 334455555555555555555555555555555555555555555444445555555555555
Q ss_pred CCCcccccCCccccCCCCCCccccCCCcccc
Q 047196 460 AGNKFSGSIPSCLGNLTSLRSPDLGSNRLTS 490 (827)
Q Consensus 460 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 490 (827)
++|+|++..|..|..+++|++|+|++|.+..
T Consensus 110 ~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~ 140 (192)
T d1w8aa_ 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred CCccccccCHHHhcCCccccccccccccccc
Confidence 5555554444455555555555555555543
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=6e-17 Score=164.34 Aligned_cols=78 Identities=13% Similarity=-0.009 Sum_probs=37.2
Q ss_pred cccEEEccCCcCccccCccccCCCCCc-eEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEec
Q 047196 381 SLENIYISNCNIGGSIPQLISNLSNLL-LLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGL 459 (827)
Q Consensus 381 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~-~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 459 (827)
.++.|++++|+++...+..+. ..+++ .+++++|+++...+..|.++++|++|+|++|+++...+..|.+++.|+++++
T Consensus 154 ~l~~L~l~~n~l~~i~~~~~~-~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 154 ESVILWLNKNGIQEIHNCAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp SCEEEECCSSCCCEECTTTTT-TCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred cceeeeccccccccccccccc-chhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence 345555555555533333322 23332 3344555555443444555666666666666655333334444444444443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=6.2e-17 Score=164.26 Aligned_cols=217 Identities=18% Similarity=0.168 Sum_probs=105.6
Q ss_pred cEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEeecccCcccCc-hhhhcCCCccEEEecC
Q 047196 222 QLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVGVVP-AAIFNMSTVKKIYLLD 300 (827)
Q Consensus 222 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~ 300 (827)
+.++.+++.++ .+|..+. +++++|+|++|+|+...+..|.++++|++|++++|.+...+| ..|.
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~------------ 75 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFS------------ 75 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEE------------
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccc------------
Confidence 45666666666 4555442 356677777777664444456667777777777766654433 2333
Q ss_pred CccccccChhhhcCCCCccEEeCc-CCccccccCccccCCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchhccc
Q 047196 301 NSLLGSFSLGIDLSLPNVERLNLG-LNRFSGTIPSFITNASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIGNLS 379 (827)
Q Consensus 301 n~l~~~~~~~~~~~l~~L~~L~L~-~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~~~~ 379 (827)
.+++++++.+. .|++....+..+.++++|+.+++++|.+....+. ..+..+.
T Consensus 76 -------------~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~--------------~~~~~l~ 128 (242)
T d1xwdc1 76 -------------NLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDV--------------HKIHSLQ 128 (242)
T ss_dssp -------------SCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCC--------------TTTCBSS
T ss_pred -------------cccccccccccccccccccccccccccccccccccchhhhcccccc--------------ccccccc
Confidence 34455555443 3455555556666677777777766665422110 0011111
Q ss_pred ccccEEEccCCcCccccCccccCCC-CCceEeccCccccccccccccCCCCCc-EEECCCCCCCCCCCccccccccccEE
Q 047196 380 MSLENIYISNCNIGGSIPQLISNLS-NLLLLDLEGNKLTGSIPVTFGRLQKLQ-GLYLPFNKLAGSIPDQLCHLARLNTL 457 (827)
Q Consensus 380 ~~L~~L~Ls~N~l~g~~p~~~~~l~-~L~~L~Ls~N~l~g~~p~~~~~l~~L~-~L~Ls~N~l~g~~p~~~~~l~~L~~L 457 (827)
.+..+...++++....+..|..++ .++.|++++|+++...+..|. ..+++ .+++++|+++...+..|.++++|++|
T Consensus 129 -~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~-~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L 206 (242)
T d1xwdc1 129 -KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVIL 206 (242)
T ss_dssp -CEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTT-TCCEEEEECTTCTTCCCCCTTTTTTSCCCSEE
T ss_pred -ccccccccccccccccccccccccccceeeeccccccccccccccc-chhhhccccccccccccccHHHhcCCCCCCEE
Confidence 344444455555544444444443 455566666665543333332 22222 22344444443222334444445555
Q ss_pred ecCCCcccccCCccccCCCCCCccc
Q 047196 458 GLAGNKFSGSIPSCLGNLTSLRSPD 482 (827)
Q Consensus 458 ~Ls~N~l~~~~p~~~~~l~~L~~L~ 482 (827)
++++|+++...+..|.+++.|++++
T Consensus 207 ~Ls~N~l~~l~~~~~~~l~~L~~l~ 231 (242)
T d1xwdc1 207 DISRTRIHSLPSYGLENLKKLRARS 231 (242)
T ss_dssp ECTTSCCCCCCSSSCTTCCEEESSS
T ss_pred ECCCCcCCccCHHHHcCCcccccCc
Confidence 5555444422222334444444333
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=6.3e-17 Score=162.51 Aligned_cols=162 Identities=22% Similarity=0.349 Sum_probs=72.5
Q ss_pred cccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecC
Q 047196 381 SLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLA 460 (827)
Q Consensus 381 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 460 (827)
+|++|++++|++++..| +..+++|+.+++++|.++. ++ .+.++++|+.+++++|...+.. .+...+.++.+.++
T Consensus 64 ~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~-i~-~l~~l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~ 137 (227)
T d1h6ua2 64 NLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLD 137 (227)
T ss_dssp TCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECC
T ss_pred CCcEeecCCceeecccc--ccccccccccccccccccc-cc-cccccccccccccccccccccc--hhccccchhhhhch
Confidence 34444444444443222 4444455555555544442 21 2444455555555554444321 13334444555555
Q ss_pred CCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccceeeecc
Q 047196 461 GNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDI 540 (827)
Q Consensus 461 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~i 540 (827)
++.+.... .+.++++|+.|++++|.+.... .+.++++|+.|||++|++++. + .++++++|++|++++|++++.
T Consensus 138 ~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i- 210 (227)
T d1h6ua2 138 LNQITNIS--PLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDV- 210 (227)
T ss_dssp SSCCCCCG--GGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBC-
T ss_pred hhhhchhh--hhccccccccccccccccccch--hhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCC-
Confidence 55443221 2344445555555555444322 144455555555555555432 1 144555555555555555532
Q ss_pred cccccCCCCCCEEECC
Q 047196 541 PSTIGDLKDLQNISLA 556 (827)
Q Consensus 541 p~~~~~l~~L~~L~Ls 556 (827)
| .++++++|+.|+++
T Consensus 211 ~-~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 211 S-PLANTSNLFIVTLT 225 (227)
T ss_dssp G-GGTTCTTCCEEEEE
T ss_pred c-ccccCCCCCEEEee
Confidence 2 14555555555554
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=1.8e-16 Score=159.10 Aligned_cols=184 Identities=21% Similarity=0.332 Sum_probs=153.6
Q ss_pred cccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecC
Q 047196 381 SLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLA 460 (827)
Q Consensus 381 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 460 (827)
+|+.|++.+|+++. ++ .+..+++|+.|++++|++++..| +..+++|+++++++|.++. ++ .+.++++|+.++++
T Consensus 42 ~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~-i~-~l~~l~~L~~l~l~ 115 (227)
T d1h6ua2 42 GITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLT 115 (227)
T ss_dssp TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECT
T ss_pred CcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc--ccccccccccccccccccc-cc-cccccccccccccc
Confidence 78889999998884 44 58899999999999999987654 8899999999999999873 43 57889999999999
Q ss_pred CCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccceeeecc
Q 047196 461 GNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDI 540 (827)
Q Consensus 461 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~i 540 (827)
+|...+.. .+...+.++.++++++.+.... .+.++++|+.|++++|.+++..+ ++++++|+.||+++|++++ +
T Consensus 116 ~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~~--l~~l~~L~~L~Ls~n~l~~-l 188 (227)
T d1h6ua2 116 STQITDVT--PLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISD-I 188 (227)
T ss_dssp TSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-C
T ss_pred cccccccc--hhccccchhhhhchhhhhchhh--hhccccccccccccccccccchh--hcccccceecccCCCccCC-C
Confidence 99987543 3667788999999999887644 36788899999999999986543 7889999999999999986 4
Q ss_pred cccccCCCCCCEEECCCCcceeecC-CCCcCCceEeCcC
Q 047196 541 PSTIGDLKDLQNISLACNGLEGLIP-ESFGYLTELNLSF 578 (827)
Q Consensus 541 p~~~~~l~~L~~L~Ls~N~l~g~ip-~~~~~L~~L~ls~ 578 (827)
| .++++++|+.|+|++|++++..| ..+.+|+.|++++
T Consensus 189 ~-~l~~l~~L~~L~Ls~N~lt~i~~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 189 S-PLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTN 226 (227)
T ss_dssp G-GGGGCTTCCEEECTTSCCCBCGGGTTCTTCCEEEEEE
T ss_pred h-hhcCCCCCCEEECcCCcCCCCcccccCCCCCEEEeeC
Confidence 4 38899999999999999997655 4567899999873
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.67 E-value=1.9e-16 Score=156.83 Aligned_cols=162 Identities=29% Similarity=0.390 Sum_probs=108.8
Q ss_pred cccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecC
Q 047196 381 SLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLA 460 (827)
Q Consensus 381 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 460 (827)
++++|++++|.++.. + .+..+++|++|++++|++++.. .++.+++|++|++++|++++ +| .+.++++|+.|+++
T Consensus 47 ~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~ 120 (210)
T d1h6ta2 47 SIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLE 120 (210)
T ss_dssp TCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECT
T ss_pred CccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-cccccccccccccc
Confidence 566677777766643 2 2566777777777777777543 25667777777777777764 33 46667777777777
Q ss_pred CCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccceeeecc
Q 047196 461 GNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDI 540 (827)
Q Consensus 461 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~i 540 (827)
+|.+.. ...+..++.++.+++++|.+++ +..+..+++|+.+++++|++++.. .++++++|+.|++++|+|+. +
T Consensus 121 ~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~-l 193 (210)
T d1h6ta2 121 HNGISD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHISD-L 193 (210)
T ss_dssp TSCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCB-C
T ss_pred cccccc--cccccccccccccccccccccc--cccccccccccccccccccccccc--cccCCCCCCEEECCCCCCCC-C
Confidence 777652 2346667777777777777764 234566777777777777776533 26677777777777777763 4
Q ss_pred cccccCCCCCCEEECC
Q 047196 541 PSTIGDLKDLQNISLA 556 (827)
Q Consensus 541 p~~~~~l~~L~~L~Ls 556 (827)
| .+.++++|+.|+|+
T Consensus 194 ~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 194 R-ALAGLKNLDVLELF 208 (210)
T ss_dssp G-GGTTCTTCSEEEEE
T ss_pred h-hhcCCCCCCEEEcc
Confidence 4 47777777777765
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.66 E-value=3.8e-16 Score=154.55 Aligned_cols=162 Identities=23% Similarity=0.278 Sum_probs=70.9
Q ss_pred CCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcCCCCCCCCcchhHhhccccccEEE
Q 047196 122 SSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLF 201 (827)
Q Consensus 122 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~~L~ 201 (827)
.+|++|++++|.++.. + .+..+++|++|+|++|++++..+ +..+++|++|++++|++++ +|. +.. +++|+.|+
T Consensus 46 ~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~~--~~~l~~L~~L~l~~n~i~~-l~~-l~~-l~~L~~L~ 118 (210)
T d1h6ta2 46 NSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LSS-LKD-LKKLKSLS 118 (210)
T ss_dssp HTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GGG-GTT-CTTCCEEE
T ss_pred cCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCccc--cccCccccccccccccccc-ccc-ccc-cccccccc
Confidence 3444444444444422 1 24444444444444444443221 2333444444444444332 221 111 22444444
Q ss_pred eecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEeecccCcc
Q 047196 202 LAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNLVG 281 (827)
Q Consensus 202 Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 281 (827)
+++|.+.. ...+.++++|+.++++.|.+++ +..+..+++|+++++++|++++. + .++++++|++|+|++|+++.
T Consensus 119 l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~ 192 (210)
T d1h6ta2 119 LEHNGISD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHISD 192 (210)
T ss_dssp CTTSCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCB
T ss_pred cccccccc--cccccccccccccccccccccc--ccccccccccccccccccccccc-c-cccCCCCCCEEECCCCCCCC
Confidence 44444332 1234445555555555555543 22344455555555555555432 2 24555555555555555543
Q ss_pred cCchhhhcCCCccEEEe
Q 047196 282 VVPAAIFNMSTVKKIYL 298 (827)
Q Consensus 282 ~~p~~~~~l~~L~~L~l 298 (827)
+| .+.++++|++|++
T Consensus 193 -l~-~l~~l~~L~~L~L 207 (210)
T d1h6ta2 193 -LR-ALAGLKNLDVLEL 207 (210)
T ss_dssp -CG-GGTTCTTCSEEEE
T ss_pred -Ch-hhcCCCCCCEEEc
Confidence 22 3444444444444
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.66 E-value=6.4e-16 Score=151.52 Aligned_cols=162 Identities=22% Similarity=0.363 Sum_probs=88.8
Q ss_pred CCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcCCCCCCCCcchhHhhccccccE
Q 047196 120 NLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKV 199 (827)
Q Consensus 120 ~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~~ 199 (827)
.+.++++|++++|+++. + +.+..+++|++|||++|++++..| +.++++|++|+++.|.+. .+|. + ..+++|+.
T Consensus 38 ~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~~-l-~~l~~L~~ 110 (199)
T d2omxa2 38 DLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DITP-L-ANLTNLTG 110 (199)
T ss_dssp HHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCGG-G-TTCTTCSE
T ss_pred HhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCcccccccccccccc-cccc-c-cccccccc
Confidence 34455555555555542 2 234455555555555555554322 444555555555554443 2332 2 22346666
Q ss_pred EEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEcccccccccccccccCcCCCcEEEeecccC
Q 047196 200 LFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIPHEIGYLPNLENLVLGFNNL 279 (827)
Q Consensus 200 L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 279 (827)
|++++|.+... ..+..+++|+.|++++|++.. + +.+..+++|++|++++|++++. + .++++++|++|++++|++
T Consensus 111 L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i 184 (199)
T d2omxa2 111 LTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKV 184 (199)
T ss_dssp EECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCC
T ss_pred ccccccccccc--cccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCC-c-cccCCCCCCEEECCCCCC
Confidence 66666655432 235566777777777776653 2 2466677777777777777643 2 366777777777777776
Q ss_pred cccCchhhhcCCCccEE
Q 047196 280 VGVVPAAIFNMSTVKKI 296 (827)
Q Consensus 280 ~~~~p~~~~~l~~L~~L 296 (827)
+.. + .+..+++|++|
T Consensus 185 ~~i-~-~l~~L~~L~~L 199 (199)
T d2omxa2 185 SDI-S-VLAKLTNLESL 199 (199)
T ss_dssp CCC-G-GGGGCTTCSEE
T ss_pred CCC-c-cccCCCCCCcC
Confidence 652 2 35555555543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.64 E-value=2.9e-16 Score=152.95 Aligned_cols=122 Identities=14% Similarity=0.169 Sum_probs=91.1
Q ss_pred ccceEecCCceEEEEEEecCCcEEEEEEEcccc------------------hHHHHHHHHHHHHHHhcCCCCceEEEeee
Q 047196 679 KENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNC------------------AMALKSFEAECEVMKNIRHRNHVKRISSC 740 (827)
Q Consensus 679 ~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~------------------~~~~~~~~~Ei~~l~~l~H~niv~~~~~~ 740 (827)
..+.||+|+||.||+|+..+|+.||||+++... ......+.+|.+.+.+++|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 467899999999999998889999999875311 01123466789999999999999877553
Q ss_pred ecCCceeeeeeccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCccee---------eeccccccc
Q 047196 741 SNEDFKALDCLHSTN-CSLNIFDKLNIMIDVASALEYLHFSHSTPVIHCDLKPKNVF---------DFGIGRLLT 805 (827)
Q Consensus 741 ~~~~~~~l~~l~~~~-~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~iiHrDlK~~NIl---------DFGla~~~~ 805 (827)
.....+++..... ..+.......++.+++++++||| +.+|+||||||+||| |||+|+...
T Consensus 84 --~~~lvme~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~~~~liDFG~a~~~~ 153 (191)
T d1zara2 84 --GNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEEGIWIIDFPQSVEVG 153 (191)
T ss_dssp --TTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETTEEEECCCTTCEETT
T ss_pred --CCEEEEEeeccccccchhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCCCEEEEECCCcccCC
Confidence 3344444443321 22344455679999999999996 568999999999998 999997654
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.63 E-value=1.2e-15 Score=149.51 Aligned_cols=159 Identities=26% Similarity=0.407 Sum_probs=101.3
Q ss_pred cccEEEccCCcCccccCccccCCCCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecC
Q 047196 381 SLENIYISNCNIGGSIPQLISNLSNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLA 460 (827)
Q Consensus 381 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 460 (827)
++++|++++|+++. ++ .+..+++|++|++++|++++..| ++++++|+.|++++|.+.. ++ .+.+++.|+.|+++
T Consensus 41 ~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l~ 114 (199)
T d2omxa2 41 QVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTLF 114 (199)
T ss_dssp TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECC
T ss_pred CCCEEECCCCCCCC-cc-ccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-cccccccccccccc
Confidence 45666666666653 22 35667777777777777765433 6677777777777777653 33 36667777777777
Q ss_pred CCcccccCCccccCCCCCCccccCCCcccccCCccccccccccccCCCCCCCCCCCcccccccccCceEEcccceeeecc
Q 047196 461 GNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSGDI 540 (827)
Q Consensus 461 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~i 540 (827)
+|.+... ..+..+++|+.|++++|++... +.+..+++|+.|++++|++++.. .++++++|+.|++++|+++. +
T Consensus 115 ~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~~-i 187 (199)
T d2omxa2 115 NNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVSD-I 187 (199)
T ss_dssp SSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-C
T ss_pred ccccccc--cccchhhhhHHhhhhhhhhccc--ccccccccccccccccccccCCc--cccCCCCCCEEECCCCCCCC-C
Confidence 7776532 2356677777777777776542 24666677777777777776532 25666777777777777664 3
Q ss_pred cccccCCCCCCEE
Q 047196 541 PSTIGDLKDLQNI 553 (827)
Q Consensus 541 p~~~~~l~~L~~L 553 (827)
| .++++++|+.|
T Consensus 188 ~-~l~~L~~L~~L 199 (199)
T d2omxa2 188 S-VLAKLTNLESL 199 (199)
T ss_dssp G-GGGGCTTCSEE
T ss_pred c-cccCCCCCCcC
Confidence 3 36666666654
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=1.7e-14 Score=149.48 Aligned_cols=101 Identities=15% Similarity=0.160 Sum_probs=47.1
Q ss_pred cEEEcCCCCCCCCcchhHhhccccccEEEeecccccccCCccCCCCCCCcEEEccCCCCccc-CCCcCcCCccccEEEcc
Q 047196 173 LDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGA-IPKEISNLTILRKISLR 251 (827)
Q Consensus 173 ~~L~L~~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~Ls 251 (827)
+.+||+++.+.+.....+.. .....+.++......... ......+|++||++++.++.. ++..+.++++|++|+|+
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~--~~~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~ 79 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLS--QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLE 79 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHH--TTCSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECT
T ss_pred CEEECCCCCCCchHHHHHHh--ccceEeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccc
Confidence 46788777665333333322 134455554444332211 222334555555555544322 22223445555555555
Q ss_pred cccccccccccccCcCCCcEEEeec
Q 047196 252 NNKLRGEIPHEIGYLPNLENLVLGF 276 (827)
Q Consensus 252 ~N~l~~~~p~~~~~l~~L~~L~Ls~ 276 (827)
+|.++...+..++.+++|++|++++
T Consensus 80 ~~~l~~~~~~~l~~~~~L~~L~Ls~ 104 (284)
T d2astb2 80 GLRLSDPIVNTLAKNSNLVRLNLSG 104 (284)
T ss_dssp TCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred ccCCCcHHHHHHhcCCCCcCccccc
Confidence 5555444444455555555555554
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.44 E-value=9.3e-14 Score=143.87 Aligned_cols=126 Identities=17% Similarity=0.228 Sum_probs=63.5
Q ss_pred ceEEecCCCCCCccccccCCCCCCcEEEcCCCCCCCCcchhHhhccccccEEEeeccccccc-CCccCCCCCCCcEEEcc
Q 047196 149 KFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLHYLKVLFLAKNMFHGQ-IPLALSKCKRLQLLNLG 227 (827)
Q Consensus 149 ~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~L~ 227 (827)
+.|||+++.+.......+.. .....+++........+.. .. ...+|++||++++.++.. ++..+.++++|++|+++
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~~-~~-~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~ 79 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAE-HF-SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLE 79 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCCS-CC-CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECT
T ss_pred CEEECCCCCCCchHHHHHHh-ccceEeeccccccccchhh-hc-cCCCCCEEECCCCccCHHHHHHHHHhCCCccccccc
Confidence 35666666664332222211 1234445444333221111 11 123666777766665533 33345666667777777
Q ss_pred CCCCcccCCCcCcCCccccEEEcccc-ccccc-ccccccCcCCCcEEEeecc
Q 047196 228 FKKLSGAIPKEISNLTILRKISLRNN-KLRGE-IPHEIGYLPNLENLVLGFN 277 (827)
Q Consensus 228 ~n~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L~~L~Ls~N 277 (827)
++.++...+..++.+++|++|+++++ .++.. +..-...+++|++|+++++
T Consensus 80 ~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c 131 (284)
T d2astb2 80 GLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWC 131 (284)
T ss_dssp TCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCC
T ss_pred ccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccc
Confidence 66666655566666666777777664 34321 1222344566666666654
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=7.1e-14 Score=131.41 Aligned_cols=128 Identities=16% Similarity=0.149 Sum_probs=69.6
Q ss_pred ccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCccccCCCcccccCCcccccccccc
Q 047196 424 FGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNRLTSVLPSTFWNLKDIL 503 (827)
Q Consensus 424 ~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 503 (827)
|.++.++++|+|++|+++ .+|..+..+++|+.|+|++|+++. ++ .+..+++|++|++++|.++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCccccccccccc
Confidence 334445555555555554 234444455555555555555552 32 355556666666666666555444455566666
Q ss_pred ccCCCCCCCCCCCc-ccccccccCceEEcccceeeecc---cccccCCCCCCEEE
Q 047196 504 FFDLSSNSLDGPLS-LDIGNLRVVIGINLSRNNFSGDI---PSTIGDLKDLQNIS 554 (827)
Q Consensus 504 ~LdLs~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~g~i---p~~~~~l~~L~~L~ 554 (827)
.|++++|+++.... ..+..++.|+.|++++|.++... +..+..+++|+.||
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred cceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 66666666653211 24556666666666666665321 12356666677665
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.42 E-value=3e-13 Score=120.84 Aligned_cols=33 Identities=27% Similarity=0.419 Sum_probs=18.7
Q ss_pred CEEECCCCCCCccCChhhhhccccceEEecCCCCC
Q 047196 125 TTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLS 159 (827)
Q Consensus 125 ~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~ 159 (827)
|+|||++|+++ .+| .+..+++|++||+++|.|+
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~ 33 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR 33 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC
Confidence 45666666665 333 3556666666666666654
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.41 E-value=8.5e-14 Score=130.87 Aligned_cols=129 Identities=18% Similarity=0.104 Sum_probs=81.1
Q ss_pred ccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcCCCCCCCCcchhHhhccc
Q 047196 116 PQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYLH 195 (827)
Q Consensus 116 ~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~~ 195 (827)
+.+.+...|++|||++|+|+ .+|..+..+++|++||||+|+++.. + .+..+++|++|++++|++
T Consensus 12 ~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l-~-~~~~l~~L~~L~ls~N~i------------- 75 (162)
T d1a9na_ 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-D-GFPLLRRLKTLLVNNNRI------------- 75 (162)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE-C-CCCCCSSCCEEECCSSCC-------------
T ss_pred HhccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc-C-CcccCcchhhhhcccccc-------------
Confidence 34677788899999999988 4566677888999999999988732 2 244444444444444444
Q ss_pred cccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCC-CcCcCCccccEEEccccccccccc----ccccCcCCCc
Q 047196 196 YLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIP-KEISNLTILRKISLRNNKLRGEIP----HEIGYLPNLE 270 (827)
Q Consensus 196 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~ 270 (827)
+...+..+..+++|+.|++++|+++.... ..+..+++|++|++++|.++. .| ..+..+++|+
T Consensus 76 ------------~~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~ 142 (162)
T d1a9na_ 76 ------------CRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVR 142 (162)
T ss_dssp ------------CEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCS
T ss_pred ------------cCCCccccccccccccceeccccccccccccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcC
Confidence 43333333445555555666555543211 345666777777777777653 33 2466778888
Q ss_pred EEE
Q 047196 271 NLV 273 (827)
Q Consensus 271 ~L~ 273 (827)
+||
T Consensus 143 ~LD 145 (162)
T d1a9na_ 143 VLD 145 (162)
T ss_dssp EET
T ss_pred eeC
Confidence 776
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.40 E-value=3.7e-13 Score=120.22 Aligned_cols=100 Identities=26% Similarity=0.361 Sum_probs=47.2
Q ss_pred eEeccCccccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCccccCCCc
Q 047196 408 LLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLGSNR 487 (827)
Q Consensus 408 ~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 487 (827)
+|||++|+++. ++ .+..+++|++|++++|+++ .+|+.+..+++|+.|++++|++++ +| .+..+++|++|++++|+
T Consensus 2 ~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence 45555555552 22 2455555555555555554 344445555555555555555542 22 24445555555555555
Q ss_pred ccccCC-ccccccccccccCCCCCCC
Q 047196 488 LTSVLP-STFWNLKDILFFDLSSNSL 512 (827)
Q Consensus 488 l~~~~p-~~~~~l~~L~~LdLs~N~l 512 (827)
++...+ ..+..+++|+.|++++|.+
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i 102 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSL 102 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcC
Confidence 443221 2333334444444444433
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.38 E-value=5.7e-14 Score=150.03 Aligned_cols=138 Identities=20% Similarity=0.296 Sum_probs=86.1
Q ss_pred CCCCCcEEEccCCCCccc----CCCcCcCCccccEEEccccccccc-----ccccccCcCCCcEEEeecccCccc----C
Q 047196 217 KCKRLQLLNLGFKKLSGA----IPKEISNLTILRKISLRNNKLRGE-----IPHEIGYLPNLENLVLGFNNLVGV----V 283 (827)
Q Consensus 217 ~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~----~ 283 (827)
..+.|+.++++.|.++.. +...+...+.|+.|+|++|.+... +...+...++|++|+|++|.++.. +
T Consensus 156 ~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L 235 (344)
T d2ca6a1 156 NAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSAL 235 (344)
T ss_dssp TCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHH
T ss_pred cCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccc
Confidence 455677777777766421 222344556777777777776532 233456677777788877776543 2
Q ss_pred chhhhcCCCccEEEecCCccccccChhh----h-cCCCCccEEeCcCCccccc----cCcccc-CCCCCcEEEcCCCcce
Q 047196 284 PAAIFNMSTVKKIYLLDNSLLGSFSLGI----D-LSLPNVERLNLGLNRFSGT----IPSFIT-NASKLVYLDMGTNSFS 353 (827)
Q Consensus 284 p~~~~~l~~L~~L~l~~n~l~~~~~~~~----~-~~l~~L~~L~L~~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~ 353 (827)
...+...++|++|++++|.+.+.-...+ . ...+.|++|++++|+++.. +...+. +.++|+.|++++|.+.
T Consensus 236 ~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 236 AIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp HHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred cccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 3445567777788887777654322111 1 1235788899999988643 223332 5678999999999885
Q ss_pred e
Q 047196 354 G 354 (827)
Q Consensus 354 g 354 (827)
.
T Consensus 316 ~ 316 (344)
T d2ca6a1 316 E 316 (344)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.37 E-value=1.3e-13 Score=147.06 Aligned_cols=142 Identities=18% Similarity=0.148 Sum_probs=86.4
Q ss_pred CCccccEEEccccccccc----ccccccCcCCCcEEEeecccCccc-----CchhhhcCCCccEEEecCCccccc----c
Q 047196 241 NLTILRKISLRNNKLRGE----IPHEIGYLPNLENLVLGFNNLVGV-----VPAAIFNMSTVKKIYLLDNSLLGS----F 307 (827)
Q Consensus 241 ~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~-----~p~~~~~l~~L~~L~l~~n~l~~~----~ 307 (827)
....|+.+++++|+++.. +...+...+.|++|+|++|+++.. +...+...++|+.|++++|.+... +
T Consensus 156 ~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L 235 (344)
T d2ca6a1 156 NAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSAL 235 (344)
T ss_dssp TCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHH
T ss_pred cCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccc
Confidence 345678888888877532 333455667888888888887542 233456677888888888876532 1
Q ss_pred ChhhhcCCCCccEEeCcCCccccccCcc----cc--CCCCCcEEEcCCCcceeecCCCccCCCCCCcccCCCchh-cccc
Q 047196 308 SLGIDLSLPNVERLNLGLNRFSGTIPSF----IT--NASKLVYLDMGTNSFSGIIPNTIGLTGNPLDGVLPTSIG-NLSM 380 (827)
Q Consensus 308 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~----~~--~l~~L~~L~Ls~N~l~g~~p~~~~l~~n~l~g~~p~~~~-~~~~ 380 (827)
...+ ...++|++|+|++|.++..-... +. ....|+.|++++|+++..-.. .+...+. +.+
T Consensus 236 ~~~l-~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~-----------~l~~~l~~~~~- 302 (344)
T d2ca6a1 236 AIAL-KSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVR-----------TLKTVIDEKMP- 302 (344)
T ss_dssp HHHG-GGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHH-----------HHHHHHHHHCT-
T ss_pred cccc-cccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHH-----------HHHHHHHccCC-
Confidence 1122 25677888888888876542222 22 235688888888877532110 1112222 223
Q ss_pred cccEEEccCCcCccc
Q 047196 381 SLENIYISNCNIGGS 395 (827)
Q Consensus 381 ~L~~L~Ls~N~l~g~ 395 (827)
+|+.|++++|++...
T Consensus 303 ~L~~L~l~~N~~~~~ 317 (344)
T d2ca6a1 303 DLLFLELNGNRFSEE 317 (344)
T ss_dssp TCCEEECTTSBSCTT
T ss_pred CCCEEECCCCcCCCc
Confidence 688888888888664
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.21 E-value=3.8e-13 Score=130.94 Aligned_cols=114 Identities=25% Similarity=0.332 Sum_probs=65.8
Q ss_pred CccccCCCCCCEEECCCCCCCccCChhhhhccccceEEecCCCCCCccccccCCCCCCcEEEcCCCCCCCCcchhHhhcc
Q 047196 115 PPQLGNLSSLTTLNLSHNKLSGDIPPSIFTMHKLKFLDFSDNQLSGSLSSVTFNLSSVLDIRLDSDKLSGELPVNICNYL 194 (827)
Q Consensus 115 ~~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~L~~n~l~g~ip~~~~~~~ 194 (827)
+.++..|++|++|+|++|+|+ .++ .+..+++|++|+|++|.++ .+|. +....
T Consensus 41 ~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-------------------------~i~~-~~~~~ 92 (198)
T d1m9la_ 41 DATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-------------------------KIEN-LDAVA 92 (198)
T ss_dssp HHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-------------------------SCSS-HHHHH
T ss_pred hhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-------------------------cccc-ccccc
Confidence 345666777777777777776 333 4667777777777777665 2332 12223
Q ss_pred ccccEEEeecccccccCCccCCCCCCCcEEEccCCCCcccCCCcCcCCccccEEEccccccccccc-ccccCcCCCcEEE
Q 047196 195 HYLKVLFLAKNMFHGQIPLALSKCKRLQLLNLGFKKLSGAIPKEISNLTILRKISLRNNKLRGEIP-HEIGYLPNLENLV 273 (827)
Q Consensus 195 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~ 273 (827)
++|++|++++|+++.. +.+.++++|++|++++|+++.... ..+..+++|++|+
T Consensus 93 ~~L~~L~l~~N~i~~l--------------------------~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~ 146 (198)
T d1m9la_ 93 DTLEELWISYNQIASL--------------------------SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLL 146 (198)
T ss_dssp HHCCEEECSEEECCCH--------------------------HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEE
T ss_pred cccccccccccccccc--------------------------ccccccccccccccccchhccccccccccCCCccceee
Confidence 3566666666655421 124455666666666666653211 3456666777777
Q ss_pred eecccCccc
Q 047196 274 LGFNNLVGV 282 (827)
Q Consensus 274 Ls~N~l~~~ 282 (827)
|++|.++..
T Consensus 147 L~~N~l~~~ 155 (198)
T d1m9la_ 147 LAGNPLYND 155 (198)
T ss_dssp ECSSHHHHH
T ss_pred cCCCccccC
Confidence 777666543
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.19 E-value=1.3e-13 Score=134.41 Aligned_cols=44 Identities=23% Similarity=0.194 Sum_probs=20.2
Q ss_pred ccccccCceEEcccceeeeccc-ccccCCCCCCEEECCCCcceee
Q 047196 520 IGNLRVVIGINLSRNNFSGDIP-STIGDLKDLQNISLACNGLEGL 563 (827)
Q Consensus 520 ~~~l~~L~~L~Ls~N~l~g~ip-~~~~~l~~L~~L~Ls~N~l~g~ 563 (827)
+..+++|+.|++++|+|+.... ..+..+++|+.|+|++|.+...
T Consensus 111 ~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~ 155 (198)
T d1m9la_ 111 IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND 155 (198)
T ss_dssp HHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHH
T ss_pred ccccccccccccccchhccccccccccCCCccceeecCCCccccC
Confidence 3344444445555554442211 2344555555555555555443
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.14 E-value=4.5e-11 Score=111.12 Aligned_cols=106 Identities=21% Similarity=0.121 Sum_probs=70.4
Q ss_pred ccEEEccCCcCccccCccccCCCCCceEeccCc-cccccccccccCCCCCcEEECCCCCCCCCCCccccccccccEEecC
Q 047196 382 LENIYISNCNIGGSIPQLISNLSNLLLLDLEGN-KLTGSIPVTFGRLQKLQGLYLPFNKLAGSIPDQLCHLARLNTLGLA 460 (827)
Q Consensus 382 L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N-~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 460 (827)
.+.++.+++++. ..|..+..+++|+.|++++| .++...+..|.++++|+.|+|++|+|+...|..|..+++|++|+|+
T Consensus 10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence 455777777776 45666667777777777655 4666556667777777777777777776666667777777777777
Q ss_pred CCcccccCCccccCCCCCCccccCCCccc
Q 047196 461 GNKFSGSIPSCLGNLTSLRSPDLGSNRLT 489 (827)
Q Consensus 461 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 489 (827)
+|+++ .+|.......+|+.|+|++|.+.
T Consensus 89 ~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 89 FNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp SSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred CCCCc-ccChhhhccccccccccCCCccc
Confidence 77776 34433333335777777777663
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.13 E-value=6.7e-11 Score=109.90 Aligned_cols=106 Identities=20% Similarity=0.118 Sum_probs=56.2
Q ss_pred CceEeccCccccccccccccCCCCCcEEECCCC-CCCCCCCccccccccccEEecCCCcccccCCccccCCCCCCccccC
Q 047196 406 LLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFN-KLAGSIPDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSPDLG 484 (827)
Q Consensus 406 L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N-~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 484 (827)
.+.++.+++.+. ..|..+..+++|+.|++++| .++...+..|.++++|+.|+|++|+++...|..|..+++|++|||+
T Consensus 10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence 344555555554 23444555555566665444 3554334455555566666666666655445555555666666666
Q ss_pred CCcccccCCccccccccccccCCCCCCCC
Q 047196 485 SNRLTSVLPSTFWNLKDILFFDLSSNSLD 513 (827)
Q Consensus 485 ~N~l~~~~p~~~~~l~~L~~LdLs~N~l~ 513 (827)
+|+|+...+..|..+ +|+.|+|++|.+.
T Consensus 89 ~N~l~~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 89 FNALESLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp SSCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred CCCCcccChhhhccc-cccccccCCCccc
Confidence 666554433333332 4555566665553
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.30 E-value=2.7e-08 Score=92.49 Aligned_cols=66 Identities=26% Similarity=0.242 Sum_probs=30.0
Q ss_pred cCCCCCCccccCCCcccccC--CccccccccccccCCCCCCCCCCCcccccccccCceEEcccceeee
Q 047196 473 GNLTSLRSPDLGSNRLTSVL--PSTFWNLKDILFFDLSSNSLDGPLSLDIGNLRVVIGINLSRNNFSG 538 (827)
Q Consensus 473 ~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~LdLs~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g 538 (827)
..+++|++|+|++|+|+..- +..+..+++|+.|||++|.++...+........|+.|++++|.++.
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD 129 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCc
Confidence 34555555555555555432 2334445555555555555543222222222334444555554443
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.22 E-value=5.5e-08 Score=90.35 Aligned_cols=86 Identities=17% Similarity=0.129 Sum_probs=39.1
Q ss_pred CCCceEeccCccccccccccccCCCCCcEEECCCCCCCCCC--CccccccccccEEecCCCcccccCCccccCCCCCCcc
Q 047196 404 SNLLLLDLEGNKLTGSIPVTFGRLQKLQGLYLPFNKLAGSI--PDQLCHLARLNTLGLAGNKFSGSIPSCLGNLTSLRSP 481 (827)
Q Consensus 404 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 481 (827)
..+..++..+|... .++..+..+++|++|+|++|+++..- +..+..+++|+.|+|++|+++..-+-.+.....|+.|
T Consensus 42 ~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L 120 (162)
T d1koha1 42 NIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEEL 120 (162)
T ss_dssp TCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSC
T ss_pred cchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhcccccee
Confidence 33344444443332 33334445666666666666665321 2233445555555555555542222122222344555
Q ss_pred ccCCCcccc
Q 047196 482 DLGSNRLTS 490 (827)
Q Consensus 482 ~Ls~N~l~~ 490 (827)
++++|.+..
T Consensus 121 ~L~~Npl~~ 129 (162)
T d1koha1 121 WLDGNSLSD 129 (162)
T ss_dssp CCTTSTTSS
T ss_pred ecCCCCcCc
Confidence 555555443
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.05 E-value=0.0001 Score=67.80 Aligned_cols=40 Identities=8% Similarity=-0.003 Sum_probs=19.9
Q ss_pred CCCCCCCcEEEccCCCCccc-------CCCcCcCCccccEEEccccc
Q 047196 215 LSKCKRLQLLNLGFKKLSGA-------IPKEISNLTILRKISLRNNK 254 (827)
Q Consensus 215 l~~l~~L~~L~L~~n~l~~~-------~p~~~~~l~~L~~L~Ls~N~ 254 (827)
+...+.|++|++++|.+... +...+..-+.|+.|+++.+.
T Consensus 96 L~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 96 TLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp TTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 44445566666665543311 22223334566666666554
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.79 E-value=0.00037 Score=63.94 Aligned_cols=65 Identities=22% Similarity=0.210 Sum_probs=32.4
Q ss_pred CCCCCcEEEccCC-CCccc----CCCcCcCCccccEEEccccccccc----ccccccCcCCCcEEEeecccCcc
Q 047196 217 KCKRLQLLNLGFK-KLSGA----IPKEISNLTILRKISLRNNKLRGE----IPHEIGYLPNLENLVLGFNNLVG 281 (827)
Q Consensus 217 ~l~~L~~L~L~~n-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~ 281 (827)
+.++|+.|+|+++ .++.. +-..+...+.|++|+|++|.+... +...+...+.|++|+|++|.++.
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~ 86 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP 86 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcch
Confidence 4466777777653 34321 122344445566666666665422 11223334556666666665543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.82 E-value=0.00055 Score=62.60 Aligned_cols=64 Identities=14% Similarity=0.177 Sum_probs=30.1
Q ss_pred cCCCCCcEEECCC-CCCCCC----CCccccccccccEEecCCCcccccC----CccccCCCCCCccccCCCcc
Q 047196 425 GRLQKLQGLYLPF-NKLAGS----IPDQLCHLARLNTLGLAGNKFSGSI----PSCLGNLTSLRSPDLGSNRL 488 (827)
Q Consensus 425 ~~l~~L~~L~Ls~-N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l 488 (827)
.+.++|+.|+|++ +.++.. +-..+...+.|+.|++++|.++... -..+...+.++.+++++|.+
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~ 86 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFI 86 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCC
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccc
Confidence 4556777777765 334321 1112334455666666666554321 11223334455555555444
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.77 E-value=0.0011 Score=60.56 Aligned_cols=18 Identities=17% Similarity=0.095 Sum_probs=10.3
Q ss_pred cCcCCccccEEEcccccc
Q 047196 238 EISNLTILRKISLRNNKL 255 (827)
Q Consensus 238 ~~~~l~~L~~L~Ls~N~l 255 (827)
.+...+.|+.|+++.+..
T Consensus 127 ~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 127 MLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHCSSCCEEECCCSSH
T ss_pred HHHhCCCcCEEeCcCCCC
Confidence 344556666666665543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=94.74 E-value=0.071 Score=51.57 Aligned_cols=76 Identities=16% Similarity=0.039 Sum_probs=44.4
Q ss_pred hHHHHHhhcccccceEecCCceEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcC-CCCceEEEeeeecCC
Q 047196 668 QDLFRATEKFSKENLIGVGSFGSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIR-HRNHVKRISSCSNED 744 (827)
Q Consensus 668 ~~~~~~~~~~~~~~~iG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~~~~~~~~~~ 744 (827)
.++.+..+.|...+..+-++-+.||+... ++..+.||+...........+.+|.+.++.+. +-.+-+++.++..++
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~ 83 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG 83 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCC
Confidence 34455555665444433344568998864 45567788876544333445788998888775 222334555555444
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=91.65 E-value=0.19 Score=48.09 Aligned_cols=59 Identities=8% Similarity=0.113 Sum_probs=37.2
Q ss_pred EecCCc-eEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCCCc--eEEEeeeecCC
Q 047196 683 IGVGSF-GSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHRNH--VKRISSCSNED 744 (827)
Q Consensus 683 iG~G~f-g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni--v~~~~~~~~~~ 744 (827)
+..|.. +.||+...++|..+.+|.-.... ...+.+|++.++.+....+ -+++.++.+++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~ 79 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAG 79 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSS
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeeccccc
Confidence 344543 67999988878788889765432 2246778888877754333 34555555544
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=86.44 E-value=0.73 Score=47.19 Aligned_cols=70 Identities=13% Similarity=0.096 Sum_probs=39.9
Q ss_pred ceEecCCceEEEEEEecC-CcEEEEEEEccc-------chHHHHHHHHHHHHHHhcC-C-C-CceEEEeeeecCCceeee
Q 047196 681 NLIGVGSFGSVYKGRLHD-GIEVAIKVFHQN-------CAMALKSFEAECEVMKNIR-H-R-NHVKRISSCSNEDFKALD 749 (827)
Q Consensus 681 ~~iG~G~fg~Vy~~~~~~-g~~vAvK~l~~~-------~~~~~~~~~~Ei~~l~~l~-H-~-niv~~~~~~~~~~~~~l~ 749 (827)
+.||.|....||+.+..+ |+.|.||.-... .+....+...|.+.++.+. + | .+.+.+.+..+.....++
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~~~~lvmE 111 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVME 111 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTTTEEEEC
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCCCCEEEEe
Confidence 458999999999998654 678999975321 1112234567888887663 2 2 234455544433333343
Q ss_pred e
Q 047196 750 C 750 (827)
Q Consensus 750 ~ 750 (827)
+
T Consensus 112 ~ 112 (392)
T d2pula1 112 D 112 (392)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=82.57 E-value=0.65 Score=46.16 Aligned_cols=42 Identities=12% Similarity=0.154 Sum_probs=31.6
Q ss_pred eEEEEEEecCCcEEEEEEEcccchHHHHHHHHHHHHHHhcCCC
Q 047196 689 GSVYKGRLHDGIEVAIKVFHQNCAMALKSFEAECEVMKNIRHR 731 (827)
Q Consensus 689 g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~Ei~~l~~l~H~ 731 (827)
-.||+.+.++|+.|++|+.+... ...+++..|.+.+..+...
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~ 77 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVND 77 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHT
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhc
Confidence 58999999999999999976432 2345677888888877643
|